PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Srinivasan, M; Asch, S; Vilendrer, S; Thomas, SC; Bajra, R; Barman, L; Edwards, LM; Filipowicz, H; Giang, L; Jee, O; Mahoney, M; Nelligan, I; Phadke, AJ; Torres, E; Artandi, M				Srinivasan, Malathi; Asch, Steven; Vilendrer, Stacie; Thomas, Samuel Crandall; Bajra, Rika; Barman, Linda; Edwards, Lauren Michelle; Filipowicz, Heather; Giang, Lena; Jee, Olivia; Mahoney, Megan; Nelligan, Ian; Phadke, Anuradha Jayant; Torres, Elise; Artandi, Maja			Qualitative Assessment of Rapid System Transformation to Primary Care Video Visits at an Academic Medical Center	ANNALS OF INTERNAL MEDICINE			English	Article								Background: The coronavirus disease 2019 pandemic spurred health systems across the world to quickly shift from in-person visits to safer video visits. Objective: To seek stakeholder perspectives on video visits' acceptability and effect 3 weeks after near-total transition to video visits. Design: Semistructured qualitative interviews. Setting: 6 Stanford general primary care and express care clinics at 6 northern California sites, with 81 providers, 123 staff, and 97 614 patient visits in 2019. Participants: 53 program participants (overlapping roles as medical providers [n = 20], medical assistants [n = 16], nurses [n = 4], technologists [n = 4], and administrators [n = 13]) were interviewed about video visit transition and challenges. Intervention: In 3 weeks, express care and primary care video visits increased from less than 10% to greater than 80% and from less than 10% to greater than 75%, respectively. New video visit providers received video visit training and care quality feedback. New system workflows were created to accommodate the new visit method. Measurements: 9 faculty, trained in qualitative research methods, conducted 53 stakeholder interviews in 4 days using purposeful (administrators and technologists) and convenience (medical assistant, nurses, and providers) sampling. A rapid qualitative analytic approach for thematic analysis was used. Results: The analysis revealed 12 themes, including Pandemic as Catalyst; Joy in Medicine; Safety in Medicine; Slipping Through the Cracks; My Role, Redefined; and The New Normal. Themes were analyzed using the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework to identify critical issues for continued program utilization. Limitations: Evaluation was done immediately after deployment. Although viewpoints may have evolved later, immediate evaluation allowed for prompt program changes and identified broader issues to address for program sustainability. Conclusion: After pandemic-related systems transformation at Stanford, critical issues to sustain video visit long-term viability were identified. Specifically, technology ease of use must improve and support multiparty videoconferencing. Providers should be able to care for their patients, regardless of geography. Providers need decision-making support with virtual examination training and home-based patient diagnostics. Finally, ongoing video visit reimbursement should be commensurate with value to the patients' health and well-being.	[Srinivasan, Malathi; Asch, Steven; Vilendrer, Stacie; Thomas, Samuel Crandall; Barman, Linda; Mahoney, Megan; Nelligan, Ian; Phadke, Anuradha Jayant; Artandi, Maja] Stanford Univ, Sch Med, 1265 Welch Rd,MC 5411,Med Sch Off Bldg, Palo Alto, CA 94305 USA; [Thomas, Samuel Crandall] Intermt Delivery Inst, Intermt Healthcare, Palo Alto, CA USA; [Bajra, Rika] Stanford Univ, Sch Med, Portola Valley, CA USA; [Edwards, Lauren Michelle; Jee, Olivia] Stanford Univ, Sch Med, Los Altos, CA USA; [Filipowicz, Heather; Giang, Lena] Stanford Hlth Care, Hoover Bldg,Suite 501,211 Quarry Rd, Palo Alto, CA 94304 USA; [Torres, Elise] Stanford Univ, Sch Med, Santa Clara, CA USA; [Vilendrer, Stacie; Thomas, Samuel Crandall; Barman, Linda; Artandi, Maja] Stanford Univ, Sch Med, Stanford Express Care, 211 Quarry Rd,Hoover Bldg,Suite 102, Palo Alto, CA 94304 USA; [Bajra, Rika] Stanford Univ, Sch Med, Stanford Primary Care Portola Valley, 3250 Alpine Rd, Portola Valley, CA 94028 USA; [Edwards, Lauren Michelle; Jee, Olivia] Stanford Univ, Sch Med, Stanford Primary Care Los Altos, 960 North San Antonio Rd,Suite 101, Los Altos, CA 94022 USA; [Phadke, Anuradha Jayant] Stanford Univ, Sch Med, Stanford Internal Med, Hoover Bldg,Suite 305,211 Quarry Rd,MC 5987, Palo Alto, CA 94304 USA; [Torres, Elise] Stanford Univ, Sch Med, Stanford Primary Care Santa Clara, 2518 Mission Coll Blvd,Suite 101, Santa Clara, CA 95054 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Srinivasan, M (corresponding author), Stanford Univ, Sch Med, 1265 Welch Rd,MC 5411,Med Sch Off Bldg, Palo Alto, CA 94305 USA.	malathis@stanford.edu		Artandi, Maja/0000-0003-2342-6277; Jee, Olivia/0000-0002-1255-7055; Edwards, Lauren/0000-0001-6766-765X; Mahoney, Megan/0000-0001-9166-9575; Giang, Lena/0000-0001-6678-3544; Srinivasan, Malathi/0000-0001-9951-0016; barman, linda/0000-0002-2619-761X	Stanford Department of Medicine and Stanford Health Care	Stanford Department of Medicine and Stanford Health Care	By the Stanford Department of Medicine and Stanford Health Care.	Adalja AA, 2020, JAMA-J AM MED ASSOC, V323, P1343, DOI 10.1001/jama.2020.3413; Artandi M, 2020, N ENGL J MED CATAL I, P1, DOI [10.1056/CAT.20.0100, DOI 10.1056/CAT.20.0100]; Asch DA, 2015, ANN INTERN MED, V163, P801, DOI 10.7326/M15-1416; Crabtree BF, 1992, DOING QUALITATIVE RE, V3; Daniel H, 2015, ANN INTERN MED, V163, P787, DOI 10.7326/M15-0498; DeJong C, 2015, JAMA-J AM MED ASSOC, V314, P2351, DOI 10.1001/jama.2015.13572; Drake C, 2019, ANN INTERN MED, V171, P382, DOI 10.7326/M19-0283; Duffy S, 2018, NEW ENGL J MED, V378, P104, DOI 10.1056/NEJMp1710735; Flannery D, 2018, HEALTH AFFAIR, V37, P2052, DOI 10.1377/hlthaff.2018.05151; Gale RC, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0853-y; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Health Resources and Services Administration, 2020, TEL PROGR; Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539; Jacob C, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/15935; Jacobson PD, 2000, TELEMED J E-HEALTH, V6, P429, DOI 10.1089/15305620050503915; Keesara S, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005835; Kwan BM, 2017, FAM SYST HEALTH, V35, P295, DOI 10.1037/fsh0000291; Lee MS, 2018, JAMA INTERN MED, V178, P782, DOI 10.1001/jamainternmed.2018.0738; Licurse AM, 2018, ANN INTERN MED, V168, P737, DOI 10.7326/M17-3070; Lurie N, 2018, JAMA INTERN MED, V178, P745, DOI 10.1001/jamainternmed.2018.1314; Matheny M, 2020, ARTIFICIAL INTELLIGE; McCloskey B, 2020, LANCET, V395, P1096, DOI 10.1016/S0140-6736(20)30681-4; Mehrotra A, 2020, NEJM CATAL INNOV CAR, P1, DOI [10.1056/CAT.20.0091, DOI 10.1056/CAT.20.0091]; Moore MA, 2016, AM FAM PHYSICIAN, V93, P101; Neil EJ, 2020, HLTHCARE IT NEWS; Redford G., 2020, DELIVERING MORE CARE; Reed ME, 2019, ANN INTERN MED, V171, P222, DOI 10.7326/M18-3081; Steinbrook R, 2014, JAMA-J AM MED ASSOC, V312, P695, DOI 10.1001/jama.2014.9809; Struminger BB, 2019, ANN INTERN MED, V171, P376, DOI 10.7326/M19-1200; Thiyagarajan Arun, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101020; Thomas SC, 2020, INTEGRATING TELEMEDI; U.S. Food and Drug Administration, 2020, FAQS TEST SARS COV 2; WHO, 2020, PUBL HLTH MASS GATH	33	41	41	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2020	173	7					527	+		10.7326/M20-1814	http://dx.doi.org/10.7326/M20-1814			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX4GS	32628536	Green Published			2022-12-28	WOS:000575671400008
J	Halpern, SD; Truog, RD; Miller, FG				Halpern, Scott D.; Truog, Robert D.; Miller, Franklin G.			Cognitive Bias and Public Health Policy During the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Halpern, Scott D.] Univ Penn, Palliat & Adv Illness Res PAIR Ctr, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Truog, Robert D.] Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA; [Truog, Robert D.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Miller, Franklin G.] Weill Cornell Med Coll, Dept Med, Div Med Eth, New York, NY USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Cornell University	Halpern, SD (corresponding author), Univ Penn, Perelman Sch Med, 423 Guardian Dr,301 Blockley Hall, Philadelphia, PA 19104 USA.	shalpern@upenn.edu						Centers for Medicare & Medicaid Services, 2019, NAT HLTH EXP HIST; Greenfield J., 2020, POLITICO; Halpern SD, 2020, ANN INTERN MED, DOI 10.7326/M20-2071; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Parodi S, 2020, NEJM CATAL, DOI [10.1056/CAT.20.0187, DOI 10.1056/CAT.20.0187]; Ritov I, 1999, ORGAN BEHAV HUM DEC, V79, P79, DOI 10.1006/obhd.1999.2839; Sen S, 2020, JAMA-J AM MED ASSOC, V323, P2522, DOI 10.1001/jama.2020.9176; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Weissman GE, 2020, ANN INTERN MED, V173, P21, DOI 10.7326/M20-1260	9	31	32	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					337	338		10.1001/jama.2020.11623	http://dx.doi.org/10.1001/jama.2020.11623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE8JP	32597963	Bronze			2022-12-28	WOS:000562851000018
J	Dyer, O				Dyer, Owen			Covid-19: Airborne transmission is being underestimated, warn experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Li Y, 2020, EVIDENCE PROBABLE AE, DOI [10.1101/2020.04.16.20067728v1, DOI 10.1101/2020.04.16.20067728V1]; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939	2	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2720	10.1136/bmj.m2720	http://dx.doi.org/10.1136/bmj.m2720			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636182	Bronze			2022-12-28	WOS:000548155700001
J	Torjesen, I				Torjesen, Ingrid			Government unveils roadmap for making UK a "science superpower"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department for Business Energy & Industrial Strategy, 2020, UK RES DEV ROADM; LIMB M, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4468; TORJESEN I, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M342	3	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2020	370								m2684	10.1136/bmj.m2684	http://dx.doi.org/10.1136/bmj.m2684			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5XW	32631852	Bronze			2022-12-28	WOS:000548163900010
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Normal service will be resumed-but not yet	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac						[Anonymous], 2020, EXPRESS STAR    0619	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2617	10.1136/bmj.m2617	http://dx.doi.org/10.1136/bmj.m2617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32605919	Bronze			2022-12-28	WOS:000548116400018
J	Wise, J				Wise, Jacqui			Covid-19: Delays in attending emergency departments may have contributed to deaths of nine children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lynn RM, 2021, ARCH DIS CHILD, V106, DOI 10.1136/archdischild-2020-319848	1	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2624	10.1136/bmj.m2624	http://dx.doi.org/10.1136/bmj.m2624			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32606039	Bronze			2022-12-28	WOS:000548116400007
J	Wise, J				Wise, Jacqui			Covid-19: Remdesivir is recommended for authorisation by European Medicines Agency	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; European Medicines Agency, 2020, TREATMENT COVID 19; KMIETOWICZ Z, 2020, BMJ-BRIT MED J, V369, P57029, DOI DOI 10.1136/BMJ.M2097	3	16	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2610	10.1136/bmj.m2610	http://dx.doi.org/10.1136/bmj.m2610			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601048	Bronze			2022-12-28	WOS:000548112700008
J	Rubin, R				Rubin, Rita			Government Not Doing All It Could to Recruit and Retain Scientists	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2452	2452		10.1001/jama.2020.10317	http://dx.doi.org/10.1001/jama.2020.10317			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2EU	32573655				2022-12-28	WOS:000595447000002
J	Shoag, JE; Nyame, YA; Gulati, R; Etzioni, R; Hu, JC				Shoag, Jonathan E.; Nyame, Yaw A.; Gulati, Roman; Etzioni, Ruth; Hu, Jim C.			Reconsidering the Trade-offs of Prostate Cancer Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PATIENT-REPORTED OUTCOMES; PSA TESTING RATES; ACTIVE SURVEILLANCE; PLCO TRIAL; MEN; BRACHYTHERAPY; ASSOCIATION; STRATEGIES; RADIATION; SURGERY	Shoag and colleagues review the long-term results of PSA screening from randomized trials and raise questions about whether the risk-benefit ratio is as strongly in favor of risk over benefit as currently gauged. The decline in PSA screening appears to have been precipitated in part by misinterpretations of data from randomized trials.	[Shoag, Jonathan E.; Hu, Jim C.] Weill Cornell Med, Dept Urol, New York, NY 10065 USA; [Nyame, Yaw A.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Nyame, Yaw A.; Gulati, Roman; Etzioni, Ruth] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA	Cornell University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Shoag, JE (corresponding author), Weill Cornell Med, Dept Urol, New York, NY 10065 USA.		Gulati, Roman/AAE-4298-2019	Gulati, Roman/0000-0002-7592-6567	Wallace Fund; Damon Runyon Cancer Research Foundation PhysicianScientist Training Award; Department of Defense [CDMRP W81XWH1910577]; National Institutes of Health [R50 CA221836, U01 CA199338]	Wallace Fund; Damon Runyon Cancer Research Foundation PhysicianScientist Training Award; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by grants from the Wallace Fund (to Drs. Shoag and Hu), a Damon Runyon Cancer Research Foundation PhysicianScientist Training Award (to Dr. Shoag), a grant from the Department of Defense (CDMRP W81XWH1910577, to Dr. Nyame), and grants from the National Institutes of Health (R50 CA221836, to Mr. Gulati, and U01 CA199338, to Dr. Etzioni).	Aronowitz R, 2019, NEW ENGL J MED, V381, P1093, DOI 10.1056/NEJMp1811521; Auvinen A, 2017, EUR J EPIDEMIOL, V32, P521, DOI 10.1007/s10654-017-0292-5; Barocas DA, 2017, JAMA-J AM MED ASSOC, V317, P1126, DOI 10.1001/jama.2017.1704; Chen RC, 2017, JAMA-J AM MED ASSOC, V317, P1141, DOI 10.1001/jama.2017.1652; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; Dalela D, 2019, EUR UROL FOCUS, V5, P77, DOI 10.1016/j.euf.2017.04.012; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Downing A, 2019, LANCET ONCOL, V20, P436, DOI 10.1016/S1470-2045(18)30780-0; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Hoffman KE, 2020, JAMA-J AM MED ASSOC, V323, P149, DOI 10.1001/jama.2019.20675; Hu JC, 2017, JAMA ONCOL, V3, P705, DOI 10.1001/jamaoncol.2016.5465; Hugosson J, 2019, EUR UROL, V76, P43, DOI 10.1016/j.eururo.2019.02.009; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Kasivisvanathan V, 2018, NEW ENGL J MED, V378, P1767, DOI 10.1056/NEJMoa1801993; Lee DJ, 2017, J UROLOGY, V198, P1231, DOI 10.1016/j.juro.2017.05.074; Li J, 2018, ANN EPIDEMIOL, V28, P328, DOI 10.1016/j.annepidem.2018.03.001; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Litwin MS, 2003, BJU INT, V91, P9, DOI 10.1046/j.1464-410X.2003.04010.x; Loeb S, 2018, JAMA-J AM MED ASSOC, V319, P2231, DOI 10.1001/jama.2018.5616; Loeb S, 2016, CURR OPIN UROL, V26, P459, DOI 10.1097/MOU.0000000000000316; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Pinsky PF, 2019, BJU INT, V123, P854, DOI 10.1111/bju.14580; Pinsky PF, 2017, CANCER-AM CANCER SOC, V123, P592, DOI 10.1002/cncr.30474; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroder FH, 2012, EUR UROL, V62, P745, DOI 10.1016/j.eururo.2012.05.068; Seibert TM, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5757; Shoag JE, 2016, NEW ENGL J MED, V375, P1500, DOI 10.1056/NEJMc1607379; Shoag JE, 2016, NEW ENGL J MED, V374, P1795, DOI 10.1056/NEJMc1515131; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Tsodikov A, 2017, ANN INTERN MED, V167, P449, DOI 10.7326/M16-2586; US Preventive Services Task Force, 2018, JAMA, V319, P1901, DOI 10.1001/jama.2018.3710; Welch HG, 2019, NEW ENGL J MED, V381, P1378, DOI 10.1056/NEJMsr1905447; Womble PR, 2015, EUR UROL, V67, P44, DOI 10.1016/j.eururo.2014.08.024	34	36	37	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2020	382	25					2465	2468		10.1056/NEJMsb2000250	http://dx.doi.org/10.1056/NEJMsb2000250			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9FX	32558473	Green Accepted			2022-12-28	WOS:000545644400016
J	Cheng, SY; Wang, CJ; Shen, ACT; Chang, SC				Cheng, Shao-Yi; Wang, C. Jason; Shen, April Chiung-Tao; Chang, Shan-Chwen			How to Safely Reopen Colleges and Universities During COVID-19: Experiences From Taiwan	ANNALS OF INTERNAL MEDICINE			English	Article								Reopening colleges and universities during the coronavirus disease 2019 (COVID-19) pandemic poses a special challenge worldwide. Taiwan is one of the few countries where schools are functioning normally. To secure the safety of students and staff, the Ministry of Education in Taiwan established general guidelines for college campuses. The guidelines delineated creation of a task force at each university; school-based risk screening based on travel history, occupation, contacts, and clusters; measures on self-management of health and quarantine; general hygiene measures (including wearing masks indoors); principles on ventilation and sanitization; regulations on school assemblies; a process for reporting suspected cases; and policies on school closing and make-up classes. It also announced that a class should be suspended if 1 student or staff member in it tested positive and that a school should be closed for 14 days if it had 2 or more confirmed cases. As of 18 June 2020, there have been 7 confirmed cases in 6 Taiwanese universities since the start of the pandemic. One university was temporarily closed, adopted virtual classes, and quickly reopened after 14 days of contact tracing and quarantine of possible contacts. Taiwan's experience suggests that, under certain circumstances, safely reopening colleges and universities this fall may be feasible with a combination of strategies that include containment (access control with contact tracing and quarantine) and mitigation (hygiene, sanitation, ventilation, and social distancing) practices.	[Cheng, Shao-Yi] Natl Taiwan Univ, Coll Med & Hosp, Hlth Ctr, Taipei, Taiwan; [Wang, C. Jason] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Shen, April Chiung-Tao] Natl Taiwan Univ, Coll Social Sci, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan; [Cheng, Shao-Yi; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med & Hosp, 7 Chung Shan S Rd Zhongshan S Rd, Taipei 100225, Taiwan	National Taiwan University; Stanford University; National Taiwan University; National Taiwan University	Chang, SC (corresponding author), Natl Taiwan Univ, 7 Chung Shan S Rd Zhongshan S Rd, Taipei 100225, Taiwan.; Chang, SC (corresponding author), Natl Taiwan Univ, Dept Internal Med, Coll Med & Hosp, 7 Chung Shan S Rd Zhongshan S Rd, Taipei 100225, Taiwan.	changsc@ntu.edu.tw	Cheng, Shao-yi/AAF-7100-2022; Cheng, Shao-Yi/AAF-4502-2022; Shen, April Chiung-Tao/M-1762-2018; Cheng, Shao-Yi/AFJ-1593-2022; Cheng, Shao-yi/AFK-0039-2022	Cheng, Shao-Yi/0000-0002-2224-4140; Shen, April Chiung-Tao/0000-0002-5865-9524; Cheng, Shao-Yi/0000-0002-2224-4140; 				[Anonymous], 2020, FOCUS TAIWAN    0418; Brady KD, 1999, BIOORGAN MED CHEM, V7, P621, DOI 10.1016/S0968-0896(99)00009-7; Department of Statistics Ministry of Education, 2019, OV INT STUD COLL U T; Lin C, 2020, EMERG INFECT DIS, V26, P1506, DOI 10.3201/eid2607.200574; Ministry of Education, 2020, GUID SEV SPEC INF PN; QS Top Universities, 2020, QS TOP U; Taiwan Centers for Disease Control, 2020, QUAR DES HOT SEN RES; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Wood G, 2020, THERES NO SIMPLE WAY	9	60	61	3	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2020	173	8					638	+		10.7326/M20-2927	http://dx.doi.org/10.7326/M20-2927			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OH7WZ	32614638	Green Published			2022-12-28	WOS:000582805500018
J	Deming, ME; Michael, NL; Robb, M; Cohen, MS; Neuzil, KM				Deming, Meagan E.; Michael, Nelson L.; Robb, Merlin; Cohen, Myron S.; Neuzil, Kathleen M.			Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Controlled human infection models have been proposed as a strategy for accelerating SARS-CoV-2 vaccine development. But scientific and technical factors make CHIMs unlikely to accelerate the establishment of vaccine efficacy.	[Deming, Meagan E.; Neuzil, Kathleen M.] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA; [Michael, Nelson L.] Walter Reed Army Inst Res, Ctr Infect Dis Res, Silver Spring, MD USA; [Robb, Merlin] Henry Jackson Fdn, Bethesda, MD USA; [Cohen, Myron S.] Univ N Carolina, Sch Med, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA	University System of Maryland; University of Maryland Baltimore; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Deming, ME (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA.		Deming, Meagan/AEX-6400-2022	Deming, Meagan/0000-0003-2574-0542	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Drs. Michael, Robb, Cohen, and Neuzil are members of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group, a publicprivate partnership sponsored by the National Institutes of Health; its other members are Paula Annunziato, M.D., Ann Arvin, M.D., Beth Bell, M.D., Susan Buchbinder, M.D., Marco Cavaleri, Ph.D., Lawrence Corey, M. D., Mark Davis, Ph.D., Emilio Emini, Ph.D., Gregory M. Glenn, M.D., Emmanuel Hanon, Ph.D., Barton Haynes, M.D., Peter Hotez, M.D., Ph.D., Kathrin Jansen, Ph.D. (cochair), Antonio Lanzavecchia, M.D., Douglas R. Lowy, M. D. (cochair), Peter Marks, M.D., Ph.D., John Mascola, M. D., Nancy Messonier, M.D., Nelson Michael, M.D., Ph.D., Paul Offit, M.D., Hanneke Schuitemaker, Ph.D., Jonathan Seals, Ph.D., Jim Tartaglia, Ph.D., and Tal Zaks, M.D., Ph.D.	BRADBURNE AF, 1967, BMJ-BRIT MED J, V3, P767, DOI 10.1136/bmj.3.5568.767; Eyal N, 2020, J INFECT DIS, V221, P1752, DOI 10.1093/infdis/jiaa152; Plotkin SA, 2020, VACCINE, V38, P3987, DOI 10.1016/j.vaccine.2020.04.039; Shah SK, 2020, SCIENCE, V368, P832, DOI 10.1126/science.abc1076; World Health Organization Advisory Group on Human Challenge Studies, 2020, FEAS POT VAL LIM EST	5	60	65	2	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2020	383	10							e63	10.1056/NEJMp2020076	http://dx.doi.org/10.1056/NEJMp2020076			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NO9YO	32610006	Bronze, Green Accepted			2022-12-28	WOS:000569841600002
J	Britton, T; Ball, F; Trapman, P				Britton, Tom; Ball, Frank; Trapman, Pieter			A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2	SCIENCE			English	Article								Despite various levels of preventive measures, in 2020, many countries have suffered severely from the coronavirus 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Using a model, we show that population heterogeneity can affect disease-induced immunity considerably because the proportion of infected individuals in groups with the highest contact rates is greater than that in groups with low contact rates. We estimate that if R-0 = 2.5 in an age-structured community with mixing rates fitted to social activity, then the disease-induced herd immunity level can be similar to 43%, which is substantially less than the classical herd immunity level of 60% obtained through homogeneous immunization of the population. Our estimates should be interpreted as an illustration of how population heterogeneity affects herd immunity rather than as an exact value or even a best estimate.	[Britton, Tom; Trapman, Pieter] Stockholm Univ, Dept Math, Stockholm, Sweden; [Ball, Frank] Univ Nottingham, Sch Math Sci, Nottingham, England	Stockholm University; University of Nottingham	Britton, T (corresponding author), Stockholm Univ, Dept Math, Stockholm, Sweden.	tom.britton@math.su.se		Britton, Tom/0000-0002-9228-7357	Swedish Research Council [2015-05015, 2016-04566]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	T.B. and P. T. acknowledge financial support from the Swedish Research Council (grant no. 2015-05015 to T.B. and grant no. 2016-04566 to P.T.).	ANDERSON R M, 1991; Andersson H, 2000, STOCHASTIC EPIDEMIC; Ball F, 2004, MATH BIOSCI, V191, P19, DOI 10.1016/j.mbs.2004.05.001; Ball F., 2020, ZENODO, DOI [10.5281/zenodo.3899252., DOI 10.1101/10.5281/ZENODO.3899252]; Bock W., 2020, MITIGATION HERD IMMU, DOI [10.1101/2020.03.25.20043109, DOI 10.1101/2020.03.25.20043109]; Broadhurst R, 2020, TRENDS ISS CRIME CRI, P1; Diekmann O., 2013, PRINCETON SERIES THE; Ethier S., 2009, MARKOV PROCESSES CHA; Ferguson NM, 2020, IMPACT NONPHARMACEUT; Ferrari MJ, 2006, P ROY SOC B-BIOL SCI, V273, P2743, DOI 10.1098/rspb.2006.3636; Flaxman S., 2020, REPORT 13 ESTIMATING, DOI 10.25561/77731; Gomes M Gabriela M, 2022, medRxiv, DOI 10.1101/2020.04.27.20081893; Instituto de Salud Carlos II, 2020, 2 ROUND NAT SER EP S; Instituto de Salud Carlos II, 2020, 2 ROUND NAT SER STUD; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Region Stockholm & Invest Stockholm, 2020, EST PEAK DAY NUMB IN; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317	18	303	310	11	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					846	+		10.1126/science.abc6810	http://dx.doi.org/10.1126/science.abc6810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA3RX	32576668	Green Published			2022-12-28	WOS:000559731300042
J	Chi, XY; Yan, RH; Zhang, J; Zhang, GY; Zhang, YY; Hao, M; Zhang, Z; Fan, PF; Dong, YZ; Yang, YL; Chen, ZS; Guo, YY; Zhang, JL; Li, YN; Song, XH; Chen, Y; Xia, L; Fu, L; Hou, LH; Xu, JJ; Yu, CM; Li, JM; Zhou, Q; Chen, W				Chi, Xiangyang; Yan, Renhong; Zhang, Jun; Zhang, Guanying; Zhang, Yuanyuan; Hao, Meng; Zhang, Zhe; Fan, Pengfei; Dong, Yunzhu; Yang, Yilong; Chen, Zhengshan; Guo, Yingying; Zhang, Jinlong; Li, Yaning; Song, Xiaohong; Chen, Yi; Xia, Lu; Fu, Ling; Hou, Lihua; Xu, Junjie; Yu, Changming; Li, Jianmin; Zhou, Qiang; Chen, Wei			A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2	SCIENCE			English	Article							CRYO-EM STRUCTURE; FUNCTIONAL RECEPTOR; CORONAVIRUS; ENTRY; ACE2; PHYLOGENIES; ACTIVATION; PNEUMONIA; VACCINES; FEATURES	Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding domain (RBD) of the Spike (S) protein but also across the full Spike (S) protein. We isolated and characterized monoclonal antibodies (mAbs) from 10 convalescent COVID-19 patients. Three mAbs showed neutralizing activities against authentic SARS-CoV-2. One mAb, named 4A8, exhibits high neutralization potency against both authentic and pseudotyped SARS-CoV-2 but does not bind the RBD. We defined the epitope of 4A8 as the N-terminal domain (NTD) of the S protein by determining with cryo-eletron microscopy its structure in complex with the S protein to an overall resolution of 3.1 angstroms and local resolution of 3.3 angstroms for the 4A8-NTD interface. This points to the NTD as a promising target for therapeutic mAbs against COVID-19.	[Chi, Xiangyang; Zhang, Jun; Zhang, Guanying; Hao, Meng; Zhang, Zhe; Fan, Pengfei; Dong, Yunzhu; Yang, Yilong; Chen, Zhengshan; Zhang, Jinlong; Song, Xiaohong; Chen, Yi; Fu, Ling; Hou, Lihua; Xu, Junjie; Yu, Changming; Li, Jianmin; Chen, Wei] Acad Mil Med Sci AMMS, Beijing Inst Biotechnol, Beijing 100071, Peoples R China; [Yan, Renhong; Zhang, Yuanyuan; Guo, Yingying; Xia, Lu; Zhou, Qiang] Westlake Univ, Sch Life Sci, Westlake Inst Adv Study, Inst Biol,Key Lab Struct Biol Zhejiang Prov, Hangzhou 310024, Zhejiang, Peoples R China; [Li, Yaning] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China	Westlake University; Tsinghua University	Li, JM; Chen, W (corresponding author), Acad Mil Med Sci AMMS, Beijing Inst Biotechnol, Beijing 100071, Peoples R China.; Zhou, Q (corresponding author), Westlake Univ, Sch Life Sci, Westlake Inst Adv Study, Inst Biol,Key Lab Struct Biol Zhejiang Prov, Hangzhou 310024, Zhejiang, Peoples R China.	lijmqz@126.com; zhouqiang@westlake.edu.cn; cw0226@foxmail.com	Li, Jin/GYQ-5363-2022; li, jian/GSE-0245-2022; Li, Jing/GYU-5036-2022; LI, JIAN/GRY-2197-2022	Fan, Pengfei/0000-0002-7212-231X; ZHANG, JUN/0000-0002-9650-112X; , Chi/0000-0002-0580-5997; Zhang, Yuanyuan/0000-0002-2500-0010; Zhang, Guanying/0000-0003-3372-3355; Yang, Yilong/0000-0003-3412-0425; Yan, Renhong/0000-0002-7122-6547	National Key R&D Program of China [2020YFC0841400]; National Natural Science Foundation of China [31971123, 81803429, 81703048, 31900671, 81920108015, 31930059]; Key R&D Program of Zhejiang Province [2020C04001]; SARS-CoV-2 emergency project of the Science and Technology Department of Zhejiang Province [2020C03129]; Leading Innovative and Entrepreneur Team Introduction Program of Hangzhou; National Science and Technology Major Project of the Ministry of Science and Technology of China [2018ZX10101003-005-007]; Special Research Program of Novel Coronavirus Pneumonia of Westlake University	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key R&D Program of Zhejiang Province; SARS-CoV-2 emergency project of the Science and Technology Department of Zhejiang Province; Leading Innovative and Entrepreneur Team Introduction Program of Hangzhou; National Science and Technology Major Project of the Ministry of Science and Technology of China; Special Research Program of Novel Coronavirus Pneumonia of Westlake University	This work was funded by the National Key R&D Program of China (2020YFC0841400), the National Natural Science Foundation of China (projects 31971123, 81803429, 81703048, 31900671, 81920108015, and 31930059), the Key R&D Program of Zhejiang Province (2020C04001), the SARS-CoV-2 emergency project of the Science and Technology Department of Zhejiang Province (2020C03129), the Leading Innovative and Entrepreneur Team Introduction Program of Hangzhou, the National Science and Technology Major Project of the Ministry of Science and Technology of China, (2018ZX10101003-005-007), and the Special Research Program of Novel Coronavirus Pneumonia of Westlake University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Burkovitz A, 2014, FEBS J, V281, P306, DOI 10.1111/febs.12597; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Dimitrov DS, 2003, CELL, V115, P652, DOI 10.1016/S0092-8674(03)00976-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Giudicelli V., 2011, COLD SPRING HARB PRO, V2011, P695, DOI DOI 10.1101/PDB.PR0T5633; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Ju B., 2020, BIORXIV, DOI [10.1101/2020.03.21.990770, 10.1101/ 2020.03.21.990770, DOI 10.1101/2020.03.21.990770]; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Krempl C, 1997, J VIROL, V71, P3285, DOI 10.1128/JVI.71.4.3285-3287.1997; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuhn JH, 2004, CELL MOL LIFE SCI, V61, P2738, DOI 10.1007/s00018-004-4242-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KUNKEL F, 1993, VIROLOGY, V195, P195, DOI 10.1006/viro.1993.1360; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Li QQ, 2017, VACCINE, V35, P5172, DOI 10.1016/j.vaccine.2017.07.101; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003; PRICE CG, 1994, ENVIRON GEOCHEM HLTH, V16, P27, DOI 10.1007/BF00149590; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15001-9; Wang L, 2018, J VIROL, V92, DOI 10.1128/JVI.01060-18; Wang LS, 2018, J VIROL, V92, DOI 10.1128/JVI.02002-17; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; Wrapp D, 2020, CELL, V181, P1004, DOI 10.1016/j.cell.2020.04.031; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Xu JY, 2019, EMERG MICROBES INFEC, V8, P841, DOI 10.1080/22221751.2019.1624482; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou HX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10897-4; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	67	729	756	20	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					650	+		10.1126/science.abc6952	http://dx.doi.org/10.1126/science.abc6952			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32571838	Green Published, Green Submitted			2022-12-28	WOS:000559184400038
J	O'Callaghan, KP; Blatz, AM; Offit, PA				O'Callaghan, Kevin P.; Blatz, Allison M.; Offit, Paul A.			Developing a SARS-CoV-2 Vaccine at Warp Speed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the mechanisms of the 5 leading COVID-19 vaccine candidates-2 messenger RNA vaccines, 1 recombinant VSV vector product, and 2 replication-defective adenovirus vector approaches-and emphasizes the need to demonstrate safety as well as efficacy to facilitate broad uptake by the public.	[O'Callaghan, Kevin P.; Blatz, Allison M.; Offit, Paul A.] Childrens Hosp Philadelphia, Div Infect Dis, 34th St & Civ Ctr Blvd,Abramson Res Bldg, Philadelphia, PA 19104 USA; [Offit, Paul A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Offit, PA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, 34th St & Civ Ctr Blvd,Abramson Res Bldg, Philadelphia, PA 19104 USA.	offit@email.chop.edu		Blatz, Allison/0000-0003-2525-1212				Cohen J., 2020, SCIENCE, V2020; Cutler D, 2020, JAMA-J AM MED ASSOC, V323, P2237, DOI 10.1001/jama.2020.7308; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Johnson & Johnson, 2020, JOHNS JOHNS ANN ACC; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; US Department of Health and Human Services,, 2020, FACT SHEET EXPL OP W; Weiland N, NY TIMES	7	49	49	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					437	438		10.1001/jama.2020.12190	http://dx.doi.org/10.1001/jama.2020.12190			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32628244	Bronze			2022-12-28	WOS:000561261900006
J	Carel, H; Ratcliffe, M; Froese, T				Carel, Havi; Ratcliffe, Matthew; Froese, Tom			The art of medicine Reflecting on experiences of social distancing	LANCET			English	Editorial Material									[Carel, Havi] Univ Bristol, Dept Philosophy, Bristol, Avon, England; [Ratcliffe, Matthew] Univ York, Dept Philosophy, York, N Yorkshire, England; [Froese, Tom] Grad Univ, Okinawa Inst Sci & Technol, Embodied Cognit Sci Unit, Onna Son, Japan	University of Bristol; University of York - UK; Okinawa Institute of Science & Technology Graduate University	Carel, H (corresponding author), Univ Bristol, Dept Philosophy, Bristol, Avon, England.	havi.carel@bristol.ac.uk	Froese, Tom/B-3301-2012	Froese, Tom/0000-0002-9899-5274; Carel, Havi/0000-0002-1260-2362					0	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2020	396	10244					87	88		10.1016/S0140-6736(20)31485-9	http://dx.doi.org/10.1016/S0140-6736(20)31485-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2JY	32619416	Green Published, Bronze			2022-12-28	WOS:000552724600011
J	Theodore, N				Theodore, Nicholas			Degenerative Cervical Spondylosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTERVERTEBRAL DISC DEGENERATION; COMPUTED-TOMOGRAPHY; PROVOCATIVE TESTS; NATURAL-HISTORY; MYELOPATHY; MANAGEMENT; DIAGNOSIS; RADICULOPATHY; DISORDERS; DISEASE	Degeneration of the elements of the cervical spine, which is almost inevitable with age, results in nerve-root and spinal cord compression and pain. Physical tests and imaging aid in determining the source of disability. Surgical and conservative treatments are available.	[Theodore, Nicholas] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Theodore, N (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,Meyer 7-113, Baltimore, MD 21287 USA.	theodore@jhmi.edu		Theodore, Nicholas/0000-0001-5355-2683				[Anonymous], 2013, SPINE, V38, pE1115; [Anonymous], 2013, PEDIAT DENT, V35, pE157; Bakhsheshian J, 2017, GLOB SPINE J, V7, P572, DOI 10.1177/2192568217699208; Benoist M, 2003, EUR SPINE J, V12, pS86, DOI 10.1007/s00586-003-0593-0; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Binch ALA, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0889-6; Binder AI, 2007, BMJ-BRIT MED J, V334, P527, DOI 10.1136/bmj.39127.608299.80; Bono CM, 2011, SPINE J, V11, P64, DOI 10.1016/j.spinee.2010.10.023; Brinjikji W, 2015, AM J NEURORADIOL, V36, P811, DOI 10.3174/ajnr.A4173; Buell TJ, 2018, NEUROSURG CLIN N AM, V29, P69, DOI 10.1016/j.nec.2017.09.004; Callaghan BC, 2016, JAMA-J AM MED ASSOC, V315, P297, DOI 10.1001/jama.2015.16832; Childress MA, 2016, AM FAM PHYSICIAN, V93, P746; Cohen SP, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3221; Cuellar JM, 2017, BULL HOSP JT DIS, V75, P21; Emery S E, 2001, J Am Acad Orthop Surg, V9, P376; Fehlings MG, 2017, GLOB SPINE J, V7, p70S, DOI 10.1177/2192568217701914; Fehlings MG, 2013, SPINE, V38, pS19, DOI 10.1097/BRS.0b013e3182a7f4de; Feng CC, 2016, CELL CYCLE, V15, P1674, DOI 10.1080/15384101.2016.1152433; Feng Y, 2016, GENES DIS, V3, P178, DOI 10.1016/j.gendis.2016.04.005; Ferrara LA, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/493605; Fritz JM, 2014, J ORTHOP SPORT PHYS, V44, P45, DOI 10.2519/jospt.2014.5065; Garcia-Cosamalon J, 2010, J ANAT, V217, P1, DOI 10.1111/j.1469-7580.2010.01227.x; Ghasemi M, 2013, J RES MED SCI, V18, pS35; Green C, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/908324; Grunhagen T, 2011, ORTHOP CLIN N AM, V42, P465, DOI 10.1016/j.ocl.2011.07.010; Gutman G, 2018, SPINE, V43, pE365, DOI 10.1097/BRS.0000000000002324; Haseeb A, 2013, CLIN IMMUNOL, V146, P185, DOI 10.1016/j.clim.2012.12.011; Hurwitz EL, 2018, EUR SPINE J, V27, P796, DOI 10.1007/s00586-017-5432-9; Inami S, 2001, J ORTHOPAED RES, V19, P593, DOI 10.1016/S0736-0266(00)00048-6; Kadow T, 2015, CLIN ORTHOP RELAT R, V473, P1903, DOI 10.1007/s11999-014-3774-8; Karadimas SK, 2013, SPINE, V38, pS21, DOI 10.1097/BRS.0b013e3182a7f2c3; Kavanagh RG, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/794087; Kelly JC, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/393642; Kjaer P, 2017, EUR SPINE J, V26, P2242, DOI 10.1007/s00586-017-5121-8; Liu SA, 2015, J NEUROSURG-SPINE, V23, P690, DOI 10.3171/2015.2.SPINE14414; Lv YW, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2234-0; Manchikanti L, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-15; Nerlich AG, 2007, EUR SPINE J, V16, P547, DOI 10.1007/s00586-006-0213-x; Nouri A, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.3.FOCUS1667; O'Neill S, 2007, EUR J PAIN, V11, P415, DOI 10.1016/j.ejpain.2006.05.009; Pawar S, 2013, J CLIN DIAGN RES, V7, P2680, DOI 10.7860/JCDR/2013/7545.3731; Perolat R, 2018, INSIGHTS IMAGING, V9, P773, DOI 10.1007/s13244-018-0638-x; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; Rao Raj D, 2008, Instr Course Lect, V57, P447; Ravindra VM, 2016, WORLD NEUROSURG, V96, P390, DOI 10.1016/j.wneu.2016.09.012; Risbud MV, 2010, AM J PATHOL, V176, P1577, DOI 10.2353/ajpath.2010.090734; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Rubinstein SM, 2007, EUR SPINE J, V16, P307, DOI 10.1007/s00586-006-0225-6; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Semenza GL, 2007, SCI STKE, V2007, pcm8, DOI [10.1126/stke.4072007cm8, DOI 10.1126/STKE.4072007CM8]; Shafaie FF, 1999, SPINE, V24, P1781, DOI 10.1097/00007632-199909010-00006; Song KJ, 2009, J SPINAL DISORD TECH, V22, P353, DOI 10.1097/BSD.0b013e31817df78e; Stoffman MR, 2005, NEUROSURGERY, V57, P307, DOI 10.1227/01.NEU.0000166664.19662.43; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Tetreault L, 2018, NEUROSURG CLIN N AM, V29, P115, DOI 10.1016/j.nec.2017.09.020; Tetreault L, 2017, SPINE, V42, P372, DOI 10.1097/BRS.0000000000001777; Theodore N, 2019, SPINE, V44, pE640, DOI 10.1097/BRS.0000000000002949; van der Werf M, 2007, J ANAT, V211, P769, DOI 10.1111/j.1469-7580.2007.00816.x; Voorhies R M, 2001, Ochsner J, V3, P78; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zaidi HA, 2014, ENCY NEUROLOGICAL SC, P1009	62	43	48	8	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					159	168		10.1056/NEJMra2003558	http://dx.doi.org/10.1056/NEJMra2003558			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9PO	32640134				2022-12-28	WOS:000571894800015
J	Lane, R				Lane, Richard			Salome Maswime: dynamic leader in global surgery	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					17	17						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32622386	Green Published, Bronze			2022-12-28	WOS:000561626100007
J	Fortea, J; Vilaplana, E; Carmona-Iragui, M; Benejam, B; Videla, L; Barroeta, I; Fernandez, S; Altuna, M; Pegueroles, J; Montal, V; Valldeneu, S; Gimenez, S; Gonzalez-Ortiz, S; Munoz, L; Estelles, T; Illan-Gala, I; Belbin, O; Camacho, V; Wilson, LR; Annus, T; Osorio, RS; Videla, S; Lehmann, S; Holland, AJ; Alcolea, D; Clarimon, J; Zaman, SH; Blesa, R; Lleo, A				Fortea, Juan; Vilaplana, Eduard; Carmona-Iragui, Maria; Benejam, Bessy; Videla, Laura; Barroeta, Isabel; Fernandez, Susana; Altuna, Miren; Pegueroles, Jordi; Montal, Victor; Valldeneu, Silvia; Gimenez, Sandra; Gonzalez-Ortiz, Sofia; Munoz, Laia; Estelles, Teresa; Illan-Gala, Ignacio; Belbin, Olivia; Camacho, Valle; Wilson, Liam Reese; Annus, Tiina; Osorio, Ricardo S.; Videla, Sebastian; Lehmann, Sylvain; Holland, Anthony J.; Alcolea, Daniel; Clarimon, Jordi; Zaman, Shahid H.; Blesa, Rafael; Lleo, Alberto			Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study	LANCET			English	Article							YOUNG-ADULTS; DEMENTIA; CHILDREN; FLUID; AGE	Background Alzheimer's disease and its complications are the leading cause of death in adults with Down syndrome. Studies have assessed Alzheimer's disease in individuals with Down syndrome, but the natural history of biomarker changes in Down syndrome has not been established. We characterised the order and timing of changes in biomarkers of Alzheimer's disease in a population of adults with Down syndrome. Methods We did a dual-centre cross-sectional study of adults with Down syndrome recruited through a population-based health plan in Barcelona (Spain) and through services for people with intellectual disabilities in Cambridge (UK). Cognitive impairment in participants with Down syndrome was classified with the Cambridge Cognitive Examination for Older Adults with Down Syndrome (CAMCOG-DS). Only participants with mild or moderate disability were included who had at least one of the following Alzheimer's disease measures: apolipoprotein E allele carrier status; plasma concentrations of amyloid beta peptides 1-42 and 1-40 and their ratio (A beta(1-42/1-40)), total tau protein, and neurofilament light chain (NFL); tau phosphorylated at threonine 181 (p-tau), and NFL in cerebrospinal fluid (CSF); and one or more of PET with F-18-fluorodeoxyglucose, PET with amyloid tracers, and MRI. Cognitively healthy euploid controls aged up to 75 years who had no biomarker abnormalities were recruited from the Sant Pau Initiative on Neurodegeneration. We used a first-order locally estimated scatterplot smoothing curve to determine the order and age at onset of the biomarker changes, and the lowest ages at the divergence with 95% CIs are also reported where appropriate. Findings Between Feb 1, 2013, and June 28, 2019 (Barcelona), and between June 1, 2009, and Dec 31, 2014 (Cambridge), we included 388 participants with Down syndrome (257 [66%] asymptomatic, 48 [12%] with prodromal Alzheimer's disease, and 83 [21%] with Alzheimer's disease dementia) and 242 euploid controls. CSF A beta 1-42/1-40 and plasma NFL values changed in individuals with Down syndrome as early as the third decade of life, and amyloid PET uptake changed in the fourth decade. (1)8F-fluorodeoxyglucose PET and CSF p-tau changes occurred later in the fourth decade of life, followed by hippocampal atrophy and changes in cognition in the fifth decade of life. Prodromal Alzheimer's disease was diagnosed at a median age of 50.2 years (IQR 47.5-54.1), and Alzheimer's disease dementia at 53.7 years (49.5-57.2). Symptomatic Alzheimer's disease prevalence increased with age in individuals with Down syndrome, reaching 90-100% in the seventh decade of life. Interpretation Alzheimer's disease in individuals with Down syndrome has a long preclinical phase in which biomarkers follow a predictable order of changes over more than two decades. The similarities with sporadic and autosomal dominant Alzheimer's disease and the prevalence of Down syndrome make this population a suitable target for Alzheimer's disease preventive treatments. Funding Instituto de Salud Carlos III, Fundacio Bancaria La Caixa, Fundacio La Marato de TV3, Medical Research Council, and National Institutes of Health. Copyright (c) 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.	[Fortea, Juan; Carmona-Iragui, Maria; Benejam, Bessy; Videla, Laura; Fernandez, Susana] Fundacio Catalana Sindrome Down, Barcelona Down Med Ctr, Barcelona, Spain; [Fortea, Juan; Vilaplana, Eduard; Carmona-Iragui, Maria; Benejam, Bessy; Videla, Laura; Barroeta, Isabel; Altuna, Miren; Pegueroles, Jordi; Montal, Victor; Valldeneu, Silvia; Munoz, Laia; Estelles, Teresa; Illan-Gala, Ignacio; Belbin, Olivia; Alcolea, Daniel; Clarimon, Jordi; Blesa, Rafael; Lleo, Alberto] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Biomed Res Inst St Pau, St Pau Memory Unit,Dept Neurol, Barcelona, Spain; [Fortea, Juan; Vilaplana, Eduard; Carmona-Iragui, Maria; Benejam, Bessy; Videla, Laura; Barroeta, Isabel; Altuna, Miren; Pegueroles, Jordi; Montal, Victor; Valldeneu, Silvia; Munoz, Laia; Estelles, Teresa; Illan-Gala, Ignacio; Belbin, Olivia; Alcolea, Daniel; Clarimon, Jordi; Blesa, Rafael; Lleo, Alberto] Ctr Biomed Invest Network Neurodegenerat Dis, Madrid, Spain; [Gimenez, Sandra] Hosp Santa Creu & Sant Pau, Resp Dept, Multidisciplinary Sleep Unit, Barcelona, Spain; [Camacho, Valle] Hosp Santa Creu & Sant Pau, Nucl Med Dept, Barcelona, Spain; [Gonzalez-Ortiz, Sofia] Hosp del Mar, Parc Salut, Barcelona, Spain; [Wilson, Liam Reese; Annus, Tiina; Holland, Anthony J.; Zaman, Shahid H.] Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Douglas House, Cambridge, England; [Osorio, Ricardo S.] New York Univ Langone Hlth, Dept Psychiat, Ctr Sleep & Brain Hlth, New York, NY USA; [Videla, Sebastian] Univ Barcelona, Dept Clin Pharmacol, Bellvitge Biomed Res Inst, Clin Res Support Unit, Barcelona, Spain; [Lehmann, Sylvain] Univ Montpellier, CHU Montpellier, INSERM, Inst Regenerat Med & Biotherapy,LBPC PPC, Montpellier, France; [Zaman, Shahid H.] Fulbourn Hosp, Cambridgeshire & Peterborough NHS Fdn Trust, Elizabeth House, Cambridge, England	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Cambridge; New York University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Fortea, J (corresponding author), Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona 08025, Spain.	jfortea@santpau.cat	Fortea, Juan/AFU-3179-2022; Camacho, Valle/AAP-3259-2020; González-Ortiz, Sofía/AGH-5444-2022; Lehmann, Sylvain/P-1301-2017	Fortea, Juan/0000-0002-1340-638X; Camacho, Valle/0000-0003-0748-0847; ALTUNA-AZKARGORTA, MIREN/0000-0001-9709-5314; Gimenez, Sandra/0000-0001-8031-2319; Illan-Gala, Ignacio/0000-0002-5418-2052; Lehmann, Sylvain/0000-0001-6117-562X; Montal, Victor/0000-0002-5714-9282; Belbin, Olivia/0000-0002-6109-6371; Alcolea, Daniel/0000-0002-3819-3245; Carmona Iragui, Maria/0000-0001-6914-2339	Fondo de Investigaciones Sanitario, Instituto de Salud Carlos III - EU European Regional Development Fund; CIBERNED programme - EU European Regional Development Fund; National Institutes of Health; Departament de Salut de la Generalitat de Catalunya; Pla Estrate`gic de Recerca i Innovacio en Salut; Fundacio La Marato de TV3; Rio Hortega grant from Accion Estrategica en Salud 2013-2016; Global Brain Health Institute; Fundacio Catalana Sindrome de Down; Fundacio Victor Grifols i Lucas; Jerome Lejeune Foundation; Generalitat de Catalunya; Fundacio Bancaria La Caixa; Medical Research Council; National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; NIHR Collaborations in Leadership for Applied Health Research and Care (CLAHRC) for the East of England; NIHR Cambridge Dementia Biomedical Research Unit; Down Syndrome Association; Health Foundation; NIHR CLAHRC East of England at Cambridgeshire and Peterborough National Health Service Foundation Trust; MRC [G1002252] Funding Source: UKRI	Fondo de Investigaciones Sanitario, Instituto de Salud Carlos III - EU European Regional Development Fund; CIBERNED programme - EU European Regional Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Departament de Salut de la Generalitat de Catalunya(Generalitat de Catalunya); Pla Estrate`gic de Recerca i Innovacio en Salut; Fundacio La Marato de TV3; Rio Hortega grant from Accion Estrategica en Salud 2013-2016; Global Brain Health Institute; Fundacio Catalana Sindrome de Down; Fundacio Victor Grifols i Lucas; Jerome Lejeune Foundation; Generalitat de Catalunya(Generalitat de Catalunya); Fundacio Bancaria La Caixa(La Caixa Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Collaborations in Leadership for Applied Health Research and Care (CLAHRC) for the East of England; NIHR Cambridge Dementia Biomedical Research Unit; Down Syndrome Association; Health Foundation; NIHR CLAHRC East of England at Cambridgeshire and Peterborough National Health Service Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Fondo de Investigaciones Sanitario, Instituto de Salud Carlos III, and the CIBERNED programme, partly jointly funded by the EU European Regional Development Fund. This work was also supported by the National Institutes of Health, Departament de Salut de la Generalitat de Catalunya, Pla Estrate`gic de Recerca i Innovacio en Salut, and Fundacio La Marato de TV3. I. II-G is supported by the Rio Hortega grant from Accion Estrategica en Salud 2013-2016, and the Global Brain Health Institute. Fundacio Catalana Sindrome de Down, Fundacio Victor Grifols i Lucas, and the Jerome Lejeune Foundation also partly supported this work. Finally, this work was supported by Generalitat de Catalunya and a grant from the Fundacio Bancaria La Caixa to RB. We thank all the participants with Down's syndrome, their families, and their carers for their support of, and dedication to, this research. We also acknowledge the Fundacio Catalana Sindrome de Down for global support; Soraya Torres and Raul Nunez for laboratory and sample handling; Reyes Alcoverro, Marta Salinas, and Tania Martinez for administrative support; and Concepcion Escola and Diana Garzon for nursing handling. We also thank the PET imaging technologist, radiographers, technicians, and radiochemists at the Wolfson Brain Imaging Centre, as well as the clinicians for their help in acquiring the data reported in this Article. We are grateful to the Medical Research Council for generously providing a grant to support this research. Additional support came from the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre, the NIHR Collaborations in Leadership for Applied Health Research and Care (CLAHRC) for the East of England, the NIHR Cambridge Dementia Biomedical Research Unit, the Down Syndrome Association, and the Health Foundation. AJH was supported during the preparation of this manuscript by the NIHR CLAHRC East of England at Cambridgeshire and Peterborough National Health Service Foundation Trust. The manuscript describes independent research, and the views expressed are those of the authors and not necessarily those of the funders. The sponsors of the study did not take part in the design and conduct of the study; collection, management, analysis and interpretation of the data; writing and review of the report; or the decision to submit the article for publication.	Abrahamson EE, 2019, DEV NEUROBIOL, V79, P750, DOI 10.1002/dneu.22713; Alcolea D, 2019, ALZH DEMENT-TRCI, V5, P597, DOI 10.1016/j.trci.2019.09.005; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Annus T, 2016, ALZHEIMERS DEMENT, V12, P538, DOI 10.1016/j.jalz.2015.07.490; Ballard C, 2016, LANCET NEUROL, V15, P622, DOI 10.1016/S1474-4422(16)00063-6; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; Carmona-Iragui M, 2017, ALZHEIMERS DEMENT, V13, P1251, DOI 10.1016/j.jalz.2017.03.007; Devenny DA, 1996, J INTELL DISABIL RES, V40, P208, DOI 10.1046/j.1365-2788.1996.761761.x; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Englund H, 2007, DEMENT GERIATR COGN, V24, P369, DOI 10.1159/000109215; Esteba-Castillo S, 2013, REV NEUROLOGIA, V57, P337, DOI 10.33588/rn.5708.2013259; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fleisher AS, 2015, JAMA NEUROL, V72, P316, DOI 10.1001/jamaneurol.2014.3314; Fortea J, 2018, LANCET NEUROL, V17, P860, DOI 10.1016/S1474-4422(18)30285-0; Grosse E., 1992, STAT MODELS S; Handen BL, 2012, ALZHEIMERS DEMENT, V8, P496, DOI 10.1016/j.jalz.2011.09.229; Hithersay R, 2019, JAMA NEUROL, V76, P152, DOI 10.1001/jamaneurol.2018.3616; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Klunk WE, 2015, ALZHEIMERS DEMENT, V11, P1, DOI 10.1016/j.jalz.2014.07.003; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Lao PJ, 2016, ALZHEIMERS DEMENT, V12, P380, DOI 10.1016/j.jalz.2015.05.013; Lott IT, 2019, NAT REV NEUROL, V15, P135, DOI 10.1038/s41582-018-0132-6; McCarron M, 2017, J INTELL DISABIL RES, V61, P843, DOI 10.1111/jir.12390; Neale N, 2018, NEUROIMAGE-CLIN, V17, P263, DOI 10.1016/j.nicl.2017.10.022; Pinter JD, 2001, NEUROLOGY, V56, P972, DOI 10.1212/WNL.56.7.972; Rafii MS, 2015, FRONT BEHAV NEUROSCI, V9, P1; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Ryman DC, 2014, NEUROLOGY, V83, P253, DOI 10.1212/WNL.0000000000000596; Sinai A, 2018, J ALZHEIMERS DIS, V61, P717, DOI 10.3233/JAD-170624; Strydom Andre, 2018, Alzheimers Dement (N Y), V4, P703, DOI 10.1016/j.trci.2018.10.006; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310	35	90	91	10	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2020	395	10242					1988	1997						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ0ZZ	32593336	Green Published, hybrid			2022-12-28	WOS:000547825600016
J	Gizon, L; Cameron, RH; Pourabdian, M; Liang, ZC; Fournier, D; Birch, AC; Hanson, CS				Gizon, Laurent; Cameron, Robert H.; Pourabdian, Majid; Liang, Zhi-Chao; Fournier, Damien; Birch, Aaron C.; Hanson, Chris S.			Meridional flow in the Sun's convection zone is a single cell in each hemisphere	SCIENCE			English	Article							OSCILLATION-NETWORK-GROUP; SOLAR; IMAGER; ROTATION	The Sun's magnetic field is generated by subsurface motions of the convecting plasma. The latitude at which the magnetic field emerges through the solar surface (as sunspots) drifts toward the equator over the course of the 11-year solar cycle. We use helioseismology to infer the meridional flow (in the latitudinal and radial directions) over two solar cycles covering 1996-2019. Two data sources are used, which agree during their overlap period of 2001-2011. The time-averaged meridional flow is shown to be a single cell in each hemisphere, carrying plasma toward the equator at the base of the convection zone with a speed of similar to 4 meters per second at 45 degrees latitude. Our results support the flux-transport dynamo model, which explains the drift of sunspot-emergence latitudes through the meridional flow.	[Gizon, Laurent; Cameron, Robert H.; Pourabdian, Majid; Liang, Zhi-Chao; Fournier, Damien; Birch, Aaron C.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Gizon, Laurent; Pourabdian, Majid] Georg August Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany; [Gizon, Laurent; Hanson, Chris S.] New York Univ Abu Dhabi, Ctr Space Sci, Abu Dhabi, U Arab Emirates	Max Planck Society; University of Gottingen	Gizon, L (corresponding author), Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany.; Gizon, L (corresponding author), Georg August Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany.; Gizon, L (corresponding author), New York Univ Abu Dhabi, Ctr Space Sci, Abu Dhabi, U Arab Emirates.	gizon@mps.mpg.de		Liang, Zhi-Chao/0000-0002-0347-7504; Fournier, Damien/0000-0001-7749-8650; Pourabdian, Majid/0000-0002-5368-7796	German Aerospace Center [DLR 50OL1701]; European Research Council [WHOLE SUN 810218]; NYUAD Institute [G1502]; International Max Planck Research School (IMPRS) for Solar System Science at the University of Gottingen	German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); European Research Council(European Research Council (ERC)European Commission); NYUAD Institute; International Max Planck Research School (IMPRS) for Solar System Science at the University of Gottingen	The data were processed at the German Data Center for SDO, funded by the German Aerospace Center under grant DLR 50OL1701. L.G. acknowledges support from European Research Council Synergy grant WHOLE SUN 810218. The Center for Space Science at New York University Abu Dhabi (NYUAD) is funded by the NYUAD Institute under grant G1502. M.P. was funded in part by the International Max Planck Research School (IMPRS) for Solar System Science at the University of Gottingen.	Bartels R., 1998, INTRO SPLINES USE CO, P9; Boning V. G. A., 2017, THESIS, DOI [10.6094/UNIFR/13652, DOI 10.6094/UNIFR/13652]; Braun DC, 2008, ASTROPHYS J LETT, V689, pL161, DOI 10.1086/595884; Cameron RH, 2018, ASTRON ASTROPHYS, V609, DOI 10.1051/0004-6361/201731481; Cameron RH, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201629746; Cameron R, 2015, SCIENCE, V347, P1333, DOI 10.1126/science.1261470; Charbonneau P., 2013, SOLAR STELLAR DYNAMO; Chen RZ, 2017, ASTROPHYS J, V849, DOI 10.3847/1538-4357/aa8eec; ChristensenDalsgaard J, 1996, SCIENCE, V272, P1286, DOI 10.1126/science.272.5266.1286; Couvidat S, 2016, SOL PHYS, V291, P1887, DOI 10.1007/s11207-016-0957-3; Durufle M., 2016, 8893 INRIA; DUVALL TL, 1993, NATURE, V362, P430, DOI 10.1038/362430a0; Featherstone NA, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/67; Fournier D, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201423580; Fournier D, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833206; Giles P. M., 2000, THESIS; Giles PM, 1997, NATURE, V390, P52, DOI 10.1038/36294; Gizon L, 2004, ASTROPHYS J, V614, P472, DOI 10.1086/423367; Gizon L, 2008, SOL PHYS, V251, P241, DOI 10.1007/s11207-008-9162-3; Gizon L, 2017, ASTRON ASTROPHYS, V600, DOI 10.1051/0004-6361/201629470; Harvey J, 1998, ESA SP PUBL, V418, P209; Harvey JW, 1996, SCIENCE, V272, P1284, DOI 10.1126/science.272.5266.1284; Hathaway DH, 2010, SCIENCE, V327, P1350, DOI 10.1126/science.1181990; Hotta H, 2017, ASTROPHYS J, V843, DOI 10.3847/1538-4357/aa784b; Hughes A. L. H., 2016, ARXIV160300836ASTROP; Kholikov S, 2014, SOL PHYS, V289, P1077, DOI 10.1007/s11207-013-0394-5; Kitchatinov LL, 2016, GEOMAGN AERONOMY+, V56, P945, DOI 10.1134/S0016793216080107; Kosovichev AG, 1997, SOL PHYS, V170, P43, DOI 10.1023/A:1004949311268; Liang ZC, 2019, ASTRON ASTROPHYS, V626, DOI 10.1051/0004-6361/201834849; Liang ZC, 2018, ASTRON ASTROPHYS, V619, DOI 10.1051/0004-6361/201833673; Liang ZC, 2017, ASTRON ASTROPHYS, V601, DOI 10.1051/0004-6361/201730416; Liang ZC, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/2/165; Mandal K, 2018, ASTROPHYS J, V863, DOI 10.3847/1538-4357/aacea2; Petrie G, 2017, SPACE SCI REV, V210, P77, DOI 10.1007/s11214-015-0189-0; Rajaguru SP, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/2/114; Rudiger G, 1989, DIFFERENTIAL ROTATIO; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; Schou J, 2002, ASTROPHYS J, V567, P1234, DOI 10.1086/338665; Tarantola A, 2005, INVERSE PROBLEM THEO; WANG YM, 1991, ASTROPHYS J, V383, P431, DOI 10.1086/170800; Zhao JW, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L29; Zhao JW, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/1/L5	42	37	38	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1469	+		10.1126/science.aaz7119	http://dx.doi.org/10.1126/science.aaz7119			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32587017				2022-12-28	WOS:000545264600039
J	Mahase, E				Mahase, Elisabeth			Covid-19: Medical leaders call for rapid review to prepare for second wave	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Victor A, 2020, BMJ-BRIT MED J, V369; Wise J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2294	2	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2020	369								m2529	10.1136/bmj.m2529	http://dx.doi.org/10.1136/bmj.m2529			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1US	32580991	Bronze			2022-12-28	WOS:000548572500008
J	Rimmer, A				Rimmer, Abi			Covid-19: Doctors "face difficulties" getting life insurance after exposure to disease	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2020, COVID 19 YOUR LIF IN; Watson Jessica, 2020, BMJ, V369, pm1808, DOI 10.1136/bmj.m1808	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2020	369								m2517	10.1136/bmj.m2517	http://dx.doi.org/10.1136/bmj.m2517			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1VB	32576557	Bronze			2022-12-28	WOS:000548573500013
J	Slomski, A				Slomski, Anita			Plant Extracts May Relieve Hangover Symptoms, Trial Suggests	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2453	2453		10.1001/jama.2020.10337	http://dx.doi.org/10.1001/jama.2020.10337			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2EU	32573667				2022-12-28	WOS:000595447000004
J							HALT-IT Trial Collaborators	Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial	LANCET			English	Article								Background Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding. Methods We did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0.9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0.9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124. Findings Between July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49.9%) or matching placebo (6015, 50.1%), of whom 11 952 (99.5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0.99, 95% CI 0.82-1.18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0.7%] of 5952 vs 46 [0.8%] of 5977; 0.92; 0.60 to 1.39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0.8%] of 5952 vs 26 [0.4%] of 5977; RR 1.85; 95% CI 1.15 to 2.98). Interpretation We found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd.	[HALT-IT Trial Collaborators] London Sch Hyg & Trop Med, Clin Trials Unit, London WC1 E7HT, England	University of London; London School of Hygiene & Tropical Medicine	London Sch Hyg & Trop Med, Clin Trials Unit, London WC1 E7HT, England.		Jarman, Heather/AAG-1159-2021; Jinga, Mariana/AAA-7101-2022; Jarman, Heather/AFM-8834-2022; Hartin, David/AAL-4469-2021; Mateescu, Radu Bogdan/T-5565-2019; Wahab, Farid Abdull/AAX-1730-2020; Henry, David/AAJ-4332-2020; Brenner, Amy/ABB-8133-2021; Lawton, Luke Douglas/AGL-2068-2022; Bataga, Simona M/H-2666-2016; Skene, Imogen/D-6153-2018; Balaban, Daniel Vasile/J-5795-2019; Loureiro, Vania/P-1186-2016	Jinga, Mariana/0000-0001-5826-0815; Jarman, Heather/0000-0002-4820-3291; Mateescu, Radu Bogdan/0000-0002-2607-8653; Wahab, Farid Abdull/0000-0003-1697-9981; Henry, David/0000-0003-2934-2242; Lawton, Luke Douglas/0000-0002-4989-731X; Bataga, Simona M/0000-0003-0662-3850; Skene, Imogen/0000-0001-5215-2899; Boger, Phil/0000-0002-0979-9686; Esmat, Serag/0000-0002-0135-042X; Bello, Folasade Adenike/0000-0002-3337-3335; Bercades, Georgia/0000-0002-5961-3149; Balaban, Daniel Vasile/0000-0003-3436-8041; Mafauzy, Mohamad Masykurin/0000-0001-7556-3703; Loureiro, Vania/0000-0003-2458-3004; Manno, Daniela/0000-0002-7026-3581; Arribas, Monica/0000-0002-1405-9391; Reed, Matthew/0000-0003-1308-4824; Odeghe, Emuobor/0000-0003-1108-9293; Goodacre, Steve/0000-0003-0803-8444; Adhikaree, Ajay/0000-0001-5125-7365; Akhter, Tayyab Saeed/0000-0002-7914-4626; Edwards, Phil/0000-0003-4431-8822; simmons, jonathan/0000-0002-6339-4110; LESI, Olufunmilayo/0000-0002-6958-1531; Boyle, Adrian/0000-0002-9009-5423	UK National Institute for Health Research Health Technology Assessment Programme [HTA/11/01/04]	UK National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR))	Funding for the HALT-IT trial was provided by the UK National Institute for Health Research Health Technology Assessment Programme (HTA/11/01/04). Funding for this trial covered trial materials, meetings, and central organisational costs. The study was designed, conducted, analysed, and interpreted by the investigators, entirely independently of all funding sources. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the funders.	Blasi A, 2020, HEPATOLOGY, V71, P1381, DOI 10.1002/hep.30915; Brenner A, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3561-7; Brenner A, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2900-4; Coats TJ, 2020, EMERG MED J, V37, P135, DOI 10.1136/emermed-2019-209181; Cook DJ, 2001, CRIT CARE, V5, P369; Gluud LL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006640.pub2; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; Lecker I, 2016, ANN NEUROL, V79, P18, DOI 10.1002/ana.24558; Lisman T, 2017, SEMIN THROMB HEMOST, V43, P178, DOI 10.1055/s-0036-1585081; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Oakland K, 2018, GUT, V67, P654, DOI 10.1136/gutjnl-2016-313428; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1794-1; Roberts I, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-450; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sivakumar H, 2016, BRIT J ANAESTH, V117, P431, DOI 10.1093/bja/aew170; Stanley AJ, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6432; van Leerdam ME, 2008, BEST PRACT RES CL GA, V22, P209, DOI 10.1016/j.bpg.2007.10.011; WOMAN Trial Collaborators, 2017, LANCET, V389, P2105	19	112	114	4	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1927	1936						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ2MV	32563378	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000552732200033
J	Ogden, CL; Kit, BK; Flegal, KM				Ogden, Cynthia L.; Kit, Brian K.; Flegal, Katherine M.			Obesity in US Children and Adults Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ogden, Cynthia L.; Kit, Brian K.; Flegal, Katherine M.] Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Ogden, CL (corresponding author), Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA.	cog-den@cdc.gov	Flegal, Katherine M/A-4608-2013	Flegal, Katherine/0000-0002-0838-469X	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Flegal KM, 2007, PREV MED, V45, P115, DOI 10.1016/j.ypmed.2007.06.011; Freedman David S., 2011, Morbidity and Mortality Weekly Report, V60, P73; Koh HK, 2011, HEALTH EDUC BEHAV, V38, P551, DOI 10.1177/1090198111428646; Ogden Cynthia L, 2010, NCHS Data Brief, P1	4	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2145	2146		10.1001/jama.2012.4728	http://dx.doi.org/10.1001/jama.2012.4728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	32632337	Green Accepted			2022-12-28	WOS:000304315200012
J	Weiss, GL; Stanisich, JJ; Sauer, MM; Lin, CW; Eras, J; Zyla, DS; Truck, J; Devuyst, O; Aebi, M; Pilhofer, M; Glockshuber, R				Weiss, Gregor L.; Stanisich, Jessica J.; Sauer, Maximilian M.; Lin, Chia-Wei; Eras, Jonathan; Zyla, Dawid S.; Truck, Johannes; Devuyst, Olivier; Aebi, Markus; Pilhofer, Martin; Glockshuber, Rudi			Architecture and function of human uromodulin filaments in urinary tract infections	SCIENCE			English	Article							TAMM-HORSFALL GLYCOPROTEIN; UROPATHOGENIC ESCHERICHIA-COLI; UROPLAKIN-IA; MOLECULAR ARCHITECTURE; UROTHELIAL RECEPTOR; ADHESIN; PROTEIN; BINDING; FIMH; POLYMERIZATION	Uromodulin is the most abundant protein in human urine, and it forms filaments that antagonize the adhesion of uropathogens: however, the filament structure and mechanism of protection remain poorly understood. We used cryo-electron tomography to show that the uromodulin filament consists of a zigzag-shaped backbone with laterally protruding arms. N-glycosylation mapping and biophysical assays revealed that uromodulin acts as a multivalent ligand for the bacterial type 1 pilus adhesin, presenting specific epitopes on the regularly spaced arms. Imaging of uromodulin-uropathogen interactions in vitro and in patient urine showed that uromodulin filaments associate with uropathogens and mediate bacterial aggregation, which likely prevents adhesion and allows clearance by micturition. These results provide a framework for understanding uromodulin in urinary tract infections and in its more enigmatic roles in physiology and disease.	[Weiss, Gregor L.; Stanisich, Jessica J.; Sauer, Maximilian M.; Eras, Jonathan; Zyla, Dawid S.; Pilhofer, Martin; Glockshuber, Rudi] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland; [Lin, Chia-Wei; Aebi, Markus] Swiss Fed Inst Technol, Inst Microbiol, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland; [Truck, Johannes] Univ Childrens Hosp Zurich, Steinwiesstr 75, CH-8032 Zurich, Switzerland; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Mech Inherited Kidney Disorders, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Devuyst, Olivier] UCLouvain Med Sch, Div Nephrol, Brussels, Belgium; [Sauer, Maximilian M.] Univ Washington, Dept Biochem, 1705 NE Pacific St, Seattle, WA 98195 USA; [Lin, Chia-Wei] Funct Genom Ctr Zurich, Winterthurerstr 190, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University Children's Hospital Zurich; University of Zurich; University of Washington; University of Washington Seattle	Pilhofer, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	pilhofer@biol.ethz.th	Żyła, Dawid/AAD-2381-2020; Lin, Chia-wei/ABA-6065-2021; Trück, Johannes/E-3459-2012	Żyła, Dawid/0000-0001-8471-469X; Lin, Chia-wei/0000-0003-4777-2916; Trück, Johannes/0000-0002-0418-7381; Weiss, Gregor/0000-0002-2132-670X; Devuyst, Olivier/0000-0003-3744-4767; Stanisich, Jessica/0000-0002-2702-8092	Boehringer Ingelheim Fonds Ph.D. fellowship; Swiss National Science Foundation [PZ00P3_161147, PZ00P3_183777, 31003A_179255, 310030B_176403/1, 31003A_156304, 310030_189044]; European Research Council [679209]; NOMIS foundation; Swiss National Centre of Competence in Research Kidney Control of Homeostasis (NCCR Kidney.CH) program; Rare Disease Initiative Zurich (Radiz); ETH Zurich	Boehringer Ingelheim Fonds Ph.D. fellowship(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); NOMIS foundation; Swiss National Centre of Competence in Research Kidney Control of Homeostasis (NCCR Kidney.CH) program; Rare Disease Initiative Zurich (Radiz); ETH Zurich(ETH Zurich)	G.L.W. was supported by a Boehringer Ingelheim Fonds Ph.D. fellowship. M.P. was supported by the Swiss National Science Foundation (no. 31003A_179255), the European Research Council (no. 679209), and the NOMIS foundation. R.G. was supported by the Swiss National Science Foundation (nos. 310030B_176403/1 and 31003A_156304). O.D. was supported by the Swiss National Centre of Competence in Research Kidney Control of Homeostasis (NCCR Kidney.CH) program, the Swiss National Science Foundation (no. 310030_189044), and the Rare Disease Initiative Zurich (Radiz). J.T. was supported by the Swiss National Science Foundation (nos. PZ00P3_161147 and PZ00P3_183777). M.P. and R.G. were also supported by basic funding from ETH Zurich.	Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Beck M, 2016, TRENDS CELL BIOL, V26, P825, DOI 10.1016/j.tcb.2016.08.006; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; Bokhove M, 2016, P NATL ACAD SCI USA, V113, P1552, DOI 10.1073/pnas.1519803113; Brunati M, 2015, ELIFE, V4, DOI 10.7554/eLife.08887; Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017; Cavallone D, 2004, J BIOL CHEM, V279, P216, DOI 10.1074/jbc.M308821200; Cavallone D, 2002, CLIN BIOCHEM, V35, P405, DOI 10.1016/S0009-9120(02)00329-6; Colon W, 1999, METHOD ENZYMOL, V309, P605; Conover MS, 2016, CELL HOST MICROBE, V20, P482, DOI 10.1016/j.chom.2016.08.013; DELL A, 1994, METHOD ENZYMOL, V230, P108; Devuyst O, 2017, NAT REV NEPHROL, V13, P525, DOI 10.1038/nrneph.2017.101; Ghirotto S, 2016, J AM SOC NEPHROL, V27, P2983, DOI 10.1681/ASN.2015070830; GRANT AMS, 1973, BIOCHEM J, V136, P659, DOI 10.1042/bj1360659; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hang I, 2015, GLYCOBIOLOGY, V25, P1335, DOI 10.1093/glycob/cwv058; HARD K, 1992, EUR J BIOCHEM, V209, P895, DOI 10.1111/j.1432-1033.1992.tb17362.x; Holden N, 2007, INFECT IMMUN, V75, P3325, DOI 10.1128/IAI.01989-06; Hong C., 2013, INT J PHARM SCI, V5, P385; HUNT JS, 1980, PATHOLOGY, V12, P609, DOI 10.3109/00313028009086814; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LINDBERG FP, 1984, EMBO J, V3, P1167, DOI 10.1002/j.1460-2075.1984.tb01946.x; Lindberg S, 2008, INFECT IMMUN, V76, P771, DOI 10.1128/IAI.01010-07; Margarit y Ros I., 2016, STREPTOCOCCUS PYOGEN; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Medeiros JM, 2018, CURR OPIN MICROBIOL, V43, P62, DOI 10.1016/j.mib.2017.12.006; Medeiros JM, 2018, ULTRAMICROSCOPY, V190, P1, DOI 10.1016/j.ultramic.2018.04.002; Min GW, 2002, J MOL BIOL, V317, P697, DOI 10.1006/jmbi.2002.5442; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; ORNDORFF PE, 1984, J BACTERIOL, V160, P61, DOI 10.1128/JB.160.1.61-66.1984; Pak J, 2001, J BIOL CHEM, V276, P9924, DOI 10.1074/jbc.M008610200; PARKKINEN J, 1988, INFECT IMMUN, V56, P2623, DOI 10.1128/IAI.56.10.2623-2630.1988; Patel S, 2017, BIOMED PHARMACOTHER, V93, P763, DOI 10.1016/j.biopha.2017.06.102; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PORTER KR, 1955, J BIOL CHEM, V212, P135; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Sauer MM, 2019, J AM CHEM SOC, V141, P936, DOI 10.1021/jacs.8b10736; Sauer MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10738; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Schaffer Miroslava, 2015, Bio Protoc, V5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; Serafini-Cessi F, 2005, GLYCOCONJUGATE J, V22, P383, DOI 10.1007/s10719-005-2142-z; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Toyota S, 1989, Nihon Hinyokika Gakkai Zasshi, V80, P1816; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; van Rooijen JJM, 1999, GLYCOBIOLOGY, V9, P21, DOI 10.1093/glycob/9.1.21; van Rooijen JJM, 2001, GLYCOCONJUGATE J, V18, P539, DOI 10.1023/A:1019644413639; Weiss GL, 2017, METHODS MOL BIOL, V1615, P353, DOI 10.1007/978-1-4939-7033-9_27; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wurpel DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093177; Wurpel DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052835; Xia Y, 2000, EMBO J, V19, P1450, DOI 10.1093/emboj/19.7.1450; Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200; Youhanna S, 2014, NEPHROL DIAL TRANSPL, V29, P136, DOI 10.1093/ndt/gft345; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005; Zhou G, 2001, J CELL SCI, V114, P4095	63	42	43	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2020	369	6506			SI		1005	+		10.1126/science.aaz9866	http://dx.doi.org/10.1126/science.aaz9866			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE2OL	32616672	Bronze, Green Accepted			2022-12-28	WOS:000562436800053
J	Wu, CCC; Peterson, A; Zinshteyn, B; Regot, S; Green, R				Wu, Colin Chih-Chien; Peterson, Amy; Zinshteyn, Boris; Regot, Sergi; Green, Rachel			Ribosome Collisions Trigger General Stress Responses to Regulate Cell Fate	CELL			English	Article							SCALE CRISPR-CAS9 KNOCKOUT; RIBOTOXIC STRESS; PROTEIN-KINASE; TRANSLATION INITIATION; ACTIVATION; RNA; GCN2; JNK; RADIATION; ZAK	Problems arising during translation of mRNAs lead to ribosome stalling and collisions that trigger a series of quality control events. However, the global cellular response to ribosome collisions has not been explored. Here, we uncover a function for ribosome collisions in signal transduction. Using translation elongation inhibitors and general cellular stress conditions, including amino acid starvation and UV irradiation, we show that ribosome collisions activate the stress-activated protein kinase (SAPK) and GCN2-mediated stress response pathways. We show that the MAPKKK ZAK functions as the sentinel for ribosome collisions and is required for immediate early activation of both SAPK (p38/JNK) and GCN2 signaling pathways. Selective ribosome profiling and biochemistry demonstrate that although ZAK generally associates with elongating ribosomes on polysomal mRNAs, it specifically auto-phosphorylates on the minimal unit of colliding ribosomes, the disome. Together, these results provide molecular insights into how perturbation of translational homeostasis regulates cell fate.	[Wu, Colin Chih-Chien; Peterson, Amy; Zinshteyn, Boris; Regot, Sergi; Green, Rachel] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD 21205 USA; [Wu, Colin Chih-Chien; Zinshteyn, Boris; Green, Rachel] Johns Hopkins Univ, Howard Hughes Med Inst, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD 21205 USA.; Green, R (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Sch Med, Baltimore, MD 21205 USA.	ragreen@jhmi.edu		Peterson, Amy/0000-0002-0848-8181; Regot, Sergi/0000-0001-9786-3897	NIH [R37GM059425]; HHMI; NSF CAREER award [MCB-1844994]; NIGMS R35 [1R35GM133499]; American Cancer Society Research Scholar Grant [133537-RSG-19-005-01-CCG]; Jerome L. Greene Foundation Discovery Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIGMS R35; American Cancer Society Research Scholar Grant(American Cancer Society); Jerome L. Greene Foundation Discovery Award	We thank Jamie Wangen, Niladri Sinha, and Kamena Kostova for critical reading; Andrew Holland for Flp-In T-REx HeLa cells; Thomas Tuschl for ZNF598 knockout cells; Christopher Shoemaker for advice on CRISPR screens; David Mohr and the Johns Hopkins Genetic Resources Core Facility for sequencing assistance; Jeff Corden for discussions. This work was supported by NIH (R37GM059425 to R.G.) and HHMI (to R.G. and C.C.-C.W.). B.Z. is an HHMI fellow of the Damon Runyon Cancer Research Foundation (DRG-2250-16). S.R. is supported by an NSF CAREER award (MCB-1844994), NIGMS R35 (1R35GM133499), American Cancer Society Research Scholar Grant (133537-RSG-19-005-01-CCG), and a Jerome L. Greene Foundation Discovery Award.	Arpat AB, 2019, BIORXIV, DOI [10.1101/710061, DOI 10.1101/710061]; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Chandrasekaran V, 2019, NAT STRUCT MOL BIOL, V26, P1132, DOI 10.1038/s41594-019-0331-x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CLEMENT E, 2020, EMBO J, V39, DOI DOI 10.15252/EMBJ.2019103365; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; Darnell AM, 2018, MOL CELL, V71, P229, DOI 10.1016/j.molcel.2018.06.041; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Delarue M, 2018, CELL, V174, P338, DOI 10.1016/j.cell.2018.05.042; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Duch A, 2012, FEBS LETT, V586, P2925, DOI 10.1016/j.febslet.2012.07.034; Garzia A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16056; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Gross EA, 2002, J BIOL CHEM, V277, P13873, DOI 10.1074/jbc.M111994200; Han Px, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107610; Harding C, 2019, ARTS, V8, DOI 10.3390/arts8030090; Hirose T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004512; Hussmann JA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005732; Inglis AJ, 2019, P NATL ACAD SCI USA, V116, P4946, DOI 10.1073/pnas.1813352116; Iordanov MS, 2002, MOL CELL BIOL, V22, P5380, DOI 10.1128/MCB.22.15.5380-5394.2002; Iordanov MS, 1998, J BIOL CHEM, V273, P15794, DOI 10.1074/jbc.273.25.15794; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Ishimura R, 2016, ELIFE, V5, DOI 10.7554/eLife.14295; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; JACKLE H, 1978, PHOTOCHEM PHOTOBIOL, V27, P309, DOI 10.1111/j.1751-1097.1978.tb07605.x; Jandhyala DM, 2008, CELL MICROBIOL, V10, P1468, DOI 10.1111/j.1462-5822.2008.01139.x; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Jimenez-Diaz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084219; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Juszkiewicz S, 2018, MOL CELL, V72, P469, DOI 10.1016/j.molcel.2018.08.037; Kant S, 2011, GENE DEV, V25, P2069, DOI 10.1101/gad.17224711; Kim TS, 2019, BMB REP, V52, P502, DOI 10.5483/BMBRep.2019.52.8.273; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Miura H, 2018, CELL REP, V24, P2658, DOI 10.1016/j.celrep.2018.08.020; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Rey C, 2016, ONCOGENE, V35, P3190, DOI 10.1038/onc.2015.379; Sanson KR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07901-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Simms CL, 2017, MOL CELL, V68, P361, DOI 10.1016/j.molcel.2017.08.019; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Vind AC, 2020, MOL CELL, V78, P700, DOI 10.1016/j.molcel.2020.03.021; Wang XS, 2005, J BIOL CHEM, V280, P19298, DOI 10.1074/jbc.M413059200; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Wu CCC, 2019, MOL CELL, V73, P959, DOI 10.1016/j.molcel.2018.12.009; Yan LL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13579-3; Yan LWL, 2019, J BIOL CHEM, V294, P15158, DOI 10.1074/jbc.REV119.006513	61	96	98	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					404	+		10.1016/j.cell.2020.06.006	http://dx.doi.org/10.1016/j.cell.2020.06.006			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32610081	Green Accepted, Bronze			2022-12-28	WOS:000552745000012
J	Nicholls, SJ; Nelson, AJ				Nicholls, Stephen J.; Nelson, Adam J.			Statins for Primary Prevention in the Elderly: The Importance of Rigorous Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nicholls, Stephen J.] Monash Univ, Victorian Heart Inst, Monash Cardiovasc Res Ctr, Melbourne, Vic, Australia; [Nelson, Adam J.] Duke Clin Res Inst, Durham, NC USA	Monash University; Duke University	Nicholls, SJ (corresponding author), Monash Univ, Victorian Heart Inst, Monash Cardiovasc Res Ctr, 246 Clayton Rd, Clayton, Vic 3168, Australia.	stephen.nicholls@monash.edu						Chu CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24248-8; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Giugliano RP, 2017, NEW ENGL J MED, V377, P633, DOI 10.1056/NEJMoa1701131; Han BH, 2017, JAMA INTERN MED, V177, P955, DOI 10.1001/jamainternmed.2017.1442; Jun JE, 2019, ATHEROSCLEROSIS, V283, P28, DOI 10.1016/j.atherosclerosis.2019.01.030; Mortensen MB, 2018, ANN INTERN MED, V169, P67, DOI 10.7326/L18-0182; Orkaby AR, 2020, JAMA-J AM MED ASSOC, V324, P68, DOI 10.1001/jama.2020.7848; Ridker PM, 2017, CIRCULATION, V135, P1979, DOI 10.1161/CIRCULATIONAHA.117.028271	8	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					45	46		10.1001/jama.2020.8390	http://dx.doi.org/10.1001/jama.2020.8390			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633787				2022-12-28	WOS:000568123600020
J	Asch, DA; Grischkan, J; Nicholson, S				Asch, David A.; Grischkan, Justin; Nicholson, Sean			The Cost, Price, and Debt of Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Asch, David A.] Univ Penn, Philadelphia, PA 19104 USA; [Asch, David A.] Corporal Michael J Crescenz Dept Vet Affairs Med, Philadelphia, PA 19104 USA; [Grischkan, Justin] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Nicholson, Sean] Cornell Univ, Ithaca, NY USA	University of Pennsylvania; Harvard University; Massachusetts General Hospital; Cornell University	Asch, DA (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.; Asch, DA (corresponding author), Corporal Michael J Crescenz Dept Vet Affairs Med, Philadelphia, PA 19104 USA.							[Anonymous], 2018, MED STUD ED DEBT COA; Greysen SR, 2011, ACAD MED, V86, P840, DOI 10.1097/ACM.0b013e31821daf03; Lynch Ashley, 2018, J Grad Med Educ, V10, P11, DOI 10.4300/JGME-D-17-00279.1; Nicholson S, 2012, HDB HLTH EC, V2, P889	4	10	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					6	9		10.1056/NEJMp1916528	http://dx.doi.org/10.1056/NEJMp1916528			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2UD	32609977				2022-12-28	WOS:000552751800005
J	Cnattingius, S; Johansson, S; Razaz, N				Cnattingius, Sven; Johansson, Stefan; Razaz, Neda			Apgar Score and Risk of Neonatal Death among Preterm Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							5 MINUTES; MORTALITY; POPULATION; COMPONENTS	Background Gestational age is the major determinant of neonatal death (death within the first 28 days of life) in preterm infants. The joint effect of gestational age and Apgar score on the risk of neonatal death is unknown. Methods Using data from the Swedish Medical Birth Register, we identified 113,300 preterm infants (22 weeks 0 days to 36 weeks 6 days of gestation) born from 1992 through 2016. In analyses stratified according to gestational age (22 to 24 weeks, 25 to 27 weeks, 28 to 31 weeks, 32 to 34 weeks, and 35 or 36 weeks), we estimated adjusted relative risks of neonatal death and absolute rate differences in neonatal mortality (i.e., the excess number of neonatal deaths per 100 births) according to the Apgar scores at 5 and 10 minutes and according to the change in the Apgar score between 5 minutes and 10 minutes. Scores range from 0 to 10, with higher scores indicating a better physical condition of the newborn. Results There were 1986 neonatal deaths (1.8%). The incidence of neonatal death ranged from 0.2% (at 36 weeks of gestation) to 76.5% (at 22 weeks of gestation). Lower Apgar scores were associated with higher relative risks of neonatal death and greater absolute rate differences in neonatal mortality in all gestational-age strata. For example, among infants born at 28 to 31 weeks, the adjusted absolute rate differences according to the 5-minute Apgar score, with those who had a score of 9 or 10 serving as the reference group, were 51.7 (95% confidence interval [CI], 38.1 to 65.4) for a score of 0 or 1, 25.5 (95% CI, 18.3 to 32.8) for a score of 2 or 3, 7.1 (95% CI, 5.1 to 9.1) for a score of 4 to 6, and 1.2 (95% CI, 0.5 to 1.9) for a score of 7 or 8. An increase in the Apgar score between 5 minutes and 10 minutes was associated with lower neonatal mortality than a stable Apgar score. Conclusions In this study, Apgar scores at 5 and 10 minutes provided prognostic information about neonatal survival among preterm infants across gestational-age strata. (Funded by the Swedish Research Council for Health, Working Life, and Welfare and Karolinska Institutet.) In this nationwide study involving preterm infants in Sweden, Apgar scores at 5 and 10 minutes and the change in the Apgar score between 5 and 10 minutes provided prognostic information about neonatal survival across gestational-age strata.	[Cnattingius, Sven; Johansson, Stefan; Razaz, Neda] Karolinska Inst, Div Clin Epidemiol, Dept Med Solna, Stockholm, Sweden; [Johansson, Stefan] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Cnattingius, S (corresponding author), Karolinska Univ Hosp Solna, Div Clin Epidemiol, Dept Med Solna, T2, SE-17176 Stockholm, Sweden.	sven.cnattingius@ki.se		Johansson, Stefan/0000-0001-8832-6918	Swedish Research Council for Health, Working Life, and Welfare [2017-00134]; Karolinska Institutet, Stockholm [2368/10-221]	Swedish Research Council for Health, Working Life, and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet, Stockholm(Karolinska Institutet)	Supported by a grant (2017-00134) from the Swedish Research Council for Health, Working Life, and Welfare and by an unrestricted grant (2368/10-221) from Karolinska Institutet, Stockholm (Distinguished Professor Award to Dr. Cnattingius).	[Anonymous], 2014, QUAL CONT SWED PAT R; APGAR V, 1953, Curr Res Anesth Analg, V32, P260; Bartman T, 2015, AM J PERINAT, V32, P1268, DOI 10.1055/s-0035-1554803; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; CATLIN EA, 1986, J PEDIATR-US, V109, P865, DOI 10.1016/S0022-3476(86)80715-6; Cnattingius S, 2017, PAEDIATR PERINAT EP, V31, P328, DOI 10.1111/ppe.12360; DRAGE JS, 1964, OBSTET GYNECOL, V24, P222; Harrison MS, 2016, SEMIN FETAL NEONAT M, V21, P74, DOI 10.1016/j.siny.2015.12.007; Haumont D, 2020, PEDIATR RES, V88, P484, DOI 10.1038/s41390-020-0769-x; Hegyi T, 1998, PEDIATRICS, V101, P77, DOI 10.1542/peds.101.1.77; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Iliodromiti S, 2014, LANCET, V384, P1749, DOI 10.1016/S0140-6736(14)61135-1; Kallen B., 2003, SWEDISH MED BIRTH RE; Lee HC, 2010, ACTA PAEDIATR, V99, P1785, DOI 10.1111/j.1651-2227.2010.01935.x; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Medlock S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023441; O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.040; Papile LA, 2001, NEW ENGL J MED, V344, P519, DOI 10.1056/NEJM200102153440709; Razaz N, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1656; Siddiqui A, 2017, PAEDIATR PERINAT EP, V31, P338, DOI 10.1111/ppe.12368; Statistics Sweden, 2020, DESTATIS; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Watterberg KL, 2015, PEDIATRICS, V136, P819, DOI 10.1542/peds.2015-2651; Weinberger B, 2000, ARCH PEDIAT ADOL MED, V154, P294, DOI 10.1001/archpedi.154.3.294; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wyckoff MH, 2012, J PEDIATR-US, V160, P239, DOI 10.1016/j.jpeds.2011.07.041; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	49	55	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					49	57		10.1056/NEJMoa1915075	http://dx.doi.org/10.1056/NEJMoa1915075			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ2UD	32609981	Bronze			2022-12-28	WOS:000552751800010
J	Ho, JSY; Angel, M; Ma, YX; Sloan, E; Wang, GJ; Martinez-Romero, C; Alenquer, M; Roudko, V; Chung, L; Zheng, SM; Chang, M; Fstkchyan, Y; Clohisey, S; Dinan, AM; Gibbs, J; Gifford, R; Shen, R; Gu, Q; Irigoyen, N; Campisi, L; Huang, C; Zhao, N; Jones, JD; van Knippenberg, I; Zhu, ZY; Moshkina, N; Meyer, L; Noel, J; Peralta, Z; Rezelj, V; Kaake, R; Rosenberg, B; Wang, B; Wei, JJ; Paessler, S; Wise, HM; Johnson, J; Vannini, A; Amorim, MJ; Baillie, JK; Miraldi, ER; Benner, C; Brierley, I; Digard, P; Luksza, M; Firth, AE; Krogan, N; Greenbaum, BD; MacLeod, MK; van Bakel, H; Garcia-Sastre, A; Yewdell, JW; Hutchinson, E; Marazzi, I				Ho, Jessica Sook Yuin; Angel, Matthew; Ma, Yixuan; Sloan, Elizabeth; Wang, Guojun; Martinez-Romero, Carles; Alenquer, Marta; Roudko, Vladimir; Liliane Chung; Zheng, Simin; Chang, Max; Fstkchyan, Yesai; Clohisey, Sara; Dinan, Adam M.; Gibbs, James; Gifford, Robert; Shen, Rong; Gu, Quan; Irigoyen, Nerea; Campisi, Laura; Huang, Cheng; Zhao, Nan; Jones, Joshua D.; van Knippenberg, Ingeborg; Zhu, Zeyu; Moshkina, Natasha; Meyer, Lea; Noel, Justine; Peralta, Zuleyma; Rezelj, Veronica; Kaake, Robyn; Rosenberg, Brad; Wang, Bo; Wei, Jiajie; Paessler, Slobodan; Wise, Helen M.; Johnson, Jeffrey; Vannini, Alessandro; Amorim, Maria Joao; Baillie, J. Kenneth; Miraldi, Emily R.; Benner, Christopher; Brierley, Ian; Digard, Paul; Luksza, Marta; Firth, Andrew E.; Krogan, Nevan; Greenbaum, Benjamin D.; MacLeod, Megan K.; van Bakel, Harm; Garcia-Sastre, Adolfo; Yewdell, Jonathan W.; Hutchinson, Edward; Marazzi, Ivan			Hybrid Gene Origination Creates Human-Virus Chimeric Proteins during Infection	CELL			English	Article							INFLUENZA-A VIRUS; READING FRAMES; VIRAL TRANSCRIPTION; SEQUENCE ALIGNMENT; TRANSLATION; GENERATION; EXPRESSION; EVOLUTION; ENDONUCLEASE; REPLICATION	RNA viruses are a major human health threat. The life cycles of many highly pathogenic RNA viruses like influenza A virus (IAV) and Lassa virus depends on host mRNA, because viral polymerases cleave 5'-m7G-capped host transcripts to prime viral mRNA synthesis ("cap-snatching"). We hypothesized that start codons within cap-snatched host transcripts could generate chimeric human-viral mRNAs with coding potential. We report the existence of this mechanism of gene origination, which we named "start-snatching." Depending on the reading frame, start-snatching allows the translation of host and viral "untranslated regions" (UTRs) to create N-terminally extended viral proteins or entirely novel polypeptides by genetic overprinting. We show that both types of chimeric proteins are made in IAV-infected cells, generate T cell responses, and contribute to virulence. Our results indicate that during infection with IAV, and likely a multitude of other human, animal and plant viruses, a host-dependent mechanism allows the genesis of hybrid genes.	[Ho, Jessica Sook Yuin; Ma, Yixuan; Wang, Guojun; Martinez-Romero, Carles; Zheng, Simin; Fstkchyan, Yesai; Campisi, Laura; Zhao, Nan; Zhu, Zeyu; Moshkina, Natasha; Noel, Justine; Rosenberg, Brad; Johnson, Jeffrey; Garcia-Sastre, Adolfo; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Angel, Matthew; Gibbs, James; Wei, Jiajie; Yewdell, Jonathan W.] NIAID, Lab Viral Dis, NIH, Bethesda, MD 20892 USA; [Kaake, Robyn; Johnson, Jeffrey; Krogan, Nevan] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Chang, Max; Benner, Christopher] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92037 USA; [Peralta, Zuleyma; Luksza, Marta; van Bakel, Harm] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Roudko, Vladimir; Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Roudko, Vladimir; Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, New York, NY 10029 USA; [Roudko, Vladimir; Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Roudko, Vladimir; Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Miraldi, Emily R.] Cincinnati Childrens Hosp, Div Immunobiol, Cincinnati, OH 45229 USA; [Miraldi, Emily R.] Cincinnati Childrens Hosp, Div Biomed Informat, Cincinnati, OH 45229 USA; [Miraldi, Emily R.] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45257 USA; [Wang, Guojun; Martinez-Romero, Carles; Garcia-Sastre, Adolfo; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Martinez-Romero, Carles; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Sloan, Elizabeth; Gifford, Robert; Gu, Quan; van Knippenberg, Ingeborg; Meyer, Lea; Rezelj, Veronica; Hutchinson, Edward] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland; [Alenquer, Marta; Amorim, Maria Joao] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Liliane Chung; Clohisey, Sara; Wang, Bo; Wise, Helen M.; Baillie, J. Kenneth; Digard, Paul] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9PS, Midlothian, Scotland; [Dinan, Adam M.; Irigoyen, Nerea; Jones, Joshua D.; Brierley, Ian; Firth, Andrew E.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 0SP, England; [MacLeod, Megan K.] Univ Glasgow, Ctr Immunobiol, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Huang, Cheng; Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Shen, Rong; Vannini, Alessandro] Inst Canc Res, Div Struct Biol, London SW7 3RP, England; [Vannini, Alessandro] Struct Biol Res Ctr, Fdn Human Technopole, I-20157 Milan, Italy; [Jones, Joshua D.] Univ Edinburgh, Edinburgh Med Sch Biomed Sci, Infect Med, Edinburgh, Midlothian, Scotland; [van Knippenberg, Ingeborg] Edinburgh Napier Univ, Dept Learning & Teaching Enhancement, Edinburgh, Midlothian, Scotland; [Rezelj, Veronica] Inst Pasteur, Dept Virol, Viral Populat & Pathogenesis Unit, CNRS,UMR 3569, Paris, France; [Wang, Guojun] Inner Mongolia Univ, Coll Life Sci, State Key Lab Reprod Regulat & Breeding Grassland, Hohhot, Peoples R China	Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Glasgow; Instituto Gulbenkian de Ciencia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Cambridge; University of Glasgow; University of Texas System; University of Texas Medical Branch Galveston; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Edinburgh; Edinburgh Napier University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Inner Mongolia University	Marazzi, I (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Marazzi, I (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.; Hutchinson, E (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.	edward.hutchinson@glasgow.ac.uk; ivan.marazzi@mssm.edu	Baillie, Kenneth/AEK-6650-2022; Hutchinson, Edward/M-7136-2016; Campisi, Laura/AAL-2064-2021; Ma, Yixuan/AHD-3710-2022; Clohisey, Sara/AAB-9321-2021; Baillie, John Kenneth/F-3124-2011; Irigoyen, Nerea/CAJ-2485-2022; yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Amorim, Maria Joao/D-7032-2013	Baillie, Kenneth/0000-0001-5258-793X; Hutchinson, Edward/0000-0003-3673-9096; Campisi, Laura/0000-0003-4173-4521; Ma, Yixuan/0000-0001-8156-4091; Clohisey, Sara/0000-0001-7489-9846; Baillie, John Kenneth/0000-0001-5258-793X; Irigoyen, Nerea/0000-0001-6346-3369; Alenquer, Marta/0000-0003-3062-1222; Rosenberg, Brad/0000-0002-5885-1276; Gu, Quan/0000-0002-1201-6734; Johnson, Jeffrey/0000-0002-4221-298X; Ho, Jessica Sook Yuin/0000-0003-2234-2602; Dinan, Adam/0000-0003-2812-1616; Chang, Max/0000-0002-4526-489X; Noel, Justine/0000-0002-0692-1412; Amorim, Maria Joao/0000-0002-4129-6659; Meyer, Lea/0000-0002-3405-7967; Sloan, Elizabeth/0000-0002-4702-1699; MacLeod, Megan/0000-0003-1843-8580; Martinez-Romero, Carles/0000-0001-8888-7715; Zheng, Simin/0000-0002-3442-1255	Burroughs Wellcome Fund (United States) [1017892]; Chan Zuckerberg Initiative (United States) [2018-191895]; NIH (United States) [R01AI113186]; NIH [U19AI135972]; MRC (United Kingdom) Career Development Award [MR/N008618/1]; MRC Programme Grant [MR/K000241/1]; Wellcome Trust (United Kingdom) Senior Investigator award [099220/Z/12/Z]; MRC [MR/M011747/1, MC_UU_12014/12]; Wellcome Trust Intermediate Clinical Fellowship [103258/Z/13/Z]; Wellcome-Beit Prize [103258/Z/13/A]; UK Intensive Care Society; BBSRC (United Kingdom) Institute Strategic Programme Grant; SHIELD Edinburgh Global Research Scholarship [MR/N02995X/1]; Wellcome Trust [106207]; European Research Council (European Union) [646891]; BBSRC Institute Strategic Programme [BB/J004324/1, BB/P013740/1]; FCT (Portugal) [PTDC/BIA-CEL/32211/2017, IF/00899/2013]; Wellcome Investigator Award [210703/Z/18/Z]; BBSRC [BBS/E/D/20002173] Funding Source: UKRI; MRC [MC_UU_12014/9, MR/K000241/1, MR/N008618/1] Funding Source: UKRI	Burroughs Wellcome Fund (United States); Chan Zuckerberg Initiative (United States); NIH (United States)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC (United Kingdom) Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (United Kingdom) Senior Investigator award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Wellcome-Beit Prize; UK Intensive Care Society; BBSRC (United Kingdom) Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SHIELD Edinburgh Global Research Scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (European Union)(European Research Council (ERC)European Commission); BBSRC Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Investigator Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Genomics and Mouse facility at Icahn School of Medicine at Mount Sinai, the Global Health and Emerging Pathogens Institute (GHEPI) at Mount Sinai, and the entire Marazzi Lab team. The authors would also like to thank Ervin Fodor, University of Oxford for support and critical comments on the project; Svenja Hester, Benjamin Thomas, and Shabaz Mohammed of the Advanced Proteomics Facility, University of Oxford for proteomics; Elly Gaunt, University of Edinburgh and Michael Goodin, University of Kentucky, for critical reading of the manuscript; and staff within the Institute of Infection, Immunity, and Inflammation Flow Cytometry Facility, the Central Research Facility at the University of Glasgow, Thomas Purnell of the Institute of Infection, Immunity and Inflammation, University of Glasgow and Dimitris Athineos of the Beatson Institute for technical assistance and discussion. I.M. is supported by the Burroughs Wellcome Fund (United States; 1017892) and by the Chan Zuckerberg Initiative (United States; 2018-191895). I.M. and H.v.B. are supported by the NIH (United States; R01AI113186). A.G.-S. and I.M. are supported by the NIH (U19AI135972 FLUOMICS). E.H., E.S., and Q.G. are supported by an MRC (United Kingdom) Career Development Award (MR/N008618/1), and E.H. carried out proteomics work when funded by an MRC Programme Grant to Prof. Ervin Fodor, University of Oxford (MR/K000241/1). V.R. and I.v.K. were supported by a Wellcome Trust (United Kingdom) Senior Investigator award (099220/Z/12/Z) awarded to Prof. Richard M. Elliott, University of Glasgow. R.G. and Q.G. were supported by the MRC (MC_UU_12014/12). J.K.B. was supported by a Wellcome Trust Intermediate Clinical Fellowship (103258/Z/13/Z), a Wellcome-Beit Prize (103258/Z/13/A), and the UK Intensive Care Society. J.K.B. and S.C. acknowledge the BBSRC (United Kingdom) Institute Strategic Programme Grant to the Roslin Institute. B.W. was supported by a SHIELD (MR/N02995X/1) Edinburgh Global Research Scholarship. A.E.F. was supported by the Wellcome Trust (106207) and European Research Council (European Union; 646891). I.B., P.D., and H.M.W. were supported by an MRC project grant (MR/M011747/1). P.D. was supported by the BBSRC Institute Strategic Programme (BB/J004324/1 and BB/P013740/1). J.D.J. was funded by a Wellcome Trust PhD scholarship. M. Alenquer and M.J.A. were supported by the FCT (Portugal) award PTDC/BIA-CEL/32211/2017 and IF/00899/2013, respectively. M.K.M. was supported by a Wellcome Investigator Award (210703/Z/18/Z).	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Bottermann M, 2018, P NATL ACAD SCI USA, V115, P10440, DOI 10.1073/pnas.1806314115; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Clohisey S, 2020, J VIROL, V94, DOI 10.1128/JVI.01720-19; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dadonaite B, 2019, NAT MICROBIOL, V4, P1781, DOI 10.1038/s41564-019-0513-7; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Dikstein R, 2012, GENE, V491, P1, DOI 10.1016/j.gene.2011.09.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolan BP, 2010, J IMMUNOL, V184, P1419, DOI 10.4049/jimmunol.0901907; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elfakess R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003094; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Gog JR, 2007, NUCLEIC ACIDS RES, V35, P1897, DOI 10.1093/nar/gkm087; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gu WF, 2015, RNA, V21, P2067, DOI 10.1261/rna.054221.115; Haimov O, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00150-17; Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hutchinson EC, 2018, METHODS MOL BIOL, V1836, P89, DOI 10.1007/978-1-4939-8678-1_5; Hutchinson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5816; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kochetov AV, 2008, FEBS LETT, V582, P1293, DOI 10.1016/j.febslet.2008.03.014; Koppstein D, 2015, NUCLEIC ACIDS RES, V43, P5052, DOI 10.1093/nar/gkv333; Kovacs E, 2010, P NATL ACAD SCI USA, V107, P5429, DOI 10.1073/pnas.0907841107; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; Machkovech HM, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007518; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McGlincy NJ, 2017, METHODS, V126, P112, DOI 10.1016/j.ymeth.2017.05.028; Mochon AB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000827; Ohno S., 1970, EVOLUTION GENE DUPLI; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Poulin F, 2003, J BIOL CHEM, V278, P52290, DOI 10.1074/jbc.M310761200; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raman SNT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00654; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Rezelj VV, 2019, J VIROL, V93, DOI 10.1128/JVI.02068-18; Rialdi A, 2017, CELL, V169, P679, DOI 10.1016/j.cell.2017.04.021; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sabath N, 2012, MOL BIOL EVOL, V29, P3767, DOI 10.1093/molbev/mss179; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sendoel A, 2017, NATURE, V541, P494, DOI 10.1038/nature21036; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Sikora D, 2017, VIROLOGY, V509, P167, DOI 10.1016/j.virol.2017.06.020; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Strelkowa N, 2012, GENETICS, V192, P671, DOI 10.1534/genetics.112.143396; Stuller KA, 2010, J IMMUNOL, V184, P3850, DOI 10.4049/jimmunol.0902935; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Tilston-Lunel NL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080220; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Wallat GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087577; Wang XQ, 2004, NUCLEIC ACIDS RES, V32, P1382, DOI 10.1093/nar/gkh305; Wei JJ, 2019, MOL CELL, V73, P1162, DOI 10.1016/j.molcel.2018.12.020; Wei JJ, 2019, VIROL SIN, V34, P162, DOI 10.1007/s12250-018-0061-y; Wei JJ, 2017, NAT MED, V23, P409, DOI 10.1038/nm.4317; Wen YR, 2009, NAT GENET, V41, P228, DOI 10.1038/ng.276; Westerhof LM, 2019, EUR J IMMUNOL, V49, P2019, DOI 10.1002/eji.201848026; Wise H. M, 2019, ALTERNATIVE AUG CODO, DOI [10.1101/738427, DOI 10.1101/738427]; Young SK, 2016, J BIOL CHEM, V291, P16927, DOI 10.1074/jbc.R116.733899; Zanker DJ, 2019, J IMMUNOL, V202, P3370, DOI 10.4049/jimmunol.1900070; Zhang Y, 2017, NUCLEIC ACIDS RES, V45, pD466, DOI 10.1093/nar/gkw857; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	86	18	18	5	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1502	+		10.1016/j.cell.2020.05.035	http://dx.doi.org/10.1016/j.cell.2020.05.035			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32559462	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000543822100010
J	Offer, G; Patel, Y; Hales, A; Diaz, LB; Marzook, M				Offer, Gregory; Patel, Yatish; Hales, Alastair; Bravo Diaz, Laura; Marzook, Mohamed			Cool metric for lithium-ion batteries could spur progress	NATURE			English	News Item						Chemistry; Energy; Industry; Engineering	TAB	A new measure for the rate of heat removal from battery packs gives manufacturers a simple way to compare products. A new measure for the rate of heat removal from battery packs gives manufacturers a simple way to compare products.	[Offer, Gregory; Patel, Yatish; Hales, Alastair; Bravo Diaz, Laura] Imperial Coll London, Electrochem Sci & Engn Grp, Mech Engn, London, England; [Offer, Gregory] Faraday Inst Multiscale Modelling, London, England; [Marzook, Mohamed] Imperial Coll London, Electrochem Sci & Engn Grp, London, England	Imperial College London; Imperial College London	Hales, A (corresponding author), Imperial Coll London, Electrochem Sci & Engn Grp, Mech Engn, London, England.	a.hales@imperial.ac.uk	Diaz, Laura Bravo/AAD-2042-2021	Diaz, Laura Bravo/0000-0002-0259-8590; Hales, Alastair/0000-0001-6126-6986				Adams D.T., 2009, Patent Application Publication, Patent No. [2009/0023056A1, 20090023056]; Choudhary A., 2020, STORAGE DISTRIBUTION; Dondelewski O, ETRANSPORTATION; Hales A, 2020, J ELECTROCHEM SOC, V167, DOI 10.1149/1945-7111/ab6985; Hales A, 2019, J ELECTROCHEM SOC, V166, pA2383, DOI 10.1149/2.0191912jes; Hunt IA, 2016, J ELECTROCHEM SOC, V163, pA1846, DOI 10.1149/2.0361609jes; Ianniciello L, 2018, J POWER SOURCES, V378, P383, DOI 10.1016/j.jpowsour.2017.12.071; Rogers G., 1992, ENG THERMODYNAMICS W; Zhao Y, 2018, J ELECTROCHEM SOC, V165, pA3169, DOI 10.1149/2.0901813jes	9	26	26	14	59	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					485	487		10.1038/d41586-020-01813-8	http://dx.doi.org/10.1038/d41586-020-01813-8			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB5RX	32576998	Green Submitted			2022-12-28	WOS:000542661100012
J	Oginuma, M; Harima, Y; Tarazona, OA; Diaz-Cuadros, M; Michaut, A; Ishitani, T; Xiong, FZ; Pourquie, O				Oginuma, Masayuki; Harima, Yukiko; Tarazona, Oscar A.; Diaz-Cuadros, Margarete; Michaut, Arthur; Ishitani, Tohru; Xiong, Fengzhu; Pourquie, Olivier			Intracellular pH controls WNT downstream of glycolysis in amniote embryos	NATURE			English	Article							PLURIPOTENT STEM-CELLS; PRESOMITIC MESODERM; BETA-CATENIN; SEGMENTATION; GRADIENT; CLOCK; DIFFERENTIATION; ACETYLATION; PROGENITORS; ELONGATION	Formation of the body of vertebrate embryos proceeds sequentially by posterior addition of tissues from the tail bud. Cells of the tail bud and the posterior presomitic mesoderm, which control posterior elongation(1), exhibit a high level of aerobic glycolysis that is reminiscent of the metabolic status of cancer cells experiencing the Warburg effect(2,3). Glycolytic activity downstream of fibroblast growth factor controls WNT signalling in the tail bud(3). In the neuromesodermal precursors of the tail bud(4), WNT signalling promotes the mesodermal fate that is required for sustained axial elongation, at the expense of the neural fate(3,5). How glycolysis regulates WNT signalling in the tail bud is currently unknown. Here we used chicken embryos and human tail bud-like cells differentiated in vitro from induced pluripotent stem cells to show that these cells exhibit an inverted pH gradient, with the extracellular pH lower than the intracellular pH, as observed in cancer cells(6). Our data suggest that glycolysis increases extrusion of lactate coupled to protons via the monocarboxylate symporters. This contributes to elevating the intracellular pH in these cells, which creates a favourable chemical environment for non-enzymatic beta -catenin acetylation downstream of WNT signalling. As acetylated beta -catenin promotes mesodermal rather than neural fate(7), this ultimately leads to activation of mesodermal transcriptional WNT targets and specification of the paraxial mesoderm in tail bud precursors. Our work supports the notion that some tumour cells reactivate a developmental metabolic programme. The authors show that metabolic activity leads to an increase in the intracellular pH of neuromesodermal precursors, and that this increase in pH, by allowing post-translational modification of beta -catenin, is required for the activation of WNT signalling and mesodermal fate acquisition.	[Oginuma, Masayuki; Harima, Yukiko; Tarazona, Oscar A.; Diaz-Cuadros, Margarete; Michaut, Arthur; Xiong, Fengzhu; Pourquie, Olivier] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Oginuma, Masayuki; Harima, Yukiko; Tarazona, Oscar A.; Diaz-Cuadros, Margarete; Michaut, Arthur; Xiong, Fengzhu; Pourquie, Olivier] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Oginuma, Masayuki; Ishitani, Tohru] Gunma Univ, IMCR, Gunma, Japan; [Ishitani, Tohru] Osaka Univ, RIMD, Osaka, Japan; [Pourquie, Olivier] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Gunma University; Osaka University; Harvard University	Pourquie, O (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Pourquie, O (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Pourquie, O (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	pourquie@genetics.med.harvard.edu	Pourquié, Olivier/CAJ-5443-2022; XIONG, FENGZHU/A-9590-2015	Pourquié, Olivier/0000-0001-5189-1227; XIONG, FENGZHU/0000-0002-6153-0254; , Tohru/0000-0002-6200-7043; MICHAUT, Arthur/0000-0003-1226-0021	US National Institutes of Health [5R01HD085121]; National Institutes of Health K99 award [HD092582]; AMED [JP19gm5010001];  [29-456];  [25117720];  [19H04768];  [16H05141];  [19H03412];  [19K06673]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health K99 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AMED; ; ; ; ; ; 	We thank N. Perrimon and members of the Pourquie laboratory for critical reading of the manuscript and discussions. Y.H. acknowledges Grant-in-Aid for JSPS Fellows (29-456). Research in the Pourquie laboratory was funded by a grant from the US National Institutes of Health (5R01HD085121). F.X. acknowledges the National Institutes of Health K99 award HD092582. This work was supported by AMED (JP19gm5010001 to T.I.), a Grant-inAid for Scientific Research on Innovative Areas (25117720 to T.I. and 19H04768 to M.O.), Scientific Research (B) (16H05141 and 19H03412 to T.I.) and Scientific Research (C) (19K06673 to M.O.).	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Buchberger A, 2000, MECH DEVELOP, V97, P223, DOI 10.1016/S0925-4773(00)00424-X; Chal J, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.157339; Chal J, 2016, NAT PROTOC, V11, P1833, DOI 10.1038/nprot.2016.110; Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297; Chalamalasetty RB, 2014, DEVELOPMENT, V141, P4285, DOI 10.1242/dev.110908; CHAMBARD JC, 1986, EXP CELL RES, V164, P282, DOI 10.1016/0014-4827(86)90029-7; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Chiche J, 2012, INT J CANCER, V130, P1511, DOI 10.1002/ijc.26125; Denans N, 2015, ELIFE, V4, DOI 10.7554/eLife.04379; Diaz-Cuadros M, 2020, NATURE, V580, P113, DOI 10.1038/s41586-019-1885-9; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; FELLENZ MP, 1988, RADIAT RES, V116, P305, DOI 10.2307/3577466; Grillo-Hill BK, 2014, METHOD CELL BIOL, V123, P429, DOI 10.1016/B978-0-12-420138-5.00023-9; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Henrique D, 2015, DEVELOPMENT, V142, P2864, DOI 10.1242/dev.119768; Hoffmeyer K, 2017, CELL REP, V18, P2815, DOI 10.1016/j.celrep.2017.02.076; Iimura T, 2008, METHOD CELL BIOL, V87, P257, DOI 10.1016/S0091-679X(08)00213-6; Kimelman D, 2016, CURR TOP DEV BIOL, V116, P517, DOI 10.1016/bs.ctdb.2015.12.008; Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834; Melnik S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0033-2; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nowotschin S, 2012, DEV BIOL, V367, P1, DOI 10.1016/j.ydbio.2012.04.012; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Oginuma M, 2017, DEV CELL, V40, P342, DOI 10.1016/j.devcel.2017.02.001; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Wagman AS, 2004, CURR PHARM DESIGN, V10, P1105, DOI 10.2174/1381612043452668; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; White KA, 2018, J CELL BIOL, V217, P3965, DOI 10.1083/jcb.201712041; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yoon JK, 2000, GENE DEV, V14, P3204, DOI 10.1101/gad.850000	39	45	45	2	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					98	+		10.1038/s41586-020-2428-0	http://dx.doi.org/10.1038/s41586-020-2428-0		JUN 2020	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32581357	Green Accepted			2022-12-28	WOS:000556407000001
J	Lunke, S; Eggers, S; Wilson, M; Patel, C; Barnett, CP; Pinner, J; Sandaradura, SA; Buckley, MF; Krzesinski, EI; de Silva, MG; Brett, GR; Boggs, K; Mowat, D; Kirk, EP; Ades, LC; Akesson, LS; Amor, DJ; Ayres, S; Baxendale, A; Borrie, S; Bray, A; Brown, NJ; Chan, CY; Chong, B; Cliffe, C; Delatycki, MB; Edwards, M; Elakis, G; Fahey, MC; Fennell, A; Fowles, L; Gallacher, L; Higgins, M; Howell, KB; Hunt, L; Hunter, MF; Jones, KJ; King, S; Kumble, S; Lang, S; Le Moing, M; Ma, A; Phelan, D; Quinn, MCJ; Richards, A; Richmond, CM; Riseley, J; Rodgers, J; Sachdev, R; Sadedin, S; Schlapbach, LJ; Smith, J; Springer, A; Tan, NB; Tan, TY; Temple, SL; Theda, C; Vasudevan, A; White, SM; Yeung, A; Zhu, Y; Martyn, M; Best, S; Roscioli, T; Christodoulou, J; Stark, Z				Lunke, Sebastian; Eggers, Stefanie; Wilson, Meredith; Patel, Chirag; Barnett, Christopher P.; Pinner, Jason; Sandaradura, Sarah A.; Buckley, Michael F.; Krzesinski, Emma I.; de Silva, Michelle G.; Brett, Gemma R.; Boggs, Kirsten; Mowat, David; Kirk, Edwin P.; Ades, Lesley C.; Akesson, Lauren S.; Amor, David J.; Ayres, Samantha; Baxendale, Anne; Borrie, Sarah; Bray, Alessandra; Brown, Natasha J.; Chan, Cheng Yee; Chong, Belinda; Cliffe, Corrina; Delatycki, Martin B.; Edwards, Matthew; Elakis, George; Fahey, Michael C.; Fennell, Andrew; Fowles, Lindsay; Gallacher, Lyndon; Higgins, Megan; Howell, Katherine B.; Hunt, Lauren; Hunter, Matthew F.; Jones, Kristi J.; King, Sarah; Kumble, Smitha; Lang, Sarah; Le Moing, Maelle; Ma, Alan; Phelan, Dean; Quinn, Michael C. J.; Richards, Anna; Richmond, Christopher M.; Riseley, Jessica; Rodgers, Jonathan; Sachdev, Rani; Sadedin, Simon; Schlapbach, Luregn J.; Smith, Janine; Springer, Amanda; Tan, Natalie B.; Tan, Tiong Y.; Temple, Suzanna L.; Theda, Christiane; Vasudevan, Anand; White, Susan M.; Yeung, Alison; Zhu, Ying; Martyn, Melissa; Best, Stephanie; Roscioli, Tony; Christodoulou, John; Stark, Zornitza		Australian Genomics Hlth Alliance	Feasibility of Ultra-Rapid Exome Sequencing in Critically Ill Infants and Children With Suspected Monogenic Conditions in the Australian Public Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VARIANTS; GENOMICS	Key PointsQuestionCan ultra-rapid genomic testing be performed for critically ill pediatric patients in a public health care system? FindingsThis multisite descriptive feasibility study included 12 Australian hospitals and 2 laboratories. Among the 108 critically ill infants and children with suspected monogenic conditions who had ultra-rapid genomic testing, the mean time to genomic test report was 3.3 days and the molecular diagnostic yield was 51%. MeaningThis study suggests feasibility of ultra-rapid genomic testing in a public setting for critically ill pediatric patients. However, further research is needed to understand its clinical value. ImportanceWidespread adoption of rapid genomic testing in pediatric critical care requires robust clinical and laboratory pathways that provide equitable and consistent service across health care systems. ObjectiveTo prospectively evaluate the performance of a multicenter network for ultra-rapid genomic diagnosis in a public health care system. Design, Setting, and ParticipantsDescriptive feasibility study of critically ill pediatric patients with suspected monogenic conditions treated at 12 Australian hospitals between March 2018 and February 2019, with data collected to May 2019. A formal implementation strategy emphasizing communication and feedback, standardized processes, coordination, distributed leadership, and collective learning was used to facilitate adoption. ExposuresUltra-rapid exome sequencing. Main Outcomes and MeasuresThe primary outcome was time from sample receipt to ultra-rapid exome sequencing report. The secondary outcomes were the molecular diagnostic yield, the change in clinical management after the ultra-rapid exome sequencing report, the time from hospital admission to the laboratory report, and the proportion of laboratory reports returned prior to death or hospital discharge. ResultsThe study population included 108 patients with a median age of 28 days (range, 0 days to 17 years); 34% were female; and 57% were from neonatal intensive care units, 33% were from pediatric intensive care units, and 9% were from other hospital wards. The mean time from sample receipt to ultra-rapid exome sequencing report was 3.3 days (95% CI, 3.2-3.5 days) and the median time was 3 days (range, 2-7 days). The mean time from hospital admission to ultra-rapid exome sequencing report was 17.5 days (95% CI, 14.6-21.1 days) and 93 reports (86%) were issued prior to death or hospital discharge. A molecular diagnosis was established in 55 patients (51%). Eleven diagnoses (20%) resulted from using the following approaches to augment standard exome sequencing analysis: mitochondrial genome sequencing analysis, exome sequencing-based copy number analysis, use of international databases to identify novel gene-disease associations, and additional phenotyping and RNA analysis. In 42 of 55 patients (76%) with a molecular diagnosis and 6 of 53 patients (11%) without a molecular diagnosis, the ultra-rapid exome sequencing result was considered as having influenced clinical management. Targeted treatments were initiated in 12 patients (11%), treatment was redirected toward palliative care in 14 patients (13%), and surveillance for specific complications was initiated in 19 patients (18%). Conclusions and RelevanceThis study suggests feasibility of ultra-rapid genomic testing in critically ill pediatric patients with suspected monogenic conditions in the Australian public health care system. However, further research is needed to understand the clinical value of such testing, and the generalizability of the findings to other health care settings. This descriptive study characterizes time from sample receipt to sequence report as a measure of the feasibility of ultra-rapid genomic diagnosis of critically ill pediatric patients with suspected monogenic conditions in an Australian public health care system.	[Lunke, Sebastian; Eggers, Stefanie; de Silva, Michelle G.; Brett, Gemma R.; Akesson, Lauren S.; Ayres, Samantha; Brown, Natasha J.; Chong, Belinda; Delatycki, Martin B.; Gallacher, Lyndon; Kumble, Smitha; Le Moing, Maelle; Phelan, Dean; Richmond, Christopher M.; Riseley, Jessica; Sadedin, Simon; Tan, Natalie B.; Tan, Tiong Y.; White, Susan M.; Yeung, Alison; Christodoulou, John; Stark, Zornitza] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, 50 Flemington Rd, Parkville, Vic 3052, Australia; [Lunke, Sebastian; de Silva, Michelle G.; Boggs, Kirsten; Ayres, Samantha; Bray, Alessandra; King, Sarah; Best, Stephanie; Christodoulou, John; Stark, Zornitza] Australian Genom Hlth Alliance, Parkville, Vic, Australia; [Lunke, Sebastian; de Silva, Michelle G.; Brett, Gemma R.; Akesson, Lauren S.; Amor, David J.; Brown, Natasha J.; Delatycki, Martin B.; Gallacher, Lyndon; Howell, Katherine B.; Tan, Tiong Y.; Theda, Christiane; White, Susan M.; Christodoulou, John; Stark, Zornitza] Univ Melbourne, Melbourne, Vic, Australia; [Wilson, Meredith; Sandaradura, Sarah A.; Boggs, Kirsten; Ades, Lesley C.; Bray, Alessandra; Jones, Kristi J.; Ma, Alan; Smith, Janine] Sydney Childrens Hosp Network Westmead, Sydney, NSW, Australia; [Wilson, Meredith; Sandaradura, Sarah A.; Ades, Lesley C.; Jones, Kristi J.; Ma, Alan; Smith, Janine; Christodoulou, John] Univ Sydney, Sydney, NSW, Australia; [Patel, Chirag; Fowles, Lindsay; Higgins, Megan; Hunt, Lauren; Quinn, Michael C. J.; Rodgers, Jonathan] Royal Brisbane & Womens Hosp, Genet Hlth Queensland, Brisbane, Qld, Australia; [Barnett, Christopher P.; Pinner, Jason; Boggs, Kirsten; Mowat, David; Kirk, Edwin P.; Baxendale, Anne; Borrie, Sarah; Bray, Alessandra; Sachdev, Rani] Sydney Childrens Hosp Network Randwick, Adelaide, SA, Australia; [Pinner, Jason; Mowat, David; Kirk, Edwin P.; Roscioli, Tony] Univ New South Wales, Sydney, NSW, Australia; [Buckley, Michael F.; Kirk, Edwin P.; Chan, Cheng Yee; Cliffe, Corrina; Elakis, George; Lang, Sarah; Richards, Anna; Temple, Suzanna L.; Zhu, Ying; Roscioli, Tony] NSW Hlth Pathol Randwick Genom Lab, Sydney, NSW, Australia; [Krzesinski, Emma I.; Akesson, Lauren S.; Fahey, Michael C.; Fennell, Andrew; Hunter, Matthew F.; Springer, Amanda; Yeung, Alison] Monash Hlth, Monash Genet, Melbourne, Vic, Australia; [Krzesinski, Emma I.; Fahey, Michael C.; Fennell, Andrew; Hunter, Matthew F.; Springer, Amanda] Monash Univ, Dept Paediat, Melbourne, Vic, Australia; [Amor, David J.; Howell, Katherine B.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Amor, David J.; Howell, Katherine B.; Theda, Christiane; Martyn, Melissa; Best, Stephanie] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Chan, Cheng Yee; Roscioli, Tony] Univ New South Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Edwards, Matthew] Hunter Genet, Newcastle, NSW, Australia; [Edwards, Matthew] Univ Western Sydney, Dept Paediat, Sch Med, Sydney, NSW, Australia; [Higgins, Megan; Hunt, Lauren] Univ Queensland, Brisbane, Qld, Australia; [King, Sarah] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [King, Sarah] Univ South Australia, Adelaide, SA, Australia; [Schlapbach, Luregn J.] Univ Queensland, Paediat Crit Care Res Grp, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Schlapbach, Luregn J.] Queensland Childrens Hosp, Brisbane, Qld, Australia; [Theda, Christiane; Vasudevan, Anand] Royal Womens Hosp, Melbourne, Vic, Australia; [Martyn, Melissa] Melbourne Genom Hlth Alliance, Melbourne, Vic, Australia; [Best, Stephanie] Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Sydney; Royal Brisbane & Women's Hospital; University of New South Wales Sydney; Monash University; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Neuroscience Research Australia; University of New South Wales Sydney; Western Sydney University; University of Queensland; Centre for Cancer Biology; SA Pathology; University of South Australia; University of Queensland; Macquarie University	Stark, Z (corresponding author), Murdoch Childrens Res Inst, Victorian Clin Genet Serv, 50 Flemington Rd, Parkville, Vic 3052, Australia.	zornitza.stark@vcgs.org.au	Brown, Natasha Jane/AAP-6872-2020; Edwards, Matthew/L-8698-2019; Martyn, Melissa/H-4960-2013; Amor, David J/A-6478-2018; Schlapbach, Luregn J/F-7465-2017; de Silva, Michelle/E-5848-2011; Hunt, Lauren/E-1151-2015	Brown, Natasha Jane/0000-0002-1822-9191; Edwards, Matthew/0000-0001-8437-8120; Amor, David J/0000-0001-7191-8511; Schlapbach, Luregn J/0000-0003-2281-2598; Patel, Chirag/0000-0002-6374-5224; de Silva, Michelle/0000-0002-2304-3834; Martyn, Melissa/0000-0001-5263-4329; Best, Stephanie/0000-0002-1107-8976; Hunt, Lauren/0000-0002-2872-0144; Phelan, Dean/0000-0002-1076-2821; Lunke, Sebastian/0000-0002-7168-0723; Richmond, Christopher/0000-0002-9778-4344; Sadedin, Simon/0000-0002-2144-7894; Chong, Belinda/0000-0002-6257-4304; Fennell, Andrew/0000-0001-6744-1810; Hunter, Matthew/0000-0002-2475-6545	National Health and Medical Research Council [GNT1113531]; Royal Children's Hospital Foundation [2017-906]; Sydney Children's Hospital Network; Channel 7 Children's Research Foundation; Victorian government's operational infrastructure support program	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Royal Children's Hospital Foundation; Sydney Children's Hospital Network; Channel 7 Children's Research Foundation; Victorian government's operational infrastructure support program	The Australian Genomics Health Alliance (Australian Genomics) project was funded by grant GNT1113531 from the National Health and Medical Research Council Targeted Call for Research, grant 2017-906 from the Royal Children's Hospital Foundation, and unspecified grants from the Sydney Children's Hospital Network and the Channel 7 Children's Research Foundation. The research conducted at the Murdoch Children's Research Institute was supported by the Victorian government's operational infrastructure support program.	Akesson LS, 2019, EUR J HUM GENET, V27, P1821, DOI 10.1038/s41431-019-0477-3; Braithwaite J, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1057-z; Clark MM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat6177; Cooper MS, 2019, BRAIN, V142, DOI 10.1093/brain/awz183; Costain G, 2019, BRAIN, V142, P1195, DOI 10.1093/brain/awz072; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Farnaes L, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0049-4; French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x; Friedman JM, 2019, GENET MED, V21, P498, DOI 10.1038/s41436-018-0055-z; Greenhalgh T, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2068; Grosse SD, 2019, GENET MED, V21, P269, DOI 10.1038/s41436-018-0124-3; Gubbels CS, 2020, GENET MED, V22, P736, DOI 10.1038/s41436-019-0708-6; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kingsmore SF, 2019, AM J HUM GENET, V105, P719, DOI 10.1016/j.ajhg.2019.08.009; Meng LY, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.3438; Mestek-Boukhibar L, 2018, J MED GENET, V55, P721, DOI 10.1136/jmedgenet-2018-105396; Petrikin JE, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0045-8; Rehman AU, 2019, HUM MUTAT, V40, P267, DOI 10.1002/humu.23694; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Richmond CM, 2020, MOL SYNDROMOL, V11, P50, DOI 10.1159/000505886; Sanford EF, 2019, PEDIATR CRIT CARE ME, V20, P1007, DOI 10.1097/PCC.0000000000002056; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stark Z, 2019, AM J HUM GENET, V105, P7, DOI 10.1016/j.ajhg.2019.06.003; Stark Z, 2019, EUR J HUM GENET, V27, P1493, DOI 10.1038/s41431-019-0429-y; Stark Z, 2018, GENET MED, V20, P1554, DOI 10.1038/gim.2018.37	26	88	88	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2503	2511		10.1001/jama.2020.7671	http://dx.doi.org/10.1001/jama.2020.7671			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32573669	Green Published, Bronze			2022-12-28	WOS:000590149400022
J	Slomski, A				Slomski, Anita			Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2453	2453		10.1001/jama.2020.10336	http://dx.doi.org/10.1001/jama.2020.10336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2EU	32573666				2022-12-28	WOS:000595447000003
J	Atkins, E; Mughal, NA; Place, F; Coughlin, PA				Atkins, Eleanor; Mughal, Nadeem A.; Place, Fiona; Coughlin, Patrick A.			Varicose veins in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC VENOUS INSUFFICIENCY; GENERAL-POPULATION; SYMPTOMS; METAANALYSIS; MANAGEMENT; DISORDERS; WOMEN; SIGNS		[Atkins, Eleanor] East Suffolk & North Essex NHS Fdn Trust, Colchester, Essex, England; [Mughal, Nadeem A.] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich, Norfolk, England; [Place, Fiona] Rookery Med Ctr, Newmarket, Suffolk, England; [Coughlin, Patrick A.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Vasc Unit, Cambridge, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; University of Cambridge	Atkins, E (corresponding author), East Suffolk & North Essex NHS Fdn Trust, Colchester, Essex, England.	eleanor.atkins@nhs.net		Coughlin, Patrick/0000-0003-1342-1114				Barros Jnr N., 2010, J VASC BRAS, V9, P29, DOI DOI 10.1590/S1677-54492010000200004; Belcaro G, 2017, INT J ANGIOL, V26, P12, DOI 10.1055/s-0033-1363784; CALLAM MJ, 1994, BRIT J SURG, V81, P167, DOI 10.1002/bjs.1800810204; Campbell WB, 2007, EUR J VASC ENDOVASC, V34, P741, DOI 10.1016/j.ejvs.2007.07.012; Cesarone MR, 2007, ANGIOLOGY, V58, p7S, DOI 10.1177/0003319706297643; Cesarone MR, 2007, ANGIOLOGY, V58, p16S, DOI 10.1177/0003319706297740; Chiesa R, 2007, J VASC SURG, V46, P322, DOI 10.1016/j.jvs.2007.04.030; Davies AH, 2019, ADV THER, V36, P5, DOI 10.1007/s12325-019-0881-7; Eds Thompson MM, 2016, OXFORD TXB VASCULAR; Evans CJ, 1999, J EPIDEMIOL COMMUN H, V53, P149, DOI 10.1136/jech.53.3.149; Ismail L, 2016, J VASC SURG-VENOUS L, V4, P518, DOI 10.1016/j.jvsv.2016.06.003; Kakkos SK, 2018, INT ANGIOL, V37, P143, DOI 10.23736/S0392-9590.18.03975-5; Lee AJ, 2015, J VASC SURG-VENOUS L, V3, P18, DOI 10.1016/j.jvsv.2014.09.008; Leon L, 2005, EUR J VASC ENDOVASC, V29, P10, DOI 10.1016/j.ejvs.2004.09.021; Michaels J A, 2006, Health Technol Assess, V10, P1; National Institute of Health and Care Excellence, 2017, CLIN KNOWL SUMM COMP; National Institute of Health and Care Excellence, 2020, CLIN KNOWL SUMM SUP; National Institute of Health and Care Excellence, 2013, VAR VEINS DIAGN MAN; Nicolaides A, 2018, INT ANGIOL, V37, P181, DOI 10.23736/S0392-9590.18.03999-8; O'Donnell TF, 2016, J VASC SURG-VENOUS L, V4, P97, DOI 10.1016/j.jvsv.2014.11.004; Onida Sarah, 2013, Practitioner, V257, P21; Paravastu SCV, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010878.pub2; POLLACK AA, 1949, J CLIN INVEST, V28, P559, DOI 10.1172/JCI102105; Scottish Intercollegiate Guidelines Network (SIGN), 2010, MAN CHRON VEN LEG UL; Shingler S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008819.pub3; Simon DA, 2004, BMJ-BRIT MED J, V328, P1358, DOI 10.1136/bmj.328.7452.1358; Tisi PV., 2011, BMJ CLIN EVID, V2011, P0212; Todd Marie, 2015, Br J Nurs, V24, P210, DOI 10.12968/bjon.2015.24.4.210	28	2	2	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2509	10.1136/bmj.m2509	http://dx.doi.org/10.1136/bmj.m2509			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OH6NA	32636215				2022-12-28	WOS:000582708000001
J	Majid, A				Majid, Aisha			People with mental health problems are more likely to be referred to government's counterterrorism programme	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Government HM, 2015, REV PREV DUT GUID EN; GULLAND A, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1998; IACOBUCCI G, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/bmj.k2869; Medact, FALS POS PREV COUNT	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2020	370								m2713	10.1136/bmj.m2713	http://dx.doi.org/10.1136/bmj.m2713			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MJ5XW	32631941				2022-12-28	WOS:000548163900002
J	Patsyk, A; Sivan, U; Segev, M; Bandres, MA				Patsyk, Anatoly; Sivan, Uri; Segev, Mordechai; Bandres, Miguel A.			Observation of branched flow of light	NATURE			English	Article								When waves propagate through a weak disordered potential with correlation length larger than the wavelength, they form channels (branches) of enhanced intensity that keep dividing as the waves propagate(1). This fundamental wave phenomenon is known as branched flow. It was first observed for electrons(1-6)and for microwave cavities(7,8), and it is generally expected for waves with vastly different wavelengths, for example, branched flow has been suggested as a focusing mechanism for ocean waves(9-11), and was suggested to occur also in sound waves(12)and ultrarelativistic electrons in graphene(13). Branched flow may act as a trigger for the formation of extreme nonlinear events(14-17)and as a channel through which energy is transmitted in a scattering medium(18). Here we present the experimental observation of the branched flow of light. We show that, as light propagates inside a thin soap membrane, smooth thickness variations in the film act as a correlated disordered potential, focusing the light into filaments that display the features of branched flow: scaling of the distance to the first branching point and the probability distribution of the intensity. We find that, counterintuitively, despite the random variations in the medium and the linear nature of the effect, the filaments remain collimated throughout their paths. Bringing branched flow to the field of optics, with its full arsenal of tools, opens the door to the investigation of a plethora of new ideas such as branched flow in nonlinear media, in curved space or in active systems with gain. Furthermore, the labile nature of soap films leads to a regime in which the branched flow of light interacts and affects the underlying disorder through radiation pressure and gradient force. Branched flow of light is experimentally observed inside a thin soap membrane, where smooth variations of the membrane thickness transform the light beam into branched filaments of enhanced intensity that keep dividing as the waves propagate.	[Patsyk, Anatoly; Sivan, Uri; Segev, Mordechai] Technion Israel Inst Technol, Dept Phys, Haifa, Israel; [Patsyk, Anatoly; Sivan, Uri; Segev, Mordechai] Technion Israel Inst Technol, Inst Solid State, Haifa, Israel; [Sivan, Uri; Segev, Mordechai] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, Haifa, Israel; [Bandres, Miguel A.] Univ Cent Florida, CREOL, Coll Opt & Photon, Orlando, FL 32816 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; State University System of Florida; University of Central Florida	Segev, M (corresponding author), Technion Israel Inst Technol, Dept Phys, Haifa, Israel.; Segev, M (corresponding author), Technion Israel Inst Technol, Inst Solid State, Haifa, Israel.; Segev, M (corresponding author), Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, Haifa, Israel.; Bandres, MA (corresponding author), Univ Cent Florida, CREOL, Coll Opt & Photon, Orlando, FL 32816 USA.	msegev@technion.ac.il; bandres@creol.ucf.edu		Bandres, Miguel A./0000-0002-7145-8567				Aidala KE, 2007, NAT PHYS, V3, P464, DOI 10.1038/nphys628; Akhmediev N, 2009, PHYS LETT A, V373, P675, DOI 10.1016/j.physleta.2008.12.036; ASHKIN A, 1982, OPT LETT, V7, P276, DOI 10.1364/OL.7.000276; Barkhofen S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.183902; Bekenstein R, 2015, NAT PHYS, V11, P872, DOI [10.1038/nphys3451, 10.1038/NPHYS3451]; Bekenstein R, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011038; Berry M. V., 1980, Progress in optics. Vol.XVIII, P257, DOI 10.1016/S0079-6638(08)70215-4; Brandstotter A, 2019, P NATL ACAD SCI USA, V116, P13260, DOI 10.1073/pnas.1905217116; Degueldre H, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.024301; Degueldre H, 2016, NAT PHYS, V12, P259, DOI [10.1038/nphys3557, 10.1038/NPHYS3557]; Dudley JM, 2014, NAT PHOTONICS, V8, DOI [10.1038/nphoton.2014.220, 10.1038/NPHOTON.2014.220]; El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632; Heller EJ, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004748; Heller E. J., 2019, BRANCHED FLOW; Hohmann R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.093901; Jura MP, 2007, NAT PHYS, V3, P841, DOI 10.1038/nphys756; Kaplan L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.184103; Kravtsov Y.A., 1993, CAUSTICS CATASTROPHE; Lamhot Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.264503; Liu B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.236804; Maryenko D, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195329; Mattheakis M, 2016, CHAOS SOLITON FRACT, V84, P73, DOI 10.1016/j.chaos.2016.01.008; Mattheakis M., 2015, EXTREME WAVES BRANCH, P425; Mattheakis M, 2018, EPL-EUROPHYS LETT, V122, DOI 10.1209/0295-5075/122/27003; Metzger JJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.203903; Metzger JJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.013901; Metzger JJ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.020601; Patsyk A, 2018, CONF LASER ELECTR; Patsyk A, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011001; Schley R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6189; Schwartz T, 2007, NATURE, V446, P52, DOI 10.1038/nature05623; Shaw S., 2002, THESIS; Topinka MA, 2001, NATURE, V410, P183, DOI 10.1038/35065553; Wolfson MA, 2001, J ACOUST SOC AM, V109, P2693, DOI 10.1121/1.1362685; Ying LH, 2011, NONLINEARITY, V24, pR67, DOI 10.1088/0951-7715/24/11/R01	35	36	38	15	155	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					60	+		10.1038/s41586-020-2376-8	http://dx.doi.org/10.1038/s41586-020-2376-8			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32612225				2022-12-28	WOS:000544773600010
J	Napolitano, G; Di Malta, C; Esposito, A; de Araujo, MEG; Pece, S; Bertalot, G; Matarese, M; Benedetti, V; Zampelli, A; Stasyk, T; Siciliano, D; Venuta, A; Cesana, M; Vilardo, C; Nusco, E; Monfregola, J; Calcagni, A; Di Fiore, PP; Huber, LA; Ballabio, A				Napolitano, Gennaro; Di Malta, Chiara; Esposito, Alessandra; de Araujo, Mariana E. G.; Pece, Salvatore; Bertalot, Giovanni; Matarese, Maria; Benedetti, Valerio; Zampelli, Angela; Stasyk, Taras; Siciliano, Diletta; Venuta, Alessandro; Cesana, Marcella; Vilardo, Claudia; Nusco, Edoardo; Monfregola, Jlenia; Calcagni, Alessia; Di Fiore, Pier Paolo; Huber, Lukas A.; Ballabio, Andrea			A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dube syndrome	NATURE			English	Article							RAG GTPASES; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL CONTROL; MOLECULAR-GENETICS; GAP ACTIVITY; ACTIVATION; AUTOPHAGY; COMPLEX; FOLLICULIN; LYSOSOME	The mechanistic target of rapamycin complex 1 (mTORC1) is a key metabolic hub that controls the cellular response to environmental cues by exerting its kinase activity on multiple substrates(1-3). However, whether mTORC1 responds to diverse stimuli by differentially phosphorylating specific substrates is poorly understood. Here we show that transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy(4,5), is phosphorylated by mTORC1 via a substrate-specific mechanism that is mediated by Rag GTPases. Owing to this mechanism, the phosphorylation of TFEB-unlike other substrates of mTORC1, such as S6K and 4E-BP1- is strictly dependent on the amino-acid-mediated activation of RagC and RagD GTPases, but is insensitive to RHEB activity induced by growth factors. This mechanism has a crucial role in Birt-Hogg-Dube syndrome, a disorder that is caused by mutations in the RagC and RagD activator folliculin (FLCN) and is characterized by benign skin tumours, lung and kidney cysts and renal cell carcinoma(6,7). We found that constitutive activation of TFEB is the main driver of the kidney abnormalities and mTORC1 hyperactivity in a mouse model of Birt-Hogg-Dube syndrome. Accordingly, depletion of TFEB in kidneys of these mice fully rescued the disease phenotype and associated lethality, and normalized mTORC1 activity. Our findings identify a mechanism that enables differential phosphorylation of mTORC1 substrates, the dysregulation of which leads to kidney cysts and cancer. Dysregulation of an mTORC1 substrate-specific mechanism leads to constitutive activation of TFEB, and promotes kidney cystogenesis and tumorigenesis in a mouse model of Birt-Hogg-Dube syndrome.	[Napolitano, Gennaro; Di Malta, Chiara; Esposito, Alessandra; Matarese, Maria; Benedetti, Valerio; Zampelli, Angela; Siciliano, Diletta; Venuta, Alessandro; Cesana, Marcella; Vilardo, Claudia; Nusco, Edoardo; Monfregola, Jlenia; Ballabio, Andrea] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Napolitano, Gennaro; Ballabio, Andrea] Univ Naples Federico II, Dept Med & Translat Sci, Med Genet Unit, Naples, Italy; [de Araujo, Mariana E. G.; Stasyk, Taras; Huber, Lukas A.] Med Univ Innsbruck, Bioctr, Inst Cell Biol, Innsbruck, Austria; [Pece, Salvatore; Bertalot, Giovanni; Di Fiore, Pier Paolo] European Inst Oncol IRCCS, IEO, Milan, Italy; [Pece, Salvatore; Di Fiore, Pier Paolo] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Calcagni, Alessia; Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Calcagni, Alessia; Ballabio, Andrea] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Huber, Lukas A.] Austrian Drug Screening Inst ADSI, Innsbruck, Austria; [Ballabio, Andrea] Univ Naples Federico II, SSM Sch Adv Studies, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Medical University of Innsbruck; IRCCS European Institute of Oncology (IEO); University of Milan; Baylor College of Medicine; Baylor College of Medicine; University of Naples Federico II	Ballabio, A (corresponding author), Telethon Inst Genet & Med TIGEM, Naples, Italy.; Ballabio, A (corresponding author), Univ Naples Federico II, Dept Med & Translat Sci, Med Genet Unit, Naples, Italy.; Ballabio, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Ballabio, A (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Ballabio, A (corresponding author), Univ Naples Federico II, SSM Sch Adv Studies, Naples, Italy.	ballabio@tigem.it	Calcagni, Alessia/AAB-7918-2021; Huber, Lukas Alfons/AAM-3499-2021; Di Malta, Chiara/AAX-6395-2020; Benedetti, Valerio/GWZ-7244-2022; Bertalot, Giovanni/AAV-8788-2021; Cesana, Marcella/AAC-2697-2022; Vilardo, Claudia/AAH-1518-2020; Monfregola, Jlenia/AAW-9055-2021; Napolitano, Gennaro/O-5377-2016	Calcagni, Alessia/0000-0002-1946-5815; Cesana, Marcella/0000-0002-9099-8681; Vilardo, Claudia/0000-0003-4713-5298; Eca Guimaraes de Araujo, Mariana/0000-0003-0576-2680; Stasyk, Taras/0000-0003-0568-6841; Venuta, Alessandro/0000-0002-9100-5151; Bertalot, Giovanni/0000-0002-4862-7705	Italian Telethon Foundation [TGM16CB6]; MIUR [PRIN 2017E5L5P3, PRIN 2017YF9FBS]; European Research Council [694282]; European Union [661271]; Huffington Foundation; European Regional Development Fund POR Campania FESR 2014/2020; US National Institutes of Health [R01-NS078072]; Associazione Italiana per la Ricerca sul Cancro A.I.R.C. [IG-22103, 5x1000-21051, MFAG-23538, IG-18988]; University of Naples 'Federico II' 'STAR L1 2018'; MCO [10000]; Italian Ministry of Health [RF-2016-02361540]	Italian Telethon Foundation(Fondazione Telethon); MIUR(Ministry of Education, Universities and Research (MIUR)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Huffington Foundation; European Regional Development Fund POR Campania FESR 2014/2020; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro A.I.R.C.(Fondazione AIRC per la ricerca sul cancro); University of Naples 'Federico II' 'STAR L1 2018'; MCO; Italian Ministry of Health(Ministry of Health, Italy)	We thank M. A. De Matteis, G. Diez-Roux, L. Murphy and C. Settembre for the critical reading of the manuscript; A. Iuliano for statistical analyisis; C. Soldati for software analysis of TFEB subcellular distribution; L. D'Orsi and N. Zampelli for technical help; and M. Mea for help in drawing the model figure. This work was supported by grants from the Italian Telethon Foundation `TGM16CB6' (A.B.); MIUR 'PRIN 2017E5L5P3' (A.B) and 'PRIN 2017YF9FBS' (G.N.); European Research Council H2020 AdG 'LYSOSOMICS 694282' (A.B.); European Union's Horizon 2020 MSCA 'REBuILD 661271' (G.N.); US National Institutes of Health `R01-NS078072' (A.B.); Huffington Foundation (A.B.); European Regional Development Fund POR Campania FESR 2014/2020 (A.B); Associazione Italiana per la Ricerca sul Cancro A.I.R.C. `IG-22103' and '5x1000-21051' (A.B.), 'MFAG-23538' (G.N.) and 'IG-18988' (P.P.D.F.); University of Naples 'Federico II' 'STAR L1 2018' (G.N.); MCO 10000 (P.P.D.F.); and Italian Ministry of Health ` RF-2016-02361540' (P.P.D.F.).	Anandapadamanaban M, 2019, SCIENCE, V366, P203, DOI 10.1126/science.aax3939; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Ballabio A, 2020, NAT REV MOL CELL BIO, V21, P101, DOI 10.1038/s41580-019-0185-4; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Calcagni A, 2016, ELIFE, V5, DOI 10.7554/eLife.17047; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; de Araujo MEG, 2017, SCIENCE, V358, P377, DOI 10.1126/science.aao1583; Di Malta C, 2017, SCIENCE, V356, P1188, DOI 10.1126/science.aag2553; Endoh M, 2020, CELL REP, V30, P1823, DOI 10.1016/j.celrep.2020.01.042; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kauffman EC, 2014, NAT REV UROL, V11, P465, DOI 10.1038/nrurol.2014.162; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lawrence RE, 2019, SCIENCE, V366, P971, DOI 10.1126/science.aax0364; Lawrence RE, 2018, NAT CELL BIOL, V20, P1052, DOI 10.1038/s41556-018-0148-6; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Napolitano G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05862-6; Napolitano G, 2015, EMBO MOL MED, V7, P158, DOI 10.15252/emmm.201404223; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Perera RM, 2019, ANNU REV CANC BIOL, V3, P203, DOI 10.1146/annurev-cancerbio-030518-055835; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Possik E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005520; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rogala KB, 2019, SCIENCE, V366, P468, DOI 10.1126/science.aay0166; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schmidt LS, 2018, GENE, V640, P28, DOI 10.1016/j.gene.2017.09.044; Schmidt LS, 2015, NAT REV UROL, V12, P558, DOI 10.1038/nrurol.2015.206; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016443.50138.CD; Shen K, 2019, CELL, V179, P1319, DOI 10.1016/j.cell.2019.10.036; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Wada S, 2016, GENE DEV, V30, P2551, DOI 10.1101/gad.287953.116; Yang HJ, 2017, NATURE, V552, P368, DOI 10.1038/nature25023	48	87	89	4	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 24	2020	585	7826					597	+		10.1038/s41586-020-2444-0	http://dx.doi.org/10.1038/s41586-020-2444-0		JUL 2020	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS9DW	32612235	Green Accepted			2022-12-28	WOS:000547610500001
J	Sokol, D; Dattani, R				Sokol, Daniel; Dattani, Rupen			How should surgeons obtain consent during the covid-19 pandemic?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel] 12 Kings Bench Walk, London, England; [Dattani, Rupen] Chelsea & Westminster Hosp, London, England	Imperial College London	Sokol, D (corresponding author), 12 Kings Bench Walk, London, England.	Sokol@12kbw.co.uk						COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X	1	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2539	10.1136/bmj.m2539	http://dx.doi.org/10.1136/bmj.m2539			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32605907	Bronze			2022-12-28	WOS:000548116400013
J	Christie, B				Christie, Bryan			Covid-19: Scotland "on track" to eliminate virus	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Records of Scotland, DEATHS INV COR SCOTL	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2609	10.1136/bmj.m2609	http://dx.doi.org/10.1136/bmj.m2609			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601074	Bronze			2022-12-28	WOS:000548112700012
J	Dyer, C				Dyer, Clare			Mesh implants: Women launch claims against NHS trusts and surgeons for failing to warn of risks	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L1503; DYER C, 2019, BMJ-BRIT MED J, V367, P57786, DOI DOI 10.1136/BMJ.L6659; Dyer C, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2201	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2020	369								m2605	10.1136/bmj.m2605	http://dx.doi.org/10.1136/bmj.m2605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ7IA	32591336				2022-12-28	WOS:000548259500001
J	Rimmer, A				Rimmer, Abi			Covid-19: Ministers urged to waive 993 visa bill for "stranded" doctors who had exams cancelled	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2020	369								m2576	10.1136/bmj.m2576	http://dx.doi.org/10.1136/bmj.m2576			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI3HF	32586790	Bronze			2022-12-28	WOS:000583173400012
J	Slomski, A				Slomski, Anita			Physical Therapy Outperforms Injections for Knee Osteoarthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2453	2453		10.1001/jama.2020.9155	http://dx.doi.org/10.1001/jama.2020.9155			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32573664				2022-12-28	WOS:000590149400004
J	Dyer, C				Dyer, Clare			Judge rules that baby should be removed from ventilator and given palliative care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2502	10.1136/bmj.m2502	http://dx.doi.org/10.1136/bmj.m2502			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571781				2022-12-28	WOS:000548535700013
J	Boyce, N; Brandon, B; Merry, G; Palmer, J; Pimm, J; Virdi, M				Boyce, Niall; Brandon, Bianca; Merry, Gabriella; Palmer, Joanna; Pimm, Jonathan; Virdi, Maneet			Wakley Prize Essay 2020: medicine and plain truths in a pandemic year	LANCET			English	Editorial Material									[Brandon, Bianca; Merry, Gabriella; Palmer, Joanna; Pimm, Jonathan; Virdi, Maneet] The Lancet, London EC2Y 5AS, England; [Boyce, Niall] Lancet Psychiat, London EC2Y 5AS, England		Pimm, J (corresponding author), The Lancet, London EC2Y 5AS, England.	joanna.palmer@lancet.com						Clarke R, 2020, GUARDIAN; Dekker Thomas., 1603, THE WONDERFULL YEARE	2	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1892	1892						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563359	Green Published, Bronze			2022-12-28	WOS:000552732200010
J	Iacobucci, G				Iacobucci, Gareth			CQC says inspections suspended for covid-19 crisis will restart in autumn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, BMJ, V368, pm1073, DOI 10.1136/bmj.m1073	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2020	369								m2467	10.1136/bmj.m2467	http://dx.doi.org/10.1136/bmj.m2467			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GM	32561538	Bronze			2022-12-28	WOS:000548534800002
J	Rowhani-Rahbar, A; Bellenger, MA; Gibb, L				Rowhani-Rahbar, A.; Bellenger, M. A.; Gibb, L.			Summary for Patients: Extreme Risk Protection Orders to Restrict Access to Firearms by Persons at Risk for Harming Themselves or Others	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2020	173	5					I13	I13		10.7326/P20-0009	http://dx.doi.org/10.7326/P20-0009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9XI	32598220				2022-12-28	WOS:000567080900001
J	Dzirasa, K				Dzirasa, Kafui			For Black Scientists, the Sorrow Is Also Personal Comment	CELL			English	Editorial Material								I have tried to live in a world that does not see color but have only succeeded in living in a world that does not see me.	[Dzirasa, Kafui] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Dzirasa, Kafui] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Dzirasa, Kafui] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27710 USA; [Dzirasa, Kafui] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Dzirasa, K (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.; Dzirasa, K (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA.; Dzirasa, K (corresponding author), Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27710 USA.; Dzirasa, K (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.	kafui.dzirasa@duke.edu	Dzirasa, Kafui/GQB-1424-2022						0	16	16	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					263	264		10.1016/j.cell.2020.06.028	http://dx.doi.org/10.1016/j.cell.2020.06.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32589944	Bronze			2022-12-28	WOS:000552745000001
J	Ikematsu, H; Hayden, FG; Kawaguchi, K; Kinoshita, M; de Jong, MD; Lee, NL; Takashima, S; Noshi, T; Tsuchiya, K; Uehara, T				Ikematsu, Hideyuki; Hayden, Frederick G.; Kawaguchi, Keiko; Kinoshita, Masahiro; de Jong, Menno D.; Lee, Nelson; Takashima, Satoru; Noshi, Takeshi; Tsuchiya, Kenji; Uehara, Takeki			Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; POSTEXPOSURE PROPHYLAXIS; LANINAMIVIR OCTANOATE; INHALED ZANAMIVIR; TRANSMISSION; OSELTAMIVIR; PREVENTION; VIRUS; INFECTIONS; EFFICACY	In a randomized, double-blind trial that treated household contacts of patients with influenza with a single dose of baloxavir or placebo, participants taking baloxavir had a lower risk of influenza (1.9%) than placebo controls (13.6%). Adverse events were similar in the two groups. Background Baloxavir marboxil (baloxavir) is a polymerase acidic protein (PA) endonuclease inhibitor with clinical efficacy in the treatment of uncomplicated influenza, including in outpatients at increased risk for complications.The postexposure prophylactic efficacy of baloxavir in the household setting is unclear. Methods We conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the postexposure prophylactic efficacy of baloxavir in household contacts of index patients with confirmed influenza during the 2018-2019 season in Japan.The participants were assigned in a 1:1 ratio to receive either a single dose of baloxavir or placebo. The primary end point was clinical influenza, as confirmed by reverse-transcriptase-polymerase-chain-reaction testing, over a period of 10 days. The occurrence of baloxavir-selected PA substitutions associated with reduced susceptibility was assessed. Results A total of 752 household contacts of 545 index patients were randomly assigned to receive baloxavir or placebo. Among the index patients, 95.6% had influenza A virus infection, 73.6% were younger than 12 years of age, and 52.7% received baloxavir. Among the participants who could be evaluated (374 in the baloxavir group and 375 in the placebo group), the percentage in whom clinical influenza developed was significantly lower in the baloxavir group than in the placebo group (1.9% vs. 13.6%) (adjusted risk ratio, 0.14; 95% confidence interval [CI], 0.06 to 0.30; P<0.001). Baloxavir was effective in high-risk, pediatric, and unvaccinated subgroups of participants. The risk of influenza infection, regardless of symptoms, was lower with baloxavir than with placebo (adjusted risk ratio, 0.43; 95% CI, 0.32 to 0.58). The incidence of adverse events was similar in the two groups (22.2% in the baloxavir group and 20.5% in the placebo group). In the baloxavir group, the viral PA substitutions I38T/M or E23K were detected in 10 (2.7%) and 5 (1.3%) participants, respectively. No transmission of these variants from baloxavir-treated index patients to participants in the placebo group was detected; however, several instances of transmission to participants in the baloxavir group could not be ruled out. Conclusions Single-dose baloxavir showed significant postexposure prophylactic efficacy in preventing influenza in household contacts of patients with influenza. (Funded by Shionogi; Japan Primary Registries Network number, JapicCTI-184180.)	[Ikematsu, Hideyuki] Ric Clin, Fukuoka, Japan; [Kawaguchi, Keiko; Kinoshita, Masahiro; Takashima, Satoru; Noshi, Takeshi; Tsuchiya, Kenji; Uehara, Takeki] Shionogi, Osaka, Japan; [Hayden, Frederick G.] Univ Virginia, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA; [de Jong, Menno D.] Univ Amsterdam, Dept Med Microbiol, Amsterdam Univ, Med Ctr, Amsterdam, Netherlands; [Lee, Nelson] Univ Alberta, Div Infect Dis, Dept Med, Edmonton, AB, Canada	University of Virginia; University of Amsterdam; University of Alberta	Hayden, FG (corresponding author), Univ Virginia Hlth Syst, Div Infect Dis & Intl Hlth, POB 801342, Charlottesville, VA 22908 USA.	fgh@virginia.edu	Lee, Nelson/B-6418-2008	Lee, Nelson/0000-0002-0783-6607	Shionogi	Shionogi	Supported by Shionogi.	[Anonymous], 2016, SAS SOFTW VERS 9 4; Baker J, 2020, PEDIAT INFECT DIS J; Carrillo-Santisteve P, 2010, EUROSURVEILLANCE, V15, P20; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; GALBRAITH AW, 1969, LANCET, V2, P1026; Gravenstein Stefan, 2005, J Am Med Dir Assoc, V6, P359, DOI 10.1016/j.jamda.2005.08.006; Hayden FG, 1999, ANTIMICROBIAL, P1344; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; Hayden FG, 2018, NEW ENGL J MED, V379, P913, DOI 10.1056/NEJMoa1716197; Hirotsu N, 2019, INFLUENZA OTHER RESP, V13, P123, DOI 10.1111/irv.12590; Ison MG, 2012, ANTIVIR THER, V17, P955, DOI 10.3851/IMP2192; Kanda T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061358; Kashiwagi S, 2016, CLIN INFECT DIS, V63, P330, DOI 10.1093/cid/ciw255; Kashiwagi S, 2013, J INFECT CHEMOTHER, V19, P740, DOI 10.1007/s10156-013-0622-9; LaForce C, 2007, CLIN THER, V29, P1579, DOI 10.1016/j.clinthera.2007.08.023; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Moreno MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2592; Omoto S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27890-4; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Sato M, 2020, J INFECT DIS, V222, P121, DOI 10.1093/infdis/jiaa061; Simmerman JM, 2011, INFLUENZA OTHER RESP, V5, P256, DOI 10.1111/j.1750-2659.2011.00205.x; Suess T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-26; Takashita E, 2019, EMERG INFECT DIS, V25, P2108, DOI 10.3201/eid2511.190757; Takashita E, 2019, EUROSURVEILLANCE, V24, P9, DOI 10.2807/1560-7917.ES.2019.24.12.1900170; Theodoropoulos N, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13275; Uehara T, 2020, J INFECT DIS, V221, P346, DOI 10.1093/infdis/jiz244; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	56	59	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2020	383	4					309	320		10.1056/NEJMoa1915341	http://dx.doi.org/10.1056/NEJMoa1915341			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MU1XJ	32640124	Bronze			2022-12-28	WOS:000555465900016
J	Mathew, R				Mathew, Rammya			Rammya Mathew: We must let patients choose how to access primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2654	10.1136/bmj.m2654	http://dx.doi.org/10.1136/bmj.m2654			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636200	Bronze			2022-12-28	WOS:000548155700014
J	Proctor, RN				Proctor, Robert N.			The Cigarette: A Political History-The Past, Present, and Future of US Tobacco	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Proctor, Robert N.] Stanford Univ, 688 San Juan St, Stanford, CA 94305 USA	Stanford University	Proctor, RN (corresponding author), Stanford Univ, 688 San Juan St, Stanford, CA 94305 USA.	rproctor@stanford.edu						Dimson E, 2015, IND THEIR RISE FALL, P5; Milov S, 2019, CIGARETTE POLITICAL, DOI [10.4159/9780674242883, DOI 10.4159/9780674242883]; Pearson D, 1969, MIAMI HERALD; SLADE J, 1995, JAMA-J AM MED ASSOC, V274, P225, DOI 10.1001/jama.274.3.225	4	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					10	11		10.1001/jama.2020.8237	http://dx.doi.org/10.1001/jama.2020.8237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633785				2022-12-28	WOS:000568123600001
J	Eaton, L				Eaton, Lynn			Declarations of pharma funding to doctors are hit by covid-19 crisis	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ABPI, DISCL UK; Mulinari S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023094; Prescription Medicines Code of Practice Authority, ABPI CONS PROP 2021	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2020	370								m2689	10.1136/bmj.m2689	http://dx.doi.org/10.1136/bmj.m2689			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5XW	32631898	Bronze			2022-12-28	WOS:000548163900011
J	Kneebone, R				Kneebone, Roger			In practice Maps and guides	LANCET			English	Editorial Material									[Kneebone, Roger] Imperial Coll London, Surg Educ, Div Surg, Dept Surg & Canc,Fac Med, London, England; [Kneebone, Roger] Chelsea & Westminster Hosp, Acad Surg, Ctr Engagement & Simulat Sci, London SW10 9NH, England	Imperial College London; Imperial College London	Kneebone, R (corresponding author), Imperial Coll London, Surg Educ, Div Surg, Dept Surg & Canc,Fac Med, London, England.; Kneebone, R (corresponding author), Chelsea & Westminster Hosp, Acad Surg, Ctr Engagement & Simulat Sci, London SW10 9NH, England.	r.kneebone@imperial.ac.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					18	18						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32622387	Green Submitted			2022-12-28	WOS:000561626100008
J	Attar, N; Campos, OA; Vogelauer, M; Cheng, C; Xue, Y; Schmollinger, S; Salwinski, L; Mallipeddi, NV; Boone, BA; Yen, LD; Yang, SC; Zikovich, S; Dardine, J; Carey, MF; Merchant, SS; Kurdistani, SK				Attar, Narsis; Campos, Oscar A.; Vogelauer, Maria; Cheng, Chen; Xue, Yong; Schmollinger, Stefan; Salwinski, Lukasz; Mallipeddi, Nathan V.; Boone, Brandon A.; Yen, Linda; Yang, Sichen; Zikovich, Shannon; Dardine, Jade; Carey, Michael F.; Merchant, Sabeeha S.; Kurdistani, Siavash K.			The histone H3-H4 tetramer isa copper reductase enzyme	SCIENCE			English	Article							NUCLEOSOME CORE PARTICLE; SACCHAROMYCES-CEREVISIAE; ELECTRON-TRANSFER; GENE DISRUPTION; CHAPERONE ASF1; BINDING; YEAST; TRANSCRIPTION; ACTIVATION; CYTOCHROME	Eukaryotic histone H3-H4 tetramers contain a putative copper (Cu2+) binding site at the H3-H3 ' dimerization interface with unknown function. The coincident emergence of eukaryotes with global oxygenation, which challenged cellular copper utilization, raised the possibility that histones may function in cellular copper homeostasis. We report that the recombinant Xenopus laevis H3-H4 tetramer is an oxidoreductase enzyme that binds Cu2+ and catalyzes its reduction to Cu1+ in vitro. Loss- and gain-of-function mutations of the putative active site residues correspondingly altered copper binding and the enzymatic activity, as well as intracellular Cu1+ abundance and copper-dependent mitochondrial respiration and Sod1 function in the yeast Saccharomyces cerevisiae. The histone H3-H4 tetramer, therefore, has a role other than chromatin compaction or epigenetic regulation and generates biousable Cu1+ ions in eukaryotes.	[Attar, Narsis; Campos, Oscar A.; Vogelauer, Maria; Cheng, Chen; Xue, Yong; Salwinski, Lukasz; Mallipeddi, Nathan V.; Boone, Brandon A.; Yang, Sichen; Zikovich, Shannon; Dardine, Jade; Carey, Michael F.; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Attar, Narsis; Campos, Oscar A.; Carey, Michael F.; Kurdistani, Siavash K.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Schmollinger, Stefan; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Salwinski, Lukasz] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Yen, Linda] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.] Univ Calif Berkeley, Berkeley QB3, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Berkeley	Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.; Kurdistani, SK (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.; Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.	skurdistani@mednet.ucla.edu		Boone, Brandon/0000-0002-6475-8000; Salwinski, Lukasz/0000-0003-4522-1969; Campos, Oscar/0000-0002-5645-7275; Attar, Narsis/0000-0002-5847-7587; Schmollinger, Stefan/0000-0002-7487-8014; Zikovich, Shannon/0000-0002-5498-3140; Cheng, Chen/0000-0002-9610-1345; Mallipeddi, Nathan/0000-0003-2193-5932; xue, yong/0000-0002-7229-7232; Vogelauer, Maria/0000-0003-1360-0526	W. M. Keck Foundation Award; NIH [GM123126, CA178415, GM074701, GM42143, CA188592, GM8042, P30 CA016042, 5P30 A1028697]; Whitcome; UCLADissertation Year Fellowships; NCI Ruth L. Kirschstein NRSA [CA186619, GM007185]; Amgen Scholars Program; UCLA-DOE Institute [DE-FCO2-02ER63421]	W. M. Keck Foundation Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome; UCLADissertation Year Fellowships; NCI Ruth L. Kirschstein NRSA; Amgen Scholars Program(Amgen); UCLA-DOE Institute	This work was supported by a W. M. Keck Foundation Award to S.K.K.and S.S.M.and by NIH grants CA178415 to S.K.K., GM074701 to M.F.C.,GM42143 to S.S.M, and CA188592 to MV. O.A.C.was supported by the Whitcome; O.A.C.and C.C. by UCLADissertation Year Fellowships; N.A. by the NCI Ruth L. Kirschstein NRSA CA186619 and NIH GM8042; LS. by NIH GM123126; L.Y.by the NCI Ruth L. Kirschstein NRSA GM007185; S.Z. by the Amgen Scholars Program; the UCLA JCCC flow cytometry core by NIH P30 CA016042 and 5P30 A1028697: and the UCLA-DOE Institute by DE-FCO2-02ER63421.	Adamczyk M, 2007, FEBS LETT, V581, P1409, DOI 10.1016/j.febslet.2007.02.063; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Agez M, 2007, STRUCTURE, V15, P191, DOI 10.1016/j.str.2007.01.002; Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; BAL W, 1995, CHEM RES TOXICOL, V8, P683, DOI 10.1021/tx00047a007; Brachmann CB, 1998, YEAST, V14, P115; Burkhead JL, 2011, J MOL BIOL, V406, P44, DOI 10.1016/j.jmb.2010.12.001; Chen SD, 2015, GENE DEV, V29, P1326, DOI 10.1101/gad.261115.115; Choi B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17072-z; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Lucas MF, 2011, BBA-BIOENERGETICS, V1807, P1305, DOI 10.1016/j.bbabio.2011.03.003; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; GEORGE GN, 1988, J BIOL CHEM, V263, P8199; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; Gregg C., 2009, J VIS EXP, V2009, P1417; Gross C, 2000, J BIOL CHEM, V275, P32310, DOI 10.1074/jbc.M005946200; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hong L, 2008, J PHYS CHEM B, V112, P604, DOI 10.1021/jp075747r; Huang HL, 2009, GENOME RES, V19, P674, DOI 10.1101/gr.083402.108; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Katz AK, 2003, HELV CHIM ACTA, V86, P1320; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klink TA, 2000, EUR J BIOCHEM, V267, P566, DOI 10.1046/j.1432-1327.2000.01037.x; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Lin SJ, 1996, MOL CELL BIOL, V16, P6303; Liu J, 2014, CHEM REV, V114, P4366, DOI 10.1021/cr400479b; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; Mattiroli F, 2017, SCIENCE, V357, P609, DOI 10.1126/science.aaj1849; McRae R, 2013, METALLOMICS, V5, P52, DOI 10.1039/c2mt20176c; Mesu JG, 2006, INORG CHEM, V45, P1960, DOI 10.1021/ic051305n; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ramachandran S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001042; Rando OJ, 2010, METHOD ENZYMOL, V470, P105, DOI 10.1016/S0076-6879(10)70005-7; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; SAAVEDRA RA, 1986, SCIENCE, V234, P1589, DOI 10.1126/science.3787266; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Sandman K, 1998, SCIENCE, V280, P501; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SOLOMON EI, 1993, METHOD ENZYMOL, V226, P1, DOI 10.1016/0076-6879(93)26003-R; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; Williams KR, 1997, J AM CHEM SOC, V119, P613, DOI 10.1021/ja963225b; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102	56	31	32	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					59	+		10.1126/science.aba8740	http://dx.doi.org/10.1126/science.aba8740			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631887	Green Submitted, Green Accepted			2022-12-28	WOS:000548751700045
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: US sees record rise in cases	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, NY TIMES; Bauchner, 2020, COMMUNICATION   0702; Best P, 2020, TRUMP ALL MASKS LOOK; Fox J, LEAST 126 000 PEOPLE; Korber B, 2020, CELL	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2020	370								m2676	10.1136/bmj.m2676	http://dx.doi.org/10.1136/bmj.m2676			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5ZW	32620598	Bronze			2022-12-28	WOS:000548169100011
J	Pandit, MK				Pandit, Maharaj K.			The Himalaya should be a nature reserve	NATURE			English	Editorial Material									[Pandit, Maharaj K.] Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi, India; [Pandit, Maharaj K.] Univ Delhi, Delhi, India	University of Delhi	Pandit, MK (corresponding author), Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi, India.; Pandit, MK (corresponding author), Univ Delhi, Delhi, India.	rajkpandit@gmail.com	Pandit, Maharaj K/A-4065-2014	Pandit, Maharaj K/0000-0001-6611-560X					0	6	6	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					9	9		10.1038/d41586-020-01809-4	http://dx.doi.org/10.1038/d41586-020-01809-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MD5NW	32601493				2022-12-28	WOS:000544019300001
J	Sinding, MHS; Gopalakrishnan, S; Ramos-Madrigal, J; de Manuel, M; Pitulko, VV; Kuderna, L; Feuerborn, TR; Frantz, LAF; Vieira, FG; Niemann, J; Castruita, JAS; Caroe, C; Andersen-Ranberg, EU; Jordan, PD; Pavlova, EY; Nikolskiy, PA; Kasparov, AK; Ivanova, VV; Willerslev, E; Skoglund, P; Fredholm, M; Wennerberg, SE; Heide-Jorgensen, MP; Dietz, R; Sonne, C; Meldgaard, M; Dalen, L; Larson, G; Petersen, B; Sicheritz-Ponten, T; Bachmann, L; Wiig, O; Marques-Bonet, T; Hansen, AJ; Gilbert, MTP				Sinding, Mikkel-Holger S.; Gopalakrishnan, Shyam; Ramos-Madrigal, Jazmin; de Manuel, Marc; Pitulko, Vladimir V.; Kuderna, Lukas; Feuerborn, Tatiana R.; Frantz, Laurent A. F.; Vieira, Filipe G.; Niemann, Jonas; Castruita, Jose A. Samaniego; Caroe, Christian; Andersen-Ranberg, Emilie U.; Jordan, Peter D.; Pavlova, Elena Y.; Nikolskiy, Pavel A.; Kasparov, Aleksei K.; Ivanova, Varvara V.; Willerslev, Eske; Skoglund, Pontus; Fredholm, Merete; Wennerberg, Sanne Eline; Heide-Jorgensen, Mads Peter; Dietz, Rune; Sonne, Christian; Meldgaard, Morten; Dalen, Love; Larson, Greger; Petersen, Bent; Sicheritz-Ponten, Thomas; Bachmann, Lutz; Wiig, Oystein; Marques-Bonet, Tomas; Hansen, Anders J.; Gilbert, M. Thomas P.			Arctic-adapted dogs emerged at the Pleistocene-Holocene transitiond	SCIENCE			English	Article							GENOME SEQUENCE; POPULATION GENOMICS; REVEALS ADAPTATION; ANCIENT; ADMIXTURE; EVOLUTION; DOMESTICATION; MITOCHONDRIAL; ASSOCIATION; FRAMEWORK	Although sled dogs are one of the most specialized groups of dogs, their origin and evolution has received much less attention than many other dog groups. We applied a genomic approach to investigate their spatiotemporal emergence by sequencing the genomes of 10 modern Greenland sled dogs, an similar to 9500-year-old Siberian dog associated with archaeological evidence for sled technology, and an similar to 33,000-year-old Siberian wolf. We found noteworthy genetic similarity between the ancient dog and modern sled dogs. We detected gene flow from Pleistocene Siberian wolves, but not modern American wolves, to present-day sled dogs. The results indicate that the major ancestry of modern sled dogs traces back to Siberia, where sled dog-specific haplotypes of genes that potentially relate to Arctic adaptation were established by 9500 years ago.	[Sinding, Mikkel-Holger S.; Gopalakrishnan, Shyam; Ramos-Madrigal, Jazmin; Feuerborn, Tatiana R.; Vieira, Filipe G.; Niemann, Jonas; Castruita, Jose A. Samaniego; Caroe, Christian; Pavlova, Elena Y.; Willerslev, Eske; Meldgaard, Morten; Petersen, Bent; Sicheritz-Ponten, Thomas; Hansen, Anders J.; Gilbert, M. Thomas P.] Univ Copenhagen, GLOBE Inst, Copenhagen, Denmark; [Sinding, Mikkel-Holger S.; Bachmann, Lutz; Wiig, Oystein] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Sinding, Mikkel-Holger S.; Feuerborn, Tatiana R.; Andersen-Ranberg, Emilie U.; Sonne, Christian; Meldgaard, Morten; Hansen, Anders J.] Univ Greenland, Qimmeq Project, Nuussuaq, Greenland; [Sinding, Mikkel-Holger S.; Heide-Jorgensen, Mads Peter] Greenland Inst Nat Resources, Nuuk, Greenland; [Sinding, Mikkel-Holger S.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [de Manuel, Marc; Kuderna, Lukas; Marques-Bonet, Tomas] Inst Evolutionary Biol UPF CSIC, Barcelona, Spain; [Pitulko, Vladimir V.; Kasparov, Aleksei K.] Russian Acad Sci, Inst Hist Mat Culture, St Petersburg, Russia; [Feuerborn, Tatiana R.; Dalen, Love] Swedish Museum Nat Hist, Dept Bioinformat & Genet, Stockholm, Sweden; [Feuerborn, Tatiana R.] Stockholm Univ, Dept Archaeol & Class Studies, Stockholm, Sweden; [Frantz, Laurent A. F.; Larson, Greger] Univ Oxford, Res Lab Archaeol & Hist Art, Palaeogenom & Bioarchaeol Res Network, Oxford, England; [Frantz, Laurent A. F.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Niemann, Jonas] Univ York, Dept Archaeol, BioArch, York, N Yorkshire, England; [Andersen-Ranberg, Emilie U.] Univ Copenhagen, Dept Vet Clin Sci, Frederiksberg C, Denmark; [Jordan, Peter D.] Univ Groningen, Arctic Ctr, Groningen, Netherlands; [Jordan, Peter D.] Univ Groningen, Groningen Inst Archaeol, Groningen, Netherlands; [Pavlova, Elena Y.] Arctic & Antarct Res Inst, St Petersburg, Russia; [Nikolskiy, Pavel A.] Russian Acad Sci, Inst Geol, Moscow, Russia; [Ivanova, Varvara V.] All Russian Res Inst Geol & Mineral Resources Wor, VNIIOkeangeol Res Inst, St Petersburg, Russia; [Willerslev, Eske] Univ Southern Denmark, Danish Inst Adv Study D IAS, Odense, Denmark; [Willerslev, Eske] Univ Cambridge, Dept Zool, Cambridge, England; [Willerslev, Eske] Univ Cambridge, Wellcome Trust Sanger Inst, Cambridge, England; [Skoglund, Pontus] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Skoglund, Pontus] Francis Crick Inst, London, England; [Fredholm, Merete] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg C, Denmark; [Wennerberg, Sanne Eline] Govt Greenland, Minist Fisheries Hunting & Agr, Nuuk, Greenland; [Dietz, Rune; Sonne, Christian] Aarhus Univ, Arctic Res Ctr, Dept Biosci, Roskilde, Denmark; [Sonne, Christian] Henan Agr Univ, Sch Forestry, Henan Prov Engn Res Ctr Biomass Value Added Prod, Zhengzhou, Henan, Peoples R China; [Dalen, Love] Ctr Palaeogenet, Stockholm, Sweden; [Petersen, Bent; Sicheritz-Ponten, Thomas] AIMST Univ, Fac Sci Appl, Ctr Excellence Om Driven Computat Biodiscovery CO, Kedah, Malaysia; [Marques-Bonet, Tomas] Catalan Inst Res & Adv Studies, Barcelona, Spain; [Marques-Bonet, Tomas] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, CNAG CRG, Barcelona, Spain; [Marques-Bonet, Tomas] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Barcelona, Spain; [Gilbert, M. Thomas P.] Norwegian Univ Sci & Technol, Univ Museum, Trondheim, Norway	University of Copenhagen; University of Oslo; Greenland Institute of Natural Resources; Trinity College Dublin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Russian Academy of Sciences; Institute for the History of Material Culture, Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Swedish Museum of Natural History; Stockholm University; University of Oxford; University of London; Queen Mary University London; University of York - UK; University of Copenhagen; University of Groningen; University of Groningen; Geological Institute, Russian Academy of Sciences; Russian Academy of Sciences; A.P. Karpinsky Russian Geological Research Institute (VSEGEI); University of Southern Denmark; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Harvard University; Harvard Medical School; Francis Crick Institute; University of Copenhagen; Aarhus University; Henan Agricultural University; Swedish Museum of Natural History; AIMST University; ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Norwegian University of Science & Technology (NTNU)	Sinding, MHS; Hansen, AJ; Gilbert, MTP (corresponding author), Univ Copenhagen, GLOBE Inst, Copenhagen, Denmark.; Sinding, MHS (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.; Sinding, MHS; Hansen, AJ (corresponding author), Univ Greenland, Qimmeq Project, Nuussuaq, Greenland.; Sinding, MHS (corresponding author), Greenland Inst Nat Resources, Nuuk, Greenland.; Sinding, MHS (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.; Marques-Bonet, T (corresponding author), Inst Evolutionary Biol UPF CSIC, Barcelona, Spain.; Marques-Bonet, T (corresponding author), Catalan Inst Res & Adv Studies, Barcelona, Spain.; Marques-Bonet, T (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, CNAG CRG, Barcelona, Spain.; Marques-Bonet, T (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Barcelona, Spain.; Gilbert, MTP (corresponding author), Norwegian Univ Sci & Technol, Univ Museum, Trondheim, Norway.	mhssinding@gmail.com; tomas.marques@upf.edu; ajhansen@sund.ku.dk; tgilbert@sund.ku.dk	Sonne, Christian/I-7532-2013; Dietz, Rune/F-9154-2015; Willerslev, Eske/AAA-5686-2019; Hansen, Anders Johannes/A-5608-2013; Pavlova, Elena/AAA-3291-2019; Dalén, Love/A-6686-2008; Jordan, Peter/HDO-4721-2022; Pitulko, Vladimir/N-4009-2019; Nikolskiy, Pavel A/C-5041-2012; Willerslev, Eske/A-9619-2011; Marques-Bonet, Tomas/ABF-3734-2020; Sicheritz-Ponten, Thomas/A-4325-2017; Gilbert, Marcus/A-8936-2013; Strander Sinding, Mikkel Holger/B-9450-2015; Ramos-Madrigal, Jazmin/C-1576-2015; Garrett Vieira, Filipe/B-9464-2015	Sonne, Christian/0000-0001-5723-5263; Dietz, Rune/0000-0001-9652-317X; Hansen, Anders Johannes/0000-0002-1890-2702; Dalén, Love/0000-0001-8270-7613; Jordan, Peter/0000-0002-2837-3920; Willerslev, Eske/0000-0002-7081-6748; Marques-Bonet, Tomas/0000-0002-5597-3075; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Pavlova, Elena/0000-0002-3010-6290; Petersen, Bent/0000-0002-2472-8317; Gilbert, Marcus/0000-0002-5805-7195; Kuderna, Lukas/0000-0002-9992-9295; Feuerborn, Tatiana/0000-0003-1610-3402; Frantz, Laurent/0000-0001-8030-3885; Skoglund, Pontus/0000-0002-3021-5913; Strander Sinding, Mikkel Holger/0000-0003-1371-219X; Ramos-Madrigal, Jazmin/0000-0002-1661-7991; de Manuel, Marc/0000-0002-1245-0127; Gopalakrishnan, Shyam/0000-0002-2004-6810; Garrett Vieira, Filipe/0000-0002-8464-7770	Velux Foundations; Aage og Johanne Louis-Hansens Fond; Rock Foundation of New York; Independent Research Fund Denmark [8028-00005B]; NHM Oslo; Marie Sklodowska-Curie Actions [H2020 655732 -WhereWolf]; Carlsberg [CF14 -0995]; Formacio de Personal Investigador fellowship from Generalitat de Catalunya [FI_B01111]; Russian Science Foundation [16-18-10265-RNF]; MINECO/FEDER, UE [BFU2017-86471-P]; Howard Hughes International Early Career; Obra Social "La Caixa"; Secretaria d'Universitats i Recerca; CERCA Programme del Departament d'Economia i Coneixement de la Generalitat de Catalunya [GRC 2017 SGR 880]; European Research Council [ERC-2015-CoG-681396-Extinction Genomics]; ERC [ERC-2013-StG-337574-UNDEAD]; Natural Environmental Research Council [NE/K005243/1, NE/K003259/1]; Francis Crick Institute [FC001595]; ArchSci2020 - European Union's EU Framework Programme for Research and Innovation Horizon 2020 under Marie Curie Actions [676154]; NERC [NE/K005243/2, NE/S00078X/1] Funding Source: UKRI; Russian Science Foundation [19-18-13025] Funding Source: Russian Science Foundation	Velux Foundations(Velux Fonden); Aage og Johanne Louis-Hansens Fond; Rock Foundation of New York; Independent Research Fund Denmark; NHM Oslo; Marie Sklodowska-Curie Actions; Carlsberg(Carlsberg Foundation); Formacio de Personal Investigador fellowship from Generalitat de Catalunya; Russian Science Foundation(Russian Science Foundation (RSF)); MINECO/FEDER, UE(Spanish Government); Howard Hughes International Early Career; Obra Social "La Caixa"(La Caixa Foundation); Secretaria d'Universitats i Recerca; CERCA Programme del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); European Research Council(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Francis Crick Institute; ArchSci2020 - European Union's EU Framework Programme for Research and Innovation Horizon 2020 under Marie Curie Actions; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Russian Science Foundation(Russian Science Foundation (RSF))	This work is embedded in "The Qimmeq Project," funded by the Velux Foundations and Aage og Johanne Louis-Hansens Fond, and supported by ArchSci2020, funded by the European Union's EU Framework Programme for Research and Innovation Horizon 2020 under Marie Curie Actions grant no. 676154. We thank the Rock Foundation of New York for funding excavations at the Zhokhov and Yana sites in a 15-year-long effort starting in 2000. M.-H.S.S. was supported by the Independent Research Fund Denmark (8028-00005B) and NHM Oslo. S.G. was supported by Marie Sklodowska-Curie Actions (H2020 655732 -WhereWolf) and Carlsberg (CF14 -0995). M.d.M.M. was supported by a Formacio de Personal Investigador fellowship from Generalitat de Catalunya (FI_B01111). V.V.P., E.Y. P., and P. A.N. were supported by the Russian Science Foundation project no. 16-18-10265-RNF. T.M.B. was supported by BFU2017-86471-P (MINECO/FEDER, UE), Howard Hughes International Early Career, Obra Social "La Caixa" and Secretaria d'Universitats i Recerca and CERCA Programme del Departament d'Economia i Coneixement de la Generalitat de Catalunya (GRC 2017 SGR 880). M.T.P.G. was supported by a European Research Council grant (ERC-2015-CoG-681396-Extinction Genomics). G.L. and L.A.F. were supported by the ERC (Grant ERC-2013-StG-337574-UNDEAD) and the Natural Environmental Research Council (Grants NE/K005243/1 and NE/K003259/1). P.S. was supported by the Francis Crick Institute (FC001595).	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Arendt M, 2016, HEREDITY, V117, P301, DOI 10.1038/hdy.2016.48; Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Baez-Ortega A, 2019, SCIENCE, V365, P464, DOI 10.1126/science.aau9923; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Botigue LR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16082; Cardona A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098076; Caroe C, 2018, METHODS ECOL EVOL, V9, P410, DOI 10.1111/2041-210X.12871; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Decker B, 2015, GENOME RES, V25, P1646, DOI 10.1101/gr.190314.115; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ersmark Erik, 2015, Open Quaternary, V1, P4, DOI 10.5334/oq.aa; Fan ZX, 2016, GENOME RES, V26, P163, DOI 10.1101/gr.197517.115; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Galinsky KJ, 2016, AM J HUM GENET, V98, P456, DOI 10.1016/j.ajhg.2015.12.022; Goldman EA., 1944, WOLVES N AM 1; Gopalakrishnan S, 2018, CURR BIOL, V28, P3441, DOI 10.1016/j.cub.2018.08.041; Gopalakrishnan S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3883-3; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Ilardo MA, 2018, CELL, V173, P569, DOI 10.1016/j.cell.2018.03.054; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kaja S, 2007, EUR J NEUROSCI, V25, P2009, DOI 10.1111/j.1460-9568.2007.05438.x; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Leathlobhair MN, 2018, SCIENCE, V361, P81, DOI 10.1126/science.aao4776; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Lynch VJ, 2015, CELL REP, V12, P217, DOI 10.1016/j.celrep.2015.06.027; Marsden CD, 2016, P NATL ACAD SCI USA, V113, P152, DOI 10.1073/pnas.1512501113; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Murchison EP, 2014, SCIENCE, V343, P437, DOI 10.1126/science.1247167; Muus B., 1981, GRONLANDS FAUNA; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pitulko VV, 2017, J ARCHAEOL SCI-REP, V13, P491, DOI 10.1016/j.jasrep.2017.04.003; Pitulko VV, 2015, ENVIRON ARCHAEOL, V20, P120, DOI 10.1179/1749631414Y.0000000040; Pitulko VV, 1996, ARCTIC ANTHROPOL, V33, P1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin N, 2008, J NEUROSCI, V28, P6231, DOI 10.1523/JNEUROSCI.0504-08.2008; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Ramsey CB, 2013, RADIOCARBON, V55, P2021; Rosenthal EA, 2013, AM J HUM GENET, V93, P1035, DOI 10.1016/j.ajhg.2013.10.019; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Schubert M, 2014, NAT PROTOC, V9, P1056, DOI 10.1038/nprot.2014.063; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; Sinding MHS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007745; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; Skotte L, 2013, GENETICS, V195, P693, DOI 10.1534/genetics.113.154138; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Turkieh A, 2014, J CLIN INVEST, V124, P2277, DOI 10.1172/JCI74668; vonHoldt BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501714; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wang GD, 2016, CELL RES, V26, P21, DOI 10.1038/cr.2015.147; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang WP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004466; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108	69	34	35	5	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1495	+		10.1126/science.aaz8599	http://dx.doi.org/10.1126/science.aaz8599			75	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32587022	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000545264600045
J	Spector, TD; Gardner, CD				Spector, Tim D.; Gardner, Christopher D.			Challenges and opportunities for better nutrition science	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Spector, Tim D.] Kings Coll London, London, England; [Gardner, Christopher D.] Stanford Univ, Palo Alto, CA 94304 USA	University of London; King's College London; Stanford University	Spector, TD (corresponding author), Kings Coll London, London, England.	tim.spector@kcl.ac.uk						[Anonymous], 2018, BMJ; Barabasi AL, 2020, NAT FOOD, V1, P33, DOI 10.1038/s43016-019-0005-1; Berry SE, 2020, NAT MED, V26, P964, DOI 10.1038/s41591-020-0934-0; Crowley J, 2019, LANCET PLANET HEALTH, V3, pE379, DOI 10.1016/S2542-5196(19)30171-8; de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/s0140-6736(17)32252-3, 10.1016/S0140-6736(17)32252-3]; Gardner CD, 2018, JAMA-J AM MED ASSOC, V319, P667, DOI 10.1001/jama.2018.0245; Hall KD, 2019, CELL METAB, V30, P67, DOI 10.1016/j.cmet.2019.05.008; Nestle M, 2019, UNSAVORY TRUTH FOOD; Spector TD, 2019, BMJ OPINION; Valdes Ana M, 2018, BMJ, V361, pk2179, DOI 10.1136/bmj.k2179; White M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m545; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	14	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2020	369								m2470	10.1136/bmj.m2470	http://dx.doi.org/10.1136/bmj.m2470			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ7IA	32591334	Green Published, hybrid			2022-12-28	WOS:000548259500003
J	Doria, A; Galecki, AT; Spino, C; Pop-Busui, R; Cherney, DZ; Lingvay, I; Parsa, A; Rossing, P; Sigal, RJ; Afkarian, M; Aronson, R; Caramori, ML; Crandall, JP; de Boer, IH; Elliott, TG; Goldfine, AB; Haw, JS; Hirsch, IB; Karger, AB; Maahs, DM; McGill, JB; Molitch, ME; Perkins, BA; Polsky, S; Pragnell, M; Robiner, WN; Rosas, SE; Senior, P; Tuttle, KR; Umpierrez, GE; Wallia, A; Weinstock, RS; Wu, C; Mauer, M				Doria, A.; Galecki, A. T.; Spino, C.; Pop-Busui, R.; Cherney, D. Z.; Lingvay, I.; Parsa, A.; Rossing, P.; Sigal, R. J.; Afkarian, M.; Aronson, R.; Caramori, M. L.; Crandall, J. P.; de Boer, I. H.; Elliott, T. G.; Goldfine, A. B.; Haw, J. S.; Hirsch, I. B.; Karger, A. B.; Maahs, D. M.; McGill, J. B.; Molitch, M. E.; Perkins, B. A.; Polsky, S.; Pragnell, M.; Robiner, W. N.; Rosas, S. E.; Senior, P.; Tuttle, K. R.; Umpierrez, G. E.; Wallia, A.; Weinstock, R. S.; Wu, C.; Mauer, M.		PERL Study Grp	Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							URIC-ACID LEVELS; FOLLOW-UP; RISK; NEPHROPATHY; DISEASE; PROGRESSION; LOSARTAN; COMPLICATIONS; CAPTOPRIL; EFFICACY	BACKGROUND Higher serum urate levels are associated with an increased risk of diabetic kidney disease. Lowering of the serum urate level with allopurinol may slow the decrease in the glomerular filtration rate (GFR) in persons with type 1 diabetes and early-to-moderate diabetic kidney disease. METHODS In a double-blind trial, we randomly assigned participants with type 1 diabetes, a serum urate level of at least 4.5 mg per deciliter, an estimated GFR of 40.0 to 99.9 ml per minute per 1.73 m(2) of body-surface area, and evidence of diabetic kidney disease to receive allopurinol or placebo. The primary outcome was the baseline-adjusted GFR, as measured with iohexol, after 3 years plus a 2-month washout period. Secondary outcomes included the decrease in the iohexol-based GFR per year and the urinary albumin excretion rate after washout. Safety was also assessed. RESULTS A total of 267 patients were assigned to receive allopurinol and 263 to receive placebo. The mean age was 51.1 years, the mean duration of diabetes 34.6 years, and the mean glycated hemoglobin level 8.2%. The mean baseline iohexol-based GFR was 68.7 ml per minute per 1.73 m(2) in the allopurinol group and 67.3 ml per minute per 1.73 m(2) in the placebo group. During the intervention period, the mean serum urate level decreased from 6.1 to 3.9 mg per deciliter with allopurinol and remained at 6.1 mg per deciliter with placebo. After washout, the between-group difference in the mean iohexol-based GFR was 0.001 ml per minute per 1.73 m(2) (95% confidence interval [CI], -1.9 to 1.9; P= 0.99). The mean decrease in the iohexolbased GFR was -3.0 ml per minute per 1.73 m(2) per year with allopurinol and -2.5 ml per minute per 1.73 m(2) per year with placebo (between-group difference, -0.6 ml per minute per 1.73 m(2) per year; 95% CI, -1.5 to 0.4). The mean urinary albumin excretion rate after washout was 40% (95% CI, 0 to 80) higher with allopurinol than with placebo. The frequency of serious adverse events was similar in the two groups. CONCLUSIONS We found no evidence of clinically meaningful benefits of serum urate reduction with allopurinol on kidney outcomes among patients with type 1 diabetes and early-to-moderate diabetic kidney disease.	[Doria, A.; Goldfine, A. B.; Rosas, S. E.] Harvard Med Sch, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Doria, A.; Goldfine, A. B.; Rosas, S. E.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA; [Galecki, A. T.; Wu, C.] Univ Michigan, Inst Gerontol, Div Geriatr, Ann Arbor, MI 48109 USA; [Galecki, A. T.; Spino, C.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Spino, C.] Univ Michigan, Stat Anal Biomed & Educ Res SABER, Ann Arbor, MI 48109 USA; [Pop-Busui, R.] Univ Michigan, Dept Internal Med Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Cherney, D. Z.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Cherney, D. Z.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Cherney, D. Z.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Perkins, B. A.] Univ Toronto, Div Endocrinol & Metab, Toronto, ON, Canada; [Cherney, D. Z.] Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; [Aronson, R.] LMC Diabet & Endocrinol, Toronto, ON, Canada; [Perkins, B. A.] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Sigal, R. J.] Univ Calgary, Fac Med, Dept Med, Calgary, AB, Canada; [Sigal, R. J.] Univ Calgary, Fac Med, Dept Cardiac Sci, Calgary, AB, Canada; [Sigal, R. J.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Sigal, R. J.] Univ Calgary, Fac Kinesiol, Dept Med, Calgary, AB, Canada; [Sigal, R. J.] Univ Calgary, Fac Kinesiol, Dept Cardiac Sci, Calgary, AB, Canada; [Sigal, R. J.] Univ Calgary, Fac Kinesiol, Dept Community Hlth Sci, Calgary, AB, Canada; [Elliott, T. G.] BCDiabet, Vancouver, BC, Canada; [Senior, P.] Univ Alberta, Div Endocrinol, Edmonton, AB, Canada; [Lingvay, I.] Univ Texas Southwestern Med Ctr, Dept Med, Dallas, TX USA; [Lingvay, I.] Univ Texas Southwestern Med Ctr, Dept Populat & Data Sci, Dallas, TX USA; [Parsa, A.] NIDDK, Div Kidney Urol & Hematol Dis, Bethesda, MD 20892 USA; [Rossing, P.] Univ Copenhagen, Steno Diabet Ctr, Copenhagen, Denmark; [Rossing, P.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Afkarian, M.] Univ Calif Davis, Dept Med, Div Nephrol, Davis, CA 95616 USA; [Maahs, D. M.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Maahs, D. M.] Stanford Univ, Stanford Diabet Res Ctr, Palo Alto, CA 94304 USA; [Caramori, M. L.; Robiner, W. N.; Mauer, M.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Caramori, M. L.; Robiner, W. N.; Mauer, M.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Karger, A. B.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Crandall, J. P.] Albert Einstein Coll Med, Div Endocrinol, New York, NY USA; [Crandall, J. P.] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, New York, NY USA; [Pragnell, M.] JDRF Juvenile Diabet Res Fdn, New York, NY USA; [de Boer, I. H.; Hirsch, I. B.] Univ Washington, Dept Med, Seattle, WA USA; [Tuttle, K. R.] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Tuttle, K. R.] Kidney Res Inst, Inst Translat Hlth Sci, Seattle, WA USA; [Tuttle, K. R.] Providence Hlth Care, Spokane, WA USA; [Haw, J. S.; Umpierrez, G. E.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [McGill, J. B.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO USA; [Molitch, M. E.; Wallia, A.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Polsky, S.] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA; [Weinstock, R. S.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Steno Diabetes Center; University of Copenhagen; University of Copenhagen; University of California System; University of California Davis; Stanford University; Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Yeshiva University; Yeshiva University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Doria, A (corresponding author), Joslin Diabet Ctr, Sect Genet & Epidemiol, 1 Joslin Pl, Boston, MA 02215 USA.; Mauer, M (corresponding author), Div Pediat Nephrol, 6th Fl,East Bldg,MB681,2450 Riverside Ave, Minneapolis, MN 55454 USA.	alessandro.doria@joslin.harvard.edu; mauer002@umn.edu	Polsky, Sarit/AAT-3067-2020; Mauer, Michael/ABD-5415-2020; Sigal, Ronald/AAU-6081-2020; de Boer, Ian/GYJ-3282-2022; rossing, peter/AAZ-3415-2021; rossing, peter/AAH-7879-2021; Senior, Peter/O-4934-2019; Doria, Alessandro/H-9157-2018	Polsky, Sarit/0000-0002-7602-0396; rossing, peter/0000-0002-1531-4294; Senior, Peter/0000-0003-1033-8673; Tuttle, Katherine/0000-0002-2235-0103; Doria, Alessandro/0000-0002-3830-4304; Goldfine, Allison/0000-0002-0345-1048; Maahs, David/0000-0002-4602-7909; Karger, Amy/0000-0002-2781-3824	NIDDK [R03-DK-094484, R34-DK-097808, UC4-DK-101108, P30-DK-036836, P30-DK-020572]; JDRF [17-2012-377]; National Center for Advancing Translational Sciences [UL1-TR-002494, UL1-TR-001422, UL1-TR-002556, UL1-TR-002319, UL1-TR-001105]; National Institute on Aging (Claude Pepper Center) [P30-AG-024824]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Aging (Claude Pepper Center)	Supported by grants from the NIDDK (R03-DK-094484, R34-DK-097808, UC4-DK-101108, P30-DK-036836, and P30-DK-020572), the JDRF (17-2012-377), the National Center for Advancing Translational Sciences (UL1-TR-002494, UL1-TR-001422, UL1-TR-002556, UL1-TR-002319, and UL1-TR-001105), and the National Institute on Aging (Claude Pepper Center grant number, P30-AG-024824).	Afkarian M, 2019, DIABETES CARE, V42, P1454, DOI 10.2337/dc19-0342; Ahola AJ, 2017, KIDNEY INT, V91, P1178, DOI 10.1016/j.kint.2016.11.025; Badve SV, 2020, NEW ENGL J MED, V382, P2504, DOI 10.1056/NEJMoa1915833; Bove M, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0793-3; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Costacou T, 2018, DIABETES CARE, V41, P426, DOI 10.2337/dc17-1118; de Boer IH, 2014, DIABETES CARE, V37, P24, DOI 10.2337/dc13-2113; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Gaspari F, 1997, KIDNEY INT, pS151; Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hovind P, 2009, DIABETES, V58, P1668, DOI 10.2337/db09-0014; Jalal DI, 2010, NEPHROL DIAL TRANSPL, V25, P1865, DOI 10.1093/ndt/gfp740; Jordan DM, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002725; Leslie RDG, 1999, DIABETES-METAB RES, V15, P65, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<65::AID-DMRR3>3.0.CO;2-X; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mathiesen ER, 1999, BRIT MED J, V319, P24, DOI 10.1136/bmj.319.7201.24; Mauer M, 2018, CONTRIB NEPHROL, V192, P103, DOI 10.1159/000484284; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; OKelly M, 2014, STAT PRACT, P1, DOI 10.1002/9781118762516; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Pilemann-Lyberg S, 2019, DIABETES CARE, V42, P1088, DOI 10.2337/dc18-2173; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Rosolowsky ET, 2011, J AM SOC NEPHROL, V22, P545, DOI 10.1681/ASN.2010040354; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Ruggenenti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032533; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Stearne MR, 1998, BRIT MED J, V317, P713; Tanamas SK, 2016, DIABETES CARE, V39, P2004, DOI 10.2337/dc16-0795; Tin A, 2019, NAT GENET, V51, P1459, DOI 10.1038/s41588-019-0504-x; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Yuan HP, 2015, J CLIN ENDOCR METAB, V100, P4198, DOI 10.1210/jc.2015-2527	37	126	126	6	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2493	2503		10.1056/NEJMoa1916624	http://dx.doi.org/10.1056/NEJMoa1916624			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF9CW	32579810	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000545636400020
J	Lassaline, N; Brechbuhler, R; Vonk, SJW; Ridderbeek, K; Spieser, M; Bisig, S; Le Feber, B; Rabouw, FT; Norris, DJ				Lassaline, Nolan; Brechbuhler, Raphael; Vonk, Sander J. W.; Ridderbeek, Korneel; Spieser, Martin; Bisig, Samuel; Le Feber, Boris; Rabouw, Freddy T.; Norris, David J.			Optical Fourier surfaces	NATURE			English	Article							SPATIAL-RESOLUTION; PHOTONIC CRYSTALS; LIGHT; TRANSMISSION; FABRICATION; PHASE	Gratings(1) and holograms(2) use patterned surfaces to tailor optical signals by diffraction. Despite their long history, variants with remarkable functionalities continue to be developed(3,4). Further advances could exploit Fourier optics(5), which specifies the surface pattern that generates a desired diffracted output through its Fourier transform. To shape the optical wavefront, the ideal surface profile should contain a precise sum of sinusoidal waves, each with a well defined amplitude, spatial frequency and phase. However, because fabrication techniques typically yield profiles with at most a few depth levels, complex 'wavy' surfaces cannot be obtained, limiting the straightforward mathematical design and implementation of sophisticated diffractive optics. Here we present a simple yet powerful approach to eliminate this design-fabrication mismatch by demonstrating optical surfaces that contain an arbitrary number of specified sinusoids. We combine thermal scanning-probe lithography(6-8) and templating(9) to create periodic and aperiodic surface patterns with continuous depth control and sub-wavelength spatial resolution. Multicomponent linear gratings allow precise manipulation of electromagnetic signals through Fourier-spectrum engineering(10). Consequently, we overcome a previous limitation in photonics by creating an ultrathin grating that simultaneously couples red, green and blue light at the same angle of incidence. More broadly, we analytically design and accurately replicate intricate two-dimensional moire patterns(11,12), quasicrystals(13,14) and holograms(15,16), demonstrating a variety of previously unattainable diffractive surfaces. This approach may find application in optical devices (biosensors(17), lasers(18,19), metasurfaces(4) and modulators(20)) and emerging areas in photonics (topological structures(21), transformation optics(22) and valleytronics(23)).	[Lassaline, Nolan; Brechbuhler, Raphael; Vonk, Sander J. W.; Ridderbeek, Korneel; Le Feber, Boris; Rabouw, Freddy T.; Norris, David J.] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Opt Mat Engn Lab, Zurich, Switzerland; [Vonk, Sander J. W.; Rabouw, Freddy T.] Univ Utrecht, Debye Inst Nanomat Sci, Utrecht, Netherlands; [Spieser, Martin; Bisig, Samuel] Heidelberg Instruments Nano SwissLitho, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Utrecht University	Norris, DJ (corresponding author), Swiss Fed Inst Technol, Dept Mech & Proc Engn, Opt Mat Engn Lab, Zurich, Switzerland.	dnorris@ethz.ch	Rabouw, Frederik/GSE-2644-2022; Norris, David J/F-4022-2010; Rabouw, Freddy T./O-9458-2017	Rabouw, Frederik/0000-0002-4775-0859; Norris, David J/0000-0002-3765-0678; Rabouw, Freddy T./0000-0002-4775-0859; Brechbuhler, Raphael/0000-0001-7498-9729; Vonk, Sander/0000-0002-4650-9473	European Research Council under the European Union's Seventh Framework Program (FP/2007-2013)/ERC [339905]; Netherlands Organisation for Scientific Research [Rubicon-680-50-1509, Veni-722.017.002, OCENW.KLEIN.008, Rubicon-680-50-1513]	European Research Council under the European Union's Seventh Framework Program (FP/2007-2013)/ERC; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank S. Bonanni, U. Drechsler, F. Enz, T. Kulmala, A. Olziersky and R. Stutz for technical assistance and D. Chelladurai, U. Durig, R. Keitel, A. Knoll, M. Kohli, N. Rotenberg, D. Thureja, J. Winkler and H. Wolf for discussions. This project was funded by the European Research Council under the European Union's Seventh Framework Program (FP/2007-2013)/ERC Grant Agreement Number 339905 (QuaDoPS Advanced Grant). F.T.R. (Rubicon-680-50-1509, Gravitation Program "Multiscale Catalytic Energy Conversion", Veni-722.017.002), S.J.W.V. (OCENW.KLEIN.008) and B.l.F. (Rubicon-680-50-1513) acknowledge support from the Netherlands Organisation for Scientific Research.	Arbabi A, 2015, NAT NANOTECHNOL, V10, P937, DOI [10.1038/nnano.2015.186, 10.1038/NNANO.2015.186]; Ayata M, 2017, SCIENCE, V358, P630, DOI 10.1126/science.aan5953; Barnes WL, 1996, PHYS REV B, V54, P6227, DOI 10.1103/PhysRevB.54.6227; Blanchard R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113023; Campbell M, 2000, NATURE, V404, P53, DOI 10.1038/35003523; Chao WL, 2005, NATURE, V435, P1210, DOI 10.1038/nature03719; DAKSS ML, 1970, APPL PHYS LETT, V16, P523, DOI 10.1063/1.1653091; Di Fabrizio E, 1999, NATURE, V401, P895, DOI 10.1038/44791; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Genevet P, 2017, OPTICA, V4, P139, DOI 10.1364/OPTICA.4.000139; Goodman J. W., 2017, INTRO FOURIER OPTICS; Hu GW, 2019, NAT PHOTONICS, V13, P467, DOI 10.1038/s41566-019-0399-1; Huang ZQ, 2019, OPTICA, V6, P119, DOI 10.1364/OPTICA.6.000119; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; Kapsalidis F, 2018, APPL PHYS B-LASERS O, V124, DOI 10.1007/s00340-018-6973-2; Khorasaninejad M, 2016, SCIENCE, V352, P1190, DOI 10.1126/science.aaf6644; Kim J, 2007, MICROELECTRON ENG, V84, P2859, DOI 10.1016/j.mee.2007.02.015; Kurvits JA, 2015, J OPT SOC AM A, V32, P2082, DOI 10.1364/JOSAA.32.002082; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Mahler L, 2010, NAT PHOTONICS, V4, P165, DOI 10.1038/NPHOTON.2009.285; MAMIN HJ, 1992, APPL PHYS LETT, V61, P1003, DOI 10.1063/1.108460; Martins ER, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3665; Matsui T, 2007, NATURE, V446, P517, DOI 10.1038/nature05620; McPeak KM, 2015, ACS PHOTONICS, V2, P326, DOI 10.1021/ph5004237; Moreno V, 1997, AM J PHYS, V65, P556, DOI 10.1119/1.18587; Nagpal P, 2009, SCIENCE, V325, P594, DOI 10.1126/science.1174655; Ozaki M, 2011, SCIENCE, V332, P218, DOI 10.1126/science.1201045; Pendry JB, 2017, SCIENCE, V358, P915, DOI 10.1126/science.aap7939; Pires D, 2010, SCIENCE, V328, P732, DOI 10.1126/science.1187851; Rawlings CD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16496-x; Rittenhouse D., 1786, T AM PHILOS SOC, V2, P201, DOI [10.2307/1005186, DOI 10.2307/1005186]; Rubin NA, 2019, SCIENCE, V365, P43, DOI 10.1126/science.aax1839; Shaltout AM, 2019, SCIENCE, V364, P648, DOI 10.1126/science.aat3100; Shi L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.153002; Sunku SS, 2018, SCIENCE, V362, P1153, DOI 10.1126/science.aau5144; Tittl A, 2018, SCIENCE, V360, P1105, DOI 10.1126/science.aas9768; Vitiello MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6884; Wang P, 2020, NATURE, V577, P42, DOI 10.1038/s41586-019-1851-6; Wang YX, 2003, NATURE, V424, P50, DOI 10.1038/nature01756; Wuttig M, 2017, NAT PHOTONICS, V11, P465, DOI [10.1038/nphoton.2017.126, 10.1038/NPHOTON.2017.126]; Yoo D, 2015, ACS NANO, V9, P10647, DOI 10.1021/acsnano.5b05279; Yoshida M, 2019, NAT MATER, V18, P121, DOI 10.1038/s41563-018-0242-y; Zheng GX, 2015, NAT NANOTECHNOL, V10, P308, DOI [10.1038/nnano.2015.2, 10.1038/NNANO.2015.2]	44	40	41	12	112	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					506	+		10.1038/s41586-020-2390-x	http://dx.doi.org/10.1038/s41586-020-2390-x			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OL0CX	32581384	Green Accepted, Green Submitted			2022-12-28	WOS:000585012000005
J	Rimmer, A				Rimmer, Abi			Covid-19: Doctors feel shut out of plans for dealing with backlog of missed care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2020, COVID 19 TRACK SURV	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2020	369								m2535	10.1136/bmj.m2535	http://dx.doi.org/10.1136/bmj.m2535			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1US	32580927	Bronze			2022-12-28	WOS:000548572500007
J	Turro, E; Astle, WJ; Megy, K; Graf, S; Greene, D; Shamardina, O; Allen, HL; Sanchis-Juan, A; Frontini, M; Thys, C; Stephens, J; Mapeta, R; Burren, OS; Downes, K; Haimel, M; Tuna, S; Deevi, SVV; Aitman, TJ; Bennett, DL; Calleja, P; Carss, K; Caulfield, MJ; Chinnery, PF; Dixon, PH; Gale, DP; James, R; Koziell, A; Laffan, MA; Levine, AP; Maher, ER; Markus, HS; Morales, J; Morrell, NW; Mumford, AD; Ormondroyd, E; Rankin, S; Rendon, A; Richardson, S; Roberts, I; Roy, NBA; Saleem, MA; Smith, KGC; Stark, H; Tan, RYY; Themistocleous, AC; Thrasher, AJ; Watkins, H; Webster, AR; Wilkins, MR; Williamson, C; Whitworth, J; Humphray, S; Bentley, DR; Kingston, N; Walker, N; Bradley, JR; Ashford, S; Penkett, CJ; Freson, K; Stirrups, KE; Raymond, FL; Ouwehand, WH				Turro, Ernest; Astle, William J.; Megy, Karyn; Graef, Stefan; Greene, Daniel; Shamardina, Olga; Allen, Hana Lango; Sanchis-Juan, Alba; Frontini, Mattia; Thys, Chantal; Stephens, Jonathan; Mapeta, Rutendo; Burren, Oliver S.; Downes, Kate; Haimel, Matthias; Tuna, Salih; Deevi, Sri V. V.; Aitman, Timothy J.; Bennett, David L.; Calleja, Paul; Carss, Keren; Caulfield, Mark J.; Chinnery, Patrick F.; Dixon, Peter H.; Gale, Daniel P.; James, Roger; Koziell, Ania; Laffan, Michael A.; Levine, Adam P.; Maher, Eamonn R.; Markus, Hugh S.; Morales, Joannella; Morrell, Nicholas W.; Mumford, Andrew D.; Ormondroyd, Elizabeth; Rankin, Stuart; Rendon, Augusto; Richardson, Sylvia; Roberts, Irene; Roy, Noemi B. A.; Saleem, Moin A.; Smith, Kenneth G. C.; Stark, Hannah; Tan, Rhea Y. Y.; Themistocleous, Andreas C.; Thrasher, Adrian J.; Watkins, Hugh; Webster, Andrew R.; Wilkins, Martin R.; Williamson, Catherine; Whitworth, James; Humphray, Sean; Bentley, David R.; Kingston, Nathalie; Walker, Neil; Bradley, John R.; Ashford, Sofie; Penkett, Christopher J.; Freson, Kathleen; Stirrups, Kathleen E.; Raymond, F. Lucy; Ouwehand, Willem H.		NIHR BioResource 100,000	Whole-genome sequencing of patients with rare diseases in a national health system	NATURE			English	Article							MUTATIONS; VARIANTS; THROMBOCYTOPENIA; MACROTHROMBOCYTOPENIA; ASSOCIATION; DIAGNOSIS; LINKS	Most patients with rare diseases do not receive a molecular diagnosis and the aetiological variants and causative genes for more than half such disorders remain to be discovered(1). Here we used whole-genome sequencing (WGS) in a national health system to streamline diagnosis and to discover unknown aetiological variants in the coding and non-coding regions of the genome. We generated WGS data for 13,037 participants, of whom 9,802 had a rare disease, and provided a genetic diagnosis to 1,138 of the 7,065 extensively phenotyped participants. We identified 95 Mendelian associations between genes and rare diseases, of which 11 have been discovered since 2015 and at least 79 are confirmed to be aetiological. By generating WGS data of UK Biobank participants(2), we found that rare alleles can explain the presence of some individuals in the tails of a quantitative trait for red blood cells. Finally, we identified four novel non-coding variants that cause disease through the disruption of transcription of ARPC1B, GATA1, LRBA and MPL. Our study demonstrates a synergy by using WGS for diagnosis and aetiological discovery in routine healthcare.	[Turro, Ernest; Megy, Karyn; Graef, Stefan; Greene, Daniel; Shamardina, Olga; Allen, Hana Lango; Sanchis-Juan, Alba; Frontini, Mattia; Stephens, Jonathan; Mapeta, Rutendo; Downes, Kate; Haimel, Matthias; Tuna, Salih; Deevi, Sri V. V.; Carss, Keren; James, Roger; Rendon, Augusto; Kingston, Nathalie; Walker, Neil; Penkett, Christopher J.; Stirrups, Kathleen E.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge, England; [Turro, Ernest; Megy, Karyn; Graef, Stefan; Shamardina, Olga; Allen, Hana Lango; Sanchis-Juan, Alba; Stephens, Jonathan; Mapeta, Rutendo; Downes, Kate; Haimel, Matthias; Tuna, Salih; Deevi, Sri V. V.; Carss, Keren; Chinnery, Patrick F.; James, Roger; Morrell, Nicholas W.; Stark, Hannah; Kingston, Nathalie; Walker, Neil; Bradley, John R.; Ashford, Sofie; Penkett, Christopher J.; Stirrups, Kathleen E.; Raymond, F. Lucy; Ouwehand, Willem H.] Cambridge Univ Hosp NHS Fdn, NIHR BioResource, Cambridge Biomed Campus, Cambridge, England; [Turro, Ernest; Astle, William J.; Greene, Daniel; Richardson, Sylvia] Univ Cambridge, Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Astle, William J.; Frontini, Mattia; Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge Biomed Campus, Cambridge, England; [Graef, Stefan; Burren, Oliver S.; Haimel, Matthias; Morrell, Nicholas W.; Smith, Kenneth G. C.; Bradley, John R.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge Biomed Campus, Cambridge, England; [Frontini, Mattia; Ouwehand, Willem H.] Univ Cambridge, British Heart Fdn, Cambridge Ctr Excellence, Cambridge, England; [Thys, Chantal; Freson, Kathleen] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Dept Cardiovasc Sci, Leuven, Belgium; [Burren, Oliver S.; Smith, Kenneth G. C.] Jeffrey Cheah Biomed Ctr, Cambridge Inst Therapeut Immunol & Infect Dis, Cambridge Biomed Campus, Cambridge, England; [Aitman, Timothy J.] Imperial Coll London, Fac Med, MRC Clin Sci Ctr, London, England; [Aitman, Timothy J.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Bennett, David L.; Themistocleous, Andreas C.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford, England; [Bennett, David L.; Ormondroyd, Elizabeth; Roberts, Irene; Roy, Noemi B. A.] Oxford Univ Hosp Trust, NIHR Oxford Biomed Res Ctr, Oxford, England; [Calleja, Paul; Rankin, Stuart] Univ Cambridge, High Performance Comp Serv, Cambridge, England; [Caulfield, Mark J.; Rendon, Augusto] Genom England Ltd, London, England; [Caulfield, Mark J.] Queen Mary Univ London, NIHR Biomed Res Ctr Barts, William Harvey Res Inst, London, England; [Chinnery, Patrick F.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England; [Chinnery, Patrick F.] MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England; [Dixon, Peter H.; Williamson, Catherine] Kings Coll London, Sch Life Course Sci, Women & Childrens Hlth, London, England; [Gale, Daniel P.; Levine, Adam P.] UCL, Dept Renal Med, London, England; [Gale, Daniel P.] UK Renal Registry, Rare Renal Dis Registry, Bristol, Avon, England; [Koziell, Ania] Kings Coll London, London, England; [Koziell, Ania] Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, Dept Paediat Nephrol, London, England; [Laffan, Michael A.] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Haematol, London, England; [Laffan, Michael A.] Imperial Coll London, Ctr Haematol, London, England; [Maher, Eamonn R.; Whitworth, James; Raymond, F. Lucy] Univ Cambridge, Dept Med Genet, Cambridge Biomed Campus, Cambridge, England; [Maher, Eamonn R.; Whitworth, James; Bradley, John R.] NIHR Cambridge Biomed Res Ctr, Cambridge Biomed Campus, Cambridge, England; [Maher, Eamonn R.; Whitworth, James] Cancer Res UK Cambridge Ctr, Cambridge Biomed Campus, Cambridge, England; [Markus, Hugh S.; Tan, Rhea Y. Y.] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge Biomed Campus, Bristol, Avon, England; [Morales, Joannella] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Mumford, Andrew D.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Mumford, Andrew D.] Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England; [Ormondroyd, Elizabeth; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Dept Cardiovasc Med, Oxford, England; [Roberts, Irene; Roy, Noemi B. A.] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England; [Roberts, Irene] Univ Oxford, Weatherall Inst Mol Med, Dept Paediat, Oxford, England; [Roy, Noemi B. A.; Watkins, Hugh] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Saleem, Moin A.] Univ Bristol, Bristol Med Sch, Bristol Renal & Childrens Renal Unit, Bristol, Avon, England; [Saleem, Moin A.] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Hosp Children, Bristol, Avon, England; [Stark, Hannah; Ashford, Sofie] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Thrasher, Adrian J.] UCL Great Ormond St Inst Child Hlth, London, England; [Watkins, Hugh] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Webster, Andrew R.] Moorfields Eye Hosp NHS Trust, London, England; [Webster, Andrew R.] UCL, UCL Inst Opthalmol, London, England; [Wilkins, Martin R.] Imperial Coll London, Dept Med, London, England; [Williamson, Catherine] Imperial Coll Healthcare NHS Trust, Dept Surg & Canc, Inst Reprod & Dev Biol, Hammersmith Hosp,Fac Med, London, England; [Humphray, Sean; Bentley, David R.] Illumina Cambridge, Saffron Walden, England; [Bradley, John R.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England; [Bradley, John R.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Renal Med, Cambridge, England; [Ouwehand, Willem H.] Wellcome Sanger Inst, Cambridge, England	University of Cambridge; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; University of Cambridge; KU Leuven; Imperial College London; University of Edinburgh; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Cambridge; University of London; Queen Mary University London; University of Cambridge; University of London; King's College London; University of London; University College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; Imperial College London; University of Cambridge; University of Cambridge; University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Bristol; University of Bristol; University of Oxford; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Bristol; Bristol Royal Hospital For Children; University of Bristol; University of Cambridge; University of London; University College London; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Imperial College London; Imperial College London; Illumina; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute	Turro, E; Ouwehand, WH (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge, England.; Turro, E; Raymond, FL; Ouwehand, WH (corresponding author), Cambridge Univ Hosp NHS Fdn, NIHR BioResource, Cambridge Biomed Campus, Cambridge, England.; Ouwehand, WH (corresponding author), NHS Blood & Transplant, Cambridge Biomed Campus, Cambridge, England.; Ouwehand, WH (corresponding author), Univ Cambridge, British Heart Fdn, Cambridge Ctr Excellence, Cambridge, England.; Raymond, FL (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Biomed Campus, Cambridge, England.; Ouwehand, WH (corresponding author), Wellcome Sanger Inst, Cambridge, England.	et341@cam.ac.uk; flr24@cam.ac.uk; who1000@cam.ac.uk	Southgate, Laura/H-7924-2019; Buckland, Matthew/H-7049-2019; MAHER, EAMONN R/A-9507-2008; Evans, D Gareth/AAB-4308-2022; Elliott, Perry/AAR-3430-2020; Rahman, Shamima/C-5232-2008; Ware, James S/G-5139-2012; Babbs, Christian/AAA-5917-2022; Gale, Daniel/D-5594-2013; Houge, Sofia Douzgou/I-2049-2019; bennett, david/ABG-1184-2020; Wilkins, Martin/ABH-1140-2021; Tait, Campbell/AFQ-8204-2022; gresele, paolo/AAG-8019-2019; wei, wei/HHR-8613-2022; Marschall, Hanns-Ulrich/K-8842-2017; Wood, Nicholas/C-2505-2009; Allsup, David/H-2195-2017; Ghio, Stefano/ABH-1151-2021; Harper, Andrew/B-7044-2017; Todd, John/A-3542-2010; Black, Graeme/K-7374-2015; Simpson, Michael/F-4737-2011; Scelsi, Laura/AAB-9729-2019; Sargur, Ravishankar/C-2270-2009	Southgate, Laura/0000-0002-2090-1450; Buckland, Matthew/0000-0002-5646-4707; MAHER, EAMONN R/0000-0002-6226-6918; Evans, D Gareth/0000-0002-8482-5784; Elliott, Perry/0000-0003-3383-3984; Rahman, Shamima/0000-0003-2088-730X; Ware, James S/0000-0002-6110-5880; Babbs, Christian/0000-0002-1898-5878; Gale, Daniel/0000-0002-9170-1579; Houge, Sofia Douzgou/0000-0001-8890-7544; Wilkins, Martin/0000-0003-3926-1171; Tait, Campbell/0000-0003-4842-6783; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Bennett, David/0000-0002-7996-2696; Edgar, John David Moore/0000-0003-2969-4475; Bueser, Teofila/0000-0001-9222-1705; Michaelides, Michel/0000-0002-1552-7046; Hudson, Gavin/0000-0001-7210-2733; Erber, Wendy/0000-0002-1028-9376; Haimel, Matthias/0000-0002-0320-0214; Bogaard, Harm Jan/0000-0001-5371-0346; Turro, Ernest/0000-0002-1820-6563; Waisfisz, Quinten/0000-0002-7384-9182; Toshner, Mark/0000-0002-3969-6143; Laffan, Michael/0000-0002-8268-3268; Kingston, Nathalie/0000-0002-9190-2231; mumford, andrew/0000-0002-5523-511X; Gomez, Keith/0000-0002-8934-0700; Yong, Patrick/0000-0003-1736-2756; Taylor, Jenny/0000-0003-3602-5704; Morrell, Nicholas/0000-0001-5700-9792; Wood, Nicholas/0000-0002-9500-3348; vonk noordegraaf, anton/0000-0002-4057-758X; Allsup, David/0000-0001-6159-6109; Dixon, Peter/0000-0002-0197-2632; Daniels, Matthew/0000-0002-9250-6214; Ghio, Stefano/0000-0002-1858-1152; Parry, David/0000-0003-0376-7736; Harper, Andrew/0000-0001-5327-0328; Saleem, Moin/0000-0002-9808-4518; Aitman, Timothy/0000-0002-7875-4502; Stephens, Jonathan/0000-0003-2020-9330; Thomas, David/0000-0002-9738-2329; Savic, Sinisa/0000-0001-7910-0554; marchbank, kevin james/0000-0003-1312-5411; Marshall, Andrew/0000-0001-8273-7089; Graf, Stefan/0000-0002-1315-8873; McMahon, Aoife/0000-0003-0978-0309; Levine, Adam/0000-0003-1333-9938; Todd, John/0000-0003-2740-8148; Bradley, John/0000-0002-7774-8805; Themistocleous, Andreas/0000-0002-1089-1543; Fowler, Tom/0000-0002-7258-2279; , Jesmeen/0000-0003-4169-8209; Matthews, Emma/0000-0002-3810-306X; Stark, Hannah/0000-0003-3095-5732; Black, Graeme/0000-0001-8727-6592; Wedderburn, Lucy/0000-0002-7495-1429; Astle, William John/0000-0001-8866-6672; Steward, Charles/0000-0001-8829-5349; Simpson, Michael/0000-0002-8539-8753; Chinnery, Patrick/0000-0002-7065-6617; Burren, Oliver/0000-0002-3388-5760; Walker, Suellen/0000-0002-6086-9459; Koelling, Nils/0000-0001-5292-4510; Daugherty, Louise/0000-0003-4546-6667; james, roger/0000-0002-0058-1357; Everington, Tamara/0000-0001-8886-0280; Morales, Joannella/0000-0002-8121-9797; Banka, Siddharth/0000-0002-8527-2210; Tuna, Salih/0000-0003-3606-4367; Ormondroyd, Elizabeth/0000-0002-9116-4064; Soranzo, Nicole/0000-0003-1095-3852; freson, kathleen/0000-0002-4381-2442; Jurkute, Neringa/0000-0002-3092-7451; Newman, William/0000-0002-6382-4678; Horvath, Rita/0000-0002-9841-170X; schulman, sol/0000-0002-5229-3592; Scelsi, Laura/0000-0001-9409-691X; Buchan, Rachel/0000-0003-2490-9289; /0000-0003-2885-4692; Burn, John/0000-0002-9823-2322; Walker, Neil/0000-0001-9796-7688; Machado, Rajiv David/0000-0001-9247-0744; Sargur, Ravishankar/0000-0002-8535-630X; Newnham, Michael/0000-0002-2972-6249; moledina, shahin/0000-0003-0262-2340; Shamardina, Olga/0000-0003-4994-2157; Olschewski, Andrea/0000-0002-8189-3634	Genomics England Ltd (GEL); Department of Health in the United Kingdom - NIHR in England; British Heart Foundation (BHF); MRC [MR/N025431/1]; NHS England; NIHR Biomedical Research Centres (BRC); NIHR BioResource Centres; NHS Blood and Transplant [9616]; Wellcome Trust [WT108749/Z/15/Z, WT200990/Z/16/Z]; Diabetes UK; Northwest Regional Development Agency; Scottish Government; Welsh Assembly Government; MRC - Wellcome Trust [WT200990/Z/16/Z]; European Molecular Biology Laboratory; MRC Programme Grant [MR/L019027/1]; European Commission [ID633491]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; European Research Council [309548, 201064/Z/16/Z]; Newton Fund (UK/Turkey) [MR/N027302/1]; European Union [202747/Z/16/Z]; NIHR Cardiovascular Biomedical Research Unit at Royal Brompton & Harefield NHS Foundation Trust and Imperial College London; University College London; Wellcome Trust Institutional Strategic Support Fund [204809/Z/16/Z]; MRC UK [G1002570]; MRC Senior Clinical Fellowship [MR/L006340/1, MR/J011711/1, NIHR-RP-2016-07-019]; Wellcome Intermediate Fellowship [098524/Z/12/A]; NIHR Barts Biomedical Research Centre - NIHR Imperial College Biomedical Research Centre; NIHR Translational Research Collaboration -Rare Diseases - NIHR Bristol Biomedical Research Centre; NIHR Translational Research Collaboration -Rare Diseases - NIHR Oxford Biomedical Research Centre; Fight for Sight (UK) Early Career Investigator Award; NIHR Moorfields Biomedical Research Centre; Moorfields Eye Hospital Special Trustees; Foundation Fighting Blindness (USA); Retinitis Pigmentosa Fighting Blindness - Retinitis Pigmentosa Fighting Blindness; Fight for Sight [1570/1571, 24TP171]; NIHR [IS-BRC-1215-20002]; NIHR Translational Research Collaboration -Rare Diseases [01/04/15-30/04/2017]; UCL Institute of Ophthalmology; Guy's and St Thomas' NHS Foundation Trust and King's College London - NIHR Biomedical Resource Centre at UCL Institute of Ophthalmology; Novo Nordisk Foundation [NNF14SA0006]; Cancer Research UK Cambridge Cancer Centre Clinical Research Training Fellowship - Kids Kidney Research; MRC, Kidney Research UK; St Peters Trust for Kidney, Bladder and Prostate Research; Northern Counties Kidney Research Fund; British Society of Haematology; BHF Programme [RG/16/4/32218]; Research Council of the University of Leuven (BOF KU Leuven, Belgium) [OT/14/098]; Academy of Medical Sciences (AMS) [NIF003\\1002] Funding Source: researchfish; Medical Research Council [MR/N010035/1, MR/N025431/1, MR/N025431/2, MR/N027302/2, MR/N027302/1, G1000848] Funding Source: researchfish; Wellcome Trust [109915/A/15/Z] Funding Source: researchfish; MRC [MR/N010035/1, MC_PC_18030, MC_PC_15080, MR/N025431/2, G1000848, MR/M009203/1, G1002528, MC_PC_14089, MC_EX_MR/M009203/1, MC_U120085815, MR/L019027/1, MR/S021329/1, G0800571, MR/L006340/1, MR/K020919/1, MR/J011711/1] Funding Source: UKRI	Genomics England Ltd (GEL); Department of Health in the United Kingdom - NIHR in England; British Heart Foundation (BHF)(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS England; NIHR Biomedical Research Centres (BRC); NIHR BioResource Centres; NHS Blood and Transplant; Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); Northwest Regional Development Agency; Scottish Government; Welsh Assembly Government; MRC - Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); European Molecular Biology Laboratory; MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Centre for Mitochondrial Research; European Research Council(European Research Council (ERC)European Commission); Newton Fund (UK/Turkey); European Union(European Commission); NIHR Cardiovascular Biomedical Research Unit at Royal Brompton & Harefield NHS Foundation Trust and Imperial College London; University College London(General Electric); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Senior Clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Intermediate Fellowship(Wellcome Trust); NIHR Barts Biomedical Research Centre - NIHR Imperial College Biomedical Research Centre; NIHR Translational Research Collaboration -Rare Diseases - NIHR Bristol Biomedical Research Centre; NIHR Translational Research Collaboration -Rare Diseases - NIHR Oxford Biomedical Research Centre; Fight for Sight (UK) Early Career Investigator Award; NIHR Moorfields Biomedical Research Centre; Moorfields Eye Hospital Special Trustees; Foundation Fighting Blindness (USA); Retinitis Pigmentosa Fighting Blindness - Retinitis Pigmentosa Fighting Blindness; Fight for Sight; NIHR(National Institute for Health Research (NIHR)); NIHR Translational Research Collaboration -Rare Diseases; UCL Institute of Ophthalmology; Guy's and St Thomas' NHS Foundation Trust and King's College London - NIHR Biomedical Resource Centre at UCL Institute of Ophthalmology; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Cancer Research UK Cambridge Cancer Centre Clinical Research Training Fellowship - Kids Kidney Research; MRC, Kidney Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); St Peters Trust for Kidney, Bladder and Prostate Research; Northern Counties Kidney Research Fund; British Society of Haematology; BHF Programme; Research Council of the University of Leuven (BOF KU Leuven, Belgium); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was made possible through access to the data and findings generated by two pilot studies for the 100,000 Genomes Project. The enrolment was coordinated for one by the NIHR BioResource and for the other by Genomics England Ltd (GEL), a company wholly owned by the Department of Health in the United Kingdom. These pilot studies were mainly funded by grants from the NIHR in England to Cambridge University Hospitals and GEL, respectively. Additional funding was provided by the British Heart Foundation (BHF), MRC, NHS England, the Wellcome Trust and many other fund providers (see funding acknowledgements for individual researchers). The pilot studies use data provided by patients and their close relatives and collected by the NHS and other healthcare providers as part of their care and support. The vast majority of participants in the two pilot studies have been enrolled in the NIHR BioResource. We thank all volunteers for their participation and the NIHR Biomedical Research Centres (BRC), NIHR BioResource Centres, NHS Trust Hospitals, NHS Blood and Transplant and their staff for their contribution. This research has been conducted using the UK Biobank resource under Application Number 9616, granting access to DNA samples and accompanying participant data. UK Biobank has received funding from the MRC, Wellcome Trust, Department of Health, BHF, Diabetes UK, Northwest Regional Development Agency, Scottish Government and Welsh Assembly Government. The MRC and Wellcome Trust had a key role in the decision to establish the UK Biobank. A. McMahon and J. Morales are funded by The Wellcome Trust (WT200990/Z/16/Z) and the European Molecular Biology Laboratory; K.G.C.S. holds a Wellcome Investigator Award, MRC Programme Grant (number MR/L019027/1); M.I.M. is a Wellcome Senior Investigator and receives support from the Wellcome Trust (090532, 0938381) and is a member of the DOLORisk consortium funded by the European Commission Horizon 2020 (ID633491); R. Horvath is a Wellcome Trust Investigator (109915/Z/15/Z), who receives support from the Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), MRC (MR/N025431/1), the European Research Council (309548), the Wellcome Trust Pathfinder Scheme (201064/Z/16/Z), the Newton Fund (UK/Turkey, MR/N027302/1) and the European Union H2020 -Research and Innovation Actions (SC1-PM-03-2017, Solve-RD); D.L.B. is a Wellcome clinical scientist (202747/Z/16/Z) and is a member of the DOLORisk consortium funded by the European Commission Horizon 2020 (ID633491); J.S.W. is funded by Wellcome Trust [107469/Z/15/Z], NIHR Cardiovascular Biomedical Research Unit at Royal Brompton & Harefield NHS Foundation Trust and Imperial College London; A.J.T. is supported by the Wellcome Trust (104807/Z/14/Z) and the NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; L. Southgate is supported by the Wellcome Trust Institutional Strategic Support Fund (204809/Z/16/Z) awarded to St George's, University of London; M.J.D. receives funding from Wellcome Trust (WT098519MA); M.C.S. holds an MRC Clinical Research Training Fellowship (MR/R002363/1); J.A.S. is funded by MRC UK grant MR/M012212/1; A.J.M. received funding from an MRC Senior Clinical Fellowship (MR/L006340/1); C. Lentaigne received funding from an MRC Clinical Research Training Fellowship (MR/J011711/1); M.R.W. holds a NIHR award to the NIHR Imperial Clinical Research Facility at Imperial College Healthcare NHS Trust; C. Williamson holds a NIHR Senior Investigator Award; M. A.; Kurian holds a NIHR Research Professorship (NIHR-RP-2016-07-019) and Wellcome Intermediate Fellowship (098524/Z/12/A); M.J.C. is an NIHR Senior Investigator and is funded by the NIHR Barts Biomedical Research Centre; N. Cooper is partially funded by NIHR Imperial College Biomedical Research Centre; C. Hadinnapola was funded through a PhD Fellowship by the NIHR Translational Research Collaboration -Rare Diseases; A.D.M. and S.K.W. were funded by the NIHR Bristol Biomedical Research Centre; E.L.M. received funding from the NIHR Biomedical Research Centre at University College London Hospitals; K.C.G. received funding from the NIHR Great Ormond Street Biomedical Research Centre; I.R. and E. Louka are supported by the NIHR Translational Research Collaboration -Rare Diseases; J.C.T., J.M.T. and S. Patel are funded by the NIHR Oxford Biomedical Research Centre; G. Arno is funded by a Fight for Sight (UK) Early Career Investigator Award (5045-5046); All authors affiliated with Moorfields Eye hospital and Institute of Ophthalmology are funded by the NIHR Moorfields Biomedical Research Centre and UCL Institute of Ophthalmology, Fight for Sight (UK) Early Career Investigator Award, Moorfields Eye Hospital Special Trustees, Moorfields Eye Charity, Foundation Fighting Blindness (USA) and Retinitis Pigmentosa Fighting Blindness; A.T.M. is funded by Retinitis Pigmentosa Fighting Blindness, P.Y.-W.-M. is supported by grants from MRC UK (G1002570), Fight for Sight (1570/1571 and 24TP171), NIHR (IS-BRC-1215-20002); S.O.B. is supported by NIHR Translational Research Collaboration -Rare Diseases (01/04/15-30/04/2017); A.R.W. works for the NIHR Moorfields Biomedical Research Centre and the UCL Institute of Ophthalmology and Moorfields Eye Hospital; the following NIHR Biomedical Research Centres contributed to the enrolment for the ICP domain: Imperial College Healthcare NHS Trust, Guy's and St Thomas' NHS Foundation Trust and King's College London. All authors affiliated with Moorfields Eye hospital and Institute of Ophthalmology are funded by the NIHR Biomedical Resource Centre at UCL Institute of Ophthalmology and Moorfields; A.C.T. is a member of the International Diabetic Neuropathy Consortium, the Novo Nordisk Foundation (NNF14SA0006) and is a member of the DOLORisk consortium funded by the European Commission Horizon 2020 (ID633491); J. Whitworth is a recipient of a Cancer Research UK Cambridge Cancer Centre Clinical Research Training Fellowship; S.A.J. is funded by Kids Kidney Research; D.P.G. is funded by the MRC, Kidney Research UK and St Peters Trust for Kidney, Bladder and Prostate Research; The MPGN/DDD/C3 Glomerulopathy Rare Disease Group contributed to the recruitment and analysis for the PMG domain; K.J.M. is supported by the Northern Counties Kidney Research Fund; P.H.D. receives funding from ICP Support; T.K.B. received a PhD fellowship from the NHSBT and British Society of Haematology; H.S.M. receives support from BHF Programme Grant RG/16/4/32218; A.L. is a BHF Senior Basic Science Research Fellow -FS/13/48/30453; K.F. and C.V.-G. are supported by the Research Council of the University of Leuven (BOF KU Leuven, Belgium; OT/14/098); H.J.B. works for the Netherlands CardioVascular Research Initiative (CVON); Fiona Cunningham, Aoife McMahon, Glen Threadgold, and Joannella Morales received funding from the Wellcome Trust (grant numbers WT108749/Z/15/Z and WT200990/Z/16/Z) and the European Molecular Biology Laboratory.; The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care of England or any of the other funding agencies.	Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Ananth AL, 2016, PEDIATR NEUROL, V59, P81, DOI 10.1016/j.pediatrneurol.2016.02.018; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Ballmaier M, 2011, SEMIN THROMB HEMOST, V37, P673, DOI 10.1055/s-0031-1291377; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Boycott KM, 2017, AM J HUM GENET, V100, P695, DOI 10.1016/j.ajhg.2017.04.003; Burren OS, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1285-0; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carss KJ, 2017, AM J HUM GENET, V100, P75, DOI 10.1016/j.ajhg.2016.12.003; de Waele L, 2010, PEDIATR RES, V67, P314, DOI 10.1203/PDR.0b013e3181caafd2; Di Michele M, 2011, J PROTEOMICS, V74, P902, DOI 10.1016/j.jprot.2011.03.007; Evans JDW, 2016, LANCET RESP MED, V4, P129, DOI 10.1016/S2213-2600(15)00544-5; Ferreira CR, 2019, AM J MED GENET A, V179, P885, DOI 10.1002/ajmg.a.61124; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Fukada M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030924; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Giardine B, 2014, NUCLEIC ACIDS RES, V42, pD1063, DOI 10.1093/nar/gkt911; Graf S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03672-4; Greene D, 2017, AM J HUM GENET, V101, P104, DOI 10.1016/j.ajhg.2017.05.015; Hadinnapola C, 2017, CIRCULATION, V136, P2022, DOI 10.1161/CIRCULATIONAHA.117.028351; Heremans J, 2018, J ALLERGY CLIN IMMUN, V142, P630, DOI 10.1016/j.jaci.2017.11.061; Horn D, 2017, AM J MED GENET A, V173, P2534, DOI 10.1002/ajmg.a.38345; Ito Y, 2018, AM J HUM GENET, V103, P144, DOI 10.1016/j.ajhg.2018.06.001; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Khan SY, 2015, MOL VIS, V21, P871; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lentaigne C, 2019, BLOOD, V134, P2070, DOI 10.1182/blood.2019000782; Lopez-Herrera G, 2012, AM J HUM GENET, V90, P986, DOI 10.1016/j.ajhg.2012.04.015; MacArthur JAL, 2014, NUCLEIC ACIDS RES, V42, pD873, DOI 10.1093/nar/gkt1198; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Merico D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9718; Meyer E, 2017, NAT GENET, V49, P223, DOI 10.1038/ng.3740; Natarajan P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05747-8; Noetzli L, 2015, NAT GENET, V47, P535, DOI 10.1038/ng.3253; Noris P, 2013, BLOOD, V122, P1987, DOI 10.1182/blood-2013-04-499319; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Padmakumar Manisha, 2019, JIMD Rep, V47, P9, DOI 10.1002/jmd2.12030; Petrovski S, 2016, AM J HUM GENET, V98, P1001, DOI 10.1016/j.ajhg.2016.03.011; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Pleines I, 2017, J CLIN INVEST, V127, P814, DOI 10.1172/JCI86154; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Sadoul K, 2012, BLOOD, V120, P4215, DOI 10.1182/blood-2012-05-428011; Sanchis-Juan A, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0606-6; Short PJ, 2018, NATURE, V555, P611, DOI 10.1038/nature25983; Sivapalaratnam S, 2017, BLOOD, V129, P520, DOI 10.1182/blood-2016-08-732248; Skultetyova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11739-3; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Stritt S, 2016, BLOOD, V127, P2903, DOI 10.1182/blood-2015-10-675629; Thaventhiran JED, 2020, NATURE, V583, P90, DOI 10.1038/s41586-020-2265-1; Tijssen MR, 2008, BRIT J HAEMATOL, V141, P808, DOI 10.1111/j.1365-2141.2008.07139.x; Tuijnenburg P, 2018, J ALLERGY CLIN IMMUN, V142, P1285, DOI 10.1016/j.jaci.2018.01.039; Turro E, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7666; Van Houten C. V, 2019, WHOLE EXOME SEQUENCI, DOI 10.1101/572347; Vissers LELM, 2017, GENET MED, V19, P1055, DOI 10.1038/gim.2017.1; WENDLING F, 1994, NATURE, V369, P571, DOI 10.1038/369571a0; Westbury SK, 2018, BLOOD ADV, V2, P2341, DOI 10.1182/bloodadvances.2018020370; Westbury SK, 2017, BLOOD, V130, P1026, DOI 10.1182/blood-2017-03-776773; Wijgaerts A, 2017, HAEMATOLOGICA, V102, P695, DOI 10.3324/haematol.2016.152777	61	172	173	6	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					96	+		10.1038/s41586-020-2434-2	http://dx.doi.org/10.1038/s41586-020-2434-2		JUN 2020	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PQ3EJ	32581362	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000556405300001
J	Rubin, R				Rubin, Rita			Cautious and Fearful Infants Grow Into Cautious and Fearful Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2452	2452		10.1001/jama.2020.9623	http://dx.doi.org/10.1001/jama.2020.9623			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32573654				2022-12-28	WOS:000590149400003
J	Wise, J				Wise, Jacqui			Covid-19: UK drops its own contact tracing app to switch to Apple and Google model	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2020	369								m2472	10.1136/bmj.m2472	http://dx.doi.org/10.1136/bmj.m2472			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GF	32561511	Bronze			2022-12-28	WOS:000548534100001
J	Caulley, L				Caulley, Lisa			Sticks and Stones - Confronting the Full Spectrum of Racism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISCRIMINATION		[Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC	Caulley, L (corresponding author), Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada.; Caulley, L (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Caulley, L (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.			Caulley, Lisa/0000-0002-9661-4634				Broman CliffordL., 2000, J BLACK PSYCHOL, V26, DOI [10.1177/0095798400026002003, DOI 10.1177/0095798400026002003]; Krieger N, 1996, AM J PUBLIC HEALTH, V86, P1370, DOI 10.2105/AJPH.86.10.1370; Landrine H., 1996, J BLACK PSYCHOL, V22, P144, DOI DOI 10.1177/00957984960222002; Utsey SO, 2008, J COUNS PSYCHOL, V55, P49, DOI 10.1037/0022-0167.55.1.49; Wallace S, 2016, AM J PUBLIC HEALTH, V106, P1294, DOI 10.2105/AJPH.2016.303121	5	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2020	383	12					1103	1105		10.1056/NEJMp2021216	http://dx.doi.org/10.1056/NEJMp2021216			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NU8QD	32603036	Bronze			2022-12-28	WOS:000573901600009
J	Sarpatwari, A; Kaltenboeck, A; Kesselheim, AS				Sarpatwari, Ameet; Kaltenboeck, Anna; Kesselheim, Aaron S.			Missed Opportunities on Emergency Remdesivir Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sarpatwari, Ameet; Kesselheim, Aaron S.] Harvard Med Sch, Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA; [Kaltenboeck, Anna] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, Drug Pricing Lab, 1275 York Ave, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Sarpatwari, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	asarpatwari@bwh.harvard.edu			Arnold Ventures; Harvard-MIT Center for Regulatory Science	Arnold Ventures; Harvard-MIT Center for Regulatory Science	Dr Sarpatwari and Dr Kesselheim's work was supported by Arnold Ventures and the Harvard-MIT Center for Regulatory Science. Ms Kaltenboeck's work was supported by Arnold Ventures.	Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Eastman RT, 2020, ACS CENTRAL SCI, V6, P672, DOI 10.1021/acscentsci.0c00489; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Institute for Clinical and Economic Review, ALT PRIC MOD REMD OT; Ison MG, 2020, JAMA-J AM MED ASSOC, V323, P2365, DOI 10.1001/jama.2020.8863; Langreth R., BLOOMBERG NEWS; Sarpatwari A, 2019, JAMA-J AM MED ASSOC, V321, P651, DOI 10.1001/jama.2019.0236; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; White DB, 2020, JAMA-J AM MED ASSOC, V323, P1773, DOI 10.1001/jama.2020.5046	9	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					331	332		10.1001/jama.2020.11932	http://dx.doi.org/10.1001/jama.2020.11932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32579163	Bronze			2022-12-28	WOS:000562851000015
J	Chou, TH; Tajima, N; Romero-Hernandez, A; Furukawa, H				Chou, Tsung-Han; Tajima, Nami; Romero-Hernandez, Annabel; Furukawa, Hiro			Structural Basis of Functional Transitions in Mammalian NMDA Receptors	CELL			English	Article							SUBUNIT ARRANGEMENT; GLUTAMATE-RECEPTOR; SYNAPTIC PLASTICITY; CRYSTAL-STRUCTURE; BINDING-SITES; ACTIVATION; MECHANISM; INHIBITION; MODULATION; DOMAIN	Excitatory neurotransmission meditated by glutamate receptors including N-methyl-D-aspartate receptors (NMDARs) is pivotal to brain development and function. NMDARs are heterotetramers composed of GIuN1 and GluN2 subunits, which bind glycine and glutamate, respectively, to activate their ion channels. Despite importance in brain physiology, the precise mechanisms by which activation and inhibition occur via subunit-specific binding of agonists and antagonists remain largely unknown. Here, we show the detailed patterns of conformational changes and inter-subunit and -domain reorientation leading to agonist-gating and subunit-dependent competitive inhibition by providing multiple structures in distinct ligand states at 4 angstrom or better. The structures reveal that activation and competitive inhibition by both GIuN1 and GIuN2 antagonists occur by controlling the tension of the linker between the ligand-binding domain and the transmembrane ion channel of the GIuN2 subunit. Our results provide detailed mechanistic insights into NMDAR pharmacology, activation, and inhibition, which are fundamental to the brain physiology.	[Chou, Tsung-Han; Tajima, Nami; Romero-Hernandez, Annabel; Furukawa, Hiro] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; [Romero-Hernandez, Annabel; Furukawa, Hiro] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Tajima, Nami] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Romero-Hernandez, Annabel] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Case Western Reserve University; Regeneron	Furukawa, H (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA.; Furukawa, H (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	furukawa@cshl.edu		Romero Hernandez, Annabel/0000-0002-5119-2319	NIH [NS111745, MH085926]; Robertson funds at Cold Spring Harbor Laboratory; Doug Fox Alzheimer's Fund; Austin's Purpose; Heartfelt Wing Alzheimer's Fund; Gertrude and Louis Feil Family Trust	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson funds at Cold Spring Harbor Laboratory; Doug Fox Alzheimer's Fund; Austin's Purpose; Heartfelt Wing Alzheimer's Fund; Gertrude and Louis Feil Family Trust	We would like to thank the staff at the beamline 23ID-B at the Advanced Photon Source at Argonne National Laboratory. Dennis Thomas and Ming Wang are thanked for managing the cryo-EM facility and the computing facility, respectively. We thank M. Mayer for fruitful discussions on iGluRs. N. Simorowski and Jue Xiang Wang are thanked for technical support, and K. Michalski is thanked for critical reading of this manuscript. This work was funded by NIH (NS111745 and MH085926), Robertson funds at Cold Spring Harbor Laboratory, Doug Fox Alzheimer's Fund, Austin's Purpose, Heartfelt Wing Alzheimer's Fund, and the Gertrude and Louis Feil Family Trust. We would like to dedicate this manuscript to the memory of Dr. James Howe, who greatly advanced the field of iGluRs.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amico-Ruvio SA, 2010, BIOPHYS J, V98, P1160, DOI 10.1016/j.bpj.2009.12.4276; Banke TG, 2005, J NEUROSCI, V25, P42, DOI 10.1523/JNEUROSCI.3154-04.2005; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; Chan K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15224-w; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Chen PE, 2008, J PHYSIOL-LONDON, V586, P227, DOI 10.1113/jphysiol.2007.143172; Chen SS, 2017, CELL, V170, P1234, DOI 10.1016/j.cell.2017.07.045; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Cooper DR, 2015, BIOPHYS J, V109, P66, DOI 10.1016/j.bpj.2015.05.025; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esmenjaud JB, 2019, EMBO J, V38, DOI 10.15252/embj.201899894; Fedele L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02927-4; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hansen KB, 2018, J GEN PHYSIOL, V150, P1081, DOI 10.1085/jgp.201812032; Iacobucci GJ, 2018, CURR OPIN PHYSIOL, V2, P114, DOI 10.1016/j.cophys.2018.02.002; Jalali-Yazdi F, 2018, CELL, V175, P1520, DOI 10.1016/j.cell.2018.10.043; Jespersen A, 2014, NEURON, V81, P366, DOI 10.1016/j.neuron.2013.11.033; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Karakas E, 2015, TRENDS BIOCHEM SCI, V40, P328, DOI 10.1016/j.tibs.2015.04.002; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Ladislav M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00113; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Li L, 2013, CELL, V153, P86, DOI 10.1016/j.cell.2013.02.051; Li Y, 2016, NEURON, V92, P1036, DOI 10.1016/j.neuron.2016.10.058; Lind GE, 2017, P NATL ACAD SCI USA, V114, pE6942, DOI 10.1073/pnas.1707752114; Lu W, 2017, SCIENCE, V355, DOI 10.1126/science.aal3729; Maneshi MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep39610; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyerson JR, 2016, NATURE, V537, P567, DOI 10.1038/nature19352; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oshima A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13681; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Regan MC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08291-1; Regan MC, 2018, NEURON, V98, P521, DOI 10.1016/j.neuron.2018.03.034; RODEMS SM, 1993, J VIROL, V67, P5776, DOI 10.1128/JVI.67.10.5776-5785.1993; Romero-Hernandez A, 2017, MOL PHARMACOL, V92, P22, DOI 10.1124/mol.116.107912; Romero-Hernandez A, 2016, NEURON, V92, P1324, DOI 10.1016/j.neuron.2016.11.006; Scanlon DP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15220; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Song XQ, 2018, NATURE, V556, P515, DOI 10.1038/s41586-018-0039-9; Tajima N, 2016, NATURE, V534, P63, DOI 10.1038/nature17679; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Twomey EC, 2017, NATURE, V549, P60, DOI 10.1038/nature23479; van Oers MM, 1999, J GEN VIROL, V80, P2253, DOI 10.1099/0022-1317-80-8-2253; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Wang JX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14321-0; Wang JX, 2019, CURR OPIN STRUC BIOL, V54, P34, DOI 10.1016/j.sbi.2018.12.009; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; XiangWei WS, 2018, CURR OPIN PHYSIOL, V2, P27, DOI 10.1016/j.cophys.2017.12.013; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140; Yao YN, 2013, STRUCTURE, V21, P1788, DOI 10.1016/j.str.2013.07.011; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zeng QQ, 2019, NATURE, V573, P526, DOI 10.1038/s41586-019-1576-6; Zhang JB, 2018, CELL REP, V25, P3582, DOI 10.1016/j.celrep.2018.11.071; Zhu H., 2019, MECH GATING PARTIAL, DOI [10.1101/786632, DOI 10.1101/786632]; Zhu SJ, 2016, CELL, V165, P704, DOI 10.1016/j.cell.2016.03.028	75	31	31	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					357	+		10.1016/j.cell.2020.05.052	http://dx.doi.org/10.1016/j.cell.2020.05.052			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32610085	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000552745000009
J	Kounatidis, I; Stanifer, ML; Phillips, MA; Paul-Gilloteaux, P; Heiligenstein, X; Wang, HC; Okolo, CA; Fish, TM; Spink, MC; Stuart, DI; Davis, I; Boulant, S; Grimes, JM; Dobbie, IM; Harkiolaki, M				Kounatidis, Ilias; Stanifer, Megan L.; Phillips, Michael A.; Paul-Gilloteaux, Perrine; Heiligenstein, Xavier; Wang, Hongchang; Okolo, Chidinma A.; Fish, Thomas M.; Spink, Matthew C.; Stuart, David, I; Davis, Ilan; Boulant, Steeve; Grimes, Jonathan M.; Dobbie, Ian M.; Harkiolaki, Maria			3D Correlative Cryo-Structured Illumination Fluorescence and Soft X-ray Microscopy Elucidates Reovirus Intracellular Release Pathway	CELL			English	Article							RESOLUTION LIMIT; TOMOGRAPHY; LIGHT; PROTEINS; RECONSTRUCTION; VISUALIZATION; TRAFFICKING; TRANSPORT; ALIGNMENT; FIXATION	Imaging of biological matter across resolution scales entails the challenge of preserving the direct and unambiguous correlation of subject features from the macroscopic to the microscopic level, Here, we present a correlative imaging platform developed specifically for imaging cells in 3D under cryogenic conditions by using X-rays and visible light. Rapid cryo-preservation of biological specimens is the current gold standard in sample preparation for ultrastructural analysis in X-ray imaging. However, cryogenic fluorescence localization methods are, in their majority, diffraction-limited and fail to deliver matching resolution, We addressed this technological gap by developing an integrated, user-friendly platform for 3D correlative imaging of cells in vitreous ice by using super-resolution structured illumination microscopy in conjunction with soft X-ray tomography. The power of this approach is demonstrated by studying the process of reovirus release from intracellular vesicles during the early stages of infection and identifying intracellular virus-induced structures.	[Kounatidis, Ilias; Phillips, Michael A.; Wang, Hongchang; Okolo, Chidinma A.; Fish, Thomas M.; Spink, Matthew C.; Stuart, David, I; Grimes, Jonathan M.; Harkiolaki, Maria] Harwell Sci & Innovat Campus, Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Stanifer, Megan L.] Heidelberg Univ Hosp, Dept Infect Dis, Mol Virol, D-69120 Heidelberg, Germany; [Phillips, Michael A.; Davis, Ilan; Dobbie, Ian M.] Univ Oxford, Micron Adv Imaging Consortium, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England; [Phillips, Michael A.; Stuart, David, I; Grimes, Jonathan M.] Henry Wellcome Bldg Genom Med, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England; [Paul-Gilloteaux, Perrine] Univ Nantes, CNRS, INSERM, Inst Thorax, Nantes, France; [Paul-Gilloteaux, Perrine] Nantes Univ, CHU Nantes, INSERM, CNRS,SFR Sante,Inserm UMS 016,UMS3556, Nantes, France; [Heiligenstein, Xavier] CryoCapCell, 155 Blvd Hop, F-75013 Paris, France; [Boulant, Steeve] Heidelberg Univ Hosp, Dept Infect Dis, Virol, D-69120 Heidelberg, Germany; [Boulant, Steeve] German Canc Res Ctr, Res Grp Cellular Polar & Viral Infect, D-69120 Heidelberg, Germany	Diamond Light Source; Ruprecht Karls University Heidelberg; University of Oxford; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Harkiolaki, M (corresponding author), Harwell Sci & Innovat Campus, Diamond Light Source, Didcot OX11 0DE, Oxon, England.	maria.harkiolaki@diamond.ac.uk	Paul-Gilloteaux, Perrine/L-8287-2018; Fish, Thomas/GZL-1090-2022; KOUNATIDIS, ILIAS/C-6404-2014; Stanifer, Megan/ABB-4254-2020	Paul-Gilloteaux, Perrine/0000-0002-4822-165X; KOUNATIDIS, ILIAS/0000-0001-9877-0457; Stanifer, Megan/0000-0002-5606-1297; Phillips, Mick/0000-0003-3578-7301; Okolo, Chidinma Adanna/0000-0001-8779-8673; Davis, Ilan/0000-0002-5385-3053; Fish, Thomas/0000-0001-7125-4137; Grimes, Jonathan Mark/0000-0001-9698-0389	Infectious Diseases Imaging Platform (IDIP) at the Center for Integrative Infectious Disease Research, Heidelberg, Germany; Wellcome Centre for Human Genetics by the Wellcome Trust ISSF [105605/Z/14/Z]; Wellcome Trust [203141/Z/16/Z]; Wellcome Strategic Awards [091911, 107457]; ANR [ANR-18-CE45-0015, ANR-10-INBS-04]; Wellcome Investigator Award [200835/Z/16/Z]; Heisenberg [BO 4340/1-1, SFB1129]; Deutsche Forschungsgemeinschaft (DFG) [240245660, SFB 1129]; Brigitte-Schlieben Lange Program from the state of Baden Wurttemberg, Germany; DFG [416072091]; Diamond; MRC [MR/N00065X/1]; Diamond Light Source [MX21046, MX18314]; MRC [MR/K01577X/1] Funding Source: UKRI	Infectious Diseases Imaging Platform (IDIP) at the Center for Integrative Infectious Disease Research, Heidelberg, Germany; Wellcome Centre for Human Genetics by the Wellcome Trust ISSF; Wellcome Trust(Wellcome Trust); Wellcome Strategic Awards; ANR(French National Research Agency (ANR)); Wellcome Investigator Award; Heisenberg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Brigitte-Schlieben Lange Program from the state of Baden Wurttemberg, Germany; DFG(German Research Foundation (DFG)); Diamond; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diamond Light Source; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Jeff Irwin for his dedicated and enthusiastic support with all technical issues and applications relating to the TXM, Damian Reynolds for technical support, Andrei Tkachuk for SXT support, Michael Schwertner for cryo-microscopy expertise, support, and advice, and Eva Pereiro for guidance, encouragement, and troubleshooting with issues on soft X-ray tomography. We also thank staff at both Micron, DLS as well as B24 team members and support personnel (past and present) for their help and perseverance. Special thanks to Adam Taylor and Adam Prescott for technical support on a day-to-day basis, Martin Harrow for IT support, Stephen Graham for contributing to our user protocols, and Liz Duke for initiating and supporting the X-ray tomography project. We thank John Sedat for sharing and discussing his prototype design of the light path, use of SLMs, timing device, and open source Python control software that formed the basis of the cryoSIM development. We would like to acknowledge the support of Vibor Laketa and the Infectious Diseases Imaging Platform (IDIP) at the Center for Integrative Infectious Disease Research, Heidelberg, Germany. M.A.P. was funded via the Wellcome Centre for Human Genetics by the Wellcome Trust ISSF (105605/Z/14/Z). The Wellcome Trust (203141/Z/16/Z) funds the Wellcome Centre for Human Genetics. I.M.D. and M.A.P. were funded in part by Wellcome Strategic Awards (091911 and 107457) (PI Ilan Davis). P.P.-G. acknowledges CROCOVAL (ANR-18-CE45-0015) and is part of the national infrastructure ``France BioImaging'' supported by the ANR PIA1 (ANR-10-INBS-04). J.M.G. was supported by a Wellcome Investigator Award (200835/Z/16/Z). S.B. was supported by Heisenberg (BO 4340/1-1 and SFB1129) and Deutsche Forschungsgemeinschaft (DFG) (project number 240245660; project 14 of SFB 1129). M.L.S. was supported by the Brigitte-Schlieben Lange Program from the state of Baden Wurttemberg, Germany and the DFG (416072091). D.I.S. is supported by Diamond and MRC (MR/N00065X/1).This work was carried out with the support of the Diamond Light Source, instrument B24 (proposals MX21046 and MX18314).	AGARWAL K, 1989, CHEM-BIOL INTERACT, V69, P1, DOI 10.1016/0009-2797(89)90094-X; Bai HB, 2020, J SYNCHROTRON RADIAT, V27, P176, DOI 10.1107/S1600577519015194; Ball G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15915; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Boulant S, 2013, MOL BIOL CELL, V24, P1196, DOI 10.1091/mbc.E12-12-0852; Bowler M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08216-4; Carlton PM, 2010, P NATL ACAD SCI USA, V107, P16016, DOI 10.1073/pnas.1004037107; Chang YW, 2014, NAT METHODS, V11, P737, DOI [10.1038/NMETH.2961, 10.1038/nmeth.2961]; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Demmerle J, 2017, NAT PROTOC, V12, P988, DOI 10.1038/nprot.2017.019; DERMODY TS, 1993, J VIROL, V67, P2055, DOI 10.1128/JVI.67.4.2055-2063.1993; Dobbie I., 2020, OPTICA, DOI [10.1364, DOI 10.1364/OP-TICA.393203]; Dobbie Ian M, 2011, Cold Spring Harb Protoc, V2011, P899, DOI 10.1101/pdb.top121; DUBOCHET J, 1981, J MICROSC-OXFORD, V124, pRP3; Duke EMH, 2014, ULTRAMICROSCOPY, V143, P77, DOI 10.1016/j.ultramic.2013.10.006; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; ECHLIN P, 1991, J MICROSC-OXFORD, V161, P159, DOI 10.1111/j.1365-2818.1991.tb03080.x; Elgass KD, 2015, J CELL SCI, V128, P2795, DOI 10.1242/jcs.169136; Fratini M, 2018, ACS INFECT DIS, V4, P1585, DOI 10.1021/acsinfecdis.8b00134; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hagen C, 2012, J STRUCT BIOL, V177, P193, DOI 10.1016/j.jsb.2011.12.012; Harkiolaki M, 2018, EMERG TOP LIFE SCI, V2, P81, DOI 10.1042/ETLS20170086; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Hell SW, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/44/443001; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hoffman DP, 2020, SCIENCE, V367, P265, DOI 10.1126/science.aaz5357; Jahn KA, 2012, MICRON, V43, P565, DOI 10.1016/j.micron.2011.12.004; Chichon FJ, 2012, J STRUCT BIOL, V177, P202, DOI 10.1016/j.jsb.2011.12.001; Karadaglic D, 2008, MICRON, V39, P808, DOI 10.1016/j.micron.2008.01.017; Kaufmann R, 2014, NANO LETT, V14, P4171, DOI 10.1021/nl501870p; Koning RI, 2018, ANN ANAT, V217, P82, DOI 10.1016/j.aanat.2018.02.004; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Le Gros MA, 2009, J MICROSC-OXFORD, V235, P1, DOI 10.1111/j.1365-2818.2009.03184.x; Li Y, 2017, EXP CELL RES, V358, P253, DOI 10.1016/j.yexcr.2017.06.022; Luengo I, 2017, J STRUCT BIOL, V198, P43, DOI 10.1016/j.jsb.2017.02.007; Maier O, 2012, J VIROL, V86, P10821, DOI 10.1128/JVI.01428-12; Mainou BA, 2012, J VIROL, V86, P8346, DOI 10.1128/JVI.00100-12; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Matsuda A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25922-7; Medeiros JM, 2018, ULTRAMICROSCOPY, V190, P1, DOI 10.1016/j.ultramic.2018.04.002; Meyer-Ilse W, 2001, J MICROSC-OXFORD, V201, P395, DOI 10.1046/j.1365-2818.2001.00845.x; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Myllys M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28844; Paez-Segala MG, 2015, NAT METHODS, V12, P215, DOI [10.1038/NMETH.3225, 10.1038/nmeth.3225]; Paul-Gilloteaux P, 2017, NAT METHODS, V14, P102, DOI 10.1038/nmeth.4170; Pereira PM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00675; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips Mick A, 2018, Wellcome Open Res, V3, P92, DOI 10.12688/wellcomeopenres.14703.1; RAMIG RF, 1977, J VIROL, V22, P726, DOI 10.1128/JVI.22.3.726-733.1977; Rayleigh L., 1879, PHILOS MAG, V8, P261, DOI DOI 10.1080/14786447908639684; Rigort A, 2015, ARCH BIOCHEM BIOPHYS, V581, P122, DOI 10.1016/j.abb.2015.02.009; Roy P., 2006, REOVIRUSES ENTRY ASS; Sartori A, 2007, J STRUCT BIOL, V160, P135, DOI 10.1016/j.jsb.2007.07.011; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider G, 2012, J STRUCT BIOL, V177, P212, DOI 10.1016/j.jsb.2011.12.023; Schneider G, 2010, NAT METHODS, V7, P985, DOI 10.1038/NMETH.1533; Schwartz CL, 2007, J MICROSC-OXFORD, V227, P98, DOI 10.1111/j.1365-2818.2007.01794.x; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; SHEPPARD CJR, 1981, J MICROSC-OXFORD, V124, P107, DOI 10.1111/j.1365-2818.1981.tb00304.x; Smith EA, 2014, BIOPHYS J, V107, P1988, DOI 10.1016/j.bpj.2014.09.011; Son Alexander I, 2013, Methods Mol Biol, V1018, P301, DOI 10.1007/978-1-62703-444-9_28; STURZENBECKER LJ, 1987, J VIROL, V61, P2351, DOI 10.1128/JVI.61.8.2351-2361.1987; Thirukkumaran Chandini, 2009, V542, P607, DOI 10.1007/978-1-59745-561-9_31; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Varsano N, 2016, J AM CHEM SOC, V138, P14931, DOI 10.1021/jacs.6b07584; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; WATARI N, 1965, AM ZOOL, V5, P678; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Zhang L, 2006, J VIROL, V80, P12367, DOI 10.1128/JVI.01343-06; Zhang PJ, 2019, CURR OPIN STRUC BIOL, V58, P249, DOI 10.1016/j.sbi.2019.05.021	75	30	29	8	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					515	+		10.1016/j.cell.2020.05.051	http://dx.doi.org/10.1016/j.cell.2020.05.051			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32610083	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000552745000019
J	Spring, LM; Specht, MC; Jimenez, RB; Isakoff, SJ; Wang, GX; Ly, A; Shin, JA; Bardia, A; Moy, B				Spring, Laura M.; Specht, Michelle C.; Jimenez, Rachel B.; Isakoff, Steven J.; Wang, Gary X.; Ly, Amy; Shin, Jennifer A.; Bardia, Aditya; Moy, Beverly			Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEOADJUVANT ENDOCRINE THERAPY; CONSERVING SURGERY; FOLLOW-UP; DOUBLE-BLIND; POSTMENOPAUSAL PATIENTS; RADIATION-THERAPY; PLUS TRASTUZUMAB; RANDOMIZED-TRIAL; RESPONSE RATE; STAGE	A 62-year-old woman was evaluated for a mass that had been identified in the left breast during the Covid-19 pandemic. Mammography revealed a mass with spiculated margins. Ultrasonography showed a solid mass, measuring 3.1 cm by 1.5 cm by 1.2 cm, and normal left axillary lymph nodes. A core-needle biopsy was performed, and management decisions were made.	[Spring, Laura M.; Isakoff, Steven J.; Shin, Jennifer A.; Bardia, Aditya; Moy, Beverly] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Specht, Michelle C.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Jimenez, Rachel B.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Wang, Gary X.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ly, Amy] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Spring, Laura M.; Isakoff, Steven J.; Shin, Jennifer A.; Bardia, Aditya; Moy, Beverly] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Specht, Michelle C.] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA; [Jimenez, Rachel B.] Harvard Med Sch, Dept Radiat Oncol, Boston, MA 02115 USA; [Wang, Gary X.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Ly, Amy] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Spring, LM (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Spring, LM (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		Isakoff, Steven/ABE-3566-2020					Alba E, 2012, ANN ONCOL, V23, P3069, DOI 10.1093/annonc/mds132; Allevi G, 2013, BRIT J CANCER, V108, P1587, DOI 10.1038/bjc.2013.151; Back AL, 2005, CA-CANCER J CLIN, V55, P164, DOI 10.3322/canjclin.55.3.164; Back A, 2020, ANN INTERN MED, V172, P759, DOI 10.7326/M20-1376; Baile WF, 2005, CURR OPIN ONCOL, V17, P331, DOI 10.1097/01.cco.0000167738.49325.2c; Bartelink H, 2015, LANCET ONCOL, V16, P47, DOI 10.1016/S1470-2045(14)71156-8; Bellon JR, 2005, J CLIN ONCOL, V23, P1934, DOI 10.1200/JCO.2005.04.032; Blum JL, 2017, J CLIN ONCOL, V35, P2647, DOI 10.1200/JCO.2016.71.4147; Brunt AM, 2016, RADIOTHER ONCOL, V120, P114, DOI 10.1016/j.radonc.2016.02.027; Brunt AM, 2020, LANCET, V395, P1613, DOI 10.1016/S0140-6736(20)30932-6; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Carey LA, 2016, J CLIN ONCOL, V34, P542, DOI 10.1200/JCO.2015.62.1268; Cataliotti L, 2006, CANCER-AM CANCER SOC, V106, P2095, DOI 10.1002/cncr.21872; Chiba A, 2017, ANN SURG ONCOL, V24, P418, DOI 10.1245/s10434-016-5585-5; Coopey S, 2011, ANN SURG ONCOL, V18, P3797, DOI 10.1245/s10434-011-1802-4; Correa C, 2017, PRACT RADIAT ONCOL, V7, P73, DOI 10.1016/j.prro.2016.09.007; D'Orsi C.J., 2014, ACR BIRADS ATLAS BRE; Dietz JR, 2020, BREAST CANCER RES TR, V181, P487, DOI 10.1007/s10549-020-05644-z; Dixon JM, 2009, BREAST CANCER RES TR, V113, P145, DOI 10.1007/s10549-008-9915-6; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Dragun AE, 2017, INT J RADIAT ONCOL, V98, P595, DOI 10.1016/j.ijrobp.2017.01.212; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Eiermann W, 2001, ANN ONCOL, V12, P1527, DOI 10.1023/A:1013128213451; Ellis MJ, 2017, J CLIN ONCOL, V35, P1061, DOI 10.1200/JCO.2016.69.4406; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Fisher B, 2002, NEW ENGL J MED, V347, P567, DOI 10.1056/NEJMoa020128; Freedman GM, 2013, RADIOTHER ONCOL, V106, P15, DOI 10.1016/j.radonc.2012.12.001; Gianni L, 2016, LANCET ONCOL, V17, P791, DOI 10.1016/S1470-2045(16)00163-7; Gradishar WJ, 2020, J NATL COMPR CANC NE, V18, P452, DOI 10.6004/jnccn.2020.0016; Harper-Wynne CL, 2002, J CLIN ONCOL, V20, P1026, DOI 10.1200/JCO.20.4.1026; Hurvitz SA, 2019, J CLIN ONCOL, V37, P2206, DOI 10.1200/JCO.19.00882; Iwata H, 2019, BREAST CANCER RES TR, V173, P123, DOI 10.1007/s10549-018-4964-y; Jones S, 2009, J CLIN ONCOL, V27, P1177, DOI 10.1200/JCO.2008.18.4028; Karlsson P, 2011, INT J RADIAT ONCOL, V80, P398, DOI 10.1016/j.ijrobp.2010.02.042; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Loibl S, 2018, LANCET ONCOL, V19, P497, DOI 10.1016/S1470-2045(18)30111-6; Marron JM, 2020, J CLIN ONCOL, V38, P2201, DOI 10.1200/JCO.20.00960; Masuda N, 2017, NEW ENGL J MED, V376, P2147, DOI 10.1056/NEJMoa1612645; Masuda N, 2012, LANCET ONCOL, V13, P345, DOI 10.1016/S1470-2045(11)70373-4; Mauri D, 2020, LANCET ONCOL, V21, P759, DOI 10.1016/S1470-2045(20)30278-3; Mehta V, 2021, NUTR CANCER, V73, P914, DOI 10.1080/01635581.2020.1778746; Nakatsukasa K, 2017, BREAST CANCER-TOKYO, V24, P63, DOI 10.1007/s12282-016-0666-7; Olivotto IA, 2009, J CLIN ONCOL, V27, P16, DOI 10.1200/JCO.2008.18.1891; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Palmieri C, 2014, BREAST CANCER RES TR, V148, P581, DOI 10.1007/s10549-014-3183-4; Pan HC, 2017, NEW ENGL J MED, V377, P1836, DOI 10.1056/NEJMoa1701830; POZO C, 1992, J CLIN ONCOL, V10, P1292, DOI 10.1200/JCO.1992.10.8.1292; Rai A, 2018, J NATL COMPR CANC NE, V16, P975, DOI 10.6004/jnccn.2018.7034; Schneeweiss A, 2013, ANN ONCOL, V24, P2278, DOI 10.1093/annonc/mdt182; Semiglazov VF, 2007, CANCER-AM CANCER SOC, V110, P244, DOI 10.1002/cncr.22789; Shah C, 2012, BREAST J, V18, P357, DOI 10.1111/j.1524-4741.2012.01252.x; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Smith BD, 2018, PRACT RADIAT ONCOL, V8, P145, DOI 10.1016/j.prro.2018.01.012; Smith IE, 2005, J CLIN ONCOL, V23, P5108, DOI 10.1200/JCO.2005.04.005; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Sparano JA, 2019, NEW ENGL J MED, V380, P2395, DOI 10.1056/NEJMoa1904819; Spring LM, 2016, JAMA ONCOL, V2, P1477, DOI 10.1001/jamaoncol.2016.1897; Tolaney SM, 2019, J CLIN ONCOL, V37, P1868, DOI 10.1200/JCO.19.00066; Vicini FA, 2019, LANCET, V394, P2155, DOI 10.1016/S0140-6736(19)32514-0; von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017; von Minckwitz G, 2017, NEW ENGL J MED, V377, P122, DOI 10.1056/NEJMoa1703643; Vujovic O, 2015, INT J RADIAT ONCOL, V91, P319, DOI 10.1016/j.ijrobp.2014.10.006; WELLISCH DK, 1989, PSYCHOSOMATICS, V30, P365, DOI 10.1016/S0033-3182(89)72241-6; Whelan TJ, 2019, LANCET, V394, P2165, DOI 10.1016/S0140-6736(19)32515-2; Yang XD, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00097; Yarnold JR, 2011, RADIOTHER ONCOL, V100, P93, DOI 10.1016/j.radonc.2011.06.026	69	11	11	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2020	383	3					262	272		10.1056/NEJMcpc2002422	http://dx.doi.org/10.1056/NEJMcpc2002422			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ8TN	32610007	Bronze, Green Published			2022-12-28	WOS:000553165300017
J	Curfman, G				Curfman, Gregory			Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Curfman, Gregory] 330 N Wabash, Chicago, IL 60611 USA		Curfman, G (corresponding author), 330 N Wabash, Chicago, IL 60611 USA.	gregory.curfman@jamanetwork.org						Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Mehta N., 2020, JAMA CARDIOL, V5, P1020, DOI [DOI 10.1001/jamacardio.2020.1855, 10.1001/jamacardio.2020.1855]; Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P1769, DOI 10.1001/jama.2020.4812; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Sukumaran V, 2017, BIOCHEM PHARMACOL, V144, P90, DOI 10.1016/j.bcp.2017.07.022	7	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2020	324	2					177	178		10.1001/jama.2020.11401	http://dx.doi.org/10.1001/jama.2020.11401			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ8RW	32558905	Bronze			2022-12-28	WOS:000553161000022
J	Nishioka, R; Kawano, M				Nishioka, Ryo; Kawano, Mitsuhiro			Tongue Ulceration from Cytomegalovirus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nishioka, Ryo; Kawano, Mitsuhiro] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan	Kanazawa University	Nishioka, R (corresponding author), Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan.	rryo125@gmail.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					67	67		10.1056/NEJMicm1914681	http://dx.doi.org/10.1056/NEJMicm1914681			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2UD	32609983				2022-12-28	WOS:000552751800012
J	[Anonymous]				[Anonymous]			Seven days in medicine: 24-30 June 2020	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2020, WEEKL NHS TEST TRAC; Office for National Statistics, 2020, COR COVID 19 REL DEA; Royal College of Surgeons of England, 2020, SURV FIND EL SURG CO	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2020	370								m2620	10.1136/bmj.m2620	http://dx.doi.org/10.1136/bmj.m2620			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MM0GY	32616475				2022-12-28	WOS:000549840000012
J	Mahase, E				Mahase, Elisabeth			Covid-19: Leicester placed under lockdown after spike in cases and hospital admissions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2635	10.1136/bmj.m2635	http://dx.doi.org/10.1136/bmj.m2635			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32605928	Bronze			2022-12-28	WOS:000548116400006
J	Robinson, F; Rathinam, S				Robinson, Francesca; Rathinam, Sridhar			Improving training for surgeons of the future: the consultant thoracic surgeon	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2474	10.1136/bmj.m2474	http://dx.doi.org/10.1136/bmj.m2474			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601066	Bronze			2022-12-28	WOS:000548112700005
J	Coyle, D; Weller, A				Coyle, Diane; Weller, Adrian			"Explaining" machine learning reveals policy challenges	SCIENCE			English	Editorial Material									[Coyle, Diane] Univ Cambridge, Bennett Inst Publ Policy, Cambridge, England; [Weller, Adrian] Univ Cambridge, Cambridge, England; [Weller, Adrian] Alan Turing Inst, London, England	University of Cambridge; University of Cambridge	Coyle, D (corresponding author), Univ Cambridge, Bennett Inst Publ Policy, Cambridge, England.	dc700@cam.ac.uk; aw665@cam.ac.uk			David MacKay Newton research fellowship at Darwin College, The Alan Turing Institute under EPSRC [EP/N510129/1, TU/B/000074]; Leverhulme Trust via CFI; Centre for Data Ethics and Innovation	David MacKay Newton research fellowship at Darwin College, The Alan Turing Institute under EPSRC; Leverhulme Trust via CFI; Centre for Data Ethics and Innovation	We are grateful to M. Kenny and N. Rabinowitz for helpful comments. A.W. acknowledges support from the David MacKay Newton research fellowship at Darwin College, The Alan Turing Institute under EPSRC grants EP/N510129/1 and TU/B/000074, the Leverhulme Trust via CFI, and the Centre for Data Ethics and Innovation.	Anderson E., 1993, VALUE ETHICS EC; [Anonymous], 2017, MYTHOS MODEL INTERPR; Aziz S, 2019, PALGR ST DIG BUS ENA, P33, DOI 10.1007/978-3-030-02330-0_3; Dattner B., 2019, HARV BUS REV, V25; Grover S, 2019, IEEE T COMPUT SOC SY, V6, P350, DOI 10.1109/TCSS.2019.2902490; Hildebrandt M., 2016, SMART TECHNOLOGIES E; LEGRAND J, 1991, BRIT J POLIT SCI, V21, P423, DOI 10.1017/S0007123400006244; Madumal P., 2019, GROUNDED INTERACTION; O'Neill O, 2018, INT J PHILOS STUD, V26, P293, DOI 10.1080/09672559.2018.1454637; Richardson R., 2019, NEW YORK U LAW REV, V192, P204; Samuelson P., 1979, FDN EC ANAL, P203; Sen A, 1999, AM ECON REV, V89, P349, DOI 10.1257/aer.89.3.349; SUNSTEIN CR, 1995, HARVARD LAW REV, V108, P1733, DOI 10.2307/1341816	15	17	19	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1433	1434		10.1126/science.aba9647	http://dx.doi.org/10.1126/science.aba9647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587011	Green Submitted			2022-12-28	WOS:000545264600026
J	Liang, L; Rasmussen, MLH; Piening, B; Shen, XT; Chen, SJ; Rost, H; Snyder, JK; Tibshirani, R; Skotte, L; Lee, NC; Contrepois, K; Feenstra, B; Zackriah, H; Snyder, M; Melbye, M				Liang, Liang; Rasmussen, Marie-Louise Hee; Piening, Brian; Shen, Xiaotao; Chen, Songjie; Rost, Hannes; Snyder, John K.; Tibshirani, Robert; Skotte, Line; Lee, Norman Cy; Contrepois, Kevin; Feenstra, Bjarke; Zackriah, Hanyah; Snyder, Michael; Melbye, Mads			Metabolic Dynamics and Prediction of Gestational Age and Time to Delivery in Pregnant Women	CELL			English	Article							SYSTEMATIC ANALYSIS; GENE-EXPRESSION; PLASMA; PREECLAMPSIA; MORTALITY; PLACENTA; ESTRIOL; TRENDS; ACID; RISK	Metabolism during pregnancy is a dynamic and precisely programmed process, the failure of which can bring devastating consequences to the mother and fetus. To define a high-resolution temporal profile of metabolites during healthy pregnancy, we analyzed the untargeted metabolome of 784 weekly blood samples from 30 pregnant women. Broad changes and a highly choreographed profile were revealed: 4,995 metabolic features (of 9,651 total), 460 annotated compounds (of 687 total), and 34 human metabolic pathways (of 48 total) were significantly changed during pregnancy. Using linear models, we built a metabolic clock with five metabolites that time gestational age in high accordance with ultrasound (R = 0.92). Furthermore, two to three metabolites can identify when labor occurs (time to delivery within two, four, and eight weeks, AUROC >= 0.85). Our study represents a weekly characterization of the human pregnancy metabolome, providing a high-resolution landscape for understanding pregnancy with potential clinical utilities.	[Liang, Liang; Piening, Brian; Shen, Xiaotao; Chen, Songjie; Rost, Hannes; Contrepois, Kevin; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Rasmussen, Marie-Louise Hee; Skotte, Line; Feenstra, Bjarke; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Snyder, John K.; Lee, Norman Cy] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Snyder, John K.; Lee, Norman Cy] Boston Univ, Chem Instrumentat Ctr, Boston, MA 02215 USA; [Tibshirani, Robert] Stanford Univ, Dept Stat & Biomed Data Sci, Stanford, CA 94305 USA; [Zackriah, Hanyah] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Melbye, Mads] Univ Copenhagen, Dept Clin Med, DK-2200 Copenhagen, Denmark; [Melbye, Mads] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Piening, Brian] Providence Portland Med Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA; [Rost, Hannes] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	Stanford University; Statens Serum Institut; Boston University; Boston University; Stanford University; University of California System; University of California Berkeley; University of Copenhagen; Stanford University; Providence Portland Medical Center; University of Toronto	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Melbye, M (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.; Melbye, M (corresponding author), Univ Copenhagen, Dept Clin Med, DK-2200 Copenhagen, Denmark.; Melbye, M (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	mpsnyder@stanford.edu; mmelbye@stanford.edu	Röst, Hannes/L-2056-2019; Shen, Xiaotao/ABP-5135-2022	Röst, Hannes/0000-0003-0990-7488; Shen, Xiaotao/0000-0002-9608-9964; Snyder, Michael/0000-0003-0784-7987; Feenstra, Bjarke/0000-0003-1478-649X; melbye, mads/0000-0001-8264-6785	Bill & Melinda Gates Foundation, United States [OPP1128928]; Center for Personal Dynamic Regulomes [2RM1HG00773506]; Oak Foundation, Switzerland [OCAY-18-598]; Independent Research Fund Denmark [6120-000998]; Carlsberg Foundation Postdoctoral Fellowship [CF15-0899]	Bill & Melinda Gates Foundation, United States(CGIAR); Center for Personal Dynamic Regulomes; Oak Foundation, Switzerland; Independent Research Fund Denmark; Carlsberg Foundation Postdoctoral Fellowship	We thank the dedicated women who made this study possible by generously participating every week during their pregnancy. We thank R. Jian, L. Tian, and C. Yeh for technical assistance; S.M.S. Rose, G. Chen, and Y. Zhang for reviewing the manuscripts. This work was supported by the Bill & Melinda Gates Foundation, United States (OPP1128928). M.S. was supported by the Center for Personal Dynamic Regulomes (2RM1HG00773506). M.M. and B.F. were supported by the Oak Foundation, Switzerland (OCAY-18-598). M.L.H.R. was supported by the Independent Research Fund Denmark (6120-000998). L.S. was supported by a Carlsberg Foundation Postdoctoral Fellowship (CF15-0899).	Alkema Leontine, 2016, Lancet, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; Bahado-Singh R.O., 2014, A J OBSTET GYNECOL, V211, pe1; Bahado-Singh RO, 2012, J MATERN-FETAL NEO M, V25, P1840, DOI 10.3109/14767058.2012.680254; Baumann D, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/s13321-014-0047-1; Bispham J, 2003, ENDOCRINOLOGY, V144, P3575, DOI 10.1210/en.2003-0320; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chan LYS, 2003, EUR J OBSTET GYN R B, V108, P142; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Chrousos George P., 1998, Annals of Internal Medicine, V129, P229; Contrepois K, 2015, MOL CELL PROTEOMICS, V14, P1684, DOI 10.1074/mcp.M114.046508; DICZFALUSY E, 1953, Acta Endocrinol Suppl (Copenh), V11, P1; Donahue SMA, 2010, OBSTET GYNECOL, V115, P357, DOI 10.1097/AOG.0b013e3181cbd5f5; Dudzik D, 2014, J PROTEOMICS, V103, P57, DOI 10.1016/j.jprot.2014.03.025; Edwin SS, 1997, J REPROD IMMUNOL, V36, P111, DOI 10.1016/S0165-0378(97)00064-8; Epskamp S, 2018, PSYCHOL METHODS, V23, P617, DOI 10.1037/met0000167; FRANDSEN VA, 1961, ACTA ENDOCRINOL-COP, V38, P383, DOI 10.1530/acta.0.0380383; Gagnon A, 2008, J OBSTET GYNAECOL CA, V30, P918, DOI 10.1016/S1701-2163(16)32973-5; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hermida RC, 1997, J PERINAT MED, V25, P254; HOPPEL CL, 1980, AM J PHYSIOL, V238, pE409, DOI 10.1152/ajpendo.1980.238.5.E409; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; King JC, 2000, AM J CLIN NUTR, V71, p1218S, DOI 10.1093/ajcn/71.5.1218s; KNUTTI R, 1981, EUR J CLIN PHARMACOL, V21, P121, DOI 10.1007/BF00637512; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; LEVITZ M, 1984, J STEROID BIOCHEM, V20, P971, DOI 10.1016/0022-4731(84)90006-2; Lopez-Hernandez Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051186; Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Maslova E, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0040-2; Mayr A, 2018, CHEM SCI, V9, P5441, DOI 10.1039/c8sc00148k; Mendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016; Minkler PE, 2005, CLIN CHIM ACTA, V352, P81, DOI 10.1016/j.cccn.2004.02.004; MOORE SA, 1995, J LIPID RES, V36, P2433; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ngo TTM, 2018, SCIENCE, V360, P1133, DOI 10.1126/science.aar3819; Pearson T, 2010, J HYPERTENS, V28, P2429, DOI 10.1097/HJH.0b013e32833e86aa; Pettker CM, 2017, OBSTET GYNECOL, V129, pE150, DOI 10.1097/AOG.0000000000002046; Prentice AM, 2000, AM J CLIN NUTR, V71, p1226S, DOI 10.1093/ajcn/71.5.1226s; Raeside JI, 2017, YALE J BIOL MED, V90, P449; Reddy DS, 2003, TRENDS PHARMACOL SCI, V24, P103, DOI 10.1016/S0165-6147(03)00023-3; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Sachse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052399; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Shen XT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09550-x; Soldin OP, 2005, FERTIL STERIL, V84, P701, DOI 10.1016/j.fertnstert.2005.02.045; STEIN SE, 1994, J AM SOC MASS SPECTR, V5, P859, DOI 10.1016/1044-0305(94)87009-8; TULCHINSKY D, 1972, AM J OBSTET GYNECOL, V112, P1095, DOI 10.1016/0002-9378(72)90185-8; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Viant MR, 2017, CURR OPIN CHEM BIOL, V36, P64, DOI 10.1016/j.cbpa.2017.01.001; Wang MH, 2002, AM J PHYSIOL-REG I, V282, pR383, DOI 10.1152/ajpregu.2002.282.2.R383; Wang Q, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0733-0; Wang XB, 2003, FERTIL STERIL, V79, P577, DOI 10.1016/S0015-0282(02)04694-0; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329	64	68	74	14	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1680	+		10.1016/j.cell.2020.05.002	http://dx.doi.org/10.1016/j.cell.2020.05.002			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32589958	Green Published, hybrid			2022-12-28	WOS:000543822100021
J	Nolen, L				Nolen, LaShyra			How Medical Education Is Missing the Bull's-eye	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nolen, LaShyra] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Nolen, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Ebede T, 2006, J AM ACAD DERMATOL, V55, P687, DOI 10.1016/j.jaad.2005.10.068; Fix AD, 2000, AM J EPIDEMIOL, V152, P756, DOI 10.1093/aje/152.8.756; Perman SM, 2019, CIRCULATION, V139, P1060, DOI 10.1161/CIRCULATIONAHA.118.037692; Stewart A., 2018, MINORITIES ARE UNDER; Woo M., 2019, LIFEHACKER      0815	5	34	34	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2489	2491		10.1056/NEJMp1915891	http://dx.doi.org/10.1056/NEJMp1915891			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9CW	32579809	Bronze			2022-12-28	WOS:000545636400019
J	Talish, M; DiLorenzo, AM				Talish, Mishaal; DiLorenzo, Ashley M.			Uremic Stomatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Talish, Mishaal; DiLorenzo, Ashley M.] MedStar Washington Hosp Ctr, Washington, DC 20010 USA	MedStar Washington Hospital Center	Talish, M (corresponding author), MedStar Washington Hosp Ctr, Washington, DC 20010 USA.	mishaal7275@gmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2556	2556		10.1056/NEJMicm1914867	http://dx.doi.org/10.1056/NEJMicm1914867			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9CW	32579815				2022-12-28	WOS:000545636400026
J	[Anonymous]				[Anonymous]			Seven days in medicine: 17-23 June 2020 Covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2020, NEW SAL TEST COR PIL; MacKenna B, 2020, BRIT J GEN PRACT, V70, pE481, DOI 10.3399/bjgp20X710993; NICE, 2020, RATIONALES COVID 19	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2020	369								m2501	10.1136/bmj.m2501	http://dx.doi.org/10.1136/bmj.m2501			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI3HF	32586792				2022-12-28	WOS:000583173400006
J	Dyer, C				Dyer, Clare			NHS trust was negligent in failing to recognise child's serious bacterial infection, says High Court	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, 1610 EWHC QB; Dyer C, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2261	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2020	369								m2527	10.1136/bmj.m2527	http://dx.doi.org/10.1136/bmj.m2527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1US	32581070				2022-12-28	WOS:000548572500006
J	Sheetz, KH; Massarweh, NN				Sheetz, Kyle H.; Massarweh, Nader N.			Centralization of High-risk Surgery in the US Feasible Solution or More Trouble Than It Is Worth?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REGIONALIZATION; CANCER		[Sheetz, Kyle H.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Sheetz, Kyle H.] Ctr Healthcare Outcomes & Policy, Ann Arbor, MI USA; [Massarweh, Nader N.] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Massarweh, Nader N.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor College of Medicine	Sheetz, KH (corresponding author), Univ Michigan, Sch Med, Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,NCRC B016,Room 100N-11, Ann Arbor, MI 48109 USA.	ksheetz@med.umich.edu			US Department of Veterans Affairs (VA) Health Services Research & Development Service of the VA Office of Research and Development Merit Review [I01 HX002447]; Center for Innovations in Quality, Effectiveness and Safety [CIN 13-413]	US Department of Veterans Affairs (VA) Health Services Research & Development Service of the VA Office of Research and Development Merit Review; Center for Innovations in Quality, Effectiveness and Safety	This work was supported by the US Department of Veterans Affairs (VA) Health Services Research & Development Service of the VA Office of Research and Development Merit Review (award I01 HX002447 [Dr Massarweh]) and Center for Innovations in Quality, Effectiveness and Safety (award CIN 13-413 [Dr Massarweh]).	Bendzsak AM, 2017, J CLIN ONCOL, V35, P2772, DOI 10.1200/JCO.2016.69.8076; Birkmeyer JD, 2003, JAMA-J AM MED ASSOC, V290, P2703, DOI 10.1001/jama.290.20.2703; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Goldberg DS, 2014, JAMA-J AM MED ASSOC, V311, P1234, DOI 10.1001/jama.2014.2520; Jacobs RC, 2019, ANN SURG, V270, P1079, DOI 10.1097/SLA.0000000000002796; Lemmens VEPP, 2011, BRIT J SURG, V98, P1455, DOI 10.1002/bjs.7581; Resio BJ, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.4595; Sheetz KH, 2020, ANN SURG, V271, P815, DOI 10.1097/SLA.0000000000003728; Sheetz KH, 2019, JAMA SURG, V154, P1005, DOI 10.1001/jamasurg.2019.3017	9	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					339	340		10.1001/jama.2020.2953	http://dx.doi.org/10.1001/jama.2020.2953			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32597965				2022-12-28	WOS:000562851000019
J	Feldstein, LR; Rose, EB; Horwitz, SM; Collins, JP; Newhams, MM; Son, MBF; Newburger, JW; Kleinman, LC; Heidemann, SM; Martin, AA; Singh, AR; Li, S; Tarquinio, KM; Jaggi, P; Oster, ME; Zackai, SP; Gillen, J; Ratner, AJ; Walsh, RF; Fitzgerald, JC; Keenaghan, MA; Alharash, H; Doymaz, S; Clouser, KN; Giuliano, JS; Gupta, A; Parker, RM; Maddux, AB; Havalad, V; Ramsingh, S; Bukulmez, H; Bradford, TT; Smith, LS; Tenforde, MW; Carroll, CL; Riggs, BJ; Gertz, SJ; Daube, A; Lansell, A; Munoz, AC; Hobbs, CV; Marohn, KL; Halasa, NB; Patel, MM; Randolph, AG				Feldstein, Leora R.; Rose, Erica B.; Horwitz, Steven M.; Collins, Jennifer P.; Newhams, Margaret M.; Son, Mary Beth F.; Newburger, Jane W.; Kleinman, Lawrence C.; Heidemann, Sabrina M.; Martin, Amarilis A.; Singh, Aalok R.; Li, Simon; Tarquinio, Keiko M.; Jaggi, Preeti; Oster, Matthew E.; Zackai, Sheemon P.; Gillen, Jennifer; Ratner, Adam J.; Walsh, Rowan F.; Fitzgerald, Julie C.; Keenaghan, Michael A.; Alharash, Hussam; Doymaz, Sule; Clouser, Katharine N.; Giuliano, John S.; Gupta, Anjali; Parker, Robert M.; Maddux, Aline B.; Havalad, Vinod; Ramsingh, Stacy; Bukulmez, Hulya; Bradford, Tamara T.; Smith, Lincoln S.; Tenforde, Mark W.; Carroll, Christopher L.; Riggs, Becky J.; Gertz, Shira J.; Daube, Ariel; Lansell, Amanda; Coronado Munoz, Alvaro; Hobbs, Charlotte V.; Marohn, Kimberly L.; Halasa, Natasha B.; Patel, Manish M.; Randolph, Adrienne G.		Overcoming COVID-19 Investigators; CDC Covid-19 Response Team	Multisystem Inflammatory Syndrome in US Children and Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOXIC-SHOCK-SYNDROME; KAWASAKI-DISEASE; INFLUENZA	This report describes the epidemiology and clinical course of patients younger than 21 years of age from 26 states who had multisystem inflammatory syndrome. Many were infected with SARS-CoV-2 at least 1 to 2 weeks before syndrome onset. The median age of the patients was 8.3 years, and 73% were previously healthy. Background Understanding the epidemiology and clinical course of multisystem inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus disease 2019 (Covid-19) is important, given the clinical and public health implications of the syndrome. Methods We conducted targeted surveillance for MIS-C from March 15 to May 20, 2020, in pediatric health centers across the United States. The case definition included six criteria: serious illness leading to hospitalization, an age of less than 21 years, fever that lasted for at least 24 hours, laboratory evidence of inflammation, multisystem organ involvement, and evidence of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on reverse-transcriptase polymerase chain reaction (RT-PCR), antibody testing, or exposure to persons with Covid-19 in the past month. Clinicians abstracted the data onto standardized forms. Results We report on 186 patients with MIS-C in 26 states. The median age was 8.3 years, 115 patients (62%) were male, 135 (73%) had previously been healthy, 131 (70%) were positive for SARS-CoV-2 by RT-PCR or antibody testing, and 164 (88%) were hospitalized after April 16, 2020. Organ-system involvement included the gastrointestinal system in 171 patients (92%), cardiovascular in 149 (80%), hematologic in 142 (76%), mucocutaneous in 137 (74%), and respiratory in 131 (70%). The median duration of hospitalization was 7 days (interquartile range, 4 to 10); 148 patients (80%) received intensive care, 37 (20%) received mechanical ventilation, 90 (48%) received vasoactive support, and 4 (2%) died. Coronary-artery aneurysms (z scores >= 2.5) were documented in 15 patients (8%), and Kawasaki's disease-like features were documented in 74 (40%). Most patients (171 [92%]) had elevations in at least four biomarkers indicating inflammation. The use of immunomodulating therapies was common: intravenous immune globulin was used in 144 (77%), glucocorticoids in 91 (49%), and interleukin-6 or 1RA inhibitors in 38 (20%). Conclusions Multisystem inflammatory syndrome in children associated with SARS-CoV-2 led to serious and life-threatening illness in previously healthy children and adolescents. (Funded by the Centers for Disease Control and Prevention.)	[Feldstein, Leora R.; Rose, Erica B.; Collins, Jennifer P.; Tenforde, Mark W.; Patel, Manish M.] Ctr Dis Control & Prevent, COVID 19 Response, Atlanta, GA USA; [Tarquinio, Keiko M.] Emory Univ, Sch Med, Dept Pediat, Div Crit Care Med, Atlanta, GA USA; [Jaggi, Preeti] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA USA; [Oster, Matthew E.] Emory Univ, Sch Med, Dept Pediat, Div Cardiol, Atlanta, GA USA; [Feldstein, Leora R.; Rose, Erica B.; Patel, Manish M.] Public Hlth Serv Commissioned Corps, Rockville, MD USA; [Riggs, Becky J.] Johns Hopkins Sch Med, Div Pediat Anesthesiol & Crit Care Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Horwitz, Steven M.] Rutgers State Univ, Robert Wood Johnson Med Sch, Bristol Myers Squibb Childrens Hosp, Div Pediat Crit Care,Dept Pediat, New Brunswick, NJ USA; [Kleinman, Lawrence C.] Rutgers Robert Wood Johnson Med Sch, Div Populat Hlth Qual & Implementat Sci PopQuIS, Dept Pediat, New Brunswick, NJ USA; [Walsh, Rowan F.] Childrens Hosp New Jersey, Newark Beth Israel, Div Pediat Cardiol, Dept Pediat, Newark, NJ USA; [Clouser, Katharine N.] Hackensack Univ, Div Hosp Med, Dept Pediat, Med Ctr, Hackensack, NJ USA; [Gertz, Shira J.] St Barnabas Hosp, Dept Pediat, Div Pediat Crit Care, Livingston, NJ USA; [Newhams, Margaret M.; Randolph, Adrienne G.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Son, Mary Beth F.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Newburger, Jane W.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Son, Mary Beth F.; Newburger, Jane W.; Randolph, Adrienne G.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Randolph, Adrienne G.] Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA; [Marohn, Kimberly L.] Baystate Med Ctr, Pediat Crit Care, Dept Pediat, Springfield, MA USA; [Heidemann, Sabrina M.; Martin, Amarilis A.] Cent Michigan Univ, Dept Pediat, Div Pediat Crit Care Med, Detroit, MI USA; [Singh, Aalok R.; Li, Simon] Maria Fareri Childrens Hosp, Westchester Med Ctr, Pediat Crit Care Div, Valhalla, NY USA; [Singh, Aalok R.; Li, Simon] New York Med Coll, Valhalla, NY 10595 USA; [Zackai, Sheemon P.; Gillen, Jennifer] Icahn Sch Med Mt Sinai, Kravis Childrens Hosp, Dept Pediat, Pediat Crit Care Med, New York, NY 10029 USA; [Ratner, Adam J.] NYU, Grossman Sch Med, Div Pediat Infect Dis, Dept Microbiol, New York, NY USA; [Keenaghan, Michael A.; Alharash, Hussam] Kings Cty Hosp, New York City Hlth & Hosp, Pediat Crit Care, New York, NY USA; [Doymaz, Sule] SUNY Downstate Hlth Sci Univ, Dept Pediat, Div Pediat Crit Care, New York, NY USA; [Daube, Ariel] Maimonides Childrens Hosp, Div Pediat Crit Care, Dept Pediat, New York, NY USA; [Fitzgerald, Julie C.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Div Crit Care, Philadelphia, PA 19104 USA; [Giuliano, John S.; Gupta, Anjali] Yale Univ, Sch Med, Dept Pediat, Div Crit Care, New Haven, CT 06510 USA; [Parker, Robert M.; Carroll, Christopher L.] Connecticut Childrens, Div Crit Care, Hartford, CT USA; [Maddux, Aline B.] Univ Colorado, Sch Med, Dept Pediat, Sect Crit Care Med, Aurora, CO USA; [Maddux, Aline B.] Childrens Hosp Colorado, Aurora, CO USA; [Havalad, Vinod; Ramsingh, Stacy] Advocate Childrens Hosp, Dept Pediat, Div Pediat Crit Care Med, Chicago, IL USA; [Bukulmez, Hulya] Case Western Reserve Univ, Dept Pediat, Div Pediat Rheumatol, MetroHlth Med Ctr, Cleveland, OH 44106 USA; [Lansell, Amanda] Rainbow Babies & Childrens Hosp, Div Pediat Hosp Med, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Bradford, Tamara T.] Louisiana State Univ, Hlth Sci Ctr, Div Cardiol, Dept Pediat, New Orleans, LA USA; [Bradford, Tamara T.] Childrens Hosp New Orleans, New Orleans, LA USA; [Smith, Lincoln S.] Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA; [Coronado Munoz, Alvaro] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Pediat Crit Care Div, Houston, TX 77030 USA; [Hobbs, Charlotte V.] Univ Mississippi, Med Ctr, Dept Microbiol, Dept Pediat,Div Infect Dis, Jackson, MS 39216 USA; [Halasa, Natasha B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Nashville, TN 37232 USA	Centers for Disease Control & Prevention - USA; Emory University; Emory University; Emory University; Johns Hopkins University; Johns Hopkins Medicine; Bristol-Myers Squibb; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Newark Beth Israel Medical Center; Hackensack University Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Baystate Medical Center; Central Michigan University; Westchester Medical Center; New York Medical College; Icahn School of Medicine at Mount Sinai; New York University; University of Pennsylvania; Pennsylvania Medicine; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Case Western Reserve University; MetroHealth System; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Mississippi; University of Mississippi Medical Center; Vanderbilt University	Patel, MM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd,MS H24-7, Atlanta, GA 30329 USA.; Randolph, AG (corresponding author), Boston Childrens Hosp, Div Crit Care Med, Bader 634, Boston, MA 02115 USA.	mpatel@cdc.gov; adrienne.randolph@childrens.harvard.edu	Kleinman, Lawrence/AAS-6934-2021; Hymes, Saul Robert/V-5312-2019; Harwayne-Gidansky, Ilana/I-9528-2019; Coronado Munoz, Alvaro Jose/AAL-4569-2020	Hymes, Saul Robert/0000-0002-2276-7160; Harwayne-Gidansky, Ilana/0000-0001-7987-6440; Coronado Munoz, Alvaro Jose/0000-0001-5349-5260; Randolph, Adrienne/0000-0002-3084-3071; Hobbs, Charlotte/0000-0003-4829-0791; Li, Simon/0000-0002-5371-1995; keenaghan, michael/0000-0001-8363-8541; Bukulmez, Hulya/0000-0002-2256-9068; Hume, Janet/0000-0002-8891-6800; Ratner, Adam/0000-0003-1761-794X; Son, Mary Beth/0000-0002-7394-2862; Maddux, Aline/0000-0002-0949-4284; Lansell, Amanda/0000-0002-5501-3373; Giuliano, John/0000-0003-2753-8460	Centers for Disease Control and Prevention [75D30120C07725]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Centers for Disease Control and Prevention under a contract to Boston Children's Hospital (75D30120C07725).	[Anonymous], 2020, JAMA; Baker AL, 2009, J PEDIATR-US, V154, P592, DOI 10.1016/j.jpeds.2008.10.006; Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Burns JC, 1996, J AM COLL CARDIOL, V28, P253, DOI 10.1016/0735-1097(96)00099-X; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467; Centers for Disease Control and Prevention, CLIN GROWTH CHARTS; Centers for Disease Control and Prevention, EM PREP RESP MULT IN; Centers for Disease Control and Prevention, COR DIS 2019 CIVOD 1; Data Resource Center for Child and Adolescent Health supported by Cooperative Agreement from the U.S. Department of Health and Human Services HRaSA Maternal and Child Health Bureau, CHILD AD HLTH MEAS I; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; Esposito S, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00124; European Centre for Disease Prevention and Control, 2020, RAP RISK ASS PAED IN; Fliesler N, 2020, BOSTON CHILDRENS HOS; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; MACDONALD KL, 1987, JAMA-J AM MED ASSOC, V257, P1053, DOI 10.1001/jama.257.8.1053; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Newburger JW, 2007, NEW ENGL J MED, V356, P663, DOI 10.1056/NEJMoa061235; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5; Randolph AG, 2011, PEDIATRICS, V128, pE1450, DOI 10.1542/peds.2011-0774; Riphagen Shelley, 2020, Lancet, V395, P1607, DOI 10.1016/S0140-6736(20)31094-1; SHACKELFORD PG, 1991, NEW ENGL J MED, V324, P1664, DOI 10.1056/NEJM199106063242311; Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; TOFTE RW, 1981, JAMA-J AM MED ASSOC, V246, P2163; Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Wang W, 2015, SEMIN ARTHRITIS RHEU, V44, P405, DOI 10.1016/j.semarthrit.2014.07.007; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; 2019, MICROBIOME, V7, P1	40	1284	1326	17	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2020	383	4					334	346		10.1056/NEJMoa2021680	http://dx.doi.org/10.1056/NEJMoa2021680			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MU1XJ	32598831	Green Published, Bronze			2022-12-28	WOS:000555465900018
J	Stone, JR; Tran, KM; Conklin, J; Mino-Kenudson, M				Stone, James R.; Tran, Kathy M.; Conklin, John; Mino-Kenudson, Mari			Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOPSY; INFECTION; PATHOLOGY	A 76-year-old woman was admitted to the hospital with confusion and hypoxemia. Multiple residents at her assisted-living facility had received a diagnosis of Covid-19. Testing of a nasopharyngeal swab was positive for SARS-CoV-2. On the fourth hospital day, respiratory distress developed; 36 hours later, the patient died. An autopsy was performed.	[Stone, James R.; Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Tran, Kathy M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Conklin, John] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Stone, James R.; Mino-Kenudson, Mari] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Tran, Kathy M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Conklin, John] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Stone, JR (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Stone, JR (corresponding author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.							Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/AJCP/AQAA062, 10.1093/ajcp/aqaa062]; Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5; De Cock KM, 2019, NEW ENGL J MED, V381, P1889, DOI 10.1056/NEJMp1909017; Dehner Louis P, 2010, Mo Med, V107, P94; Hoyert Donna L, 2011, NCHS Data Brief, P1; Leone O, 2012, CARDIOVASC PATHOL, V21, P245, DOI 10.1016/j.carpath.2011.10.001; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Oppewal F, 2001, FAM PRACT, V18, P304, DOI 10.1093/fampra/18.3.304; Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x; Rosenbaum GE, 2000, ARCH INTERN MED, V160, P374, DOI 10.1001/archinte.160.3.374; Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x; Sala S, 2020, EUR HEART J, V41, P1861, DOI 10.1093/eurheartj/ehaa286; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Simpson Scott, 2020, Radiol Cardiothorac Imaging, V2, pe200152, DOI [10.1097/RTI.0000000000000524, 10.1148/ryct.2020200152]; Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828; Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x; Tsitsikas DA, 2011, J CLIN PATHOL, V64, P412, DOI 10.1136/jcp.2010.086645; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X	23	10	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2020	383	4					380	387		10.1056/NEJMcpc2004974	http://dx.doi.org/10.1056/NEJMcpc2004974			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MU1XJ	32640127	Green Published, Bronze			2022-12-28	WOS:000555465900023
J	Venturutti, L; Teater, M; Zhai, A; Chadburn, A; Babiker, L; Kim, D; Beguelin, W; Lee, TC; Kim, Y; Chin, CR; Yewdell, WT; Raught, B; Phillip, JM; Jiang, YW; Staudt, LM; Green, MR; Chaudhuri, J; Elemento, O; Farinha, P; Weng, AP; Nissen, MD; Steidl, C; Morin, RD; Scott, DW; Prive, GG; Melnick, AM				Venturutti, Leandro; Teater, Matt; Zhai, Andrew; Chadburn, Amy; Babiker, Leena; Kim, Daleum; Beguelin, Wendy; Lee, Tak C.; Kim, Youngjun; Chin, Christopher R.; Yewdell, William T.; Raught, Brian; Phillip, Jude M.; Jiang, Yanwen; Staudt, Louis M.; Green, Michael R.; Chaudhuri, Jayanta; Elemento, Olivier; Farinha, Pedro; Weng, Andrew P.; Nissen, Michael D.; Steidl, Christian; Morin, Ryan D.; Scott, David W.; Prive, Gilbert G.; Melnick, Ari M.			TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate	CELL			English	Article							B-CELL LYMPHOMA; TRANSCRIPTION FACTOR BLIMP-1; CLASS SWITCH RECOMBINATION; DIGITAL GENE-EXPRESSION; GERMINAL-CENTER; MASS-SPECTROMETRY; PLASMA-CELL; COREPRESSOR COMPLEX; BCL6; REPRESSION	The most aggressive B cell lymphomas frequently manifest extranodal distribution and carry somatic mutations in the poorly characterized gene TBL1XR1. Here, we show that TBL1XR1 mutations skew the humoral immune response toward generating abnormal immature memory B cells (MB), while impairing plasma cell differentiation. At the molecular level, TBL1XR1 mutants co-opt SMRT/HDAC3 repressor complexes toward binding the MB cell transcription factor (TF) BACH2 at the expense of the germinal center (GC) TF BCL6, leading to pre-memory transcriptional reprogramming and cell-fate bias. Upon antigen recall, TBL1XR1 mutant MB cells fail to differentiate into plasma cells and instead preferentially reenter new GC reactions, providing evidence for a cyclic reentry lymphomagenesis mechanism. Ultimately, TBL1XR1 alterations lead to a striking extranodal immunoblastic lymphoma phenotype that mimics the human disease. Both human and murine lymphomas feature expanded MB-like cell populations, consistent with a MB-cell origin and delineating an unforeseen pathway for malignant transformation of the immune system.	[Venturutti, Leandro; Teater, Matt; Babiker, Leena; Kim, Daleum; Beguelin, Wendy; Lee, Tak C.; Chin, Christopher R.; Phillip, Jude M.; Jiang, Yanwen; Melnick, Ari M.] Cornell Univ, Dept Med, Div Hematol Oncol, Weill Cornell Med, New York, NY 10021 USA; [Zhai, Andrew] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Chadburn, Amy] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA; [Kim, Youngjun; Chaudhuri, Jayanta] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Chin, Christopher R.] Triinst Program Computat Biol & Med, New York, NY 10065 USA; [Yewdell, William T.; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Raught, Brian; Prive, Gilbert G.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Staudt, Louis M.] NCI, Ctr Canc Genom, Bethesda, MD 20892 USA; [Green, Michael R.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Green, Michael R.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Chaudhuri, Jayanta] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York, NY 10021 USA; [Farinha, Pedro; Steidl, Christian; Morin, Ryan D.; Scott, David W.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC V5Z 1L3, Canada; [Weng, Andrew P.; Nissen, Michael D.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Weng, Andrew P.] BC Canc Agcy, Dept Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada; [Prive, Gilbert G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Prive, Gilbert G.] Princess Margaret Canc Ctr, Toronto, ON M5S 1A8, Canada	Cornell University; University of Toronto; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Melnick, AM (corresponding author), Cornell Univ, Dept Med, Div Hematol Oncol, Weill Cornell Med, New York, NY 10021 USA.	amm2014@med.cornell.edu	Morin, Ryan/AAE-7824-2019; Kim, Youngjun/HCH-4290-2022	Morin, Ryan/0000-0003-2932-7800; Kim, Youngjun/0000-0003-3346-9457; Farinha, Pedro/0000-0001-9364-9391; Chin, Christopher/0000-0002-2140-3197	Leukemia and Lymphoma Society [LLS-TRP-6572-19, LLS-SCOR-7012-16]; National Cancer Institute [NCI-R35-CA220499]; Chemotherapy Foundation; Follicular Lymphoma Consortium	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chemotherapy Foundation; Follicular Lymphoma Consortium	We thank all members of the Melnick Lab for thoughtful discussions and suggestions, and Hao Shen for his support with mice colonies. We acknowledge the Epigenomics, Genomics, and Flow Cytometry cores (WCM); the Molecular Cytology core (MSKCC); and the Center of Comparative Medicine and Pathology (WCM/MSKCC). L.V. is a Career Development Program Fellow from the Leukemia and Lymphoma Society (5469-18). A.M.M. is supported by the National Cancer Institute (NCI-R35-CA220499), the Leukemia and Lymphoma Society (LLS-TRP-6572-19, LLS-SCOR-7012-16), the Chemotherapy Foundation, and the Follicular Lymphoma Consortium.	Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Arthur SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06354-3; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Beguelin W, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01029-x; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Beham-Schmid C, 2017, MEMO-MAG EUR MED ONC, V10, P248, DOI 10.1007/s12254-017-0367-8; Cardenas MG, 2016, J CLIN INVEST, V126, P3351, DOI 10.1172/JCI85795; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Chapuy B, 2016, BLOOD, V127, P869, DOI 10.1182/blood-2015-10-673236; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dominguez PM, 2018, CANCER DISCOV, V8, P1632, DOI 10.1158/2159-8290.CD-18-0657; Egle A, 2004, BLOOD, V103, P2276, DOI 10.1182/blood-2003-07-2469; Ennishi D, 2017, BLOOD, V129, P2760, DOI 10.1182/blood-2016-11-747022; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Geng JL, 2019, J IMMUNOL, V202, P2991, DOI 10.4049/jimmunol.1801626; Gonzalez-Aguilar A, 2012, CLIN CANCER RES, V18, P5203, DOI 10.1158/1078-0432.CCR-12-0845; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Hashwah H, 2017, P NATL ACAD SCI USA, V114, P9701, DOI 10.1073/pnas.1619555114; Hatzi K, 2019, NAT IMMUNOL, V20, P86, DOI 10.1038/s41590-018-0273-1; Hatzi K, 2014, TRENDS MOL MED, V20, P343, DOI 10.1016/j.molmed.2014.03.001; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Heinen CA, 2016, J MED GENET, V53, P330, DOI 10.1136/jmedgenet-2015-103233; Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183; Huang CX, 2014, BLOOD, V123, P1012, DOI 10.1182/blood-2013-07-518605; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; Jain BP, 2018, PROTEIN J, V37, P391, DOI 10.1007/s10930-018-9785-7; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kashyap R, 2011, CANCER IMAGING, V11, P166, DOI 10.1102/1470-7330.2011.0023; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kowarz E, 2015, BIOTECHNOL J, V10, P647, DOI 10.1002/biot.201400821; Krysiak K, 2017, BLOOD, V129, P473, DOI 10.1182/blood-2016-07-729954; Kuo TC, 2007, J EXP MED, V204, P819, DOI 10.1084/jem.20062104; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Laskowski RA, 2016, HUM MOL GENET, V25, P927, DOI 10.1093/hmg/ddv625; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Ma M.C.J., 2019, BIORXIV, DOI [10.1101/674259, DOI 10.1101/674259]; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Miles RR, 2005, MOL CELL PROTEOMICS, V4, P1898, DOI 10.1074/mcp.M500112-MCP200; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Mondello P, 2020, CANCER DISCOV, V10, P440, DOI 10.1158/2159-8290.CD-19-0116; Mort RL, 2014, CELL CYCLE, V13, P2681, DOI 10.4161/15384101.2015.945381; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; National Research Council (US) Institute for Laboratory Animal Research, 1996, GUIDE CARE USE LAB A, DOI [10.17226/5140, DOI 10.17226/5140, 10.17226/5140.]; Nissen MD, 2020, CYTOM PART A, V97, P620, DOI 10.1002/cyto.a.23919; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Oliver AM, 1997, J IMMUNOL, V158, P1108; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Page` s H., 2019, BIOSTRINGS EFFICIENT; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Phelan JD, 2018, NATURE, V560, P387, DOI 10.1038/s41586-018-0290-0; Polo JM, 2008, BLOOD, V112, P644, DOI 10.1182/blood-2008-01-131813; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott DW, 2015, J CLIN ONCOL, V33, P2848, DOI 10.1200/JCO.2014.60.2383; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Singh M, 2020, CELL, V180, P878, DOI 10.1016/j.cell.2020.01.029; Stengel KR, 2019, NUCLEIC ACIDS RES, V47, P10612, DOI 10.1093/nar/gkz816; Stewart I, 2018, IMMUNITY, V49, P477, DOI 10.1016/j.immuni.2018.08.025; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sungalee S, 2014, J CLIN INVEST, V124, P5337, DOI 10.1172/JCI72415; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Wang JQ, 2017, J EXP MED, V214, P2759, DOI 10.1084/jem.20161454; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pD339, DOI 10.1093/nar/gku1023; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Wright GW, 2020, CANCER CELL, V37, P551, DOI 10.1016/j.ccell.2020.03.015; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-31; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	114	32	33	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					297	+		10.1016/j.cell.2020.05.049	http://dx.doi.org/10.1016/j.cell.2020.05.049			47	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32619424	hybrid, Green Accepted			2022-12-28	WOS:000552745000005
J	Zhou, T; Damsky, W; Weizman, OE; McGeary, MK; Hartmann, KP; Rosen, CE; Fischer, S; Jackson, R; Flavell, RA; Wang, J; Sanmamed, MF; Bosenberg, MW; Ring, AM				Zhou, Ting; Damsky, William; Weizman, Orr-El; McGeary, Meaghan K.; Hartmann, K. Patricia; Rosen, Connor E.; Fischer, Suzanne; Jackson, Ruaidhri; Flavell, Richard A.; Wang, Jun; Sanmamed, Miguel F.; Bosenberg, Marcus W.; Ring, Aaron M.			IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy	NATURE			English	Article							T-CELL RESPONSE; METASTATIC MELANOMA; ACTIVATION; INSIGHTS; AUGMENTATION; MUTATIONS; THERAPY	Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer, but they have only modest efficacy and limited tolerability(1,2). In an effort to identify alternative cytokine pathways for immunotherapy, we found that components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. However, recombinant IL-18 previously did not demonstrate efficacy in clinical trials(3). Here we show that IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice. Using directed evolution, we engineered a 'decoy-resistant' IL-18 (DR-18) that maintains signalling potential but is impervious to inhibition by IL-18BP. Unlike wild-type IL-18, DR-18 exerted potent anti-tumour effects in mouse tumour models by promoting the development of poly-functional effector CD8(+)T cells, decreasing the prevalence of exhausted CD8(+)T cells that express the transcriptional regulator of exhaustion TOX, and expanding the pool of stem-like TCF1(+)precursor CD8(+)T cells. DR-18 also enhanced the activity and maturation of natural killer cells to effectively treat anti-PD-1 resistant tumours that have lost surface expression of major histocompatibility complex class I molecules. These results highlight the potential of the IL-18 pathway for immunotherapeutic intervention and implicate IL-18BP as a major therapeutic barrier. An engineered version of IL-18 that is resistant to binding by the soluble decoy receptor IL-18BP shows strong anti-tumour activity in mouse models of cancer.	[Zhou, Ting; Weizman, Orr-El; Hartmann, K. Patricia; Rosen, Connor E.; Fischer, Suzanne; Jackson, Ruaidhri; Flavell, Richard A.; Bosenberg, Marcus W.; Ring, Aaron M.] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Damsky, William; Bosenberg, Marcus W.] Yale Sch Med, Dept Dermatol, New Haven, CT USA; [McGeary, Meaghan K.; Bosenberg, Marcus W.] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Wang, Jun] NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Sanmamed, Miguel F.] Clin Univ Navarra, Dept Oncol, Pamplona, Spain; [Ring, Aaron M.] Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; New York University; NYU Langone Medical Center; University of Navarra; Yale University	Ring, AM (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.; Ring, AM (corresponding author), Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	aaron.ring@yale.edu	; F Sanmamed, Miguel/I-5572-2017	Zhou, Ting/0000-0001-8783-8380; Flavell, Richard/0000-0003-4461-0778; Wang, Jun/0000-0002-6346-2929; F Sanmamed, Miguel/0000-0002-7295-6074; McGeary, Meaghan/0000-0002-8505-7158; Ring, Aaron/0000-0003-3699-2446				[Anonymous], SCI REP; Apetoh L, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.998538; Ardolino M, 2014, J CLIN INVEST, V124, P4781, DOI 10.1172/JCI74337; Atkins MB, 2000, CANCER J SCI AM, V6, pS11; Belkaya S, 2019, J EXP MED, V216, P1777, DOI 10.1084/jem.20190669; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carbotti G, 2013, CLIN CANCER RES, V19, P4611, DOI 10.1158/1078-0432.CCR-13-0568; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gubin MM, 2018, CELL, V175, P1014, DOI 10.1016/j.cell.2018.09.030; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hirakawa M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89278; Hu BL, 2017, CELL REP, V20, P3025, DOI 10.1016/j.celrep.2017.09.002; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Kim SHM, 2001, P NATL ACAD SCI USA, V98, P3304, DOI 10.1073/pnas.051634098; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Ma ZF, 2016, CLIN CANCER RES, V22, P2969, DOI 10.1158/1078-0432.CCR-15-1655; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nakamura K, 2018, CANCER CELL, V33, P634, DOI 10.1016/j.ccell.2018.02.007; Park CC, 2001, J IMMUNOL, V167, P1644, DOI 10.4049/jimmunol.167.3.1644; Robertson MJ, 2008, CLIN CANCER RES, V14, P3462, DOI 10.1158/1078-0432.CCR-07-4740; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Tarhini AA, 2009, CANCER-AM CANCER SOC, V115, P859, DOI 10.1002/cncr.24100; Terme M, 2011, CANCER RES, V71, P5393, DOI 10.1158/0008-5472.CAN-11-0993; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Vidal-Vanaclocha F, 2000, P NATL ACAD SCI USA, V97, P734, DOI 10.1073/pnas.97.2.734; Waldmann TA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028472; Wang J, 2017, PIGM CELL MELANOMA R, V30, P428, DOI 10.1111/pcmr.12591; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862	43	83	91	2	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 23	2020	583	7817					609	+		10.1038/s41586-020-2422-6	http://dx.doi.org/10.1038/s41586-020-2422-6			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MP1EM	32581358	Green Accepted			2022-12-28	WOS:000551954700012
J	Lunyera, J; Mohottige, D; Alexopoulos, AS; Campbell, H; Cameron, CB; Sagalla, N; Amrhein, TJ; Crowley, MJ; Dietch, JR; Gordon, AM; Kosinski, AS; Cantrell, S; Williams, JW; Gierisch, JM; Ear, B; Goldstein, KM				Lunyera, Joseph; Mohottige, Dinushika; Alexopoulos, Anastasia-Stefania; Campbell, Hilary; Cameron, C. Blake; Sagalla, Nicole; Amrhein, Timothy J.; Crowley, Matthew J.; Dietch, Jessica R.; Gordon, Adelaide M.; Kosinski, Andrzej S.; Cantrell, Sarah; Williams, John W., Jr.; Gierisch, Jennifer M.; Ear, Belinda; Goldstein, Karen M.			Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC KIDNEY-DISEASE; GADOBENATE DIMEGLUMINE; CONTRAST AGENTS; GADOXETATE DISODIUM; LIVER-DISEASE; RENAL-DISEASE; ENHANCED MRI; SAFETY; PATHOPHYSIOLOGY; GADOBUTROL	Background: The risk for nephrogenic systemic fibrosis (NSF) after exposure to newer versus older gadolinium-based contrast agents (GBCAs) remains unclear. Purpose: To synthesize evidence about NSF risk with newer versus older GBCAs across the spectrum of kidney function. Data Sources: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science for English-language references from inception to 5 March 2020. Study Selection: Randomized controlled trials, cohort studies, and case-control studies that assessed NSF occurrence after GBCA exposure. Data Extraction: Data were abstracted by 1 investigator and verified by a second. Investigator pairs assessed risk of bias by using validated tools. Data Synthesis: Of 32 included studies, 20 allowed for assessment of NSF risk after exposure to newer GBCAs and 12 (11 cohort studies and 1 case-control study) allowed for comparison of NSF risk between newer and older GBCAs. Among 83 291 patients exposed to newer GBCAs, no NSF cases developed (exact 95% CI, 0.0001 to 0.0258 case). Among the 12 studies (n = 118 844) that allowed risk comparison between newer and older GBCAs, 37 NSF cases developed after exposure to older GBCAs (exact CI, 0.0001 to 0.0523 case) and 4 occurred (3 confounded) after exposure to newer GBCAs (exact CI, 0.0018 to 0.0204 case). Data were scant for patients with acute kidney injury or those at risk for chronic kidney disease. Limitations: Study heterogeneity prevented meta-analysis. Risk of bias was high in most studies because of inadequate exposure and outcome ascertainment. Conclusion: Although NSF occurrence after exposure to newer GBCAs is very rare, the relatively scarce data among patients with acute kidney injury and those with risk factors for chronic kidney disease limit conclusions about safety in these populations.	[Lunyera, Joseph; Mohottige, Dinushika; Williams, John W., Jr.] Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, 200 Morris St,3rd Floor, Durham, NC 27701 USA; [Cameron, C. Blake; Sagalla, Nicole; Cantrell, Sarah; Goldstein, Karen M.] Duke Univ, Sch Med, Durham, NC USA; [Mohottige, Dinushika; Alexopoulos, Anastasia-Stefania; Crowley, Matthew J.; Kosinski, Andrzej S.] Duke Univ, Med Ctr, Durham, NC USA; [Alexopoulos, Anastasia-Stefania; Sagalla, Nicole; Amrhein, Timothy J.; Crowley, Matthew J.; Gordon, Adelaide M.; Williams, John W., Jr.; Ear, Belinda; Goldstein, Karen M.] Durham Vet Affairs Hlth Care Syst, Durham, NC USA; [Campbell, Hilary] Duke Univ, Margolis Ctr Hlth Policy, Durham, NC USA; [Dietch, Jessica R.] Stanford Univ, Palo Alto, CA 94304 USA; [Dietch, Jessica R.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Kosinski, Andrzej S.] Duke Clin Res Inst, Durham, NC USA; [Cantrell, Sarah] Duke Univ, Med Ctr, Lib & Arch, Durham, NC USA; [Gierisch, Jennifer M.] Duke Univ, Sch Med, Durham Vet Affairs Hlth Care Syst, Durham, NC USA; [Gierisch, Jennifer M.] Duke Univ, Durham, NC USA; [Alexopoulos, Anastasia-Stefania; Sagalla, Nicole; Crowley, Matthew J.] 508 Fulton St, Durham, NC 27705 USA; [Campbell, Hilary] 100 Fuqua Dr,Box 90120, Durham, NC 27708 USA; [Cameron, C. Blake] 2424 Erwin Rd,Suite 605, Durham, NC 27705 USA; [Amrhein, Timothy J.] Duke Univ, Med Ctr, Dept Radiol, Box 3808, Durham, NC 27710 USA; [Dietch, Jessica R.] 401 Quarry Rd, Palo Alto, CA 94304 USA; [Gordon, Adelaide M.; Ear, Belinda; Goldstein, Karen M.] Durham Vet Affairs Med Ctr, 411 West Chapel Hill St,Suite 600, Durham, NC 27701 USA; [Kosinski, Andrzej S.] 200 Morris St, Durham, NC 27701 USA; [Cantrell, Sarah] 10 Searle Ctr Dr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Duke University; Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Lunyera, J (corresponding author), Duke Univ, Sch Med, Div Gen Internal Med, 200 Morris St,3rd Floor, Durham, NC 27701 USA.	joseph.lunyera@duke.edu; adelaide.gordon@va.gov	Dietch, Jessica/AAG-2441-2020; Gierisch, Jennifer/GLU-1269-2022; Cantrell, Sarah/T-5729-2019; Lunyera, Joseph/O-2078-2015	Dietch, Jessica/0000-0001-9434-0791; Cantrell, Sarah/0000-0003-2694-7836; Lunyera, Joseph/0000-0002-9350-320X; Goldstein, Karen/0000-0003-4419-5869	U.S. Department of Veterans Affairs [PROSPERO: CRD42019135783]	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs. (PROSPERO: CRD42019135783)	Abu-Alfa AK, 2011, ADV CHRONIC KIDNEY D, V18, P188, DOI 10.1053/j.ackd.2011.03.001; Abujudeh HH, 2009, J MAGN RESON IMAGING, V30, P1335, DOI 10.1002/jmri.21976; Agarwal R, 2009, NEPHROL DIAL TRANSPL, V24, P856, DOI 10.1093/ndt/gfn593; Alfano G, 2020, MAGN RESON IMAGING, V70, P1, DOI 10.1016/j.mri.2020.02.012; American College of Radiology, ACR MAN CONTR MED; Amet S, 2014, INVEST RADIOL, V49, P109, DOI 10.1097/RLI.0000000000000000; Anzalone N, 2013, NEUROSURGERY, V72, P691, DOI 10.1227/NEU.0b013e3182889ddf; Attari H, 2019, RADIOLOGY, V292, P376, DOI 10.1148/radiol.2019182916; Beam AS, 2017, RADIOL TECHNOL, V88, P583; Becker S, 2012, NEPHRON CLIN PRACT, V121, pC91, DOI 10.1159/000345150; Bhave G, 2008, J UROLOGY, V180, P830, DOI 10.1016/j.juro.2008.05.005; Bruce R, 2016, INVEST RADIOL, V51, P701, DOI 10.1097/RLI.0000000000000259; Bryant BJ, 2009, CLIN RADIOL, V64, P706, DOI 10.1016/j.crad.2009.04.004; Busse J, METHODS COMMENTARY R; Chrysochou C, 2010, CLIN J AM SOC NEPHRO, V5, P484, DOI 10.2215/CJN.06580909; Chrysochou C, 2009, J MAGN RESON IMAGING, V29, P887, DOI 10.1002/jmri.21708; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cochrane Effective Practice and Organisation of Care (EPOC), 2017, SUGG RISK BIAS CRIT; Cowper SE, 2008, EUR J RADIOL, V66, P191, DOI 10.1016/j.ejrad.2008.01.016; Davenport MS, 2019, RADIOLOGY, V292, P387, DOI 10.1148/radiol.2019191158; De-Hua C, 2019, ACTA RADIOL, V60, P1450, DOI 10.1177/0284185119840649; Deray G, 2013, EUR RADIOL, V23, P1250, DOI 10.1007/s00330-012-2705-x; Elmholdt TR, 2011, BRIT J DERMATOL, V165, P828, DOI 10.1111/j.1365-2133.2011.10465.x; European Medicines Agency, GAD CONT CONTR AG; Evidence Partners Inc, 2018, DISTILLERAI; Flynn MM, 2019, TRANSPLANTATION, V103, pE159, DOI 10.1097/TP.0000000000002678; Gheuens E, 2014, INVEST RADIOL, V49, P505, DOI 10.1097/RLI.0000000000000045; Girardi M, 2011, J AM ACAD DERMATOL, V65, P1095, DOI 10.1016/j.jaad.2010.08.041; Glutig K, 2016, PEDIATR RADIOL, V46, P1317, DOI 10.1007/s00247-016-3599-6; Grebe SO, 2008, CLIN EXP NEPHROL, V12, P403, DOI 10.1007/s10157-008-0063-4; Hoppe H, 2010, EUR RADIOL, V20, P595, DOI 10.1007/s00330-009-1586-0; Hultcrantz M, 2017, J CLIN EPIDEMIOL, V87, P4, DOI 10.1016/j.jclinepi.2017.05.006; Idee JM, 2008, TOXICOLOGY, V248, P77, DOI 10.1016/j.tox.2008.03.012; Janus N, 2010, EUR J RADIOL, V73, P357, DOI 10.1016/j.ejrad.2008.11.021; Kanal E, 2020, AM J NEURORADIOL, V41, P393, DOI 10.3174/ajnr.A6448; Kitajima K, 2012, INT J UROL, V19, P806, DOI 10.1111/j.1442-2042.2012.03042.x; Lauenstein T, 2015, INVEST RADIOL, V50, P416, DOI 10.1097/RLI.0000000000000145; Leyba K, 2019, CURR OPIN NEPHROL HY, V28, P154, DOI 10.1097/MNH.0000000000000475; Marckmann P, 2008, CURR OPIN NEPHROL HY, V17, P315, DOI 10.1097/MNH.0b013e3282f4b605; Martin DR, 2010, J MAGN RESON IMAGING, V31, P440, DOI 10.1002/jmri.22024; Mazhar SM, 2009, J MAGN RESON IMAGING, V30, P1313, DOI 10.1002/jmri.21983; McDonald RJ, 2018, RADIOLOGY, V289, P517, DOI 10.1148/radiol.2018181151; McKinney AM, 2015, EUR J RADIOL, V84, P2539, DOI 10.1016/j.ejrad.2015.09.004; McWilliams RG, 2020, J MAGN RESON IMAGING, V51, P607, DOI 10.1002/jmri.26851; Michaely HJ, 2017, INVEST RADIOL, V52, P55, DOI 10.1097/RLI.0000000000000307; Morcos SK, 2008, EUR J RADIOL, V66, P175, DOI 10.1016/j.ejrad.2008.01.025; Nainani N, 2009, AM J NEPHROL, V29, P1, DOI 10.1159/000149628; Nandwana SB, 2015, RADIOLOGY, V276, P741, DOI 10.1148/radiol.2015142423; Prince MR, 2008, RADIOLOGY, V248, P807, DOI 10.1148/radiol.2483071863; Prince MR, 2017, EUR RADIOL, V27, P286, DOI 10.1007/s00330-016-4268-8; Reilly RF, 2008, CLIN J AM SOC NEPHRO, V3, P747, DOI 10.2215/CJN.05721207; Runge VM, 2018, INVEST RADIOL, V53, P571, DOI 10.1097/RLI.0000000000000507; Runge VM, 2008, INVEST RADIOL, V43, P893, DOI 10.1097/RLI.0b013e31818e659e; Schieda N, 2019, CAN ASSOC RADIOL J, V70, P226, DOI 10.1016/j.carj.2019.04.001; Schieren G, 2008, AM J KIDNEY DIS, V51, P976, DOI 10.1053/j.ajkd.2008.02.299; Scott LJ, 2018, CLIN DRUG INVEST, V38, P773, DOI 10.1007/s40261-018-0674-9; Shaffer KM, 2015, LIVER TRANSPLANT, V21, P1340, DOI 10.1002/lt.24118; Smorodinsky E, 2015, J MAGN RESON IMAGING, V41, P1259, DOI 10.1002/jmri.24650; Soulez G, 2015, AM J ROENTGENOL, V205, P469, DOI 10.2214/AJR.14.14268; Soyer P, 2017, J MAGN RESON IMAGING, V45, P988, DOI 10.1002/jmri.25486; Tsushima Y, 2018, JPN J RADIOL, V36, P676, DOI 10.1007/s11604-018-0778-4; U.S. Food and Drug Administration, FDA DRUG SAF COMM NE; Wagner B, 2016, AM J PHYSIOL-RENAL, V311, pF1, DOI 10.1152/ajprenal.00166.2016; Woolen SA, 2020, JAMA INTERN MED, V180, P223, DOI 10.1001/jamainternmed.2019.5284; Young LK, 2019, EUR RADIOL, V29, P1922, DOI 10.1007/s00330-018-5737-z; Zhang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129720; Zou ZT, 2011, JACC-CARDIOVASC IMAG, V4, P1206, DOI 10.1016/j.jcmg.2011.08.013; Zou ZT, 2009, J MAGN RESON IMAGING, V30, P1309, DOI 10.1002/jmri.21769	68	7	7	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2020	173	2					110	+		10.7326/M20-0299	http://dx.doi.org/10.7326/M20-0299			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ0RK	32568573	Green Accepted			2022-12-28	WOS:000552604300017
J	Taylor, AL; Habibi, R; Burci, GL; Dagron, S; Eccleston-Turner, M; Gostin, LO; Meier, BM; Phelan, A; Villarreal, PA; Yamin, AE; Chirwa, D; Forman, L; Ooms, G; Sekalala, S; Hoffman, SJ				Taylor, Allyn L.; Habibi, Roojin; Burci, Gian Luca; Dagron, Stephanie; Eccleston-Turner, Mark; Gostin, Lawrence O.; Meier, Benjamin Mason; Phelan, Alexandra; Villarreal, Pedro A.; Yamin, Alicia Ely; Chirwa, Danwood; Forman, Lisa; Ooms, Gorik; Sekalala, Sharifah; Hoffman, Steven J.			Solidarity in the wake of COVID-19: reimagining the International Health Regulations	LANCET			English	Editorial Material									[Taylor, Allyn L.] Univ Washington, Sch Law, Seattle, WA 98195 USA; [Habibi, Roojin; Hoffman, Steven J.] York Univ, Global Strategy Lab, Toronto, ON, Canada; [Burci, Gian Luca] Grad Inst Int & Dev Studies, Geneva, Switzerland; [Dagron, Stephanie] Univ Geneva, Geneva, Switzerland; [Eccleston-Turner, Mark] Keele Univ, Keele, Staffs, England; [Gostin, Lawrence O.; Phelan, Alexandra] Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Meier, Benjamin Mason] Univ N Carolina, Chapel Hill, NC 27515 USA; [Phelan, Alexandra] Georgetown Univ, Med Ctr, Ctr Global Hlth Sci & Secur, Washington, DC 20007 USA; [Villarreal, Pedro A.] Planck Inst Comparat Publ Law & Int Law, Heidelberg, Germany; [Yamin, Alicia Ely] Harvard Univ, Cambridge, MA 02138 USA; [Chirwa, Danwood] Univ Cape Town, Fac Law, Cape Town, South Africa; [Forman, Lisa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Ooms, Gorik] London Sch Hyg & Trop Med, London, England; [Sekalala, Sharifah] Univ Warwick, Sch Law, Coventry, W Midlands, England	University of Washington; University of Washington Seattle; York University - Canada; University of Geneva; Keele University; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; Georgetown University; Harvard University; University of Cape Town; University of Toronto; University of London; London School of Hygiene & Tropical Medicine; University of Warwick	Taylor, AL (corresponding author), Univ Washington, Sch Law, Seattle, WA 98195 USA.	taylora8@uw.edu	Habibi, Roojin/AAR-3799-2021; Villarreal, Pedro A./GRS-9561-2022; Ooms, Gorik/A-2537-2015	Ooms, Gorik/0000-0002-9804-0128; Forman, Lisa/0000-0002-4200-9359; Eccleston-Turner, Mark/0000-0002-2589-0738; Villarreal, Pedro A./0000-0003-4216-1542; Habibi, Roojin/0000-0001-7948-0438				Aitken T, 2020, J INFECTION, V81, P353, DOI 10.1016/j.jinf.2020.05.001; Chayes Abram, 1998, THE NEW SOVEREIGNTY; Eccleston-Turner M, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001618; Global Health Security Index; A World At Risk, 2019, WORLD RISK ANN REP G; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; ICAO, 2020, EFF NOV COR COVID 19; Tam, 2020, INTERIM REPORT WHOS; Taylor AL, 2007, J LAW MED ETHICS, V35, P556, DOI 10.1111/j.1748-720X.2007.00180.x; Taylor Allyn L., 2019, OXFORD HDB UN TREATI, P345; WHO, 2005, 583 WHO WHA; World Bank, 2020, GLOBAL PAYMENT SYSTE, DOI 10.1596/978-1-4648-1553-9; World Health Organization, 2020, DIR GEN OP REM MED B; World Trade Organization, 2020, TRADE SET PLUNGE COV	13	25	26	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2020	396	10244					82	83		10.1016/S0140-6736(20)31417-3	http://dx.doi.org/10.1016/S0140-6736(20)31417-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2JY	32569580	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000552724600008
J	Hallifax, RJ; McKeown, E; Sivakumar, P; Fairbairn, I; Peter, C; Leitch, A; Knight, M; Stanton, A; Ijaz, A; Marciniak, S; Cameron, J; Bhatta, A; Blyth, KG; Reddy, R; Harris, MC; Maddekar, N; Walker, S; West, A; Laskawiec-Szkonter, M; Corcoran, JP; Gerry, S; Roberts, C; Harvey, JE; Maskell, N; Miller, RF; Rahman, NM				Hallifax, Rob J.; McKeown, Edward; Sivakumar, Parthipan; Fairbairn, Ian; Peter, Christy; Leitch, Andrew; Knight, Matthew; Stanton, Andrew; Ijaz, Asim; Marciniak, Stefan; Cameron, James; Bhatta, Amrithraj; Blyth, Kevin G.; Reddy, Raja; Harris, Marie-Clare; Maddekar, Nadeem; Walker, Steven; West, Alex; Laskawiec-Szkonter, Magda; Corcoran, John P.; Gerry, Stephen; Roberts, Corran; Harvey, John E.; Maskell, Nick; Miller, Robert F.; Rahman, Najib M.			Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial	LANCET			English	Article							CHEST TUBE SIZE; EPIDEMIOLOGY	Background Primary spontaneous pneumothorax occurs in otherwise healthy young patients. Optimal management is not defined and often results in prolonged hospitalisation. Data on efficacy of ambulatory options are poor. We aimed to describe the duration of hospitalisation and safety of ambulatory management compared with standard care. Methods In this open-label, randomised controlled trial, adults (aged 16-55 years) with symptomatic primary spontaneous pneumothorax were recruited from 24 UK hospitals during a period of 3 years. Patients were randomly assigned (1:1) to treatment with either an ambulatory device or standard guideline-based management (aspiration, standard chest tube insertion, or both). The primary outcome was total length of hospital stay including re-admission up to 30 days after randomisation. Patients with available data were included in the primary analysis and all assigned patients were included in the safety analysis. The trial was prospectively registered with the International Standard Randomised Clinical Trials Number, ISRCTN79151659. Findings Of 776 patients screened between July, 2015, and March, 2019, 236 (30%) were randomly assigned to ambulatory care (n=117) and standard care (n=119). At day 30, the median hospitalisation was significantly shorter in the 114 patients with available data who received ambulatory treatment (0 days [IQR 0-3]) than in the 113 with available data who received standard care (4 days [IQR 0-8]; p<0.0001; median difference 2 days [95% CI 1-3]). 110 (47%) of 236 patients had adverse events, including 64 (55%) of 117 patients in the ambulatory care arm and 46 (39%) of 119 in the standard care arm. All 14 serious adverse events occurred in patients who received ambulatory care, eight (57%) of which were related to the intervention, including an enlarging pneumothorax, asymptomatic pulmonary oedema, and the device malfunctioning, leaking, or dislodging. Interpretation Ambulatory management of primary spontaneous pneumothorax significantly reduced the duration of hospitalisation including re-admissions in the first 30 days, but at the expense of increased adverse events. This data suggests that primary spontaneous pneumothorax can be managed for outpatients, using ambulatory devices in those who require intervention.	[Hallifax, Rob J.] Univ Oxford, Oxford Ctr Resp Med, Oxford OX3 7LE, England; [Laskawiec-Szkonter, Magda; Rahman, Najib M.] Univ Oxford, Oxford Resp Trials Unit, Oxford, England; [McKeown, Edward] Royal Berkshire Natl Hlth Serv NHS Fdn Trust, Reading, Berks, England; [Sivakumar, Parthipan; West, Alex] Guys & St Thomas NHS Fdn Trust, London, England; [Fairbairn, Ian] NHS Fife, Queen Margaret Hosp, Dunfermline, Fife, Scotland; [Peter, Christy] Royal United Hosp Bath NHS Fdn Trust, Bath, Avon, England; [Leitch, Andrew] NHS Lothian, Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Knight, Matthew] West Hertfordshire Hosp NHS Trust, Watford, England; [Stanton, Andrew] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England; [Ijaz, Asim] Univ Hosp Morecambe Bay NHS Fdn Trust, Lancaster, England; [Marciniak, Stefan] Univ Cambridge, Dept Med, Cambridge, England; [Cameron, James; Harvey, John E.] North Bristol NHS Trust, Bristol, Avon, England; [Bhatta, Amrithraj] Blackpool Fylde & Wyre Hosp NHS Fdn Trust, Blackpool, England; [Blyth, Kevin G.] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland; [Blyth, Kevin G.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Reddy, Raja] Kettering & Dist Gen Hosp, Kettering, England; [Harris, Marie-Clare] NHS Lothian, Royal Infirm Edinburgh, Edinburgh, Midlothian, Scotland; [Maddekar, Nadeem] Univ Hosp North Midlands, Stoke On Trent, Staffs, England; [Walker, Steven; Maskell, Nick] Univ Bristol, Acad Resp Unit, Bristol, Avon, England; [Corcoran, John P.] Univ Hosp Plymouth NHS Trust, Plymouth, Devon, England; [Gerry, Stephen; Roberts, Corran] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England; [Miller, Robert F.] UCL, Inst Global Hlth, London, England	University of Oxford; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of Edinburgh; University of Cambridge; North Bristol NHS Trust; Queen Elizabeth University Hospital (QEUH); University of Glasgow; Royal Infirmary of Edinburgh; University of Bristol; University of Oxford; University of London; University College London	Hallifax, RJ (corresponding author), Univ Oxford, Oxford Ctr Resp Med, Oxford OX3 7LE, England.	robert.hallifax@ndm.ox.ac.uk	, Matthew/AAZ-4939-2020	Miller, Robert/0000-0003-2067-4291; Hallifax, Rob/0000-0002-9467-668X; Rahman, Najib M/0000-0003-1195-1680; Knight, Matthew/0000-0003-1761-0115; Sivakumar, Parthipan/0000-0003-3740-2612; maskell, nick/0000-0002-1276-6500	UK National Institute for Health Research; MRC [MR/R009120/1] Funding Source: UKRI	UK National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK National Institute for Health Research.	Bobbio A, 2015, THORAX, V70, P653, DOI 10.1136/thoraxjnl-2014-206577; Brims FJH, 2013, THORAX, V68, P664, DOI 10.1136/thoraxjnl-2012-202875; Brown SGA, 2020, NEW ENGL J MED, V382, P405, DOI 10.1056/NEJMoa1910775; Chee CBE, 1998, RESP MED, V92, P757, DOI 10.1016/S0954-6111(98)90008-7; Gupta D, 2000, THORAX, V55, P666, DOI 10.1136/thorax.55.8.666; Hallifax R, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2019-000403; Hallifax RJ, 2018, JAMA-J AM MED ASSOC, V320, P1471, DOI 10.1001/jama.2018.14299; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; Mishra EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123798; National Institute for Health Research, 2019, GOOD CLIN PRACT; Psallidas I, 2017, BMJ OPEN RESPIR RES, V4, DOI [10.1136/bmjresp-2016-000171, 10.1136/bmjresp-2017-000225]; Rahman NM, 2015, JAMA-J AM MED ASSOC, V314, P2641, DOI 10.1001/jama.2015.16840; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Rahman NM, 2010, CHEST, V137, P536, DOI 10.1378/chest.09-1044; SCHOENENBERGER RA, 1991, ARCH SURG-CHICAGO, V126, P764; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; United States Food and Drug Administration, 2016, FDA EXP US XALK TREA	17	34	35	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					39	49						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ND0VO	32622394	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000561626100015
J	Elitt, MS; Barbar, L; Shick, HE; Powers, BE; Maeno-Hikichi, Y; Madhavan, M; Allan, KC; Nawash, BS; Gevorgyan, AS; Hung, S; Nevin, ZS; Olsen, HE; Hitomi, M; Schlatzer, DM; Zhao, HT; Swayze, A; LePage, DF; Jiang, WH; Conlon, RA; Rigo, F; Tesar, PJ				Elitt, Matthew S.; Barbar, Lilianne; Shick, H. Elizabeth; Powers, Berit E.; Maeno-Hikichi, Yuka; Madhavan, Mayur; Allan, Kevin C.; Nawash, Baraa S.; Gevorgyan, Artur S.; Hung, Stevephen; Nevin, Zachary S.; Olsen, Hannah E.; Hitomi, Midori; Schlatzer, Daniela M.; Zhao, Hien T.; Swayze, Adam; LePage, David F.; Jiang, Weihong; Conlon, Ronald A.; Rigo, Frank; Tesar, Paul J.			Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease	NATURE			English	Article							CELL-BASED TREATMENT; CNS MYELIN; RNA; MOUSE; DEGENERATION; LACKING; ABSENCE; AXONS; MICE	In a mouse model of the leukodystrophy Pelizaeus-Merzbacher disease, myelination, motor performance, respiratory function and lifespan are improved by suppressing proteolipid protein expression, suggestingPLP1as a therapeutic target for human patients with this disease and, more broadly, antisense oligonucleotides as a pharmaceutical modality for treatment of myelin disorders. Mutations inPLP1, the gene that encodes proteolipid protein (PLP), result in failure of myelination and neurological dysfunction in the X-chromosome-linked leukodystrophy Pelizaeus-Merzbacher disease (PMD)(1,2). MostPLP1mutations, including point mutations and supernumerary copy variants, lead to severe and fatal disease. Patients who lackPLP1expression, andPlp1-null mice, can display comparatively mild phenotypes, suggesting thatPLP1suppression might provide a general therapeutic strategy for PMD1,3-5. Here we show, using CRISPR-Cas9 to suppressPlp1expression in thejimpy(Plp1(jp)) point-mutation mouse model of severe PMD, increased myelination and restored nerve conduction velocity, motor function and lifespan of the mice to wild-type levels. To evaluate the translational potential of this strategy, we identified antisense oligonucleotides that stably decrease the levels ofPlp1mRNA and PLP protein throughout the neuraxis in vivo. Administration of a single dose ofPlp1-targeting antisense oligonucleotides in postnataljimpymice fully restored oligodendrocyte numbers, increased myelination, improved motor performance, normalized respiratory function and extended lifespan up to an eight-month end point. These results suggest thatPLP1suppression could be developed as a treatment for PMD in humans. More broadly, we demonstrate that oligonucleotide-based therapeutic agents can be delivered to oligodendrocytes in vivo to modulate neurological function and lifespan, establishing a new pharmaceutical modality for myelin disorders.	[Elitt, Matthew S.; Barbar, Lilianne; Shick, H. Elizabeth; Maeno-Hikichi, Yuka; Madhavan, Mayur; Allan, Kevin C.; Nawash, Baraa S.; Gevorgyan, Artur S.; Hung, Stevephen; Nevin, Zachary S.; Olsen, Hannah E.; LePage, David F.; Jiang, Weihong; Conlon, Ronald A.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Powers, Berit E.; Zhao, Hien T.; Swayze, Adam; Rigo, Frank] Ionis Pharmaceut, Carlsbad, CA USA; [Hitomi, Midori] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Schlatzer, Daniela M.] Case Western Reserve Univ, Sch Med, Dept Med, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Case Western Reserve University; Ionis Pharmaceuticals, Inc.; Cleveland Clinic Foundation; Case Western Reserve University	Tesar, PJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	paul.tesar@case.edu	Tesar, Paul/GPK-5942-2022; Tesar, Paul J/C-9848-2014	Tesar, Paul/0000-0003-1532-3155; Tesar, Paul J/0000-0003-1532-3155; Nevin, Zachary/0000-0003-4987-924X; Elitt, Matthew/0000-0002-7296-164X; Barbar, Lilianne/0000-0001-9887-4248	National Institutes of Health [R01NS093357, T32GM007250, F30HD084167, F30HD096784, T32NS077888]; New York Stem Cell Foundation; European Leukodystrophy Association; Research Institute for Children's Health; Genomics, Small Molecule Drug Development, Transgenic and Rodent Behavioral core facilities of the Case Western Reserve University (CWRU) Comprehensive Cancer Center [P30CA043703]; Data Analytics Core of the Department of Population and Quantitative Health Sciences at CWRU; CWRU Light Microscopy Imaging Center [S10OD016164]; electron microscopy division of the Cleveland Clinic Lerner Research Institute Imaging Core; University of Chicago Genomics Facility	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; European Leukodystrophy Association; Research Institute for Children's Health; Genomics, Small Molecule Drug Development, Transgenic and Rodent Behavioral core facilities of the Case Western Reserve University (CWRU) Comprehensive Cancer Center; Data Analytics Core of the Department of Population and Quantitative Health Sciences at CWRU; CWRU Light Microscopy Imaging Center; electron microscopy division of the Cleveland Clinic Lerner Research Institute Imaging Core; University of Chicago Genomics Facility	This research was supported, in part, by grants from the National Institutes of Health R01NS093357 (P.J.T.), T32GM007250 (M.S.E, Z.S.N. and K.C.A), F30HD084167 (Z.S.N.), F30HD096784 (K.C.A.) and T32NS077888 (K.C.A.); the New York Stem Cell Foundation (P.J.T); the European Leukodystrophy Association (P.J.T.); and philanthropic contributions from the Research Institute for Children's Health and the Geller, Goodman, Fakhouri, Long, Matreyek, Peterson and Weidenthal families. Additional support was provided by the Genomics, Small Molecule Drug Development, Transgenic and Rodent Behavioral core facilities of the Case Western Reserve University (CWRU) Comprehensive Cancer Center (P30CA043703), the Data Analytics Core of the Department of Population and Quantitative Health Sciences at CWRU, the CWRU Light Microscopy Imaging Center (S10OD016164), the electron microscopy division of the Cleveland Clinic Lerner Research Institute Imaging Core, and the University of Chicago Genomics Facility. We thank L. Landmesser, P. MacFarlane, R. Miller, P. Scacheri, T. Wynshaw-Boris, B. Clayton, S. Edelheit, A. Miron, H. Arakawa, P. Philippidou, A. Vagnozzi, L. Hu, E. Cohn, M. Scavuzzo, C. Allan and J. Cregg for technical assistance, discussion and review of the manuscript.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Elitt MS, 2018, STEM CELL REP, V11, P711, DOI 10.1016/j.stemcr.2018.07.015; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Freeman SA, 2015, P NATL ACAD SCI USA, V112, pE321, DOI 10.1073/pnas.1419099112; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Garbern JY, 2002, BRAIN, V125, P551, DOI 10.1093/brain/awf043; Glascock Jacqueline J, 2011, J Vis Exp, DOI 10.3791/2968; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Gruenenfelder FI, 2020, BRAIN, V143, P1383, DOI 10.1093/brain/awaa080; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hagemann TL, 2018, ANN NEUROL, V83, P27, DOI 10.1002/ana.25118; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Inoue K, 2019, ADV EXP MED BIOL, V1190, P201, DOI 10.1007/978-981-32-9636-7_13; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lager AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06102-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Li H, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125052; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mazur C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129240; Miller MJ, 2003, J NEUROSCI, V23, P2265; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; Nakagata N, 1997, BIOL REPROD, V57, P1050, DOI 10.1095/biolreprod57.5.1050; NAVE KA, 1986, P NATL ACAD SCI USA, V83, P9264, DOI 10.1073/pnas.83.23.9264; Tran NH, 2019, NAT METHODS, V16, P63, DOI 10.1038/s41592-018-0260-3; Tran NH, 2017, P NATL ACAD SCI USA, V114, P8247, DOI 10.1073/pnas.1705691114; Nobuta H, 2019, CELL STEM CELL, V25, P531, DOI 10.1016/j.stem.2019.09.003; Osorio MJ, 2017, STEM CELLS, V35, P311, DOI 10.1002/stem.2530; RENIER WO, 1981, ACTA NEUROPATHOL, V54, P11, DOI 10.1007/BF00691328; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saher G, 2012, NAT MED, V18, P1130, DOI 10.1038/nm.2833; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Tantzer S, 2018, MOL THER-NUCL ACIDS, V12, P420, DOI 10.1016/j.omtn.2018.05.019; Tatar CL, 2010, ASN NEURO, V2, DOI 10.1042/AN20100016; Ueda A, 2018, HUM GENOME VAR, V5, DOI 10.1038/hgv.2018.13; Uschkureit T, 2001, GLIA, V35, P63, DOI 10.1002/glia.1071; Wishnew J, 2014, PEDIATRICS, V134, pE1451, DOI 10.1542/peds.2013-3604; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wolf N. I., 1993, GENE REV; Wu Q, 2000, J NEUROSCI, V20, P2609	47	21	21	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 17	2020	585	7825					397	+		10.1038/s41586-020-2494-3	http://dx.doi.org/10.1038/s41586-020-2494-3		JUL 2020	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR0WV	32610343	Green Accepted, Green Submitted			2022-12-28	WOS:000567780000001
J	Daly, S; Rosu, F; Gabelica, V				Daly, Steven; Rosu, Frederic; Gabelica, Valerie			Mass-resolved electronic circular dichroism ion spectroscopy	SCIENCE			English	Article							INFRARED-SPECTROSCOPY; MOBILITY MEASUREMENTS; QUADRUPLEX STRUCTURES; DNA; SPECTROMETRY; PHOTODETACHMENT; COLD	DNA and proteins are chiral: Their three-dimensional structures cannot be superimposed with their mirror images. Circular dichroism spectroscopy is widely used to characterize chiral compounds, but data interpretation is difficult in the case of mixtures. We recorded the electronic circular dichroism spectra of DNA helices separated in a mass spectrometer. We studied guanine-rich strands having various secondary structures, electrosprayed them as negative ions, irradiated them with an ultraviolet nanosecond optical parametric oscillator laser, and measured the difference in electron photodetachment efficiency between left and right circularly polarized light. The reconstructed circular dichroism ion spectra resembled those of their solution-phase counterparts, thereby allowing us to assign the DNA helical topology. The ability to measure circular dichroism directly on biomolecular ions expands the capabilities of mass spectrometry for structural analysis.	[Daly, Steven; Gabelica, Valerie] Univ Bordeaux, INSERM, F-33607 Pessac, France; [Daly, Steven; Gabelica, Valerie] CNRS, Lab Acides Nucl Regulat Nat & Artificielle, IECB, ARNA,U1212,UMR5320, F-33607 Pessac, France; [Rosu, Frederic] Univ Bordeaux, CNRS, Pessac, France; [Rosu, Frederic] INSERM, Inst Europeen Chim & Biol, IECB, UMS3033,US001, F-33607 Pessac, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Gabelica, V (corresponding author), Univ Bordeaux, INSERM, F-33607 Pessac, France.; Gabelica, V (corresponding author), CNRS, Lab Acides Nucl Regulat Nat & Artificielle, IECB, ARNA,U1212,UMR5320, F-33607 Pessac, France.	v.gabelica@iecb.u-bordeaux.fr	Rosu, Frédéric/E-6403-2011; Gabelica, Valérie/E-9417-2011	Rosu, Frédéric/0000-0003-3674-7539; Gabelica, Valérie/0000-0001-9496-0165; daly, steven/0000-0002-3268-8247	European Research Council [ERC-2013-CoG-616551-DNAFOLDIMS]	European Research Council(European Research Council (ERC)European Commission)	European Research Council, ERC-2013-CoG-616551-DNAFOLDIMS.	Arago D. F. J., 1811, MEM LINST, V12, P93; Awad H, 2013, MASS SPECTROM REV, V32, P466, DOI 10.1002/mas.21379; Breunig HG, 2009, CHEMPHYSCHEM, V10, P1199, DOI 10.1002/cphc.200900103; Chung WJ, 2015, P NATL ACAD SCI USA, V112, P2729, DOI 10.1073/pnas.1418718112; Clemmer DE, 1997, J MASS SPECTROM, V32, P577; Daly S, 2019, FARADAY DISCUSS, V217, P361, DOI 10.1039/c8fd00207j; de Souza AR, 2017, ACS SYM SER, V1258, P91; FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0; Frisch M. J., 2016, GAUSSIAN 16 REV B 01; Gabelica V, 2008, J AM CHEM SOC, V130, P1810, DOI 10.1021/ja077321w; Gabelica V, 2007, J AM CHEM SOC, V129, P4706, DOI 10.1021/ja068440z; Gabelica V, 2006, ANAL CHEM, V78, P6564, DOI 10.1021/ac060753p; Gabelica V, 2018, J AM SOC MASS SPECTR, V29, P2189, DOI 10.1007/s13361-018-2029-4; Garand E, 2012, SCIENCE, V335, P694, DOI 10.1126/science.1214948; Hong A, 2014, ANGEW CHEM INT EDIT, V53, P7805, DOI 10.1002/anie.201403916; Horsch P, 2011, PHYS CHEM CHEM PHYS, V13, P2378, DOI 10.1039/c0cp01903h; Janssen MHM, 2014, PHYS CHEM CHEM PHYS, V16, P856, DOI 10.1039/c3cp53741b; Kamrath MZ, 2018, ACCOUNTS CHEM RES, V51, P1487, DOI 10.1021/acs.accounts.8b00133; Karsisiotis AI, 2011, ANGEW CHEM INT EDIT, V50, P10645, DOI 10.1002/anie.201105193; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lepelmeier J, 2016, CHEMPHYSCHEM, V17, P4052, DOI 10.1002/cphc.201600811; Li R, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2338519; Liko I, 2016, CURR OPIN STRUC BIOL, V40, P136, DOI 10.1016/j.sbi.2016.09.008; Liu CD, 2019, CHEM SCI, V10, P218, DOI 10.1039/c8sc03813a; Lossl P, 2016, EMBO J, V35, P2634, DOI 10.15252/embj.201694818; Marchand A, 2016, NUCLEIC ACIDS RES, V44, P10999, DOI 10.1093/nar/gkw970; MCLAFFERTY FW, 1981, SCIENCE, V214, P280, DOI 10.1126/science.7280693; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; Nahon L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2336432; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Rosu F, 2012, J PHYS CHEM A, V116, P5383, DOI 10.1021/jp302468x; Schaefer B, 2007, AM J PHYS, V75, P163, DOI 10.1119/1.2386162; Seo J, 2017, NAT CHEM, V9, P39, DOI [10.1038/NCHEM.2615, 10.1038/nchem.2615]; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; Stewart JJP, 2013, J MOL MODEL, V19, P1, DOI 10.1007/s00894-012-1667-x; Swasey SM, 2018, J PHYS CHEM LETT, V9, P6605, DOI 10.1021/acs.jpclett.8b02851; Tao WA, 2001, ANAL CHEM, V73, P1692, DOI 10.1021/ac001150v; von Grafenstein UB, 2006, CHEMPHYSCHEM, V7, P2085, DOI 10.1002/cphc.200600376; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	40	31	30	10	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1465	+		10.1126/science.abb1822	http://dx.doi.org/10.1126/science.abb1822			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32587016	Green Submitted			2022-12-28	WOS:000545264600038
J	Koundouros, N; Karali, E; Tripp, A; Valle, A; Inglese, P; Perry, NJS; Magee, DJ; Virmouni, SA; Elder, GA; Tyson, AL; Doria, ML; van Weverwijk, A; Soares, RF; Isacke, CM; Nicholson, JK; Glen, RC; Takats, Z; Poulogiannis, G				Koundouros, Nikos; Karali, Evdoxia; Tripp, Aurelien; Valle, Adamo; Inglese, Paolo; Perry, Nicholas J. S.; Magee, David J.; Virmouni, Sara Anjomani; Elder, George A.; Tyson, Adam L.; Doria, Maria Luisa; van Weverwijk, Antoinette; Soares, Renata F.; Isacke, Clare M.; Nicholson, Jeremy K.; Glen, Robert C.; Takats, Zoltan; Poulogiannis, George			Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids	CELL			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); MASS-SPECTROMETRY; BREAST-CANCER; PATHWAY; 3-KINASE; GROWTH; INHIBITOR; ACTIVATION; DISCOVERY; MUTATION	Oncogenic transformation is associated with profound changes in cellular metabolism, but whether tracking these can improve disease stratification or influence therapy decision-making is largely unknown. Using the 'Knife to sample the aerosol of cauterized specimens, we demonstrate a new mode of real-time diagnosis, coupling metabolic phenotype to mutant PIK3CA genotype. Oncogenic PIK3CA results in an increase in arachidonic acid and a concomitant overproduction of eicosanoids, acting to promote cell proliferation beyond a cell-autonomous manner Mechanistically, mutant PIK3CA drives a multimodal signaling network involving mTORC2-PKC zeta-mediated activation of the calcium-dependent phospholipase A2 (cPLA2). Notably, inhibiting cPLA2 synergizes with fatty acid-free diet to restore immunogenicity and selectively reduce mutant PIK3CA-induced tumorigenicity. Besides highlighting the potential for metabolic phenotyping in stratified medicine, this study reveals an important role for activated PI3K signaling in regulating arachidonic acid metabolism, uncovering a targetable metabolic vulnerability that largely depends on dietary fat restriction.	[Koundouros, Nikos; Karali, Evdoxia; Tripp, Aurelien; Valle, Adamo; Perry, Nicholas J. S.; Magee, David J.; Virmouni, Sara Anjomani; Elder, George A.; Poulogiannis, George] Inst Canc Res, Div Canc Biol, Signalling & Canc Metab Team, 237 Fulham Rd, London SW3 6JB, England; [Koundouros, Nikos; Inglese, Paolo; Doria, Maria Luisa; Soares, Renata F.; Nicholson, Jeremy K.; Glen, Robert C.; Takats, Zoltan; Poulogiannis, George] Imperial Coll London, Dept Metab Digest & Reprod, Div Syst Med, London SW7 2AZ, England; [Valle, Adamo] Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Energy Metab & Nutr, Palma De Mallorca 07122, Spain; [Valle, Adamo] Univ Balearic Isl, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca 07120, Spain; [Valle, Adamo] Inst Salud Carlos III, Biomed Res Networking Ctr Physiopathol Obes & Nut, Madrid 28029, Spain; [Magee, David J.] Royal Marsden Hosp, Pain Med Dept, London, England; [Virmouni, Sara Anjomani] Brunel Univ London, Coll Hlth & Life Sci, Dept Life Sci, Uxbridge UB8 3PH, Middx, England; [Elder, George A.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Tyson, Adam L.] Inst Canc Res, Div Canc Biol, Flow Cytometry & Light Microscopy Core Facil, 237 Fulham Rd, London SW3 6JB, England; [Tyson, Adam L.] UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, 25 Howland St, London W1T 4JG, England; [van Weverwijk, Antoinette; Isacke, Clare M.] Inst Canc Res, Breast Canc Now Res Ctr, 237 Fulham Rd, London SW3 6JB, England; [van Weverwijk, Antoinette] Netherlands Canc Inst, Div Tumor Biol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Nicholson, Jeremy K.] Murdoch Univ, Australian Natl Phenome Ctr, Hlth Futures Inst, Perth, WA 6150, Australia; [Glen, Robert C.] Univ Cambridge, Ctr Mol Informat, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Imperial College London; Universitat de les Illes Balears; Institut Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes Balears; Instituto de Salud Carlos III; Royal Marsden NHS Foundation Trust; Brunel University; University of London; Queen Mary University London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Netherlands Cancer Institute; Murdoch University; University of Cambridge	Poulogiannis, G (corresponding author), Inst Canc Res, Div Canc Biol, Signalling & Canc Metab Team, 237 Fulham Rd, London SW3 6JB, England.; Takats, Z; Poulogiannis, G (corresponding author), Imperial Coll London, Dept Metab Digest & Reprod, Div Syst Med, London SW7 2AZ, England.	z.takats@imperial.ac.uk; george.poulogiannis@icr.ac.uk	Nicholson, Jeremy K/B-3395-2012; Inglese, Paolo/HDN-0003-2022; Poulogiannis, George/AAY-2210-2021; Valle, Adamo/H-7042-2017	Nicholson, Jeremy K/0000-0002-8123-8349; Inglese, Paolo/0000-0001-6179-9643; Tripp, Aurelien/0000-0002-7547-4441; Magee, David/0000-0001-5566-1445; Poulogiannis, George/0000-0002-0529-8614; Valle, Adamo/0000-0001-7217-2811; Isacke, Clare/0000-0002-9222-3345; Tyson, Adam/0000-0003-3225-1130; Koundouros, Nikos/0000-0001-8378-9673	ICR PhD studentship; Institute of Cancer Research; Cancer Research UK Grand Challenge award [C59824/A25044]; European Research Council; National Institute for Health Research (Imperial Biomedical Research Centre); Ministry of Education, Culture and Sport under the Program for Promoting and Hiring of Talent and its Employability (Subprogram for Mobility "Jose Castillejo'') of the Spanish Government; Comunitat Autonoma de les Illes Balears, Direccio General d'lnnovacio i Recerca [AAEE003/2017]; Fons Europeu de Desenvolupament Regional de la Unio Europea (FEDER)	ICR PhD studentship; Institute of Cancer Research; Cancer Research UK Grand Challenge award; European Research Council(European Research Council (ERC)European Commission); National Institute for Health Research (Imperial Biomedical Research Centre); Ministry of Education, Culture and Sport under the Program for Promoting and Hiring of Talent and its Employability (Subprogram for Mobility "Jose Castillejo'') of the Spanish Government; Comunitat Autonoma de les Illes Balears, Direccio General d'lnnovacio i Recerca; Fons Europeu de Desenvolupament Regional de la Unio Europea (FEDER)	We thank Naomi Guppy and Farzana Noor (Breast Cancer Now Histopathology, ICR, London, UK) and Elena Miranda and Adriana Resende Alves (Pathology Core Facility, University College London Cancer Institute) for support with immunohistochemistry, hematoxylin, and eosin analysis; and Champions Oncology (London, UK) for kindly providing breast, pancreatic, ovarian, sarcoma, and colorectal cancer PDX tumor specimens. We would also like to thank Edward St. John for enabling access to primary breast tumor samples, Verena M. Horneffer-van der Sluis for assistance with eicosanoid analysis, and the Biological Services Unit staff at the Institute of Cancer Research (Chelsea site) for their assistance with in vivo experiments. N.K. was supported by an ICR PhD studentship. The work described and the laboratory of G.P. was supported by the Institute of Cancer Research and a Cancer Research UK Grand Challenge award (C59824/A25044). Work in the Z.T. lab was supported by the European Research Council (MASSLIP Consolidator grant), Cancer Research UK Grand Challenge award (C59824/A25044), and the National Institute for Health Research (Imperial Biomedical Research Centre). A.V. was funded by the Ministry of Education, Culture and Sport under the Program for Promoting and Hiring of Talent and its Employability (Subprogram for Mobility "Jose Castillejo'') of the Spanish Government and by Comunitat Autonoma de les Illes Balears, Direccio General d'lnnovacio i Recerca (AAEE003/2017) and Fons Europeu de Desenvolupament Regional de la Unio Europea (FEDER).	Alexander J, 2017, SURG ENDOSC, V31, P1361, DOI 10.1007/s00464-016-5121-5; Alexander LD, 2006, KIDNEY INT, V69, P1823, DOI 10.1038/sj.ki.5000363; AMBS P, 1995, BIOCHEM J, V311, P189, DOI 10.1042/bj3110189; Balog J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005623; Basingab FS, 2016, CANCER IMMUNOL RES, V4, P400, DOI 10.1158/2326-6066.CIR-15-0146; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Borcoman E, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1581556; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gavaghan CL, 2000, FEBS LETT, V484, P169, DOI 10.1016/S0014-5793(00)02147-5; Gibb S, 2012, BIOINFORMATICS, V28, P2270, DOI 10.1093/bioinformatics/bts447; Greene ER, 2011, PROSTAG OTH LIPID M, V96, P27, DOI 10.1016/j.prostaglandins.2011.08.004; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Guri Y, 2017, CANCER CELL, V32, P807, DOI 10.1016/j.ccell.2017.11.011; Henry WS, 2017, CANCER RES, V77, P790, DOI 10.1158/0008-5472.CAN-16-2400; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Hopkins BD, 2018, NATURE, V560, P499, DOI 10.1038/s41586-018-0343-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes-Fulford M, 2006, CANCER RES, V66, P1427, DOI 10.1158/0008-5472.CAN-05-0914; Janiszewska M, 2015, NAT GENET, V47, P1212, DOI 10.1038/ng.3391; Kanai S, 2016, J PHARMACOL EXP THER, V356, P604, DOI 10.1124/jpet.115.229906; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Lala PK, 2018, CANCER METAST REV, V37, P369, DOI 10.1007/s10555-018-9734-0; Lee G, 2017, CELL, V171, P1545, DOI 10.1016/j.cell.2017.10.037; Lee KL, 2007, J MED CHEM, V50, P1380, DOI 10.1021/jm061131z; Lee SW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1730-5; Li X, 2014, EMBO REP, V15, P191, DOI 10.1002/embr.201338119; Li X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192464; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Lien EC, 2016, RECENT RESULTS CANC, V207, P39, DOI 10.1007/978-3-319-42118-6_3; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Mckew JC, 2008, J MED CHEM, V51, P3388, DOI 10.1021/jm701467e; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Okada S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080889; Okkenhaug K, 2016, CANCER DISCOV, V6, P1090, DOI 10.1158/2159-8290.CD-16-0716; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; Ricoult SJH, 2016, ONCOGENE, V35, P1250, DOI 10.1038/onc.2015.179; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Sonnweber T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113285; St John ER, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0845-2; Tarrado-Castellarnau M, 2016, ONCOTARGET, V7, P62726, DOI 10.18632/oncotarget.10911; Tomoo T, 2014, J MED CHEM, V57, P7244, DOI 10.1021/jm500494y; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wolfer AM, 2015, ANAL CHEM, V87, P11721, DOI 10.1021/acs.analchem.5b02794; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	65	49	50	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1596	+		10.1016/j.cell.2020.05.053	http://dx.doi.org/10.1016/j.cell.2020.05.053			43	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32559461	Green Published, hybrid			2022-12-28	WOS:000543822100016
J	Kurnsteiner, P; Wilms, MB; Weisheit, A; Gault, B; Jagle, EA; Raabe, D				Kuernsteiner, Philipp; Wilms, Markus Benjamin; Weisheit, Andreas; Gault, Baptiste; Jaegle, Eric Aime; Raabe, Dierk			High-strength Damascus steel by additive manufacturing	NATURE			English	Article							H13 TOOL STEEL; MECHANICAL-PROPERTIES; MICROSTRUCTURAL EVOLUTION; HEAT-TREATMENT; LASER; BEHAVIOR; PRECIPITATION; DEPOSITION; NANOPRECIPITATION	Laser additive manufacturing is attractive for the production of complex, three-dimensional parts from metallic powder using a computer-aided design model(1-3). The approach enables the digital control of the processing parameters and thus the resulting alloy's microstructure, for example, by using high cooling rates and cyclic re-heating(4-10). We recently showed that this cyclic re-heating, the so-called intrinsic heat treatment, can trigger nickel-aluminium precipitation in an iron-nickel-aluminium alloy in situ during laser additive manufacturing(9). Here we report a Fe19Ni5Ti (weight per cent) steel tailor-designed for laser additive manufacturing. This steel is hardened in situ by nickel-titanium nanoprecipitation, and martensite is also formed in situ, starting at a readily accessible temperature of 200 degrees Celsius. Local control of both the nanoprecipitation and the martensitic transformation during the fabrication leads to complex microstructure hierarchies across multiple length scales, from approximately 100-micrometre-thick layers down to nanoscale precipitates. Inspired by ancient Damascus steels(11-14)-which have hard and soft layers, originally introduced via the folding and forging techniques of skilled blacksmiths-we produced a material consisting of alternating soft and hard layers. Our material has a tensile strength of 1,300 megapascals and 10 per cent elongation, showing superior mechanical properties to those of ancient Damascus steel(12). The principles of in situ precipitation strengthening and local microstructure control used here can be applied to a wide range of precipitation-hardened alloys and different additive manufacturing processes.	[Kuernsteiner, Philipp; Gault, Baptiste; Jaegle, Eric Aime; Raabe, Dierk] Max Planck Inst Eisenforsch GmbH, Dept Microstruct Phys & Alloy Design, Dusseldorf, Germany; [Wilms, Markus Benjamin; Weisheit, Andreas] Fraunhofer Inst Laser Technol ILT, Aachen, Germany; [Gault, Baptiste] Imperial Coll London, Royal Sch Mines, Dept Mat, London, England; [Jaegle, Eric Aime] Univ Bundeswehr Munchen, Inst Mat Sci, Neubiberg, Germany	Max Planck Society; Fraunhofer Gesellschaft; Imperial College London; Bundeswehr University Munich	Kurnsteiner, P (corresponding author), Max Planck Inst Eisenforsch GmbH, Dept Microstruct Phys & Alloy Design, Dusseldorf, Germany.	p.kuernsteiner@mpie.de	Kürnsteiner, Philipp/K-9202-2017	Kürnsteiner, Philipp/0000-0002-3351-3545; Wilms, Markus B./0000-0002-6072-572X; Gault, Baptiste/0000-0002-4934-0458				Bajaj P, 2020, MAT SCI ENG A-STRUCT, V772, DOI 10.1016/j.msea.2019.138633; Becker TH, 2016, RAPID PROTOTYPING J, V22, P487, DOI 10.1108/RPJ-08-2014-0096; Bodziak S, 2019, MATER CHARACT, V151, P73, DOI 10.1016/j.matchar.2019.02.033; Casati R, 2016, J MATER SCI TECHNOL, V32, P738, DOI 10.1016/j.jmst.2016.06.016; Casati R, 2016, METALS-BASEL, V6, DOI 10.3390/met6090218; CERNY M, 2013, ACTA UNIV SIL MEND B, V61, P25; Costa L, 2005, ACTA MATER, V53, P3987, DOI 10.1016/j.actamat.2005.05.003; Cottam R, 2014, J MATER RES, V29, P1978, DOI 10.1557/jmr.2014.190; Gu DD, 2012, INT MATER REV, V57, P133, DOI 10.1179/1743280411Y.0000000014; Haubrich J, 2019, ACTA MATER, V167, P136, DOI 10.1016/j.actamat.2019.01.039; Hellman OC, 2000, MICROSC MICROANAL, V6, P437, DOI 10.1007/s100050010051; Herzog D, 2016, ACTA MATER, V117, P371, DOI 10.1016/j.actamat.2016.07.019; Jaegle EA, 2017, MATERIALS, V10, DOI 10.3390/ma10010008; Kaspar R, 2001, MATERIALPRUFUNG, V43, P18; Kempen K, 2011, PHYSCS PROC, V12, P255, DOI 10.1016/j.phpro.2011.03.033; Kim H, 2017, MATERIALS, V10, DOI 10.3390/ma10111283; Krakhmalev P, 2015, MATER DESIGN, V87, P380, DOI 10.1016/j.matdes.2015.08.045; Kurnsteiner P, 2020, ADDIT MANUF, V32, DOI 10.1016/j.addma.2019.100910; Kurnsteiner P, 2017, ACTA MATER, V129, P52, DOI 10.1016/j.actamat.2017.02.069; Larson D. J., 2013, LOCAL ELECT ATOM PRO; Lefebvre W, 2007, SURF INTERFACE ANAL, V39, P206, DOI 10.1002/sia.2516; LUCAS GE, 1986, FUSION TECHNOL, V10, P728, DOI 10.13182/FST86-A24827; Marquis EA, 2008, MICROSC MICROANAL, V14, P561, DOI 10.1017/S1431927608080793; Mazumder J, 1997, JOM-J MIN MET MAT S, V49, P55, DOI 10.1007/BF02914687; Mintach R., 2012, MATER ENG, V19, P22; Pereloma EV, 2009, METALL MATER TRANS A, V40A, P3069, DOI 10.1007/s11661-009-9993-z; Pereloma EV, 2004, ACTA MATER, V52, P5589, DOI 10.1016/j.actamat.2004.08.018; PETERSON DT, 1990, MATER CHARACT, V24, P355, DOI 10.1016/1044-5803(90)90042-I; Sames WJ, 2016, INT MATER REV, V61, P315, DOI 10.1080/09506608.2015.1116649; Schill R., 2000, 13 EUR C FRACT; SHA W, 1993, METALL TRANS A, V24, P1251, DOI 10.1007/BF02668193; Tan CL, 2017, MATER DESIGN, V134, P23, DOI 10.1016/j.matdes.2017.08.026; Verhoeven JD, 2002, STEEL RES, V73, P356, DOI 10.1002/srin.200200221; Vurpillot F, 2000, APPL PHYS LETT, V76, P3127, DOI 10.1063/1.126545; Xu W, 2017, ACTA MATER, V125, P390, DOI 10.1016/j.actamat.2016.12.027; Zheng B, 2008, METALL MATER TRANS A, V39A, P2228, DOI 10.1007/s11661-008-9557-7	36	121	129	65	307	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					515	+		10.1038/s41586-020-2409-3	http://dx.doi.org/10.1038/s41586-020-2409-3			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OL0DJ	32581379				2022-12-28	WOS:000585013200001
J	Lomivorotov, V; Kornilov, I; Boboshko, V; Shmyrev, V; Bondarenko, I; Soynov, I; Voytov, A; Polyanskih, S; Strunin, O; Bogachev-Prokophiev, A; Landoni, G; Neto, CN; Nicolau, GO; Izquierdo, LS; Nascimento, VN; Wen, Z; Hu, RJ; Zhang, HB; Bazylev, V; Evdokimov, M; Sulejmanov, S; Chernogrivov, A; Ponomarev, D				Lomivorotov, Vladimir; Kornilov, Igor; Boboshko, Vladimir; Shmyrev, Vladimir; Bondarenko, Ilya; Soynov, Ilya; Voytov, Alexey; Polyanskih, Stanislav; Strunin, Oleg; Bogachev-Prokophiev, Alexander; Landoni, Giovanni; Nigro Neto, Caetano; Nicolau, Gretel Oliveira; Izquierdo, Leonardo Saurith; Nascimento, Vinicius Nogueira; Wen, Zhang; Hu Renjie; Zhang Haibo; Bazylev, Vladlen; Evdokimov, Mikhail; Sulejmanov, Shahrijar; Chernogrivov, Aleksei; Ponomarev, Dmitry			Effect of Intraoperative Dexamethasone on Major Complications and Mortality Among Infants Undergoing Cardiac Surgery: The DECISION Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIGH-DOSE METHYLPREDNISOLONE; CARDIOPULMONARY BYPASS; HEART-SURGERY; CHILDREN; PLACEBO; PROTEIN; RISK	Key PointsQuestionWhat is the effect of dexamethasone on complications and mortality in infants undergoing cardiac surgery? FindingsIn this randomized clinical trial that involved 394 infants, intraoperative administration of dexamethasone 1 mg/kg, compared with placebo, did not significantly reduce the primary composite end point of death, nonfatal myocardial infarction, need for extracorporeal membrane oxygenation, cardiopulmonary resuscitation, acute kidney injury, prolonged mechanical ventilation, or neurological complications (38.1% vs 45.5%, respectively; hazard ratio, 0.82). MeaningAmong patients younger than 12 months undergoing cardiac surgery with cardiopulmonary bypass, intraoperative dexamethasone did not significantly reduce major complications and mortality compared with placebo. ImportanceCorticosteroids are widely used in pediatric cardiac surgery to blunt systemic inflammatory response and to reduce complications; nevertheless, their clinical efficacy is uncertain. ObjectiveTo determine whether intraoperative administration of dexamethasone is more effective than placebo for reducing major complications and mortality during pediatric cardiac surgery. Design, Setting, and ParticipantsThe Intraoperative Dexamethasone in Pediatric Cardiac Surgery was an investigator-initiated, double-blind, multicenter randomized trial that involved 4 centers in China, Brazil, and Russia. A total of 394 infants younger than 12 months, undergoing cardiac surgery with cardiopulmonary bypass were enrolled from December 2015 to October 2018, with follow-up completed in November 2018. InterventionsThe dexamethasone group (n=194) received 1 mg/kg of dexamethasone; the control group (n=200) received an equivolume of 0.9% sodium chloride intravenously after anesthesia induction. Main Outcomes and MeasuresThe primary end point was a composite of death, nonfatal myocardial infarction, need for extracorporeal membrane oxygenation, need for cardiopulmonary resuscitation, acute kidney injury, prolonged mechanical ventilation, or neurological complications within 30 days after surgery. There were 17 secondary end points, including the individual components of the primary end point, and duration of mechanical ventilation, inotropic index, intensive care unit stay, readmission to intensive care unit, and length of hospitalization. ResultsAll of the 394 patients randomized (median age, 6 months; 47.2% boys) completed the trial. The primary end point occurred in 74 patients (38.1%) in the dexamethasone group vs 91 patients (45.5%) in the control group (absolute risk reduction, 7.4%; 95% CI, -0.8% to 15.3%; hazard ratio, 0.82; 95% CI, 0.60 to 1.10; P=.20). Of the 17 prespecified secondary end points, none showed a statistically significant difference between groups. Infections occurred in 4 patients (2.0%) in the dexamethasone group vs 3 patients (1.5%) in the control group. Conclusions and RelevanceAmong infants younger than 12 months undergoing cardiac surgery with cardiopulmonary bypass, intraoperative administration of dexamethasone, compared with placebo, did not significantly reduce major complications and mortality at 30 days. However, the study may have been underpowered to detect a clinically important difference. Trial RegistrationClinicalTrials.gov Identifier: NCT02615262 This randomized trial compares the effect of intravenous dexamethasone vs saline on death, need for ECMO or CPR, and other complications among infants younger than 12 months undergoing cardiac surgery with cardiopulmonary bypass.	[Lomivorotov, Vladimir; Kornilov, Igor; Boboshko, Vladimir; Shmyrev, Vladimir; Bondarenko, Ilya; Soynov, Ilya; Voytov, Alexey; Polyanskih, Stanislav; Strunin, Oleg; Bogachev-Prokophiev, Alexander; Ponomarev, Dmitry] EN Meshalkin Natl Med Res Ctr, 15 Rechkunovskaya St, Novosibirsk 630055, Russia; [Lomivorotov, Vladimir] Novosibirsk State Univ, Novosibirsk, Russia; [Landoni, Giovanni] IRCCS San Raffaele Sci Inst, Milan, Italy; [Landoni, Giovanni] Univ Vita Salute San Raffaele, Milan, Italy; [Nigro Neto, Caetano; Nicolau, Gretel Oliveira; Izquierdo, Leonardo Saurith; Nascimento, Vinicius Nogueira] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Wen, Zhang; Hu Renjie; Zhang Haibo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai, Peoples R China; [Bazylev, Vladlen; Evdokimov, Mikhail; Sulejmanov, Shahrijar; Chernogrivov, Aleksei] Fed Ctr Cardiovasc Surg, Penza, Russia	Meshalkin National Medical Research Center; Novosibirsk State University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Instituto Dante Pazzanese de Cardiologia; Shanghai Jiao Tong University	Ponomarev, D (corresponding author), EN Meshalkin Natl Med Res Ctr, 15 Rechkunovskaya St, Novosibirsk 630055, Russia.	d_ponomarev@meshalkin.ru	Neto, Caetano Nigro/M-4649-2016; Kornilov, Igor/ABH-4637-2020	Neto, Caetano Nigro/0000-0001-8134-3440; Kornilov, Igor/0000-0002-0599-6076; LANDONI, Giovanni/0000-0002-8594-5980; Strunin, Oleg/0000-0003-2537-954X; Zhang, Wen/0000-0001-8726-1286				Agarwal HS, 2014, J THORAC CARDIOV SUR, V148, P609, DOI 10.1016/j.jtcvs.2013.10.031; Bocsi J, 2011, CYTOM PART B-CLIN CY, V80B, P212, DOI 10.1002/cyto.b.20587; Broglio K, 2018, JAMA-J AM MED ASSOC, V319, P2223, DOI 10.1001/jama.2018.6360; Bronicki RA, 2000, ANN THORAC SURG, V69, P1490, DOI 10.1016/S0003-4975(00)01082-1; Brudney CS, 2005, J CARDIOTHOR VASC AN, V19, P188, DOI 10.1053/j.jvca.2005.01.029; Dieleman JM, 2012, JAMA-J AM MED ASSOC, V308, P1761, DOI 10.1001/jama.2012.14144; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Graham EM, 2019, J AM COLL CARDIOL, V74, P659, DOI 10.1016/j.jacc.2019.05.060; Graham EM, 2011, J THORAC CARDIOV SUR, V142, P1523, DOI 10.1016/j.jtcvs.2011.04.019; Heying R, 2012, ANN THORAC SURG, V93, P869, DOI 10.1016/j.athoracsur.2011.11.059; Hickey PA, 2016, ANN THORAC SURG, V102, P1375, DOI 10.1016/j.athoracsur.2016.03.019; Hill KD, 2017, CIRCULATION, V136; Hirleman E, 2008, PERFUSION-UK, V23, P311, DOI 10.1177/0267659109105079; Jacobs ML, 2017, ANN THORAC SURG, V104, P731, DOI 10.1016/j.athoracsur.2017.07.001; Jafar N, 2016, AM J MED SCI, V351, P201, DOI 10.1016/j.amjms.2015.11.011; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Keski-Nisula J, 2013, ANN THORAC SURG, V95, P2126, DOI 10.1016/j.athoracsur.2013.02.013; Kunst G, 2019, BRIT J ANAESTH, V123, P713, DOI 10.1016/j.bja.2019.09.012; Lindberg L, 2003, BRIT J ANAESTH, V90, P728, DOI 10.1093/bja/aeg125; Neuhof Christiane, 2003, Pediatr Crit Care Med, V4, P299, DOI 10.1097/01.PCC.0000074264.13983.99; Pasquali SK, 2012, PEDIATRICS, V129, pE385, DOI 10.1542/peds.2011-2034; Pesonen E, 2016, ACTA ANAESTH SCAND, V60, P1386, DOI 10.1111/aas.12785; Pesonen E, 2017, J CARDIOTHOR VASC AN, V31, P1952, DOI 10.1053/j.jvca.2017.05.013; Ponomarev D, 2018, CONTEMP CLIN TRIALS, V72, P16, DOI 10.1016/j.cct.2018.07.005; Roeleveld PP, 2018, WORLD J PEDIATR CONG, V9, P10, DOI 10.1177/2150135117731725; Schroeder VA, 2003, CIRCULATION, V107, P2823, DOI 10.1161/01.CIR.0000070955.55636.25; Scrascia G, 2014, PEDIATR CRIT CARE ME, V15, P435, DOI 10.1097/PCC.0000000000000128; Soler YA, 2013, PEDIATR CRIT CARE ME, V14, pE189, DOI 10.1097/PCC.0b013e3182745675; Stiller B, 2001, INTENS CARE MED, V27, P193, DOI 10.1007/s001340000704; Suominen PK, 2017, ANN THORAC SURG, V104, P1378, DOI 10.1016/j.athoracsur.2017.01.111; Tolles J, 2016, JAMA-J AM MED ASSOC, V315, P1046, DOI 10.1001/jama.2016.1825; Whitlock RP, 2015, LANCET, V386, P1243, DOI 10.1016/S0140-6736(15)00273-1	32	20	21	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2485	2492		10.1001/jama.2020.8133	http://dx.doi.org/10.1001/jama.2020.8133			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32573670	Bronze, Green Published			2022-12-28	WOS:000590149400020
J	Mahase, E				Mahase, Elisabeth			Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273:24, DOI 10.1056/NEJMOA2021436, 10.1101/2020.06.22.20137273, 10.1101/2020.06.22.20137273v1, DOI 10.1101/2020.07.15.20151852]; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1422	2	38	38	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2020	369								m2512	10.1136/bmj.m2512	http://dx.doi.org/10.1136/bmj.m2512			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1VB	32576548	Bronze			2022-12-28	WOS:000548573500005
J	Wise, J				Wise, Jacqui			Economic recovery plan should be linked with achieving net zero, says citizens' assembly	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Climate Assembly UK, 2020, INT BRIEF COV 19 REC	1	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2505	10.1136/bmj.m2505	http://dx.doi.org/10.1136/bmj.m2505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571769	Bronze			2022-12-28	WOS:000548535700007
J	Mccaw, ZR; Tian, L; Vassy, JL; Ritchie, CS; Lee, CC; Kim, DH; Wei, LJ				McCaw, Zachary R.; Tian, Lu; Vassy, Jason L.; Ritchie, Christine Seel; Lee, Chien-Chang; Kim, Dae Hyun; Wei, Lee-Jen			How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19	ANNALS OF INTERNAL MEDICINE			English	Article							TIME	Clinical trials of treatments for coronavirus disease 2019 (COVID-19) draw intense public attention. More than ever, valid, transparent, and intuitive summaries of the treatment effects, including efficacy and harm, are needed. In recently published and ongoing randomized comparative trials evaluating treatments for COVID-19, time to a positive outcome, such as recovery or improvement, has repeatedly been used as either the primary or key secondary end point. Because patients may die before recovery or improvement, data analysis of this end point faces a competing risk problem. Commonly used survival analysis techniques, such as the Kaplan-Meier method, often are not appropriate for such situations. Moreover, almost all trials have quantified treatment effects by using the hazard ratio, which is difficult to interpret for a positive event, especially in the presence of competing risks. Using 2 recent trials evaluating treatments (remdesivir and convalescent plasma) for COVID-19 as examples, a valid, well-established yet underused procedure is presented for estimating the cumulative recovery or improvement rate curve across the study period. Furthermore, an intuitive and clinically interpretable summary of treatment efficacy based on this curve is also proposed. Clinical investigators are encouraged to consider applying these methods for quantifying treatment effects in future studies of COVID-19.	[Tian, Lu] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94943 USA; [Vassy, Jason L.] VA Boston Healthcare Syst, Boston, MA USA; [Vassy, Jason L.; Kim, Dae Hyun] Harvard Med Sch, Boston, MA 02115 USA; [Ritchie, Christine Seel] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ritchie, Christine Seel] Mongan Inst, Boston, MA USA; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei 100, Taiwan; [Wei, Lee-Jen] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Wei, Lee-Jen] Harvard Univ, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Taiwan University; National Taiwan University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Wei, LJ (corresponding author), Harvard Univ, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA.	wei@hsph.harvard.edu	Wei, Lee-Jen/CAI-0175-2022; Lee, Chien-Chang/HHM-5986-2022; McCaw, Zachary/GPW-8740-2022	Kim, Dae Hyun/0000-0001-7290-6838; LEE, CHIEN-CHANG/0000-0002-1243-2463; tian, lu/0000-0002-5893-0169; McCaw, Zachary/0000-0002-2006-9828	NHGRI NIH HHS [R35 HG010706] Funding Source: Medline; NIA NIH HHS [R21 AG060227] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2020, HOM PAG; Austin PC, 2017, STAT MED, V36, P1203, DOI 10.1002/sim.7215; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Gray B., CMPRSK SUBDISTRIBUTI; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4; Kim DH, 2017, JAMA CARDIOL, V2, P1179, DOI 10.1001/jamacardio.2017.2922; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Li L, 2020, JAMA-J AM MED ASSOC, V324, P519, DOI 10.1001/jama.2020.13216; McCaw Z., 2020, ZRMACC CICS; McCaw ZR, 2019, AM J MED, V132, P13, DOI 10.1016/j.amjmed.2018.07.026; Pak K, 2017, JAMA ONCOL, V3, P1692, DOI 10.1001/jamaoncol.2017.2797; Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849; Therneau TM., SURVIVAL SURVIVAL AN; Tian L, SURV2SAMPLECOMP INFE; Tian L, 2014, BIOSTATISTICS, V15, P222, DOI 10.1093/biostatistics/kxt050; Uno H, 2014, J CLIN ONCOL, V32, P2380, DOI 10.1200/JCO.2014.55.2208; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Wolkewitz M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5060; Zhao LH, 2018, JAMA CARDIOL, V3, P357, DOI 10.1001/jamacardio.2018.0127	24	26	26	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2020	173	8					632	+		10.7326/M20-4044	http://dx.doi.org/10.7326/M20-4044			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OH7WZ	32634024	Green Published			2022-12-28	WOS:000582805500017
J	del Amo, J; Polo, R; Moreno, S; Diaz, A; Martinez, E; Arribas, JR; Jarrin, I; Hernan, MA				del Amo, Julia; Polo, Rosa; Moreno, Santiago; Diaz, Asuncion; Martinez, Esteban; Ramon Arribas, Jose; Jarrin, Inma; Hernan, Miguel A.		Spanish HIV COVID-19 Collaboration	Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTION; AGE	Background: The incidence and severity of coronavirus disease 2019 (COVID-19) among HIV-positive persons receiving anti-retroviral therapy (ART) have not been characterized in large populations. Objective: To describe the incidence and severity of COVID-19 by nucleos(t)ide reverse transcriptase inhibitor (NRTI) use among HIV-positive persons receiving ART. Design: Cohort study. Setting: HIV clinics in 60 Spanish hospitals between 1 February and 15 April 2020. Participants: 77 590 HIV-positive persons receiving ART. Measurements: Estimated risks (cumulative incidences) per 10 000 persons and 95% CIs for polymerase chain reaction-confirmed COVID-19 diagnosis, hospitalization, intensive care unit (ICU) admission, and death. Risk and 95% CIs for COVID-19 diagnosis and hospital admission by use of the NRTIs tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC), tenofovir alafen-amide (TAF)/FTC, abacavir (ABC)/lamivudine (3TC), and others were estimated through Poisson regression models. Results: Of 77 590 HIV-positive persons receiving ART, 236 were diagnosed with COVID-19, 151 were hospitalized, 15 were admitted to the ICU, and 20 died. The risks for COVID-19 diag-nosis and hospitalization were greater in men and persons older than 70 years. The risk for COVID-19 hospitalization was 20.3 (95% CI, 15.2 to 26.7) among patients receiving TAF/FTC, 10.5 (CI, 5.6 to 17.9) among those receiving TDF/FTC, 23.4 (CI, 17.2 to 31.1) among those receiving ABC/3TC, and 20.0 (CI, 14.2 to 27.3) for those receiving other regimens. The corresponding risks for COVID-19 diagnosis were 39.1 (CI, 31.8 to 47.6), 16.9 (CI, 10.5 to 25.9), 28.3 (CI, 21.5 to 36.7), and 29.7 (CI, 22.6 to 38.4), respectively. No patient receiving TDF/FTC was admitted to the ICU or died. Limitation: Residual confounding by comorbid conditions cannot be completely excluded. Conclusion: HIV-positive patients receiving TDF/FTC have a lower risk for COVID-19 and related hospitalization than those receiving other therapies. These findings warrant further investigation in HIV preexposure prophylaxis studies and randomized trials in persons without HIV.	[del Amo, Julia; Polo, Rosa] Minist Hlth, Natl Plan AIDS, Paseo Prado 19, Madrid 28004, Spain; [Moreno, Santiago] Univ Hosp Ramon Y Cajal, M-607,Km 9,100, Madrid 28034, Spain; [Diaz, Asuncion; Jarrin, Inma] Inst Hlth Carlos III, Natl Ctr Epidemiol, Av Monforte de Lemos 5, Madrid 28029, Spain; [Martinez, Esteban] Univ Hosp Clin, Carrer Villarroel 170, Barcelona 08036, Spain; [Ramon Arribas, Jose] Univ Hosp La Paz, IdiPAZ, Paseo Castellana 261, Madrid 28046, Spain; [Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard Mit Div Hlth Sci & Technol, 677 Huntington Ave, Boston, MA 02115 USA	Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	del Amo, J (corresponding author), Minist Hlth, Natl Plan AIDS, Paseo Prado 19, Madrid 28004, Spain.	jamo@mscbs.es; ijarrin@isciii.es	Pérez, Maria Ángeles Muñoz/ABH-4734-2020; Gómez, Javier/AAX-6677-2020; Portillo, Alexy Inciarte/AAH-1727-2022; Portillo, Alexy Inciarte/ACQ-2720-2022; Rull, Anna/A-9438-2017; Montejano, Rocio/H-5344-2017; Diaz, Asuncion/Q-6016-2017; Oteo, Jose A./AAB-3134-2020; Montero, Marta/H-7555-2017; Arribas, Jose/A-1595-2015; Lopez.Cortes, Luis Fernando/S-5625-2018; Moreno, Santiago/T-2653-2017	Portillo, Alexy Inciarte/0000-0003-1896-3457; Portillo, Alexy Inciarte/0000-0003-1896-3457; Rull, Anna/0000-0002-8907-7754; Montejano, Rocio/0000-0002-3446-0545; Diaz, Asuncion/0000-0002-8309-4270; Oteo, Jose A./0000-0001-7080-6542; JARRIN, INMA/0000-0002-7485-2252; Garcia Perez, Jorge N./0000-0003-4986-6094; Sanmarti Vilamala, Montserrat/0000-0002-0432-7073; de Lagarde, Maria/0000-0002-7712-6977; Curran, Adrian/0000-0002-1263-0814; De Lazzari, Elisa/0000-0003-2614-6545; Montero, Marta/0000-0002-3432-5394; /0000-0001-7808-5479; , IIS Galicia Sur/0000-0003-3812-7413; Espinosa, Nuria/0000-0003-2249-2352; del Arco Jimenez, Alfonso/0000-0002-5432-4591; Diaz-Brito, Vicens/0000-0002-9734-9334; Cabello-Ubeda, Alfonso/0000-0001-8429-8358; Mican, Rafael/0000-0002-6626-4266; Garcia de Lomas Guerrero, Jose Maria/0000-0001-8160-8488; Arribas, Jose/0000-0002-7410-9450; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Iniesta, Carlos/0000-0002-0928-2679; Suarez-Garcia, Ines/0000-0002-7016-716X; Martinez Sanchez, Elena Vanessa/0000-0003-1620-7113; Moreno, Santiago/0000-0002-2843-1094; Perez-Molina, Jose Antonio/0000-0001-8735-4124; Velasco Arribas, Maria/0000-0001-6554-2095	Instituto de Salud Carlos III [COV20/01112, RD16/0002]; National Institutes of Health [R37 AI102634]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By grants COV20/01112 and RD16/0002 from Instituto de Salud Carlos III and grant R37 AI102634 from the National Institutes of Health.	Alejos B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221598; Alejos B, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004727; Alvarez S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230339; Blanco JL, 2020, LANCET HIV, V7, pE314, DOI 10.1016/S2352-3018(20)30111-9; Borobia AM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061733; Chen XP, 2004, CLIN INFECT DIS, V38, P1030, DOI 10.1086/386340; Chien MC, 2020, J PROTEOME RES, V19, P4690, DOI [10.1021/acs.jproteome.0c00392, 10.1101/2020.03.18.997585]; Cottrell ML, 2017, J ANTIMICROB CHEMOTH, V72, P1731, DOI 10.1093/jac/dkx064; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Di Mascio M, 2009, ANTIMICROB AGENTS CH, V53, P4086, DOI 10.1128/AAC.00419-09; Elfiky AA, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117592; Elfiky AA, 2020, LIFE SCI, V248, DOI 10.1016/j.lfs.2020.117477; European Centre for Disease Prevention and Control, HIV AIDS SURVEILLANC; European Medicines Agency Committee for Medicinal Products for Human Use, 2020, ASSESSMENT REPORT VE; Government of Spain Ministry of Health, 2020, HOSPITAL SURVEY OF P; Government of Spain Ministry of Health, 2020, COVID 19 SITUATION I; Government of Spain Ministry of Health Alerts and Emergencies Coordination Center, 2019, SCIENTIFIC AND TECHN; Government of Spain National Center of Epidemiology-Institute of Health Carlos III/National AIDS Plan-Subdirectorate General Directorate of Public Health Quality and Innovation, 2016, ESTIMATES FOR HIV CO; Gross AM, 2016, MOL CELL, V62, P157, DOI 10.1016/j.molcel.2016.03.019; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo W., 2020, SSRN ELECT J, DOI 10.2139/ssrn.3550029; Harter G, 2020, INFECTION, V48, P681, DOI 10.1007/s15010-020-01438-z; Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277; Jockusch S., 2020, TRIPHOSPHATES 2 COMP, DOI 10.1101/2020.04.03.022939; Ju J., 2020, NUCLEOTIDE ANALOGUES, DOI 10.1101/2020.01.30.927574; Kostecka P, 2012, INT IMMUNOPHARMACOL, V12, P342, DOI 10.1016/j.intimp.2011.12.005; Lipsitch M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003846; Melchjorsen J, 2011, JAIDS-J ACQ IMM DEF, V57, P265, DOI 10.1097/QAI.0b013e3182185276; Park D, 2020, MBIO, V11, DOI 10.1128/mBio.03328-19; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Peters HL, 2015, CURR MED CHEM, V22, P3910, DOI 10.2174/0929867322666150818103624; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Sanchez-Conde M, 2019, EPIGENOMICS-UK, V11, P501, DOI 10.2217/epi-2018-0130; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; Twigg Homer L. III, 2010, HIV Therapy, V4, P247, DOI [10.2217/hiv.10.5, 10.2217/HIV.10.5]; Wang WJ, 2020, CELL MOL IMMUNOL, V17, P650, DOI 10.1038/s41423-020-0447-2; World Health Organization, CORONAVIRUS DISEASE; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang JZY, INT J INFECT DIS; Zidek Z, 2003, EUR J PHARMACOL, V475, P149, DOI 10.1016/S0014-2999(03)02110-1; Zidek Z, 2001, ANTIMICROB AGENTS CH, V45, P3381, DOI 10.1128/AAC.45.12.3381-3386.2001	42	175	176	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2020	173	7					536	+		10.7326/M20-3689	http://dx.doi.org/10.7326/M20-3689			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX4GS	32589451	Green Published			2022-12-28	WOS:000575671400009
J	Lee, HS; Beilhartz, GL; Kucharska, I; Raman, S; Cui, H; Lam, MHY; Liang, HZ; Rubinstein, JL; Schramek, D; Julien, JP; Melnyk, RA; Taipale, M				Lee, Hunsang; Beilhartz, Greg L.; Kucharska, Iga; Raman, Swetha; Cui, Hong; Lam, Mandy Hiu Yi; Liang, Huazhu; Rubinstein, John L.; Schramek, Daniel; Julien, Jean-Philippe; Melnyk, Roman A.; Taipale, Mikko			Recognition of Semaphorin Proteins by P. sordellii Lethal Toxin Reveals Principles of Receptor Specificity in Clostridial Toxins	CELL			English	Article							LAMINA-RESTRICTED PROJECTION; CRYO-EM; STRUCTURAL BASIS; FRIZZLED PROTEINS; BINDING; TRANSLOCATION; PLEXIN-A4; VISUALIZATION; ANGIOGENESIS; IDENTIFY	Pathogenic clostridial species secrete potent toxins that induce severe host tissue damage. Paeniclostridium sordellii lethal toxin (TcsL) causes an almost invariably lethal toxic shock syndrome associated with gynecological infections. TcsL is 87% similar to C. difficile TcdB, which enters host cells via Frizzled receptors in colon epithelium. However, P. sordellii infections target vascular endothelium, suggesting that TcsL exploits another receptor. Here, using CRISPR/Cas9 screening, we establish semaphorins SEMA6A and SEMA6B as TcsL receptors. We demonstrate that recombinant SEMA6A can protect mice from TcsL-induced edema. A 3.3 angstrom cryo-EM structure shows that TcsL binds SEMA6A with the same region that in TcdB binds structurally unrelated Frizzled. Remarkably, 15 mutations in this evolutionarily divergent surface are sufficient to switch binding specificity of TcsL to that of TcdB. Our findings establish semaphorins as physiologically relevant receptors for TcsL and reveal the molecular basis for the difference in tissue targeting and disease pathogenesis between highly related toxins.	[Lee, Hunsang; Lam, Mandy Hiu Yi; Taipale, Mikko] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Beilhartz, Greg L.; Kucharska, Iga; Raman, Swetha; Cui, Hong; Liang, Huazhu; Rubinstein, John L.; Julien, Jean-Philippe; Melnyk, Roman A.] Hosp Sick Children Res Inst, Program Mol Med, Toronto, ON M5G 0A4, Canada; [Liang, Huazhu; Rubinstein, John L.; Julien, Jean-Philippe; Melnyk, Roman A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Schramek, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Schramek, Daniel; Taipale, Mikko] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Julien, Jean-Philippe; Taipale, Mikko] Canadian Inst Adv Res CIFAR, Mol Architecture Life Program, Toronto, ON M5G 1M1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Canadian Institute for Advanced Research (CIFAR)	Taipale, M (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.; Julien, JP; Melnyk, RA (corresponding author), Hosp Sick Children Res Inst, Program Mol Med, Toronto, ON M5G 0A4, Canada.; Julien, JP; Melnyk, RA (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.; Taipale, M (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.; Julien, JP (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.; Julien, JP; Taipale, M (corresponding author), Canadian Inst Adv Res CIFAR, Mol Architecture Life Program, Toronto, ON M5G 1M1, Canada.	jean-philippe.julien@sickkids.ca; roman.melnyk@sickkids.ca; mikko.taipale@utoronto.ca	Lee, Hunsang/ABC-5697-2020; Schramek, Daniel/AAL-1470-2020	Schramek, Daniel/0000-0001-9977-2104; Taipale, Mikko/0000-0003-3811-1761	University of Toronto's Medicine by Design initiative (MbD New Ideas Award); University of Toronto's Medicine by Design initiative (MbD Postdoctoral fellowship); Canada First Research Excellence Fund (CFREF); Krembil Award; CIHR [RN292258 -366017]; NSERC [RGPIN-2017-06817]; CIFAR Azrieli Global Scholar program; Ontario Early Researcher Awards program; Canada Research Chairs program; Canada Foundation for Innovation; Ontario Research Fund	University of Toronto's Medicine by Design initiative (MbD New Ideas Award); University of Toronto's Medicine by Design initiative (MbD Postdoctoral fellowship); Canada First Research Excellence Fund (CFREF); Krembil Award; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIFAR Azrieli Global Scholar program; Ontario Early Researcher Awards program; Canada Research Chairs program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund	The authors would like to thank Dr. Amy Tong, Mr. Christopher Mogg, Mr. Syed Haider, and Ms. Melissa Geng for their help with this project. We are grateful to Dr. Samir Benlekbir for help with cryo-EM data collection and for advice regarding specimen preparation. M.T. and H.L. were supported by the University of Toronto's Medicine by Design initiative (MbD New Ideas Award to M.T. and MbD Postdoctoral fellowship to H.L.). Medicine by Design receives funding from the Canada First Research Excellence Fund (CFREF). D.S. is supported by a Krembil Award. R.A.M. is supported by a CIHR Project Grant (RN292258 -366017) and an NSERC Discovery grant (RGPIN-2017-06817). This research was supported by the CIFAR Azrieli Global Scholar program (to J.-P.J. and M.T.), the Ontario Early Researcher Awards program (to J.-P.J. and M.T.), and the Canada Research Chairs program (J.L.R., J-P.J., and M.T.). Cryo-EM data were collected at the Toronto High Resolution High Throughput cryo-EM facility, supported by the Canada Foundation for Innovation and Ontario Research Fund.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKTORIES K, 1995, TRENDS CELL BIOL, V5, P441, DOI 10.1016/S0962-8924(00)89107-2; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Aldape MJ, 2016, ANAEROBE, V38, P103, DOI 10.1016/j.anaerobe.2016.01.004; Carter GP, 2011, INFECT IMMUN, V79, P1025, DOI 10.1128/IAI.00968-10; ChavesOlarte E, 1997, J CLIN INVEST, V100, P1734, DOI 10.1172/JCI119698; Chen P, 2019, NAT STRUCT MOL BIOL, V26, P712, DOI 10.1038/s41594-019-0268-0; Chen P, 2018, SCIENCE, V360, P664, DOI 10.1126/science.aar1999; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chong E, 2016, OBSTET GYNECOL, V127, P360, DOI 10.1097/AOG.0000000000001239; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; Dong D, 2019, NATURE, V573, P546, DOI 10.1038/s41586-019-1537-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer M, 2005, NEW ENGL J MED, V353, P2352, DOI 10.1056/NEJMoa051620; Geny B, 2007, AM J PATHOL, V170, P1003, DOI 10.2353/ajpath.2007.060583; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gupta P, 2017, J BIOL CHEM, V292, P17290, DOI 10.1074/jbc.M117.806687; Haklai-Topper L, 2010, EMBO J, V29, P2635, DOI 10.1038/emboj.2010.147; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Ho CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.023; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Jongbloets BC, 2014, DEVELOPMENT, V141, P3292, DOI 10.1242/dev.105544; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kigel B, 2011, BLOOD, V118, P4285, DOI 10.1182/blood-2011-03-341388; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Lyumkis D, 2019, J BIOL CHEM, V294, P5181, DOI 10.1074/jbc.REV118.005602; Marr CR, 2014, J STRUCT BIOL, V185, P42, DOI 10.1016/j.jsb.2013.11.002; Neufeld G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006718; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Orrell KE, 2017, CRIT REV BIOCHEM MOL, V52, P461, DOI 10.1080/10409238.2017.1325831; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Perez-Branguli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158686; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Raman S, 2019, P NATL ACAD SCI USA, V116, P6812, DOI 10.1073/pnas.1817246116; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; Schorch B, 2014, P NATL ACAD SCI USA, V111, P6431, DOI 10.1073/pnas.1323790111; Segarra M, 2012, BLOOD, V120, P4104, DOI 10.1182/blood-2012-02-410076; Simeon R, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000311; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Tao L, 2019, NAT MICROBIOL, V4, P1760, DOI 10.1038/s41564-019-0464-z; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; Terwilliger T.C., 2019, IMPROVEMENT CRYO EM; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Visser JJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08149; Wong AHM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01706-x; Worzfeld T, 2014, NAT REV DRUG DISCOV, V13, P603, DOI 10.1038/nrd4337; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Xu XM, 2000, J NEUROSCI, V20, P2638; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169; Zhang ZF, 2014, P NATL ACAD SCI USA, V111, P3721, DOI 10.1073/pnas.1400680111	61	15	17	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					345	+		10.1016/j.cell.2020.06.005	http://dx.doi.org/10.1016/j.cell.2020.06.005			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32589945	Green Published, Bronze			2022-12-28	WOS:000552745000008
J	Hashim, H; Worthington, J; Abrams, P; Young, G; Taylor, H; Noble, SM; Brookes, ST; Cotterill, N; Page, T; Swami, KS; Lane, JA				Hashim, Hashim; Worthington, Jo; Abrams, Paul; Young, Grace; Taylor, Hilary; Noble, Sian M.; Brookes, Sara T.; Cotterill, Nikki; Page, Tobias; Swami, K. Satchi; Lane, J. Athene		UNBLOCS Trial Grp	Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; COMPLICATIONS; BPH	Background Transurethral resection of the prostate (TURP) is the standard operation for benign prostatic obstruction. Thulium laser transurethral vaporesection of the prostate (ThuVARP) is a technique with suggested advantages over TURP, including reduced complications and hospital stay. We aimed to investigate TURP versus ThuVARP in men with lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruction. Methods In this randomised, blinded, parallel-group, pragmatic equivalence trial, men in seven UK hospitals with bothersome lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruction were randomly assigned (1:1) at the point of surgery to receive ThuVARP or TURP. Patients were masked until follow-up completion. Centres used their usual TURP procedure (monopolar or bipolar). All trial surgeons underwent training on the ThuVARP technique. Co-primary outcomes were maximum urinary flow rate (Qmax) and International Prostate Symptom Score (IPSS) at 12-months post-surgery. Equivalence was defined as a difference of 2.5 points or less for IPSS and 4 mL per s or less for Qmax. Analysis was done according to the intention-to-treat principle. The trial is registered with the ISRCTN Registry, ISRCTN00788389. Findings Between July 23, 2014, and Dec 30, 2016, 410 men were randomly assigned to ThuVARP or TURP, 205 per study group. TURP was superior for Qmax (mean 23.2 mL per s for TURP and 20.2 mL per s for ThuVARP; adjusted difference in means -3.12, 95% CI -5.79 to -0.45). Equivalence was shown for IPSS (mean 6.3 for TURP and 6.4 for ThuVARP; adjusted difference in means 0.28, -0.92 to 1.49). Mean hospital stay was 48 h in both study groups. 91 (45%) of 204 patients in the TURP group and 96 (47%) of 203 patients in the ThuVARP group had at least one complication. Interpretation TURP and ThuVARP were equivalent for urinary symptom improvement (IPSS) 12-months post-surgery, and TURP was superior for Qmax. Anticipated laser benefits for ThuVARP of reduced hospital stay and complications were not observed.	[Hashim, Hashim; Abrams, Paul; Cotterill, Nikki] North Bristol NHS Trust, Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England; [Worthington, Jo; Young, Grace; Taylor, Hilary; Noble, Sian M.; Brookes, Sara T.; Lane, J. Athene] Univ Bristol, Bristol Trials Ctr, Bristol Randomised Trials Collaborat, Bristol, Avon, England; [Page, Tobias] Newcastle Tyne Hosp NHS Fdn Trust, Freeman Hosp, Dept Urol, Newcastle Upon Tyne, Tyne & Wear, England; [Swami, K. Satchi] NHS Grampian, Aberdeen Royal Infirm, Urol Dept, Aberdeen, Scotland	North Bristol NHS Trust; Southmead Hospital; University of Bristol; Newcastle Freeman Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Aberdeen	Hashim, H (corresponding author), North Bristol NHS Trust, Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England.	h.hashim@gmail.com	Cotterill, Nikki/GZG-4518-2022	Cotterill, Nikki/0000-0001-6921-2712; Noble, Sian/0000-0002-8011-0722; Taylor, Hilary/0000-0002-7948-5535; page, toby/0000-0002-1961-1405	UK National Institute for Health Research Health Technology Assessment Programme	UK National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR))	UK National Institute for Health Research Health Technology Assessment Programme.	[Anonymous], 2017, PRAVILA REGULIROVANI; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Cornu JN, 2015, EUR UROL, V67, P1066, DOI 10.1016/j.eururo.2014.06.017; Deng Z, 2018, WORLD J UROL, V36, P1355, DOI 10.1007/s00345-018-2287-6; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Donovan JL, 1996, BRIT J UROL, V77, P554, DOI 10.1046/j.1464-410X.1996.93013.x; Frankel SJ, 1998, J CLIN EPIDEMIOL, V51, P677, DOI 10.1016/S0895-4356(98)00044-4; Gardener N, 2004, DEV PSYCHOMETRIC EVA; Gu CH, 2020, WORLD J UROL, V38, P907, DOI 10.1007/s00345-019-02852-1; Herrmann TRW, 2012, EUR UROL, V61, P783, DOI 10.1016/j.eururo.2012.01.010; HUNTER DJW, 1995, UROLOGY, V45, P962, DOI 10.1016/S0090-4295(99)80116-2; Karavitakis M, 2019, EUR UROL, V75, P788, DOI 10.1016/j.eururo.2019.01.046; Kelleher CJ, 1997, BRIT J OBSTET GYNAEC, V104, P1374, DOI 10.1111/j.1471-0528.1997.tb11006.x; Lan Y, 2018, LASER MED SCI, V33, P1411, DOI 10.1007/s10103-018-2539-0; Marra G, 2016, INT J UROL, V23, P22, DOI 10.1111/iju.12866; National Institute for Health and Care Excellence, 2010, LOW UR TRACT SYMPT M; National Institute for Health and Care Excellence, 2016, GREENLIGHT XPS TREAT; Rassweiler J, 2006, EUR UROL, V50, P969, DOI 10.1016/j.eururo.2005.12.042; Rosen RC, INT INDEX ERECTILE F; Schumi J, LOOKING GLASS UNDERS; Sharaf A, 2016, J UROLOGY, V195, pE515, DOI 10.1016/j.juro.2016.02.1775; Speakman M, 2015, BJU INT, V115, P508, DOI 10.1111/bju.12745; Szlauer R, 2009, EUR UROL, V55, P368, DOI 10.1016/j.eururo.2008.10.034; Worthington J, HLTH TECHNOL ASSESS; Worthington J, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1916-5; Xia SJ, 2008, EUR UROL, V53, P382, DOI 10.1016/j.eururo.2007.05.019; Young G, 2018, STAT ANAL PLAN UNBLO	28	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					50	61						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ND0VO	32622397	Green Published, hybrid			2022-12-28	WOS:000561626100016
J	Dahlke, FT; Wohlrab, S; Butzin, M; Portner, HO				Dahlke, Flemming T.; Wohlrab, Sylke; Butzin, Martin; Poertner, Hans-Otto			Thermal bottlenecks in the life cycle define climate vulnerability of fish	SCIENCE			English	Article							WATER TEMPERATURE; ATLANTIC COD; HOLDING TEMPERATURE; MAXIMUM-LIKELIHOOD; GAMETE QUALITY; EGG QUALITY; FRESH-WATER; MARINE; MATURATION; REPRODUCTION	Species vulnerability to climate change depends on the most temperature-sensitive life stages, but for major animal groups such as fish, life cycle bottlenecks are often not clearly defined. We used observational, experimental, and phylogenetic data to assess stage-specific thermal tolerance metrics for 694 marine and freshwater fish species from all climate zones. Our analysis shows that spawning adults and embryos consistently have narrower tolerance ranges than larvae and nonreproductive adults and are most vulnerable to climate warming. The sequence of stage-specific thermal tolerance corresponds with the oxygen-limitation hypothesis, suggesting a mechanistic link between ontogenetic changes in cardiorespiratory (aerobic) capacity and tolerance to temperature extremes. A logarithmic inverse correlation between the temperature dependence of physiological rates (development and oxygen consumption) and thermal tolerance range is proposed to reflect a fundamental, energetic trade-off in thermal adaptation. Scenario-based climate projections considering the most critical life stages (spawners and embryos) clearly identify the temperature requirements for reproduction as a critical bottleneck in the life cycle of fish. By 2100, depending on the Shared Socioeconomic Pathway (SSP) scenario followed, the percentages of species potentially affected by water temperatures exceeding their tolerance limit for reproduction range from similar to 10% (SSP 1-1.9) to similar to 60% (SSP 5-8.5). Efforts to meet ambitious climate targets (SSP 1-1.9) could therefore benefit many fish species and people who depend on healthy fish stocks.	[Dahlke, Flemming T.; Wohlrab, Sylke; Butzin, Martin; Poertner, Hans-Otto] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Wohlrab, Sylke] Helmholtz Inst Funct Marine Biodivers, D-26129 Oldenburg, Germany; [Poertner, Hans-Otto] Univ Bremen, D-28359 Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Dahlke, FT; Portner, HO (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27570 Bremerhaven, Germany.; Portner, HO (corresponding author), Univ Bremen, D-28359 Bremen, Germany.	flemming.dahlke@gmx.de; hans.poertner@awi.de	Pörtner, Hans-O./K-9429-2016	Pörtner, Hans-O./0000-0001-6535-6575; Butzin, Martin/0000-0002-9275-7304; Dahlke, Flemming/0000-0003-0095-2362; Wohlrab, Sylke/0000-0003-3190-0880	research project METAFISCH of the German Federal Ministry of Education and Research (BMBF) [FZK01LS1604A]; Deutsche Forschungsgemeinschaft as part of the Research Unit Tersane [Po 278/16-1, Po 278/16-2, FO 2332]; Alfred Wegener Institute; Helmholtz Centre for Polar and Marine Research; Carl von Ossietzky University Oldenburg; Ministry for Science and Culture of Lower Saxony; Volkswagen Foundation through the Niedersachsisches Vorab grant program [ZN3285]	research project METAFISCH of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft as part of the Research Unit Tersane(German Research Foundation (DFG)); Alfred Wegener Institute; Helmholtz Centre for Polar and Marine Research; Carl von Ossietzky University Oldenburg; Ministry for Science and Culture of Lower Saxony; Volkswagen Foundation through the Niedersachsisches Vorab grant program	Supported by the research project METAFISCH of the German Federal Ministry of Education and Research (BMBF grant FZK01LS1604A to H.-O. P. and F.T.D.) and by the Deutsche Forschungsgemeinschaft (Po 278/16-1 and -2) as part of the Research Unit Tersane (FO 2332). S.W. was funded through HIFMB based on the collaboration between the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research, and the Carl von Ossietzky University Oldenburg, initially funded by the Ministry for Science and Culture of Lower Saxony and the Volkswagen Foundation through the Niedersachsisches Vorab grant program (grant ZN3285).	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2019, IPSL IPAL CM6A LR MO, DOI 10.22033/ESGF/CMIP6.5261; [Anonymous], 2019, IPSL IPSL CM6A LR MO, DOI 10.22033/ESGF/CMIP6.5271; Baisez Aurore, 2011, Endangered Species Research, V15, P265, DOI 10.3354/esr00384; Barbut L, 2019, LIMNOL OCEANOGR, V64, P1150, DOI 10.1002/lno.11104; Baril M., 2002, ECOLOGY BEHAVIOUR CO, P175; Barneche DR, 2018, SCIENCE, V360, P642, DOI 10.1126/science.aao6868; BAROUDY E, 1994, J FISH BIOL, V45, P407, DOI 10.1111/j.1095-8649.1994.tb01323.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BATTAGLENE SC, 1992, NEW ZEAL J MAR FRESH, V26, P179, DOI 10.1080/00288330.1992.9516513; Bennett JM, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.22; Bivand RS, 2008, USE R, P1; Bjornsson B, 2002, CAN J FISH AQUAT SCI, V59, P494, DOI [10.1139/f02-028, 10.1139/F02-028]; BRETT JR, 1956, Q REV BIOL, V31, P75, DOI 10.1086/401257; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown NP, 2006, AQUACULTURE, V261, P993, DOI 10.1016/j.aquaculture.2006.08.025; Bruge A, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00086; Bruggeman J, 2009, NUCLEIC ACIDS RES, V37, pW179, DOI 10.1093/nar/gkp370; Byrne M, 2020, GLOBAL CHANGE BIOL, V26, P80, DOI 10.1111/gcb.14882; Chang J, 2019, METHODS ECOL EVOL, V10, P1118, DOI 10.1111/2041-210X.13182; Ciannelli L, 2015, ICES J MAR SCI, V72, P285, DOI 10.1093/icesjms/fsu145; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Clarke A, 2017, PRINCIPLES OF THERMAL ECOLOGY: TEMPERATURE, ENERGY AND LIFE, P1, DOI 10.1093/oso/9780199551668.001.0001; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Comte L, 2017, NAT CLIM CHANGE, V7, P718, DOI 10.1038/NCLIMATE3382; Copernicus Climate Change Service (C3S), ERA5 5 GEN ECMWF ATM; Dahlke F, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.212589; Dahlke FT, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas8821; Dahlke FT, 2017, GLOBAL CHANGE BIOL, V23, P1499, DOI 10.1111/gcb.13527; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; DEVAUCHELLE N, 1988, AQUACULTURE, V69, P159, DOI 10.1016/0044-8486(88)90194-9; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Donelson JM, 2010, MAR ECOL PROG SER, V401, P233, DOI 10.3354/meps08366; Duarte CM, 2020, NATURE, V580, P39, DOI 10.1038/s41586-020-2146-7; Elisio M, 2012, COMP BIOCHEM PHYS A, V163, P47, DOI 10.1016/j.cbpa.2012.05.178; Eme J, 2015, COMP BIOCHEM PHYS A, V179, P71, DOI 10.1016/j.cbpa.2014.09.005; Eyring V, 2016, GEOSCI MODEL DEV, V9, P1937, DOI 10.5194/gmd-9-1937-2016; Garcia-Lopez A, 2006, AQUACULTURE, V261, P789, DOI 10.1016/j.aquaculture.2006.09.005; Gidden MJ, 2019, GEOSCI MODEL DEV, V12, P1443, DOI 10.5194/gmd-12-1443-2019; Gillet C, 1991, AQUAT LIVING RESOUR, V4, P109, DOI 10.1051/alr:1991010; Goolsby EW, 2017, ECOL EVOL, V7, P2791, DOI 10.1002/ece3.2837; Goolsby EW, 2017, METHODS ECOL EVOL, V8, P22, DOI 10.1111/2041-210X.12612; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; Hasnain SS, 2013, CAN J FISH AQUAT SCI, V70, P964, DOI 10.1139/cjfas-2012-0217; Hoegh-Guldberg O, 2019, SCIENCE, V365, P1263, DOI 10.1126/science.aaw6974; Hokanson K. E. F., 1990, NATL COMPENDIUM FRES, VII; HOKANSON KE, 1973, J FISH RES BOARD CAN, V30, P975, DOI 10.1139/f73-158; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Keck F, 2016, ECOL EVOL, V6, P2774, DOI 10.1002/ece3.2051; Lahnsteiner F, 2012, FISH PHYSIOL BIOCHEM, V38, P455, DOI 10.1007/s10695-011-9526-8; Langangen O, 2014, ICES J MAR SCI, V71, P1129, DOI 10.1093/icesjms/fst007; Lefevre S, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow009; Leo E, 2018, CONSERV PHYSIOL, V6, DOI 10.1093/conphys/coy050; Lim BS, 2003, FISH PHYSIOL BIOCHEM, V28, P161, DOI 10.1023/B:FISH.0000030511.73742.35; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1553, DOI 10.1139/z97-782; Melendez C., 2019, THESIS; Motani R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11597; Moyano M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179928; Neuheimer AB, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4349; O'Neill BC, 2016, GEOSCI MODEL DEV, V9, P3461, DOI 10.5194/gmd-9-3461-2016; Pankhurst NW, 2010, J FISH BIOL, V76, P69, DOI 10.1111/j.1095-8649.2009.02484.x; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; Pankhurst NW, 1996, AQUACULTURE, V146, P277, DOI 10.1016/S0044-8486(96)01374-9; Peck MA, 2016, J FISH BIOL, V88, P173, DOI 10.1111/jfb.12810; Peck MA, 2012, ADV ECOL RES, V47, P177, DOI 10.1016/B978-0-12-398315-2.00003-X; Penone C, 2014, METHODS ECOL EVOL, V5, P961, DOI 10.1111/2041-210X.12232; Pinsky ML, 2019, NATURE, V569, P108, DOI 10.1038/s41586-019-1132-4; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Poertner H.O., 2005, Fish Physiology, V22, P79; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Portner HO, 2017, J EXP BIOL, V220, P2685, DOI 10.1242/jeb.134585; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Portner H.-O., 2014, OCEAN SYSTEMS CLIM A; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Pountney SM, 2020, AQUACULTURE, V522, DOI 10.1016/j.aquaculture.2020.735121; Przeslawski R, 2015, GLOBAL CHANGE BIOL, V21, P2122, DOI 10.1111/gcb.12833; Punzet M, 2012, J HYDROMETEOROL, V13, P1052, DOI 10.1175/JHM-D-11-0138.1; Rabosky DL, 2018, NATURE, V559, P392, DOI 10.1038/s41586-018-0273-1; Righton DA, 2010, MAR ECOL PROG SER, V420, P1, DOI 10.3354/meps08889; Rombough P.J., 1988, P59; Rombough P. J., 1997, SOC EXPT BIOL SEMINA, V61, P177; Scarponi P, 2018, DATA BRIEF, V17, P292, DOI 10.1016/j.dib.2018.01.026; Schleuning M, 2020, TRENDS ECOL EVOL, V35, P319, DOI 10.1016/j.tree.2019.12.010; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Shiogama H., 2019, MIROC MIROC6 MODEL O, DOI [10.22033/ESGF/CMIP6.5741, DOI 10.22033/ESGF/CMIP6.5741]; Sibly R. M., 2012, METABOLIC ECOLOGY SC; Smith TP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13109-1; Sunday J, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2019.0036; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Swart N. C., 2019, CCCMA CANESM5 MODEL, DOI [10.22033/ESGF/CMIP6.3693, DOI 10.22033/ESGF/CMIP6.3693]; Swart N. C., 2019, CCCMA CANESM5 MODEL, DOI [10.22033/ESGF/CMIP6.3682, DOI 10.22033/ESGF/CMIP6.3682]; Swart N. C., 2019, **DATA OBJECT**, DOI [10.22033/ESGF/CMIP6.3696, DOI 10.22033/ESGF/CMIP6.3696]; Swart N.C., 2019, CCCMA CANESM5 MODEL, DOI [10.22033/ESGF/CMIP6.3610, DOI 10.22033/ESGF/CMIP6.3610]; Tatebe H., 2018, MIROC MIROC6 MODEL O, DOI [10.22033/ESGF/CMIP6.5603, DOI 10.22033/ESGF/CMIP6.5603]; Trisos CH, 2020, NATURE, V580, P496, DOI 10.1038/s41586-020-2189-9; Tsoukali S, 2016, MAR ECOL PROG SER, V555, P151, DOI 10.3354/meps11758; Tveiten H, 2001, J FISH BIOL, V58, P374, DOI 10.1111/j.1095-8649.2001.tb02259.x; Tveiten H, 2008, CYBIUM, V32, P195; Vilela B, 2015, METHODS ECOL EVOL, V6, P1229, DOI 10.1111/2041-210X.12401; Walsh BS, 2019, TRENDS ECOL EVOL, V34, P249, DOI 10.1016/j.tree.2018.12.002; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wootton RJ, 2014, REPROD BIOL TELEOST; Wu RSS, 2009, FISH PHYSIOL, V27, P79, DOI 10.1016/S1546-5098(08)00003-4; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zuo H, 2019, OCEAN SCI, V15, P779, DOI 10.5194/os-15-779-2019	110	193	194	29	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					65	+		10.1126/science.aaz3658	http://dx.doi.org/10.1126/science.aaz3658			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631888	Green Published			2022-12-28	WOS:000548751700046
J	Lin, YH; Sakai, N; Da, P; Wu, JY; Sansom, HC; Ramadan, AJ; Mahesh, S; Liu, JL; Oliver, RDJ; Lim, J; Aspitarte, L; Sharma, K; Madhu, PK; Morales-Vilches, AB; Nayak, PK; Bai, S; Gao, F; Grovenor, CRM; Johnston, MB; Labram, JG; Durrant, JR; Ball, JM; Wenger, B; Stannowski, B; Snaith, HJ				Lin, Yen-Hung; Sakai, Nobuya; Da, Peimei; Wu, Jiaying; Sansom, Harry C.; Ramadan, Alexandra J.; Mahesh, Suhas; Liu, Junliang; Oliver, Robert D. J.; Lim, Jongchul; Aspitarte, Lee; Sharma, Kshama; Madhu, P. K.; Morales-Vilches, Anna B.; Nayak, Pabitra K.; Bai, Sai; Gao, Feng; Grovenor, Chris R. M.; Johnston, Michael B.; Labram, John G.; Durrant, James R.; Ball, James M.; Wenger, Bernard; Stannowski, Bernd; Snaith, Henry J.			A piperidinium salt stabilizes efficient metal-halide perovskite solar cells	SCIENCE			English	Article							CHARGE-DENSITY DEPENDENCE; OPEN-CIRCUIT VOLTAGE; CARRIER MOBILITY; INDUCED DEGRADATION; RECOMBINATION; FORMAMIDINIUM; PHOTOVOLTAICS; TRANSPORT; KINETICS; LIGHT	Longevity has been a long-standing concern for hybrid perovskite photovoltaics. We demonstrate high-resilience positive-intrinsic-negative perovskite solar cells by incorporating a piperidinium-based ionic compound into the formamidinium-cesium lead-trihalide perovskite absorber. With the bandgap tuned to be well suited for perovskite-on-silicon tandem cells, this piperidinium additive enhances the open-circuit voltage and cell efficiency. This additive also retards compositional segregation into impurity phases and pinhole formation in the perovskite absorber layer during aggressive aging. Under full-spectrum simulated sunlight in ambient atmosphere, our unencapsulated and encapsulated cells retain 80 and 95% of their peak and post-burn-in efficiencies for 1010 and 1200 hours at 60 degrees and 85 degrees C, respectively. Our analysis reveals detailed degradation routes that contribute to the failure of aged cells.	[Lin, Yen-Hung; Sakai, Nobuya; Da, Peimei; Sansom, Harry C.; Ramadan, Alexandra J.; Mahesh, Suhas; Oliver, Robert D. J.; Lim, Jongchul; Nayak, Pabitra K.; Johnston, Michael B.; Ball, James M.; Wenger, Bernard; Snaith, Henry J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Wu, Jiaying; Durrant, James R.] Imperial Coll London, Dept Chem, London W12 0BZ, England; [Wu, Jiaying; Durrant, James R.] Imperial Coll London, Ctr Plast Elect, London W12 0BZ, England; [Liu, Junliang; Grovenor, Chris R. M.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Aspitarte, Lee; Labram, John G.] Oregon State Univ, Sch Elect Engn & Comp Sci, Corvallis, OR 97331 USA; [Sharma, Kshama; Madhu, P. K.; Nayak, Pabitra K.] Tata Inst Fundamental Res, TIFR Ctr Interdisciplinary Sci, Hyderabad 500107, India; [Morales-Vilches, Anna B.; Stannowski, Bernd] Helmholtz Zentrum Berlin Mat & Energie GmbH, PVcomB, D-12489 Berlin, Germany; [Bai, Sai; Gao, Feng] Linkoping Univ, Dept Phys Chem & Biol IFM, S-58183 Linkoping, Sweden; [Durrant, James R.] Swansea Univ, Coll Engn, Sustainable Prod Engn Ctr Innovat Funct Ind Coati, Bay Campus, Swansea SA1 8EN, W Glam, Wales; [Lim, Jongchul] Chungnam Natl Univ, Grad Sch Energy Sci & Technol, Daejeon 34134, South Korea	University of Oxford; Imperial College London; Imperial College London; University of Oxford; Oregon State University; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Linkoping University; Swansea University; Chungnam National University	Lin, YH; Snaith, HJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	yen-hung.lin@physics.ox.ac.uk; henry.snaith@physics.ox.ac.uk	Snaith, Henry J/A-7367-2016; Wu, Jiaying/ABE-3868-2020; Durrant, James R/A-6198-2009; Ball, James/HHM-5640-2022; Liu, Junliang/ADF-8374-2022; Ramadan, Alexandra J/D-7749-2015; Bai, Sai/K-2333-2015; Nayak, Pabitra/AFV-5126-2022; Johnston, Michael/B-9813-2008; Gao, Feng/AAF-6971-2019; Lin, Yen-Hung/F-7111-2013	Snaith, Henry J/0000-0001-8511-790X; Wu, Jiaying/0000-0001-9674-2903; Durrant, James R/0000-0001-8353-7345; Liu, Junliang/0000-0002-9278-6463; Ramadan, Alexandra J/0000-0003-4572-3459; Nayak, Pabitra/0000-0002-7845-5318; Johnston, Michael/0000-0002-0301-8033; Gao, Feng/0000-0002-2582-1740; Lin, Yen-Hung/0000-0001-6819-1235; Sakai, Nobuya/0000-0003-2142-6564; Sansom, Harry/0000-0003-0329-2822; Oliver, Robert/0000-0003-4980-7940; Labram, John/0000-0001-6562-9895; Mahesh, Suhas/0000-0002-3897-7963; Lim, Jongchul/0000-0001-8609-8747	U. K. Engineering and Physical Sciences Research Council (EPSRC) [EP/S004947/1, EP/P006329/1]; EPSRC [EP/M018237/1]; Rhodes Scholarship (India); Penrose Scholarship; Rhodes Scholarship (Worcester); EPSRC [EP/P032591/1, EP/S004947/1, EP/P006329/1] Funding Source: UKRI	U. K. Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Rhodes Scholarship (India); Penrose Scholarship; Rhodes Scholarship (Worcester); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the U. K. Engineering and Physical Sciences Research Council (EPSRC) grants EP/S004947/1 and EP/P006329/1. J. Liu and C.R.M. G. are grateful for support for the nanoSIMS facility from EPSRC under grant EP/M018237/1. S.M. is grateful for the support of the Rhodes Scholarship (India and Worcester). R.D.J.O. gratefully acknowledges the Penrose Scholarship for funding his studentship.	Andaji-Garmaroudi Z, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201903109; Aristidou N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15218; Bai S, 2019, NATURE, V571, P245, DOI 10.1038/s41586-019-1357-2; Brenes R, 2018, ADV MATER, V30, DOI 10.1002/adma.201706208; Bush KA, 2018, ACS ENERGY LETT, V3, P1225, DOI 10.1021/acsenergylett.8b00544; Bush KA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.9; Chen W, 2018, ADV MATER, V30, DOI 10.1002/adma.201800515; Christians JA, 2018, NAT ENERGY, V3, P68, DOI 10.1038/s41560-017-0067-y; Credgington D, 2012, J PHYS CHEM LETT, V3, P1465, DOI 10.1021/jz300293q; Crovetto A, 2019, CHEM MATER, V31, P3359, DOI 10.1021/acs.chemmater.9b00478; Deledalle F, 2014, J PHYS CHEM C, V118, P8837, DOI 10.1021/jp502948y; Dequilettes DW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11683; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Fu F, 2019, ENERG ENVIRON SCI, V12, P3074, DOI 10.1039/c9ee02043h; Georgiadou DG, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201901371; Godding JSW, 2019, JOULE, V3, P2716, DOI 10.1016/j.joule.2019.08.006; Govinda S, 2018, J PHYS CHEM C, V122, P13758, DOI 10.1021/acs.jpcc.8b00602; Habisreutinger SN, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201601079; Habisreutinger SN, 2016, APL MATER, V4, DOI 10.1063/1.4961210; Habisreutinger SN, 2014, NANO LETT, V14, P5561, DOI 10.1021/nl501982b; Horantner MT, 2017, ENERG ENVIRON SCI, V10, P1983, DOI 10.1039/c7ee01232b; Hou Y, 2017, SCIENCE, V358, P1192, DOI 10.1126/science.aao5561; Hutter EM, 2018, ACS OMEGA, V3, P11655, DOI 10.1021/acsomega.8b01705; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Jung EH, 2019, NATURE, V567, P511, DOI 10.1038/s41586-019-1036-3; Kaltenbrunner M, 2015, NAT MATER, V14, P1032, DOI [10.1038/NMAT4388, 10.1038/nmat4388]; Kato Y, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201500195; Katsidis CC, 2002, APPL OPTICS, V41, P3978, DOI 10.1364/AO.41.003978; Khenkin MV, 2020, NAT ENERGY, V5, P35, DOI 10.1038/s41560-019-0529-5; Kim GY, 2018, NAT MATER, V17, P445, DOI 10.1038/s41563-018-0038-0; KIM KS, 1973, ANAL CHEM, V45, P2214, DOI 10.1021/ac60335a009; Kirchartz T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.115209; Kohnen E, 2019, SUSTAIN ENERG FUELS, V3, P1995, DOI 10.1039/c9se00120d; Kumar GR, 2016, PHYS CHEM CHEM PHYS, V18, P7284, DOI 10.1039/c5cp06232b; Labram JG, 2017, J APPL PHYS, V122, DOI 10.1063/1.4990802; Labram JG, 2017, J MATER CHEM C, V5, P5930, DOI 10.1039/c7tc01161j; Lee JW, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201501310; Leijtens T, 2018, NAT ENERGY, V3, P828, DOI 10.1038/s41560-018-0190-4; Levine I, 2018, J APPL PHYS, V124, DOI 10.1063/1.5037637; Li KX, 2019, APPL SURF SCI, V464, P311, DOI 10.1016/j.apsusc.2018.09.101; Li Z, 2016, CHEM MATER, V28, P284, DOI 10.1021/acs.chemmater.5b04107; Lim J, 2019, ENERG ENVIRON SCI, V12, P169, DOI 10.1039/c8ee03395a; Mazzarella L, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201803241; McMeekin DP, 2016, SCIENCE, V351, P151, DOI 10.1126/science.aad5845; Motti SG, 2019, NAT PHOTONICS, V13, P532, DOI 10.1038/s41566-019-0435-1; O'Regan BC, 2005, J PHYS CHEM B, V109, P4616, DOI 10.1021/jp0468049; O'Regan BC, 2007, J PHYS CHEM C, V111, P14001, DOI 10.1021/jp073056p; Oga H, 2014, J AM CHEM SOC, V136, P13818, DOI 10.1021/ja506936f; OHTA K, 1988, APPL SPECTROSC, V42, P952, DOI 10.1366/0003702884430380; Ouyang YX, 2019, J MATER CHEM A, V7, P2275, DOI 10.1039/c8ta12193a; Pimpinelli A., 2010, PHYS CRYSTAL GROWTH; Poczatek C., 2009, OPENMIMS IMAGEJ PLUG; Prasanna R, 2019, NAT ENERGY, V4, P939, DOI 10.1038/s41560-019-0471-6; Ramadan AJ, 2018, CHEM MATER, V30, P7737, DOI 10.1021/acs.chemmater.8b03084; Ramadan AJ, 2017, J PHYS CHEM LETT, V8, P4172, DOI 10.1021/acs.jpclett.7b01677; Rehman W, 2017, ENERG ENVIRON SCI, V10, P361, DOI 10.1039/c6ee03014a; Reid OG, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa9559; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Saliba M, 2016, ENERG ENVIRON SCI, V9, P1989, DOI 10.1039/c5ee03874j; Savenije TJ, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155205; Savenije TJ, 2013, J PHYS CHEM C, V117, P24085, DOI 10.1021/jp406706u; Shuttle CG, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3006316; Shuttle CG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2891871; Shuttle CG, 2010, ADV FUNCT MATER, V20, P698, DOI 10.1002/adfm.200901734; Snaith HJ, 2018, NAT ENERGY, V3, P459, DOI 10.1038/s41560-018-0174-4; Song ZN, 2018, SUSTAIN ENERG FUELS, V2, P2460, DOI 10.1039/c8se00358k; Sutton RJ, 2018, ACS ENERGY LETT, V3, P1787, DOI 10.1021/acsenergylett.8b00672; The National Renewable Energy Laboratory, BEST RES CELL EFF CH; Turren-Cruz SH, 2018, SCIENCE, V362, P449, DOI 10.1126/science.aat3583; VANBERKEL C, 1993, J APPL PHYS, V73, P5264, DOI 10.1063/1.353755; VERWEY JF, 1967, PHYSICA, V35, P386, DOI 10.1016/0031-8914(67)90186-3; Wang LG, 2019, SCIENCE, V363, P265, DOI 10.1126/science.aau5701; Wang SH, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.195; Wang ZP, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.135; Wheeler S, 2017, J PHYS CHEM C, V121, P13496, DOI 10.1021/acs.jpcc.7b02411; Yang S, 2019, SCIENCE, V365, P473, DOI 10.1126/science.aax3294; Yi CY, 2016, ENERG ENVIRON SCI, V9, P656, DOI 10.1039/c5ee03255e; Zheng XP, 2020, NAT ENERGY, V5, P131, DOI 10.1038/s41560-019-0538-4; ZHOU XL, 1989, SURF SCI, V219, P294, DOI 10.1016/0039-6028(89)90214-8	80	290	295	74	658	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					96	+		10.1126/science.aba1628	http://dx.doi.org/10.1126/science.aba1628			64	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631893	Green Submitted, Green Accepted			2022-12-28	WOS:000548751700053
J	Rudolph, J; Luger, K				Rudolph, Johannes; Luger, Karolin			The secret life of histones	SCIENCE			English	Editorial Material							NUCLEOSOME CORE PARTICLE; BINDING		[Rudolph, Johannes; Luger, Karolin] Univ Colorado, Dept Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Rudolph, J (corresponding author), Univ Colorado, Dept Biochem, Boulder, CO 80309 USA.	johannes.rudolph@colorado.edu; karolin.luger@colorado.edu		SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331				Adamczyk M, 2007, FEBS LETT, V581, P1409, DOI 10.1016/j.febslet.2007.02.063; Attar N, 2020, SCIENCE, V369, P59, DOI 10.1126/science.aba8740; BAL W, 1995, CHEM RES TOXICOL, V8, P683, DOI 10.1021/tx00047a007; Gurard-Levin ZA, 2014, ANNU REV BIOCHEM, V83, P487, DOI 10.1146/annurev-biochem-060713-035536; Henikoff S, 2017, CURR BIOL, V27, pR1118, DOI 10.1016/j.cub.2017.08.063; Koch KA, 1997, CHEM BIOL, V4, P549, DOI 10.1016/S1074-5521(97)90241-6; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mattiroli F, 2017, SCIENCE, V357, P609, DOI 10.1126/science.aaj1849; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; SAAVEDRA RA, 1986, SCIENCE, V234, P1589, DOI 10.1126/science.3787266; Talbert PB, 2019, NAT REV GENET, V20, P283, DOI 10.1038/s41576-019-0105-7	11	3	3	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					33	33		10.1126/science.abc8242	http://dx.doi.org/10.1126/science.abc8242			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MK4IZ	32631882				2022-12-28	WOS:000548751700034
J	Sokolovskaya, OM; Shelton, AN; Taga, ME				Sokolovskaya, Olga M.; Shelton, Amanda N.; Taga, Michiko E.			Sharing vitamins: Cobamides unveil microbial interactions	SCIENCE			English	Review							BASE-OFF ANALOG; COENZYME B-12; ANAEROBIC BIOSYNTHESIS; COBALAMIN ANALOGS; SPOROMUSA-OVATA; LOWER LIGAND; IDENTIFICATION; METABOLISM; GROWTH; GENES	Microbial communities are essential to fundamental processes on Earth. Underlying the compositions and functions of these communities are nutritional interdependencies among individual species. One class of nutrients, cobamides (the family of enzyme cofactors that includes vitamin B-12), is widely used for a variety of microbial metabolic functions, but these structurally diverse cofactors are synthesized by only a subset of bacteria and archaea. Advances at different scales of study-from individual isolates, to synthetic consortia, to complex communities-have led to an improved understanding of cobamide sharing. Here, we discuss how cobamides affect microbes at each of these three scales and how integrating different approaches leads to a more complete understanding of microbial interactions.	[Sokolovskaya, Olga M.; Shelton, Amanda N.; Taga, Michiko E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Taga, ME (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	taga@berkeley.edu		Shelton, Amanda/0000-0001-9296-8331; Taga, Michiko/0000-0002-9148-5925; Sokolovskaya, Olga/0000-0003-1202-4248	National Institutes of Health [R01GM114535]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge National Institutes of Health grant R01GM114535.	Abreu NA, 2016, FEMS MICROBIOL REV, V40, P648, DOI 10.1093/femsre/fuw019; Agarwal S, 2019, BBA-PROTEINS PROTEOM, V1867, P140, DOI 10.1016/j.bbapap.2018.11.004; Allen RH, 2008, AM J CLIN NUTR, V87, P1324, DOI 10.1093/ajcn/87.5.1324; Aretakis JR, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00170-19; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BARKER HA, 1960, J BIOL CHEM, V235, P480; BASSFORD PJ, 1977, J BACTERIOL, V132, P796, DOI 10.1128/JB.132.3.796-805.1977; Bellin DL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4256; Belzer C, 2017, MBIO, V8, DOI [10.1128/mBio.00770-17, 10.1128/mbio.00770-17]; BERMAN D, 1956, APPL MICROBIOL, V4, P49, DOI 10.1128/AEM.4.1.49-52.1956; Bertrand EM, 2015, P NATL ACAD SCI USA, V112, P9938, DOI 10.1073/pnas.1501615112; Blaby-Haas CE, 2019, ANNU REV PLANT BIOL, V70, P605, DOI 10.1146/annurev-arplant-050718-095841; Bridwell-Rabb J, 2017, CURR OPIN CHEM BIOL, V37, P63, DOI 10.1016/j.cbpa.2017.01.013; CALAFAT AM, 1995, BIOCHEMISTRY-US, V34, P14125, DOI 10.1021/bi00043a017; Campanello GC, 2018, J AM CHEM SOC, V140, P13205, DOI 10.1021/jacs.8b08659; Cassat JE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan6361; Chan CH, 2011, MOL MICROBIOL, V81, P952, DOI 10.1111/j.1365-2958.2011.07741.x; CHIAO JS, 1953, APPL MICROBIOL, V1, P42, DOI 10.1128/AEM.1.1.42-46.1953; Cooper MB, 2019, ISME J, V13, P334, DOI 10.1038/s41396-018-0274-y; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Crofts TS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00592; Crofts TS, 2013, CHEM BIOL, V20, P1265, DOI 10.1016/j.chembiol.2013.08.006; D'Souza G, 2018, NAT PROD REP, V35, P455, DOI 10.1039/c8np00009c; D'Souza G, 2014, EVOLUTION, V68, P2559, DOI 10.1111/evo.12468; Deery E, 2012, NAT CHEM BIOL, V8, P933, DOI [10.1038/NCHEMBIO.1086, 10.1038/nchembio.1086]; Degnan PH, 2014, CELL METAB, V20, P769, DOI 10.1016/j.cmet.2014.10.002; Degnan PH, 2014, CELL HOST MICROBE, V15, P47, DOI 10.1016/j.chom.2013.12.007; Deobald D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58873-z; DePas WH, 2016, MBIO, V7, DOI 10.1128/mBio.00796-16; Deptula P, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0363-9; Dolinsek J, 2016, FEMS MICROBIOL REV, V40, P961, DOI 10.1093/femsre/fuw024; Doxey AC, 2015, ISME J, V9, P461, DOI 10.1038/ismej.2014.142; Ferreyra JA, 2014, CELL HOST MICROBE, V16, P770, DOI 10.1016/j.chom.2014.11.003; FORD JE, 1958, J GEN MICROBIOL, V19, P161, DOI 10.1099/00221287-19-1-161; Froese DS, 2019, J INHERIT METAB DIS, V42, P673, DOI 10.1002/jimd.12009; Fukuoka M, 2005, FEBS J, V272, P4787, DOI 10.1111/j.1742-4658.2005.04892.x; Gallo S, 2008, CHEMBIOCHEM, V9, P1408, DOI 10.1002/cbic.200800099; Girard CL, 2009, J DAIRY SCI, V92, P4524, DOI 10.3168/jds.2009-2049; Gopinath K, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120175; Gray MJ, 2010, MOL MICROBIOL, V77, P1429, DOI 10.1111/j.1365-2958.2010.07294.x; Gray MJ, 2009, MOL MICROBIOL, V74, P1198, DOI 10.1111/j.1365-2958.2009.06928.x; Hazra AB, 2015, P NATL ACAD SCI USA, V112, P10792, DOI 10.1073/pnas.1509132112; Hazra AB, 2013, CHEM BIOL, V20, P1275, DOI 10.1016/j.chembiol.2013.08.007; Heal KR, 2017, P NATL ACAD SCI USA, V114, P364, DOI 10.1073/pnas.1608462114; Helliwell KE, 2015, ISME J, V9, P1446, DOI 10.1038/ismej.2014.230; Helliwell KE, 2011, MOL BIOL EVOL, V28, P2921, DOI 10.1093/molbev/msr124; Helliwell KE, 2016, CURR BIOL, V26, P999, DOI 10.1016/j.cub.2016.02.041; Herrmann AM, 2007, SOIL BIOL BIOCHEM, V39, P1835, DOI 10.1016/j.soilbio.2007.03.011; Huemer M, 2019, J INHERIT METAB DIS, V42, P686, DOI 10.1002/jimd.12012; Jeter VL, 2019, BIOCHEMISTRY-US, V58, P951, DOI 10.1021/acs.biochem.8b01253; Johnson WM, 2016, ISME J, V10, P2304, DOI 10.1038/ismej.2016.6; Kang DZ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2009; Kazamia E, 2012, ENVIRON MICROBIOL, V14, P1466, DOI 10.1111/j.1462-2920.2012.02733.x; Keller S, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00584-17; Keller S, 2016, J BACTERIOL, V198, P2236, DOI 10.1128/JB.00289-16; Keller S, 2014, ENVIRON MICROBIOL, V16, P3361, DOI 10.1111/1462-2920.12268; Kelly Caleb J, 2019, Gut Microbes, V10, P654, DOI 10.1080/19490976.2019.1597667; Krautler B, 2003, HELV CHIM ACTA, V86, P3698, DOI 10.1002/hlca.200390313; Krysenko S, 2019, MBIO, V10, DOI 10.1128/mBio.00326-19; LaMattina JW, 2016, J BIOL CHEM, V291, P15515, DOI 10.1074/jbc.M116.721142; Lawrence AD, 2018, CELL CHEM BIOL, V25, P941, DOI 10.1016/j.chembiol.2018.04.012; LAWRENCE JG, 1995, J BACTERIOL, V177, P6371, DOI 10.1128/jb.177.22.6371-6380.1995; LENGYEL P, 1960, P NATL ACAD SCI USA, V46, P1312, DOI 10.1073/pnas.46.10.1312; Lu XD, 2020, ISME J, V14, P53, DOI 10.1038/s41396-019-0502-0; Ma AT, 2020, MOL MICROBIOL, V113, P89, DOI 10.1111/mmi.14402; Ma AT, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00035-17; Magnusdottir S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00148; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Mehta AP, 2015, J AM CHEM SOC, V137, P10444, DOI 10.1021/jacs.5b03576; Men YJ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03508-16; Men Y, 2015, ENVIRON MICROBIOL, V17, P4873, DOI 10.1111/1462-2920.12500; Men YJ, 2014, APPL ENVIRON MICROB, V80, P2133, DOI 10.1128/AEM.03477-13; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mireku SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41575; Mok KC, 2013, J BACTERIOL, V195, P1902, DOI 10.1128/JB.01282-12; Moore SJ, 2012, BIOCHEM SOC T, V40, P581, DOI 10.1042/BST20120066; Mukherjee S, 2019, BIOINFORMATICS, V35, P3541, DOI 10.1093/bioinformatics/btz093; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Parks JM, 2013, SCIENCE, V339, P1332, DOI 10.1126/science.1230667; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Picking JW, 2019, J BIOL CHEM, V294, P13697, DOI 10.1074/jbc.RA119.009886; Podar M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500675; Poppe L, 1997, EUR J BIOCHEM, V250, P303, DOI 10.1111/j.1432-1033.1997.0303a.x; Poppe L, 2000, J MOL CATAL B-ENZYM, V10, P345, DOI 10.1016/S1381-1177(00)00136-3; Radler MI, 2019, J BIOL CHEM, V294, P11712, DOI 10.1074/jbc.RA119.007609; Rempel S, 2020, NATURE, V580, P409, DOI 10.1038/s41586-020-2072-8; Rempel S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05441-9; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Romine MF, 2017, ISME J, V11, P1434, DOI 10.1038/ismej.2017.2; Romine MF, 2017, P NATL ACAD SCI USA, V114, pE1205, DOI 10.1073/pnas.1612360114; Roper JM, 2000, J BIOL CHEM, V275, P40316, DOI 10.1074/jbc.M007146200; Rosnow JJ, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00955-18; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Ryan DJ, 2019, ANAL CHEM, V91, P7578, DOI 10.1021/acs.analchem.8b05889; Santos JA, 2018, ELIFE, V7, DOI 10.7554/eLife.35828; SAUER H, 1977, BRIT J HAEMATOL, V36, P189, DOI 10.1111/j.1365-2141.1977.tb00639.x; Schiessl KT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08733-w; Schubert T, 2019, MICROB BIOTECHNOL, V12, P346, DOI 10.1111/1751-7915.13339; Seth EC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00350; Shelton AN, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00584-19; Shelton AN, 2019, ISME J, V13, P789, DOI 10.1038/s41396-018-0304-9; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; Sokolovskaya OM, 2019, MBIO, V10, DOI 10.1128/mBio.01303-19; STABLER SP, 1991, J CLIN INVEST, V87, P1422, DOI 10.1172/JCI115148; Suffridge CP, 2018, J GEOPHYS RES-BIOGEO, V123, P2890, DOI 10.1029/2018JG004554; Tang YZ, 2010, P NATL ACAD SCI USA, V107, P20756, DOI 10.1073/pnas.1009566107; Tanioka Y, 2010, FEBS LETT, V584, P3223, DOI 10.1016/j.febslet.2010.06.013; Tavares NK, 2018, MOL MICROBIOL, V110, P239, DOI 10.1111/mmi.14100; Tavares NK, 2018, BIOCHEMISTRY-US, V57, P4478, DOI 10.1021/acs.biochem.8b00546; Vetting MW, 2015, BIOCHEMISTRY-US, V54, P909, DOI 10.1021/bi501388y; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Wang PH, 2020, P NATL ACAD SCI USA, V117, P1395, DOI 10.1073/pnas.1914380117; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; WATANABE F, 1992, J GEN MICROBIOL, V138, P1807, DOI 10.1099/00221287-138-9-1807; Weinberg Z, 2017, P NATL ACAD SCI USA, V114, pE2077, DOI 10.1073/pnas.1619581114; Wexler AG, 2018, ELIFE, V7, DOI 10.7554/eLife.37138; Widner FJ, 2016, ANGEW CHEM INT EDIT, V55, P11281, DOI 10.1002/anie.201603738; Wienhausen G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01985; Xu YX, 2018, PROCEEDINGS OF THE 2ND ACM SIGSPATIAL INTERNATIONAL WORKSHOP ON AI FOR GEOGRAPHIC KNOWLEDGE DISCOVERY (GEOAI 2018), P9, DOI 10.1145/3281548.3281556; Yan J, 2018, NAT CHEM BIOL, V14, P8, DOI [10.1038/NCHEMBIO.2512, 10.1038/nchembio.2512]; Yan J, 2016, ISME J, V10, P1092, DOI 10.1038/ismej.2015.197; Yan J, 2012, APPL ENVIRON MICROB, V78, P6630, DOI 10.1128/AEM.01535-12; Yi S, 2012, APPL ENVIRON MICROB, V78, P7745, DOI 10.1128/AEM.02150-12; Zallot R, 2017, ACS CHEM BIOL, V12, P844, DOI 10.1021/acschembio.6b01100; Zarzycki J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42757; Zelder F, 2015, CHEMBIOCHEM, V16, P1264, DOI 10.1002/cbic.201500072; Zhang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-78; Zhu X, 2019, J AGR FOOD CHEM, V67, P916, DOI 10.1021/acs.jafc.8b05730	128	49	51	15	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					48	+	eaba0165	10.1126/science.aba0165	http://dx.doi.org/10.1126/science.aba0165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631870	Green Accepted			2022-12-28	WOS:000548751700041
J	Dyer, C				Dyer, Clare			Trainee doctor who slapped and throttled his wife is struck off after GMC appeal	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2020	370								m2652	10.1136/bmj.m2652	http://dx.doi.org/10.1136/bmj.m2652			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MM0GY	32616484				2022-12-28	WOS:000549840000007
J	Vize, R				Vize, Richard			England's new covid-19 monitoring outfit: the Joint Biosecurity Centre	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@publicpolicymedia.com						Department of Health and Social Care, 2020, UPD UK CHIEF MED OFF; Donnelly L., 2020, TELEGRAPH; Garside J., 2020, GUARDIAN; Goodman P., 2020, CONSERVATIVE HO 0529; HM Government, TERR NAT EM; House of Commons Local Government Committee, 2020, OR EV WORK DEP HC 30; Woodcock A, 2020, INDEPENDENT	7	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2020	370								m2604	10.1136/bmj.m2604	http://dx.doi.org/10.1136/bmj.m2604			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MM0GY	32616525	Bronze			2022-12-28	WOS:000549840000001
J	Pashkovski, SL; Iurilli, G; Brann, D; Chicharro, D; Drummey, K; Franks, K; Panzeri, S; Datta, SR				Pashkovski, Stan L.; Iurilli, Giuliano; Brann, David; Chicharro, Daniel; Drummey, Kristen; Franks, Kevin; Panzeri, Stefano; Datta, Sandeep Robert			Structure and flexibility in cortical representations of odour space	NATURE			English	Article							OLFACTORY CORTEX; SPARSENESS; ORGANIZATION; CIRCUITS; NEURONS; QUALITY; OUTPUT; CODES; MODEL; MICE	The cortex organizes sensory information to enable discrimination and generalization(1-4). As systematic representations of chemical odour space have not yet been described in the olfactory cortex, it remains unclear how odour relationships are encoded to place chemically distinct but similar odours, such as lemon and orange, into perceptual categories, such as citrus(5-7). Here, by combining chemoinformatics and multiphoton imaging in the mouse, we show that both the piriform cortex and its sensory inputs from the olfactory bulb represent chemical odour relationships through correlated patterns of activity. However, cortical odour codes differ from those in the bulb: cortex more strongly clusters together representations for related odours, selectively rewrites pairwise odour relationships, and better matches odour perception. The bulb-to-cortex transformation depends on the associative network originating within the piriform cortex, and can be reshaped by passive odour experience. Thus, cortex actively builds a structured representation of chemical odour space that highlights odour relationships; this representation is similar across individuals but remains plastic, suggesting a meansthrough which the olfactory system can assign related odour cuesto common and yet personalized percepts.	[Pashkovski, Stan L.; Iurilli, Giuliano; Brann, David; Chicharro, Daniel; Drummey, Kristen; Datta, Sandeep Robert] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Iurilli, Giuliano] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst, Rovereto, Italy; [Chicharro, Daniel; Panzeri, Stefano] Ist Italiano Tecnol, Neural Computat Lab, Rovereto, Italy; [Franks, Kevin] Duke Univ, Dept Neurobiol, Durham, NC USA	Harvard University; Harvard Medical School; Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT; Duke University	Datta, SR (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.	srdatta@hms.harvard.edu	; Panzeri, Stefano/L-5977-2013	Datta, Sandeep/0000-0002-8068-3862; Panzeri, Stefano/0000-0003-1700-8909; Iurilli, Giuliano/0000-0001-9037-2489; Chicharro, Daniel/0000-0002-4038-258X	NIH P30 grants [HD18655, NS072030]; Vallee Foundation; National Institutes of Health [RO11DC016222, U19 NS112953, NS108410, DA036922]; Simons Collaboration on the Global Brain; Bertarelli Foundation Fellowship; Stuart H.Q. and Victoria Quan Fellowship; Armenise Foundation Career Development Award	NIH P30 grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vallee Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Collaboration on the Global Brain; Bertarelli Foundation Fellowship; Stuart H.Q. and Victoria Quan Fellowship; Armenise Foundation Career Development Award	We thank members of the Datta laboratory, J. Pillow, R. Axel, L. Abbott, A. Litvin-Kumar, C. Schoonover, A. Fink and V. Ruta for comments on the manuscript, S. Knemeyer for technical illustrations, and N. Bhagat for laboratory assistance. We thank N. Mathur for assistance with viral delivery of GCaMP6s. We thank A. Giessel for early development of tools for image acquisition and analysis. We thank O. Mazor and P. Gorelik from the Research Instrumentation Core Facility and Ludo Cacheux for engineering support. Core facility support is provided by NIH P30 grants HD18655 and NS072030. S.R.D. is supported by fellowships from the Vallee Foundation, by grants RO11DC016222 and U19 NS112953 from the National Institutes of Health and by the Simons Collaboration on the Global Brain. S.P. is supported by grant NS108410 from the National Institutes of Health. D.C. is supported by a Bertarelli Foundation Fellowship. S.L.P. is supported by grant DA036922 from the National Institutes of Health and the Stuart H.Q. and Victoria Quan Fellowship. G.I. is supported by the Armenise Foundation Career Development Award.	Abbott L. F., 2009, INTERACTIONS INTRINS; AMOORE JE, 1963, NATURE, V198, P271, DOI 10.1038/198271a0; Babadi B, 2014, NEURON, V83, P1213, DOI 10.1016/j.neuron.2014.07.035; Barak O, 2013, J NEUROSCI, V33, P3844, DOI 10.1523/JNEUROSCI.2753-12.2013; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Bekkers JM, 2013, TRENDS NEUROSCI, V36, P429, DOI 10.1016/j.tins.2013.04.005; Bolding KA, 2018, SCIENCE, V361, P1088, DOI 10.1126/science.aat6904; Boyd AM, 2015, CELL REP, V10, P1032, DOI 10.1016/j.celrep.2015.01.047; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carey RM, 2011, J NEUROSCI, V31, P10615, DOI 10.1523/JNEUROSCI.1805-11.2011; Chae H, 2019, NAT NEUROSCI, V22, P1306, DOI 10.1038/s41593-019-0442-z; Challis RC, 2019, NAT PROTOC, V14, P379, DOI 10.1038/s41596-018-0097-3; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Cheung MC, 2009, CHEM SENSES, V34, P63, DOI 10.1093/chemse/bjn051; Cleland TA, 2002, BEHAV NEUROSCI, V116, P222, DOI 10.1037//0735-7044.116.2.222; Courtiol E, 2017, PERCEPTION, V46, P320, DOI 10.1177/0301006616663216; Cowley BR, 2017, PR MACH LEARN RES, V54, P242; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Diodato A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12238; Doevendans PA, 1998, CARDIOVASC RES, V39, P34, DOI 10.1016/S0008-6363(98)00073-X; DRAVNIEKS A, 1982, SCIENCE, V218, P799, DOI 10.1126/science.7134974; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Fournel A, 2016, HUM BRAIN MAPP, V37, P2161, DOI 10.1002/hbm.23164; Friedrich RW, 2014, FEBS LETT, V588, P2504, DOI 10.1016/j.febslet.2014.05.055; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Hagiwara A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00018; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Iurilli G, 2017, NEURON, V93, P1180, DOI 10.1016/j.neuron.2017.02.010; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Litwin-Kumar A, 2017, NEURON, V93, P1153, DOI 10.1016/j.neuron.2017.01.030; Luna VM, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00069; Ma LM, 2012, P NATL ACAD SCI USA, V109, P5481, DOI 10.1073/pnas.1117491109; Maklad A, 2001, ANAT RECORD, V263, P99, DOI 10.1002/ar.1083; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Minamisawa G, 2011, J PHYSIOL SCI, V61, P343, DOI 10.1007/s12576-011-0155-x; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Moldestad O, 2009, J NEUROSCI METH, V176, P57, DOI 10.1016/j.jneumeth.2008.08.015; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Otazu GH, 2015, NEURON, V86, P1461, DOI 10.1016/j.neuron.2015.05.023; Pachitariu M., 2017, BIORXIV, DOI DOI 10.1101/061507; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Platt JC, 2000, ADV NEUR IN, P61; Roland B, 2017, ELIFE, V6, DOI 10.7554/eLife.26337; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Schaffer ES, 2018, NEURON, V98, P736, DOI 10.1016/j.neuron.2018.04.004; SCHIFFMAN SS, 1974, SCIENCE, V185, P112, DOI 10.1126/science.185.4146.112; SCHOENFELD TA, 1984, J COMP NEUROL, V227, P121, DOI 10.1002/cne.902270113; Sell CS, 2014, CHEMISTRY AND THE SENSE OF SMELL, P237; Shakhawat AM, 2014, J NEUROSCI, V34, P10206, DOI 10.1523/JNEUROSCI.1942-14.2014; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Srinivasan S., 2017, PREPRINT, DOI DOI 10.1101/099002V1.FULL; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027	64	44	44	4	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					253	+		10.1038/s41586-020-2451-1	http://dx.doi.org/10.1038/s41586-020-2451-1		JUL 2020	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH5KF	32612230	Green Accepted			2022-12-28	WOS:000544885800005
J	Zhao, M; Veeranki, SP; Magnussen, CG; Xi, B				Zhao, Min; Veeranki, Sreenivas P.; Magnussen, Costan G.; Xi, Bo			Recommended physical activity and all cause and cause specific mortality in US adults: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE	OBJECTIVE To determine the association between recommended physical activity according to the 2018 physical activity guidelines for Americans and all cause and cause specific mortality using a nationally representative sample of US adults. DESIGN Population based cohort study. SETTING National Health Interview Survey (1997-2014) with linkage to the National Death Index records to 31 December 2015. PARTICIPANTS 479 856 adults aged 18 years or older. EXPOSURES Participant self-reports of the amount of leisure time spent in aerobic physical activity and muscle strengthening activity each week were combined and categorised into four groups: insufficient activity, aerobic activity only, muscle strengthening only, and both aerobic and muscle strengthening activities according to the physical activity guidelines. MAIN OUTCOME MEASURES All cause mortality and cause specific mortality (cardiovascular disease, cancer, chronic lower respiratory tract diseases, accidents and injuries, Alzheimer's disease, diabetes mellitus, influenza and pneumonia, and nephritis, nephrotic syndrome, or nephrosis) obtained from the National Death Index records. RESULTS During a median follow-up of 8.75 years, 59 819 adults died from all causes, 13 509 from cardiovascular disease, 14 375 from cancer, 3188 from chronic lower respiratory tract diseases, 2477 from accidents and injuries, 1470 from Alzheimer's disease, 1803 from diabetes mellitus, 1135 from influenza and pneumonia, and 1129 from nephritis, nephrotic syndrome, or nephrosis. Compared with those who did not meet the physical activity guidelines (n=268 193), those who engaged in recommended muscle strengthening activity (n=21 428; hazard ratio 0.89, 95% confidence interval 0.85 to 0.94) or aerobic activity (n=113 851; 0.71, 0.69 to 0.72) were found to be at reduced risk of all cause mortality; and even larger survival benefits were found in those engaged in both activities (n=76 384; 0.60, 0.57 to 0.62). In addition, similar patterns were reported for cause specific mortality from cardiovascular disease, cancer, and chronic lower respiratory tract diseases. CONCLUSIONS Adults who engage in leisure time aerobic and muscle strengthening activities at levels recommended by the 2018 physical activity guidelines for Americans show greatly reduced risk of all cause and cause specific mortality. These data suggest that the physical activity levels recommended in the guidelines are associated with important survival benefits.	[Zhao, Min] Shandong Univ, Dept Nutr & Food Hyg, Sch Publ Hlth, Cheeloo Coll Med, Jinan, Shandong, Peoples R China; [Zhao, Min] Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Natl Hlth Commiss, Jinan, Shandong, Peoples R China; [Zhao, Min] Chinese Acad Med Sci, Shandong Univ, State & Shandong Prov Joint Key Lab Translat Card, Dept Cardiol,Qilu Hosp,Cheeloo Coll Med, Jinan, Shandong, Peoples R China; [Veeranki, Sreenivas P.] Precis Hlth Econ & Outcomes Res, Los Angeles, CA USA; [Veeranki, Sreenivas P.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Magnussen, Costan G.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7000, Australia; [Magnussen, Costan G.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Magnussen, Costan G.] Univ Turku, Ctr Populat Hlth Res, Turku, Finland; [Magnussen, Costan G.] Turku Univ Hosp, Turku, Finland; [Xi, Bo] Shandong Univ, Sch Publ Hlth, Dept Epidemiol, Cheeloo Coll Med, Jinan 250012, Shandong, Peoples R China	Shandong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Shandong University; University of Texas System; University of Texas Medical Branch Galveston; University of Tasmania; Menzies Institute for Medical Research; University of Turku; University of Turku; University of Turku; Shandong University	Xi, B (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol, Cheeloo Coll Med, Jinan 250012, Shandong, Peoples R China.	xibo2007@126.com	Magnussen, Costan/J-7177-2014	Magnussen, Costan/0000-0002-6238-5730; Xi, Bo/0000-0003-0491-5585	Innovation Team of "Climbing" Program of Shandong University; Youth Team of Humanistic and Social Science of Shandong University [20820IFYT1902]; National Heart Foundation of Australia [100849]	Innovation Team of "Climbing" Program of Shandong University; Youth Team of Humanistic and Social Science of Shandong University; National Heart Foundation of Australia(National Heart Foundation of Australia)	BX was supported by the Innovation Team of "Climbing" Program of Shandong University, and Youth Team of Humanistic and Social Science of Shandong University (20820IFYT1902). CGM was supported by a National Heart Foundation of Australia future leader fellowship (100849). The funders had no role in the study design or implementation; data collection, management, analysis, or interpretation; manuscript preparation, review, or approval; or the decision to submit the manuscript for publication.	Autenrieth CS, 2011, EUR J EPIDEMIOL, V26, P91, DOI 10.1007/s10654-010-9517-6; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Kamada M, 2017, J AM HEART ASSOC, V6, DOI [10.1161/jaha.117.007677, 10.1161/JAHA.117.007677]; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lochner K, 2008, AM J EPIDEMIOL, V168, P336, DOI 10.1093/aje/kwn123; National Center for Health Statistics, NHANES EP FOLL UP SU; National Center for Health Statistics Centers for Disease Control and Prevention, LINK NAT CTR HLTH ST; Petter M, 2009, EUR J CARDIOV PREV R, V16, P515, DOI 10.1097/HJR.0b013e3283299585; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Sallis R, 2015, PROG CARDIOVASC DIS, V57, P375, DOI 10.1016/j.pcad.2014.10.003; Schoenborn CA, 2011, AM J PREV MED, V40, P514, DOI 10.1016/j.amepre.2010.12.029; Stamatakis E, 2018, AM J EPIDEMIOL, V187, P1102, DOI 10.1093/aje/kwx345; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th; Xi B, 2017, J AM COLL CARDIOL, V70, P913, DOI 10.1016/j.jacc.2017.06.054; Zhao GX, 2014, BRIT J SPORT MED, V48, P244, DOI 10.1136/bjsports-2013-092731	19	88	89	3	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2031	10.1136/bmj.m2031	http://dx.doi.org/10.1136/bmj.m2031			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611588	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000548489100005
J	Devi, S				Devi, Sharmila			Access to health care under threat in Afghanistan	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2020	395	10242					1962	1962						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MJ0ZZ	32593330	Green Published, Bronze			2022-12-28	WOS:000547825600011
J	Armstrong, S				Armstrong, Stephen			Why covid-19 antibody tests are not the game changer the UK government claims	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						Andersson M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2420; BOSSUYT PM, 2015, BMJ-BRIT MED J, V351, DOI DOI 10.1136/BMJ.H5527; Bridge-Wilkinson A, 2020, PARLIAMENTARY R 0518; Bryan A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00941-20; Deeks J, 2020, TWITTER; NHS England, 2020, ANT TEST PROGR ROLL; Public Health England, 2020, COV 19 LAB EV SER AS; Roche, 2020, ROCH COVID 19 ANT TE	8	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2020	369								m2469	10.1136/bmj.m2469	http://dx.doi.org/10.1136/bmj.m2469			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1US	32580936	Bronze			2022-12-28	WOS:000548572500011
J	Loh, PR; Genovese, G; McCarroll, SA				Loh, Po-Ru; Genovese, Giulio; McCarroll, Steven A.			Monogenic and polygenic inheritance become instruments for clonal selection	NATURE			English	Article							ATM ACTIVATION; JAK2 HAPLOTYPE; C-MPL; HEMATOPOIESIS; MOSAICISM; MUTATIONS; RISK; PREDISPOSITION; CLASSIFICATION; SUSCEPTIBILITY	Clonally expanded blood cells that contain somatic mutations (clonal haematopoiesis) are commonly acquired with age and increase the risk of blood cancer(1-9). The blood clones identified so far contain diverse large-scale mosaic chromosomal alterations (deletions, duplications and copy-neutral loss of heterozygosity (CN-LOH)) on all chromosomes(1,2,5,6,9), but the sources of selective advantage that drive the expansion of most clones remain unknown. Here, to identify genes, mutations and biological processes that give selective advantage to mutant clones, we analysed genotyping data from the blood-derived DNA of 482,789 participants from the UK Biobank(10). We identified 19,632 autosomal mosaic chromosomal alterations and analysed these for relationships to inherited genetic variation. We found 52 inherited, rare, large-effect coding or splice variants in 7 genes that were associated with greatly increased vulnerability to clonal haematopoiesis with specific acquired CN-LOH mutations. Acquired mutations systematically replaced the inherited risk alleles (at MPL) or duplicated them to the homologous chromosome (at FH, NBN, MRE11, ATM, SH2B3 and TM2D3). Three of the genes (MRE11, NBN and ATM) encode components of the MRN-ATM pathway, which limits cell division after DNA damage and telomere attrition(11-13); another two (MPL and SH2B3) encode proteins that regulate the self-renewal of stem cells(14-16). In addition, we found that CN-LOH mutations across the genome tended to cause chromosomal segments with alleles that promote the expansion of haematopoietic cells to replace their homologous (allelic) counterparts, increasing polygenic drive for blood-cell proliferation traits. Readily acquired mutations that replace chromosomal segments with their homologous counterparts seem to interact with pervasive inherited variation to create a challenge for lifelong cytopoiesis. Analysis of blood-derived DNA from participants in the UK Biobank demonstrates that clonal expansions of acquired copy-neutral loss of heterozygosity mutations act on inherited alleles along a chromosome arm by modifying their allelic dosages.	[Loh, Po-Ru] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Loh, Po-Ru; Genovese, Giulio; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Genovese, Giulio; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Genovese, Giulio; McCarroll, Steven A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Loh, PR (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA.; Loh, PR; Genovese, G; McCarroll, SA (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Genovese, G; McCarroll, SA (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Genovese, G; McCarroll, SA (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	poruloh@broadinstitute.org; giulio.genovese@gmail.com; mccarroll@hms.harvard.edu		Loh, Po-Ru/0000-0001-5542-9064; McCarroll, Steven/0000-0002-6954-8184	US National Institutes of Health (NIH) [DP2 ES030554]; Burroughs Wellcome Fund Career Award at the Scientific Interfaces; Next Generation Fund at the Broad Institute of MIT and Harvard; Glenn Foundation for Medical Research; AFAR; US NIH [R01 HG006855]; US Department of Defense Breast Cancer Research Breakthrough Award [W81XWH-16-1-0316]; Netherlands Scientific Organization [NWO 480-05-003]; Dutch Brain Foundation; VU University Amsterdam	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award at the Scientific Interfaces; Next Generation Fund at the Broad Institute of MIT and Harvard; Glenn Foundation for Medical Research; AFAR; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense Breast Cancer Research Breakthrough Award(United States Department of Defense); Netherlands Scientific Organization; Dutch Brain Foundation; VU University Amsterdam	We thank S. Bakhoum, S. Raychaudhuri, M. Sherman, S. Elledge and C. Terao for discussions. This research was conducted using the UK Biobank Resource under application no. 19808. P.-R.L. was supported by US National Institutes of Health (NIH) grant DP2 ES030554, a Burroughs Wellcome Fund Career Award at the Scientific Interfaces, the Next Generation Fund at the Broad Institute of MIT and Harvard, a Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty award, and a Sloan Research Fellowship. G.G. and S.A.M. were supported by US NIH grant R01 HG006855. G.G. was supported by US Department of Defense Breast Cancer Research Breakthrough Award W81XWH-16-1-0316. Computational analyses were performed on the O2 High Performance Compute Cluster, supported by the Research Computing Group, at Harvard Medical School (http://rc.hms.harvard.edu), and on the Genetic Cluster Computer (http://www.geneticcluster.org) hosted by SURFsara and financially supported by the Netherlands Scientific Organization (NWO 480-05-003 PI: Posthuma) along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam. We thank S. Elledge, B. Ebert, and C. Patil for helpful comments on the manuscript.	Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chase A, 2015, LEUKEMIA, V29, P2069, DOI 10.1038/leu.2015.130; Choate KA, 2010, SCIENCE, V330, P94, DOI 10.1126/science.1192280; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Deng YB, 2009, NATURE, V460, P914, DOI 10.1038/nature08196; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Loh PR, 2018, NATURE, V559, P350, DOI 10.1038/s41586-018-0321-x; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Machiela MJ, 2015, AM J HUM GENET, V96, P487, DOI 10.1016/j.ajhg.2015.01.011; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Meuwissen THE, 2001, GENETICS, V157, P1819; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Pedersen BS, 2018, BIOINFORMATICS, V34, P867, DOI 10.1093/bioinformatics/btx699; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Regier AA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06159-4; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schultz KAP, 2017, CLIN CANCER RES, V23, pE76, DOI 10.1158/1078-0432.CCR-17-0629; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tesi B, 2017, BLOOD, V129, P2266, DOI 10.1182/blood-2016-10-743302; Thompson DJ, 2019, NATURE, V575, P652, DOI 10.1038/s41586-019-1765-3; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turner JJ, 2010, BLOOD, V116, pE90, DOI 10.1182/blood-2010-06-289561; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Van Hout VC, 2019, WHOLE EXOME SEQUENCI, DOI DOI 10.1101/572347V1; Vattathil S, 2016, AM J HUM GENET, V98, P571, DOI 10.1016/j.ajhg.2016.02.003; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869	54	46	46	3	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					136	+		10.1038/s41586-020-2430-6	http://dx.doi.org/10.1038/s41586-020-2430-6		JUN 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32581363	Green Submitted, Green Accepted			2022-12-28	WOS:000556404200001
J	Oliver, D				Oliver, David			David Oliver: Preventing more deaths in care homes in a second pandemic surge	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Davidoliver372@googlemail.com						British Geriatrics Society, 2020, COMMUNICATION   0616; British Geriatrics Society, EFF HEALTHC OLD PEOP; Gordon A, 2020, TACKLING COVID 19 OU; Gordon AL, 2020, AGE AGEING, V49, P701, DOI 10.1093/ageing/afaa113; Health Foundation, 2019, NEW AN FINDS ENC RES; Launder M., 2020, NURS PRACT, V21; Lithander FE, 2020, AGE AGEING, V49, P501, DOI 10.1093/ageing/afaa093; Middleton J, 2020, MAIL ONLINE; Mortimer R., 2019, FT ADVISER       DEC; Oliver D, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2334	10	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2020	369								m2461	10.1136/bmj.m2461	http://dx.doi.org/10.1136/bmj.m2461			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1VB	32576549	Bronze			2022-12-28	WOS:000548573500009
J	Zarocostas, J				Zarocostas, John			Plain packaging ruling hailed as a victory for tobacco control	LANCET			English	Editorial Material								The decision of the World Trade Organization's appeals body is expected to spur more countries to implement similar stringent packaging laws. John Zarocostas reports from Geneva.											0	1	1	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1895	1895						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563362				2022-12-28	WOS:000552732200013
J	Serchen, J; Doherty, R; Atiq, O; Hilden, D				Serchen, Josh; Doherty, Robert; Atiq, Omar; Hilden, David		Amer Coll Phys	Racism and Health in the United States: A Policy Statement From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							MENTAL-HEALTH; LAW-ENFORCEMENT; SHOOTER BIAS; DISCRIMINATION; DECISION; VIOLENCE; RACE	Racial minorities in the United States have reported experiencing widespread racism throughout all aspects of life, from housing to education to employment. Existing research has examined the role of racism, discrimination, and violence in one's interaction with the health care system and their association with poorer mental and physical health. Systemic racism that underlies the fabric of society often manifests itself in prominent institutions, such as law enforcement agencies, regardless of individual intent. Overt and covert racist laws and policies, personal implicit biases, and other factors result in Black individuals and other people of color being the subject of law enforcement violence and criminal justice system interactions at disproportionately high rates. The demonstrated association between discriminatory law enforcement practices and violence and personal and community health necessitates treating these issues as public health issues worthy of a public policy intervention. Addressing some of the sources of institutional racism and harm through transparency and accountability measures is the first of many steps required to begin correcting historical racial injustices.	[Serchen, Josh; Doherty, Robert] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA; [Atiq, Omar] Univ Arkansas Med Sci, 4301 West Markham St,Slot 508, Little Rock, AR 72205 USA; [Hilden, David] Univ Minnesota, Med Sch, HCMC Dept Med G5,701 Pk Ave, Minneapolis, MN 55415 USA	American College of Physicians; University of Arkansas System; University of Arkansas Medical Sciences; University of Minnesota System; University of Minnesota Twin Cities	Serchen, J (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	jserchen@acponline.org						Alang S, 2017, AM J PUBLIC HEALTH, V107, P662, DOI 10.2105/AJPH.2017.303691; American Public Health Association, 2018, ADDRESSING LAW ENFOR; [Anonymous], 2015, FINAL REPORT OF THE; [Anonymous], 2020, VIOLENCE AND SOCIAL; [Anonymous], 2020, WASHINGTON POST; Armstrong K, 2007, AM J PUBLIC HEALTH, V97, P1283, DOI 10.2105/AJPH.2005.080762; Asmundson Gordon J. G., 2008, Cognitive Behaviour Therapy, V37, P66, DOI 10.1080/16506070801969005; Bor J, 2018, LANCET, V392, P302, DOI [10.1016/S0140-6736(18)31130-9, 10.1016/s0140-6736(18)31130-9]; Bove V, 2017, AM ECON J-ECON POLIC, V9, P1, DOI 10.1257/pol.20150478; Brady SS, 2006, J ADOLESCENT HEALTH, V39, P610, DOI 10.1016/j.jadohealth.2006.03.007; Bui AL, 2018, J EPIDEMIOL COMMUN H, V72, P715, DOI 10.1136/jech-2017-210059; Carron PN, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2283; Correll J, 2014, SOC PERSONAL PSYCHOL, V8, P201, DOI 10.1111/spc3.12099; Darling-Hammond L., 2016, UNEQUAL OPPORTUNITY; Edwards F, 2019, P NATL ACAD SCI USA, V116, P16793, DOI 10.1073/pnas.1821204116; Feldman WB, 2018, HEALTH AFFAIR, V37, P1605, DOI 10.1377/hlthaff.2018.0501; Gee GC, 2011, DU BOIS REV, V8, P115, DOI 10.1017/S1742058X11000130; Geller A, 2014, AM J PUBLIC HEALTH, V104, P2321, DOI 10.2105/AJPH.2014.302046; Gill C, 2014, J EXP CRIMINOL, V10, P399, DOI 10.1007/s11292-014-9210-y; Gomez MB, 2016, J URBAN HEALTH, V93, pS154, DOI 10.1007/s11524-015-0022-9; Gould E, 2019, STATE WORKING AM WAG; Grother P., 2019, FACE RECOGNITION V 3, DOI [10.6028/NIST.IR.8280, DOI 10.6028/NIST.IR.8280]; Haar RJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018154; Haar RJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4814-6; Hartley Tara A, 2013, Int J Emerg Ment Health, V15, P241; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Jacoby S.F., 2018, HEALTH AFFAIR, DOI [10.1377/hblog20180926.69826, DOI 10.1377/HBLOG20180926.69826]; Jacoby SF, 2018, SOC SCI MED, V199, P115, DOI 10.1016/j.socscimed.2017.05.037; Kahn KB, 2017, J SOC ISSUES, V73, P723, DOI 10.1111/josi.12245; Kahn KB, 2016, SOC ISS POLICY REV, V10, P82, DOI 10.1111/sipr.12019; Kahn KB, 2011, GROUP PROCESS INTERG, V14, P569, DOI 10.1177/1368430210374609; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Krieger N, 1996, AM J PUBLIC HEALTH, V86, P1370, DOI 10.2105/AJPH.86.10.1370; Landrine H., 1996, J BLACK PSYCHOL, V22, P144, DOI DOI 10.1177/00957984960222002; Lee RT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210698; McIntosh K., 2020, EXAMINING BLACK WHIT; McKesson D., 2016, POLICE USE FORCE POL; McVean A., 2019, 40 YEARS HUMAN EXPER; Mummolo J, 2018, P NATL ACAD SCI USA, V115, P9181, DOI 10.1073/pnas.1805161115; Musgrave S, 2014, PENTAGON FINALLY DET; Neel J., 2017, POLL MOST AM THINK T; Obasogie OK, 2017, AM J LAW MED, V43, P279, DOI 10.1177/0098858817723665; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Ott KC, 2017, B AM COLL SURG; Patton D, 2019, J INTERPERS VIOLENCE, V34, P135, DOI 10.1177/0886260516669545; Peeples L, 2019, NATURE, V573, P24, DOI 10.1038/d41586-019-02601-9; powell j.a., 2008, NC L REV, V86, P791; Robert Wood Johnson Foundation, 2017, DISCRIMINATION IN AM; Ross J., 2020, NBC NEWS; Sadler MS, 2012, J SOC ISSUES, V68, P286, DOI 10.1111/j.1540-4560.2012.01749.x; Sewell AA, 2016, J URBAN HEALTH, V93, pS42, DOI 10.1007/s11524-015-0016-7; Sheats KJ, 2018, AM J PREV MED, V55, P462, DOI 10.1016/j.amepre.2018.05.017; Thompson VLS, 1996, COMMUNITY MENT HLT J, V32, P223; Tooker J, 2015, SERVING OUR PATIENTS; Turner M. A., 2013, HOUSING DISCRIMINATI; Unkelbach C, 2009, REV INT PSYCHOL SOC, V22, P181; Waxman O., 2017, TIME; Williams DR, 2019, HEALTH SERV RES, V54, P1374, DOI 10.1111/1475-6773.13222; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; Williams DR, 2000, ETHNIC HEALTH, V5, P243, DOI 10.1080/713667453	60	33	33	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2020	173	7					556	+		10.7326/M20-4195	http://dx.doi.org/10.7326/M20-4195			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NX4GS	32559145				2022-12-28	WOS:000575671400011
J							WHO-UNICEF-Lancet Commissioners	After COVID-19, a future for the world's children?	LANCET			English	Editorial Material							HEALTH							George, Asha/0000-0002-5968-1424; Sachdev, Harshpal Singh/0000-0002-4956-9391				Andrew A., 2020, ARE MOTHERS FATHERS; [Anonymous], 2020, NEW YORK TIMES STATE, DOI 10.1016/S2468-2667(20)30117-1; Bandiera O, 2018, EC LIVES YOUNG WOMEN; Banks J., 2020, W2016 IFS; Clark H, 2020, LANCET, V395, P605, DOI 10.1016/S0140-6736(19)32540-1; Cluver L, 2020, LANCET, V395, pE64, DOI 10.1016/S0140-6736(20)30736-4; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Elliot JK, 2020, GLOBAL NEWS 0319; Evans S, 2020, ANAL CORONAVIRUS SET; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Nott D, 2020, LANCET, V395, P1532, DOI 10.1016/S0140-6736(20)31036-9; Orben A, 2020, LANCET CHILD ADOLESC, V4, P634, DOI 10.1016/S2352-4642(20)30186-3; Peterman A, 2020, PANDEMICS VIOLENCE W; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; Sprang G, 2013, DISASTER MED PUBLIC, V7, P105, DOI 10.1017/dmp.2013.22; UN Committee on the Rights of the Child, 2020, WARNS GRAVE PHYS EMO; UNESCO, 2020, UN WORLD WAT DEV REP; UNICEF Lao PDR, 2020, KEEP CHILDR SAF ONL; United Nations, 2020, SHAR RESP GLOB SOL R; US Centers for Disease Control and Prevention, 2020, ORD SUSP INTR PERS C; World Food Programme, 2020, HINDUSTAN TIMES 0829	21	38	40	3	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2020	396	10247					298	300		10.1016/S0140-6736(20)31481-1	http://dx.doi.org/10.1016/S0140-6736(20)31481-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0RO	32622373	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000561615700007
J	Austin, JM; Kachalia, A				Austin, J. Matthew; Kachalia, Allen			The State of Health Care Quality Measiirement in the Era of COVID-19 The Importance of Doing Better	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Austin, J. Matthew; Kachalia, Allen] Johns Hopkins Med, Johns Hopkins Armstrong Inst Patient Safety & Qua, Baltimore, MD USA; [Austin, J. Matthew] Johns Hopkins Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Kachalia, Allen] Johns Hopkins Med, Dept Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Austin, JM (corresponding author), Johns Hopkins Armstrong Inst Patient Safety & Qua, Johns Hopkins Med, Dept Anesthesiol & Crit Care Med, 750 E Pratt St,15th Floor, Baltimore, MD 21202 USA.	jmaustin@jhmi.edu						[Anonymous], 2020, CMS ANN REL CLIN PRO; Borgert M, 2016, INT J QUAL HEALTH C, V28, P601, DOI 10.1093/intqhc/mzw071; Clark RC, 2018, J NURS CARE QUAL, V33, P291, DOI 10.1097/NCQ.0000000000000289; Leapfrog Group, 2020, LEAPFR GROUPS RESP C	4	27	27	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					333	334		10.1001/jama.2020.11461	http://dx.doi.org/10.1001/jama.2020.11461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE8JP	32584373	Bronze			2022-12-28	WOS:000562851000016
J	Voelker, R				Voelker, Rebecca			Relief From Heavy Bleeding Due to Uterine Fibroids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					19	19		10.1001/jama.2020.11456	http://dx.doi.org/10.1001/jama.2020.11456			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633789				2022-12-28	WOS:000568123600005
J	Jones, H				Jones, Helen			Why I ... practise kung fu	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2020	370								m2589	10.1136/bmj.m2589	http://dx.doi.org/10.1136/bmj.m2589			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5XW	32631814	Bronze			2022-12-28	WOS:000548163900004
J	Stepanov, P; Das, I; Lu, XB; Fahimniya, A; Watanabe, K; Taniguchi, T; Koppens, FHL; Lischner, J; Levitov, L; Efetov, DK				Stepanov, Petr; Das, Ipsita; Lu, Xiaobo; Fahimniya, Ali; Watanabe, Kenji; Taniguchi, Takashi; Koppens, Frank H. L.; Lischner, Johannes; Levitov, Leonid; Efetov, Dmitri K.			Untying the insulating and superconducting orders in magic-angle graphene	NATURE			English	Article							DIRAC FERMIONS; BILAYER; STATES	Tuning the electronic interactions by changing the dielectric environment of twisted bilayer graphene reveals the disappearance of the insulating states and their replacement by superconducting phases, suggesting a competition between the two phases. The coexistence of superconducting and correlated insulating states in magic-angle twisted bilayer graphene(1-11)prompts fascinating questions about their relationship. Independent control of the microscopic mechanisms that govern these phases could help uncover their individual roles and shed light on their intricate interplay. Here we report on direct tuning of electronic interactions in this system by changing the separation distance between the graphene and a metallic screening layer(12,13). We observe quenching of correlated insulators in devices with screening layer separations that are smaller than the typical Wannier orbital size of 15 nanometres and with twist angles that deviate slightly from the magic angle of 1.10 +/- 0.05 degrees. Upon extinction of the insulating orders, the vacated phase space is taken over by superconducting domes that feature critical temperatures comparable to those in devices with strong insulators. In addition, we find that insulators at half-filling can reappear in small out-of-plane magnetic fields of 0.4 tesla, giving rise to quantized Hall states with a Chern number of 2. Our study suggests re-examination of the often-assumed 'parent-and-child' relation between the insulating and superconducting phases in moire graphene, and suggests a way of directly probing the microscopic mechanisms of superconductivity in strongly correlated systems.	[Stepanov, Petr; Das, Ipsita; Lu, Xiaobo; Koppens, Frank H. L.; Efetov, Dmitri K.] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona, Spain; [Fahimniya, Ali; Levitov, Leonid] MIT, Dept Phys, Cambridge, MA 02139 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Lischner, Johannes] Imperial Coll London, Dept Mat, London, England; [Lischner, Johannes] Imperial Coll London, Dept Phys, London, England; [Lischner, Johannes] Imperial Coll London, Thomas Young Ctr Theory & Simulat Mat, London, England	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Massachusetts Institute of Technology (MIT); National Institute for Materials Science; Imperial College London; Imperial College London; Imperial College London	Efetov, DK (corresponding author), Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona, Spain.	dmitri.efetov@icfo.eu	Watanabe, Kenji/ABB-2135-2021; Efetov, Dmitri/P-5697-2018	Watanabe, Kenji/0000-0003-3701-8119; Efetov, Dmitri/0000-0001-5862-0462; Fahimniya, Ali/0000-0003-2711-5935; Lu, Xiaobo/0000-0003-3149-4755	Ministry of Economy and Competitiveness of Spain through the "Severo Ochoa" programme for Centres of Excellence in RD [SE5-0522]; Fundacio' Privada Cellex; Fundacio' Privada Mir-Puig; Generalitat de Catalunya through the CERCA program; H2020 Programme [820378]; Project 2D.SIPC; La Caixa Foundation; Science and Technology Center for Integrated Quantum Materials, NSF [DMR-1231319]; Army Research Office [W911NF-18-1-0116]; ERC consolidator grant TOPONANOP [726001]; Elemental Strategy Initiative by MEXT, Japan; CREST, JST [JPMJCR15F3]; European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant [754510]; EPSRC [EP/S025324/1] Funding Source: UKRI	Ministry of Economy and Competitiveness of Spain through the "Severo Ochoa" programme for Centres of Excellence in RD; Fundacio' Privada Cellex(Foundation CELLEX); Fundacio' Privada Mir-Puig; Generalitat de Catalunya through the CERCA program; H2020 Programme; Project 2D.SIPC; La Caixa Foundation(La Caixa Foundation); Science and Technology Center for Integrated Quantum Materials, NSF; Army Research Office; ERC consolidator grant TOPONANOP; Elemental Strategy Initiative by MEXT, Japan; CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful for discussions with P. Jarillo-Herrero, A. MacDonald, A. Young, L. Balents, A. Bernevig, B. Lian and C. Dean. D.K.E. acknowledges support from the Ministry of Economy and Competitiveness of Spain through the "Severo Ochoa" programme for Centres of Excellence in R&D (SE5-0522), Fundacio' Privada Cellex, Fundacio' Privada Mir-Puig, the Generalitat de Catalunya through the CERCA program, the H2020 Programme under grant agreement number 820378, Project 2D center dot SIPC and the La Caixa Foundation. L.L. acknowledges support from the Science and Technology Center for Integrated Quantum Materials, NSF grant number DMR-1231319; and Army Research Office Grant W911NF-18-1-0116. F.H.L.K. acknowledges support from the ERC consolidator grant TOPONANOP (grant agreement number 726001). K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by MEXT, Japan, and CREST (JPMJCR15F3), JST. P.S. acknowledges support from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement number 754510.	Bultinck N., 2019, GROUND STATE HIDDEN; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen GR, 2020, NATURE, V579, P56, DOI 10.1038/s41586-020-2049-7; Choi Y, 2019, NAT PHYS, V15, P1174, DOI 10.1038/s41567-019-0606-5; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Goodwin ZAH, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.121106; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Jiang YH, 2019, NATURE, V573, P91, DOI 10.1038/s41586-019-1460-4; Kerelsky A, 2019, NATURE, V572, P95, DOI 10.1038/s41586-019-1431-9; Kim K, 2017, P NATL ACAD SCI USA, V114, P3364, DOI 10.1073/pnas.1620140114; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Liu X., 2019, SPIN POLARIZED CORRE; Lu XB, 2019, NATURE, V574, P653, DOI 10.1038/s41586-019-1695-0; Nandkishore R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115124; Nandkishore R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156803; Nilsson F, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.075135; Pizarro JM, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.161102; Po HC, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.195455; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Serlin M, 2020, SCIENCE, V367, P900, DOI 10.1126/science.aay5533; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; Xie YL, 2019, NATURE, V572, P101, DOI 10.1038/s41586-019-1422-x; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910; Zou LJ, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.085435	30	202	204	21	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2020	583	7816					375	+		10.1038/s41586-020-2459-6	http://dx.doi.org/10.1038/s41586-020-2459-6		JUL 2020	13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4AA	32632215	Green Submitted			2022-12-28	WOS:000545886600001
J	Christie, B				Christie, Bryan			Alcohol: WHO tells Europe to raise prices to reduce harm	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Health Organization, 2020, ALC PRIC WHO EUR REG	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2649	10.1136/bmj.m2649	http://dx.doi.org/10.1136/bmj.m2649			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611539				2022-12-28	WOS:000548489100002
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: NHS leaders braced for longer waiting times as service deals with fallout	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		RIMMER A, 2020, BMJ-BRIT MED J, V369, P2634	1	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370									10.1136/bmj.m2639	http://dx.doi.org/10.1136/bmj.m2639			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OH7TL	32611540	Bronze			2022-12-28	WOS:000582796300001
J	Ruano, R				Ruano, Rodrigo			Prenatal regenerative fetoscopic interventions for congenital anomalies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							URINARY-TRACT OBSTRUCTION; HERNIA IN-UTERO; FETAL LUNG-VOLUME; POSTNATAL RENAL-FUNCTION; ENDOSCOPIC TRACHEAL OCCLUSION; TO-HEAD RATIO; DIAPHRAGMATIC-HERNIA; SPINA-BIFIDA; PULMONARY HYPOPLASIA; CLINICAL-EXPERIENCE	Fetal intervention has progressed in the past two decades from experimental proof-of-concept to practice-adopted, life saving interventions in human fetuses with congenital anomalies. This progress is informed by advances in innovative research, prenatal diagnosis, and fetal surgical techniques. Invasive open hysterotomy, associated with notable maternal-fetal risks, is steadily replaced by less invasive fetoscopic alternatives. A better understanding of the natural history and pathophysiology of congenital diseases has advanced the prenatal regenerative paradigm. By altering the natural course of disease through regrowth or redevelopment of malformed fetal organs, prenatal regenerative medicine has transformed maternal-fetal care. This review discusses the uses of regenerative medicine in the prenatal diagnosis and management of three congenital diseases: congenital diaphragmatic hernia, lower urinary tract obstruction, and spina bifida.	[Ruano, Rodrigo] Mayo Clin, Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Rochester, MN 55905 USA; [Ruano, Rodrigo] Mayo Clin, Coll Med, Ctr Regenerat Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Ruano, R (corresponding author), Mayo Clin, Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Rochester, MN 55905 USA.; Ruano, R (corresponding author), Mayo Clin, Coll Med, Ctr Regenerat Med, Rochester, MN 55905 USA.	ruano.rodrigo@mayo.edu			State of Minnesota [RMM 102516008]; Regenerative Medicine Minnesota Clinical Trial grant: "Fetoscopic Regenerative Therapy for Severe Pulmonary Hypoplasia - a feasibility pre-randomized control trial study"	State of Minnesota(University of Minnesota System); Regenerative Medicine Minnesota Clinical Trial grant: "Fetoscopic Regenerative Therapy for Severe Pulmonary Hypoplasia - a feasibility pre-randomized control trial study"	I acknowledge the financial support from the State of Minnesota (RMM 102516008). Dr R. Ruano is a recipient of the Regenerative Medicine Minnesota Clinical Trial grant: "Fetoscopic Regenerative Therapy for Severe Pulmonary Hypoplasia -a feasibility pre-randomized control trial study."	Abdennadher W, 2015, ULTRASOUND OBST GYN, V46, P306, DOI 10.1002/uog.14734; Adzick NS, 2013, EARLY HUM DEV, V89, P881, DOI 10.1016/j.earlhumdev.2013.09.010; Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; ADZICK NS, 1985, J PEDIATR SURG, V20, P673, DOI 10.1016/S0022-3468(85)80022-1; Albanese CT, 1998, PRENATAL DIAG, V18, P1138, DOI 10.1002/(SICI)1097-0223(199811)18:11<1138::AID-PD416>3.0.CO;2-A; ALCORN D, 1977, J ANAT, V123, P649; Alfaraj MA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.050; Antiel RM, 2017, SEMIN FETAL NEONAT M, V22, P423, DOI 10.1016/j.siny.2017.05.002; Anumba DO, 2005, PRENATAL DIAG, V25, P7, DOI 10.1002/pd.1074; Au KS, 2010, DEV DISABIL RES REV, V16, P6, DOI 10.1002/ddrr.93; Barghorn A, 1998, PEDIATR PATHOL LAB M, V18, P5, DOI 10.1080/107710498174173; Baschat AA, 2018, ULTRASOUND OBST GYN, V52, P400, DOI 10.1002/uog.19083; Basta AM, 2016, FETAL DIAGN THER, V39, P248, DOI 10.1159/000440649; Basurto D, 2019, BEST PRACT RES CL OB, V58, P93, DOI 10.1016/j.bpobgyn.2018.12.010; Belfort MA, 2017, OBSTET GYNECOL, V129, P20, DOI 10.1097/AOG.0000000000001749; Bernardes LS, 2009, ULTRASOUND OBST GYN, V34, P419, DOI 10.1002/uog.6413; Bienstock JL, 2014, OBSTET GYNECOL, V124, P413, DOI 10.1097/AOG.0000000000000339; Borgstedt-Bakke JH, 2017, J NEUROSURG-PEDIATR, V19, P227, DOI 10.3171/2016.8.PEDS1654; Boulet S. L., 2009, Morbidity and Mortality Weekly Report, V57, P1409; Bratu I, 2001, J PEDIATR SURG, V36, P739, DOI 10.1053/jpsu.2001.22950; Bruner JP, 2000, FETAL DIAGN THER, V15, P83, DOI 10.1159/000020981; Bruner JP, 1997, AM J OBSTET GYNECOL, V176, P256, DOI 10.1016/S0002-9378(97)80050-6; Burgos CM, 2016, FETAL DIAGN THER, V39, P241, DOI 10.1159/000439303; Carreras E, 2016, ULTRASOUND OBST GYN, V47, P162, DOI 10.1002/uog.15732; Centers for Disease Control and Prevention, 2019, DAT STAT SPIN BIF; Chandrasekharan Praveen Kumar, 2017, Matern Health Neonatol Perinatol, V3, P6, DOI 10.1186/s40748-017-0045-1; Chervenak FA, 2018, SEMIN FETAL NEONAT M, V23, P64, DOI 10.1016/j.siny.2017.09.008; Chiu PPL, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00036; Copp AJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.7; Cordier AG, 2015, ULTRASOUND OBST GYN, V46, P155, DOI 10.1002/uog.14759; Cordier AG, 2015, J MATERN-FETAL NEO M, V28, P190, DOI 10.3109/14767058.2014.906576; Cortes MS, 2019, ULTRASOUND OBST GYN, V53, P314, DOI 10.1002/uog.20220; COSTLOW RD, 1981, TOXICOLOGY, V20, P209, DOI 10.1016/0300-483X(81)90052-4; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; deMello DE, 2000, PEDIATR DEVEL PATHOL, V3, P439, DOI 10.1007/s100240010090; Deprest J, 2004, ULTRASOUND OBST GYN, V24, P121, DOI 10.1002/uog.1711; DIFIORE JW, 1995, J PEDIATR SURG, V30, P917, DOI 10.1016/0022-3468(95)90313-5; Dott MM, 2003, BIRTH DEFECTS RES A, V67, P261, DOI 10.1002/bdra.10039; Enninga EA, 2018, MINERVA PEDIATR, V70, P263, DOI 10.23736/S0026-4946.17.05105-2; Ethun CG, 2013, J PEDIATR SURG, V48, P956, DOI 10.1016/j.jpedsurg.2013.02.011; Farmer DL, 2003, ARCH SURG-CHICAGO, V138, P872, DOI 10.1001/archsurg.138.8.872; Farrugia MK, 2017, J PEDIATR UROL, V13, P320, DOI [10.1016/j.jpurol.2017.02.005, 10.1016/j.jpurol.2017.02.021]; Fauza DO, 2014, SEMIN PEDIATR SURG, V23, P135, DOI 10.1053/j.sempedsurg.2014.04.004; FAUZA DO, 1994, J PEDIATR SURG, V29, P882, DOI 10.1016/0022-3468(94)90008-6; Flageole H, 1998, J PEDIATR SURG, V33, P299, DOI 10.1016/S0022-3468(98)90451-1; Flake AW, 2000, AM J OBSTET GYNECOL, V183, P1059, DOI 10.1067/mob.2000.108871; Fontanella F, 2018, ULTRASOUND OBST GYN, V52, P739, DOI 10.1002/uog.18990; Fontanella F, 2019, ULTRASOUND OBST GYN, V53, P520, DOI 10.1002/uog.19172; Fontanella F, 2017, ULTRASOUND OBST GYN, V50, P458, DOI 10.1002/uog.17422; Fontanella F, 2019, FETAL DIAGN THER, V45, P155, DOI 10.1159/000488282; Gallot D, 2006, EUR J OBSTET GYN R B, V125, P202, DOI 10.1016/j.ejogrb.2005.06.030; Garne E, 2002, ULTRASOUND OBST GYN, V19, P329, DOI 10.1046/j.1469-0705.2002.00635.x; GEORGE DK, 1987, AM REV RESPIR DIS, V136, P947, DOI 10.1164/ajrccm/136.4.947; Ghaedi Mahboobe, 2015, Curr Transplant Rep, V2, P81; GLICK PL, 1983, J PEDIATR SURG, V18, P681, DOI 10.1016/S0022-3468(83)80003-7; Gratacos E, 2001, SURG ENDOSC, V15, P368, DOI 10.1007/s004640090024; Gucciardo L, 2008, BEST PRACT RES CL OB, V22, P123, DOI 10.1016/j.bpobgyn.2007.08.006; HARRISON MR, 1990, J PEDIATR SURG, V25, P47, DOI 10.1016/S0022-3468(05)80163-0; HARRISON MR, 1990, NEW ENGL J MED, V322, P1582, DOI 10.1056/NEJM199005313222207; HARRISON MR, 1981, J PEDIATR SURG, V16, P934, DOI 10.1016/S0022-3468(81)80849-4; HARRISON MR, 1980, SURGERY, V88, P174; HARRISON MR, 1980, SURGERY, V88, P260; Harrison MR, 1997, J PEDIATR SURG, V32, P1637, DOI 10.1016/S0022-3468(97)90472-3; Harrison MR, 1996, J PEDIATR SURG, V31, P1339, DOI 10.1016/S0022-3468(96)90824-6; Harrison MR, 2003, J PEDIATR SURG, V38, P1012, DOI 10.1016/S0022-3468(03)00182-9; Harrison MR, 1998, J PEDIATR SURG, V33, P1017, DOI 10.1016/S0022-3468(98)90524-3; Harrison MR, 2003, NEW ENGL J MED, V349, P1916, DOI 10.1056/NEJMoa035005; HARRISON MR, 1982, PEDIATR ANN, V11, P896; HARRISON MR, 1982, NEW ENGL J MED, V307, P1651, DOI 10.1056/NEJM198212233072623; HARRISON MR, 1993, J PEDIATR SURG, V28, P1411, DOI 10.1016/S0022-3468(05)80338-0; HARRISON MR, 1983, J PEDIATR SURG, V18, P247, DOI 10.1016/S0022-3468(83)80094-3; Harrison MR, 2001, AM J OBSTET GYNECOL, V185, P730, DOI 10.1067/mob.2001.117344; HASHIM E, 1995, J PEDIATR SURG, V30, P1172, DOI 10.1016/0022-3468(95)90015-2; Hedrick HL, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.001; HEDRICK MH, 1994, J PEDIATR SURG, V29, P612, DOI 10.1016/0022-3468(94)90724-2; Inversetti A, 2019, ULTRASOUND OBST GYN, V53, P293, DOI 10.1002/uog.20188; Jani J, 2008, ULTRASOUND OBST GYN, V31, P37, DOI 10.1002/uog.5198; Jani J, 2007, ULTRASOUND OBST GYN, V30, P67, DOI 10.1002/uog.4052; Jani J, 2006, ULTRASOUND OBST GYN, V27, P18, DOI 10.1002/uog.2688; Jani J, 2008, ULTRASOUND OBST GYN, V32, P793, DOI 10.1002/uog.6234; Jani JC, 2009, ULTRASOUND OBST GYN, V34, P304, DOI 10.1002/uog.6450; Jani JC, 2009, ULTRASOUND OBST GYN, V33, P64, DOI 10.1002/uog.6141; Johnson MP, 2018, FETAL DIAGN THER, V44, P10, DOI 10.1159/000478011; Joyeux L, 2018, ARCH DIS CHILD-FETAL, V103, pF589, DOI 10.1136/archdischild-2018-315143; Joyeux L, 2016, FETAL DIAGN THER, V39, P161, DOI 10.1159/000443498; Kabagambe SK, 2018, FETAL DIAGN THER, V43, P161, DOI 10.1159/000479505; Kehl S, 2014, J ULTRAS MED, V33, P759, DOI 10.7863/ultra.33.5.759; Keswani SG, 2017, OPERAT OBSTETR, V4; Kitagawa H, 2001, J PEDIATR SURG, V36, P1698, DOI 10.1053/jpsu.2001.27964; Kitano Y, 2011, ULTRASOUND OBST GYN, V37, P277, DOI 10.1002/uog.8892; Kohl T, 2006, FETAL DIAGN THER, V21, P185, DOI 10.1159/000089301; Langham MR, 1996, CLIN PERINATOL, V23, P671, DOI 10.1016/S0095-5108(18)30201-X; Lazar DA, 2012, J PEDIATR SURG, V47, P1058, DOI 10.1016/j.jpedsurg.2012.03.003; LEVIN DL, 1978, J PEDIATR-US, V92, P478, DOI 10.1016/S0022-3476(78)80453-3; Lewis MA, 2008, SEMIN FETAL NEONAT M, V13, P118, DOI 10.1016/j.siny.2007.09.011; LILEY AW, 1963, BRIT MED J, P1107, DOI 10.1136/bmj.2.5365.1107; LUKS FI, 1994, FETAL DIAGN THER, V9, P105, DOI 10.1159/000263916; Luks FI, 2000, EUR J OBSTET GYN R B, V92, P115, DOI 10.1016/S0301-2115(00)00434-6; Luks FI, 2000, SURGERY, V128, P266, DOI 10.1067/msy.2000.107373; Lusk LA, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.036; Mahieu-Caputo D, 2001, BRIT J OBSTET GYNAEC, V108, P863, DOI 10.1111/j.1471-0528.2001.00184.x; Malin G, 2012, BJOG-INT J OBSTET GY, V119, P1455, DOI 10.1111/j.1471-0528.2012.03476.x; Manrique S, 2019, EUR J ANAESTH, V36, P175, DOI 10.1097/EJA.0000000000000930; MANSON JM, 1986, ENVIRON HEALTH PERSP, V70, P137, DOI 10.2307/3430350; Matsell DG, 1996, CLIN INVEST MED, V19, P444; Mayer S, 2011, SEMIN PEDIATR SURG, V20, P161, DOI 10.1053/j.sempedsurg.2011.03.006; McGivern MR, 2015, ARCH DIS CHILD-FETAL, V100, pF137, DOI 10.1136/archdischild-2014-306174; Metkus AP, 1996, J PEDIATR SURG, V31, P148, DOI 10.1016/S0022-3468(96)90338-3; Miller JL, 2019, MINERVA GINECOL, V71, P163, DOI 10.23736/S0026-4784.18.04355-1; Miniati Doug, 2007, Semin Pediatr Surg, V16, P80, DOI 10.1053/j.sempedsurg.2007.01.002; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Moise KJ, 2017, OBSTET GYNECOL, V130, P648, DOI 10.1097/AOG.0000000000002221; Moise KJJr, 2013, SEM PERINATOL; Moldenhauer JS, 2019, BEST PRACT RES CL OB, V58, P121, DOI 10.1016/j.bpobgyn.2019.03.004; Moron AF, 2018, BJOG-INT J OBSTET GY, V125, P1280, DOI 10.1111/1471-0528.15312; Morris RK, 2007, PRENATAL DIAG, V27, P900, DOI 10.1002/pd.1810; Morris RK, 2011, ULTRASOUND OBST GYN, V37, P629, DOI 10.1002/uog.8981; Morris RK, 2009, BJOG-INT J OBSTET GY, V116, P1290, DOI 10.1111/j.1471-0528.2009.02194.x; Morris RK, 2011, EARLY HUM DEV, V87, P607, DOI 10.1016/j.earlhumdev.2011.07.004; Morris RK, 2013, LANCET, V382, P1496, DOI 10.1016/S0140-6736(13)60992-7; Mous DS, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0104-2017; MULLER F, 1993, OBSTET GYNECOL, V82, P813; Mychaliska GB, 1997, J PEDIATR SURG, V32, P227, DOI 10.1016/S0022-3468(97)90184-6; Nagaraj UD, 2020, PRENATAL DIAG, V40, P49, DOI 10.1002/pd.5540; NARDO L, 1995, PEDIATR RES, V38, P690, DOI 10.1203/00006450-199511000-00010; Nassr AA, 2019, ULTRASOUND OBST GYN, V54, P500, DOI 10.1002/uog.20288; Nassr AA, 2017, ULTRASOUND OBST GYN, V49, P696, DOI 10.1002/uog.15988; Nelson TJ, 2008, CTS-CLIN TRANSL SCI, V1, P168, DOI 10.1111/j.1752-8062.2008.00039.x; NICOLINI U, 1992, BRIT J OBSTET GYNAEC, V99, P46, DOI 10.1111/j.1471-0528.1992.tb14391.x; Nicolini U, 2001, PRENATAL DIAG, V21, P964, DOI 10.1002/pd.212; Novoa VNY, 2020, J MATERN-FETAL NEO M, V33, P1786, DOI 10.1080/14767058.2018.1528222; O'Hare EM, 2019, FETAL DIAGN THER, V45, P365, DOI 10.1159/000497472; Ochsenbein-Kolble N, 2019, FETAL DIAGN THER, V45, P248, DOI 10.1159/000488941; Oluyomi-Obi T, 2017, J PEDIATR SURG, V52, P881, DOI 10.1016/j.jpedsurg.2016.12.008; Parera MC, 2005, AM J PHYSIOL-LUNG C, V288, pL141, DOI 10.1152/ajplung.00148.2004; Peralta CFA, 2005, ULTRASOUND OBST GYN, V26, P718, DOI 10.1002/uog.2651; Pringle KC, 2003, PATHOLOGY, V35, P518, DOI 10.1080/00313020310001619145; Quan Y, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-15; QUINTERO RA, 1995, AM J OBSTET GYNECOL, V172, P206, DOI 10.1016/0002-9378(95)90115-9; RICHARDS DS, 1992, OBSTET GYNECOL, V80, P537; Roberts DJ, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0586-5; Robyr R, 2005, ULTRASOUND OBST GYN, V25, P478, DOI 10.1002/uog.1878; Ruano R, 2016, ULTRASOUND OBST GYN, V48, P476, DOI 10.1002/uog.15844; Ruano R, 2015, ULTRASOUND OBST GYN, V45, P452, DOI 10.1002/uog.14652; Ruano R, 2014, ULTRASOUND OBST GYN, V43, P662, DOI 10.1002/uog.13223; Ruano R, 2004, BJOG-INT J OBSTET GY, V111, P423, DOI 10.1111/j.1471-0528.2004.00100.x; Ruano R, 2004, J ULTRAS MED, V23, P353, DOI 10.7863/jum.2004.23.3.353; Ruano R, 2013, ULTRASOUND OBST GYN, V42, P70, DOI 10.1002/uog.12414; Ruano R, 2012, ULTRASOUND OBST GYN, V39, P20, DOI 10.1002/uog.10142; Ruano R, 2012, ULTRASOUND OBST GYN, V39, P42, DOI 10.1002/uog.10095; Ruano R, 2011, ULTRASOUND OBST GYN, V37, P696, DOI 10.1002/uog.8963; Ruano Rodrigo, 2006, Clinics, V61, P197, DOI 10.1590/S1807-59322006000300003; Ruano R, 2006, AM J OBSTET GYNECOL, V195, P1720, DOI 10.1016/j.ajog.2006.05.010; Ruano R, 2020, MAYO CLIN PROC, V95, P738, DOI 10.1016/j.mayocp.2019.10.039; Ruano R, 2019, EXPERT REV MED DEVIC, V16, P643, DOI 10.1080/17434440.2019.1641404; Ruano R, 2019, CLIN PHARMACOL THER, V105, P39, DOI 10.1002/cpt.1262; Ruano R, 2018, MAYO CLIN PROC, V93, P693, DOI 10.1016/j.mayocp.2018.02.026; Ruano R, 2017, PEDIATR NEPHROL, V32, P1871, DOI 10.1007/s00467-017-3593-8; Ruano R, 2016, PEDIATR NEPHROL, V31, P605, DOI 10.1007/s00467-015-3246-8; Ruano R, 2012, OBSTET GYNECOL, V119, P93, DOI 10.1097/AOG.0b013e31823d3aea; Ruano R, 2011, PRENATAL DIAG, V31, P667, DOI 10.1002/pd.2736; Russo FM, 2018, PRENATAL DIAG, V38, P629, DOI 10.1002/pd.5297; Sananes N, 2015, ULTRASOUND OBST GYN, V45, P183, DOI 10.1002/uog.13405; Sananes N, 2016, J ULTRAS MED, V35, P1437, DOI 10.7863/ultra.15.07020; Sananes N, 2016, PRENATAL DIAG, V36, P297, DOI 10.1002/pd.4771; Sawin KJ, 2015, J PEDIATR-US, V166, P444, DOI 10.1016/j.jpeds.2014.09.039; Schilders KAA, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0358-z; Sefton EM, 2018, DEV BIOL, V440, P64, DOI 10.1016/j.ydbio.2018.04.010; Skari H, 2000, J PEDIATR SURG, V35, P1187, DOI 10.1053/jpsu.2000.8725; Sluiter I, 2013, EXP MOL PATHOL, V94, P195, DOI 10.1016/j.yexmp.2012.09.010; Stenmark KR, 2003, AM J RESP CELL MOL, V28, P133, DOI 10.1165/rcmb.F259; Stoll C, 2015, GENET COUNSEL, V26, P281; Style CC, 2019, ULTRASOUND OBST GYN, V54, P752, DOI 10.1002/uog.20216; Terzic A, 2013, MAYO CLIN PROC, V88, P766, DOI 10.1016/j.mayocp.2013.04.017; Thomas AN, 2017, J PERINAT MED, V45, P585, DOI 10.1515/jpm-2016-0367; TORFS CP, 1992, TERATOLOGY, V46, P555, DOI 10.1002/tera.1420460605; VANDENHOF MC, 1990, AM J OBSTET GYNECOL, V162, P322, DOI 10.1016/0002-9378(90)90378-K; VanderWall KJ, 1997, J PEDIATR SURG, V32, P970, DOI 10.1016/S0022-3468(97)90379-1; Victoria T, 2012, PRENATAL DIAG, V32, P715, DOI 10.1002/pd.3890; Vinit N, 2020, FETAL DIAGN THER, V47, P74, DOI 10.1159/000500569; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Welsh A, 2003, PRENATAL DIAG, V23, P1033, DOI 10.1002/pd.717; WENSTROM KD, 1991, AM J OBSTET GYNECOL, V165, P838, DOI 10.1016/0002-9378(91)90425-Q; WIGGLESWORTH J S, 1987, Pediatric Pathology, V7, P515; Williams H, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-7; WILSON JM, 1993, J PEDIATR SURG, V28, P1433, DOI 10.1016/0022-3468(93)90426-L	186	5	5	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m1624	10.1136/bmj.m1624	http://dx.doi.org/10.1136/bmj.m1624			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611543				2022-12-28	WOS:000548489100004
J	Tomkins, C; Purshouse, C; Heywood, R; Miola, J; Cave, E; Devaney, S				Tomkins, Christine; Purshouse, Craig; Heywood, Rob; Miola, Jose; Cave, Emma; Devaney, Sarah			Should doctors tackling covid-19 be immune from negligence liability claims?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tomkins, Christine] Med Def Union, London, England; [Purshouse, Craig; Miola, Jose] Univ Leeds, Sch Law, Leeds, W Yorkshire, England; [Heywood, Rob] Univ East Anglia, UEA Law Sch, Norwich, Norfolk, England; [Cave, Emma] Univ Durham, Durham Law Sch, Durham, England; [Devaney, Sarah] Univ Manchester, Sch Social Sci, Dept Law, Manchester, Lancs, England	University of Leeds; University of East Anglia; Durham University; University of Manchester	Tomkins, C (corresponding author), Med Def Union, London, England.; Purshouse, C (corresponding author), Univ Leeds, Sch Law, Leeds, W Yorkshire, England.	media@themdu.com; c.j.purshouse@leeds.ac.uk		Miola, Jose/0000-0001-9682-2284				Sumption J., 2018, PROF NEG, V34, P113	1	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2487	10.1136/bmj.m2487	http://dx.doi.org/10.1136/bmj.m2487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611590	Green Accepted, Bronze			2022-12-28	WOS:000548489100007
J	Minxha, J; Adolphs, R; Fusi, S; Mamelak, AN; Rutishauser, U				Minxha, Juri; Adolphs, Ralph; Fusi, Stefano; Mamelak, Adam N.; Rutishauser, Ueli			Flexible recruitment of memory-based choice representations by the human medial frontal cortex	SCIENCE			English	Article							HIPPOCAMPAL-PREFRONTAL INTERACTIONS; TEMPORAL-LOBE; RECOGNITION MEMORY; CINGULATE CORTEX; SINGLE NEURONS; INTEGRATIVE THEORY; WORKING-MEMORY; BRAIN NETWORKS; MECHANISMS; RETRIEVAL	Decision-making in complex environments relies on flexibly using prior experience. This process depends on the medial frontal cortex (MFC) and the medial temporal lobe, but it remains unknown how these structures implement selective memory retrieval. We recorded single neurons in the MFC, amygdala, and hippocampus while human subjects switched between making recognition memory-based and categorization-based decisions. The MFC rapidly implemented changing task demands by using different subspaces of neural activity and by representing the currently relevant task goal. Choices requiring memory retrieval selectively engaged phase-locking of MFC neurons to amygdala and hippocampus field potentials, thereby enabling the routing of memories. These findings reveal a mechanism for flexibly and selectively engaging memory retrieval and show that memory-based choices are preferentially represented in the frontal cortex when required.	[Minxha, Juri; Mamelak, Adam N.; Rutishauser, Ueli] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Minxha, Juri; Adolphs, Ralph; Rutishauser, Ueli] CALTECH, Div Biol & Biol Engn, Computat & Neural Syst Program, Pasadena, CA 91125 USA; [Minxha, Juri; Fusi, Stefano] Columbia Univ, Coll Phys & Surg, Ctr Theoret Neurosci, New York, NY USA; [Adolphs, Ralph] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Rutishauser, Ueli] Cedars Sinai Med Ctr, Ctr Neural Sci & Med, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Rutishauser, Ueli] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; California Institute of Technology; Columbia University; California Institute of Technology; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Rutishauser, U (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA.; Rutishauser, U (corresponding author), CALTECH, Div Biol & Biol Engn, Computat & Neural Syst Program, Pasadena, CA 91125 USA.; Rutishauser, U (corresponding author), Cedars Sinai Med Ctr, Ctr Neural Sci & Med, Dept Biomed Sci, Los Angeles, CA 90048 USA.; Rutishauser, U (corresponding author), Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA.	ueli.rutishauser@csmc.edu	Rutishauser, Ueli/AAH-8348-2021; Fusi, Stefano/E-9109-2011; Mamelak, Adam/H-8347-2014	Rutishauser, Ueli/0000-0002-9207-7069; Adolphs, Ralph/0000-0002-8053-9692; Minxha, Juri/0000-0003-4942-3269; Fusi, Stefano/0000-0002-3035-6652; Mamelak, Adam/0000-0002-4245-6431	NIMH [R01MH110831]; BRAIN initiative through the NIH Office of the Director [U01NS103792]; Caltech NIMH Conte Center [P50MH094258]; National Science Foundation [BCS-1554105, DBI-1707398]; Memory and Cognitive Disorders Award from the McKnight Foundation for Neuroscience; Simons Foundation Collaboration on the Global Brain [542941, PG007079]	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); BRAIN initiative through the NIH Office of the Director; Caltech NIMH Conte Center; National Science Foundation(National Science Foundation (NSF)); Memory and Cognitive Disorders Award from the McKnight Foundation for Neuroscience; Simons Foundation Collaboration on the Global Brain	This work was supported by NIMH (R01MH110831 to U.R.), the BRAIN initiative through the NIH Office of the Director (U01NS103792 to U.R.), the Caltech NIMH Conte Center (P50MH094258 to R.A. and U.R.), the National Science Foundation (CAREER Award BCS-1554105 to U.R. and NeuroNex Program award DBI-1707398 to S.F.), a Memory and Cognitive Disorders Award from the McKnight Foundation for Neuroscience (to U.R.), and the Simons Foundation Collaboration on the Global Brain (542941 to R.A. and PG007079 to S.F.).	Anderson KL, 2010, CEREB CORTEX, V20, P1604, DOI 10.1093/cercor/bhp223; Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; Badre D, 2006, P NATL ACAD SCI USA, V103, P7186, DOI 10.1073/pnas.0509550103; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Benoit RG, 2012, NEURON, V76, P450, DOI 10.1016/j.neuron.2012.07.025; Bernardi S, 2019, GEOMETRY ABSTRACTION, P408633, DOI [10.1101/408633, DOI 10.1101/408633]; Bornstein AM, 2017, NAT NEUROSCI, V20, P997, DOI 10.1038/nn.4573; Brincat SL, 2015, NAT NEUROSCI, V18, P576, DOI 10.1038/nn.3954; Burgos-Robles A, 2017, NAT NEUROSCI, V20, P824, DOI 10.1038/nn.4553; Cowley BR, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066012; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dixon ML, 2014, NEUROPSYCHOLOGIA, V62, P321, DOI 10.1016/j.neuropsychologia.2014.05.024; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Efron B, 1993, INTRO BOOTSTRAP, DOI DOI 10.1111/1467-9639.00050; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Ezzyat Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02753-0; Ezzyat Y, 2017, CURR BIOL, V27, P1251, DOI 10.1016/j.cub.2017.03.028; Farovik A, 2011, NAT NEUROSCI, V14, P1416, DOI 10.1038/nn.2919; Favila SE, 2018, J NEUROSCI, V38, P7809, DOI 10.1523/JNEUROSCI.0564-18.2018; Freedman DJ, 2016, ANNU REV NEUROSCI, V39, P129, DOI 10.1146/annurev-neuro-071714-033919; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fu ZZ, 2019, NEURON, V101, P165, DOI 10.1016/j.neuron.2018.11.016; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gordon JA, 2011, CURR OPIN NEUROBIOL, V21, P486, DOI 10.1016/j.conb.2011.02.012; Hahn G, 2019, NAT REV NEUROSCI, V20, P117, DOI 10.1038/s41583-018-0094-0; Harris AZ, 2015, ANNU REV NEUROSCI, V38, P171, DOI 10.1146/annurev-neuro-071714-034111; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Hyman JM, 2012, P NATL ACAD SCI USA, V109, P5086, DOI 10.1073/pnas.1114415109; Hyman JM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00024; Ito HT, 2018, NEURON, V99, P576, DOI 10.1016/j.neuron.2018.07.021; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kaminski J, 2017, NAT NEUROSCI, V20, P590, DOI 10.1038/nn.4509; Karalis N, 2016, NAT NEUROSCI, V19, P605, DOI 10.1038/nn.4251; Klavir O, 2013, NEURON, V80, P1290, DOI 10.1016/j.neuron.2013.09.035; Kornblith S, 2017, CURR BIOL, V27, P1026, DOI 10.1016/j.cub.2017.02.013; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Li T, 2019, EURASIP J WIREL COMM, V2019; Likhtik E, 2015, TRENDS NEUROSCI, V38, P158, DOI 10.1016/j.tins.2014.12.007; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Mayr U, 2000, J EXP PSYCHOL LEARN, V26, P1124, DOI 10.1037/0278-7393.26.5.1124; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minxha J., 2020, OSF, DOI [10.17605/OSF.IO/U3KCP., DOI 10.17605/OSF.IO/U3KCP]; Minxha J, 2018, NEUROMETHODS, V134, P267, DOI 10.1007/978-1-4939-7549-5_14; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Pho GN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05012-y; Polyn SM, 2008, TRENDS COGN SCI, V12, P24, DOI 10.1016/j.tics.2007.10.010; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Remondes M, 2013, NEURON, V80, P1277, DOI 10.1016/j.neuron.2013.08.037; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rugg MD, 1997, NEUROREPORT, V8, P1283, DOI 10.1097/00001756-199703240-00045; Rugg MD, 2013, CURR OPIN NEUROBIOL, V23, P255, DOI 10.1016/j.conb.2012.11.005; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rutishauser U, 2006, J NEUROSCI METH, V154, P204, DOI 10.1016/j.jneumeth.2005.12.033; Rutishauser U, 2015, NAT NEUROSCI, V18, P1041, DOI 10.1038/nn.4041; Rutishauser U, 2014, SINGLE NEURON STUDIES OF THE HUMAN BRAIN: PROBING COGNITION, P59; Sestieri C, 2017, NAT REV NEUROSCI, V18, P183, DOI 10.1038/nrn.2017.6; Sestieri C, 2014, J NEUROSCI, V34, P6993, DOI 10.1523/JNEUROSCI.3911-13.2014; Shadlen MN, 2016, NEURON, V90, P927, DOI 10.1016/j.neuron.2016.04.036; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shimamura Arthur P., 1995, P803; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Stefanini F, 2020, NEURON, V107, P703, DOI 10.1016/j.neuron.2020.05.022; Tyszka JM, 2016, HUM BRAIN MAPP, V37, P3979, DOI 10.1002/hbm.23289; Vilberg KL, 2012, J NEUROSCI, V32, P15679, DOI 10.1523/JNEUROSCI.3065-12.2012; Voytek B, 2015, NAT NEUROSCI, V18, P1318, DOI 10.1038/nn.4071; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Watrous AJ, 2013, NAT NEUROSCI, V16, P349, DOI 10.1038/nn.3315; Westphal AJ, 2017, J NEUROSCI, V37, P3523, DOI 10.1523/JNEUROSCI.2509-16.2017; WILSON FAW, 1993, EXP BRAIN RES, V93, P367; Xiao XQ, 2017, J NEUROSCI, V37, P2986, DOI 10.1523/JNEUROSCI.2324-16.2017; Yamamoto J, 2014, CELL, V157, P845, DOI 10.1016/j.cell.2014.04.009; Yu Byron M., 2008, NIPS, P1881; Yu JY, 2015, NEUROBIOL LEARN MEM, V117, P34, DOI 10.1016/j.nlm.2014.02.002	90	27	27	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1448	+	eaba3313	10.1126/science.aba3313	http://dx.doi.org/10.1126/science.aba3313			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32586990	Green Accepted, Green Submitted			2022-12-28	WOS:000545264600034
J	Glausiusz, J				Glausiusz, Josie			PAVING OVER THE PAST	NATURE			English	News Item																		Elad I., 2018, ESUR ASAWIR EXCAVATI, V130; Haddad E., 2019, BET SHEMESH TEL BET, V131	2	0	0	1	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					474	477		10.1038/d41586-020-01811-w	http://dx.doi.org/10.1038/d41586-020-01811-w			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OL0BS	32581385				2022-12-28	WOS:000585008900001
J	[Anonymous]				[Anonymous]			NHS Test and Trace: it didn't have to be this way	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Garside J., 2020, GUARDIAN; Hancock Matt, 2020, COMMUNICATION   0602; Heren K., 2020, EVENING STANDARD; Independent Sage, TEST TRAC MISS 75 CA; Marsh S, 2020, GUARDIAN; Savage M, 2020, OBSERVER	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2471	10.1136/bmj.m2471	http://dx.doi.org/10.1136/bmj.m2471			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571787	Bronze			2022-12-28	WOS:000548535700011
J	Oener, SZ; Foster, MJ; Boettcher, SW				Oener, Sebastian Z.; Foster, Marc J.; Boettcher, Shannon W.			Accelerating water dissociation in bipolar membranes and for electrocatalysis	SCIENCE			English	Article							ELECTROCHEMICAL CO2 REDUCTION; ION-EXCHANGE MEMBRANES; INTERMEDIATE LAYER; CURRENT-DENSITY; ELECTRIC-FIELD; SOLID-SURFACES; PH GRADIENTS; INTERFACE; OXIDE; ELECTROLYSIS	Catalyzing water dissociation (WD) into protons and hydroxide ions is important both for fabricating bipolar membranes (BPMs) that can couple different pH environments into a single electrochemical device and for accelerating electrocatalytic reactions that consume protons in neutral to alkaline media. We designed a BPM electrolyzer to quantitatively measure WD kinetics and show that, for metal nanoparticles, WD activity correlates with alkaline hydrogen evolution reaction activity. By combining metal -oxide WD catalysts that are efficient near the acidic proton -exchange layer with those efficient near the alkaline hydroxide-exchange layer, we demonstrate a BPM driving WD with overpotentials of <10 mV at 20 mA.cm(-2) and pure water BPM electrolyzers that operate with an alkaline anode and acidic cathode at 500 mA.cm(-2) with a total electrolysis voltage of similar to 2.2 V.	[Oener, Sebastian Z.; Foster, Marc J.; Boettcher, Shannon W.] Univ Oregon, Inst Mat Sci, Dept Chem & Biochem, Eugene, OR 97403 USA; [Foster, Marc J.] Univ Oregon, Oregon Ctr Electrochem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Oener, SZ; Boettcher, SW (corresponding author), Univ Oregon, Inst Mat Sci, Dept Chem & Biochem, Eugene, OR 97403 USA.	szo@uoregon.edu; swb@uoregon.edu	Oener, Sebastian/AAB-2087-2021; Oener, Sebastian/AGI-5431-2022	Oener, Sebastian/0000-0003-0770-4089; Oener, Sebastian/0000-0003-0770-4089; Foster, Marc/0000-0001-5323-3199; Boettcher, Shannon/0000-0001-8971-9123	National Science Foundation Chemical Catalysis program [CHE-1566348]; German Research Foundation (Deutsche Forschungsgemeinschaft) [408246589 (OE 710/1-1)]; M. J. Murdock Charitable Trust; W. M. Keck Foundation; ONAMI; NSF	National Science Foundation Chemical Catalysis program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); M. J. Murdock Charitable Trust; W. M. Keck Foundation(W.M. Keck Foundation); ONAMI; NSF(National Science Foundation (NSF))	This work was supported by the National Science Foundation Chemical Catalysis program under grant no. CHE-1566348. S.Z.O acknowledges support from a research fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft) under project no. 408246589 (OE 710/1-1). We acknowledge use of shared instrumentation in the CAMCOR and Rapid Materials Prototyping facilities, which are supported by grants from the M. J. Murdock Charitable Trust, the W. M. Keck Foundation, ONAMI, and the NSF.	Abdu S, 2013, ACS APPL MATER INTER, V5, P10445, DOI 10.1021/am403019y; Ahlfield JM, 2017, J ELECTROCHEM SOC, V164, pF1165, DOI 10.1149/2.1041712jes; Ali H, 2019, J MATER CHEM A, V7, P6665, DOI 10.1039/c8ta09414d; Balster J, 2007, J MEMBRANE SCI, V287, P246, DOI 10.1016/j.memsci.2006.10.042; Balster J, 2010, J MEMBRANE SCI, V365, P389, DOI 10.1016/j.memsci.2010.09.034; Bertini I., 1994, BIOINORG CHEM, P37; Blommaert MA, 2019, J MATER CHEM A, V7, P19060, DOI 10.1039/c9ta04592a; BOEHM HP, 1971, DISCUSS FARADAY SOC, P264; Chen XT, 2017, ANGEW CHEM INT EDIT, V56, P15025, DOI 10.1002/anie.201709455; Danilovic N, 2012, ANGEW CHEM INT EDIT, V51, P12495, DOI 10.1002/anie.201204842; EIGEN M, 1955, Z ELEKTROCHEM, V59, P986; ERTL G, 1962, Z ELEKTROCHEM, V66, P560; Fu RQ, 2006, DESALINATION, V196, P260, DOI 10.1016/j.desal.2006.03.009; Fu RQ, 2005, J COLLOID INTERF SCI, V285, P281, DOI 10.1016/j.jcis.2004.11.050; Grew KN, 2016, J ELECTROCHEM SOC, V163, pF1572, DOI 10.1149/2.0941614jes; Hanada F., 1991, European Patent, Patent No. [EP0459820B1, 0459820B1]; Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6; Kang MS, 2004, J COLLOID INTERF SCI, V273, P523, DOI 10.1016/j.jcis.2004.01.050; Kemperman A.J.B., 2000, HDB BIPOLAR MEMBRANE; Kosmulski M, 2009, SURFACTANT SCI SER, P1; Krol JJ, 1998, SEP PURIF TECHNOL, V14, P41, DOI 10.1016/S1383-5866(98)00058-6; Ledezma-Yanez I, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.31; Li YGC, 2019, ACS ENERGY LETT, V4, P1427, DOI 10.1021/acsenergylett.9b00975; Li YGC, 2018, ADV SUSTAIN SYST, V2, DOI 10.1002/adsu.201700187; Li YGC, 2016, ACS ENERGY LETT, V1, P1149, DOI 10.1021/acsenergylett.6b00475; Lin M, 2019, ACS APPL ENERG MATER, V2, P5843, DOI 10.1021/acsaem.9b00986; Liu ES, 2019, J AM CHEM SOC, V141, P3232, DOI 10.1021/jacs.8b13228; Liu XD, 2014, PHYS CHEM CHEM PHYS, V16, P26909, DOI 10.1039/c4cp02955k; Luo MC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13833-8; Luo T, 2018, J MEMBRANE SCI, V555, P429, DOI 10.1016/j.memsci.2018.03.051; Man IC, 2011, CHEMCATCHEM, V3, P1159, DOI 10.1002/cctc.201000397; McCrum IT, 2016, J PHYS CHEM C, V120, P457, DOI 10.1021/acs.jpcc.5b10979; McDonald MB, 2014, CHEMSUSCHEM, V7, P3021, DOI 10.1002/cssc.201402288; McDonald MB, 2014, ACS APPL MATER INTER, V6, P13790, DOI 10.1021/am503242v; Mel'nikov SS, 2011, PETROL CHEM+, V51, P577, DOI 10.1134/S0965544111070097; Mills JN, 2014, PHYS CHEM CHEM PHYS, V16, P13699, DOI 10.1039/c4cp00760c; Moqadam M, 2018, P NATL ACAD SCI USA, V115, pE4569, DOI 10.1073/pnas.1714070115; ODA Y, 1968, DESALINATION, V5, P129, DOI 10.1016/S0011-9164(00)80208-8; Oener SZ, 2017, ACS ENERGY LETT, V2, P2625, DOI 10.1021/acsenergylett.7b00764; Oener S. Z., 2020, TABULATED DATA ACCEL, DOI [10.5281/zenodo.3897673., DOI 10.5281/ZENODO.3897673]; Oener S. Z., 2020, ACCELERATING WATER D; Onsager L, 1934, J CHEM PHYS, V2, DOI 10.1063/1.1749541; OVESEN CV, 1992, J CATAL, V134, P445, DOI 10.1016/0021-9517(92)90334-E; Park M, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201900694; Pourbaix M., 1974, ATLAS ELECTROCHEMICA; Rajesh AM, 2012, ELECTROCHIM ACTA, V66, P325, DOI 10.1016/j.electacta.2012.01.102; Rajesh AM, 2011, J MEMBRANE SCI, V372, P249, DOI 10.1016/j.memsci.2011.02.009; Reier T, 2012, ACS CATAL, V2, P1765, DOI 10.1021/cs3003098; Reiter RS, 2016, J ELECTROCHEM SOC, V163, pH3132, DOI 10.1149/2.0201604jes; Ridley MK, 2006, LANGMUIR, V22, P10972, DOI 10.1021/la061774h; Rong QF, 2004, J COLLOID INTERF SCI, V278, P318, DOI 10.1016/j.jcis.2004.06.006; Sheldeshov N. V., 1994, ELEKTROKHIMIYA, V30, P1458; Shen CH, 2017, ENERG ENVIRON SCI, V10, P1435, DOI 10.1039/c7ee00345e; SIMONS R, 1979, NATURE, V280, P824, DOI 10.1038/280824a0; SIMONS R, 1978, J MEMBRANE BIOL, V38, P11, DOI 10.1007/BF01875160; Smith DS, 2001, ENVIRON SCI TECHNOL, V35, P4637, DOI 10.1021/es0018668; Sterrer M, 2019, J MATER RES, V34, P360, DOI 10.1557/jmr.2018.454; STRATHMANN H, 1993, DESALINATION, V90, P303, DOI 10.1016/0011-9164(93)80183-N; Strathmann H, 1997, J MEMBRANE SCI, V125, P123, DOI 10.1016/S0376-7388(96)00185-8; Subbaraman R, 2011, SCIENCE, V334, P1256, DOI 10.1126/science.1211934; Tanaka Y, 2007, MEMBR SCI TECH SER, V12, P1; THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X; Vermaas DA, 2016, ACS ENERGY LETT, V1, P1143, DOI 10.1021/acsenergylett.6b00557; Vermaas DA, 2015, J MATER CHEM A, V3, P19556, DOI 10.1039/c5ta06315a; Wang QY, 2017, J MEMBRANE SCI, V524, P370, DOI 10.1016/j.memsci.2016.11.056; Wilhelm FG, 2002, IND ENG CHEM RES, V41, P579, DOI 10.1021/ie010524n; Xia JB, 2018, J MEMBRANE SCI, V565, P157, DOI 10.1016/j.memsci.2018.07.073; Xu DY, 2019, ACS CATAL, V9, P7, DOI 10.1021/acscatal.8b04001; Xue YH, 2007, J COLLOID INTERF SCI, V316, P604, DOI 10.1016/j.jcis.2007.08.052; Yan ZF, 2018, ENERG ENVIRON SCI, V11, P2235, DOI 10.1039/c8ee01192c; Yaroslavtsev AB, 2003, USP KHIM+, V72, P438; ZABOLOTSKII VI, 1988, USP KHIM+, V57, P1403; Zhao W, 2016, ACS CATAL, V6, P7377, DOI 10.1021/acscatal.6b01997; Zheng J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501602	74	123	127	90	349	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2020	369	6507					1099	+		10.1126/science.aaz1487	http://dx.doi.org/10.1126/science.aaz1487			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NL6KN	32616669	Bronze			2022-12-28	WOS:000567522200044
J	Wu, L; Hollinshead, KER; Hao, YH; Au, C; Kroehling, L; Ng, C; Lin, WY; Li, DY; Silva, HM; Shin, J; Lafaille, JJ; Possemato, R; Pacold, ME; Papagiannakopoulos, T; Kimmelman, AC; Satija, R; Littman, DR				Wu, Lin; Hollinshead, Kate E. R.; Hao, Yuhan; Au, Christy; Kroehling, Lina; Ng, Charles; Lin, Woan-Yu; Li, Dayi; Silva, Hernandez Moura; Shin, Jong; Lafaille, Juan J.; Possemato, Richard; Pacold, Michael E.; Papagiannakopoulos, Thales; Kimmelman, Alec C.; Satija, Rahul; Littman, Dan R.			Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy	CELL			English	Article							T-CELLS; ISOMERASE DEFICIENCY; CYTOKINE MILIEU; MOLECULAR-BASIS; TISSUE HYPOXIA; GUT MICROBIOTA; T(H)17 CELLS; TGF-BETA; RECEPTOR; DIFFERENTIATION	Targeting glycolysis has been considered therapeutically intractable owing to its essential housekeeping role. However, the context-dependent requirement for individual glycolytic steps has not been fully explored. We show that CRISPR-mediated targeting of glycolysis in T cells in mice results in global loss of Th17 cells, whereas deficiency of the glycolytic enzyme glucose phosphate isomerase (Gpi1) selectively eliminates inflammatory encephalitogenic and colitogenic Th17 cells, without substantially affecting homeostatic microbiota-specific Th17 cells. In homeostatic Th17 cells, partial blockade of glycolysis upon Gpi1 inactivation was compensated by pentose phosphate pathway flux and increased mitochondrial respiration. In contrast, inflammatory Th17 cells experience a hypoxic microenvironment known to limit mitochondrial respiration, which is incompatible with loss of Gpi1. Our study suggests that inhibiting glycolysis by targeting Gpi1 could be an effective therapeutic strategy with minimum toxicity for Th17-mediated autoimmune diseases, and, more generally, that metabolic redundancies can be exploited for selective targeting of disease processes.	[Wu, Lin; Au, Christy; Kroehling, Lina; Ng, Charles; Lin, Woan-Yu; Li, Dayi; Silva, Hernandez Moura; Lafaille, Juan J.; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10003 USA; [Hollinshead, Kate E. R.; Pacold, Michael E.; Kimmelman, Alec C.] NYU, Dept Radiat Oncol, Sch Med, New York, NY USA; [Hollinshead, Kate E. R.; Pacold, Michael E.; Kimmelman, Alec C.] NYU, Perlmutter Canc Ctr, Sch Med, New York, NY USA; [Wu, Lin; Hao, Yuhan; Satija, Rahul] New York Genome Ctr, New York, NY 10013 USA; [Hao, Yuhan; Satija, Rahul] NYU, Ctr Genom & Syst Biol, New York, NY USA; [Au, Christy; Littman, Dan R.] Howard Hughes Med Inst, New York, NY 10065 USA; [Shin, Jong; Lafaille, Juan J.; Possemato, Richard; Papagiannakopoulos, Thales; Littman, Dan R.] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA	New York University; New York University; New York University; New York University; Howard Hughes Medical Institute; New York University	Wu, L; Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10003 USA.; Wu, L (corresponding author), New York Genome Ctr, New York, NY 10013 USA.; Littman, DR (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.; Littman, DR (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.	lin.wu@med.nyu.edu; dan.littman@med.nyu.edu	HAO, YuHan/GWR-2654-2022; Li, Dayi/AAJ-4246-2020; Hao, Yuhan/AEN-2112-2022	Possemato, Richard/0000-0002-2401-0030; Shin, Jong/0000-0001-8898-0987	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; National Multiple Sclerosis Society Fellowship [FG 2089-A-1]; NIH [R01AI121436]; Howard Hughes Medical Institute; Helen and Martin Kimmel Center for Biology and Medicine; Immunology and Inflammation training grant [T32AI100853]	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center; National Multiple Sclerosis Society Fellowship(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen and Martin Kimmel Center for Biology and Medicine; Immunology and Inflammation training grant	We thank the NYU Langone Genome Technology Center for expert library preparation and sequencing. This shared resource is partially supported by the Cancer Center Support Grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. We thank Drew R. Jones and Rebecca E. Rose in the NYU Metabolomics Laboratory for helpful discussion and aid with LC-MS data generation and analysis. We thank S.Y. Kim in the NYU Rodent Genetic Engineering Laboratory (RGEL) for generating the Tpi1 conditional KO mice. We thank Anne R. Bresnick (Department of Biochemistry, Albert Einstein College of Medicine) for sharing the S100a4 mutant mice. This work was supported by National Multiple Sclerosis Society Fellowship FG 2089-A-1 (L.W.), Immunology and Inflammation training grant T32AI100853 (C.N.), NIH grant R01AI121436 (D.R.L.), the Howard Hughes Medical Institute (D.R.L.), and the Helen and Martin Kimmel Center for Biology and Medicine (D.R.L.)	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Baronciani L, 1996, BLOOD, V88, P2306, DOI 10.1182/blood.V88.6.2306.bloodjournal8862306; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bulcha JT, 2019, CELL REP, V26, P460, DOI 10.1016/j.celrep.2018.12.064; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Davies AL, 2013, ANN NEUROL, V74, P815, DOI 10.1002/ana.24006; de Padua MC, 2017, ONCOTARGET, V8, P87623, DOI 10.18632/oncotarget.21007; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fotiadou C, 2018, PSORIASIS-TARGETS TH, V8, P1, DOI 10.2147/PTT.S98893; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hanzel J, 2020, EXPERT OPIN BIOL TH, V20, P399, DOI 10.1080/14712598.2020.1697227; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Horlbeck MA, 2018, CELL, V174, P953, DOI 10.1016/j.cell.2018.06.010; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Johnson TW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167196; Kanno H, 1996, BLOOD, V88, P2321, DOI 10.1182/blood.V88.6.2321.bloodjournal8862321; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kugler W, 1998, HUM GENET, V103, P450, DOI 10.1007/s004390050849; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kumar P, 2016, IMMUNITY, V44, P659, DOI 10.1016/j.immuni.2016.02.007; Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y; LEE WNP, 1998, AM J PHYSIOL, V274, pE84; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li ZH, 2010, MOL BIOL CELL, V21, P2598, DOI 10.1091/mbc.E09-07-0609; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McMullin MF, 1999, J CLIN PATHOL, V52, P241, DOI 10.1136/jcp.52.4.241; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Milner JD, 2013, NAT REV IMMUNOL, V13, P635, DOI 10.1038/nri3493; Morrison PJ, 2013, MUCOSAL IMMUNOL, V6, P1143, DOI 10.1038/mi.2013.11; Moschen AR, 2019, NAT REV GASTRO HEPAT, V16, P185, DOI 10.1038/s41575-018-0084-8; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; NAUGHTON DP, 1993, FEBS LETT, V332, P221, DOI 10.1016/0014-5793(93)80636-9; Ng CT, 2010, ANN RHEUM DIS, V69, P1389, DOI 10.1136/ard.2009.119776; Ng C, 2019, GENE DEV, V33, P669, DOI 10.1101/gad.322024.118; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Olenchock BA, 2017, IMMUNITY, V46, P703, DOI 10.1016/j.immuni.2017.04.013; Omenetti S, 2019, IMMUNITY, V51, P77, DOI 10.1016/j.immuni.2019.05.004; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Pariser D, 2018, DERMATOLOGY THER, V8, P17, DOI 10.1007/s13555-017-0211-4; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Peters CL, 2004, ARTHRITIS RHEUM-US, V50, P291, DOI 10.1002/art.11473; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Schneider AS, 2000, BEST PRACT RES CL HA, V13, P119, DOI 10.1053/beha.2000.0061; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Strober BE, 2018, BRIT J DERMATOL, V178, pE105, DOI 10.1111/bjd.16051; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tahir H, 2018, RHEUMATOLOGY, V57, P23, DOI 10.1093/rheumatology/key152; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Van Welden S, 2017, NAT REV GASTRO HEPAT, V14, P596, DOI 10.1038/nrgastro.2017.101; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang EA, 2017, EUR J RHEUMATOL, V4, P272, DOI 10.5152/eurjrheum.2017.17037; WARBURG O, 1958, Z NATURFORSCH PT B, V13, P515, DOI 10.1515/znb-1958-0806; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang RZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16477; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zaidi AU, 2017, PEDIATR HEMAT ONCOL, V34, P449, DOI 10.1080/08880018.2017.1383541; Zanella A, 2005, BRIT J HAEMATOL, V130, P11, DOI 10.1111/j.1365-2141.2005.05527.x; Zhao DX, 2018, MOL CELL, V69, P699, DOI 10.1016/j.molcel.2018.01.017; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	95	39	41	7	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					641	+		10.1016/j.cell.2020.06.014	http://dx.doi.org/10.1016/j.cell.2020.06.014			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32615085	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000558649000011
J	Desai, AN; Kim, AY				Desai, Angel N.; Kim, Arthur Y.			Management of Hepatitis A in 2020-2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMMUNE GLOBULIN; PROPHYLAXIS; VACCINE		[Desai, Angel N.] JAMA, 330 N Wabash Ave, Chicago, IL 60654 USA; [Kim, Arthur Y.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Kim, Arthur Y.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Desai, AN (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60654 USA.	angel.n.desai@gmail.com						Centers for Disease Control and Prevention, 2020, IMM SCHED REC AD IMM; Centers for Disease Control and Prevention, HEP QUEST ANSW HLTH; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P453; Foster MA, 2019, MMWR-MORBID MORTAL W, V68, P413, DOI 10.15585/mmwr.mm6818a2; Lemon SM, 2017, J HEPATOL; McMahon BJ, 1996, ARCH PEDIAT ADOL MED, V150, P733, DOI 10.1001/archpedi.1996.02170320079014; Nelson NP, 2018, MMWR-MORBID MORTAL W, V67, P1216, DOI 10.15585/mmwr.mm6743a5; Nelson NP, 2017, MMWR-MORBID MORTAL W, V66, P959, DOI 10.15585/mmwr.mm6636a5; Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546; WINOKUR PL, 1992, CLIN INFECT DIS, V14, P580, DOI 10.1093/clinids/14.2.580	10	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					383	384		10.1001/jama.2020.4017	http://dx.doi.org/10.1001/jama.2020.4017			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32628251				2022-12-28	WOS:000562851000028
J	Home, BD; Grajower, MM; Anderson, JL				Home, Benjamin D.; Grajower, Martin M.; Anderson, Jeffrey L.			Limited Evidence for the Health Effects and Safety of Intermittent Fasting among Patients With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLYCEMIC CONTROL; MELLITUS		[Home, Benjamin D.; Anderson, Jeffrey L.] Intermt Med Ctr, Heart Inst, Salt Lake City, UT USA; Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Grajower, Martin M.] Albert Einstein Coll Med, Div Endocrinol, Bronx, NY 10467 USA; [Anderson, Jeffrey L.] Univ Utah, Sch Med, Dept Internal Med, Cardiol Div, Salt Lake City, UT USA	Intermountain Healthcare; Intermountain Medical Center; Stanford University; Yeshiva University; Albert Einstein College of Medicine; Utah System of Higher Education; University of Utah	Home, BD (corresponding author), Intermt Heart Inst, 5121 S Cottonwood St, Salt Lake City, UT 84107 USA.	benjamin.horne@imail.org						Aminian A, 2019, JAMA-J AM MED ASSOC, V322, P1271, DOI 10.1001/jama.2019.14231; Ash S, 2003, INT J OBESITY, V27, P797, DOI 10.1038/sj.ijo.0802295; Carter S, 2016, DIABETES RES CLIN PR, V122, P106, DOI 10.1016/j.diabres.2016.10.010; Carter S, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0756; Corley BT, 2018, DIABETIC MED, V35, P588, DOI 10.1111/dme.13595; Grajower MM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040873; Jamshed H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061234; Li CY, 2017, EXP CLIN ENDOCR DIAB, V125, P618, DOI 10.1055/s-0043-101700; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Trepanowski JF, 2017, JAMA INTERN MED, V177, P930, DOI 10.1001/jamainternmed.2017.0936	10	21	24	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					341	342		10.1001/jama.2020.3908	http://dx.doi.org/10.1001/jama.2020.3908			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32614382				2022-12-28	WOS:000562851000020
J	Qing, H; Desrouleaux, R; Israni-Winger, K; Mineur, YS; Fogelman, N; Zhang, CL; Rashed, S; Palm, NW; Sinha, R; Picciotto, MR; Perry, RJ; Wang, A				Qing, Hua; Desrouleaux, Reina; Israni-Winger, Kavita; Mineur, Yann S.; Fogelman, Nia; Zhang, Cuiling; Rashed, Saleh; Palm, Noah W.; Sinha, Rajita; Picciotto, Marina R.; Perry, Rachel J.; Wang, Andrew			Origin and Function of Stress-Induced IL-6 in Murine Models	CELL			English	Article							BROWN-ADIPOSE-TISSUE; GLUCOSE-HOMEOSTASIS; PSYCHOLOGICAL STRESS; INSULIN SENSITIVITY; INFLAMMATORY CYTOKINES; CUMULATIVE ADVERSITY; HEPATIC INFLAMMATION; SKELETAL-MUSCLE; INTERLEUKIN-6; RESISTANCE	Acute psychological stress has long been known to decrease host fitness to inflammation in a wide variety of diseases, but how this occurs is incompletely understood. Using mouse models, we show that interleukin-6 (IL-6) is the dominant cytokine inducible upon acute stress alone. Stress-inducible IL-6 is produced from brown adipocytes in a beta-3-adrenergic-receptor-dependent fashion. During stress, endocrine IL-6 is the required instructive signal for mediating hyperglycemia through hepatic gluconeogenesis, which is necessary for anticipating and fueling "fight or flight" responses. This adaptation comes at the cost of enhancing mortality to a subsequent inflammatory challenge. These findings provide a mechanistic understanding of the ontogeny and adaptive purpose of IL-6 as a bona fide stress hormone coordinating systemic immunome-tabolic reprogramming. This brain-brown fat-liver axis might provide new insights into brown adipose tissue as a stress-responsive endocrine organ and mechanistic insight into targeting this axis in the treatment of inflammatory and neuropsychiatric diseases.	[Qing, Hua; Desrouleaux, Reina; Zhang, Cuiling; Wang, Andrew] Yale Univ, Sch Med, Dept Med Rheumatol Allergy & Immunol, New Haven, CT 06520 USA; [Qing, Hua; Desrouleaux, Reina; Israni-Winger, Kavita; Zhang, Cuiling; Rashed, Saleh; Palm, Noah W.; Wang, Andrew] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Fogelman, Nia; Sinha, Rajita] Yale Sch Med, Yale Stress Ctr, New Haven, CT USA; [Fogelman, Nia; Sinha, Rajita] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Fogelman, Nia; Sinha, Rajita] Yale Sch Med, Dept Neurosci, New Haven, CT USA; [Mineur, Yann S.; Picciotto, Marina R.] Yale Univ, Dept Psychiat, Yale Interdept Neurosci Program, New Haven, CT 06520 USA; [Perry, Rachel J.] Yale Univ, Dept Med Endocrinol, New Haven, CT USA; [Perry, Rachel J.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA; [Desrouleaux, Reina] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Case Western Reserve University	Wang, A (corresponding author), Yale Univ, Sch Med, Dept Med Rheumatol Allergy & Immunol, New Haven, CT 06520 USA.; Wang, A (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.	andrew.wang@yale.edu	Fogelman, Nia/AAL-9270-2021; Picciotto, Marina/F-8747-2012	Desrouleaux, Reina/0000-0002-3570-0125; Picciotto, Marina/0000-0002-4404-1280; Perry, Rachel/0000-0003-0748-8064	Gruber Fellowship; NIH Pathway to Independence Award [K99/R00 CA215315]; NIH [R01-DK099039, DA050986, MH077681, DA14241, K08AI128745, P30-DK079310]	Gruber Fellowship; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Wang, Picciotto, Sinha, and Perry labs for helpful discussions. We are indebted to Dr. Ruslan Medzhitov for his guidance and support. We thank Ali Nasiri and Wanling Zhu for the mouse metabolic flux phenotyping, Dr. Mamula's lab for sharing equipment, and Dr. Akiko Iwasaki for use of thermoneutral cabinets. We thank Mrs. Krista Wang, Dr. Ruth Franklin, and Dr. Harding Luan for review of the manuscript. Invasive hemodynamic monitoring was performed through the George M. O'Brien Kidney Center at Yale (NIH P30-DK079310). A.W. was supported by the NIH Clinical Investigator Award (K08AI128745). K.I.-W. was supported by a Gruber Fellowship. Metabolic flux analysis performed in the Perry lab was supported by an NIH Pathway to Independence Award (K99/R00 CA215315) to R.J.P. M.R.P. was supported by NIH grants DA050986, MH077681, and DA14241. R.S. was supported by NIH grant R01-DK099039.	Abreu-Vieira G, 2015, AM J PHYSIOL-ENDOC M, V308, pE822, DOI 10.1152/ajpendo.00494.2014; Agac D, 2018, BRAIN BEHAV IMMUN, V74, P176, DOI 10.1016/j.bbi.2018.09.004; [Anonymous], 1849, GENUINE WORKS HIPPOC; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Banzet S, 2009, J APPL PHYSIOL, V107, P1830, DOI 10.1152/japplphysiol.00739.2009; Batty GD, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j108; Benrick A, 2012, EXP PHYSIOL, V97, P1224, DOI 10.1113/expphysiol.2012.065508; Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317; BLACK DS, 2016, ANN NY ACAD SCI, V1373, P13, DOI DOI 10.1111/NYAS.12998; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Castaneda S, 2019, CLIN EXP RHEUMATOL, V37, P465; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Cheng YY, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0169-z; Chowdhury S, 2020, J CLIN INVEST, V130, P2888, DOI 10.1172/JCI133572; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Covarrubias AJ, 2014, CELL METAB, V19, P898, DOI 10.1016/j.cmet.2014.05.009; de Jong JMA, 2019, NAT METAB, V1, P830, DOI 10.1038/s42255-019-0101-4; DEPOCAS F, 1984, CAN J PHYSIOL PHARM, V62, P1327, DOI 10.1139/y84-222; Eisner MD, 2005, ANN ALLERG ASTHMA IM, V94, P566, DOI 10.1016/S1081-1206(10)61135-0; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Findeisen M, 2019, NATURE, V574, P63, DOI 10.1038/s41586-019-1601-9; Frank MG, 2013, BRAIN BEHAV IMMUN, V33, P1, DOI 10.1016/j.bbi.2013.02.004; Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050; Gao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096741; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Kappelmann N, 2018, MOL PSYCHIATR, V23, P335, DOI 10.1038/mp.2016.167; Kataoka N, 2014, CELL METAB, V20, P346, DOI 10.1016/j.cmet.2014.05.018; KAWATE R, 1994, PHYSIOL BEHAV, V55, P921, DOI 10.1016/0031-9384(94)90080-9; Kelly JR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00392; Khandaker GM, 2014, JAMA PSYCHIAT, V71, P1121, DOI 10.1001/jamapsychiatry.2014.1332; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kotch C, 2019, EXPERT REV CLIN IMMU, V15, P813, DOI 10.1080/1744666X.2019.1629904; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Leitner BP, 2017, P NATL ACAD SCI USA, V114, P8649, DOI 10.1073/pnas.1705287114; LEMAY LG, 1990, PHYSIOL BEHAV, V47, P957, DOI 10.1016/0031-9384(90)90024-X; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu LY, 2002, AM J RESP CRIT CARE, V165, P1062, DOI 10.1164/ajrccm.165.8.2109065; Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Mineur YS, 2007, NEUROPHARMACOLOGY, V52, P1256, DOI 10.1016/j.neuropharm.2007.01.006; Mohr DC, 2004, BMJ-BRIT MED J, V328, P731, DOI 10.1136/bmj.38041.724421.55; Moraes MN, 2017, BBA-MOL CELL RES, V1864, P2415, DOI 10.1016/j.bbamcr.2017.09.011; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nandi D, 2010, IMMUNOBIOLOGY, V215, P443, DOI 10.1016/j.imbio.2009.08.003; Nellan A, 2018, BLOOD, V132, P662, DOI 10.1182/blood-2018-05-846428; Nguyen NLT, 2017, AM J PHYSIOL-REG I, V312, pR132, DOI 10.1152/ajpregu.00344.2016; Niraula A, 2019, BIOL PSYCHIAT, V85, P679, DOI 10.1016/j.biopsych.2018.09.030; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Path G, 2000, EUR J CLIN INVEST, V30, P91, DOI 10.1046/j.1365-2362.2000.0300s3091.x; Pbert L, 2012, THORAX, V67, P769, DOI 10.1136/thoraxjnl-2011-200253; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Perry RJ, 2018, CELL, V172, P234, DOI 10.1016/j.cell.2017.12.001; Perry RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01143-w; Perry RJ, 2017, J CLIN INVEST, V127, P657, DOI 10.1172/JCI88477; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Porter C, 2016, CELL METAB, V24, P246, DOI 10.1016/j.cmet.2016.07.004; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Reza MM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01131-0; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Rouget C, 2004, BRIT J PHARMACOL, V141, P831, DOI 10.1038/sj.bjp.0705616; Roussou E, 2013, RHEUMATOL INT, V33, P1367, DOI 10.1007/s00296-011-2292-1; Russell G, 2019, NAT REV ENDOCRINOL, V15, P525, DOI 10.1038/s41574-019-0228-0; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Seo D, 2014, NEUROPSYCHOPHARMACOL, V39, P670, DOI 10.1038/npp.2013.250; Simpson R, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-15; Steensberg A, 2003, J PHYSIOL-LONDON, V548, P631, DOI 10.1113/jphysiol.2002.032938; Stumvoll M, 1998, AM J PHYSIOL-ENDOC M, V274, pE817, DOI 10.1152/ajpendo.1998.274.5.E817; Timper K, 2017, CELL REP, V19, P267, DOI 10.1016/j.celrep.2017.03.043; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; Vida M, 2015, DIS MODEL MECH, V8, P721, DOI 10.1242/dmm.019166; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wang LC, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0401-5; Weickert MO, 2006, DIABETOLOGIA, V49, P1732, DOI 10.1007/s00125-006-0295-3; Weis S, 2017, CELL, V169, P1263, DOI 10.1016/j.cell.2017.05.031; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Yan C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143217; Zhang C, 2016, DEV MKT SCI, P6; Zhang JC, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.112; Zhang WL, 2014, J BIOL CHEM, V289, P32178, DOI 10.1074/jbc.M114.601096	102	64	67	8	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					372	+		10.1016/j.cell.2020.05.054	http://dx.doi.org/10.1016/j.cell.2020.05.054			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32610084	Green Accepted, Bronze			2022-12-28	WOS:000552745000010
J	Griffin, S				Griffin, Shaun			Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					Eckerle I, 2020, LANCET, V396, P514, DOI 10.1016/S0140-6736(20)31482-3; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5	2	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2728	10.1136/bmj.m2728	http://dx.doi.org/10.1136/bmj.m2728			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636189	Bronze			2022-12-28	WOS:000548155700003
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Major US medical organisations urge people to wear masks	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, NY TIMES; Branham D., 2020, DALLAS MORNING NEWS; CNN Politics, CNN POLITICS; Neal DJ, 2020, MIAMI HERALD; Oppel Jr R.A., 2020, NEW YORK TIMES; Singman B., MARK MEADOWS SAYS TH	6	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2723	10.1136/bmj.m2723	http://dx.doi.org/10.1136/bmj.m2723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636181	Bronze			2022-12-28	WOS:000548155700002
J	Quinn, KL; Stukel, T; Stall, NM; Huang, AJ; Isenberg, S; Tanuseputro, P; Goldman, R; Cam, P; Kavalieratos, D; Detsky, AS; Bell, CM				Quinn, Kieran L.; Stukel, Therese; Stall, Nathan M.; Huang, Anjie; Isenberg, Sarina; Tanuseputro, Peter; Goldman, Russell; Cam, Peter; Kavalieratos, Dio; Detsky, Allan S.; Bell, Chaim M.			Association between palliative care and healthcare outcomes among adults with terminal non-cancer illness: population based matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; HEART-FAILURE; RANDOMIZED-TRIAL; END; DISEASE; TRAJECTORIES; INDICATORS; PATIENT; BURDEN; PLACE	OBJECTIVE To measure the associations between newly initiated palliative care in the last six months of life, healthcare use, and location of death in adults dying from non-cancer illness, and to compare these associations with those in adults who die from cancer at a population level. DESIGN Population based matched cohort study. SETTING Ontario, Canada between 2010 and 2015. PARTICIPANTS 113 540 adults dying from cancer and non-cancer illness who were given newly initiated physician delivered palliative care in the last six months of life administered across all healthcare settings. Linked health administrative data were used to directly match patients on cause of death, hospital frailty risk score, presence of metastatic cancer, residential location (according to 1 of 14 local health integration networks that organise all healthcare services in Ontario), and a propensity score to receive palliative care that was derived by using age and sex. MAIN OUTCOME MEASURES Rates of emergency department visits, admissions to hospital, and admissions to the intensive care unit, and odds of death at home versus in hospital after first palliative care visit, adjusted for patient characteristics (such as age, sex, and comorbidities). RESULTS In patients dying from non-cancer illness related to chronic organ failure (such as heart failure, cirrhosis, and stroke), palliative care was associated with reduced rates of emergency department visits (crude rate 1.9 (standard deviation 6.2) v 2.9 (8.7) per person year; adjusted rate ratio 0.88, 95% confidence interval 0.85 to 0.91), admissions to hospital (crude rate 6.1 (standard deviation 10.2) v 8.7 (12.6) per person year; adjusted rate ratio 0.88, 95% confidence interval 0.86 to 0.91), and admissions to the intensive care unit (crude rate 1.4 (standard deviation 5.9) v 2.9 (8.7) per person year; adjusted rate ratio 0.59, 95% confidence interval 0.56 to 0.62) compared with those who did not receive palliative care. Additionally increased odds of dying at home or in a nursing home compared with dying in hospital were found in these patients (n=6936 (49.5%) v n=9526 (39.6%); adjusted odds ratio 1.67, 95% confidence interval 1.60 to 1.74). Overall, in patients dying from dementia, palliative care was associated with increased rates of emergency department visits (crude rate 1.2 (standard deviation 4.9) v 1.3 (5.5) per person year; adjusted rate ratio 1.06, 95% confidence interval 1.01 to 1.12) and admissions to hospital (crude rate 3.6 (standard deviation 8.2) v 2.8 (7.8) per person year; adjusted rate ratio 1.33, 95% confidence interval 1.27 to 1.39), and reduced odds of dying at home or in a nursing home (n=6667 (72.1%) v n=13 384 (83.5%); adjusted odds ratio 0.68, 95% confidence interval 0.64 to 0.73). However, these rates differed depending on whether patients dying with dementia lived in the community or in a nursing home. No association was found between healthcare use and palliative care for patients dying from dementia who lived in the community, and these patients had increased odds of dying at home. CONCLUSIONS These findings highlight the potential benefits of palliative care in some non-cancer illnesses. Increasing access to palliative care through sustained investment in physician training and current models of collaborative palliative care could improve end-of-life care, which might have important implications for health policy.	[Quinn, Kieran L.; Cam, Peter; Detsky, Allan S.; Bell, Chaim M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Quinn, Kieran L.; Stukel, Therese; Huang, Anjie; Tanuseputro, Peter; Cam, Peter; Bell, Chaim M.] Inst Clin Evaluat Sci ICES, Toronto, ON, Canada; [Quinn, Kieran L.; Stukel, Therese; Huang, Anjie; Tanuseputro, Peter; Cam, Peter; Bell, Chaim M.] Inst Clin Evaluat Sci ICES, Ottawa, ON, Canada; [Quinn, Kieran L.; Stukel, Therese; Stall, Nathan M.; Cam, Peter; Detsky, Allan S.; Bell, Chaim M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Quinn, Kieran L.; Cam, Peter; Detsky, Allan S.; Bell, Chaim M.] Sinai Hlth Syst, Dept Med, Toronto, ON, Canada; [Stall, Nathan M.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Stall, Nathan M.] Univ Toronto, Div Geriatr Med, Dept Med, Toronto, ON, Canada; [Isenberg, Sarina] Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Isenberg, Sarina] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Isenberg, Sarina; Goldman, Russell] Temmy Latner Ctr Palliat Care, Toronto, ON, Canada; [Tanuseputro, Peter] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Tanuseputro, Peter] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Tanuseputro, Peter] Bruyere Res Inst, Ottawa, ON, Canada; [Tanuseputro, Peter] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Goldman, Russell] Sinai Hlth Syst, Interdept Div Palliat Care, Toronto, ON, Canada; [Kavalieratos, Dio] Emory Univ, Dept Med, Atlanta, GA 30322 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Emory University	Quinn, KL (corresponding author), Sinai Hlth Syst, 60 Murray St,2nd Floor Room 404, Toronto, ON M5T 3L9, Canada.	kieran.quinn@sinaihealth.ca	Kavalieratos, Dio/GLV-4567-2022; Kavalieratos, Dio/GLR-1388-2022; Isenberg, Sarina/AAE-4407-2021	Kavalieratos, Dio/0000-0001-5283-0792; Quinn, Kieran/0000-0002-1681-5170	Institute for Clinical Evaluative Sciences (ICES); Sinai Health System Research Foundation; CIHR Vanier Scholarship Program; Eliot Phillipson Clinician-Scientist Training Program; Clinician Investigator Program at the University of Toronto; National Institutes of Health [K01HL133466]; Cystic Fibrosis Foundation; Milbank Foundation; Ontario Ministry of Health and Long term Care (MOHLTC)	Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Sinai Health System Research Foundation; CIHR Vanier Scholarship Program(Canadian Institutes of Health Research (CIHR)); Eliot Phillipson Clinician-Scientist Training Program; Clinician Investigator Program at the University of Toronto; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Milbank Foundation; Ontario Ministry of Health and Long term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long term Care (MOHLTC). The analysis was supported by a research grant KLQ and CMB received from the Sinai Health System Research Foundation to perform this work. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions and statements expressed herein are those of the author, and not necessarily those of CIHI. We thank IMS Brogan for use of their Drug Information Database. KLQ and NMS receive funding from the CIHR Vanier Scholarship Program, the Eliot Phillipson Clinician-Scientist Training Program, and the Clinician Investigator Program at the University of Toronto. DK receives research funding from the National Institutes of Health (K01HL133466), the Cystic Fibrosis Foundation, and the Milbank Foundation.	Agar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181020; Ahronheim J C, 2000, J Palliat Med, V3, P265, DOI 10.1089/jpm.2000.3.265; Aiken LS, 2006, J PALLIAT MED, V9, P111, DOI 10.1089/jpm.2006.9.111; Alla F, 2002, EUR J HEART FAIL, V4, P337, DOI 10.1016/S1388-9842(02)00006-5; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1218, DOI 10.1002/pds.1674; Bahadori Katayoon, 2007, Int J Chron Obstruct Pulmon Dis, V2, P241; Barbera Lisa, 2015, CMAJ Open, V3, pE292, DOI 10.9778/cmajo.20150005; Bekelman DB, 2018, JAMA INTERN MED, V178, P511, DOI 10.1001/jamainternmed.2017.8667; Brannstrom M, 2014, EUR J HEART FAIL, V16, P1142, DOI 10.1002/ejhf.151; Braun LT, 2016, CIRCULATION, V134, pE198, DOI 10.1161/CIR.0000000000000438; Brown CRL, 2018, PALLIATIVE MED, V32, P1334, DOI 10.1177/0269216318780223; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Courtright KR, 2018, ANN INTERN MED, V168, P71, DOI 10.7326/M17-2164; De Roo ML, 2013, J PAIN SYMPTOM MANAG, V46, P556, DOI 10.1016/j.jpainsymman.2012.09.013; De Schreye R, 2017, PALLIATIVE MED, V31, P932, DOI 10.1177/0269216317705099; Gaertner J, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2925; Gershon AS, 2018, AM J RESP CRIT CARE, V198, P1389, DOI 10.1164/rccm.201803-0592OC; Gilbert T, 2018, LANCET, V391, P1775, DOI 10.1016/S0140-6736(18)30668-8; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Harrison MB, 2002, MED CARE, V40, P271, DOI 10.1097/00005650-200204000-00003; Health Quality Ontario, 2016, PALL CAR END LIF; Howlett JG, 2016, CAN J CARDIOL, V32, P296, DOI 10.1016/j.cjca.2015.06.019; Hua M, 2017, J PALLIAT MED, V20, P372, DOI 10.1089/jpm.2016.0363; Kavalieratos D, 2017, J AM COLL CARDIOL, V70, P1919, DOI 10.1016/j.jacc.2017.08.036; Kavalieratos D, 2016, JAMA-J AM MED ASSOC, V316, P2104, DOI 10.1001/jama.2016.16840; Kelley AS, 2015, ANN INTERN MED, V163, P729, DOI 10.7326/M15-0381; Lang JJ, 2018, CAN MED ASSOC J, V190, pE1296, DOI 10.1503/cmaj.180698; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Maetens A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025180; McAlister F, 2019, BMJ QUAL SAF, V28, P284, DOI 10.1136/bmjqs-2018-008661; McDermott C, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653589; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Mizuno A, 2017, J CARDIOL, V70, P335, DOI 10.1016/j.jjcc.2017.02.010; Muggah E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-452; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Nieminen MS, 2015, INT J CARDIOL, V191, P256, DOI 10.1016/j.ijcard.2015.04.235; Possin KL, 2019, JAMA INTERN MED, V179, P1658, DOI 10.1001/jamainternmed.2019.4101; Quinn KL, 2019, J GEN INTERN MED, V34, P2763, DOI 10.1007/s11606-019-05333-8; Qureshi D, 2018, J PALLIAT MED, V21, P1588, DOI 10.1089/jpm.2018.0049; Qureshi D, 2019, PALLIATIVE MED, V33, P150, DOI 10.1177/0269216318815794; Rabow MW, 2004, ARCH INTERN MED, V164, P83, DOI 10.1001/archinte.164.1.83; Radwany SM, 2014, POPUL HEALTH MANAG, V17, P106, DOI 10.1089/pop.2013.0017; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rogers JG, 2017, J AM COLL CARDIOL, V70, P332, DOI 10.1016/j.jacc.2017.05.030; Seow H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021147; Seow H, 2016, J PALLIAT MED, V19, P16, DOI 10.1089/jpm.2015.0063; Seow H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3496; Sidebottom AC, 2015, J PALLIAT MED, V18, P134, DOI 10.1089/jpm.2014.0192; Singer AE, 2016, J PALLIAT MED, V19, P995, DOI 10.1089/jpm.2015.0367; Stall NM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9557; Tanuseputro P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191322; Tanuseputro P, 2017, PALLIATIVE MED, V31, P247, DOI 10.1177/0269216316653524; Tanuseputro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121759; Teno JM, 2018, JAMA-J AM MED ASSOC, V320, P264, DOI 10.1001/jama.2018.8981; Wong FKY, 2016, HEART, V102, P1100, DOI 10.1136/heartjnl-2015-308638; Yosick L, 2019, J PALLIAT MED, V22, P1075, DOI 10.1089/jpm.2018.0489; ZIMMER JG, 1985, AM J PUBLIC HEALTH, V75, P134, DOI 10.2105/AJPH.75.2.134	60	34	34	4	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2020	370								m2257	10.1136/bmj.m2257	http://dx.doi.org/10.1136/bmj.m2257			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MJ5XW	32631907	hybrid, Green Published			2022-12-28	WOS:000548163900006
J	Arya, S				Arya, Shalini			A child of the slums	SCIENCE			English	Editorial Material								scrambled up a ladder to the tin roof of our house, clutching a book about the evolution of animals. I was 10 years old, and I'd just finished cooking dinner for my entire family-a task that was my daily responsibility. From my perch, I could look out at the slum where we lived in a small town in India. But that wasn't what drew me to the roof: We didn't have any lamps in our house, so I needed sunlight to read my book. I didn't know it at the time, but that study routine was my ticket to a career as a scientist.	[Arya, Shalini] Inst Chem Technol, Mumbai, Maharashtra, India	Institute of Chemical Technology - Mumbai	Arya, S (corresponding author), Inst Chem Technol, Mumbai, Maharashtra, India.								0	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					110	110		10.1126/science.369.6499.110	http://dx.doi.org/10.1126/science.369.6499.110			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MK4IZ	32631895				2022-12-28	WOS:000548751700055
J	Luick, N; Sobirey, L; Bohlen, M; Singh, VP; Mathey, L; Lompe, T; Moritz, H				Luick, Niclas; Sobirey, Lennart; Bohlen, Markus; Singh, Vijay Pal; Mathey, Ludwig; Lompe, Thomas; Moritz, Henning			An ideal Josephson junction in an ultracold two-dimensional Fermi gas	SCIENCE			English	Article								The role of reduced dimensionality in high-temperature superconductors is still under debate. Recently, ultracold atoms have emerged as an ideal model system to study such strongly correlated two-dimensional (2D) systems. Here, we report on the realization of a Josephson junction in an ultracold 2D Fermi gas. We measure the frequency of Josephson oscillations as a function of the phase difference across the junction and find excellent agreement with the sinusoidal current phase relation of an ideal Josephson junction. Furthermore, we determine the critical current of our junction in the crossover from tightly bound molecules to weakly bound Cooper pairs. Our measurements clearly demonstrate phase coherence and provide strong evidence for superfluidity in a strongly interacting 2D Fermi gas.	[Luick, Niclas; Sobirey, Lennart; Bohlen, Markus; Lompe, Thomas; Moritz, Henning] Univ Hamburg, Inst Laserphys, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Luick, Niclas; Sobirey, Lennart; Bohlen, Markus; Singh, Vijay Pal; Mathey, Ludwig; Lompe, Thomas; Moritz, Henning] Univ Hamburg, Hamburg Ctr Ultrafast Imaging, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Bohlen, Markus] Sorbonne Univ, Coll France, CNRS, ENS Univ PSL,Lab Kastler Brossel, 24 Rue Lhomond, F-75005 Paris, France; [Singh, Vijay Pal; Mathey, Ludwig] Univ Hamburg, Zentrum Opt Quantentechnol, Luruper Chaussee 149, D-22761 Hamburg, Germany	University of Hamburg; University of Hamburg; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); University of Hamburg	Lompe, T (corresponding author), Univ Hamburg, Inst Laserphys, Luruper Chaussee 149, D-22761 Hamburg, Germany.; Lompe, T (corresponding author), Univ Hamburg, Hamburg Ctr Ultrafast Imaging, Luruper Chaussee 149, D-22761 Hamburg, Germany.	tlompe@physik.uni-hamburg.de	Moritz, Henning/E-7919-2010	Moritz, Henning/0000-0002-4854-5806; Bohlen, Markus/0000-0003-4108-0409; Sobirey, Lennart/0000-0002-5567-9327; Singh, Vijay Pal/0000-0001-8881-978X; Lompe, Thomas/0000-0002-7880-1639; Luick, Niclas/0000-0003-3283-8695	European Union's Seventh Framework Programme (FP7/2007-2013) [335431]; DFG [SFB 925]; excellence cluster "The Hamburg Centre for Ultrafast Imaging" [EXC 1074, 194651731]; excellence cluster "Advanced Imaging of Matter" [EXC 2056, 390715994]; Labex ICFP of Ecole Normale Superieure Paris	European Union's Seventh Framework Programme (FP7/2007-2013); DFG(German Research Foundation (DFG)); excellence cluster "The Hamburg Centre for Ultrafast Imaging"; excellence cluster "Advanced Imaging of Matter"; Labex ICFP of Ecole Normale Superieure Paris	This work was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 335431 and by the DFG in the framework of SFB 925 and the excellence clusters "The Hamburg Centre for Ultrafast Imaging" - EXC 1074 - project ID 194651731 and "Advanced Imaging of Matter" - EXC 2056 - project ID 390715994. M.B. acknowledges support by Labex ICFP of Ecole Normale Superieure Paris.	Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; Ancilotto F, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.033627; ANDERSON PW, 1963, PHYS REV LETT, V10, P230, DOI 10.1103/PhysRevLett.10.230; Azurenko AM, 2017, NATURE, V545, P462, DOI 10.1038/nature22362; Betz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.020407; Boettcher I, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.045303; Burchianti A, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.025302; Cataliotti FS, 2001, SCIENCE, V293, P843, DOI 10.1126/science.1062612; Eckel S, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.063619; Eckel S, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031052; Fenech K, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.045302; Frohlich B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105301; Golubov AA, 2004, REV MOD PHYS, V76, P411, DOI 10.1103/RevModPhys.76.411; Hadzibabic Z, 2011, RIV NUOVO CIMENTO, V34, P389, DOI 10.1393/ncr/i2011-10066-3; Hu W, 2014, NAT MATER, V13, P705, DOI [10.1038/nmat3963, 10.1038/NMAT3963]; Hueck K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.060402; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Kinnunen JJ, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aaa4ad; LeBlanc LJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.025302; Lee JG, 2013, SCI REP-UK, V3, DOI [10.1038/srep01034, 10.1038/srep02197]; Levinsen J., 2015, ANN REV COLD ATOMS M, V3, P1; Levy S, 2007, NATURE, V449, P579, DOI 10.1038/nature06186; Luick N., 2020, ZENODO, DOI [10.5281/zenodo.3786298, DOI 10.5281/ZENODO.3786298]; Luick N., 2020, ZENODO, DOI [10.5281/zenodo.3744797, DOI 10.5281/ZENODO.3744797]; Luick N., 2020, ZENODO, DOI [10.5281/zenodo, DOI 10.5281/ZENODO]; Makhalov V, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.045301; Meier F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.033610; Mitra D, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.093601; Murthy PA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043611; Okamoto J, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.144505; Ong W, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.110403; Petrov DS, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.031601; Petrov DS, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012706; Prokof'ev NV, 2018, J EXP THEOR PHYS+, V127, P860, DOI 10.1134/S1063776118110092; Ries MG, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.230401; Ryu C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.205301; Singh V. P., 2020, ARXIV200208375CONDMA; Singh VP, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.043631; Sommer AT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.045302; Spagnolli G, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.230403; Spuntarelli A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.040401; Turlapov AV, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa7ad9; Valtolina G, 2015, SCIENCE, V350, P1505, DOI 10.1126/science.aac9725; Watanabe G, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.053602; Zaccanti M, 2019, PHYS REV A, V100, DOI 10.1103/PhysRevA.100.063601	46	29	30	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					89	+		10.1126/science.aaz2342	http://dx.doi.org/10.1126/science.aaz2342			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631891	Green Submitted			2022-12-28	WOS:000548751700051
J	Iacobucci, G				Iacobucci, Gareth			New GP partners in England can now access "golden hello" of up to 20 pound 000	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England, NEW PARTN PAYM SCHEM; RIMMER A, 2020, BMJ-BRIT MED J, V368, P33962, DOI DOI 10.1136/BMJ.M533	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2020	370								m2665	10.1136/bmj.m2665	http://dx.doi.org/10.1136/bmj.m2665			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MM0GY	32616619				2022-12-28	WOS:000549840000009
J	Nowogrodzki, A				Nowogrodzki, Anna			WHAT PROJECT-MANAGEMENT SOFTWARE CAN DO FOR SCIENTISTS	NATURE			English	Editorial Material																			0	0	0	4	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					157	158		10.1038/d41586-020-01918-0	http://dx.doi.org/10.1038/d41586-020-01918-0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MD5NW	32601495				2022-12-28	WOS:000544019300008
J	Yu, HC; McCuller, L; Tse, M; Kijbunchoo, N; Barsotti, L; Mavalvala, N				Yu, Haocun; McCuller, L.; Tse, M.; Kijbunchoo, N.; Barsotti, L.; Mavalvala, N.		LIGO Sci Collaboration	Quantum correlations between light and the kilogram-mass mirrors of LIGO	NATURE			English	Article							NOISE	The measurement of minuscule forces and displacements with ever greater precision is inhibited by the Heisenberg uncertainty principle, which imposes a limit to the precision with which the position of an object can be measured continuously, known as the standard quantum limit(1-4). When light is used as the probe, the standard quantum limit arises from the balance between the uncertainties of the photon radiation pressure applied to the object and of the photon number in the photoelectric detection. The only way to surpass the standard quantum limit is by introducing correlations between the position/momentum uncertainty of the object and the photon number/phase uncertainty of the light that it reflects(5). Here we confirm experimentally the theoretical prediction(5)that this type of quantum correlation is naturally produced in the Laser Interferometer Gravitational-wave Observatory (LIGO). We characterize and compare noise spectra taken without squeezing and with squeezed vacuum states injected at varying quadrature angles. After subtracting classical noise, our measurements show that the quantum mechanical uncertainties in the phases of the 200-kilowatt laser beams and in the positions of the 40-kilogram mirrors of the Advanced LIGO detectors yield a joint quantum uncertainty that is a factor of 1.4 (3 decibels) below the standard quantum limit. We anticipate that the use of quantum correlations will improve not only the observation of gravitational waves, but also more broadly future quantum noise-limited measurements. Quantum correlations between the laser beams and the positions of the 40-kg mirrors of LIGO are confirmed experimentally, enabling high-precision measurements of both gravitational waves and macroscopic quantum states.	[Yu, Haocun; McCuller, L.; Tse, M.; Barsotti, L.; Mavalvala, N.] MIT, LIGO, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kijbunchoo, N.] Australian Natl Univ, OzGrav, Canberra, ACT, Australia	Massachusetts Institute of Technology (MIT); Australian National University	Yu, HC; McCuller, L (corresponding author), MIT, LIGO, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	haocunyu@mit.edu; mcculler@mit.edu	Helmling-Cornell, Adrian/AAG-8500-2020; McClelland, David E/E-6765-2010; Mow-Lowry, Conor M/F-8843-2015; Yu, Haocun/ABA-5429-2020; McRae, Terry/J-5986-2015; Ward, Robert/I-8032-2014	Helmling-Cornell, Adrian/0000-0002-7709-8638; McClelland, David E/0000-0001-6210-5842; Mow-Lowry, Conor M/0000-0002-0351-4555; /0000-0003-0219-9706; Fulda, Paul/0000-0003-2564-2045; McRae, Terry/0000-0002-6540-6824; Ward, Robert/0000-0001-5503-5241; Dwyer, Sheila/0000-0002-2068-277X; Mansell, Georgia/0000-0003-4736-6678; Toland, Karl/0000-0001-9537-9698; Dupej, Peter/0000-0001-9215-5576; Blair, Carl/0000-0003-4566-6888; Ottaway, David/0000-0001-6794-1591; Venugopalan, Gautam/0000-0003-4414-9918; Spencer, Andrew/0000-0003-4418-3366; Sun, Ling/0000-0001-7959-892X; Mozzon, Simone/0000-0002-8855-2509; Corbitt, Thomas/0000-0002-5520-8541; /0000-0003-1510-4921; Yu, Haocun/0000-0002-7597-098X; Karki, Sudarshan/0000-0001-9982-3661; Buikema, Aaron/0000-0001-9409-5757; Xiao, Liting/0000-0003-2703-449X; schwartz, eyal/0000-0001-8922-7794; Zweizig, John/0000-0002-1521-3397; Nuttall, Laura Kate/0000-0001-7472-0201; Covas, Pep/0000-0002-1845-9309; McCuller, Lee/0000-0003-0851-0593; Asali, Yasmeen/0000-0002-8320-2198; Lundgren, Andrew/0000-0002-0363-4469	STFC [ST/N005422/1, ST/S000305/1, ST/N000072/1, Gravitational Waves, ST/S00243X/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.131103; Braginsky V. B., 1992, QUANTUM MEASUREMENT; Braginsky VB, 1996, REV MOD PHYS, V68, P1, DOI 10.1103/RevModPhys.68.1; Buonanno A, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.042006; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Cripe J, 2019, NATURE, V568, P364, DOI 10.1038/s41586-019-1051-4; Danilishin S, 2008, CREATION QUANTUM OSC; Kimble HJ, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.022002; Kiwamu I, 2017, T1700131 LIGO; Kwee P, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.062006; Mason D, 2019, NAT PHYS, V15, P745, DOI 10.1038/s41567-019-0533-5; Moller CB, 2017, NATURE, V547, P191, DOI 10.1038/nature22980; Purdue P, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.122004; Purdy TP, 2017, SCIENCE, V356, P1265, DOI 10.1126/science.aag1407; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Sudhir V, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.031055; Suh J, 2014, SCIENCE, V344, P1262, DOI 10.1126/science.1253258; Sun L., 2020, CHARACTERIZATION SYS; Teufel JD, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.013602; Tse M, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.231107; Unruh W. G., 1982, QUANTUM OPTICS EXPT; Wilson DJ, 2015, NATURE, V524, P325, DOI 10.1038/nature14672	22	58	58	2	44	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					43	+		10.1038/s41586-020-2420-8	http://dx.doi.org/10.1038/s41586-020-2420-8			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32612226	Green Submitted, Green Accepted			2022-12-28	WOS:000544773600007
J	Griffin, S				Griffin, Shaun			Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1422; Torjesen I, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2263	2	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2650	10.1136/bmj.m2650	http://dx.doi.org/10.1136/bmj.m2650			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611587	Bronze			2022-12-28	WOS:000548489100010
J	Horton, R				Horton, Richard			Offline: The second wave	LANCET			English	Editorial Material												richard.horton@lancet.com							0	12	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2020	395	10242					1960	1960						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MJ0ZZ	32593328	Bronze, Green Published			2022-12-28	WOS:000547825600009
J	Gonzalez-Rubio, G; Mosquera, J; Kumar, V; Pedrazo-Tardajos, A; Llombart, P; Solis, DM; Lobato, I; Noya, EG; Guerrero-Martinez, A; Taboada, JM; Obelleiro, F; MacDowell, LG; Bals, S; Liz-Marzan, LM				Gonzalez-Rubio, Guillermo; Mosquera, Jesus; Kumar, Vished; Pedrazo-Tardajos, Adrian; Llombart, Pablo; Solis, Diego M.; Lobato, Ivan; Noya, Eva G.; Guerrero-Martinez, Andres; Taboada, Jose M.; Obelleiro, Fernando; MacDowell, Luis G.; Bals, Sara; Liz-Marzan, Luis M.			Micelle-directed chiral seeded growth on anisotropic gold nanocrystals	SCIENCE			English	Article							ELECTRON TOMOGRAPHY; MOLECULAR-DYNAMICS; MEDIATED GROWTH; NANORODS; SHAPE; CRYSTAL	Surfactant-assisted seeded growth of metal nanoparticles (NPs) can be engineered to produce anisotropic gold nanocrystals with high chiroptical activity through the templating effect of chiral micelles formed in the presence of dissymmetric cosurfactants. Mixed micelles adsorb on gold nanorods, forming quasihelical patterns that direct seeded growth into NPs with pronounced morphological and optical handedness. Sharp chiral wrinkles lead to chiral plasmon modes with high dissymmetry factors (similar to 0.20). Through variation of the dimensions of chiral wrinkles, the chiroptical properties can be tuned within the visible and near-infrared electromagnetic spectrum. The micelle-directed mechanism allows extension to other systems, such as the seeded growth of chiral platinum shells on gold nanorods. This approach provides a reproducible, simple, and scalable method toward the fabrication of NPs with high chiral optical activity.	[Gonzalez-Rubio, Guillermo; Mosquera, Jesus; Kumar, Vished; Liz-Marzan, Luis M.] CIC BiomaGUNE, Basque Res & Technol Alliance BRTA, Donostia San Sebastian 20014, Spain; [Pedrazo-Tardajos, Adrian; Bals, Sara] Univ Antwerp, Electron Microscopy Mat Res EMAT, B-2020 Antwerp, Belgium; [Llombart, Pablo; Guerrero-Martinez, Andres; MacDowell, Luis G.] Univ Complutense Madrid, Dept Quim Fis, Madrid 28040, Spain; [Llombart, Pablo] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Solis, Diego M.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Taboada, Jose M.; Liz-Marzan, Luis M.] Univ Extremadura, Dept Tecnol Comp Comunicac, Caceres 10003, Spain; [Obelleiro, Fernando; Liz-Marzan, Luis M.] Univ Vigo, Dept Teoria Senal & Comunicac, Vigo 36310, Spain; [Liz-Marzan, Luis M.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain; [Liz-Marzan, Luis M.] CIBER Bioingn Biomat & Nanomed CIBER BBN, Donostia San Sebastian 20014, Spain	CIC biomaGUNE; University of Antwerp; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Pennsylvania; Universidad de Extremadura; Universidade de Vigo; Basque Foundation for Science; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Liz-Marzan, LM (corresponding author), CIC BiomaGUNE, Basque Res & Technol Alliance BRTA, Donostia San Sebastian 20014, Spain.; Bals, S (corresponding author), Univ Antwerp, Electron Microscopy Mat Res EMAT, B-2020 Antwerp, Belgium.; Liz-Marzan, LM (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.; Liz-Marzan, LM (corresponding author), CIBER Bioingn Biomat & Nanomed CIBER BBN, Donostia San Sebastian 20014, Spain.	sara.bals@uantwerpen.be; llizmarzan@cicbiomagune.es	Mosquera Mosquera, Jesus/A-9616-2016; Gonzalez-Rubio, Guillermo/L-4234-2017; González-Rubio, Guillermo/AAC-2374-2020; MacDowell, Luis G/H-3497-2017; Liz-Marzán, Luis M/B-8910-2011; Mosquera, Jesus/GZG-7896-2022; Noya, Eva/F-4958-2010; Bals, Sara/F-6963-2016; Taboada, Jose M./A-2897-2010	Mosquera Mosquera, Jesus/0000-0001-6878-4567; González-Rubio, Guillermo/0000-0003-2647-651X; MacDowell, Luis G/0000-0003-1900-1241; Liz-Marzán, Luis M/0000-0002-6647-1353; Noya, Eva/0000-0002-6359-1026; Bals, Sara/0000-0002-4249-8017; Kumar, Vished/0000-0002-8068-0098; Pedrazo-Tardajos, Adrian/0000-0003-4181-9226; Taboada, Jose M./0000-0003-1660-8910; Guerrero-Martinez, Andres/0000-0001-8576-2896; Lobato Hoyos, Ivan Pedro/0000-0003-4088-6398	European Research Council (ERC AdG grant) [787510]; Spanish MICIU [BES-2014-068972, TEC2017-85376-C2-1-R, TEC2017-85376-C2-2-R, RTI2018-095844-B-I00, FIS2017-89361-C3-2-P, FJCI-2015-25080]; European Commission under the Horizon 2020 Programme [731019]; ERC [815128]; ERDF; Galician Regional Government; Spanish Network of Supercomputing [QCM-2018-3-0039, QCM-2019-10038]; Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency [MDM-2017-0720]	European Research Council (ERC AdG grant)(European Research Council (ERC)); Spanish MICIU(Spanish Government); European Commission under the Horizon 2020 Programme; ERC(European Research Council (ERC)European Commission); ERDF(European Commission); Galician Regional Government; Spanish Network of Supercomputing; Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency(Spanish Government)	L.M.L.-M. acknowledges funding from the European Research Council (ERC AdG grant no. 787510). G.G.-R. and J.M. thank the Spanish MICIU for FPI (BES-2014-068972) and Juan de la Cierva (FJCI-2015-25080) fellowships. S.B., L.M.L.-M., V.K., and A.P.-T. acknowledge financial support from the European Commission under the Horizon 2020 Programme by grant no. 731019 (EUSMI) and ERC Consolidator grant no. 815128 (REALNANO). J.M.T. and F.O. acknowledge financial support from the Spanish MICIU (grants TEC2017-85376-C2-1-R and TEC2017-85376-C2-2-R), as well as from the ERDF and the Galician Regional Government as part of the agreement for funding the Atlantic Research Center for Information and Communication Technologies (AtlantTIC). A.G.-M. acknowledges financial support from the Spanish MICIU (grant no. RTI2018-095844-B-I00). E.G.N. and L.G.M. acknowledge funds from the Spanish MICIU (grant no. FIS2017-89361-C3-2-P), as well as the use of the Mare-Nostrum supercomputer and the technical support provided by Barcelona Supercomputing Center from the Spanish Network of Supercomputing (grant nos. QCM-2018-3-0039 and QCM-2019-10038). This work was performed under the Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency (grant no. MDM-2017-0720).	Altantzis T, 2019, NANO LETT, V19, P477, DOI 10.1021/acs.nanolett.8b04303; Bailey J, 1998, SCIENCE, V281, P672, DOI 10.1126/science.281.5377.672; Batista CAS, 2015, SCIENCE, V350, P138, DOI 10.1126/science.1242477; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen CL, 2008, J AM CHEM SOC, V130, P13555, DOI 10.1021/ja805683r; Engel S, 2017, CHEM SOC REV, V46, P2057, DOI 10.1039/c7cs00023e; Fan ZY, 2012, NANO LETT, V12, P3283, DOI 10.1021/nl3013715; FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0; Gailhanou M., 2003, J APPL CRYSTALLOGR, V24, P14012; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Gonzalez-Rubio G, 2019, ACS NANO, V13, P4424, DOI 10.1021/acsnano.8b09658; Goris B, 2012, ULTRAMICROSCOPY, V113, P120, DOI 10.1016/j.ultramic.2011.11.004; Govorov AO, 2010, NANO LETT, V10, P1374, DOI 10.1021/nl100010v; Greciano EE, 2019, J AM CHEM SOC, V141, P7463, DOI 10.1021/jacs.9b02045; GREEN MM, 1989, J AM CHEM SOC, V111, P6452, DOI 10.1021/ja00198a084; Guerrero-Martinez A, 2011, ANGEW CHEM INT EDIT, V50, P5499, DOI 10.1002/anie.201007536; HANEIN D, 1994, SCIENCE, V263, P1413, DOI 10.1126/science.8128221; Hanske C, 2017, J PHYS CHEM C, V121, P10899, DOI 10.1021/acs.jpcc.6b12161; Hao CL, 2020, ADV MATER, V32, DOI 10.1002/adma.201802075; Heinz H, 2008, J PHYS CHEM C, V112, P17281, DOI 10.1021/jp801931d; Heinz H, 2009, J AM CHEM SOC, V131, P9704, DOI 10.1021/ja900531f; Hentschel M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602735; HODGE LA, 1979, NATURE, V280, P250, DOI 10.1038/280250a0; Hong S, 2011, CHEM MATER, V23, P2011, DOI 10.1021/cm103273c; Ito TH, 2016, LANGMUIR, V32, P8461, DOI 10.1021/acs.langmuir.6b02367; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Karimullah AS, 2015, ADV MATER, V27, P5610, DOI 10.1002/adma.201501816; Kim JY, 2019, J AM CHEM SOC, V141, P11739, DOI 10.1021/jacs.9b00700; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Lee HE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14117-x; Lee HE, 2018, NATURE, V556, P360, DOI 10.1038/s41586-018-0034-1; Llombart P, 2019, COLLOID SURFACE A, V580, DOI 10.1016/j.colsurfa.2019.123730; Lohse SE, 2014, CHEM MATER, V26, P34, DOI 10.1021/cm402384j; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Taboada JM, 2013, P IEEE, V101, P350, DOI 10.1109/JPROC.2012.2194269; Mark AG, 2013, NAT MATER, V12, P802, DOI [10.1038/NMAT3685, 10.1038/nmat3685]; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Solis DM, 2015, IEEE T ANTENN PROPAG, V63, P2141, DOI 10.1109/TAP.2015.2406891; Meena SK, 2016, ANGEW CHEM INT EDIT, V55, P11960, DOI 10.1002/anie.201604594; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Palik E., 1985, HDB OPTICAL CONSTANT, V1; Perez-Juste J, 2004, ADV FUNCT MATER, V14, P571, DOI 10.1002/adfm.200305068; Personick ML, 2013, J AM CHEM SOC, V135, P18238, DOI 10.1021/ja408645b; Pong BK, 2005, LANGMUIR, V21, P11599, DOI 10.1021/la052116k; Ray K, 1999, SCIENCE, V283, P814, DOI 10.1126/science.283.5403.814; Scarabelli L, 2013, CHEM MATER, V25, P4232, DOI 10.1021/cm402177b; Solis DM, 2015, PROG ELECTROMAGN RES, V154, P35, DOI 10.2528/PIER15110103; Solis DM, 2014, ACS NANO, V8, P7559, DOI 10.1021/nn5037703; Taboada JM, 2011, J OPT SOC AM A, V28, P1341, DOI 10.1364/JOSAA.28.001341; Xia YN, 2017, ANGEW CHEM INT EDIT, V56, P60, DOI 10.1002/anie.201604731; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Ye XC, 2013, NANO LETT, V13, P765, DOI 10.1021/nl304478h; Yoon TP, 2003, SCIENCE, V299, P1691, DOI 10.1126/science.1083622; Zanaga D, 2016, PART PART SYST CHAR, V33, P396, DOI 10.1002/ppsc.201600021; Zhang J, 2010, J AM CHEM SOC, V132, P14012, DOI 10.1021/ja106394k; Zheng GC, 2018, ANGEW CHEM INT EDIT, V57, P16452, DOI 10.1002/anie.201810693; Zhu HW, 2005, SMALL, V1, P1180, DOI 10.1002/smll.200500200	60	104	104	63	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1472	+		10.1126/science.aba0980	http://dx.doi.org/10.1126/science.aba0980			55	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32587018	Green Accepted, Green Submitted			2022-12-28	WOS:000545264600040
J	Normile, D				Normile, Dennis			Mars mission would put China among space leaders	SCIENCE			English	Editorial Material																			0	1	1	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1420	1420						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587004				2022-12-28	WOS:000545264600018
J	Kim, JG; Nozawa, S; Kim, H; Choi, EH; Sato, T; Kim, TW; Kim, KH; Ki, H; Kim, J; Choi, M; Lee, Y; Heo, J; Oang, KY; Ichiyanagi, K; Fukaya, R; Lee, JH; Park, J; Eom, I; Chun, SH; Kim, S; Kim, M; Katayama, T; Togashi, T; Owada, S; Yabashi, M; Lee, SJ; Lee, S; Ahn, CW; Ahn, DS; Moon, J; Choi, S; Kim, J; Joo, T; Kim, J; Adachi, SI; Ihee, H				Kim, Jong Goo; Nozawa, Shunsuke; Kim, Hanui; Choi, Eun Hyuk; Sato, Tokushi; Kim, Tae Wu; Kim, Kyung Hwan; Ki, Hosung; Kim, Jungmin; Choi, Minseo; Lee, Yunbeom; Heo, Jun; Oang, Key Young; Ichiyanagi, Kouhei; Fukaya, Ryo; Lee, Jae Hyuk; Park, Jaeku; Eom, Intae; Chun, Sae Hwan; Kim, Sunam; Kim, Minseok; Katayama, Tetsuo; Togashi, Tadashi; Owada, Sigeki; Yabashi, Makina; Lee, Sang Jin; Lee, Seonggon; Ahn, Chi Woo; Ahn, Doo-Sik; Moon, Jiwon; Choi, Seungjoo; Kim, Joonghan; Joo, Taiha; Kim, Jeongho; Adachi, Shin-ichi; Ihee, Hyotcherl			Mapping the emergence of molecular vibrations mediating bond formation	NATURE			English	Article							FREE-ELECTRON LASER; WAVE-PACKET; FEMTOSECOND; DYNAMICS	Fundamental studies of chemical reactions often consider the molecular dynamics along a reaction coordinate using a calculated or suggested potential energy surface(1-5). But fully mapping such dynamics experimentally, by following all nuclear motions in a time-resolved manner-that is, the motions of wavepackets-is challenging and has not yet been realized even for the simple stereotypical bimolecular reaction(6-8): A-B + C -> A + B-C. Here we track the trajectories of these vibrational wavepackets during photoinduced bond formation of the gold trimer complex [Au(CN)(2)(-)](3) in an aqueous monomer solution, using femtosecond X-ray liquidography(9-12) with X-ray free-electron lasers(13,14). In the complex, which forms when three monomers A, B and C cluster together through non-covalent interactions(15,16), the distance between A and B is shorter than that between B and C. Tracking the wavepacket in three-dimensional nuclear coordinates reveals that within the first 60 femtoseconds after photoexcitation, a covalent bond forms between A and B to give A-B + C. The second covalent bond, between B and C, subsequently forms within 360 femtoseconds to give a linear and covalently bonded trimer complex A-B-C. The trimer exhibits harmonic vibrations that we map and unambiguously assign to specific normal modes using only the experimental data. In principle, more intense X-rays could visualize the motion not only of highly scattering atoms such as gold but also of lighter atoms such as carbon and nitrogen, which will open the door to the direct tracking of the atomic motions involved in many chemical reactions.	[Kim, Jong Goo; Kim, Hanui; Choi, Eun Hyuk; Kim, Tae Wu; Ki, Hosung; Kim, Jungmin; Choi, Minseo; Lee, Yunbeom; Heo, Jun; Lee, Sang Jin; Lee, Seonggon; Ahn, Chi Woo; Ahn, Doo-Sik; Ihee, Hyotcherl] Korea Adv Inst Sci & Technol, Dept Chem, Daejeon, South Korea; [Kim, Jong Goo; Kim, Hanui; Choi, Eun Hyuk; Kim, Tae Wu; Ki, Hosung; Kim, Jungmin; Choi, Minseo; Lee, Yunbeom; Heo, Jun; Lee, Sang Jin; Lee, Seonggon; Ahn, Chi Woo; Ahn, Doo-Sik; Ihee, Hyotcherl] Korea Adv Inst Sci & Technol, KI BioCentury, Daejeon, South Korea; [Kim, Jong Goo; Kim, Hanui; Choi, Eun Hyuk; Kim, Tae Wu; Ki, Hosung; Kim, Jungmin; Choi, Minseo; Lee, Yunbeom; Heo, Jun; Lee, Sang Jin; Lee, Seonggon; Ahn, Chi Woo; Ahn, Doo-Sik; Ihee, Hyotcherl] Ctr Nanomat & Chem React, Inst Basic Sci, Daejeon, South Korea; [Nozawa, Shunsuke; Ichiyanagi, Kouhei; Fukaya, Ryo; Adachi, Shin-ichi] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki, Japan; [Nozawa, Shunsuke; Adachi, Shin-ichi] Grad Univ Adv Studies, Sch High Energy Accelerator Sci, Dept Mat Struct Sci, Tsukuba, Ibaraki, Japan; [Sato, Tokushi] Deutsch Elektronen Synchrotron DESY, Ctr Free Electron Laser Sci CFEL, Hamburg, Germany; [Sato, Tokushi] European XFEL, Schenefeld, Germany; [Kim, Kyung Hwan; Joo, Taiha] Pohang Univ Sci & Technol POSTECH, Dept Chem, Pohang, South Korea; [Oang, Key Young] Korea Atom Energy Res Inst, Quantum Opt Div, Radiat Ctr Ultrafast Sci, Daejeon, South Korea; [Lee, Jae Hyuk; Park, Jaeku; Eom, Intae; Chun, Sae Hwan; Kim, Sunam; Kim, Minseok] Pohang Accelerator Lab, Pohang, South Korea; [Katayama, Tetsuo; Togashi, Tadashi; Owada, Sigeki; Yabashi, Makina] Japan Synchrotron Radiat Res Inst, Sayo, Japan; [Katayama, Tetsuo; Togashi, Tadashi; Owada, Sigeki; Yabashi, Makina] RIKEN, SPring Ctr 8, Sayo, Japan; [Moon, Jiwon; Kim, Joonghan] Catholic Univ Korea, Dept Chem, Bucheon, South Korea; [Choi, Seungjoo; Kim, Jeongho] Inha Univ, Dept Chem, Incheon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS); High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European XFEL; Pohang University of Science & Technology (POSTECH); Korea Atomic Energy Research Institute (KAERI); Pohang University of Science & Technology (POSTECH); Japan Synchrotron Radiation Research Institute; RIKEN; Catholic University of Korea; Inha University	Ihee, H (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Daejeon, South Korea.; Ihee, H (corresponding author), Korea Adv Inst Sci & Technol, KI BioCentury, Daejeon, South Korea.; Ihee, H (corresponding author), Ctr Nanomat & Chem React, Inst Basic Sci, Daejeon, South Korea.	hyotcherl.ihee@kaist.ac.kr	Joo, Taiha/C-4495-2008; Ichiyanagi, Kouhei/W-3442-2018; Kim, Jeongho/AAK-8380-2020; Yabashi, Makina/A-2832-2015	Ichiyanagi, Kouhei/0000-0001-7446-034X; Kim, Jeongho/0000-0003-4085-293X; Yabashi, Makina/0000-0002-2472-1684; Lee, Seonggon/0000-0002-3434-2418; Nozawa, Shunsuke/0000-0003-4977-6849; Lee, Sang Jin/0000-0002-1302-0241; Eun Hyuk, Choi/0000-0001-9051-9946; Adachi, Shin-ichi/0000-0002-3676-1165; Kim, Tae Wu/0000-0002-6370-0907; Heo, Jun/0000-0002-6625-7349; Ki, Hosung/0000-0001-8273-6596; Chun, Sae Hwan/0000-0001-8222-4849; Kim, Kyung Hwan/0000-0002-0482-9786	Institute for Basic Science [IBS-R004]; X-ray Free-Electron Laser Priority Strategic Program of MEXT, Japan; Photon and Quantum Basic Research Coordinated Development Program of MEXT, Japan; JSPS KAKENHI [JP17H06141, JP17H06372, JP17H06438, JP19H05782]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2016R1E1A1A01941978]	Institute for Basic Science; X-ray Free-Electron Laser Priority Strategic Program of MEXT, Japan; Photon and Quantum Basic Research Coordinated Development Program of MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Institute for Basic Science (IBS-R004). This work was supported by the X-ray Free-Electron Laser Priority Strategic Program and the Photon and Quantum Basic Research Coordinated Development Program of MEXT, Japan. This work was supported by JSPS KAKENHI grant numbers JP17H06141, JP17H06372, JP17H06438 and JP19H05782. This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2016R1E1A1A01941978). Experiments were performed at the XSS of PAL-XFEL (proposal numbers 2017-2nd-XSS-001 and 2018-2nd-XSS-005), and at the BL3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (proposal numbers 2016A8035, 2016A8055, 2016B8056, 2016B8073, 2017A8043, 2017A8053, 2017B8029, 2018A8006, 2018B8015, 2019A8012 and 2019B8025).	BAUMERT T, 1992, CHEM PHYS LETT, V191, P639, DOI 10.1016/0009-2614(92)85602-7; Biasin E, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.013002; Cho S, 2011, J PHYS CHEM A, V115, P3990, DOI 10.1021/jp109174f; Cui GL, 2013, ANGEW CHEM INT EDIT, V52, P10281, DOI 10.1002/anie.201305487; Debnarova A, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2400231; Glownia JM, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.153003; Haldrup K, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.063001; Henriksen NE, 2008, J PHYS CHEM B, V112, P558, DOI 10.1021/jp075497e; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Iwamura M, 2013, J AM CHEM SOC, V135, P538, DOI 10.1021/ja310004z; Kang HS, 2017, NAT PHOTONICS, V11, P708, DOI 10.1038/s41566-017-0029-8; Katayama T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11499-w; Kim KH, 2015, NATURE, V518, P385, DOI 10.1038/nature14163; Kjaer KS, 2019, CHEM SCI, V10, P5749, DOI 10.1039/c8sc04023k; KRAUSE JL, 1993, J CHEM PHYS, V99, P6562, DOI 10.1063/1.465848; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Lemke HT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15342; Lin JJ, 2003, SCIENCE, V300, P966, DOI 10.1126/science.1083672; McClure SD, 2014, J PHYS CHEM B, V118, P1296, DOI 10.1021/jp411924c; Pan HL, 2017, NAT CHEM, V9, P1175, DOI [10.1038/NCHEM.2858, 10.1038/nchem.2858]; POLLARD WT, 1992, ANNU REV PHYS CHEM, V43, P497, DOI 10.1146/annurev.physchem.43.1.497; Pyykko P, 2004, ANGEW CHEM INT EDIT, V43, P4412, DOI 10.1002/anie.200300624; Ren ZF, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/80/2/026401; Schoenlein RW, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7080850; Sohn SH, 2019, J PHYS CHEM A, V123, P6904, DOI 10.1021/acs.jpca.9b05613; Stankus B, 2019, NAT CHEM, V11, P716, DOI 10.1038/s41557-019-0291-0; van Driel TB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13678; Wolf TJA, 2019, NAT CHEM, V11, P504, DOI 10.1038/s41557-019-0252-7; Yang J, 2018, SCIENCE, V361, P64, DOI 10.1126/science.aat0049; Yang J, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.153002	30	38	38	11	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					520	+		10.1038/s41586-020-2417-3	http://dx.doi.org/10.1038/s41586-020-2417-3			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OL0DJ	32581378	Green Published			2022-12-28	WOS:000585013200002
J	Slomski, A				Slomski, Anita			Clopidogrel Noninferior to Ticagrelor With Less Bleeding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2453	2453		10.1001/jama.2020.10338	http://dx.doi.org/10.1001/jama.2020.10338			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2EU	32573668				2022-12-28	WOS:000595447000005
J	Anderson, CTM				Anderson, Chase T. M.			Taking Back Our Voices - #HumanityIsOurLane	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Anderson, Chase T. M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Anderson, CTM (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.							Belli B, 2020, YALE NEWS       0224; Fowers A, 2020, WASHINGTON POST; Patel N, 2020, GUARDIAN; Thames A, 2019, CONVERSATION; Uche B, 2020, STAT-US	5	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2020	383	17					1609	1611		10.1056/NEJMp2021291	http://dx.doi.org/10.1056/NEJMp2021291			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OH4XI	32603037	Bronze			2022-12-28	WOS:000582579100007
J	Teasdale, B; Schulman, KA				Teasdale, Ben; Schulman, Kevin A.			Are US Hospitals Still "Recession-proof"?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Teasdale, Ben; Schulman, Kevin A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Schulman, Kevin A.] Stanford Univ, Clin Excellence Res Ctr, Stanford, CA 94305 USA; [Schulman, Kevin A.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Teasdale, B (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							[Anonymous], 2018, TRENDW CHARTB 2018; Centers for Medicare & Medicaid Services, NAT HLTH EXP DAT HIS; Fulton BD, 2017, HEALTH AFFAIR, V36, P1530, DOI 10.1377/hlthaff.2017.0556; Kaiser Family Foundation, 2019 EMPL HLTH BEN S; White Chapin., 2019, PRICES PAID HOSP PRI	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2020	383	13							e82	10.1056/NEJMp2018846	http://dx.doi.org/10.1056/NEJMp2018846			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NX2KQ	32610005	Bronze			2022-12-28	WOS:000575544000003
J	Varghese, B; Chew, E; Konig, MF				Varghese, Bibin; Chew, Erin; Konig, Maximilian F.			Digit Ulcerations in a Young Woman Raynaud phenomenon in the context of systemic sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BOTULINUM TOXIN; AUTOANTIBODIES		[Varghese, Bibin; Chew, Erin] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA; [Konig, Maximilian F.] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Konig, MF (corresponding author), Johns Hopkins Univ, Sch Med, Div Rheumatol, 5200 Eastern Ave,Mason F Lord Bldg CT,Ste 4100, Baltimore, MD 21224 USA.	konig@jhmi.edu	Konig, Maximilian F/I-9356-2019	Konig, Maximilian F/0000-0001-5045-5255; Chew, Erin/0000-0002-2748-125X	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health [T32AR048522]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health under Award T32AR048522.	Bello RJ, 2017, ARTHRITIS RHEUMATOL, V69, P1661, DOI 10.1002/art.40123; Dellavance A, 2009, RHEUMATOLOGY, V48, P632, DOI 10.1093/rheumatology/kep070; Herrick AL, 2017, THER ADV MUSCULOSKEL, V9, P317, DOI 10.1177/1759720X17740074; Hughes M, 2017, RHEUMATOLOGY, V56, P14, DOI 10.1093/rheumatology/kew047; Koenig M, 2008, ARTHRITIS RHEUM-US, V58, P3902, DOI 10.1002/art.24038; Kowal-Bielecka O, 2017, ANN RHEUM DIS, V76, P1327, DOI 10.1136/annrheumdis-2016-209909; Spencer-Green G, 1998, ARCH INTERN MED, V158, P595, DOI 10.1001/archinte.158.6.595; Steen VD, 1998, ARTHRITIS RHEUM, V41, P1613, DOI 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O; Uppal L, 2014, J HAND SURG-EUR VOL, V39, P876, DOI 10.1177/1753193413516242; Wigley FM, 2016, NEW ENGL J MED, V375, P556, DOI 10.1056/NEJMra1507638	10	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					385	386		10.1001/jama.2020.6084	http://dx.doi.org/10.1001/jama.2020.6084			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32568390	Green Accepted			2022-12-28	WOS:000562851000029
J	Nguyen, PT; Dorman, LC; Pan, S; Vainchtein, ID; Han, RT; Nakao-Inoue, H; Taloma, SE; Barron, JJ; Molofsky, AB; Kheirbek, MA; Molofsky, AV				Nguyen, Phi T.; Dorman, Leah C.; Pan, Simon; Vainchtein, Ilia D.; Han, Rafael T.; Nakao-Inoue, Hiromi; Taloma, Sunrae E.; Barron, Jerika J.; Molofsky, Ari B.; Kheirbek, Mazen A.; Molofsky, Anna, V			Microglial Remodeling of the Extracellular Matrix Promotes Synapse Plasticity	CELL			English	Article							GRANULE CELLS; HIPPOCAMPAL NEUROGENESIS; MONOCULAR DEPRIVATION; NEURONAL COMPETITION; PATTERN SEPARATION; NMDA RECEPTORS; DENTATE GYRUS; ENGRAM CELLS; MEMORY; EXPERIENCE	Synapse remodeling is essential to encode experiences into neuronal circuits. Here, we define a molecular interaction between neurons and microglia that drives experience-dependent synapse remodeling in the hippocampus. We find that the cytokine interleukin-33 (IL-33) is expressed by adult hippocampal neurons in an experience-dependent manner and defines a neuronal subset primed for synaptic plasticity. Loss of neuronal IL-33 or the microglial IL-33 receptor leads to impaired spine plasticity, reduced newborn neuron integration, and diminished precision of remote fear memories. Memory precision and neuronal IL-33 are decreased in aged mice, and IL-33 gain of function mitigates age-related decreases in spine plasticity. We find that neuronal IL-33 instructs microglial engulfment of the extracellular matrix (ECM) and that its loss leads to impaired ECM engulfment and a concomitant accumulation of ECM proteins in contact with synapses. These data define a cellular mechanism through which microglia regulate experience-dependent synapse remodeling and promote memory consolidation.	[Nguyen, Phi T.; Dorman, Leah C.; Pan, Simon; Vainchtein, Ilia D.; Han, Rafael T.; Nakao-Inoue, Hiromi; Taloma, Sunrae E.; Barron, Jerika J.; Kheirbek, Mazen A.; Molofsky, Anna, V] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Nguyen, Phi T.; Dorman, Leah C.; Pan, Simon; Vainchtein, Ilia D.; Han, Rafael T.; Nakao-Inoue, Hiromi; Taloma, Sunrae E.; Barron, Jerika J.; Kheirbek, Mazen A.; Molofsky, Anna, V] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Nguyen, Phi T.; Barron, Jerika J.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Dorman, Leah C.; Pan, Simon] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA; [Kheirbek, Mazen A.; Molofsky, Anna, V] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Molofsky, AV (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.; Molofsky, AV (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Molofsky, AV (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA.	anna.molofsky@ucsf.edu	Kheirbek, Mazen A/J-3656-2015	Kheirbek, Mazen A/0000-0001-9157-7363; Dorman, Leah/0000-0002-5511-887X; Taloma, Sunrae/0000-0002-7210-8614; Barron, Jerika/0000-0002-8983-3126; Pan, Simon/0000-0003-2847-0584; Nakao-Inoue, Hiromi/0000-0001-5418-0973; Han, Rafael/0000-0002-0123-877X	Pew Charitable Trusts; NIMH [R01 MH108623, R01 MH111754, R01 MH117961, R01MH119349, DP2MH116507]; Brain and Behavior Research Foundation; Burroughs Wellcome Fund; National Science Foundation [1650113]; One Mind Rising Star Award; Human Frontier Science Program; Esther A. and Joseph Klingenstein Fund; McKnight Memory and Cognitive Disorders Award	Pew Charitable Trusts; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Research Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF)); One Mind Rising Star Award; Human Frontier Science Program(Human Frontier Science Program); Esther A. and Joseph Klingenstein Fund; McKnight Memory and Cognitive Disorders Award	We are grateful to Drs. E. Huang, S. Villeda, and members of the Molofsky Lab for helpful comments on the manuscript. We also thank the Mucosal Immunology Studies Team (MIST) for Il33<SUP>H2B-mCherry</SUP>, the UCSF Laboratory for Cell Analysis, and the Chan-Zuckerberg Biohub for sequencing support. A.V.M is supported by the Pew Charitable Trusts, NIMH (R01MH119349 and DP2MH116507), the Brain and Behavior Research Foundation, and the Burroughs Wellcome Fund. P.T.N. is supported by a graduate research fellowship from the National Science Foundation (Grant #1650113). M.A.K. is supported by NIMH (R01 MH108623, R01 MH111754, and R01 MH117961), a One Mind Rising Star Award, the Human Frontier Science Program, the Pew Charitable Trusts, the Esther A. and Joseph Klingenstein Fund, and the McKnight Memory and Cognitive Disorders Award.	Alvarez DD, 2016, SCIENCE, V354, P459, DOI 10.1126/science.aaf2156; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Basu R, 2017, NEURON, V96, P160, DOI 10.1016/j.neuron.2017.09.009; Bednarek E, 2011, NEURON, V69, P1132, DOI 10.1016/j.neuron.2011.02.034; Bennett FC, 2019, CLIN EXP IMMUNOL, V197, P294, DOI 10.1111/cei.13334; Bergami M, 2015, NEURON, V85, P710, DOI 10.1016/j.neuron.2015.01.001; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; Bolos M, 2018, BRAIN BEHAV IMMUN, V68, P76, DOI 10.1016/j.bbi.2017.10.002; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Breton-Provencher V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12659; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Danielson NB, 2016, NEURON, V90, P101, DOI 10.1016/j.neuron.2016.02.019; de Vivo L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2491; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Duan X, 2018, NEURON, V99, P1145, DOI 10.1016/j.neuron.2018.08.019; Eyo UB, 2015, J NEUROSCI, V35, P2417, DOI 10.1523/JNEUROSCI.3279-14.2015; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Fan XL, 2017, ANNU REV NEUROSCI, V40, P251, DOI 10.1146/annurev-neuro-072116-031357; Favuzzi E, 2017, NEURON, V95, P639, DOI 10.1016/j.neuron.2017.06.028; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Fu AKY, 2016, P NATL ACAD SCI USA, V113, pE2705, DOI 10.1073/pnas.1604032113; Galatro TF, 2017, METHODS MOL BIOL, V1559, P333, DOI 10.1007/978-1-4939-6786-5_23; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guo NN, 2018, NAT MED, V24, P438, DOI 10.1038/nm.4491; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hanawa-Suetsugu K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12738-w; Ibi D, 2008, J NEUROCHEM, V105, P921, DOI 10.1111/j.1471-4159.2007.05207.x; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Jaeger BN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05418-8; Josselyn SA, 2020, SCIENCE, V367, P39, DOI 10.1126/science.aaw4325; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kelley KW, 2018, NAT NEUROSCI, V21, P1171, DOI 10.1038/s41593-018-0216-z; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; Knoferle J, 2014, J NEUROSCI, V34, P14069, DOI 10.1523/JNEUROSCI.2281-14.2014; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Levy AD, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00116; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madry C, 2018, NEURON, V97, P299, DOI 10.1016/j.neuron.2017.12.002; Mayer J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-52; McAvoy KM, 2016, NEURON, V91, P1356, DOI 10.1016/j.neuron.2016.08.009; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Miller SM, 2019, NAT NEUROSCI, V22, P1565, DOI 10.1038/s41593-019-0484-2; Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Oh MM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.002.2010; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Orlando C, 2012, J NEUROSCI, V32, P18009, DOI 10.1523/JNEUROSCI.2406-12.2012; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Pan S, 2020, NAT NEUROSCI, V23, P487, DOI 10.1038/s41593-019-0582-1; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Park S, 2016, NEUROPSYCHOPHARMACOL, V41, P2987, DOI 10.1038/npp.2016.73; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pikkarainen T, 1999, J BIOL CHEM, V274, P10975, DOI 10.1074/jbc.274.16.10975; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Ramanathan KR, 2018, J NEUROSCI, V38, P9925, DOI 10.1523/JNEUROSCI.1429-18.2018; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Rowlands D, 2018, J NEUROSCI, V38, P10102, DOI 10.1523/JNEUROSCI.1122-18.2018; Roy DS, 2017, P NATL ACAD SCI USA, V114, pE9972, DOI 10.1073/pnas.1714248114; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Ryan TJ, 2015, SCIENCE, V348, P1007, DOI 10.1126/science.aaa5542; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sipe GO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10905; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Steadman PE, 2020, NEURON, V105, P150, DOI 10.1016/j.neuron.2019.10.013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sun XC, 2020, CELL, V181, P410, DOI 10.1016/j.cell.2020.02.055; Susuki K, 2013, NEURON, V78, P469, DOI 10.1016/j.neuron.2013.03.005; Talabot-Ayer D, 2012, J LEUKOCYTE BIOL, V91, P119, DOI 10.1189/jlb.0811425; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tonnesen J, 2018, CELL, V172, P1108, DOI 10.1016/j.cell.2018.02.007; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tsien RY, 2013, P NATL ACAD SCI USA, V110, P12456, DOI 10.1073/pnas.1310158110; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Valenzuela JC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0606; van der Laan LJW, 1999, J IMMUNOL, V162, P939; Vegh MJ, 2014, MOL CELL PROTEOMICS, V13, P2975, DOI 10.1074/mcp.M113.032086; Vegh MJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0076-z; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	103	167	171	13	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					388	+		10.1016/j.cell.2020.05.050	http://dx.doi.org/10.1016/j.cell.2020.05.050			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32615087	Bronze, Green Accepted			2022-12-28	WOS:000552745000011
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Is lifestyle a choice?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Foster HME, 2018, LANCET PUBLIC HEALTH, V3, pE576, DOI 10.1016/S2468-2667(18)30200-7; Oxfordshire Community Foundation, 2018, LIF EXP DIFF 15 YEAR	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2701	10.1136/bmj.m2701	http://dx.doi.org/10.1136/bmj.m2701			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636197	Bronze			2022-12-28	WOS:000548155700009
J	Carvalho, AF; Firth, J; Vieta, E				Carvalho, Andre F.; Firth, Joseph; Vieta, Eduard			Bipolar Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COMPARATIVE EFFICACY; COMBINATION THERAPY; TREATMENT-RESISTANT; DOUBLE-BLIND; ACUTE MANIA; I DISORDER; LITHIUM; METAANALYSIS; PREVALENCE; DEPRESSION		[Carvalho, Andre F.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Carvalho, Andre F.] Ctr Addict & Mental Hlth, Bell Gateway Bldg,100 Stokes St,4th Fl, Toronto, ON M6J 1H4, Canada; [Carvalho, Andre F.] Deakin Univ, Sch Med, Barwon Hlth, IMPACT Innovat Mental & Phys Hlth & Clin Treatmen, Geelong, Vic, Australia; [Firth, Joseph] Western Sydney Univ, NICM Hlth Res Inst, Westmead, NSW, Australia; [Firth, Joseph] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Div Psychol & Mental Hlth, Manchester, Lancs, England; [Vieta, Eduard] Univ Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Hosp Clin, Psychiat & Psychol Dept,Inst Neurosci, Barcelona, Spain; [Vieta, Eduard] CIBERSAM Biomed Res Networking Ctr Mental Hlth Ne, Barcelona, Spain	University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Deakin University; Western Sydney University; University of Manchester; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Carvalho, AF (corresponding author), Ctr Addict & Mental Hlth, Bell Gateway Bldg,100 Stokes St,4th Fl, Toronto, ON M6J 1H4, Canada.	andrefc7@hotmail.com	Firth, Joseph/ABE-6809-2020; Vieta, Eduard/I-6330-2013	Firth, Joseph/0000-0002-0618-2752; Vieta, Eduard/0000-0002-0548-0053				Melo MCA, 2016, J AFFECT DISORDERS, V198, P32, DOI 10.1016/j.jad.2016.03.004; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4; Anmella G, 2019, EUR NEUROPSYCHOPHARM, V29, P1199, DOI 10.1016/j.euroneuro.2019.09.007; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001; Berk M, 2017, WORLD PSYCHIATRY, V16, P236, DOI 10.1002/wps.20441; Bortolato B, 2017, BIPOLAR DISORD, V19, P84, DOI 10.1111/bdi.12490; Brus MJ, 2014, J PSYCHIATR PRACT, V20, P428, DOI 10.1097/01.pra.0000456591.20622.9e; Carvalho AF, 2014, J AFFECT DISORDERS, V163, P56, DOI 10.1016/j.jad.2014.03.035; Chatterton ML, 2017, BRIT J PSYCHIAT, V210, P333, DOI 10.1192/bjp.bp.116.195321; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Das AK, 2005, JAMA-J AM MED ASSOC, V293, P956, DOI 10.1001/jama.293.8.956; Daveney J, 2019, GEN HOSP PSYCHIAT, V58, P71, DOI 10.1016/j.genhosppsych.2019.03.006; DelBello MP, 2017, J AM ACAD CHILD PSY, V56, P1015, DOI 10.1016/j.jaac.2017.10.006; Dong M, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796019000593; Fernandes BS, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0849-x; Firth J, 2019, LANCET PSYCHIAT, V6, P675, DOI 10.1016/S2215-0366(19)30132-4; Fornaro M, 2015, J AFFECT DISORDERS, V178, P88, DOI 10.1016/j.jad.2015.02.032; Fountoulakis KN, 2020, INT J NEUROPSYCHOPH, V23, P230, DOI 10.1093/ijnp/pyz064; Fristad MA, 2016, J CLIN PSYCHIAT, V77, DOI 10.4088/JCP.15017su1c.04; Geddes JR, 2016, LANCET PSYCHIAT, V3, P31, DOI 10.1016/S2215-0366(15)00450-2; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Geller B, 2012, ARCH GEN PSYCHIAT, V69, P515, DOI 10.1001/archgenpsychiatry.2011.1508; Gordovez FJA, 2020, MOL PSYCHIATR, V25, P544, DOI 10.1038/s41380-019-0634-7; Grande I, 2015, CNS DRUGS, V29, P221, DOI 10.1007/s40263-015-0235-1; Hayes JF, 2015, ACTA PSYCHIAT SCAND, V131, P417, DOI 10.1111/acps.12408; Hibar DP, 2018, MOL PSYCHIATR, V23, P932, DOI 10.1038/mp.2017.73; Hidalgo-Mazzei D, 2019, BRIT J PSYCHIAT, V214, P27, DOI 10.1192/bjp.2018.257; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Joslyn C, 2016, BIPOLAR DISORD, V18, P389, DOI 10.1111/bdi.12419; Kessing LV, 2015, J AFFECT DISORDERS, V180, P142, DOI 10.1016/j.jad.2015.03.027; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; Licht RW, 2012, CNS NEUROSCI THER, V18, P219, DOI 10.1111/j.1755-5949.2011.00260.x; Maj M, 2005, BRIT J PSYCHIAT, V186, P182, DOI 10.1192/bjp.186.3.182; McGirr A, 2016, LANCET PSYCHIAT, V3, P1138, DOI 10.1016/S2215-0366(16)30264-4; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Misiak B, 2018, MOL NEUROBIOL, V55, P5075, DOI 10.1007/s12035-017-0708-y; Miskowiak KW, 2018, BIPOLAR DISORD, V20, P184, DOI 10.1111/bdi.12595; Miura T, 2014, LANCET PSYCHIAT, V1, P351, DOI 10.1016/S2215-0366(14)70314-1; Morris G, 2019, NEUROSCI BIOBEHAV R, V107, P862, DOI 10.1016/j.neubiorev.2019.09.025; Murri MB, 2016, PSYCHONEUROENDOCRINO, V63, P327, DOI 10.1016/j.psyneuen.2015.10.014; Nierenberg AA, 2016, J CLIN PSYCHIAT, V77, P90, DOI 10.4088/JCP.14m09349; Pacchiarotti I, 2013, AM J PSYCHIAT, V170, P1249, DOI 10.1176/appi.ajp.2013.13020185; Passos IC, 2016, ACTA PSYCHIAT SCAND, V134, P91, DOI 10.1111/acps.12581; Pinto JV, 2020, BIPOLAR DISORD, V22, P360, DOI 10.1111/bdi.12850; Plans L, 2019, J AFFECT DISORDERS, V242, P111, DOI 10.1016/j.jad.2018.08.054; Post RM, 2016, BIPOLAR DISORD, V18, P315, DOI 10.1111/bdi.12401; Reed GM, 2019, WORLD PSYCHIATRY, V18, P3, DOI 10.1002/wps.20611; Rosenblat JD, 2016, BIPOLAR DISORD, V18, P89, DOI 10.1111/bdi.12373; Salcedo S, 2016, J AFFECT DISORDERS, V201, P203, DOI 10.1016/j.jad.2016.05.018; Severus E, 2014, INT J BIPOLAR DISORD, V2, DOI 10.1186/s40345-014-0015-8; Silva MT, 2013, J AFFECT DISORDERS, V146, P310, DOI 10.1016/j.jad.2012.11.001; Stahl Eli A, 2019, Nat Genet, V51, P793, DOI 10.1038/s41588-019-0397-8; van der Loos MLM, 2009, J CLIN PSYCHIAT, V70, P223, DOI 10.4088/JCP.08m04152; Vancampfort D, 2016, WORLD PSYCHIATRY, V15, P166, DOI 10.1002/wps.20309; Vancampfort D, 2013, AM J PSYCHIAT, V170, P265, DOI 10.1176/appi.ajp.2012.12050620; Vieta E, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.8; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Woltmann E, 2012, AM J PSYCHIAT, V169, P790, DOI 10.1176/appi.ajp.2012.11111616; Yee CS, 2019, INT J NEUROPSYCHOPH, V22, P531, DOI 10.1093/ijnp/pyz034; Yildiz A, 2015, PSYCHOL MED, V45, P299, DOI 10.1017/S0033291714001305; Zhang L, 2017, J AFFECT DISORDERS, V207, P413, DOI 10.1016/j.jad.2016.08.062; Zimmerman M, 2008, J CLIN PSYCHIAT, V69, P935, DOI 10.4088/JCP.v69n0608; Zimmerman M, 2017, DEPRESS ANXIETY, V34, P779, DOI 10.1002/da.22644	67	140	147	20	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					58	66		10.1056/NEJMra1906193	http://dx.doi.org/10.1056/NEJMra1906193			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2UD	32609982				2022-12-28	WOS:000552751800011
J	Scimone, ML; Atabay, KD; Fincher, CT; Bonneau, AR; Li, DYJ; Reddien, PW				Scimone, M. Lucila; Atabay, Kutay D.; Fincher, Christopher T.; Bonneau, Ashley R.; Li, Dayan J.; Reddien, Peter W.			Muscle and neuronal guidepost-like cells facilitate planarian visual system regeneration	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; VENTRAL TANGENTIAL MIGRATION; OPTIC CHIASM; PIONEER NEURONS; GENE-EXPRESSION; MIDLINE; GROWTH; AXONS; MAINTENANCE; PROJECTIONS	Neuronal circuits damaged or lost after injury can be regenerated in some adult organisms, but the mechanisms enabling this process are largely unknown. We used the planarian Schmidtea mediterranea to study visual system regeneration after injury. We identify a rare population of muscle cells tightly associated with photoreceptor axons at stereotyped positions in both uninjured and regenerating animals. Together with a neuronal population, these cells promote de novo assembly of the visual system in diverse injury and eye transplantation contexts. These muscle guidepost-like cells are specified independently of eyes, and their position is defined by an extrinsic array of positional information cues. These findings provide a mechanism, involving adult formation of guidepost-like cells typically observed in embryos, for axon pattern restoration in regeneration.	[Scimone, M. Lucila; Atabay, Kutay D.; Fincher, Christopher T.; Bonneau, Ashley R.; Li, Dayan J.; Reddien, Peter W.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Scimone, M. Lucila; Atabay, Kutay D.; Fincher, Christopher T.; Bonneau, Ashley R.; Li, Dayan J.; Reddien, Peter W.] Whitehead Inst, 455 Main St, Cambridge, MA 02142 USA; [Scimone, M. Lucila; Atabay, Kutay D.; Fincher, Christopher T.; Bonneau, Ashley R.; Li, Dayan J.; Reddien, Peter W.] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Reddien, PW (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Reddien, PW (corresponding author), Whitehead Inst, 455 Main St, Cambridge, MA 02142 USA.; Reddien, PW (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	reddien@wi.mit.edu		Atabay, Kutay Deniz/0000-0001-6920-5053; Li, Dayan/0000-0001-8154-9019; /0000-0002-5569-333X; Scimone, Maria/0000-0002-3226-6888; Fincher, Christopher/0000-0003-0022-1260	Eleanor Schwartz Charitable Foundation	Eleanor Schwartz Charitable Foundation	P.W.R. is an investigator of HHMI and an associate member of the Broad Institute. We thank the Eleanor Schwartz Charitable Foundation for support.	Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Amamoto R, 2016, ELIFE, V5, DOI 10.7554/eLife.13998; Atabay KD, 2018, SCIENCE, V360, P404, DOI 10.1126/science.aap8179; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; Bielle F, 2011, NEURON, V69, P1085, DOI 10.1016/j.neuron.2011.02.026; Blader P, 1997, SCIENCE, V278, P1937, DOI 10.1126/science.278.5345.1937; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Cebria F, 2007, DEV BIOL, V307, P394, DOI 10.1016/j.ydbio.2007.05.006; Cebria F, 2007, DEVELOPMENT, V134, P833, DOI 10.1242/dev.02794; Chao DL, 2009, NAT REV NEUROSCI, V10, P262, DOI 10.1038/nrn2594; Cote LE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09539-6; Cowles MW, 2013, DEVELOPMENT, V140, P4691, DOI 10.1242/dev.098616; EDWARDS JS, 1981, J NEUROSCI, V1, P250; Fincher CT, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1736; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Hayashi T, 2011, DEVELOPMENT, V138, P3679, DOI 10.1242/dev.060194; Hill EM, 2015, DEVELOPMENT, V142, P4217, DOI 10.1242/dev.123612; Hirata T, 2012, DEV NEUROBIOL, V72, P1559, DOI 10.1002/dneu.22030; Hutter H, 2003, DEVELOPMENT, V130, P5307, DOI 10.1242/dev.00727; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Ito K, 2008, J NEUROSCI, V28, P4414, DOI 10.1523/JNEUROSCI.0372-08.2008; Jaworski A, 2012, NAT NEUROSCI, V15, P367, DOI 10.1038/nn.3037; Kawasaki T, 2006, DEVELOPMENT, V133, P845, DOI 10.1242/dev.02257; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Lander R, 2016, ELIFE, V5, DOI 10.7554/eLife.12850; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; Laumer CE, 2015, CURR BIOL, V25, P2000, DOI 10.1016/j.cub.2015.06.068; LoCascio SA, 2017, DEV CELL, V40, P381, DOI 10.1016/j.devcel.2017.02.002; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MARCUS RC, 1995, J NEUROSCI, V15, P3716; Martin-Duran JM, 2010, DEV BIOL, V340, P145, DOI 10.1016/j.ydbio.2010.01.018; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Niquille M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000230; Nomura T, 2006, DEVELOPMENT, V133, P1335, DOI 10.1242/dev.02290; Oderberg IM, 2017, CURR BIOL, V27, P733, DOI 10.1016/j.cub.2017.01.024; Okamoto K, 2005, ZOOL SCI, V22, P535, DOI 10.2108/zsj.22.535; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; PIKE SH, 1992, DEVELOPMENT, V114, P825; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Reddien PW, 2018, CELL, V175, P327, DOI 10.1016/j.cell.2018.09.021; Roberts-Galbraith RH, 2016, ELIFE, V5, DOI 10.7554/eLife.17002; Ross KG, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-014-0050-9; Sakai F, 2000, ZOOL SCI, V17, P375, DOI 10.2108/jsz.17.375; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sato Y, 1998, J NEUROSCI, V18, P7800; Scimone ML, 2018, CURR BIOL, V28, P3787, DOI 10.1016/j.cub.2018.10.030; Scimone ML, 2017, NATURE, V551, P623, DOI 10.1038/nature24660; Scimone ML, 2014, STEM CELL REP, V3, P339, DOI 10.1016/j.stemcr.2014.06.001; Scimone ML, 2011, DEVELOPMENT, V138, P4387, DOI 10.1242/dev.068098; Scimone ML, 2016, ELIFE, V5, DOI 10.7554/eLife.12845; Squarzoni P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00248; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1995, SCIENCE, V269, P98, DOI 10.1126/science.7541558; Stoeckli ET, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.151415; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Witchley JN, 2013, CELL REP, V4, P633, DOI 10.1016/j.celrep.2013.07.022; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	71	13	15	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1447	+	eaba3203	10.1126/science.aba3203	http://dx.doi.org/10.1126/science.aba3203			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32586989	Green Submitted, Green Accepted			2022-12-28	WOS:000545264600033
J	Stergachis, AB; Debo, BM; Haugen, E; Churchman, LS; Stamatoyannopoulos, JA				Stergachis, Andrew B.; Debo, Brian M.; Haugen, Eric; Churchman, L. Stirling; Stamatoyannopoulos, John A.			Single-molecule regulatory architectures captured by chromatin fiber sequencing	SCIENCE			English	Article							LOCUS-CONTROL REGION; MICROCOCCAL NUCLEASE; DNA METHYLATION; ACTIVE GENES; NUCLEOSOME; ACCESSIBILITY; BINDING; IDENTIFICATION; EXPRESSION; PRINCIPLES	Gene regulation is chiefly determined at the level of individual linear chromatin molecules, yet our current understanding of cis-regulatory architectures derives from fragmented sampling of large numbers of disparate molecules. We developed an approach for precisely stenciling the structure of individual chromatin fibers onto their composite DNA templates using nonspecific DNA N-6-adenine methyltransferases. Single-molecule long-read sequencing of chromatin stencils enabled nucleotide-resolution readout of the primary architecture of multikilobase chromatin fibers (Fiber-seq). Fiber-seq exposed widespread plasticity in the linear organization of individual chromatin fibers and illuminated principles guiding regulatory DNA actuation, the coordinated actuation of neighboring regulatory elements, single-molecule nucleosome positioning, and single-molecule transcription factor occupancy. Our approach and results open new vistas on the primary architecture of gene regulation.	[Stergachis, Andrew B.; Debo, Brian M.] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Debo, Brian M.; Churchman, L. Stirling] Harvard Med Sch, Blavatnik Inst, Dept Genet, Boston, MA 02115 USA; [Haugen, Eric; Stamatoyannopoulos, John A.] Altius Inst Biomed Sci, Seattle, WA USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Gen Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stergachis, AB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA.; Stamatoyannopoulos, JA (corresponding author), Altius Inst Biomed Sci, Seattle, WA USA.; Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Gen Sci, Seattle, WA 98195 USA.; Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	absterga@u.washington.edu; jstam@altius.org		Stergachis, Andrew/0000-0002-1299-3674; Haugen, Eric/0000-0001-7444-8981	NIH [UM1HG009444, T32GM007748]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants UM1HG009444 to J.A.S. and T32GM007748 supporting A.B.S.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Anton BP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161499; Baldi S, 2018, MOL CELL, V72, P661, DOI 10.1016/j.molcel.2018.09.032; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BLOOM KS, 1978, CELL, V15, P141, DOI 10.1016/0092-8674(78)90090-9; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chereji RV, 2016, NUCLEIC ACIDS RES, V44, P1036, DOI 10.1093/nar/gkv978; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; Drozdz M, 2012, NUCLEIC ACIDS RES, V40, P2119, DOI 10.1093/nar/gkr1039; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Horton JR, 2006, J MOL BIOL, V358, P559, DOI 10.1016/j.jmb.2006.02.028; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; John S., 2013, CURRENT PROTOCOLS MO, P21271; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; KLADDE MP, 1994, P NATL ACAD SCI USA, V91, P1361, DOI 10.1073/pnas.91.4.1361; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krebs AR, 2017, MOL CELL, V67, P411, DOI 10.1016/j.molcel.2017.06.027; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Luo GZ, 2017, NAT STRUCT MOL BIOL, V24, P503, DOI 10.1038/nsmb.3412; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; McIntyre ABR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08289-9; Mieczkowski J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11485; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Murray IA, 2018, NUCLEIC ACIDS RES, V46, P840, DOI 10.1093/nar/gkx1191; Nabilsi NH, 2014, GENOME RES, V24, P329, DOI 10.1101/gr.161737.113; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Pai AA, 2017, ELIFE, V6, DOI 10.7554/eLife.32537.001; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shipony Z, 2020, NAT METHODS, V17, P319, DOI 10.1038/s41592-019-0730-2; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Tanaka K, 2007, BIOORG MED CHEM LETT, V17, P1912, DOI 10.1016/j.bmcl.2007.01.040; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wang YH, 2019, GENOME RES, V29, P1329, DOI 10.1101/gr.251116.119; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	53	37	37	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1449	+		10.1126/science.aaz1646	http://dx.doi.org/10.1126/science.aaz1646			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32587015				2022-12-28	WOS:000545264600035
J	Wheat, JC; Sella, Y; Willcockson, M; Skoultchi, AI; Bergman, A; Singer, RH; Steidl, U				Wheat, Justin C.; Sella, Yehonatan; Willcockson, Michael; Skoultchi, Arthur I.; Bergman, Aviv; Singer, Robert H.; Steidl, Ulrich			Single-molecule imaging of transcription dynamics in somatic stem cells	NATURE			English	Article							HEMATOPOIETIC STEM; GENE-EXPRESSION; LINEAGE CHOICE; PU.1; GATA-1; HETEROGENEITY; REPRESSION; REDUCTION; MOUSE; STATE	Molecular noise is a natural phenomenon that is inherent to all biological systems(1,2). How stochastic processes give rise to the robust outcomes that support tissue homeostasis remains unclear. Here we use single-molecule RNA fluorescent in situ hybridization (smFISH) on mouse stem cells derived from haematopoietic tissue to measure the transcription dynamics of three key genes that encode transcription factors: PU.1 (also known as Spi1), Gata1 and Gata2. We find that infrequent, stochastic bursts of transcription result in the co-expression of these antagonistic transcription factors in the majority of haematopoietic stem and progenitor cells. Moreover, by pairing smFISH with time-lapse microscopy and the analysis of pedigrees, we find that although individual stem-cell clones produce descendants that are in transcriptionally related states-akin to a transcriptional priming phenomenon-the underlying transition dynamics between states are best captured by stochastic and reversible models. As such, a stochastic process can produce cellular behaviours that may be incorrectly inferred to have arisen from deterministic dynamics. We propose a model whereby the intrinsic stochasticity of gene expression facilitates, rather than impedes, the concomitant maintenance of transcriptional plasticity and stem cell robustness. Single-molecule fluorescence in situ hybridization and live-cell imaging are used to study the contribution of transcriptional noise to stem cell heterogeneity, revealing that stochastic transcription dynamics are conducive to concomitant stem-cell maintenance and tissue homeostasis.	[Wheat, Justin C.; Willcockson, Michael; Skoultchi, Arthur I.; Singer, Robert H.; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; [Wheat, Justin C.; Steidl, Ulrich] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Res & R, New York, NY 10461 USA; [Sella, Yehonatan; Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, New York, NY USA; [Bergman, Aviv; Singer, Robert H.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Bergman, Aviv] Santa Fe Inst, Santa Fe, NM 87501 USA; [Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, New York, NY USA; [Singer, Robert H.] Gruss Lipper Biophoton Ctr, Albert Einstein Coll Med, New York, NY USA; [Singer, Robert H.] Janelia Res Campus HHMI, Ashburn, VA USA; [Steidl, Ulrich] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med Oncol, New York, NY 10467 USA; [Steidl, Ulrich] Albert Einstein Coll Med, Albert Einstein Canc Ctr, New York, NY 10461 USA	Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; The Santa Fe Institute; Yeshiva University; Yeshiva University; Montefiore Medical Center; Yeshiva University; Yeshiva University	Steidl, U (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.; Steidl, U (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Res & R, New York, NY 10461 USA.; Steidl, U (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med Oncol, New York, NY 10467 USA.; Steidl, U (corresponding author), Albert Einstein Coll Med, Albert Einstein Canc Ctr, New York, NY 10461 USA.	ulrich.steidl@einsteinmed.org		Willcockson, Michael/0000-0001-6710-1293; singer, robert/0000-0002-6725-0093; Wheat, Justin/0000-0003-0018-4981	Ruth L. Kirschstein National Research Service Award [F30GM122308-03]; MSTP [T32GM007288-43, U01DA047729, R01CA217092]; Albert Einstein Cancer Center core support grant [P30CA013330]; Stem Cell Isolation and Xenotransplantation Core Facility (NYSTEM) of the Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine [C029154]	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP; Albert Einstein Cancer Center core support grant; Stem Cell Isolation and Xenotransplantation Core Facility (NYSTEM) of the Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine	We thank D. Shechter, K. Gritsman, R. Coleman, J. Biswas, E. Tutucci, M. V. Ugalde and R. Pisczcatowski for discussions; F. Mueller for assistance with FISH-QUANT; M. Elowitz and S. Hormoz for the scripts used for KCA; M. Lopez-Jones for assistance in probe design; D. Loeffler and T. Schroeder for input on time-lapse imaging of HSC; and D. Sun for assistance with flow cytometry and cell sorting. R.H.S. is a senior fellow of the Howard Hughes Medical Institute. A.B is an external professor of the Santa Fe Institute. This research was supported by the Ruth L. Kirschstein National Research Service Award F30GM122308-03 and MSTP training grant T32GM007288-43 to J.C.W., U01DA047729 to R.H.S. and R01CA217092 to U.S. U.S. was supported as a Research Scholar of the Leukemia and Lymphoma Society and is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research of the Albert Einstein College of Medicine. This work was supported through the Albert Einstein Cancer Center core support grant (P30CA013330), and the Stem Cell Isolation and Xenotransplantation Core Facility (NYSTEM grant #C029154) of the Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine.	[Anonymous], 2018, NATURE, V562, P367, DOI DOI 10.1038/S41586-018-0590-4; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Buggenthin F, 2017, NAT METHODS, V14, P403, DOI 10.1038/nmeth.4182; CHEN HM, 1993, J BIOL CHEM, V268, P8230; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; Dore LC, 2012, BLOOD, V119, P3724, DOI 10.1182/blood-2011-09-380634; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hilsenbeck O, 2016, NAT BIOTECHNOL, V34, P703, DOI 10.1038/nbt.3626; Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320; Hormoz S, 2016, CELL SYST, V3, P419, DOI 10.1016/j.cels.2016.10.015; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Loeffler D, 2018, BLOOD, V131, P1425, DOI 10.1182/blood-2017-07-794131; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Skinner SO, 2016, ELIFE, V5, DOI 10.7554/eLife.12175; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Strasser MK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05037-3; Torre E, 2018, CELL SYST, V6, P171, DOI 10.1016/j.cels.2018.01.014; Tsanov N, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw784; Tusi BK, 2018, NATURE, V555, P54, DOI 10.1038/nature25741; Will B, 2015, NAT MED, V21, P1172, DOI 10.1038/nm.3936; Zhang P, 2000, BLOOD, V96, P2641	40	24	25	4	60	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 16	2020	583	7816					431	+		10.1038/s41586-020-2432-4	http://dx.doi.org/10.1038/s41586-020-2432-4		JUN 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP4XR	32581360	Green Published, Green Accepted			2022-12-28	WOS:000556404800001
J	Woolf, SH; Chapman, DA; Sabo, RT; Weinberger, DM; Hill, L				Woolf, Steven H.; Chapman, Derek A.; Sabo, Roy T.; Weinberger, Daniel M.; Hill, Latoya			Excess Deaths From COVID-19 and Other Causes, March-April 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study uses data from the National Center for Health Statistics to estimate excess deaths (ie, the difference between observed and expected deaths) in the US and the District of Columbia in the early weeks of the COVID-19 pandemic.	[Woolf, Steven H.; Chapman, Derek A.; Hill, Latoya] Virginia Commonwealth Univ, Sch Med, Ctr Soc & Hlth, 830 E Main St,Ste 5035, Richmond, VA 23298 USA; [Sabo, Roy T.] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA; [Weinberger, Daniel M.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	Virginia Commonwealth University; Virginia Commonwealth University; Yale University	Woolf, SH (corresponding author), Virginia Commonwealth Univ, Sch Med, Ctr Soc & Hlth, 830 E Main St,Ste 5035, Richmond, VA 23298 USA.	steven.woolf@vcuhealth.org			National Center for Advancing Translational Sciences [UL1TR002649]	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was partially funded by the National Center for Advancing Translational Sciences (grant UL1TR002649).	National Center for Health Statistics, WEEKL COUNTS DEATHS; QuickFacts New York City New York U.S. CENSUS BUREAU, QUICKFACTS NEW YORK; U.S. Census Bureau, 2018 AM COMM SURV 1	3	211	215	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					510	513		10.1001/jama.2020.11787	http://dx.doi.org/10.1001/jama.2020.11787			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32609307	Green Published, Bronze			2022-12-28	WOS:000561261900023
J	Dufort, EM; Koumans, EH; Chow, EJ; Rosenthal, EM; Muse, A; Rowlands, J; Barranco, MA; Maxted, AM; Rosenberg, ES; Easton, D; Udo, T; Kumar, J; Pulver, W; Smith, L; Hutton, B; Blog, D; Zucker, H				Dufort, Elizabeth M.; Koumans, Emilia H.; Chow, Eric J.; Rosenthal, Elizabeth M.; Muse, Alison; Rowlands, Jemma; Barranco, Meredith A.; Maxted, Angela M.; Rosenberg, Eli S.; Easton, Delia; Udo, Tomoko; Kumar, Jessica; Pulver, Wendy; Smith, Lou; Hutton, Brad; Blog, Debra; Zucker, Howard		New York State Ctr Dis Control	Multisystem Inflammatory Syndrome in Children in New York State	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KAWASAKI-DISEASE	A multisystem inflammatory syndrome in children is associated with Covid-19. This report from New York State presents a descriptive analysis that summarizes the clinical presentation, complications, and outcomes of 99 pediatric patients meeting the New York State Department of Health definition of this syndrome. Background A multisystem inflammatory syndrome in children (MIS-C) is associated with coronavirus disease 2019. The New York State Department of Health (NYSDOH) established active, statewide surveillance to describe hospitalized patients with the syndrome. Methods Hospitals in New York State reported cases of Kawasaki's disease, toxic shock syndrome, myocarditis, and potential MIS-C in hospitalized patients younger than 21 years of age and sent medical records to the NYSDOH. We carried out descriptive analyses that summarized the clinical presentation, complications, and outcomes of patients who met the NYSDOH case definition for MIS-C between March 1 and May 10, 2020. Results As of May 10, 2020, a total of 191 potential cases were reported to the NYSDOH. Of 95 patients with confirmed MIS-C (laboratory-confirmed acute or recent severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection) and 4 with suspected MIS-C (met clinical and epidemiologic criteria), 53 (54%) were male; 31 of 78 (40%) were black, and 31 of 85 (36%) were Hispanic. A total of 31 patients (31%) were 0 to 5 years of age, 42 (42%) were 6 to 12 years of age, and 26 (26%) were 13 to 20 years of age. All presented with subjective fever or chills; 97% had tachycardia, 80% had gastrointestinal symptoms, 60% had rash, 56% had conjunctival injection, and 27% had mucosal changes. Elevated levels of C-reactive protein,d-dimer, and troponin were found in 100%, 91%, and 71% of the patients, respectively; 62% received vasopressor support, 53% had evidence of myocarditis, 80% were admitted to an intensive care unit, and 2 died. The median length of hospital stay was 6 days. Conclusions The emergence of multisystem inflammatory syndrome in children in New York State coincided with widespread SARS-CoV-2 transmission; this hyperinflammatory syndrome with dermatologic, mucocutaneous, and gastrointestinal manifestations was associated with cardiac dysfunction.	[Dufort, Elizabeth M.; Muse, Alison; Rowlands, Jemma; Maxted, Angela M.; Easton, Delia; Kumar, Jessica; Pulver, Wendy; Smith, Lou; Hutton, Brad; Blog, Debra; Zucker, Howard] New York State Dept Hlth, Empire State Plaza,Corning Tower,Rm 503, Albany, NY 12237 USA; [Koumans, Emilia H.; Chow, Eric J.] CDC, Ctr Dis Control & Prevent CDC COVID 19 Response, Atlanta, GA 30333 USA; [Chow, Eric J.] CDC, Epidem Intelligence Serv, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA; [Rosenthal, Elizabeth M.; Barranco, Meredith A.; Rosenberg, Eli S.; Udo, Tomoko] SUNY Albany, Sch Publ Hlth, Rensselaer, NY USA	State University of New York (SUNY) System; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Dufort, EM (corresponding author), New York State Dept Hlth, Empire State Plaza,Corning Tower,Rm 503, Albany, NY 12237 USA.	elizabeth.dufort@health.ny.gov	Chow, Eric J./T-6061-2019	Chow, Eric J./0000-0003-3349-9330; Barranco, Meredith/0000-0003-1659-9508; Rosenthal, Elizabeth/0000-0003-3908-4136; Rowlands, Jemma/0000-0002-2320-495X				Belhadjer Z, 2020, CIRCULATION; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Centers for Disease Control and Prevention, VINT 2018 BRIDG RAC; Centers for Disease Control and Prevention, 2020, IMMUNOLOGIYA; Cheung EW, 2020, JAMA; Children's Minnesota, 2019, CHEM PROC; Dominguez SR, 2008, PEDIATRICS, V122, pE786, DOI 10.1542/peds.2008-1275; Dong Y, 2020, PEDIATRICS, V145; European Centre for Disease Prevention and Control, 2020, RAP RISK ASS PAED IN; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Johns Hopkins University Coronavirus Resource Center, 2020, COVID 19 US CAS 2020; Jones Veena G, 2020, Hosp Pediatr, V10, P537, DOI 10.1542/hpeds.2020-0123; Kahl L, 2018, HARRIET LANE HDB, V21st; Miller J, 2020, GASTROENTEROLOGY; New York State Department of Health, 2020, NYSDOH COVID 19 TRAC; New York State Department of Health, 2020, COMM DIS REP REQ; New York State Department of Health, 2020, HLTH ADV PED MULT IN; Nir A, 2009, PEDIATR CARDIOL, V30, P3, DOI 10.1007/s00246-008-9258-4; Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]; Rosenberg ES, 2020, CLIN INFECT DIS; Royal College of Paediatrics and Child Health, 2020, GUID PAED MULT INFL; Rubin, 2020, J. Pediatr.; Shekerdemian LS, 2020, JAMA PEDIAT; Ueda Y, 2015, INT MED CASE REP J, V8, P225, DOI 10.2147/IMCRJ.S90685; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Whittaker E, 2020, JAMA; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	29	698	725	5	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2020	383	4					347	358		10.1056/NEJMoa2021756	http://dx.doi.org/10.1056/NEJMoa2021756			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MU1XJ	32598830	Bronze, Green Published			2022-12-28	WOS:000555465900019
J	An, H; Ordureau, A; Korner, M; Paulo, JA; Harper, JW				An, Heeseon; Ordureau, Alban; Koerner, Maria; Paulo, Joao A.; Harper, J. Wade			Systematic quantitative analysis of ribosome inventory during nutrient stress	NATURE			English	Article							PROTEIN-PHOSPHORYLATION; EXPRESSION; STARVATION; DISCOVERY; AUTOPHAGY; TEX264; GROWTH; AGE	Mammalian cells reorganize their proteomes in response to nutrient stress through translational suppression and degradative mechanisms using the proteasome and autophagy systems(1,2). Ribosomes are central targets of this response, asthey are responsible for translation and subject to lysosomal turnover during nutrient stress(3-5). The abundance of ribosomal (r)-proteins (around 6% of the proteome; 10(7) copies per cell)(6,7) and their high arginine and lysine content has led to the hypothesis that they are selectively used as a source of basic amino acids during nutrient stress through autophagy(4,7). However, the relative contributions of translational and degradative mechanisms to the control of r-protein abundance during acute stress responses is poorly understood, as is the extent to which r-proteins are used to generate amino acids when specific building blocks are limited(7). Here, we integrate quantitative global translatome and degradome proteomics(8) with genetically encoded Ribo-Keima(5) and Ribo-Halo reporters to interrogate r-protein homeostasis with and without active autophagy. In conditions of acute nutrient stress, cells strongly suppress the translation of r-proteins, but, notably, r-protein degradation occurs largely through non-autophagic pathways. Simultaneously, the decrease in r-protein abundance is compensated for by a reduced dilution of pre-existing ribosomes and a reduction in cell volume, thereby maintaining the density of ribosomes within single cells. Withdrawal of basic or hydrophobic amino acids induces translational repression without differential induction of ribophagy, indicating that ribophagy is not used to selectively produce basic amino acids during acute nutrient stress. We present a quantitative framework that describes the contributions of biosynthetic and degradative mechanisms to r-protein abundance and proteome remodelling in conditions of nutrient stress.	[An, Heeseon; Ordureau, Alban; Koerner, Maria; Paulo, Joao A.; Harper, J. Wade] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA; [Koerner, Maria] Univ Wurzburg, Dept Biochem, Wurzburg, Germany	Harvard University; Harvard Medical School; University of Wurzburg	Harper, JW (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Ordureau, Alban/C-7558-2012	Ordureau, Alban/0000-0002-4924-8520; An, Heeseon/0000-0002-8518-4077	National Institutes of Health [R37NS083524, RO1AG011085, RO1GM095567, RO1GM132129]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (grants R37NS083524, RO1AG011085 and RO1GM095567 to J.W.H. and grant RO1GM132129 to J.A.P.). We acknowledge the Nikon Imaging Center (Harvard Medical School) for imaging assistance. We thank S. Gruver and M. Kirschner for providing MoxiGo II access and training.	An H, 2020, J MOL BIOL, V432, P170, DOI 10.1016/j.jmb.2019.06.001; An H, 2019, MOL CELL, V74, P891, DOI 10.1016/j.molcel.2019.03.034; An H, 2018, NAT CELL BIOL, V20, P135, DOI 10.1038/s41556-017-0007-x; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Chino H, 2019, MOL CELL, V74, P909, DOI 10.1016/j.molcel.2019.03.033; Darnell AM, 2018, MOL CELL, V71, P229, DOI 10.1016/j.molcel.2018.06.041; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Erickson BK, 2019, J PROTEOME RES, V18, P1299, DOI 10.1021/acs.jproteome.8b00899; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Hoxhaj G, 2017, CELL REP, V21, P1331, DOI 10.1016/j.celrep.2017.10.029; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Itzhak DN, 2016, ELIFE, V5, DOI 10.7554/eLife.16950; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Kirkin V, 2019, MOL CELL, V76, P268, DOI 10.1016/j.molcel.2019.09.005; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Liu Y, 2017, DEV CELL, V43, P240, DOI 10.1016/j.devcel.2017.09.022; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Miettinen TP, 2015, CELL REP, V13, P2610, DOI 10.1016/j.celrep.2015.11.045; Nguyen AT, 2017, SCIENCE, V357, DOI 10.1126/science.aan0218; Ohana RF, 2009, PROTEIN EXPRES PURIF, V68, P110, DOI 10.1016/j.pep.2009.05.010; Paulo JA, 2016, J PROTEOMICS, V148, P85, DOI 10.1016/j.jprot.2016.07.005; Poillet-Perez L, 2018, NATURE, V563, P569, DOI 10.1038/s41586-018-0697-7; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Savitski MM, 2015, MOL CELL PROTEOMICS, V14, P2394, DOI 10.1074/mcp.M114.046995; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schweppe DK, 2020, J PROTEOME RES, V19, P2026, DOI 10.1021/acs.jproteome.9b00860; Schweppe DK, 2019, ANAL CHEM, V91, P4010, DOI 10.1021/acs.analchem.8b05399; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shim MS, 2020, AUTOPHAGY, V16, P1248, DOI 10.1080/15548627.2019.1662584; Sung MK, 2016, ELIFE, V5, DOI 10.7554/eLife.19105; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Thoreen CC, 2017, BIOCHEM SOC T, V45, P213, DOI 10.1042/BST20160072; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001; Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663; Yanagitani K, 2017, SCIENCE, V357, P472, DOI 10.1126/science.aan0178; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	44	33	33	4	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					303	+		10.1038/s41586-020-2446-y	http://dx.doi.org/10.1038/s41586-020-2446-y			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH5KF	32612236	Green Accepted			2022-12-28	WOS:000546767100024
J	Gaeta, JM; De Las Nueces, D; Munson, DG; Barocas, JA; Walsh, KE				Gaeta, Jessie M.; De Las Nueces, Denise; Munson, David G.; Barocas, Joshua A.; Walsh, Kathleen E.			Case 21-2020: A 66-Year-Old Homeless Man with Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE	A 66-year-old homeless man was evaluated for cough and rhinorrhea during the Covid-19 pandemic. He had tested positive for SARS-CoV-2 through a universal testing program at a homeless shelter, and he was admitted to a medical respite facility. Systemwide management strategies have been implemented.	[Gaeta, Jessie M.; De Las Nueces, Denise; Barocas, Joshua A.] Boston Med Ctr, Dept Med, Boston, MA 02118 USA; [Walsh, Kathleen E.] Boston Med Ctr, Dept Adm, Boston, MA 02118 USA; [Gaeta, Jessie M.; De Las Nueces, Denise; Barocas, Joshua A.] Boston Univ, Med Ctr, Dept Med, Boston, MA 02118 USA; [Walsh, Kathleen E.] Boston Univ, Med Ctr, Dept Hlth Law Policy & Management, Boston, MA 02118 USA; [Gaeta, Jessie M.; De Las Nueces, Denise; Munson, David G.] Massachusetts Gen Hosp, Boston Hlth Care Homeless Program, Boston, MA 02114 USA; [Munson, David G.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Munson, David G.] Harvard Med Sch, Boston, MA 02115 USA	Boston Medical Center; Boston Medical Center; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gaeta, JM (corresponding author), Boston Med Ctr, Dept Med, Boston, MA 02118 USA.; Gaeta, JM (corresponding author), Boston Univ, Med Ctr, Dept Med, Boston, MA 02118 USA.; Gaeta, JM (corresponding author), Massachusetts Gen Hosp, Boston Hlth Care Homeless Program, Boston, MA 02114 USA.							[Anonymous], 2020, COVID 19 FOR CUM DEA; [Anonymous], 2020, CAS US ATL; Baggett TP., 2020, EPIDEMIOLOGY COVID 1; Baggett TP, 2020, JAMA-J AM MED ASSOC, V323, P2191, DOI 10.1001/jama.2020.6887; Baggett TP, 2018, J AM COLL CARDIOL, V71, P2585, DOI 10.1016/j.jacc.2018.02.077; Brown RT, 2017, GERONTOLOGIST, V57, P757, DOI 10.1093/geront/gnw011; Centers for Disease Control and Prevention, 2020, DISC TRANSM BAS PREC; Centers for Disease Control and Prevention, 2020, INT GUID HOM SERV PR; Department of Housing and Urban Development, 2020, 2019 AHAR 1; Leung CS, 2008, J URBAN HEALTH, V85, P402, DOI 10.1007/s11524-008-9270-2; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Snyder LD, 2004, CHEST, V125, P1719, DOI 10.1378/chest.125.5.1719	12	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					170	178		10.1056/NEJMcpc2002421	http://dx.doi.org/10.1056/NEJMcpc2002421			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9PO	32579806	Green Published, Bronze			2022-12-28	WOS:000571894800017
J	Iacobucci, G				Iacobucci, Gareth			Cystic fibrosis: NHS England strikes deal to offer triple combination treatment	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		KMIETOWICZ Z, 2019, BMJ-BRIT MED J, V367, P49013, DOI DOI 10.1136/BMJ.L6206	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2643	10.1136/bmj.m2643	http://dx.doi.org/10.1136/bmj.m2643			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611555				2022-12-28	WOS:000548489100018
J	Krausgruber, T; Fortelny, N; Fife-Gernedl, V; Senekowitsch, M; Schuster, LC; Lercher, A; Nemc, A; Schmidl, C; Rendeiro, AF; Bergthaler, A; Bock, C				Krausgruber, Thomas; Fortelny, Nikolaus; Fife-Gernedl, Victoria; Senekowitsch, Martin; Schuster, Linda C.; Lercher, Alexander; Nemc, Amelie; Schmidl, Christian; Rendeiro, Andre F.; Bergthaler, Andreas; Bock, Christoph			Structural cells are key regulators of organ-specific immune responses	NATURE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; STROMAL CELLS; SYSTEMS IMMUNOLOGY; INFLAMMATION; INNATE; MOUSE; INTERFACE; CHROMATIN; ATLAS; SEQ	The mammalian immune system implements a remarkably effective set of mechanisms for fighting pathogens(1). Its main components are haematopoietic immune cells, including myeloid cells that control innate immunity, and lymphoid cells that constitute adaptive immunity(2). However, immune functions are not unique to haematopoietic cells, and many other cell types display basic mechanisms of pathogen defence(3-5). To advance our understanding of immunology outside the haematopoietic system, here we systematically investigate the regulation of immune genes in the three major types of structural cells: epithelium, endothelium and fibroblasts. We characterize these cell types across twelve organs in mice, using cellular phenotyping, transcriptome sequencing, chromatin accessibility profiling and epigenome mapping. This comprehensive dataset revealed complex immune gene activity and regulation in structural cells. The observed patterns were highly organ-specific and seem to modulate the extensive interactions between structural cells and haematopoietic immune cells. Moreover, we identified an epigenetically encoded immune potential in structural cells under tissue homeostasis, which was triggered in response to systemic viral infection. This study highlights the prevalence and organ-specific complexity of immune gene activity in non-haematopoietic structural cells, and it provides a high-resolution, multi-omics atlas of the epigenetic and transcriptional networks that regulate structural cells in the mouse.	[Krausgruber, Thomas; Fortelny, Nikolaus; Fife-Gernedl, Victoria; Senekowitsch, Martin; Schuster, Linda C.; Lercher, Alexander; Nemc, Amelie; Schmidl, Christian; Rendeiro, Andre F.; Bergthaler, Andreas; Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Schuster, Linda C.] German Canc Res Ctr, Div Chromatin Networks, Heidelberg, Germany; [Schuster, Linda C.] Bioquant, Heidelberg, Germany; [Schmidl, Christian] Regensburg Ctr Intervent Immunol RCI, Regensburg, Germany	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Bock, C (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria.; Bock, C (corresponding author), Med Univ Vienna, Dept Lab Med, Vienna, Austria.	cbock@cemm.oeaw.ac.at	Krausgruber, Thomas/H-8490-2018; Schmidl, Christian/HDO-6299-2022; Rendeiro, André F./AAC-4747-2019; Bergthaler, Andreas/ABG-5047-2020; Bock, Christoph/AAE-7618-2019	Krausgruber, Thomas/0000-0002-1374-0329; Schmidl, Christian/0000-0002-0522-202X; Rendeiro, André F./0000-0001-9362-5373; Bergthaler, Andreas/0000-0003-0597-1976; Bock, Christoph/0000-0001-6091-3088; Schuster, Linda/0000-0003-3470-5490; Lercher, Alexander/0000-0003-3478-5304; Fife, Victoria/0000-0003-0052-5731; Fortelny, Nikolaus/0000-0003-4025-9968	Austrian Science Fund (FWF) Special Research Programme grants [FWF SFB F6102, FWF SFB F7001]; Lise Meitner fellowship from the Austrian Science Fund [FWF M2403]; European Molecular Biology Organization (EMBO ALTF) [241-2017]; DOC fellowship of the Austrian Academy of Sciences; ERC (European Union) [677006, 679146]; New Frontiers Group award of the Austrian Academy of Sciences	Austrian Science Fund (FWF) Special Research Programme grants(Austrian Science Fund (FWF)); Lise Meitner fellowship from the Austrian Science Fund; European Molecular Biology Organization (EMBO ALTF)(European Molecular Biology Organization (EMBO)); DOC fellowship of the Austrian Academy of Sciences; ERC (European Union)(European Research Council (ERC)); New Frontiers Group award of the Austrian Academy of Sciences	We thank the Core Facility Flow Cytometry of the Medical University of Vienna for cell sorting service; the Biomedical Sequencing Facility at CeMM for assistance with next-generation sequencing; S. Zahalka and S. Knapp for help and advice with the preparation of lung samples; S. Niggemeyer, J. Riede, S. Jungwirth and N. Fleischmann for animal caretaking; and all members of the Bock laboratory for their help and advice. This work was conducted in the context of two Austrian Science Fund (FWF) Special Research Programme grants (FWF SFB F6102; FWF SFB F7001). T.K. is supported by a Lise Meitner fellowship from the Austrian Science Fund (FWF M2403). N.F. is supported by a fellowship from the European Molecular Biology Organization (EMBO ALTF 241-2017). A.L. is supported by a DOC fellowship of the Austrian Academy of Sciences. A.B. is supported by an ERC Starting Grant (European Union's Horizon 2020 research and innovation programme, grant agreement no. 677006). C.B. is supported by a New Frontiers Group award of the Austrian Academy of Sciences and by an ERC Starting Grant (European Union's Horizon 2020 research and innovation programme, grant agreement no. 679146).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; [Anonymous], 2018, NATURE, V562, P367, DOI DOI 10.1038/S41586-018-0590-4; Baazim H, 2019, NAT IMMUNOL, V20, P701, DOI 10.1038/s41590-019-0397-y; Bergthaler A, 2010, P NATL ACAD SCI USA, V107, P21641, DOI 10.1073/pnas.1011998107; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Davis MM, 2017, NAT IMMUNOL, V18, P725, DOI 10.1038/ni.3768; Guerrero-Juarez CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08247-x; Gustafsson C, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5299-0; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Humbert M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2016.00684; ImmGen Consortium, FIN IMMGEN SORT SOP; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Krausgruber T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11627; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lercher A, 2019, IMMUNITY, V51, P1074, DOI 10.1016/j.immuni.2019.10.014; Li B, 2017, SCI REP; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Nowarski R, 2017, CELL, V168, P362, DOI 10.1016/j.cell.2016.11.040; Parikh K, 2019, NATURE, V567, P49, DOI 10.1038/s41586-019-0992-y; Pawlina, 2019, HISTOLOGY TEXT ATLAS; Perez-Shibayama C, 2019, IMMUNOL REV, V289, P31, DOI 10.1111/imr.12748; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pillai S, 2017, CELLULAR MOL IMMUNOL; Pinschewer DD, 2010, INT IMMUNOL, V22, P749, DOI 10.1093/intimm/dxq061; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/nmeth.3542, 10.1038/NMETH.3542]; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Villani AC, 2018, ANNU REV IMMUNOL, V36, P813, DOI 10.1146/annurev-immunol-042617-053035; Wang Y, 2014, GENOMICS, V103, P222, DOI 10.1016/j.ygeno.2014.02.002; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313	46	144	144	5	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					296	+		10.1038/s41586-020-2424-4	http://dx.doi.org/10.1038/s41586-020-2424-4		JUL 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH5KF	32612232	Green Accepted			2022-12-28	WOS:000545291100001
J	Rice, DB; Raffoul, H; Ioannidis, JPA; Moher, D				Rice, Danielle B.; Raffoul, Hana; Ioannidis, John P. A.; Moher, David			Academic criteria for promotion and tenure in biomedical sciences faculties: cross sectional analysis of international sample of universities	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INCREASING VALUE; REDUCING WASTE	OBJECTIVE To determine the presence of a set of pre-specified traditional and non-traditional criteria used to assess scientists for promotion and tenure in faculties of biomedical sciences among universities worldwide. DESIGN Cross sectional study. SETTING International sample of universities. PARTICIPANTS 170 randomly selected universities from the Leiden ranking of world universities list. MAIN OUTCOME MEASURE Presence of of five traditional (for example, number of publications) and seven non-traditional (for example, data sharing) criteria in guidelines for assessing assistant professors, associate professors, and professors and the granting of tenure in institutions with biomedical faculties. RESULTS A total of 146 institutions had faculties of biomedical sciences, and 92 had eligible guidelines available for review. Traditional criteria of peer reviewed publications, authorship order, journal impact factor, grant funding, and national or international reputation were mentioned in 95% (n=87), 37% (34), 28% (26), 67% (62), and 48% (44) of the guidelines, respectively. Conversely, among non-traditional criteria, only citations (any mention in 26%; n=24) and accommodations for employment leave (37%; 34) were relatively commonly mentioned. Mention of alternative metrics for sharing research (3%; n=3) and data sharing (1%; 1) was rare, and three criteria (publishing in open access mediums, registering research, and adhering to reporting guidelines) were not found in any guidelines reviewed. Among guidelines for assessing promotion to full professor, traditional criteria were more commonly reported than non-traditional criteria (traditional criteria 54.2%, non-traditional items 9.5%; mean difference 44.8%, 95% confidence interval 39.6% to 50.0%; P=0.001). Notable differences were observed across continents in whether guidelines were accessible (Australia 100% (6/6), North America 97% (28/29), Europe 50% (27/54), Asia 58% (29/50), South America 17% (1/6)), with more subtle differences in the use of specific criteria. CONCLUSION This study shows that the evaluation of scientists emphasises traditional criteria as opposed to non-traditional criteria. This may reinforce research practices that are known to be problematic while insufficiently supporting the conduct of better quality research and open science. Institutions should consider incentivising non-traditional criteria.	[Rice, Danielle B.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Rice, Danielle B.; Raffoul, Hana] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Raffoul, Hana] Univ Waterloo, Fac Engn, Waterloo, ON, Canada; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford, CA USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Biomed Data Sci & Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Moher, David] Ottawa Hosp Res Inst, Ctr Journal, Clin Epidemiol Program, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada	McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Waterloo; Stanford University; Stanford University; Stanford University; Stanford University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Moher, D (corresponding author), Ottawa Hosp Res Inst, Ctr Journal, Clin Epidemiol Program, Ottawa, ON, Canada.; Moher, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	dmoher@ohri.ca	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859	Canadian Institutes of Health Research Vanier graduate scholarship; Laura and John Arnold Foundation	Canadian Institutes of Health Research Vanier graduate scholarship(Canadian Institutes of Health Research (CIHR)); Laura and John Arnold Foundation	No funding was received for this work. DBR is funded through a Canadian Institutes of Health Research Vanier graduate scholarship. DM is funded by a university research chair. METRICS is funded by a grant from the Laura and John Arnold Foundation. Funding sources did not have any role in the design and conduct of the study, data collection and analysis, interpretation of study findings, or the decision to publish.	Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Flier J, 2017, NATURE, V549, P133, DOI 10.1038/549133a; Ghent University, 2017, PRINC EV RES; Hammarfelt B, 2017, ASLIB J INFORM MANAG, V69, P607, DOI 10.1108/AJIM-01-2017-0006; Ioannidis JPA, 2017, JAMA-J AM MED ASSOC, V317, P1019, DOI 10.1001/jama.2017.0549; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Mckiernan EC, 2019, ELIFE, V8, DOI 10.7554/eLife.47338; McKiernan EC, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002614; Mello MM, 2018, NEW ENGL J MED, V378, P2202, DOI 10.1056/NEJMsa1713258; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004089; Moher D, 2016, EUR J CLIN INVEST, V46, P383, DOI 10.1111/eci.12612; Moher D, 2016, LANCET, V387, P1573, DOI 10.1016/S0140-6736(15)00307-4; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Tabachnick B. G., 2007, USING MULTIVARIATE S, V5th; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wilkinson Mark D, 2016, Sci Data, V3, P160018, DOI 10.1038/sdata.2016.18; Wolff C, 2016, UK SURVEY ACAD 2015	20	54	54	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2020	369								m2081	10.1136/bmj.m2081	http://dx.doi.org/10.1136/bmj.m2081			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI3HF	32586791	Green Published, hybrid			2022-12-28	WOS:000583173400001
J	Wise, J				Wise, Jacqui			Covid-19: Health and care workers will be "highest priority" for vaccination, says JCVI	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Joint Committee on Vaccination and Immunisation, 2020, INT ADV PRIOR GRUOPS; MAHASE E, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1679	2	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2020	369								m2477	10.1136/bmj.m2477	http://dx.doi.org/10.1136/bmj.m2477			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GM	32561527	Bronze			2022-12-28	WOS:000548534800001
J	Kolmer, M; Steiner, AK; Izydorczyk, I; Ko, W; Engelund, M; Szymonski, M; Li, AP; Amsharov, K				Kolmer, Marek; Steiner, Ann-Kristin; Izydorczyk, Irena; Ko, Wonhee; Engelund, Mads; Szymonski, Marek; Li, An-Ping; Amsharov, Konstantin			Rational synthesis of atomically precise graphene nanoribbons directly on metal oxide surfaces	SCIENCE			English	Article							POLYMERIZATION; NANOGRAPHENES; FLUOROARENES	Atomically precise graphene nanoribbons (GNRs) attract great interest because of their highly tunable electronic, optical, and transport properties. However, on-surface synthesis of GNRs is typically based on metal surface-assisted chemical reactions, where metallic substrates strongly screen their designer electronic properties and limit further applications. Here, we present an on-surface synthesis approach to forming atomically precise GNRs directly on semiconducting metal oxide surfaces. The thermally triggered multistep transformations preprogrammed in our precursors' design rely on highly selective and sequential activations of carbon-bromine (C-Br) and carbon-fluorine ( C-F) bonds and cyclodehydrogenation. The formation of planar armchair GNRs terminated by well-defined zigzag ends is confirmed by scanning tunneling microscopy and spectroscopy, which also reveal weak interaction between GNRs and the rutile titanium dioxide substrate.	[Kolmer, Marek; Ko, Wonhee; Li, An-Ping] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Steiner, Ann-Kristin; Amsharov, Konstantin] Friedrich Alexander Univ Erlangen Nuremberg, Dept Organ Chem, Nikolaus Fiebiger Str 10, D-91058 Erlangen, Germany; [Izydorczyk, Irena; Szymonski, Marek] Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, NANOSAM, Ctr Nanometer Scale Sci & Adv Mat, Lojasiewicza 11, PL-30348 Krakow, Poland; [Ko, Wonhee; Li, An-Ping] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Engelund, Mads] Espeem SARL Espeem Com, 9 Rue Haut Fournaux, L-4365 Esch Sur Alzette, Luxembourg; [Amsharov, Konstantin] Martin Luther Univ Halle Wittenberg, Inst Chem, Organ Chem, Kurt Mothes Str 2, D-06120 Halle, Germany	United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Erlangen Nuremberg; Jagiellonian University; University of Tennessee System; University of Tennessee Knoxville; Martin Luther University Halle Wittenberg	Li, AP (corresponding author), Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.; Amsharov, K (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Organ Chem, Nikolaus Fiebiger Str 10, D-91058 Erlangen, Germany.; Li, AP (corresponding author), Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA.; Amsharov, K (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Chem, Organ Chem, Kurt Mothes Str 2, D-06120 Halle, Germany.	apli@ornl.gov; konstantin.amsharov@fau.de	Kolmer, Marek/D-9766-2012; Ko, Wonhee/ABG-1509-2020; Li, An-Ping/B-3191-2012	Kolmer, Marek/0000-0002-6786-9697; Li, An-Ping/0000-0003-4400-7493; Izydorczyk, Irena/0000-0003-1561-119X; Steiner, Ann-Kristin/0000-0003-0833-8500; Engelund, Mads/0000-0001-9291-5213; Ko, Wonhee/0000-0002-6155-1485	Center for Nanophase Materials Sciences (CNMS); University of Tennessee [ONR N00014-16-1-3213, ONR N00014-20-1-2302]; Polish Ministry of Science and Higher Education [0341/IP3/2016/74]; Deutsche Forschungsgemeinschaft [182849149-SFB 953 A6, AM407]	Center for Nanophase Materials Sciences (CNMS)(United States Department of Energy (DOE)); University of Tennessee; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Center for Nanophase Materials Sciences (CNMS), which is a U.S. Department of Energy Office of Science User Facility (M.K., W.K., A.-P.L.). Research was partially funded by grants ONR N00014-16-1-3213 and ONR N00014-20-1-2302 from the University of Tennessee (W.K., A.-P.L.). Preliminary research was supported by the Polish Ministry of Science and Higher Education, contract no. 0341/IP3/2016/74 (I.I.). A.K.S. and K.A. thank the Deutsche Forschungsgemeinschaft for financial support (Projektnummer 182849149-SFB 953 A6 and AM407).	Akhmetov V, 2019, CHEM-EUR J, V25, P11609, DOI 10.1002/chem.201902586; Akhmetov V, 2019, CHEM-EUR J, V25, P7607, DOI 10.1002/chem.201901450; Amsharov KY, 2012, J ORG CHEM, V77, P5445, DOI 10.1021/jo300783y; Amsharov KY, 2012, ANGEW CHEM INT EDIT, V51, P4594, DOI 10.1002/anie.201200516; Amsharov K, 2016, PHYS STATUS SOLIDI B, V253, P2473, DOI 10.1002/pssb.201600211; Barin GB, 2019, ACS APPL NANO MATER, V2, P2184, DOI 10.1021/acsanm.9b00151; Benz L, 2009, J AM CHEM SOC, V131, P15026, DOI 10.1021/ja905522c; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Cao T, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.076401; Clair S, 2019, CHEM REV, V119, P4717, DOI 10.1021/acs.chemrev.8b00601; Deniz O, 2017, NANO LETT, V17, P2197, DOI 10.1021/acs.nanolett.6b04727; Feng, 2017, ADV POLYM SCI; Golor M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.085504; Groning O, 2018, NATURE, V560, P209, DOI 10.1038/s41586-018-0375-9; Jacobse PH, 2018, ACS NANO, V12, P7048, DOI 10.1021/acsnano.8b02770; Ko W, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201903770; Koch M, 2012, NAT NANOTECHNOL, V7, P713, DOI [10.1038/nnano.2012.169, 10.1038/NNANO.2012.169]; Kolmer M, 2019, SCIENCE, V363, P57, DOI 10.1126/science.aav4954; Kolmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09315-6; Kolmer M, 2015, CHEM COMMUN, V51, P11276, DOI 10.1039/c5cc02989a; Kolmer M, 2013, ANGEW CHEM INT EDIT, V52, P10300, DOI 10.1002/anie.201303657; Konishi A, 2010, J AM CHEM SOC, V132, P11021, DOI 10.1021/ja1049737; KRAPCHO AP, 1985, SYNTHETIC COMMUN, V15, P907, DOI 10.1080/00397918508063889; Li JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08060-6; Li Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216804; Llinas JP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00734-x; Lombardi F, 2019, SCIENCE, V366, P1107, DOI 10.1126/science.aay7203; Miettinen AL, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.045425; Mishra S, 2020, NAT NANOTECHNOL, V15, P22, DOI 10.1038/s41565-019-0577-9; Mishra S, 2020, J AM CHEM SOC, V142, P1147, DOI 10.1021/jacs.9b09212; Natterer FD, 2017, NATURE, V543, P226, DOI 10.1038/nature21371; Paz O, 2006, PHYS STATUS SOLIDI B, V243, P1080, DOI 10.1002/pssb.200541453; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Radocea A, 2017, NANO LETT, V17, P170, DOI 10.1021/acs.nanolett.6b03709; Ravat P, 2018, J AM CHEM SOC, V140, P10839, DOI 10.1021/jacs.8b05465; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; Rizzo DJ, 2018, NATURE, V560, P204, DOI 10.1038/s41586-018-0376-8; Sharapa D, 2018, PHYS STATUS SOLIDI B, V255, DOI 10.1002/pssb.201800189; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Solomek T, 2019, TRENDS CHEM, V1, P705, DOI 10.1016/j.trechm.2019.08.005; Solomek T, 2018, J ORG CHEM, V83, P4769, DOI 10.1021/acs.joc.8b00656; Steiner AK, 2017, ANGEW CHEM INT EDIT, V56, P14732, DOI 10.1002/anie.201707272; Talirz L, 2016, ADV MATER, V28, P6222, DOI 10.1002/adma.201505738; Talirz L, 2013, J AM CHEM SOC, V135, P2060, DOI 10.1021/ja311099k; TERSOFF J, 1983, PHYS REV LETT, V50, P1998, DOI 10.1103/PhysRevLett.50.1998; Treier M, 2011, NAT CHEM, V3, P61, DOI [10.1038/nchem.891, 10.1038/NCHEM.891]; Vasseur G, 2016, J AM CHEM SOC, V138, P5685, DOI 10.1021/jacs.6b02151; von Kugelgen S, 2019, SCIENCE, V366, P1070, DOI 10.1126/science.aaz4044; Wang SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11507; Willke P, 2019, NAT PHYS, V15, P1005, DOI 10.1038/s41567-019-0573-x; Yang K, 2019, SCIENCE, V366, P509, DOI 10.1126/science.aay6779; Zhou XH, 2020, ADV MATER, V32, DOI 10.1002/adma.201905957	52	62	63	19	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2020	369	6503					571	+		10.1126/science.abb8880	http://dx.doi.org/10.1126/science.abb8880			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV7YK	32586951	Bronze, Green Submitted			2022-12-28	WOS:000556568100047
J	McKenzie, KC				McKenzie, Katherine C.			A Cruel COVID-19 Irony	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McKenzie, Katherine C.] Yale Sch Med, Dept Internal Med, New Haven, CT USA	Yale University	McKenzie, KC (corresponding author), Yale Sch Med, Yale Ctr Asylum Med, Dept Internal Med, 367 Cedar St, New Haven, CT 06510 USA.	katherine.mckenzie@yale.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					345	346		10.1001/jama.2020.11882	http://dx.doi.org/10.1001/jama.2020.11882			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32602892	Bronze			2022-12-28	WOS:000562851000022
J	Dyer, C				Dyer, Clare			GP who missed case of fatal Addison's disease has suspension cut short after pleas from colleague	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L6678	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2020	370								m2682	10.1136/bmj.m2682	http://dx.doi.org/10.1136/bmj.m2682			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5ZW	32620679				2022-12-28	WOS:000548169100007
J	Kwon, WJ; Del Pace, G; Panza, R; Inguscio, M; Zwerger, W; Zaccanti, M; Scazza, F; Roati, G				Kwon, W. J.; Del Pace, G.; Panza, R.; Inguscio, M.; Zwerger, W.; Zaccanti, M.; Scazza, F.; Roati, G.			Strongly correlated superfluid order parameters from dc Josephson supercurrents	SCIENCE			English	Article							GAS; CONDENSATION; RESONANCE; SYMMETRY; FRACTION; PAIRS	The direct-current (dc) Josephson effect provides a phase-sensitive tool for investigating superfluid order parameters. We report on the observation of dc Josephson supercurrents in strongly interacting fermionic superfluids across a tunneling barrier in the absence of any applied potential difference. For sufficiently strong barriers, we observed a sinusoidal current-phase relation, in agreement with Josephson's seminal prediction. We mapped out the zero-resistance state and its breakdown as a function of junction parameters, extracting the Josephson critical current behavior. By comparing our results with an analytic model, we determined the pair condensate fraction throughout the Bardeen-Cooper-Schrieffer-Bose-Einstein condensation crossover. Our work suggests that coherent Josephson transport may be used to pin down superfluid order parameters in diverse atomic systems, even in the presence of strong correlations.	[Kwon, W. J.; Panza, R.; Inguscio, M.; Zaccanti, M.; Scazza, F.; Roati, G.] Consiglio Nazl Ric CNR INO, Ist Nazl Ott, I-50019 Sesto Fiorentino, Italy; [Kwon, W. J.; Del Pace, G.; Panza, R.; Inguscio, M.; Zaccanti, M.; Scazza, F.; Roati, G.] European Lab Nonlinear Spect LENS, I-50019 Sesto Fiorentino, Italy; [Del Pace, G.] Univ Florence, Dept Phys & Astron, I-50019 Sesto Fiorentino, Italy; [Inguscio, M.] Campus Biomed Univ Rome, Dept Engn, I-00128 Rome, Italy; [Zwerger, W.] Tech Univ Munich, Phys Dept, D-85747 Garching, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Florence; University Campus Bio-Medico - Rome Italy; Technical University of Munich	Scazza, F (corresponding author), Consiglio Nazl Ric CNR INO, Ist Nazl Ott, I-50019 Sesto Fiorentino, Italy.; Scazza, F (corresponding author), European Lab Nonlinear Spect LENS, I-50019 Sesto Fiorentino, Italy.	scazza@lens.unifi.it	Kwon, Woo Jin/L-8278-2016; Zwerger, Wilhelm/B-9847-2008; Scazza, Francesco/AAR-9311-2020; Roati, Giacomo/AFZ-0793-2022; Zaccanti, Matteo/D-2474-2014; Del Pace, Giulia/ABF-8726-2021	Kwon, Woo Jin/0000-0001-9773-4024; Scazza, Francesco/0000-0001-5527-1068; Zaccanti, Matteo/0000-0001-6214-4921; Inguscio, Massimo/0000-0001-8152-8103; DEL PACE, GIULIA/0000-0002-0882-2143	European Research Council GA [307032 QuFerm2D, 637738 PoLiChroM]; Fondazione Cassa di Risparmio di Firenze project [QuSim2D 2016.0770]; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie [705269, 843303]	European Research Council GA; Fondazione Cassa di Risparmio di Firenze project(Fondazione Cassa Risparmio Firenze); European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie	Supported by European Research Council GA no. 307032 QuFerm2D and no. 637738 PoLiChroM, Fondazione Cassa di Risparmio di Firenze project QuSim2D 2016.0770, and European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie GAs no. 705269 and no. 843303.	Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; AMBEGAOKAR V, 1963, PHYS REV LETT, V10, P486, DOI 10.1103/PhysRevLett.10.486; ANDERSON JT, 1969, PHYS REV LETT, V23, P128, DOI 10.1103/PhysRevLett.23.128; Anderson P. W., 1964, LECT MANY BODY PROBL, V2; Astrakharchik GE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.230405; Barone A., 1982, PHYS APPL JOSEPHSON; BEENAKKER CWJ, 1991, PHYS REV LETT, V66, P3056, DOI 10.1103/PhysRevLett.66.3056; BLOCH F, 1970, PHYS REV B, V2, P109, DOI 10.1103/PhysRevB.2.109; Burchianti A, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.025302; Burchianti A, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043408; Chien CC, 2015, NAT PHYS, V11, P998, DOI [10.1038/NPHYS3531, 10.1038/nphys3531]; Clarke J., 2004, SQUID HDB, V1; Datta S., 1997, CAMBRIDGE STUDIES SE; Eckel S, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031052; Eckel S, 2014, NATURE, V506, P200, DOI 10.1038/nature12958; Fernandez FM, 2011, AM J PHYS, V79, P877, DOI 10.1119/1.3596393; Fukushima N, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.033609; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Giovanazzi S, 2000, PHYS REV LETT, V84, P4521, DOI 10.1103/PhysRevLett.84.4521; Goldobin E, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224523; GORKOV LP, 1961, SOV PHYS JETP-USSR, V13, P1018; Haussmann R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023610; Haussmann R, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.063602; Heiselberg H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040402; Horikoshi M, 2010, SCIENCE, V327, P442, DOI 10.1126/science.1183012; Hoskinson E, 2006, NAT PHYS, V2, P23, DOI 10.1038/nphys190; Hueck K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.060402; Husmann D, 2015, SCIENCE, V350, P1498, DOI 10.1126/science.aac9584; JAKLEVIC RC, 1964, PHYS REV LETT, V12, P159, DOI 10.1103/PhysRevLett.12.159; Jendrzejewski F, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.045305; Jiang L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.236401; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Krinner S, 2016, P NATL ACAD SCI USA, V113, P8144, DOI 10.1073/pnas.1601812113; LeBlanc LJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.025302; Lebrat M, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011053; Levy S, 2007, NATURE, V449, P579, DOI 10.1038/nature06186; LIKHAREV KK, 1979, REV MOD PHYS, V51, P101, DOI 10.1103/RevModPhys.51.101; MCCUMBER DE, 1968, J APPL PHYS, V39, P3113, DOI 10.1063/1.1656743; Meier F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.033610; Naraschewski M, 1998, PHYS REV A, V58, P2423, DOI 10.1103/PhysRevA.58.2423; Piazza F, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.033613; Pigneur M, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.173601; POPEL R, 1992, METROLOGIA, V29, P153, DOI 10.1088/0026-1394/29/2/005; Ramanathan A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130401; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Reinaudi G, 2007, OPT LETT, V32, P3143, DOI 10.1364/OL.32.003143; Ryu C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.205301; Salasnich L, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.023621; Sato Y, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016401; Sidorenkov LA, 2013, NATURE, V498, P78, DOI 10.1038/nature12136; Spagnolli G, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.230403; Spuntarelli A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.040401; Stadler D, 2012, NATURE, V491, P736, DOI 10.1038/nature11613; STEWART WC, 1968, APPL PHYS LETT, V12, P277, DOI 10.1063/1.1651991; ter Haar D, 1975, PROBLEMS QUANTUM MEC, V3rd; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Valtolina G, 2015, SCIENCE, V350, P1505, DOI 10.1126/science.aac9725; VANHARLINGEN DJ, 1995, REV MOD PHYS, V67, P515, DOI 10.1103/RevModPhys.67.515; Wen W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.014528; Xhani K, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.045301; YANG CN, 1962, REV MOD PHYS, V34, P694, DOI 10.1103/RevModPhys.34.694; Zaccanti M, 2019, PHYS REV A, V100, DOI 10.1103/PhysRevA.100.063601; Zou P, 2014, J LOW TEMP PHYS, V177, P240, DOI 10.1007/s10909-014-1209-2; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301; Zwerger W., 2012, BCS BEC CROSSOVER UN, V836; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	68	31	31	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					84	+		10.1126/science.aaz2463	http://dx.doi.org/10.1126/science.aaz2463			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631890	Green Submitted			2022-12-28	WOS:000548751700050
J	Rimmer, A				Rimmer, Abi			Distribution of faulty and out of date PPE is "national scandal," says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Leclere M., CORONAVIRUS KENT GPS; Pearce C., FACE MASKS USED PRAC	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2020	370								m2678	10.1136/bmj.m2678	http://dx.doi.org/10.1136/bmj.m2678			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5ZW	32620547	Bronze			2022-12-28	WOS:000548169100002
J	Wise, J				Wise, Jacqui			Gambling: Academics call for statutory levy to reduce harm	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Advisory Board for Safer Gambling, 2020, PROGR REP NAT STRAT; Wardle H, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2613	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2600	10.1136/bmj.m2600	http://dx.doi.org/10.1136/bmj.m2600			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611554				2022-12-28	WOS:000548489100016
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... Mr Bean's checklist	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		WHO, WHO REM PUBL REM VIG	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2611	10.1136/bmj.m2611	http://dx.doi.org/10.1136/bmj.m2611			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601057	Bronze			2022-12-28	WOS:000548112700002
J	Mizrahi, JD; Surana, R; Valle, JW; Shroff, RT				Mizrahi, Jonathan D.; Surana, Rishi; Valle, Juan W.; Shroff, Rachna T.			Pancreatic cancer	LANCET			English	Review							TOTAL LAPAROSCOPIC PANCREATICODUODENECTOMY; CARBOHYDRATE ANTIGEN 19-9; HIGH-RISK INDIVIDUALS; DUCTAL ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; CONSENSUS STATEMENT; RACIAL DISPARITIES; MUTATION CARRIERS; HOSPITAL VOLUME; EARLY-ONSET	Pancreatic cancer is a highly fatal disease with a 5-year survival rate of approximately 10% in the USA, and it is becoming an increasingly common cause of cancer mortality. Risk factors for developing pancreatic cancer include family history, obesity, type 2 diabetes, and tobacco use. Patients typically present with advanced disease due to lack of or vague symptoms when the cancer is still localised. High quality computed tomography with intravenous contrast using a dual phase pancreatic protocol is typically the best method to detect a pancreatic tumour and to determine surgical resectability. Endoscopic ultrasound is an increasingly used complementary staging modality which also allows for diagnostic confirmation when combined with fine needle aspiration. Patients with pancreatic cancer are often divided into one of four categories based on extent of disease: resectable, borderline resectable, locally advanced, and metastatic; patient condition is also an important consideration. Surgical resection represents the only chance for cure, and advancements in adjuvant chemotherapy have improved long-term outcomes in these patients. Systemic chemotherapy combinations including FOLFIRINOX (5-fluorouracil, folinic acid [leucovorin], irinotecan, and oxaliplatin) and gemcitabine plus nab-paclitaxel remain the mainstay of treatment for patients with advanced disease. Data on the benefit of PARP inhibition as maintenance therapy in patients with germline BRCA1 or BRACA2 mutations might prove to be a harbinger of advancement in targeted therapy. Additional research efforts are focusing on modulating the pancreatic tumour microenvironment to enhance the efficacy of the immunotherapeutic strategies.	[Mizrahi, Jonathan D.; Surana, Rishi] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Valle, Juan W.] Univ Manchester, Christie NHS Fdn Trust, Dept Med Oncol, Div Canc Sci, Manchester, Lancs, England; [Shroff, Rachna T.] Univ Arizona, Canc Ctr, Dept Med, Div Hematol & Oncol, Tucson, AZ 85724 USA	University of Texas System; UTMD Anderson Cancer Center; Christie NHS Foundation Trust; University of Manchester; University of Arizona	Shroff, RT (corresponding author), Univ Arizona, Canc Ctr, Dept Med, Div Hematol & Oncol, Tucson, AZ 85724 USA.	rshroff@arizona.edu						AbbVie, 2019, ABBVIE PROV UPD PHAS; Abrams RA, 2009, ANN SURG ONCOL, V16, P1751, DOI 10.1245/s10434-009-0413-9; Al-Hawary MM, 2014, RADIOLOGY, V270, P248, DOI 10.1148/radiol.13131184; Alistar A, 2017, LANCET ONCOL, V18, P770, DOI 10.1016/S1470-2045(17)30314-5; American Cancer Society, 2020, CANC FACTS FIG 2020; Andersen DK, 2017, DIABETES, V66, P1103, DOI 10.2337/db16-1477; Arcidiacono PG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007519.pub2; Artinyan A, 2011, CANCER-AM CANCER SOC, V117, P2044, DOI 10.1002/cncr.25763; Asokkumar R, 2019, ENDOSC INT OPEN, V7, pE955, DOI 10.1055/a-0903-2565; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Bang YJ, 2018, ANN ONCOL, V29, P2052, DOI 10.1093/annonc/mdy264; Bauer TM, 2013, CANCER-AM CANCER SOC, V119, P285, DOI 10.1002/cncr.27734; Benzel J, 2018, ONCOL RES TREAT, V41, P611, DOI 10.1159/000493473; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Blackford A, 2009, CANCER RES, V69, P3681, DOI 10.1158/0008-5472.CAN-09-0015; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Canto MI, 2006, CLIN GASTROENTEROL H, V4, P766, DOI 10.1016/j.cgh.2006.02.005; Canto MI, 2013, GUT, V62, P339, DOI 10.1136/gutjnl-2012-303108; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Chan KKW, 2020, CANCER MED-US, V9, P160, DOI 10.1002/cam4.2705; Chauffert B, 2008, ANN ONCOL, V19, P1592, DOI 10.1093/annonc/mdn281; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Chew HK, 2006, ARCH INTERN MED, V166, P458; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Conroy T, 2018, NEW ENGL J MED, V379, P2395, DOI 10.1056/NEJMoa1809775; Conroy T, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.18_suppl.LBA4001; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Croome KP, 2014, ANN SURG, V260, P633, DOI 10.1097/SLA.0000000000000937; DeWitt J, 2004, ANN INTERN MED, V141, P753, DOI 10.7326/0003-4819-141-10-200411160-00006; Domchek SM, 2016, GYNECOL ONCOL, V140, P199, DOI 10.1016/j.ygyno.2015.12.020; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Golan T, 2019, NEW ENGL J MED, V381, P317, DOI 10.1056/NEJMoa1903387; Guo JL, 2016, INT J BIOL SCI, V12, P292, DOI 10.7150/ijbs.14995; Hammel P, 2016, JAMA-J AM MED ASSOC, V315, P1844, DOI 10.1001/jama.2016.4324; Hartwig W, 2013, ANN SURG ONCOL, V20, P2188, DOI 10.1245/s10434-012-2809-1; Hata T, 2016, ANN SURG, V263, P664, DOI 10.1097/SLA.0000000000001437; Ho V, 2003, ANN SURG, V237, P509, DOI 10.1097/00000658-200304000-00012; Holter S, 2015, J CLIN ONCOL, V33, P3124, DOI 10.1200/JCO.2014.59.7401; Isaji S, 2018, PANCREATOLOGY, V18, P2, DOI 10.1016/j.pan.2017.11.011; Jang RW, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju424; Kastrinos F, 2009, JAMA-J AM MED ASSOC, V302, P1790, DOI 10.1001/jama.2009.1529; Kasumova GG, 2018, ANN SURG ONCOL, V25, P51, DOI 10.1245/s10434-016-5676-3; Katz MHG, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.1137; Kendrick ML, 2010, ARCH SURG-CHICAGO, V145, P19, DOI 10.1001/archsurg.2009.243; Khawja SN, 2015, PANCREAS, V44, P522, DOI 10.1097/MPA.0000000000000323; Kim EJ, 2013, CANCER-AM CANCER SOC, V119, P2692, DOI 10.1002/cncr.28117; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Lu C, 2015, WORLD J GASTROENTERO, V21, P8678, DOI 10.3748/wjg.v21.i28.8678; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; Ma SJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9126; Macdonald S, 2006, BRIT J CANCER, V94, P1272, DOI 10.1038/sj.bjc.6603089; Maisey NR, 2005, BRIT J CANCER, V93, P740, DOI 10.1038/sj.bjc.6602760; Mann DV, 2000, EUR J SURG ONCOL, V26, P474, DOI 10.1053/ejso.1999.0925; Marthey L, 2015, ANN SURG ONCOL, V22, P295, DOI 10.1245/s10434-014-3898-9; McWilliams RR, 2016, PANCREAS, V45, P311, DOI 10.1097/MPA.0000000000000392; Millikan KW, 1999, AM SURGEON, V65, P618; Millikan KW, 1999, AM SURGEON, V65, P623; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Moss AC, 2007, CANCER TREAT REV, V33, P213, DOI 10.1016/j.ctrv.2006.10.006; Murphy MM, 2009, CANCER-AM CANCER SOC, V115, P3979, DOI 10.1002/cncr.24433; Naudin S, 2020, EUR J EPIDEMIOL, V35, P975, DOI 10.1007/s10654-019-00559-6; Neoptolemos JP, 2017, LANCET, V389, P1011, DOI 10.1016/S0140-6736(16)32409-6; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2001, LANCET, V358, P1576, DOI 10.1016/S0140-6736(01)06651-X; NIEDERAU C, 1992, PANCREAS, V7, P66, DOI 10.1097/00006676-199201000-00011; O'Hara MH, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-CT004; O'Reilly EM, 2019, JAMA ONCOL, V5, P1431, DOI 10.1001/jamaoncol.2019.1588; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Okasha H, 2017, WORLD J GASTROENTERO, V23, P5962, DOI 10.3748/wjg.v23.i32.5962; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P438, DOI 10.1001/jama.2019.10232; Palanivelu C, 2007, J AM COLL SURGEONS, V205, P222, DOI 10.1016/j.jamcollsurg.2007.04.004; Pelzer U, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00155; Pereira SP, 2020, LANCET GASTROENTEROL, V5, P698, DOI 10.1016/S2468-1253(19)30416-9; Philip PA, 2020, LANCET GASTROENTEROL, V5, P285, DOI 10.1016/S2468-1253(19)30327-9; Pishvaian MJ, 2020, LANCET ONCOL, V21, P508, DOI 10.1016/S1470-2045(20)30074-7; Pishvaian MJ, 2018, CLIN CANCER RES, V24, P5018, DOI 10.1158/1078-0432.CCR-18-0531; Pisters PWT, 2001, BRIT J SURG, V88, P325, DOI 10.1046/j.1365-2168.2001.01695.x; Pourshams A, 2019, LANCET GASTROENTEROL, V4, P934, DOI 10.1016/S2468-1253(19)30347-4; Puleo F, 2018, GASTROENTEROLOGY, V155, P1999, DOI 10.1053/j.gastro.2018.08.033; Puli SR, 2007, GASTROINTEST ENDOSC, V65, P788, DOI 10.1016/j.gie.2006.08.028; Raimondi S, 2007, CANCER EPIDEM BIOMAR, V16, P1894, DOI 10.1158/1055-9965.EPI-07-0341; Rebours V, 2015, CLIN CANCER RES, V21, P3522, DOI 10.1158/1078-0432.CCR-14-2385; Riall TS, 2010, CANCER-AM CANCER SOC, V116, P930, DOI 10.1002/cncr.24836; Saad ED, 2002, J GASTROINTEST CANC, V32, P35, DOI 10.1385/IJGC:32:1:35; Scarpa A, 2018, GUT, V67, P1561, DOI 10.1136/gutjnl-2018-316151; Schmidt-Hansen M, 2016, PANCREAS, V45, P814, DOI 10.1097/MPA.0000000000000527; Shroff RT, 2018, JCO PRECIS ONCOL, V2, DOI 10.1200/PO.17.00316; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Smith JK, 2013, J SURG RES, V185, P15, DOI 10.1016/j.jss.2013.05.058; Sohal DPS, 2018, J CLIN ONCOL, V36, P2545, DOI 10.1200/JCO.2018.78.9636; Solomon S, 2012, CANCER J, V18, P485, DOI 10.1097/PPO.0b013e318278c4a6; Stoffel EM, 2019, J CLIN ONCOL, V37, P153, DOI 10.1200/JCO.18.01489; Stolzenberg-Solomon RZ, 2013, AM J CLIN NUTR, V98, P1057, DOI 10.3945/ajcn.113.058123; Sung H, 2019, LANCET PUBLIC HEALTH, V4, pE137, DOI 10.1016/S2468-2667(18)30267-6; Tempero MA, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.4000; Tempero MA, 2019, J NATL COMPR CANC NE, V17, P603, DOI 10.6004/jnccn.2019.5007; Tzeng CWD, 2014, HPB, V16, P430, DOI 10.1111/hpb.12154; United States Food and Drug Administration, 2019, FDA APPR OL GBRCAM M; Upadhrasta S, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091472; Vachiranubhap Busakorn, 2009, Top Magn Reson Imaging, V20, P3, DOI 10.1097/RMR.0b013e3181b48392; Vadhan-Raj S, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.4016; Valls C, 2002, AM J ROENTGENOL, V178, P821, DOI 10.2214/ajr.178.4.1780821; Van Buren G, 2013, ANN SURG ONCOL, V20, P3787, DOI 10.1245/s10434-013-3161-9; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X; Varadhachary GR, 2006, ANN SURG ONCOL, V13, P1035, DOI 10.1245/ASO.2006.08.011; Vasen HFA, 2000, INT J CANCER, V87, P809, DOI 10.1002/1097-0215(20000915)87:6<809::AID-IJC8>3.3.CO;2-L; Versteijne E, 2020, J CLIN ONCOL, V38, P1763, DOI 10.1200/JCO.19.02274; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Walter FM, 2016, LANCET GASTROENTEROL, V1, P298, DOI 10.1016/S2468-1253(16)30079-6; Wang Y, 2019, J GASTROINTEST CANC, V50, P62, DOI [10.1007/s12029-017-0028-5, 10.1111/jcpt.12653]; Wang-Gillam A, 2016, LANCET, V387, P545, DOI 10.1016/S0140-6736(15)00986-1; Wong D, 2008, PANCREAS, V37, P269, DOI 10.1097/MPA.0b013e31816d8185; Wong GY, 2004, JAMA-J AM MED ASSOC, V291, P1092, DOI 10.1001/jama.291.9.1092; Zachar Z, 2011, J MOL MED, V89, P1137, DOI 10.1007/s00109-011-0785-8; Zureikat AH, 2011, J GASTROINTEST SURG, V15, P1151, DOI 10.1007/s11605-011-1530-x	122	706	732	63	249	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2020	395	10242					2008	2020						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ0ZZ	32593337				2022-12-28	WOS:000547825600018
J	Cook, NR; He, FJ; MacGregor, GA; Graudal, N				Cook, Nancy R.; He, Feng J.; MacGregor, Graham A.; Graudal, Niels			Sodium and health-concordance and controversy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URINARY SODIUM; POTASSIUM EXCRETION; BLOOD-PRESSURE; DIETARY-SODIUM; CARDIOVASCULAR-DISEASE; BASE-LINE; SALT; MORTALITY; CONSUMPTION; HYPERTENSION		[Cook, Nancy R.] Harvard Med Sch, Div Prevent Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [He, Feng J.; MacGregor, Graham A.] Queen Mary Univ London, Ctr Environm & Prevent Med, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England; [Graudal, Niels] Rigshosp, Copenhagen Lupus & Vasculitis Clin, Copenhagen Univ Hosp, Copenhagen, Denmark	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; Queen Mary University London; Rigshospitalet; University of Copenhagen	Cook, NR (corresponding author), Harvard Med Sch, Div Prevent Med, Brigham & Womens Hosp, Boston, MA 02115 USA.	ncook@bwh.harvard.edu	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744; MacGregor, Graham/0000-0001-9206-4500; He, Feng/0000-0003-2807-4119				Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Adler AJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-232; Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Antman EM, 2014, CIRCULATION, V129, pE660, DOI 10.1161/CIR.0000000000000051; Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/s2213-8587(18)30288-2, 10.1016/S2213-8587(18)30288-2]; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Christopher PP, 2019, ANN INTERN MED, V170, P409, DOI 10.7326/M18-3382; Cobb LK, 2014, CIRCULATION, V129, P1173, DOI 10.1161/CIR.0000000000000015; Cogswell ME, 2018, JAMA-J AM MED ASSOC, V319, P1209, DOI 10.1001/jama.2018.1156; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Coxson PG, 2013, HYPERTENSION, V61, P564, DOI 10.1161/HYPERTENSIONAHA.111.201293; ELLIOTT P, 1988, BRIT MED J, V297, P319; Engberink RHGO, 2017, CIRCULATION, V136, P917, DOI 10.1161/CIRCULATIONAHA.117.029028; Gardener H, 2012, STROKE, V43, P1200, DOI 10.1161/STROKEAHA.111.641043; Graudal N, 2018, PROG CARDIOVASC DIS, V61, P20, DOI 10.1016/j.pcad.2018.04.008; Graudal N, 2016, AM J HYPERTENS, V29, P543, DOI 10.1093/ajh/hpw006; Graudal N, 2014, AM J HYPERTENS, V27, P1129, DOI 10.1093/ajh/hpu028; Graudal NA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub4; He F. J., 2013, BMJ, V346; He FJ, 2019, HYPERTENSION, V74, P572, DOI 10.1161/HYPERTENSIONAHA.119.13117; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Huang LP, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m315; Humalda JK, 2020, AM J KIDNEY DIS, V75, P847, DOI 10.1053/j.ajkd.2019.10.012; Jones DW, 2018, HYPERTENSION, V72, P10, DOI 10.1161/HYPERTENSIONAHA.118.11103; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kieneker LM, 2018, MAYO CLIN PROC, V93, P1803, DOI 10.1016/j.mayocp.2018.05.028; Lerchl K, 2015, HYPERTENSION, V66, P850, DOI 10.1161/HYPERTENSIONAHA.115.05851; Lowell BB, 2019, NEW ENGL J MED, V380, P459, DOI 10.1056/NEJMra1812053; Lucko AM, 2018, J CLIN HYPERTENS, V20, P1220, DOI 10.1111/jch.13353; McCarron DA, 2013, AM J HYPERTENS, V26, P1218, DOI 10.1093/ajh/hpt139; Mente A, 2016, LANCET, V388, P465, DOI 10.1016/S0140-6736(16)30467-6; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Millwood IY, 2019, LANCET, V394, P1618, DOI 10.1016/S0140-6736(19)31907-5; Millwood IY, 2019, LANCET, V393, P1831, DOI 10.1016/S0140-6736(18)31772-0; National Academies of Sciences Engineering and Medicine, 2019, DIET REF INT SOD AN; Neal B, 2017, AM HEART J, V188, P109, DOI 10.1016/j.ahj.2017.02.033; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Pazoki R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11451-y; Pfister R, 2014, EUR J HEART FAIL, V16, P394, DOI 10.1002/ejhf.56; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Rakova N, 2017, J CLIN INVEST, V127, P1932, DOI 10.1172/JCI88530; Ravindrarajah R, 2017, CIRCULATION, V135, P2357, DOI 10.1161/CIRCULATIONAHA.116.026687; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sattar N, 2017, CIRCULATION, V135, P2369, DOI 10.1161/CIRCULATIONAHA.117.028307; Scientific Advisory Committee on Nutrition, 2003, SALT HLTH; Sterns RH, 2016, CURR OPIN NEPHROL HY, V25, P114, DOI 10.1097/MNH.0000000000000200; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Takachi R, 2010, AM J CLIN NUTR, V91, P456, DOI 10.3945/ajcn.2009.28587; Thout SR, 2019, J CLIN HYPERTENS, V21, P710, DOI 10.1111/jch.13546; Titze J, 2015, CURR OPIN NEPHROL HY, V24, P14, DOI 10.1097/MNH.0000000000000085; US Department of Health and Human Services and USDA, 2015, DIET GUID AM 2015 20; WHO, 2012, GUID SOD INT AD CHIL; Zanetti D, 2020, HYPERTENSION, V75, P714, DOI 10.1161/HYPERTENSIONAHA.119.14028	59	25	24	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2020	369								m2440	10.1136/bmj.m2440	http://dx.doi.org/10.1136/bmj.m2440			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ7IA	32591335	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000548259500002
J	Kuehn, BM				Kuehn, Bridget M.			Hypertension Rates in Rural Areas Outpace Those in Urban Locales	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2454	2454		10.1001/jama.2020.9382	http://dx.doi.org/10.1001/jama.2020.9382			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2EU	32573675				2022-12-28	WOS:000595447000007
J	Hata, SR				Hata, Susan R.			The Ritual of the Table	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hata, Susan R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hata, Susan R.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hata, SR (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Hata, SR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.								0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2020	383	14					1301	1303		10.1056/NEJMp2014455	http://dx.doi.org/10.1056/NEJMp2014455			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NX3MO	32640125	Bronze			2022-12-28	WOS:000575616600006
J	Hesse, EM; Navarro, RA; Daley, MF; Getahun, D; Henninger, ML; Jackson, LA; Nordin, J; Olson, SC; Zerbo, O; Zheng, CY; Duffy, J				Hesse, Elisabeth M.; Navarro, Ronald A.; Daley, Matthew F.; Getahun, Darios; Henninger, Michelle L.; Jackson, Lisa A.; Nordin, James; Olson, Scott C.; Zerbo, Ousseny; Zheng, Chengyi; Duffy, Jonathan			Risk for Subdeltoid Bursitis After Influenza Vaccination A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							SHOULDER; INJURIES; SAFETY	Background: Subdeltoid bursitis has been reported as an ad verse event after intramuscular vaccination in the deltoid muscle. Most published case reports involved influenza vaccine. Objective: To estimate the risk for subdeltoid bursitis after influenza vaccination. Design: Retrospective cohort study. Setting: The Vaccine Safety Datalink, which contains health encounter data for 10.2 million members of 7 U.S. health care organizations. Patients: Persons who received an inactivated influenza vaccine during the 2016-2017 influenza season. Measurements: Potential incident cases were identified by searching administrative data for persons with a shoulder bursitis diagnostic code within 180 days after receiving an injectable influenza vaccine in the same arm. The date of reported bursitis symptom onset was abstracted from the medical record. A selfcontrolled risk interval analysis was used to calculate the incidence rate ratio of bursitis in a risk interval of 0 to 2 days after vaccination versus a control interval of 30 to 60 days, which represents the background rate. The attributable risk was also estimated. Results: The cohort included 2 943 493 vaccinated persons. Sixteen cases of symptom onset in the risk interval and 51 cases of symptom onset in the control interval were identified. The median age of persons in the risk interval was 57.5 years (range, 24 to 98 years), and 69% were women. The incidence rate ratio was 3.24 (95% CI, 1.85 to 5.68). The attributable risk was 7.78 (CI, 2.19 to 13.38) additional cases of bursitis per 1 million persons vaccinated. Limitation: The results may not be generalizable to vaccinations done in other types of health care settings. Conclusion: Although an increased risk for bursitis after vaccination was present, the absolute risk was small.	[Hesse, Elisabeth M.; Duffy, Jonathan] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Hesse, Elisabeth M.; Duffy, Jonathan] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA USA; [Navarro, Ronald A.] Kaiser Permanente South Bay Med Ctr, Coastline MOB, 25821 South Vermont Ave, Harbor City, CA 90710 USA; [Daley, Matthew F.] Kaiser Permanente Colorado, Inst Hlth Res, POB 378066, Denver, CO 80237 USA; [Getahun, Darios; Zheng, Chengyi] Kaiser Permanente, 100 South Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA; [Henninger, Michelle L.] Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA; [Jackson, Lisa A.] Kaiser Permanente Washington Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA; [Nordin, James] HealthPartners Inst Educ & Res, POB 1524,MS 23301A, Minneapolis, MN 55440 USA; [Olson, Scott C.] Ctr Clin Epidemiol & Populat Hlth, Marshfield Clin Res Inst, 1000 North Oak Ave ML2, Marshfield, WI 54449 USA; [Zerbo, Ousseny] Kaiser Permanente Vaccine Study Ctr, 1 Kaiser Plaza,16th Floor, Oakland, CA 94612 USA; [Hesse, Elisabeth M.] Ctr Dis Control & Prevent, 1600 Clifton Rd,MS H24-11, Atlanta, GA 30329 USA; [Duffy, Jonathan] Ctr Dis Control & Prevent, 1600 Clifton Rd,MS V118-4, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hesse, EM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS H24-11, Atlanta, GA 30329 USA.	ehesse@cdc.gov	Navarro, Ronald A/AAE-1422-2019; zheng, chengyi/AAC-6284-2022	Navarro, Ronald A/0000-0003-1869-6440; 	CDC	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	By internal funds of the CDC. The Vaccine Safety Datalink sites are funded through a contract from the CDC.	[Anonymous], 2015, EPIDEMIOLOGY PREVENT; Atanasoff S, 2010, VACCINE, V28, P8049, DOI 10.1016/j.vaccine.2010.10.005; Baker MA, 2015, AM J EPIDEMIOL, V181, P608, DOI 10.1093/aje/kwu322; Barnes MG, 2012, J AM BOARD FAM MED, V25, P919, DOI 10.3122/jabfm.2012.06.110334; Bodor M, 2007, VACCINE, V25, P585, DOI 10.1016/j.vaccine.2006.08.034; Centers for Disease Control and Prevention, 2019, RES LIB VACC ADM; Centers for Disease Control and Prevention, 2016, 2016 2017 EST INFL I; Commission on Accreditation of Allied Health Education Programs, 2015, STAND GUID ACCR ED P; Committee to Review Adverse Effects of Vaccines Institute of Medicine, 2012, ADVERSE EFFECTS VACC; Cook IF, 2014, HUM VACC IMMUNOTHER, V10, P605, DOI 10.4161/hv.27232; Cross GB, 2016, AUST FAM PHYSICIAN, V45, P303; Grohskopf LA, 2018, MMWR RECOMM REP, V67, DOI 10.15585/mmwr.rr6703a1; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Health Resources and Services Administration, VACC INJ TABL; Health Resources and Services Administration Health and Human Services Administration, NAT VACC INJ COMP PR; Hesse EM, 2020, VACCINE, V38, P1076, DOI 10.1016/j.vaccine.2019.11.032; Hogan MA, 2008, NURSING FUNDAMENTALS; Kraus R, 2010, KNEE SURG SPORT TR A, V18, P1738, DOI 10.1007/s00167-010-1092-6; Kroger AT, GEN BEST PRACTICE GU; Kuether G, 2011, VACCINE, V29, P6830, DOI 10.1016/j.vaccine.2011.07.052; Li RX, 2016, J BIOPHARM STAT, V26, P686, DOI 10.1080/10543406.2015.1052819; Arias LHM, 2017, VACCINE, V35, P4870, DOI 10.1016/j.vaccine.2017.07.055; McNeil MM, 2014, VACCINE, V32, P5390, DOI 10.1016/j.vaccine.2014.07.073; Meissner HC, 2017, AAP NEWS J      0901; Moyer JE, 2016, ORTHOP CLIN N AM, V47, P749, DOI 10.1016/j.ocl.2016.05.003; Musonda P, 2006, STAT MED, V25, P2618, DOI 10.1002/sim.2477; Okur G, 2014, SKELETAL RADIOL, V43, P1325, DOI 10.1007/s00256-014-1875-9; Salmon JH, 2015, VACCINE, V33, P6152, DOI 10.1016/j.vaccine.2015.09.090; Shimabukuro T., 2017, REPORTS SHOULDER DYS; Uchida S, 2012, VACCINE, V31, P27, DOI 10.1016/j.vaccine.2012.10.075; Walker-Bone K, 2004, ARTHRIT RHEUM-ARTHR, V51, P642, DOI 10.1002/art.20535	32	12	12	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2020	173	4					253	+		10.7326/M19-3176	http://dx.doi.org/10.7326/M19-3176			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9TG	32568572				2022-12-28	WOS:000567070300014
J	Sugisawa, E; Takayama, Y; Takemura, N; Kondo, T; Hatakeyama, S; Kumagai, Y; Sunagawa, M; Tominaga, M; Maruyama, K				Sugisawa, Erika; Takayama, Yasunori; Takemura, Naoki; Kondo, Takeshi; Hatakeyama, Shigetsugu; Kumagai, Yutaro; Sunagawa, Masataka; Tominaga, Makoto; Maruyama, Kenta			RNA Sensing by Gut Piezo1 Is Essential for Systemic Serotonin Synthesis	CELL			English	Article							ION-CHANNEL PIEZO1; OSTEOCLAST FUSION; CATION CHANNEL; BONE-FORMATION; CELLS; MICROBIOTA; EXPRESSION; DIFFERENTIATION; ARCHITECTURE; HOMEOSTASIS	Gastrointestinal enterochromaffin cells regulate bone and gut homeostasis via serotonin (5-hydroxytryptamine [5-HT]) production. A recent report suggested that gut microbes regulate 5-HT levels; however, the precise underlying molecular mechanisms are unexplored. Here, we reveal that the cation channel Piezo1 in the gut acts as a sensor of single-stranded RNA (ssRNA) governing 5-HT production. Intestinal epithelium-specific deletion of mouse Piezo1 profoundly disturbed gut peristalsis, impeded experimental colitis, and suppressed serum 5-HT levels. Because of systemic 5-HT deficiency, conditional knockout of Piezo1 increased bone formation. Notably, fecal ssRNA was identified as a natural Piezo1 ligand, and ssRNA-stimulated 5-HT synthesis from the gut was evoked in a MyD88/TRIF-independent manner. Colonic infusion of RNase A suppressed gut motility and increased bone mass. These findings suggest gut ssRNA as a master determinant of systemic 5-HT levels, indicating the ssRNA-Piezo1 axis as a potential prophylactic target for treatment of bone and gut disorders.	[Sugisawa, Erika; Maruyama, Kenta] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan; [Takayama, Yasunori; Sunagawa, Masataka] Showa Univ, Sch Med, Dept Physiol, Tokyo 1428555, Japan; [Takemura, Naoki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Bioresponse Regulat, Suita, Osaka 5650871, Japan; [Kondo, Takeshi; Hatakeyama, Shigetsugu] Hokkaido Univ, Fac Med, Dept Biochem, Sapporo, Hokkaido 0608636, Japan; [Kondo, Takeshi; Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0608636, Japan; [Kumagai, Yutaro] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, Tsukuba, Ibaraki 3058565, Japan; [Tominaga, Makoto; Maruyama, Kenta] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan	Osaka University; Showa University; Osaka University; Hokkaido University; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan	Maruyama, K (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan.; Maruyama, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan.	maruyama@biken.osaka-u.ac.jp	Sunagawa, Masataka/ABE-4996-2021; KONDO, Takeshi/AGV-4963-2022; Takayama, Yasunori/AAG-1133-2021	Hatakeyama, Shigetsugu/0000-0002-2150-9979	Takeda Science Foundation; KAKENHI [JP16K15665, JP18H02970, JP19K22712]; Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED); Lotte Foundation; Kowa Life Science Foundation; Kanzawa Medical Research Foundation; Akashi Medical Foundation; Yakult Bioscience Research Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Lydia O'Leary Memorial Pias Dermatological Foundation; Canon Foundation; Life Science Foundation; Japan Dairy Association	Takeda Science Foundation(Takeda Science Foundation (TSF)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Lotte Foundation; Kowa Life Science Foundation; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Akashi Medical Foundation; Yakult Bioscience Research Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Lydia O'Leary Memorial Pias Dermatological Foundation; Canon Foundation(Canon Foundation); Life Science Foundation; Japan Dairy Association(Japan Dairy Association (J Milk))	We thank K. Shinno, B.R. Sahoo, N. Fukuda, and C. Okahata for technical assistance; C. Okahata, Y. Ishii, and Y. Ito for secretarial assistance; H. Tanaka and S. Sato for fruitful discussions; and A. Patapoutian for providing the Piezo1-IresGFP/pcDNA3.1 plasmid and Piezo1-knockout HEK293T cells. This research was supported by a grant from the Takeda Science Foundation (K.M.), KAKENHI (JP16K15665, JP18H02970, JP16K15665, and JP19K22712 to K.M.), Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED) (to K.M.), Lotte Foundation (to K.M.), Kowa Life Science Foundation (to K.M.), Kanzawa Medical Research Foundation (to K.M.), Akashi Medical Foundation (to K.M.), Yakult Bioscience Research Foundation (to K.M.), Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (to K.M.), Japan Dairy Association (to K.M.), Lydia O'Leary Memorial Pias Dermatological Foundation (to K.M.), Canon Foundation (to K.M.), and Life Science Foundation (to K.M.).	Albarran-Juarez J, 2018, J EXP MED, V215, P2655, DOI 10.1084/jem.20180483; Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Alcaino C, 2018, P NATL ACAD SCI USA, V115, pE7632, DOI 10.1073/pnas.1804938115; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Anderson EO, 2018, CELL REP, V23, P701, DOI 10.1016/j.celrep.2018.03.094; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Bai T, 2017, J NEUROGASTROENTEROL, V23, P453, DOI 10.5056/jnm16114; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Chesler AT, 2016, NEW ENGL J MED, V375, P1355, DOI 10.1056/NEJMoa1602812; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COOPER HS, 1993, LAB INVEST, V69, P238; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cui M, 2012, J BONE MINER RES, V27, P2097, DOI 10.1002/jbmr.1662; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Deshmukh SD, 2012, J IMMUNOL, V188, P774, DOI 10.4049/jimmunol.1101383; Dubin AE, 2017, NEURON, V94, P266, DOI 10.1016/j.neuron.2017.03.039; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fujimoto K, 2017, MUCOSAL IMMUNOL, V10, P446, DOI 10.1038/mi.2016.58; Gautam J, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0559-6; Ge JP, 2015, NATURE, V527, P64, DOI 10.1038/nature15247; Ge XL, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-016-1105-4; Gendaszewska-Darmach E, 2016, ONCOTARGET, V7, P69358, DOI 10.18632/oncotarget.12541; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Kuchimaru T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05366-3; Kumar M, 2019, PSYCHIAT RES, V276, P39, DOI 10.1016/j.psychres.2019.04.006; Lang K, 2018, CELL TISSUE RES, V371, P251, DOI 10.1007/s00441-017-2755-0; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Linan-Rico A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00564; Lukacs V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9329; Ma S, 2018, CELL, V173, P443, DOI 10.1016/j.cell.2018.02.047; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; Maruyama K, 2013, J EXP MED, V210, P1947, DOI 10.1084/jem.20130512; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Mercado CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02795; Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808; Nonomura K, 2018, P NATL ACAD SCI USA, V115, P12817, DOI 10.1073/pnas.1817070115; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park CK, 2014, NEURON, V82, P47, DOI 10.1016/j.neuron.2014.02.011; Psichas Arianna, 2017, J Vis Exp, DOI 10.3791/55687; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; RAND M, 1951, NATURE, V168, P385, DOI 10.1038/168385b0; Retailleau K, 2015, CELL REP, V13, P1161, DOI 10.1016/j.celrep.2015.09.072; Romac JMJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04194-9; Rose T, 2016, SCIENCE, V352, P1319, DOI 10.1126/science.aad3358; Shah KM, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.65; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yamazaki D, 2016, J CELL SCI, V129, P1940, DOI 10.1242/jcs.182220; Yan J, 2016, P NATL ACAD SCI USA, V113, pE7554, DOI 10.1073/pnas.1607235113; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253; Zhang YX, 2017, BBA-MOL BASIS DIS, V1863, P1326, DOI 10.1016/j.bbadis.2017.03.021; Zhang ZZ, 2018, CANCER RES, V78, P3147, DOI 10.1158/0008-5472.CAN-17-3006	72	42	45	4	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					609	+		10.1016/j.cell.2020.06.022	http://dx.doi.org/10.1016/j.cell.2020.06.022			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32640190	Bronze			2022-12-28	WOS:000558649000009
J	VanderWeele, TJ				VanderWeele, Tyler J.			Challenges Estimating Total Lives Lost in COVID-19 Decisions Consideration of Mortality Related to Unemployment, Social Isolation, and Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses how COVID-19-related policy decisions lead to trade-offs between medical, economic, social, and psychological outcomes, and emphasizes the need to account for deaths associated with unemployment and depression when estimating excess mortality.	[VanderWeele, Tyler J.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	VanderWeele, TJ (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	tvanderw@hsph.harvard.edu						[Anonymous], 2020, PUBLIC DISCOURSE; Goodman-Bacon A, 2020, 1870 DIW BERL; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Layard R., 2020, 13186 IZA; Li SS, 2016, JAMA INTERN MED, V176, P777, DOI 10.1001/jamainternmed.2016.1615; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Stephenson J., 2020, JAMA HLTH FORUM; Sud A, 2020, ANN ONCOL, V31, P1065, DOI 10.1016/j.annonc.2020.05.009; VanderWeele TJ, 2017, P NATL ACAD SCI USA, V114, P8148, DOI 10.1073/pnas.1702996114; Wei JK, 2019, BRIT J PSYCHIAT, V215, P449, DOI 10.1192/bjp.2019.74	10	43	44	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					445	446		10.1001/jama.2020.12187	http://dx.doi.org/10.1001/jama.2020.12187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32639547	Bronze			2022-12-28	WOS:000561261900010
J	Massarweh, NN; Itani, KMF; Morris, MS				Massarweh, Nader N.; Itani, Kamal M. F.; Morris, Melanie S.			The VA MISSION Act and the Future of Veterans' Access to Quality Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AFFAIRS		[Massarweh, Nader N.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Massarweh, Nader N.] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Itani, Kamal M. F.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Itani, Kamal M. F.] VA Boston Hlth Care Syst, Boston, MA USA; [Morris, Melanie S.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Morris, Melanie S.] Birmingham VA Med Ctr, Birmingham, AL USA	Baylor College of Medicine; Baylor College of Medicine; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Massarweh, NN (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd,OCL 112, Houston, TX 77030 USA.	massarwe@bcm.edu						Department of Veterans Affairs. Veterans Community Care Program, 2019, FED REGISTER, V84, P26278; Matula SR, 2010, J AM COLL SURGEONS, V211, P823, DOI 10.1016/j.jamcollsurg.2010.09.001; O'Hanlon C, 2017, J GEN INTERN MED, V32, P105, DOI 10.1007/s11606-016-3775-2; Penn M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7096; Thorpe JM, 2019, JAMA INTERN MED, V179, P1584, DOI 10.1001/jamainternmed.2019.2788; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575	6	23	23	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					343	344		10.1001/jama.2020.4505	http://dx.doi.org/10.1001/jama.2020.4505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32602896				2022-12-28	WOS:000562851000021
J	Ji, AL; Rubin, AJ; Thrane, K; Jiang, SZ; Reynolds, DL; Meyers, RM; Guo, MG; George, BM; Mollbrink, A; Bergenstrahle, J; Larsson, L; Bai, YH; Zhu, BK; Bhaduri, A; Meyers, JM; Rovira-Clave, X; Hollmig, ST; Aasi, SZ; Nolan, GP; Lundeberg, J; Khavari, PA				Ji, Andrew L.; Rubin, Adam J.; Thrane, Kim; Jiang, Sizun; Reynolds, David L.; Meyers, Robin M.; Guo, Margaret G.; George, Benson M.; Mollbrink, Annelie; Bergenstrahle, Joseph; Larsson, Ludvig; Bai, Yunhao; Zhu, Bokai; Bhaduri, Aparna; Meyers, Jordan M.; Rovira-Clave, Xavier; Hollmig, S. Tyler; Aasi, Sumaira Z.; Nolan, Garry P.; Lundeberg, Joakim; Khavari, Paul A.			Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma	CELL			English	Article							BREAST-CANCER; GENE-EXPRESSION; HAIR FOLLICLE; BETA; MICROENVIRONMENT; HETEROGENEITY; VISUALIZATION; METASTASIS; MECHANISMS; MUTATIONS	To define the cellular composition and architecture of cutaneous squamous cell carcinoma (cSCC), we combined single-cell RNA sequencing with spatial transcriptomics and multiplexed ion beam imaging from a series of human cSCCs and matched normal skin. cSCC exhibited four tumor subpopulations, three recapitulating normal epidermal states, and a tumor-specific keratinocyte (TSK) population unique to cancer, which localized to a fibrovascular niche. Integration of single-cell and spatial data mapped ligand-receptor networks to specific cell types, revealing TSK cells as a hub for intercellular communication. Multiple features of potential immunosuppression were observed, including T regulatory cell (Treg) co-localization with CD8 T cells in compartmentalized tumor stroma. Finally, single-cell characterization of human tumor xenografts and in vivo CRISPR screens identified essential roles for specific tumor subpopulation-enriched gene networks in tumorigenesis. These data define cSCC tumor and stromal cell subpopulations, the spatial niches where they interact, and the communicating gene networks that they engage in cancer.	[Ji, Andrew L.; Rubin, Adam J.; Reynolds, David L.; Meyers, Robin M.; Guo, Margaret G.; Meyers, Jordan M.; Hollmig, S. Tyler; Aasi, Sumaira Z.; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Ji, Andrew L.; Khavari, Paul A.] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Thrane, Kim; Mollbrink, Annelie; Bergenstrahle, Joseph; Larsson, Ludvig; Lundeberg, Joakim] KTH Royal Inst Technol, Dept Gene Technol, Sci Life Lab, Tomtebodavagen 23, S-17165 Solna, Sweden; [Jiang, Sizun; Bai, Yunhao; Zhu, Bokai; Rovira-Clave, Xavier; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [George, Benson M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Bhaduri, Aparna] Univ Calif San Francisco UCSF, Dept Neurol, San Francisco, CA 94122 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA	Stanford University; Stanford Cancer Institute; Stanford University; Royal Institute of Technology; Stanford University; Stanford University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA.; Khavari, PA (corresponding author), Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA.; Khavari, PA (corresponding author), Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.	khavari@stanford.edu	Zhu, Bokai/ABE-9378-2021; Jiang, Sizun/AAO-2333-2020; huang, dezhi/ABC-6566-2021	Jiang, Sizun/0000-0001-6149-3142; Thrane, Kim/0000-0003-3109-5551; Nolan, Garry/0000-0002-8862-9043; Guo, Margaret/0000-0001-7713-3846; Ji, Andrew/0000-0001-9688-5680; Zhu, Bokai/0000-0003-3599-9419	US Veterans Affairs Office of Research and Development [I01BX00140908]; National Institutes of Health (NIH) [CA142635, AR43799, 2U19AI057229-16, 5P01HL10879707, 5R01GM10983604, 5R33CA18365403, 5U01AI101984-07, 5UH2AR06767604, 5R01CA19665703, 5U54CA20997103, 5F99CA212231-02, 1F32CA233203-01, 5U01AI140498-02, 1U54HG010426-01]; Swedish Cancer Society [5UG3DK114937-02, 1U19AI135976-01, IDIQ17X149, 1U2CCA233238-01, 1U2CCA233195-01, T32AR007422, 5U19AI100627-07, 1R01HL120724-01A1, R33CA183692, R01HL128173-04, 5P01AI131374-02]; Swedish Foundation for Strategic Research; Swedish Research Council; Department of Defense [W81XWH-14-1-0180, W81XWH-12-1-0591]; Food and Drug Administration [HHSF223201610018C, DSTL/AGR00980]; Cancer Research UK [C27165/A29073]; Bill and Melinda Gates Foundation [OPP1113682]; Cancer Research Institute; Celgene [133826, 134073]; Rachford & Carlotta A. Harris Endowed Chair; Leukemia & Lymphoma Society Career Development Program; Stanford Dean's Fellowship; NIH [S10OD018220]; Parker Institute for Cancer Immunotherapy	US Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Department of Defense(United States Department of Defense); Food and Drug Administration(United States Department of Health & Human Services); Cancer Research UK(Cancer Research UK); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Cancer Research Institute; Celgene(Bristol-Myers SquibbCelgene Corporation); Rachford & Carlotta A. Harris Endowed Chair; Leukemia & Lymphoma Society Career Development Program; Stanford Dean's Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy	We thank members of the Khavari laboratory for helpful discussions and the National Genomics Infrastructure (NGI), Sweden and SNIC/UPPMAX for providing sequencing and computational infrastructure support, and Jamaica Jensen for histology support. This work was supported by the US Veterans Affairs Office of Research and Development I01BX00140908 (P.A.K.); National Institutes of Health (NIH) CA142635 and AR43799 (P.A.K.); 2U19AI057229-16, 5P01HL10879707, 5R01GM10983604, 5R33CA18365403, 5U01AI101984-07, 5UH2AR06767604, 5R01CA19665703, 5U54CA20997103, 5F99CA212231-02, 1F32CA233203-01, 5U01AI140498-02, 1U54HG010426-01, 5U19AI100627-07, 1R01HL120724-01A1, R33CA183692, R01HL128173-04, 5P01AI131374-02, 5UG3DK114937-02, 1U19AI135976-01, IDIQ17X149, 1U2CCA233238-01, and 1U2CCA233195-01 (G.P.N.); T32AR007422 (A.L.J.); Swedish Cancer Society (J.L.); Swedish Foundation for Strategic Research and the Swedish Research Council (J.L.); The Department of Defense (W81XWH-14-1-0180 and W81XWH-12-1-0591) (G.P.N.); Food and Drug Administration (HHSF223201610018C and DSTL/AGR00980) (G.P.N.); Cancer Research UK (C27165/A29073) (G.P.N); The Bill and Melinda Gates Foundation (OPP1113682) (G.P.N.); The Cancer Research Institute (G.P.N.); The Parker Institute for Cancer Immunotherapy (G.P.N.); Celgene (133826 and 134073) (G.P.N.); and the Rachford & Carlotta A. Harris Endowed Chair (G.P.N.). S.J. was supported by the Leukemia & Lymphoma Society Career Development Program and the Stanford Dean's Fellowship. Sequencing of scRNA-seq libraries was performed by the Stanford Functional Genomics Facility (supported by NIH grant S10OD018220).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; [Anonymous], 2020, UMAP UNIFORM MANIFOL; Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Browaeys R, 2019, NAT METHODS, V17, P159, DOI [10.1101/820936, DOI 10.1101/820936]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; Diggins KE, 2017, NAT METHODS, V14, P275, DOI [10.1038/NMETH.4149, 10.1038/nmeth.4149]; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Han GJ, 2018, NAT PROTOC, V13, P2121, DOI 10.1038/s41596-018-0016-7; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Ho W.J., 2019, JCI INSIGHT; Hu B, 2012, CELL, V149, P1207, DOI 10.1016/j.cell.2012.03.048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemt A., 2016, SCI REP, V6, P1; Jenh CH, 2001, CYTOKINE, V15, P113, DOI 10.1006/cyto.2001.0923; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Joost S, 2016, CELL SYST, V3, P221, DOI 10.1016/j.cels.2016.08.010; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karia PS, 2013, J AM ACAD DERMATOL, V68, P957, DOI 10.1016/j.jaad.2012.11.037; Keenan TE, 2019, NAT MED, V25, P389, DOI 10.1038/s41591-019-0382-x; Keren L., 2019, SCI ADV, V5, P1; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Kiss M, 2018, CELL IMMUNOL, V330, P188, DOI 10.1016/j.cellimm.2018.02.008; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lee CS, 2014, NAT GENET, V46, P1060, DOI 10.1038/ng.3091; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li YY, 2015, CLIN CANCER RES, V21, P1447, DOI 10.1158/1078-0432.CCR-14-1773; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu J., 2011, SMART MATER STRUCT, V20, P1; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Lohr M, 2001, CANCER RES, V61, P550; Lopez-Pajares V, 2015, DEV CELL, V32, P693, DOI 10.1016/j.devcel.2015.01.028; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maubec E, 2011, J CLIN ONCOL, V29, P3419, DOI 10.1200/JCO.2010.34.1735; McFaline-Figueroa JL, 2019, NAT GENET, V51, P1389, DOI 10.1038/s41588-019-0489-5; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Miao YX, 2019, CELL, V177, P1172, DOI 10.1016/j.cell.2019.03.025; Migden MR, 2018, NEW ENGL J MED, V379, P341, DOI 10.1056/NEJMoa1805131; Munn DH, 2016, TRENDS IMMUNOL, V37, P193, DOI 10.1016/j.it.2016.01.002; Navarro JF, 2017, BIOINFORMATICS, V33, P2591, DOI 10.1093/bioinformatics/btx211; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Pan J, 2018, CELL SYST, V6, P555, DOI 10.1016/j.cels.2018.04.011; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Prat A, 2017, CANCER RES, V77, P3540, DOI 10.1158/0008-5472.CAN-16-3556; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Purba TS, 2015, EXP DERMATOL, V24, P462, DOI 10.1111/exd.12700; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Redjimi N, 2012, CANCER RES, V72, P4351, DOI 10.1158/0008-5472.CAN-12-0579; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Rognoni E, 2014, NAT MED, V20, P350, DOI 10.1038/nm.3490; Rubin AJ, 2019, CELL, V176, P361, DOI 10.1016/j.cell.2018.11.022; Salmen F, 2018, BIORXIV, DOI DOI 10.1101/358937; Salmen F, 2018, NAT PROTOC, V13, P2501, DOI 10.1038/s41596-018-0045-2; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; South AP, 2014, J INVEST DERMATOL, V134, P2630, DOI 10.1038/jid.2014.154; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Thrane K, 2018, CANCER RES, V78, P5970, DOI 10.1158/0008-5472.CAN-18-0747; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Van Valen DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005177; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wagner J, 2019, CELL, V177, P1330, DOI 10.1016/j.cell.2019.03.005; Wainberg M., 2019, GENOME WIDE ALMANAC, DOI [10.1101/827071, DOI 10.1101/827071]; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; White D.E., 2004, CANCER CELL, V6; Wong K, 2018, BIOINFORMATICS, V34, P1966, DOI 10.1093/bioinformatics/bty030; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Yuen GJ, 2016, TRENDS CANCER, V2, P747, DOI 10.1016/j.trecan.2016.10.010; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	100	167	168	29	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					497	+		10.1016/j.cell.2020.05.039	http://dx.doi.org/10.1016/j.cell.2020.05.039			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32579974	Green Published, hybrid			2022-12-28	WOS:000552745000018
J	Woolston, C				Woolston, Chris			SEEKING AN 'EXIT PLAN'	NATURE			English	Editorial Material						Industry; Careers; Institutions		The pandemic is prompting some early-career researchers to rethink their hopes for a university post. The pandemic is prompting some early-career researchers to rethink their hopes for a university post.											0	6	6	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2020	583	7817					645	646		10.1038/d41586-020-02029-6	http://dx.doi.org/10.1038/d41586-020-02029-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ML9ZR	32632314				2022-12-28	WOS:000549820400001
J	Wang, HH; Lau, E; Horton, R				Wang, Helena Hui; Lau, Esther; Horton, Richard			The Wakley-Wu Lien Teh Prize Essay 2020: Chinese health workers' experiences during the COVID-19 pandemic	LANCET			English	Editorial Material									[Wang, Helena Hui] The Lancet, Beijing 100738, Peoples R China; [Lau, Esther] Lancet Child & Adolescent Hlth, London, England; [Horton, Richard] The Lancet, London, England		Wang, HH (corresponding author), The Lancet, Beijing 100738, Peoples R China.	he.wang@lancet.com						[Anonymous], 2020, NEW YORK TIMES STATE, DOI 10.1016/S2468-2667(20)30117-1; Boyce N, 2020, LANCET, V395, P1892, DOI 10.1016/S0140-6736(20)31415-X; Lau E, 2020, LANCET, V395, P173, DOI 10.1016/S0140-6736(19)33179-4; Wang HH, 2019, LANCET, V394, P11, DOI 10.1016/S0140-6736(19)31517-X; Wu LT, 1911, LANCET, V177, P1117	5	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					13	13						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32622383	Bronze, Green Published			2022-12-28	WOS:000561626100023
J	Ortega, RP				Ortega, Rodrigo Perez			IMPROBABLE OASIS	SCIENCE			English	News Item														Perez-Ortega, Rodrigo/0000-0001-8891-8753					0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					20	25		10.1126/science.369.6499.20	http://dx.doi.org/10.1126/science.369.6499.20			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631878				2022-12-28	WOS:000548751700015
J	Downer, S; Berkowitz, SA; Harlan, TS; Olstad, DL; Mozaffarian, D				Downer, Sarah; Berkowitz, Seth A.; Harlan, Timothy S.; Olstad, Dana Lee; Mozaffarian, Dariush			Food is medicine: actions to integrate food and nutrition into healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Downer, Sarah] Harvard Univ, Harvard Law Sch, Ctr Hlth Law & Policy Innovat, Cambridge, MA 02138 USA; [Berkowitz, Seth A.] Univ North Carolina Chapel Hill, Sch Med, Div Gen Med & Clin Epidemiol, Dept Med, Chapel Hill, NC USA; [Berkowitz, Seth A.] Univ North Carolina Chapel Hill, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Harlan, Timothy S.] George Washington Univ, Sch Med & Hlth Sci, Sect Gen Internal Med, Culinary Med Program, Washington, DC 20052 USA; [Olstad, Dana Lee] Univ Calgary, Dept Community Hlth Sci, Cumming Sch Med, Calgary, AB, Canada; [Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA	Harvard University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; George Washington University; University of Calgary; Tufts University	Downer, S (corresponding author), Harvard Univ, Harvard Law Sch, Ctr Hlth Law & Policy Innovat, Cambridge, MA 02138 USA.	sdowner@law.harvard.edu	Mozaffarian, Dariush/ABC-2822-2020; Olstad, Dana Lee/R-2767-2016	Olstad, Dana Lee/0000-0001-9787-9952	Rockefeller Foundation; Laura and John Arnold Foundation; MAC AIDS Fund; Bristol-Myers Squibb Foundation; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [K23DK109200]; Aspen Institute; US Department of Agriculture; Robert Wood Johnson Foundation; Commonwealth Fund; Humana Foundation; Canadian Institutes of Health Research; Social Sciences and Humanities Research Council of Canada; O'Brien Institute for Public Health; I Can For Kids Foundation; Alberta Innovates; Alberta Health Services; Canadian Foundation for Dietetic Research; Calgary Centre for Clinical Research; SecondBite; University of Calgary; Heart and Stroke Foundation of Canada; Libin Cardiovascular Research Institute of Alberta; National Institutes of Health; Gates Foundation	Rockefeller Foundation; Laura and John Arnold Foundation; MAC AIDS Fund; Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Aspen Institute; US Department of Agriculture(United States Department of Agriculture (USDA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Commonwealth Fund; Humana Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); O'Brien Institute for Public Health; I Can For Kids Foundation; Alberta Innovates; Alberta Health Services; Canadian Foundation for Dietetic Research; Calgary Centre for Clinical Research; SecondBite; University of Calgary; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Libin Cardiovascular Research Institute of Alberta; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gates Foundation(Bill & Melinda Gates Foundation)	We have read and understood BMJ policy on declaration of interests and have the following interests to declare: SD reports organisational funding from the Rockefeller Foundation, the Laura and John Arnold Foundation, the MAC AIDS Fund, and the Bristol-Myers Squibb Foundation. She sits on the American Cancer Society's National Lung Cancer Roundtable (unpaid) and on the Advisory Board for the Aspen Institute Food and Society Program's food is medicine initiative. Funding for SAB's work on the studies cited in this article was provided by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number K23DK109200. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. SAB has also received funding from the Aspen Institute, the US Department of Agriculture, the Robert Wood Johnson Foundation, and the Commonwealth Fund. He serves on the research advisory committee (unpaid) of the Social Intervention Research and Evaluation Network. TH reports past funding from the Robert Wood Johnson Foundation and the Humana Foundation; speaker fees from Optum, Omnia Education, beef.org, NACCME, DairyMAX; serves on the board of the Culinary Medicine Specialist Board; receives book royalties from Pritichett and Hull and Perseus; and is the owner and editor and chief of drgourmet.com and Dr Gourmet published materials. DLO reports research funding from the Canadian Institutes of Health Research, the Social Sciences and Humanities Research Council of Canada, the O'Brien Institute for Public Health, I Can For Kids Foundation, Alberta Innovates, Alberta Health Services, the Canadian Foundation for Dietetic Research, the Calgary Centre for Clinical Research, SecondBite, the University of Calgary, the Heart and Stroke Foundation of Canada, and the Libin Cardiovascular Research Institute of Alberta. DM reports research funding from the National Institutes of Health and the Gates Foundation; personal fees from GOED, Nutrition Impact, Bunge, Indigo Agriculture, Motif FoodWorks, Amarin, Acasti Pharma, Cleveland Clinic Foundation, America's Test Kitchen, and Danone; scientific advisory board, Brightseed, DayTwo, Elysium Health, Filtricine, HumanCo, and Tiny Organics; and chapter royalties from UpToDate.	[Anonymous], SECT GEN INT MED G W; Downer S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2482	2	58	59	10	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2482	10.1136/bmj.m2482	http://dx.doi.org/10.1136/bmj.m2482			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601089	hybrid, Green Published			2022-12-28	WOS:000548112700007
J	Jaffe, S				Jaffe, Susan			LGBTQ discrimination in US health care under scrutiny	LANCET			English	Editorial Material																			0	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2020	395	10242					1961	1961						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MJ0ZZ	32593329				2022-12-28	WOS:000547825600010
J	Badve, SV; Pascoe, EM; Biostat, M; Tiku, A; Boudville, N; Brown, FG; Cass, A; Clarke, P; Dalbeth, N; Day, RO; de Zoysa, JR; Douglas, B; Faull, R; Harris, DC; Hawley, CM; Jones, GRD; Kanellis, J; Palmer, SC; Perkovic, V; Rangan, GK; Reidlinger, D; Robison, L; Walker, RJ; Walters, G; Johnson, DW				Badve, Sunil V.; Pascoe, Elaine M.; Biostat, M.; Tiku, Anushree; Boudville, Neil; Brown, Fiona G.; Cass, Alan; Clarke, Philip; Dalbeth, Nicola; Day, Richard O.; de Zoysa, Janak R.; Douglas, Bettina; Faull, Randall; Harris, David C.; Hawley, Carmel M.; Jones, Graham R. D.; Kanellis, John; Palmer, Suetonia C.; Perkovic, Vlado; Rangan, Gopala K.; Reidlinger, Donna; Robison, Laura; Walker, Robert J.; Walters, Giles; Johnson, David W.		CKD-FIX Study Investigators	Effects of Allopurinol on the Progression of Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACID-LOWERING THERAPY; URIC-ACID; RENAL-DISEASE; HYPERURICEMIA; OUTCOMES; RISK	BACKGROUND Elevated serum urate levels are associated with progression of chronic kidney disease. Whether urate-lowering treatment with allopurinol can attenuate the decline of the estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease who are at risk for progression is not known. METHODS In this randomized, controlled trial, we randomly assigned adults with stage 3 or 4 chronic kidney disease and no history of gout who had a urinary albumin:creatinine ratio of 265 or higher (with albumin measured in milligrams and creatinine in grams) or an eGFR decrease of at least 3.0 ml per minute per 1.73 m(2) of body-surface area in the preceding year to receive allopurinol (100 to 300 mg daily) or placebo. The primary outcome was the change in eGFR from randomization to week 104, calculated with the Chronic Kidney Disease Epidemiology Collaboration creatinine equation. RESULTS Enrollment was stopped because of slow recruitment after 369 of 620 intended patients were randomly assigned to receive allopurinol (185 patients) or placebo (184 patients). Three patients per group withdrew immediately after randomization. The remaining 363 patients (mean eGFR, 31.7 ml per minute per 1.73 m(2); median urine albumin:creatinine ratio, 716.9; mean serum urate level, 8.2 mg per deciliter) were included in the assessment of the primary outcome. The change in eGFR did not differ significantly between the allopurinol group and the placebo group (-3.33 ml per minute per 1.73 m(2) per year [95% confidence interval {CI}, -4.11 to -2.55] and -3.23 ml per minute per 1.73 m(2) per year [95% CI, -3.98 to -2.47], respectively; mean difference, -0.10 ml per minute per 1.73 m(2) per year [95% CI, -1.18 to 0.97]; P = 0.85). Serious adverse events were reported in 84 of 182 patients (46%) in the allopurinol group and in 79 of 181 patients (44%) in the placebo group. CONCLUSIONS In patients with chronic kidney disease and a high risk of progression, urate-lowering treatment with allopurinol did not slow the decline in eGFR as compared with placebo.	[Badve, Sunil V.; Tiku, Anushree] St George Hosp, Dept Renal Med, Sydney, NSW, Australia; [Badve, Sunil V.; Tiku, Anushree; Perkovic, Vlado] George Inst Global Hlth, Renal & Metab Div, Level 5,1 King St, Newtown, NSW 2042, Australia; [Day, Richard O.; Jones, Graham R. D.] St Vincents Clin Sch, Sydney, NSW, Australia; [Day, Richard O.] Univ New South Wales Med, Dept Clin Pharmacol, Sydney, NSW, Australia; [Day, Richard O.] Univ New South Wales Med, Dept Toxicol, Sydney, NSW, Australia; [Jones, Graham R. D.] SydPath, Chem Pathol, Sydney, NSW, Australia; [Harris, David C.; Rangan, Gopala K.] Univ Sydney, St Vincents Hosp, Ctr Transplant & Renal Res, Westmead Inst Med Res, Sydney, NSW, Australia; [Harris, David C.; Rangan, Gopala K.] Westmead Hosp, Western Sydney Local Hlth Dist, Dept Renal Med, Sydney, NSW, Australia; [Perkovic, Vlado] Royal North Shore Hosp, Dept Nephrol, Sydney, NSW, Australia; [Badve, Sunil V.; Pascoe, Elaine M.; Boudville, Neil; Hawley, Carmel M.; Reidlinger, Donna; Robison, Laura; Johnson, David W.] Univ Queensland, Australasian Kidney Trials Network, Brisbane, Qld, Australia; [Douglas, Bettina; Hawley, Carmel M.; Johnson, David W.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia; [Johnson, David W.] Translat Res Inst, Brisbane, Qld, Australia; [Boudville, Neil] Univ Western Australia, Sch Med, Perth, WA, Australia; [Brown, Fiona G.; Kanellis, John] Monash Univ, Monash Med Ctr, Dept Nephrol, Melbourne, Vic, Australia; [Cass, Alan] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Faull, Randall] Univ Adelaide, Adelaide, SA, Australia; [Faull, Randall] Cent Northern Adelaide Renal & Transplantat Serv, Adelaide, SA, Australia; [Walters, Giles] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Walters, Giles] Canberra Hosp, Dept Nephrol, Canberra, ACT, Australia; [Clarke, Philip] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Oxford, England; [Dalbeth, Nicola; de Zoysa, Janak R.] Univ Auckland, Dept Med, Auckland, New Zealand; [de Zoysa, Janak R.] Waitemata Dist Hlth Board, Renal Serv, Auckland, New Zealand; [Palmer, Suetonia C.] Univ Otago Christchurch, Dept Med, Christchurch, New Zealand; [Walker, Robert J.] Univ Otago, Dunedin Sch Med, Dunedin, New Zealand	St George Hospital; George Institute for Global Health; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Royal North Shore Hospital; University of Queensland; University of Western Australia; Monash University; Charles Darwin University; Menzies School of Health Research; University of Adelaide; Australian National University; Australian National University; Canberra Hospital; University of Oxford; University of Auckland; University of Otago; University of Otago	Badve, SV (corresponding author), George Inst Global Hlth, Renal & Metab Div, Level 5,1 King St, Newtown, NSW 2042, Australia.	sbadve@georgeinstitute.org.au	Perkovic, Vlado/AAY-1933-2021; Boudville, Neil/H-8864-2014; Douglas, Bettina/E-9507-2013; Badve, Sunil/F-9049-2010; Johnson, David/F-2897-2011; REIDLINGER, Donna/R-8735-2018; Jose, Matthew/A-9565-2012	Douglas, Bettina/0000-0001-8664-6504; Badve, Sunil/0000-0003-2269-312X; Boudville, Neil/0000-0002-5884-640X; Kanellis, John/0000-0002-2748-5955; Johnson, David/0000-0001-5491-3460; de Zoysa, Janak/0000-0001-7528-9230; Neal, Bruce/0000-0002-0490-7465; Walters, Giles/0000-0003-4854-9353; REIDLINGER, Donna/0000-0002-3365-9923; Krishnasamy, Rathika/0000-0001-6974-7880; Jose, Matthew/0000-0002-9589-0071	National Health and Medical Research Council of Australia [APP1043203]; Health Research Council of New Zealand [14/117]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand)	Supported by grants from the National Health and Medical Research Council of Australia (APP1043203) and the Health Research Council of New Zealand (14/117).	Ahola AJ, 2017, KIDNEY INT, V91, P1178, DOI 10.1016/j.kint.2016.11.025; Badve SV, 2016, NEPHROL DIAL TRANSPL, V31, P1425, DOI 10.1093/ndt/gfv269; Badve SV, 2011, NAT REV NEPHROL, V7, P295, DOI 10.1038/nrneph.2010.186; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Doria A, 2020, NEW ENGL J MED, V382, P2493, DOI 10.1056/NEJMoa1916624; Garcia-Hernandez A, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i12; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Grams ME, 2019, J AM SOC NEPHROL, V30, P1746, DOI 10.1681/ASN.2019010008; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hughes K, 2014, KIDNEY INT, V85, P344, DOI 10.1038/ki.2013.353; Inker LA, 2019, J AM SOC NEPHROL, V30, P1735, DOI 10.1681/ASN.2019010007; Jalal DI, 2013, AM J KIDNEY DIS, V61, P134, DOI 10.1053/j.ajkd.2012.07.021; Jalal DI, 2010, NEPHROL DIAL TRANSPL, V25, P1865, DOI 10.1093/ndt/gfp740; Jing JJ, 2015, NEPHROL DIAL TRANSPL, V30, P613, DOI 10.1093/ndt/gfu352; Johnson RJ, 2018, AM J KIDNEY DIS, V71, P851, DOI 10.1053/j.ajkd.2017.12.009; Kimura K, 2018, AM J KIDNEY DIS, V72, P798, DOI 10.1053/j.ajkd.2018.06.028; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Levey AS, 2020, AM J KIDNEY DIS, V75, P84, DOI 10.1053/j.ajkd.2019.06.009; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; McMullan CJ, 2017, CLIN J AM SOC NEPHRO, V12, P807, DOI 10.2215/CJN.10771016; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Sircar D, 2015, AM J KIDNEY DIS, V66, P945, DOI 10.1053/j.ajkd.2015.05.017; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075	25	156	159	13	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2504	2513		10.1056/NEJMoa1915833	http://dx.doi.org/10.1056/NEJMoa1915833			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF9CW	32579811	Bronze			2022-12-28	WOS:000545636400021
J	Saltelli, A; Bammer, G; Bruno, I; Charters, E; Di Fiore, M; Didier, E; Espeland, WN; Kay, J; Lo Piano, S; Mayo, D; Pielke, R; Portaluri, T; Porter, TM; Puy, A; Rafols, I; Ravetz, JR; Reinert, E; Sarewitz, D; Stark, PB; Stirling, A; van der Sluijs, J; Vineis, P				Saltelli, Andrea; Bammer, Gabriele; Bruno, Isabelle; Charters, Erica; Di Fiore, Monica; Didier, Emmanuel; Espeland, Wendy Nelson; Kay, John; Lo Piano, Samuele; Mayo, Deborah; Pielke, Roger, Jr.; Portaluri, Tommaso; Porter, Theodore M.; Puy, Arnald; Rafols, Ismael; Ravetz, Jerome R.; Reinert, Erik; Sarewitz, Daniel; Stark, Philip B.; Stirling, Andrew; van der Sluijs, Jeroen; Vineis, Paolo			Five ways to ensure that models serve society: a manifesto	NATURE			English	Editorial Material									[Saltelli, Andrea] Univ Bergen, Ctr Study Sci & Humanities, Bergen, Norway; [Saltelli, Andrea] Open Univ Catalonia, Open Evidence Res, Barcelona, Spain	University of Bergen; UOC Universitat Oberta de Catalunya	Saltelli, A (corresponding author), Univ Bergen, Ctr Study Sci & Humanities, Bergen, Norway.; Saltelli, A (corresponding author), Open Univ Catalonia, Open Evidence Res, Barcelona, Spain.	andrea.saltelli@uib.no	van der Sluijs, Jeroen P/B-6302-2008; Puy, Arnald/AAA-3340-2021; Rafols, Ismael/D-1509-2009; Lo Piano, Samuele/N-1469-2017	van der Sluijs, Jeroen P/0000-0002-1346-5953; Puy, Arnald/0000-0001-9469-2156; Rafols, Ismael/0000-0002-6527-7778; saltelli, andrea/0000-0003-4222-6975; Lo Piano, Samuele/0000-0002-2625-483X; Di Fiore, Monica/0000-0002-2621-8775; Charters, Erica/0000-0001-8503-3992	ESRC [ES/R008884/1, ES/L01632X/1, ES/K006371/1, ES/S008241/1, ES/I021620/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Behrend MR, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008033; Bruno I, 2014, PARTECIP CONFL, V7, P198, DOI 10.1285/i20356609v7i2p198; Devlin H., 2020, GUARDIAN; Espeland W.N., 2008, EUR J SOCIOL, V49, P401, DOI DOI 10.1017/S0003975609000150; Ferguson N., 2020, IMPERIAL COLL LONDON; Kay J., 2020, RADICAL UNCERTAINTY; Mayo DG, 2018, STATISTICAL INFERENCE AS SEVERE TESTING: HOW TO GET BEYOND THE STATISTICS WARS, DOI 10.1017/9781107286184; Porter T.M, 1996, POLITICAL PHILOS QUA; Puy A, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL087360; Sarewitz D.R., 2000, PREDICTION SCI DECIS; Stirling A., POLITICS CLOSES UNCE	11	121	125	5	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					482	484		10.1038/d41586-020-01812-9	http://dx.doi.org/10.1038/d41586-020-01812-9			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OL0BX	32581374	Green Submitted			2022-12-28	WOS:000585009400001
J	Goyal, P; Ringel, JB; Rajan, M; Choi, JJ; Pinheiro, LC; Li, HA; Wehmeyer, GT; Alshak, MN; Jabri, A; Schenck, EJ; Chen, RJ; Satlin, MJ; Campion, TR; Nahid, M; Plataki, M; Hoffman, KL; Reshetnyak, E; Hupert, N; Horn, EM; Martinez, FJ; Gulick, RM; Safford, MM				Goyal, Parag; Ringel, Joanna Bryan; Rajan, Mangala; Choi, Justin J.; Pinheiro, Laura C.; Li, Han A.; Wehmeyer, Graham T.; Alshak, Mark N.; Jabri, Assem; Schenck, Edward J.; Chen, Ruijun; Satlin, Michael J.; Campion, Thomas R., Jr.; Nahid, Musarrat; Plataki, Maria; Hoffman, Katherine L.; Reshetnyak, Evgeniya; Hupert, Nathaniel; Horn, Evelyn M.; Martinez, Fernando J.; Gulick, Roy M.; Safford, Monika M.			Obesity and COVID-19 in New York City: A Retrospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Letter									[Goyal, Parag; Ringel, Joanna Bryan; Rajan, Mangala; Choi, Justin J.; Pinheiro, Laura C.; Jabri, Assem; Schenck, Edward J.; Chen, Ruijun; Satlin, Michael J.; Campion, Thomas R., Jr.; Nahid, Musarrat; Plataki, Maria; Hoffman, Katherine L.; Reshetnyak, Evgeniya; Hupert, Nathaniel; Horn, Evelyn M.; Martinez, Fernando J.; Gulick, Roy M.; Safford, Monika M.] Weill Cornell Med, New York, NY USA; [Li, Han A.; Wehmeyer, Graham T.; Alshak, Mark N.] Weill Cornell Med Coll, New York, NY USA; [Chen, Ruijun] Columbia Univ, New York, NY USA	Cornell University; Cornell University; Columbia University	Goyal, P (corresponding author), Weill Cornell Med, Dept Med, 420 East 70th St,LH-365, New York, NY 10021 USA.	pag9051@med.cornell.edu	Satlin, Michael/AAZ-3906-2020; Schenck, Edward/AAX-8836-2020	Schenck, Edward/0000-0002-7950-5989; Alshak, Mark/0000-0003-3893-6683; Choi, Justin/0000-0003-3335-2750; Wehmeyer, Graham/0000-0003-2321-1970; Chen, RuiJun/0000-0001-5281-4143; Li, Han/0000-0001-5441-0740	NewYork-Presbyterian Hospital; Clinical and Translational Science Center [UL1 TR000457]; Joint Clinical Trials Office; National Institute on Aging [R03AG056446]; American Heart Association [18IPA34170185]; KL2 award from the National Center for Advancing Translational Sciences of the National Institutes of Health; Merck; Allergan; BioFire Diagnostics; Weill Cornell Medical College	NewYork-Presbyterian Hospital; Clinical and Translational Science Center; Joint Clinical Trials Office; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); KL2 award from the National Center for Advancing Translational Sciences of the National Institutes of Health; Merck(Merck & Company); Allergan(AbbVieAllergan); BioFire Diagnostics; Weill Cornell Medical College	By NewYork-Presbyterian Hospital and Weill Cornell Medical College, including the Clinical and Translational Science Center (UL1 TR000457) and Joint Clinical Trials Office. Dr. Goyal is supported by grant R03AG056446 from the National Institute on Aging and grant 18IPA34170185 from the American Heart Association. Dr. Choi is supported by a KL2 award from the National Center for Advancing Translational Sciences of the National Institutes of Health. Dr. Satlin is supported by research grants from Merck, Allergan, and BioFire Diagnostics.	Dixon AE, 2018, EXPERT REV RESP MED, V12, P755, DOI 10.1080/17476348.2018.1506331; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Jose RJ, 2020, OBESITY, V28, P1007, DOI 10.1002/oby.22835; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Plataki M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127823	5	50	50	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2020	173	10					855	+		10.7326/M20-2730	http://dx.doi.org/10.7326/M20-2730			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OU5XD	32628537	Green Published			2022-12-28	WOS:000591600700030
J	Mello, MM; Silverman, RD; Omer, SB				Mello, Michelle M.; Silverman, Ross D.; Omer, Saad B.			Ensuring Uptake of Vaccines against SARS-CoV-2	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mello, Michelle M.] Stanford Univ, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Stanford Hlth Policy, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Silverman, Ross D.] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Hlth Policy & Management, Indianapolis, IN 46204 USA; [Silverman, Ross D.] Indiana Univ, Robert H McKinney Sch Law, Indianapolis, IN 46204 USA; [Omer, Saad B.] Yale Inst Global Hlth, New Haven, CT USA; [Omer, Saad B.] Yale Sch Med, New Haven, CT USA; [Omer, Saad B.] Yale Sch Publ Hlth, New Haven, CT USA; [Omer, Saad B.] Yale Sch Nursing, New Haven, CT USA	Stanford University; Stanford University; Stanford University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Yale University; Yale University; Yale University	Mello, MM (corresponding author), Stanford Univ, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA.; Mello, MM (corresponding author), Stanford Univ, Sch Med, Stanford Hlth Policy, Stanford, CA 94305 USA.; Mello, MM (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.			Mello, Michelle/0000-0003-2877-4270; Silverman, Ross D./0000-0003-4492-3096				[Anonymous], 2020, ASS PRESS; Hartocollis A, 2009, NY TIMES; Mello MM, 2012, AM J PUBLIC HEALTH, V102, P893, DOI 10.2105/AJPH.2011.300576; Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711; Trogen B, 2020, JAMA-J AM MED ASSOC, V323, P2460, DOI 10.1001/jama.2020.8917	5	53	53	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2020	383	14					1296	1299		10.1056/NEJMp2020926	http://dx.doi.org/10.1056/NEJMp2020926			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NX3MO	32589371	Green Published, Bronze			2022-12-28	WOS:000575616600004
J	Miller, T; Cudkowicz, M; Shaw, PJ; Andersen, PM; Atassi, N; Bucelli, RC; Genge, A; Glass, J; Ladha, S; Ludolph, AL; Maragakis, NJ; McDermott, CJ; Pestronk, A; Ravits, J; Salachas, F; Trudell, R; Van Damme, P; Zinman, L; Bennett, CF; Lane, R; Sandrock, A; Runz, H; Graham, D; Houshyar, H; McCampbell, A; Nestorov, I; Chang, I; McNeill, M; Fanning, L; Fradette, S; Ferguson, TA				Miller, Timothy; Cudkowicz, Merit; Shaw, Pamela J.; Andersen, Peter M.; Atassi, Nazem; Bucelli, Robert C.; Genge, Angela; Glass, Jonathan; Ladha, Shafeeq; Ludolph, Albert L.; Maragakis, Nicholas J.; McDermott, Christopher J.; Pestronk, Alan; Ravits, John; Salachas, Francois; Trudell, Randall; Van Damme, Philip; Zinman, Lorne; Bennett, C. Frank; Lane, Roger; Sandrock, Alfred; Runz, Heiko; Graham, Danielle; Houshyar, Hani; McCampbell, Alexander; Nestorov, Ivan; Chang, Ih; McNeill, Manjit; Fanning, Laura; Fradette, Stephanie; Ferguson, Toby A.			Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SHAM CONTROL; MUTATION; NUSINERSEN	BackgroundTofersen is an antisense oligonucleotide that mediates the degradation of superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protein synthesis. Intrathecal administration of tofersen is being studied for the treatment of amyotrophic lateral sclerosis (ALS) due to SOD1 mutations. MethodsWe conducted a phase 1-2 ascending-dose trial evaluating tofersen in adults with ALS due to SOD1 mutations. In each dose cohort (20, 40, 60, or 100 mg), participants were randomly assigned in a 3:1 ratio to receive five doses of tofersen or placebo, administered intrathecally for 12 weeks. The primary outcomes were safety and pharmacokinetics. The secondary outcome was the change from baseline in the cerebrospinal fluid (CSF) SOD1 concentration at day 85. Clinical function and vital capacity were measured. ResultsA total of 50 participants underwent randomization and were included in the analyses; 48 participants received all five planned doses. Lumbar puncture-related adverse events were observed in most participants. Elevations in CSF white-cell count and protein were reported as adverse events in 4 and 5 participants, respectively, who received tofersen. Among participants who received tofersen, one died from pulmonary embolus on day 137, and one from respiratory failure on day 152; one participant in the placebo group died from respiratory failure on day 52. The difference at day 85 in the change from baseline in the CSF SOD1 concentration between the tofersen groups and the placebo group was 2 percentage points (95% confidence interval [CI], -18 to 27) for the 20-mg dose, -25 percentage points (95% CI, -40 to -5) for the 40-mg dose, -19 percentage points (95% CI, -35 to 2) for the 60-mg dose, and -33 percentage points (95% CI, -47 to -16) for the 100-mg dose. ConclusionsIn adults with ALS due to SOD1 mutations, CSF SOD1 concentrations decreased at the highest concentration of tofersen administered intrathecally over a period of 12 weeks. CSF pleocytosis occurred in some participants receiving tofersen. Lumbar puncture-related adverse events were observed in most participants. (Funded by Biogen; ClinicalTrials.gov number, NCT02623699; EudraCT number, 2015-004098-33.) In a phase 1-2 dose-escalation trial involving adults with ALS due to SOD1 mutations who received intrathecal tofersen (an antisense oligonucleotide) or placebo, the levels of mutant SOD1 in the CSF were 33 percentage points lower in the highest-dose tofersen group than in the placebo group.	[Sandrock, Alfred; Runz, Heiko; Graham, Danielle; Houshyar, Hani; McCampbell, Alexander; Nestorov, Ivan; Chang, Ih; Fanning, Laura; Fradette, Stephanie; Ferguson, Toby A.] Biogen, 225 Binney St, Cambridge, MA 02142 USA; [Miller, Timothy; Bucelli, Robert C.; Pestronk, Alan] Washington Univ, Sch Med, St Louis, MO USA; [Cudkowicz, Merit; Atassi, Nazem] Harvard Med Sch, Massachusetts Gen Hosp, Healey Ctr ALS, Boston, MA 02115 USA; [Shaw, Pamela J.; McDermott, Christopher J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Shaw, Pamela J.; McDermott, Christopher J.] Univ Sheffield, NIHR Sheffield Biomed Res Ctr, Sheffield, S Yorkshire, England; [Shaw, Pamela J.; McDermott, Christopher J.] Univ Sheffield, Clin Res Facil, Sheffield, S Yorkshire, England; [Shaw, Pamela J.; McDermott, Christopher J.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [McNeill, Manjit] Biogen, Maidenhead, Berks, England; [Andersen, Peter M.] Umea Univ, Dept Clin Sci, Neurosci, Umea, Sweden; [Genge, Angela] Montreal Neurol Hosp & Inst, Montreal, PQ, Canada; [Zinman, Lorne] Sunnybrook Res Inst, Toronto, ON, Canada; [Glass, Jonathan] Emory Univ, Atlanta, GA 30322 USA; [Ladha, Shafeeq] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Ludolph, Albert L.] Univ Ulm, Ulm, Germany; [Maragakis, Nicholas J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Ravits, John] Univ Calif San Diego, La Jolla, CA 92093 USA; [Bennett, C. Frank; Lane, Roger] Ionis Pharmaceut, Carlsbad, CA USA; [Salachas, Francois] Hop La Pitie Salpetriere, Paris ALS Ctr, Paris, France; [Trudell, Randall] Univ Tennessee, Med Ctr, Knoxville, TN USA; [Van Damme, Philip] Katholieke Univ Leuven, VIB Ctr Brain & Dis Res, Univ Hosp Leuven, Leuven, Belgium	Biogen; Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Umea University; McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Emory University; Barrow Neurological Institute; Ulm University; Johns Hopkins University; University of California System; University of California San Diego; Ionis Pharmaceuticals, Inc.; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Tennessee System; University of Tennessee Health Science Center; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Miller, T (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.; Ferguson, TA (corresponding author), Biogen, 225 Binney St, Cambridge, MA 02142 USA.	miller.t@wustl.edu; miller.t@wustl.edu	Van Damme, Philip/A-6464-2009; McDermott, Chris/GQZ-3919-2022; McDermott, Christopher/AAU-4988-2020; CUDKOWICZ, MERIT/GWM-6585-2022; Graham, Danielle L/K-8459-2014	Van Damme, Philip/0000-0002-4010-2357; McDermott, Christopher/0000-0002-1269-9053; CUDKOWICZ, MERIT/0000-0002-7075-1681; Shaw, Pamela/0000-0002-8925-2567; Andersen, Peter Munch/0000-0003-0094-5429	Biogen; Benevolent AI; Orion; Cytokinetics; Pfizer; ALS Association; Neuralstem; Amylyx Pharmaceuticals	Biogen(Biogen); Benevolent AI; Orion; Cytokinetics; Pfizer(Pfizer); ALS Association; Neuralstem; Amylyx Pharmaceuticals	Supported by Biogen. Dr. Miller reports receiving advisory board fees from Biogen, receiving consulting fees from Cytokinetics and Disarm Therapeutics, having a licensing agreement with C2N Diagnostics and Ionis Pharmaceuticals, and holding a patent (10,273,474) on antisense oligonucleotides that lower tau, licensed to Ionis Pharmaceuticals; Dr. Cudkowicz, receiving consulting fees from Biogen, Takeda Pharmaceutical, Cytokinetics, Immunity Pharma, Anelixis Therapeutics, Aclipse Therapeutics, Orion, Biohaven Pharmaceuticals, Sunovion, ALS Biopharma, Mitsubishi Tanabe Pharma, Avanir Pharmaceuticals, Wave Life Sciences, AveXis, Revalesio, and Disarm Therapeutics and fees for serving on a data and safety monitoring board from Eli Lilly; Dr. Shaw, receiving commercial sponsorship and advisory board fees from Biogen, grant support and advisory board fees from Benevolent AI, commercial sponsorship from Orion and Cytokinetics, and grant support from Pfizer; Dr. Andersen, receiving consulting fees from Orphazyme and Roche-Genentech; Dr. Atassi, receiving advisory board fees from Biogen, being employed by Sanofi-Genzyme, and being previously employed by Massachusetts General Hospital; Dr. Bucelli, being employed by and receiving fees for a continuing medical education course from Washington University School of Medicine and holding equity in NeuroQuestions.com; Dr. Genge, receiving consulting fees from AL-S Pharma, Cytokinetics, Alexion, Calico, and Sanofi and serving as site principal investigator, serving on a steering committee, and serving as a consultant for Biogen; Dr. Glass, receiving grant support from ALS Association and commercial sponsorship from Biogen, Cytokinetics, Neuralstem, and Amylyx Pharmaceuticals; Dr. Maragakis, receiving commercial sponsorship from Biogen, Orion, and Cytokinetics; Dr. McDermott, receiving consulting fees from Orion, Orphazyme, and Biogen and being employed by the University of Sheffield; Dr. Salachas, receiving advisory board fees from Biogen; Dr. Zinman, receiving advisory board fees from Biogen; Dr. Bennett, being employed by and holding stock in Ionis Pharmaceuticals, holding a patent (PCT/US15/023934) on compositions for modulating SOD1 expression and a patent (PCT/US19/065936) on compositions and methods for treating and preventing amyotrophic lateral sclerosis; Dr. Lane, being employed by and holding stock in Ionis Pharmaceuticals; Drs. Sandrock, Runz, Graham, Houshyar, McCampbell, and Nestorov being employed by and holding stock in Biogen; Dr. Chang, being previously employed by and holding stock in Biogen; and Ms. McNeill and Drs. Fanning, Fradette, and Ferguson being employed by and holding stock in Biogen. No other potential conflict of interest relevant to this article was reported.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; ALSoD, RES SODI; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; Bali T, 2017, J NEUROL NEUROSUR PS, V88, P99, DOI 10.1136/jnnp-2016-313521; Bidhendi EE, 2018, ACTA NEUROPATHOL, V136, P939, DOI 10.1007/s00401-018-1915-y; Bunton-Stasyshyn RKA, 2015, NEUROSCIENTIST, V21, P519, DOI 10.1177/1073858414561795; Coppede F, 2018, AMYOTROPH LAT SCL FR, V19, P93, DOI 10.1080/21678421.2017.1367401; Crisp MJ, 2015, J CLIN INVEST, V125, P2772, DOI 10.1172/JCI80705; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Hayashi Yuki, 2015, Advances in Biological Regulation, V60, P95, DOI 10.1016/j.jbior.2015.10.006; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; McCampbell A, 2018, J CLIN INVEST, V128, P3558, DOI 10.1172/JCI99081; Mercuri E, 2018, NEW ENGL J MED, V378, P625, DOI 10.1056/NEJMoa1710504; Miller T, 2019, ANN M AM AC NEUR PHI; Muller K, 2018, J NEUROL NEUROSUR PS, V89, P817, DOI 10.1136/jnnp-2017-317611; Rinaldi C, 2018, NAT REV NEUROL, V14, P9, DOI 10.1038/nrneurol.2017.148; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Wurster CD, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418776932	20	191	195	13	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					109	119		10.1056/NEJMoa2003715	http://dx.doi.org/10.1056/NEJMoa2003715			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9PO	32640130	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000571894800010
J	Williamson, EJ; Walker, AJ; Bhaskaran, K; Bacon, S; Bates, C; Morton, CE; Curtis, HJ; Mehrkar, A; Evans, D; Inglesby, P; Cockburn, J; McDonald, HI; MacKenna, B; Tomlinson, L; Douglas, IJ; Rentsch, CT; Mathur, R; Wong, AYS; Grieve, R; Harrison, D; Forbes, H; Schultze, A; Croker, R; Parry, J; Hester, F; Harper, S; Perera, R; Evans, SJW; Smeeth, L; Ben Goldacre				Williamson, Elizabeth J.; Walker, Alex J.; Bhaskaran, Krishnan; Bacon, Seb; Bates, Chris; Morton, Caroline E.; Curtis, Helen J.; Mehrkar, Amir; Evans, David; Inglesby, Peter; Cockburn, Jonathan; McDonald, Helen, I; MacKenna, Brian; Tomlinson, Laurie; Douglas, Ian J.; Rentsch, Christopher T.; Mathur, Rohini; Wong, Angel Y. S.; Grieve, Richard; Harrison, David; Forbes, Harriet; Schultze, Anna; Croker, Richard; Parry, John; Hester, Frank; Harper, Sam; Perera, Rafael; Evans, Stephen J. W.; Smeeth, Liam; Ben Goldacre			Factors associated with COVID-19-related death using OpenSAFELY	NATURE			English	Article							PRIMARY-CARE; HEALTH; RATES	Coronavirus disease 2019 (COVID-19) has rapidly affected mortality worldwide(1). There is unprecedented urgency to understand who is most at risk of severe outcomes, and this requires new approaches for the timely analysis of large datasets. Working on behalf of NHS England, we created OpenSAFELY-a secure health analytics platform that covers 40% of all patients in England and holds patient data within the existing data centre of a major vendor of primary care electronic health records. Here we used OpenSAFELY to examine factors associated with COVID-19-related death. Primary care records of 17,278,392 adults were pseudonymously linked to 10,926 COVID-19-related deaths. COVID-19-related death was associated with: being male (hazard ratio (HR) 1.59 (95% confidence interval 1.53-1.65)); greater age and deprivation (both with a strong gradient); diabetes; severe asthma; and various other medical conditions. Compared with people of white ethnicity, Black and South Asian people were at higher risk, even after adjustment for other factors (HR 1.48 (1.29-1.69) and 1.45 (1.32-1.58), respectively). We have quantified a range of clinical factors associated with COVID-19-related death in one of the largest cohort studies on this topic so far. More patient records are rapidly being added to OpenSAFELY, we will update and extend our results regularly. OpenSAFELY, a new health analytics platform that includes data from over 17 million adult NHS patients in England, is used to examine factors associated with COVID-19-related death.	[Williamson, Elizabeth J.; Bhaskaran, Krishnan; McDonald, Helen, I; Tomlinson, Laurie; Douglas, Ian J.; Rentsch, Christopher T.; Mathur, Rohini; Wong, Angel Y. S.; Grieve, Richard; Forbes, Harriet; Schultze, Anna; Evans, Stephen J. W.; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hearth, London, England; [Walker, Alex J.; Bacon, Seb; Morton, Caroline E.; Curtis, Helen J.; Mehrkar, Amir; Evans, David; Inglesby, Peter; MacKenna, Brian; Croker, Richard; Perera, Rafael; Ben Goldacre] Univ Oxford, Nuffield Dept Primary Care Hearth Sci, DataLab, Oxford, England; [Bates, Chris; Cockburn, Jonathan; Parry, John; Hester, Frank; Harper, Sam] TPP, Horsforth, England; [McDonald, Helen, I; Smeeth, Liam] NIHR Hearth Protect Res Unit Immunisat, London, England; [Harrison, David] Intens Care Natl Audit & Res Ctr ICNARC, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Intensive Care National Audit & Research Centre	Ben Goldacre (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hearth Sci, DataLab, Oxford, England.	ben.gordacre@phc.ox.ac.uk	Harrison, David A/O-4355-2018; Smeeth, Liam/X-5862-2018; Walker, Alex/H-1037-2014	Harrison, David A/0000-0002-9002-9098; Bates, Christopher/0000-0003-0113-2593; Evans, Stephen/0000-0002-1474-2596; Smeeth, Liam/0000-0002-9168-6022; Tomlinson, Laurie/0000-0001-8848-9493; Walker, Alex/0000-0003-4932-6135; Perera, Rafael/0000-0003-2418-2091; McDonald, Helen/0000-0003-0576-2015; Bhaskaran, Krishnan/0000-0001-5364-8757; Forbes, Harriet/0000-0001-6888-2212; Rentsch, Christopher/0000-0002-1408-7907; Evans, David/0000-0002-1100-079X; Grieve, Richard/0000-0001-8899-1301; MacKenna, Brian/0000-0002-3786-9063; Williamson, Elizabeth/0000-0001-6905-876X	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; NIHR Applied Research Collaboration Oxford and Thames Valley; Mohn-Westlake Foundation; NHS England; Health Foundation; Wellcome; Royal Society; NIHR Health Protection Research Unit in Immunisation; Public Health England; LSHTM; BHF; Wellcome Trust; MRC; NIHR; GSK; UKRI	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Applied Research Collaboration Oxford and Thames Valley; Mohn-Westlake Foundation; NHS England; Health Foundation; Wellcome; Royal Society(Royal Society of London); NIHR Health Protection Research Unit in Immunisation; Public Health England; LSHTM; BHF(British Heart Foundation); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); GSK(GlaxoSmithKline); UKRI(UK Research & Innovation (UKRI))	All authors are from The OpenSAFELY Collaborative. We are grateful for all the support received from the TPP Technical Operations team throughout this work; for assistance from the information governance and database teams at NHS England and NHSX; and for additional discussions on disease characterization, codelists and methodology with H. Drysdale, B. Nicholson, N. DeVito, W. Hulme, I. Lipska, J. Morley, J. Quint and T. Pham. No dedicated funding has yet been obtained for this work. TPP provided technical expertise and infrastructure within their data centre pro bono in the context of a national emergency. The work of B.G. on better use of data in healthcare more broadly is currently funded in part by: the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, NIHR Applied Research Collaboration Oxford and Thames Valley, the Mohn-Westlake Foundation, NHS England and the Health Foundation; all DataLab staff are supported by the grants of B.G. for this work. L.S. reports grants from Wellcome, MRC, NIHR, UKRI, British Council, GSK, British Heart Foundation and Diabetes UK outside this work; K.B. holds a Sir Henry Dale fellowship jointly funded by Wellcome and the Royal Society; H.I.M. is funded by the NIHR Health Protection Research Unit in Immunisation (a partnership between Public Health England and LSHTM); A.Y.S.W. holds a fellowship from BHF; R.M. holds a Sir Henry Wellcome fellowship funded by the Wellcome Trust; E.J.W. holds grants from MRC; R.G. holds grants from NIHR and MRC; I.J.D. holds grants from NIHR and GSK; and H.F. holds a UKRI fellowship. The views expressed are those of the authors and not necessarily those of the NIHR, NHS England, Public Health England or the Department of Health and Social Care. The funders had no role in the study design; the collection, analysis and interpretation of data; the writing of the report; and the decision to submit the article for publication.	Boddington NL., 2020, COVID 19 GREAT BRITA, DOI [10.1101/2020.05.18.20086157, DOI 10.1101/2020.05.18.20086157]; Carpenter J., 2012, MULTIPLE IMPUTATION, DOI DOI 10.1002/9781119942283; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; COOK S, 2020, J MED INTERNET RES, DOI DOI 10.2196/17003; Deng GT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02902-w; Department of Health and Social Care, 2020, COR COVID 19 NOT ORG; Department of Social Care and Public Health England, 2020, NUMB COR COVID 19 CA; Docherty A.B., 2020, MEDRXIV, DOI [10.1136/bmj.m1985, 10.1101/2020.04.23.20076042v1, DOI 10.1101/2020.04.23.20076042]; Farsalinos K., 2020, SMOKING VAPING HOSPI, DOI 10.32388/z69o8a.13.; Forbes H., 2014, CLIN CODE LIST SLE C, DOI [10.17037/DATA.162, DOI 10.17037/DATA.162]; GOV.UK, 2020, WITHDR GUID SOC DIST; Grint DJ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034886; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Halpin DMG, 2020, LANCET RESP MED, V8, P436, DOI 10.1016/S2213-2600(20)30167-3; Harcourt S, 2018, VACCINE, V36, P565, DOI 10.1016/j.vaccine.2017.11.076; Intensive Care National Audit and Research Centre, 2020, COVID 19 REP; Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1548; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; MacKenna B., 2019, WHAT IS DM NHS DICT; MacKenna B., 2018, GHOST BRANDED GENERI; MacKenna B., 2020, OPENSAFELY CODELISTS; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; McDonald H., 2020, OPENSAFELY CODELISTS; Miyara M., 2020, QEIOS, DOI [DOI 10.32388/WPP19W.3, 10.32388/WPP19W.3]; Morton C., 2020, OPEN SAFELY CODELIST; Morton C., 2020, OPENSAFELY CODELISTS; NHS Digital, 2018, DAT SEC PROT TOOLK; NHS Digital, 2019, ISB1523 AN STAND PUB; NHS Digital, 2020, GP SYST CHOIC; NHS Digital, 2020, BETA DAT SEC STAND; NHS England, 2020, COVID 19 DAIL DEATHS; Nissen F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017474; Office for National Statistics, 2019, POP CHAR RES TABL; Office for National Statistics, 2020, DEATHS REG WEEKL ENG; Opondo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129515; Public Health England, 2013, UK IMM SCHED GREEN B; Public Health England, 2020, DISP RISK OUTC COVID; Pujades-Rodriguez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151245; Rentsch Christopher T, 2020, medRxiv, DOI [10.1101/2020.05.12.20099135, 10.1101/2020.04.09.20059964]; Sanderson J, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-113; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Simons D., 2020, QEIOS; Smeeth L., 2020, OPENSAFELY CODELISTS; Strongman H, 2019, LANCET, V394, P1041, DOI 10.1016/S0140-6736(19)31674-5; The Institute for Fiscal Studies, 2020, AR SOM ETHN GROUPS M; Pham TM, 2019, STAT MED, V38, P792, DOI 10.1002/sim.8004; UK Government, 2020, COR COVID 19 CAS UK; UK Health Security Agency, 2020, GUID SHIELD PROT PEO; Who, 2022, WEEKL OP UPD COVID 1; Wong A., 2019, CLIN CODE LIST PSORI, DOI [10.17037/DATA.00001255, DOI 10.17037/DATA.00001255]; World Health Organization, 2020, DIR GEN OP REM MED B	54	2883	2929	46	155	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2020	584	7821					430	+		10.1038/s41586-020-2521-4	http://dx.doi.org/10.1038/s41586-020-2521-4		JUL 2020	14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NG4DR	32640463	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000556238700001
J	Voelker, R				Voelker, Rebecca			Expanded Indication for Triple-Drug Antibiotic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					19	19		10.1001/jama.2020.11457	http://dx.doi.org/10.1001/jama.2020.11457			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633790				2022-12-28	WOS:000568123600007
J	Dyer, C				Dyer, Clare			Coroners consider systemic failings in deaths of patients of convicted breast surgeon	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3757; Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m465	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2020	370								m2712	10.1136/bmj.m2712	http://dx.doi.org/10.1136/bmj.m2712			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5XW	32631906				2022-12-28	WOS:000548163900008
J	Jumbam, DT; Reddy, CL; Makasa, E; Boatin, AA; Rogo, K; Chu, KM; Nangombe, B; Oladapo, OT; Meara, JG; Maswime, S				Jumbam, Desmond T.; Reddy, Che L.; Makasa, Emmanuel; Boatin, Adeline A.; Rogo, Khama; Chu, Kathryn M.; Nangombe, Benetus; Oladapo, Olufemi T.; Meara, John G.; Maswime, Salome			Investing in surgery: a value proposition for African leaders	LANCET			English	Editorial Material							CONSEQUENCES; HEALTH		[Jumbam, Desmond T.; Reddy, Che L.; Boatin, Adeline A.; Meara, John G.] Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA; [Boatin, Adeline A.] Harvard Med Sch, Dept Obstet & Gynecol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Jumbam, Desmond T.; Reddy, Che L.; Meara, John G.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA; [Makasa, Emmanuel] Univ Witwatersrand, Wits Ctr Surg Care Primary Hlth & Sustainable Dev, Johannesburg, South Africa; [Makasa, Emmanuel] Off President, PSDM Cabinet Off, Lusaka, Zambia; [Rogo, Khama] World Bank Grp, Washington, DC USA; [Chu, Kathryn M.] Stellenbosch Univ, Dept Global Hlth, Cape Town, South Africa; [Nangombe, Benetus] Minist Hlth & Social Serv, Off Execut Director, Windhoek, Namibia; [Oladapo, Olufemi T.] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland; [Maswime, Salome] Univ Cape Town, Dept Surg, Global Surg Div, ZA-7925 Cape Town, South Africa	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; University of Witwatersrand; The World Bank; Stellenbosch University; The World Bank; United Nations Population Fund; World Health Organization; University of Cape Town	Maswime, S (corresponding author), Univ Cape Town, Dept Surg, Global Surg Div, ZA-7925 Cape Town, South Africa.	salome.maswime@uct.ac.za	Maswime, Salome/AAL-9390-2021; Jumbam, Desmond/AAQ-6800-2021	Maswime, Salome/0000-0003-4013-5164; Jumbam, Desmond/0000-0002-3062-2519	General Electric Foundation	General Electric Foundation(General Electric)	JGM declares that the Program in Global Surgery and Social Change receives grant funding from the General Electric Foundation for the SS2020 project. All other authors declare no competing interests.	African Health Observatory, 2018, ATL AFR HLTH STAT; Alkire BC, 2015, LANCET GLOB HEALTH, V3, pS21, DOI 10.1016/S2214-109X(15)70088-4; [Anonymous], 2015, LANCET GLOB HEALT S2; Bickler SN, 2015, ESSENTIAL SURG DIS C, V1; Bishop D, 2019, LANCET GLOB HEALTH, V7, pE513, DOI 10.1016/S2214-109X(19)30036-1; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Hutch A, 2017, WORLD J SURG, V41, P3046, DOI 10.1007/s00268-017-4307-x; Khanna T, 2011, 2013490 SOC SCI RES; Marquez PV, 2013, CHALLENGE NONCOMMUNI; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Nepogodiev D, 2020, BRIT J SURG, V107, P1440, DOI 10.1002/bjs.11746; Onarheim KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150120; SADC secretariat, 2018, MED STAT JOINT M SAD; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS8, DOI 10.1016/S2214-109X(14)70384-5; Taylor A, 2017, EXPANDING ACCESS LOW; The World Bank, 2018, WORLD BANK N MAC COU; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; World Health Organization, 2018, INT CLASS FUNCT DIS; World Health Organization Regional Office for Africa, 2019, HEAV BURD PROD COST	19	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					7	9						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32622399	Green Published, Bronze			2022-12-28	WOS:000561626100020
J	Dyer, O				Dyer, Owen			Covid-19: No large hidden outbreak in Africa but health worker shortage worsens	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cabore JW, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002647	1	2	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2020	370								m2685	10.1136/bmj.m2685	http://dx.doi.org/10.1136/bmj.m2685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5ZW	32620546	Bronze			2022-12-28	WOS:000548169100014
J	Kim, J; Saremi, S; Acharya, M; Velarde, G; Parsonnet, E; Donahue, P; Qualls, A; Garcia, D; Martin, LW				Kim, Jieun; Saremi, Sahar; Acharya, Megha; Velarde, Gabriel; Parsonnet, Eric; Donahue, Patrick; Qualls, Alexander; Garcia, David; Martin, Lane W.			Ultrahigh capacitive energy density in ion-bombarded relaxor ferroelectric films	SCIENCE			English	Article							THIN-FILMS; STRAIN; TEMPERATURE; PERFORMANCE; POLYMER	Dielectric capacitors can store and release electric energy at ultrafast rates and are extensively studied for applications in electronics and electric power systems. Among various candidates, thin films based on relaxor ferroelectrics, a special kind of ferroelectric with nanometer-sized domains, have attracted special attention because of their high energy densities and efficiencies. We show that high-energy ion bombardment improves the energy storage performance of relaxor ferroelectric thin films. Intrinsic point defects created by ion bombardment reduce leakage, delay low-field polarization saturation, enhance high-field polarizability, and improve breakdown strength. We demonstrate energy storage densities as high as similar to 133 joules per cubic centimeter with efficiencies exceeding 75%. Deterministic control of defects by means of postsynthesis processing methods such as ion bombardment can be used to overcome the trade-off between high polarizability and breakdown strength.	[Kim, Jieun; Saremi, Sahar; Acharya, Megha; Velarde, Gabriel; Donahue, Patrick; Garcia, David; Martin, Lane W.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Parsonnet, Eric; Qualls, Alexander] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Martin, Lane W.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Martin, LW (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.; Martin, LW (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.	lwmartin@berkeley.edu	Martin, Lane W./H-2409-2011	Martin, Lane W./0000-0003-1889-2513; Parsonnet, Eric/0000-0003-0723-6887; Donahue, Patrick/0000-0001-6052-2394; Kim, Jieun/0000-0002-2885-1566; Qualls, Alexander/0000-0001-9070-026X	U.S. Department of Energy (DOE) Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-05CH11231, KC23MP]; Kwanjeong Educational Foundation; DOE Office of Science, Office of Basic Energy Sciences [DE-SC-0012375]; NSF [DMR-1708615, DMR1608938, OISE-1545907]; Intel Corp. through the FEINMAN program	U.S. Department of Energy (DOE) Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Kwanjeong Educational Foundation; DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Intel Corp. through the FEINMAN program	Supported by the U.S. Department of Energy (DOE) Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under contract DE-AC02-05CH11231 (Materials Project program KC23MP) for the development of novel functional materials. Also supported by the Kwanjeong Educational Foundation (J.K.); DOE Office of Science, Office of Basic Energy Sciences, under award DE-SC-0012375 for the study of ferroelectric materials (S.S.); NSF grant DMR-1708615 (G.V.); Intel Corp. through the FEINMAN program (E.P.); NSF grant DMR1608938 (P.D.); and NSF grant OISE-1545907 (D.G.).	Baek SH, 2011, SCIENCE, V334, P958, DOI 10.1126/science.1207186; Chiang Y.-M., 1997, PHYS CERAMICS; Chu BJ, 2006, SCIENCE, V313, P334, DOI 10.1126/science.1127798; Damjanovic D, 1998, REP PROG PHYS, V61, P1267, DOI 10.1088/0034-4885/61/9/002; Damodaran AR, 2014, ADV MATER, V26, P6341, DOI 10.1002/adma.201400254; Hao XH, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802794; Herklotz A, 2019, NANO LETT, V19, P1033, DOI 10.1021/acs.nanolett.8b04322; Hu WB, 2013, NAT MATER, V12, P821, DOI [10.1038/nmat3691, 10.1038/NMAT3691]; Karthik J, 2012, ADV MATER, V24, P1610, DOI 10.1002/adma.201104697; Lee D, 2012, ADV MATER, V24, P6490, DOI 10.1002/adma.201203101; Li Q, 2015, NATURE, V523, P576, DOI 10.1038/nature14647; McMillen M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772016; McPherson JW, 2003, IEEE T ELECTRON DEV, V50, P1771, DOI 10.1109/TED.2003.815141; Mei AB, 2019, APL MATER, V7, DOI 10.1063/1.5125809; Palneedi H, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201803665; Pan H, 2019, SCIENCE, V365, P578, DOI 10.1126/science.aaw8109; Prateek, 2016, CHEM REV, V116, P4260, DOI 10.1021/acs.chemrev.5b00495; Ren XB, 2004, NAT MATER, V3, P91, DOI 10.1038/nmat1051; ROBERTSON J, 1993, APPL PHYS LETT, V63, P1519, DOI 10.1063/1.110761; Saremi S, 2018, AM CERAM SOC BULL, V97, P16; Saremi S, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.207602; Saremi S, 2018, PHYS REV MATER, V2, DOI 10.1103/PhysRevMaterials.2.084414; Saremi S, 2018, ADV MATER INTERFACES, V5, DOI 10.1002/admi.201700991; Saremi S, 2016, ADV MATER, V28, P10750, DOI 10.1002/adma.201603968; SCOTT JF, 1991, J APPL PHYS, V70, P382, DOI 10.1063/1.350286; Sun ZX, 2017, ADV MATER, V29, DOI 10.1002/adma.201604427; VIEHLAND D, 1990, J APPL PHYS, V68, P2916, DOI 10.1063/1.346425; Warren WL, 1996, J APPL PHYS, V79, P9250, DOI 10.1063/1.362600; Xu B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15682; Yang LT, 2019, J MATER CHEM A, V7, P8573, DOI 10.1039/c9ta01165j; Yao ZH, 2017, ADV MATER, V29, DOI 10.1002/adma.201601727; Zhang L, 2017, RSC ADV, V7, P8388, DOI 10.1039/c6ra27847g; Zhang Z, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2192623; Ziegler JF, 2010, NUCL INSTRUM METH B, V268, P1818, DOI 10.1016/j.nimb.2010.02.091	34	100	98	45	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					81	+		10.1126/science.abb0631	http://dx.doi.org/10.1126/science.abb0631			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631889	Green Published			2022-12-28	WOS:000548751700049
J	Laudadio, G; Deng, YC; van der Wal, K; Ravelli, D; Nuno, M; Fagnoni, M; Guthrie, D; Sun, YH; Noel, T				Laudadio, Gabriele; Deng, Yuchao; van der Wal, Klaas; Ravelli, Davide; Nuno, Manuel; Fagnoni, Maurizio; Guthrie, Duncan; Sun, Yuhan; Noel, Timothy			C(sp(3))-H functionalizations of light hydrocarbons using decatungstate photocatalysis in flow	SCIENCE			English	Article							H BOND FUNCTIONALIZATION; ACTIVATION; REDUCTION; ACCEPTOR; METHANE; ANION	Direct activation of gaseous hydrocarbons remains a major challenge for the chemistry community. Because of the intrinsic inertness of these compounds, harsh reaction conditions are typically required to enable C(sp(3))-H bond cleavage, barring potential applications in synthetic organic chemistry. Here, we report a general and mild strategy to activate C(sp(3))-H bonds in methane, ethane, propane, and isobutane through hydrogen atom transfer using inexpensive decatungstate as photocatalyst at room temperature. The corresponding carbon-centered radicals can be effectively trapped by a variety of Michael acceptors, leading to the corresponding hydroalkylated adducts in good isolated yields and high selectivity (38 examples).	[Laudadio, Gabriele; Deng, Yuchao; van der Wal, Klaas; Noel, Timothy] Eindhoven Univ Technol, Dept Chem Engn & Chem, Micro Flow Chem & Synthet Methodol, Eindhoven, Netherlands; [Deng, Yuchao; Sun, Yuhan] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China; [Deng, Yuchao; Sun, Yuhan] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai 201210, Peoples R China; [Ravelli, Davide; Fagnoni, Maurizio] Univ Pavia, Dept Chem, PhotoGreen Lab, I-27100 Pavia, Italy; [Nuno, Manuel; Guthrie, Duncan] Vapourtec, Bury St Edmunds IP28 6TS, Suffolk, England	Eindhoven University of Technology; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; University of Pavia	Noel, T (corresponding author), Eindhoven Univ Technol, Dept Chem Engn & Chem, Micro Flow Chem & Synthet Methodol, Eindhoven, Netherlands.	t.noel@tue.nl	Laudadio, Gabriele/V-4494-2019; Ravelli, Davide/I-1906-2013; Noel, Timothy/U-2246-2017	Laudadio, Gabriele/0000-0002-2749-8393; Ravelli, Davide/0000-0003-2201-4828; Guthrie, Duncan/0000-0003-4203-3719; Noel, Timothy/0000-0002-3107-6927; FAGNONI, MAURIZIO/0000-0003-0247-7585; Nuno, Manuel/0000-0001-6639-4856; Deng, Yuchao/0000-0003-0843-7517	Dutch Science Foundation (NWO) [14150]; China Scholarship Council (CSC)	Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO)); China Scholarship Council (CSC)(China Scholarship Council)	We acknowledge financial support from the Dutch Science Foundation (NWO) for a VIDI grant for T.N. (SensPhotoFlow, no. 14150). Y.D.'s stay at the Eindhoven University of Technology was financially supported by the China Scholarship Council (CSC).	Ballini R, 2003, TETRAHEDRON, V59, P3603, DOI 10.1016/S0040-4020(03)00508-8; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; Bonfield HE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13988-4; CABARET D, 1976, J ORGANOMET CHEM, V113, P215, DOI 10.1016/S0022-328X(00)87330-1; Cambie D, 2016, CHEM REV, V116, P10276, DOI 10.1021/acs.chemrev.5b00707; Capaldo L, 2017, EUR J ORG CHEM, V2017, P2056, DOI 10.1002/ejoc.201601485; Chaudhuri A., 2020, PROCESS INTENSIFICAT, DOI [10.26434/chemrxiv.11560224.v1, DOI 10.26434/CHEMRXIV.11560224.V1]; Chen GB, 2019, ANGEW CHEM INT EDIT, V58, P17528, DOI 10.1002/anie.201814313; CHIKASHITA H, 1987, J CHEM SOC PERK T 1, P699, DOI 10.1039/p19870000699; Crabtree RH, 2001, J CHEM SOC DALTON, P2437, DOI 10.1039/b103147n; Deng HP, 2018, ANGEW CHEM INT EDIT, V57, P12661, DOI 10.1002/anie.201804844; Fagnou K, 2003, CHEM REV, V103, P169, DOI 10.1021/cr020007u; Gunsalus NJ, 2017, CHEM REV, V117, P8521, DOI 10.1021/acs.chemrev.6b00739; Gutmann B, 2015, ANGEW CHEM INT EDIT, V54, P6688, DOI 10.1002/anie.201409318; Halperin SD, 2014, ANGEW CHEM INT EDIT, V53, P4690, DOI 10.1002/anie.201400420; Hartwig JF, 2016, ACS CENTRAL SCI, V2, P281, DOI 10.1021/acscentsci.6b00032; Hartwig JF, 2016, J AM CHEM SOC, V138, P2, DOI 10.1021/jacs.5b08707; Hu AH, 2018, SCIENCE, V361, P668, DOI 10.1126/science.aat9750; Jin Z, 2020, SCIENCE, V367, P193, DOI 10.1126/science.aaw1108; Kockmann N, 2017, REACT CHEM ENG, V2, P258, DOI 10.1039/c7re00021a; Koppaka A, 2019, ANGEW CHEM INT EDIT, V58, P2241, DOI 10.1002/anie.201809159; KUCHIN AV, 1987, ZH OBSHCH KHIM+, V57, P1763; Laudadio G, 2018, ANGEW CHEM INT EDIT, V57, P4078, DOI 10.1002/anie.201800818; Li H, 2011, CATAL SCI TECHNOL, V1, P191, DOI 10.1039/c0cy00076k; Lin R, 2017, CHEM REV, V117, P4182, DOI 10.1021/acs.chemrev.6b00551; Liu C, 2011, CHEM REV, V111, P1780, DOI 10.1021/cr100379j; Luo Y.R., 2002, HDB BOND DISSOCIATIO, DOI 10.1201/9781420039863; Mallia CJ, 2016, ORG PROCESS RES DEV, V20, P327, DOI 10.1021/acs.oprd.5b00222; Manley DW, 2014, J ORG CHEM, V79, P1386, DOI 10.1021/jo4027929; Meynhardt B, 1999, EUR J ORG CHEM, V1999, P2327, DOI 10.1002/(SICI)1099-0690(199909)1999:9<2327::AID-EJOC2327>3.0.CO;2-H; Murphy JJ, 2016, NATURE, V532, P218, DOI 10.1038/nature17438; Okuro K, 2012, J ORG CHEM, V77, P4420, DOI 10.1021/jo300173g; Perry IB, 2018, NATURE, V560, P70, DOI 10.1038/s41586-018-0366-x; PETRIER C, 1985, J ORG CHEM, V50, P5761, DOI 10.1021/jo00350a065; Plutschack MB, 2017, CHEM REV, V117, P11796, DOI 10.1021/acs.chemrev.7b00183; Protti S, 2009, CHEM COMMUN, P7351, DOI 10.1039/b917732a; Ramachary DB, 2008, EUR J ORG CHEM, V2008, P975, DOI 10.1002/ejoc.200701014; Ravelli D, 2018, ACS CATAL, V8, P701, DOI 10.1021/acscatal.7b03354; Ravelli D, 2016, ACCOUNTS CHEM RES, V49, P2232, DOI 10.1021/acs.accounts.6b00339; Reed D J, 2000, KIRK OTHMER ENCY CHE, V6, P226; Rossberg M., 2006, ULLMANNS ENCY IND CH; Rossberg M., 2006, ULLMANNS ENCY IND CH; Schultz DM, 2017, ANGEW CHEM INT EDIT, V56, P15274, DOI 10.1002/anie.201707537; Tanielian C, 1998, COORDIN CHEM REV, V178, P1165, DOI 10.1016/S0010-8545(98)00160-X; Tzirakis MD, 2009, CHEM SOC REV, V38, P2609, DOI 10.1039/b812100c; U.S. Environmental Protection Agency (EPA), 2004, CHLOR CHLOR HYDR MAN; Uchikura T, 2019, CHEM COMMUN, V55, P11171, DOI 10.1039/c9cc05336k; van Leeuwen T, 2019, ANGEW CHEM INT EDIT, V58, P4953, DOI 10.1002/anie.201814497; Wakita T, 2004, J PESTIC SCI, V29, P356, DOI 10.1584/jpestics.29.356; Yu YQ, 2013, J CHIN CHEM SOC-TAIP, V60, P288, DOI 10.1002/jccs.201200391	50	150	150	33	263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					92	+		10.1126/science.abb4688	http://dx.doi.org/10.1126/science.abb4688			116	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631892				2022-12-28	WOS:000548751700052
J	Mahase, E				Mahase, Elisabeth			Covid-19: How does local lockdown work, and is it effective?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, SKY NEWS; Independent SAGE, 2020, STAT LEIC LOC LOCKD; Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2647; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2635; Public Health England, 2020, RAP INV TEAM PREL IN; Public Health England, 2020, NAT COVID 19 SURV RE	6	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2020	370								m2679	10.1136/bmj.m2679	http://dx.doi.org/10.1136/bmj.m2679			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5ZW	32620558	Bronze			2022-12-28	WOS:000548169100003
J	Rimmer, A				Rimmer, Abi			Sixty seconds on ... NHS Charities Together ...	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Vinter R., 2020, YORKSHIRE POST  0703	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2020	370								m2681	10.1136/bmj.m2681	http://dx.doi.org/10.1136/bmj.m2681			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5ZW	32620706	Bronze			2022-12-28	WOS:000548169100004
J	Wise, J				Wise, Jacqui			Remdesivir: US purchase of world stocks sparks new "hunger games," warn observers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, PUBLIC CITIZ; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Department of Health and Human Services, 2020, TRUMP ADM SEC NEW SU	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2020	370								m2661	10.1136/bmj.m2661	http://dx.doi.org/10.1136/bmj.m2661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5ZW	32620681	Bronze			2022-12-28	WOS:000548169100013
J	Lakhotia, H; Kim, HY; Zhan, M; Hu, S; Meng, S; Goulielmakis, E				Lakhotia, H.; Kim, H. Y.; Zhan, M.; Hu, S.; Meng, S.; Goulielmakis, E.			Laser picoscopy of valence electrons in solids	NATURE			English	Article							HIGH-HARMONIC GENERATION; THEORETICAL CALCULATION; ABSOLUTE RADII; BAND-STRUCTURE; LIGHT; ATOMS; RADIATION; DYNAMICS; SURFACE	Laser-generated high-harmonic emission is used to image the valence potential and electron density in magnesium fluoride and calcium fluoride at the picometre scale, enabling direct probing of material properties. Valence electrons contribute a small fraction of the total electron density of materials, but they determine their essential chemical, electronic and optical properties. Strong laser fields can probe electrons in valence orbitals(1-3)and their dynamics(4-6)in the gas phase. Previous laser studies of solids have associated high-harmonic emission(7-12)with the spatial arrangement of atoms in the crystal lattice(13,14)and have used terahertz fields to probe interatomic potential forces(15). Yet the direct, picometre-scale imaging of valence electrons in solids has remained challenging. Here we show that intense optical fields interacting with crystalline solids could enable the imaging of valence electrons at the picometre scale. An intense laser field with a strength that is comparable to the fields keeping the valence electrons bound in crystals can induce quasi-free electron motion. The harmonics of the laser field emerging from the nonlinear scattering of the valence electrons by the crystal potential contain the critical information that enables picometre-scale, real-space mapping of the valence electron structure. We used high harmonics to reconstruct images of the valence potential and electron density in crystalline magnesium fluoride and calcium fluoride with a spatial resolution of about 26 picometres. Picometre-scale imaging of valence electrons could enable direct probing of the chemical, electronic, optical and topological properties of materials.	[Lakhotia, H.; Kim, H. Y.; Zhan, M.; Goulielmakis, E.] Univ Rostock, Inst Phys, Rostock, Germany; [Lakhotia, H.; Kim, H. Y.; Zhan, M.; Goulielmakis, E.] Max Planck Inst Quantum Opt, Garching, Germany; [Hu, S.; Meng, S.] Chinese Acad Sci, Inst Phys, Beijing, Peoples R China	University of Rostock; Max Planck Society; Chinese Academy of Sciences; Institute of Physics, CAS	Goulielmakis, E (corresponding author), Univ Rostock, Inst Phys, Rostock, Germany.; Goulielmakis, E (corresponding author), Max Planck Inst Quantum Opt, Garching, Germany.	e.goulielmakis@uni-rostock.de	Meng, Sheng/A-7171-2010; Goulielmakis, Eleftherios/AAZ-1052-2020; Goulielmakis, Eleftherios/F-1693-2011	Meng, Sheng/0000-0002-1553-1432; Zhan, Minjie/0000-0001-9043-1178; Goulielmakis, Eleftherios/0000-0003-3386-0245; Hu, Shiqi/0000-0002-1174-3518; Kim, Hee-Yong/0000-0002-7427-8035	European Research Council Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; Castro A, 2004, J CHEM PHYS, V121, P3425, DOI 10.1063/1.1774980; Garg M, 2016, NATURE, V538, P359, DOI 10.1038/nature19821; Gavrila M, 2002, J PHYS B-AT MOL OPT, V35, pR147, DOI 10.1088/0953-4075/35/18/201; GAVRILA M, 1984, PHYS REV LETT, V52, P613, DOI 10.1103/PhysRevLett.52.613; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Ghosh DC, 2003, INT J MOL SCI, V4, P379, DOI 10.3390/i4060379; Ghosh DC, 2002, INT J MOL SCI, V3, P87, DOI 10.3390/i3020087; Golde D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075330; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; Gruzdev VE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205106; Haessler S, 2010, NAT PHYS, V6, P200, DOI 10.1038/NPHYS1511; Hassan MT, 2016, NATURE, V530, P66, DOI 10.1038/nature16528; HENNEBERGER WC, 1968, PHYS REV LETT, V21, P838, DOI 10.1103/PhysRevLett.21.838; Higuchi T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.213901; HOLTHAUS M, 1992, Z PHYS B CON MAT, V89, P251, DOI 10.1007/BF01320944; HULLER S, 1993, PHYS REV A, V48, P3906, DOI 10.1103/PhysRevA.48.3906; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kak A. C., 2011, PRINCIPLES COMPUTERI; KALMAN P, 1995, PHYS REV A, V52, pR21, DOI 10.1103/PhysRevA.52.R21; Kemper AF, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/023003; Kubel M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09036-w; Lanin AA, 2017, OPTICA, V4, P516, DOI 10.1364/OPTICA.4.000516; Longhi S, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.032122; Luu TT, 2015, NATURE, V521, P498, DOI 10.1038/nature14456; McIver JW, 2020, NAT PHYS, V16, P38, DOI 10.1038/s41567-019-0698-y; Medisauskas L, 2019, J PHYS B-AT MOL OPT, V52, DOI 10.1088/1361-6455/aaef42; Meng S, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2960628; MIRANDA LCM, 1983, SOLID STATE COMMUN, V45, P783, DOI 10.1016/0038-1098(83)90799-8; Morales F, 2011, P NATL ACAD SCI USA, V108, P16906, DOI 10.1073/pnas.1105916108; Ndabashimiye G, 2016, NATURE, V534, P520, DOI 10.1038/nature17660; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Schultze M, 2013, NATURE, V493, P75, DOI 10.1038/nature11720; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sivis M, 2017, SCIENCE, V357, P303, DOI 10.1126/science.aan2395; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; SMITH SJ, 1953, PHYS REV, V92, P1069, DOI 10.1103/PhysRev.92.1069; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Taylor G, 2003, ACTA CRYSTALLOGR D, V59, P1881, DOI 10.1107/S0907444903017815; TZOAR N, 1975, PHYS REV B, V12, P1132, DOI 10.1103/PhysRevB.12.1132; Vampa G, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.193603; Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517; Vampa G, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.064302; Villeneuve DM, 2017, SCIENCE, V356, P1150, DOI 10.1126/science.aam8393; von Hoegen A, 2018, NATURE, V555, P79, DOI 10.1038/nature25484; Wang YH, 2013, SCIENCE, V342, P453, DOI 10.1126/science.1239834; Warren B, 1990, XRAY DIFFRACTION, P253; Wu MX, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.043839; You YS, 2018, J PHYS B-AT MOL OPT, V51, DOI 10.1088/1361-6455/aac11d; You YS, 2016, NAT PHYS, V1, P1	55	59	60	8	83	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					55	+		10.1038/s41586-020-2429-z	http://dx.doi.org/10.1038/s41586-020-2429-z			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32612227				2022-12-28	WOS:000544773600009
J	Hill, L; Ebert, A; Jaritz, M; Wutz, G; Nagasaka, K; Tagoh, H; Kostanova-Poliakova, D; Schindler, K; Sun, Q; Bonelt, P; Fischer, M; Peters, JM; Busslinger, M				Hill, Louisa; Ebert, Anja; Jaritz, Markus; Wutz, Gordana; Nagasaka, Kota; Tagoh, Hiromi; Kostanova-Poliakova, Daniela; Schindler, Karina; Sun, Qiong; Boenelt, Peter; Fischer, Maria; Peters, Jan-Michael; Busslinger, Meinrad			Wapl repression by Pax5 promotes V gene recombination by Igh loop extrusion	NATURE			English	Article							LYMPHOID-SPECIFIC EXPRESSION; CHROMATIN; COHESIN; MICE; DNA; DOMAINS; GENERATION; IDENTITY; GENOME; LOCUS	Pax5 regulates contraction of the immunoglobulin heavy chain (Igh) locus-an essential step in V(D)J recombination-by promoting chromatin loop extrusion via repression ofWaplexpression. Nuclear processes, such as V(D)J recombination, are orchestrated by the three-dimensional organization of chromosomes at multiple levels, including compartments(1)and topologically associated domains (TADs)(2,3)consisting of chromatin loops(4). TADs are formed by chromatin-loop extrusion(5-7), which depends on the loop-extrusion function of the ring-shaped cohesin complex(8-12). Conversely, the cohesin-release factor Wapl(13,14)restricts loop extension(10,15). The generation of a diverse antibody repertoire, providing humoral immunity to pathogens, requires the participation of allVgenes in V(D)J recombination(16), which depends on contraction of the 2.8-Mb-long immunoglobulin heavy chain (Igh) locus by Pax5(17,18). However, how Pax5 controlsIghcontraction in pro-B cells remains unknown. Here we demonstrate that locus contraction is caused by loop extrusion across the entireIghlocus. Notably, the expression of Wapl is repressed by Pax5 specifically in pro-B and pre-B cells, facilitating extended loop extrusion by increasing the residence time of cohesin on chromatin. Pax5 mediates the transcriptional repression ofWaplthrough a single Pax5-binding site by recruiting the polycomb repressive complex 2 to induce bivalent chromatin at theWaplpromoter. Reduced Wapl expression causes global alterations in the chromosome architecture, indicating that the potential to recombine allVgenes entails structural changes of the entire genome in pro-B cells.	[Hill, Louisa; Ebert, Anja; Jaritz, Markus; Wutz, Gordana; Nagasaka, Kota; Tagoh, Hiromi; Kostanova-Poliakova, Daniela; Schindler, Karina; Sun, Qiong; Boenelt, Peter; Fischer, Maria; Peters, Jan-Michael; Busslinger, Meinrad] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Tagoh, Hiromi] Univ Oxford, Ludwig Inst Canc Res, Oxford, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Ludwig Institute for Cancer Research; University of Oxford	Busslinger, M (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria.	busslinger@imp.ac.at	; Busslinger, Meinrad/J-1249-2016; Tagoh, Hiromi/B-2954-2009	Jaritz, Markus/0000-0002-9326-2047; Busslinger, Meinrad/0000-0002-9111-9351; Tagoh, Hiromi/0000-0001-9905-6992; Hill, Louisa/0000-0002-6258-6161; Nagasaka, Kota/0000-0003-0765-638X	Boehringer Ingelheim; European Research Council (ERC) under the European Union [740349-PlasmaCellControl, 693949-CohesinMolMech]; Austrian Industrial Research Promotion Agency [FFG-852936]; Human Frontier Science Program [RGP0057/2018, LT001527/2017]	Boehringer Ingelheim(Boehringer Ingelheim); European Research Council (ERC) under the European Union(European Research Council (ERC)); Austrian Industrial Research Promotion Agency; Human Frontier Science Program(Human Frontier Science Program)	We thank W. C. Skarnes for advice and help with the Floxin method, M. Leeb for assistance with ES cell derivation, E. Lieberman Aiden for discussion, R. Stocsits for advice with Hi-C analysis, K. Aumayr's team for flow cytometric sorting, C. Theussl's team for generating gene-modified mice and A. Sommer's team at the Vienna BioCenter Core Facilities for Illumina sequencing. This research was supported by Boehringer Ingelheim, the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement 740349-PlasmaCellControl and 693949-CohesinMolMech), the Austrian Industrial Research Promotion Agency (Headquarter Grant FFG-852936), the Human Frontier Science Program grant RGP0057/2018 (to J.-M.P.) and a long-term fellowship from the Human Frontier Science Program LT001527/2017 (to K.N.).	ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chovanec P, 2018, NAT PROTOC, V13, P1232, DOI 10.1038/nprot.2018.021; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Fuxa M, 2007, J IMMUNOL, V178, P3031, DOI 10.4049/jimmunol.178.5.3031; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Holzmann J, 2019, ELIFE, V8, DOI 10.7554/eLife.46269; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Jain S, 2018, CELL, V174, P102, DOI 10.1016/j.cell.2018.04.035; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Proudhon C, 2015, ADV IMMUNOL, V128, P123, DOI 10.1016/bs.ai.2015.07.003; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Singla V, 2010, NAT METHODS, V7, P50, DOI [10.1038/NMETH.1406, 10.1038/nmeth.1406]; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; Thongjuea S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt373; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2019, NATURE, V573, P600, DOI 10.1038/s41586-019-1547-y	65	30	30	1	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					142	+		10.1038/s41586-020-2454-y	http://dx.doi.org/10.1038/s41586-020-2454-y		JUL 2020	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32612238	Green Submitted, Green Accepted			2022-12-28	WOS:000544885800002
J	Voosen, P				Voosen, Paul			NASA's Perseverance rover aims to find out whether ancient Mars was warm and wet or cold and dry	SCIENCE			English	Editorial Material																			0	2	2	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1416	1421						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587003				2022-12-28	WOS:000545264600017
J	John, CC; Opoka, RO; Latham, TS; Hume, HA; Nabaggala, C; Kasirye, P; Ndugwa, CM; Lane, A; Ware, RE				John, Chandy C.; Opoka, Robert O.; Latham, Teresa S.; Hume, Heather A.; Nabaggala, Catherine; Kasirye, Phillip; Ndugwa, Christopher M.; Lane, Adam; Ware, Russell E.			Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOPPLER FLOW VELOCITIES; YOUNG-CHILDREN; DISEASE; PHARMACOKINETICS; TRIAL; HYDROXYCARBAMIDE; PHARMACODYNAMICS; MULTICENTER; HEMOGLOBIN; THERAPY	BACKGROUND Hydroxyurea has proven safety, feasibility, and efficacy in children with sickle cell anemia in sub-Saharan Africa, with studies showing a reduced incidence of vaso-occlusive events and reduced mortality. Dosing standards remain undetermined, however, and whether escalation to the maximum tolerated dose confers clinical benefits that outweigh treatment-related toxic effects is unknown. METHODS In a randomized, double-blind trial, we compared hydroxyurea at a fixed dose (approximately 20 mg per kilogram of body weight per day) with dose escalation (approximately 30 mg per kilogram per day). The primary outcome was a hemoglobin level of 9.0 g or more per deciliter or a fetal hemoglobin level of 20% or more after 24 months. Secondary outcomes included the incidences of malaria, vaso-occlusive crises, and serious adverse events. RESULTS Children received hydroxyurea at a fixed dose (94 children; mean [+/- SD] age, 4.6 +/- 1.0 years) or with dose escalation (93 children; mean age, 4.8 +/- 0.9 years); the mean doses were 19.2 +/- 1.8 mg per kilogram per day and 29.5 +/- 3.6 mg per kilogram per day, respectively. The data and safety monitoring board halted the trial when the numbers of clinical events were significantly lower among children receiving escalated dosing than among those receiving a fixed dose. At trial closure, 86% of the children in the dose-escalation group had reached the primary-outcome thresholds, as compared with 37% of the children in the fixed-dose group (P<0.001). Children in the dose-escalation group had fewer sickle cell-related adverse events (incidence rate ratio, 0.43; 95% confidence interval [CI], 0.34 to 0.54), vaso-occlusive pain crises (incidence rate ratio, 0.43; 95% CI, 0.34 to 0.56), cases of acute chest syndrome or pneumonia (incidence rate ratio, 0.27; 95% CI, 0.11 to 0.56), transfusions (incidence rate ratio, 0.30; 95% CI, 0.20 to 0.43), and hospitalizations (incidence rate ratio, 0.21; 95% CI, 0.13 to 0.34). Laboratory-confirmed dose-limiting toxic effects were similar in the two groups, and there were no cases of severe neutropenia or thrombocytopenia. CONCLUSIONS Among children with sickle cell anemia in sub-Saharan Africa, hydroxyurea with dose escalation had superior clinical efficacy to that of fixed-dose hydroxyurea, with equivalent safety.	[John, Chandy C.] Indiana Univ, Dept Pediat, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46204 USA; [Opoka, Robert O.; Hume, Heather A.; Nabaggala, Catherine; Kasirye, Phillip; Ndugwa, Christopher M.] Makerere Univ, Dept Pediat & Child Hlth, Kampala, Uganda; [Opoka, Robert O.; Nabaggala, Catherine] Global Hlth Uganda, Kampala, Uganda; [Kasirye, Phillip] Mulago Hosp, Kampala, Uganda; [Latham, Teresa S.; Lane, Adam; Ware, Russell E.] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Dept Pediat, Cincinnati, OH 45229 USA; [Ware, Russell E.] Cincinnati Childrens Hosp Med Ctr, Global Hlth Ctr, Cincinnati, OH 45229 USA; [Lane, Adam; Ware, Russell E.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Hume, Heather A.] Univ Montreal, Ctr Hosp Univ St Justine, Dept Pediat, Montreal, PQ, Canada	Indiana University System; Indiana University-Purdue University Indianapolis; Makerere University; Mulago National Referral Hospital; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Ware, RE (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Hematol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	russell.ware@cchmc.org	John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411; Ware, Russell/0000-0001-9582-0594; Opoka, Robert/0000-0003-3240-2058	Doris Duke Charitable Foundation [ICRA 2016156]; Cincinnati Children's Research Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Cincinnati Children's Research Foundation	Supported by a grant (ICRA 2016156, to Dr. John) from the Doris Duke Charitable Foundation and by the Cincinnati Children's Research Foundation.	Anyanwu JN, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5599; CHARACHE S, 1992, BLOOD, V79, P2555; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Dakshina S, 2019, HIV MED, V20, P248, DOI 10.1111/hiv.12702; de Montalembert M, 2006, HAEMATOLOGICA, V91, P1685; de Montalembert M, 2006, HAEMATOLOGICA, V91, P125; Dong M, 2016, BRIT J CLIN PHARMACO, V81, P742, DOI 10.1111/bcp.12851; Ferster A, 1996, BLOOD, V88, P1960, DOI 10.1182/blood.V88.6.1960.bloodjournal8861960; Ferster A, 2001, BLOOD, V97, P3628, DOI 10.1182/blood.V97.11.3628; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Gulbis B, 2005, BLOOD, V105, P2685, DOI 10.1182/blood-2004-07-2704; Hodel EM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-138; Kinney TR, 1999, BLOOD, V94, P1550; Kiser JJ, 2012, THER DRUG MONIT, V34, P446, DOI 10.1097/FTD.0b013e31825c4bc3; McGann PT, 2019, AM J HEMATOL, V94, P871, DOI 10.1002/ajh.25510; McGann PT, 2017, BLOOD, V129, P155, DOI 10.1182/blood-2016-09-702324; McGann PT, 2016, PEDIATR BLOOD CANCER, V63, P98, DOI 10.1002/pbc.25705; McGann PT, 2015, EXPERT OPIN DRUG SAF, V14, P1749, DOI 10.1517/14740338.2015.1088827; Opoka RO, 2020, HAEMATOLOGICA, V105, pE272, DOI 10.3324/haematol.2019.231407; Opoka RO, 2017, BLOOD, V130, P2585, DOI 10.1182/blood-2017-06-788935; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Power-Hays A, 2020, CURR OPIN HEMATOL, V27, P172, DOI 10.1097/MOH.0000000000000582; Smart LR, 2018, SEMIN HEMATOL, V55, P102, DOI 10.1053/j.seminhematol.2018.04.010; Taylor WRJ, 2006, B WORLD HEALTH ORGAN, V84, P956, DOI 10.2471/BLT.06.031492; Thornburg CD, 2009, PEDIATR BLOOD CANCER, V52, P609, DOI 10.1002/pbc.21738; Tshilolo L, 2019, NEW ENGL J MED, V380, P121, DOI [10.1056/NEJMoa1813598, 10.1056/nejmoa1813598]; Wang WC, 2001, J PEDIATR-US, V139, P790, DOI 10.1067/mpd.2001.119590; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2017, LANCET, V390, P311, DOI 10.1016/S0140-6736(17)30193-9; Ware Russell E, 2009, Hematology Am Soc Hematol Educ Program, P62, DOI 10.1182/asheducation-2009.1.62; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Ware RE, 2011, BLOOD, V118, P4985, DOI 10.1182/blood-2011-07-364190; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852; World Health Organization, 2019, WHO MOD LIST ESS MED; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517; Zimmerman SA, 2004, BLOOD, V103, P2039, DOI 10.1182/blood-2003-07-2475; Zimmerman SA, 2007, BLOOD, V110, P1043, DOI 10.1182/blood-2006-11-057893	39	33	33	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2524	2533		10.1056/NEJMoa2000146	http://dx.doi.org/10.1056/NEJMoa2000146			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF9CW	32579813	Bronze, Green Published			2022-12-28	WOS:000545636400023
J	Sanford, JA; Nogiec, CD; Lindholm, ME; Adkins, JN; Amar, D; Dasari, S; Drugan, JK; Fernandez, FM; Radom-Aizik, S; Schenk, S; Snyder, MP; Tracy, RP; Vanderboom, P; Trappe, S; Walsh, MJ				Sanford, James A.; Nogiec, Christopher D.; Lindholm, Malene E.; Adkins, Joshua N.; Amar, David; Dasari, Surendra; Drugan, Jonelle K.; Fernandez, Facundo M.; Radom-Aizik, Shlomit; Schenk, Simon; Snyder, Michael P.; Tracy, Russell P.; Vanderboom, Patrick; Trappe, Scott; Walsh, Martin J.		Mol Transducers Physical Activity	Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise	CELL			English	Review							HUMAN SKELETAL-MUSCLE; HUMAN ADIPOSE-TISSUE; RESISTANCE EXERCISE; MICRORNA EXPRESSION; GENE-EXPRESSION; TIME-COURSE; METABOLISM; NETWORK; METABOLOMICS; BIOLOGY	Exercise provides a robust physiological stimulus that evokes cross-talk among multiple tissues that when repeated regularly (i.e., training) improves physiological capacity, benefits numerous organ systems, and decreases the risk for premature mortality. However, a gap remains in identifying the detailed molecular signals induced by exercise that benefits health and prevents disease. The Molecular Transducers of Physical Activity Consortium (MoTrPAC) was established to address this gap and generate a molecular map of exercise. Preclinical and clinical studies will examine the systemic effects of endurance and resistance exercise across a range of ages and fitness levels by molecular probing of multiple tissues before and after acute and chronic exercise. From this multi-omic and bioinformatic analysis, a molecular map of exercise will be established. Altogether, MoTrPAC will provide a public database that is expected to enhance our understanding of the health benefits of exercise and to provide insight into how physical activity mitigates disease.	[Sanford, James A.; Adkins, Joshua N.] Pacific Northwest Natl Lab, Richland, WA 99354 USA; [Nogiec, Christopher D.; Walsh, Martin J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Lindholm, Malene E.; Amar, David; Snyder, Michael P.] Stanford Univ, Stanford, CA 94305 USA; [Dasari, Surendra; Vanderboom, Patrick] Mayo Clin, Rochester, MN 55901 USA; [Drugan, Jonelle K.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Fernandez, Facundo M.] Georgia Inst Technol, Atlanta, GA 30322 USA; [Radom-Aizik, Shlomit] Univ Calif Irvine, Irvine, CA 92617 USA; [Schenk, Simon] Univ Calif San Diego, La Jolla, CA 92093 USA; [Tracy, Russell P.] Univ Vermont, Burlington, VT 05405 USA; [Trappe, Scott] Ball State Univ, Muncie, IN 47306 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Icahn School of Medicine at Mount Sinai; Stanford University; Mayo Clinic; National Institutes of Health (NIH) - USA; University System of Georgia; Georgia Institute of Technology; University of California System; University of California Irvine; University of California System; University of California San Diego; University of Vermont; Ball State University	Walsh, MJ (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.; Trappe, S (corresponding author), Ball State Univ, Muncie, IN 47306 USA.	strappe@bsu.edu; martin.walsh@mssm.edu	Kellis, Manolis/ABE-7385-2020; Buford, Thomas W/B-1111-2011; Rivas, Manuel/ABE-8173-2020; Piehowski, Paul D/AAH-5497-2019; Coen, Paul M./J-2708-2012; Ge, Yongchao/AAG-9317-2021; Lindholm, Malene/E-5125-2017	Kellis, Manolis/0000-0001-7113-9630; Buford, Thomas W/0000-0002-9541-4358; Rivas, Manuel/0000-0003-1457-9925; Piehowski, Paul D/0000-0001-5108-2227; Coen, Paul M./0000-0002-2805-2115; Ge, Yongchao/0000-0001-6448-5703; Smith, Gregory/0000-0003-0112-6134; Spratt, Heidi/0000-0002-9420-5028; Volpi, Elena/0000-0001-8776-0384; Gay, Nicole Renee/0000-0001-9138-9354; Snyder, Michael/0000-0003-0784-7987; hansen, joshua/0000-0001-9237-2773; Broskey, Nicholas/0000-0002-1197-5116; Sanford, James/0000-0001-7901-5579; Cutter, Gary/0000-0002-8455-980X; Hastie, Trevor/0000-0002-0164-3142; Burant, Charles/0000-0001-9189-5003; Maner-Smith, Kristal/0000-0002-2274-4284; zhao, bingqing/0000-0001-5000-7436; Chambers, Toby L./0000-0001-7567-1819; Zaslavsky, Elena/0000-0002-4828-7771; Nair, Venugopalan/0000-0002-8231-6230; Hutchinson-Bunch, Chelsea/0000-0002-4184-3085; Gaul, David/0000-0002-9308-1895; Lindholm, Malene/0000-0002-5763-7833; Wheeler, Matthew/0000-0001-8721-3022; Ravussin, Eric/0000-0003-2129-547X	NIH [U24OD026629, U24DK112349, U24DK112342, U24DK112340, U24DK112341, U24DK112326, U24DK112331, U24DK112348, U01AR071133, U01AR071130, U01AR071124-01, U01AR071128, U01AR071150, U01AR071160, U01AR071158, U24AR071113, U01AG055133, U01AG055137, U01AG055135]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to gratefully acknowledge Jill K. Gregory, CMI, FAMI (Certified Medical Illustrator) of the Icahn School of Medicine at Mount Sinai for working with the writing group to generate the figures enclosed within this article. Additionally, the authors would like to gratefully acknowledge the expert administrative functions by Heather Kiesel of the University of Florida for help organizing efforts by the MoTrPAC Writing Group to better enable the completion of this article. The MoTrPAC Study is supported by NIH grants U24OD026629 (Bioinformatics Center), U24DK112349, U24DK112342, U24DK112340, U24DK112341, U24DK112326, U24DK112331, U24DK112348 (Chemical Analysis Sites), U01AR071133, U01AR071130, U01AR071124-01, U01AR071128, U01AR071150, U01AR071160, U01AR071158 (Clinical Centers), U24AR071113 (Consortium Coordinating Center), U01AG055133, U01AG055137, and U01AG055135 (PASS/Animal Sites). The views expressed are those of the authors and do not necessarily reflect those of the NIH or the Department of Health and Human Services of the United States.	Al Mulla N, 2000, J PHYSIOL-LONDON, V524, P919, DOI 10.1111/j.1469-7793.2000.00919.x; Amar D, 2015, BIOINFORMATICS, V31, P17, DOI 10.1093/bioinformatics/btv228; Amar D, 2014, NUCLEIC ACIDS RES, V42, P4208, DOI 10.1093/nar/gku102; Barrachina MN, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800247; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bolster DR, 2003, J PHYSIOL-LONDON, V553, P213, DOI 10.1113/jphysiol.2003.047019; Booth FW, 2017, PHYSIOL REV, V97, P1351, DOI 10.1152/physrev.00019.2016; Bouchard C, 2011, COMPR PHYSIOL, V1, P1603, DOI 10.1002/cphy.c100059; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Burniston JG, 2008, BBA-PROTEINS PROTEOM, V1784, P1077, DOI 10.1016/j.bbapap.2008.04.007; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Carter AC, 2017, NAT BIOTECHNOL, V35, P1128, DOI 10.1038/nbt.4030; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; COGGAN AR, 1990, J APPL PHYSIOL, V68, P990, DOI 10.1152/jappl.1990.68.3.990; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Emmerich CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002187; Farinatti PTV, 2011, J STRENGTH COND RES, V25, P3181, DOI 10.1519/JSC.0b013e318212e415; Fukai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164877; Gallant A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-23; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Heaney L.M., 2017, J SPORTS SCI, V37, P959; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jo K, 2016, BIOINFORMATICS, V32, P128, DOI 10.1093/bioinformatics/btw275; KJAER M, 1991, J APPL PHYSIOL, V71, P552, DOI 10.1152/jappl.1991.71.2.552; Kleinert M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28540-5; Leonska-Duniec A, 2016, BIOL SPORT, V33, P207, DOI 10.5604/20831862.1201052; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Lindholm ME, 2014, EPIGENETICS-US, V9, P1557, DOI 10.4161/15592294.2014.982445; Ling C, 2014, DRUG DISCOV TODAY, V19, P1015, DOI 10.1016/j.drudis.2014.03.006; Loos RJF, 2015, MED SCI SPORT EXER, V47, P1105, DOI 10.1249/MSS.0000000000000645; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Magherini F, 2012, J PROTEOMICS, V75, P978, DOI 10.1016/j.jprot.2011.10.017; Mertins P, 2018, NAT PROTOC, V13, P1632, DOI 10.1038/s41596-018-0006-9; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nieman DC, 2014, AM J PHYSIOL-REG I, V307, pR68, DOI 10.1152/ajpregu.00092.2014; Nieman DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072215; Pacheco C, 2018, BIOL SPORT, V35, P3, DOI 10.5114/biolsport.2018.70746; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; PHILLIPS SM, 1997, AM J PHYSIOL, V273, pE9; Radom-Aizik S, 2016, PEDIATR EXERC SCI, V28, P194, DOI 10.1123/pes.2015-0270; Radom-Aizik S, 2014, BRAIN BEHAV IMMUN, V39, P121, DOI 10.1016/j.bbi.2014.01.003; Radom-Aizik S, 2013, J APPL PHYSIOL, V114, P628, DOI 10.1152/japplphysiol.01341.2012; Raue U, 2012, J APPL PHYSIOL, V112, P1625, DOI 10.1152/japplphysiol.00435.2011; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Ronn T, 2014, ACTA PHYSIOL, V211, P188, DOI 10.1111/apha.12247; Ronn T, 2013, EPIGENOMICS-UK, V5, P603, DOI 10.2217/epi.13.61; Safdar A, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029827; Schulz MH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-104; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Sollanek KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171007; Stanford KI, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029801; Steensberg A., 2000, J PHYSL, V529, P237; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Whitham M, 2018, CELL METAB, V27, P237, DOI 10.1016/j.cmet.2017.12.001; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Xiao Q, 2016, INT J EPIDEMIOL, V45, P1433, DOI 10.1093/ije/dyw033; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004	66	61	62	11	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1464	1474		10.1016/j.cell.2020.06.004	http://dx.doi.org/10.1016/j.cell.2020.06.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32589957	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000543822100007
J	Rimmer, A				Rimmer, Abi			Sixty seconds on ... the two metre rule	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cabinet Office, 2020, GUID STAYING AL SAF; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Iacobucci G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2381; World Health Organization, COR DIS ADV PUBL	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2020	369								m2507	10.1136/bmj.m2507	http://dx.doi.org/10.1136/bmj.m2507			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1US	32580973	Bronze			2022-12-28	WOS:000548572500012
J	Wilder-Smith, A; Lindsay, SW; Scott, TW; Ooi, EE; Gubler, DJ; Das, P				Wilder-Smith, Annelies; Lindsay, Steven W.; Scott, Thomas W.; Ooi, Eng Eong; Gubler, Duane J.; Das, Pamela			The Lancet Commission on dengue and other Aedes-transmitted viral diseases	LANCET			English	Editorial Material									[Wilder-Smith, Annelies] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Wilder-Smith, Annelies] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany; [Lindsay, Steven W.] Univ Durham, Dept Biosci, Durham, England; [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Ooi, Eng Eong; Gubler, Duane J.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore; [Das, Pamela] The Lancet, London, England	University of London; London School of Hygiene & Tropical Medicine; Ruprecht Karls University Heidelberg; Durham University; University of California System; University of California Davis; National University of Singapore	Wilder-Smith, A (corresponding author), London Sch Hyg & Trop Med, London WC1E 7HT, England.; Wilder-Smith, A (corresponding author), Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.	annelies.wilder-smith@lshtm.ac.uk	Scott, Thomas W/ABB-3526-2021	Lindsay, Steve/0000-0002-3461-9050				Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655; [Anonymous], 2014, PLOS CURR, DOI DOI 10.3389/FNHUM.2014.00847; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Gubler DJ, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay097; Hamer DH, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz012; Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004; Wilder-Smith A, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2019.1666566; Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1; Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7	10	5	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1890	1891						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563358				2022-12-28	WOS:000552732200009
J	Reversat, A; Gaertner, F; Merrin, J; Stopp, J; Tasciyan, S; Aguilera, J; de Vries, I; Hauschild, R; Hons, M; Piel, M; Callan-Jones, A; Voituriez, R; Sixt, M				Reversat, Anne; Gaertner, Florian; Merrin, Jack; Stopp, Julian; Tasciyan, Saren; Aguilera, Juan; de Vries, Ingrid; Hauschild, Robert; Hons, Miroslav; Piel, Matthieu; Callan-Jones, Andrew; Voituriez, Raphael; Sixt, Michael			Cellular locomotion using environmental topography	NATURE			English	Article							LEUKOCYTE MIGRATION; CONFINEMENT; CHEMOKINES; COMPLEX; FLOW	Within three-dimensional environments, leukocytes can migrate even in the complete absence of adhesive forces using the topographical features of the substrate to propel themselves. Eukaryotic cells migrate by coupling the intracellular force of the actin cytoskeleton to the environment. While force coupling is usually mediated by transmembrane adhesion receptors, especially those of the integrin family, amoeboid cells such as leukocytes can migrate extremely fast despite very low adhesive forces(1). Here we show that leukocytes cannot only migrate under low adhesion but can also transmit forces in the complete absence of transmembrane force coupling. When confined within three-dimensional environments, they use the topographical features of the substrate to propel themselves. Here the retrograde flow of the actin cytoskeleton follows the texture of the substrate, creating retrograde shear forces that are sufficient to drive the cell body forwards. Notably, adhesion-dependent and adhesion-independent migration are not mutually exclusive, but rather are variants of the same principle of coupling retrograde actin flow to the environment and thus can potentially operate interchangeably and simultaneously. As adhesion-free migration is independent of the chemical composition of the environment, it renders cells completely autonomous in their locomotive behaviour.	[Reversat, Anne; Gaertner, Florian; Merrin, Jack; Stopp, Julian; Tasciyan, Saren; Aguilera, Juan; de Vries, Ingrid; Hauschild, Robert; Hons, Miroslav; Sixt, Michael] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Hons, Miroslav] Czech Acad Sci, Inst Sci Instruments, Brno, Czech Republic; [Piel, Matthieu] PSL Res Univ, Inst Curie, CNRS, UMR 144, Paris, France; [Piel, Matthieu] PSL Res Univ, Inst Pierre Gilles Gennes, Paris, France; [Callan-Jones, Andrew] Univ Paris Diderot, Lab Mat & Syst Complexes, UMR CNRS 7057, Paris, France; [Voituriez, Raphael] Univ Paris 06, Lab Phys Theor Matiere Condensee, CNRS, Paris, France; [Voituriez, Raphael] Univ Paris 06, Lab Jean Perrin, CNRS, Paris, France; [Reversat, Anne] Univ Liverpool, Inst TransLat Med, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England; [Hons, Miroslav] Charles Univ Prague, Fac Med 1, BIOCEV, Vestec, Czech Republic	Institute of Science & Technology - Austria; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Liverpool; Charles University Prague	Reversat, A; Sixt, M (corresponding author), Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria.; Reversat, A (corresponding author), Univ Liverpool, Inst TransLat Med, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England.	anne.reversat@gmail.com; sixt@ist.ac.at	Gaertner, Florian/AAY-1420-2021; Gaertner, Florian/GXG-7213-2022; Hons, Miroslav/AAK-5115-2021	Gaertner, Florian/0000-0001-6120-3723; Hons, Miroslav/0000-0002-6625-3348; STOPP, Julian/0000-0002-1732-6109; Reversat, Anne/0000-0003-0666-8928; voituriez, raphael/0000-0001-8746-5713; Sixt, Michael/0000-0002-6620-9179	European Research Council (ERC) [StG 281556, CoG 724373]; Austrian Science Fund (FWF) [P29911]; WWTF; European Regional Development Fund [CZ.02.1.01/0.0/0.0/15_003/0000476]; European Union [747687]	European Research Council (ERC)(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); WWTF; European Regional Development Fund(European Commission); European Union(European Commission)	We thank A. Leithner and J. Renkawitz for discussion and critical reading of the manuscript; J. Schwarz and M. Mehling for establishing the microfluidic setups; the Bioimaging Facility of IST Austria for excellent support, as well as the Life Science Facility and the Miba Machine Shop of IST Austria; and F. N. Arslan, L. E. Burnett and L. Li for their work during their rotation in the IST PhD programme. This work was supported by the European Research Council (ERC StG 281556 and CoG 724373) to M.S. and grants from the Austrian Science Fund (FWF P29911) and the WWTF to M.S. M.H. was supported by the European Regional Development Fund Project (CZ.02.1.01/0.0/0.0/15_003/0000476). F.G. received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement no. 747687.	ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; Bae AJ, 2010, P NATL ACAD SCI USA, V107, pE165, DOI 10.1073/pnas.1011900107; Bergert M, 2015, NAT CELL BIOL, V17, P524, DOI 10.1038/ncb3134; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cramer, 1997, FRONT BIOSCI, V2, pd260, DOI DOI 10.2741/A189; Driscoll MK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002392; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Hons M, 2018, NAT IMMUNOL, V19, P606, DOI 10.1038/s41590-018-0109-z; Howe JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074382; Jankowiak G, 2020, MATH MOD METH APPL S, V30, P513, DOI 10.1142/S021820252050013X; Kepiro M, 2014, ANGEW CHEM INT EDIT, V53, P8211, DOI 10.1002/anie.201403540; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Le Berre M, 2012, INTEGR BIOL-UK, V4, P1406, DOI 10.1039/c2ib20056b; Leithner A., 2016, PROTOC EXCH, DOI [10.1038/protex.2016.063, DOI 10.1038/PR0TEX.2016.063]; Leithner A, 2016, NAT CELL BIOL, V18, P1253, DOI 10.1038/ncb3426; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Mandeville JTH, 1997, J LEUKOCYTE BIOL, V61, P188, DOI 10.1002/jlb.61.2.188; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Renkawitz J, 2018, METHOD CELL BIOL, V147, P79, DOI 10.1016/bs.mcb.2018.07.004; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schmidt S, 2010, CELL TISSUE RES, V339, P83, DOI 10.1007/s00441-009-0892-9; Schwarz J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36440; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sixt M, 2011, METHODS MOL BIOL, V769, P149, DOI 10.1007/978-1-61779-207-6_11; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Vargas P, 2017, CURR OPIN CELL BIOL, V48, P72, DOI 10.1016/j.ceb.2017.04.007; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499	32	68	69	6	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					582	+		10.1038/s41586-020-2283-z	http://dx.doi.org/10.1038/s41586-020-2283-z		MAY 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OL0DJ	32581372	Green Submitted			2022-12-28	WOS:000532688300008
J	Lan, PF; Zhou, B; Tan, M; Li, SB; Cao, M; Wu, J; Lei, M				Lan, Pengfei; Zhou, Bin; Tan, Ming; Li, Shaobai; Cao, Mi; Wu, Jian; Lei, Ming			Structural insight into precursor ribosomal RNA processing by ribonuclease MRP	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PROTEIN SUBUNITS; P HOLOENZYME; CELL-CYCLE; REVEALS; YEAST; COMPONENT; COMPLEX; P/MRP; ENDORIBONUCLEASE	Ribonuclease (RNase) MRP is a conserved eukaryotic ribonucleoprotein complex that plays essential roles in precursor ribosomal RNA (pre-rRNA) processing and cell cycle regulation. In contrast to RNase P, which selectively cleaves transfer RNA-like substrates, it has remained a mystery how RNase MRP recognizes its diverse substrates. To address this question, we determined cryo-electron microscopy structures of Saccharomyces cerevisiae RNase MRP alone and in complex with a fragment of pre-rRNA. These structures and the results of biochemical studies reveal that coevolution of both protein and RNA subunits has transformed RNase MRP into a distinct ribonuclease that processes single-stranded RNAs by recognizing a short, loosely defined consensus sequence. This broad substrate specificity suggests that RNase MRP may have myriad yet unrecognized substrates that could play important roles in various cellular contexts.	[Lan, Pengfei; Zhou, Bin; Tan, Ming; Li, Shaobai; Cao, Mi; Wu, Jian; Lei, Ming] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai 200011, Peoples R China; [Lan, Pengfei; Zhou, Bin; Tan, Ming; Li, Shaobai; Cao, Mi; Wu, Jian; Lei, Ming] Shanghai Inst Precis Med, Shanghai 200125, Peoples R China; [Lei, Ming] Shanghai Jiao Tong Univ, Chinese Minist Educ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wu, J; Lei, M (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai 200011, Peoples R China.; Wu, J; Lei, M (corresponding author), Shanghai Inst Precis Med, Shanghai 200125, Peoples R China.; Lei, M (corresponding author), Shanghai Jiao Tong Univ, Chinese Minist Educ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Shanghai 200025, Peoples R China.	wujian@shsmu.edu.cn; leim@shsmu.edu.cn	; Wu, Jian/O-1598-2018	Tan, Ming/0000-0002-6315-669X; Wu, Jian/0000-0002-2072-0967; Lan, Pengfei/0000-0002-7654-2717	National Natural Science Foundation of China [31525007, 31930063, 31900929, U1932114]; Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support [20181711]; Shanghai Sailing Program [19YF1425400]; Young Elite Scientist Sponsorship Program of China Association for Science and Technology [2018QNRC001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support; Shanghai Sailing Program; Young Elite Scientist Sponsorship Program of China Association for Science and Technology	Supported by grants from the National Natural Science Foundation of China (31525007 and 31930063 to M.L., 31900929 and U1932114 to P.L.), Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support (20181711 to J.W.), thHe Shanghai Sailing Program (19YF1425400 to P.L.), and the Young Elite Scientist Sponsorship Program of China Association for Science and Technology (2018QNRC001 to P.L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altman S., 1999, RNA WORLD, P351; Aulds J, 2012, J BIOL CHEM, V287, P37089, DOI 10.1074/jbc.M112.389023; Chamberlain JR, 1998, GENE DEV, V12, P1678, DOI 10.1101/gad.12.11.1678; Chen WY, 2010, NUCLEIC ACIDS RES, V38, P8316, DOI 10.1093/nar/gkq668; CHU S, 1994, P NATL ACAD SCI USA, V91, P659, DOI 10.1073/pnas.91.2.659; Court DL, 2013, ANNU REV GENET, V47, P405, DOI 10.1146/annurev-genet-110711-155618; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DENG YH, 2018, J CLIN ONCOL S, V36; Doudna JA, 2002, NATURE, V418, P222, DOI 10.1038/418222a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esakova O, 2008, RNA, V14, P1558, DOI 10.1261/rna.1106408; Esakova O, 2013, NUCLEIC ACIDS RES, V41, P7084, DOI 10.1093/nar/gkt432; Esakova O, 2011, RNA, V17, P356, DOI 10.1261/rna.2393711; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gill T, 2006, J CELL BIOL, V173, P35, DOI 10.1083/jcb.200512025; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; GOLD HA, 1989, SCIENCE, V245, P1377, DOI 10.1126/science.2476849; Goldfarbi KC, 2017, GENE DEV, V31, P59, DOI 10.1101/gad.286963.116; Gopalan V, 2018, RNA, V24, P1, DOI 10.1261/rna.063107.117; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; Hernandez-Cid A, 2012, IUBMB LIFE, V64, P521, DOI 10.1002/iub.1052; Hipp K, 2012, NUCLEIC ACIDS RES, V40, P3275, DOI 10.1093/nar/gkr1217; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Januszyk K, 2014, CURR OPIN STRUC BIOL, V24, P132, DOI 10.1016/j.sbi.2014.01.011; Jarrous N, 1998, RNA, V4, P407; Jarrous N, 2010, NUCLEIC ACIDS RES, V38, P7885, DOI 10.1093/nar/gkq701; KARWAN R, 1991, GENE DEV, V5, P1264, DOI 10.1101/gad.5.7.1264; Kazantsev AV, 2005, P NATL ACAD SCI USA, V102, P13392, DOI 10.1073/pnas.0506662102; Kimura M, 2017, BIOSCI BIOTECH BIOCH, V81, P1670, DOI 10.1080/09168451.2017.1353404; Krasilnikov AS, 2004, SCIENCE, V306, P104, DOI 10.1126/science.1101489; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; Lan PF, 2018, SCIENCE, V362, P657, DOI 10.1126/science.aat6678; Li X, 2004, NUCLEIC ACIDS RES, V32, P3703, DOI 10.1093/nar/gkh689; Li X, 2002, RNA, V8, P740, DOI 10.1017/S1355838202022082; Lindahl L, 2009, RNA, V15, P1407, DOI 10.1261/rna.1302909; Lopez MD, 2009, RNA BIOL, V6, P208, DOI 10.4161/rna.6.3.8584; Lygerou Z, 1996, SCIENCE, V272, P268, DOI 10.1126/science.272.5259.268; Makino DL, 2013, NAT REV MOL CELL BIO, V14, P654, DOI 10.1038/nrm3657; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; Mattijssen S, 2010, WIRES RNA, V1, P102, DOI 10.1002/wrna.9; Oshima K, 2018, ACTA CRYSTALLOGR F, V74, P57, DOI 10.1107/S2053230X17018039; Perederina A, 2011, RNA, V17, P1922, DOI 10.1261/rna.2855511; Perederina A, 2010, EMBO J, V29, P761, DOI 10.1038/emboj.2009.396; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Rosenblad MA, 2006, NUCLEIC ACIDS RES, V34, P5145, DOI 10.1093/nar/gkl626; Salinas K, 2005, J BIOL CHEM, V280, P11352, DOI 10.1074/jbc.M409568200; SCHMITT ME, 1993, MOL CELL BIOL, V13, P7935, DOI 10.1128/MCB.13.12.7935; Thiel CT, 2005, AM J HUM GENET, V77, P795, DOI 10.1086/497708; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; van Eenennaam H, 2002, ARTHRITIS RHEUM, V46, P3266, DOI 10.1002/art.10673; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Wan FT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10496-3; Welting TJM, 2006, RNA, V12, P1373, DOI 10.1261/rna.2293906; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wu J, 2018, CELL, V175, P1393, DOI 10.1016/j.cell.2018.10.003; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu YL, 2006, RNA, V12, P699, DOI 10.1261/rna.2284906; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	68	16	16	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2020	369	6504					656	+		10.1126/science.abc0149	http://dx.doi.org/10.1126/science.abc0149			57	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ5SN	32586950	Bronze			2022-12-28	WOS:000559184400039
J	Mahase, E				Mahase, Elisabeth			Covid-19: Four in 10 cases in Italian town that locked down early were asymptomatic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															Veneto Region; Wellcome Trust; Royal Society; European Union; UK Medical Research Council; UK Department for International Development; Abdul Latif Jameel Foundation	Veneto Region(Regione Veneto); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Abdul Latif Jameel Foundation	The research was funded by the Veneto Region, Wellcome Trust, Royal Society, the European Union, the UK Medical Research Council, the UK Department for International Development, and the Abdul Latif Jameel Foundation.	Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1	1	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2647	10.1136/bmj.m2647	http://dx.doi.org/10.1136/bmj.m2647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611551	Bronze			2022-12-28	WOS:000548489100001
J	Mo, Y; Lim, C; Watson, JA; White, NJ; Cooper, B				Mo, Yin; Lim, Cherry; Watson, James A.; White, Nicholas J.; Cooper, Ben S.			Non-adherence in non-inferiority trials: pitfalls and recommendations	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CAUSAL; DURATION; EFFICACY; CARE	Non-adherence in non-inferiority trials can affect treatment effect estimates and often increases the chance of claiming non-inferiority under the standard intention-to-treat analysis. This article discusses the implications of different patterns of non-adherence in non-inferiority trials and offers practical recommendations for trial design, alternative analysis strategies, and outcome reporting to reduce bias in treatment estimates and improve transparency in reporting.	[Mo, Yin; Lim, Cherry; Watson, James A.; White, Nicholas J.; Cooper, Ben S.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Mo, Yin] Natl Univ Singapore Hosp, Univ Med Cluster, Singapore, Singapore; [Mo, Yin] Natl Univ Singapore, Dept Med, Singapore, Singapore; [Mo, Yin; Lim, Cherry; Watson, James A.; White, Nicholas J.; Cooper, Ben S.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 7BN, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; National University of Singapore; National University of Singapore; University of Oxford	Mo, Y (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Mo, Y (corresponding author), Natl Univ Singapore Hosp, Univ Med Cluster, Singapore, Singapore.; Mo, Y (corresponding author), Natl Univ Singapore, Dept Med, Singapore, Singapore.; Mo, Y (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 7BN, England.	moyin@tropmedres.ac	Cooper, Ben/HGC-7082-2022	Cooper, Ben/0000-0002-9445-7217; White, Nicholas/0000-0002-1897-1978; Mo, Yin/0000-0002-0216-9550	Singapore National Medical Research Council Research Fellowship (NMRC) [0051/2017]; UK Medical Research Council/Department for International Development [MR/K006924/1]; Wellcome Trust [206736/Z/17/Z]; Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme [106698]; MRC [MR/K006924/1] Funding Source: UKRI	Singapore National Medical Research Council Research Fellowship (NMRC); UK Medical Research Council/Department for International Development; Wellcome Trust(Wellcome Trust); Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	YM is supported by the Singapore National Medical Research Council Research Fellowship (grant NMRC/Fellowship/0051/2017). BSC is supported by UK Medical Research Council/Department for International Development (grant MR/K006924/1). CL is supported by the Wellcome Trust (206736/Z/17/Z). The Mahidol-Oxford Tropical Medicine Research Unit is supported by the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme (106698).	Aberegg SK, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019494; Abraha I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2445; Al-Lamee R, 2018, LANCET, V391, P31, DOI 10.1016/S0140-6736(17)32714-9; Angrist JD, 1993, J AM STAT ASSOC, V91, P444; [Anonymous], 2006, STAT MED, V25, P1628, DOI 10.1002/sim.2584; Blatch-Jones AJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022233; Butler K, 2016, LANCET HIV, V3, pE421, DOI 10.1016/S2352-3018(16)30054-6; European Agency for the Evaluation of Medicinal Products, 2000, POINTS CONS SWITCH S; Grothey A, 2018, NEW ENGL J MED, V378, P1177, DOI 10.1056/NEJMoa1713709; Harhay MO, 2014, AM J RESP CRIT CARE, V189, P1469, DOI 10.1164/rccm.201401-0056CP; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Holland TL, 2018, JAMA-J AM MED ASSOC, V320, P1249, DOI 10.1001/jama.2018.13155; Kistin C, 2015, JAMA-J AM MED ASSOC, V314, P1561, DOI 10.1001/jama.2015.10962; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Mansournia MA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4587; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; Mo Y, 2020, WELLCOME OPEN RES, V4, P207, DOI [10.12688/wellcomeopenres.15636.2, DOI 10.12688/WELLCOMEOPENRES.15636.2]; Montedori A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-58; Munteanu D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183302; Orkin C, 2019, CLIN INFECT DIS, V68, P535, DOI 10.1093/cid/ciy540; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Rehal S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012594; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Sanchez MM, 2006, STAT MED, V25, P1169, DOI 10.1002/sim.2244; Sayasone S, 2018, LANCET INFECT DIS, V18, P155, DOI 10.1016/S1473-3099(17)30624-2; Scharfstein DO, 1999, J AM STAT ASSOC, V94, P1096, DOI 10.2307/2669923; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Swanson SA, 2018, J AM STAT ASSOC, V113, P933, DOI 10.1080/01621459.2018.1434530; U.S. Food & Drug Administration Guidance Document, 2016, NON CLIN TRIALS; US Food and Drug Administration, NON CLIN TRIALS; US Food and Drug Administration (FDA), 2010, GUID IND NON CLIN TR; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; VANHERWAARDEN N, 2015, BMJ-BRIT MED J, V350, P1389, DOI DOI 10.1136/BMJ.H1389; Vansteelandt S, 2018, SCAND J STAT, V45, P941, DOI 10.1111/sjos.12329	38	20	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2215	10.1136/bmj.m2215	http://dx.doi.org/10.1136/bmj.m2215			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611541	hybrid, Green Published			2022-12-28	WOS:000548489100020
J	Rimmer, A				Rimmer, Abi			Covid-19: RCGP apologises for covid-19 "lifestyle" event title	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2623	10.1136/bmj.m2623	http://dx.doi.org/10.1136/bmj.m2623			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601105	Bronze			2022-12-28	WOS:000548112700020
J	Zhang, FF; Barr, SI; McNulty, H; Li, D; Blumberg, JB				Zhang, Fang Fang; Barr, Susan, I; McNulty, Helene; Li, Duo; Blumberg, Jeffrey B.			Health effects of vitamin and mineral supplements	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE; FOLIC-ACID; DIETARY-SUPPLEMENTS; PRIMARY PREVENTION; CANCER PREVENTION; BETA-CAROTENE; RISK; CALCIUM; ADULTS; WOMEN		[Zhang, Fang Fang; Blumberg, Jeffrey B.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Barr, Susan, I] Univ British Columbia, Vancouver, BC, Canada; [McNulty, Helene] Ulster Univ, Nutr Innovat Ctr Food & Hlth, Coleraine, Londonderry, North Ireland; [Li, Duo] Qingdao Univ, Inst Nutr & Hlth, Qingdao, Peoples R China	Tufts University; University of British Columbia; Ulster University; Qingdao University	Zhang, FF (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	fang_fang.zhang@tufts.edu	Zhang, Fang/HHN-2153-2022; Blumberg, Jeffrey/ABH-7888-2020; Li, Duo/N-3682-2013	McNulty, Helene/0000-0002-4366-6457; Li, Duo/0000-0001-5227-5565	National Institutes of Health, NIMHD [R01 MD 011501]; Bristol Mayer Squibb Foundation (Bridging Cancer Care Programme); National Natural Science Foundation of China [NSFC 81773433]; Key Scientific Research Projects in Shandong Providence China [2017YYSP007]; Danone; DSM Nutritional Products, Switzerland	National Institutes of Health, NIMHD; Bristol Mayer Squibb Foundation (Bridging Cancer Care Programme); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific Research Projects in Shandong Providence China; Danone(Danone Nutricia); DSM Nutritional Products, Switzerland	All authors have read and understood BMJ policy on declaration of interests and declared the following: FFZ declares funding from the National Institutes of Health, NIMHD (R01 MD 011501) and the Bristol Mayer Squibb Foundation (Bridging Cancer Care Programme). DL declares funding from the National Natural Science Foundation of China (NSFC 81773433) and Key Scientific Research Projects in Shandong Providence China (2017YYSP007). JBB declares funding from Danone. HM declares funding from DSM Nutritional Products, Switzerland. The funders had no role in the design or conduct of the study, collection, management, analysis, or the interpretation of the data. JBB reports service on scientific advisory boards of AdvoCare International, California Prune Board, California Walnut Commission, Church and Dwight, Cranberry Marketing Committee, Guiding Stars, Quaker Oats, Segterra, and SmartyPants, not related to this work.	ABDELHAMID R, 2018, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003177.PUB3; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; [Anonymous], [No title captured]; Bailey RL, 2015, ANN NUTR METAB, V66, P22, DOI 10.1159/000371618; Bailey RL, 2011, AM J CLIN NUTR, V94, P1376, DOI 10.3945/ajcn.111.020289; Bishai D, 2002, ECON DEV CULT CHANGE, V51, P37, DOI 10.1086/345361; Black LI, 2007, NATL HLTH STAT REPOR, V2015, P1; Blumberg JB, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010004; Blumberg JB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121325; Blumberg JB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080849; Briefel R, 2006, J AM DIET ASSOC, V106, pS52, DOI 10.1016/j.jada.2005.09.041; Burt LA, 2019, JAMA-J AM MED ASSOC, V322, P736, DOI 10.1001/jama.2019.11889; Chen F, 2019, ANN INTERN MED, V170, P604, DOI 10.7326/M18-2478; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Ford JA, 2014, AM J CLIN NUTR, V100, P746, DOI 10.3945/ajcn.113.082602; Harrison RA, 2004, BRIT J NUTR, V91, P617, DOI 10.1079/BJN20031076; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Hu Y, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013543; Huo Y, 2015, JAMA-J AM MED ASSOC, V313, P1325, DOI 10.1001/jama.2015.2274; Jenkins DJA, 2018, J AM COLL CARDIOL, V71, P2570, DOI 10.1016/j.jacc.2018.04.020; Kang M, 2014, EUR J CLIN NUTR, V68, P804, DOI 10.1038/ejcn.2014.77; Kantor ED, 2016, JAMA-J AM MED ASSOC, V316, P1464, DOI 10.1001/jama.2016.14403; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lappe J, 2017, JAMA-J AM MED ASSOC, V317, P1234, DOI 10.1001/jama.2017.2115; Manson JE, 2020, CIRC RES, V126, P112, DOI 10.1161/CIRCRESAHA.119.314541; Manson JE, 2020, J STEROID BIOCHEM, V198, DOI 10.1016/j.jsbmb.2019.105522; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; MARTICARVAJAL AJ, 2017, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD006612.PUB5, 10.1002/14651858.CD006612.pub5]; Mason JB, 2009, NUTR REV, V67, P206, DOI 10.1111/j.1753-4887.2009.00190.x; Moyer VA, 2013, ANN INTERN MED, V158, P691, DOI 10.7326/0003-4819-158-9-201305070-00603; Murphy SP, 2007, AM J CLIN NUTR, V85, p280S; O'Brien SK, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101154; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pittas AG, 2019, NEW ENGL J MED, V381, P520, DOI 10.1056/NEJMoa1900906; Qato DM, 2018, JAMA PEDIATR, V172, P780, DOI 10.1001/jamapediatrics.2018.1008; Scragg R, 2017, JAMA CARDIOL, V2, P608, DOI 10.1001/jamacardio.2017.0175; Seida JC, 2014, J CLIN ENDOCR METAB, V99, P3551, DOI 10.1210/jc.2014-2136; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Shakur YA, 2012, J NUTR, V142, P534, DOI 10.3945/jn.111.149450; Skeie G, 2009, EUR J CLIN NUTR, V63, pS226, DOI 10.1038/ejcn.2009.83; Song MY, 2020, JAMA ONCOL, V6, P108, DOI 10.1001/jamaoncol.2019.4587; Song YQ, 2009, AM J CLIN NUTR, V90, P429, DOI 10.3945/ajcn.2009.27491; Aung T, 2018, JAMA CARDIOL, V3, P225, DOI 10.1001/jamacardio.2017.5205; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; Yang BY, 2016, AM J CLIN NUTR, V103, P886, DOI 10.3945/ajcn.115.117994; Yao P, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17789; Zhao JG, 2017, JAMA-J AM MED ASSOC, V318, P2466, DOI 10.1001/jama.2017.19344	48	23	23	4	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2511	10.1136/bmj.m2511	http://dx.doi.org/10.1136/bmj.m2511			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601065	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000548112700017
J	Mahase, E				Mahase, Elisabeth			Covid-19: MPs reject calls to routinely test health and care workers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Hunt J., 2020, TELEGRAPH	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2020	369								m2573	10.1136/bmj.m2573	http://dx.doi.org/10.1136/bmj.m2573			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI3HF	32586914	Bronze			2022-12-28	WOS:000583173400011
J	Baraniuk, C				Baraniuk, Chris			Covid-19 antibody tests: a briefing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chrisbaraniuk@gmail.com						Abbott, 2020, UPD ABB WORK COV 19; [Anonymous], 2020, GERMANY RAMPS ANTIBO; Association of British HealthTech Industries, 2020, COV 19 TEST UPD; Center for Health Security, 2020, GLOB PROGR COV 19 SE; Kirkpatrick D., 2020, NY TIMES; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Public Health England, 2020, EV ROCH EL ANTISARS; Public Health England (PHE), 2020, EV ABB SARS COV 2 IG; Roxby P., 2020, BBC NEWS; *U S FOOD DRUG ADM, 2020, EUA AUTH SER TEST PE	10	8	8	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2020	369								m2284	10.1136/bmj.m2284	http://dx.doi.org/10.1136/bmj.m2284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1US	32580937	Bronze			2022-12-28	WOS:000548572500001
J	Papasergi-Scott, MM; Robertson, MJ; Seven, AB; Panova, O; Mathiesen, JM; Skiniotis, G				Papasergi-Scott, Makaia M.; Robertson, Michael J.; Seven, Alpay B.; Panova, Ouliana; Mathiesen, Jesper M.; Skiniotis, Georgios			Structures of metabotropic GABA(B)receptor	NATURE			English	Article							GABA(B) RECEPTOR; ALLOSTERIC MODULATORS; MOLECULAR-DYNAMICS; PROTEIN; SUBUNITS; BRAIN; TRAFFICKING; EXPRESSION; MECHANISM; BINDING	Cryo-electron microscopy structures of heterodimeric and homodimeric full-length GABA(B)receptors, combined with cellular signalling assays, shed light on the mechanisms that underpin signal transduction mediated by these receptors. Stimulation of the metabotropic GABA(B)receptor by gamma-aminobutyric acid (GABA) results in prolonged inhibition of neurotransmission, which is central to brain physiology(1). GABA(B)belongs to family C of the G-protein-coupled receptors, which operate as dimers to transform synaptic neurotransmitter signals into a cellular response through the binding and activation of heterotrimeric G proteins(2,3). However, GABA(B)is unique in its function as an obligate heterodimer in which agonist binding and G-protein activation take place on distinct subunits(4,5). Here we present cryo-electron microscopy structures of heterodimeric and homodimeric full-length GABA(B)receptors. Complemented by cellular signalling assays and atomistic simulations, these structures reveal that extracellular loop 2 (ECL2) of GABA(B)has an essential role in relaying structural transitions by ordering the linker that connects the extracellular ligand-binding domain to the transmembrane region. Furthermore, the ECL2 of each of the subunits of GABA(B)caps and interacts with the hydrophilic head of a phospholipid that occupies the extracellular half of the transmembrane domain, thereby providing a potentially crucial link between ligand binding and the receptor core that engages G proteins. These results provide a starting framework through which to decipher the mechanistic modes of signal transduction mediated by GABA(B)dimers, and have important implications for rational drug design that targets these receptors.	[Papasergi-Scott, Makaia M.; Robertson, Michael J.; Seven, Alpay B.; Panova, Ouliana; Skiniotis, Georgios] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Papasergi-Scott, Makaia M.; Robertson, Michael J.; Seven, Alpay B.; Panova, Ouliana; Skiniotis, Georgios] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Mathiesen, Jesper M.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	Stanford University; Stanford University; University of Copenhagen	Skiniotis, G (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.; Skiniotis, G (corresponding author), Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA.	yiorgo@stanford.edu		Robertson, Michael/0000-0003-2610-680X; Papasergi-Scott, Makaia M./0000-0003-3238-3213; Seven, Alpay/0000-0001-6212-9908; Skiniotis, Georgios/0000-0003-0238-7846; Mathiesen, Jesper Mosolff/0000-0003-4251-4416; Panova, Ouliana/0000-0002-5089-620X	National Institutes of Health (NIH) [R01 NS092695]; National Science Foundation [ACI-1548562]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work is supported by National Institutes of Health (NIH) grant R01 NS092695 (G.S. and J.M.M.) and used the Extreme Science and Engineering Discovery Environment (XSEDE)56 resource comet-gpu through sdsc-comet allocation TG-MCB190153, which is supported by National Science Foundation grant number ACI-1548562. We thank Q. Qu for advice and assistance with cryo-EM.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Audet M, 2019, PROTEIN SCI, V28, P292, DOI 10.1002/pro.3509; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Bowery NG, 1997, BRIT J PHARMACOL, V120, P452, DOI 10.1111/j.1476-5381.1997.tb06835.x; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Burman KJ, 2003, BRAIN RES, V970, P35, DOI 10.1016/S0006-8993(02)04269-5; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Chun L, 2012, ACTA PHARMACOL SIN, V33, P312, DOI 10.1038/aps.2011.186; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enna S J, 1997, Expert Opin Investig Drugs, V6, P1319, DOI 10.1517/13543784.6.10.1319; Franek M, 1999, NEUROPHARMACOLOGY, V38, P1657, DOI 10.1016/S0028-3908(99)00135-5; Frangaj A, 2018, NEUROPHARMACOLOGY, V136, P68, DOI 10.1016/j.neuropharm.2017.10.011; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Gasparini F, 2007, CURR NEUROPHARMACOL, V5, P187, DOI 10.2174/157015907781695900; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hilger D., 2019, PREPRINT, DOI [10.1101/660837V1, DOI 10.1101/660837V1]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyland NP, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00124; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; KATO K, 1983, LIFE SCI, V32, P879, DOI 10.1016/0024-3205(83)90225-4; Koehl A, 2019, NATURE, V566, P79, DOI 10.1038/s41586-019-0881-4; la Cour CM, 2008, J NEUROCHEM, V105, P308, DOI 10.1111/j.1471-4159.2007.05131.x; Laurent B, 2015, BIOINFORMATICS, V31, P1478, DOI 10.1093/bioinformatics/btu822; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Malcangio M, 2018, NEUROPHARMACOLOGY, V136, P102, DOI 10.1016/j.neuropharm.2017.05.012; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mukherjee RS, 2006, MOL PHARMACOL, V70, P1406, DOI 10.1124/mol.106.024463; Ng TKY, 2001, J COMP NEUROL, V433, P458, DOI 10.1002/cne.1153; Pagano A, 2001, J NEUROSCI, V21, P1189; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Robertson MJ, 2020, STRUCTURE, V28, P707, DOI 10.1016/j.str.2020.04.018; Robertson MJ, 2015, J CHEM THEORY COMPUT, V11, P3499, DOI 10.1021/acs.jctc.5b00356; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Xue L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10834-5; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	63	40	40	10	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					310	+		10.1038/s41586-020-2469-4	http://dx.doi.org/10.1038/s41586-020-2469-4		JUN 2020	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA5BI	32580208	Green Accepted, Green Submitted			2022-12-28	WOS:000556239200001
J	Baker, P; White, A; Morgan, R				Baker, Peter; White, Alan; Morgan, Rosemary			Men's health: COVID-19 pandemic highlights need for overdue policy action	LANCET			English	Editorial Material									[Baker, Peter] Mens Hlth Forum, Global Action Mens Hlth, London N1 6AH, England; [White, Alan] Leeds Beckett Univ, Leeds, W Yorkshire, England; [Morgan, Rosemary] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Leeds Beckett University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Baker, P (corresponding author), Mens Hlth Forum, Global Action Mens Hlth, London N1 6AH, England.	peter.baker@gamh.org		Morgan, Rosemary/0000-0001-5009-8470	US National Institute for Health Research; Canadian Institute for Health Research for research on COVID-19 and gender	US National Institute for Health Research; Canadian Institute for Health Research for research on COVID-19 and gender(Canadian Institutes of Health Research (CIHR))	PB is the Director of Global Action on Men's Health (GAMH), is the author of the GAMH report From the Margins to the Mainstream, and receives fees from the charity. AW is a patron of The Men's Health Forum (Great Britain), is a member of GAMH, and was an unpaid adviser on the GAMH report. RM was not involved in contributing to the GAMH report and has received grants from the US National Institute for Health Research for research on gender and influenza and from the Canadian Institute for Health Research for research on COVID-19 and gender.	Baker P., 2020, MARGINS MAINSTREAM A; Baker P, 2014, B WORLD HEALTH ORGAN, V92, P618, DOI 10.2471/BLT.13.132795; Bali S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002595; Betron M, 2020, GLOB PUBLIC HEALTH, V15, P1090, DOI 10.1080/17441692.2020.1769702; Chandan JS, 2020, LANCET PUBLIC HEALTH, V5, pE309, DOI 10.1016/S2468-2667(20)30112-2; Darmstadt GL, 2019, LANCET, V393, P2374, DOI 10.1016/S0140-6736(19)30985-7; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Global Health, 2020, COVID 19 SEX DIS DAT; Gouvernement du Quebec, 2017, SANT BIEN ETR HOMM 2; Heilman B., 2019, COST MAN BOX STUDY E; Ilga Europe, 2020, COVID 19 SPEC IMP LG; Pan D, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100404; Richardson N., 2019, MENS HLTH EQUITY HDB; Rovito MJ, 2017, AM J MENS HEALTH, V11, P1804, DOI 10.1177/1557988317723424; Rozenberg S, 2020, MATURITAS, V138, P62, DOI 10.1016/j.maturitas.2020.05.009; The WHO Regional Office for Europe, 2018, HLTH WELL BE PROF E; UNAIDS, 2017, BLIND SPOT ADDR BLIN; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; WHO, 2019, WORLD HLTH STAT 2019	19	39	41	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1886	1888						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563357	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000552732200007
J	Brunt, AM; Haviland, JS; Wheatley, DA; Sydenham, MA; Alhasso, A; Bloomfield, DJ; Chan, C; Churn, M; Cleator, S; Coles, CE; Goodman, A; Harnett, A; Hopwood, P; Kirby, AM; Kirwan, CC; Morris, C; Nabi, Z; Sawyer, E; Somaiah, N; Stones, L; Syndikus, I; Bliss, JM; Yarnold, JR				Brunt, Adrian Murray; Haviland, Joanne S.; Wheatley, Duncan A.; Sydenham, Mark A.; Alhasso, Abdulla; Bloomfield, David J.; Chan, Charlie; Churn, Mark; Cleator, Susan; Coles, Charlotte E.; Goodman, Andrew; Harnett, Adrian; Hopwood, Penelope; Kirby, Anna M.; Kirwan, Cliona C.; Morris, Carolyn; Nabi, Zohal; Sawyer, Elinor; Somaiah, Navita; Stones, Liba; Syndikus, Isabel; Bliss, Judith M.; Yarnold, John R.		FAST-Forward Trial Management Grp	Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial	LANCET			English	Article							CONSERVING SURGERY; UK STANDARDIZATION; RADIATION-THERAPY; IN-SITU; CANCER; IRRADIATION; WOMEN; HEARTSPARE; CARCINOMA; RISK	Background We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after primary surgery for early breast cancer. Here, we present 5-year results of the FAST-Forward trial. Methods FAST-Forward is a multicentre, phase 3, randomised, non-inferiority trial done at 97 hospitals (47 radiotherapy centres and 50 referring hospitals) in the UK. Patients aged at least 18 years with invasive carcinoma of the breast (pT1-3, pN0-1, M0) after breast conservation surgery or mastectomy were eligible. We randomly allocated patients to either 40 Gy in 15 fractions (over 3 weeks), 27 Gy in five fractions (over 1 week), or 26 Gy in five fractions (over 1 week) to the whole breast or chest wall. Allocation was not masked because of the nature of the intervention. The primary endpoint was ipsilateral breast tumour relapse; assuming a 2% 5-year incidence for 40 Gy, non-inferiority was predefined as <= 1.6% excess for five-fraction schedules (critical hazard ratio [HR] of 1.81). Normal tissue effects were assessed by clinicians, patients, and from photographs. This trial is registered at isrctn.com, ISRCTN19906132. Findings Between Nov 24, 2011, and June 19, 2014, we recruited and obtained consent from 4096 patients from 97 UK centres, of whom 1361 were assigned to the 40 Gy schedule, 1367 to the 27 Gy schedule, and 1368 to the 26 Gy schedule. At a median follow-up of 71.5 months (IQR 71.3 to 71.7), the primary endpoint event occurred in 79 patients (31 in the 40 Gy group, 27 in the 27 Gy group, and 21 in the 26 Gy group); HRs versus 40 Gy in 15 fractions were 0.86 (95% CI 0.51 to 1.44) for 27 Gy in five fractions and 0.67 (0.38 to 1.16) for 26 Gy in five fractions. 5-year incidence of ipsilateral breast tumour relapse after 40 Gy was 2.1% (1.4 to 3.1); estimated absolute differences versus 40 Gy in 15 fractions were -0.3% (-1.0 to 0.9) for 27 Gy in five fractions (probability of incorrectly accepting an inferior five-fraction schedule: p=0.0022 vs 40 Gy in 15 fractions) and -0.7% (-1.3 to 0.3) for 26 Gy in five fractions (p=0.00019 vs 40 Gy in 15 fractions). At 5 years, any moderate or marked clinician-assessed normal tissue effects in the breast or chest wall was reported for 98 of 986 (9.9%) 40 Gy patients, 155 (15.4%) of 1005 27 Gy patients, and 121 of 1020 (11.9%) 26 Gy patients. Across all clinician assessments from 1-5 years, odds ratios versus 40 Gy in 15 fractions were 1.55 (95% CI 1.32 to 1.83, p<0.0001) for 27 Gy in five fractions and 1.12 (0.94 to 1.34, p=0.20) for 26 Gy in five fractions. Patient and photographic assessments showed higher normal tissue effect risk for 27 Gy versus 40 Gy but not for 26 Gy versus 40 Gy. Interpretation 26 Gy in five fractions over 1 week is non-inferior to the standard of 40 Gy in 15 fractions over 3 weeks for local tumour control, and is as safe in terms of normal tissue effects up to 5 years for patients prescribed adjuvant local radiotherapy after primary surgery for early-stage breast cancer. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd.	[Brunt, Adrian Murray] Univ Hosp North Midlands, Stoke On Trent, Staffs, England; [Brunt, Adrian Murray] Univ Keele, Stoke On Trent, Staffs, England; [Brunt, Adrian Murray; Haviland, Joanne S.; Sydenham, Mark A.; Hopwood, Penelope; Stones, Liba; Bliss, Judith M.] Inst Canc Res, Clin Trials & Stat Unit, London SM2 5NG, England; [Wheatley, Duncan A.] Royal Cornwall Hosp, Truro, England; [Alhasso, Abdulla] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Bloomfield, David J.] Brighton & Sussex Univ Hosp, Brighton, E Sussex, England; [Chan, Charlie] Nuffield Hlth Cheltenham Hosp, Cheltenham, Glos, England; [Churn, Mark] Worcestershire Acute Hosp NHS Trust, Worcester, England; [Cleator, Susan] Imperial Healthcare NHS Trust, London, England; [Coles, Charlotte E.] Univ Cambridge, Cambridge, England; [Goodman, Andrew] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Goodman, Andrew] Torbay Hosp NHS Fdn Trust, Torquay, England; [Harnett, Adrian] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [Kirby, Anna M.; Somaiah, Navita; Yarnold, John R.] Royal Marsden NHS Fdn Trust, London, England; [Kirby, Anna M.; Somaiah, Navita; Yarnold, John R.] Inst Canc Res, London, England; [Kirwan, Cliona C.] Univ Manchester, Manchester, Lancs, England; [Morris, Carolyn] Independent Canc Patients Voice, London, England; [Nabi, Zohal] Mt Vernon Canc Ctr, Northwood, Middx, England; [Sawyer, Elinor] Kings Coll London, London, England; [Syndikus, Isabel] Clatterbridge Canc Ctr, Wirral, Merseyside, England	Keele University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Cornwall Hospital; Beatson Oncology Centre; Brighton and Sussex University Hospitals NHS Trust; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; University of Cambridge; University of Exeter; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Manchester; Mount Vernon Cancer Centre; University of London; King's College London; Clatterbridge Cancer Centre	Brunt, AM (corresponding author), Inst Canc Res, Clin Trials & Stat Unit, London SM2 5NG, England.	fastforward-icrctsu@icr.ac.uk	Kirwan, Cliona/HHZ-8872-2022	Haviland, Joanne/0000-0001-5728-3636; Wheatley, Duncan/0000-0002-1919-5114; Brunt, Adrian Murray/0000-0002-4797-5097; Kirwan, Cliona/0000-0002-1725-4790; Bliss, Judith/0000-0001-7957-7424; Somaiah, Navita/0000-0003-4609-0518; Griffin, Susan/0000-0003-2188-8400	National Institute for Health Research Health Technology Assessment Programme; National Institute for Health Research [NF-SI-0616-10107, 09/01/47] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research Health Technology Assessment Programme.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Bartlett FR, 2017, CLIN ONCOL-UK, V29, pE51, DOI 10.1016/j.clon.2016.11.005; Bartlett FR, 2013, RADIOTHER ONCOL, V108, P242, DOI 10.1016/j.radonc.2013.04.021; Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]; Brunt AM, 2018, INT J RADIAT ONCOL, V102, P1603, DOI 10.1016/j.ijrobp.2018.08.049; Brunt AM, 2016, RADIOTHER ONCOL, V120, P114, DOI 10.1016/j.radonc.2016.02.027; Coles CE, 2017, LANCET, V390, P1048, DOI 10.1016/S0140-6736(17)31145-5; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Galecki J, 2006, ACTA ONCOL, V45, P280, DOI 10.1080/02841860500371907; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Haviland JS, 2008, CLIN ONCOL-UK, V20, P497, DOI 10.1016/j.clon.2008.03.017; Haviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3; Howard DR, 2018, STAT METHODS MED RES, V27, P1513, DOI 10.1177/0962280216664759; Mannino M, 2009, RADIOTHER ONCOL, V90, P14, DOI 10.1016/j.radonc.2008.05.002; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; National Institute for Health and Care Excellence, 2018, EARL LOC ADV BREAT C; Offersen B, 2018, RADIOTHER ONCOL, V127, pS312, DOI 10.1016/S0167-8140(18)30906-X; Owen JR, 2006, LANCET ONCOL, V7, P467, DOI 10.1016/S1470-2045(06)70699-4; PIERCE SM, 1992, INT J RADIAT ONCOL, V23, P915, DOI 10.1016/0360-3016(92)90895-O; Polgar C, 2017, LANCET ONCOL, V18, P259, DOI 10.1016/S1470-2045(17)30011-6; Smith BD, 2018, PRACT RADIAT ONCOL, V8, P145, DOI 10.1016/j.prro.2018.01.012; Vicini FA, 2019, LANCET, V394, P2155, DOI 10.1016/S0140-6736(19)32514-0; Wang SL, 2019, LANCET ONCOL, V20, P352, DOI 10.1016/S1470-2045(18)30813-1; Whelan T, 2002, J NATL CANCER I, V94, P1143; Whelan TJ, 2019, LANCET, V394, P2165, DOI 10.1016/S0140-6736(19)32515-2; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260; Yarnold J, 2005, RADIOTHER ONCOL, V75, P9, DOI 10.1016/j.radonc.2005.01.005; Yarnold JR, 2011, RADIOTHER ONCOL, V100, P93, DOI 10.1016/j.radonc.2011.06.026	30	313	313	3	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2020	395	10237					1613	1626		10.1016/S0140-6736(20)30932-6	http://dx.doi.org/10.1016/S0140-6736(20)30932-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ1JO	32580883	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000540986100025
J	Butler, CC; Lau, M; Gillespie, D; Owen-Jones, E; Lown, M; Wootton, M; Calder, PC; Bayer, AJ; Moore, M; Little, P; Davies, J; Edwards, A; Shepherd, V; Hood, K; Hobbs, FDR; Davoudianfar, M; Rutter, H; Stanton, H; Lowe, R; Fuller, R; Francis, NA				Butler, Christopher C.; Lau, Mandy; Gillespie, David; Owen-Jones, Eleri; Lown, Mark; Wootton, Mandy; Calder, Philip C.; Bayer, Antony J.; Moore, Michael; Little, Paul; Davies, Jane; Edwards, Alison; Shepherd, Victoria; Hood, Kerenza; Hobbs, F. D. Richard; Davoudianfar, Mina; Rutter, Heather; Stanton, Helen; Lowe, Rachel; Fuller, Richard; Francis, Nick A.			Effect of Probiotic Use on Antibiotic Administration Among Care Home Residents: A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; DIARRHEA	Key PointsQuestionDoes a dose of a daily oral probiotic combination of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis BB-12 reduce cumulative systemic antibiotic administration days for all-cause, acute infections in care home residents? FindingsIn this randomized clinical trial that included 310 participants, this daily probiotic combination, compared with placebo, did not significantly reduce antibiotic administration over 1 year (mean cumulative antibiotic administration days, 12.9 vs 12.0). MeaningThe findings do not support the use of probiotics for reducing antibiotic administration in older adults living in care homes. ImportanceProbiotics are frequently used by residents in care homes (residential homes or nursing homes that provide residents with 24-hour support for personal care or nursing care), although the evidence on whether probiotics prevent infections and reduce antibiotic use in these settings is limited. ObjectiveTo determine whether a daily oral probiotic combination of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis BB-12 compared with placebo reduces antibiotic administration in care home residents. Design, Setting, and ParticipantsPlacebo-controlled randomized clinical trial of 310 care home residents, aged 65 years and older, recruited from 23 care homes in the United Kingdom between December 2016 and May 2018, with last follow-up on October 31, 2018. InterventionsStudy participants were randomized to receive a daily capsule containing a probiotic combination of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis BB-12 (total cell count per capsule, 1.3x10(10) to 1.6x10(10)) (n=155), or daily matched placebo (n=155), for up to 1 year. Main Outcomes and MeasuresThe primary outcome was cumulative antibiotic administration days for all-cause infections measured from randomization for up to 1 year. ResultsAmong 310 randomized care home residents (mean age, 85.3 years; 66.8% women), 195 (62.9%) remained alive and completed the trial. Participant diary data (daily data including study product use, antibiotic administration, and signs of infection) were available for 98.7% randomized to the probiotic group and 97.4% randomized to placebo. Care home residents randomized to the probiotic group had a mean of 12.9 cumulative systemic antibiotic administration days (95% CI, 0 to 18.05), and residents randomized to placebo had a mean of 12.0 days (95% CI, 0 to 16.95) (absolute difference, 0.9 days [95% CI, -3.25 to 5.05]; adjusted incidence rate ratio, 1.13 [95% CI, 0.79 to 1.63]; P=.50). A total of 120 care home residents experienced 283 adverse events (150 adverse events in the probiotic group and 133 in the placebo group). Hospitalizations accounted for 94 of the events in probiotic group and 78 events in the placebo group, and deaths accounted for 33 of the events in the probiotic group and 32 of the events in the placebo group. Conclusions and RelevanceAmong care home residents in the United Kingdom, a daily dose of a probiotic combination of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis BB-12 did not significantly reduce antibiotic administration for all-cause infections. These findings do not support the use of probiotics in this setting. Trial RegistrationISRCTN Identifier:16392920 This randomized clinical trial compares the effects of daily combination probiotics (Lactobacillus and Bifidobacterium spp) vs placebo on cumulative antibiotic use for all-cause infections over 1 year among care home residents in Wales.	[Butler, Christopher C.; Hobbs, F. D. Richard; Davoudianfar, Mina; Rutter, Heather] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Primary Care Bldg, Oxford, England; [Lau, Mandy; Gillespie, David; Owen-Jones, Eleri; Davies, Jane; Edwards, Alison; Shepherd, Victoria; Hood, Kerenza; Stanton, Helen; Lowe, Rachel] Cardiff Univ, Ctr Trials Res, Heath Pk, Cardiff, Wales; [Lown, Mark; Moore, Michael; Little, Paul; Fuller, Richard; Francis, Nick A.] Univ Southampton, Primary Care & Populat Sci Unit, Aldermoor Hlth Ctr, Aldermoor Close, Southampton, Hants, England; [Wootton, Mandy] Univ Hosp Wales, Specialist Antimicrobial Chemotherapy Unit, Publ Hlth Wales Microbiol, Heath Pk, Cardiff, Wales; [Calder, Philip C.] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Calder, Philip C.] Univ Southampton, Southampton, Hants, England; [Bayer, Antony J.] Cardiff Univ, Sch Med, Neuadd Meirionnydd, Div Populat Med, Cardiff, Wales	University of Oxford; Cardiff University; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; Cardiff University	Butler, CC (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Radcliffe Primary Care Bldg, Oxford OX2 6GG, England.	christopher.butler@phc.ox.ac.uk	Bayer, Antony/H-4434-2019; Lowe, Rachel/GXN-3278-2022; Francis, Nick/B-7413-2009; Hood, Kerenza/C-2528-2008; Moore, Michael/C-3447-2011; Calder, Philip/E-9739-2013	Bayer, Antony/0000-0002-7514-248X; Francis, Nick/0000-0001-8939-7312; Lowe, Rachel/0000-0002-7306-0085; Lown, Mark/0000-0001-8309-568X; Hood, Kerenza/0000-0002-5268-8631; Moore, Michael/0000-0002-5127-4509; Little, Paul/0000-0003-3664-1873; Calder, Philip/0000-0002-6038-710X	MRC; NIHR; Chief Scientist Office-Scotland; Health and Care ResearchWales; Health and Social Care Research and Development Division (Public Health Agency) Northern Ireland [13/95/10]; EME program	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Chief Scientist Office-Scotland; Health and Care ResearchWales; Health and Social Care Research and Development Division (Public Health Agency) Northern Ireland; EME program	This project was funded by the EME program, which is funded by the MRC and NIHR, with contributions from Chief Scientist Office-Scotland, Health and Care ResearchWales, and the Health and Social Care Research and Development Division (part of the Public Health Agency) Northern Ireland (grant 13/95/10, Probiotics to Reduce Infections in Care Home Residents [PRINCESS]). Chr Hansen provided the probiotic combination and matched placebo capsules at no cost to the study.	Allen SJ, 2013, LANCET, V382, P1249, DOI 10.1016/S0140-6736(13)61218-0; BUTLER CC, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.E682; Carvour ML, 2019, AM J INFECT CONTROL, V47, P2, DOI 10.1016/j.ajic.2018.07.014; Cook JA, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3750; Couzner L, 2013, APPL HEALTH ECON HEA, V11, P415, DOI 10.1007/s40258-013-0039-8; Davies SC, 2018, J ANTIMICROB CHEMOTH, V73, P833, DOI 10.1093/jac/dkx535; European Medicines Agency Committee for Medicinal Products for Human Use, 2020, E9R1 ICH; Gillespie D, 2015, AGE AGEING, V44, P853, DOI 10.1093/ageing/afv072; Global Market Insights, 2016, PROB MARK SIZ EXC US; Grand View Research, 2018, US HOSP NURS HOM PRO; Hillier S, 2007, J ANTIMICROB CHEMOTH, V60, P92, DOI 10.1093/jac/dkm141; King S, 2019, EUR J PUBLIC HEALTH, V29, P494, DOI 10.1093/eurpub/cky185; King S, 2014, BRIT J NUTR, V112, P41, DOI 10.1017/S0007114514000075; Mane J, 2011, NUTR HOSP, V26, P228, DOI 10.3305/nh.201126.1.5112; Nagata S, 2016, ANN NUTR METAB, V68, P51, DOI 10.1159/000442305; Ouwehand AC, 2016, ANN MED, V48, P246, DOI 10.3109/07853890.2016.1161232; Owen-Jones E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027513; Smieszek T, 2018, J ANTIMICROB CHEMOTH, V73, P36, DOI 10.1093/jac/dkx500; Suez J, 2019, NAT MED, V25, P716, DOI 10.1038/s41591-019-0439-x; Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; van Puyenbroeck K, 2012, AM J CLIN NUTR, V95, P1165, DOI 10.3945/ajcn.111.026831; Vihta KD, 2018, LANCET INFECT DIS, V18, P1138, DOI 10.1016/S1473-3099(18)30353-0; Wachholz PA, 2018, AGE AGEING, V47, P527, DOI 10.1093/ageing/afy006; Wang B, 2018, J AM GERIATR SOC, V66, P1346, DOI 10.1111/jgs.15396	25	11	11	4	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					47	56		10.1001/jama.2020.8556	http://dx.doi.org/10.1001/jama.2020.8556			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633801	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000568123600021
J	Orkaby, AR; Driver, JA; Ho, YL; Lu, B; Costa, L; Honerlaw, J; Galloway, A; Vassy, JL; Forman, DE; Gaziano, JM; Gagnon, DR; Wilson, PWF; Cho, K; Djousse, L				Orkaby, Ariela R.; Driver, Jane A.; Ho, Yuk-Lam; Lu, Bing; Costa, Lauren; Honerlaw, Jacqueline; Galloway, Ashley; Vassy, Jason L.; Forman, Daniel E.; Gaziano, J. Michael; Gagnon, David R.; Wilson, Peter W. F.; Cho, Kelly; Djousse, Luc			Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY PREVENTION; DISEASE; INDIVIDUALS; THERAPY; RISK	Key PointsQuestionAmong US veterans 75 years and older and free of atherosclerotic cardiovascular disease at baseline, is statin use associated with lower risk of mortality? FindingsIn this retrospective cohort study that used propensity score overlap weighting and included 326981 participants, statin use, compared with no statin use, was significantly associated with a lower risk of all-cause and cardiovascular mortality (hazard ratios, 0.75 and 0.80, respectively). MeaningAmong older US veterans without atherosclerotic cardiovascular disease at baseline, statin therapy was significantly associated with a lower risk of mortality. ImportanceData are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in adults 75 years and older. ObjectiveTo evaluate the role of statin use for mortality and primary prevention of ASCVD in veterans 75 years and older. Design, Setting, and ParticipantsRetrospective cohort study that used Veterans Health Administration (VHA) data on adults 75 years and older, free of ASCVD, and with a clinical visit in 2002-2012. Follow-up continued through December 31, 2016. All data were linked to Medicare and Medicaid claims and pharmaceutical data. A new-user design was used, excluding those with any prior statin use. Cox proportional hazards models were fit to evaluate the association of statin use with outcomes. Analyses were conducted using propensity score overlap weighting to balance baseline characteristics. ExposuresAny new statin prescription. Main Outcomes and MeasuresThe primary outcomes were all-cause and cardiovascular mortality. Secondary outcomes included a composite of ASCVD events (myocardial infarction, ischemic stroke, and revascularization with coronary artery bypass graft surgery or percutaneous coronary intervention). ResultsOf 326981 eligible veterans (mean [SD] age, 81.1 [4.1] years; 97% men; 91% white), 57178 (17.5%) newly initiated statins during the study period. During a mean follow-up of 6.8 (SD, 3.9) years, a total 206902 deaths occurred including 53296 cardiovascular deaths, with 78.7 and 98.2 total deaths/1000 person-years among statin users and nonusers, respectively (weighted incidence rate difference [IRD]/1000 person-years, -19.5 [95% CI, -20.4 to -18.5]). There were 22.6 and 25.7 cardiovascular deaths per 1000 person-years among statin users and nonusers, respectively (weighted IRD/1000 person-years, -3.1 [95 CI, -3.6 to -2.6]). For the composite ASCVD outcome there were 123379 events, with 66.3 and 70.4 events/1000 person-years among statin users and nonusers, respectively (weighted IRD/1000 person-years, -4.1 [95% CI, -5.1 to -3.0]). After propensity score overlap weighting was applied, the hazard ratio was 0.75 (95% CI, 0.74-0.76) for all-cause mortality, 0.80 (95% CI, 0.78-0.81) for cardiovascular mortality, and 0.92 (95% CI, 0.91-0.94) for a composite of ASCVD events when comparing statin users with nonusers. Conclusions and RelevanceAmong US veterans 75 years and older and free of ASCVD at baseline, new statin use was significantly associated with a lower risk of all-cause and cardiovascular mortality. Further research, including from randomized clinical trials, is needed to more definitively determine the role of statin therapy in older adults for primary prevention of ASCVD. This retrospective cohort study uses Veterans Health Administration data on adults free of atherosclerotic cardiovascular disease (ASCVD) to evaluate the association between new statin use and all-cause and cardiovascular mortality, and a composite of ASCVD events (myocardial infarction, ischemic stroke, and revascularization with CABG surgery or PCI), in veterans 75 years and older.	[Orkaby, Ariela R.; Driver, Jane A.] VA Boston Healthcare Syst, New England Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Orkaby, Ariela R.; Driver, Jane A.; Ho, Yuk-Lam; Lu, Bing; Costa, Lauren; Honerlaw, Jacqueline; Galloway, Ashley; Vassy, Jason L.; Gaziano, J. Michael; Gagnon, David R.; Cho, Kelly; Djousse, Luc] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA USA; [Orkaby, Ariela R.; Driver, Jane A.; Gaziano, J. Michael; Cho, Kelly; Djousse, Luc] Harvard Med Sch, Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA; [Lu, Bing; Vassy, Jason L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Forman, Daniel E.] Univ Pittsburgh, Med Ctr, Sect Geriatr Cardiol, Pittsburgh, PA USA; [Forman, Daniel E.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, 150 S Huntington St, Pittsburgh, PA 02130 USA; [Gagnon, David R.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wilson, Peter W. F.] Atlanta VA Med Ctr, Decatur, GA USA; [Wilson, Peter W. F.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; [Wilson, Peter W. F.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Emory University; Rollins School Public Health	Orkaby, AR (corresponding author), VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, 150 S Huntington St, Pittsburgh, PA 02130 USA.	aorkaby@bwh.harvard.edu		Orkaby, Ariela/0000-0002-4297-6306; Galloway, Ashley/0000-0003-3083-5386	VA CSRD CDA-2 award [IK2-CX001800]; National Institute on Aging [R03-AG060169]; VA Merit Award [I01 CX001025]; Department of Veterans Affairs, VA Health Services Research and Development Service, VA Information Resource Center [SDR 02-237, 98-004]	VA CSRD CDA-2 award; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); VA Merit Award(US Department of Veterans Affairs); Department of Veterans Affairs, VA Health Services Research and Development Service, VA Information Resource Center(US Department of Veterans Affairs)	This research was supported by VA CSR&D CDA-2 award IK2-CX001800 (Dr Orkaby), National Institute on Aging R03-AG060169 (Dr Orkaby), and VA Merit Award I01 CX001025 (Dr Wilson and Dr Cho). This article does not represent the views of the Department of Veterans Affairs or the US government. Support for VA/Centers for Medicare & Medicaid Services data is provided by the Department of Veterans Affairs, VA Health Services Research and Development Service, VA Information Resource Center (project numbers SDR 02-237 and 98-004).	Alexander KP, 2007, CIRCULATION, V115, P2549, DOI 10.1161/CIRCULATIONAHA.107.182615; [Anonymous], 2014, VA DOD CLIN PRACTICE; [Anonymous], 2017, MORT RAT LIF EXP VET; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bezin J, 2019, AM J MED, V132, P740, DOI 10.1016/j.amjmed.2018.12.032; Bitzur R, 2016, DIABETES CARE, V39, pS253, DOI 10.2337/dcS15-3022; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Djousse Luc, 2019, J Clin Cardiol Cardiovasc Ther, V1, DOI 10.31546/JCCCVT.1002; Eibner Christine, 2016, Rand Health Q, V5, P13; Elze MC, 2017, J AM COLL CARDIOL, V69, P345, DOI 10.1016/j.jacc.2016.10.060; Floyd JS, 2016, PHARMACOEPIDEM DR S, V25, P467, DOI 10.1002/pds.3921; Fulcher J, 2019, LANCET, V393, P407, DOI 10.1016/S0140-6736(18)31942-1; Giral P, 2019, EUR HEART J, V40, P3516, DOI 10.1093/eurheartj/ehz458; Grundy SM, 2019, CIRCULATION, V139, pE1082, DOI 10.1161/CIR.0000000000000625; Han BH, 2017, JAMA INTERN MED, V177, P955, DOI 10.1001/jamainternmed.2017.1442; Hawley CE, 2019, DRUG AGING, V36, P687, DOI 10.1007/s40266-019-00673-w; Huesch MD, 2018, JAMA INTERN MED, V178, P560, DOI 10.1001/jamainternmed.2017.7844; Joint Department of Veterans Affairs (VA) and Department of Defense (DoD) Suicide Data Repository-National Death Index (NDI), DEF SUIC PREV OFF; Jun JE, 2019, ATHEROSCLEROSIS, V283, P28, DOI 10.1016/j.atherosclerosis.2019.01.030; Kim K, 2019, ATHEROSCLEROSIS, V284, P31, DOI 10.1016/j.atherosclerosis.2019.02.026; Kutner JS, 2015, JAMA INTERN MED, V175, P691, DOI 10.1001/jamainternmed.2015.0289; Lee SJ, 2018, J AM GERIATR SOC, V66, P229, DOI 10.1111/jgs.15216; Li F, 2019, AM J EPIDEMIOL, V188, P250, DOI 10.1093/aje/kwy201; Orkaby AR, 2017, J AM GERIATR SOC, V65, P2362, DOI 10.1111/jgs.14993; Ortman JM, 2014, AGING NATION OLDER P; Price Lauren E, 2015, Nurs Adm Q, V39, P311, DOI 10.1097/NAQ.0000000000000118; Ramos R, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3359; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ridker PM, 2017, CIRCULATION, V135, P1979, DOI 10.1161/CIRCULATIONAHA.117.028271; Savarese G, 2013, J AM COLL CARDIOL, V62, P2090, DOI 10.1016/j.jacc.2013.07.069; Seeger JD, 2007, MED CARE, V45, pS143, DOI 10.1097/MLR.0b013e318074ce79; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SONG RJ, 2016, CIRCULATION S1, V134; Teng M, 2015, DRUG AGING, V32, P649, DOI 10.1007/s40266-015-0290-9; US Department of Veterans Affairs, 2015, SYST REC NOT 97VA10P; Wong ES, 2016, MED CARE RES REV, V73, P493, DOI 10.1177/1077558715617382; Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007	39	73	74	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					68	78		10.1001/jama.2020.7848	http://dx.doi.org/10.1001/jama.2020.7848			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633800	Green Published, Bronze			2022-12-28	WOS:000568123600023
J	Oliver, D				Oliver, David			David Oliver: Caring about language doesn't mean we can't care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Royal College of Nursing, 2019, ROYAL COLL NURS STYL; Walden C, 2020, TELEGRAPH	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2524	10.1136/bmj.m2524	http://dx.doi.org/10.1136/bmj.m2524			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611553	Bronze			2022-12-28	WOS:000548489100012
J	Rimmer, A				Rimmer, Abi			Covid-19: Surgeons embrace virtual consultations to meet patients' needs during pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of Surgeons of England, 2020, CONS TREATM COV 19 I; Royal College of Surgeons of England, 2020, VIRT CONS	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2644	10.1136/bmj.m2644	http://dx.doi.org/10.1136/bmj.m2644			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611542	Bronze			2022-12-28	WOS:000548489100003
J	Torjesen, I				Torjesen, Ingrid			Evidence does not support vitamin D for reducing respiratory infections, reviews conclude	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; NICE, 2020, COV 19 RAP EV SUMM V; Royal Society, 2020, VIT D COV 19; Scientific Advisory Commission on Nutrition, 2020, RAP REV VIT D AC RES; Torjesen I, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2475	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2629	10.1136/bmj.m2629	http://dx.doi.org/10.1136/bmj.m2629			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32606036	Bronze			2022-12-28	WOS:000548116400009
J	Wise, J				Wise, Jacqui			Covid-19: Timing is critical for antibody tests, finds Cochrane review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Andersson M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2420; Deeks JJ, 2020, COCHRANE DATABASE SY, V6; NHS England, 2020, ANT TEST PROGR ROLL; Public Health England, 2020, COVID 19 LAB EV SER	4	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2020	369								m2584	10.1136/bmj.m2584	http://dx.doi.org/10.1136/bmj.m2584			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI3HF	32586794	hybrid			2022-12-28	WOS:000583173400014
J	Marklund, E; van Oosten, B; Mao, GZ; Amselem, E; Kipper, K; Sabantsev, A; Emmerich, A; Globisch, D; Zheng, X; Lehmann, LC; Berg, OG; Johansson, M; Elf, J; Deindl, S				Marklund, Emil; van Oosten, Brad; Mao, Guanzhong; Amselem, Elias; Kipper, Kalle; Sabantsev, Anton; Emmerich, Andrew; Globisch, Daniel; Zheng, Xuan; Lehmann, Laura C.; Berg, Otto G.; Johansson, Magnus; Elf, Johan; Deindl, Sebastian			DNA surface exploration and operator bypassing during target search	NATURE			English	Article							ENERGY-TRANSFER; SINGLE; PROTEIN; TRANSLOCATION; MICROSCOPY; DIFFUSION; DYNAMICS	Many proteins that bind specific DNA sequences search the genome by combining three-dimensional diffusion with one-dimensional sliding on nonspecific DNA(1-5). Here we combine resonance energy transfer and fluorescence correlation measurements to characterize how individual lac repressor (LacI) molecules explore the DNA surface during the one-dimensional phase of target search. To track the rotation of sliding LacI molecules on the microsecond timescale, we use real-time single-molecule confocal laser tracking combined with fluorescence correlation spectroscopy (SMCT-FCS). The fluctuations in fluorescence signal are accurately described by rotation-coupled sliding, in which LacI traverses about 40 base pairs (bp) per revolution. This distance substantially exceeds the 10.5-bp helical pitch of DNA; this suggests that the sliding protein frequently hops out of the DNA groove, which would result in the frequent bypassing of target sequences. We directly observe such bypassing using single-molecule fluorescence resonance energy transfer (smFRET). A combined analysis of the smFRET and SMCT-FCS data shows that LacI hops one or two grooves (10-20 bp) every 200-700 mu s. Our data suggest a trade-off between speed and accuracy during sliding: the weak nature of nonspecific protein-DNA interactions underlies operator bypassing, but also speeds up sliding. We anticipate that SMCT-FCS, which monitors rotational diffusion on the microsecond timescale while tracking individual molecules with millisecond resolution, will be applicable to the real-time investigation of many other biological interactions and will effectively extend the accessible time regime for observing these interactions by two orders of magnitude. Single-molecule fluorescence resonance energy transfer and real-time confocal laser tracking with fluorescence correlation spectroscopy together characterize how individual lac repressor molecules bypass operator sites while exploring the DNA surface at microsecond timescales.	[Marklund, Emil; van Oosten, Brad; Mao, Guanzhong; Amselem, Elias; Kipper, Kalle; Sabantsev, Anton; Emmerich, Andrew; Zheng, Xuan; Lehmann, Laura C.; Berg, Otto G.; Johansson, Magnus; Elf, Johan; Deindl, Sebastian] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Globisch, Daniel] Uppsala Univ, Dept Med Chem, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University	Elf, J; Deindl, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden.	johan.elf@icm.uu.se; sebastian.deindl@icm.uu.se	Globisch, Daniel/C-7307-2011; Van Oosten, Brad/F-3661-2014; Johansson, Magnus/J-8841-2014	Globisch, Daniel/0000-0002-4526-5788; Deindl, Sebastian/0000-0001-6807-8654; Lehmann, Laura C./0000-0003-2518-5606; Zheng, Xuan/0000-0002-1700-9082; Van Oosten, Brad/0000-0002-2165-2572; Marklund, Emil/0000-0002-1150-7304; Johansson, Magnus/0000-0001-8811-2629; Sabantsev, Anton/0000-0002-8559-8894	(European Research Council ERC); Swedish Research Council (VR); Knut and Alice Wallenberg Foundation (KAW)	(European Research Council ERC)(European Research Council (ERC)European Commission); Swedish Research Council (VR)(Swedish Research Council); Knut and Alice Wallenberg Foundation (KAW)(Knut & Alice Wallenberg Foundation)	We thank P. Blainey and K. Xiong for advice on flow-stretching; C. Joo for discussions; J. Laksman for initial code; and D. Fange, I. Barkefors and M. Ehrenberg for helpful comments on the manuscript. The project was funded by the European Research Council ERC), the Swedish Research Council (VR) and the Knut and Alice Wallenberg Foundation (KAW).	Backer AS, 2016, OPTICA, V3, P659, DOI 10.1364/OPTICA.3.000659; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 1996, PHYS REV LETT, V77, P3979, DOI 10.1103/PhysRevLett.77.3979; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Persson F, 2013, NAT METHODS, V10, P265, DOI [10.1038/NMETH.2367, 10.1038/nmeth.2367]; Persson F, 2009, SMALL, V5, P190, DOI 10.1002/smll.200800423; Sosa H, 2001, NAT STRUCT BIOL, V8, P540, DOI 10.1038/88611; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Verbrugge S, 2007, BIOPHYS J, V92, P2536, DOI 10.1529/biophysj.106.093575; Verbrugge S, 2009, P NATL ACAD SCI USA, V106, P17741, DOI 10.1073/pnas.0905177106; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675	18	27	27	5	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2020	583	7818					858	+		10.1038/s41586-020-2413-7	http://dx.doi.org/10.1038/s41586-020-2413-7		JUN 2020	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT2XH	32581356	Green Submitted			2022-12-28	WOS:000556397700001
J	Rimmer, A				Rimmer, Abi			How can I make the most of my time shielding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2443	10.1136/bmj.m2443	http://dx.doi.org/10.1136/bmj.m2443			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571961	Bronze			2022-12-28	WOS:000548535700004
J	Caturegli, G; Materi, J; Howard, BM; Caturegli, P				Caturegli, Giorgio; Materi, Joshua; Howard, Brittney M.; Caturegli, Patrizio			Clinical Validity of Serum Antibodies to SARS-CoV-2 A Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article								Background: The clinical utility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies remains undefined. Objective: To determine the clinical validity and utility of SARS-CoV-2 antibodies. Design: Case-control study. Setting: First month of testing for coronavirus disease 2019 (COVID-19) by using a nucleic acid amplification test (NAAT) on nasopharyngeal swabs at the Johns Hopkins Hospital, Baltimore, Maryland (11 066 persons). Participants: Of the 11 066 tested persons, 115 (1%) were hospitalized adults investigated for COVID-19. Clinical record review was performed to classify them into a COVID-19 case group (n = 60) or a non-COVID-19 control group (n = 55). The laboratory control groups comprised 513 persons not tested by NAAT: 160 healthy laboratory employees, 101 persons positive for IgG antibodies against Epstein-Barr virus capsid antigen, 215 positive for thyroperoxidase antibody, and 37 positive for rheumatoid factor. Measurements: Serum IgG and IgA antibodies against SARS-CoV-2 spike protein were detected by using enzyme-linked immunosorbent assay. Results: Sensitivity and specificity of the SARS-CoV-2 IgG assay were 0.976 (95% CI, 0.928 to 0.995) and 0.988 (CI, 0.974 to 0.995), respectively, when performed 14 days or later after symptom onset, but sensitivity decreased at earlier time points. Immunoglobulin G developed rapidly and was sustained at high levels throughout follow-up (up to 58 days). Antibodies to SARS-CoV-2 predicted the odds of developing acute respiratory distress syndrome, which increased by 62% (CI, 48% to 81%; P < 0.001) for every 2-fold increase in IgG. Of 11 066 NAAT-tested patients, 457 were repeatedly NAAT-negative, and serum samples were obtained for 18 such patients (6 COVID-19 case patients and 12 non-COVID-19 control patients). Antibodies were present in 5 of 6 case patients and none of the 12 control patients (P = 0.001). Limitations: The study was retrospective and performed at a single center; the sample was small; follow-up was limited; and selection bias may have occurred. Conclusion: Antibodies to SARS-CoV-2 demonstrate infection when measured at least 14 days after symptom onset, are associated with clinical severity, and provide valuable diagnostic support in patients who test negative by NAAT but remain clinically suspicious for COVID-19. Primary Funding Source: Clinical Immunology Laboratory, Department of Pathology, Johns Hopkins Hospital.	[Caturegli, Giorgio; Materi, Joshua; Howard, Brittney M.; Caturegli, Patrizio] Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Caturegli, P (corresponding author), Johns Hopkins Pathol, Ross Bldg,Room 656,720 Rutland Ave, Baltimore, MD 21205 USA.	pcat@jhmi.edu		Caturegli, Patrizio/0000-0001-6768-6308; Materi, Joshua/0000-0001-9786-9068; Caturegli, Giorgio/0000-0001-6508-7096	Clinical Immunology Laboratory, Department of Pathology, Johns Hopkins Hospital	Clinical Immunology Laboratory, Department of Pathology, Johns Hopkins Hospital	Clinical Immunology Laboratory, Department of Pathology, Johns Hopkins Hospital.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Barnes E, 2020, EVALUATION ANTIBODY, DOI 10.1101/2020.04.15.20066407v1.full.pdf; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; Cai XH, 2020, BLOOD TRANSFUS-ITALY, V18, P79, DOI 10.2450/2020.0076-20; Center for Drug Evaluation and Research U. S. Food and Drug Administration, 2020, EUROIMMUN ANT SARS C; Cheng MP, 2020, ANN INTERN MED, V172, P726, DOI 10.7326/M20-1301; Curfman G, 2020, JAMA-J AM MED ASSOC, V324, P177, DOI 10.1001/jama.2020.11401; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Diggle PJ, 1995, J AM STAT ASSOC; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Du Z, 2020, J MED VIROL, V92, P1735, DOI 10.1002/jmv.25820; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Huang AT, 2020, NAT COMMUN, DOI [10.1101/2020.04.14.20065771, DOI 10.1038/S41467-020-18450-4]; Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X; Infantino M, 2020, ISR MED ASSOC J, V22, P203; Kadkhoda K, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00344-20; KELEN GD, 1988, NEW ENGL J MED, V318, P1645, DOI 10.1056/NEJM198806233182503; Kucirka L, 2020, VARIATION FALSE NEGA, DOI [10.1101/2020.04.07.20051474, DOI 10.1101/2020.04.07.20051474, 10.7326/M20-1495]; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Lassaunie` re R, 2020, MEDRXIV, DOI [10.1101/2020.04.09.20056325., 10.1101/2020.04.09.20056325]; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lou B, SEROLOGY CHARACTERIS, DOI 10.1101/2020.03.23.20041707; Martinez DA, 2020, JAMA-J AM MED ASSOC, V324, P392, DOI 10.1001/jama.2020.11374; Mayerhofer TG, 2019, CHEMPHYSCHEM, V20, P2748, DOI 10.1002/cphc.201900787; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; National Center for Health Statistics Centers for Disease Control and Prevention, 2020, COVID 19 PAND PLANN; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Sisk JM, 2018, J GEN VIROL, V99, P619, DOI 10.1099/jgv.0.001047; Steensels D, 2020, JAMA-J AM MED ASSOC, V324, P195, DOI 10.1001/jama.2020.11160; van den Heuvel H, 2019, HUM IMMUNOL, V80, P97, DOI 10.1016/j.humimm.2018.10.014; Vardhana SA, 2020, J EXP MED, V217, DOI 10.1084/jem.20200678; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Whitman JD, 2020, NAT BIOTECHNOL, V38, P1174, DOI [10.1038/s41587-020-0659-0, 10.1101/2020.04.25.20074856]; Woloshin S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2015897; Woo PCY, 2004, CLIN DIAGN LAB IMMUN, V11, P665, DOI 10.1128/CDLI.11.4.665-668.2004; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344	42	29	30	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2020	173	8					614	+		10.7326/M20-2889	http://dx.doi.org/10.7326/M20-2889			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OH7WZ	32628534	Green Published			2022-12-28	WOS:000582805500015
J	Chou, R; Dana, T; Jungbauer, R; Weeks, C; McDonagh, MS				Chou, Roger; Dana, Tracy; Jungbauer, Rebecca; Weeks, Chandler; McDonagh, Marian S.			Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings A Living Rapid Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; INFLUENZA-LIKE ILLNESS; N95 RESPIRATORS; MEDICAL MASKS; SARS PATIENTS; RISK-FACTORS; CORONAVIRUS INFECTION; CLINICAL-TRIAL; HAND HYGIENE; TRANSMISSION	Background: Recommendations on masks for preventing coronavirus disease 2019 (COVID-19) vary. Purpose: To examine the effectiveness of N95, surgical, and cloth masks in community and health care settings for preventing respiratory virus infections, and effects of reuse or extended use of N95 masks. Data Sources: Multiple electronic databases, including the World Health Organization COVID-19 database and medRxiv preprint server (2003 through 14 April 2020; surveillance through 2 June 2020), and reference lists. Study Selection: Randomized trials of masks and risk for respiratory virus infection, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and observational studies of mask use and coronavirus infection risk were included. New evidence will be incorporated by using living review methods. Data Extraction: One reviewer abstracted data and assessed methodological limitations; a second reviewer provided verification. Data Synthesis: 39 studies (18 randomized controlled trials and 21 observational studies; 33 867 participants) were included. No study evaluated reuse or extended use of N95 masks. Evidence on SARS-CoV-2 was limited to 2 observational studies with serious limitations. Community mask use was possibly associated with decreased risk for SARS-CoV-1 infection in observational studies. In high- or moderate-risk health care settings, observational studies found that risk for infection with SARS-CoV-1 and Middle East respiratory syndrome coronavirus probably decreased with mask use versus nonuse and possibly decreased with N95 versus surgical mask use. Randomized trials in community settings found possibly no difference between N95 versus surgical masks and probably no difference between surgical versus no mask in risk for influenza or influenza-like illness, but compliance was low. In health care settings, N95 and surgical masks were probably associated with similar risks for influenza-like illness and laboratory-confirmed viral infection; clinical respiratory illness had inconsistency. Bothersome symptoms were common. Limitations: There were few SARS-CoV-2 studies, observational studies have methodological limitations, and the review was done by using streamlined methods. Conclusion: Evidence on mask effectiveness for respiratory infection prevention is stronger in health care than community settings. N95 respirators might reduce SARS-CoV-1 risk versus surgical masks in health care settings, but applicability to SARS-CoV-2 is uncertain.	[Chou, Roger; Dana, Tracy; Jungbauer, Rebecca; Weeks, Chandler; McDonagh, Marian S.] Oregon Hlth & Sci Univ, 3181 Sw Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 Sw Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu			AHRQ [HHSA290201500009I, 75Q80119F32021]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By AHRQ (contract HHSA290201500009I, task order 75Q80119F32021).	Aiello AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029744; Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Alfelali M, FACEMASK VERSUS FACE; Alraddadi BM, 2016, EMERG INFECT DIS, V22, P1915, DOI 10.3201/eid2211.160920; Bach M., 2017, UNDERSTANDING RESP P; Barasheed Osamah, 2014, Infectious Disorders - Drug Targets, V14, P110; Bartoszko JJ, 2020, INFLUENZA OTHER RESP, V14, P365, DOI 10.1111/irv.12745; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Campbell Marion K, 2004, BMC Med Res Methodol, V4, P9, DOI 10.1186/1471-2288-4-9; Canini L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013998; Caputo KM, 2006, CAN J ANAESTH, V53, P122, DOI 10.1007/BF03021815; Centers for Disease Control and Prevention, 2020, DEC REUS FILT FAC RE; Centers for Disease Control and Prevention, 2020, CHIN J CHILD HLTH CA; Centers For Disease Control and Prevention, 2020, COVID 19 GUIDANCE MA; Centre for Research Synthesis and Decision Analysis University of Bristol, 2020, ROBINS TOOL RISK BIA; Chen WQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-81; Chou R, 2020, AHRQ PUBLICATION, V20-EHC016, DOI [10.23970/AHRQEPCCOVIDMASKS, DOI 10.23970/AHRQEPCCOVIDMASKS]; Chou R, 2020, ANN INTERN MED, V173, P120, DOI 10.7326/M20-1632; Chughtai AA, 2016, ANN OCCUP HYG, V60, P619, DOI 10.1093/annhyg/mew008; Cold Spring Harbor Laboratory, 2020, MEDRXIV PREPR SERV H; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; ECRI, 2020, CLIN EV ASS SAF EXT; Elliott JH, 2017, J CLIN EPIDEMIOL, V91, P23, DOI 10.1016/j.jclinepi.2017.08.010; Haby MM, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0155-7; Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5; Jefferson T, 2020, PHYS INTERVENTIONS 1, DOI 10.1101/2020.03.30.2 0047217v2; Jia N, 2009, TROP MED INT HEALTH, V14, P21, DOI 10.1111/j.1365-3156.2008.02147.x; Larson EL, 2010, PUBLIC HEALTH REP, V125, P178, DOI 10.1177/003335491012500206; Lau JTF, 2004, EMERG INFECT DIS, V10, P280, DOI 10.3201/eid1002.030534; Lau JTF, 2004, EMERG INFECT DIS, V10, P235; Loeb M, 2004, EMERG INFECT DIS, V10, P251, DOI 10.3201/eid1002.030838; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; Long YL, 2020, J EVID-BASED MED, V13, P93, DOI 10.1111/jebm.12381; Ma Huai-jian, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P741; MacIntyre CR, 2020, INT J NURS STUD, V108, DOI 10.1016/j.ijnurstu.2020.103629; MacIntyre CR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006577; MacIntyre CR, 2013, AM J RESP CRIT CARE, V187, P960, DOI 10.1164/rccm.201207-1164OC; MacIntyre CR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012330; MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Nishiura H, 2005, AM J TROP MED HYG, V73, P17, DOI 10.4269/ajtmh.2005.73.17; Nishiyama A, 2008, JPN J INFECT DIS, V61, P388; Pei Li-ying, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P271; Raboud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010717; Radonovich LJ, 2019, JAMA-J AM MED ASSOC, V322, P824, DOI 10.1001/jama.2019.11645; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Scales DC, 2003, EMERG INFECT DIS, V9, P1205, DOI 10.3201/eid0910.030525; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Simmerman JM, 2011, INFLUENZA OTHER RESP, V5, P256, DOI 10.1111/j.1750-2659.2011.00205.x; Suess Thorsten, 2012, BMC Infect Dis, V12, P26, DOI 10.1186/1471-2334-12-26; Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI [10.1017/S0950268804002766, 10.1017/s0950268804002766]; Tuan PA, 2007, EPIDEMIOL INFECT, V135, P392, DOI 10.1017/S0950268806006996; U.S. Preventive Services Task Force, 2017, PROC MAN APP 6 CRIT; Wang X, 2020, J HOSP INFECT, V105, P104, DOI 10.1016/j.jhin.2020.02.021; Wells G., 2000, NEWCASTLE OTTAWA SCA; WHO, 2020, ADV US MASKS CONT CO; Wilder-Smith A, 2005, EMERG INFECT DIS, V11, P1142, DOI 10.3201/eid1107.041165; Wilson NM, 2020, ANAESTHESIA, V75, P1086, DOI 10.1111/anae.15093; World Health Organization, 2020, GLOB RES COR DIS COV; World Health Organization (WHO), 2020, SHORT PERS PROT EQ E; Wu J, 2004, EMERG INFECT DIS, V10, P210, DOI 10.3201/eid1002.030730; Yin Wen-wu, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P18	64	85	87	5	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2020	173	7					542	+		10.7326/M20-3213	http://dx.doi.org/10.7326/M20-3213			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX4GS	32579379	Green Published			2022-12-28	WOS:000575671400010
J	Lee, HJ; Lee, M; Lee, K; Jo, J; Yang, H; Kim, Y; Chae, SC; Waghmare, U; Lee, JH				Lee, Hyun-Jae; Lee, Minseong; Lee, Kyoungjun; Jo, Jinhyeong; Yang, Hyemi; Kim, Yungyeom; Chae, Seung Chul; Waghmare, Umesh; Lee, Jun Hee			Scale-free ferroelectricity induced by flat phonon bands in HfO2	SCIENCE			English	Article							TOTAL-ENERGY CALCULATIONS; DOPED HAFNIUM OXIDE; THIN-FILMS; EPITAXIAL-GROWTH; PHASE-TRANSITION; POLARIZATION; FIELD; NANOSCALE; ZRO2	Discovery of robust yet reversibly switchable electric dipoles at reduced dimensions is critical to the advancement of nanoelectronics devices. Energy bands flat in momentum space generate robust localized states that are activated independently of each other. We determined that flat bands exist and induce robust yet independently switchable dipoles that exhibit a distinct ferroelectricity in hafnium dioxide (HfO2). Flat polar phonon bands in HfO2 cause extreme localization of electric dipoles within its irreducible half-unit cell widths (similar to 3 angstroms). Contrary to conventional ferroelectrics with spread dipoles, those intrinsically localized dipoles are stable against extrinsic effects such as domain walls, surface exposure, and even miniaturization down to the angstrom scale. Moreover, the subnanometer-scale dipoles are individually switchable without creating any domain-wall energy cost. This offers unexpected opportunities for ultimately dense unit cell-by-unit cell ferroelectric switching devices that are directly integrable into silicon technology.	[Lee, Hyun-Jae; Lee, Minseong; Jo, Jinhyeong; Yang, Hyemi; Kim, Yungyeom; Lee, Jun Hee] Ulsan Natl Inst Sci & Technol UNIST, Sch Energy & Chem Engn, Ulsan 44919, South Korea; [Lee, Kyoungjun; Chae, Seung Chul] Seoul Natl Univ, Dept Phys Educ, Seoul 08826, South Korea; [Waghmare, Umesh] Jawaharlal Nehru Ctr Adv Sci Res, Theoret Sci Unit, Bangalore 560064, Karnataka, India	Ulsan National Institute of Science & Technology (UNIST); Seoul National University (SNU); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Lee, JH (corresponding author), Ulsan Natl Inst Sci & Technol UNIST, Sch Energy & Chem Engn, Ulsan 44919, South Korea.	junhee@unist.ac.kr		Chae, Seung Chul/0000-0002-0913-027X; Lee, Jun Hee/0000-0001-5121-244X; Waghmare, Umesh/0000-0002-9378-155X; Lee, Kyoungjun/0000-0003-0472-3583; Lee, Minseong/0000-0002-2369-9913	Creative Materials Discovery [2017M3D1A1040828]; MOTIE (Ministry of Trade, Industry Energy) [10080657]; KRSC (Korea Semiconductor Research Consortium); J. C. Bose National Fellowship of SERB, Government of India; Department of Science and Technology for the India-Korea Joint Network Center in computational materials science; Basic Research Laboratory [NRF2017R1A4A1015323]	Creative Materials Discovery; MOTIE (Ministry of Trade, Industry Energy); KRSC (Korea Semiconductor Research Consortium); J. C. Bose National Fellowship of SERB, Government of India; Department of Science and Technology for the India-Korea Joint Network Center in computational materials science; Basic Research Laboratory	This work is supported by the Creative Materials Discovery (2017M3D1A1040828), the MOTIE (Ministry of Trade, Industry Energy) (10080657), KRSC (Korea Semiconductor Research Consortium) program, and Basic Research Laboratory (NRF2017R1A4A1015323). U.W. thanks UNIST for hospitality and funding from a J. C. Bose National Fellowship of SERB, Government of India, and support from the Department of Science and Technology for the India-Korea Joint Network Center in computational materials science. We appreciate the Supercomputing Center/Korea Institute of Science and Technology Information for supercomputing resources, including technical support (KSC-2020-CRE-0088).	Ahn CH, 2004, SCIENCE, V303, P488, DOI 10.1126/science.1092508; Alessandri C, 2018, IEEE ELECTR DEVICE L, V39, P1780, DOI 10.1109/LED.2018.2872124; Batra R, 2017, CHEM MATER, V29, P9102, DOI 10.1021/acs.chemmater.7b02835; Batra R, 2017, J PHYS CHEM C, V121, P4139, DOI 10.1021/acs.jpcc.6b11972; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Boscke TS, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3636434; Boescke TS, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3634052; Buragohain P, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5030562; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Cheema SS, 2020, NATURE, V580, P478, DOI 10.1038/s41586-020-2208-x; Choudhury N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.134111; Choudhury S, 2008, J APPL PHYS, V104, DOI 10.1063/1.3000459; Chu MW, 2004, NAT MATER, V3, P87, DOI 10.1038/nmat1057; Clima S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867975; Falkowski M, 2018, NPJ COMPUT MATER, V4, DOI 10.1038/s41524-018-0133-4; Fu D., 2012, ADV FERROELECTRICS, V3; Grimley ED, 2018, ADV MATER INTERFACES, V5, DOI 10.1002/admi.201701258; Hoffmann M, 2018, NANOSCALE, V10, P10891, DOI 10.1039/c8nr02752h; Hoffmann M, 2017, APPL PHYS LETT, V111, DOI 10.1063/1.5003612; Huan TD, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064111; Ihlefeld JF, 2016, J AM CERAM SOC, V99, P2537, DOI 10.1111/jace.14387; Kim H, 2003, APPL PHYS LETT, V83, P2647, DOI 10.1063/1.1613031; Kim MK, 2019, NANO LETT, V19, P2044, DOI 10.1021/acs.nanolett.9b00180; Kim WH, 2014, MATER LETT, V124, P47, DOI 10.1016/j.matlet.2014.03.069; KINGSMITH RD, 1993, PHYS REV B, V47, P1651, DOI 10.1103/PhysRevB.47.1651; Klepper KB, 2007, J CRYST GROWTH, V307, P457, DOI 10.1016/j.jcrysgro.2007.06.028; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Kunneth C, 2018, ACS APPL NANO MATER, V1, P254, DOI 10.1021/acsanm.7b00124; Kumar S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115411; Li Z, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4511; Lomenzo PD, 2014, J VAC SCI TECHNOL B, V32, DOI 10.1116/1.4873323; Maeda T, 2017, IEEE INT MEM WORKSH, P107; Mandar H, 2013, J MATER RES, V28, P1680, DOI 10.1557/jmr.2013.120; Materlik R, 2015, J APPL PHYS, V117, DOI 10.1063/1.4916707; Mikolajick T, 2018, MRS BULL, V43, P340, DOI 10.1557/mrs.2018.92; Mittmann T, 2019, ADV MATER INTERFACES, V6, DOI 10.1002/admi.201900042; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Muller J, 2012, NANO LETT, V12, P4318, DOI 10.1021/nl302049k; Mueller S, 2012, ECS J SOLID STATE SC, V1, pN123, DOI 10.1149/2.002301jss; Mueller S, 2012, ADV FUNCT MATER, V22, P2412, DOI 10.1002/adfm.201103119; Mukherjee S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.245504; Mulaosmanovic H., 2015, IEDM, DOI [10.1109/IEDM.2015.7409777, DOI 10.1109/IEDM.2015.7409777]; Mulaosmanovic H, 2018, ACS APPL MATER INTER, V10, P23997, DOI 10.1021/acsami.8b08967; Mulaosmanovic H, 2017, ACS APPL MATER INTER, V9, P3792, DOI 10.1021/acsami.6b13866; Nagarajan V, 1999, J APPL PHYS, V86, P595, DOI 10.1063/1.370772; Pantel D, 2010, J APPL PHYS, V107, DOI 10.1063/1.3392884; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Reyes-Lillo SE, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.140103; Richter C, 2017, ADV ELECTRON MATER, V3, DOI 10.1002/aelm.201700131; Rosenthal A, 2003, SENSOR ACTUAT B-CHEM, V93, P552, DOI 10.1016/S0925-4005(03)00236-3; Sai N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107601; Schroeder U, 2018, INORG CHEM, V57, P2752, DOI 10.1021/acs.inorgchem.7b03149; Schroeder U, 2014, JPN J APPL PHYS, V53, P85, DOI 10.7567/JJAP.53.08LE02; Schulenburg J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167207; Sheppard PW, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3677230; Son JY, 2008, J APPL PHYS, V104, DOI 10.1063/1.2978220; Terki R, 2008, MATER LETT, V62, P1484, DOI 10.1016/j.matlet.2007.09.006; VANDERBILT D, 1993, PHYS REV B, V48, P4442, DOI 10.1103/PhysRevB.48.4442; Waghmare UV, 1997, PHYS REV B, V55, P6161, DOI 10.1103/PhysRevB.55.6161; WANG YG, 1995, PHYS REV B, V51, P17235, DOI 10.1103/PhysRevB.51.17235; WIEDER HH, 1957, J APPL PHYS, V28, P367, DOI 10.1063/1.1722749; Xu L, 2017, J APPL PHYS, V122, DOI 10.1063/1.5003918; Zhang L, 2012, BIOENGINEERED, V3, P8, DOI 10.4161/bbug.3.1.17696; Zhang YB, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.035143; Zhou DY, 2015, ACTA MATER, V99, P240, DOI 10.1016/j.actamat.2015.07.035	71	114	113	55	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2020	369	6509			SI		1343	+		10.1126/science.aba0067	http://dx.doi.org/10.1126/science.aba0067			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO9YB	32616670	Bronze			2022-12-28	WOS:000569840300047
J	Yeh, JM; Lowry, KP; Schechter, CB; Diller, LR; Alagoz, O; Armstrong, GT; Hampton, JM; Leisenring, W; Liu, Q; Mandelblatt, JS; Miglioretti, DL; Moskowitz, CS; Oeffinger, KC; Trentham-Dietz, A; Stout, NK				Yeh, Jennifer M.; Lowry, Kathryn P.; Schechter, Clyde B.; Diller, Lisa R.; Alagoz, Oguzhan; Armstrong, Gregory T.; Hampton, John M.; Leisenring, Wendy; Liu, Qi; Mandelblatt, Jeanne S.; Miglioretti, Diana L.; Moskowitz, Chaya S.; Oeffinger, Kevin C.; Trentham-Dietz, Amy; Stout, Natasha K.			Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation A Comparative Modeling Study	ANNALS OF INTERNAL MEDICINE			English	Article							HODGKINS LYMPHOMA; 5-YEAR SURVIVORS; ADULT SURVIVORS; UNITED-STATES; WOMEN; RISK; CARE; ADOLESCENT; MORTALITY; INTERVENTION	Background: Surveillance with annual mammography and breast magnetic resonance imaging (MRI) is recommended for female survivors of childhood cancer treated with chest radiation, yet benefits, harms, and costs are uncertain. Objective: To compare the benefits, harms, and cost-effectiveness of breast cancer screening strategies in childhood cancer survivors. Design: Collaborative simulation modeling using 2 Cancer Intervention and Surveillance Modeling Network breast cancer models. Data Sources: Childhood Cancer Survivor Study and published data. Target Population: Women aged 20 years with a history of chest radiotherapy. Time Horizon: Lifetime. Perspective: Payer. Intervention: Annual MRI with or without mammography, starting at age 25, 30, or 35 years. Outcome Measures: Breast cancer deaths averted, false-positive screening results, benign biopsy results, and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: Lifetime breast cancer mortality risk without screening was 10% to 11% across models. Compared with no screening, starting at age 25 years, annual mammography with MRI averted the most deaths (56% to 71%) and annual MRI (without mammography) averted 56% to 62%. Both strategies had the most screening tests, false-positive screening results, and benign biopsy results. For an ICER threshold of less than $100 000 per quality-adjusted life-year gained, screening beginning at age 30 years was preferred. Results of Sensitivity Analysis: Assuming lower screening performance, the benefit of adding mammography to MRI increased in both models, although the conclusions about preferred starting age remained unchanged. Limitation: Elevated breast cancer risk was based on survivors diagnosed with childhood cancer between 1970 and 1986. Conclusion: Early initiation (at ages 25 to 30 years) of annual breast cancer screening with MRI, with or without mammography, might reduce breast cancer mortality by half or more in survivors of childhood cancer.	[Yeh, Jennifer M.; Stout, Natasha K.] Harvard Med Sch, Boston, MA 02115 USA; [Yeh, Jennifer M.] Boston Childrens Hosp, Boston, MA 02115 USA; [Lowry, Kathryn P.] Univ Washington, Seattle, WA 98195 USA; [Schechter, Clyde B.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Diller, Lisa R.] Dana Farber Boston Childrens Canc & Blood Disorde, 450 Brookline Ave, Boston, MA 02115 USA; [Alagoz, Oguzhan; Hampton, John M.; Trentham-Dietz, Amy] Univ Wisconsin, 1513 Univ Ave, Madison, WI 53706 USA; [Armstrong, Gregory T.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Leisenring, Wendy] Univ Wisconsin, Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Liu, Qi] Univ Alberta, 11405 87th Ave, Edmonton, AB T6G 1C9, Canada; [Mandelblatt, Jeanne S.] Georgetown Univ, Washington, DC USA; [Miglioretti, Diana L.] Univ Calif Davis, Sch Med, Davis, CA 95616 USA; [Moskowitz, Chaya S.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Oeffinger, Kevin C.] Duke Canc Inst, 2424 Erwin Dr,Suite 601, Durham, NC 27705 USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; [Yeh, Jennifer M.] Harvard Med Sch, Div Gen Pediat, Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA; [Lowry, Kathryn P.] Univ Washington, Seattle Canc Care Alliance, 825 Eastlake Ave East, Seattle, WA 98109 USA; [Schechter, Clyde B.] Albert Einstein Coll Med, Dept Family & Social Med, 1300 Morris Pk Ave,Block Bldg 406, Bronx, NY 10461 USA; [Hampton, John M.; Trentham-Dietz, Amy] Univ Wisconsin, Dept Population Hlth Sci, 610 Walnut St,WARF Room 307, Madison, WI 53726 USA; [Hampton, John M.; Trentham-Dietz, Amy] Univ Wisconsin, Carbone Canc Ctr, 610 Walnut St,WARF Room 307, Madison, WI 53726 USA; [Armstrong, Gregory T.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Leisenring, Wendy] Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave North, Seattle, WA 98109 USA; [Mandelblatt, Jeanne S.] Georgetown Univ, Lombardi Comprehens Canc Ctr, 3300 Whitehaven St Northwest,Suite 4100, Washington, DC 20007 USA; [Miglioretti, Diana L.] Univ Calif Davis, Dept Publ Hlth Sci, Sch Med, One Shields Ave,Med Sci 1C,Room 145, Davis, CA 95616 USA; [Moskowitz, Chaya S.] Mem Sloan Kettering Canc Ctr, 485 Lexington Ave,2nd Floor, New York, NY 10017 USA; [Stout, Natasha K.] Harvard Med Sch, Dept Populat Med, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Landmark Ctr, 401 Pk Dr,Suite 401, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; University of Wisconsin System; University of Wisconsin Madison; St Jude Children's Research Hospital; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Alberta; Georgetown University; University of California System; University of California Davis; Memorial Sloan Kettering Cancer Center; Duke University; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Yeshiva University; Albert Einstein College of Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; St Jude Children's Research Hospital; Fred Hutchinson Cancer Center; Georgetown University; University of California System; University of California Davis; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Yeh, JM (corresponding author), Boston Childrens Hosp, Div Gen Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	jennifer.yeh@childrens.harvard.edu	Armstrong, Gregory/N-8096-2018	Liu, Qi/0000-0002-7208-515X; Leisenring, Wendy/0000-0001-7405-0906; Schechter, Clyde/0000-0003-0010-2827	American Cancer Society [RSG-16-018-01-CPHPS]; National Institutes of Health; National Cancer Institute at the National Institutes of Health [U01CA199218, U24CA55727, R01CA134722]; Cancer Center Support grant [CA21765]; American Lebanese Syrian Associated Charities	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	American Cancer Society and National Institutes of Health.; By the American Cancer Society (Research Scholar Grant RSG-16-018-01-CPHPS [J.M. Yeh, Principal Investigator]) and National Cancer Institute at the National Institutes of Health (grants U01CA199218 [J.S. Mandelblatt, C.B. Schechter, and A. Trentham-Dietz, Principal Investigators], U24CA55727 [G.T. Armstrong, Principal Investigator], and R01CA134722 [K.C. Oeffinger and J. Ford, Principal Investigators]). St. Jude Children's Research Hospital also is supported by Cancer Center Support grant CA21765 (C. Roberts, Principal Investigator) and the American Lebanese Syrian Associated Charities.	Alagoz O, 2018, MED DECIS MAKING, V38, p3S, DOI 10.1177/0272989X17737507; Alagoz O, 2018, MED DECIS MAKING, V38, p99S, DOI 10.1177/0272989X17711927; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Armstrong GT, 2016, NEW ENGL J MED, V374, P833, DOI 10.1056/NEJMoa1510795; Best T, 2011, NAT MED, V17, P941, DOI 10.1038/nm.2407; Caro JJ, 2012, VALUE HEALTH, V15, P796, DOI 10.1016/j.jval.2012.06.012; Chiarelli AM, 2020, JNCI-J NATL CANCER I, V112, P136, DOI 10.1093/jnci/djz079; Children's Oncology Group, 2020, LONG TERM FOLL UP GU; Conant EF, 2019, JAMA ONCOL, V5, P635, DOI 10.1001/jamaoncol.2018.7078; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Ehrhardt MJ, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.18.01099; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Elkin EB, 2011, J CLIN ONCOL, V29, P2466, DOI 10.1200/JCO.2010.32.4079; Furzer J, 2020, JNCI-J NATL CANCER I, V112, P63, DOI 10.1093/jnci/djz037; Gangnon RE, 2018, MED DECIS MAKING, V38, p24S, DOI 10.1177/0272989X17717981; Gangnon RE, 2015, CANCER EPIDEM BIOMAR, V24, P905, DOI 10.1158/1055-9965.EPI-14-1286; Habbema JDF, 2014, ANN INTERN MED, V161, P812, DOI 10.7326/M14-0845; Henderson TO, 2016, J CLIN ONCOL, V34, P910, DOI 10.1200/JCO.2015.62.3314; Henderson TO, 2010, ANN INTERN MED, V152, P444, DOI 10.7326/0003-4819-152-7-201004060-00009; Hodgson DC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw010; Institute of Medicine and National Research Council, 2005, CANC PATIENT CANC SU; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Lee JM, 2017, RADIOLOGY, V285, P44, DOI 10.1148/radiol.2017162033; Lowry KP, 2020, JNCI-J NATL CANCER I, V112, P582, DOI 10.1093/jnci/djz184; Mandelblatt JCK, 2015, AHRQ PUBLICATION; Mandelblatt JS, 2018, MED DECIS MAKING, V38, p9S, DOI 10.1177/0272989X17700624; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Mariotto A, CANC EPIDEMIOL BIOMA; Mariotto Angela B., 2020, Journal of the National Cancer Institute Monographs, P22, DOI 10.1093/jncimonographs/lgz032; Milano MT, 2010, J CLIN ONCOL, V28, P5088, DOI 10.1200/JCO.2010.29.5683; Monticciolo DL, 2018, J AM COLL RADIOL, V15, P408, DOI 10.1016/j.jacr.2017.11.034; Morton LM, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx058; Moskowitz CS, 2019, J CLIN ONCOL, V37, P2120, DOI 10.1200/JCO.18.02219; Moskowitz CS, 2014, J CLIN ONCOL, V32, P2217, DOI 10.1200/JCO.2013.54.4601; Mulder RL, 2013, LANCET ONCOL, V14, pE621, DOI 10.1016/S1470-2045(13)70303-6; Munoz DF, 2018, MED DECIS MAKING, V38, p32S, DOI 10.1177/0272989X17743236; Nathan PC, 2013, J CANCER SURVIV, V7, P275, DOI 10.1007/s11764-013-0271-0; National Comprehensive Cancer Network, 2019, NCCN CLIN PRACT GUID; NCCN, 2020, BREAST CANC; Neumann PJ, 2000, HEALTH AFFAIR, V19, P92, DOI 10.1377/hlthaff.19.2.92; Neumann PJ., 2017, COST EFFECTIVENESS H, V2; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Oeffinger KC, 2019, J CLIN ONCOL, V37, P2131, DOI 10.1200/JCO.19.00547; Owens DK, 2016, ANN INTERN MED, V165, P501, DOI 10.7326/M15-2531; Park ER, 2017, JAMA INTERN MED, V177, P1855, DOI 10.1001/jamainternmed.2017.5047; Phi XA, 2015, J CLIN ONCOL, V33, P349, DOI 10.1200/JCO.2014.56.6232; Phillips SM, 2015, CANCER EPIDEM BIOMAR, V24, P653, DOI 10.1158/1055-9965.EPI-14-1418; Plevritis SK, 2018, JAMA-J AM MED ASSOC, V319, P154, DOI 10.1001/jama.2017.19130; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schechter CB, 2018, MED DECIS MAKING, V38, p66S, DOI 10.1177/0272989X17698685; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Stout NK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju092; Suh E, 2014, ANN INTERN MED, V160, P11, DOI 10.7326/M13-1941; Teepen JC, 2017, J CLIN ONCOL, V35, P2288, DOI 10.1200/JCO.2016.71.6902; Turcotte LM, 2017, JAMA-J AM MED ASSOC, V317, P814, DOI 10.1001/jama.2017.0693; van den Broek JJ, 2018, MED DECIS MAKING, V38, p112S, DOI 10.1177/0272989X17743244; van den Broek JJ, 2018, MED DECIS MAKING, V38, p140S, DOI 10.1177/0272989X17718168; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Yan AP, 2020, J CLIN ONCOL, V38, P1711, DOI 10.1200/JCO.19.01825; Yeh JM, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw046; Yeh JM, 2020, JAMA ONCOL, DOI [10.1001/jamaoncol.2019.5582, DOI 10.1001/JAMA0NC0L.2019.5582]	62	12	12	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2020	173	5					331	+		10.7326/M19-3481	http://dx.doi.org/10.7326/M19-3481			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9XI	32628531	Green Accepted			2022-12-28	WOS:000567080900007
J	Lee, CG; Cefalu, WT				Lee, Christine G.; Cefalu, William T.			The Right Diabetes Medication for the Right Patient for the Right Outcome: Can a Network Meta-analysis Help Us Decide?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lee, Christine G.; Cefalu, William T.] NIDDK, NIH, 6707 Democracy Blvd,Room 7217, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Lee, CG (corresponding author), NIDDK, NIH, 6707 Democracy Blvd,Room 7217, Bethesda, MD 20892 USA.	Christine.lee2@nih.gov		Lee, Christine/0000-0001-5637-8924				Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS66, DOI 10.2337/dc20-S006; American Diabetes Association, 2020, Diabetes Care, V43, pS98, DOI 10.2337/dc20-S009; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Karagiannis T, 2020, J GEN INTERN MED, DOI 10.1007/s11606-019-05608-0; Kent DM, 2020, ANN INTERN MED, V172, pW1, DOI 10.7326/M18-3668; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Riley RD, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3932; Tsapas A, 2020, ANN INTERN MED, V173, P278, DOI 10.7326/M20-0864; Zheng SL, 2018, JAMA-J AM MED ASSOC, V319, P1580, DOI 10.1001/jama.2018.3024	9	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2020	173	4					311	+		10.7326/M20-4266	http://dx.doi.org/10.7326/M20-4266			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9TG	32598225				2022-12-28	WOS:000567070300025
J	Markenscoff-Papadimitriou, E; Whalen, S; Przytycki, P; Thomas, R; Binyameen, F; Nowakowski, TJ; Kriegstein, AR; Sanders, SJ; State, MW; Pollard, KS; Rubenstein, JL				Markenscoff-Papadimitriou, Eirene; Whalen, Sean; Przytycki, Pawel; Thomas, Reuben; Binyameen, Fadya; Nowakowski, Tomasz J.; Kriegstein, Arnold R.; Sanders, Stephan J.; State, Matthew W.; Pollard, Katherine S.; Rubenstein, John L.			A Chromatin Accessibility Atlas of the Developing Human Telencephalon	CELL			English	Article							SUBCORTICAL PROJECTION NEURONS; TRANSCRIPTIONAL REGULATION; GENOMIC ANALYSIS; CEREBRAL-CORTEX; ENHANCERS; SPECIFICATION; ARCHITECTURE; TRANSLATION; MUTATIONS; ELEMENTS	To discover regulatory elements driving the specificity of gene expression in different cell types and regions of the developing human brain, we generated an atlas of open chromatin from nine dissected regions of the mid-gestation human telencephalon, as well as microdissected upper and deep layers of the prefrontal cortex. We identified a subset of open chromatin regions (OCRs), termed predicted regulatory elements (pREs), that are likely to function as developmental brain enhancers. pREs showed temporal, regional, and laminar differences in chromatin accessibility and were correlated with gene expression differences across regions and gestational ages. We identified two functional de novo variants in a pRE for autismrisk gene SLC6A1, and using CRISPRa, demonstrated that this pRE regulates SCL6A1. Additionally, mouse transgenic experiments validated enhancer activity for pREs proximal to FEZF2 and BCL11A. Thus, this atlas serves as a resource for decoding neurodevelopmental gene regulation in health and disease.	[Markenscoff-Papadimitriou, Eirene; Binyameen, Fadya; Nowakowski, Tomasz J.; Sanders, Stephan J.; State, Matthew W.; Rubenstein, John L.] Univ Calif San Francisco, Langley Porter Psychiat Inst, Dept Psychiat, UCSF Weill Inst Neurosci, San Francisco, CA 94115 USA; [Whalen, Sean; Przytycki, Pawel; Thomas, Reuben; Pollard, Katherine S.] Gladstone Inst, San Francisco, CA 94158 USA; [Nowakowski, Tomasz J.; Pollard, Katherine S.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Sanders, Stephan J.; Pollard, Katherine S.] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA; [Sanders, Stephan J.; Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Quantitat Biol Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rubenstein, JL (corresponding author), Univ Calif San Francisco, Langley Porter Psychiat Inst, Dept Psychiat, UCSF Weill Inst Neurosci, San Francisco, CA 94115 USA.; Pollard, KS (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Pollard, KS (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Pollard, KS (corresponding author), Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA.; Pollard, KS (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.; Pollard, KS (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA.; Pollard, KS (corresponding author), Univ Calif San Francisco, Quantitat Biol Inst, San Francisco, CA 94143 USA.	katherine.pollard@gladstone.ucsf.edu; john.rubenstein@ucsf.edu	State, Matthew/W-2256-2019	State, Matthew/0000-0003-1624-8302	NIH [R01NS099099, R01MH049428]; NIMH [R01 MH109907, U01 MH116438, U01 MH105989]; Nina Ireland	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Nina Ireland	ATAC-seq and ChIP-seq datasets for early neural differentiation time points were provided by the Ahituv lab (Inoue et al., 2018). This work was supported by the research grants from Nina Ireland (to J.L.R.), NIH (R01NS099099 and R01MH049428 to J.L.R.), and NIMH (R01 MH109907 and U01 MH116438 to K.S.P. and U01 MH105989 to A.R.K.).	Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; An JY, 2018, SCIENCE, V362, P1270, DOI 10.1126/science.aat6576; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cavalcante RG, 2017, BIOINFORMATICS, V33, P2381, DOI 10.1093/bioinformatics/btx183; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de la Torre-Ubieta L, 2018, CELL, V172, P289, DOI 10.1016/j.cell.2017.12.014; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dickel DE, 2018, CELL, V172, P491, DOI 10.1016/j.cell.2017.12.017; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Erwin GD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003677; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Golonzhka O, 2015, NEURON, V88, P1192, DOI 10.1016/j.neuron.2015.10.045; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heyne HO, 2018, NAT GENET, V50, P1048, DOI 10.1038/s41588-018-0143-7; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Inoue F., 2018, MASSIVELY PARALLEL C, DOI [10.1101/370452, DOI 10.1101/370452]; Katayama Y, 2016, NATURE, V537, P675, DOI 10.1038/nature19357; Korb E, 2017, CELL, V170, P1209, DOI 10.1016/j.cell.2017.07.033; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Lee J., 2016, KUNDAJELAB ATAC DNAS; Li MF, 2018, SCIENCE, V362, P1264, DOI 10.1126/science.aat7615; Li Q., 2014, IDR IRREPRODUCIBLE D; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Matharu N, 2019, SCIENCE, V363, P246, DOI 10.1126/science.aau0629; McKinney W., 2012, PYTHON DATA ANAL DAT; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Meuleman W., 2019, INDEX BIOL SPECTRUM, DOI [10.1101/822510, DOI 10.1101/822510]; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Nowakowski TJ, 2016, NEURON, V91, P1219, DOI 10.1016/j.neuron.2016.09.005; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pattabiraman K, 2014, NEURON, V82, P989, DOI 10.1016/j.neuron.2014.04.014; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2009, R LANG ENV STAT COMP; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Rubenstein J., 2013, NEURAL CIRCUIT DEV F; Rubenstein J.L.R., 2013, NEUROGENESIS BASAL G; Sandberg M, 2018, NEURAL DEV, V13, DOI 10.1186/s13064-018-0119-4; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Sestan N, 2018, NEURON, V100, P406, DOI 10.1016/j.neuron.2018.10.015; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silberberg SN, 2016, NEURON, V92, P59, DOI 10.1016/j.neuron.2016.09.027; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Tucker ES, 2008, J NEUROSCI, V28, P9504, DOI 10.1523/JNEUROSCI.2341-08.2008; Velmeshev D, 2019, SCIENCE, V364, P685, DOI 10.1126/science.aav8130; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Werling DM, 2018, NAT GENET, V50, P727, DOI 10.1038/s41588-018-0107-y; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	77	26	26	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					754	+		10.1016/j.cell.2020.06.002	http://dx.doi.org/10.1016/j.cell.2020.06.002			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32610082	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000558649000019
J	Kavanagh, MM; Katz, IT; Holmes, CB				Kavanagh, Matthew M.; Katz, Ingrid T.; Holmes, Charles B.			Reckoning with mortality: global health, HIV, and the politics of data	LANCET			English	Editorial Material									[Kavanagh, Matthew M.] Georgetown Univ, Dept Int Hlth, Washington, DC 20057 USA; [Kavanagh, Matthew M.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Holmes, Charles B.] Georgetown Univ, Ctr Innovat Global Hlth, Washington, DC USA; [Katz, Ingrid T.] Harvard Univ, Harvard Global Hlth Inst, Boston, MA 02115 USA; [Katz, Ingrid T.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Holmes, Charles B.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Georgetown University; Georgetown University; Georgetown University; Harvard University; Harvard University; Harvard Medical School; Johns Hopkins University	Kavanagh, MM (corresponding author), Georgetown Univ, Dept Int Hlth, Washington, DC 20057 USA.	matthew.kavanagh@georgetown.edu						[Anonymous], 2019, PRESIDENTS EMERGENCY; Geng EH, 2015, LANCET HIV, V2, pE107, DOI 10.1016/S2352-3018(15)00002-8; Haachambwa L, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz336; Haas AD, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25084; Holmes CB, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002489; Institute for Health Metrics and Evaluation, 2019, GLOB BURD DIS COMP; Jerven M, 2018, LANCET, V392, P468, DOI 10.1016/S0140-6736(18)31700-8; Jha P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-19; Koblinsky M, 2017, GLOB HEALTH-SCI PRAC, V5, P333, DOI 10.9745/GHSP-D-17-00308; Labhardt ND, 2011, TROP MED INT HEALTH, V16, P1276, DOI 10.1111/j.1365-3156.2011.02827.x; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Meintjes G, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002269; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Ousley J, 2018, CLIN INFECT DIS, V66, pS126, DOI 10.1093/cid/ciy103; Serbanescu F, 2019, GLOB HEALTH-SCI PRAC, V7, pS27, DOI 10.9745/GHSP-D-18-00428; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shringarpure KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132543; Tichenor Marlee, 2019, Wellcome Open Res, V4, P35, DOI 10.12688/wellcomeopenres.15011.2; UNAIDS, 2019, AIDS INF; UNAIDS, 2019, 2019 GLOB AIDS UPD C; UNICEF, 2018, FUT WOM CHILDR UNICE; World Health Organization (WHO), 2017, GUIDELINES MANAGING	22	7	7	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2020	396	10246					288	290		10.1016/S0140-6736(20)31046-1	http://dx.doi.org/10.1016/S0140-6736(20)31046-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK8ZY	32628903	Bronze, Green Published			2022-12-28	WOS:000567020100019
J	King, T; Hewitt, B; Crammond, B; Sutherland, G; Maheen, H; Kavanagh, A				King, Tania; Hewitt, Belinda; Crammond, Bradley; Sutherland, Georgina; Maheen, Humaira; Kavanagh, Anne			Reordering gender systems: can COVID-19 lead to improved gender equality and health?	LANCET			English	Editorial Material							WORK; SUPPORT; FATHERS		[King, Tania; Crammond, Bradley; Sutherland, Georgina; Maheen, Humaira; Kavanagh, Anne] Univ Melbourne, Ctr Hlth Equ, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Hewitt, Belinda] Univ Melbourne, Sch Social & Polit Sci, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne	King, T (corresponding author), Univ Melbourne, Ctr Hlth Equ, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia.	tking@unimelb.edu.au		Kavanagh, Anne/0000-0002-1573-3464; King, Tania/0000-0002-1201-2485; Maheen, Humaira/0000-0002-7474-7727				Alon T, 2020, NBER WORKING PAPER S; [Anonymous], 2019, GENDER EQUITY HLTH W; Brandth B, 2019, COMMIMITY WORK FAM, V22, P43, DOI 10.1080/13668803.2018.1472067; Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557; Heise L, 2019, LANCET, V393, P2440, DOI 10.1016/S0140-6736(19)30652-X; Heymann J, 2019, LANCET, V393, P2522, DOI 10.1016/S0140-6736(19)30656-7; International Labor Organization, 2020, COVID 19 RESP GETT G; International Labour Organization, 2019, ORG WORLD EMPL SOC O; Kushi S, 2018, COMP EUR POLIT, V16, P434, DOI 10.1057/cep.2016.21; Marchand A, 2016, SOC SCI MED, V166, P160, DOI 10.1016/j.socscimed.2016.08.021; Mathers CD, 1998, MED J AUSTRALIA, V168, P178, DOI 10.5694/j.1326-5377.1998.tb126776.x; Moran J, 2019, COMMIMITY WORK FAM, V22, P111, DOI 10.1080/13668803.2018.1470966; Pearse R, 2016, FEM ECON, V22, P30, DOI 10.1080/13545701.2015.1078485; Perales F, 2013, WORK EMPLOY SOC, V27, P600, DOI 10.1177/0950017012460305; Ray R, 2010, J EUR SOC POLICY, V20, P196, DOI 10.1177/0958928710364434; Rubery J, 2015, SOC POLIT, V22, P513, DOI 10.1093/sp/jxv036; Saraceno C, 2011, DEMOGR RES, V25, P371, DOI 10.4054/DemRes.2011.25.11; Sullivan O, 2019, NAT HUM BEHAV, V3, P201, DOI 10.1038/s41562-019-0536-3; Waring M, 2003, CAR WORK CAR JOBS FU, V11, P35, DOI 10.1080/741954251	19	38	38	3	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2020	396	10244					80	81		10.1016/S0140-6736(20)31418-5	http://dx.doi.org/10.1016/S0140-6736(20)31418-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2JY	32569582	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000552724600007
J	Kalluri, P				Kalluri, Pratyusha			Don't ask if artificial intelligence is good or fair, ask how it shifts power	NATURE			English	Editorial Material									[Kalluri, Pratyusha] Stanford Univ, Radical AI Network, Stanford, CA 94305 USA	Stanford University	Kalluri, P (corresponding author), Stanford Univ, Radical AI Network, Stanford, CA 94305 USA.	pkalluri@stanford.edu							0	48	48	3	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					169	169		10.1038/d41586-020-02003-2	http://dx.doi.org/10.1038/d41586-020-02003-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MH5OK	32636520				2022-12-28	WOS:000546778100001
J	Flies, AS				Flies, Andrew S.		Wild Comparative Immunology Consor	Rewilding immunology	SCIENCE			English	Editorial Material									[Flies, Andrew S.] Univ Tasmania, Menzies Inst Med Res, Coll Hlth & Med, Hobart, Tas 7000, Australia	University of Tasmania; Menzies Institute for Medical Research	Flies, AS (corresponding author), Univ Tasmania, Menzies Inst Med Res, Coll Hlth & Med, Hobart, Tas 7000, Australia.	andy.flies@utas.edu.au	Flies, Andrew S/Q-7535-2018; Rossjohn, Jamie/F-9032-2013; Peters, Anne/A-1821-2010	Flies, Andrew S/0000-0002-4550-1859; Le Nours, Jerome/0000-0002-2221-7636; Rossjohn, Jamie/0000-0002-2020-7522; Power, Michelle/0000-0003-3160-4301; Peters, Anne/0000-0001-8071-0560	Menzies Institute for Medical Research at the University of Tasmania; Australian Research Council Centre of Excellence for Advanced Molecular Imaging; Department of Biochemistry and Molecular Biology at Monash University; Millennium Bioscience	Menzies Institute for Medical Research at the University of Tasmania; Australian Research Council Centre of Excellence for Advanced Molecular Imaging(Australian Research Council); Department of Biochemistry and Molecular Biology at Monash University; Millennium Bioscience	The 2019 Wild and Comparative Immunology workshop (www.wacimmuno.com) was supported by the Menzies Institute for Medical Research at the University of Tasmania, the Australian Research Council Centre of Excellence for Advanced Molecular Imaging, the Department of Biochemistry and Molecular Biology at Monash University, and Millennium Bioscience.We thank E. Flies for comments and edits on the manuscript and all participants in the 2019 Wild and Comparative workshop.	Abolins S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14811; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; DARZYNKIEWICZ Z, 1988, CELL TISSUE KINET, V21, P169, DOI 10.1111/j.1365-2184.1988.tb00855.x; Flies AS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba5031; Flies AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137679; Fountain-Jones NM, 2018, BIOL REV, V93, P950, DOI 10.1111/brv.12380; Grogan LF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02536; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Leung JM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004108; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Vaughan AN, 2000, J IMMUNOL, V165, P3175, DOI 10.4049/jimmunol.165.6.3175; Watson J, 2011, REV SCI TECH OIE, V30, P87; Wrapp D, 2020, CELL, V181, P1004, DOI 10.1016/j.cell.2020.04.031	15	14	14	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					37	+		10.1126/science.abb8664	http://dx.doi.org/10.1126/science.abb8664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MK4IZ	32631885				2022-12-28	WOS:000548751700037
J	Huang, XY; Zhang, RP				Huang, Xiaoyan; Zhang, Ruiping			Zebra Bodies in the Kidney	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huang, Xiaoyan; Zhang, Ruiping] Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China	University of Hong Kong	Huang, XY (corresponding author), Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China.	huangxy@hku-szh.org	Huang, Xiaoyan/AAU-7670-2020; Zhang, Rui/GXN-3801-2022	Huang, Xiaoyan/0000-0002-7959-423X; 					0	1	1	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1							e2	10.1056/NEJMicm1912889	http://dx.doi.org/10.1056/NEJMicm1912889			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2UD	32609984				2022-12-28	WOS:000552751800017
J	Jehan, F; Nisar, I; Kerai, S; Balouch, B; Brown, N; Rahman, N; Rizvi, A; Shafiq, Y; Zaidi, AKM				Jehan, Fyezah; Nisar, Imran; Kerai, Salima; Balouch, Benazir; Brown, Nick; Rahman, Najeeb; Rizvi, Arjumand; Shafiq, Yasir; Zaidi, Anita K. M.			Randomized Trial of Amoxicillin for Pneumonia in Pakistan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDHOOD PNEUMONIA; ORAL AMOXICILLIN; YOUNG-CHILDREN; MULTICENTER; ETIOLOGY; BURDEN	BACKGROUND The World Health Organization (WHO) recommends oral amoxicillin for patients who have pneumonia with tachypnea, yet trial data indicate that not using amoxicillin to treat this condition may be noninferior to using amoxicillin. METHODS We conducted a double-blind, randomized, placebo-controlled noninferiority trial involving children at primary health care centers in low-income communities in Karachi, Pakistan. Children who were 2 to 59 months of age and who met WHO criteria for nonsevere pneumonia with tachypnea were randomly assigned to a 3-day course of a suspension of amoxicillin (the active control) of 50 mg per milliliter or matched volume of placebo (the test regimen), according to WHO weight bands (500 mg every 12 hours for a weight of 4 to <10 kg, 1000 mg every 12 hours for a weight of 10 to <14 kg, or 1500 mg every 12 hours for a weight of 14 to <20 kg). The primary outcome was treatment failure during the 3-day course of amoxicillin or placebo. The prespecified noninferiority margin was 1.75 percentage points. RESULTS From November 9, 2014, through November 30, 2017, a total of 4002 children underwent randomization (1999 in the placebo group and 2003 in the amoxicillin group). In the per-protocol analysis, the incidence of treatment failure was 4.9% among placebo recipients (95 of 1927 children) and 2.6% among amoxicillin recipients (51 of 1929 children) (between-group difference, 2.3 percentage points; 95% confidence interval [CI], 0.9 to 3.7). Results were similar in the intention-to-treat analysis. The presence of fever and wheeze predicted treatment failure. The number needed to treat to prevent one treatment failure was 44 (95% CI, 31 to 80). One patient (<0.1%) in each group died. Relapse occurred in 40 children (2.2%) in the placebo group and in 58 children (3.1%) in the amoxicillin group. CONCLUSIONS Among children younger than 5 years of age with nonsevere pneumonia, the frequency of treatment failure was higher in the placebo group than in the amoxicillin group, a difference that did not meet the noninferiority margin for placebo.	[Jehan, Fyezah; Nisar, Imran; Kerai, Salima; Balouch, Benazir; Brown, Nick; Rahman, Najeeb; Rizvi, Arjumand; Shafiq, Yasir; Zaidi, Anita K. M.] Aga Khan Univ, Karachi, Pakistan; [Brown, Nick] Uppsala Univ, Uppsala, Sweden; [Zaidi, Anita K. M.] Bill & Melinda Gates Fdn, Seattle, WA USA	Aga Khan University; Uppsala University; Bill & Melinda Gates Foundation	Jehan, F (corresponding author), Aga Khan Univ, Dept Pediat & Child Hlth, Stadium Rd,POB 3500, Karachi 74800, Pakistan.	fyezah.jehan@aku.edu	kerai, Salima/ACH-5247-2022	kerai, Salima/0000-0003-0912-9057; Nisar, Muhammad Imran/0000-0002-2378-4720	Department for International Development; Medical Research Council; Wellcome; MRC [MR/L004283/1] Funding Source: UKRI	Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Joint Global Health Trials Scheme [of the Department for International Development, Medical Research Council, and Wellcome] and others; RETAPP ClinicalTrials.gov number, NCT02372461.	Awasthi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001991; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Downie L, 2013, ARCH DIS CHILD, V98, P146, DOI 10.1136/archdischild-2012-302033; Enoch AJ, 2016, ARCH DIS CHILD, V101, P694, DOI 10.1136/archdischild-2015-309638; Escadafal C, 2016, INT J INFECT DIS, V53, P26, DOI 10.1016/j.ijid.2016.11.073; Ginsburg AS, 2019, JAMA PEDIATR, V173, P21, DOI 10.1001/jamapediatrics.2018.3407; Grant GB, 2009, LANCET INFECT DIS, V9, P185, DOI 10.1016/S1473-3099(09)70044-1; Hay AD, 2016, LANCET RESP MED, V4, P902, DOI 10.1016/S2213-2600(16)30223-5; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; Isaacs D, 2013, ARCH DIS CHILD, V98, P90, DOI 10.1136/archdischild-2012-303111; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Kerai S, 2019, AM J TROP MED HYG, V101, P1034, DOI 10.4269/ajtmh.18-0656; Leung DT, 2016, PEDIATR CLIN N AM, V63, P67, DOI 10.1016/j.pcl.2015.08.003; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; McAllister DA, 2019, LANCET GLOB HEALTH, V7, pE47, DOI 10.1016/S2214-109X(18)30408-X; MULHOLLAND EK, 1992, PEDIATR INFECT DIS J, V11, P77, DOI 10.1097/00006454-199202000-00004; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Picot VS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0635-8; Torrazza RM, 2011, J PERINATOL, V31, pS29, DOI 10.1038/jp.2010.172; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; World Health Organization, 2014, REV WHO CLASS TREATM; Zhang SS, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010408	25	20	21	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					24	34		10.1056/NEJMoa1911998	http://dx.doi.org/10.1056/NEJMoa1911998			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ2UD	32609980	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000552751800008
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Admit ethnic minority pregnant women to hospital earlier, says NHS England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2628	10.1136/bmj.m2628	http://dx.doi.org/10.1136/bmj.m2628			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32606048	Bronze			2022-12-28	WOS:000548116400012
J	Gnecchi, M; Moretti, F; Bassi, EM; Leonardi, S; Totaro, R; Perotti, L; Zuccaro, V; Perlini, S; Preda, L; Baldanti, F; Bruno, R; Visconti, LO				Gnecchi, Massimiliano; Moretti, Francesco; Bassi, Emilio Maria; Leonardi, Sergio; Totaro, Rossana; Perotti, Luciano; Zuccaro, Valentina; Perlini, Stefano; Preda, Lorenzo; Baldanti, Fausto; Bruno, Raffaele; Visconti, Luigi Oltrona			Myocarditis in a 16-year-old boy positive for SARS-CoV-2	LANCET			English	Editorial Material									[Gnecchi, Massimiliano; Moretti, Francesco; Leonardi, Sergio; Totaro, Rossana] Fdn IRCCS Policlin San Matteo, Coronary Care Unit, Pavia, Italy; [Gnecchi, Massimiliano; Moretti, Francesco; Leonardi, Sergio; Totaro, Rossana] Fdn IRCCS Policlin San Matteo, Lab Clin & Expt Cardiol, Pavia, Italy; [Bassi, Emilio Maria; Perotti, Luciano] Fdn IRCCS Policlin San Matteo, Radiol Unit, Pavia, Italy; [Perotti, Luciano] Fdn IRCCS Policlin San Matteo, Anaesthesia & Resuscitat Unit, Pavia, Italy; [Zuccaro, Valentina] Fdn IRCCS Policlin San Matteo, Infect Dis Unit, Pavia, Italy; [Perlini, Stefano] Fdn IRCCS Policlin San Matteo, Emergency Dept, Pavia, Italy; [Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Pavia, Italy; [Visconti, Luigi Oltrona] Fdn IRCCS Policlin San Matteo, Cardiol Unit, Pavia, Italy; [Gnecchi, Massimiliano; Moretti, Francesco; Leonardi, Sergio] Univ Pavia, Dept Mol Med, Cardiol Unit, DEA Tower A, I-27100 Pavia, Italy; [Perlini, Stefano] Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy; [Preda, Lorenzo; Baldanti, Fausto; Bruno, Raffaele] Univ Pavia, Dept Clin Surg Diagnost & Paediat Sci, Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; University of Pavia	Gnecchi, M (corresponding author), Univ Pavia, Dept Mol Med, Cardiol Unit, DEA Tower A, I-27100 Pavia, Italy.	m.gnecchi@unipv.it	PREDA, LORENZO/AAC-1969-2019; Gnecchi, Massimiliano/X-7095-2019; Baldanti, Fausto/J-4924-2018; Gnecchi, Massimiliano/J-8609-2018; Moretti, Francesco/AAX-2056-2020; Bruno, Raffaele/AAB-9491-2022	PREDA, LORENZO/0000-0002-5479-2766; Gnecchi, Massimiliano/0000-0001-7435-4328; Baldanti, Fausto/0000-0002-3358-8969; Gnecchi, Massimiliano/0000-0001-7435-4328; Moretti, Francesco/0000-0002-3013-4195; Bruno, Raffaele/0000-0002-0235-9207; Perotti, Luciano/0000-0002-3503-3967					0	33	34	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2020	395	10242					E116	E116						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MJ0ZZ	32593338	Green Published, Bronze			2022-12-28	WOS:000547825600002
J	Davies, MB				Davies, Melvyn B.			Multiple, quiet, and close by	SCIENCE			English	Editorial Material									[Davies, Melvyn B.] Lund Univ, Lund Observ, Dept Astron & Theoret Phys, Lund, Sweden	Lund University	Davies, MB (corresponding author), Lund Univ, Lund Observ, Dept Astron & Theoret Phys, Lund, Sweden.	mbd@astro.lu.se			Knut and Alice Wallenberg Foundation [2014.0017]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	M.B.D. is supported by the project grant 2014.0017 "IMPACT" from the Knut and Alice Wallenberg Foundation.	Coleman GAL, 2016, MON NOT R ASTRON SOC, V457, P2480, DOI 10.1093/mnras/stw149; France K, 2016, ASTROPHYS J, V820, DOI 10.3847/0004-637X/820/2/89; Gillon M, 2017, NATURE, V542, P456, DOI 10.1038/nature21360; Jeffers SV, 2020, SCIENCE, V368, P1477, DOI 10.1126/science.aaz0795; Kreidberg L, 2016, ASTROPHYS J LETT, V832, DOI 10.3847/2041-8205/832/1/L12; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Kempton EMR, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aadf6f; Mulders GD, 2015, ASTROPHYS J, V814, DOI 10.1088/0004-637X/814/2/130; Pu BN, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/44; Snellen IAG, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa7fbc; Weiss LM, 2018, ASTRON J, V155, DOI 10.3847/1538-3881/aa9ff6	12	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1432	1432		10.1126/science.abb0217	http://dx.doi.org/10.1126/science.abb0217			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587010				2022-12-28	WOS:000545264600025
J	Rosenberg, ES				Rosenberg, Eric S.			Case 20-2020: A 7-Year-Old Girl with Severe Psychological Distress after Family Separation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDHOOD; HEALTH											Allen S, 2018, COMMUNICATION   0717; American Academy of Pediatrics, 2014, MED HOM APPR ID RESP; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Amuedo-Dorantes C, 2017, IMMIGRATION ENFORCEM; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; [Anonymous], 2018, NEGL AB UN IMM CHILD; [Anonymous], 2019, NBC NEWS; Capps R., 2016, PROFILE US CHILDREN; Chiedi JM, 2019, UNACCOMPANIED ALIEN; Child Welfare Information Gateway, 2016, DET BEST INT CHILD; Cohen JA, 2008, ARCH PEDIAT ADOL MED, V162, P447, DOI 10.1001/archpedi.162.5.447; Department of Homeland Security Office of Inspector General, 2019, MAN AL DHS NEEDS ADD; Greenberg M., 2019, IMMIGRANT FAMILIES C; Habbach Hajar, 2020, YOU WILL NEVER SEE Y; Halevy-Mizrahi NR, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-2524; La Rooy D, 2015, J CRIMINOL RES POLIC, V1, P76, DOI 10.1108/JCRPP-01-2015-0001; Linton JM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0483; Lustig SL, 2008, J IMMIGR MINOR HEALT, V10, P7, DOI 10.1007/s10903-007-9056-8; MacLean SA, 2019, SOC SCI MED, V230, P303, DOI 10.1016/j.socscimed.2019.04.013; Marsac ML, 2016, JAMA PEDIATR, V170, P70, DOI 10.1001/jamapediatrics.2015.2206; McKenzie KC, 2019, J GEN INTERN MED, V34, P137, DOI 10.1007/s11606-018-4524-5; Miller KK, 2019, CHILDREN-BASEL, V6, DOI 10.3390/children6080094; National Child Traumatic Stress Network, 2019, CREAT TRAUM INF SYST; National Child Traumatic Stress Network Complex Trauma Taskforce, 2003, COMPLEX TRAUMA CHILD; Office of Inspector General, 2019, DHS LACK TECHN NEED; Office of the United Nations High Commissioner for Human Rights, 1999, IST PROT MAN EFF INV; Pynoos RS, 2009, J TRAUMA STRESS, V22, P391, DOI 10.1002/jts.20450; Saxe G.N., 2007, COLLABORATIVE TREATM; Schock K, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.26286; Schweikart Scott J, 2019, AMA J ETHICS, V21, P67; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Substance Abuse and Mental Health Services Administration, 2014, HHS PUBLICATION NO S; Tedeschi FK, 2017, J AM ACAD PSYCHIATRY, V45, P161; The National Child Traumatic Stress Network, TRAUM SEP REF IMM CH; United States Commission on Civil Rights, 2019, TRAUM BORD HUM COST; van den Heuvel LL, 2013, NEUROPSYCHIATRY-LOND, V3, P497, DOI 10.2217/npy.13.61; Winer, 2019, MENTAL HLTH PRACTICE	38	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2557	2565		10.1056/NEJMcpc2002413	http://dx.doi.org/10.1056/NEJMcpc2002413			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9CW	32579817				2022-12-28	WOS:000545636400027
J	Rimmer, A				Rimmer, Abi			Covid-19: Doctors may quit without proper post-pandemic support, defence body warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2476	10.1136/bmj.m2476	http://dx.doi.org/10.1136/bmj.m2476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QD5QH	32571800	Bronze			2022-12-28	WOS:000615571900001
J	Aitken, S; Anderson, C; Connor, F; Consortium, LCE; Semple, C; Lopez-Bigas, N; Flicek, P; Odom, D; Taylor, M				Aitken, S.; Anderson, C.; Connor, F.; Consortium, L. C. E.; Semple, C.; Lopez-Bigas, N.; Flicek, P.; Odom, D.; Taylor, M.			Pervasive lesion segregation shapes cancer genome evolution	VIRCHOWS ARCHIV			English	Meeting Abstract									[Aitken, S.; Anderson, C.; Connor, F.; Consortium, L. C. E.; Semple, C.; Lopez-Bigas, N.; Flicek, P.; Odom, D.; Taylor, M.] Univ Cambridge, Cambridge Inst, Canc Res UK, Cambridge, England; [Aitken, S.; Anderson, C.; Connor, F.; Consortium, L. C. E.; Semple, C.; Lopez-Bigas, N.; Flicek, P.; Odom, D.; Taylor, M.] Univ Cambridge, Dept Pathol, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge			Anderson, Craig/K-2050-2013; Pich, Oriol/M-6865-2015; Taylor, Martin/C-3825-2009	Anderson, Craig/0000-0002-2832-9313; Ewing, Ailith/0000-0002-2272-1277; Lopez-Arribillaga, Erika/0000-0002-9451-6635; Yates, Andrew/0000-0002-8886-4772; Pich, Oriol/0000-0002-1956-1882; Flicek, Paul/0000-0002-3897-7955; Aitken, Sarah/0000-0002-1897-4140; Semple, Colin/0000-0003-1765-4118; Sentis, Ines/0000-0001-8320-9579; Luft, Juliet/0000-0003-2458-9377; Arnedo-Pac, Claudia/0000-0002-2037-8487; Beentjes, Sjoerd Viktor/0000-0002-7998-4262; Taylor, Martin/0000-0001-7656-330X; Kentepozidou, Elissavet/0000-0003-0732-6452	Wellcome Trust PhD Training Fellowship for Clinicians [WT106563/Z/14/Z]; National Institute for Health Research (NIHR) Clinical Lectureship	Wellcome Trust PhD Training Fellowship for Clinicians(Wellcome Trust); National Institute for Health Research (NIHR) Clinical Lectureship(National Institute for Health Research (NIHR))	S.J.A. received a Wellcome Trust PhD Training Fellowship for Clinicians (WT106563/Z/14/Z) and is now funded by a National Institute for Health Research (NIHR) Clinical Lectureship.		0	20	21	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	DEC	2020	477			1		OFP-12-004	S33	S34						2	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	VL0WQ	32581361	Green Accepted, Green Submitted			2022-12-28	WOS:000787261900120
J	Frattaroli, S; Irvin, NA				Frattaroli, Shannon; Irvin, Nathan A.			Extreme Risk Protection Orders in Washington: A Tool for Reducing the Lethality of Dangerous Behaviors	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Frattaroli, Shannon] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Gun Policy & Res, 624 North Broadway, Baltimore, MD 21205 USA; [Irvin, Nathan A.] Johns Hopkins Sch Med, Baltimore, MD USA; [Irvin, Nathan A.] Johns Hopkins Bayview Med Ctr, 4940 Eastern Ave,Suite A-150, Baltimore, MD 21075 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Frattaroli, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Gun Policy & Res, 624 North Broadway, Baltimore, MD 21205 USA.	sfratta1@jhu.edu		Frattaroli, Shannon/0000-0002-2973-277X; Irvin, Nathan/0000-0002-7972-6431				Consortium for Risk Based Firearm Policy, 2013, GUNS PUBL HLTH MENT; McGinty EE, 2014, AM J PUBLIC HEALTH, V104, pE22, DOI 10.2105/AJPH.2014.302171; Rowhani-Rahbar A, 2020, ANN INTERN MED, V173, P342, DOI 10.7326/M20-0594	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2020	173	5					392	+		10.7326/M20-4323	http://dx.doi.org/10.7326/M20-4323			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK9XI	32598222				2022-12-28	WOS:000567080900018
J	Fryhofer, SA; Fryhofer, GW				Fryhofer, Sandra Adamson; Fryhofer, George W.			Vaccination-Induced Bursitis: Technique Matters	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fryhofer, Sandra Adamson] Emory Univ, Sch Med, 3290 Northside Pkwy,Suite 840, Atlanta, GA 30327 USA; [Fryhofer, George W.] Univ Penn, Philadelphia, PA 19104 USA; [Fryhofer, George W.] 3737 Market St, Philadelphia, PA 19104 USA	Emory University; University of Pennsylvania	Fryhofer, SA (corresponding author), Emory Univ, Sch Med, 3290 Northside Pkwy,Suite 840, Atlanta, GA 30327 USA.	sandra@drsandrafryhofer.com	Fryhofer, George/L-1954-2016	Fryhofer, George/0000-0002-8105-0637; Fryhofer, Sandra/0000-0001-5956-4095				Centers for Disease Control and Prevention, 2018, 2016 2017 EST INFL I; Health Resources and Services Administration, 2020, NAT VACC INJ COMP PR; Hesse EM, 2020, ANN INTERN MED, V173, P253, DOI 10.7326/M19-3176; Hesse EM, 2020, VACCINE, V38, P1076, DOI 10.1016/j.vaccine.2019.11.032; Institute of Medine, 2012, ADVERSE EFFECTS VACC; Kroger A, 2017, GEN BEST PRACTICE GU; Shimabukuro T., 2017, REPORTS SHOULDER DYS; Walker-Bone K, 2004, ARTHRIT RHEUM-ARTHR, V51, P642, DOI 10.1002/art.20535	8	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2020	173	4					308	+		10.7326/M20-3302	http://dx.doi.org/10.7326/M20-3302			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9TG	32568575				2022-12-28	WOS:000567070300024
J	Li, QK; Chen, Q; Klauser, PC; Li, MY; Zheng, F; Wang, NX; Li, XY; Zhang, QB; Fu, XM; Wang, Q; Xu, Y; Wang, L				Li, Qingke; Chen, Qu; Klauser, Paul C.; Li, Mengyuan; Zheng, Feng; Wang, Nanxi; Li, Xiaoying; Zhang, Qianbing; Fu, Xuemei; Wang, Qian; Xu, Yang; Wang, Lei			Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics	CELL			English	Article							MODIFIED T-CELLS; PD-1/PD-L1 INTERACTION; STRUCTURAL BASIS; HUMANIZED MICE; CROSS-LINKING; GENETIC-CODE; IMMUNOTHERAPY; BINDING; EPHA2; PD-1	Small molecule covalent drugs provide desirable therapeutic properties over noncovalent ones for treating challenging diseases. The potential of covalent protein drugs, however, remains unexplored due to protein's inability to bind targets covalently. We report a proximity-enabled reactive therapeutics (PERx) approach to generate covalent protein drugs. Through genetic code expansion, a latent bioreactive amino acid fluorosulfate-L-tyrosine (FSY) was incorporated into human programmed cell death protein-1 (PD-1). Only when PD-1 interacts with PD-L1 did the FSY react with a proximal histidine of PD-L1 selectively, enabling irreversible binding of PD-1 to only PD-L1 in vitro and in vivo. When administrated in immune-humanized mice, the covalent PD-1(FSY) exhibited strikingly more potent antitumor effect over the noncovalent wild-type PD-1, attaining therapeutic efficacy equivalent or superior to anti-PD-L1 antibody. PERx should provide a general platform technology for converting various interacting proteins into covalent binders, achieving specific covalent protein targeting for biological studies and therapeutic capability unattainable with conventional noncovalent protein drugs.	[Li, Qingke; Chen, Qu; Li, Mengyuan; Li, Xiaoying; Zhang, Qianbing; Xu, Yang] Southern Med Univ, Guangdong Prov Key Lab Canc Immunotherapy, Canc Res Inst, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China; [Li, Qingke; Li, Mengyuan; Zheng, Feng; Wang, Qian] Chinese Acad Sci, Tech Inst Phys & Chem, Hangzhou Res Inst, Hangzhou 310018, Peoples R China; [Klauser, Paul C.; Wang, Nanxi; Wang, Lei] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Klauser, Paul C.; Wang, Nanxi; Wang, Lei] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Chen, Qu; Fu, Xuemei; Xu, Yang] Sun Yat Sen Univ, Affiliated Hosp 8, Shenzhen 518033, Guangdong, Peoples R China	Southern Medical University - China; Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Sun Yat Sen University	Xu, Y (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Canc Immunotherapy, Canc Res Inst, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China.; Wang, Q (corresponding author), Chinese Acad Sci, Tech Inst Phys & Chem, Hangzhou Res Inst, Hangzhou 310018, Peoples R China.; Wang, L (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.; Wang, L (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.; Xu, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 8, Shenzhen 518033, Guangdong, Peoples R China.	qianwang@mail.ipc.ac.cn; xuyang65@mail.sysu.edu.cn; lei.wang2@ucsf.edu	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022; Wang, Lei/E-7912-2011	Wang, Lei/0000-0002-5859-2526; Qingke, Li/0000-0002-3889-8827; Xu, Yang/0000-0001-5574-921X; Klauser, Paul/0000-0001-7900-7659	Zhejiang Public Welfare Technology and Application Research Program [LGF19H300002]; Shenzhen Sanming Project of Medicine [SZSM201602102]	Zhejiang Public Welfare Technology and Application Research Program; Shenzhen Sanming Project of Medicine	Q.W. acknowledges support from Zhejiang Public Welfare Technology and Application Research Program (LGF19H300002). F.X. acknowledges support from Shenzhen Sanming Project of Medicine (SZSM201602102).	Akinleye A, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0779-5; Allen TM, 2019, NAT IMMUNOL, V20, P770, DOI 10.1038/s41590-019-0416-z; Bauer RA, 2015, DRUG DISCOV TODAY, V20, P1061, DOI 10.1016/j.drudis.2015.05.005; Chen WT, 2016, J AM CHEM SOC, V138, P7353, DOI 10.1021/jacs.6b02960; Chow KKH, 2013, MOL THER, V21, P629, DOI 10.1038/mt.2012.210; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; De La Rochere P, 2018, TRENDS IMMUNOL, V39, P748, DOI 10.1016/j.it.2018.07.001; Dong HD, 1999, NAT MED, V5, P1365; Dong JJ, 2014, ANGEW CHEM INT EDIT, V53, P9430, DOI 10.1002/anie.201309399; Eigenbrot C, 2010, P NATL ACAD SCI USA, V107, P15039, DOI 10.1073/pnas.1005025107; Ekerljung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049579; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Jin CH, 2019, EBIOMEDICINE, V39, P173, DOI 10.1016/j.ebiom.2018.12.013; Johnson DS, 2010, FUTURE MED CHEM, V2, P949, DOI 10.4155/FMC.10.21; Kanduti Domen, 2016, Mater Sociomed, V28, P133, DOI 10.5455/msm.2016.28.133-137; Kaufman HL, 2016, LANCET ONCOL, V17, P1374, DOI 10.1016/S1470-2045(16)30364-3; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lazar-Molnar E, 2017, EBIOMEDICINE, V17, P30, DOI 10.1016/j.ebiom.2017.02.004; Lee CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-255; Lee JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13354; Li CL, 2018, CANCER IMMUNOL RES, V6, P178, DOI 10.1158/2326-6066.CIR-17-0035; Li N, 2018, TRANSL ONCOL, V11, P11, DOI 10.1016/j.tranon.2017.10.009; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Liu J, 2019, J AM CHEM SOC, V141, P9458, DOI 10.1021/jacs.9b01738; Lonsdale R, 2018, CHEM SOC REV, V47, P3816, DOI 10.1039/c7cs00220c; Mardiana S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2293; Maute RL, 2015, P NATL ACAD SCI USA, V112, pE6506, DOI 10.1073/pnas.1519623112; Newick K, 2017, ANNU REV MED, V68, P139, DOI 10.1146/annurev-med-062315-120245; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; PLoS ONE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039314; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Rong ZL, 2014, CELL STEM CELL, V14, P121, DOI 10.1016/j.stem.2013.11.014; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sanmamed MF, 2018, CELL, V175, P313, DOI 10.1016/j.cell.2018.09.035; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Shi H, 2018, J THORAC DIS, V10, P2779, DOI 10.21037/jtd.2018.04.91; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Syed YY, 2017, DRUGS, V77, P1369, DOI 10.1007/s40265-017-0782-5; Tan SG, 2016, PROTEIN CELL, V7, P866, DOI 10.1007/s13238-016-0337-7; Tang HD, 2016, CANCER CELL, V29, P285, DOI 10.1016/j.ccell.2016.02.004; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2017, ACCOUNTS CHEM RES, V50, P2767, DOI 10.1021/acs.accounts.7b00376; Wang L, 2017, NEW BIOTECHNOL, V38, P16, DOI 10.1016/j.nbt.2016.10.003; Wang NX, 2018, J AM CHEM SOC, V140, P4995, DOI 10.1021/jacs.8b01087; Wege AK, 2018, BIODRUGS, V32, P245, DOI 10.1007/s40259-018-0275-4; Xiang Z, 2014, ANGEW CHEM INT EDIT, V53, P2190, DOI 10.1002/anie.201308794; Xiang Z, 2013, NAT METHODS, V10, P885, DOI [10.1038/NMETH.2595, 10.1038/nmeth.2595]; Xuan WM, 2017, ANGEW CHEM INT EDIT, V56, P5096, DOI 10.1002/anie.201611841; Yi ZZ, 2018, MOL THER-METH CLIN D, V9, P70, DOI 10.1016/j.omtm.2018.01.009; Zak KM, 2015, STRUCTURE, V23, P2341, DOI 10.1016/j.str.2015.09.010; Zarganes-Tzitzikas T, 2016, EXPERT OPIN THER PAT, V26, P973, DOI 10.1080/13543776.2016.1206527; Zhao TB, 2015, CELL STEM CELL, V17, P353, DOI 10.1016/j.stem.2015.07.021	55	54	56	21	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2020	182	1					85	+		10.1016/j.cell.2020.05.028	http://dx.doi.org/10.1016/j.cell.2020.05.028			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ML0RP	32579975	Bronze			2022-12-28	WOS:000549184500010
J	Acosta, LMY				Acosta, Lealani Mae Y.			A Healing Handicraft	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Acosta, Lealani Mae Y.] Vanderbilt Univ, Med Ctr, Dept Neurol, A-1088 Med Ctr North, Nashville, TN 37212 USA	Vanderbilt University	Acosta, LMY (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, A-1088 Med Ctr North, Nashville, TN 37212 USA.	lealani.mae.acosta@vumc.org		Acosta, Lealani Mae/0000-0002-3704-124X					0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					41	42		10.1001/jama.2020.10239	http://dx.doi.org/10.1001/jama.2020.10239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633804				2022-12-28	WOS:000568123600018
J	Sridhar, D; Chen, AD				Sridhar, Devi; Chen, Adriel			Why Scotland's slow and steady approach to covid-19 is working	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sridhar, Devi] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Sridhar, Devi; Chen, Adriel] Global Hlth Governance Programme, Edinburgh, Midlothian, Scotland; [Chen, Adriel] NHS Lanarkshire, Bothwell, Scotland	University of Edinburgh	Sridhar, D (corresponding author), Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland.; Sridhar, D (corresponding author), Global Hlth Governance Programme, Edinburgh, Midlothian, Scotland.							[Anonymous], 2020, MOST SCOTS TRUST HOL; Nishiura H, 2020, MEDRXIV; Qian H, 2020, INDOOR TRANSMISSION, DOI [10.1101/2020.04.04.20053058v1, DOI 10.1101/2020.04.04.20053058V1]; Scottish Government, COR FRAM DEC MAK; Woodward A., 2020, BUSINESS INSIDER	5	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2020	370								m2669	10.1136/bmj.m2669	http://dx.doi.org/10.1136/bmj.m2669			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5XW	32631899				2022-12-28	WOS:000548163900005
J	Sunday, J				Sunday, Jennifer			When do fish succumb to heat?	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; MARINE; TEMPERATURE; LIMITATION; OXYGEN		[Sunday, Jennifer] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Sunday, J (corresponding author), McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada.	jennifer.sunday@mcgill.ca	Sunday, Jennifer/ABE-7396-2020					Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Comte L, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2214; Dahlke FT, 2020, SCIENCE, V369, P65, DOI 10.1126/science.aaz3658; FAO, 2016, STAT WORLD FISH AQ 2; Gilbert B, 2014, ECOL LETT, V17, P902, DOI 10.1111/ele.12307; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Kindsvater HK, 2016, ECOL EVOL, V6, P2125, DOI 10.1002/ece3.2012; Pinsky ML, 2019, NATURE, V569, P108, DOI 10.1038/s41586-019-1132-4; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Trisos CH, 2020, NATURE, V580, P496, DOI 10.1038/s41586-020-2189-9	12	2	2	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					35	36		10.1126/science.abd1272	http://dx.doi.org/10.1126/science.abd1272			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MK4IZ	32631884				2022-12-28	WOS:000548751700036
J	Dyer, C				Dyer, Clare			Police launch investigation into maternity services at scandal hit Midlands trust	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1616	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2020	370								m2653	10.1136/bmj.m2653	http://dx.doi.org/10.1136/bmj.m2653			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MM0GY	32616508				2022-12-28	WOS:000549840000003
J	Fauci, AS; Lane, HC				Fauci, Anthony S.; Lane, H. Clifford			Four Decades of HIV/AIDS - Much Accomplished, Much to Do	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTION; RISK		[Fauci, Anthony S.; Lane, H. Clifford] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402	5	45	48	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					1	4		10.1056/NEJMp1916753	http://dx.doi.org/10.1056/NEJMp1916753			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2UD	32609976	Bronze			2022-12-28	WOS:000552751800003
J	Link, JO; Rhee, MS; Tse, WC; Zheng, J; Somoza, JR; Rowe, W; Begley, R; Chiu, A; Mulato, A; Hansen, D; Singer, E; Tsai, LK; Bam, RA; Chou, CH; Canales, E; Brizgys, G; Zhang, JR; Li, JY; Graupe, M; Morganelli, P; Liu, Q; Wu, QY; Halcomb, RL; Saito, RD; Schroeder, SD; Lazerwith, SE; Bondy, S; Jin, DB; Hung, M; Novikov, N; Liu, XH; Villasenor, AG; Cannizzaro, CE; Hu, EY; Anderson, RL; Appleby, TC; Lu, B; Mwangi, J; Liclican, A; Niedziela-Majka, A; Papalia, GA; Wong, MH; Leavitt, SA; Xu, YL; Koditek, D; Stepan, GJ; Yu, H; Pagratis, N; Clancy, S; Ahmadyar, S; Cai, TZ; Sellers, S; Wolckenhauer, SA; Ling, J; Callebaut, C; Margot, N; Ram, RR; Liu, YP; Hyland, R; Sinclair, GI; Ruane, PJ; Crofoot, GE; McDonald, CK; Brainard, DM; Lad, L; Swaminathan, S; Sundquist, WI; Sakowicz, R; Chester, AE; Lee, WE; Daar, ES; Yant, SR; Cihlar, T				Link, John O.; Rhee, Martin S.; Tse, Winston C.; Zheng, Jim; Somoza, John R.; Rowe, William; Begley, Rebecca; Chiu, Anna; Mulato, Andrew; Hansen, Derek; Singer, Eric; Tsai, Luong K.; Bam, Rujuta A.; Chou, Chien-Hung; Canales, Eda; Brizgys, Gediminas; Zhang, Jennifer R.; Li, Jiayao; Graupe, Michael; Morganelli, Philip; Liu, Qi; Wu, Qiaoyin; Halcomb, Randall L.; Saito, Roland D.; Schroeder, Scott D.; Lazerwith, Scott E.; Bondy, Steven; Jin, Debi; Hung, Magdeleine; Novikov, Nikolai; Liu, Xiaohong; Villasenor, Armando G.; Cannizzaro, Carina E.; Hu, Eric Y.; Anderson, Robert L.; Appleby, Todd C.; Lu, Bing; Mwangi, Judy; Liclican, Albert; Niedziela-Majka, Anita; Papalia, Giuseppe A.; Wong, Melanie H.; Leavitt, Stephanie A.; Xu, Yili; Koditek, David; Stepan, George J.; Yu, Helen; Pagratis, Nikos; Clancy, Sheila; Ahmadyar, Shekeba; Cai, Terrence Z.; Sellers, Scott; Wolckenhauer, Scott A.; Ling, John; Callebaut, Christian; Margot, Nicolas; Ram, Renee R.; Liu, Ya-Pei; Hyland, Rob; Sinclair, Gary I.; Ruane, Peter J.; Crofoot, Gordon E.; McDonald, Cheryl K.; Brainard, Diana M.; Lad, Latesh; Swaminathan, Swami; Sundquist, Wesley I.; Sakowicz, Roman; Chester, Anne E.; Lee, William E.; Daar, Eric S.; Yant, Stephen R.; Cihlar, Tomas			Clinical targeting of HIV capsid protein with a long-acting small molecule	NATURE			English	Article							PREEXPOSURE PROPHYLAXIS; INHIBITOR; EFFICACY; VIRUS; MEN	The small molecule GS-6207, which disrupts the function of the HIV capsid protein, shows potential as a long-acting therapeutic agent for the treatment and prevention of HIV infection. Oral antiretroviral agents provide life-saving treatments for millions of people living with HIV, and can prevent new infections via pre-exposure prophylaxis(1-5). However, some people living with HIV who are heavily treatment-experienced have limited or no treatment options, owing to multidrug resistance(6). In addition, suboptimal adherence to oral daily regimens can negatively affect the outcome of treatment-which contributes to virologic failure, resistance generation and viral transmission-as well as of pre-exposure prophylaxis, leading to new infections(1,2,4,7-9). Long-acting agents from new antiretroviral classes can provide much-needed treatment options for people living with HIV who are heavily treatment-experienced, and additionally can improve adherence(10). Here we describe GS-6207, a small molecule that disrupts the functions of HIV capsid protein and is amenable to long-acting therapy owing to its high potency, low in vivo systemic clearance and slow release kinetics from the subcutaneous injection site. Drawing on X-ray crystallographic information, we designed GS-6207 to bind tightly at a conserved interface between capsid protein monomers, where it interferes with capsid-protein-mediated interactions between proteins that are essential for multiple phases of the viral replication cycle. GS-6207 exhibits antiviral activity at picomolar concentrations against all subtypes of HIV-1 that we tested, and shows high synergy and no cross-resistance with approved antiretroviral drugs. In phase-1 clinical studies, monotherapy with a single subcutaneous dose of GS-6207 (450 mg) resulted in a mean log(10)-transformed reduction of plasma viral load of 2.2 after 9 days, and showed sustained plasma exposure at antivirally active concentrations for more than 6 months. These results provide clinical validation for therapies that target the functions of HIV capsid protein, and demonstrate the potential of GS-6207 as a long-acting agent to treat or prevent infection with HIV.	[Link, John O.; Rhee, Martin S.; Tse, Winston C.; Zheng, Jim; Somoza, John R.; Rowe, William; Begley, Rebecca; Chiu, Anna; Mulato, Andrew; Hansen, Derek; Singer, Eric; Tsai, Luong K.; Bam, Rujuta A.; Chou, Chien-Hung; Canales, Eda; Brizgys, Gediminas; Zhang, Jennifer R.; Li, Jiayao; Graupe, Michael; Morganelli, Philip; Liu, Qi; Wu, Qiaoyin; Halcomb, Randall L.; Saito, Roland D.; Schroeder, Scott D.; Lazerwith, Scott E.; Bondy, Steven; Jin, Debi; Hung, Magdeleine; Novikov, Nikolai; Liu, Xiaohong; Villasenor, Armando G.; Cannizzaro, Carina E.; Hu, Eric Y.; Anderson, Robert L.; Appleby, Todd C.; Lu, Bing; Mwangi, Judy; Liclican, Albert; Niedziela-Majka, Anita; Papalia, Giuseppe A.; Wong, Melanie H.; Leavitt, Stephanie A.; Xu, Yili; Koditek, David; Stepan, George J.; Yu, Helen; Pagratis, Nikos; Clancy, Sheila; Ahmadyar, Shekeba; Cai, Terrence Z.; Sellers, Scott; Wolckenhauer, Scott A.; Ling, John; Callebaut, Christian; Margot, Nicolas; Ram, Renee R.; Liu, Ya-Pei; Hyland, Rob; Brainard, Diana M.; Lad, Latesh; Swaminathan, Swami; Sakowicz, Roman; Chester, Anne E.; Lee, William E.; Yant, Stephen R.; Cihlar, Tomas] Gilead Sci, Foster City, CA 94404 USA; [Sinclair, Gary I.] AIDS Arms Inc, DBA Prism Hlth North Texas, Dallas, TX USA; [Ruane, Peter J.] Ruane Clin Res Grp Inc, Los Angeles, CA USA; [Crofoot, Gordon E.] Crofoot Res Ctr Inc, Houston, TX USA; [McDonald, Cheryl K.] Texas Ctr Infect Dis Associates, Ft Worth, TX USA; [Sundquist, Wesley I.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Daar, Eric S.] Univ Calif Los Angeles, Harbor UCLA Med Ctr, David Geffen Sch Med, Div HIV Med, Torrance, CA USA; [Tse, Winston C.; Saito, Roland D.] Vir Biotechnol Inc, San Francisco, CA USA; [Liu, Qi] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Halcomb, Randall L.] Terns Pharmaceut, Foster City, CA USA; [Anderson, Robert L.] MyoKardia Inc, San Francisco, CA USA; [Cai, Terrence Z.] Bayer, Berkeley, CA USA	Gilead Sciences; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Food & Drug Administration (FDA); Bayer AG	Yant, SR (corresponding author), Gilead Sci, Foster City, CA 94404 USA.	stephen.yant@gilead.com			NIAID NIH HHS [P50 AI150464] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Bam RA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01369-16, 10.1128/AAC.01369-16]; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bhattacharya A, 2014, P NATL ACAD SCI USA, V111, P18625, DOI 10.1073/pnas.1419945112; BIC, 2019, COMMUNICATION 1115; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Carnes SK, 2018, CURR OPIN HIV AIDS, V13, P359, DOI 10.1097/COH.0000000000000472; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Emu B, 2018, NEW ENGL J MED, V379, P645, DOI 10.1056/NEJMoa1711460; Fernandez J, 2019, NAT MICROBIOL, V4, P1840, DOI 10.1038/s41564-019-0575-6; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Graupe M, 2018, US patent, Patent No. [10 985 B2, 10985]; Gulick RM, 2019, ANNU REV MED, V70, P137, DOI 10.1146/annurev-med-041217-013717; Huang PT, 2019, CELL REP, V28, P2373, DOI 10.1016/j.celrep.2019.07.079; Hung M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058035; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Li GD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-126; Margot NA, 2010, ANTIMICROB AGENTS CH, V54, P2345, DOI 10.1128/AAC.01784-09; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Matreyek KA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003693; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Perrier M, 2017, J ANTIMICROB CHEMOTH, V72, P2954, DOI 10.1093/jac/dkx208; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Prichard M N, 1996, Antivir Ther, V1, P9; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Thenin-Houssier S, 2016, CURR HIV RES, V14, P270, DOI 10.2174/1570162X14999160224103555; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tsiang M, 2016, ANTIMICROB AGENTS CH, V60, P7086, DOI 10.1128/AAC.01474-16; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Yamashita M, 2017, TRENDS MICROBIOL, V25, P741, DOI 10.1016/j.tim.2017.04.004; Yant S. R, 2019, 10 IAS C HIV SCI; Yant SR, 2019, NAT MED, V25, P1377, DOI 10.1038/s41591-019-0560-x	43	100	102	5	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 27	2020	584	7822					614	+		10.1038/s41586-020-2443-1	http://dx.doi.org/10.1038/s41586-020-2443-1		JUL 2020	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NF3UH	32612233	Green Accepted			2022-12-28	WOS:000547610500002
J	Liu, KW; Wu, LJ; Yuan, SG; Wu, M; Xu, YM; Sun, QQ; Li, S; Zhao, SW; Hua, T; Liu, ZJ				Liu, Kaiwen; Wu, Lijie; Yuan, Shuguang; Wu, Meng; Xu, Yueming; Sun, Qianqian; Li, Shu; Zhao, Suwen; Hua, Tian; Liu, Zhi-Jie			Structural basis of CXC chemokine receptor 2 activation and signalling	NATURE			English	Article							CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; TERMINAL DOMAIN; INTERLEUKIN-8; BINDING; RECOGNITION; LIGAND; ELECTROSTATICS; MODULATION	Chemokines and their receptors mediate cell migration, which influences multiple fundamental biological processes and disease conditions such as inflammation and cancer(1). Although ample effort has been invested into the structural investigation of the chemokine receptors and receptor-chemokine recognition(2-4), less is known about endogenous chemokine-induced receptor activation and G-protein coupling. Here we present the cryo-electron microscopy structures of interleukin-8 (IL-8, also known as CXCL8)-activated human CXC chemokine receptor 2 (CXCR2) in complex with G(i) protein, along with a crystal structure of CXCR2 bound to a designed allosteric antagonist. Our results reveal a unique shallow mode of binding between CXCL8 and CXCR2, and also show the interactions between CXCR2 and G(i) protein. Further structural analysis of the inactive and active states of CXCR2 reveals a distinct activation process and the competitive small-molecule antagonism of chemokine receptors. In addition, our results provide insights into how a G-protein-coupled receptor is activated by an endogenous protein molecule, which will assist in the rational development of therapeutics that target the chemokine system for better pharmacological profiles. Structures of the G(i)-coupled CXC chemokine receptor 2 (CXCR2) in complex with CXCL8 and in complex with an allosteric antagonist provide insight into the ligand binding and activation of CXCR2 and its mode of G-protein coupling.	[Liu, Kaiwen; Wu, Lijie; Wu, Meng; Xu, Yueming; Sun, Qianqian; Zhao, Suwen; Hua, Tian; Liu, Zhi-Jie] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China; [Liu, Kaiwen; Wu, Meng; Zhao, Suwen; Liu, Zhi-Jie] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Liu, Kaiwen; Wu, Meng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Kaiwen] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Yuan, Shuguang; Li, Shu] Chinese Acad Sci, Res Ctr Comp Aided Drug Discovery, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	ShanghaiTech University; ShanghaiTech University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Hua, T; Liu, ZJ (corresponding author), ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China.; Liu, ZJ (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	huatian@shanghaitech.edu.cn; Liuzhj@shanghaitech.edu.cn	liu, kaiwen/GVS-5259-2022	Zhao, Suwen/0000-0001-5609-434X; li, shu/0000-0002-4434-6172; Wu, Lijie/0000-0002-2253-0497	National Natural Science Foundation of China [31930060, 91953202]; CAS Strategic Priority Research Program [XDB37030104]; National Key Research and Development Program of China [2018YFA0507000]; Shenzhen Institutes of Advanced Technology, CAS grant [1105150101]; Interdisciplinary Centre for Mathematical and Computational Modelling in Warsaw [GB71-3, GB70-3]; Shanghai Municipal Government; ShanghaiTech University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Strategic Priority Research Program; National Key Research and Development Program of China; Shenzhen Institutes of Advanced Technology, CAS grant; Interdisciplinary Centre for Mathematical and Computational Modelling in Warsaw; Shanghai Municipal Government; ShanghaiTech University	This work was supported by the National Natural Science Foundation of China grants 31930060 and 91953202 (Z.-J.L.), CAS Strategic Priority Research Program XDB37030104 (Z.-J.L.), the National Key Research and Development Program of China grant 2018YFA0507000 (T.H.), Shenzhen Institutes of Advanced Technology, CAS grant 1105150101 (S.Y. and S.L.) and the Interdisciplinary Centre for Mathematical and Computational Modelling in Warsaw grants GB70-3 and GB71-3 (S.Y.). We thank the Shanghai Municipal Government and ShanghaiTech University for financial support; J.-L. Liu and N. Chen at the cell expression core, Q.-W. Tan at the cloning core and staff members at the purification and assay cores of the iHuman Institute for their support; and G.-J. Song, I. Wilson and G. Yang for discussions. The cryo-EM data were collected at the Bio-Electron Microscopy Facility, ShanghaiTech University, with the assistance of D.-D. Liu and Y.-H. Liu. The synchrotron radiation experiments were performed at the BL41XU of SPring-8 with approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposals 2018B2722 and 2019A2522).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Berkamp S, 2017, J BIOMOL NMR, V69, P111, DOI 10.1007/s10858-017-0128-3; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chan HCS, 2018, CHEM SCI, V9, DOI 10.1039/c8sc01680a; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng Y, 2019, BBA-REV CANCER, V1871, P289, DOI 10.1016/j.bbcan.2019.01.005; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Draper-Joyce CJ, 2018, NATURE, V558, P559, DOI 10.1038/s41586-018-0236-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Nafria J, 2018, NATURE, V558, P620, DOI 10.1038/s41586-018-0241-9; Gonsiorek W, 2007, J PHARMACOL EXP THER, V322, P477, DOI 10.1124/jpet.106.118927; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Hua T, 2020, CELL, V180, P655, DOI 10.1016/j.cell.2020.01.008; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaeger K, 2019, CELL, V178, P1222, DOI 10.1016/j.cell.2019.07.028; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Joseph PRB, 2013, BIOCHEM J, V456, P241, DOI 10.1042/BJ20130148; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Legler DF, 2017, MOL PHARMACOL, V91, P331, DOI 10.1124/mol.116.107151; Lowman HB, 1997, PROTEIN SCI, V6, P598; Maeda S, 2019, SCIENCE, V364, P552, DOI 10.1126/science.aaw5188; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monteclaro FS, 1997, J BIOL CHEM, V272, P23186, DOI 10.1074/jbc.272.37.23186; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Ngo T, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000656; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Oswald C, 2016, NATURE, V540, P462, DOI 10.1038/nature20606; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ravindran A, 2013, J BIOL CHEM, V288, P12244, DOI 10.1074/jbc.M112.443762; Roumen L, 2012, Drug Discov Today Technol, V9, pe281, DOI 10.1016/j.ddtec.2012.05.002; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Shaw DE, 2014, INT CONF HIGH PERFOR, P41, DOI 10.1109/SC.2014.9; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xing CR, 2020, CELL, V180, P645, DOI 10.1016/j.cell.2020.01.007; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002; Zheng Y, 2016, NATURE, V540, P458, DOI 10.1038/nature20605; Zhu YM, 2004, BRIT J CANCER, V91, P1970, DOI 10.1038/sj.bjc.6602227	69	74	74	11	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2020	585	7823					135	+		10.1038/s41586-020-2492-5	http://dx.doi.org/10.1038/s41586-020-2492-5		JUL 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NJ1LP	32610344				2022-12-28	WOS:000563193600001
J	Loveland, AB; Demo, G; Korostelev, AA				Loveland, Anna B.; Demo, Gabriel; Korostelev, Andrei A.			Cryo-EM of elongating ribosome with EF-Tu center dot GTP elucidates tRNA proofreading	NATURE			English	Article							AMINOACYL-TRANSFER-RNA; ALLOSTERIC 3-SITE MODEL; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; PROTEIN L7/12; 70S RIBOSOME; VISUALIZATION; RESOLUTION; HYDROLYSIS	Ribosomes accurately decode mRNA by proofreading each aminoacyl-tRNA that is delivered by the elongation factor EF-Tu(1). To understand the molecular mechanism of this proofreading step it is necessary to visualize GTP-catalysed elongation, which has remained a challenge(2-4). Here we use time-resolved cryogenic electron microscopy to reveal 33 ribosomal states after the delivery of aminoacyl-tRNA by EF-Tu center dot GTP. Instead of locking cognate tRNA upon initial recognition, the ribosomal decoding centre dynamically monitors codon-anticodon interactions before and after GTP hydrolysis. GTP hydrolysis enables the GTPase domain of EF-Tu to extend away, releasing EF-Tu from tRNA. The 30S subunit then locks cognate tRNA in the decoding centre and rotates, enabling the tRNA to bypass 50S protrusions during accommodation into the peptidyl transferase centre. By contrast, the decoding centre fails to lock near-cognate tRNA, enabling the dissociation of near-cognate tRNA both during initial selection (before GTP hydrolysis) and proofreading (after GTP hydrolysis). These findings reveal structural similarity between ribosomes in initial selection states(5,6)and in proofreading states, which together govern the efficient rejection of incorrect tRNA. Time-resolved cryogenic electron microscopy structures of a ribosome during the delivery of aminoacyl-tRNA by EF-Tu center dot GTP capture 33 ribosomal states, enabling visualization of the initial selection, proofreading and peptidyl transfer stages.	[Loveland, Anna B.; Demo, Gabriel; Korostelev, Andrei A.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, RNA Therapeut Inst, Worcester, MA 01605 USA; [Demo, Gabriel] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	University of Massachusetts System; University of Massachusetts Worcester; Masaryk University Brno	Korostelev, AA (corresponding author), Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, RNA Therapeut Inst, Worcester, MA 01605 USA.	andrei.korostelev@umassmed.edu	Demo, Gabriel/D-7261-2012	Demo, Gabriel/0000-0002-5472-9249; Korostelev, Andrei/0000-0003-1588-717X	NIH [R01 GM106105, R01 GM107465, R35 GM127094]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Rigney for help with grid preparation and screening at the cryo-EM facility at Brandeis University; C. Xu and K. Song for data collection at the cryo-EM facility at UMass Medical School; D. Conte Jr., D. Ermolenko, A. Korennykh and members of the Korostelev laboratory for comments on the manuscript; and D. Grunwald and D. Susorov for help with the video. This study was supported by NIH grants R01 GM106105, R01 GM107465 and R35 GM127094 (to A.A.K.). A.B.L. performed part of this work as a Howard Hughes Medical Institute Fellow of the Helen Hay Whitney Foundation.	Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; Abeyrathne PD, 2016, ELIFE, V5, DOI 10.7554/eLife.14874; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; DeLano W.L, PYMOL MOL GRAPHICS S; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dinos G, 2005, NUCLEIC ACIDS RES, V33, P5291, DOI 10.1093/nar/gki833; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; EHRENBERG M, 1980, BIOPHYS J, V31, P333, DOI 10.1016/S0006-3495(80)85063-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; Fislage M, 2018, NUCLEIC ACIDS RES, V46, P5861, DOI 10.1093/nar/gky346; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fu Z, 2016, STRUCTURE, V24, P2092, DOI 10.1016/j.str.2016.09.014; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Graf M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05465-1; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Ieong KW, 2016, P NATL ACAD SCI USA, V113, P13744, DOI 10.1073/pnas.1610917113; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; Kaledhonkar S, 2019, NATURE, V570, P400, DOI 10.1038/s41586-019-1249-5; Kavaliauskas D, 2018, NUCLEIC ACIDS RES, V46, P8651, DOI 10.1093/nar/gky651; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Koripella RK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12970; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; LEIJONMARCK M, 1987, J MOL BIOL, V195, P555, DOI 10.1016/0022-2836(87)90183-5; Loveland AB, 2017, NATURE, V546, P113, DOI 10.1038/nature22397; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Maracci C, 2014, P NATL ACAD SCI USA, V111, P14418, DOI 10.1073/pnas.1412676111; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; Nikolay R, 2018, MOL CELL, V70, P881, DOI 10.1016/j.molcel.2018.05.003; Noel JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13314; Noller HF, 2017, NAT STRUCT MOL BIOL, V24, P1021, DOI 10.1038/nsmb.3505; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Passos DO, 2015, J STRUCT BIOL, V192, P235, DOI 10.1016/j.jsb.2015.10.002; Pavlov MY, 2018, ANNU REV BIOPHYS, V47, P525, DOI 10.1146/annurev-biophys-060414-034148; Petropoulos AD, 2012, J BIOL CHEM, V287, P11642, DOI 10.1074/jbc.C111.330068; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Polikanov YS, 2014, NAT STRUCT MOL BIOL, V21, P787, DOI 10.1038/nsmb.2871; Rodnina MV, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0182; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Semenkov YP, 1996, P NATL ACAD SCI USA, V93, P12183, DOI 10.1073/pnas.93.22.12183; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Svidritskiy E, 2018, STRUCTURE, V26, P821, DOI 10.1016/j.str.2018.04.001; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; THOMPSON RC, 1981, J BIOL CHEM, V256, P81; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Wieden HJ, 2001, J MOL EVOL, V52, P129, DOI 10.1007/s002390010141; Yang H, 2018, PROTEINS, V86, P1037, DOI 10.1002/prot.25575; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang JJ, 2018, NUCLEIC ACIDS RES, V46, P1362, DOI 10.1093/nar/gkx1256; Zhang JJ, 2015, P NATL ACAD SCI USA, V112, P9602, DOI 10.1073/pnas.1506823112; Zhou GF, 1998, ACTA CRYSTALLOGR D, V54, P391, DOI 10.1107/S0907444997011530; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	87	35	36	3	25	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 27	2020	584	7822					640	+		10.1038/s41586-020-2447-x	http://dx.doi.org/10.1038/s41586-020-2447-x		JUL 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NF3UH	32612237	Green Accepted			2022-12-28	WOS:000544885800003
J	[Anonymous]				[Anonymous]			Covid care creates oxygen drought	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2615	10.1136/bmj.m2615	http://dx.doi.org/10.1136/bmj.m2615			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611584	Bronze			2022-12-28	WOS:000548489100014
J	Jeffers, SV; Dreizier, S; Barnes, JR; Haswell, CA; Nelson, RP; Rodriguez, E; Lopez-Gonzalez, MJ; Morales, N; Luque, R; Zechmeister, M; Vogt, SS; Jenkins, JS; Palle, E; Berdinas, ZM; Coleman, GAL; Diaz, MR; Ribas, I; Jones, HRA; Butler, RP; Tinney, CG; Bailey, J; Carter, BD; O'Toole, S; Wittenmyer, RA; Crane, JD; Feng, F; Shectman, SA; Teske, J; Reiners, A; Amado, PJ; Anglada-Escude, G				Jeffers, S. V.; Dreizier, S.; Barnes, J. R.; Haswell, C. A.; Nelson, R. P.; Rodriguez, E.; Lopez-Gonzalez, M. J.; Morales, N.; Luque, R.; Zechmeister, M.; Vogt, S. S.; Jenkins, J. S.; Palle, E.; Berdinas, Z. M.; Coleman, G. A. L.; Diaz, M. R.; Ribas, I.; Jones, H. R. A.; Butler, R. P.; Tinney, C. G.; Bailey, J.; Carter, B. D.; O'Toole, S.; Wittenmyer, R. A.; Crane, J. D.; Feng, F.; Shectman, S. A.; Teske, J.; Reiners, A.; Amado, P. J.; Anglada-Escude, G.			A multiplanet system of super-Earths orbiting the brightest red dwarf star GJ 887	SCIENCE			English	Article							PLANETARY SYSTEMS; STABILITY; CANDIDATE; SEARCH; RADIUS	The closet exoplanets to the Sun provide opportunities for detailed characterization of planets outside the Solar System. We report the discovery, using radial velocity measurements, of a compact multiplanet system of super-Earth exoplanets orbiting the nearby red dwarf star GJ 887. The two planets have orbital periods of 9.3 and 21.8 days. Assuming an Earth-like albedo, the equilibrium temperature of the 21.8-day planet is similar to 350 kelvin. The planets are interior to, but close to the inner edge of, the liquid-water habitable zone. We also detect an unconfirmed signal with a period of similar to 50 days, which could correspond to a third super-Earth in a more temperate orbit. Our observations show that GJ 887 has photometric variability below 500 parts per million, which is unusually quiet for a red dwarf.	[Jeffers, S. V.; Dreizier, S.; Zechmeister, M.; Reiners, A.] Georg August Univ, Inst Astrophys, D-37077 Gottingen, Germany; [Barnes, J. R.; Haswell, C. A.] Open Univ, Sch Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Nelson, R. P.; Coleman, G. A. L.; Anglada-Escude, G.] Queen Mary Univ London, Sch Phys & Astron, London E1 4NS, England; [Rodriguez, E.; Lopez-Gonzalez, M. J.; Morales, N.; Amado, P. J.] CSIC, Inst Astrofis Andalucia, Granada 18008, Spain; [Luque, R.; Palle, E.] Inst Astrofis Canarias, Tenerife 38205, Spain; [Luque, R.; Palle, E.] Univ La Laguna, Dept Astrofis, Tenerife 38206, Spain; [Vogt, S. S.] Univ Calif Santa Cruz, Lick Observ, Santa Cruz, CA 95064 USA; [Jenkins, J. S.; Berdinas, Z. M.; Diaz, M. R.] Univ Chile, Dept Astron, Santiago, Chile; [Jenkins, J. S.] Ctr Astrofis & Tecnol Afines, Santiago, Chile; [Coleman, G. A. L.] Univ Bern, Phys Inst, CH-3012 Bern, Switzerland; [Ribas, I.; Anglada-Escude, G.] Campus Univ Autonoma Barcelona, Inst Ciencies Espai, Consejo Super Invest Cient, E-08193 Bellaterra, Spain; [Ribas, I.; Anglada-Escude, G.] Ist Estudis Espacials Catalunya, E-08034 Barcelona, Spain; [Jones, H. R. A.] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Butler, R. P.; Feng, F.] Carnegie Inst Sci, Earth & Planets Lab, Washington, DC 20015 USA; [Tinney, C. G.; Bailey, J.] Univ New South Wales, Exoplanetary Sci, Sch Phys, Sydney, NSW 2052, Australia; [Carter, B. D.] Univ Southern Queensland, Ctr Astrophys, Springfield Central, Qld 4300, Australia; [O'Toole, S.] Macquarie Univ, Australian Astron Opt, N Ryde, NSW 2113, Australia; [Wittenmyer, R. A.] Univ Southern Queensland, Ctr Astrophys, Toowoomba, Qld 4350, Australia; [Crane, J. D.; Shectman, S. A.; Teske, J.] Observ Carnegie Inst Sci, Pasadena, CA 91101 USA	University of Gottingen; Open University - UK; University of London; Queen Mary University London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of California System; University of California Santa Cruz; Universidad de Chile; University of Bern; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Institut d'Estudis Espacials de Catalunya (IEEC); University of Hertfordshire; Carnegie Institution for Science; University of New South Wales Sydney; University of Southern Queensland; Macquarie University; University of Southern Queensland; Carnegie Institution for Science	Jeffers, SV (corresponding author), Georg August Univ, Inst Astrophys, D-37077 Gottingen, Germany.	sandrajeffers.astro@gmail.com	Luque, Rafael/AAU-1245-2021; Butler, Robert Paul/B-1125-2009; Ribas, Ignasi/M-2134-2014; Vogt, Steven/AAC-3358-2021; Lopez-Gonzalez, Maria Jose/AAB-9217-2019; Gonzalez, Maria Jose Lopez/L-4596-2017; Anglada-Escude, Guillem/Y-3162-2018; Feng, Fabo/F-1579-2015	Luque, Rafael/0000-0002-4671-2957; Butler, Robert Paul/0000-0003-1305-3761; Ribas, Ignasi/0000-0002-6689-0312; Lopez-Gonzalez, Maria Jose/0000-0001-8104-5128; Gonzalez, Maria Jose Lopez/0000-0001-8104-5128; Reiners, Ansgar/0000-0003-1242-5922; O'Toole, Simon/0000-0003-2839-8527; Anglada-Escude, Guillem/0000-0002-3645-5977; Tinney, C.G./0000-0002-7595-0970; Jones, Hugh/0000-0003-0433-3665; Zechmeister, Mathias/0000-0002-6532-4378; Nelson, Richard/0000-0002-9687-8779; Morales Palomino, Nicolas F./0000-0003-0419-1599; Dreizler, Stefan/0000-0001-6187-5941; Feng, Fabo/0000-0001-6039-0555	German Science Foundation (DFG) Research Unit [FOR2544, JE 701/3-1]; DFG [SPP 1992, JE 701/5-1]; STFC [ST/P000584/1, ST/T000295/1, ST/P000592/1]; Spanish Agencia Estatal de Investigacion [AYA2017-89637R, AYA2016-79425-C3-3-S, ESP2017-87676-C5-2-R, ESP2017-87143R, PGC2018-098153-B-C31, ESP2016-80435-C2-2-R]; Centre of Excellence "Severo Ochoa" Instituto de Astrofisica de Andalucia [SEV-2017-0709]; CONICYT/FONDECYT [3180405]; Swiss National Science Foundation; CONICYT/PFCHA-Doctorado Nacional, Chile [21140646]; Spanish Ministry of Science and Innovation [ESP2016-80435-C2-1-R, PGC2018-098153-B-C33]; European Regional Development Fund [ESP2016-80435-C2-1-R, PGC2018-098153-B-C33]; Generalitat de Catalunya/CERCA program; U.K.Science and Technology Facilities Council [ST/M001008/1]; Australian Research Council [DP0774000, DP130102695, DP170103491]; NASA through Hubble Fellowship - Space Telescope Science Institute [HST-HF2-51399.001]; Ministerio de Ciencia, Innovacion y Universidades Ramon y Cajal fellowship [RYC-2017-22489]; Science and Technology Facilities Council [ST/P000592/1]; NASA [NAS5-26555]; STFC [ST/T000341/1, ST/M001008/1] Funding Source: UKRI	German Science Foundation (DFG) Research Unit(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Spanish Agencia Estatal de Investigacion(Spanish Government); Centre of Excellence "Severo Ochoa" Instituto de Astrofisica de Andalucia; CONICYT/FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CONICYT/PFCHA-Doctorado Nacional, Chile; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Generalitat de Catalunya/CERCA program; U.K.Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Australian Research Council(Australian Research Council); NASA through Hubble Fellowship - Space Telescope Science Institute; Ministerio de Ciencia, Innovacion y Universidades Ramon y Cajal fellowship; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NASA(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	S.V.J. acknowledges the support of the German Science Foundation (DFG) Research Unit FOR2544 "Blue Planets around Red Stars" project (JE 701/3-1) and DFG priority program SPP 1992 "Exploring the Diversity of Extrasolar Planets" JE 701/5-1. J.R.Ba.nd CA.H. acknowledge support from STFC Consolidated Grants ST/P000584/1 and ST/T000295/1. R.PN. was supported by STFC Consolidated Grant ST/P000592/1. E.R. M.J.L.-G. N,M., and P.J.A. acknowledge support from the Spanish Agencia Estatal de Investigacion through projects AYA2017-89637R, AYA2016-79425-C3-3-S, ESP2017-87676-C5-2-R, and ESP2017-87143R and the Centre of Excellence "Severo Ochoa" Instituto de Astrofisica de Andalucia (SEV-2017-0709). E.P. acknowledges support from the Spanish Agencia Estatal de Investigacion PGC2018-098153-B-C31 and ESP2016-80435-C2-2-R. Z.M.B. acknowledges funds from CONICYT/FONDECYT Postdoctorado 3180405. G.A.L.C. acknowledges support from the Swiss National Science Foundation. M.R.D.acknowledges support of CONICYT/PFCHA-Doctorado Nacional 21140646, Chile. I.R. acknowledges support from the Spanish Ministry of Science and Innovation and the European Regional Development Fund through grants ESP2016-80435-C2-1-R and PGC2018-098153-B-C33 and the Generalitat de Catalunya/CERCA program. H.R.A.J. acknowledges support from the U.K.Science and Technology Facilities Council grant ST/M001008/1. C.G.T. is supported by Australian Research Council grants DP0774000, DP130102695, and DP170103491. J.T. wassupported by NASA through Hubble Fellowship grant HST-HF2-51399.001 awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS5-26555. G.A.-E is supported by the Ministerio de Ciencia, Innovacion y Universidades Ramon y Cajal fellowship RYC-2017-22489 and by the Science and Technology Facilities Council grant number ST/P000592/1.	Anglada-Escude G, 2012, ASTROPHYS J SUPPL S, V200, DOI 10.1088/0067-0049/200/2/15; Astudillo-Defru N, 2017, ASTRON ASTROPHYS, V600, DOI 10.1051/0004-6361/201527078; Baluev RV, 2009, MON NOT R ASTRON SOC, V393, P969, DOI 10.1111/j.1365-2966.2008.14217.x; Barnes JR, 2016, MON NOT R ASTRON SOC, V462, P1012, DOI 10.1093/mnras/stw1713; Barnes JR, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/42; Berdifias Z. M., 2018, HIGHL SPAN ASTR 10 P, P266; Boyajian TS, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/112; Brown AGA, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833051; Browning MK, 2010, ASTRON J, V139, P504, DOI 10.1088/0004-6256/139/2/504; Butler RP, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa66ca; Chambers JE, 1996, ICARUS, V119, P261, DOI 10.1006/icar.1996.0019; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Coleman GAL, 2016, MON NOT R ASTRON SOC, V457, P2480, DOI 10.1093/mnras/stw149; Crane JD, 2010, PROC SPIE, V7735, DOI 10.1117/12.857792; Demory BO, 2009, ASTRON ASTROPHYS, V505, P205, DOI 10.1051/0004-6361/200911976; DIEGO F, 1990, P SOC PHOTO-OPT INS, V1235, P562, DOI 10.1117/12.19119; Dobbs-Dixon I, 2004, ASTROPHYS J, V610, P464, DOI 10.1086/421510; DUNCAN DK, 1991, ASTROPHYS J SUPPL S, V76, P383, DOI 10.1086/191572; Eggleton PP, 1998, ASTROPHYS J, V499, P853, DOI 10.1086/305670; Espinoza N, 2019, MON NOT R ASTRON SOC, V490, P2262, DOI 10.1093/mnras/stz2688; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Gillon M, 2017, NATURE, V542, P456, DOI 10.1038/nature21360; Giuppone CA, 2013, MON NOT R ASTRON SOC, V436, P3547, DOI 10.1093/mnras/stt1831; GLADMAN B, 1993, ICARUS, V106, P247, DOI 10.1006/icar.1993.1169; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Hansen BMS, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/53; Jeffers SV, 2018, ASTRON ASTROPHYS, V614, DOI 10.1051/0004-6361/201629599; Jeffers SV, 2014, MON NOT R ASTRON SOC, V438, P2717, DOI 10.1093/mnras/stt1950; Jenkins JS, 2019, MON NOT R ASTRON SOC, V487, P268, DOI 10.1093/mnras/stz1268; Kopparapu RK, 2014, ASTROPHYS J LETT, V787, DOI 10.1088/2041-8205/787/2/L29; Lambrechts M, 2019, ASTRON ASTROPHYS, V627, DOI 10.1051/0004-6361/201834229; Laskar J, 2017, ASTRON ASTROPHYS, V605, DOI 10.1051/0004-6361/201630022; Lo Curto G., 2015, MESSENGER, V162, P9; Lovis C, 2007, ASTRON ASTROPHYS, V468, P1115, DOI 10.1051/0004-6361:20077249; Lucy LB, 2005, ASTRON ASTROPHYS, V439, P663, DOI 10.1051/0004-6361:20052909; Luque R, 2019, ASTRON ASTROPHYS, V628, DOI 10.1051/0004-6361/201935801; Kempton EMR, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aadf6f; Mann AW, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/64; Marzari F, 2002, ICARUS, V156, P570, DOI 10.1006/icar.2001.6786; Mayor M., 2003, MESSENGER, V114, P20; McQuillan A, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/24; Meschiari S, 2009, PUBL ASTRON SOC PAC, V121, P1016, DOI 10.1086/605730; Newton ER, 2018, ASTRON J, V156, DOI 10.3847/1538-3881/aad73b; Perryman M, 2018, EXOPLANET HDB; Pojmanski G, 1997, ACTA ASTRONOM, V47, P467; Poon STS, 2020, MON NOT R ASTRON SOC, V491, P5595, DOI 10.1093/mnras/stz3296; Press W.H, 1996, FORTRAN NUMERICAL RE, V1; Pu BN, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/44; Rabus M, 2019, MON NOT R ASTRON SOC, V484, P2674, DOI 10.1093/mnras/sty3430; Ribas I, 2018, NATURE, V563, P365, DOI 10.1038/s41586-018-0677-y; Ricker GR, 2015, J ASTRON TELESC INST, V1, DOI 10.1117/1.JATIS.1.1.014003; Saikia SB, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201629518; Schweitzer A, 2019, ASTRON ASTROPHYS, V625, DOI 10.1051/0004-6361/201834965; Segransan D, 2003, ASTRON ASTROPHYS, V397, pL5, DOI 10.1051/0004-6361:20021714; Sicardy B, 2011, NATURE, V478, P493, DOI 10.1038/nature10550; Snellen IAG, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa7fbc; Tal-Or L, 2019, MON NOT R ASTRON SOC, V484, pL8, DOI 10.1093/mnrasl/sly227; Terquem C, 1998, ASTROPHYS J, V502, P788, DOI 10.1086/305927; Teske JK, 2016, ASTRON J, V152, DOI 10.3847/0004-6256/152/6/167; Tinney CG, 2001, ASTROPHYS J, V551, P507, DOI 10.1086/320097; Trifonov T., 2019, ASCL1906004; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Weiss LM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/14; Wu YQ, 2019, ASTROPHYS J, V874, DOI 10.3847/1538-4357/ab06f8; YODER CF, 1981, ICARUS, V47, P1, DOI 10.1016/0019-1035(81)90088-9; Zechmeister M, 2009, ASTRON ASTROPHYS, V496, P577, DOI 10.1051/0004-6361:200811296	69	20	20	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1477	+		10.1126/science.aaz0795	http://dx.doi.org/10.1126/science.aaz0795			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32587019	Green Submitted, Green Accepted			2022-12-28	WOS:000545264600041
J	Spikes, M				Spikes, Montrai			The pressure to assimilate	SCIENCE			English	Editorial Material									[Spikes, Montrai] Univ Oklahoma, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Spikes, M (corresponding author), Univ Oklahoma, Norman, OK 73019 USA.								0	3	3	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1506	1506						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587023				2022-12-28	WOS:000545264600047
J	Rimmer, A				Rimmer, Abi			Presenting clinical features on darker skin: five minutes with ... Malone Mukwende	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2020	369								m2578	10.1136/bmj.m2578	http://dx.doi.org/10.1136/bmj.m2578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI3HF	32586787				2022-12-28	WOS:000583173400013
J	Villarino, AV; Gadina, M; O'Shea, JJ; Kanno, Y				Villarino, Alejandro V.; Gadina, Massimo; O'Shea, John J.; Kanno, Yuka			SnapShot: JAK-STAT Signaling II	CELL			English	Editorial Material									[Villarino, Alejandro V.; Gadina, Massimo; O'Shea, John J.; Kanno, Yuka] Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Villarino, AV (corresponding author), Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, NIH, Bethesda, MD 20892 USA.		Kanno, Yuka/B-5802-2013	Kanno, Yuka/0000-0001-5668-9319; Villarino, Alejandro/0000-0001-8068-2176	NIAMS Intramural Research Program	NIAMS Intramural Research Program	This work was supported by the NIAMS Intramural Research Program.	Basters A, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180250; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Gadina M, 2020, J IMMUNOL, V204, P2011, DOI 10.4049/jimmunol.1901477; Garama DJ, 2016, CYTOKINE, V87, P20, DOI 10.1016/j.cyto.2016.05.019; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Morris R, 2018, PROTEIN SCI, V27, P1984, DOI 10.1002/pro.3519; Stark GR, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028555; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tangye SG, 2017, J IMMUNOL, V199, P1949, DOI 10.4049/jimmunol.1700842; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691	10	21	22	10	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1696	+		10.1016/j.cell.2020.04.052	http://dx.doi.org/10.1016/j.cell.2020.04.052			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32589961	Bronze			2022-12-28	WOS:000543822100023
J	Horton, R				Horton, Richard			Offline: A novel solution to live with coronavirus	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1894	1894						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563361	Green Published, Bronze			2022-12-28	WOS:000552732200012
J	Barnett, ML; Hu, L; Martin, T; Grabowski, DC				Barnett, Michael L.; Hu, Lissy; Martin, Thomas; Grabowski, David C.			Mortality, Admissions, and Patient Census at SNFs in 3 US Cities During the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study uses Medicare's Nursing Home Compare and a university long-term care database to compare census, admissions, discharges, and mortality at skilled nursing facilities (SNFs) in 3 metropolitan areas during March-May 2020 vs March-May 2019.	[Barnett, Michael L.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge 411, Boston, MA 02115 USA; [Hu, Lissy; Martin, Thomas] CarePort Hlth Inc, Boston, MA USA; [Grabowski, David C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Barnett, ML (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge 411, Boston, MA 02115 USA.	mbarnett@hsph.harvard.edu	Barnett, Michael/AAF-4017-2019; Barnett, Michael/ABA-4159-2021	Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609; Grabowski, David/0000-0003-2915-5770	National Institute on Aging, National Institutes of Health [K23 AG058806-01]	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant K23 AG058806-01 from the National Institute on Aging, National Institutes of Health.	[Anonymous], NY TIMES; Baum A, 2020, JAMA, DOI 10.1001/jama.2020.9972; Brown University School of Public Health, LTCFOCUS LONG TERM C; Henry J. Kaiser Family Foundation, 2020, STAT DAT POL ACT ADD; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412	5	34	35	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					507	509		10.1001/jama.2020.11642	http://dx.doi.org/10.1001/jama.2020.11642			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32579161	Green Published, Bronze			2022-12-28	WOS:000561261900022
J	Zylke, JW; Bauchner, H				Zylke, Jody W.; Bauchner, Howard			Mortality and Morbidity The Measure of a Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zylke, Jody W.; Bauchner, Howard] JAMA, 330 N Wabash Ave,Ste 39300, Chicago, IL 60611 USA		Zylke, JW (corresponding author), JAMA, 330 N Wabash Ave,Ste 39300, Chicago, IL 60611 USA.	jody.zylke@jamanetwork.org						[Anonymous], 2020, CAL CRASH SHELT IN P; Anthony T, 2020, AP NEWS         0527; Baum A, 2020, JAMA-J AM MED ASSOC, V324, P96, DOI 10.1001/jama.2020.9972; Boserup B, 2020, AM J EMERG MED, V38, P2753, DOI 10.1016/j.ajem.2020.04.077; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gill JR, 2020, JAMA-J AM MED ASSOC, V324, P27, DOI 10.1001/jama.2020.9536; McGinty EE, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.9740, DOI 10.1001/JAMA.2020.974032492088]; Sakamoto H, 2020, JAMA-J AM MED ASSOC, V323, P1969, DOI 10.1001/jama.2020.6173; Santos-Lozada AR, 2018, JAMA-J AM MED ASSOC, V320, P1491, DOI 10.1001/jama.2018.10929; Sharfstein JM, 2020, JAMA-J AM MED ASSOC, V324, P133, DOI 10.1001/jama.2020.10175; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P510, DOI 10.1001/jama.2020.11787	12	36	37	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					458	459		10.1001/jama.2020.11761	http://dx.doi.org/10.1001/jama.2020.11761			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32609308	Bronze			2022-12-28	WOS:000561261900016
J	Janke, K; Biester, K; Krause, D; Richter, B; Schurmann, C; Hirsch, K; Horn, H; Kerekes, MF; Kohlepp, P; Wieseler, B				Janke, Kirsten; Biester, Katharina; Krause, Dietmar; Richter, Bernd; Schuermann, Christoph; Hirsch, Katharina; Hoern, Helmut; Kerekes, Michaela Florina; Kohlepp, Petra; Wieseler, Beate			Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PERSPECTIVE; REMISSION; OUTCOMES; TRIAL	OBJECTIVE To assess the comparative effectiveness of biological medicines in rheumatoid arthritis in sufficiently similar patient populations, based on the current definitions of key outcomes. DESIGN Systematic review and network meta-analysis including aggregate results from reanalysed individual patient data. DATA SOURCES Clinical study reports and aggregate results from reanalyses of individual patient data on key outcomes for rheumatoid arthritis provided by study sponsors for studies conducted up to 2017, and several databases and registries from inception up to February 2017. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials investigating patient relevant outcomes in adults with rheumatoid arthritis treated with biological medicines in combination with methotrexate after methotrexate failure for at least 24 weeks. RESULTS 45 eligible trials were identified. Combining data from clinical study reports and aggregate results from reanalyses of individual patient data allowed extensive analyses yielding sufficiently similar populations and homogeneous study results for network meta-analyses, including up to 35 studies on eight biological medicines combined with methotrexate. These analyses showed few statistically significant differences between the combination treatments. For example, anakinra showed less benefit than almost all the other seven biological medicines regarding clinical remission or low disease activity (clinical disease activity index <= 2.8 or <= 10, respectively) and certolizumab pegol showed more harm than the other seven biological medicines regarding serious adverse events or infections. Some outcomes had very wide 95% confidence intervals, potentially implying unidentified differences between the eight biological medicines, but wide 95% confidence intervals were less prominent for low disease activity, serious adverse events, and infections. Owing to a lack of head-to-head trials, results were mainly based on indirect comparisons with a limited number of studies, and recently approved Janus kinase inhibitors could not be included. CONCLUSIONS For patients with rheumatoid arthritis after methotrexate failure, only minor differences in benefits and harms were seen between biological medicines in combination with methotrexate. However, the analysis was hampered by a lack of long term direct comparisons. The substantial information gain achieved by the reanalysis of individual patient data calls for the routine availability of individual patient data.	[Janke, Kirsten; Biester, Katharina; Hoern, Helmut; Kerekes, Michaela Florina; Kohlepp, Petra; Wieseler, Beate] Inst Qual & Efficiency Hlth Care, Drug Assessment Dept, Mediapk 8, D-50670 Cologne, Germany; [Schuermann, Christoph; Hirsch, Katharina] Inst Qual & Efficiency Hlth Care, Med Biometry Dept, Cologne, Germany; [Krause, Dietmar] Rheumatol Practice Gladbeck, Gladbeck, Germany; [Richter, Bernd] Heinrich Heine Univ Dusseldorf, Fac Med, Inst Gen Practice, Cochrane Metab & Endocrine Disorders Grp, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Wieseler, B (corresponding author), Inst Qual & Efficiency Hlth Care, Drug Assessment Dept, Mediapk 8, D-50670 Cologne, Germany.	beate.wieseler@icjwig.de		Janke, Kirsten/0000-0002-7818-0123; Wieseler, Beate/0000-0002-3519-754X	Institute for Quality and Efficiency in Health Care	Institute for Quality and Efficiency in Health Care	This work was supported by the Institute for Quality and Efficiency in Health Care. No external financial support was received. Eight of the 10 authors are IQWiG employees and (as the remaining two authors) were involved in the study design and in the collection, analysis, and interpretation of data as well as in the writing of the report and the decision to submit the article for publication.	Ahlmen M, 2005, RHEUMATOLOGY, V44, P105, DOI 10.1093/rheumatology/keh412; Bierer BE, 2016, NEW ENGL J MED, V374, P2411, DOI 10.1056/NEJMp1605348; Bruce Bonnie, 2003, Health Qual Life Outcomes, V1, P20, DOI 10.1186/1477-7525-1-20; Cope S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-93; Deeks JJ, 2019, COCHRANE HDB SYSTEMA; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Donegan S, 2013, RES SYNTH METHODS, V4, P291, DOI 10.1002/jrsm.1085; Efthimiou O, 2016, RES SYNTH METHODS, V7, P236, DOI 10.1002/jrsm.1195; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Glinatsi D, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1891-x; Hazlewood GS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010227.pub2; Hazlewood GS, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1777; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2017, TOF RHEUM ARTHR; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2017, GEN METH VERS 5 0; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2013, BIOT PROD DRUGS 2 LI; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2017, SAR RHEUM ARTH; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2019, BIOT HERG WIRKST RHE; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2017, BAR RHEUM ARTHR; Ioannidis JPA, 2013, NAT REV RHEUMATOL, V9, P665, DOI 10.1038/nrrheum.2013.134; Kirwan JR, 2007, J RHEUMATOL, V34, P1174; Kohler M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h796; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Mbuagbaw L, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0473-z; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Robert Koch-Institut, 2015, GES DEUTSCHL; Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058; Rutherford AI, 2018, ANN RHEUM DIS, V77, P905, DOI 10.1136/annrheumdis-2017-212825; Salanti G, 2019, RANKING MULITIPLE HL, P169; Sanderson T, 2010, ARTHRIT CARE RES, V62, P640, DOI 10.1002/acr.20034; Scutellari PN, 1998, EUR J RADIOL, V27, pS31, DOI 10.1016/S0720-048X(98)00040-0; Singh JA, 2017, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD012591; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Singh JA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012657; Singh JA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012437; Singh JA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012183; Smolen JS, 2020, ANN RHEUM DIS, V79, P685, DOI 10.1136/annrheumdis-2019-216655; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2014, ANN RHEUM DIS, V73, P3, DOI 10.1136/annrheumdis-2013-204317; Smolen JS, 2011, ARTHRITIS RHEUM-US, V63, P43, DOI 10.1002/art.27740; Taichman DB, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001950; Veroniki AA, 2018, J CLIN EPIDEMIOL, V100, P122, DOI 10.1016/j.jclinepi.2018.02.009; Watts R, 2009, OXFORD DESK REFERENC, DOI [10.1093/med/9780199229994.001.0001, DOI 10.1093/MED/9780199229994.001.0001]; Wieseler B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8141; Young A, 2000, RHEUMATOLOGY, V39, P603, DOI 10.1093/rheumatology/39.6.603	45	17	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2288	10.1136/bmj.m2288	http://dx.doi.org/10.1136/bmj.m2288			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636183	Green Published, hybrid			2022-12-28	WOS:000548155700008
J	Voelker, R				Voelker, Rebecca			New Diagnostic Agent Detects Tau Pathology in the Brain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					19	19		10.1001/jama.2020.11003	http://dx.doi.org/10.1001/jama.2020.11003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633788				2022-12-28	WOS:000568123600006
J	Thornton, J				Thornton, Jacqui			Covid-19: Lack of testing in Brazil is a "major failure," says MSF	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Frontieres MS, MSF RESPONSE CORONAV; Frontieres MS, 2020, BRAZILS COVID 19 NIG; WHO, 2020, COR SIT REP	3	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2020	370								m2659	10.1136/bmj.m2659	http://dx.doi.org/10.1136/bmj.m2659			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MM0GY	32616564	Bronze			2022-12-28	WOS:000549840000002
J	Sarkar, S				Sarkar, Sonia			Religious discrimination is hindering the covid-19 response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												26.sarkar@gmail.com						Akbar SZ, 2020, TEMPORAL PATTERNS CO; [Anonymous], 2020, VIDEO 2 MUSLIM MEN A; [Anonymous], 2020, CESNUR HUMAN RIGHTS; [Anonymous], 2020, SCROLL; [Anonymous], 2020, BBC URDU        0318; [Anonymous], 2020, NEW INDIAN EXPR 0515; [Anonymous], 2020, WIRE; Bhardwaj A., 2020, TABLIGHI JAMAAT CHIE; Equality Labs, 2020, STOPCOVIDISLAMAPHOBI; Iyer A., 2020, QUINT           0413; Mirza JA, 2020, PAKISTANS HAZARA SHI	11	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2280	10.1136/bmj.m2280	http://dx.doi.org/10.1136/bmj.m2280			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601047	Bronze			2022-12-28	WOS:000548112700013
J	Head, E; Ances, B				Head, Elizabeth; Ances, Beau			Biomarkers in Down syndrome can help us understand Alzheimer's disease	LANCET			English	Editorial Material							ADULTS		[Head, Elizabeth] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Ances, Beau] Washington Univ, Dept Neurol, St Louis, MO 63110 USA	University of California System; University of California Irvine; Washington University (WUSTL)	Head, E (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA.	heade@uci.edu						Cohen AD, 2018, ALZHEIMERS DEMENT, V14, P743, DOI 10.1016/j.jalz.2018.01.002; Fortea J, 2020, LANCET, V395, P1988, DOI 10.1016/S0140-6736(20)30689-9; Head E, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0499-4; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Lee JH, 2017, NEUROBIOL AGING, V56, P150, DOI 10.1016/j.neurobiolaging.2017.04.018; Lott IT, 2019, NAT REV NEUROL, V15, P135, DOI 10.1038/s41582-018-0132-6; Mapstone M, 2020, ALZHEIMERS DEMENT, V12; Petersen M, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12023; Rafii MS, 2016, CNS DRUGS, V30, P567, DOI 10.1007/s40263-016-0353-4; Schupf N, 2018, FREE RADICAL BIO MED, V114, P62, DOI 10.1016/j.freeradbiomed.2017.08.019; Strydom Andre, 2018, Alzheimers Dement (N Y), V4, P703, DOI 10.1016/j.trci.2018.10.006; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Zigman WB, 2008, INT REV RES MENT RET, V36, P103, DOI 10.1016/S0074-7750(08)00004-9	13	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2020	395	10242					1951	1953						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MJ0ZZ	32593327	hybrid			2022-12-28	WOS:000547825600019
J	Pettifor, A				Pettifor, Ann			Rebuild the ramshackle global financial system	NATURE			English	Editorial Material						Economics; Government; Society; Policy		Economic researchers neglect the role of financialization in global existential crises. Economic researchers neglect the role of financialization in global existential crises.				ann.pettifor@primeeconomics.org							0	0	0	4	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					461	461		10.1038/d41586-020-01507-1	http://dx.doi.org/10.1038/d41586-020-01507-1			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB5RX	32576994				2022-12-28	WOS:000542661100002
J	Wu, K; Hirsch, LJ; Babl, FE; Josephson, SA				Wu, Ken; Hirsch, Lawrence J.; Babl, Franz E.; Josephson, S. Andrew			Choosing Anticonvulsant Medications to Manage Status Epilepticus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONVULSIVE STATUS EPILEPTICUS; 2ND-LINE TREATMENT; OPEN-LABEL; LEVETIRACETAM; MULTICENTER; PHENYTOIN; CHILDREN		[Hirsch, Lawrence J.] Yale Univ, Sch Med, Dept Neurol, Div Epilepsy & EEG, New Haven, CT 06510 USA; [Hirsch, Lawrence J.] Yale Univ, Sch Med, Dept Neurol, Comprehens Epilepsy Ctr, New Haven, CT 06510 USA; [Babl, Franz E.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Emergency Dept,Royal Childrens Hosp, Melbourne, Vic, Australia; [Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Josephson, S. Andrew] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA; [Josephson, S. Andrew] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA	Yale University; Yale University; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hirsch, LJ (corresponding author), Yale Univ, Sch Med, Dept Neurol, Div Epilepsy & EEG, New Haven, CT 06510 USA.; Hirsch, LJ (corresponding author), Yale Univ, Sch Med, Dept Neurol, Comprehens Epilepsy Ctr, New Haven, CT 06510 USA.			Hirsch, Lawrence/0000-0002-6333-832X				Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Chaves J, 2005, EPILEPSIA, V46, P133, DOI 10.1111/j.1528-1167.2005.00325.x; Dalziel SR, 2019, LANCET, V393, P2135, DOI 10.1016/S0140-6736(19)30722-6; Food and Drug Administration, 2009, INF HEALTHC PROF RIS; Fujikawa TG, 2000, EPILEPSIA, V41, P981, DOI 10.1111/j.1528-1157.2000.tb00283.x; Gaffield ME, 2011, CONTRACEPTION, V83, P16, DOI 10.1016/j.contraception.2010.06.013; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Hirsch LJ, 2008, NEUROLOGY, V71, P1527, DOI 10.1212/01.wnl.0000334295.50403.4c; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Kapur J, 2019, NEW ENGL J MED, V381, P2103, DOI 10.1056/NEJMoa1905795; Lyttle MD, 2019, LANCET, V393, P2125, DOI 10.1016/S0140-6736(19)30724-X; Nass RD, 2017, SEIZURE-EUR J EPILEP, V47, P51, DOI 10.1016/j.seizure.2017.02.013; Navarro V, 2016, LANCET NEUROL, V15, P47, DOI 10.1016/S1474-4422(15)00296-3; Fernandez IS, 2019, NEUROLOGY, V92, pE2339, DOI 10.1212/WNL.0000000000007503; Sazgar Mona, 2019, Continuum (Minneap Minn), V25, P408, DOI 10.1212/CON.0000000000000713; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202	16	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2569	2572		10.1056/NEJMclde2004317	http://dx.doi.org/10.1056/NEJMclde2004317			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9CW	32579819				2022-12-28	WOS:000545636400029
J	Griffin, S				Griffin, Shaun			Covid-19: Continued outbreaks in care homes risk extending pandemic, say experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					Garside J., 2020, GUARDIAN; GRIFFIN S, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2039; Griffin S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2310	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2020	369								m2530	10.1136/bmj.m2530	http://dx.doi.org/10.1136/bmj.m2530			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1US	32580958	Bronze			2022-12-28	WOS:000548572500003
J	Saevarsdottir, S; Olafsdottir, TA; Ivarsdottir, EV; Halldorsson, GH; Gunnarsdottir, K; Sigurdsson, A; Johannesson, A; Sigurdsson, JK; Juliusdottir, T; Lund, SH; Arnthorsson, AO; Styrmisdottir, EL; Gudmundsson, J; Grondal, GM; Steinsson, K; Alfredsson, L; Askling, J; Benediktsson, R; Bjarnason, R; Geirsson, AJ; Gudbjornsson, B; Gudjonsson, H; Hjaltason, H; Hreidarsson, AB; Klareskog, L; Kockum, I; Kristjansdottir, H; Love, TJ; Ludviksson, BR; Olsson, T; Onundarson, PT; Orvar, KB; Padyukov, L; Sigurgeirsson, B; Tragante, V; Bjarnadottir, K; Rafnar, T; Masson, G; Sulem, P; Gudbjartsson, DF; Melsted, P; Thorleifsson, G; Norddahl, GL; Thorsteinsdottir, U; Jonsdottir, I; Stefansson, K				Saevarsdottir, Saedis; Olafsdottir, Thorunn A.; Ivarsdottir, Erna V.; Halldorsson, Gisli H.; Gunnarsdottir, Kristbjorg; Sigurdsson, Asgeir; Johannesson, Ari; Sigurdsson, Jon K.; Juliusdottir, Thorhildur; Lund, Sigrun H.; Arnthorsson, Asgeir O.; Styrmisdottir, Edda L.; Gudmundsson, Julius; Grondal, Gerdur M.; Steinsson, Kristjan; Alfredsson, Lars; Askling, Johan; Benediktsson, Rafn; Bjarnason, Ragnar; Geirsson, Arni J.; Gudbjornsson, Bjorn; Gudjonsson, Hallgrimur; Hjaltason, Haukur; Hreidarsson, Astradur B.; Klareskog, Lars; Kockum, Ingrid; Kristjansdottir, Helga; Love, Thorvardur J.; Ludviksson, Bjorn R.; Olsson, Tomas; Onundarson, Pall T.; Orvar, Kjartan B.; Padyukov, Leonid; Sigurgeirsson, Bardur; Tragante, Vinicius; Bjarnadottir, Kristbjorg; Rafnar, Thorunn; Masson, Gisli; Sulem, Patrick; Gudbjartsson, Daniel F.; Melsted, Pall; Thorleifsson, Gudmar; Norddahl, Gudmundur L.; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari			FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease	NATURE			English	Article							GENOME-WIDE ASSOCIATION; DENDRITIC CELL-DEVELOPMENT; LOCI; HYPOTHYROIDISM; VARIANTS; POWER	Autoimmune thyroid disease is the most common autoimmune disease and is highly heritable(1). Here, by using a genome-wide association study of 30,234 cases and 725,172 controls from Iceland and the UK Biobank, we find 99 sequence variants at 93 loci, of which 84 variants are previously unreported(2-7). A low-frequency (1.36%) intronic variant in FLT3 (rs76428106-C) has the largest effect on risk of autoimmune thyroid disease (odds ratio (OR) = 1.46, P = 2.37 x 10(-24)). rs76428106-C is also associated with systemic lupus erythematosus (OR = 1.90, P = 6.46 x 10(-4)), rheumatoid factor and/or anti-CCP-positive rheumatoid arthritis (OR = 1.41, P = 4.31 x 10(-4)) and coeliac disease (OR = 1.62, P = 1.20 x 10(-4)). FLT3 encodes fms-related tyrosine kinase 3, a receptor that regulates haematopoietic progenitor and dendritic cells. RNA sequencing revealed that rs76428106-C generates a cryptic splice site, which introduces a stop codon in 30% of transcripts that are predicted to encode a truncated protein, which lacks its tyrosine kinase domains. Each copy of rs76428106-C doubles the plasma levels of the FTL3 ligand. Activating somatic mutations in FLT3 are associated with acute myeloid leukaemia(8) with a poor prognosis and rs76428106-C also predisposes individuals to acute myeloid leukaemia (OR = 1.90, P = 5.40 x 10(-3)). Thus, a predicted loss-of-function germline mutation in FLT3 causes a reduction in full-length FLT3, with a compensatory increase in the levels of its ligand and an increased disease risk, similar to that of a gain-of-function mutation. A predicted loss-of-function germline mutation in FLT3 causes a reduction in full-length FLT3, with a compensatory increase in the levels of FLT3 ligand, leading to increased risk of autoimmune thyroid disease.	[Saevarsdottir, Saedis; Olafsdottir, Thorunn A.; Ivarsdottir, Erna V.; Halldorsson, Gisli H.; Gunnarsdottir, Kristbjorg; Sigurdsson, Asgeir; Sigurdsson, Jon K.; Juliusdottir, Thorhildur; Lund, Sigrun H.; Arnthorsson, Asgeir O.; Styrmisdottir, Edda L.; Gudmundsson, Julius; Tragante, Vinicius; Bjarnadottir, Kristbjorg; Rafnar, Thorunn; Masson, Gisli; Sulem, Patrick; Gudbjartsson, Daniel F.; Melsted, Pall; Thorleifsson, Gudmar; Norddahl, Gudmundur L.; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari] deCODE genet Amgen, Reykjavik, Iceland; [Saevarsdottir, Saedis; Askling, Johan; Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Dept Med, Stockholm, Sweden; [Saevarsdottir, Saedis; Olafsdottir, Thorunn A.; Grondal, Gerdur M.; Steinsson, Kristjan; Benediktsson, Rafn; Bjarnason, Ragnar; Geirsson, Arni J.; Gudbjornsson, Bjorn; Gudjonsson, Hallgrimur; Hjaltason, Haukur; Hreidarsson, Astradur B.; Love, Thorvardur J.; Ludviksson, Bjorn R.; Onundarson, Pall T.; Orvar, Kjartan B.; Sigurgeirsson, Bardur; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland; [Saevarsdottir, Saedis; Johannesson, Ari; Grondal, Gerdur M.; Steinsson, Kristjan; Benediktsson, Rafn; Geirsson, Arni J.; Gudjonsson, Hallgrimur; Hreidarsson, Astradur B.; Orvar, Kjartan B.] Natl Univ Hosp Iceland, Dept Med, Landspitali, Reykjavik, Iceland; [Ivarsdottir, Erna V.; Gudbjartsson, Daniel F.; Melsted, Pall] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Grondal, Gerdur M.; Steinsson, Kristjan; Gudbjornsson, Bjorn; Kristjansdottir, Helga] Natl Univ Hosp Iceland, Ctr Rheumatol Res, Landspitali, Reykjavik, Iceland; [Steinsson, Kristjan; Love, Thorvardur J.] Iceland Med Ctr, Reykjavik, Iceland; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Bjarnason, Ragnar] Natl Univ Hosp Iceland, Childrens Med Ctr, Landspitali, Reykjavik, Iceland; [Hjaltason, Haukur] Natl Univ Hosp Iceland, Dept Neurol, Landspitali, Reykjavik, Iceland; [Kockum, Ingrid; Olsson, Tomas] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Stockholm, Sweden; [Love, Thorvardur J.] Natl Univ Hosp Iceland, Dept Sci, Landspitali, Reykjavik, Iceland; [Ludviksson, Bjorn R.; Jonsdottir, Ingileif] Natl Univ Hosp Iceland, Dept Immunol, Landspitali, Reykjavik, Iceland; [Onundarson, Pall T.] Natl Univ Hosp Iceland, Dept Hematol, Landspitali, Reykjavik, Iceland	Karolinska Institutet; University of Iceland; University of Iceland; Karolinska Institutet; Karolinska Institutet	Saevarsdottir, S; Stefansson, K (corresponding author), deCODE genet Amgen, Reykjavik, Iceland.; Saevarsdottir, S (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.; Saevarsdottir, S; Stefansson, K (corresponding author), Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland.; Saevarsdottir, S (corresponding author), Natl Univ Hosp Iceland, Dept Med, Landspitali, Reykjavik, Iceland.	saedis.saevarsdottir@decode.is; kstefans@decode.is	Lúðvíksson, Björn Rúnar/AFQ-7993-2022; Kockum, Ingrid/O-8781-2018; Lund, Sigrún Helga/AAG-6042-2019; Benediktsson, Rafn/R-2457-2018; Bjarnason, Ragnar/M-2375-2015	Kockum, Ingrid/0000-0002-0867-4726; Lund, Sigrún Helga/0000-0002-3806-2296; Sigurgeirsson, Bardur/0000-0002-9733-9742; Gudbjornsson, Bjorn/0000-0003-4631-6505; Olafsdottir, Thorunn/0000-0001-5454-938X; Benediktsson, Rafn/0000-0002-2954-9801; Bjarnason, Ragnar/0000-0002-7121-9689; Halldorsson, Gisli/0000-0001-7067-9862; Love, THorvardur Jon/0000-0002-2680-6120; Olsson, Tomas/0000-0002-2938-1877; Askling, Johan/0000-0003-0433-0616; Saevarsdottir, Saedis/0000-0001-9392-6184	NORDFORSK; Swedish Research Council	NORDFORSK; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank the individuals who participated in this study and the staff at the Icelandic Patient Recruitment Center, the deCODE genetics core facilities, SRQ-Biobank, EIRA and EIMS study secretary in Sweden, as well as funding from NORDFORSK and the Swedish Research Council; all our colleagues who contributed to the data collection and phenotypic characterization of clinical samples as well as to the genotyping and analysis of the whole-genome association data. This research has been conducted using the UK Biobank Resource (application number 24711) and the study was approved by the National Bioethics Committees in Iceland (IRB approval no. VSN-16-042) and Sweden (IRB approval no. 96-174, 2006/476-31/4, 2007/889-31/2 and 2015.1746-31.4).	Antonelli A, 2015, AUTOIMMUN REV, V14, P174, DOI 10.1016/j.autrev.2014.10.016; Benonisdottir S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13490; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Boddu PC, 2019, BEST PRACT RES CL HA, V32, P74, DOI 10.1016/j.beha.2019.02.002; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burch HB, 2019, NEW ENGL J MED, V381, P749, DOI 10.1056/NEJMra1901214; Chen YL, 2013, J EXP MED, V210, P2515, DOI 10.1084/jem.20130536; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Cope AP, 2019, CLIN THER, V41, P1299, DOI 10.1016/j.clinthera.2019.04.014; Daver N, 2019, LEUKEMIA, V33, P299, DOI 10.1038/s41375-018-0357-9; Dehlin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003633; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Fallahi P, 2019, BEST PRACT RES CL EN, V33, DOI 10.1016/j.beem.2019.101372; Gaitonde DY, 2012, AM FAM PHYSICIAN, V86, P244; Gudbjartsson DF, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.11; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; HOLM LE, 1985, NEW ENGL J MED, V312, P601, DOI 10.1056/NEJM198503073121001; Horwitz DA, 2019, TRENDS IMMUNOL, V40, P888, DOI 10.1016/j.it.2019.08.003; Hwangbo Y, 2018, ENDOCRINOL METAB, V33, P175, DOI 10.3803/EnM.2018.33.2.175; Jain D, 2017, HUM MOL GENET, V26, P1193, DOI 10.1093/hmg/ddx024; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Luo Y, 2017, NAT GENET, V49, P186, DOI 10.1038/ng.3761; Maraskovsky E, 2000, BLOOD, V96, P878, DOI 10.1182/blood.V96.3.878.015k15_878_884; Muskardin TLW, 2018, NAT REV RHEUMATOL, V14, P214, DOI 10.1038/nrrheum.2018.31; Musumeci A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01222; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Ramos MI, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4403; Sandhofer N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28032; Sigurdardottir LG, 2012, ACTA ONCOL, V51, P880, DOI 10.3109/0284186X.2012.698751; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Styrkarsdottir U, 2018, NAT GENET, V50, P1681, DOI 10.1038/s41588-018-0247-0; Suhre K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14357; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Sveinbjornsson G, 2016, NAT GENET, V48, P314, DOI 10.1038/ng.3507; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Vasu C, 2003, J IMMUNOL, V170, P5511, DOI 10.4049/jimmunol.170.11.5511; Welsh S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3391-x; Wu YD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09572-5; Zhao SX, 2013, HUM MOL GENET, V22, P3347, DOI 10.1093/hmg/ddt183	44	32	32	3	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 27	2020	584	7822					619	+		10.1038/s41586-020-2436-0	http://dx.doi.org/10.1038/s41586-020-2436-0		JUN 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP5LD	32581359				2022-12-28	WOS:000556406300001
J	Raymond, FL				Raymond, F. Lucy			Clinical Genomics in Critically Ill Infants and Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Cambridge Biomed Campus, Cambridge CB2 OXY, England	University of Cambridge	Raymond, FL (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge Biomed Campus, Cambridge CB2 OXY, England.	flr24@cam.ac.uk						Braithwaite J, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1057-z; Carss KJ, 2017, AM J HUM GENET, V100, P75, DOI 10.1016/j.ajhg.2016.12.003; Chen X, 2020, GENET MED, V22, P945, DOI 10.1038/s41436-020-0754-0; Dolzhenko E, 2019, BIOINFORMATICS, V35, P4754, DOI 10.1093/bioinformatics/btz431; Farnaes L, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0049-4; French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x; Greenhalgh T, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2068; Gubbels CS, 2020, GENET MED, V22, P736, DOI 10.1038/s41436-019-0708-6; Lunke S, 2020, JAMA-J AM MED ASSOC, V323, P2503, DOI 10.1001/jama.2020.7671; National Center for Biotechnology Information US National Library of Medicine, OMIM DAT; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ross LF, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1031; Sanchis-Juan A, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0606-6; Sanford EF, 2019, PEDIATR CRIT CARE ME, V20, P1007, DOI 10.1097/PCC.0000000000002056; Schwarze K, 2018, GENET MED, V20, P1122, DOI 10.1038/gim.2017.247	15	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2480	2482		10.1001/jama.2020.8112	http://dx.doi.org/10.1001/jama.2020.8112			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32573653				2022-12-28	WOS:000590149400018
J	Mahase, E				Mahase, Elisabeth			Covid-19: Ethnic minority doctors feel more pressured and less protected than white colleagues, survey finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2390; Iacobucci G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2264; Iacobucci G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1820	3	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2506	10.1136/bmj.m2506	http://dx.doi.org/10.1136/bmj.m2506			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571793	Bronze			2022-12-28	WOS:000548535700002
J	Mahase, E				Mahase, Elisabeth			Covid-19: Local health teams trace eight times more contacts than national service	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2020, NHS TEST TRAC EXP ST; Mueller B, 2020, NY TIMES; ONS, 2020, COR COV 19 INF SURV	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2486	10.1136/bmj.m2486	http://dx.doi.org/10.1136/bmj.m2486			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571795	Bronze			2022-12-28	WOS:000548535700005
J	Palmer, J				Palmer, Joanna			Framing health stories: Highlights 2020 photography competition open for submissions	LANCET			English	Editorial Material									[Palmer, Joanna] The Lancet, London EC2Y 5AS, England		Palmer, J (corresponding author), The Lancet, London EC2Y 5AS, England.	joanna.palmer@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1893	1893						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563360	Green Published, Bronze			2022-12-28	WOS:000552732200011
J	Ellinghaus, D; Degenhardt, F; Bujanda, L; Buti, M; Albillos, A; Invernizzi, P; Fernandez, J; Prati, D; Baselli, G; Asselta, R; Grimsrud, MM; Milani, C; Aziz, F; Kassens, J; May, S; Wendorff, M; Wienbrandt, L; Uellendahl-Werth, F; Zheng, TH; Yi, XL; de Pablo, R; Chercoles, AG; Palom, A; Garcia-Fernandez, AE; Rodriguez-Frias, F; Zanella, A; Bandera, A; Protti, A; Aghemo, A; Lleo, A; Biondi, A; Caballero-Garralda, A; Gori, A; Tanck, A; Nolla, AC; Latiano, A; Fracanzani, AL; Peschuck, A; Julia, A; Pesenti, A; Voza, A; Jimenez, D; Mateos, B; Jimenez, BN; Quereda, C; Paccapelo, C; Gassner, C; Angelini, C; Cea, C; Solier, A; Pestana, D; Muniz-Diaz, E; Sandoval, E; Paraboschi, EM; Navas, E; Sanchez, FG; Ceriotti, F; Martinelli-Boneschi, F; Peyvandi, F; Blasi, F; Tellez, L; Blanco-Grau, A; Hemmrich-Stanisak, G; Grasselli, G; Costantino, G; Cardamone, G; Foti, G; Aneli, S; Kurihara, H; ElAbd, H; My, I; Galvan-Femenia, I; Martin, J; Erdmann, J; Ferrusquia-Acosta, J; Garcia-Etxebarria, K; Izquierdo-Sanchez, L; Bettini, LR; Sumoy, L; Terranova, L; Moreira, L; Santoro, L; Scudeller, L; Mesonero, F; Roade, L; Ruhlemann, MC; Schaefer, M; Carrabba, M; Riveiro-Barciela, M; Basso, MEF; Valsecchi, MG; Hernandez-Tejero, M; Acosta-Herrera, M; D'Angio, M; Baldini, M; Cazzaniga, M; Schulzky, M; Cecconi, M; Wittig, M; Ciccarelli, M; Rodriguez-Gandia, M; Bocciolone, M; Miozzo, M; Montano, N; Braun, N; Sacchi, N; Martinez, N; Ozer, O; Palmieri, O; Faverio, P; Preatoni, P; Bonfanti, P; Omodei, P; Tentorio, P; Castro, P; Rodrigues, PM; Blandino, A; de Cid, R; Ferrer, R; Gualtierotti, R; Nieto, R; Goerg, S; Badalamenti, S; Marsal, S; Matullo, G; Pelusi, S; Juzenas, S; Aliberti, S; Monzani, V; Moreno, V; Wesse, T; Lenz, TL; Pumarola, T; Rimoldi, V; Bosari, S; Albrecht, W; Peter, W; Romero-Gomez, M; D'Amato, M; Duga, S; Banales, JM; Hov, JR; Folseraas, T; Valenti, L; Franke, A; Karlsen, TH				Ellinghaus, David; Degenhardt, Frauke; Bujanda, Luis; Buti, Maria; Albillos, Agustin; Invernizzi, Pietro; Fernandez, Javier; Prati, Daniele; Baselli, Guido; Asselta, Rosanna; Grimsrud, Marit M.; Milani, Chiara; Aziz, Fatima; Kassens, Jan; May, Sandra; Wendorff, Mareike; Wienbrandt, Lars; Uellendahl-Werth, Florian; Zheng, Tenghao; Yi, Xiaoli; de Pablo, Raul; Chercoles, Adolfo G.; Palom, Adriana; Garcia-Fernandez, Alba-Estela; Rodriguez-Frias, Francisco; Zanella, Alberto; Bandera, Alessandra; Protti, Alessandro; Aghemo, Alessio; Lleo, Ana; Biondi, Andrea; Caballero-Garralda, Andrea; Gori, Andrea; Tanck, Anja; Nolla, Anna Carreras; Latiano, Anna; Fracanzani, Anna Ludovica; Peschuck, Anna; Julia, Antonio; Pesenti, Antonio; Voza, Antonio; Jimenez, David; Mateos, Beatriz; Jimenez, Beatriz Nafria; Quereda, Carmen; Paccapelo, Cinzia; Gassner, Christoph; Angelini, Claudio; Cea, Cristina; Solier, Aurora; Pestana, David; Muniz-Diaz, Eduardo; Sandoval, Elena; Paraboschi, Elvezia M.; Navas, Enrique; Sanchez, Felix Garcia; Ceriotti, Ferruccio; Martinelli-Boneschi, Filippo; Peyvandi, Flora; Blasi, Francesco; Tellez, Luis; Blanco-Grau, Albert; Hemmrich-Stanisak, Georg; Grasselli, Giacomo; Costantino, Giorgio; Cardamone, Giulia; Foti, Giuseppe; Aneli, Serena; Kurihara, Hayato; ElAbd, Hesham; My, Ilaria; Galvan-Femenia, Ivan; Martin, Javier; Erdmann, Jeanette; Ferrusquia-Acosta, Jose; Garcia-Etxebarria, Koldo; Izquierdo-Sanchez, Laura; Bettini, Laura R.; Sumoy, Lauro; Terranova, Leonardo; Moreira, Leticia; Santoro, Luigi; Scudeller, Luigia; Mesonero, Francisco; Roade, Luisa; Ruhlemann, Malte C.; Schaefer, Marco; Carrabba, Maria; Riveiro-Barciela, Mar; Basso, Maria E. Figuera; Valsecchi, Maria G.; Hernandez-Tejero, Maria; Acosta-Herrera, Marialbert; D'Angio, Mariella; Baldini, Marina; Cazzaniga, Marina; Schulzky, Martin; Cecconi, Maurizio; Wittig, Michael; Ciccarelli, Michele; Rodriguez-Gandia, Miguel; Bocciolone, Monica; Miozzo, Monica; Montano, Nicola; Braun, Nicole; Sacchi, Nicoletta; Martinez, Nilda; Ozer, Onur; Palmieri, Orazio; Faverio, Paola; Preatoni, Paoletta; Bonfanti, Paolo; Omodei, Paolo; Tentorio, Paolo; Castro, Pedro; Rodrigues, Pedro M.; Blandino, Aaron; de Cid, Rafael; Ferrer, Ricard; Gualtierotti, Roberta; Nieto, Rosa; Goerg, Siegfried; Badalamenti, Salvatore; Marsal, Sara; Matullo, Giuseppe; Pelusi, Serena; Juzenas, Simonas; Aliberti, Stefano; Monzani, Valter; Moreno, Victor; Wesse, Tanja; Lenz, Tobias L.; Pumarola, Tomas; Rimoldi, Valeria; Bosari, Silvano; Albrecht, Wolfgang; Peter, Wolfgang; Romero-Gomez, Manuel; D'Amato, Mauro; Duga, Stefano; Banales, Jesus M.; Hov, Johannes R.; Folseraas, Trine; Valenti, Luca; Franke, Andre; Karlsen, Tom H.		Severe Covid-19 GWAS Grp	Genomewide Association Study of Severe Covid-19 with Respiratory Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ABO BLOOD-GROUP; WIDE ASSOCIATION; SUSCEPTIBILITY; METAANALYSIS; INFECTION; INCREASES; NUMBER; ACE2	BackgroundThere is considerable variation in disease behavior among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19). Genomewide association analysis may allow for the identification of potential genetic factors involved in the development of Covid-19. MethodsWe conducted a genomewide association study involving 1980 patients with Covid-19 and severe disease (defined as respiratory failure) at seven hospitals in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe. After quality control and the exclusion of population outliers, 835 patients and 1255 control participants from Italy and 775 patients and 950 control participants from Spain were included in the final analysis. In total, we analyzed 8,582,968 single-nucleotide polymorphisms and conducted a meta-analysis of the two case-control panels. ResultsWe detected cross-replicating associations with rs11385942 at locus 3p21.31 and with rs657152 at locus 9q34.2, which were significant at the genomewide level (P<5x10(-8)) in the meta-analysis of the two case-control panels (odds ratio, 1.77; 95% confidence interval [CI], 1.48 to 2.11; P=1.15x10(-10); and odds ratio, 1.32; 95% CI, 1.20 to 1.47; P=4.95x10(-8), respectively). At locus 3p21.31, the association signal spanned the genes SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6 and XCR1. The association signal at locus 9q34.2 coincided with the ABO blood group locus; in this cohort, a blood-group-specific analysis showed a higher risk in blood group A than in other blood groups (odds ratio, 1.45; 95% CI, 1.20 to 1.75; P=1.48x10(-4)) and a protective effect in blood group O as compared with other blood groups (odds ratio, 0.65; 95% CI, 0.53 to 0.79; P=1.06x10(-5)). ConclusionsWe identified a 3p21.31 gene cluster as a genetic susceptibility locus in patients with Covid-19 with respiratory failure and confirmed a potential involvement of the ABO blood-group system. (Funded by Stein Erik Hagen and others.) During the peak of hospitalizations of patients with severe Covid-19 in Italy and Spain in March, a group of researchers in these and other countries obtained and analyzed samples, resulting in the identification of two chromosomal loci associated with the disorder.	[Ellinghaus, David; Degenhardt, Frauke; Kassens, Jan; May, Sandra; Wendorff, Mareike; Wienbrandt, Lars; Uellendahl-Werth, Florian; Yi, Xiaoli; Tanck, Anja; Peschuck, Anna; Gassner, Christoph; Hemmrich-Stanisak, Georg; Ruhlemann, Malte C.; Basso, Maria E. Figuera; Schulzky, Martin; Wittig, Michael; Braun, Nicole; Juzenas, Simonas; Wesse, Tanja; Albrecht, Wolfgang; D'Amato, Mauro; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany; [Braun, Nicole; Franke, Andre] Univ Hosp Schleswig Holstein, Campus Kiel, Kiel, Germany; [Erdmann, Jeanette] Univ Lubeck, Inst Cardiogenet, Lubeck, Germany; [Erdmann, Jeanette] German Res Ctr Cardiovasc Res, Partner Site Hamburg Lubeck Kiel, Lubeck, Germany; [Erdmann, Jeanette] Univ Heart Ctr Lubeck, Lubeck, Germany; [Goerg, Siegfried] Univ Hosp Schleswig Holstein, Inst Transfus Med, Lubeck, Germany; [Schaefer, Marco; Peter, Wolfgang] Stefan Morsch Stiftung, Birkenfeld, Germany; [Ozer, Onur; Lenz, Tobias L.] Max Planck Inst Evolutionary Biol, Res Grp Evolutionary Immunogen, Plon, Germany; [Ellinghaus, David] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Dis Syst Biol, Copenhagen, Denmark; [Bujanda, Luis; Garcia-Etxebarria, Koldo; Izquierdo-Sanchez, Laura; Rodrigues, Pedro M.; Banales, Jesus M.] Univ Basque Country, Dept Liver & Gastrointestinal Dis, Biodonostia Hlth Res Inst, Donostia Univ Hospital, San Sebastian, Spain; [Chercoles, Adolfo G.; Jimenez, Beatriz Nafria] Donostialdea Integrated Hlth Org, Osakidetza Basque Hlth Serv, Clin Biochem Dept, San Sebastian, Spain; [D'Amato, Mauro] Biodonostia Hlth Res Inst, Dept Liver & Gastrointestinal Dis, San Sebastian, Spain; [Bujanda, Luis; Buti, Maria; Albillos, Agustin; Palom, Adriana; Rodriguez-Frias, Francisco; Mateos, Beatriz; Tellez, Luis; Garcia-Etxebarria, Koldo; Izquierdo-Sanchez, Laura; Mesonero, Francisco; Roade, Luisa; Riveiro-Barciela, Mar; Rodriguez-Gandia, Miguel; Rodrigues, Pedro M.; Romero-Gomez, Manuel; Banales, Jesus M.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Albillos, Agustin; Mateos, Beatriz; Tellez, Luis; Mesonero, Francisco; Rodriguez-Gandia, Miguel] Univ Alcala, Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria, Dept Gastroenterol, Madrid, Spain; [de Pablo, Raul; Blanco-Grau, Albert] Univ Alcala, Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria, Dept Intens Care, Madrid, Spain; [Jimenez, David; Solier, Aurora; Nieto, Rosa] Univ Alcala, Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria, Dept Resp Dis, Madrid, Spain; [Quereda, Carmen; Navas, Enrique] Univ Alcala, Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria, Dept Infect Dis, Madrid, Spain; [Pestana, David; Martinez, Nilda] Univ Alcala, Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria, Dept Anesthesiol, Madrid, Spain; [Sanchez, Felix Garcia] Ctr Transfus Madrid, Histocompatibilidad & Biol Mol, Madrid, Spain; [Buti, Maria; Palom, Adriana; Roade, Luisa; Riveiro-Barciela, Mar] Univ Barcelona, Hosp Univ Vall dHebron, Liver Unit, Hosp Clin,Dept Internal Med, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain; [Fernandez, Javier; Aziz, Fatima; Sandoval, Elena; Ferrusquia-Acosta, Jose; Moreira, Leticia; Hernandez-Tejero, Maria; Castro, Pedro] August Pi & Sunyer Biomed Res Inst, Barcelona, Spain; [Fernandez, Javier] European Fdn Study Chron Liver Failure, Barcelona, Spain; [Palom, Adriana; Rodriguez-Frias, Francisco; Julia, Antonio; Marsal, Sara] Vall dHebron Inst Recerca, Barcelona, Spain; [Garcia-Fernandez, Alba-Estela; Rodriguez-Frias, Francisco; Caballero-Garralda, Andrea; Cea, Cristina; Blanco-Grau, Albert] Autonomous Univ Barcelona, Univ Hosp Vall dHebron, Immunohematol Dept, Dept Biochem,Banc Sang & Teixits, Barcelona, Spain; [Ferrer, Ricard] Autonomous Univ Barcelona, Univ Hosp Vall dHebron, Immunohematol Dept, Dept Intens Care,Banc Sang & Teixits, Barcelona, Spain; [Pumarola, Tomas] Autonomous Univ Barcelona, Univ Hosp Vall dHebron, Immunohematol Dept, Dept Microbiol,Banc Sang & Teixits, Barcelona, Spain; [Muniz-Diaz, Eduardo] Autonomous Univ Barcelona, Univ Hosp Vall dHebron, Immunohematol Dept, Banc Sang & Teixits, Barcelona, Spain; [Moreno, Victor] Consortium Biomed Res Epidemiol & Publ Hlth, Catalan Inst Oncol, Bellvitge Biomed Res Inst, Barcelona, Spain; [Moreno, Victor] Univ Barcelona, Barcelona, Spain; [Pumarola, Tomas] Autonoma Univ Barcelona, Barcelona, Spain; [Buti, Maria; Rodriguez-Frias, Francisco; Riveiro-Barciela, Mar] Univ Autonoma Barcelona, Bellaterra, Spain; [Nolla, Anna Carreras; Galvan-Femenia, Ivan; de Cid, Rafael] Germans Trias & Pujol Res Inst, GenomesForLife GCAT Lab Grp, Badalona, Spain; [Sumoy, Lauro] Germans Trias & Pujol Res Inst, High Content Genom & Bioinformat Unit, Badalona, Spain; [Martin, Javier; Acosta-Herrera, Marialbert] Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Romero-Gomez, Manuel] Univ Seville, Virgen Rocio Univ Hosp, Inst Biomed Seville, Digest Dis Unit, Seville, Spain; [D'Amato, Mauro; Banales, Jesus M.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Invernizzi, Pietro; Milani, Chiara] Univ Milano Bicocca, Div Gastroenterol, Dept Med & Surg, Ctr Autoimmune Liver Dis, Milan, Italy; [Prati, Daniele; Baselli, Guido; Zanella, Alberto; Bandera, Alessandra; Gori, Andrea; Fracanzani, Anna Ludovica; Pesenti, Antonio; Paccapelo, Cinzia; Ceriotti, Ferruccio; Martinelli-Boneschi, Filippo; Peyvandi, Flora; Blasi, Francesco; Grasselli, Giacomo; Costantino, Giorgio; Terranova, Leonardo; Santoro, Luigi; Scudeller, Luigia; Carrabba, Maria; Baldini, Marina; Miozzo, Monica; Montano, Nicola; Gualtierotti, Roberta; Pelusi, Serena; Aliberti, Stefano; Monzani, Valter; Bosari, Silvano; Valenti, Luca] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Asselta, Rosanna; Protti, Alessandro; Aghemo, Alessio; Lleo, Ana; Paraboschi, Elvezia M.; Cardamone, Giulia; Cecconi, Maurizio; Rimoldi, Valeria; Duga, Stefano] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Asselta, Rosanna; Protti, Alessandro; Aghemo, Alessio; Lleo, Ana; Voza, Antonio; Angelini, Claudio; Paraboschi, Elvezia M.; Kurihara, Hayato; My, Ilaria; Cecconi, Maurizio; Ciccarelli, Michele; Bocciolone, Monica; Preatoni, Paoletta; Omodei, Paolo; Tentorio, Paolo; Badalamenti, Salvatore; Duga, Stefano] IRCCS, Humanitas Clin & Res Ctr, Milan, Italy; [Zanella, Alberto; Bandera, Alessandra; Gori, Andrea; Fracanzani, Anna Ludovica; Pesenti, Antonio; Martinelli-Boneschi, Filippo; Peyvandi, Flora; Blasi, Francesco; Grasselli, Giacomo; Costantino, Giorgio; Miozzo, Monica; Montano, Nicola; Gualtierotti, Roberta; Pelusi, Serena; Aliberti, Stefano; Bosari, Silvano; Valenti, Luca] Univ Milan, Milan, Italy; [Valsecchi, Maria G.] Ctr Bioinformat Biostat & Bioimaging, Milan, Italy; [Cazzaniga, Marina] Univ Milano Bicocca, Phase 1 Res Ctr, Sch Med & Surg, Milan, Italy; [Foti, Giuseppe] Univ Milano Bicocca, Dept Emergency Anesthesia & Intens Care, Milan, Italy; [Faverio, Paola] Univ Milano Bicocca, Dept Pneumol, Milan, Italy; [Bonfanti, Paolo] Univ Milano Bicocca, Dept Infect Dis, Milan, Italy; [Invernizzi, Pietro; Milani, Chiara] San Gerardo Hosp, European Reference Network Hepatol Dis, Monza, Italy; [Bonfanti, Paolo] San Gerardo Hosp, Infect Dis Unit, Monza, Italy; [Biondi, Andrea; Bettini, Laura R.; D'Angio, Mariella] Univ Milano Bicocca, Fdn MBBM Osped, Pediat Dept, San Gerardo, Italy; [Biondi, Andrea; Bettini, Laura R.; D'Angio, Mariella] Univ Milano Bicocca, Fdn MBBM Osped, European Reference Network PaedCan, EuroBloodNet,MetabERN,Ctr Tettamanti, San Gerardo, Italy; [Latiano, Anna; Palmieri, Orazio] Fdn IRCCS Casa Sollievo Sofferenza, Gastroenterol Unit, San Giovanni Rotondo, Italy; [Aneli, Serena; Matullo, Giuseppe] Univ Torino, Dept Med Sci, Turin, Italy; [Sacchi, Nicoletta] EO Osped Galliera, Italian Bone Marrow Donor Registry, Genoa, Italy; [Grimsrud, Marit M.; Hov, Johannes R.; Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Div Surg Inflammatory Dis & Transplantat, Dept Transplantat Med, Rikshospitalet,Norwegian PSC Res Ctr, Oslo, Norway; [Grimsrud, Marit M.; Hov, Johannes R.; Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Internal Med Res Inst, Div Surg Inflammatory Dis & Transplantat, Rikshospitalet, Oslo, Norway; [Grimsrud, Marit M.; Hov, Johannes R.; Folseraas, Trine; Karlsen, Tom H.] Univ Oslo, Postboks 4950 Nydalen, N-0424 Oslo, Norway; [Hov, Johannes R.; Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Div Canc Med Surg & Transplantat, Sect Gastroenterol, Dept Transplantat Med,Rikshospitalet, Oslo, Norway; [Zheng, Tenghao; D'Amato, Mauro] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Gassner, Christoph] Private Univ Principal Liechtenstein, Vilnius, Lithuania; [Juzenas, Simonas] Vilnius Univ, Inst Biotechnol, Vilnius, Lithuania; [D'Amato, Mauro] Karolinska Inst, Dept Med Solna, Unit Clin Epidemiol, Stockholm, Sweden	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; German Centre for Cardiovascular Research; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; University of Copenhagen; Instituto de Investigacion Sanitaria Biodonostia; University of Basque Country; Instituto de Investigacion Sanitaria Biodonostia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Hospital Universitari Vall d'Hebron; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Basque Foundation for Science; University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; Humanitas University; University of Milan; University of Milano-Bicocca; University of Milano-Bicocca; University of Milano-Bicocca; University of Milano-Bicocca; San Gerardo Hospital; San Gerardo Hospital; University of Milano-Bicocca; University of Milano-Bicocca; University of Turin; Ente Ospedaliero Ospedali Galliera; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; Monash University; Vilnius University; Karolinska Institutet	Franke, A (corresponding author), Univ Kiel, Univ Hosp Schleswig Holstein, Rosalind Franklin Str 12, D-24105 Kiel, Germany.; Karlsen, TH (corresponding author), Oslo Univ Hosp, Div Surg Inflammatory Dis & Transplantat, Rikshospitalet, Postboks 4950 Nydalen, N-0424 Oslo, Norway.; Franke, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany.; Karlsen, TH (corresponding author), Univ Oslo, Postboks 4950 Nydalen, N-0424 Oslo, Norway.	a.franke@mucosa.de; t.h.karlsen@medisin.uio.no	De Santis, Maria/K-2644-2018; CANOS, AVELINO CORMA/A-3040-2013; Romero-Gomez, Manuel/L-8030-2014; Fedeli, Carlo/AAB-5357-2022; Desai, Antonio/ABB-4966-2020; Carrabba, Maria/AAM-5651-2020; Femenía, Iván Galván/AAU-2847-2021; Lleo, Ana/AAA-5759-2019; Scudeller, Luigia/K-9625-2014; Bujanda, Luis/AAB-2485-2021; Rimoldi, Valeria/AAB-4865-2020; Garcia-Etxebarria, Koldo/AAQ-4638-2021; Kurihara, Hayato/AAW-5550-2020; Cecconi, Maurizio/A-6241-2012; costantino, giorgio/AAC-6441-2022; D'Amato, Mauro/F-2450-2010; cazzaniga, marina/AAB-9950-2022; Latiano, Anna/R-1965-2016; Téllez, Luis/AAF-7220-2021; Wienbrandt, Lars/O-8383-2016; My, Ilaria/AAK-8169-2021; Franke, Andre/B-2151-2010; D'Amato, Mauro/B-5050-2019; Aliberti, Stefano/K-9115-2016; Ciccarelli, Michele/GZG-8536-2022; Lenz, Tobias L/D-1387-2009; Invernizzi, Pietro/AAB-8367-2022; Erdmann, Jeanette/P-7513-2014; Palmieri, Orazio/J-7697-2012; de cid, rafael/Q-2952-2016; Desai, Antonio/ABH-8942-2020; Miozzo, Monica Rosa/AAC-6401-2022; Rühlemann, Malte Christoph/AAA-6528-2019; Martín, Javier/AAV-5209-2021; Gualtierotti, Roberta/V-5991-2019; Baselli, Guido Alessandro/AAG-7485-2021; Tentorio, Paolo Francesco/GYV-3460-2022; Voza, Antonio/AEW-4659-2022; Gori, Andrea/AAC-6078-2022; Generali, Elena/AAV-5348-2020; Rodrigues, Pedro/GOP-0244-2022; D'Antuono, Felice/AAV-2822-2020; Izquierdo-Sanchez, Laura/AAL-3946-2021; Cecconi, Maurizio/HDN-8785-2022; pelusi, serena/AAC-2725-2022; Rando-Segura, Ariadna/AAQ-8459-2021; Paraboschi, Elvezia Maria/K-6799-2016; Bandera, Alessandra/AAC-6081-2022; Castro, Pedro/AAG-2513-2021; Rebollo, Pedro Castro/AAF-4792-2021; Aghemo, Alessio/ABE-5976-2021; Asselta, Rosanna/AAC-2367-2019; Martin, Javier/B-8141-2008; Aneli, Serena/AAU-1253-2021; Sumoy, Lauro/AGZ-3186-2022; Moreno, Victor/A-1697-2010; MATULLO, Giuseppe/K-6383-2016; Bosari, Silvano/K-7744-2016; Rodrigues, Pedro/M-6227-2017; Juzenas, Simonas/F-3187-2018; Ferrusquia-Acosta, Jose/P-4297-2015; Ferrer, Ricard/K-9022-2017; Valenti, Luca/B-3695-2009; Duga, Stefano/F-8173-2014; Blasi, Francesco/O-5885-2017	De Santis, Maria/0000-0002-3196-1336; CANOS, AVELINO CORMA/0000-0002-2232-3527; Romero-Gomez, Manuel/0000-0001-8494-8947; Fedeli, Carlo/0000-0002-2272-542X; Desai, Antonio/0000-0003-4674-4905; Carrabba, Maria/0000-0002-0717-9096; Femenía, Iván Galván/0000-0002-6124-3730; Lleo, Ana/0000-0002-0561-7902; Scudeller, Luigia/0000-0001-7240-9567; Bujanda, Luis/0000-0002-4353-9968; Rimoldi, Valeria/0000-0002-5598-3986; Garcia-Etxebarria, Koldo/0000-0002-6107-9416; Kurihara, Hayato/0000-0002-8826-9631; Cecconi, Maurizio/0000-0002-4376-6538; costantino, giorgio/0000-0002-6391-3849; D'Amato, Mauro/0000-0003-2743-5197; Latiano, Anna/0000-0003-3719-2061; Wienbrandt, Lars/0000-0001-5685-2032; Franke, Andre/0000-0003-1530-5811; D'Amato, Mauro/0000-0003-2743-5197; Aliberti, Stefano/0000-0002-0090-4531; Ciccarelli, Michele/0000-0002-8617-4153; Lenz, Tobias L/0000-0002-7203-0044; Invernizzi, Pietro/0000-0003-3262-1998; Erdmann, Jeanette/0000-0002-4486-6231; Palmieri, Orazio/0000-0002-0019-7929; de cid, rafael/0000-0003-3579-6777; Desai, Antonio/0000-0003-4674-4905; Miozzo, Monica Rosa/0000-0002-6523-4575; Rühlemann, Malte Christoph/0000-0002-0685-0052; Gualtierotti, Roberta/0000-0001-6465-7624; Baselli, Guido Alessandro/0000-0002-0234-6828; Tentorio, Paolo Francesco/0000-0003-2868-6158; Voza, Antonio/0000-0001-7309-6929; Generali, Elena/0000-0002-5898-1767; D'Antuono, Felice/0000-0002-9973-0593; Izquierdo-Sanchez, Laura/0000-0002-7016-8314; Cecconi, Maurizio/0000-0002-4376-6538; Rando-Segura, Ariadna/0000-0003-4555-7286; Paraboschi, Elvezia Maria/0000-0002-7935-798X; Rebollo, Pedro Castro/0000-0002-6118-8970; Aghemo, Alessio/0000-0003-0941-3226; Asselta, Rosanna/0000-0001-5351-0619; Martin, Javier/0000-0002-2202-0622; Aneli, Serena/0000-0003-4303-2507; Sumoy, Lauro/0000-0003-0005-4618; Roade, Luisa/0000-0002-8160-9613; van Heel, David/0000-0002-0637-2265; Barberi, Caterina/0000-0002-5197-4484; FRANCHI, ELOISA/0000-0002-4364-5410; Nafria, Beatriz/0000-0002-4698-5680; Chwialkowska, Karolina/0000-0001-8053-8959; Moreno, Victor/0000-0002-2818-5487; ANGELINI, CLAUDIO/0000-0002-4814-8712; Arning, Nicolas/0000-0002-9105-9571; Motta, Francesca/0000-0002-8093-2734; MATULLO, Giuseppe/0000-0003-0674-7757; Bosari, Silvano/0000-0002-9744-6951; Biondi, Andrea/0000-0002-6757-6173; Bonfanti, Paolo/0000-0001-7289-8823; Kassens, Jan Christian/0000-0001-7840-1160; Rodrigues, Pedro/0000-0001-6193-7436; Gassner, Christoph/0000-0002-6580-7855; Finer, Sarah/0000-0002-2684-4653; Earle, Sarah/0000-0002-0738-7557; Degenhardt, Frauke/0000-0001-7516-3179; Tellez, Luis/0000-0002-9254-3891; carreras, anna/0000-0002-8789-067X; Juzenas, Simonas/0000-0001-9293-0691; Nakanishi, Tomoko/0000-0001-9510-5646; Ferrusquia-Acosta, Jose/0000-0001-8034-1291; Armstrong, Jacob/0000-0003-4349-4453; Protti, Alessandro/0000-0002-0172-6079; Spata, Gianmarco/0000-0002-6410-8833; Loiacono, Ferdinando/0000-0002-6052-8558; Buti Ferret, Maria/0000-0002-0732-3078; Garcia-Fernandez, Alba Estela/0000-0003-4957-0373; Wendorff, Mareike/0000-0001-8185-8516; Ferrer, Ricard/0000-0002-4859-4747; Santoro, Luigi/0000-0002-3920-4786; Valenti, Luca/0000-0001-8909-0345; Duga, Stefano/0000-0003-3457-1410; BANDERA, ALESSANDRA/0000-0001-9440-4601; Banales, Jesus/0000-0002-5224-2373; Prati, Daniele/0000-0002-2281-7498; Ellinghaus, David/0000-0002-4332-6110; Puggioni, Francesca/0000-0001-6638-5626; BADALAMENTI, SALVATORE/0000-0002-0394-0730; Blasi, Francesco/0000-0002-2285-9970	Deutsche Forschungsgemeinschaft Cluster of Excellence "Precision Medicine in Chronic Inflammation" [EXC2167]; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Covid-19 Biobank grant; Italian Ministry of Health [RF-2016-02364358]; Ministero dell'Istruzione, dell'Universita e della Ricerca project "Dipartimenti di Eccellenza 2018-2022" [D15D18000410001]; Spanish Ministry of Science and Innovation JdC fellowship [IJC2018-035131-I]; GCAT Cession Research Project [PI-2020-01]; Stefan-Morsch-Stiftung	Deutsche Forschungsgemeinschaft Cluster of Excellence "Precision Medicine in Chronic Inflammation"(German Research Foundation (DFG)); Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Covid-19 Biobank grant; Italian Ministry of Health(Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca project "Dipartimenti di Eccellenza 2018-2022"; Spanish Ministry of Science and Innovation JdC fellowship(Ministry of Science and Innovation, Spain (MICINN)); GCAT Cession Research Project; Stefan-Morsch-Stiftung	Supported by a philanthropic donation from Stein Erik Hagen and Canica; by a grant from the Deutsche Forschungsgemeinschaft Cluster of Excellence "Precision Medicine in Chronic Inflammation" (EXC2167); by a Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Covid-19 Biobank grant (to Dr. Valenti); by grants from the Italian Ministry of Health (RF-2016-02364358, to Dr. Valenti) and Ministero dell'Istruzione, dell'Universita e della Ricerca project "Dipartimenti di Eccellenza 2018-2022" (D15D18000410001 to the Department of Medical Sciences, University of Turin; by a grant from the Spanish Ministry of Science and Innovation JdC fellowship (IJC2018-035131-I, to Dr. Acosta-Herrera); and by the GCAT Cession Research Project PI-2020-01. HLA typing was performed and supported by the Stefan-Morsch-Stiftung.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; [Anonymous], 2018, CANCER DISCOV, V8, pOF6; [Anonymous], 2020, BMJ-BRIT MED J, V369, pm2170, DOI 10.1136/bmj.m2170; Aziz M, 2020, J MED VIROL, V92, P2283, DOI 10.1002/jmv.25948; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575; Breiman A, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008556; Bugert P, 2012, TRANSFUS MED HEMOTH, V39, P182, DOI 10.1159/000339235; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen RC, 2020, CHEST, V158, P97, DOI 10.1016/j.chest.2020.04.010; Cheng YF, 2005, JAMA-J AM MED ASSOC, V293, P1450, DOI 10.1001/jama.293.12.1450-c; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Covid 19 Host Genetics Initiative, 2020, EUR J HUM GENET, V28, P715, DOI 10.1038/s41431-020-0636-6; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Franchini M, 2014, CLIN CHEM LAB MED, V52, P1273, DOI 10.1515/cclm-2014-0564; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Galvan-Femenia I, 2018, J MED GENET, V55, P765, DOI 10.1136/jmedgenet-2018-105437; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hickey MJ, 2007, VIRAL IMMUNOL, V20, P599, DOI 10.1089/vim.2007.0056; Julia A, 2016, RHEUMATOLOGY, V55, P1106, DOI 10.1093/rheumatology/kew035; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kuba K, 2010, PHARMACOL THERAPEUT, V128, P119, DOI 10.1016/j.pharmthera.2010.06.003; Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Lopez-Isac E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12760-y; Marini JJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2747-4; Murray GP, 2020, J CLIN PATHOL, V73, P347, DOI 10.1136/jclinpath-2019-206182; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Robinson J, 2020, NUCLEIC ACIDS RES, V48, pD948, DOI 10.1093/nar/gkz950; Taliun Daniel, 2021, Nature, V590, P290, DOI 10.1038/s41586-021-03205-y; THOMSON G, 1975, NATURE, V254, P363, DOI 10.1038/254363a0; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Vuille-Dit-Bille RN, 2015, AMINO ACIDS, V47, P693, DOI 10.1007/s00726-014-1889-6; Wein AN, 2019, J EXP MED, V216, P2748, DOI 10.1084/jem.20181308; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhao J, 2020, CLIN INFECT DIS, DOI 10.1101/2020.03.11.20031096; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zietz Michael, 2020, medRxiv, DOI 10.1101/2020.04.08.20058073; 2012, SURG OBES RELAT DIS, V8, pE1002	42	972	994	19	114	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2020	383	16					1522	1534		10.1056/NEJMoa2020283	http://dx.doi.org/10.1056/NEJMoa2020283			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OE4ES	32558485	Green Published, Bronze			2022-12-28	WOS:000580486200009
J	Rowhani-Rahbar, A; Bellenger, MA; Gibb, L; Chesnut, H; Lowry-Schiller, M; Gause, E; Haviland, MJ; Rivara, FP				Rowhani-Rahbar, Ali; Bellenger, M. Alex; Gibb, Lauren; Chesnut, Heather; Lowry-Schiller, Madison; Gause, Emma; Haviland, Miriam J.; Rivara, Frederick P.			Extreme Risk Protection Orders in Washington A Statewide Descriptive Study	ANNALS OF INTERNAL MEDICINE			English	Article								Background: In the United States, 74% of homicides and 51% of suicides involve firearms. Using extreme risk protection order (ERPO) laws, petitioners can request restricting firearm access for individuals (known as "respondents") who pose a risk to themselves or others. Objective: To characterize respondents and circumstances of ERPOs. Design: Descriptive study. Setting: State of Washington. Participants: All ERPO respondents during 8 December 2016 to 10 May 2019. Measurements: Reason for filing the ERPO; characteristics of respondents; respondent's reported history of domestic violence perpetration, mental illness, substance misuse, and suicide ideation or attempt; number and type of firearms removed; and ERPO petition outcome (granted or not granted). Results: The ERPOs were filed for concerns about harm to self (n = 67), harm to others (n = 86), or harm to both self and others (n = 84). Of all ERPOs, 87% were filed by law enforcement and 81% were granted. At least 1 firearm was removed from 64% of respondents, with a total of 641 firearms removed. The petitioner reported prior domestic violence perpetration by the respondent in 24% of cases, and a prior diagnosis of a mental health condition and substance misuse for the respondent in 40% and 47% of cases, respectively. Of all respondents, 62% had a history of suicidal ideation or attempt according to the petitioner. As part of the ERPO process, the court ordered mental health evaluation in 30% of cases. Limitation: Filing of the forms was inconsistent. Conclusion: Laws regarding ERPOs are a potential tool to help protect patients or family members from harming themselves or others by restricting firearm possession and purchase. Further studies are needed to determine the long-term effects of these laws and identify approaches to increase their use.	[Rowhani-Rahbar, Ali; Lowry-Schiller, Madison; Gause, Emma] Univ Washington, Harborview Injury Prevent & Res Ctr, Sch Publ Hlth, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali; Bellenger, M. Alex; Gibb, Lauren; Chesnut, Heather; Lowry-Schiller, Madison; Gause, Emma; Haviland, Miriam J.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Firearm Injury & Policy Res Program, Seattle, WA 98195 USA; [Chesnut, Heather] Seattle Univ, Criminal Justice Masters Program, Seattle, WA 98122 USA; [Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle University; University of Washington; University of Washington Seattle	Rowhani-Rahbar, A (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, Box 357236, Seattle, WA 98195 USA.	rowhani@uw.edu		Gause, Emma/0000-0002-1484-5296; Rowhani-Rahbar, Ali/0000-0002-2705-4485	State of Washington	State of Washington	State of Washington.; By the State of Washington.	Broadwater L., 2019, SHERIFF MARYLANDS RE; Conner A, 2019, ANN INTERN MED, V171, P885, DOI 10.7326/M19-1324; Frattaroli S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.18037; King County, 2019, REG DOM VIOL FIR ENF; Kivisto AJ, 2018, PSYCHIAT SERV, V69, P855, DOI 10.1176/appi.ps.201700250; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Revelle W, PSYCH PROCEDURES PER; Shortell G, 2020, CNN POLITICS    0210; Swanson J.W., 2017, LAW CONT PROB, V80, P179, DOI 10.1097/AOG.0000000000004391; Swanson JW, 2019, PSYCHIAT SERV, V70, P953, DOI 10.1176/appi.ps.201900291; Swanson JW, 2019, J AM ACAD PSYCHIATRY, V47, P188, DOI 10.29158/JAAPL.003835-19; Swanson JW, 2016, HEALTH AFFAIR, V35, P1067, DOI 10.1377/hlthaff.2016.0017; U.S. Census Bureau, 2020, 2014 2018 ACS 5 YEAR; Wintemute GJ, 2019, ANN INTERN MED, V171, P655, DOI 10.7326/M19-2162	14	12	12	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2020	173	5					342	+		10.7326/M20-0594	http://dx.doi.org/10.7326/M20-0594			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9XI	32598226				2022-12-28	WOS:000567080900008
J	Kamysbayev, V; Filatov, AS; Hu, HC; Rui, X; Lagunas, F; Wang, D; Klie, RF; Talapin, DV				Kamysbayev, Vladislav; Filatov, Alexander S.; Hu, Huicheng; Rui, Xue; Lagunas, Francisco; Wang, Di; Klie, Robert F.; Talapin, Dmitri, V			Covalent surface modifications and superconductivity of two-dimensional metal carbide MXenes	SCIENCE			English	Article							X-RAY-DIFFRACTION; TRANSITION; TI3C2; FUNCTIONALIZATION; SEMICONDUCTORS	Versatile chemical transformations of surface functional groups in two-dimensional transition-metal carbides (MXenes) open up a previously unexplored design space for this broad class of functional materials. We introduce a general strategy to install and remove surface groups by performing substitution and elimination reactions in molten inorganic salts. Successful synthesis of MXenes with oxygen, imido, sulfur, chlorine, selenium, bromine, and tellurium surface terminations, as well as bare MXenes (no surface termination), was demonstrated. These MXenes show distinctive structural and electronic properties. For example, the surface groups control interatomic distances in the MXene lattice, and Tn+1Cn (n = 1, 2) MXenes terminated with telluride (Te2-) ligands show a giant (>18%) in-plane lattice expansion compared with the unstrained titanium carbide lattice. The surface groups also control superconductivity of niobium carbide MXenes.	[Kamysbayev, Vladislav; Filatov, Alexander S.; Hu, Huicheng; Wang, Di; Talapin, Dmitri, V] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Kamysbayev, Vladislav; Filatov, Alexander S.; Hu, Huicheng; Wang, Di; Talapin, Dmitri, V] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Rui, Xue; Lagunas, Francisco; Klie, Robert F.] Univ Illinois, Dept Phys, Chicago, IL 60607 USA; [Talapin, Dmitri, V] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Argonne National Laboratory	Talapin, DV (corresponding author), Univ Chicago, Dept Chem, Chicago, IL 60637 USA.; Talapin, DV (corresponding author), Univ Chicago, James Franck Inst, Chicago, IL 60637 USA.; Talapin, DV (corresponding author), Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA.	dvtalapin@uchicago.edu	Rui, Xue/AFV-7300-2022; Hu, Huicheng/H-2542-2018; Hu, Huicheng/AAH-6213-2021	Rui, Xue/0000-0001-7318-5614; Hu, Huicheng/0000-0001-9647-1672; Hu, Huicheng/0000-0001-9647-1672; Filatov, Alexander/0000-0002-8378-1994; Kamysbayev, Vladislav/0000-0002-5668-577X	Department of Defense (DOD) Air Force Office of Scientific Research [FA9550-18-1-0099]; Office of Basic Energy Sciences, U.S. Department of Energy [DESC0019375]; National Science Foundation [DMR-0959470, DMR-1626065, DMR-1611371, DMR-2004880, DMREF CBET1729420]; U.S. DOE [DE-AC02-06CH11357]; Canadian Light Source	Department of Defense (DOD) Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); U.S. DOE(United States Department of Energy (DOE)); Canadian Light Source	V.K., H.H., D.W., and D.V.T. were supported by the Department of Defense (DOD) Air Force Office of Scientific Research grant FA9550-18-1-0099; by the Office of Basic Energy Sciences, U.S. Department of Energy, award no. DESC0019375; and by the National Science Foundation awards nos. DMR-1611371 and DMR-2004880. X.R., F.L., and R.F.K. were supported by the National Science Foundation (DMREF CBET1729420). The JEOL JEM ARM200CF in the UIC Research Resources Center was acquired and upgraded using grants from the National Science Foundation (DMR-0959470 and DMR-1626065). This research used resources of the Center for Nanoscale Materials and the Advanced Photon Source, an Office of Science User Facilities operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, supported by the U.S. DOE under contract no. DE-AC02-06CH11357, and the Canadian Light Source and its funding partners.	Alhabeb M, 2017, CHEM MATER, V29, P7633, DOI 10.1021/acs.chemmater.7b02847; Anasori B, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.98; Beecher AN, 2014, J AM CHEM SOC, V136, P10645, DOI 10.1021/ja503590h; Beloborodov IS, 2007, REV MOD PHYS, V79, P469, DOI 10.1103/RevModPhys.79.469; Berdiyorov GR, 2016, AIP ADV, V6, DOI 10.1063/1.4948799; Dash A, 2019, NAT MATER, V18, P465, DOI 10.1038/s41563-019-0328-1; Deeva EB, 2019, CHEM MATER, V31, P4505, DOI 10.1021/acs.chemmater.9b01105; EHRLICH P, 1949, Z FUER ANORGANISCHE, V0260; EHRLICH P, 1961, Z ANORG ALLG CHEM, V312, P80, DOI 10.1002/zaac.19613120112; Fu ZH, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.104103; Ghidiu M, 2017, J AM CERAM SOC, V100, P5395, DOI 10.1111/jace.15124; Guo J, 2018, ADV MATER, V30, DOI 10.1002/adma.201801846; Halim J, 2019, J PHYS-CONDENS MAT, V31, DOI 10.1088/1361-648X/ab00a2; Halim J, 2014, CHEM MATER, V26, P2374, DOI 10.1021/cm500641a; Hope MA, 2016, PHYS CHEM CHEM PHYS, V18, P5099, DOI 10.1039/c6cp00330c; Hu T, 2018, J PHYS CHEM C, V122, P18501, DOI 10.1021/acs.jpcc.8b04427; Hu T, 2015, PHYS CHEM CHEM PHYS, V17, P9997, DOI 10.1039/c4cp05666c; Ibragimova R, 2019, ACS NANO, V13, P9171, DOI 10.1021/acsnano.9b03511; Jansen M, 2002, ANGEW CHEM INT EDIT, V41, P3747, DOI 10.1002/1521-3773(20021018)41:20<3746::AID-ANIE3746>3.0.CO;2-2; Kamysbayev V, 2019, ACS NANO, V13, P12415, DOI 10.1021/acsnano.9b06207; Khazaei M, 2013, ADV FUNCT MATER, V23, P2185, DOI 10.1002/adfm.201202502; Kim D, 2019, ACS NANO, V13, P13818, DOI 10.1021/acsnano.9b04088; Li M, 2019, J AM CHEM SOC, V141, P4730, DOI 10.1021/jacs.9b00574; Li TF, 2018, ANGEW CHEM INT EDIT, V57, P6115, DOI 10.1002/anie.201800887; Li YB, 2020, NAT MATER, V19, P894, DOI 10.1038/s41563-020-0657-0; Liu XF, 2013, CHEM SOC REV, V42, P8237, DOI 10.1039/c3cs60159e; Liu YY, 2016, J AM CHEM SOC, V138, P15853, DOI 10.1021/jacs.6b10834; Lu J, 2019, NANOSCALE ADV, V1, P3680, DOI 10.1039/c9na00324j; Luo Y-R., 2007, COMPREHENSIVE HDB CH, DOI [10.1201/9781420007282, DOI 10.1201/9781420007282]; Mashtalir O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2664; Meng QQ, 2018, NANOSCALE, V10, P3385, DOI 10.1039/c7nr07649e; Naguib M, 2013, J AM CHEM SOC, V135, P15966, DOI 10.1021/ja405735d; ONODA M, 1987, J LESS-COMMON MET, V132, P195, DOI 10.1016/0022-5088(87)90576-5; Palisaitis J, 2018, NANOSCALE, V10, P10850, DOI 10.1039/c8nr01986j; Pang SY, 2019, J AM CHEM SOC, V141, P9610, DOI 10.1021/jacs.9b02578; Persson I, 2018, 2D MATER, V5, DOI 10.1088/2053-1583/aa89cd; Qin Y., 2019, J PHYS CONDENS MATT, V32, DOI DOI 10.1088/1361; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; RICHARDS.JH, 1965, J AM CERAM SOC, V48, P497, DOI 10.1111/j.1151-2916.1965.tb14647.x; SAHA NC, 1992, J APPL PHYS, V72, P3072, DOI 10.1063/1.351465; Sarycheva A, 2020, CHEM MATER, V32, P3480, DOI 10.1021/acs.chemmater.0c00359; Scabarozi TH, 2009, THIN SOLID FILMS, V517, P2920, DOI 10.1016/j.tsf.2008.12.047; Shahzad F, 2016, SCIENCE, V353, P1137, DOI 10.1126/science.aag2421; Si C, 2015, ACS APPL MATER INTER, V7, P17510, DOI 10.1021/acsami.5b05401; Sokol M, 2019, TRENDS CHEM, V1, P210, DOI 10.1016/j.trechm.2019.02.016; Srivastava V, 2018, J AM CHEM SOC, V140, P12144, DOI 10.1021/jacs.8b06971; Stephens PW, 1999, J APPL CRYSTALLOGR, V32, P281, DOI 10.1107/S0021889898006001; Thompson JW., 2004, J APPL CRYSTALLOGR, V37, P678, DOI 10.1107/S0021889804011744; Toby BH, 2013, J APPL CRYSTALLOGR, V46, P544, DOI 10.1107/S0021889813003531; TROYANOV SI, 1991, ZH NEORG KHIM+, V36, P1117; TROYANOV SI, 1990, ZH NEORG KHIM+, V35, P882; Wang DS, 2019, ACS NANO, V13, P11078, DOI 10.1021/acsnano.9b03412; Xia Y, 2018, NATURE, V557, P409, DOI 10.1038/s41586-018-0109-z; Zhang CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08383-y; Zhang H, 2017, NATURE, V542, P328, DOI 10.1038/nature21041; Zhang JQ, 2018, NAT CATAL, V1, P985, DOI 10.1038/s41929-018-0195-1; Zhang N, 2018, 2D MATER, V5, DOI 10.1088/2053-1583/aacfb3; Zhou LJ, 2018, J PHYS CHEM LETT, V9, P6915, DOI 10.1021/acs.jpclett.8b03077	59	439	438	242	1418	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2020	369	6506			SI		979	+		10.1126/science.aba8311	http://dx.doi.org/10.1126/science.aba8311			76	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE2OL	32616671	Bronze			2022-12-28	WOS:000562436800048
J	Eisenman, DJ				Eisenman, David J.			Rereading Arrowsmith in the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Eisenman, David J.] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Eisenman, DJ (corresponding author), Dept Otorhinolaryngol Head & Neck Surg, 16 S Eutaw St,Frenkil Bldg,Ste 500, Baltimore, MD 21201 USA.	deisenman@som.umaryland.edu						Angus DC, 2020, JAMA-J AM MED ASSOC, V323, P1895, DOI 10.1001/jama.2020.4984; Kalil AC, 2020, JAMA-J AM MED ASSOC, V323, P1897, DOI 10.1001/jama.2020.4742; Manson K., 2020, FINANC TIMES, P3	3	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					319	320		10.1001/jama.2020.11489	http://dx.doi.org/10.1001/jama.2020.11489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32589200	Bronze			2022-12-28	WOS:000562851000001
J	Kalantar-Zadeh, K; Wightman, A; Liao, S				Kalantar-Zadeh, Kamyar; Wightman, Aaron; Liao, Solomon			Ensuring Choice for People with Kidney Failure - Dialysis, Supportive Care, and Hope	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								For patients with advanced kidney disease, especially hospitalized patients, dialysis may be presented as the opposite end of the treatment spectrum from comfort care. Collaborative efforts and amended policies could allow patients to have a better range of options.	[Kalantar-Zadeh, Kamyar] Univ Calif Irvine, Sch Med, Div Nephrol & Hypertens & Kidney Transplantat, Orange, CA 92668 USA; [Liao, Solomon] Univ Calif Irvine, Div Palliat Med, Hospitalist Program, Orange, CA 92668 USA; [Kalantar-Zadeh, Kamyar] Tibor Rubin Vet Adm Healthcare Syst, Long Beach, CA 90822 USA; [Wightman, Aaron] Univ Washington, Sch Med, Dept Pediat, Div Bioeth & Palliat Care, Seattle, WA 98195 USA; [Wightman, Aaron] Univ Washington, Sch Med, Dept Pediat, Div Nephrol, Seattle, WA 98195 USA; [Wightman, Aaron] Seattle Childrens Hosp, Treuman Katz Ctr Pediat Bioeth, Seattle, WA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Kalantar-Zadeh, K (corresponding author), Univ Calif Irvine, Sch Med, Div Nephrol & Hypertens & Kidney Transplantat, Orange, CA 92668 USA.; Kalantar-Zadeh, K (corresponding author), Tibor Rubin Vet Adm Healthcare Syst, Long Beach, CA 90822 USA.		Kalantar-Zadeh, Kamyar/Q-4734-2018	Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Wightman, Aaron/0000-0003-0167-0420				Ko GJ, 2019, J AM MED DIR ASSOC, V20, P743, DOI 10.1016/j.jamda.2018.11.030; Ladin K, 2018, AM J KIDNEY DIS, V71, P627, DOI 10.1053/j.ajkd.2017.11.011; Lam DY, 2019, CLIN J AM SOC NEPHRO, V14, P635, DOI 10.2215/CJN.09330818; Saran R, 2019, AM J KIDNEY DIS, V73, pSVII; Wong SPY, 2016, JAMA INTERN MED, V176, P228, DOI 10.1001/jamainternmed.2015.7412	5	61	66	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					99	101		10.1056/NEJMp2001794	http://dx.doi.org/10.1056/NEJMp2001794			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NR9PO	32640129	Green Published			2022-12-28	WOS:000571894800007
J	Roland, M; Everington, S; Marshall, M				Roland, Martin; Everington, Sam; Marshall, Martin			Social Prescribing - Transforming the Relationship between Physicians and Their Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Many patients present to their physician with a problem that is not purely medical. Approaches that rely on social prescribing recognize that lifestyle changes could help alleviate many problems and that supportive resources are often available in a patient's community.	[Roland, Martin] Univ Cambridge, Cambridge, England; [Everington, Sam] Bromley Bow Hlth Ctr, London, England; [Marshall, Martin] Royal Coll Gen Practitioners, London, England	University of Cambridge	Roland, M (corresponding author), Univ Cambridge, Cambridge, England.			Roland, Martin/0000-0002-8533-3060				[Anonymous], 2018, BMJ-BRIT MED J, V362, pk3210; [Anonymous], 2017, CANCER DISCOV, V7, pOF12; Bickerdike L, 2017, BMJ OPEN, V04, P7; Chatterjee HJ, 2018, ARTS HEALTH, V10, P97, DOI 10.1080/17533015.2017.1334002; NHS England, 2019, SOC PRESCR COMM BAS	5	24	26	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					97	99		10.1056/NEJMp1917060	http://dx.doi.org/10.1056/NEJMp1917060			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NR9PO	32640128	Green Published			2022-12-28	WOS:000571894800006
J	Mahase, E				Mahase, Elisabeth			Government must apologise to those affected by Primodos, valproate, and mesh, says review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		WISE J, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.K887	1	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2726	10.1136/bmj.m2726	http://dx.doi.org/10.1136/bmj.m2726			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636188				2022-12-28	WOS:000548155700005
J	Wise, J				Wise, Jacqui			GPs call for cut in red tape to manage aftermath of covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of General Practitioners, 2020, GEN PRACT POST COV W	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2729	10.1136/bmj.m2729	http://dx.doi.org/10.1136/bmj.m2729			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636191	Bronze			2022-12-28	WOS:000548155700017
J	Oksdath-Mansilla, G				Oksdath-Mansilla, Gabriela			Stronger bonds bring bigger challenges	SCIENCE			English	Editorial Material							FUNCTIONALIZATION; ACTIVATION		[Oksdath-Mansilla, Gabriela] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Organ, INFIQC CONICET UNC, Ciudad Univ,X5000HUA, Cordoba, Argentina	National University of Cordoba	Oksdath-Mansilla, G (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Organ, INFIQC CONICET UNC, Ciudad Univ,X5000HUA, Cordoba, Argentina.	goksdath@fcq.unc.edu.ar			National Research Council of Argentina (CONICET) INFIQC-CONICET; Universidad Nacional de Cordoba (UNC)	National Research Council of Argentina (CONICET) INFIQC-CONICET; Universidad Nacional de Cordoba (UNC)	I thank F.R. Bisogno and F. Politano for fruitful discussions. The National Research Council of Argentina (CONICET) INFIQC-CONICET, and Universidad Nacional de Cordoba (UNC) are kindly acknowledged for their support.	Capaldo L, 2017, EUR J ORG CHEM, V2017, P2056, DOI 10.1002/ejoc.201601485; Cook AK, 2016, SCIENCE, V351, P1421, DOI 10.1126/science.aad9289; Hu AH, 2018, SCIENCE, V361, P668, DOI 10.1126/science.aat9750; Kockmann N, 2017, REACT CHEM ENG, V2, P258, DOI 10.1039/c7re00021a; Laudadio G., 2020, SCIENCE, V368, P92; Politano F, 2018, ORG PROCESS RES DEV, V22, P1045, DOI 10.1021/acs.oprd.8b00213; Pombeiro A. J. L., 2019, ALKANE FUNCTIONALIZA; Ravelli D, 2018, ACS CATAL, V8, P701, DOI 10.1021/acscatal.7b03354; Ravelli D, 2016, CHEM REV, V116, P9850, DOI 10.1021/acs.chemrev.5b00662; Saint-Denis TG, 2018, SCIENCE, V359, P759, DOI 10.1126/science.aao4798; Tang XX, 2018, CHEM SCI, V9, P288, DOI 10.1039/c7sc03610h; Xia GQ, 2019, NAT CHEM, V11, P571, DOI 10.1038/s41557-019-0245-6	12	0	0	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					34	35		10.1126/science.abc6168	http://dx.doi.org/10.1126/science.abc6168			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MK4IZ	32631883				2022-12-28	WOS:000548751700035
J	Kar, P				Kar, Partha			Partha Kar: To tackle racism, the NHS needs policies with teeth	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Diabet & Endocrinol, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Diabet & Endocrinol, Portsmouth, Hants, England.	drparthakar@gmail.com	Kar, Partha/AAT-4839-2020					KAR P, 2020, BMJ-BRIT MED J, V369, P71436, DOI DOI 10.1136/BMJ.M1804; NHS, 2020, NHS WORKF RAC EQ STA; Public Health England, 2020, UNDERSTANDING IMPACT	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2583	10.1136/bmj.m2583	http://dx.doi.org/10.1136/bmj.m2583			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32605918	Bronze			2022-12-28	WOS:000548116400001
J	Jaffe, S				Jaffe, Susan			Aletha Maybank: AMA's Chief Health Equity Officer	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2020	395	10242					1963	1963						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ0ZZ	32593331	Green Published			2022-12-28	WOS:000547825600012
J	Alavi, S; Mitchell, JD; Cho, JY; Liu, R; Macbeth, JC; Hsiao, A				Alavi, Salma; Mitchell, Jonathan D.; Cho, Jennifer Y.; Liu, Rui; Macbeth, John C.; Hsiao, Ansel			Interpersonal Gut Microbiome Variation Drives Susceptibility and Resistance to Cholera Infection	CELL			English	Article							VIBRIO-CHOLERAE; EXPRESSION; TOXIN; GENES; ACID; INHIBITION; PH	The gut microbiome is the resident microbial community of the gastrointestinal tract. This community is highly diverse, but how microbial diversity confers resistance or susceptibility to intestinal pathogens is poorly understood, Using transplantation of human microbiomes into several animal models of infection, we show that key microbiome species shape the chemical environment of the gut through the activity of the enzyme bile salt hydrolase. The activity of this enzyme reduced colonization by the major human diarrheal pathogen Vibrio cholerae by degrading the bile salt taurocholate that activates the expression of virulence genes. The absence of these functions and species permits increased infection loads on a personal microbiome-specific basis. These findings suggest new targets for individualized preventative strategies of V. cholerae infection through modulating the structure and function of the gut microbiome.	[Alavi, Salma; Mitchell, Jonathan D.; Cho, Jennifer Y.; Liu, Rui; Macbeth, John C.; Hsiao, Ansel] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA; [Cho, Jennifer Y.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Liu, Rui] Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA; [Macbeth, John C.] Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Hsiao, A (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.	ansel.hsiao@ucr.edu		Cho, Jennifer/0000-0002-2138-7510	National Institute of General Medical Sciences [R35GM124724]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jun Zhu and Gary Dunny for the kind gifts of V. cholerae and E. faecalis strains, respectively. We thank the Metabolomics Core Facility at University of California, Riverside for mass spectrometry studies. This work was supported by the National Institute of General Medical Sciences (R35GM124724 to A.H.).	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clemens JD, 2017, LANCET, V390, P1539, DOI 10.1016/S0140-6736(17)30559-7; Dalia AB, 2014, P NATL ACAD SCI USA, V111, P8937, DOI 10.1073/pnas.1406478111; David LA, 2015, MBIO, V6, DOI 10.1128/mBio.00381-15; DESMET I, 1995, J APPL BACTERIOL, V79, P292; Di Ciaula A, 2017, ANN HEPATOL, V16, pS4, DOI 10.5604/01.3001.0010.5493; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; FRETER R, 1956, J EXP MED, V104, P411, DOI 10.1084/jem.104.3.411; FRETER R, 1955, J INFECT DIS, V97, P57, DOI 10.1093/infdis/97.1.57; Gupta S, 1997, INFECT IMMUN, V65, P1131, DOI 10.1128/IAI.65.3.1131-1134.1997; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Hsiao A, 2014, NATURE, V515, P423, DOI 10.1038/nature13738; Humbert L, 2012, J CHROMATOGR B, V899, P135, DOI 10.1016/j.jchromb.2012.05.015; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Jung SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004837; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kieser S, 2018, ENVIRON MICROBIOL, V20, P2256, DOI 10.1111/1462-2920.14274; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Klose KE, 2000, TRENDS MICROBIOL, V8, P189, DOI 10.1016/S0966-842X(00)01721-2; Kovacikova G, 2010, J BACTERIOL, V192, P4181, DOI 10.1128/JB.00193-10; Krukonis ES, 2000, MOL MICROBIOL, V38, P67, DOI 10.1046/j.1365-2958.2000.02111.x; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Li JN, 2019, BBA-MOL BASIS DIS, V1865, P895, DOI 10.1016/j.bbadis.2018.05.011; Liu Z, 2006, J BACTERIOL, V188, P2446, DOI 10.1128/JB.188.7.2446-2453.2006; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; Marciani L, 2013, EUR J CLIN NUTR, V67, P1182, DOI 10.1038/ejcn.2013.168; Midani FS, 2018, J INFECT DIS, V218, P645, DOI 10.1093/infdis/jiy192; Midgett CR, 2017, MOL MICROBIOL, V105, P258, DOI 10.1111/mmi.13699; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; MURACA M, 1991, J LIPID RES, V32, P371; Olivier V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007352; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plecha SC, 2015, J BACTERIOL, V197, P1716, DOI 10.1128/JB.02409-14; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Song ZW, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0628-3; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao WJ, 2018, SCIENCE, V359, P210, DOI 10.1126/science.aap8775; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	48	53	56	5	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1533	+		10.1016/j.cell.2020.05.036	http://dx.doi.org/10.1016/j.cell.2020.05.036			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32631492	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000543822100012
J	Hung, WY; Huang, CY				Hung, Wan-Yu; Huang, Cheng-Yen			Mesenteric Volvulus from Jejunal Diverticulosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hung, Wan-Yu; Huang, Cheng-Yen] Changhua Christian Hosp, Changhua Christian Med Fdn, Changhua, Taiwan	Changhua Christian Hospital	Hung, WY (corresponding author), Changhua Christian Hosp, Changhua Christian Med Fdn, Changhua, Taiwan.	dipoledipoleforce@yahoo.com.tw		Hung, Wan-Yu/0000-0002-1859-747X					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26								10.1056/NEJMicm1911732	http://dx.doi.org/10.1056/NEJMicm1911732			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9CW	32579816				2022-12-28	WOS:000545636400015
J	Bromage, D; Mayhew, J; Sado, D				Bromage, Daniel; Mayhew, Joseph; Sado, Daniel			Managing heart failure related peripheral oedema in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES		[Bromage, Daniel] Kings Coll London, British Heart Fdn Ctr Excellence, London, England; [Mayhew, Joseph] Nexus, Surrey Docks Hlth Ctr, London, England; [Mayhew, Joseph] Clin Effectiveness, London, England; [Sado, Daniel] Kings Coll London, Dept Cardiol, London, England	University of London; King's College London; University of London; King's College London	Bromage, D (corresponding author), Kings Coll London, British Heart Fdn Ctr Excellence, London, England.	dan.bromage@nhs.net						Aliti GB, 2013, JAMA INTERN MED, V173, P1058, DOI 10.1001/jamainternmed.2013.552; Anisman SD, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l359; Conrad N, 2018, LANCET, V391, P572, DOI 10.1016/S0140-6736(17)32520-5; Faris RF, 2012, COCHRANE DB SYST REV, P2, DOI [10.1002/14651858:CD003838:pub.3, DOI 10.1002/14651858:CD003838:PUB.3]; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Halliday BP, 2019, LANCET, V393, P61, DOI 10.1016/S0140-6736(18)32484-X; National Institute for Health and Care Excellence, 2018, CHRON HEART FAIL AD; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2099	10.1136/bmj.m2099	http://dx.doi.org/10.1136/bmj.m2099			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571780				2022-12-28	WOS:000548535700003
J	Roehr, B				Roehr, Bob			Covid-19 is threatening the survival of US primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		American Academy of Family Physicians, 2020, OTH WARN AZ IMM PRIM; Centers for Medicare and Medicaid Services, 2020, MED ACC ADV PAYM; Centers for Medicare and Medicaid Services, PRIM CAR 1 MOD OPT; Cohrs R., 2020, HOSPITALS GET MORE 8; Ganguli I, 2020, ANN INTERN MED, V172, P240, DOI 10.7326/M19-1834; Health Rosetta, PRIM CAR MARSH PLAN; Kane L., 2020, MEDSCAPE PHYS COMPEN; Mehrotra A., 2020, COMMONWEALTH FUND, DOI DOI 10.26099/2V5T-9Y63; Patient Centred Primary Care Collaborative, SPEND PRIM CAR; Quarles L., 2020, IM PHYS COVID DONT A; Roehr B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4253	11	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2333	10.1136/bmj.m2333	http://dx.doi.org/10.1136/bmj.m2333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571895	Bronze			2022-12-28	WOS:000548535700010
J	Levy, A; Rivera, S				Levy, Antonin; Rivera, Sofia			1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard? Comment	LANCET			English	Editorial Material							RADIATION-THERAPY; CANCER		[Rivera, Sofia] Gustave Roussy Canc Campus, Dept Radiotherapy, 114 Rue Edouard Vaillant, F-94805 Villejuif, France; Univ Paris Sud, 114 Rue Edouard Vaillant, F-94805 Villejuif, France	UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Rivera, S (corresponding author), Gustave Roussy Canc Campus, Dept Radiotherapy, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	sofia.rivera@gustaveroussy.fr	Levy, Antonin/U-8791-2019	Levy, Antonin/0000-0003-4798-8899				Azria D, 2015, EBIOMEDICINE, V2, P1965, DOI 10.1016/j.ebiom.2015.10.024; Brunt AM, 2020, LANCET, V395, P1613, DOI 10.1016/S0140-6736(20)30932-6; Coles CE, 2020, CLIN ONCOL-UK, V32, P279, DOI 10.1016/j.clon.2020.03.006; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Donovan E, 2007, RADIOTHER ONCOL, V82, P254, DOI 10.1016/j.radonc.2006.12.008; Haviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3; Mamounas EP, 2019, LANCET ONCOL, V20, P88, DOI 10.1016/S1470-2045(18)30621-1; Seibold P, 2019, RADIOTHER ONCOL, V138, P59, DOI 10.1016/j.radonc.2019.04.034; Sjostrom M, 2019, J CLIN ONCOL, V37, P3340, DOI 10.1200/JCO.19.00761; Wang SL, 2019, LANCET ONCOL, V20, P352, DOI 10.1016/S1470-2045(18)30813-1; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260	11	9	9	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2020	395	10237					1588	1589		10.1016/S0140-6736(20)30978-8	http://dx.doi.org/10.1016/S0140-6736(20)30978-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LZ1JO	32580882	Green Published, hybrid			2022-12-28	WOS:000540986100007
J	Gupta, A				Gupta, Arjun			Plans and Pandemics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gupta, Arjun] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Gupta, A (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.			Gupta, Arjun/0000-0003-0875-4731					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2020	383	8							e53	10.1056/NEJMp2013693	http://dx.doi.org/10.1056/NEJMp2013693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NG2MJ	32573996	Bronze			2022-12-28	WOS:000563818700002
J	Serafeim, G; Rischbieth, AM; Koh, HK				Serafeim, George; Rischbieth, Amanda M.; Koh, Howard K.			Sustainability, Business, and Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses examples of how many private sector businesses have aligned their core missions with civil and human rights and sustainability reforms, and emphasizes the importance of engaging the sector in achieving public health goals and accelerating worldwide recovery from the COVID-19 pandemic.	[Serafeim, George] Harvard Sch Business, Boston, MA USA; [Rischbieth, Amanda M.; Koh, Howard K.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave,Kresge 401, Boston, MA 02115 USA; [Koh, Howard K.] Harvard Kennedy Sch, Cambridge, MA USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Koh, HK (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave,Kresge 401, Boston, MA 02115 USA.	hkoh@hsph.harvard.edu			Division of Faculty Research and Development of Harvard Business School; Templeton Foundation [61075]; Robert Wood Johnson Foundation [74275]; Harvard Catalyst Community Engagement Program, Harvard Clinical and Translation Science Center [UL1TR002541]; JPB Foundation [1085]	Division of Faculty Research and Development of Harvard Business School; Templeton Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Harvard Catalyst Community Engagement Program, Harvard Clinical and Translation Science Center; JPB Foundation	Dr Serafeim receives financial support from the Division of Faculty Research and Development of Harvard Business School. Faculty grant support for Dr Koh is provided in part by the Templeton Foundation (award 61075); the Robert Wood Johnson Foundation (award 74275); the Harvard Catalyst Community Engagement Program, Harvard Clinical and Translation Science Center (award UL1TR002541); and the JPB Foundation (award 1085).	[Anonymous], 2019, ROADM STAK CAP 2019; Business Roundtable, 2019, BUSINESS ROUNDTABLE; Grewal, 2016, ESG METRICS RESHAPIN; Hanbury, 2019, BUSINESS INSIDER; Koh HK, 2019, JAMA-J AM MED ASSOC, V321, P33, DOI 10.1001/jama.2018.18935; Shepardson D, 2020, TRUMP FINALIZES ROLL; Stengel G., 2020, FORBES	7	5	5	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2020	324	2					147	148		10.1001/jama.2020.8714	http://dx.doi.org/10.1001/jama.2020.8714			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ8RW	32629479	Bronze, Green Accepted			2022-12-28	WOS:000553161000016
J	Dance, A; Ousnamer, Z				Dance, Amber; Ousnamer, Zach			Where I work Zach Ousnamer	NATURE			English	Editorial Material						Careers; Astronomy and astrophysics; Planetary science		Engineer and roboticist Zach Ousnamer is helping to prepare NASA's Perseverance rover for its launch to the red planet. Engineer and roboticist Zach Ousnamer is helping to prepare NASA's Perseverance rover for its launch to the red planet.	[Ousnamer, Zach] Jet Prop Lab, NASAs Mars 2020 Mission, Pasadena, CA USA	National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)									0	0	0	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					324	324		10.1038/d41586-020-01933-1	http://dx.doi.org/10.1038/d41586-020-01933-1			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9LN	32632243	Bronze			2022-12-28	WOS:000545659300001
J	Gertz, MA; Dispenzieri, A				Gertz, Morie A.; Dispenzieri, Angela			Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LIGHT-CHAIN AMYLOIDOSIS; HIGH-DOSE MELPHALAN; CARDIAC AMYLOIDOSIS; AL AMYLOIDOSIS; TRANSTHYRETIN AMYLOIDOSIS; STAGING SYSTEM; DIAGNOSIS; DEXAMETHASONE; RISK; POLYNEUROPATHY	Key PointsQuestionWhen should clinicians suspect and how should they diagnose systemic amyloidosis? FindingsSystemic amyloidosis should be suspected in patients with nondiabetic proteinuria, heart failure with preserved ejection fraction, unexplained peripheral neuropathy, or atypical monoclonal gammopathy of undetermined significance. MeaningLate diagnosis of amyloidosis is a barrier to improved outcomes. Early recognition by primary care clinicians is vital for effective therapy to have a meaningful effect on survival. ImportanceMany patients with systemic amyloidosis are underdiagnosed. Overall, 25% of patients with immunoglobulin light chain (AL) amyloidosis die within 6 months of diagnosis and 25% of patients with amyloid transthyretin (ATTR) amyloidosis die within 24 months of diagnosis. Effective therapy exists but is ineffective if end-organ damage is severe. ObjectiveTo provide evidence-based recommendations that could allow clinicians to diagnose this rare set of diseases earlier and enable accurate staging and counseling about prognosis. Evidence ReviewA comprehensive literature search was conducted by a reference librarian with publication dates from January 1, 2000, to December 31, 2019. Key search terms included amyloid, amyloidosis, nephrotic syndrome, heart failure preserved ejection fraction, and peripheral neuropathy. Exclusion criteria included case reports, non-English-language text, and case series of fewer than 10 patients. The authors independently selected and appraised relevant literature. FindingsThere was a total of 1769 studies in the final data set. Eighty-one articles were included in this review, of which 12 were randomized clinical trials of therapy that included 3074 patients, 9 were case series, and 3 were cohort studies. The incidence of AL amyloidosis is approximately 12 cases per million persons per year and there is an estimated prevalence of 30000 to 45000 cases in the US and European Union. The incidence of variant ATTR amyloidosis is estimated to be 0.3 cases per year per million persons with a prevalence estimate of 5.2 cases per million persons. Wild-type ATTR is estimated to have a prevalence of 155 to 191 cases per million persons. Amyloidosis should be considered in the differential diagnosis of adult nondiabetic nephrotic syndrome; heart failure with preserved ejection fraction, particularly if restrictive features are present; unexplained hepatomegaly without imaging abnormalities; peripheral neuropathy with distal sensory symptoms, such as numbness, paresthesia, and dysesthesias (although the autonomic manifestations occasionally may be the presenting feature); and monoclonal gammopathy of undetermined significance with atypical clinical features. Staging can be performed using blood testing only. Therapeutic decision-making for AL amyloidosis involves choosing between high-dose chemotherapy and stem cell transplant or bortezomib-based chemotherapy. There are 3 therapies approved by the US Food and Drug Administration for managing ATTR amyloidosis, depending on clinical phenotype. Conclusions and RelevanceAll forms of amyloidosis are underdiagnosed. All forms now have approved therapies that have been demonstrated to improve either survival or disability and quality of life. The diagnosis should be considered in patients that have a multisystem disorder involving the heart, kidney, liver, or nervous system. This systematic review summarizes the characteristic presentations, diagnosis, and management of immunoglobulin light chain (AL) and amyloid transthyretin (ATTR) amyloidosis.	[Gertz, Morie A.; Dispenzieri, Angela] Mayo Clin, Dept Med, Div Hematol, 200 First St SW,Mayo West 10, Rochester, MN 55905 USA	Mayo Clinic	Gertz, MA (corresponding author), Mayo Clin, Dept Med, Div Hematol, 200 First St SW,Mayo West 10, Rochester, MN 55905 USA.	gertm@mayo.edu						Adams D, 2018, NEW ENGL J MED, V379, P11, DOI 10.1056/NEJMoa1716153; Adams D, 2017, CURR OPIN NEUROL, V30, P481, DOI 10.1097/WCO.0000000000000476; Barge-Caballero G, 2019, EUR HEART J, V40, P1307, DOI 10.1093/eurheartj/ehz128; Benson MD, 2018, NEW ENGL J MED, V379, P22, DOI 10.1056/NEJMoa1716793; Benson MD, 2018, AMYLOID, V25, P215, DOI 10.1080/13506129.2018.1549825; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bochtler T, 2016, BLOOD, V128, P594, DOI 10.1182/blood-2015-10-676361; Bochtler T, 2015, J CLIN ONCOL, V33, P1371, DOI 10.1200/JCO.2014.57.4947; Buxbaum JN, 2017, GENET MED, V19, P733, DOI 10.1038/gim.2016.200; Cappelli F, 2015, CLIN CARDIOL, V38, P69, DOI 10.1002/clc.22353; Carr AS, 2019, J NEUROMUSCULAR DIS, V6, P267, DOI 10.3233/JND-180348; Carvalho A, 2015, LIVER TRANSPLANT, V21, P282, DOI 10.1002/lt.24058; Cibeira MT, 2015, BLOOD, V126, P564, DOI 10.1182/blood-2015-06-648113; Comenzo R, 2019, EUR HEM ASS M JUN 15; Cortese A, 2017, J NEUROL NEUROSUR PS, V88, P457, DOI 10.1136/jnnp-2016-315262; Di Girolamo M, 2011, AMYLOID, V18, P83, DOI 10.3109/13506129.2011.574354030; Di Nunzio D, 2019, CURR CARDIOL REP, V21, DOI 10.1007/s11886-019-1094-z; Dispenzieri A, 2004, J CLIN ONCOL, V22, P3751, DOI 10.1200/JCO.2004.03.029; Dispenzieri A, 2019, BLOOD, V134, DOI 10.1182/blood-2019-124409; Dittrich T, 2019, HAEMATOLOGICA, V104, DOI 10.3324/haematol.2018.205336; Dyck PJB, 2019, J NEUROL SCI, V405, DOI 10.1016/j.jns.2019.116424; Engineer DP, 2018, SAUDI J KIDNEY DIS T, V29, P1065, DOI 10.4103/1319-2442.243966; Finsterer J, 2019, ACTA NEUROL SCAND, V139, P92, DOI 10.1111/ane.13035; Gavriatopoulou M, 2018, LEUKEMIA, V32, P1883, DOI 10.1038/s41375-018-0209-7; Geller HI, 2017, MAYO CLIN PROC, V92, P1800, DOI 10.1016/j.mayocp.2017.09.016; Gilbertson JA, 2015, J CLIN PATHOL, V68, P314, DOI 10.1136/jclinpath-2014-202722; Gillmore JD, 2018, EUR HEART J, V39, P2799, DOI 10.1093/eurheartj/ehx589; Gillmore JD, 2016, CIRCULATION, V133, P2404, DOI 10.1161/CIRCULATIONAHA.116.021612; Hwa YL, 2016, AM J HEMATOL, V91, P984, DOI 10.1002/ajh.24453; Jaccard A, 2007, NEW ENGL J MED, V357, P1083, DOI 10.1056/NEJMoa070484; Judge DP, 2019, J AM COLL CARDIOL, V74, P285, DOI 10.1016/j.jacc.2019.03.012; KASTRITIS E, 2016, BLOOD, V128; Katzmann JA, 2009, CLIN CHEM, V55, P1517, DOI 10.1373/clinchem.2009.126664; Kaufman GP, 2017, BLOOD, V130, P900, DOI 10.1182/blood-2017-01-763599; Kimmich C, 2017, AMYLOID, V24, P52, DOI 10.1080/13506129.2017.1314959; Kourelis TV, 2017, MAYO CLIN PROC, V92, P908, DOI 10.1016/j.mayocp.2017.02.016; Kristen AV, 2007, AM J HEMATOL, V82, P328, DOI 10.1002/ajh.20745; Kumar S, 2012, J CLIN ONCOL, V30, P989, DOI 10.1200/JCO.2011.38.5724; Kyle RA, 2019, MAYO CLIN PROC, V94, P465, DOI 10.1016/j.mayocp.2018.08.041; Kyriakou P, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0952-8; Lin HM, 2017, CURR MED RES OPIN, V33, P1017, DOI 10.1080/03007995.2017.1297930; Lousada I, 2015, ADV THER, V32, P920, DOI 10.1007/s12325-015-0250-0; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Maurer MS, 2016, J AM COLL CARDIOL, V68, P161, DOI 10.1016/j.jacc.2016.03.596; Merlini G, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0034-3; Merlini G, 2017, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2017.1.1; Milani P, 2017, BLOOD, V130, P625, DOI 10.1182/blood-2017-02-767467; Mohammed SF, 2014, JACC-HEART FAIL, V2, P113, DOI 10.1016/j.jchf.2013.11.004; Mollee P, 2014, INTERN MED J, V44, P7, DOI 10.1111/imj.12288; Monteiro C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126526; Moore PT, 2017, HEART LUNG CIRC, V26, P1183, DOI 10.1016/j.hlc.2016.12.017; Muchtar E, 2019, MAYO CLIN PROC, V94, P472, DOI 10.1016/j.mayocp.2018.08.006; Muchtar E, 2018, LEUKEMIA, V32, P2240, DOI 10.1038/s41375-018-0060-x; Muchtar E, 2017, ANN MED, V49, P545, DOI 10.1080/07853890.2017.1304649; Obici L, 2016, CURR OPIN NEUROL, V29, pS27, DOI 10.1097/WCO.0000000000000290; Oda S, 2017, CIRC J, V81, P1014, DOI 10.1253/circj.CJ-16-1259; Palladini G, 2017, CLIN CHEM LAB MED, V55, P1734, DOI 10.1515/cclm-2016-1024; Palladini G, 2017, BLOOD, V129, P2120, DOI 10.1182/blood-2016-12-756528; Palladini G, 2015, BLOOD, V126, P612, DOI 10.1182/blood-2015-01-620302; Palladini G, 2014, HAEMATOLOGICA, V99, P743, DOI 10.3324/haematol.2013.095463; Palladini G, 2012, J CLIN ONCOL, V30, P4541, DOI 10.1200/JCO.2011.37.7614; Popat R, 2018, BRIT J HAEMATOL, V182, P936, DOI 10.1111/bjh.14897; Quarta CC, 2017, EUR HEART J, V38, P1905, DOI 10.1093/eurheartj/ehx047; Ritts AJ, 2017, HEART FAIL CLIN, V13, P409, DOI 10.1016/j.hfc.2016.12.003; Sachchithanantham S, 2016, J CLIN ONCOL, V34, P2037, DOI 10.1200/JCO.2015.63.3123; Sattianayagam PT, 2012, EUR HEART J, V33, P1120, DOI 10.1093/eurheartj/ehr383; Shen KN, 2019, AMYLOID, V26, P66, DOI 10.1080/13506129.2019.1594759; Siddiqi OK, 2018, TRENDS CARDIOVAS MED, V28, P10, DOI 10.1016/j.tcm.2017.07.004; Sidiqi MH, 2018, J CLIN ONCOL, V36, P1323, DOI 10.1200/JCO.2017.76.9554; Sperry BW, 2018, J AM COLL CARDIOL, V72, P2040, DOI 10.1016/j.jacc.2018.07.092; Suhr OB, 2012, DEGENER NEUROL NEURO, V2, P93, DOI 10.2147/DNND.S24652; Suzuki T, 2016, ANN HEMATOL, V95, P279, DOI 10.1007/s00277-015-2549-y; Tanskanen M, 2008, ANN MED, V40, P232, DOI 10.1080/07853890701842988; Thompson CA, 2010, AM J HEMATOL, V85, P171, DOI 10.1002/ajh.21603; Ueda M, 2011, MODERN PATHOL, V24, P1533, DOI 10.1038/modpathol.2011.117; Varga C, 2018, BLOOD, V132, P1992, DOI 10.1182/blood-2018-07-865857; Varga C, 2019, BONE MARROW TRANSPL, V54, P508, DOI 10.1038/s41409-018-0284-4; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wechalekar AD, 2016, LANCET, V387, P2641, DOI 10.1016/S0140-6736(15)01274-X	79	61	67	3	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					79	89		10.1001/jama.2020.5493	http://dx.doi.org/10.1001/jama.2020.5493			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633805				2022-12-28	WOS:000568123600024
J	Lenzer, J				Lenzer, Jeanne			"Best" hospitals in US get poor marks in new rating system	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lown Institute, 2020, LOWN I HOSP IND	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2725	10.1136/bmj.m2725	http://dx.doi.org/10.1136/bmj.m2725			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636185				2022-12-28	WOS:000548155700015
J	Pajvani, UB; Sussel, L				Pajvani, Utpal B.; Sussel, Lori			An Ultradian Notch in Beta-Cell Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pajvani, Utpal B.] Columbia Univ, Dept Med, New York, NY 10027 USA; [Pajvani, Utpal B.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Sussel, Lori] Univ Colorado, Barbara Davis Ctr Diabet, Anschutz Med Campus, Aurora, CO USA	Columbia University; Columbia University; University of Colorado System; University of Colorado Anschutz Medical Campus	Pajvani, UB (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.; Pajvani, UB (corresponding author), Columbia Univ, Inst Human Nutr, New York, NY 10032 USA.							Afelik S, 2013, WIRES DEV BIOL, V2, P531, DOI 10.1002/wdev.99; Bartolome A, 2019, J CLIN INVEST, V129, P268, DOI 10.1172/JCI98098; Isomura A, 2014, DEVELOPMENT, V141, P3627, DOI 10.1242/dev.104497; Seymour PA, 2020, DEV CELL, V52, P731, DOI 10.1016/j.devcel.2020.01.015; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017	5	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					80	82		10.1056/NEJMcibr2001628	http://dx.doi.org/10.1056/NEJMcibr2001628			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2UD	32609988				2022-12-28	WOS:000552751800016
J	Jennings, A; Cunnane, SC; Minihane, AM				Jennings, Amy; Cunnane, Stephen C.; Minihane, Anne Marie			Can nutrition support healthy cognitive ageing and reduce dementia risk?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCOSAHEXAENOIC ACID SUPPLEMENTATION; BRAIN ENERGY-METABOLISM; ALZHEIMERS-DISEASE; DOSE-RESPONSE; FATTY-ACIDS; MOUSE MODEL; DIET; ASSOCIATION; IMPAIRMENT; DECLINE		[Jennings, Amy; Minihane, Anne Marie] Univ East Anglia, Nutr & Prevent Med Grp, Norwich Med Sch, Norwich NR4 7UK, Norfolk, England; [Cunnane, Stephen C.] Univ Sherbrooke, Res Ctr Aging, Sherbrooke, PQ, Canada; [Cunnane, Stephen C.] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke	Minihane, AM (corresponding author), Univ East Anglia, Nutr & Prevent Med Grp, Norwich Med Sch, Norwich NR4 7UK, Norfolk, England.	a.minihane@uea.ac.uk		Minihane, Anne Marie/0000-0001-9042-4226				Akbaraly TN, 2019, JAMA-J AM MED ASSOC, V321, P957, DOI 10.1001/jama.2019.1432; Aridi YS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070674; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Brandt J, 2019, J ALZHEIMERS DIS, V68, P969, DOI 10.3233/JAD-180995; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Castellano CA, 2017, J ALZHEIMERS DIS, V56, P1459, DOI 10.3233/JAD-161163; Castellano CA, 2015, J ALZHEIMERS DIS, V43, P1343, DOI 10.3233/JAD-141074; Croteau E, 2018, J ALZHEIMERS DIS, V64, P551, DOI 10.3233/JAD-180202; Cunnane SC, 2020, NAT REV DRUG DISCOV; Cunnane SC, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00053; Cunnane SC, 2016, ANN NY ACAD SCI, V1367, P12, DOI 10.1111/nyas.12999; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; Fortier M, 2019, ALZHEIMERS DEMENT, V15, P625, DOI 10.1016/j.jalz.2018.12.017; Gallaway PJ, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7020022; Garcia-Mantrana I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00890; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; Hosking DE, 2019, ALZHEIMERS DEMENT, V15, P581, DOI 10.1016/j.jalz.2018.12.011; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V320, P969, DOI 10.1001/jama.2018.11025; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kirkpatrick CF, 2019, J CLIN LIPIDOL, V13, P689, DOI 10.1016/j.jacl.2019.08.003; Lehtisalo J, 2019, ALZHEIMERS DEMENT, V15, P410, DOI 10.1016/j.jalz.2018.10.001; Lewis F., 2014, TRAJECTORY DEMENTIA; Li D, 2018, AGING CELL, V17, DOI 10.1111/acel.12768; Lourida I, 2019, JAMA-J AM MED ASSOC, V322, P430, DOI 10.1001/jama.2019.9879; LYINGTUNELL U, 1981, ACTA NEUROL SCAND, V63, P337; Martinez-Lapiscina EH, 2013, J NUTR HEALTH AGING, V17, P544, DOI 10.1007/s12603-013-0027-6; Martinsen A, 2019, FASEB J, V33, P10315, DOI 10.1096/fj.201900423R; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1007, DOI 10.1016/j.jalz.2014.11.009; Mozaffarian D, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k822; Neth BJ, 2020, NEUROBIOL AGING, V86, P54, DOI 10.1016/j.neurobiolaging.2019.09.015; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Ogawa M, 1996, J NEUROL SCI, V139, P78, DOI 10.1016/S0022-510X(96)00033-0; Pontifex M, 2018, NEUROBIOL AGING, V69, P209, DOI 10.1016/j.neurobiolaging.2018.05.017; Pottala JV, 2014, NEUROLOGY, V82, P435, DOI 10.1212/WNL.0000000000000080; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Samieri C, 2018, AM J EPIDEMIOL, V187, P933, DOI 10.1093/aje/kwx330; Scarmeas N, 2018, LANCET NEUROL, V17, P1006, DOI 10.1016/S1474-4422(18)30338-7; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Scientific Advisory Commission on Nutrition, 2018, STAT DIET COGN IMP D; Shannon OM, 2019, AM J CLIN NUTR, V110, P938, DOI 10.1093/ajcn/nqz114; Smith PJ, 2010, HYPERTENSION, V55, P1331, DOI 10.1161/HYPERTENSIONAHA.109.146795; Soininen H, 2017, LANCET NEUROL, V16, P965, DOI 10.1016/S1474-4422(17)30332-0; Solfrizzi V, 2018, J ALZHEIMERS DIS, V64, pS229, DOI 10.3233/JAD-179940; Sommerlad A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002862; Stonehouse W, 2013, AM J CLIN NUTR, V97, P1134, DOI 10.3945/ajcn.112.053371; Taylor Matthew K, 2018, Alzheimers Dement (N Y), V4, P28, DOI 10.1016/j.trci.2017.11.002; Umhau JC, 2009, J LIPID RES, V50, P1259, DOI 10.1194/jlr.M800530-JLR200; Valdes Ana M, 2018, BMJ, V361, pk2179, DOI 10.1136/bmj.k2179; World Health Organization, 2019, RISK RED COGN DECL D; Wu L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41317; Wu SQ, 2015, NEUROSCI BIOBEHAV R, V48, P1, DOI 10.1016/j.neubiorev.2014.11.008; Xu Q, 2020, CLIN NUTR, V39, P2092, DOI 10.1016/j.clnu.2019.10.017; Yassine HN, 2017, JAMA NEUROL, V74, P337, DOI 10.1001/jamaneurol.2016.4899; Zhang Y, 2018, J INTERN MED, V284, P399, DOI 10.1111/joim.12786; Zhang YP, 2018, J NEUROL NEUROSUR PS, V89, P382, DOI 10.1136/jnnp-2017-316176; Zhang Y, 2016, AM J CLIN NUTR, V103, P330, DOI 10.3945/ajcn.115.124081; Zilberter M, 2013, J NEUROCHEM, V125, P157, DOI 10.1111/jnc.12127	60	27	27	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2020	369								m2269	10.1136/bmj.m2269	http://dx.doi.org/10.1136/bmj.m2269			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ7IA	32591407	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000548259500010
J	Cooper, GF; Macpherson, CG; Blundy, JD; Maunder, B; Allen, RW; Goes, S; Collier, JS; Bie, LD; Harmon, N; Hicks, SP; Iveson, AA; Prytulak, J; Rietbrock, A; Rychert, CA; Davidson, JP				Cooper, George F.; Macpherson, Colin G.; Blundy, Jon D.; Maunder, Benjamin; Allen, Robert W.; Goes, Saskia; Collier, Jenny S.; Bie, Lidong; Harmon, Nicholas; Hicks, Stephen P.; Iveson, Alexander A.; Prytulak, Julie; Rietbrock, Andreas; Rychert, Catherine A.; Davidson, Jon P.		VoiLA Team	Variable water input controls evolution of the Lesser Antilles volcanic arc	NATURE			English	Article							ISOTOPE VARIATIONS; CRUSTAL STRUCTURE; SUBDUCTION ZONE; RAYLEIGH-WAVES; MANTLE; BORON; SERPENTINIZATION; INVERSION; EXCHANGE; INSIGHTS	Oceanic lithosphere carries volatiles, notably water, into the mantle through subduction at convergent plate boundaries. This subducted water exercises control on the production of magma, earthquakes, formation of continental crust and mineral resources. Identifying different potential fluid sources (sediments, crust and mantle lithosphere) and tracing fluids from their release to the surface has proved challenging(1). Atlantic subduction zones are a valuable endmember when studying this deep water cycle because hydration in Atlantic lithosphere, produced by slow spreading, is expected to be highly non-uniform(2). Here, as part of a multi-disciplinary project in the Lesser Antilles volcanic arc(3), we studied boron trace element and isotopic fingerprints of melt inclusions. These reveal that serpentine-that is, hydrated mantle rather than crust or sediments-is a dominant supplier of subducted water to the central arc. This serpentine is most likely to reside in a set of major fracture zones subducted beneath the central arc over approximately the past ten million years. The current dehydration of these fracture zones coincides with the current locations of the highest rates of earthquakes and prominent low shear velocities, whereas the preceding history of dehydration is consistent with the locations of higher volcanic productivity and thicker arc crust. These combined geochemical and geophysical data indicate that the structure and hydration of the subducted plate are directly connected to the evolution of the arc and its associated seismic and volcanic hazards.	[Cooper, George F.; Blundy, Jon D.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Macpherson, Colin G.; Iveson, Alexander A.; Prytulak, Julie; Davidson, Jon P.] Univ Durham, Dept Earth Sci, Durham, England; [Maunder, Benjamin; Allen, Robert W.; Goes, Saskia; Collier, Jenny S.; Hicks, Stephen P.] Imperial Coll London, Dept Earth Sci & Engn, London, England; [Harmon, Nicholas; Rychert, Catherine A.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Bie, Lidong; Rietbrock, Andreas] Karlsruhe Inst Technol, Geophys Inst GPI, Karlsruhe, Germany; [Cooper, George F.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, Wales	University of Bristol; Durham University; Imperial College London; NERC National Oceanography Centre; University of Southampton; Helmholtz Association; Karlsruhe Institute of Technology; Cardiff University	Cooper, GF (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.; Cooper, GF (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, Wales.	CooperG3@cardiff.ac.uk	Hicks, Stephen P/I-7155-2012; Facility, Edinburgh Ion Microprobe/AAD-8512-2020; Macpherson, Colin/F-3861-2012	Hicks, Stephen P/0000-0002-7476-3284; Facility, Edinburgh Ion Microprobe/0000-0001-6248-6657; Allen, Robert/0000-0002-8971-651X; Kendall, John Michael/0000-0002-1486-3945; Davy, Richard/0000-0002-6663-3324; Collier, Jennifer/0000-0003-0453-1928; Macpherson, Colin/0000-0001-5302-6405; Wilkinson, Jamie/0000-0002-7706-6003; Bie, Lidong/0000-0002-8130-7084; Maunder, Benjamin/0000-0003-1068-1017; Cooper, George/0000-0002-8818-3328	VoiLA NERC consortium grant [NE/K010824/1]; EIMF [IMF619/0517, IMF653/0518]; NERC [NE/K010743/1, NE/K010824/1, NE/K004328/1] Funding Source: UKRI	VoiLA NERC consortium grant; EIMF; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank our project partners R. Robertson, J. Latchman, S. Tait and F. Kruger for support and discussion over the course of this project. We thank C. J. de Hoog for assistance with SIMS analysis at the EIMF, S. Kearns for help with EPMA analysis, the German Instrument Pool for Amphibian Seismology (DEPAS), hosted by the Alfred Wegener Institute Bremerhaven, for providing the ocean-bottom and temporary island seismometers, and the Scripps Institution of Oceanography (OBSIP) for providing additional ocean-bottom seismometers. This research was funded by the VoiLA NERC consortium grant (NE/K010824/1). SIMS analysis was funded by EIMF proposals IMF619/0517 and IMF653/0518.	Bach W, 2010, ELEMENTS, V6, P173, DOI 10.2113/gselements.6.3.173; Benton LD, 2001, EARTH PLANET SC LETT, V187, P273, DOI 10.1016/S0012-821X(01)00286-2; Bezard R, 2014, EARTH PLANET SC LETT, V395, P51, DOI 10.1016/j.epsl.2014.03.038; Bie LD, 2020, SEISMOL RES LETT, V91, P237, DOI 10.1785/0220190147; Boschi C, 2008, GEOCHIM COSMOCHIM AC, V72, P1801, DOI 10.1016/j.gca.2008.01.013; Boschi C, 2013, LITHOS, V178, P3, DOI 10.1016/j.lithos.2013.06.003; Bouvier AS, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003051; Bouvier AS, 2019, EARTH PLANET SC LETT, V507, P30, DOI 10.1016/j.epsl.2018.11.036; BOUYSSE P, 1990, TECTONOPHYSICS, V175, P349, DOI 10.1016/0040-1951(90)90180-G; BOYNTON CH, 1979, GEOPHYS J ROY ASTR S, V58, P371, DOI 10.1111/j.1365-246X.1979.tb01031.x; Braszus B., 2019, THESIS; Carpentier M, 2008, EARTH PLANET SC LETT, V272, P199, DOI 10.1016/j.epsl.2008.04.036; Collier J. S., 2015, VOILA VOLATILE RECYC, P79; Collier J.S, 2017, VOILA VOLATILE RECYC; Davy RG, 2020, J GEOPHYS RES-SOL EA, V125, DOI 10.1029/2019JB019100; De Hoog JCM, 2018, ADV ISOTOP GEOCHEM, P217, DOI 10.1007/978-3-319-64666-4_9; Escartin J, 2008, NATURE, V455, P790, DOI 10.1038/nature07333; Forsyth DW, 2005, GEOPHYS MONOGR SER, V157, P81, DOI 10.1029/156GM06; Goes S., 2019, EOS T AM GEOPHYS UN, V100, DOI [10.1029/2019EO117309, DOI 10.1029/2019EO117309, 10.1029/2019eo117309]; Grevemeyer I, 2018, GEOSPHERE, V14, P395, DOI 10.1130/GES01537.1; Gurenko AA, 2005, J PETROL, V46, P2495, DOI 10.1093/petrology/egi063; Hacker BR, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001707; Halpaap F, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7369; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10987, DOI 10.1029/2000JB900042; Harmon N, 2019, GEOPHYS J INT, V219, P725, DOI 10.1093/gji/ggz290; Harmon N, 2016, J GEOPHYS RES-SOL EA, V121, P5966, DOI 10.1002/2016JB012934; Hayes GP, 2014, GEOPHYS J INT, V196, P510, DOI 10.1093/gji/ggt385; Hicks S.P., 2019, AGU FALL M 2019; Humphreys MCS, 2006, AM MINERAL, V91, P667, DOI 10.2138/am.2006.1936; Jones RE, 2014, EARTH PLANET SC LETT, V408, P390, DOI 10.1016/j.epsl.2014.10.004; Kaliwoda M, 2011, LITHOS, V125, P51, DOI 10.1016/j.lithos.2011.01.006; Kirby S. H., 1996, GEOPHYS MONOGR SER, V96, P195, DOI DOI 10.1029/GM096P0195; LANDISMAN M, 1969, GEOPHYS J ROY ASTR S, V17, P369, DOI 10.1111/j.1365-246X.1969.tb00246.x; Leeman W.P., 1996, SUBDUCTION TOP BOTTO, V96, P269; Leeman WP, 2017, GEOCHEM GEOPHY GEOSY, V18, P1126, DOI 10.1002/2016GC006523; Levshin AL, 2001, PURE APPL GEOPHYS, V158, P1531, DOI 10.1007/PL00001233; Macdonald R, 2000, EARTH-SCI REV, V49, P1, DOI 10.1016/S0012-8252(99)00069-0; Manea VC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6095; Marschall HR, 2018, ADV ISOTOP GEOCHEM, P189, DOI 10.1007/978-3-319-64666-4_8; Marschall HR, 2017, GEOCHIM COSMOCHIM AC, V207, P102, DOI 10.1016/j.gca.2017.03.028; McCaig AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07064-6; Melekhova E, 2019, EARTH PLANET SC LETT, V516, P12, DOI 10.1016/j.epsl.2019.03.030; Muller RD, 2019, TECTONICS, V38, P1884, DOI 10.1029/2018TC005462; Paulatto M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15980; Perrin A, 2016, GEOCHEM GEOPHY GEOSY, V17, P4105, DOI 10.1002/2016GC006527; Plank T., 2014, CRUSTACEANA, V4, P607, DOI DOI 10.1016/B978-0-08-095975-7.00319-3; Sandwell DT, 2014, SCIENCE, V346, P65, DOI 10.1126/science.1258213; Schlaphorst D, 2016, GEOPHYS J INT, V204, P1405, DOI 10.1093/gji/ggv509; SPIVACK AJ, 1987, GEOCHIM COSMOCHIM AC, V51, P1033, DOI 10.1016/0016-7037(87)90198-0; Tonarini S, 2011, EARTH PLANET SC LETT, V301, P275, DOI 10.1016/j.epsl.2010.11.008; Van Avendonk HJA, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003592; van Keken PE, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007922; Vils F, 2009, EARTH PLANET SC LETT, V286, P414, DOI 10.1016/j.epsl.2009.07.005; WADGE G, 1984, GEOLOGY, V12, P555, DOI 10.1130/0091-7613(1984)12<555:COVPRA>2.0.CO;2; Yang YJ, 2006, GEOPHYS J INT, V166, P1148, DOI 10.1111/j.1365-246X.2006.02972.x	56	42	44	3	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					525	+		10.1038/s41586-020-2407-5	http://dx.doi.org/10.1038/s41586-020-2407-5			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OL0DJ	32581382	Green Accepted, Green Submitted			2022-12-28	WOS:000585013200003
J	Rivilla, I; Aparicio, B; Bueno, JM; Casanova, D; Tonnele, C; Freixa, Z; Herrero, P; Rogero, C; Miranda, JI; Martinez-Ojeda, RM; Monrabal, F; Olave, B; Schafer, T; Artal, P; Nygren, D; Cossio, FP; Gomez-Cadenas, JJ				Rivilla, Ivan; Aparicio, Borja; Bueno, Juan M.; Casanova, David; Tonnele, Claire; Freixa, Zoraida; Herrero, Pablo; Rogero, Celia; Miranda, Jose, I; Martinez-Ojeda, Rosa M.; Monrabal, Francesc; Olave, Benet; Schafer, Thomas; Artal, Pablo; Nygren, David; Cossio, Fernando P.; Gomez-Cadenas, Juan J.			Fluorescent bicolour sensor for low-background neutrinoless double beta decay experiments	NATURE			English	Article							ALKALI-METAL; PROBE; DERIVATIVES; MASSES	Observation of the neutrinoless double beta decay is the only practical way to establish that neutrinos are their own antiparticles(1). Because of the small masses of neutrinos, the lifetime of neutrinoless double beta decay is expected to be at least ten orders of magnitude greater than the typical lifetimes of natural radioactive chains, which can mimic the experimental signature of neutrinoless double beta decay(2). The most robust identification of neutrinoless double beta decay requires the definition of a signature signal-such as the observation of the daughter atom in the decay-that cannot be generated by radioactive backgrounds, as well as excellent energy resolution. In particular, the neutrinoless double beta decay of(136)Xe could be established by detecting the daughter atom,Ba-136(2+), in its doubly ionized state(3-8). Here we demonstrate an important step towards a 'barium-tagging' experiment, which identifies double beta decay through the detection of a single Ba(2+)ion. We propose a fluorescent bicolour indicator as the core of a sensor that can detect single Ba(2+)ions in a high-pressure xenon gas detector. In a sensor made of a monolayer of such indicators, the Ba(2+)dication would be captured by one of the molecules and generate a Ba2+-coordinated species with distinct photophysical properties. The presence of such a single Ba2+-coordinated indicator would be revealed by its response to repeated interrogation with a laser system, enabling the development of a sensor able to detect single Ba(2+)ions in high-pressure xenon gas detectors for barium-tagging experiments. A fluorescent bicolour sensor is proposed as the basis of a barium-tagging technique for the detection of neutrinoless double beta decay in xenon gas experiments.	[Rivilla, Ivan; Casanova, David; Tonnele, Claire; Herrero, Pablo; Rogero, Celia; Monrabal, Francesc; Cossio, Fernando P.; Gomez-Cadenas, Juan J.] Donostia Int Phys Ctr DIPC, San Sebastian, Spain; [Aparicio, Borja; Cossio, Fernando P.] Univ Basque Country UPV EHU, Dept Organ Chem 1, Ctr Innovac Quim Avanzada ORFEO CINQA, San Sebastian, Spain; [Bueno, Juan M.; Martinez-Ojeda, Rosa M.; Artal, Pablo] Univ Murcia, Lab Opt LOUM, Murcia, Spain; [Bueno, Juan M.; Martinez-Ojeda, Rosa M.; Artal, Pablo] Univ Murcia, Ctr Invest Opt & Nanofis CiOyN, Murcia, Spain; [Casanova, David; Freixa, Zoraida; Monrabal, Francesc; Schafer, Thomas; Gomez-Cadenas, Juan J.] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Freixa, Zoraida] Univ Basque Country UPV EHU, Fac Chem, Dept Appl Chem, San Sebastian, Spain; [Rogero, Celia] Mat Phys Ctr CFM CSIC UPV EHU, San Sebastian, Spain; [Miranda, Jose, I] Univ Basque Country UPV EHU, SGIker NMR Facil, San Sebastian, Spain; [Olave, Benet; Schafer, Thomas] Univ Basque Country UPV EHU, POLYMAT, NanoBioSeparat Grp, San Sebastian, Spain; [Nygren, David] Univ Texas Arlington, Dept Phys, POB 19059, Arlington, TX 76019 USA	University of Basque Country; University of Murcia; University of Murcia; Basque Foundation for Science; University of Basque Country; University of Basque Country; University of Basque Country; POLYMAT; University of Texas System; University of Texas Arlington	Cossio, FP; Gomez-Cadenas, JJ (corresponding author), Donostia Int Phys Ctr DIPC, San Sebastian, Spain.; Cossio, FP (corresponding author), Univ Basque Country UPV EHU, Dept Organ Chem 1, Ctr Innovac Quim Avanzada ORFEO CINQA, San Sebastian, Spain.; Gomez-Cadenas, JJ (corresponding author), Ikerbasque, Basque Fdn Sci, Bilbao, Spain.	fp.cossio@ehu.es; jjgomezcadenas@dipc.org	Monrabal, Francesc/R-5374-2018; Rogero, Celia/Q-1907-2017; Casanova, David/F-9752-2011; Artal, Pablo/AGV-7547-2022; Rivilla, Iván/H-5643-2016; Martínez-Ojeda, Rosa/AAJ-2437-2020; Aparicio Gil, Borja/H-1586-2017; Olave, Benat/A-2072-2017; Miranda, Jose/A-5693-2016	Monrabal, Francesc/0000-0002-4047-5620; Rogero, Celia/0000-0002-2812-8853; Casanova, David/0000-0002-8893-7089; Artal, Pablo/0000-0003-1284-6591; Rivilla, Iván/0000-0003-1984-7183; Martínez-Ojeda, Rosa/0000-0002-2957-9883; Tonnele, Claire/0000-0003-0791-8239; Herrero-Gomez, Pablo/0000-0002-1517-7779; Aparicio Gil, Borja/0000-0002-4933-2001; Olave, Benat/0000-0002-3331-1986; Bueno, Juan M./0000-0002-9711-8034; Miranda, Jose/0000-0002-7646-6857	European Research Council (ERC) [339787-NEXT]; Ministry of Science and Innovation of Spain; FEDER [FIS2014-53371-C04, FIS2016-76163-R, MAT2016-78293-C6-5-R, MINECO/FEDER CT2016-80955-P, CTQ2016-80375-P, CTQ2014-51912-REDC]; Basque Government (GV/EJ) [IT-1346-19, IT-1180-19]; Agencia de Ciencia y Tecnologia de la Region de Murcia [19897/GERM/15]; Interred PCTEFA V-A Spain/France/Andorra Program [EFA 194/16/TNSI]	European Research Council (ERC)(European Research Council (ERC)European Commission); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Basque Government (GV/EJ)(Basque Government); Agencia de Ciencia y Tecnologia de la Region de Murcia; Interred PCTEFA V-A Spain/France/Andorra Program	We acknowledge the support of our colleagues in the NEXT collaboration in the development of this work as a part of the R&D programme to develop a background-free experiment based on Ba<SUP>2+</SUP> tagging. We also acknowledge support from the following agencies and institutions: the European Research Council (ERC) under Advanced Grant 339787-NEXT; the Ministry of Science and Innovation of Spain and FEDER under grants FIS2014-53371-C04, FIS2016-76163-R, MAT2016-78293-C6-5-R, MINECO/FEDER CT2016-80955-P, CTQ2016-80375-P and CTQ2014-51912-REDC; Interred PCTEFA V-A Spain/France/Andorra Program (EFA 194/16/TNSI); the Basque Government (GV/EJ) under grants IT-1346-19 and IT-1180-19; and Agencia de Ciencia y Tecnologia de la Region de Murcia (19897/GERM/15). The authors also thank the SGI/IZO-SGIker UPV/EHU, Fundacion Seneca and DIPC for computational and analytical resources.	Aginagalde M, 2010, J ORG CHEM, V75, P2776, DOI 10.1021/jo9022815; Agostini M, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.132503; Alduino C, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.132501; Alvarez V, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/06/T06001; Amor R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147115; Avila FJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46568-z; Bainglass E, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.062509; Batsanov SS, 2001, INORG MATER+, V37, P871, DOI 10.1023/A:1011625728803; BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030; BISSELL RA, 1992, J CHEM SOC PERK T 2, P1559, DOI 10.1039/p29920001559; Bolotnikov A, 1997, NUCL INSTRUM METH A, V396, P360, DOI 10.1016/S0168-9002(97)00784-5; BOURSON J, 1993, J PHYS CHEM-US, V97, P4552, DOI 10.1021/j100119a050; Bueno JM, 2011, INVEST OPHTH VIS SCI, V52, P5325, DOI 10.1167/iovs.11-7184; Byrnes N. K., 2019, M DIV PART FIELDS AM; Carter KP, 2014, CHEM REV, V114, P4564, DOI 10.1021/cr400546e; Chambers C, 2019, NATURE, V569, P203, DOI 10.1038/s41586-019-1169-4; CROSSLEY R, 1994, J CHEM SOC PERK T 2, P1615, DOI 10.1039/p29940001615; Danilov M, 2000, PHYS LETT B, V480, P12, DOI 10.1016/S0370-2693(00)00404-4; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Elliott SR, 2002, ANNU REV NUCL PART S, V52, P115, DOI 10.1146/annurev.nucl.52.050102.090641; EXO-200 Collaboration, 2015, PHYS REV C, V92; FUKUGITA M, 1986, PHYS LETT B, V174, P45, DOI 10.1016/0370-2693(86)91126-3; Gell-Mann M., 1979, P SUP STON BROOK WOR, P27; GOLCHINI K, 1990, AM J PHYSIOL, V258, pF438, DOI 10.1152/ajprenal.1990.258.2.F438; Gomez-Cadenas JJ, 2012, RIV NUOVO CIMENTO, V35, P29, DOI 10.1393/ncr/i2012-10074-9; Gomez-Cadenas J. J., 2019, PREPRINT; HUSTON ME, 1988, J AM CHEM SOC, V110, P4460, DOI 10.1021/ja00221a083; Ji HF, 1999, PHOTOCHEM PHOTOBIOL, V69, P513, DOI 10.1111/j.1751-1097.1999.tb03321.x; Jones BJP, 2016, J INSTRUM, V11, DOI 10.1088/1748-0221/11/12/P12011; Ko CC, 2018, ACCOUNTS CHEM RES, V51, P149, DOI 10.1021/acs.accounts.7b00426; Li J, 2017, CHEM SOC REV, V46, P2437, DOI 10.1039/c6cs00619a; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Maitra R, 2017, EUR J ORG CHEM, V2017, P5975, DOI 10.1002/ejoc.201701109; Majorana E., 1937, NUOVO CIMENTO, V5, P171, DOI [10.1007/BF02961314, DOI 10.1007/BF02961314]; Martin-Albo J, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2016)159; McDonald AD, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.132504; MOE MK, 1991, PHYS REV C, V44, pR931, DOI 10.1103/PhysRevC.44.R931; MOHAPATRA RN, 1980, PHYS REV LETT, V44, P912, DOI 10.1103/PhysRevLett.44.912; Mong B, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.022505; Nakahara Y, 2005, ORG BIOMOL CHEM, V3, P1787, DOI 10.1039/b501233c; Nygren D, 2009, NUCL INSTRUM METH A, V603, P337, DOI 10.1016/j.nima.2009.01.222; Nygren DR, 2015, J PHYS CONF SER, V650, DOI 10.1088/1742-6596/650/1/012002; SAKHAROV AD, 1967, PISMA ESKP TEOR FIZ, V5, P32, DOI DOI 10.1070/PU1991V034N05ABEH002497; Sinclair D, 2011, J PHYS CONF SER, V309, DOI 10.1088/1742-6596/309/1/012005; SMITH GA, 1988, BIOCHEM J, V250, P227, DOI 10.1042/bj2500227; Thapa P, 2019, SCI REP, V9; Valeur B., 2012, MOL FLUORESCENCE PRI, V2, DOI DOI 10.1002/9783527650002; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; YANAGIDA T, 1980, PROG THEOR PHYS, V64, P1103, DOI 10.1143/PTP.64.1103; Yang JS, 2004, J ORG CHEM, V69, P719, DOI 10.1021/jo035462k; Zhang Q, 2018, HETEROCYCL COMMUN, V24, P141, DOI 10.1515/hc-2018-0031; Zhang Y, 2018, CHEM COMMUN, V54, DOI 10.1039/c8cc03094d; Zinter JP, 2011, OPT EXPRESS, V19, P15348, DOI 10.1364/OE.19.015348	54	12	12	9	82	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					48	+		10.1038/s41586-020-2431-5	http://dx.doi.org/10.1038/s41586-020-2431-5		JUN 2020	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32572207				2022-12-28	WOS:000542095200001
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Public health agencies review whether vitamin D supplements could reduce risk	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Jolliffe DA, 2020, AM J RESP CRIT CARE, DOI [10.1164/rccm.201909-18670C, DOI 10.1164/RCCM.201909-18670C]; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; NHS, VITAMIN D; Public Health Scotland, 2020, VIT D ADV ALL AG GRO; Queen Mary University of London, COV UK	5	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2020	369								m2475	10.1136/bmj.m2475	http://dx.doi.org/10.1136/bmj.m2475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GM	32561509	Bronze			2022-12-28	WOS:000548534800005
J	Dickey, J; Phelan, C				Dickey, John; Phelan, Christopher			Unrepaired Tetralogy of Fallot in Adulthood	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dickey, John; Phelan, Christopher] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Dickey, J (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01655 USA.	john.dickey@umassmemorial.org							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2020	382	25							e97	10.1056/NEJMicm1912128	http://dx.doi.org/10.1056/NEJMicm1912128			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9FX	32558471				2022-12-28	WOS:000545644400027
J	Kishore, S; Hayden, M				Kishore, Sanjay; Hayden, Margaret			Community Health Centers and Covid-19-Time for Congress to Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kishore, Sanjay; Hayden, Margaret] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Kishore, S (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Corallo B, 2020, IMPACT CORONAVIRUS C; Heisler EJ., 2017, FEDERAL HLTH CTR OVE; Kim J-H, HLTH AFFAIRS BLOG, DOI [10.1377/ hblog20200529.449762, DOI 10.1377/HBLOG20200529.449762, 10.1377/hblog20200529.449762]; National Association of Community Health Centers, 2020, NAT FIND HLTH CTR RE; Shin P, 2020, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20200409.175784, DOI 10.1377/HBLOG20200409.175784]	5	10	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2020	383	8							e54	10.1056/NEJMp2020576	http://dx.doi.org/10.1056/NEJMp2020576			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NG2MJ	32589372	Bronze			2022-12-28	WOS:000563818700003
J	Tsapas, A; Avgerinos, I; Karagiannis, T; Malandris, K; Manolopoulos, A; Andreadis, P; Liakos, A; Matthews, DR; Bekiari, E				Tsapas, Apostolos; Avgerinos, Ioannis; Karagiannis, Thomas; Malandris, Konstantinos; Manolopoulos, Apostolos; Andreadis, Panagiotis; Liakos, Aris; Matthews, David R.; Bekiari, Eleni			Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes A Systematic Review and Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							CARDIOVASCULAR OUTCOMES; ASSOCIATION; HETEROGENEITY; CONSISTENCY; EXTENT	Background: Several pharmacologic options for type 2 diabetes are available. Purpose: To compare benefits and harms of glucose-lowering drugs in adults with type 2 diabetes. Data Sources: Several databases from inception through 18 December 2019 and ClinicalTrials.gov on 10 April 2020. Study Selection: English-language randomized trials that had at least 24 weeks of intervention and assessed the effects of glucose-lowering drugs on mortality, glycemic, and vascular outcomes. Data Extraction: Pairs of reviewers extracted data and appraised risk of bias. Data Synthesis: 453 trials assessing 21 antidiabetic interventions from 9 drug classes were included. Interventions included monotherapies (134 trials), add-on to metformin-based therapies (296 trials), and monotherapies versus add-on to metformin therapies (23 trials). There were no differences between treatments in drug-naive patients at low cardiovascular risk. Insulin regimens and specific glucagon-like peptide-1 receptor agonists (GLP-1 RAs) added to metformin-based background therapy produced the greatest reductions in hemoglobin A(1c) level. In patients at low cardiovascular risk receiving metformin-based background treatment (298 trials), there were no clinically meaningful differences between treatments for mortality and vascular outcomes. In patients at increased cardiovascular risk receiving metformin-based background treatment (21 trials), oral sema-glutide, empagliflozin, liraglutide, extended-release exenatide, and dapagliflozin reduced all-cause mortality. Oral semaglutide, empagliflozin, and liraglutide also reduced cardiovascular death. Odds of stroke were lower with subcutaneous semaglutide and dulaglutide. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduced heart failure hospitalization and end-stage renal disease. Subcutaneous semaglutide and canagliflozin increased diabetic retinopathy and amputation, respectively. Limitation: Inconsistent definitions of cardiovascular risk and low-level confidence in some estimates for patients at low cardiovascular risk. Conclusion: In diabetic patients at low cardiovascular risk, no treatment differs from placebo for vascular outcomes. In patients at increased cardiovascular risk receiving metformin-based background therapy, specific GLP-1 RAs and SGLT-2 inhibitors have a favorable effect on certain cardiovascular outcomes.	[Tsapas, Apostolos; Avgerinos, Ioannis; Karagiannis, Thomas; Malandris, Konstantinos; Manolopoulos, Apostolos; Andreadis, Panagiotis; Liakos, Aris; Bekiari, Eleni] Aristotle Univ Thessaloniki, Clin Res & Evidence Based Med Unit, Konstantinoupoleos 49, Thessaloniki 54642, Greece; [Tsapas, Apostolos; Bekiari, Eleni] Aristotle Univ Thessaloniki, Ctr Diabet, Thessaloniki, Greece; [Tsapas, Apostolos; Matthews, David R.] Univ Oxford, Harris Manchester Coll, Oxford, England; [Andreadis, Panagiotis] North West Anglia NHS Fdn Trust, Peterborough City Hosp, Peterborough, England; [Matthews, David R.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Matthews, David R.] Harris Manchester Coll, Mansfield Rd, Oxford OX1 3TD, England	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; University of Oxford; University of Oxford; University of Oxford	Tsapas, A (corresponding author), Aristotle Univ Thessaloniki, Clin Res & Evidence Based Med Unit, Konstantinoupoleos 49, Thessaloniki 54642, Greece.	atsapas@auth.gr	Avgerinos, Ioannis/AGY-7425-2022; Manolopoulos, Apostolos/GZG-5125-2022; Liakos, Aris/H-2630-2016; Karagiannis, Thomas/H-9476-2019	Avgerinos, Ioannis/0000-0003-2232-1342; Manolopoulos, Apostolos/0000-0003-1055-0324; Bekiari, Eleni/0000-0001-9975-3835; Liakos, Aris/0000-0003-3261-2979; Karagiannis, Thomas/0000-0001-5242-0574	European Foundation for the Study of Diabetes PAtient-Centred Treatment to support a holistic approach toward type 2 diabetes (PACT) Programme - AstraZeneca	European Foundation for the Study of Diabetes PAtient-Centred Treatment to support a holistic approach toward type 2 diabetes (PACT) Programme - AstraZeneca	By the European Foundation for the Study of Diabetes PAtient-Centred Treatment to support a holistic approach toward type 2 diabetes (PACT) Programme, supported by an unrestricted educational grant from AstraZeneca.	American Diabetes Association, 2020, Diabetes Care, V43, pS98, DOI 10.2337/dc20-S009; Amod A, 2020, DIABETES THER, V11, P53, DOI [10.2337/dci19-0066, 10.1007/s13300-019-00715-x]; Brignardello-Petersen R, 2019, J CLIN EPIDEMIOL, V105, P60, DOI 10.1016/j.jclinepi.2018.08.022; Cefalu WT, 2018, DIABETES CARE, V41, P14, DOI 10.2337/dci17-0057; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; CINeMA, 2017, CINEMA CONF NETW MET; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cosentino F., 2020, EUR HEART J, V41, P255, DOI [10.1093/eurheartj/ehz486, DOI 10.1093/eurheartj/ehz486]; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Fei Y, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0916-z; Gerstein HC, 2019, LANCET, V394, P121, DOI 10.1016/S0140-6736(19)31149-3; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins JPT, 2015, LANCET, V386, P628, DOI 10.1016/S0140-6736(15)61478-7; Husain M, 2019, NEW ENGL J MED, V381, P841, DOI 10.1056/NEJMoa1901118; Hussein H, 2020, DIABETES OBES METAB, V22, P1035, DOI 10.1111/dom.14008; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Jia Y, 2019, OBES REV, V20, P1, DOI 10.1111/obr.12753; Karagiannis T, 2020, J GEN INTERN MED, DOI 10.1007/s11606-019-05608-0; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Kristensen SL, 2019, LANCET DIABETES ENDO, V7, P776, DOI 10.1016/S2213-8587(19)30249-9; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; Neuen BL, 2019, LANCET DIABETES ENDO, V7, P845, DOI 10.1016/S2213-8587(19)30256-6; Nikolakopoulou A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003082; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Rhodes KM, 2015, J CLIN EPIDEMIOL, V68, P52, DOI 10.1016/j.jclinepi.2014.08.012; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V321, P69, DOI 10.1001/jama.2018.18269; Rucker G., 2019, NETMETA NETWORK META; Rucker G, 2014, STAT MED, V33, P4353, DOI 10.1002/sim.6236; Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058; Schwarzer G., 2007, R NEWS, V7, P40; Sharp SJ, 1996, BRIT MED J, V313, P735; Tang HL, 2018, DIABETES OBES METAB, V20, P1262, DOI 10.1111/dom.13232; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; Zelniker TA, 2019, CIRCULATION, V139, P2022, DOI 10.1161/CIRCULATIONAHA.118.038868; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X; Zheng SL, 2018, JAMA-J AM MED ASSOC, V319, P1580, DOI 10.1001/jama.2018.3024; Zhu JH, 2020, LANCET DIABETES ENDO, V8, P192, DOI 10.1016/S2213-8587(19)30422-X	37	91	92	5	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2020	173	4					278	+		10.7326/M20-0864	http://dx.doi.org/10.7326/M20-0864			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9TG	32598218				2022-12-28	WOS:000567070300017
J	Deng, W; Bao, LL; Liu, JN; Xiao, C; Liu, JY; Xue, J; Lv, Q; Qi, FF; Gao, H; Yu, P; Xu, YF; Qu, YJ; Li, FD; Xiang, ZG; Yu, HS; Gong, SR; Liu, MY; Wang, GP; Wang, SY; Song, ZQ; Liu, Y; Zhao, WJ; Han, YL; Zhao, LN; Liu, X; Wei, Q; Qin, C				Deng, Wei; Bao, Linlin; Liu, Jiangning; Xiao, Chong; Liu, Jiayi; Xue, Jing; Lv, Qi; Qi, Feifei; Gao, Hong; Yu, Pin; Xu, Yanfeng; Qu, Yajin; Li, Fengdi; Xiang, Zhiguang; Yu, Haisheng; Gong, Shuran; Liu, Mingya; Wang, Guanpeng; Wang, Shunyi; Song, Zhiqi; Liu, Ying; Zhao, Wenjie; Han, Yunlin; Zhao, Linna; Liu, Xing; Wei, Qiang; Qin, Chuan			Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques	SCIENCE			English	Article							SARS	Coronavirus disease 2019 (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. It is unclear whether convalescing patients have a risk of reinfection. We generated a rhesus macaque model of SARS-CoV-2 infection that was characterized by interstitial pneumonia and systemic viral dissemination mainly in the respiratory and gastrointestinal tracts. Rhesus macaques reinfected with the identical SARS-CoV-2 strain during the early recovery phase of the initial SARS-CoV-2 infection did not show detectable viral dissemination, clinical manifestations of viral disease, or histopathological changes. Comparing the humoral and cellular immunity between primary infection and rechallenge revealed notably enhanced neutralizing antibody and immune responses. Our results suggest that primary SARS-CoV-2 exposure protects against subsequent reinfection in rhesus macaques.	[Deng, Wei; Bao, Linlin; Liu, Jiangning; Xiao, Chong; Xue, Jing; Lv, Qi; Qi, Feifei; Gao, Hong; Yu, Pin; Xu, Yanfeng; Qu, Yajin; Li, Fengdi; Xiang, Zhiguang; Yu, Haisheng; Gong, Shuran; Liu, Mingya; Wang, Guanpeng; Wang, Shunyi; Song, Zhiqi; Liu, Ying; Zhao, Wenjie; Han, Yunlin; Zhao, Linna; Liu, Xing; Wei, Qiang; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, NHC Key Lab Human Dis Comparat Med, Beijing Key Lab Anim Models Emerging & Remerging, Beijing, Peoples R China; [Deng, Wei; Bao, Linlin; Liu, Jiangning; Xiao, Chong; Xue, Jing; Lv, Qi; Qi, Feifei; Gao, Hong; Yu, Pin; Xu, Yanfeng; Qu, Yajin; Li, Fengdi; Xiang, Zhiguang; Yu, Haisheng; Gong, Shuran; Liu, Mingya; Wang, Guanpeng; Wang, Shunyi; Song, Zhiqi; Liu, Ying; Zhao, Wenjie; Han, Yunlin; Zhao, Linna; Liu, Xing; Wei, Qiang; Qin, Chuan] Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China; [Liu, Jiayi] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Qin, C (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, NHC Key Lab Human Dis Comparat Med, Beijing Key Lab Anim Models Emerging & Remerging, Beijing, Peoples R China.; Qin, C (corresponding author), Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China.	qinchuan@pumc.edu.cn	qin, chuan/ABG-4508-2020; Deng, Wei/GWC-9207-2022	, jiayi/0000-0002-5617-7054; gao, hong/0000-0002-2488-8695; Liu, Jiangning/0000-0002-1264-6664; Xue, Jing/0000-0002-9113-2433; DENG, WEI/0000-0002-1619-2313	CAMS initiative for Innovative Medicine of China [2016-I2M-2-006]; National Key Research and Development Project of China [2016YFD0500304]; National Mega projects of China for Major Infectious Diseases [2017ZX10304402]	CAMS initiative for Innovative Medicine of China; National Key Research and Development Project of China; National Mega projects of China for Major Infectious Diseases	This work was supported by the CAMS initiative for Innovative Medicine of China (grant No. 2016-I2M-2-006), National Mega projects of China for Major Infectious Diseases (2017ZX10304402), and National Key Research and Development Project of China (grant no. 2016YFD0500304).	An J, 2020, CHAOS, V30, DOI 10.1063/1.5126116; [Anonymous], 2020, DIAGN TREATM PROT NO; Aquino-Jarquin G, 2019, NANOMED-NANOTECHNOL, V18, P428, DOI 10.1016/j.nano.2019.03.006; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Lu S, 2020, COMP SARS COV 2 INFE, DOI 10.1101/2020.04.08.031807; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Rockx Barry, 2020, Science, V368, P1012, DOI 10.1126/science.abb7314; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Wang SF, 2014, BIOCHEM BIOPH RES CO, V451, P208, DOI 10.1016/j.bbrc.2014.07.090; WHO, 2020, WHO COR COVID 19 DAS; Williamson Brandi N, 2020, bioRxiv, DOI 10.1101/2020.04.15.043166; World Health Organization, 2020, COR DIS COVID 19 PAN; Wu F., 2020, NEUTRALIZING ANTIBOD, DOI [10.1101/2020.03.30.20047365, DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]; Yu P, 2020, ANIM MODEL EXP MED, V3, P93, DOI 10.1002/ame2.12108; Zhou L, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, P281, DOI 10.3760/cma.j.cn112147-20200229-00219; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	18	275	284	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2020	369	6505					818	+		10.1126/science.abc5343	http://dx.doi.org/10.1126/science.abc5343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA3RX	32616673	Green Published			2022-12-28	WOS:000559731300036
J	Verschueren, E; Husain, B; Yuen, K; Sun, Y; Paduchuri, S; Senbabaoglu, Y; Lehoux, I; Arena, TA; Wilson, B; Lianoglou, S; Bakalarski, C; Franke, Y; Chan, P; Wong, AW; Gonzalez, LC; Mariathasan, S; Turley, SJ; Lill, JR; Martinez-Martin, N				Verschueren, Erik; Husain, Bushra; Yuen, Kobe; Sun, Yi; Paduchuri, Sairupa; Senbabaoglu, Yasin; Lehoux, Isabelle; Arena, Tia A.; Wilson, Blair; Lianoglou, Steve; Bakalarski, Corey; Franke, Yvonne; Chan, Pamela; Wong, Athena W.; Gonzalez, Lino C.; Mariathasan, Sanjeev; Turley, Shannon J.; Lill, Jennie R.; Martinez-Martin, Nadia			The Immunoglobulin Superfamily Receptome Defines Cancer-Relevant Networks Associated with Clinical Outcome	CELL			English	Article							SCALE-FREE NETWORKS; PROTEIN COMPLEXES; TUMOR-SUPPRESSOR; EPH RECEPTORS; INTERACTOME; MODULATORS; REVEALS; EPHRINS	Cell surface receptors and their interactions play a central role in physiological and pathological signaling. Despite its clinical relevance, the immunoglobulin superfamily (IgSF) remains uncharacterized and underrepresented in databases. Here, we present a systematic extracellular protein map, the IgSF interactome. Using a high-throughput technology to interrogate most single transmembrane receptors for binding to 445 IgSF proteins, we identify over 500 interactions, 82% previously undocumented, and confirm more than 60 receptor-ligand pairs using orthogonal assays. Our study reveals a map of cell-type-specific interactions and the landscape of dysregulated receptor-ligand crosstalk in cancer, including selective loss of function for tumor-associated mutations. Furthermore, investigation of the IgSF interactome in a large cohort of cancer patients identifies interacting protein signatures associated with clinical outcome. The IgSF interactome represents an important resource to fuel biological discoveries and a framework for understanding the functional organization of the surfaceome during homeostasis and disease, ultimately informing therapeutic development.	[Verschueren, Erik] Galapagos NV, Mechelen, Belgium; [Husain, Bushra; Bakalarski, Corey; Lill, Jennie R.; Martinez-Martin, Nadia] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA; [Yuen, Kobe; Mariathasan, Sanjeev] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA USA; [Sun, Yi] Univ Birmingham, Dept Biochem, Birmingham, W Midlands, England; [Paduchuri, Sairupa] Genentech Inc, Prot Chem, San Francisco, CA USA; [Senbabaoglu, Yasin] Genentech Inc, Bioinformat, San Francisco, CA USA; [Lehoux, Isabelle; Franke, Yvonne] Genentech Inc, BioMol Resources Dept, San Francisco, CA USA; [Arena, Tia A.; Wong, Athena W.] Genentech Inc, Res Mat Grp, San Francisco, CA USA; [Wilson, Blair; Chan, Pamela] Genentech Inc, Biochem & Mol Pharmacol, San Francisco, CA USA; [Lianoglou, Steve] Denali Therapeut, San Francisco, CA USA; [Gonzalez, Lino C.] 23 & Me, San Francisco, CA USA; [Turley, Shannon J.] Genentech Inc, Canc Immunol Dept, San Francisco, CA USA	Galapagos NV; Roche Holding; Genentech; Roche Holding; Genentech; University of Birmingham; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Martinez-Martin, N (corresponding author), Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA.	martinez-martin.nadia@gene.com		Lianoglou, Steve/0000-0002-0924-1754; Arena, Tia/0000-0002-4283-6223	Genentech Inc.	Genentech Inc.(Roche HoldingGenentech)	We are thankful to Genentech internal Reviewers for their critical assessment of this work. We thank Lovejit Singh, Andrew Perez, aYnd Andy Chang for excellent technical assistance. We thank Sarah Hymowitz and Melissa Starovasnik for supporting the completion of this project. The current study was fully funded by Genentech Inc.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Arnett HA, 2014, NAT REV IMMUNOL, V14, P559, DOI 10.1038/nri3715; Bae H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00424-0; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Bausch-Fluck D, 2018, P NATL ACAD SCI USA, V115, pE10988, DOI 10.1073/pnas.1808790115; Bos AB, 2015, BIOTECHNOL BIOENG, V112, P1832, DOI 10.1002/bit.25601; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Chang GM, 2010, CLIN CANCER RES, V16, P5390, DOI 10.1158/1078-0432.CCR-10-1461; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chung M, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00596-19; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Davis ZH, 2015, MOL CELL, V57, P349, DOI 10.1016/j.molcel.2014.11.026; Du Y, 2015, CHIN J CANCER, V34, P61, DOI 10.5732/cjc.014.10146; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Husain B, 2019, MOL CELL PROTEOMICS, V18, P2310, DOI 10.1074/mcp.TIR119.001433; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; kesson A L., 2017, SCIENCE, V356; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Martinez-Martin N, 2018, CELL, V174, P1158, DOI 10.1016/j.cell.2018.06.028; Martinez-Martin N, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2197615; Martinez-Martin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11473; Mohebiany AN, 2013, FEBS J, V280, P388, DOI 10.1111/j.1742-4658.2012.08653.x; Nusinow DP, 2020, CELL, V180, P387, DOI 10.1016/j.cell.2019.12.023; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; Orsulic S, 2000, J CELL SCI, V113, P1793; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Peyser ND, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135750; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Pierson E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004220; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ramani SR, 2012, ANAL BIOCHEM, V420, P127, DOI 10.1016/j.ab.2011.09.017; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Shah NJ, 2018, HUM VACC IMMUNOTHER, V14, P269, DOI 10.1080/21645515.2017.1403694; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; van der Touw W, 2017, CANCER IMMUNOL IMMUN, V66, P1079, DOI 10.1007/s00262-017-2023-x; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wright GJ, 2010, BIOCHEM SOC T, V38, P919, DOI 10.1042/BST0380919; Wright GJ, 2009, MOL BIOSYST, V5, P1405, DOI [10.1039/B903580J, 10.1039/b903580j]; Yap EH, 2014, J MOL BIOL, V426, P945, DOI 10.1016/j.jmb.2013.11.009; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhu CJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1090-3	54	27	27	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2020	182	2					329	+		10.1016/j.cell.2020.06.007	http://dx.doi.org/10.1016/j.cell.2020.06.007			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MQ2RP	32589946	Bronze			2022-12-28	WOS:000552745000007
J	Navathe, AS; Boyle, CW; Emanuel, EJ				Navathe, Amol S.; Boyle, Connor W.; Emanuel, Ezekiel J.			Alternative Payment Models-Victims of Their Own Success?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Navathe, Amol S.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA; [Navathe, Amol S.; Boyle, Connor W.; Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Navathe, Amol S.; Boyle, Connor W.; Emanuel, Ezekiel J.] Univ Penn, Healthcare Transformat Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Navathe, AS (corresponding author), Univ Penn, Div Hlth Policy, 423 Guardian Dr,1108 Blockely Hall, Philadelphia, PA 19104 USA.	amol@wharton.upenn.edu		Navathe, Amol/0000-0001-7182-4988				Elmendorf DW, 2012, COMMUNICATION   0724; Emanuel EJ, 2020, TRILLION DOLLAR REVO; Getzen TE, 2016, N AM ACTUAR J, V20, P101, DOI 10.1080/10920277.2015.1110490; Holahan J., 2019, SLOW GROWTH MED MED; US Congressional Budget Office, 2007, LONG TERM OUTL HLTH; Verma S., 2019, QUALITY PAYMENT PROG	6	12	11	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2020	324	3					237	238		10.1001/jama.2020.4133	http://dx.doi.org/10.1001/jama.2020.4133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MU9CI	32568369				2022-12-28	WOS:000555963000011
J	Gewin, V; Wright, V; Richards, M; Taylor, K; Pittman, N; Henderson, H; Abdi, A				Gewin, Virginia; Wright, Vashan; Richards, Mark; Taylor, Kishana; Pittman, Nikea; Henderson, Henry; Abdi, Abdulhakim			FIGHTING RACISM DEMANDS MORE THAN JUST WORDS	NATURE			English	Editorial Material									[Wright, Vashan] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Richards, Mark] Imperial Coll London, London, England; [Taylor, Kishana] Univ Calif Davis, Davis, CA 95616 USA; [Pittman, Nikea] Univ N Carolina, Chapel Hill, NC 27515 USA; [Henderson, Henry] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Abdi, Abdulhakim] Lund Univ, S-22100 Lund, Sweden	Woods Hole Oceanographic Institution; Imperial College London; University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Lund University									0	16	16	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					319	322		10.1038/d41586-020-01883-8	http://dx.doi.org/10.1038/d41586-020-01883-8			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF1CP	32620869				2022-12-28	WOS:000545088500001
J	Kabashima, K; Matsumura, T; Komazaki, H; Kawashima, M				Kabashima, Kenji; Matsumura, Takayo; Komazaki, Hiroshi; Kawashima, Makoto		Nemolizumab-JP01 Study Grp	Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERITY INDEX; INTERLEUKIN-31 RECEPTOR; EUROPEAN GUIDELINES; OBJECTIVE SCORAD; ECZEMA AREA; MANAGEMENT; DUPILUMAB; PLACEBO; ADULTS; VALIDATION	BackgroundNemolizumab is a subcutaneously administered humanized monoclonal antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in atopic dermatitis. In phase 2 studies, nemolizumab lessened the severity of atopic dermatitis. MethodsIn a 16-week, double-blind, phase 3 trial, we randomly assigned Japanese patients with atopic dermatitis and moderate-to-severe pruritus and an inadequate response to topical agents in a 2:1 ratio to receive subcutaneous nemolizumab (60 mg) or placebo every 4 weeks until week 16, with concomitant topical agents. The primary end point was the mean percent change in the visual-analogue scale (VAS) score for pruritus (range, 0 to 100, with higher scores indicating worse pruritus) from baseline to week 16. Secondary end points included the time course of change in the VAS score for pruritus up to week 4, the change in the Eczema Area and Severity Index (EASI) score (range, 0 to 72, with higher scores indicating greater severity), a score of 4 or less on the Dermatology Life Quality Index (DLQI; range, 0 to 30, with higher scores indicating a greater effect on daily life), a score of 7 or less on the Insomnia Severity Index (ISI; range, 0 to 28, with higher scores indicating greater severity), and safety. ResultsA total of 143 patients were randomly assigned to receive nemolizumab and 72 to receive placebo. The median VAS score for pruritus at baseline was 75. At week 16, the mean percent change in the VAS score was -42.8% in the nemolizumab group and -21.4% in the placebo group (difference, -21.5 percentage points; 95% confidence interval, -30.2 to -12.7; P<0.001). The mean percent change in the EASI score was -45.9% with nemolizumab and -33.2% with placebo. The percentage of patients with a DLQI score of 4 or less was 40% in the nemolizumab group and 22% in the placebo group; the percentage of patients with an ISI score of 7 or less was 55% and 21%, respectively. The incidence of injection-related reactions was 8% with nemolizumab and 3% with placebo. ConclusionsIn this 16-week trial, the use of subcutaneous nemolizumab in addition to topical agents for atopic dermatitis resulted in a greater reduction in pruritus than placebo plus topical agents. The incidence of injection-site reactions was greater with nemolizumab than with placebo. Longer and larger trials are necessary to determine whether nemolizumab has a durable effect and is safe for atopic dermatitis. (Funded by Maruho; JapicCTI number, 173740.) In a 16-week, randomized trial involving patients with atopic dermatitis, the monoclonal antibody nemolizumab was more effective than placebo for the relief of pruritus. The incidence of injection-site reactions was higher with nemolizumab than with placebo.	[Kabashima, Kenji] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto, Japan; [Matsumura, Takayo] Maruho, Dept Clin Dev, Kyoto, Japan; [Komazaki, Hiroshi] Maruho, Dept Data Sci, Kyoto, Japan; [Kawashima, Makoto] Tokyo Womens Med Univ, Tokyo, Japan	Kyoto University; Tokyo Women's Medical University	Kabashima, K (corresponding author), Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara, Kyoto 6068507, Japan.	kaba@kuhp.kyoto-u.ac.jp		Komine, Mayumi/0000-0002-1086-1803	Maruho	Maruho	Supported by Maruho.	[Anonymous], 2012, REGEN MED S3, V7, pS14; Avena-Woods C, 2017, AM J MANAG CARE, V23, pS115; Bagci IS, 2018, J ALLERGY CLIN IMMUN, V141, P858, DOI 10.1016/j.jaci.2017.10.045; Barbier N, 2004, BRIT J DERMATOL, V150, P96, DOI 10.1111/j.1365-2133.2004.05696.x; Basra MKA, 2015, DERMATOLOGY, V230, P27, DOI 10.1159/000365390; Blauvelt A, 2017, LANCET, V389, P2287, DOI 10.1016/S0140-6736(17)31191-1; Bridgman AC, 2018, ANN ALLERG ASTHMA IM, V120, P603, DOI 10.1016/j.anai.2018.03.009; Charman CR, 2004, ARCH DERMATOL, V140, P1513, DOI 10.1001/archderm.140.12.1513; Chopra R, 2017, BRIT J DERMATOL, V177, P1316, DOI 10.1111/bjd.15641; Chrostowska-Plak D, 2013, J EUR ACAD DERMATOL, V27, pE239, DOI 10.1111/j.1468-3083.2012.04578.x; Dainichi T, 2018, NAT IMMUNOL, V19, P1286, DOI 10.1038/s41590-018-0256-2; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Jacob SE, 2006, J AM ACAD DERMATOL, V54, P723, DOI 10.1016/j.jaad.2005.12.028; Kabashima K, 2018, J ALLERGY CLIN IMMUN, V142, P1121, DOI 10.1016/j.jaci.2018.03.018; Katoh N, 2019, J DERMATOL, V46, P1053, DOI 10.1111/1346-8138.15090; Klonowska J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103086; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Nakagawa, 2011, NISHI J DERMATOL, V73, P278; Nemoto O, 2016, BRIT J DERMATOL, V174, P296, DOI 10.1111/bjd.14207; Oyama S, 2018, EXP DERMATOL, V27, P14, DOI 10.1111/exd.13236; Ramirez FD, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2019.0025; Reich A, 2012, ACTA DERM-VENEREOL, V92, P497, DOI 10.2340/00015555-1265; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Schmitt J, 2007, J ALLERGY CLIN IMMUN, V120, P1389, DOI 10.1016/j.jaci.2007.08.011; Schram ME, 2012, ALLERGY, V67, P99, DOI 10.1111/j.1398-9995.2011.02719.x; Shirley M, 2017, DRUGS, V77, P1115, DOI 10.1007/s40265-017-0768-3; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P327, DOI 10.1016/j.jaad.2014.03.030; Silverberg JI, 2020, J ALLERGY CLIN IMMUN, V145, P173, DOI 10.1016/j.jaci.2019.08.013; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Torres T, 2019, ACTA MEDICA PORT, V32, P606, DOI 10.20344/amp.11963; Wahlgren Carl-Fredrik, 1999, Journal of Dermatology (Tokyo), V26, P770; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wollenberg A, 2018, J EUR ACAD DERMATOL, V32, P850, DOI 10.1111/jdv.14888; Wollenberg A, 2018, J EUR ACAD DERMATOL, V32, P657, DOI 10.1111/jdv.14891; Yosipovitch G, 2019, BRIT J DERMATOL, V181, P761, DOI 10.1111/bjd.17744; 2019, LANCET DIGITAL HLTH, V1, pCD012	40	110	113	2	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					141	150		10.1056/NEJMoa1917006	http://dx.doi.org/10.1056/NEJMoa1917006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9PO	32640132	Bronze			2022-12-28	WOS:000571894800013
J	Horton, R				Horton, Richard			Offline: It's time to convene nations to end this pandemic	LANCET			English	Editorial Material												richard.horton@lancet.com							0	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					14	14						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32622384	Green Published, Bronze			2022-12-28	WOS:000561626100005
J	Ginsburg, AS; Mvalo, T; Nkwopara, E; McCollum, ED; Phiri, M; Schmicker, R; Hwang, J; Ndamala, CB; Phiri, A; Lufesi, N; May, S				Ginsburg, Amy-Sarah; Mvalo, Tisungane; Nkwopara, Evangelyn; McCollum, Eric D.; Phiri, Melda; Schmicker, Robert; Hwang, Jun; Ndamala, Chifundo B.; Phiri, Ajib; Lufesi, Norman; May, Susanne			Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY CASE-MANAGEMENT; AGED 2-59 MONTHS; ORAL AMOXICILLIN; CHILDHOOD PNEUMONIA; DOUBLE-BLIND; DISTRICT; PAKISTAN	BACKGROUND Evidence regarding the appropriate duration of treatment with antibiotic agents in children with pneumonia in low-resource settings in Africa is lacking. METHODS We conducted a double-blind, randomized, controlled, noninferiority trial in Lilongwe, Malawi, to determine whether treatment with amoxicillin for 3 days is less effective than treatment for 5 days in children with chest-indrawing pneumonia (cough lasting <14 days or difficulty breathing, along with visible indrawing of the chest wall with or without fast breathing for age). Children not infected with human immunodeficiency virus (HIV) who were 2 to 59 months of age and had chest-indrawing pneumonia were randomly assigned to receive amoxicillin twice daily for either 3 days or 5 days. Children were followed for 14 days. The primary outcome was treatment failure by day 6; noninferiority of the 3-day regimen to the 5-day regimen would be shown if the percentage of children with treatment failure in the 3-day group was no more than 1.5 times that in the 5-day group. Prespecified secondary analyses included assessment of treatment failure or relapse by day 14. RESULTS From March 29, 2016, to April 1, 2019, a total of 3000 children underwent randomization: 1497 children were assigned to the 3-day group, and 1503 to the 5-day group. Among children with day 6 data available, treatment failure had occurred in 5.9% in the 3-day group (85 of 1442 children) and in 5.2% (75 of 1456) in the 5-day group (adjusted difference, 0.7 percentage points; 95% confidence interval [CI], -0.9 to 2.4) - a result that satisfied the criterion for noninferiority of the 3-day regimen to the 5-day regimen. Among children with day 14 data available, 176 of 1411 children (12.5%) in the 3-day group and 154 of 1429 (10.8%) in the 5-day group had had treatment failure by day 6 or relapse by day 14 (between-group difference, 1.7 percentage points; 95% CI, -0.7 to 4.1). The percentage of children with serious adverse events was similar in the two groups (9.8% in the 3-day group and 8.8% in the 5-day group). CONCLUSIONS In HIV-uninfected Malawian children, treatment with amoxicillin for chest-indrawing pneumonia for 3 days was noninferior to treatment for 5 days.	[Ginsburg, Amy-Sarah; Schmicker, Robert; Hwang, Jun; May, Susanne] Univ Washington, Dept Biostat, Clin Trial Ctr, Bldg 29,Suite 250,6200 NE 74th St, Seattle, WA 98115 USA; [Mvalo, Tisungane; Phiri, Melda; Ndamala, Chifundo B.] Univ North Carolina Project, Lilongwe Med Relief Fund Trust, Tidziwe Ctr, Lilongwe, Malawi; [Lufesi, Norman] Malawi Minist Hlth, Acute Resp Infect & Emergency Triage Assessment &, Lilongwe, Malawi; [Phiri, Ajib] Univ Malawi, Coll Med, Dept Pediat & Child Hlth, Blantyre, Malawi; [Nkwopara, Evangelyn] Save Children, Fairfield, CT USA; [McCollum, Eric D.] Johns Hopkins Sch Med, Dept Pediat, Eudowood Div Pediat Resp Sci, Baltimore, MD USA; [McCollum, Eric D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Malawi; Save the Children; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ginsburg, AS (corresponding author), Univ Washington, Dept Biostat, Clin Trial Ctr, Bldg 29,Suite 250,6200 NE 74th St, Seattle, WA 98115 USA.	messageforamy@gmail.com		Mvalo, Tisungane/0000-0002-6775-7919	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funded by the Bill and Melinda Gates Foundation; ClinicalTrials.gov number, NCT02678195.	Addo-Yobo E, 2011, TROP MED INT HEALTH, V16, P995, DOI 10.1111/j.1365-3156.2011.02787.x; Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; [Anonymous], 2014, INT MAN CHILDH ILL C; Awasthi S, 2004, BMJ-BRIT MED J, V328, P791; Bari A, 2011, LANCET, V378, P1796, DOI 10.1016/S0140-6736(11)61140-9; Das RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066232; Ginsburg AS, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3379-z; Greenberg D, 2014, PEDIATR INFECT DIS J, V33, P136, DOI 10.1097/INF.0000000000000023; Grimwood K, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0006-x; Haider BA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005976.pub2; Hazir T, 2002, LANCET, V360, P835; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Huber P.J., 1967, P 5 BERKELEY S MATH, V1, P221; King C, 2018, PLOS ONE, V13, pe0206404; Lassi ZS, 2014, ARCH DIS CHILD, V99, P687, DOI 10.1136/archdischild-2013-304023; Lassi ZS, 2017, COCHRANE DB SYST REV, V10, pCD008032; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; McMullan BJ, 2016, LANCET INFECT DIS, V16, pE139, DOI 10.1016/S1473-3099(16)30024-X; Nascimento-Carvalho CM, 2013, PEDIATR INFECT DIS J, V32, P1281, DOI 10.1097/INF.0b013e3182a4dcfa; Nightingale R, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0024-8; O'Brien KL, 2019, LANCET, V394, P757, DOI 10.1016/S0140-6736(19)30721-4; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Soofi S, 2012, LANCET, V379, P729, DOI 10.1016/S0140-6736(11)61714-5; Theodoratou E, 2014, LANCET INFECT DIS, V14, P1250, DOI 10.1016/S1473-3099(14)70990-9; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; World Health Organization, 2014, REV WHO CLASS TREATM	28	32	35	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					13	23		10.1056/NEJMoa1912400	http://dx.doi.org/10.1056/NEJMoa1912400			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ2UD	32609979	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000552751800007
J	Dyer, O				Dyer, Owen			Abortion: US Supreme Court strikes down Louisiana's restrictive law	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L6967	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2636	10.1136/bmj.m2636	http://dx.doi.org/10.1136/bmj.m2636			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32605917				2022-12-28	WOS:000548116400017
J	Lavezzo, E; Franchin, E; Ciavarella, C; Cuomo-Dannenburg, G; Barzon, L; Del Vecchio, C; Rossi, L; Manganelli, R; Loregian, A; Navarin, N; Abate, D; Sciro, M; Merigliano, S; De Canale, E; Vanuzzo, MC; Besutti, V; Saluzzo, F; Onelia, F; Pacenti, M; Parisi, SG; Carretta, G; Donato, D; Flor, L; Cocchio, S; Masi, G; Sperduti, A; Cattarino, L; Salvador, R; Nicoletti, M; Caldart, F; Castelli, G; Nieddu, E; Labella, B; Fava, L; Drigo, M; Gaythorpe, KAM; Brazzale, AR; Toppo, S; Trevisan, M; Baldo, V; Donnelly, CA; Ferguson, NM; Dorigatti, I; Crisanti, A				Lavezzo, Enrico; Franchin, Elisa; Ciavarella, Constanze; Cuomo-Dannenburg, Gina; Barzon, Luisa; Del Vecchio, Claudia; Rossi, Lucia; Manganelli, Riccardo; Loregian, Arianna; Navarin, Nicolo; Abate, Davide; Sciro, Manuela; Merigliano, Stefano; De Canale, Ettore; Vanuzzo, Maria Cristina; Besutti, Valeria; Saluzzo, Francesca; Onelia, Francesco; Pacenti, Monia; Parisi, Saverio G.; Carretta, Giovanni; Donato, Daniele; Flor, Luciano; Cocchio, Silvia; Masi, Giulia; Sperduti, Alessandro; Cattarino, Lorenzo; Salvador, Renato; Nicoletti, Michele; Caldart, Federico; Castelli, Gioele; Nieddu, Eleonora; Labella, Beatrice; Fava, Ludovico; Drigo, Matteo; Gaythorpe, Katy A. M.; Brazzale, Alessandra R.; Toppo, Stefano; Trevisan, Marta; Baldo, Vincenzo; Donnelly, Christl A.; Ferguson, Neil M.; Dorigatti, Ilaria; Crisanti, Andrea		Imperial Coll COVID-19 Response Te	Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'	NATURE			English	Article							CORONAVIRUS; COVID-19	The authors describe the prevalence of SARS-CoV-2 infection, viral load and the frequency of symptomatic versus asymptomatic and presymptomatic infection in an Italian town, before and after a strict 14-day lockdown. On 21 February 2020, a resident of the municipality of Vo', a small town near Padua (Italy), died of pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection(1). This was the first coronavirus disease 19 (COVID-19)-related death detected in Italy since the detection of SARS-CoV-2 in the Chinese city of Wuhan, Hubei province(2). In response, the regional authorities imposed the lockdown of the whole municipality for 14 days(3). Here we collected information on the demography, clinical presentation, hospitalization, contact network and the presence of SARS-CoV-2 infection in nasopharyngeal swabs for 85.9% and 71.5% of the population of Vo' at two consecutive time points. From the first survey, which was conducted around the time the town lockdown started, we found a prevalence of infection of 2.6% (95% confidence interval (CI): 2.1-3.3%). From the second survey, which was conducted at the end of the lockdown, we found a prevalence of 1.2% (95% CI: 0.8-1.8%). Notably, 42.5% (95% CI: 31.5-54.6%) of the confirmed SARS-CoV-2 infections detected across the two surveys were asymptomatic (that is, did not have symptoms at the time of swab testing and did not develop symptoms afterwards). The mean serial interval was 7.2 days (95% CI: 5.9-9.6). We found no statistically significant difference in the viral load of symptomatic versus asymptomatic infections (P= 0.62 and 0.74 forEandRdRpgenes, respectively, exact Wilcoxon-Mann-Whitney test). This study sheds light on the frequency of asymptomatic SARS-CoV-2 infection, their infectivity (as measured by the viral load) and provides insights into its transmission dynamics and the efficacy of the implemented control measures.	[Lavezzo, Enrico; Franchin, Elisa; Barzon, Luisa; Del Vecchio, Claudia; Manganelli, Riccardo; Loregian, Arianna; Abate, Davide; Saluzzo, Francesca; Onelia, Francesco; Parisi, Saverio G.; Masi, Giulia; Toppo, Stefano; Trevisan, Marta; Crisanti, Andrea] Univ Padua, Dept Mol Med, Padua, Italy; [Ciavarella, Constanze; Cuomo-Dannenburg, Gina; Cattarino, Lorenzo; Gaythorpe, Katy A. M.; Donnelly, Christl A.; Ferguson, Neil M.; Dorigatti, Ilaria] Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England; [Rossi, Lucia; Sciro, Manuela; De Canale, Ettore; Vanuzzo, Maria Cristina; Besutti, Valeria; Pacenti, Monia; Carretta, Giovanni; Donato, Daniele; Flor, Luciano] Azienda Osped Padova, Padua, Italy; [Navarin, Nicolo; Sperduti, Alessandro] Univ Padua, Dept Math Tullio Levi Civita, Padua, Italy; [Navarin, Nicolo; Sperduti, Alessandro; Toppo, Stefano] Univ Padua, CRIBI Biotech Ctr, Padua, Italy; [Merigliano, Stefano; Salvador, Renato] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Cocchio, Silvia; Baldo, Vincenzo] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy; [Nicoletti, Michele; Caldart, Federico; Castelli, Gioele; Nieddu, Eleonora; Labella, Beatrice; Fava, Ludovico; Drigo, Matteo] Univ Padua, Sch Med, Padua, Italy; [Brazzale, Alessandra R.] Univ Padua, Dept Stat Sci, Padua, Italy; [Donnelly, Christl A.] Univ Oxford, Dept Stat, Oxford, England; [Crisanti, Andrea] Imperial Coll London, Dept Life Sci, London, England	University of Padua; Imperial College London; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; University of Padua; University of Padua; University of Padua; University of Padua; University of Padua; University of Oxford; Imperial College London	Crisanti, A (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.; Dorigatti, I (corresponding author), Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England.; Crisanti, A (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	i.dorigatti@imperial.ac.uk; andrea.crisanti@unipd.it	Mishra, Swapnil/AAT-3955-2020; Cucunuba, Zulma M/X-5670-2019; Saluzzo, Francesca/AAS-3932-2021; Caldart, Federico/AAA-8981-2021; Merigliano, Stefano/AAY-3023-2021; Brazzale, Alessandra R./AAN-7617-2021; Barzon, Luisa/K-7961-2016; Castelli, Gioele/AAS-4201-2020; TREVISAN, MARTA/K-6591-2016; Imai, Natsuko/J-5817-2017	Mishra, Swapnil/0000-0002-8759-5902; Cucunuba, Zulma M/0000-0002-8165-3198; Saluzzo, Francesca/0000-0001-6705-1716; Caldart, Federico/0000-0002-2798-552X; Brazzale, Alessandra R./0000-0003-1989-2697; Barzon, Luisa/0000-0003-0720-8456; Castelli, Gioele/0000-0002-5925-4035; LOREGIAN, ARIANNA/0000-0002-8900-861X; /0000-0002-8913-0391; Cattarino, Lorenzo/0000-0003-3975-550X; Pacenti, Monia/0000-0002-9792-9195; Bhatt, Samir/0000-0002-0891-4611; Ciavarella, Constanze/0000-0002-3053-4391; Nicoletti, Michele/0000-0002-0233-9134; nouvellet, pierre/0000-0002-6094-5722; Verity, Robert/0000-0002-3902-8567; TREVISAN, MARTA/0000-0002-3148-7240; Imai, Natsuko/0000-0002-4218-9716; Navarin, Nicolo/0000-0002-4108-1754; Watson, Oliver/0000-0003-2374-0741; Lavezzo, Enrico/0000-0002-3902-8356; Cuomo-Dannenburg, Gina/0000-0001-6821-0352; FitzJohn, Richard/0000-0001-8888-3837; DEL VECCHIO, CLAUDIA/0000-0001-5645-9126	Veneto region; UK Medical Research Council (MRC) [MR/R015600/1]; UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; Abdul Latif Jameel Foundation; European Union; Sir Henry Dale Fellowship by the Royal Society; Wellcome Trust [213494/Z/18/Z, 203851/Z/16/Z]; Royal Society; European Union [874735]; MRC [MC_PC_19012, MR/R015600/1] Funding Source: UKRI	Veneto region(Regione Veneto); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Abdul Latif Jameel Foundation; European Union(European Commission); Sir Henry Dale Fellowship by the Royal Society; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Mayor of the municipality of Vo', G. Martini, for his unreserved support throughout the study; a special thanks to the population of Vo' who volunteered en masse to this study; M. Perilli and S. Guglielmo for assistance in data collection and consistency check; and F. Bosa and G. Rupolo from the Italian Red Cross for the support in patient samplings. This work was supported by the Veneto region and was jointly funded by the UK Medical Research Council (MRC; grant MR/R015600/1), the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, the Abdul Latif Jameel Foundation and is also part of the EDCTP2 programme supported by the European Union. I.D. acknowledges research funding from a Sir Henry Dale Fellowship funded by the Royal Society and Wellcome Trust (grant 213494/Z/18/Z). C.C. acknowledges funding from the Wellcome Trust (grant 203851/Z/16/Z). L.C.O. from the Imperial College COVID-19 Response Team and G.C.-D. acknowledge research funding from The Royal Society. L.B., E.L. and S.T. acknowledge research funding from the European Union's Horizon 2020 research and innovation programme, under grant agreement no. 874735 (VEO).	Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Cai JH, 2020, CLIN INFECT DIS, V71, P1547, DOI 10.1093/cid/ciaa198; Centers for Disease Control and Prevention, INT GUID COLL HANDL; Centre for Health Protection of the Hong Kong Special Administrative Region Government, 2020, CHP CLOS MON CLUST P; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Crisanti A., 2020, GUARDIAN; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Nagraj V P, 2018, F1000Res, V7, P566, DOI 10.12688/f1000research.14492.2; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Python Software Foundation, 2020, PYTH LANG REF VERS 2; R Development Core Team, 2009, R LANG ENV STAT COMP; Robert CP., 2015, WILEY STATSREF STAT, P1; Saini V., 2020, EU OBSERVER; Vollmer M. A. C., 2020, 20 IMP COLL LOND; Volz E., 2020, 5 IMP COLL LOND; World Health Organisation (WHO), 2020, NOV COR COVID 19 SIT; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zimmermann P, 2020, PEDIATR INFECT DIS J, V39, P355, DOI 10.1097/INF.0000000000002660	23	557	564	9	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2020	584	7821					425	+		10.1038/s41586-020-2488-1	http://dx.doi.org/10.1038/s41586-020-2488-1		JUN 2020	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NG4DR	32604404	Green Submitted, Bronze			2022-12-28	WOS:000556239500001
J	Nicholson, TW; Talbot, NP; Nickol, A; Chadwick, AJ; Lawton, O				Nicholson, Thomas W.; Talbot, Nick P.; Nickol, Annabel; Chadwick, Andrew J.; Lawton, Oliver			Respiratory failure and non-invasive respiratory support during the covid-19 pandemic: an update for re-deployed hospital doctors and primary care physicians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nicholson, Thomas W.] Frimley Hlth Fdn Trust, Wexham Pk Hosp, Dept Thorac Med, Slough SL2 4HL, Berks, England; [Talbot, Nick P.; Nickol, Annabel] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford Ctr Resp Med, Headington OX3 7LE, England; [Talbot, Nick P.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Chadwick, Andrew J.] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Intens Care Med, Headington OX3 9DU, England; [Lawton, Oliver] Clarendon Lodge Med Practice, Royal Leamington Spa CV32 5SS, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust	Nicholson, TW (corresponding author), Frimley Hlth Fdn Trust, Wexham Pk Hosp, Dept Thorac Med, Slough SL2 4HL, Berks, England.	Thomas.nicholson2@nhs.net		Talbot, Nick/0000-0002-9186-8950					0	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2446	10.1136/bmj.m2446	http://dx.doi.org/10.1136/bmj.m2446			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32605992	Bronze, Green Submitted			2022-12-28	WOS:000548116400008
J	Rillig, MC; Lehmann, A				Rillig, Matthias C.; Lehmann, Anika			Microplastic in terrestrial ecosystems	SCIENCE			English	Editorial Material							SEA		[Rillig, Matthias C.; Lehmann, Anika] Free Univ Berlin, Inst Biol, Berlin, Germany	Free University of Berlin	Rillig, MC (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	rillig@zedat.fu-berlin.de; lehmann.anika@googlemail.com	Rillig, Matthias C./B-3675-2009; Rillig, Matthias C./AAE-6980-2019; Lehmann, Anika/AAC-8434-2022	Rillig, Matthias C./0000-0003-3541-7853; Rillig, Matthias C./0000-0003-3541-7853; Lehmann, Anika/0000-0002-9101-9297	ERC Advanced Grant [694368]; Federal Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft; Federal Ministry of Education and Research (project BIBS); Federal Ministry of Education and Research (project uPlastic)	ERC Advanced Grant(European Research Council (ERC)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (project BIBS); Federal Ministry of Education and Research (project uPlastic)	M.C.R. acknowledges funding from an ERC Advanced Grant (694368), from the Federal Ministry of Education and Research (BMBF; projects BIBS and uPlastic), and from the Deutsche Forschungsgemeinschaft.	Bank MS, 2019, ENVIRON SCI TECHNOL, V53, P7177, DOI 10.1021/acs.est.9b02942; Brahney J, 2020, SCIENCE, V368, P1257, DOI 10.1126/science.aaz5819; Lwanga EH, 2016, ENVIRON SCI TECHNOL, V50, P2685, DOI 10.1021/acs.est.5b05478; Li J, 2020, ENVIRON POLLUT, V257, DOI 10.1016/j.envpol.2019.113570; Machado AAD, 2019, ENVIRON SCI TECHNOL, V53, P6044, DOI 10.1021/acs.est.9b01339; Machado AAD, 2018, ENVIRON SCI TECHNOL, V52, P9656, DOI 10.1021/acs.est.8b02212; Mohrig D, 2020, SCIENCE, V368, P1055, DOI 10.1126/science.abc1510; Ren XW, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113347; Rillig MC, 2018, ENVIRON SCI TECHNOL, V52, P6079, DOI 10.1021/acs.est.8b02338; Rillig MC, 2012, ENVIRON SCI TECHNOL, V46, P6453, DOI 10.1021/es302011r; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; van Kleunen M., 2020, PLANTS PEOPLE PLANET, V2, P157; Wan Y, 2019, SCI TOTAL ENVIRON, V654, P576, DOI 10.1016/j.scitotenv.2018.11.123; Wang WF, 2020, SCI TOTAL ENVIRON, V708, DOI 10.1016/j.scitotenv.2019.134841; Weithmann N, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap8060	15	241	249	113	633	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1430	1431		10.1126/science.abb5979	http://dx.doi.org/10.1126/science.abb5979			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587009	Green Accepted			2022-12-28	WOS:000545264600024
J	Palmer, BF; Clegg, DJ				Palmer, Biff F.; Clegg, Deborah J.			Salicylate Toxicity	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							WHOLE-BOWEL IRRIGATION; ACID-BASE DISTURBANCES; ACTIVATED-CHARCOAL; AMERICAN ASSOCIATION; POSITION PAPER; ASPIRIN; INTOXICATION; INHIBITION; ELECTROLYTE; ABSORPTION	ON PRESENTATION TO THE EMERGENCY DEPARTMENT, PATIENTS WITH fever, tachypnea, rales on lung examination, and acid-base disturbances are often given a suspected diagnosis of viral infection, yet persons with salicylate toxicity may present with similar symptoms. This article highlights the risk factors for salicylate toxicity; reviews the pathophysiological effects; notes the hidden sources of salicylates, including foods, drugs, and topical ointments, that if used in combination may result in unintended toxic effects; and discusses treatment strategies. Especially during the current pandemic, clinicians should be aware of the potential for salicylate poisoning,(1) which occurred in the 1918-1919 pandemic of Spanish influenza.(2)	[Palmer, Biff F.] Univ Texas Southwestern Med Ctr Dallas, Dept Med, Div Nephrol, Dallas, TX 75390 USA; [Clegg, Deborah J.] Drexel Univ, Coll Nursing & Hlth Profess, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Drexel University	Palmer, BF (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	biff.palmer@utsouthwestern.edu						ANDERSEN R, 1978, INTENS CARE MED, V4, P211, DOI 10.1007/BF01902550; ANDERSON RJ, 1976, ANN INTERN MED, V85, P745, DOI 10.7326/0003-4819-85-6-745; ANDERSON RJ, 1981, ANN INTERN MED, V95, P188, DOI 10.7326/0003-4819-95-2-188; ARENA FP, 1978, ARCH INTERN MED, V138, P1153, DOI 10.1001/archinte.138.7.1153; BAILEY RB, 1989, J AM GERIATR SOC, V37, P556, DOI 10.1111/j.1532-5415.1989.tb05689.x; Chyka PA, 2007, CLIN TOXICOL, V45, P95, DOI 10.1080/15563650600907140; Crichton J U, 1960, Can Med Assoc J, V83, P1144; Dargan PI, 2002, EMERG MED J, V19, P206, DOI 10.1136/emj.19.3.206; Duthie GG, 2011, FOOD FUNCT, V2, P515, DOI 10.1039/c1fo10128e; EICHENHOLZ A, 1963, METABOLISM, V12, P164; Fertel BS, 2009, KIDNEY INT, V75, P1349, DOI 10.1038/ki.2008.443; FILIPPONE GA, 1987, ARCH INTERN MED, V147, P1390, DOI 10.1001/archinte.147.8.1390; GABOW PA, 1978, ARCH INTERN MED, V138, P1481, DOI 10.1001/archinte.138.10.1481; Glassock RJ, 2011, CLIN J AM SOC NEPHRO, V6, P2318, DOI 10.2215/CJN.00900111; Goodman JW, 2006, SEMIN DIALYSIS, V19, P402, DOI 10.1111/j.1525-139X.2006.00194.x; Greenberg MI, 2003, ANN EMERG MED, V41, P583, DOI 10.1067/mem.2003.128; GREER HD, 1965, J AMER MED ASSOC, V193, P555, DOI 10.1001/jama.1965.03090070005001; Gummin DD, 2019, CLIN TOXICOL, V57, P1220, DOI 10.1080/15563650.2019.1677022; Gumz ML, 2010, AM J PHYSIOL-RENAL, V298, pF12, DOI 10.1152/ajprenal.90723.2008; HAAS R, 1985, BIOCHEM PHARMACOL, V34, P901, DOI 10.1016/0006-2952(85)90774-9; Hanzik PJ, 1913, J AMER MED ASSOC, V60, P957, DOI 10.1001/jama.1913.04340130005003; HILL JB, 1973, NEW ENGL J MED, V288, P1110, DOI 10.1056/NEJM197305242882107; Hoffman RS, 2019, CLIN TOXICOL, V57, P377, DOI 10.1080/15563650.2018.1517882; HOOD VL, 1990, AM J PHYSIOL, V259, pE327, DOI 10.1152/ajpendo.1990.259.3.E327; Juurlink DN, 2015, ANN EMERG MED, V66, P165, DOI 10.1016/j.annemergmed.2015.03.031; KAPLAN EH, 1954, ARCH BIOCHEM BIOPHYS, V51, P47, DOI 10.1016/0003-9861(54)90452-X; Kashani KB, 2018, NEPHRON, V138, P186, DOI 10.1159/000484636; KIRSHENBAUM LA, 1989, CLIN PHARMACOL THER, V46, P264, DOI 10.1038/clpt.1989.137; LEATHERMAN JW, 1991, CHEST, V100, P1391, DOI 10.1378/chest.100.5.1391; LEVENTHAL LJ, 1989, AM J EMERG MED, V7, P409, DOI 10.1016/0735-6757(89)90049-1; LEVY G, 1965, J PHARM SCI, V54, P959, DOI 10.1002/jps.2600540703; LEVY G, 1972, CLIN PHARMACOL THER, V13, P317; Levy G., 1985, CLIN PHARMACOKINET, V10, P164; MCQUEEN DS, 1989, BRIT J PHARMACOL, V98, P413, DOI 10.1111/j.1476-5381.1989.tb12612.x; MONTGOMERY H, 1994, AM J EMERG MED, V12, P531, DOI 10.1016/0735-6757(94)90271-2; Montinari MR, 2019, VASC PHARMACOL, V113, P1, DOI 10.1016/j.vph.2018.10.008; Moss MJ, 2019, CLIN TOXICOL, V57, P137, DOI 10.1080/15563650.2018.1502442; Mowry JB, 2015, CLIN TOXICOL, V53, P962, DOI 10.3109/15563650.2015.1102927; Nulton-Persson AC, 2004, J CARDIOVASC PHARM, V44, P591, DOI 10.1097/00005344-200411000-00012; Palmer BF, 2019, AM J KIDNEY DIS, V74, P682, DOI 10.1053/j.ajkd.2019.03.427; Palmer BF, 2017, NEW ENGL J MED, V377, P1368, DOI 10.1056/NEJMra1704724; Palmer BF, 2015, NEW ENGL J MED, V373, P548, DOI 10.1056/NEJMra1503102; Palmer BF, 2012, AM J KIDNEY DIS, V60, P834, DOI 10.1053/j.ajkd.2012.03.025; PAUL BN, 1972, J AM GERIATR SOC, V20, P387, DOI 10.1111/j.1532-5415.1972.tb01640.x; PEI YPC, 1987, AM J MED, V82, P381, DOI 10.1016/0002-9343(87)90094-5; Proudfoot AT, 2004, J TOXICOL-CLIN TOXIC, V42, P1, DOI 10.1081/CLT-120028740; Qian K, 2015, DIABETES-METAB RES, V31, P562, DOI 10.1002/dmrr.2655; Rao R. B., 1999, Journal of Toxicology Clinical Toxicology, V37, P605; REID J, 1957, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5053.1071; Rivera W, 2004, ANN PHARMACOTHER, V38, P1186, DOI 10.1345/aph.1D575; SMITH MJH, 1956, BIOCHEM J, V63, P524, DOI 10.1042/bj0630524; SMITH MJH, 1971, J PHARM PHARMACOL, V23, P729, DOI 10.1111/j.2042-7158.1971.tb08598.x; Starko KM, 2009, CLIN INFECT DIS, V49, P1405, DOI 10.1086/606060; STEELE TE, 1986, PSYCHOSOMATICS, V27, P455, DOI 10.1016/S0033-3182(86)72675-3; STEPHENS TW, 1983, BIOCHEM J, V212, P521, DOI 10.1042/bj2120521; SWAIN AR, 1985, J AM DIET ASSOC, V85, P950; SWEENEY KR, 1986, CLIN PHARMACOL THER, V40, P518, DOI 10.1038/clpt.1986.217; Thanacoody R, 2015, CLIN TOXICOL, V53, P5, DOI 10.3109/15563650.2014.989326; Thompson TM, 2016, WEST J EMERG MED, V17, P181, DOI 10.5811/westjem.2016.1.29262; THURSTON JH, 1970, J CLIN INVEST, V49, P2139, DOI 10.1172/JCI106431; VASUVATTAKUL S, 1995, NEPHRON, V69, P311, DOI 10.1159/000188476; WINTERS RW, 1959, PEDIATRICS, V23, P260; Wong OF, 2010, HONG KONG J EMERG ME, V17, P276, DOI 10.1177/102490791001700314; WOODS HF, 1974, CLIN EXP PHARMACOL P, V1, P535, DOI 10.1111/j.1440-1681.1974.tb00574.x; WORTZMAN DJ, 1987, ANN EMERG MED, V16, P434, DOI 10.1016/S0196-0644(87)80366-9; Yip Luke, 1994, Emergency Medicine Clinics of North America, V12, P351; YU TF, 1959, J CLIN INVEST, V38, P1298, DOI 10.1172/JCI103905	67	21	22	2	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2544	2555		10.1056/NEJMra2010852	http://dx.doi.org/10.1056/NEJMra2010852			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF9CW	32579814				2022-12-28	WOS:000545636400025
J	Russell, AB				Russell, Alistair B.			Cap-Snatching Leads to Novel Viral Proteins	CELL			English	Editorial Material								Some negative-sense RNA viruses prime mRNA transcription using host 50 cap sequences, usurping host translational machinery and evading antiviral surveillance. In this issue of Cell, Ho et al. identify an additional consequence of this viral strategy: the acquisition of upstream start codons from host-derived sequences and subsequent translation of novel viral products.	[Russell, Alistair B.] Univ Calif San Diego, Dept Biol, San Diego, CA 92103 USA	University of California System; University of California San Diego	Russell, AB (corresponding author), Univ Calif San Diego, Dept Biol, San Diego, CA 92103 USA.	a5russell@ucsd.edu			Damon Runyon Cancer Research Foundation [DFS-36-19]; NIAID [1K22AI141678]	Damon Runyon Cancer Research Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work from A.B.R. in this field is supported in part by the Damon Runyon Cancer Research Foundation (DFS-36-19) and NIAID (1K22AI141678).	Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Dubois J, 2014, MBIO, V5, DOI 10.1128/mBio.00070-14; Fitzsimmons WJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006459; Ho JSY, 2020, CELL, V181, P1502, DOI 10.1016/j.cell.2020.05.035; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; La Gruta NL, 2014, TRENDS IMMUNOL, V35, P396, DOI 10.1016/j.it.2014.06.004; Lopez CB, 2014, J VIROL, V88, P8720, DOI 10.1128/JVI.00707-14; Walker AP, 2019, TRENDS MICROBIOL, V27, P398, DOI 10.1016/j.tim.2018.12.013; Wei JJ, 2019, VIROL SIN, V34, P162, DOI 10.1007/s12250-018-0061-y	10	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1450	1451		10.1016/j.cell.2020.05.044	http://dx.doi.org/10.1016/j.cell.2020.05.044			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32589954	Bronze			2022-12-28	WOS:000543822100003
J	Rimmer, A				Rimmer, Abi			Covid-19: UK prime minister announces relaxation of lockdown and social distancing rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		SAGE Environmental and Modelling Group, 2020, TRANSM SARS COV 2 MI	1	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2020	369								m2526	10.1136/bmj.m2526	http://dx.doi.org/10.1136/bmj.m2526			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1US	32580929	Bronze			2022-12-28	WOS:000548572500005
J	Darrow, JJ; Chong, JE; Kesselheim, AS				Darrow, Jonathan J.; Chong, Jessica E.; Kesselheim, Aaron S.			Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Darrow, Jonathan J.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Darrow, JJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA.	jjdarrow@bwh.harvard	Chong, Jessica/GZH-1625-2022		Arnold Ventures; Harvard-MIT Center for Regulatory Science	Arnold Ventures; Harvard-MIT Center for Regulatory Science	The authors acknowledge funding support from Arnold Ventures and the Harvard-MIT Center for Regulatory Science. We thank Theresa Harnak for her contributions.		0	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2020	369								m2236	10.1136/bmj.m2236	http://dx.doi.org/10.1136/bmj.m2236			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1VB	32576554				2022-12-28	WOS:000548573500008
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: When will we be well again?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac						Campbell J., 2020, SCOTSMAN; Garner P., 2020, BMJ OPINION; Harding, 2020, GUARDIAN	3	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2020	369								m2490	10.1136/bmj.m2490	http://dx.doi.org/10.1136/bmj.m2490			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1VB	32576550	Bronze			2022-12-28	WOS:000548573500011
J	Wallace, BI; Waljee, AK				Wallace, Beth I.; Waljee, Akbar K.			Burst Case Scenario: Why Shorter May Not Be Any Better When It Comes to Corticosteroids	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA; Michigan Med, Inst Healthcare Policy & Innovat, Ann Arbor, MI USA; [Wallace, Beth I.] Michigan Med, 300 North Ingalls Bldg,Room 7C27, Ann Arbor, MI 48109 USA; [Waljee, Akbar K.] VA Ann Arbor Healthcare Syst, Gastroenterol 111D, 2215 Fuller Rd, Ann Arbor, MI 48105 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Wallace, BI (corresponding author), Michigan Med, 300 North Ingalls Bldg,Room 7C27, Ann Arbor, MI 48109 USA.	brennerb@umich.edu	Waljee, Akbar K/G-2067-2010; Wallace, Beth I./AAG-2429-2020	Waljee, Akbar K/0000-0003-1964-8790; Wallace, Beth I./0000-0003-1802-1427	National Institutes of Health [5-KL2-TR002241-04]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Wallace's effort during the composition of this manuscript was supported by grant 5-KL2-TR002241-04 from the National Institutes of Health.	Benard-Laribiere A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015905; Bloechliger M, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0742-y; Dvorin EL, 2018, JAMA INTERN MED, V178, P852, DOI 10.1001/jamainternmed.2018.0103; FREYBERG RH, 1951, JAMA-J AM MED ASSOC, V147, P1538, DOI 10.1001/jama.1951.03670330030008; George M, 2019, ARTHRITIS RHEUMA S10, V71; Hay AD, 2017, JAMA-J AM MED ASSOC, V318, P721, DOI 10.1001/jama.2017.10572; HENCH PS, 1950, ARCH INTERN MED, V85, P545, DOI 10.1001/archinte.1950.00230100002001; WALJEE AK, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1415; Wallace BI, 2020, SEMIN ARTHRITIS RHEU, V50, P228, DOI 10.1016/j.semarthrit.2019.09.002; Yao TC, 2020, ANN INTERN MED, V173, P325, DOI 10.7326/M20-0432	10	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2020	173	5					390	+		10.7326/M20-4234	http://dx.doi.org/10.7326/M20-4234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9XI	32628530				2022-12-28	WOS:000567080900017
J	Al Saidi, AMO; Nur, FA; Al-Mandhari, AS; El Rabbat, M; Hafeet, A; Abubakar, A				Al Saidi, Ahmed Mohammed Obaid; Nur, Fowsiya Abikar; Al-Mandhari, Ahmed Salim; El Rabbat, Maha; Hafeet, Assad; Abubakar, Abdinasir			Decisive leadership is a necessity in the COVID-19 response	LANCET			English	Editorial Material									[Al Saidi, Ahmed Mohammed Obaid] Minist Hlth, Muscat, Oman; [Nur, Fowsiya Abikar] Minist Hlth & Human Serv, Mogadishu, Somalia; [Al-Mandhari, Ahmed Salim; Abubakar, Abdinasir] World Hlth Org, Reg Off Eastern Mediterranean, POB 7608, Cairo 11371, Egypt; [El Rabbat, Maha] Middle East & North Africa Hlth Policy Forum, Cairo, Egypt; [Hafeet, Assad] Hlth Serv Acad, Islamabad, Pakistan	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Health Services Academy	Abubakar, A (corresponding author), World Hlth Org, Reg Off Eastern Mediterranean, POB 7608, Cairo 11371, Egypt.	abubakara@who.int						Algaissi AA, 2020, J INFECT PUBLIC HEAL, V13, P834, DOI 10.1016/j.jiph.2020.04.016; Alsharaydeh I, 2020, INT J GYNECOL OBSTET, V150, P159, DOI 10.1002/ijgo.13240; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, JAMA INTERN MED, DOI DOI 10.1001/JAMAINTERNMED.2020.1447; Baumann B, 2020, HEINRICH BOLL STIFTU; Dalglish SL, 2020, LANCET, V395, P1189, DOI 10.1016/S0140-6736(20)30739-X; Forman R, 2020, HEALTH POLICY, V124, P577, DOI 10.1016/j.healthpol.2020.05.008; Gadarian SK, 2020, SSRN, DOI [10.2139/ssrn.3562796, DOI 10.2139/SSRN.3562796]; Gaskell J, 2020, CENTRALISED MULTILEV; Gibney E, 2020, NATURE, V581, P15, DOI 10.1038/d41586-020-01248-1; Hale T, 2020, LOCKDOWN ROLLBACK CH; Hsiang S, 2020, NATURE, V585, pE7, DOI [10.1038/s41586-020-2404-8, 10.1038/s41586-020-2691-0]; Karim SSA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2014960; Kupferschmidt K, 2020, SCIENCE, V367, P1061, DOI 10.1126/science.367.6482.1061; Lee VJ, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa039; Mahmud I, 2020, INT J HEALTH SCI-IJH, V14, P1; Ministry of Public Health Lebanon, 2020, NOV COR 2019; OECD, 2020, SUPP CONT TEACH LEAR; Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090; WHO, 2020, WHO UN FDN PARTN LAU; WHO, 2020, WHO COR DIS COVID 1; World Health Organization, 2020, MERS SIT UPD	22	37	37	8	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2020	396	10247					295	298		10.1016/S0140-6736(20)31493-8	http://dx.doi.org/10.1016/S0140-6736(20)31493-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0RO	32628904	Bronze, Green Published			2022-12-28	WOS:000561615700006
J	Fosbol, EL; Butt, JH; Ostergaard, L; Andersson, C; Selmer, C; Kragholm, K; Schou, M; Phelps, M; Gislason, GH; Gerds, TA; Torp-Pedersen, C; Kober, L				Fosbol, Emil L.; Butt, Jawad H.; ostergaard, Lauge; Andersson, Charlotte; Selmer, Christian; Kragholm, Kristian; Schou, Morten; Phelps, Matthew; Gislason, Gunnar H.; Gerds, Thomas A.; Torp-Pedersen, Christian; Kober, Lars			Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENTRICULAR DYSFUNCTION; FUNCTIONAL RECEPTOR; HEART-FAILURE; MODULATION; SYSTEM; TRIAL; ACE2	Importance It has been hypothesized that angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) may make patients more susceptible to coronavirus disease 2019 (COVID-19) and to worse outcomes through upregulation of the functional receptor of the virus, angiotensin-converting enzyme 2. Objective To examine whether use of ACEI/ARBs was associated with COVID-19 diagnosis and worse outcomes in patients with COVID-19. Design, Setting, and Participants To examine outcomes among patients with COVID-19, a retrospective cohort study using data from Danish national administrative registries was conducted. Patients with COVID-19 from February 22 to May 4, 2020, were identified using ICD-10 codes and followed up from day of diagnosis to outcome or end of study period (May 4, 2020). To examine susceptibility to COVID-19, a Cox regression model with a nested case-control framework was used to examine the association between use of ACEI/ARBs vs other antihypertensive drugs and the incidence rate of a COVID-19 diagnosis in a cohort of patients with hypertension from February 1 to May 4, 2020. Exposures ACEI/ARB use was defined as prescription fillings 6 months prior to the index date. Main Outcomes and Measures In the retrospective cohort study, the primary outcome was death, and a secondary outcome was a composite outcome of death or severe COVID-19. In the nested case-control susceptibility analysis, the outcome was COVID-19 diagnosis. Results In the retrospective cohort study, 4480 patients with COVID-19 were included (median age, 54.7 years [interquartile range, 40.9-72.0]; 47.9% men). There were 895 users (20.0%) of ACEI/ARBs and 3585 nonusers (80.0%). In the ACEI/ARB group, 18.1% died within 30 days vs 7.3% in the nonuser group, but this association was not significant after adjustment for age, sex, and medical history (adjusted hazard ratio [HR], 0.83 [95% CI, 0.67-1.03]). Death or severe COVID-19 occurred in 31.9% of ACEI/ARB users vs 14.2% of nonusers by 30 days (adjusted HR, 1.04 [95% CI, 0.89-1.23]). In the nested case-control analysis of COVID-19 susceptibility, 571 patients with COVID-19 and prior hypertension (median age, 73.9 years; 54.3% men) were compared with 5710 age- and sex-matched controls with prior hypertension but not COVID-19. Among those with COVID-19, 86.5% used ACEI/ARBs vs 85.4% of controls; ACEI/ARB use compared with other antihypertensive drugs was not significantly associated with higher incidence of COVID-19 (adjusted HR, 1.05 [95% CI, 0.80-1.36]). Conclusions and Relevance Prior use of ACEI/ARBs was not significantly associated with COVID-19 diagnosis among patients with hypertension or with mortality or severe disease among patients diagnosed as having COVID-19. These findings do not support discontinuation of ACEI/ARB medications that are clinically indicated in the context of the COVID-19 pandemic.	[Fosbol, Emil L.; Butt, Jawad H.; ostergaard, Lauge; Kober, Lars] Univ Hosp Copenhagen, Rigshosp, Ctr Heart, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark; [Andersson, Charlotte] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med,Boston Med Ctr, Boston, MA 02118 USA; [Selmer, Christian] Bispebjerg & Frederiksberg Hosp, Dept Endocrinol, Copenhagen, Denmark; [Kragholm, Kristian] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Schou, Morten; Gislason, Gunnar H.] Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Hellerup, Denmark; [Phelps, Matthew; Gislason, Gunnar H.; Gerds, Thomas A.] Danish Heart Fdn, Dept Cardiovasc Epidemiol & Res, Copenhagen, Denmark; [Torp-Pedersen, Christian] Hillerod Hosp, Dept Clin Epidemiol, Hillerod, Denmark; [Torp-Pedersen, Christian] Hillerod Hosp, Dept Cardiol, Hillerod, Denmark	Rigshospitalet; Boston Medical Center; Boston University; University of Copenhagen; Bispebjerg Hospital; Aalborg University; Aalborg University Hospital; University of Copenhagen; University of Copenhagen	Fosbol, EL (corresponding author), Univ Hosp Copenhagen, Rigshosp, Ctr Heart, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	elf@heart.dk	Selmer, Christian/H-3314-2019; Gislason, Gunnar/B-7561-2009; Butt, Jawad Haider/AGB-5014-2022	Selmer, Christian/0000-0002-0534-3163; Gislason, Gunnar/0000-0002-0548-402X; Butt, Jawad Haider/0000-0002-7380-4144; Phelps, Matthew David/0000-0003-0344-2026; Kragholm, Kristian/0000-0001-9629-8670; Gerds, Thomas Alexander/0000-0002-5955-816X; Kober, Lars/0000-0002-6635-1466; Fosbol, Emil/0000-0002-2048-4167				Borgan O, 2013, HDB SURVIVAL ANAL; Bozkurt B, 2020, HARRINGTON R HFSA AC; Burchill LJ, 2012, CLIN SCI, V123, P649, DOI 10.1042/CS20120162; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; de Simone G, 2020, POS STAT ESC COUNC H; Diaz JH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa041; Esler M, 2020, J HYPERTENS, V38, P781, DOI 10.1097/HJH.0000000000002450; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Group CS., 1987, NEW ENGL J MED, V316, P1429, DOI DOI 10.1056/NEJM198706043162301; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Halliday BP, 2019, LANCET, V393, P61, DOI 10.1016/S0140-6736(18)32484-X; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Lakshmanan AP, 2012, MOL CELL ENDOCRINOL, V348, P104, DOI 10.1016/j.mce.2011.07.041; Li J, 2020, JAMA CARDIOL, DOI [10.1001/jamacardio.2020.1624, DOI 10.1001/JAMACARDIO.2020.162432324209]; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Mehta N, 2020, JAMA CARDIOL, DOI [10.1001/jamacardio.2020.1855, DOI 10.1001/JAMACARDIO.2020.185532369097]; Messerli FH, 2020, CIRCULATION, V141, P2042, DOI 10.1161/CIRCULATIONAHA.120.047022; Ocaranza MP, 2006, HYPERTENSION, V48, P572, DOI 10.1161/01.HYP.0000237862.94083.45; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Ozenne BMH, 2020, BIOMETRICAL J, V62, P751, DOI 10.1002/bimj.201800298; PFLUGFELDER PW, 1993, J AM COLL CARDIOL, V22, P1557, DOI 10.1016/0735-1097(93)90578-O; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Schmidt M, 2019, CLIN EPIDEMIOL, V11, P563, DOI 10.2147/CLEP.S179083; Sommerstein R, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016509; Sukumaran V, 2012, FREE RADICAL RES, V46, P850, DOI 10.3109/10715762.2012.684878; Sukumaran V, 2012, MOL CELL ENDOCRINOL, V351, P208, DOI 10.1016/j.mce.2011.12.010; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Zhong JC, 2011, REGUL PEPTIDES, V166, P90, DOI 10.1016/j.regpep.2010.09.005; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	34	261	268	5	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2020	324	2					168	177		10.1001/jama.2020.11301	http://dx.doi.org/10.1001/jama.2020.11301			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ8RW	32558877	Bronze, Green Published			2022-12-28	WOS:000553161000021
J	Odio, CD; O'Brien, CR; Jacox, J; Jain, D; Lee, AI				Odio, Camila D.; O'Brien, Corey R.; Jacox, Jeremy; Jain, Dhanpat; Lee, Alfred I.			Cryptic Cachexia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WHIPPLES-DISEASE; TROPHERYMA-WHIPPLEI; DIAGNOSIS; CEFTRIAXONE		[Odio, Camila D.; O'Brien, Corey R.; Jacox, Jeremy] Yale Sch Med, Dept Med, New Haven, CT 06510 USA; [Lee, Alfred I.] Yale Sch Med, Sect Hematol, New Haven, CT USA; [Jain, Dhanpat] Yale Sch Med, Sect Digest Dis, Dept Pathol, New Haven, CT USA	Yale University; Yale University; Yale University	Odio, CD (corresponding author), Yale Sch Med, Dept Med, New Haven, CT 06510 USA.	camila.odio@nih.gov	Odio, Camila/CAF-7842-2022	Odio, Camila/0000-0002-1730-4380; Jacox, Jeremy/0000-0001-9187-7374				Amsler L, 2003, INFECTION, V31, P81, DOI 10.1007/s15010-002-3083-0; Baisden BL, 2002, AM J CLIN PATHOL, V118, P742; CHEARS WC, 1961, AM J MED, V30, P226, DOI 10.1016/0002-9343(61)90094-8; Compain C, 2013, MEDICINE, V92, P324, DOI 10.1097/MD.0000000000000010; Dolmans RAV, 2017, CLIN MICROBIOL REV, V30, P529, DOI 10.1128/CMR.00033-16; Fenollar F, 2007, NEW ENGL J MED, V356, P55, DOI 10.1056/NEJMra062477; Feurle GE, 2013, J INFECTION, V66, P263, DOI 10.1016/j.jinf.2012.12.004; Feurle GE, 2010, GASTROENTEROLOGY, V138, P478, DOI 10.1053/j.gastro.2009.10.041; Lagier JC, 2014, J ANTIMICROB CHEMOTH, V69, P219, DOI 10.1093/jac/dkt310; Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760; Marth T, 2016, LANCET INFECT DIS, V16, pE13, DOI 10.1016/S1473-3099(15)00537-X; PLAYFORD RJ, 1992, GUT, V33, P132, DOI 10.1136/gut.33.1.132; Ramzan NN, 1997, ANN INTERN MED, V126, P520, DOI 10.7326/0003-4819-126-7-199704010-00004; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2	14	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					68	74		10.1056/NEJMcps1817531	http://dx.doi.org/10.1056/NEJMcps1817531			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2UD	32609985				2022-12-28	WOS:000552751800013
J	Roehr, B				Roehr, Bob			PRIVATE HEALTHCARE The health of private insurance in the US during covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												bobroehr@aol.com						[Anonymous], 2020, NEWSWIRE	1	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2020	370								370:m2606	10.1136/bmj.m2606	http://dx.doi.org/10.1136/bmj.m2606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MM0GY	32616480	Bronze			2022-12-28	WOS:000549840000005
J	Mahase, E				Mahase, Elisabeth			Covid-19: Oxford team begins vaccine trials in Brazil and South Africa to determine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, REUTERS	1	14	16	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2612	10.1136/bmj.m2612	http://dx.doi.org/10.1136/bmj.m2612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601063	Bronze			2022-12-28	WOS:000548112700009
J	Kuzmin, E; VanderSluis, B; Ba, ANN; Wang, W; Koch, EN; Usaj, M; Khmelinskii, A; Usaj, MM; van Leeuwen, J; Kraus, O; Tresenrider, A; Pryszlak, M; Hu, MC; Varriano, B; Costanzo, M; Knop, M; Moses, A; Myers, CL; Andrews, BJ; Boone, C				Kuzmin, Elena; VanderSluis, Benjamin; Ba, Alex N. Nguyen; Wang, Wen; Koch, Elizabeth N.; Usaj, Matej; Khmelinskii, Anton; Usaj, Mojca Mattiazzi; van Leeuwen, Jolanda; Kraus, Oren; Tresenrider, Amy; Pryszlak, Michael; Hu, Ming-Che; Varriano, Brenda; Costanzo, Michael; Knop, Michael; Moses, Alan; Myers, Chad L.; Andrews, Brenda J.; Boone, Charles			Exploring whole-genome duplicate gene retention with complex genetic interaction analysis	SCIENCE			English	Article							PHYLOGENETIC ANALYSIS; FUNCTIONAL-ANALYSIS; PROTEIN COMPLEXES; MESSENGER-RNAS; YEAST; EVOLUTION; LANDSCAPE; FITNESS; ROBUSTNESS; EXPRESSION	Whole-genome duplication has played a central role in the genome evolution of many organisms, including the human genome. Most duplicated genes are eliminated, and factors that influence the retention of persisting duplicates remain poorly understood. We describe a systematic complex genetic interaction analysis with yeast paralogs derived from the whole-genome duplication event. Mapping of digenic interactions for a deletion mutant of each paralog, and of trigenic interactions for the double mutant, provides insight into their roles and a quantitative measure of their functional redundancy. Trigenic interaction analysis distinguishes two classes of paralogs: a more functionally divergent subset and another that retained more functional overlap. Gene feature analysis and modeling suggest that evolutionary trajectories of duplicated genes are dictated by combined functional and structural entanglement factors.	[Kuzmin, Elena; Usaj, Matej; Usaj, Mojca Mattiazzi; van Leeuwen, Jolanda; Kraus, Oren; Pryszlak, Michael; Hu, Ming-Che; Varriano, Brenda; Costanzo, Michael; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Kuzmin, Elena; Kraus, Oren; Pryszlak, Michael; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [VanderSluis, Benjamin; Wang, Wen; Koch, Elizabeth N.; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Ba, Alex N. Nguyen; Moses, Alan] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Ba, Alex N. Nguyen; Moses, Alan] Univ Toronto, Ctr Anal Evolut & Funct, Toronto, ON, Canada; [Khmelinskii, Anton; Knop, Michael] Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Tresenrider, Amy] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Knop, Michael] German Canc Res Ctr, Cell Morphogenesis & Signal Transduct, D-69120 Heidelberg, Germany; [Moses, Alan] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Kuzmin, Elena] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Ba, Alex N. Nguyen] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Khmelinskii, Anton] Inst Mol Biol, Mainz, Germany; [van Leeuwen, Jolanda] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	University of Toronto; University of Toronto; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of California System; University of California Berkeley; Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; McGill University; Harvard University; Institute of Molecular Biology (IMB); University of Lausanne	Andrews, BJ; Boone, C (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada.; Andrews, BJ; Boone, C (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada.; Myers, CL (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	chadm@umn.edu; brenda.andrews@utoronto.ca; charlie.boone@utoronto.ca	Wang, Wen/E-6320-2012; Usaj, Matej/J-5454-2015	Wang, Wen/0000-0002-5812-6744; Khmelinskii, Anton/0000-0002-0256-5190; Usaj, Matej/0000-0003-0675-2847; van Leeuwen, Jolanda/0000-0003-3991-518X; Mattiazzi Usaj, Mojca/0000-0002-7389-8478	NIH [R01HG005853, R01HG005084, R01GM104975]; Canadian Institutes of Health Research grants [FDN-143264, FDN-143265]; NSF [DBI\0953881]; Natural Science and Engineering Research Council of Canada Postgraduate Scholarship-Doctoral PGS D2; University of Toronto Open Fellowship; University of Minnesota Doctoral Dissertation Fellowship (B.V.); Deutsche Forschungsgemeinschaft [CRC1036/TP10]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research grants(Canadian Institutes of Health Research (CIHR)); NSF(National Science Foundation (NSF)); Natural Science and Engineering Research Council of Canada Postgraduate Scholarship-Doctoral PGS D2(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto Open Fellowship(University of Toronto); University of Minnesota Doctoral Dissertation Fellowship (B.V.); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by NIH grant R01HG005853 (C.B., B.J.A., and C.L.M.), Canadian Institutes of Health Research grants FDN-143264 and FDN-143265 (C.B. and B.J.A.), NIH grants R01HG005084 and R01GM104975 (C.L.M.), and NSF grant DBI\0953881 (C.L.M.). Computing resources and data storage services were partially provided by the Minnesota Supercomputing Institute and the UMN Office of Information Technology, respectively. Additional support was provided by Natural Science and Engineering Research Council of Canada Postgraduate Scholarship-Doctoral PGS D2 (E.K. and A.N.N.B.), a University of Toronto Open Fellowship (E.K.), a University of Minnesota Doctoral Dissertation Fellowship (B.V.), and Deutsche Forschungsgemeinschaft grant CRC1036/TP10 (A.K. and M.K.). C.B. is a fellow of the Canadian Institute for Advanced Research (CIFAR).	Ba ANN, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003977; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Baryshnikova A, 2016, CELL SYST, V2, P412, DOI 10.1016/j.cels.2016.04.014; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Baudot A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r76; Belenkiy R, 2000, BBA-BIOMEMBRANES, V1467, P207, DOI 10.1016/S0005-2736(00)00222-4; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bradley PH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000270; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cheng Z, 2018, CELL, V172, P910, DOI 10.1016/j.cell.2018.01.035; Chong YT, 2015, CELL, V161, P1413, DOI 10.1016/j.cell.2015.04.051; Conant GC, 2006, PLOS BIOL, V4, P545, DOI 10.1371/journal.pbio.0040109; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Deshpande R., 2017, EFFICIENT STRATEGIES; Diss G, 2017, SCIENCE, V355, P630, DOI 10.1126/science.aai7685; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Force A, 1999, GENETICS, V151, P1531; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grassi L, 2010, MOL BIOSYST, V6, P2305, DOI 10.1039/c003507f; Gu X, 2005, P NATL ACAD SCI USA, V102, P707, DOI 10.1073/pnas.0409186102; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Hakes L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r209; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Khmelinskii A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023794; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kondrashov FA, 2006, J THEOR BIOL, V239, P141, DOI 10.1016/j.jtbi.2005.08.033; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Kuzmin E., 2016, COLD SPRING HARB PRO, V2016; Kuzmin Elena, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot088807; Kuzmin E, 2018, SCIENCE, V360, DOI 10.1126/science.aao1729; Kuzmin E, 2014, METHODS MOL BIOL, V1205, P143, DOI 10.1007/978-1-4939-1363-3_10; Li JJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001187; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Marcet-Houben M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002220; Marchant A, 2019, ELIFE, V8, DOI 10.7554/eLife.46754; Marques AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r54; Marshall AN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003376; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Nguyen Ba Alex N, 2012, Sci Signal, V5, prs1, DOI 10.1126/scisignal.2002515; NOVICK P, 1985, CELL, V40, P405, DOI 10.1016/0092-8674(85)90154-0; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; OHNO S, 1970, EVOLUTION GENE DUPLI, P59; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Qian WF, 2009, GENOME BIOL EVOL, V1, P198, DOI 10.1093/gbe/evp021; Ryan O, 2012, SCIENCE, V337, P1353, DOI 10.1126/science.1224339; Santos B, 2000, MOL BIOL CELL, V11, P435, DOI 10.1091/mbc.11.2.435; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sung MK, 2008, YEAST, V25, P301, DOI 10.1002/yea.1588; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Thornton J., 2006, EVOL GENET, P160; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Usaj M, 2017, G3-GENES GENOM GENET, V7, P1539, DOI 10.1534/g3.117.040220; van Hoof A, 2005, GENETICS, V171, P1455, DOI 10.1534/genetics.105.044057; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; van Leeuwen J, 2016, SCIENCE, V354, DOI 10.1126/science.aag0839; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Vest KE, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150223; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wagner A, 2000, GENETICS, V154, P1389; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhao YN, 2018, PROTEINS, V86, P945, DOI 10.1002/prot.25526; Zou J, 2009, MOL BIOL CELL, V20, P3239, DOI 10.1091/mbc.E08-12-1255	95	33	33	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1446	+	eaaz5667	10.1126/science.aaz5667	http://dx.doi.org/10.1126/science.aaz5667			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32586993	Green Accepted			2022-12-28	WOS:000545264600032
J	Wise, J				Wise, Jacqui			Ebola: DRC's 10th outbreak is declared over	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Health Organization, GO DAT MAN COMPL DAT	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2020	369								m2601	10.1136/bmj.m2601	http://dx.doi.org/10.1136/bmj.m2601			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ7IA	32591369				2022-12-28	WOS:000548259500007
J	Roderick, P; Macfarlane, A; Pollock, AM				Roderick, Peter; Macfarlane, Alison; Pollock, Allyson M.			Getting back on track: control of covid-19 outbreaks in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Roderick, Peter; Pollock, Allyson M.] Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Macfarlane, Alison] City Univ London, Sch Hlth Sci, London, England	Newcastle University - UK; City University London	Roderick, P (corresponding author), Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England.	peter.roderick@newcastle.ac.uk						[Anonymous], 2020, SECRETARY STATE MAKE; [Anonymous], 2020, GUARDIAN; [Anonymous], CONTR FIND; Cabinet Office, 2020, OUR PLAN REB UK GOV; Department of Health and Social Care, 2020, GUID NHS TEST TRAC I; Department of Health and Social Care, 2020, GUID COVID 19 TEST D; Department of Health and Social Care, 2020, TEST COR PRIV INF GU; Department of Health Social Care., 2020, COR COVID 19 SCAL OU; NHS, 2020, HUFFINGTON POST; NHS, 2020, COVID 19 DAT STOR RE; NHS England, 2020, NHSIMPR GUID STAND O; NHS England NHS Improvement, 2020, GUID STAND OP PROC G, P11; Norgrove D., 2020, RESPONSE M HANCOCK R; Norgrove D., 2020, COMMUNICATION   0511; Public Health England, ANN REP ACC; Public Health England, 2020, STAY HOM GUID HOUS P; Public Health England, 2020, GUID NOT DIS CAUS OR; Public Health England, 2020, AUSTR COVID 19 CAS S; Raffle AE, 2019, SCREENING EVIDENCE P, V2nd	19	17	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2020	369								m2484	10.1136/bmj.m2484	http://dx.doi.org/10.1136/bmj.m2484			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI3HF	32586845	Green Accepted, Bronze			2022-12-28	WOS:000583173400005
J	Slomski, A				Slomski, Anita			C-Reactive Protein Test Reduces Antibiotics for COPD Flare-ups	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2453	2453		10.1001/jama.2020.10335	http://dx.doi.org/10.1001/jama.2020.10335			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2EU	32573665				2022-12-28	WOS:000595447000006
J	Yao, TC; Huang, YW; Chang, SM; Tsai, SY; Wu, AC; Tsai, HJ				Yao, Tsung-Chieh; Huang, Ya-Wen; Chang, Sheng-Mao; Tsai, Shun-Yu; Wu, Ann Chen; Tsai, Hui-Ju			Association Between Oral Corticosteroid Bursts and Severe Adverse Events A Nationwide Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CASE SERIES; RISK; SEPSIS	Background: Long-term use of oral corticosteroids has known adverse effects, but the risk from brief oral steroid bursts (<= 14 days) is largely unknown. Objective: To examine the associations between steroid bursts and severe adverse events, specifically gastrointestinal (GI) bleeding, sepsis, and heart failure. Design: Self-controlled case series. Setting: Entire National Health Insurance Research Database of medical claims records in Taiwan. Participants: Adults aged 20 to 64 years with continuous enrollment in the National Health Insurance program from 1 January 2013 to 31 December 2015. Measurements: Incidence rates of severe adverse events in steroid burst users and non-steroid users, as well as incidence rate ratios (IRRs) for severe adverse events within 5 to 30 and 31 to 90 days after initiation of steroid therapy. Results: Of 15 859 129 adult participants, 2 623 327 who received a single steroid burst were included. The most common indications were skin disorders and respiratory tract infections. The incidence rates per 1000 person-years in steroid bursts were 27.1 (95% CI, 26.7 to 27.5) for GI bleeding, 1.5 (CI, 1.4 to 1.6) for sepsis, and 1.3 (CI, 1.2 to 1.4) for heart failure. Rates of GI bleeding (IRR, 1.80 [CI, 1.75 to 1.84]), sepsis (IRR, 1.99 [CI, 1.70 to 2.32]), and heart failure (IRR, 2.37 [CI, 2.13 to 2.63]) significantly increased within 5 to 30 days after steroid therapy initiation and attenuated during the subsequent 31 to 90 days. Limitation: Persons younger than 20 years or older than 64 years were not included. Conclusion: Oral corticosteroid bursts are frequently prescribed in the general adult population in Taiwan. The highest rates of GI bleeding, sepsis, and heart failure occurred within the first month after initiation of steroid therapy.	[Yao, Tsung-Chieh] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Yao, Tsung-Chieh] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Ya-Wen; Tsai, Shun-Yu; Tsai, Hui-Ju] Natl Hlth Res Inst, Inst Populat Hlth Sci, 35 Keyan Rd, Zhunan 35053, Taiwan; [Chang, Sheng-Mao] Natl Cheng Kung Univ, Tainan, Taiwan; [Wu, Ann Chen] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; [Wu, Ann Chen] Boston Childrens Hosp, Boston, MA USA	Chang Gung Memorial Hospital; Chang Gung University; National Health Research Institutes - Taiwan; National Cheng Kung University; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Tsai, HJ (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, 35 Keyan Rd, Zhunan 35053, Taiwan.; Yao, TC (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, 5 Fu Hsin St, Taoyuan 33305, Taiwan.	yao@adm.cgmh.org.tw; tsaihj@nhri.edu.tw		Chang, Sheng-Mao/0000-0003-2785-0155	National Health Research Institutes of Taiwan [PH-109-PP-08]; Ministry of Science and Technology of Taiwan [MOST 107-2314-B-400-031-MY3, MOST 106-2314-B-182-051-MY3]; Chang Gung Medical Foundation [CMRPG3J0121]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [1R01HD085993-01]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Medical Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	By grant PH-109-PP-08 from the National Health Research Institutes of Taiwan (Dr. Tsai), grants MOST 107-2314-B-400-031-MY3 (Dr. Tsai) and MOST 106-2314-B-182-051-MY3 (Dr. Yao) from the Ministry of Science and Technology of Taiwan, grant CMRPG3J0121 from the Chang Gung Medical Foundation (Dr. Yao), and grant 1R01HD085993-01 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (Dr. Wu).	Aertgeerts B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4090; Al Efraij K, 2019, J ASTHMA, V56, P1334, DOI 10.1080/02770903.2018.1539100; Christiansen CF, 2009, ARCH INTERN MED, V169, P1677, DOI 10.1001/archinternmed.2009.297; Dix D, 2012, CLIN INFECT DIS, V55, P1608, DOI 10.1093/cid/cis774; Ebell MH, 2018, AM FAM PHYSICIAN, V98, P12; Ernst P, 2017, COPD, V14, P137, DOI 10.1080/15412555.2016.1238450; Fardet L, 2007, DRUG SAFETY, V30, P861, DOI 10.2165/00002018-200730100-00005; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Farrington P., 2018, SELF CONTROLLED CASE; Fuhlbrigge AL, 2012, ALLERGY ASTHMA PROC, V33, P82, DOI 10.2500/aap.2012.33.3499; Gault N, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-016-0278-0; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; Narum S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004587; NASHEL DJ, 1986, AM J MED, V80, P925, DOI 10.1016/0002-9343(86)90639-X; Petersen I, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4515; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rogers MAM, 2018, J DIABETES, V10, P546, DOI 10.1111/1753-0407.12631; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Souverein PC, 2004, HEART, V90, P859, DOI 10.1136/hrt.2003.020180; Sullivan PW, 2018, J ALLERGY CLIN IMMUN, V141, P110, DOI 10.1016/j.jaci.2017.04.009; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Volmer T, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00703-2018; WALJEE AK, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1415; Waljee AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158017; Walsh LJ, 1996, BRIT MED J, V313, P344, DOI 10.1136/bmj.313.7053.344; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2018, STAT MED, V37, P643, DOI 10.1002/sim.7536; Whitworth JA, 2000, HYPERTENSION, V36, P912, DOI 10.1161/01.HYP.36.5.912; Williams DM, 2018, RESP CARE, V63, P655, DOI 10.4187/respcare.06314	30	46	49	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2020	173	5					325	+		10.7326/M20-0432	http://dx.doi.org/10.7326/M20-0432			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9XI	32628532				2022-12-28	WOS:000567080900006
J	Parodi, M; Errichetti, E				Parodi, Maria; Errichetti, Enzo			Eruptive Mucosal and Ungual Melanoma Metastases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 47-year old man presented with numerous pigmented lesions on the nail beds, penis, and oral mucosa. Biopsy confirmed a diagnosis of mucosal and ungual melanoma metastases.	[Parodi, Maria; Errichetti, Enzo] Univ Hosp Santa Maria Misericordia, Udine, Italy	Hospital Santa Maria della Misericordia	Errichetti, E (corresponding author), Univ Hosp Santa Maria Misericordia, Udine, Italy.	enzoerri@yahoo.it							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					169	169		10.1056/NEJMicm1915587	http://dx.doi.org/10.1056/NEJMicm1915587			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NR9PO	32640135				2022-12-28	WOS:000571894800016
J	Schwalb, A; Seas, C				Schwalb, Alvaro; Seas, Carlos			Chromoblastomycosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 41-year-old farmer presented with a 20-year history of slowly growing lesions on the right leg. Cultures grew Fonsecaea pedrosoi, and a diagnosis of chromoblastomycosis was made.	[Schwalb, Alvaro; Seas, Carlos] Inst Med Trop Alexander von Humboldt, Lima, Peru	Universidad Peruana Cayetano Heredia	Schwalb, A (corresponding author), Inst Med Trop Alexander von Humboldt, Lima, Peru.	alvaro.schwalb@upch.pe	Schwalb, Alvaro/AAW-5757-2020	Schwalb, Alvaro/0000-0002-6518-9719					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2							e7	10.1056/NEJMicm1913199	http://dx.doi.org/10.1056/NEJMicm1913199			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NR9PO	32640136	Green Published			2022-12-28	WOS:000571894800003
J	Callaghan, BC; Price, RS; Feldman, EL				Callaghan, Brian C.; Price, Ray S.; Feldman, Eva L.			Distal Symmetric Polyneuropathy in 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEUROPATHY; MANAGEMENT		[Callaghan, Brian C.; Feldman, Eva L.] Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,4021 BSRB, Ann Arbor, MI 48104 USA; [Callaghan, Brian C.; Price, Ray S.] Vet Affairs Healthcare Syst, Ann Arbor, MI USA; [Feldman, Eva L.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Pennsylvania	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,4021 BSRB, Ann Arbor, MI 48104 USA.	efeldman@med.umich.edu			NIDDK NIH HHS [R01 DK115687] Funding Source: Medline; NINDS NIH HHS [R21 NS102924] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Callaghan BC, 2019, NEUROLOGY, V92, pE2604, DOI 10.1212/WNL.0000000000007564; Callaghan BC, 2019, PAIN, V160, P592, DOI 10.1097/j.pain.0000000000001439; Callaghan BC, 2018, CLIN NEUROPHYSIOL, V129, P654, DOI 10.1016/j.clinph.2018.01.003; Callaghan BC, 2016, JAMA NEUROL, V73, P1468, DOI 10.1001/jamaneurol.2016.3745; Callaghan BC, 2015, JAMA-J AM MED ASSOC, V314, P2172, DOI 10.1001/jama.2015.13611; Callaghan BC, 2014, JAMA NEUROL, V71, P1143, DOI 10.1001/jamaneurol.2014.1279; Davies B, 2015, PHYSIOTHERAPY, V101, P319, DOI 10.1016/j.physio.2015.04.003; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Peters A, 2017, DIABETOLOGIA, V60, P980, DOI 10.1007/s00125-017-4253-z	10	10	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					90	91		10.1001/jama.2020.0700	http://dx.doi.org/10.1001/jama.2020.0700			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633792				2022-12-28	WOS:000568123600025
J	Dal Co, A; Brenner, MP				Dal Co, Alma; Brenner, Michael P.			Tracing cell trajectories in a biofilm	SCIENCE			English	Editorial Material									[Dal Co, Alma; Brenner, Michael P.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02139 USA	Harvard University	Dal Co, A (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02139 USA.	adalco@g.harvard.edu; brenner@seas.harvard.edu			National Science Foundation [DMS-1715477]; Materials Research Science and Engineering Center [DMR-1420570]; Office of Naval Research [N00014-17-1-3029]; Simons Foundation	National Science Foundation(National Science Foundation (NSF)); Materials Research Science and Engineering Center(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Simons Foundation	A.D.C. and M.P.B. are supported by the National Science Foundation (DMS-1715477), Materials Research Science and Engineering Center (DMR-1420570), the Office of Naval Research (N00014-17-1-3029), and the Simons Foundation.	Dal Co A, 2020, NAT ECOL EVOL, V4, P366, DOI 10.1038/s41559-019-1080-2; Dal Co A, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2019.0080; Dragos A, 2018, CURR BIOL, V28, P1903, DOI 10.1016/j.cub.2018.04.046; Drescher K, 2016, P NATL ACAD SCI USA, V113, pE2066, DOI 10.1073/pnas.1601702113; Evans AC, 1929, J BACTERIOL, V17, P63, DOI 10.1128/JB.17.2.63-77.1929; Hall CW, 2017, FEMS MICROBIOL REV, V41, P276, DOI [10.1093/femsre/fux010, 10.1093/femsre/f]; Hartmann R, 2019, NAT PHYS, V15, P251, DOI 10.1038/s41567-018-0356-9; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Qin BY, 2020, SCIENCE, V369, P71, DOI 10.1126/science.abb8501; Raghupathi PK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02649; Seminara A, 2012, P NATL ACAD SCI USA, V109, P1116, DOI 10.1073/pnas.1109261108; van Gestel J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002141; van Vliet S, 2018, CELL SYST, V6, P496, DOI 10.1016/j.cels.2018.03.009; Vlamakis H., 2007, CHEMTRACTS, V20, P427; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960	15	3	3	6	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					30	31		10.1126/science.abd1225	http://dx.doi.org/10.1126/science.abd1225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MK4IZ	32631880				2022-12-28	WOS:000548751700032
J	Monroe, C				Monroe, Christopher			Remote quantum computing is the future	NATURE			English	Editorial Material								Conditions created by the COVID-19 shutdown are delivering one experiment's 'best data ever'.	[Monroe, Christopher] Univ Maryland, College Pk, MD 20742 USA; [Monroe, Christopher] Duke Univ, Durham, NC USA; [Monroe, Christopher] IonQ, College Pk, MD 20740 USA	University System of Maryland; University of Maryland College Park; Duke University	Monroe, C (corresponding author), Univ Maryland, College Pk, MD 20742 USA.; Monroe, C (corresponding author), Duke Univ, Durham, NC USA.; Monroe, C (corresponding author), IonQ, College Pk, MD 20740 USA.	monroe@umd.edu	Monroe, Christopher R/G-8105-2011						0	1	1	5	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					10	10		10.1038/d41586-020-01937-x	http://dx.doi.org/10.1038/d41586-020-01937-x			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME4ZX	32606471	Bronze			2022-12-28	WOS:000544665900001
J	Altmann, M; Altmann, S; Rodriguez, PA; Weller, B; Vergara, LE; Palme, J; de la Rosa, NM; Sauer, M; Wenig, M; Villaecija-Aguilar, JA; Sales, J; Lin, CW; Pandiarajan, R; Young, V; Strobel, A; Gross, L; Carbonnel, S; Kugler, KG; Garcia-Molina, A; Bassel, GW; Falter, C; Mayer, KFX; Gutjahr, C; Vlot, AC; Grill, E; Falter-Braun, P				Altmann, Melina; Altmann, Stefan; Rodriguez, Patricia A.; Weller, Benjamin; Vergara, Lena Elorduy; Palme, Julius; de la Rosa, Nora; Sauer, Mayra; Wenig, Marion; Villaecija-Aguilar, Jose Antonio; Sales, Jennifer; Lin, Chung-Wen; Pandiarajan, Ramakrishnan; Young, Veronika; Strobel, Alexandra; Gross, Lisa; Carbonnel, Samy; Kugler, Karl G.; Garcia-Molina, Antoni; Bassel, George W.; Falter, Claudia; Mayer, Klaus F. X.; Gutjahr, Caroline; Vlot, A. Corina; Grill, Erwin; Falter-Braun, Pascal			Extensive signal integration by the phytohormone protein network	NATURE			English	Article							ACID RECEPTORS; SALICYLIC-ACID; ARABIDOPSIS; HORMONE; FRAMEWORK; SOFTWARE; PLATFORM; DATABASE; MAP	Plant hormones coordinate responses to environmental cues with developmental programs(1), and are fundamental for stress resilience and agronomic yield(2). The core signalling pathways underlying the effects of phytohormones have been elucidated by genetic screens and hypothesis-driven approaches, and extended by interactome studies of select pathways(3). However, fundamental questions remain about how information from different pathways is integrated. Genetically, most phenotypes seem to be regulated by several hormones, but transcriptional profiling suggests that hormones trigger largely exclusive transcriptional programs(4). We hypothesized that protein-protein interactions have an important role in phytohormone signal integration. Here, we experimentally generated a systems-level map of the Arabidopsis phytohormone signalling network, consisting of more than 2,000 binary protein-protein interactions. In the highly interconnected network, we identify pathway communities and hundreds of previously unknown pathway contacts that represent potential points of crosstalk. Functional validation of candidates in seven hormone pathways reveals new functions for 74% of tested proteins in 84% of candidate interactions, and indicates that a large majority of signalling proteins function pleiotropically in several pathways. Moreover, we identify several hundred largely small-molecule-dependent interactions of hormone receptors. Comparison with previous reports suggests that noncanonical and nontranscription-mediated receptor signalling is more common than hitherto appreciated.	[Altmann, Melina; Altmann, Stefan; Rodriguez, Patricia A.; Weller, Benjamin; Vergara, Lena Elorduy; Palme, Julius; de la Rosa, Nora; Sauer, Mayra; Lin, Chung-Wen; Pandiarajan, Ramakrishnan; Young, Veronika; Strobel, Alexandra; Garcia-Molina, Antoni; Falter, Claudia; Falter-Braun, Pascal] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Network Biol INET, Munich, Germany; [Wenig, Marion; Sales, Jennifer; Vlot, A. Corina] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol BIOP, Inducible Resistance Signaling Grp, Munich, Germany; [Villaecija-Aguilar, Jose Antonio; Gutjahr, Caroline] Tech Univ Munich TUM, Plant Genet, TUM Sch Life Sci, Freising Weihenstephan, Germany; [Gross, Lisa; Grill, Erwin] Tech Univ Munich TUM, TUM Sch Life Sci, Bot, Freising Weihenstephan, Germany; [Carbonnel, Samy; Gutjahr, Caroline] Ludwig Maximilians Univ LMU Munchen, Fac Biol, Genet, Planegg Martinsried, Germany; [Kugler, Karl G.; Mayer, Klaus F. X.] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Plant Genome & Syst Biol PGSB, Munich, Germany; [Bassel, George W.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Mayer, Klaus F. X.] Tech Univ Munich TUM, TUM Sch Life Sci, Freising Weihenstephan, Germany; [Falter-Braun, Pascal] Ludwig Maximilians Univ LMU Munchen, Fac Biol, Microbe Host Interact, Planegg Martinsried, Germany; [Palme, Julius] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Garcia-Molina, Antoni] Ludwig Maximilians Univ LMU Munchen, Fac Biol, Plant Mol Biol, Planegg Martinsried, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Birmingham; Technical University of Munich; University of Munich; Harvard University; Harvard Medical School; University of Munich	Falter-Braun, P (corresponding author), Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Network Biol INET, Munich, Germany.; Falter-Braun, P (corresponding author), Ludwig Maximilians Univ LMU Munchen, Fac Biol, Microbe Host Interact, Planegg Martinsried, Germany.	pascal.falter-braun@helmholtz-muenchen.de	GARCIA-MOLINA, ANTONI/AAU-1181-2020; Villaécija-Aguilar, José Antonio/AAP-9681-2021; CARBONNEL, Samy/AAF-1182-2021; Gutjahr, Caroline/H-8390-2013; Falter-Braun, Pascal/B-9669-2013; Vlot, Corina/M-7351-2014	GARCIA-MOLINA, ANTONI/0000-0002-7790-9736; Villaécija-Aguilar, José Antonio/0000-0001-6378-105X; CARBONNEL, Samy/0000-0003-2564-7161; Gutjahr, Caroline/0000-0001-6163-745X; Young, Veronika/0000-0002-1524-8039; Weller, Benjamin/0000-0002-0231-595X; Falter-Braun, Pascal/0000-0003-2012-6746; Lin, Chung-Wen/0000-0002-2509-0562; Vlot, Corina/0000-0002-8146-6018	Deutsche Forschungsgemeinschaft (DFG) Emmy Noether program [GU1423/1-1]; DFG [SFB924]; Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry for Education, Science, Research and Technology) [031L0141]; European Research Council [648420]; BBSRC [BB/N009754/1, BB/L010232/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG) Emmy Noether program(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry for Education, Science, Research and Technology)(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all INET members for helpful discussions. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Emmy Noether program (grant GU1423/1-1) to C.G.; by DFG grant SFB924 to A.C.V., C.G., E.G. and P.F.-B.; by the Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry for Education, Science, Research and Technology) grant 031L0141 e:Bio-Modul III: ChlamyInt to P.F.-B.; and by the European Research Council's Horizon 2020 Research and Innovation Programme (grant agreement 648420) to P.F.-B.	Aleman F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28941; Altmann Melina, 2018, Curr Protoc Plant Biol, V3, pe20067, DOI 10.1002/cppb.20067; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Belda-Palazon B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046907; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braun P, 2012, PROTEOMICS, V12, P1499, DOI 10.1002/pmic.201100598; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Ding YL, 2018, CELL, V173, P1454, DOI 10.1016/j.cell.2018.03.044; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gehl C, 2011, PLANT J, V67, P542, DOI 10.1111/j.1365-313X.2011.04607.x; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hermann M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00088; Jiang ZQ, 2011, NUCLEIC ACIDS RES, V39, pD1123, DOI 10.1093/nar/gkq1066; Klepikova AV, 2016, PLANT J, V88, P1058, DOI 10.1111/tpj.13312; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Kuai XHZ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00235; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Lumba S, 2014, DEV CELL, V29, P360, DOI 10.1016/j.devcel.2014.04.004; Lumba S, 2010, ANNU REV CELL DEV BI, V26, P445, DOI 10.1146/annurev-cellbio-100109-103956; Nakata M., 2014, BIO-PROTOCOL, V4, P1098, DOI DOI 10.21769/BIOPROTOC.1098; Nee G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00113-6; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Scaffidi A, 2014, PLANT PHYSIOL, V165, P1221, DOI 10.1104/pp.114.240036; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tischer SV, 2017, P NATL ACAD SCI USA, V114, P10280, DOI 10.1073/pnas.1706593114; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Villaecija-Aguilar JA, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008327; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Waters MT, 2017, ANNU REV PLANT BIOL, V68, P291, DOI 10.1146/annurev-arplant-042916-040925; Wenig M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11798-2; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhao Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005051	49	51	51	13	155	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					271	+		10.1038/s41586-020-2460-0	http://dx.doi.org/10.1038/s41586-020-2460-0		JUL 2020	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH5KF	32612234	Green Accepted			2022-12-28	WOS:000544885800004
J	Yang, ANC; Stevens, MY; Chen, MCB; Lee, DVP; Stahli, D; Gate, D; Contrepois, K; Chen, WN; Iram, T; Zhang, LC; Vest, RT; Chaney, A; Lehallier, B; Olsson, N; du Bois, H; Hsieh, R; Cropper, HC; Berdnik, D; Li, LL; Wang, EY; Traber, GM; Bertozzi, CR; Luo, J; Snyder, MP; Elias, JE; Quake, SR; James, ML; Wyss-Coray, T				Yang, Andrew C.; Stevens, Marc Y.; Chen, Michelle B.; Lee, Davis P.; Stahli, Daniel; Gate, David; Contrepois, Kevin; Chen, Winnie; Iram, Tal; Zhang, Lichao; Vest, Ryan T.; Chaney, Aisling; Lehallier, Benoit; Olsson, Niclas; du Bois, Haley; Hsieh, Ryan; Cropper, Haley C.; Berdnik, Daniela; Li, Lulin; Wang, Elizabeth Y.; Traber, Gavin M.; Bertozzi, Carolyn R.; Luo, Jian; Snyder, Michael P.; Elias, Joshua E.; Quake, Stephen R.; James, Michelle L.; Wyss-Coray, Tony			Physiological blood-brain transport is impaired with age by a shift in transcytosis	NATURE			English	Article							ALZHEIMERS-DISEASE; ENDOTHELIAL-CELLS; GENE ONTOLOGY; BARRIER; PERMEABILITY; PERICYTES; IDENTIFICATION; LOCALIZATION; PROGENITOR; RECEPTORS	Tagging and tracking the blood plasma proteome as a discovery tool reveals widespread endogenous transport of proteins into the healthy brain and the pharmacologically modifiable mechanisms by which the brain endothelium regulates this process with age. The vascular interface of the brain, known as the blood-brain barrier (BBB), is understood to maintain brain function in part via its low transcellular permeability(1-3). Yet, recent studies have demonstrated that brain ageing is sensitive to circulatory proteins(4,5). Thus, it is unclear whether permeability to individually injected exogenous tracers-as is standard in BBB studies-fully represents blood-to-brain transport. Here we label hundreds of proteins constituting the mouse blood plasma proteome, and upon their systemic administration, study the BBB with its physiological ligand. We find that plasma proteins readily permeate the healthy brain parenchyma, with transport maintained by BBB-specific transcriptional programmes. Unlike IgG antibody, plasma protein uptake diminishes in the aged brain, driven by an age-related shift in transport from ligand-specific receptor-mediated to non-specific caveolar transcytosis. This age-related shift occurs alongside a specific loss of pericyte coverage. Pharmacological inhibition of the age-upregulated phosphatase ALPL, a predicted negative regulator of transport, enhances brain uptake of therapeutically relevant transferrin, transferrin receptor antibody and plasma. These findings reveal the extent of physiological protein transcytosis to the healthy brain, a mechanism of widespread BBB dysfunction with age and a strategy for enhanced drug delivery.	[Yang, Andrew C.; Chen, Michelle B.; Quake, Stephen R.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA USA; [Yang, Andrew C.; Bertozzi, Carolyn R.; Wyss-Coray, Tony] Stanford Univ, ChEM H, Stanford, CA 94305 USA; [Yang, Andrew C.; Stevens, Marc Y.; Lee, Davis P.; Stahli, Daniel; Gate, David; Chen, Winnie; Iram, Tal; Vest, Ryan T.; Chaney, Aisling; Lehallier, Benoit; du Bois, Haley; Hsieh, Ryan; Cropper, Haley C.; Berdnik, Daniela; Li, Lulin; Wang, Elizabeth Y.; Luo, Jian; James, Michelle L.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Stevens, Marc Y.; Chaney, Aisling; Cropper, Haley C.; James, Michelle L.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA USA; [Contrepois, Kevin; Traber, Gavin M.; Snyder, Michael P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA USA; [Zhang, Lichao; Elias, Joshua E.; Quake, Stephen R.] Chan Zuckerberg Biohub, Stanford, CA USA; [Vest, Ryan T.] Dept Chem Engn, Stanford, CA USA; [Olsson, Niclas] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA USA; [Bertozzi, Carolyn R.; Wyss-Coray, Tony] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Luo, Jian] Vet Adm Palo Alto Healthcare Syst, Palo Alto, CA USA; [James, Michelle L.; Wyss-Coray, Tony] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA; [Wyss-Coray, Tony] Stanford Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA; [Olsson, Niclas] Calico Life Sci LLC, San Francisco, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Wyss-Coray, T (corresponding author), Stanford Univ, ChEM H, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA.	twc@stanford.edu	Gate, David/AAM-5007-2021; Iram, Tal/GSE-3876-2022	Gate, David/0000-0003-0481-9657; Chaney, Aisling/0000-0003-2789-7615; Snyder, Michael/0000-0003-0784-7987; du Bois, Haley/0000-0002-2754-9971; Chen, Winnie/0000-0002-9653-4036; Wyss-Coray, Tony/0000-0001-5893-0831; Cropper, Haley/0000-0003-1497-0182; Yang, Andrew/0000-0002-6756-4746	Department of Veterans Affairs; National Institute on Aging [DP1-AG053015, T32-AG0047126, 1RF1AG059694]; National Institute of General Medical Sciences [R01-GM059907]; NOMIS Foundation; Glenn Foundation for Aging Research; National Institutes of Health [3P50HG00773505S1]; Big Idea Brain Rejuvenation Project from the Wu Tsai Neurosciences Institute; Siebel Scholarship; National Institutes of Health from the National Center for Research Resources (NCRR) [1S10OD025091-01, 1S10OD01227601]; AHA-Allen Initiative in Brain Health and Cognitive Impairment [19PABHI34580007]	Department of Veterans Affairs(US Department of Veterans Affairs); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NOMIS Foundation; Glenn Foundation for Aging Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Big Idea Brain Rejuvenation Project from the Wu Tsai Neurosciences Institute; Siebel Scholarship; National Institutes of Health from the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AHA-Allen Initiative in Brain Health and Cognitive Impairment	We thank K. Brewer, O. Leventhal, N. Schaum, S. R. Shuken, C. Munson, J. V. Pluvinage, C. A. Maat, N. Khoury and other members of the Wyss-Coray, James, Snyder and Elias laboratories for feedback and support; H. Zhang and K. Dickey for laboratory management; B. Carter for flow cytometry technical expertise; J. Mulholland and Y. Lim of the Stanford Cell Sciences Imaging Facility for help with high-resolution microscopy; and U. Langen and C. Gu for the MFSD2A antibody. This work was funded by the Department of Veterans Affairs (to T.W.-C.), the National Institute on Aging (DP1-AG053015 to T.W.-C., T32-AG0047126 to A.C.Y. and 1RF1AG059694 to T.W.-C. and J.L.), the National Institute of General Medical Sciences (R01-GM059907 to C.R.B.), the NOMIS Foundation (to T.W.-C.), the Glenn Foundation for Aging Research (to T.W.-C.), the National Institutes of Health (3P50HG00773505S1 to M.P.S.), and the Big Idea Brain Rejuvenation Project from the Wu Tsai Neurosciences Institute (to T.W.-C., J.E.E. and C.R.B.). A.C.Y was supported by a Siebel Scholarship. M.Y.S. is a Wallenberg Foundation postdoctoral fellow. S.R.Q. is a Chan Zuckerberg Investigator. We acknowledge the National Institutes of Health shared equipment grants, 1S10OD025091-01 and 1S10OD01227601 from the National Center for Research Resources (NCRR). This study was supported by the AHA-Allen Initiative in Brain Health and Cognitive Impairment: 19PABHI34580007. The statements in this work are solely the responsibility of the authors and do not necessarily represent the views of the American Heart Association (AHA) or the Paul G. Allen Frontiers Group.	Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043; [Anonymous], 2018, NATURE, V562, P367, DOI DOI 10.1038/S41586-018-0590-4; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Ben-Ari Fuchs S, 2016, OMICS, V20, P139, DOI 10.1089/omi.2015.0168; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berry KAZ, 2017, J LIPID RES, V58, P926, DOI 10.1194/jlr.M074955; Boulay AC, 2015, JOVE-J VIS EXP, DOI 10.3791/53208; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cajka T, 2017, ANAL CHEM, V89, P12360, DOI 10.1021/acs.analchem.7b03404; Calve S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32377; Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067; Chaney A, 2019, J NUCL MED, V60, P122, DOI 10.2967/jnumed.118.209155; Chaney AM, 2018, JOVE-J VIS EXP, V136, P57243; Chen MB, 2020, CELL REP, V30, P4418, DOI 10.1016/j.celrep.2020.03.012; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Contrepois K, 2018, SCI REP, V8; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Dahl R, 2009, J MED CHEM, V52, P6919, DOI 10.1021/jm900383s; Dan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081051; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Dominguez E, 2014, INT J CARDIOVAS IMAG, V30, P1237, DOI 10.1007/s10554-014-0454-4; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erdo F, 2017, J CEREBR BLOOD F MET, V37, P4, DOI 10.1177/0271678X16679420; Ferreira CL, 2010, EUR J NUCL MED MOL I, V37, P2117, DOI 10.1007/s00259-010-1506-1; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ilovich O, 2015, RADIOLOGY, V276, P191, DOI 10.1148/radiol.15140058; James ML, 2012, J MED CHEM, V55, P8272, DOI 10.1021/jm300371c; Kadakkuzha BM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00063; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Luo Jian, 2014, Front Neurol, V5, P12, DOI 10.3389/fneur.2014.00012; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Paris-Robidas S, 2016, J CEREBR BLOOD F MET, V36, P731, DOI 10.1177/0271678X15608201; Petersen MA, 2018, NAT REV NEUROSCI, V19, P283, DOI 10.1038/nrn.2018.13; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pluvinage JV, 2019, NATURE, V568, P187, DOI 10.1038/s41586-019-1088-4; PODUSLO JF, 1994, P NATL ACAD SCI USA, V91, P5705, DOI 10.1073/pnas.91.12.5705; PRESTON JE, 1995, DEV BRAIN RES, V87, P69, DOI 10.1016/0165-3806(95)00060-Q; Profaci CP, 2020, J EXP MED, V217, DOI 10.1084/jem.20190062; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Sabbagh MF, 2018, ELIFE, V7, DOI 10.7554/eLife.36187; Saunders NR, 2018, J PHYSIOL-LONDON, V596, P5723, DOI 10.1113/JP275376; Saunders NR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00404; Saunders NR, 2013, MOL ASPECTS MED, V34, P742, DOI 10.1016/j.mam.2012.11.006; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; SIMIONESCU M, 1988, J SUBMICR CYTOL PATH, V20, P243; Singh I, 2013, P NATL ACAD SCI USA, V110, P14771, DOI 10.1073/pnas.1302212110; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tournoux F, 2011, J AM SOC ECHOCARDIOG, V24, P465, DOI 10.1016/j.echo.2010.12.019; Treweek JB, 2015, NAT PROTOC, V10, P1860, DOI 10.1038/nprot.2015.122; TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vardy ERLC, 2012, NEURODEGENER DIS, V9, P31, DOI 10.1159/000329722; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xavier ALR, 2018, JOVE-J VIS EXP, V135, P57378, DOI DOI 10.3791/; Ximerakis M, 2019, NAT NEUROSCI, V22, P1696, DOI 10.1038/s41593-019-0491-3; Yanagida K, 2017, P NATL ACAD SCI USA, V114, P4531, DOI 10.1073/pnas.1618659114; Yang AC, 2018, J AM CHEM SOC, V140, P7046, DOI 10.1021/jacs.8b03074; Yousef H, 2019, NAT MED, V25, P988, DOI 10.1038/s41591-019-0440-4; Yu YJ, 2013, NEUROTHERAPEUTICS, V10, P459, DOI 10.1007/s13311-013-0187-4; Zarb Y, 2019, BRAIN, V142, P885, DOI 10.1093/brain/awz032; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	92	125	131	26	83	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 16	2020	583	7816					425	+		10.1038/s41586-020-2453-z	http://dx.doi.org/10.1038/s41586-020-2453-z		JUL 2020	36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4AA	32612231	Green Accepted			2022-12-28	WOS:000544885800001
J	O'Dowd, A				O'Dowd, Adrian			Drug misuse rose 30% in past decade and covid-19 could worsen situation, UN report warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		United Nations Office on Drugs and Crime, 2020, WORLD DRUG REP 2020	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2631	10.1136/bmj.m2631	http://dx.doi.org/10.1136/bmj.m2631			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32605941	Bronze			2022-12-28	WOS:000548116400005
J	Dyer, C				Dyer, Clare			Reach agreement on GP safeguarding fees or risk legal action, judge tells local agencies	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2020	369								m2585	10.1136/bmj.m2585	http://dx.doi.org/10.1136/bmj.m2585			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI3HF	32586793				2022-12-28	WOS:000583173400015
J	Rimmer, A				Rimmer, Abi			Five minutes with ... Aarti Bansal	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2483	10.1136/bmj.m2483	http://dx.doi.org/10.1136/bmj.m2483			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571798				2022-12-28	WOS:000548535700001
J	Marchalik, D; Petrov, D				Marchalik, Daniel; Petrov, Dmitriy			From literature to medicine Seeing COVID-19 through Jose Saramago's Blindness	LANCET			English	Editorial Material									[Marchalik, Daniel] Georgetown Univ, Sch Med, MedStar Hlth, Off Phys Well Being & Literature & Med Track, Washington, DC 20007 USA; [Petrov, Dmitriy] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	Georgetown University; University of Pennsylvania	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, MedStar Hlth, Off Phys Well Being & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com							0	1	2	4	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1899	1899						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563364	Green Published			2022-12-28	WOS:000552732200016
J	Perner, A; Moller, MH				Perner, Anders; Moller, Morten Hylander			Tranexamic acid for severe gastrointestinal bleeding	LANCET			English	Editorial Material									[Perner, Anders; Moller, Morten Hylander] Univ Copenhagen, Dept Intens Care, Rigshosp, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Perner, A (corresponding author), Univ Copenhagen, Dept Intens Care, Rigshosp, DK-2100 Copenhagen, Denmark.	anders.perner@regionh.dk			Novo Nordisk Foundation; Ferring Pharmaceuticals; Fresenius Kabi	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ferring Pharmaceuticals(Ferring Pharmaceuticals); Fresenius Kabi	AP receives research funding from the Novo Nordisk Foundation for clinical trials in intensive care patients unrelated to the topic of this Comment. The Department of Intensive Care, Rigshospitalet, has had research funding for research from Ferring Pharmaceuticals and Fresenius Kabi within the last 3 years. MHM declares no competing interests.	Adamsen S, 2007, SCAND J GASTROENTERO, V42, P318, DOI 10.1080/00365520600880989; Barkun AN, 2019, ANN INTERN MED, V171, P805, DOI 10.7326/M19-1795; Bennett C, 2014, COCHRANE DB SYST REV, V2014; HALT-IT Trial Collaborators, 2020, LANCET, V395, P1927, DOI 10.1016/S0140-6736(20)30848-5; Lau JYW, 2013, LANCET, V381, P2033, DOI 10.1016/S0140-6736(13)60596-6; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	8	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1885	1886						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563356	hybrid			2022-12-28	WOS:000552732200006
J	McCullough, M				McCullough, Melissa			Ethical decision making in a pandemic: where are the voices of vulnerable people?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McCullough, Melissa] Royal Coll Surg, Dublin, Ireland; [McCullough, Melissa] Hlth & Social Care Board, Belfast, Antrim, North Ireland; [McCullough, Melissa] Irish Med Council, Undergrad Med Educ, Dublin, Ireland; [McCullough, Melissa] Doctor Care Anywhere, Clin Governance Board, London, England	Royal College of Surgeons - Ireland	McCullough, M (corresponding author), Royal Coll Surg, Dublin, Ireland.; McCullough, M (corresponding author), Hlth & Social Care Board, Belfast, Antrim, North Ireland.; McCullough, M (corresponding author), Irish Med Council, Undergrad Med Educ, Dublin, Ireland.; McCullough, M (corresponding author), Doctor Care Anywhere, Clin Governance Board, London, England.	melissa@mtmresearch.com						[Anonymous], 2020, GUARDIAN; Beauchamp T, 2013, PRINCIPLES BIOMEDICA; Booth R, 2020, GUARDIAN; Department of Health and Social Care, 2020, RESP COV 19 ETH FRAM; Ferriss S., 2020, NURSING HOME WORKERS; Grey S, 2020, REUTERS LONDON  0505; McCullough M., 2020, IRISH NEWS      0114; NICE, 2020, COV 19 RAP GUID CRIT; Office for National Statistics, 2020, DAT NUMB DEATHS CAR; Triggle N., 2020, BBC	10	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2020	369								m2406	10.1136/bmj.m2406	http://dx.doi.org/10.1136/bmj.m2406			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GM	32561520	Bronze			2022-12-28	WOS:000548534800004
J	Wise, J; Coombes, R				Wise, Jacqui; Coombes, Rebecca			Covid-19: The inside story of the RECOVERY trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYDROXYCHLOROQUINE					rcoombes@bmj.com						Department of Health and Social Care, 2020, COV 19 TREATM COULD; European Medicines Agency, 2020, CALL POOL EU RES RES; KMIETOWICZ Z, 2020, BMJ-BRIT MED J, V369, P57029, DOI DOI 10.1136/BMJ.M2097; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1422; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2378; Torjesen I, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2263; Watson JA, 2020, CONCENTRATION DEPEND, DOI [10.1101/2020.04.24.20078303, DOI 10.1101/2020.04.24.20078303]	7	32	32	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2020	370								m2670	10.1136/bmj.m2670	http://dx.doi.org/10.1136/bmj.m2670			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5ZR	32641290	Bronze			2022-12-28	WOS:000548168600007
J	McDermott, MT				McDermott, Michael T.			Hypothyroidism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SUBCLINICAL THYROID-DYSFUNCTION; HEALTH-STATUS; TASK-FORCE; LEVOTHYROXINE; RISK; MANAGEMENT; PREGNANCY; HORMONE; ASSOCIATION; POPULATION		[McDermott, Michael T.] Univ Colorado, Sch Med, Denver, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	McDermott, MT (corresponding author), Univ Colorado, Sch Med, Denver, CO 80309 USA.		McDermott, Michael Francis/GZM-5330-2022		American College of Physicians	American College of Physicians	American College of Physicians.	Abrahamsen B, 2015, J BONE MINER RES, V30, P898, DOI 10.1002/jbmr.2416; Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; Beynon J, 2008, CRIT CARE, V12, DOI 10.1186/cc6218; Biondi B, 2014, ENDOCR REV, V35, P433, DOI 10.1210/er.2013-1083; Bloomgarden ZT, 2012, ENDOCR PRACT, V18, P6, DOI 10.4158/EP12300.RA; Blum MR, 2015, JAMA-J AM MED ASSOC, V313, P2055, DOI 10.1001/jama.2015.5161; Bolk N, 2007, CLIN ENDOCRINOL, V66, P43, DOI 10.1111/j.1365-2265.2006.02681.x; Boonen E, 2014, J CLIN ENDOCR METAB, V99, P1569, DOI 10.1210/jc.2013-4115; Brenta G, 2013, ARQ BRAS ENDOCRINOL, V57, P265, DOI 10.1590/S0004-27302013000400003; Burch HB, 2019, NEW ENGL J MED, V381, P749, DOI 10.1056/NEJMra1901214; Carle A, 2016, AM J MED, V129, P1082, DOI 10.1016/j.amjmed.2016.06.013; Carle A, 2014, EUR J ENDOCRINOL, V171, P593, DOI 10.1530/EJE-14-0481; Casey BM, 2007, OBSTET GYNECOL, V109, P1129, DOI 10.1097/01.AOG.0000262054.03531.24; Chaker L, 2017, LANCET, V390, P1550, DOI 10.1016/S0140-6736(17)30703-1; Chaker L, 2016, NEUROLOGY, V87, P1688, DOI 10.1212/WNL.0000000000003227; Chiong YV, 2015, TRANSL RES, V166, P233, DOI 10.1016/j.trsl.2015.01.003; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Duntas LH, 2002, THYROID, V12, P287, DOI 10.1089/10507250252949405; Madariaga AG, 2014, J CLIN ENDOCR METAB, V99, P923, DOI 10.1210/jc.2013-2409; Gereben B, 2015, NAT REV ENDOCRINOL, V11, P642, DOI 10.1038/nrendo.2015.155; Grossman A, 2018, EUR J INTERN MED, V50, P65, DOI 10.1016/j.ejim.2017.11.010; Grunenwald S, 2015, PITUITARY, V18, P169, DOI 10.1007/s11102-014-0559-8; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hattori N, 2015, CLIN ENDOCRINOL, V83, P923, DOI 10.1111/cen.12643; Ito M, 2017, THYROID, V27, P484, DOI 10.1089/thy.2016.0426; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Klaver EI, 2013, THYROID, V23, P1066, DOI 10.1089/thy.2013.0017; Klubo-Gwiezdzinska J, 2012, MED CLIN N AM, V96, P385, DOI 10.1016/j.mcna.2012.01.015; LeFevre ML, 2015, ANN INTERN MED, V162, P641, DOI 10.7326/M15-0483; Li D, 2017, JAMA-J AM MED ASSOC, V318, P1150, DOI 10.1001/jama.2017.13705; McAninch EA, 2016, ANN INTERN MED, V164, P50, DOI 10.7326/M15-1799; Mooijaart SP, 2019, JAMA-J AM MED ASSOC, V322, P1977, DOI [10.1001/jama.2019.17274, 10.1001/jama.201917274]; Negro R, 2014, ENDOCR PRACT, V20, P901, DOI 10.4158/EP13378.OR; Ogunsakin A, 2017, NEW ENGL J MED, V377, DOI 10.1056/NEJMc1709989; Pasqualetti G, 2015, J CLIN ENDOCR METAB, V100, P4240, DOI 10.1210/jc.2015-2046; Pearce SHS, 2013, EUR THYROID J, V2, P215, DOI 10.1159/000356507; Peterson SJ, 2018, THYROID, V28, P707, DOI 10.1089/thy.2017.0681; Popoveniuc G, 2014, ENDOCR PRACT, V20, P808, DOI 10.4158/EP13460.OR; Razvi S, 2012, ARCH INTERN MED, V172, P811, DOI 10.1001/archinternmed.2012.1159; REESJONES RW, 1980, JAMA-J AM MED ASSOC, V243, P549, DOI 10.1001/jama.243.6.549; Rieben C, 2016, J CLIN ENDOCR METAB, V101, P4945, DOI 10.1210/jc.2016-2129; Rosario PW, 2017, NEW ENGL J MED, V377, P1404, DOI 10.1056/NEJMc1709853; Samuels MH, 2007, THYROID, V17, P249, DOI 10.1089/thy.2006.0252; Samuels MH, 2016, THYROID, V26, P1173, DOI 10.1089/thy.2016.0141; Samuels MH, 2014, J CLIN ENDOCR METAB, V99, P843, DOI 10.1210/jc.2013-3686; Santini F, 2005, J CLIN ENDOCR METAB, V90, P124, DOI 10.1210/jc.2004-1306; Santoro N, 2016, J CLIN ENDOCR METAB, V101, P1318, DOI 10.1210/jc.2016-1271; Simonsick EM, 2009, ARCH INTERN MED, V169, P2011, DOI 10.1001/archinternmed.2009.392; Sorensen JR, 2016, THYROID, V26, P1519, DOI 10.1089/thy.2015.0642; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; Szczepanek-Parulska E, 2017, J CLIN ENDOCR METAB, V102, P3124, DOI 10.1210/jc.2017-00784; Thvilum M, 2014, THYROID, V24, P802, DOI 10.1089/thy.2013.0555; Vaidya B, 2007, J CLIN ENDOCR METAB, V92, P203, DOI 10.1210/jc.2006-1748; Vita R, 2014, J CLIN ENDOCR METAB, V99, P4481, DOI 10.1210/jc.2014-2684; Wiersinga WM, 2012, EUR THYROID J, V1, P55, DOI [10.1159/000339444, 10.1159/000337020]; Zulewski H, 1997, J CLIN ENDOCR METAB, V82, P771, DOI 10.1210/jc.82.3.771	56	17	20	3	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2020	173	1					ITC1	+		10.7326/AITC202007070	http://dx.doi.org/10.7326/AITC202007070			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MI6BV	32628881				2022-12-28	WOS:000547491700001
J	Cluver, CA; Herbst, P; Griffith-Richards, S; Hassan, M; Allwood, B				Cluver, Catherine Anne; Herbst, Philip; Griffith-Richards, Stephanie; Hassan, Muhammed; Allwood, Brian			Coarctation of the aorta: a rare cause of severe hypertension in pregnancy	LANCET			English	Editorial Material									[Cluver, Catherine Anne; Herbst, Philip; Griffith-Richards, Stephanie; Hassan, Muhammed; Allwood, Brian] Stellenbosch Univ, Fac Med & Hlth Sci, ZA-7505 Cape Town, Western Cape, South Africa; [Cluver, Catherine Anne] Univ Melbourne, Dept Obstet & Gynaecol, Translat Obstet Grp, Melbourne, Vic, Australia; [Cluver, Catherine Anne] Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia	Stellenbosch University; University of Melbourne	Cluver, CA (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, ZA-7505 Cape Town, Western Cape, South Africa.	cathycluver@hotmail.com	Cluver, Catherine/O-7978-2018	Cluver, Catherine/0000-0002-0406-8964					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					62	62						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32622398				2022-12-28	WOS:000561626100017
J	Armstrong, DJ; Lopez, TA; Adibekyan, V; Booth, RA; Bryant, EM; Collins, KA; Deleuil, M; Emsenhuber, A; Huang, CLX; King, GW; Lillo-Box, J; Lissauer, JJ; Matthews, E; Mousis, O; Nielsen, LD; Osborn, H; Otegi, J; Santos, NC; Sousa, SG; Stassun, KG; Veras, D; Ziegler, C; Acton, JS; Almenara, JM; Anderson, DR; Barrado, D; Barros, SCC; Bayliss, D; Belardi, C; Bouchy, F; Briceno, C; Brogi, M; Brown, DJA; Burleigh, MR; Casewell, SL; Chaushev, A; Ciardi, DR; Collins, KI; Colon, KD; Cooke, BF; Crossfield, IJM; Diaz, RF; Mena, ED; Demangeon, ODS; Dorn, C; Dumusque, X; Eigmuller, P; Fausnaugh, M; Figueira, P; Gan, TJ; Gandhi, S; Gill, S; Gonzales, EJ; Goad, MR; Gunther, MN; Helled, R; Hojjatpanah, S; Howell, SB; Jackman, J; Jenkins, JS; Jenkins, JM; Jensen, ELN; Kennedy, GM; Latham, DW; Law, N; Lendl, M; Lozovsky, M; Mann, AW; Moyano, M; McCormac, J; Meru, F; Mordasini, C; Osborn, A; Pollacco, D; Queloz, D; Raynard, L; Ricker, GR; Rowden, P; Santerne, A; Schlieder, JE; Seager, S; Sha, LZ; Tan, TG; Tilbrook, RH; Ting, E; Udry, S; Vanderspek, R; Watson, CA; West, RG; Wilson, PA; Winn, JN; Wheatley, P; Villasenor, JN; Vines, JI; Zhan, ZC				Armstrong, David J.; Lopez, Theo A.; Adibekyan, Vardan; Booth, Richard A.; Bryant, Edward M.; Collins, Karen A.; Deleuil, Magali; Emsenhuber, Alexandre; Huang, Chelsea X.; King, George W.; Lillo-Box, Jorge; Lissauer, Jack J.; Matthews, Elisabeth; Mousis, Olivier; Nielsen, Louise D.; Osborn, Hugh; Otegi, Jon; Santos, Nuno C.; Sousa, Sergio G.; Stassun, Keivan G.; Veras, Dimitri; Ziegler, Carl; Acton, Jack S.; Almenara, Jose M.; Anderson, David R.; Barrado, David; Barros, Susana C. C.; Bayliss, Daniel; Belardi, Claudia; Bouchy, Francois; Briceno, Cesar; Brogi, Matteo; Brown, David J. A.; Burleigh, Matthew R.; Casewell, Sarah L.; Chaushev, Alexander; Ciardi, David R.; Collins, Kevin I.; Colon, Knicole D.; Cooke, Benjamin F.; Crossfield, Ian J. M.; Diaz, Rodrigo F.; Mena, Elisa Delgado; Demangeon, Olivier D. S.; Dorn, Caroline; Dumusque, Xavier; Eigmueller, Philipp; Fausnaugh, Michael; Figueira, Pedro; Gan, Tianjun; Gandhi, Siddharth; Gill, Samuel; Gonzales, Erica J.; Goad, Michael R.; Gunther, Maximilian N.; Helled, Ravit; Hojjatpanah, Saeed; Howell, Steve B.; Jackman, James; Jenkins, James S.; Jenkins, Jon M.; Jensen, Eric L. N.; Kennedy, Grant M.; Latham, David W.; Law, Nicholas; Lendl, Monika; Lozovsky, Michael; Mann, Andrew W.; Moyano, Maximiliano; McCormac, James; Meru, Farzana; Mordasini, Christoph; Osborn, Ares; Pollacco, Don; Queloz, Didier; Raynard, Liam; Ricker, George R.; Rowden, Pamela; Santerne, Alexandre; Schlieder, Joshua E.; Seager, Sara; Sha, Lizhou; Tan, Thiam-Guan; Tilbrook, Rosanna H.; Ting, Eric; Udry, Stephane; Vanderspek, Roland; Watson, Christopher A.; West, Richard G.; Wilson, Paul A.; Winn, Joshua N.; Wheatley, Peter; Villasenor, Jesus Noel; Vines, Jose I.; Zhan, Zhuchang			A remnant planetary core in the hot-Neptune desert	NATURE			English	Article							EQUATION-OF-STATE; LOW-MASS STARS; GIANT PLANETS; EXTRASOLAR PLANETS; OLIGARCHIC GROWTH; ATMOSPHERIC LOSS; EVOLUTION; MODELS; CONSTRAINTS; EXOPLANETS	The interiors of giant planets remain poorly understood. Even for the planets in the Solar System, difficulties in observation lead to large uncertainties in the properties of planetary cores. Exoplanets that have undergone rare evolutionary processes provide a route to understanding planetary interiors. Planets found in and near the typically barren hot-Neptune 'desert'(1,2)(a region in mass-radius space that contains few planets) have proved to be particularly valuable in this regard. These planets include HD149026b(3), which is thought to have an unusually massive core, and recent discoveries such as LTT9779b(4)and NGTS-4b(5), on which photoevaporation has removed a substantial part of their outer atmospheres. Here we report observations of the planet TOI-849b, which has a radius smaller than Neptune's but an anomalously large mass of39.1-2.6+2.7Earth masses and a density of5.2-0.8+0.7grams per cubic centimetre, similar to Earth's. Interior-structure models suggest that any gaseous envelope of pure hydrogen and helium consists of no more than3.9-0.9+0.8 per cent of the total planetary mass. The planet could have been a gas giant before undergoing extreme mass loss via thermal self-disruption or giant planet collisions, or it could have avoided substantial gas accretion, perhaps through gap opening or late formation(6). Although photoevaporation rates cannot account for the mass loss required to reduce a Jupiter-like gas giant, they can remove a small (a few Earth masses) hydrogen and helium envelope on timescales of several billion years, implying that any remaining atmosphere on TOI-849b is likely to be enriched by water or other volatiles from the planetary interior. We conclude that TOI-849b is the remnant core of a giant planet. Observations of TOI-849b reveal a radius smaller than Neptune's but a large mass of about 40 Earth masses, indicating that the planet is the remnant core of a gas giant.	[Armstrong, David J.; Bryant, Edward M.; King, George W.; Veras, Dimitri; Anderson, David R.; Bayliss, Daniel; Brogi, Matteo; Brown, David J. A.; Cooke, Benjamin F.; Gill, Samuel; Jackman, James; Kennedy, Grant M.; McCormac, James; Meru, Farzana; Osborn, Ares; Pollacco, Don; West, Richard G.; Wilson, Paul A.; Wheatley, Peter] Univ Warwick, Ctr Exoplanets & Habitabil, Coventry, W Midlands, England; [Armstrong, David J.; Bryant, Edward M.; King, George W.; Veras, Dimitri; Anderson, David R.; Bayliss, Daniel; Brogi, Matteo; Brown, David J. A.; Cooke, Benjamin F.; Gandhi, Siddharth; Gill, Samuel; Jackman, James; Kennedy, Grant M.; McCormac, James; Meru, Farzana; Osborn, Ares; Pollacco, Don; West, Richard G.; Wilson, Paul A.; Wheatley, Peter] Univ Warwick, Dept Phys, Coventry, W Midlands, England; [Lopez, Theo A.; Deleuil, Magali; Mousis, Olivier; Osborn, Hugh; Santerne, Alexandre] Aix Marseille Univ, CNRS, CNES, LAM, Marseilles, France; [Adibekyan, Vardan; Santos, Nuno C.; Sousa, Sergio G.; Barros, Susana C. C.; Mena, Elisa Delgado; Demangeon, Olivier D. S.; Figueira, Pedro; Hojjatpanah, Saeed] Univ Porto, Inst Astrofis & Ciencias Espaco, CAUP, Porto, Portugal; [Booth, Richard A.] Univ Cambridge, Inst Astron, Cambridge, England; [Collins, Karen A.] Harvard & Smithsonian, Ctr Astrophys, Cambridge, MA USA; [Emsenhuber, Alexandre] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Emsenhuber, Alexandre; Mordasini, Christoph] Univ Bern, Phys Inst, Bern, Switzerland; [Huang, Chelsea X.; Matthews, Elisabeth; Crossfield, Ian J. M.; Fausnaugh, Michael; Gunther, Maximilian N.; Ricker, George R.; Seager, Sara; Sha, Lizhou; Vanderspek, Roland; Villasenor, Jesus Noel] MIT, Dept Phys, Cambridge, MA 02139 USA; [Huang, Chelsea X.; Matthews, Elisabeth; Crossfield, Ian J. M.; Fausnaugh, Michael; Gunther, Maximilian N.; Ricker, George R.; Seager, Sara; Sha, Lizhou; Vanderspek, Roland; Villasenor, Jesus Noel] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Lillo-Box, Jorge; Barrado, David] CSIC, INTA, Ctr Astrobiol, Dept Astrofis, Madrid, Spain; [Lissauer, Jack J.; Howell, Steve B.; Jenkins, Jon M.; Ting, Eric] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Nielsen, Louise D.; Otegi, Jon; Bouchy, Francois; Dumusque, Xavier; Lendl, Monika; Udry, Stephane] Univ Geneva, Observ Astron, Versoix, Switzerland; [Otegi, Jon; Dorn, Caroline; Helled, Ravit; Lozovsky, Michael] Univ Zurich, Inst Computat Sci, Zurich, Switzerland; [Santos, Nuno C.; Hojjatpanah, Saeed] Univ Porto, Fac Ciencias, Dept Fis & Astron, Porto, Portugal; [Stassun, Keivan G.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Stassun, Keivan G.] Fisk Univ, Dept Phys, Nashville, TN USA; [Ziegler, Carl] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON, Canada; [Acton, Jack S.; Belardi, Claudia; Burleigh, Matthew R.; Casewell, Sarah L.; Goad, Michael R.; Raynard, Liam; Tilbrook, Rosanna H.] Univ Leicester, Sch Phys & Astron, Leicester, Leics, England; [Almenara, Jose M.] Univ Grenoble Alpes, CNRS, IPAG, Grenoble, France; [Briceno, Cesar] Cerro Tololo Interamer Observ, La Serena, Chile; [Brogi, Matteo] INAF Osservatorio Astrofis Torino, Pino Torinese, Italy; [Chaushev, Alexander] TU Berlin, Ctr Astron & Astrophys, Berlin, Germany; [Ciardi, David R.] CALTECH, IPAC NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Collins, Kevin I.] George Mason Univ, Fairfax, VA 22030 USA; [Colon, Knicole D.; Schlieder, Joshua E.] NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Code 667, Greenbelt, MD USA; [Diaz, Rodrigo F.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Diaz, Rodrigo F.] Univ Buenos Aires, CONICET, IAFE, Buenos Aires, DF, Argentina; [Diaz, Rodrigo F.] Int Ctr Adv Studies, Campus Miguelente, Buenos Aires, DF, Argentina; [Diaz, Rodrigo F.] UNSAM, ECyT, ICIFI, CONICET, Campus Miguelente, Buenos Aires, DF, Argentina; [Eigmueller, Philipp] German Aerosp Ctr, Inst Planetary Res, Berlin, Germany; [Figueira, Pedro] European Southern Observ, Santiago, Chile; [Gan, Tianjun] Tsinghua Univ, Dept Astron, Beijing, Peoples R China; [Gan, Tianjun] Tsinghua Univ, Tsinghua Ctr Astrophys, Beijing, Peoples R China; [Gonzales, Erica J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Jenkins, James S.; Vines, Jose I.] Univ Chile, Dept Astron, Santiago, Chile; [Jenkins, James S.] Ctr Astrofis & Tecnol Afines, Santiago, Chile; [Jensen, Eric L. N.] Swarthmore Coll, Dept Phys & Astron, Swarthmore, PA 19081 USA; [Latham, David W.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Law, Nicholas; Mann, Andrew W.] Univ North Carolina Chapel Hill, Dept Phys & Astron, Chapel Hill, NC USA; [Lendl, Monika] Austrian Acad Sci, Space Res Inst, Graz, Austria; [Moyano, Maximiliano] Univ Catolica Norte, Inst Astron, Antofagasta, Chile; [Queloz, Didier] Univ Cambridge, Cavendish Lab, Cambridge, England; [Rowden, Pamela] Open Univ, Sch Phys Sci, Milton Keynes, Bucks, England; [Seager, Sara; Zhan, Zhuchang] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Seager, Sara] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Tan, Thiam-Guan] Perth Exoplanet Survey Telescope, Perth, WA, Australia; [Watson, Christopher A.] Queens Univ Belfast, Astrophys Res Ctr, Belfast, Antrim, North Ireland; [Winn, Joshua N.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	University of Warwick; University of Warwick; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universidade do Porto; University of Cambridge; Smithsonian Institution; University of Arizona; University of Bern; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Geneva; University of Zurich; Universidade do Porto; Vanderbilt University; Fisk University; University of Toronto; University of Leicester; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); National Optical Astronomy Observatory; Istituto Nazionale Astrofisica (INAF); Technical University of Berlin; California Institute of Technology; George Mason University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto de Astronomia y Fisica del Espacio (IAFE); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Helmholtz Association; German Aerospace Centre (DLR); European Southern Observatory; Tsinghua University; Tsinghua University; University of California System; University of California Santa Cruz; Universidad de Chile; Swarthmore College; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Austrian Academy of Sciences; Universidad Catolica del Norte; University of Cambridge; Open University - UK; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Queens University Belfast; Princeton University	Armstrong, DJ (corresponding author), Univ Warwick, Ctr Exoplanets & Habitabil, Coventry, W Midlands, England.; Armstrong, DJ (corresponding author), Univ Warwick, Dept Phys, Coventry, W Midlands, England.	d.j.armstrong@warwick.ac.uk	Zhan, Zhuchang/AAL-2256-2021; Adibekyan, Vardan/AAD-6544-2022; Lillo-Box, Jorge/I-2841-2015; Navascues, David Barrado/C-1439-2017; Sousa, Sérgio G./I-7466-2013; Brogi, Matteo/GWM-8542-2022; Mena, Elisa Delgado/M-9178-2013; Briceno, Cesar/AGQ-0172-2022; Günther, Maximilian N./ABC-5730-2021; Figueira, Pedro/J-4916-2013; Anderson, David/ADM-7446-2022; Casewell, Sarah/AAJ-7254-2021; Santos, Nuno C/E-9957-2011; Lillo-Box, Jorge/A-2202-2019; Moyano, Maximiliano/AAM-9994-2020; Santerne, Alexandre/M-9265-2013	Zhan, Zhuchang/0000-0002-4142-1800; Adibekyan, Vardan/0000-0002-0601-6199; Lillo-Box, Jorge/0000-0003-3742-1987; Navascues, David Barrado/0000-0002-5971-9242; Sousa, Sérgio G./0000-0001-9047-2965; Mena, Elisa Delgado/0000-0003-4434-2195; Briceno, Cesar/0000-0001-7124-4094; Günther, Maximilian N./0000-0002-3164-9086; Figueira, Pedro/0000-0001-8504-283X; Anderson, David/0000-0001-7416-7522; Santos, Nuno C/0000-0003-4422-2919; Lillo-Box, Jorge/0000-0003-3742-1987; Moyano, Maximiliano/0000-0002-7927-9555; Armstrong, David/0000-0002-5080-4117; Jensen, Eric/0000-0002-4625-7333; Queloz, Didier/0000-0002-3012-0316; udry, Stephane/0000-0001-7576-6236; Lozovsky, Michael/0000-0001-5451-3221; Gan, Tianjun/0000-0002-4503-9705; Emsenhuber, Alexandre/0000-0002-8811-1914; Mann, Andrew/0000-0003-3654-1602; Gandhi, Siddharth/0000-0001-9552-3709; Bryant, Edward/0000-0001-7904-4441; Gonzales, Erica/0000-0002-9329-2190; Helled, Ravit/0000-0001-5555-2652; Ciardi, David/0000-0002-5741-3047; Wheatley, Peter/0000-0003-1452-2240; Raynard, Liam/0000-0001-6472-9122; Santerne, Alexandre/0000-0002-3586-1316; Mordasini, Christoph/0000-0002-1013-2811; Sha, Lizhou/0000-0001-5401-8079; Burleigh, Matthew/0000-0003-0684-7803; Collins, Kevin/0000-0003-2781-3207; Bouchy, Francois/0000-0002-7613-393X; Osborn, Ares/0000-0002-5899-7750; Rowden, Pamela/0000-0002-4829-7101; Barros, Susana/0000-0003-2434-3625; Dyregaard Nielsen, Louise/0000-0002-5254-2499; Huang, Xu/0000-0003-0918-7484; Veras, Dimitri/0000-0001-8014-6162; Vines, Jose/0000-0002-1896-2377; West, Richard/0000-0001-6604-5533; Latham, David/0000-0001-9911-7388; Kennedy, Grant/0000-0001-6831-7547; Goad, Michael/0000-0002-2908-7360	TESS missions; STFC [ST/R00384X/1, ST/S000631/1, ST/P003850/1, ST/T000406/1, ST/S002642/1, ST/R003726/1, ST/M001962/1, ST/P000495/1, 1622607, ST/S000623/1] Funding Source: UKRI	TESS missions; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This paper includes data collected by the TESS missions, which are publicly available from MAST. Funding for the TESS mission is provided by NASA's Science Mission directorate. We acknowledge the use of public TESS Alert data from pipelines at the TESS Science Office and at the TESS Science Processing Operations Center. Resources supporting this work were provided by the NASA High-End Computing (HEC) Program through the NASA Advanced Supercomputing (NAS) Division at Ames Research Center for the production of the SPOC data products. This research made use of the Exoplanet Follow-up Observation Program website and the NASA Exoplanet Archive, which are operated by the California Institute of Technology, under contract with the National Aeronautics and Space Administration under the Exoplanet Exploration Program. This work makes use of observations from the LCOGT network and is based in part on observations collected at the European Organisation for Astronomical Research in the Southern Hemisphere under ESO programme IDs 1102.C-0249 and P103.C-0449. Some of the observations presented in the paper used the High-Resolution Imaging instrument Zorro at Gemini South (programme ID GS-2019B-Q-111). Zorro was funded by the NASA Exoplanet Exploration Program and built at the NASA Ames Research Center by S.B.H., N. Scott, E. P. Horch and E. Quigley. D.J.A., D.V. and S.L.C. acknowledge support from the STFC via Ernest Rutherford Fellowships ST/R00384X/1, ST/P003850/1 and ST/R003726/1, respectively. M.B. and S.Gandhi acknowledge support from the STFC research grant ST/S000631/1. G.M.K. is supported by the Royal Society as a Royal Society University Research Fellow. F.M. acknowledges support from a Royal Society Dorothy Hodgkin Fellowship. K.G.S. acknowledges partial support from NASA grant 17-XRP17 2-0024. C.Z. is supported by a Dunlap Fellowship at the Dunlap Institute for Astronomy and Astrophysics, funded through an endowment established by the Dunlap family and the University of Toronto. A.W.M. was supported by NASA grant 80NSSC19K0097 to the University of North Carolina at Chapel Hill. D.J.A.B. acknowledges support from the UK Space Agency. C.X.H. and M.N.G. acknowledge support from the Juan Carlos Torres Fellowship. This work was financed by FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the COMPETE 2020 Operational Programme for Competitiveness and Internationalisation (POCI) and by Portuguese funds through FCT (FundacAo para a Ciencia e a Tecnologia) in the framework of projects UID/FIS/04434/2019; PTDC/FIS-AST/32113/2017 and POCI-01-0145-FEDER-032113; PTDC/FIS-AST/28953/2017 and POCI-01-0145-FEDER-028953. S.G.S., V.A., S.C.C.B. and O.D.S.D. acknowledge support from FCT through Investigador FCT contracts IF/00028/2014/CP1215/CT0002, IF/00650/2015/CP1273/CT0001, IF/01312/2014/CP1215/CT0004 and DL 57/2016/CP1364/CT0004. S.H. acknowledges support from fellowships PD/BD/128119/2016 funded by FCT (Portugal). Work by J.N.W. was partly funded by the Heising-Simons Foundation. C.A.W. acknowledges support from UK Science Technology and Facility Council grant ST/P000312/1. J.L.-B. and D. Barrado are funded by the Spanish State Research Agency (AEI) Projects ESP2017-87676-C5-1-R and MDM-2017-0737 Unidad de Excelencia Maria de Maeztu - Centro de Astrobiologia (INTA-CSIC). J.S.J. acknowledges funding by Fondecyt through grant 1161218 and partial support from CATA-Basal (PB06, Conicyt). J.I.V. acknowledges support from CONICYT-PFCHA/Doctorado Nacional-21191829, Chile.; The French group acknowledges financial support from the French Programme National de Planetologie (PNP, INSU). F.M. acknowledges support from the Royal Society Dorothy Hodgkin Fellowship. C.M. and A.E. acknowledge support from the Swiss National Science Foundation under grant BSSGI0_155816 "PlanetsInTime". Parts of this work have been carried out within the framework of the NCCR PlanetS supported by the Swiss National Science Foundation.	Adibekyan VZ, 2015, MON NOT R ASTRON SOC, V450, P1900, DOI 10.1093/mnras/stv716; Adibekyan VZ, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219401; Allard F, 2012, PHILOS T R SOC A, V370, P2765, DOI 10.1098/rsta.2011.0269; Andrews SM, 2010, ASTROPHYS J, V723, P1241, DOI 10.1088/0004-637X/723/2/1241; Ansdell M, 2018, ASTROPHYS J, V859, DOI 10.3847/1538-4357/aab890; Armstrong DJ, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201525889; Baraffe I, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425481; Baranne A, 1996, ASTRON ASTROPHYS SUP, V119, P373, DOI 10.1051/aas:1996251; Benitez-Llambay P, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015774; Bodenheimer P, 2000, ICARUS, V143, P2, DOI 10.1006/icar.1999.6246; BODENHEIMER P, 1986, ICARUS, V67, P391, DOI 10.1016/0019-1035(86)90122-3; Bodenheimer P, 2018, ASTROPHYS J, V868, DOI 10.3847/1538-4357/aae928; Boisse I, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201014354; Broeg CH, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117038; Brouwers MG, 2018, ASTRON ASTROPHYS, V611, DOI 10.1051/0004-6361/201731824; BROWN AGA, 2018, ASTRON ASTROPHYS, V616, DOI DOI 10.1051/0004-6361/201833051; Brown TM, 2013, PUBL ASTRON SOC PAC, V125, P1031, DOI 10.1086/673168; Cameron AC, 2018, MON NOT R ASTRON SOC, V476, P2542, DOI 10.1093/mnras/sty292; Chadney JM, 2015, ICARUS, V250, P357, DOI 10.1016/j.icarus.2014.12.012; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Claret A, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116451; Clarke CJ, 2001, MON NOT R ASTRON SOC, V328, P485, DOI 10.1046/j.1365-8711.2001.04891.x; Coleman GAL, 2014, MON NOT R ASTRON SOC, V445, P479, DOI 10.1093/mnras/stu1715; Collins KA, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/153/2/77; Connolly JAD, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002540; Cutri R. M., 2013, VIZIER ONLINE DATA C, P2328; Delrez L, 2016, MON NOT R ASTRON SOC, V458, P4025, DOI 10.1093/mnras/stw522; Diaz RF, 2014, MON NOT R ASTRON SOC, V441, P983, DOI 10.1093/mnras/stu601; Dorn C, 2017, ASTRON ASTROPHYS, V597, DOI 10.1051/0004-6361/201628749; Dotter A, 2008, ASTROPHYS J SUPPL S, V178, P89, DOI 10.1086/589654; Erkaev NV, 2007, ASTRON ASTROPHYS, V472, P329, DOI 10.1051/0004-6361:20066929; Fendyke SM, 2014, MON NOT R ASTRON SOC, V437, P96, DOI 10.1093/mnras/stt1867; Ford EB, 2006, ASTROPHYS J, V652, pL137, DOI 10.1086/510235; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; FRIED DL, 1978, J OPT SOC AM, V68, P1651, DOI 10.1364/JOSA.68.001651; Hamer JH, 2019, ASTRON J, V158, DOI 10.3847/1538-3881/ab3c56; Henden A.A., 2015, AM ASTRONOMICAL SOC, V225, P336; Hormuth F., 2008, Journal of Physics: Conference Series, V131, DOI 10.1088/1742-6596/131/1/012051; Howell SB, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/19; Iaroslavitz E, 2007, ICARUS, V187, P600, DOI 10.1016/j.icarus.2006.10.008; IDA S, 1993, ICARUS, V106, P210, DOI 10.1006/icar.1993.1167; Ikoma M, 2006, ASTROPHYS J, V650, P1150, DOI 10.1086/507088; Inaba S, 2003, ASTRON ASTROPHYS, V410, P711, DOI 10.1051/0004-6361:20031248; Ivanov PB, 2004, MON NOT R ASTRON SOC, V347, P437, DOI 10.1111/j.1365-2966.2004.07238.x; Jackson AP, 2012, MON NOT R ASTRON SOC, V422, P2024, DOI 10.1111/j.1365-2966.2012.20657.x; Janson M, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/156; Jenkins J, 2019, AAS DIVISION EXTREME, V51, P10307; Jenkins JM, 2016, PROC SPIE, V9913, DOI 10.1117/12.2233418; Jensen E., 2013, ASCL1306007; Jin S, 2018, ASTROPHYS J, V853, DOI 10.3847/1538-4357/aa9f1e; Jin S, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/1/65; Kane SR, 2017, ASTROPHYS J LETT, V839, DOI 10.3847/2041-8213/aa6bf2; King GW, 2018, MON NOT R ASTRON SOC, V478, P1193, DOI 10.1093/mnras/sty1110; Kipping DM, 2014, MON NOT R ASTRON SOC, V440, P2164, DOI 10.1093/mnras/stu318; Kipping DM, 2010, MON NOT R ASTRON SOC, V408, P1758, DOI 10.1111/j.1365-2966.2010.17242.x; Kubyshkina D, 2018, ASTRON ASTROPHYS, V619, DOI 10.1051/0004-6361/201833737; Kubyshkina D, 2018, ASTROPHYS J LETT, V866, DOI 10.3847/2041-8213/aae586; Kurucz R.L., 1993, SYNTHE SPECTRUM SYNT; Lammer H, 2003, ASTROPHYS J, V598, pL121, DOI 10.1086/380815; Laughlin G, 2002, ASTRON J, V124, P592, DOI 10.1086/341173; Lee EJ, 2019, ASTROPHYS J, V878, DOI 10.3847/1538-4357/ab1b40; Lee EJ, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/1/41; Leleu A, 2019, ASTRON ASTROPHYS, V624, DOI 10.1051/0004-6361/201834901; Leleu A, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201630073; Lillo-Box J, 2018, ASTRON ASTROPHYS, V609, DOI 10.1051/0004-6361/201730652; Lillo-Box J, 2018, ASTRON ASTROPHYS, V618, DOI 10.1051/0004-6361/201833312; Lillo-Box J, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201423497; Lillo-Box J, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322001; Lillo-Box J, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219631; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lozovsky M, 2018, ASTROPHYS J, V866, DOI 10.3847/1538-4357/aadd09; Lozovsky M, 2017, ASTROPHYS J, V836, DOI 10.3847/1538-4357/836/2/227; LYNDENBELL D, 1974, MON NOT R ASTRON SOC, V168, P603, DOI 10.1093/mnras/168.3.603; Madhusudhan N, 2009, ASTROPHYS J, V693, P784, DOI 10.1088/0004-637X/693/1/784; Matsuyama I, 2003, ASTROPHYS J, V582, P893, DOI 10.1086/344638; Mayor M., 2003, MESSENGER, V114, P20; McCormac J, 2013, PUBL ASTRON SOC PAC, V125, P548, DOI 10.1086/670940; MIZUNO H, 1978, PROG THEOR PHYS, V60, P699, DOI 10.1143/PTP.60.699; Mordasini C, 2009, ASTRON ASTROPHYS, V501, P1139, DOI 10.1051/0004-6361/200810301; Mordasini C., 2018, HDB EXOPLANETS, P2425; Munari U, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/5/81; NAKAMOTO T, 1994, ASTROPHYS J, V421, P640, DOI 10.1086/173678; Ohtsuki K, 2002, ICARUS, V155, P436, DOI 10.1006/icar.2001.6741; Owen JE, 2018, MON NOT R ASTRON SOC, V479, P5012, DOI 10.1093/mnras/sty1760; Paardekooper SJ, 2011, MON NOT R ASTRON SOC, V410, P293, DOI 10.1111/j.1365-2966.2010.17442.x; Pepe F., 2002, MESSENGER, V110, P9; Piso AMA, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/82; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Rafikov RR, 2006, ASTROPHYS J, V648, P666, DOI 10.1086/505695; Ricker GR, 2015, J ASTRON TELESC INST, V1, DOI 10.1117/1.JATIS.1.1.014003; Santerne A, 2015, MON NOT R ASTRON SOC, V451, P2337, DOI 10.1093/mnras/stv1080; Santos NC, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321286; Sato B, 2005, ASTROPHYS J, V633, P465, DOI 10.1086/449306; SAUMON D, 1995, ASTROPHYS J SUPPL S, V99, P713, DOI 10.1086/192204; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Schonrich R, 2019, MON NOT R ASTRON SOC, V487, P3568, DOI 10.1093/mnras/stz1451; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Shi Y, 2019, SPECTROCHIM ACTA A, V209, P8, DOI 10.1016/j.saa.2018.10.033; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Sneden C, 1973, THESIS; Sousa SG, 2007, ASTRON ASTROPHYS, V469, P783, DOI 10.1051/0004-6361:20077288; Sousa SG, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201322290; Southworth J, 2008, MON NOT R ASTRON SOC, V386, P1644, DOI 10.1111/j.1365-2966.2008.13145.x; Stassun KG, 2019, ASTRON J, V158, DOI 10.3847/1538-3881/ab3467; Stassun KG, 2018, ASTROPHYS J, V862, DOI 10.3847/1538-4357/aacafc; Stassun KG, 2018, ASTRON J, V155, DOI 10.3847/1538-3881/aa998a; Stassun KG, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa5df3; Stassun KG, 2016, ASTRON J, V152, DOI 10.3847/0004-6256/152/6/180; Strehl K., 1902, ASTRON NACHR, V158, P89, DOI 10.1002/asna.19021580604; Szabo GM, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L44; Thommes EW, 2003, ICARUS, V161, P431, DOI 10.1016/S0019-1035(02)00043-X; Tinetti G, 2018, EXP ASTRON, V46, P135, DOI 10.1007/s10686-018-9598-x; Tokovinin A, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aaa7d9; Torres G, 2010, ASTRON ASTROPHYS REV, V18, P67, DOI 10.1007/s00159-009-0025-1; Triaud A. H. M. J, 2018, HDB EXOPLANETS, P1375, DOI DOI 10.1007/978-3-319-55333-7_2; Tychoniec L, 2018, ASTROPHYS J SUPPL S, V238, DOI 10.3847/1538-4365/aaceae; Van Eylen V, 2019, ASTRON J, V157, DOI 10.3847/1538-3881/aaf22f; Vanderburg A, 2014, PUBL ASTRON SOC PAC, V126, P948, DOI 10.1086/678764; Vazan A, 2013, MON NOT R ASTRON SOC, V434, P3283, DOI 10.1093/mnras/stt1248; Venuti L, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201629537; Veras D, 2019, MON NOT R ASTRON SOC, V489, P2941, DOI 10.1093/mnras/stz2339; Vick M, 2019, MON NOT R ASTRON SOC, V484, P5645, DOI 10.1093/mnras/stz354; Vick M, 2018, MON NOT R ASTRON SOC, V476, P482, DOI 10.1093/mnras/sty225; WATSON AJ, 1981, ICARUS, V48, P150, DOI 10.1016/0019-1035(81)90101-9; West RG, 2019, MON NOT R ASTRON SOC, V486, P5094, DOI 10.1093/mnras/stz1084; Wheatley PJ, 2018, MON NOT R ASTRON SOC, V475, P4476, DOI 10.1093/mnras/stx2836; Winn JN, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa7b7c; Wu YQ, 2018, ASTRON J, V155, DOI 10.3847/1538-3881/aaa970; Xie JW, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/25; Zeng L, 2013, PUBL ASTRON SOC PAC, V125, P227, DOI 10.1086/669163; Ziegler C, 2020, ASTRON J, V159, DOI 10.3847/1538-3881/ab55e9	140	45	45	3	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					39	+		10.1038/s41586-020-2421-7	http://dx.doi.org/10.1038/s41586-020-2421-7			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32612222	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000544773600006
J	Arp, TB; Kistner-Morris, J; Aji, V; Cogdell, RJ; van Grondelle, R; Gabor, NM				Arp, Trevor B.; Kistner-Morris, Jed; Aji, Vivek; Cogdell, Richard J.; van Grondelle, Rienk; Gabor, Nathaniel M.			Quieting a noisy antenna reproduces photosynthetic light-harvesting spectra	SCIENCE			English	Article							ENERGY-TRANSFER; MODEL; PRINCIPLES; DESIGN; LEAVES	Photosynthesis achieves near unity light-harvesting quantum efficiency yet it remains unknown whether there exists a fundamental organizing principle giving rise to robust light harvesting in the presence of dynamic light conditions and noisy physiological environments. Here, we present a noise-canceling network model that relates noisy physiological conditions, power conversion efficiency, and the resulting absorption spectra of photosynthetic organisms. Using light conditions in full solar exposure, light filtered by oxygenic phototrophs, and light filtered under seawater, we derived optimal absorption characteristics for efficient solar power conversion. We show how light-harvesting antennae can be tuned to maximize power conversion efficiency by minimizing excitation noise, thus providing a unified theoretical basis for the observed wavelength dependence of absorption in green plants, purple bacteria, and green sulfur bacteria.	[Arp, Trevor B.; Kistner-Morris, Jed; Gabor, Nathaniel M.] Univ Calif Riverside, Lab Quantum Mat Optoelect, Riverside, CA 92521 USA; [Arp, Trevor B.; Kistner-Morris, Jed; Aji, Vivek; Gabor, Nathaniel M.] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Cogdell, Richard J.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G128QQ, Lanark, Scotland; [Cogdell, Richard J.; van Grondelle, Rienk; Gabor, Nathaniel M.] Canadian Inst Adv Res, Toronto, ON M5G 1M1, Canada; [van Grondelle, Rienk] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands	University of California System; University of California Riverside; University of California System; University of California Riverside; University of Glasgow; Canadian Institute for Advanced Research (CIFAR); Vrije Universiteit Amsterdam	Gabor, NM (corresponding author), Univ Calif Riverside, Lab Quantum Mat Optoelect, Riverside, CA 92521 USA.; Gabor, NM (corresponding author), Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA.; Cogdell, RJ (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G128QQ, Lanark, Scotland.; Cogdell, RJ; van Grondelle, R; Gabor, NM (corresponding author), Canadian Inst Adv Res, Toronto, ON M5G 1M1, Canada.; van Grondelle, R (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands.	richard.cogdell@glasgow.ac.uk; r.van.grondelle@vu.nl; nathaniel.gabor@ucr.edu		Arp, Trevor/0000-0002-0754-9579; Gabor, Nathaniel/0000-0002-0351-2787; Kistner-Morris, Jedediah/0000-0002-1572-4779; Cogdell, Richard/0000-0003-2119-6607; van grondelle, rienk/0000-0002-7282-5226	Air Force Office of Scientific Research Young Investigator Program (YIP) award [FA9550-16-1-0216]; National Science Foundation Division of Materials Research CAREER award [1651247]; U.S. Department of the Navy Historically Black Colleges, Universities and Minority Serving Institutions (HBCU/MI) award [N00014-19-1-2574]; Cottrell Scholar Award; Canadian Institute for Advanced Research (CIFAR) Azrieli Global Scholar Award; Fellowships and Internships in Extremely Large Data Sets (FIELDS) program, a NASA MUREP Institutional Research Opportunity (MIRO) program [NNX15AP99A]; Photosynthetic Antenna Research Center, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]; Biotechnological and Biological Sciences Research Council (BBSRC); Royal Netherlands Academy of Arts and Sciences; Canadian Institute for Advanced Research (CIFAR); BBSRC [BB/N016734/1] Funding Source: UKRI	Air Force Office of Scientific Research Young Investigator Program (YIP) award(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation Division of Materials Research CAREER award; U.S. Department of the Navy Historically Black Colleges, Universities and Minority Serving Institutions (HBCU/MI) award; Cottrell Scholar Award; Canadian Institute for Advanced Research (CIFAR) Azrieli Global Scholar Award(Canadian Institute for Advanced Research (CIFAR)); Fellowships and Internships in Extremely Large Data Sets (FIELDS) program, a NASA MUREP Institutional Research Opportunity (MIRO) program; Photosynthetic Antenna Research Center, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Biotechnological and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Netherlands Academy of Arts and Sciences; Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	T.B.A., J. K.-M., and N.M.G were supported by the Air Force Office of Scientific Research Young Investigator Program (YIP) award no. FA9550-16-1-0216, National Science Foundation Division of Materials Research CAREER award no. 1651247, and the U.S. Department of the Navy Historically Black Colleges, Universities and Minority Serving Institutions (HBCU/MI) award no. N00014-19-1-2574. N.M.G. acknowledges support from a Cottrell Scholar Award and a Canadian Institute for Advanced Research (CIFAR) Azrieli Global Scholar Award. T.B.A. acknowledges support from the Fellowships and Internships in Extremely Large Data Sets (FIELDS) program, a NASA MUREP Institutional Research Opportunity (MIRO) program grant no. NNX15AP99A. R.J.C. gratefully acknowledges support from the Photosynthetic Antenna Research Center, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award no. DE-SC 0001035 and the Biotechnological and Biological Sciences Research Council (BBSRC). R.v.G. was supported by the Royal Netherlands Academy of Arts and Sciences and the Canadian Institute for Advanced Research (CIFAR).	Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Andrews BW, 2006, PLOS COMPUT BIOL, V2, P1407, DOI 10.1371/journal.pcbi.0020154; [Anonymous], 2002, PHOTOSYNTHETICA; Arp TB, 2016, NANO LETT, V16, P7461, DOI 10.1021/acs.nanolett.6b03136; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Banavar JR, 2000, PHYS REV LETT, V84, P4745, DOI 10.1103/PhysRevLett.84.4745; Bohn S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.088702; Borrego CM, 1999, PHOTOSYNTH RES, V60, P257, DOI 10.1023/A:1006230820007; BRUNE DC, 1987, BIOCHEMISTRY-US, V26, P8644, DOI 10.1021/bi00400a023; BUCY RS, 1967, J MATH ANAL APPL, V20, P1, DOI 10.1016/0022-247X(67)90101-1; Buiteveld H., 1994, P SOC PHOTO-OPT INS, V2258, P174, DOI DOI 10.1117/12.190060; Bumba L, 2004, PHOTOSYNTHETICA, V42, P193, DOI 10.1023/B:PHOT.0000040590.10919.02; Clarkson P.M., 2017, OPTIMAL ADAPTIVE SIG; Cogdell RJ, 2003, FEBS LETT, V555, P35, DOI 10.1016/S0014-5793(03)01102-5; Coletta T., 2019, ARXIV180709048V2MATH; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; De Ridder D, 2014, NEUROSCI BIOBEHAV R, V44, P16, DOI 10.1016/j.neubiorev.2013.03.021; Dengel S, 2015, BIOGEOSCIENCES, V12, P4195, DOI 10.5194/bg-12-4195-2015; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; Du H., 2007, PHOTOCHEM PHOTOBIOL, V68, P2; Durand M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016116; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FLEMING GR, 1994, PHYS TODAY, V47, P48, DOI 10.1063/1.881413; Haehne H, 2018, EPL-EUROPHYS LETT, V121, DOI 10.1209/0295-5075/121/30001; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jenkins PP, 2014, IEEE J PHOTOVOLT, V4, P202, DOI 10.1109/JPHOTOV.2013.2283578; Kanitscheider I, 2015, P NATL ACAD SCI USA, V112, pE6973, DOI 10.1073/pnas.1508738112; Katifori E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048704; Kato M, 2014, CHEM SOC REV, V43, P6485, DOI 10.1039/c4cs00031e; Kharcheva A.V., 2016, WDS16 P CONTR PAP PH, P214; Kiang NY, 2007, ASTROBIOLOGY, V7, P222, DOI 10.1089/ast.2006.0105; Klickstein I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15145; KOU LH, 1993, APPL OPTICS, V32, P3531, DOI 10.1364/AO.32.003531; Kruger TPJ, 2016, PHYSICA B, V480, P7, DOI 10.1016/j.physb.2015.08.005; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Laisk A, 2014, BBA-BIOENERGETICS, V1837, P315, DOI 10.1016/j.bbabio.2013.12.001; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Liang M, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2016-60845-8; Mirkovic T., 2016, CHEM REV, V117, P249, DOI [10.1021/acs.chemrev.6b00002, DOI 10.1021/acs.chemrev.6b00002, DOI 10.1016/j.bbabio.2007.07.006]; Nesti T, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.258301; Olsen J. M., 1988, GREEN PHOTOSYNTHETIC, P315; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Romero E, 2017, NATURE, V543, P355, DOI 10.1038/nature22012; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Schafer B, 2018, NAT ENERGY, V3, P119, DOI 10.1038/s41560-017-0058-z; Schmietendorf K, 2017, EUR PHYS J B, V90, DOI 10.1140/epjb/e2017-80352-8; Scholes GD, 2017, NATURE, V543, P647, DOI 10.1038/nature21425; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/NCHEM.1145, 10.1038/nchem.1145]; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; VANGRONDELLE R, 1985, BIOCHIM BIOPHYS ACTA, V811, P147, DOI 10.1016/0304-4173(85)90017-5; VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X; WATSON AJ, 1983, TELLUS B, V35, P284, DOI 10.1111/j.1600-0889.1983.tb00031.x; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Wraight C. A., 2009, PURPLE PHOTOTROPHIC, P379; Xiao YD, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042804; Yan G, 2015, NAT PHYS, V11, P779, DOI [10.1038/NPHYS3422, 10.1038/nphys3422]	57	19	19	8	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1490	+		10.1126/science.aba6630	http://dx.doi.org/10.1126/science.aba6630			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32587021	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000545264600044
J	Dyer, C				Dyer, Clare			Vulnerable children were harmed by charity's "systemic" failures, inquiry finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, CHAR COMM ENGL WAL	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2020	369								m2537	10.1136/bmj.m2537	http://dx.doi.org/10.1136/bmj.m2537			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI3HF	32586851				2022-12-28	WOS:000583173400010
J	Lee, JH; Park, CK; Chen, G; Han, QJ; Xie, RG; Liu, T; Ji, RR; Lee, SY				Lee, Jun-Ho; Park, Chul-Kyu; Chen, Gang; Han, Qingjian; Xie, Rou-Gang; Liu, Tong; Ji, Ru-Rong; Lee, Seok-Yong			RETRACTION: A Monoclonal Antibody that Targets a Na(V)1.7 Channel Voltage Sensor for Pain and Itch Relief (Retraction of Vol 157, Pg 1393, 2014)	CELL			English	Retraction												ru-rong.ji@duke.edu; sylee@biochem.duke.edu	Ji, Ru-Rong/L-7070-2017	Ji, Ru-Rong/0000-0002-9355-3688				Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064	1	1	1	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1695	1695		10.1016/j.cell.2020.06.019	http://dx.doi.org/10.1016/j.cell.2020.06.019			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32589960	Green Accepted, Bronze			2022-12-28	WOS:000543822100022
J	Nelson, B				Nelson, Bryn			US healthcare workers march against racism despite the risks	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												bdnelson@nasw.org						[Anonymous], 2020, NY TIMES; Seo H., 2020, POPULAR SCI	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2020	369								m2460	10.1136/bmj.m2460	http://dx.doi.org/10.1136/bmj.m2460			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GM	32561541	Bronze			2022-12-28	WOS:000548534800007
J	Fuller, DH; Berglund, P				Fuller, Deborah H.; Berglund, Peter			Amplifying RNA Vaccine Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMMUNE-RESPONSES	There are several strategies to elicit immunity with an RNA vaccine; they all involve coaxing the host cell to replicate and translate an exogenous RNA encoding the vaccine antigen. A recent study describes a new, versatile approach.	[Fuller, Deborah H.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Berglund, Peter] HDT Bio, Seattle, WA USA	University of Washington; University of Washington Seattle	Fuller, DH (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.			Fuller, Deborah/0000-0001-7315-2441				Beissert T, 2020, MOL THER, V28, P119, DOI 10.1016/j.ymthe.2019.09.009; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; Vogel AB, 2018, MOL THER, V26, P446, DOI 10.1016/j.ymthe.2017.11.017; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; ZHOU XZ, 1995, P NATL ACAD SCI USA, V92, P3009, DOI 10.1073/pnas.92.7.3009	5	66	67	8	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2020	382	25					2469	2471		10.1056/NEJMcibr2009737	http://dx.doi.org/10.1056/NEJMcibr2009737			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9FX	32558474	Bronze			2022-12-28	WOS:000545644400017
J	Saloner, B; Parish, K; Ward, JA; DiLaura, G; Dolovich, S				Saloner, Brendan; Parish, Kalind; Ward, Julie A.; DiLaura, Grace; Dolovich, Sharon			COVID-19 Cases and Deaths in Federal and State Prisons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study describes coronavirus disease 2019 (COVID-19) case rates and deaths among federal and state prisoners and compares them with corresponding rates for the US population.	[Saloner, Brendan; Ward, Julie A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 344, Baltimore, MD 21205 USA; [Parish, Kalind; DiLaura, Grace] UCLA Law COVID 19 Bars Data Project, Los Angeles, CA USA; [Dolovich, Sharon] Univ Calif Los Angeles, Sch Med, UCLA Law COVID 19 Bars Data Project, Los Angeles, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Saloner, B (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 344, Baltimore, MD 21205 USA.	bsaloner@jhu.edu	Ward, Julie/ABB-2035-2020; Parish, Kalind/AAG-4349-2021	Ward, Julie/0000-0002-1604-349X	NICHD NIH HHS [T32 HD094687] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aspinwall C, THESE PRISONS ARE DO; Hawks Laura, 2020, JAMA INT MED; Schneider EC, 2020, NEW ENGL J MED, V383, P299, DOI 10.1056/NEJMp2014836; UCLA Law, UCLA COVID 19 BARS D; US Centers for Disease Control and Prevention (CDC), COR DIS 2019 COVID 1	5	159	162	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					602	603		10.1001/jama.2020.12528	http://dx.doi.org/10.1001/jama.2020.12528			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8HM	32639537	Green Published, Bronze			2022-12-28	WOS:000562845100025
J	Luoma, AM; Suo, SB; Williams, HL; Sharova, T; Sullivan, K; Manos, M; Bowling, P; Hodi, FS; Rahma, O; Sullivan, RJ; Boland, GM; Nowak, JA; Dougan, SK; Dougan, M; Yuan, GC; Wucherpfennig, KW				Luoma, Adrienne M.; Suo, Shengbao; Williams, Hannah L.; Sharova, Tatyana; Sullivan, Keri; Manos, Michael; Bowling, Peter; Hodi, F. Stephen; Rahma, Osama; Sullivan, Ryan J.; Boland, Genevieve M.; Nowak, Jonathan A.; Dougan, Stephanie K.; Dougan, Michael; Yuan, Guo-Cheng; Wucherpfennig, Kai W.			Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy	CELL			English	Article							T-CELLS; REGULATORY T; THERAPY; ANTI-CTLA-4; HOMEOSTASIS; IPILIMUMAB; EXPRESSION; SIGNATURES; NIVOLUMAB; COLITIS	Checkpoint blockade with antibodies specific for the PD-1 and CTLA-4 inhibitory receptors can induce durable responses in a wide range of human cancers. However, the immunological mechanisms responsible for severe inflammatory side effects remain poorly understood. Here we report a comprehensive single-cell analysis of immune cell populations in colitis, a common and severe side effect of checkpoint blockade. We observed a striking accumulation of CD8 T cells with highly cytotoxic and proliferative states and no evidence of regulatory T cell depletion. T cell receptor (TCR) sequence analysis demonstrated that a substantial fraction of colitis-associated CD8 T cells originated from tissue-resident populations, explaining the frequently early onset of colitis symptoms following treatment initiation. Our analysis also identified cytokines, chemokines, and surface receptors that could serve as therapeutic targets for colitis and potentially other inflammatory side effects of checkpoint blockade.	[Luoma, Adrienne M.; Dougan, Stephanie K.; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Luoma, Adrienne M.; Dougan, Stephanie K.; Wucherpfennig, Kai W.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Suo, Shengbao; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Suo, Shengbao; Yuan, Guo-Cheng] Harvard Med Sch, Boston, MA 02215 USA; [Williams, Hannah L.; Manos, Michael; Bowling, Peter; Hodi, F. Stephen; Rahma, Osama] Dana Farber Canc Inst Boston, Dept Med Oncol, Boston, MA 02215 USA; [Sharova, Tatyana; Sullivan, Ryan J.; Boland, Genevieve M.] Harvard Med Sch, Canc Ctr, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sharova, Tatyana; Boland, Genevieve M.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Sullivan, Keri; Dougan, Michael] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Sullivan, Keri; Dougan, Michael] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sullivan, Keri; Dougan, Michael] Harvard Med Sch, Boston, MA 02114 USA; [Manos, Michael; Bowling, Peter; Hodi, F. Stephen] Dana Farber Canc Inst, Ctr Immunooncol, Boston, MA 02115 USA; [Manos, Michael; Bowling, Peter; Hodi, F. Stephen; Wucherpfennig, Kai W.] Harvard Med Sch, Boston, MA 02115 USA; [Rahma, Osama] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Rahma, Osama] Dana Farber Harvard Canc Ctr, Boston, MA USA; [Nowak, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA.; Wucherpfennig, KW (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.; Dougan, M (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Dougan, M (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Dougan, M (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Wucherpfennig, KW (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mldougan@partners.org; kai_wucherpfennig@dfci.harvard.edu	Boland, Genevieve/AAP-2767-2021	Williams, Hannah/0000-0003-0434-3900	Team Award from the American Cancer Society [MRAT-18-113-01]; Melanoma Research Alliance [597698]; NIH [R01 CA238039, P01 CA163222, T32CA207021]; National Institutes of Health Mentored Clinical Scientist Development Award [1K08DK114563-01]; American Gastroenterological Association Research Scholars Award	Team Award from the American Cancer Society; Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Mentored Clinical Scientist Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association Research Scholars Award	This work was supported by a Team Award from the American Cancer Society (MRAT-18-113-01), the Melanoma Research Alliance (597698 to K.W.W., S.K.D., M.D., G.-C.Y., and R.J.S.), NIH grants R01 CA238039 (to K.W.W.), P01 CA163222 (to K.W.W. and F.S.H.), and T32CA207021 (to A.M.L. and K.W.W.); National Institutes of Health Mentored Clinical Scientist Development Award 1K08DK114563-01 (to M.D.); and the American Gastroenterological Association Research Scholars Award (to M.D.). We would like to thank all of the patients who participated in this study and the nursing and surgical technicians from the MGH endoscopy unit who provided care for the patients and made safe biopsy collection feasible. We would further like to thank Md Aladdin Bhuiyan, Elisa Bello, Patrick Lenehan, and Max Heckler for providing specific technical assistance and Ruben Dries for helpful discussions. We thank Susannah Phillips, J. Harrison Carmichael, and Dennie Frederick for help with clinical sample collection. We thank the Center for Cancer Genome Discovery (DFCI) for sequencing of scRNA-seq libraries.	Abu-Sbeih H, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0461-4; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Arbour KC, 2018, J CLIN ONCOL, V36, P2872, DOI 10.1200/JCO.2018.79.0006; Badran YR, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0711-0; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Coutzac C, 2017, J CROHNS COLITIS, V11, P1238, DOI 10.1093/ecco-jcc/jjx081; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dougan M, 2020, J CLIN INVEST, V130, P51, DOI 10.1172/JCI131194; Dougan M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01547; Downey SG, 2007, CLIN CANCER RES, V13, P6681, DOI 10.1158/1078-0432.CCR-07-0187; Faje AT, 2018, CANCER-AM CANCER SOC, V124, P3706, DOI 10.1002/cncr.31629; Foppen MHG, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2017-000278; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Grover S, 2019, CANCER-AM CANCER SOC, V125, P1768, DOI 10.1002/cncr.32005; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang B, 2019, CELL, V179, P1160, DOI 10.1016/j.cell.2019.10.027; Hughes MS, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0756-0; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Joosse ME, 2019, MUCOSAL IMMUNOL, V12, P21, DOI 10.1038/s41385-018-0113-5; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Langer V, 2019, J CLIN INVEST, V129, P4691, DOI 10.1172/JCI124884; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lord JD, 2010, DIGEST DIS SCI, V55, P1396, DOI 10.1007/s10620-009-0839-8; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Martin JC, 2019, CELL, V178, P1493, DOI 10.1016/j.cell.2019.08.008; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Neurath MF, 2019, NAT IMMUNOL, V20, P970, DOI 10.1038/s41590-019-0415-0; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Sergushichev A., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma A, 2019, CLIN CANCER RES, V25, P1233, DOI 10.1158/1078-0432.CCR-18-0762; Sherwood AM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002536; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Solomon BL, 2018, CANCER IMMUNOL IMMUN, V67, P1659, DOI 10.1007/s00262-018-2246-5; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suo SB, 2018, CELL REP, V25, P1436, DOI 10.1016/j.celrep.2018.10.045; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Xiao G, 2015, ONCOTARGET, V6, P14165, DOI 10.18632/oncotarget.3690; Yoshino K, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6138-7; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zeissig S, 2015, GUT, V64, P1889, DOI 10.1136/gutjnl-2014-308541; Zhang ML, 2020, HISTOPATHOLOGY, V76, P233, DOI 10.1111/his.13963	66	108	111	6	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					655	+		10.1016/j.cell.2020.06.001	http://dx.doi.org/10.1016/j.cell.2020.06.001			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32603654	Bronze, Green Accepted			2022-12-28	WOS:000558649000012
J	Oguri, Y; Shinoda, K; Kim, H; Alba, DL; Bolus, WR; Wang, Q; Brown, Z; Pradhan, RN; Tajima, K; Yoneshiro, T; Ikeda, K; Chen, Y; Cheang, RT; Tsujino, K; Kim, CR; Greiner, VJ; Datta, R; Yang, CD; Atabai, K; McManus, MT; Koliwad, SK; Spiegelman, BM; Kajimura, S				Oguri, Yasuo; Shinoda, Kosaku; Kim, Hyeonwoo; Alba, Diana L.; Bolus, W. Reid; Wang, Qiang; Brown, Zachary; Pradhan, Rachana N.; Tajima, Kazuki; Yoneshiro, Takeshi; Ikeda, Kenji; Chen, Yong; Cheang, Rachel T.; Tsujino, Kazuyuki; Kim, Caroline R.; Greiner, Vanille Juliette; Datta, Ritwik; Yang, Christopher D.; Atabai, Kamran; McManus, Michael T.; Koliwad, Suneil K.; Spiegelman, Bruce M.; Kajimura, Shingo			CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK Signaling	CELL			English	Article							BROWN ADIPOSE-TISSUE; IN-VIVO; TRANSCRIPTION FACTOR; TETRASPANIN CD81; WHITE FAT; IDENTIFICATION; ADIPOCYTES; THERMOGENESIS; RESISTANCE; CONVERSION	Adipose tissues dynamically remodel their cellular composition in response to external cues by stimulating beige adipocyte biogenesis; however, the developmental origin and pathways regulating this process remain insufficiently understood owing to adipose tissue heterogeneity. Here, we employed single-cell RNA-seq and identified a unique subset of adipocyte progenitor cells (APCs) that possessed the cell-intrinsic plasticity to give rise to beige fat. This beige APC population is proliferative and marked by cell-surface proteins, including PDGFR alpha, Sca1, and CD81. Notably, CD81 is not only a beige APC marker but also required for de novo beige fat biogenesis following cold exposure. CD81 forms a complex with alpha V/eta 1 and alpha V/beta 5 integrins and mediates the activation of integrin-FAK signaling in response to irisin. Importantly, CD81 loss causes diet-induced obesity, insulin resistance, and adipose tissue inflammation. These results suggest that CD81 functions as a key sensor of external inputs and controls beige APC proliferation and whole-body energy homeostasis.	[Oguri, Yasuo; Shinoda, Kosaku; Alba, Diana L.; Bolus, W. Reid; Wang, Qiang; Brown, Zachary; Pradhan, Rachana N.; Tajima, Kazuki; Yoneshiro, Takeshi; Ikeda, Kenji; Chen, Yong; Cheang, Rachel T.; Greiner, Vanille Juliette; McManus, Michael T.; Koliwad, Suneil K.; Kajimura, Shingo] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Oguri, Yasuo; Shinoda, Kosaku; Wang, Qiang; Brown, Zachary; Pradhan, Rachana N.; Tajima, Kazuki; Yoneshiro, Takeshi; Ikeda, Kenji; Chen, Yong; Kajimura, Shingo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Oguri, Yasuo; Shinoda, Kosaku; Wang, Qiang; Brown, Zachary; Pradhan, Rachana N.; Tajima, Kazuki; Yoneshiro, Takeshi; Ikeda, Kenji; Chen, Yong; Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Oguri, Yasuo; Wang, Qiang; Kajimura, Shingo] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Shinoda, Kosaku] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, New York, NY USA; [Kim, Hyeonwoo; Kim, Caroline R.; Spiegelman, Bruce M.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; [Alba, Diana L.; Bolus, W. Reid; Cheang, Rachel T.; Koliwad, Suneil K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ikeda, Kenji] Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Tokyo, Japan; [Chen, Yong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med, Wuhan, Peoples R China; [Tsujino, Kazuyuki] Natl Hosp Org Osaka Toneyama Med Ctr, Dept Resp Med, Osaka, Japan; [Greiner, Vanille Juliette; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Datta, Ritwik; Yang, Christopher D.; Atabai, Kamran] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yeshiva University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Francisco; Tokyo Medical & Dental University (TMDU); Huazhong University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kajimura, S (corresponding author), Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA.; Kajimura, S (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Kajimura, S (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.; Kajimura, S (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA.	skajimur@bidmc.harvard.edu	Datta, Ritwik/AFS-6077-2022; Yoneshiro, Takeshi/V-3856-2019; Kajimura, Shingo/AAC-5090-2019	Yoneshiro, Takeshi/0000-0001-5298-5831; Kajimura, Shingo/0000-0003-0672-5910; Yang, Christopher/0000-0002-2090-1880; Oguri, Yasuo/0000-0002-7435-6961; Brown, Zachary/0000-0002-1665-0310; Cheang, Rachel TengChi/0000-0001-8091-2197; Kim, Caroline/0000-0002-4517-3226; Alba, Diana/0000-0002-1398-9861; Pradhan, Rachana/0000-0001-7352-8111	NIH [DK97441, DK112268, DK110098, DK110426, P30DK026687, 5T32HL007374-38]; Edward Mallinckrodt, Jr. Foundation; National Center for Advancing Translational Sciences, NIH, through UCSF-CTSI [UL1 TR000004]; JPB Foundation; JSPS Overseas Research Fellowships; American Diabetes Association [1-18-PMF-003]; Vera M. Long fellowship; Uehara Memorial Foundation; Larry L. Hillblom Foundation [2019-D-004-FEL]; Manpei Suzuki Diabetes Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; National Center for Advancing Translational Sciences, NIH, through UCSF-CTSI; JPB Foundation; JSPS Overseas Research Fellowships; American Diabetes Association(American Diabetes Association); Vera M. Long fellowship; Uehara Memorial Foundation(Uehara Memorial Foundation); Larry L. Hillblom Foundation; Manpei Suzuki Diabetes Foundation	We are grateful to C. Paillart for his support in the CLAMSstudies, D. Scheel for histology, and Pollen and Nowakowski for single-cell analysis. This work was supported by the NIH (DK97441 and DK112268 to S.K., DK110098 to K.A., DK110426 and P30DK026687 to K.S., and 5T32HL007374-38 to H.K.) the Edward Mallinckrodt, Jr. Foundation (to S.K.), the National Center for Advancing Translational Sciences, NIH, through UCSF-CTSI (UL1 TR000004 to S.K.K.), the JPB Foundation (to B.M.S.), JSPS Overseas Research Fellowships (to Y.O.), the American Diabetes Association (1-18-PMF-003 to D.L.A.), the Vera M. Long fellowship (to R.N.P.), the Uehara Memorial Foundation (to T.Y.), and a Larry L. Hillblom Foundation fellowship (2019-D-004-FEL to R.D.). Y.O. and K. Tajima were supported by the post-doctoral fellowship from the Manpei Suzuki Diabetes Foundation.	Alba DL, 2018, J CLIN ENDOCR METAB, V103, P3194, DOI 10.1210/jc.2017-02301; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; Berry DC, 2017, CELL METAB, V25, P481, DOI 10.1016/j.cmet.2017.01.011; Berry DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10184; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bredella MA, 2013, OBESITY, V21, P2458, DOI 10.1002/oby.20424; Burl RB, 2018, CELL METAB, V28, P300, DOI 10.1016/j.cmet.2018.05.025; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; Chen Y, 2019, NATURE, V565, P180, DOI 10.1038/s41586-018-0801-z; Cherukuri A, 2004, J IMMUNOL, V172, P370, DOI 10.4049/jimmunol.172.1.370; Chouchani ET, 2019, NAT METAB, V1, P189, DOI 10.1038/s42255-018-0021-8; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Fan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030794; Finlin BS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121510; Galmozzi A, 2014, CELL REP, V9, P1584, DOI 10.1016/j.celrep.2014.10.066; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hasegawa Y, 2018, CELL METAB, V27, P180, DOI 10.1016/j.cmet.2017.12.005; Heinonen S, 2017, DIABETOLOGIA, V60, P169, DOI 10.1007/s00125-016-4121-2; Hepler C, 2018, ELIFE, V7, DOI 10.7554/eLife.39636; Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429; Jokinen R, 2018, INT J OBESITY, V42, P817, DOI 10.1038/ijo.2017.299; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kim H, 2018, CELL, V175, P1756, DOI 10.1016/j.cell.2018.10.025; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lin JZ, 2018, CELL REP, V23, P1977, DOI 10.1016/j.celrep.2018.04.057; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Luk CT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14360; Marcelin G, 2017, CELL METAB, V25, P673, DOI 10.1016/j.cmet.2017.01.010; Mather KJ, 2001, J CLIN ENDOCR METAB, V86, P5457, DOI 10.1210/jc.86.11.5457; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; McQueen AE, 2017, J BIOL CHEM, V292, P16122, DOI 10.1074/jbc.M117.803973; Merrick D., 2019, IDENTIFICATION MESEN, P364; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Raajendiran A, 2019, CELL REP, V27, P1528, DOI 10.1016/j.celrep.2019.04.010; Sanchez-Gurmaches J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5099; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Schwalie PC, 2018, NATURE, V559, P103, DOI 10.1038/s41586-018-0226-8; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shao ML, 2019, DIABETES, V68, P1874, DOI 10.2337/db19-0308; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shinoda K, 2015, CELL METAB, V22, P997, DOI 10.1016/j.cmet.2015.09.029; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC; Tajima K, 2019, NAT METAB, V1, P886, DOI 10.1038/s42255-019-0106-z; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Termini CM, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00034; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tsujino K, 2017, AM J PHYSIOL-LUNG C, V313, pL878, DOI 10.1152/ajplung.00062.2017; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018; Wang WS, 2019, CELL METAB, V30, P174, DOI 10.1016/j.cmet.2019.05.005; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2019, NATURE, V572, P614, DOI 10.1038/s41586-019-1503-x; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	67	91	93	9	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					563	+		10.1016/j.cell.2020.06.021	http://dx.doi.org/10.1016/j.cell.2020.06.021			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32615086	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000558649000006
J	Maciejewski, ML; Basu, A				Maciejewski, Matthew L.; Basu, Anirban			Regression Discontinuity Design	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Maciejewski, Matthew L.] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, 411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA; [Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, Durham, NC 27706 USA; [Basu, Anirban] Univ Washington, Dept Pharm, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA; [Basu, Anirban] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Basu, Anirban] Univ Washington, Dept Econ, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maciejewski, ML (corresponding author), Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, 411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA.; Maciejewski, ML (corresponding author), Duke Univ, Med Ctr, 411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA.	Matthew.Maciejetvski@va.gov			Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs [CIN 13-410]; Research Career Scientist award from the VA [RCS 10-391]	Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); Research Career Scientist award from the VA	This work was supported by the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs (CIN 13-410). Dr Maciejewski was supported by a Research Career Scientist award from the VA (RCS 10-391).	Almond D, 2010, Q J ECON, V125, P591, DOI 10.1162/qjec.2010.125.2.591; Haukoos JS, 2015, JAMA-J AM MED ASSOC, V314, P1637, DOI 10.1001/jama.2015.13480; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Shadish WR, 2011, PSYCHOL METHODS, V16, P179, DOI 10.1037/a0023345; Sukul D, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3290; THISTLETHWAITE DL, 1960, J EDUC PSYCHOL, V51, P309, DOI 10.1037/h0044319	6	10	12	3	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					381	382		10.1001/jama.2020.3822	http://dx.doi.org/10.1001/jama.2020.3822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE8JP	32614409				2022-12-28	WOS:000562851000027
J	Bhasin, S; Gill, TM; Reuben, DB; Latham, NK; Ganz, DA; Greene, EJ; Dziura, J; Basaria, S; Gurwitz, JH; Dykes, PC; McMahon, S; Storer, TW; Gazarian, P; Miller, ME; Travison, TG; Esserman, D; Carnie, MB; Goehring, L; Fagan, M; Greenspan, SL; Alexander, N; Wiggins, J; Ko, F; Siu, AL; Volpi, E; Wu, AW; Rich, J; Waring, SC; Wallace, RB; Casteel, C; Resnick, NM; Magaziner, J; Charpentier, P; Lu, C; Araujo, K; Rajeevan, H; Meng, C; Allore, H; Brawley, BF; Eder, R; McGloin, JM; Skokos, EA; Duncan, PW; Baker, D; Boult, C; Correa-de-Araujo, R; Peduzzi, P				Bhasin, Shalender; Gill, Thomas M.; Reuben, David B.; Latham, Nancy K.; Ganz, David A.; Greene, Erich J.; Dziura, James; Basaria, Shehzad; Gurwitz, Jerry H.; Dykes, Patricia C.; McMahon, Siobhan; Storer, Thomas W.; Gazarian, Priscilla; Miller, Michael E.; Travison, Thomas G.; Esserman, Denise; Carnie, Martha B.; Goehring, Lori; Fagan, Maureen; Greenspan, Susan L.; Alexander, Neil; Wiggins, Jocelyn; Ko, Fred; Siu, Albert L.; Volpi, Elena; Wu, Albert W.; Rich, Jeremy; Waring, Stephen C.; Wallace, Robert B.; Casteel, Carri; Resnick, Neil M.; Magaziner, Jay; Charpentier, Peter; Lu, Charles; Araujo, Katy; Rajeevan, Haseena; Meng, Can; Allore, Heather; Brawley, Brooke F.; Eder, Rich; McGloin, Joanne M.; Skokos, Eleni A.; Duncan, Pamela W.; Baker, Dorothy; Boult, Chad; Correa-de-Araujo, Rosaly; Peduzzi, Peter			A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; UNITED-STATES; INTERVENTION; MANAGEMENT; QUALITY; ADULTS; REDUCE; RISK	BackgroundInjuries from falls are major contributors to complications and death in older adults. Despite evidence from efficacy trials that many falls can be prevented, rates of falls resulting in injury have not declined. MethodsWe conducted a pragmatic, cluster-randomized trial to evaluate the effectiveness of a multifactorial intervention that included risk assessment and individualized plans, administered by specially trained nurses, to prevent fall injuries. A total of 86 primary care practices across 10 health care systems were randomly assigned to the intervention or to enhanced usual care (the control) (43 practices each). The participants were community-dwelling adults, 70 years of age or older, who were at increased risk for fall injuries. The primary outcome, assessed in a time-to-event analysis, was the first serious fall injury, adjudicated with the use of participant report, electronic health records, and claims data. We hypothesized that the event rate would be lower by 20% in the intervention group than in the control group. ResultsThe demographic and baseline characteristics of the participants were similar in the intervention group (2802 participants) and the control group (2649 participants); the mean age was 80 years, and 62.0% of the participants were women. The rate of a first adjudicated serious fall injury did not differ significantly between the groups, as assessed in a time-to-first-event analysis (events per 100 person-years of follow-up, 4.9 in the intervention group and 5.3 in the control group; hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.25). The rate of a first participant-reported fall injury was 25.6 events per 100 person-years of follow-up in the intervention group and 28.6 events per 100 person-years of follow-up in the control group (hazard ratio, 0.90; 95% CI, 0.83 to 0.99; P=0.004). The rates of hospitalization or death were similar in the two groups. ConclusionsA multifactorial intervention, administered by nurses, did not result in a significantly lower rate of a first adjudicated serious fall injury than enhanced usual care. (Funded by the Patient-Centered Outcomes Research Institute and others; STRIDE ClinicalTrials.gov number, NCT02475850.) Injuries from falls are major contributors to death and complications in older adults. In this pragmatic, cluster-randomized trial, a multifactorial intervention that was administered by nurses did not result in a significantly lower rate of first adjudicated serious fall injury than enhanced usual care.	[Bhasin, Shalender; Latham, Nancy K.; Basaria, Shehzad; Storer, Thomas W.; Travison, Thomas G.; Goehring, Lori; Brawley, Brooke F.; Eder, Rich] Brigham & Womens Hosp, Res Program Mens Hlth Aging & Metab, Boston Claude Pepper Older Americans Independence, Boston, MA USA; [Bhasin, Shalender; Latham, Nancy K.; Basaria, Shehzad; Dykes, Patricia C.; Storer, Thomas W.; Gazarian, Priscilla; Travison, Thomas G.; Carnie, Martha B.; Goehring, Lori; Brawley, Brooke F.; Eder, Rich] Brigham & Womens Hosp, Boston, MA USA; [Travison, Thomas G.] Harvard Med Sch, Hebrew SeniorLife, Marcus Inst Aging Res, Boston, MA 02115 USA; [Gazarian, Priscilla] Univ Massachusetts, Boston, MA 02125 USA; [Gurwitz, Jerry H.] Meyers Primary Care Inst, Worcester, MA USA; [Gill, Thomas M.; Charpentier, Peter; Araujo, Katy; McGloin, Joanne M.; Skokos, Eleni A.; Baker, Dorothy] Yale Univ, Yale Claude D Pepper Older Amer Independence Ctr, New Haven, CT USA; [Greene, Erich J.; Dziura, James; Esserman, Denise; Lu, Charles; Rajeevan, Haseena; Meng, Can; Allore, Heather; Peduzzi, Peter] Yale Univ, Yale Ctr Analyt Sci, New Haven, CT USA; [Gill, Thomas M.; Allore, Heather] Yale Univ, Yale Sch Med, Dept Internal Med, Sect Geriatr, New Haven, CT USA; [Reuben, David B.; Ganz, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Multicampus Program Geriatr Med & Gerontol, Los Angeles, CA 90095 USA; [Ganz, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Geriatr Res Educ & Clin Ctr, Los Angeles, CA USA; [Reuben, David B.; Ganz, David A.] Univ Calif Los Angeles, Claude D Pepper Older Amer Independence Ctr, Los Angeles, CA USA; [Rich, Jeremy] HealthCare Partners, El Segundo, CA USA; [McMahon, Siobhan] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA; [Waring, Stephen C.] Essentia Hlth, Duluth, MN USA; [Miller, Michael E.; Duncan, Pamela W.] Wake Forest Univ, Sch Med, Winston Salem, NC 27101 USA; [Fagan, Maureen] Univ Miami Hlth Syst, Miami, FL USA; [Greenspan, Susan L.; Resnick, Neil M.] Univ Pittsburgh, Div Geriatr & Gerontol, Pittsburgh Claude D Pepper Older Amer Independ Ct, Pittsburgh, PA USA; [Alexander, Neil; Wiggins, Jocelyn] Univ Michigan, Ann Arbor, MI 48109 USA; [Ko, Fred; Siu, Albert L.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Volpi, Elena] Univ Texas Med Branch, Sealy Ctr Aging, UTMB Pepper D Older Amer Independence Ctr, Galveston, TX 77555 USA; [Wu, Albert W.; Boult, Chad] Johns Hopkins Univ, Baltimore, MD USA; [Magaziner, Jay] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Correa-de-Araujo, Rosaly] NIA, Bethesda, MD 20892 USA; [Wallace, Robert B.; Casteel, Carri] Univ Iowa, Iowa City, IA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Hebrew SeniorLife; University of Massachusetts System; University of Massachusetts Boston; Yale University; Yale University; Yale University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Iowa	Bhasin, S (corresponding author), Brigham & Womens Hosp, Res Program Mens Hlth Aging & Metab, 221 Longwood Ave, Boston, MA 02115 USA.	sbhasin@bwh.harvard.edu	Gill, Thomas M./H-7043-2019; Wu, Albert/AAJ-4780-2021; Gazarian, Priscilla/H-6445-2019; Greene, Erich/AFV-3135-2022; Waring, Stephen/AAR-6870-2021; Volpi, Elena/I-4459-2012	Gill, Thomas M./0000-0002-6450-0368; Gazarian, Priscilla/0000-0002-4928-293X; Waring, Stephen/0000-0002-9674-0083; Ko, Fred/0000-0001-7091-640X; Meng, Can/0000-0002-8257-6243; Greene, Erich/0000-0002-9473-830X; McMahon, Siobhan/0000-0002-3036-9859	Patient-Centered Outcomes Research Institute; National Institute on Aging of the National Institutes of Health (NIH) [5U01AG048270]; Boston Claude D. Pepper Older Americans Independence Center at Brigham and Women's Hospital [P30AG013679]; Harvard Catalyst, the Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH) [UL1TR001102]; Harvard University; Claude D. Pepper Older Americans Independence Centers at the University of California, Los Angeles [P30AG028748]; Yale University [P30AG021342]; Mount Sinai Medical Center [P30AG2874106]; University of Texas Medical Branch [P30AG024832]; University of Michigan [P30AG024824]; University of Pittsburgh [P30AG024827]; Wake Forest University School of Medicine [P30AG021332]; Older Americans Independence Center National Coordinating Center [U24AG059624]; New York Academy of Medicine; Clinical and Translational Science Awards program of the National Center for Advancing Translational Sciences of the NIH [UL1TR000142]; National Institute on Aging [K07AG043587]; University of Minnesota Clinical and Translational Science Institute - National Center for Advancing Translational Sciences of the NIH [KL2TR000113, UL1TR000114]; Michigan Medicine, its academic health care system; University of Pittsburgh Medical Center, its academic health care system	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Institute on Aging of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Boston Claude D. Pepper Older Americans Independence Center at Brigham and Women's Hospital; Harvard Catalyst, the Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH); Harvard University; Claude D. Pepper Older Americans Independence Centers at the University of California, Los Angeles; Yale University; Mount Sinai Medical Center; University of Texas Medical Branch; University of Michigan(University of Michigan System); University of Pittsburgh(University of Pittsburgh); Wake Forest University School of Medicine; Older Americans Independence Center National Coordinating Center; New York Academy of Medicine; Clinical and Translational Science Awards program of the National Center for Advancing Translational Sciences of the NIH; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Minnesota Clinical and Translational Science Institute - National Center for Advancing Translational Sciences of the NIH; Michigan Medicine, its academic health care system; University of Pittsburgh Medical Center, its academic health care system	Supported by the Patient-Centered Outcomes Research Institute and the National Institute on Aging of the National Institutes of Health (NIH) through a cooperative agreement (5U01AG048270) between the National Institute on Aging and Brigham and Women's Hospital. The project is part of the Falls Injuries Prevention Partnership between the National Institute on Aging and Patient-Centered Outcomes Research Institute. This research is partially supported by the Boston Claude D. Pepper Older Americans Independence Center at Brigham and Women's Hospital (P30AG013679) and Harvard Catalyst, the Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH Award UL1TR001102) and financial contributions from Harvard University and its affiliated academic health care centers. Support was also provided by the Claude D. Pepper Older Americans Independence Centers at the University of California, Los Angeles (P30AG028748), Yale University (P30AG021342), Mount Sinai Medical Center (P30AG2874106), the University of Texas Medical Branch (P30AG024832), the University of Michigan (P30AG024824), the University of Pittsburgh (P30AG024827), Wake Forest University School of Medicine (P30AG021332), and the Older Americans Independence Center National Coordinating Center (U24AG059624). Mount Sinai Medical Center also received grant support from the New York Academy of Medicine. Additional support at Yale University was provided by the Clinical and Translational Science Awards program of the National Center for Advancing Translational Sciences of the NIH (UL1TR000142) and by the National Institute on Aging to Dr. Gill (Academic Leadership Award K07AG043587). Dr. McMahon was supported by grants (KL2TR000113 and UL1TR000114) from the University of Minnesota Clinical and Translational Science Institute, which is funded by the National Center for Advancing Translational Sciences of the NIH. The University of Michigan also received support from Michigan Medicine, its academic health care system. The University of Pittsburgh also received support from the University of Pittsburgh Medical Center, its academic health care system.	Askari M, 2016, OSTEOPOROSIS INT, V27, P569, DOI 10.1007/s00198-015-3235-6; Barreto PD, 2019, JAMA INTERN MED, V179, P394, DOI 10.1001/jamainternmed.2018.5406; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Bhasin S, 2018, J GERONTOL A-BIOL, V73, P1053, DOI 10.1093/gerona/glx190; Burns E, 2018, MMWR-MORBID MORTAL W, V67, P509, DOI 10.15585/mmwr.mm6718a1; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Choi NG, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1329-2; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Fixsen D, 2011, J SAFETY RES, V42, P419, DOI 10.1016/j.jsr.2011.10.002; Ganz DA, 2020, NEW ENGL J MED, V382, P734, DOI 10.1056/NEJMcp1903252; Ganz DA, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-019-0190-2; Ganz DA, 2015, J AM GERIATR SOC, V63, P63, DOI 10.1111/jgs.13154; Gill TM, 2020, J AM GERIATR SOC, V68, P1242, DOI 10.1111/jgs.16356; Gill TM, 2018, J GERONTOL A-BIOL, V73, P1495, DOI 10.1093/gerona/gly076; Greene EJ, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.c01; Grossman DC, 2018, JAMA-J AM MED ASSOC, V319, P1696, DOI 10.1001/jama.2018.3097; Guirguis-Blake JM, 2018, JAMA-J AM MED ASSOC, V319, P1705, DOI 10.1001/jama.2017.21962; Guirguis-Blake JM, 2018, INTERVENTIONS PREVEN; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; LEE EW, 1992, NATO ADV SCI I E-APP, V211, P237; Medical Dictionary for Regulatory Activities, MEDDRA VERS 18 1 ENG; National Center for Health Statistics, 2017, HLTH US 2016 CHARTB; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; R Project for Statistical Computing, 2020, PACKAGE SURVIVAL; Reuben DB, 2017, J AM GERIATR SOC, V65, P2733, DOI 10.1111/jgs.15121; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Sherrington C, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012424.pub2; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Tricco AC, 2017, JAMA-J AM MED ASSOC, V318, P1687, DOI 10.1001/jama.2017.15006; 2012, DRUG DISCOV TODAY TE, V9, pCD007	35	71	71	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					129	140		10.1056/NEJMoa2002183	http://dx.doi.org/10.1056/NEJMoa2002183			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NR9PO	32640131	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000571894800012
J	Magistro, G; Stief, CG				Magistro, Giuseppe; Stief, Christian G.			Surgery for benign prostatic obstruction	LANCET			English	Editorial Material							TRANSURETHRAL RESECTION		[Magistro, Giuseppe; Stief, Christian G.] Ludwig Maximilian Univ Munich, Dept Urol, D-81377 Munich, Germany	University of Munich	Stief, CG (corresponding author), Ludwig Maximilian Univ Munich, Dept Urol, D-81377 Munich, Germany.	christian.stief@med.uni-muenchen.de		Stief, Christian/0000-0003-3291-9460				Deng Z, 2018, WORLD J UROL, V36, P1355, DOI 10.1007/s00345-018-2287-6; Gravas S, 2016, EAU GUIDELINES MANAG; Hashim H, 2020, LANCET, V396, P50, DOI 10.1016/S0140-6736(20)30537-7; Lan Y, 2018, LASER MED SCI, V33, P1411, DOI 10.1007/s10103-018-2539-0; Magistro G, 2017, EUR UROL, V72, P986, DOI 10.1016/j.eururo.2017.07.005; McVary KT RC, 2010, AM UROLOGICAL ASS GU; Reich O, 2008, J UROLOGY, V180, P246, DOI 10.1016/j.juro.2008.03.058; Wettstein MS, 2020, WORLD J UROL, V38, P741, DOI 10.1007/s00345-019-02799-3	8	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					5	7						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32622396	hybrid			2022-12-28	WOS:000561626100019
J	DeRocher, KA; Smeets, PJM; Goodge, BH; Zachman, MJ; Balachandran, PV; Stegbauer, L; Cohen, MJ; Gordon, LM; Rondinelli, JM; Kourkoutis, LF; Joester, D				DeRocher, Karen A.; Smeets, Paul J. M.; Goodge, Berit H.; Zachman, Michael J.; Balachandran, Prasanna V.; Stegbauer, Linus; Cohen, Michael J.; Gordon, Lyle M.; Rondinelli, James M.; Kourkoutis, Lena F.; Joester, Derk			Chemical gradients in human enamel crystallites	NATURE			English	Article							X-RAY-ABSORPTION; ATOM-PROBE TOMOGRAPHY; ELECTRON-MICROSCOPY; MAGNESIUM; PSEUDOPOTENTIALS; HYDROXYAPATITE; CHEMISTRY	Dental enamel is a principal component of teeth(1), and has evolved to bear large chewing forces, resist mechanical fatigue and withstand wear over decades(2). Functional impairment and loss of dental enamel, caused by developmental defects or tooth decay (caries), affect health and quality of life, with associated costs to society(3). Although the past decade has seen progress in our understanding of enamel formation (amelogenesis) and the functional properties of mature enamel, attempts to repair lesions in this material or to synthesize it in vitro have had limited success(4-6). This is partly due to the highly hierarchical structure of enamel and additional complexities arising from chemical gradients(7-9). Here we show, using atomic-scale quantitative imaging and correlative spectroscopies, that the nanoscale crystallites of hydroxylapatite (Ca-5(PO4)(3)(OH)), which are the fundamental building blocks of enamel, comprise two nanometric layers enriched in magnesium flanking a core rich in sodium, fluoride and carbonate ions; this sandwich core is surrounded by a shell with lower concentration of substitutional defects. A mechanical model based on density functional theory calculations and X-ray diffraction data predicts that residual stresses arise because of the chemical gradients, in agreement with preferential dissolution of the crystallite core in acidic media. Furthermore, stresses may affect the mechanical resilience of enamel. The two additional layers of hierarchy suggest a possible new model for biological control over crystal growth during amelogenesis, and hint at implications for the preservation of biomarkers during tooth development. Hydroxylapatite crystallites in human dental enamel show gradients in chemical composition, with a layer of magnesium enrichment on each side of a core rich in sodium, fluoride and carbonate ions.	[DeRocher, Karen A.; Smeets, Paul J. M.; Stegbauer, Linus; Cohen, Michael J.; Gordon, Lyle M.; Rondinelli, James M.; Joester, Derk] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Goodge, Berit H.; Zachman, Michael J.; Kourkoutis, Lena F.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Goodge, Berit H.; Kourkoutis, Lena F.] Cornell Univ, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY USA; [Balachandran, Prasanna V.] Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA USA; [Balachandran, Prasanna V.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA USA; [Zachman, Michael J.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN USA	Northwestern University; Cornell University; Cornell University; University of Virginia; University of Virginia; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences	Joester, D (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	d-joester@northwestern.edu	Stegbauer, Linus/ABH-9430-2020; Joester, Derk/B-7525-2009; Kourkoutis, Lena/B-4229-2010	Stegbauer, Linus/0000-0003-1823-7949; Goodge, Berit/0000-0003-0948-7698; Zachman, Michael/0000-0003-1910-1357; Gordon, Lyle/0000-0001-8335-0126; DeRocher, Karen/0000-0002-0953-9112; Kourkoutis, Lena/0000-0002-1303-1362	NIDCR NIH HHS [R03 DE025303, R01 DE025702] Funding Source: Medline; NIH HHS [R03 DE025303-01, R01 DE025702-01] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Antao SM, 2004, AM MINERAL, V89, P1142; AOBA T, 1992, J DENT RES, V71, P1826, DOI 10.1177/00220345920710111201; BABUSHKIN O, 1994, J MATER CHEM, V4, P413, DOI 10.1039/jm9940400413; Ben Abdelkader S, 2001, THERMOCHIM ACTA, V376, P25, DOI 10.1016/S0040-6031(01)00565-2; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; CALVO C, 1975, AM MINERAL, V60, P120; Chai H, 2009, P NATL ACAD SCI USA, V106, P7289, DOI 10.1073/pnas.0902466106; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; Dal Corso A, 2014, COMP MATER SCI, V95, P337, DOI 10.1016/j.commatsci.2014.07.043; de Juan A, 2006, CRIT REV ANAL CHEM, V36, P163, DOI 10.1080/10408340600970005; Deymier AC, 2017, BIOMATERIALS, V127, P75, DOI 10.1016/j.biomaterials.2017.02.029; DOLLASE WA, 1986, AM MINERAL, V71, P163; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gault B., 2012, ATOM PROBE MICROSCOP, V160; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gordon LM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00057; Gordon LM, 2015, SCIENCE, V347, P746, DOI 10.1126/science.1258950; Gordon LM, 2012, ACS NANO, V6, P10667, DOI 10.1021/nn3049957; HARRIES JE, 1987, J CRYST GROWTH, V84, P563, DOI 10.1016/0022-0248(87)90046-7; Hart JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07709-4; HOLT C, 1988, J CRYST GROWTH, V92, P239, DOI 10.1016/0022-0248(88)90455-1; Hubbard MJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00546; HUGHES JM, 1989, AM MINERAL, V74, P870; Kirkham J, 2007, J DENT RES, V86, P426, DOI 10.1177/154405910708600507; Klein OD, 2017, INT J ORAL SCI, V9, DOI 10.1038/ijos.2017.40; La Fontaine A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601145; Lacruz RS, 2017, PHYSIOL REV, V97, P939, DOI 10.1152/physrev.00030.2016; Langelier B, 2017, SCI REP-UK, V7, DOI 10.1038/srep39958; Larson D. J., 2013, LOCAL ELECT ATOM PRO; Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017; LeGeros R Z, 1996, Adv Dent Res, V10, P225; Luder HU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078529; Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034; Nakano Y, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00258; Nanci A., 2008, 10 CATES ORAL HISTOL, Vedn 7; Park YC, 2014, J MICROSC-OXFORD, V255, P180, DOI 10.1111/jmi.12150; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Qi ML, 2016, ACTA METALL SIN-ENGL, V29, P609, DOI 10.1007/s40195-016-0431-0; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Reeder RJ, 1999, AM MINERAL, V84, P1049; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Reyes-Gasga J, 2016, MICROSC MICROANAL, V22, P1047, DOI 10.1017/S1431927616011648; ROBINSON C, 1981, J CRYST GROWTH, V53, P160, DOI 10.1016/0022-0248(81)90062-2; ROBINSON C, 1995, INT J DEV BIOL, V39, P145; Robinson C, 2000, CRIT REV ORAL BIOL M, V11, P481, DOI 10.1177/10454411000110040601; ROBINSON C, 1981, CARIES RES, V15, P70, DOI 10.1159/000260502; Robinson C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00388; Rohatgi A., 2019, WEBPLOTDIGITIZER VER; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Stoffers A, 2017, MICROSC MICROANAL, V23, P291, DOI 10.1017/S1431927617000034; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; TOHDA H, 1987, J DENT RES, V66, P1647, DOI 10.1177/00220345870660110901; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; VOEGEL JC, 1977, CALC TISS RES, V24, P19, DOI 10.1007/BF02223292; Yahyazadehfar M, 2014, APPL MECH REV, V66, DOI 10.1115/1.4027431; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Yanagisawa T, 2003, J ELECTRON MICROSC, V52, P605, DOI 10.1093/jmicro/52.6.605; Yilmaz ED, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0130; Zachman MJ, 2018, NATURE, V560, P345, DOI 10.1038/s41586-018-0397-3; Zhang YR, 2014, INT J ORAL SCI, V6, P61, DOI 10.1038/ijos.2014.21	62	62	64	14	124	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					66	+		10.1038/s41586-020-2433-3	http://dx.doi.org/10.1038/s41586-020-2433-3			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32612224	Green Accepted			2022-12-28	WOS:000544773600011
J	Gay, E				Gay, Elizabeth			Blame	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gay, Elizabeth] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Gay, E (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					9	11		10.1056/NEJMp2000393	http://dx.doi.org/10.1056/NEJMp2000393			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2UD	32609978				2022-12-28	WOS:000552751800006
J	Bastos, ML; Tavaziva, G; Abidi, SK; Campbell, JR; Haraoui, LP; Johnston, JC; Lan, ZY; Law, S; MacLean, E; Trajman, A; Menzies, D; Benedetti, A; Khan, FA				Bastos, Mayara Lisboa; Tavaziva, Gamuchirai; Abidi, Syed Kunal; Campbell, Jonathon R.; Haraoui, Louis -Patrick; Johnston, James C.; Lan, Zhiyi; Law, Stephanie; MacLean, Emily; Trajman, Anete; Menzies, Dick; Benedetti, Andrea; Khan, Faiz Ahmad			Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONAVIRUS NUCLEOCAPSID PROTEIN; INFECTED PATIENTS; SERODIAGNOSIS; ANTIBODIES; CARE	OBJECTIVE To determine the diagnostic accuracy of serological tests for coronavirus disease-2019 (covid-19). DESIGN Systematic review and meta-analysis. DATA SOURCES Medline, bioRxiv, and medRxiv from 1 January to 30 April 2020, using subject headings or subheadings combined with text words for the concepts of covid-19 and serological tests for covid-19. ELIGIBILITY CRITERIA AND DATA ANALYSIS Eligible studies measured sensitivity or specificity, or both of a covid-19 serological test compared with a reference standard of viral culture or reverse transcriptase polymerase chain reaction. Studies were excluded with fewer than five participants or samples. Risk of bias was assessed using quality assessment of diagnostic accuracy studies 2 (QUADAS-2). Pooled sensitivity and specificity were estimated using random effects bivariate meta-analyses. MAIN OUTCOME MEASURES The primary outcome was overall sensitivity and specificity, stratified by method of serological testing (enzyme linked immunosorbent assays (ELISAs), lateral flow immunoassays (LFIAs), or chemiluminescent immunoassays (CLIAs)) and immunoglobulin class (IgG, IgM, or both). Secondary outcomes were stratum specific sensitivity and specificity within subgroups defined by study or participant characteristics, including time since symptom onset. RESULTS 5016 references were identified and 40 studies included. 49 risk of bias assessments were carried out (one for each population and method evaluated). High risk of patient selection bias was found in 98% (48/49) of assessments and high or unclear risk of bias from performance or interpretation of the serological test in 73% (36/49). Only 10% (4/40) of studies included outpatients. Only two studies evaluated tests at the point of care. For each method of testing, pooled sensitivity and specificity were not associated with the immunoglobulin class measured. The pooled sensitivity of ELISAs measuring IgG or IgM was 84.3% (95% confidence interval 75.6% to 90.9%), of LFIAs was 66.0% (49.3% to 79.3%), and of CLIAs was 97.8% (46.2% to 100%). In all analyses, pooled sensitivity was lower for LFIAs, the potential point-of-care method. Pooled specificities ranged from 96.6% to 99.7%. Of the samples used for estimating specificity, 83% (10 465/12 547) were from populations tested before the epidemic or not suspected of having covid-19. Among LFIAs, pooled sensitivity of commercial kits (65.0%, 49.0% to 78.2%) was lower than that of non-commercial tests (88.2%, 83.6% to 91.3%). Heterogeneity was seen in all analyses. Sensitivity was higher at least three weeks after symptom onset (ranging from 69.9% to 98.9%) compared with within the first week (from 13.4% to 50.3%). CONCLUSION Higher quality clinical studies assessing the diagnostic accuracy of serological tests for covid-19 are urgently needed. Currently, available evidence does not support the continued use of existing point-of-care serological tests.	[Bastos, Mayara Lisboa; Tavaziva, Gamuchirai; Abidi, Syed Kunal; Campbell, Jonathon R.; Lan, Zhiyi; Trajman, Anete; Menzies, Dick; Benedetti, Andrea; Khan, Faiz Ahmad] McGill Univ, Ctr Hlth, Ctr Outcomes Res & Evaluat, Resp Epidemiol & Clin Res Unit,Res Inst, Montreal, PQ, Canada; [Bastos, Mayara Lisboa; Trajman, Anete] Univ Estado Rio De Janeiro, Social Med Inst, Rio De Janeiro, Brazil; [Haraoui, Louis -Patrick] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Microbiol & Infect Dis, Sherbrooke, PQ, Canada; [Johnston, James C.] Univ British Columbia, Vancouver, BC, Canada; [Law, Stephanie] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Campbell, Jonathon R.; MacLean, Emily; Menzies, Dick; Benedetti, Andrea; Khan, Faiz Ahmad] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Campbell, Jonathon R.; MacLean, Emily; Menzies, Dick; Benedetti, Andrea; Khan, Faiz Ahmad] McGill Univ, Dept Biostat & Occupat Hlth, Montreal, PQ, Canada; [Campbell, Jonathon R.; MacLean, Emily; Menzies, Dick; Benedetti, Andrea; Khan, Faiz Ahmad] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; Universidade do Estado do Rio de Janeiro; University of Sherbrooke; University of British Columbia; Harvard University; Harvard Medical School; McGill University; McGill University; McGill University	Khan, FA (corresponding author), McGill Univ, Ctr Hlth, Ctr Outcomes Res & Evaluat, Resp Epidemiol & Clin Res Unit,Res Inst, Montreal, PQ, Canada.; Khan, FA (corresponding author), McGill Univ, Dept Epidemiol, Montreal, PQ, Canada.; Khan, FA (corresponding author), McGill Univ, Dept Biostat & Occupat Hlth, Montreal, PQ, Canada.; Khan, FA (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	faiz.ahmadkhan@mcgill.ca	Campbell, Jonathon/AAN-4252-2021; Haraoui, Louis-Patrick/ABH-3490-2021	Campbell, Jonathon/0000-0003-2341-2166; Haraoui, Louis-Patrick/0000-0002-3713-7866; MacLean, Emily L./0000-0001-9272-0985	McGill Interdisciplinary Initiative in Infection and Immunity (MI4) [ECRF-R1-30]; Canadian Institutes of Health Research [FRD143350]; Fonds de Recherche Sante Quebec (FRSQ) [258907, 287869]; Conselho Nacional de Ensino, Pesquisa e Desenvolvimento Tecnologico [303267/2018-6]; McGill University Department of Medicine; FRSQ	McGill Interdisciplinary Initiative in Infection and Immunity (MI4); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Sante Quebec (FRSQ); Conselho Nacional de Ensino, Pesquisa e Desenvolvimento Tecnologico; McGill University Department of Medicine; FRSQ(Fonds de la Recherche en Sante du Quebec)	This study was funded (publication costs) by a grant (ECRF-R1-30) from the McGill Interdisciplinary Initiative in Infection and Immunity (MI4). MB is supported by the Canadian Institutes of Health Research (award #FRD143350). JRC is supported by Fonds de Recherche Sante Quebec (FRSQ award #258907 and #287869). SL holds a research training award from the FRSQ. AB holds a research salary award from the FRSQ. AT is supported by Conselho Nacional de Ensino, Pesquisa e Desenvolvimento Tecnologico (award #303267/2018-6). FAK receives salary support from the McGill University Department of Medicine. MI4 and these agencies had no input into the study design, data collection, data analysis or interpretation, report writing, or the decision to submit the paper for publication.	American Society for Microbiology, 2020, ASM EXP COR TEST REA; [Anonymous], 2020, LANCET, V395, P755, DOI 10.1016/S0140-6736(20)30522-5; [Anonymous], 2019, METAANALYSIS DIAGNOS; Barnes E, 2020, EVALUATION ANTIBODY, DOI 10.1101/2020.04.15.20066407v1.full.pdf; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beeching NJ, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1403; Burbelo Peter D, 2020, medRxiv, DOI 10.1101/2020.04.20.20071423; Cai X., 2020, J INFECT DIS; Cassaniti I, 2020, J MED VIROL, V92, P1724, DOI 10.1002/jmv.25800; Chen ZH, 2020, ANAL CHEM, V92, P7226, DOI 10.1021/acs.analchem.0c00784; Chen ZH, 2020, KOREAN J RADIOL, V21, P623, DOI 10.3348/kjr.2020.0195; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Dohla M, 2020, PUBLIC HEALTH, V182, P170, DOI 10.1016/j.puhe.2020.04.009; Freeman Brandi, 2020, bioRxiv, DOI 10.1101/2020.04.24.057323; Gao HX, 2020, CHINESE MED J-PEKING, V133, P1479, DOI 10.1097/CM9.0000000000000820; Gao Y, 2020, J MED VIROL, V92, P1975, DOI 10.1002/jmv.25919; Garcia F.P., 2020, RAPID DIAGNOSIS SARS, DOI 10.1101/2020.04.11.20062158; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Hatcher, 2020, NAT MED, V29, P1, DOI [10.1101/2020.03.18.20038018, DOI 10.1101/2020.03.18.20038018, 10.3389/fmolb.2020.604252, DOI 10.1038/S41591-020-0897-1]; Hoffman Tove, 2020, Infection Ecology & Epidemiology, V10, P1754538, DOI 10.1080/20008686.2020.1754538; Imai K, CLIN EVALUATION IMMU, DOI [10.1101/2020.04.22.20075564, DOI 10.1101/2020.04.22.20075564]; Infantino M, 2020, J MED VIROL, V92, P1671, DOI 10.1002/jmv.25932; Jia X, 2020, CLIN SIGNIFICANCE IG, DOI 10.1101/2020.02.28.20029025; Jin YJ, 2020, INT J INFECT DIS, V94, P49, DOI 10.1016/j.ijid.2020.03.065; Lassauniere R., 2020, MEDRXIV, DOI 10.1101/2020.04.09.20056325; Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727; Lin D, 2020, EVALUATIONS SEROLOGI, DOI [10.1101/2020.03.27.20045153, DOI 10.1101/2020.03.27.20045153]; Liu L, 2020, MICROBES INFECT, V22, P206, DOI 10.1016/j.micinf.2020.05.008; Liu WB, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00461-20; Liu YJ, 2020, ARTECH HSE MOB COMM, P1; Lou B, SEROLOGY CHARACTERIS, DOI 10.1101/2020.03.23.20041707; Ma H., 2020, COVID 19 DIAGNOSIS S, P1, DOI [10.1101/2 020.04.17.20064907, 10.1101/2020.04.17.20064907]; Majumder MS, 2020, LANCET GLOB HEALTH, V8, pE627, DOI 10.1016/S2214-109X(20)30113-3; Maxmen Amy, 2020, Nature, DOI 10.1038/d41586-020-01163-5; Meyer B, 2014, VIRUS RES, V194, P175, DOI 10.1016/j.virusres.2014.03.018; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Pan YB, 2020, J INFECTION, V81, pE28, DOI 10.1016/j.jinf.2020.03.051; Paradiso AV, 2020, CLIN MEANINGS RAPID, DOI 10.1101/2020.04.03.20052183; Perera RAPM, 2020, EUROSURVEILLANCE, V25, P14, DOI 10.2807/1560-7917.ES.2020.25.16.2000421; Qian C, 2020, DEV MULTICENTER PERF, DOI [10.1101/2020.04.16.20067231, DOI 10.1101/2020.04.16.20067231]; R Development Core Team, 2009, R LANG ENV STAT COMP; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Song H, 2020, SEROLOGICAL DIAGNOST, DOI 10.1101/2020.03.26.20042184; Su Y., 2020, CLIN INFECT DIS, V71, P2027, DOI [DOI 10.1093/cid/ciaa344, 10.1093/cid/ciaa344]; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Whitman JD, 2020, NAT BIOTECHNOL, V38, P1174, DOI [10.1038/s41587-020-0659-0, 10.1101/2020.04.25.20074856]; WHO, 2020, ADV US POINT OF CAR; Winichakoon P, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00297-20; Woo PCY, 2005, J CLIN MICROBIOL, V43, P3054, DOI 10.1128/JCM.43.7.3054-3058.2005; Woo PCY, 2004, J CLIN MICROBIOL, V42, P2306, DOI 10.1128/JCM.42.5.2306-2309.2004; Xiang F, 2020, CLIN INFECT DIS, V19, P19; Xiao AT, 2020, J INFECTION, V81, P174, DOI 10.1016/j.jinf.2020.03.012; Xie J, 2020, J MED VIROL, V24, P24; Yangchun F, 2020, OPTIMIZE CLIN LAB DI, DOI [10.1101/202 0.04.07.20053660, DOI 10.1101/2020.04.07.20053660]; Zhang P, 2020, EVALUATION RECOMBINA, DOI [10.1101/2020.03.17.20036954, DOI 10.1101/2020.03.17.20036954]; Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071; Zhong L, 2020, SCI CHINA LIFE SCI, V63, P777, DOI 10.1007/s11427-020-1688-9	59	462	471	11	69	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2516	10.1136/bmj.m2516	http://dx.doi.org/10.1136/bmj.m2516			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611558	hybrid, Green Published			2022-12-28	WOS:000548489100021
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19 cases increase steeply in US south and west	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, NY TIMES; [Anonymous], 2019, TRANSCRIPT CDC TELEB; Blitzer R, 2020, FOX NEWS SUNDAY 0628; Johns Hopkins University Coronavirus Resource Center, TEST HUB WHICH US ST; Stolberg SG, 2020, NY TIMES	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2616	10.1136/bmj.m2616	http://dx.doi.org/10.1136/bmj.m2616			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601090	Bronze			2022-12-28	WOS:000548112700016
J	Duffy, CDP				Duffy, Christopher D. P.			The simplicity of robust light harvesting	SCIENCE			English	Editorial Material							QUANTUM COHERENCE; PHOTOSYNTHESIS		[Duffy, Christopher D. P.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England	University of London; Queen Mary University London	Duffy, CDP (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	c.duffy@qmul.ac.uk						Arp TB, 2020, SCIENCE, V368, P1490, DOI 10.1126/science.aba6630; Borrego CM, 1999, PHOTOSYNTH RES, V60, P257, DOI 10.1023/A:1006230820007; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Kruger TPJ, 2016, PHYSICA B, V480, P7, DOI 10.1016/j.physb.2015.08.005; Maly P, 2018, PHYS CHEM CHEM PHYS, V20, P4360, DOI 10.1039/c7cp06139k; Ruban AV, 2006, J BIOL CHEM, V281, P14981, DOI 10.1074/jbc.M511415200; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/NCHEM.1145, 10.1038/nchem.1145]; Wilkins DM, 2015, J CHEM THEORY COMPUT, V11, P3411, DOI 10.1021/ct501066k	12	2	2	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1427	1428		10.1126/science.abc8063	http://dx.doi.org/10.1126/science.abc8063			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587007				2022-12-28	WOS:000545264600022
J	Li, L; Liu, ZX; Ren, XF; Wang, SM; Su, VC; Chen, MK; Chu, CH; Kuo, HY; Liu, BH; Zang, WB; Guo, GC; Zhang, LJ; Wang, ZL; Zhu, SN; Tsai, DP				Li, Lin; Liu, Zexuan; Ren, Xifeng; Wang, Shuming; Su, Vin-Cent; Chen, Mu-Ku; Chu, Cheng Hung; Kuo, Hsin Yu; Liu, Biheng; Zang, Wenbo; Guo, Guangcan; Zhang, Lijian; Wang, Zhenlin; Zhu, Shining; Tsai, Din Ping			Metalens-array-based high-dimensional and multiphoton quantum source	SCIENCE			English	Article							ENTANGLEMENT; POLARIZATION; METASURFACE; RESOLUTION; PHASE	The development of two-dimensional metasurfaces has shown great potential in quantum-optical technologies because of the excellent flexibility in light-field manipulation. By integrating a metalens array with a nonlinear crystal, we demonstrate a 100-path spontaneous parametric down-conversion photon-pair source in a 10 x 10 array, which shows promise for high-dimensional entanglement and multiphoton-state generation. We demonstrate two-, three- and four-dimensional two-photon path entanglement with different phases encoded by metalenses with fidelities of 98.4, 96.6, and 95.0%, respectively. Furthermore, four-photon and six-photon generation isobserved with high indistinguishability of photons generated from different metalenses. Our metalens-array-based quantum photon source is compact, stable, and controllable, indicating a new platform for integrated quantum devices.	[Li, Lin; Liu, Zexuan; Wang, Shuming; Zang, Wenbo; Zhang, Lijian; Wang, Zhenlin; Zhu, Shining] Nanjing Univ, Sch Phys, Coll Engn & Appl Sci, Natl Lab Solid State Microstruct, Nanjing 210093, Peoples R China; [Li, Lin; Chen, Mu-Ku; Tsai, Din Ping] Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Peoples R China; [Li, Lin; Chen, Mu-Ku; Chu, Cheng Hung; Kuo, Hsin Yu; Tsai, Din Ping] Acad Sinica, Res Ctr Appl Sci, Taipei 11529, Taiwan; [Li, Lin] East China Normal Univ, Sch Phys & Elect Sci, State Key Lab Precis Spect, Shanghai 200062, Peoples R China; [Liu, Zexuan; Wang, Shuming; Zhang, Lijian; Zhu, Shining] Nanjing Univ, Key Lab Intelligent Opt Sensing & Manipulat, Minist Educ, Nanjing 210093, Peoples R China; [Liu, Zexuan; Wang, Shuming; Zang, Wenbo; Zhang, Lijian; Wang, Zhenlin; Zhu, Shining] Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Peoples R China; [Ren, Xifeng; Liu, Biheng; Guo, Guangcan] Univ Sci & Technol China, Key Lab Quantum Informat, CASU, Hefei 230026, Peoples R China; [Ren, Xifeng; Liu, Biheng; Guo, Guangcan] Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Hefei 230026, Peoples R China; [Su, Vin-Cent] Natl United Univ, Dept Elect Engn, Miaoli 36003, Taiwan; [Chen, Mu-Ku; Chu, Cheng Hung; Kuo, Hsin Yu; Tsai, Din Ping] Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan	Nanjing University; Hong Kong Polytechnic University; Academia Sinica - Taiwan; East China Normal University; Nanjing University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; National United University; National Taiwan University	Wang, SM; Zhang, LJ; Wang, ZL; Zhu, SN (corresponding author), Nanjing Univ, Sch Phys, Coll Engn & Appl Sci, Natl Lab Solid State Microstruct, Nanjing 210093, Peoples R China.; Tsai, DP (corresponding author), Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Peoples R China.; Tsai, DP (corresponding author), Acad Sinica, Res Ctr Appl Sci, Taipei 11529, Taiwan.; Wang, SM; Zhang, LJ; Zhu, SN (corresponding author), Nanjing Univ, Key Lab Intelligent Opt Sensing & Manipulat, Minist Educ, Nanjing 210093, Peoples R China.; Wang, SM; Zhang, LJ; Wang, ZL; Zhu, SN (corresponding author), Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Peoples R China.; Tsai, DP (corresponding author), Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan.	wangshuming@nju.edu.cn; lijian.zhang@nju.edu.cn; zlwang@nju.edu.cn; zhusn@nju.edu.cn; dinping.tsai@polyu.edu.hk	Chen, Mu Ku/K-8600-2013; Tsai, Din Ping/F-1734-2011; Ren, Xifeng/L-8357-2019; Li, Lin/F-8397-2016; Chu, Cheng Hung/B-3258-2015; Kuo, Hsin Yu/W-2509-2017	Chen, Mu Ku/0000-0002-6697-0398; Tsai, Din Ping/0000-0002-0883-9906; Li, Lin/0000-0002-5533-0723; Chu, Cheng Hung/0000-0002-8749-3930; Kuo, Hsin Yu/0000-0002-9786-1485; Wang, Shuming/0000-0002-0191-407X; Ren, Xifeng/0000-0001-6559-8101; Liu, Zexuan/0000-0001-7319-5759	National Program on Key Basic Research Project of China [2017YFA0303700, 2016YFA0301700, 2018YFA030602, 2019YFA0308704]; National Natural Science Foundation of China [116210911, 1822406, 11834007, 117741646, 1590932, 11774333, 11690032, 91836303, 61490711]; Anhui Initiative in Quantum Information Technologies [AHY130300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB24030601]; Shenzhen Science and Technology Innovation Commission [SGDX2019081623281169]	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Initiative in Quantum Information Technologies; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shenzhen Science and Technology Innovation Commission	The authors acknowledge financial support from the National Program on Key Basic Research Project of China (2017YFA0303700, 2016YFA0301700, 2018YFA030602, 2019YFA0308704), National Natural Science Foundation of China(no. 116210911,1822406, 11834007, 117741646, 1590932, 11774333,11690032, 91836303, 61490711), Anhui Initiative in Quantum Information Technologies (No. AHY130300), the Strategic Priority Research Program of the Chinese Academy of Sciences (no. XDB24030601), and Shenzhen Science and Technology Innovation Commission (no. SGDX2019081623281169).	Arbabi A, 2015, NAT NANOTECHNOL, V10, P937, DOI [10.1038/nnano.2015.186, 10.1038/NNANO.2015.186]; Aspuru-Guzik A, 2012, NAT PHYS, V8, P285, DOI [10.1038/NPHYS2253, 10.1038/nphys2253]; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Georgi P, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0182-6; Giovannetti V, 2011, NAT PHOTONICS, V5, P222, DOI [10.1038/NPHOTON.2011.35, 10.1038/nphoton.2011.35]; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Gisin N, 2007, NAT PHOTONICS, V1, P165, DOI 10.1038/nphoton.2007.22; Jha PK, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.025501; Khasminskaya S, 2016, NAT PHOTONICS, V10, P727, DOI [10.1038/NPHOTON.2016.178, 10.1038/nphoton.2016.178]; Khorasaninejad M, 2016, SCIENCE, V352, P1190, DOI 10.1126/science.aaf6644; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Lin RJ, 2019, NAT NANOTECHNOL, V14, P227, DOI 10.1038/s41565-018-0347-0; Lo HK, 2014, NAT PHOTONICS, V8, P595, DOI 10.1038/NPHOTON.2014.149; Malik M, 2016, NAT PHOTONICS, V10, P248, DOI [10.1038/nphoton.2016.12, 10.1038/NPHOTON.2016.12]; Niu XL, 2008, OPT LETT, V33, P968, DOI 10.1364/OL.33.000968; O'Brien JL, 2007, SCIENCE, V318, P1567, DOI 10.1126/science.1142892; Pirandola S, 2018, NAT PHOTONICS, V12, P724, DOI 10.1038/s41566-018-0301-6; Scarani V, 2009, REV MOD PHYS, V81, P1301, DOI 10.1103/RevModPhys.81.1301; Stay T., 2018, SCIENCE, V361, P1101; Tang H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat3174; Wang H, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.250503; Wang JW, 2018, SCIENCE, V360, P285, DOI 10.1126/science.aar7053; Wang K, 2018, SCIENCE, V361, P1104, DOI 10.1126/science.aat8196; Wang SM, 2018, NAT NANOTECHNOL, V13, P227, DOI 10.1038/s41565-017-0052-4; Wang SM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00166-7; Yu NF, 2014, NAT MATER, V13, P139, DOI [10.1038/nmat3839, 10.1038/NMAT3839]; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zheng GX, 2015, NAT NANOTECHNOL, V10, P308, DOI [10.1038/nnano.2015.2, 10.1038/NNANO.2015.2]	28	126	135	58	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1487	+		10.1126/science.aba9779	http://dx.doi.org/10.1126/science.aba9779			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF3SA	32587020				2022-12-28	WOS:000545264600043
J	Park, J; Fu, ZA; Frangaj, A; Liu, J; Mosyak, L; Shen, T; Slavkovich, VN; Ray, KM; Taura, J; Cao, B; Geng, Y; Zuo, H; Kou, YJ; Grassucci, R; Chen, SX; Liu, Z; Lin, X; Williams, JP; Rice, WJ; Eng, ET; Huang, RK; Soni, RK; Kloss, B; Yu, ZH; Javitch, JA; Hendrickson, WA; Slesinger, PA; Quick, M; Graziano, J; Yu, HT; Fiehn, O; Clarke, OB; Frank, J; Fan, QR				Park, Jinseo; Fu, Ziao; Frangaj, Aurel; Liu, Jonathan; Mosyak, Lidia; Shen, Tong; Slavkovich, Vesna N.; Ray, Kimberly M.; Taura, Jaume; Cao, Baohua; Geng, Yong; Zuo, Hao; Kou, Yongjun; Grassucci, Robert; Chen, Shaoxia; Liu, Zheng; Lin, Xin; Williams, Justin P.; Rice, William J.; Eng, Edward T.; Huang, Rick K.; Soni, Rajesh K.; Kloss, Brian; Yu, Zhiheng; Javitch, Jonathan A.; Hendrickson, Wayne A.; Slesinger, Paul A.; Quick, Matthias; Graziano, Joseph; Yu, Hongtao; Fiehn, Oliver; Clarke, Oliver B.; Frank, Joachim; Fan, Qing R.			Structure of human GABA(B) receptor in an inactive state	NATURE			English	Article							CRYO-EM; CRYSTAL-STRUCTURE; GB2 SUBUNITS; EXPRESSION; VISUALIZATION; TRAFFICKING; VALIDATION; RHODOPSIN; PROTEINS; DOMAIN	The human GABA(B) receptor-a member of the class C family of G-protein-coupled receptors (GPCRs)-mediates inhibitory neurotransmission and has been implicated in epilepsy, pain and addiction(1). A unique GPCR that is known to require heterodimerization for function(2-6), the GABA(B) receptor has two subunits, GABA(B1) and GABA(B2), that are structurally homologous but perform distinct and complementary functions. GABA(B1) recognizes orthosteric ligands(7,8), while GABA(B2) couples with G proteins(9-14). Each subunit is characterized by an extracellular Venus flytrap (VFT) module, a descending peptide linker, a seven-helix transmembrane domain and a cytoplasmic tail(15). Although the VFT heterodimer structure has been resolved(16), the structure of the full-length receptor and its transmembrane signalling mechanism remain unknown. Here we present a near full-length structure of the GABA(B) receptor at atomic resolution, captured in an inactive state by cryo-electron microscopy. Our structure reveals several ligands that preassociate with the receptor, including two large endogenous phospholipids that are embedded within the transmembrane domains to maintain receptor integrity and modulate receptor function. We also identify a previously unknown heterodimer interface between transmembrane helices 3 and 5 of both subunits, which serves as a signature of the inactive conformation. A unique 'intersubunit latch' within this transmembrane interface maintains the inactive state, and its disruption leads to constitutive receptor activity. The structure of the GABA(B) receptor in an inactive state reveals, amongst other features, a latch between the two subunits that locks the transmembrane domain interface, and the presence of large phospholipids that may modulate receptor function.	[Park, Jinseo; Frangaj, Aurel; Liu, Jonathan; Mosyak, Lidia; Ray, Kimberly M.; Cao, Baohua; Zuo, Hao; Javitch, Jonathan A.; Fan, Qing R.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Fu, Ziao; Grassucci, Robert; Liu, Zheng; Hendrickson, Wayne A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Shen, Tong; Fiehn, Oliver] Univ Calif Davis, NIH West Coast Metab Ctr, Davis, CA 95616 USA; [Slavkovich, Vesna N.; Graziano, Joseph] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Taura, Jaume; Slesinger, Paul A.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Nash Family Dept Neurosci, New York, NY 10029 USA; [Geng, Yong; Kou, Yongjun] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Struct & Funct Drug Targets, Key Lab Receptor Res, Shanghai, Peoples R China; [Chen, Shaoxia] MRC Lab Mol Biol, Cambridge, England; [Lin, Xin; Javitch, Jonathan A.; Quick, Matthias] Columbia Univ, Dept Psychiat, New York, NY USA; [Lin, Xin; Javitch, Jonathan A.; Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Williams, Justin P.; Javitch, Jonathan A.; Hendrickson, Wayne A.; Clarke, Oliver B.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Rice, William J.; Eng, Edward T.] New York Struct Biol Ctr, Simons Electron Microscopy Ctr, Natl Resource Automated Mol Microscopy, New York, NY USA; [Huang, Rick K.; Yu, Zhiheng] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Soni, Rajesh K.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Prote Shared Resource, New York, NY USA; [Kloss, Brian; Hendrickson, Wayne A.] New York Struct Biol Ctr, Ctr Membrane Prot Prod & Anal, New York, NY USA; [Yu, Hongtao] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Clarke, Oliver B.] Columbia Univ, Dept Anesthesiol, New York, NY 10032 USA; [Clarke, Oliver B.] Columbia Univ, Irving Inst Clin & Translat Res, New York, NY 10032 USA; [Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Fan, Qing R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University; University of California System; University of California Davis; Columbia University; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; MRC Laboratory Molecular Biology; Columbia University; New York State Psychiatry Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; Columbia University; Columbia University; Columbia University	Fan, QR (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.; Frank, J (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.; Clarke, OB (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.; Clarke, OB (corresponding author), Columbia Univ, Dept Anesthesiol, New York, NY 10032 USA.; Clarke, OB (corresponding author), Columbia Univ, Irving Inst Clin & Translat Res, New York, NY 10032 USA.; Frank, J (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.; Fan, QR (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	oc2188@cumc.columbia.edu; jf2192@cumc.columbia.edu; qf13@cumc.columbia.edu	Lin, Xin/ABA-2496-2021; Fu, Ziao/K-8758-2017	Eng, Edward/0000-0002-8014-7269; Fu, Ziao/0000-0001-5036-1945; Zuo, Hao/0000-0002-8812-7385; Rice, William/0000-0002-5187-255X	Simons Foundation [SF349247]; NYSTAR; National Institutes of Health (NIH) [GM103310]; NIH [R01GM088454, R01GM125801, R01GM107462, P41GM116799, U2C ES030158]; MRC [MC_U105184326] Funding Source: UKRI	Simons Foundation; NYSTAR; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Henderson for early-stage cryo-EM investigation and critical reading of the manuscript; C. S. Zuker for advice and financial support; C. Karan and R. Realubit for assistance with the EnVision plate reader at Columbia Genome Center; A. Sobolevsky, K. Saotome and E. Cao for BacMam vectors; Y. H. Wong for a Gaqi5 chimera plasmid; and B. K. Kobilka and B. Skiniotis for advice. Titan Krios data collection was performed at the Simons Electron Microscopy Center, directed by B. O. Carragher and C. Potter, supported by grants from the Simons Foundation (SF349247), NYSTAR and the National Institutes of Health (NIH; GM103310). This work was supported by NIH grants R01GM088454 (to Q.R.F.), R01GM125801 (to Q.R.F., P.A.S. and M.Q.), R01GM107462 (to W.A.H.), P41GM116799 (to W.A.H.), and U2C ES030158 for lipid identification (to O.F.). Q.R.F. was an Irma Hirschl Career Scientist, Pew Scholar, McKnight Scholar and Schaefer Scholar.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Burmakina S, 2014, P NATL ACAD SCI USA, V111, P6958, DOI 10.1073/pnas.1400081111; Chen KLB, 1999, BIOL TRACE ELEM RES, V67, P109, DOI 10.1007/BF02784067; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; Geng Y, 2012, NAT NEUROSCI, V15, P970, DOI 10.1038/nn.3133; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Gupta K, 2018, NAT PROTOC, V13, P1106, DOI 10.1038/nprot.2018.014; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Koehl A, 2019, NATURE, V566, P79, DOI 10.1038/s41586-019-0881-4; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Mafu S, 2017, P NATL ACAD SCI USA, V114, P974, DOI 10.1073/pnas.1612901114; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mukherjee RS, 2006, MOL PHARMACOL, V70, P1406, DOI 10.1124/mol.106.024463; Ng GYK, 1999, J BIOL CHEM, V274, P7607, DOI 10.1074/jbc.274.12.7607; Novotny M, 2004, PROTEINS, V54, P260, DOI 10.1002/prot.10553; Pagano A, 2001, J NEUROSCI, V21, P1189; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pin JP, 2016, NATURE, V540, P60, DOI 10.1038/nature20566; Pruszkowski E, 1998, ATOM SPECTROSC, V19, P111; Punjani A, 2020, BIORXIV, DOI [10.1101/2020.04.08.032466, DOI 10.1101/2020.04.08.032466(]; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Thal DM, 2018, NATURE, V559, P45, DOI 10.1038/s41586-018-0259-z; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xue L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10834-5; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	58	33	34	3	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2020	584	7820					304	+		10.1038/s41586-020-2452-0	http://dx.doi.org/10.1038/s41586-020-2452-0		JUN 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP3LE	32581365	Green Submitted, Green Accepted			2022-12-28	WOS:000556406500001
J	Gerada, C				Gerada, Clare			Clare Gerada: What to do with appraisal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gerada, Clare] Hurley Grp, London, England		Gerada, C (corresponding author), Hurley Grp, London, England.	clare.gerada@nhs.net						Colthart I, 2008, BRIT J GEN PRACT, V58, P82, DOI 10.3399/bjgp08X264036; Dale J, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0489-9	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2450	10.1136/bmj.m2450	http://dx.doi.org/10.1136/bmj.m2450			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571807	Bronze			2022-12-28	WOS:000548535700008
J	Wise, J				Wise, Jacqui			Medical cannabis: campaigner calls on home secretary to deliver on access promises	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HURLEY R, 2018, BMJ-BRIT MED J, V361, P18960, DOI DOI 10.1136/BMJ.K2695	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2020	369								m2508	10.1136/bmj.m2508	http://dx.doi.org/10.1136/bmj.m2508			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1GV	32571806				2022-12-28	WOS:000548535700012
J	Srivastava, AB; Mariani, JJ; Levin, FR				Srivastava, A. Benjamin; Mariani, John J.; Levin, Frances R.			New directions in the treatment of opioid withdrawal	LANCET			English	Review							MEDICATION-ASSISTED TREATMENT; DOUBLE-BLIND; USE DISORDER; BUPRENORPHINE-NALOXONE; EXTENDED-RELEASE; UNITED-STATES; CHRONIC PAIN; DRUG; GABAPENTIN; PLACEBO	The treatment of opioid withdrawal is an important area of clinical concern when treating patients with chronic, non-cancer pain, patients with active opioid use disorder, and patients receiving medication for opioid use disorder. Current standards of care for medically supervised withdrawal include treatment with mu-opioid receptor agonists, (eg, methadone), partial agonists (eg, buprenorphine), and a2-adrenergic receptor agonists (eg, clonidine and lofexidine). Newer agents likewise exploit these pharmacological mechanisms, including tramadol (mu-opioid receptor agonism) and tizanidine (alpha 2 agonism). Areas for future research include managing withdrawal in the context of stabilising patients with opioid use disorder to extended-release naltrexone, transitioning patients with opioid use disorder from methadone to buprenorphine, and tapering opioids in patients with chronic, non-cancer pain.	[Srivastava, A. Benjamin; Mariani, John J.; Levin, Frances R.] Columbia Univ, NewYork State Psychiat Inst, Div Subst Use Disorders, Dept Psychiat,Irving Med Ctr, New York, NY 10023 USA	Columbia University; NewYork-Presbyterian Hospital; New York State Psychiatry Institute	Srivastava, AB (corresponding author), Columbia Univ, NewYork State Psychiat Inst, Div Subst Use Disorders, Dept Psychiat,Irving Med Ctr, New York, NY 10023 USA.	benjamin.srivastava@nyspi.columbia.edu			US National Institutes of Drug Abuse [T32 DA007294-26]	US National Institutes of Drug Abuse	This Therapeutics paper was primarily funded by the US National Institutes of Drug Abuse T32 DA007294-26 (FRL was the principal investigator).	Alper KR, 2008, J ETHNOPHARMACOL, V115, P9, DOI 10.1016/j.jep.2007.08.034; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Antonio T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077262; Arout CA, 2015, CNS DRUGS, V29, P465, DOI 10.1007/s40263-015-0255-x; Bisaga A, 2018, DRUG ALCOHOL DEPEN, V187, P171, DOI 10.1016/j.drugalcdep.2018.02.023; Bisaga A, 2018, AM J ADDICTION, V27, P177, DOI 10.1111/ajad.12711; Blanco C, 2019, LANCET, V393, P1760, DOI 10.1016/S0140-6736(18)33078-2; Boyer EW, 2008, ADDICTION, V103, P1048, DOI 10.1111/j.1360-0443.2008.02209.x; Brown TK, 2018, AM J DRUG ALCOHOL AB, V44, P24, DOI 10.1080/00952990.2017.1320802; Darke S, 2017, ADDICTION, V112, P199, DOI 10.1111/add.13512; DAY E, 2005, COCHRANE DB SYST REV, V2; Dematteis M, 2017, EXPERT OPIN PHARMACO, V18, P1987, DOI 10.1080/14656566.2017.1409722; Dirks J, 2002, ANESTHESIOLOGY, V97, P560, DOI 10.1097/00000542-200209000-00007; Doughty B, 2019, ANN PHARMACOTHER, V53, P746, DOI 10.1177/1060028019828954; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Drug Enforcement Administration Department of Justice, 2014, Fed Regist, V79, P37623; Dunn KE, 2017, JAMA PSYCHIAT, V74, P885, DOI 10.1001/jamapsychiatry.2017.1838; Eccleston C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010323.pub3; Fiellin DA, 2014, JAMA INTERN MED, V174, P1947, DOI 10.1001/jamainternmed.2014.5302; Fishman M, 2019, J ADDICT MED, V13, P169, DOI 10.1097/ADM.0000000000000474; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; GOLD MS, 1981, LANCET, V1, P621; Gorodetzky CW, 2017, DRUG ALCOHOL DEPEN, V176, P79, DOI 10.1016/j.drugalcdep.2017.02.020; Gowing L, 2017, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD002021.PUB4; Gowing L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002025.pub5; Gowing L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002024.pub5; Haight BR, 2019, LANCET, V393, P778, DOI 10.1016/S0140-6736(18)32259-1; JASINSKI DR, 1985, ARCH GEN PSYCHIAT, V42, P1063; Khazaeli A, 2018, J ADDICT MED, V12, P493, DOI 10.1097/ADM.0000000000000435; Kheirabadi GR, 2008, ADDICTION, V103, P1495, DOI 10.1111/j.1360-0443.2008.02248.x; Kheirabadi GR, 2018, ADDICT DISORD TREAT, V17, P55, DOI 10.1097/ADT.0000000000000127; Kleber Herbert D, 2007, Dialogues Clin Neurosci, V9, P455; Kosten TR, 2019, AM J ADDICTION, V28, P55, DOI 10.1111/ajad.12862; Kosten Thomas R, 2002, Sci Pract Perspect, V1, P13; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; KOSTEN TR, 1990, J NERV MENT DIS, V178, P217, DOI 10.1097/00005053-199004000-00001; Kraepelin E., 1899, PSYCHIAT LEHRBUCH ST; Kreek MJ, 2010, J ADDICT DIS, V29, P200, DOI 10.1080/10550881003684798; Kreek MJ, 2002, NEUROPSYCHOPHARMACOL; Lee JD, 2018, LANCET, V391, P309, DOI 10.1016/S0140-6736(17)32812-X; Lintzeris N, 2018, J ADDICT MED, V12, P234, DOI 10.1097/ADM.0000000000000396; Lofwall MR, 2018, JAMA INTERN MED, V178, P764, DOI 10.1001/jamainternmed.2018.1052; Maculaitis R, 2008, HUM EXP TOXICOL, V27, P181, DOI 10.1177/0960327107087802; Malcolm BJ, 2018, J PSYCHOACTIVE DRUGS, V50, P256, DOI 10.1080/02791072.2018.1447175; Mannelli Paolo, 2012, Curr Drug Abuse Rev, V5, P52; Matusow H, 2013, J SUBST ABUSE TREAT, V44, P473, DOI 10.1016/j.jsat.2012.10.004; Mazei-Robison MS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012070; McElrath K, 2018, SUBST USE MISUSE, V53, P334, DOI 10.1080/10826084.2017.1342662; Miettinen TJ, 1996, ANESTH ANALG, V82, P817, DOI 10.1097/00000539-199604000-00024; Naples JG, 2016, CLIN GERIATR MED, V32, P725, DOI 10.1016/j.cger.2016.06.006; National Institute of Diabetes and Digestive and Kidney Diseases, 2017, CLON; Noller GE, 2018, AM J DRUG ALCOHOL AB, V44, P37, DOI 10.1080/00952990.2017.1310218; Oesterle TS, 2019, MAYO CLIN PROC, V94, P2072, DOI 10.1016/j.mayocp.2019.03.029; Overbeek Daniel L, 2019, Clin Pract Cases Emerg Med, V3, P24, DOI 10.5811/cpcem.2018.11.40588; Prozialeck WC, 2012, J AM OSTEOPATH ASSOC, V112, P792; Roman PM, 2011, ADDICT BEHAV, V36, P584, DOI 10.1016/j.addbeh.2011.01.032; Rosenberg JM, 2018, PAIN MED, V19, P928, DOI 10.1093/pm/pnx203; Rosenthal RN, 2016, JAMA-J AM MED ASSOC, V316, P282, DOI 10.1001/jama.2016.9382; Rudolf G, 2018, AM J DRUG ALCOHOL AB, V44, P302, DOI 10.1080/00952990.2017.1334209; Salehi M, 2011, J CLIN PSYCHOPHARM, V31, P593, DOI 10.1097/JCP.0b013e31822bb378; Sanders NC, 2013, EXP CLIN PSYCHOPHARM, V21, P294, DOI 10.1037/a0033724; Sigmon SC, 2013, JAMA PSYCHIAT, V70, P1347, DOI 10.1001/jamapsychiatry.2013.2216; Sigmon SC, 2012, AM J DRUG ALCOHOL AB, V38, P187, DOI 10.3109/00952990.2011.653426; Stanciu CN, 2019, J PSYCHOACTIVE DRUGS, V51, P12, DOI 10.1080/02791072.2018.1562133; Taylor CP, 2007, EPILEPSY RES, V73, P137, DOI 10.1016/j.eplepsyres.2006.09.008; Terasaki D, 2019, PHARMACOTHERAPY, V39, P1023, DOI 10.1002/phar.2313; The Medical Letter, 2016, JAMA-J AM MED ASSOC, V316, P1820; Toce MS, 2018, J MED TOXICOL, V14, P306, DOI 10.1007/s13181-018-0685-1; Tofighi B, 2019, SUBST USE MISUSE, V54, P2409, DOI 10.1080/10826084.2019.1653324; U.S. Department of Health and Human Services,, 2019, PAIN MAN BEST PRACT; UK Home Office, 2019, LIST MOST COMM ENC D; United States Drug Enforcement Administration, 2019, DRUG SCHED; Vazzana M, 2015, BIOMED PHARMACOTHER, V70, P234, DOI 10.1016/j.biopha.2015.01.022; Vernon MK, 2016, ADDICT BEHAV, V60, P109, DOI 10.1016/j.addbeh.2016.03.028; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Weiss RD, 2014, J SUBST ABUSE TREAT, V47, P140, DOI 10.1016/j.jsat.2014.03.004; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; Winstock AR, 2009, DRUG ALCOHOL REV, V28, P686, DOI 10.1111/j.1465-3362.2009.00127.x; Woody GE, 2008, JAMA-J AM MED ASSOC, V300, P2003, DOI 10.1001/jama.2008.574; World Health Organization, 2007, SER ICD 10 INT STAT	80	27	27	2	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1938	1948						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563380	Green Accepted			2022-12-28	WOS:000552732200035
J	Huang, B; Tian, L; McCaw, ZR; Luo, XD; Talukder, E; Rothenberg, M; Xie, WL; Choueiri, TK; Kim, DH; Wei, LJ				Huang, Bo; Tian, Lu; McCaw, Zachary R.; Luo, Xiaodong; Talukder, Enayet; Rothenberg, Mace; Xie, Wanling; Choueiri, Toni K.; Kim, Dae Hyun; Wei, Lee-Jen			Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies	ANNALS OF INTERNAL MEDICINE			English	Article							RHEUMATOID-ARTHRITIS; INFERENCE; DURATION	In comparative studies, treatment effect is often assessed using a binary outcome that indicates response to the therapy. Commonly used summary measures for response include the cumulative and current response rates at a specific time point. The current response rate is sometimes called the probability of being in response (PBIR), which regards a patient as a responder only if they have achieved and remain in response at present. The methods used in practice for estimating these rates, however, may not be appropriate. Moreover, whereas an effective treatment is expected to achieve a rapid and sustained response, the response at a fixed time point does not provide information about the duration of response (DOR). As an alternative, a curve constructed from the current response rates over the entire study period may be considered, which can be used for visualizing how rapidly patients responded to therapy and how long responses were sustained. The area under the PBIR curve is the mean DOR. This connection between response and DOR makes this curve attractive for assessing the treatment effect. In contrast to the conventional method for analyzing the DOR data, which uses responders only, the above procedure includes all patients in the study. Although discussed extensively in the statistical literature, estimation of the current response rate curve has garnered little attention in the medical literature. This article illustrates how to construct and analyze such a curve using data from a recent study for treating renal cell carcinoma. Clinical trialists are encouraged to consider this robust and clinically interpretable procedure as an additional tool for evaluating treatment effects in clinical studies.	[Huang, Bo; Talukder, Enayet] Pfizer, Groton, CT USA; [Tian, Lu] Stanford Univ, Stanford, CA 94305 USA; [McCaw, Zachary R.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Luo, Xiaodong] Sanofi, Bridgewater, NJ USA; [Rothenberg, Mace] Pfizer, New York, NY USA; [Xie, Wanling; Choueiri, Toni K.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Dae Hyun] Harvard Med Sch, Hebrew SeniorLife, Hinda & Arthur Marcus Inst Aging Res, Boston, MA 02115 USA; [Wei, Lee-Jen] Harvard Univ, 655 Huntington Ave, Boston, MA 02115 USA	Pfizer; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Sanofi-Aventis; Pfizer; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Hebrew SeniorLife; Harvard University	Wei, LJ (corresponding author), Harvard Univ, 655 Huntington Ave, Boston, MA 02115 USA.	wei@hsph.harvard.edu	McCaw, Zachary/GPW-8740-2022; Choueiri, Toni/K-5238-2019; Wei, Lee-Jen/CAI-0175-2022	Choueiri, Toni/0000-0002-9201-3217; McCaw, Zachary/0000-0002-2006-9828; tian, lu/0000-0002-5893-0169; Kim, Dae Hyun/0000-0001-7290-6838	National Institutes of Health; NIA [R21 AG060227]; NHLBI [R01 HL089778]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By grants and contracts from the National Institutes of Health, including NHLBI R01 HL089778 (L.T. and L.W.) and NIA R21 AG060227 (D.H.K. and L.W.).	Aaronson ST, 2017, AM J PSYCHIAT, V174, P640, DOI 10.1176/appi.ajp.2017.16010034; Barnett ML, 1998, ARTHRITIS RHEUM, V41, P290, DOI 10.1002/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; BEGG CB, 1982, BIOMETRICS, V38, P59, DOI 10.2307/2530288; Blumenthal GM, 2016, JAMA ONCOL, V2, P780, DOI 10.1001/jamaoncol.2015.6352; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellis S, 2008, CONTEMP CLIN TRIALS, V29, P456, DOI 10.1016/j.cct.2007.10.008; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1564, DOI 10.1002/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO;2-M; Gouskova NA, 2014, BIOMETRICS, V70, P441, DOI 10.1111/biom.12140; Huang B, 2018, JAMA ONCOL, V4, P874, DOI 10.1001/jamaoncol.2018.0275; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; MORGAN TM, 1988, CONTROL CLIN TRIALS, V9, P11, DOI 10.1016/0197-2456(88)90004-9; Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047; PEPE MS, 1991, J AM STAT ASSOC, V86, P770, DOI 10.2307/2290411; Pilie PG, 2019, LANCET, V393, P2362, DOI 10.1016/S0140-6736(19)30949-3; Rugo HS, 2017, JAMA-J AM MED ASSOC, V317, P37, DOI 10.1001/jama.2016.18305; Smolen JS, 2019, LANCET, V393, P2303, DOI 10.1016/S0140-6736(19)30419-2; TEMKIN NR, 1978, BIOMETRICS, V34, P571, DOI 10.2307/2530376; Tsai WY., 2017, FRONTIERS BIOSTATIST, P151; U.S. Food and Drug Administration, 2020, FDA APPR MIT LOW GRA; Uno H, 2019, JNCI CANCER SPECT, V3, DOI 10.1093/jncics/pkz058; US Food and Drug Administration, 2018, CLIN TRIAL ENDP APPR	23	9	9	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2020	173	5					368	+		10.7326/M20-0104	http://dx.doi.org/10.7326/M20-0104			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK9XI	32628533	Green Accepted			2022-12-28	WOS:000567080900011
J	Marks, PW; Hahn, S				Marks, Peter W.; Hahn, Stephen			Identifying the Risks of Unproven Regenerative Medicine Therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Marks, Peter W.; Hahn, Stephen] US FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Marks, PW (corresponding author), US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave,WO71-7232, Silver Spring, MD 20993 USA.	peter.marks@fda.hhs.gov						Cossu G, 2018, LANCET, V391, P883, DOI 10.1016/S0140-6736(17)31366-1; Food and Drug Administration, REP PROD PROBL COMPL; Food and Drug Administration, MEDWATCH FORMS FDA S; Knoepfler PS, 2019, REGEN MED, V14, P735, DOI 10.2217/rme-2019-0064; Kuriyan AE, 2017, NEW ENGL J MED, V376, P1047, DOI 10.1056/NEJMoa1609583; Rubin R, 2018, JAMA-J AM MED ASSOC, V320, P1421, DOI 10.1001/jama.2018.13861; Srivastava A, 2016, CYTOTHERAPY, V18, P117, DOI 10.1016/j.jcyt.2015.11.004	7	11	11	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2020	324	3					241	242		10.1001/jama.2020.9375	http://dx.doi.org/10.1001/jama.2020.9375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MU9CI	32629463				2022-12-28	WOS:000555963000013
J	Rollston, R; Wilkinson, E; Abouelazm, R; Mladenov, P; Horanieh, N; Jabbarpour, Y				Rollston, Rebekah; Wilkinson, Elizabeth; Abouelazm, Rasha; Mladenov, Petar; Horanieh, Nour; Jabbarpour, Yalda			Comprehensive sexuality education to address gender-based violence	LANCET			English	Editorial Material									[Rollston, Rebekah] Tufts Univ, Cambridge Hlth Alliance, Sch Med, Malden, MA 02148 USA; [Wilkinson, Elizabeth; Jabbarpour, Yalda] Robert Graham Ctr, Washington, DC USA; [Abouelazm, Rasha] United Nations Ent Gender Equal & Empowerment Wom, Cairo, Egypt; [Mladenov, Petar] United Nations Populat Fund UNFPA, Sofia, Bulgaria; [Horanieh, Nour] London Sch Hyg & Trop Med, London, England	Harvard University; Cambridge Health Alliance; Tufts University; University of London; London School of Hygiene & Tropical Medicine	Rollston, R (corresponding author), Tufts Univ, Cambridge Hlth Alliance, Sch Med, Malden, MA 02148 USA.	rrollston@challiance.org		Jabbarpour, Yalda/0000-0003-3147-7437				[Anonymous], 2020, UN LAUNCH COVID 19 P; Beachum L., 2019, WASH POST; Begum R, 2017, JORDAN TIMES    0401; Chandan JS, 2020, LANCET PUBLIC HEALTH, V5, pE309, DOI 10.1016/S2468-2667(20)30112-2; Ott H., 2020, CBS NEWS; Rollston R, 2020, ARCGIS; SIECUS, 2020, NAT SEX ED STAND; Soyong Harley C., 2019, SIECUS SEX SOCIAL CH; UN Women, 2020, COVID 19 END VIOL WO; UN Women, 2020, BRIEF OV UN VIOL WOM; UNESCO, 2018, INT TECHNICAL GUIDAN; UNFPA, 2006, Y PEER EMP YOUNG PEO; United Nations Educational Scientific and Cultural Organization (UNESCO), 2018, COMPR SEX ED PREV GE	13	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2020	396	10245					148	150		10.1016/S0140-6736(20)31477-X	http://dx.doi.org/10.1016/S0140-6736(20)31477-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MN8IK	32615078	Green Published, Bronze			2022-12-28	WOS:000551085400007
J	Mueller, C; Berry, JD; McKenna-Yasek, DM; Gernoux, G; Owegi, MA; Pothier, LM; Douthwright, CL; Gelevski, D; Luppino, SD; Blackwood, M; Wightman, NS; Oakley, DH; Frosch, MP; Flotte, TR; Cudkowicz, ME; Brown, RH				Mueller, Christian; Berry, James D.; McKenna-Yasek, Diane M.; Gernoux, Gwladys; Owegi, Margaret A.; Pothier, Lindsay M.; Douthwright, Catherine L.; Gelevski, Dario; Luppino, Sarah D.; Blackwood, Meghan; Wightman, Nicholas S.; Oakley, Derek H.; Frosch, Matthew P.; Flotte, Terrence R.; Cudkowicz, Merit E.; Brown, Robert H., Jr.			SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXTENDS SURVIVAL	Two patients with familial amyotrophic lateral sclerosis (ALS) and mutations in the gene encoding superoxide dismutase 1 (SOD1) were treated with a single intrathecal infusion of adeno-associated virus encoding a microRNA targeting SOD1. In Patient 1, SOD1 levels in spinal cord tissue as analyzed on autopsy were lower than corresponding levels in untreated patients with SOD1-mediated ALS and in healthy controls. Levels of SOD1 in cerebrospinal fluid were transiently and only slightly lower in Patient 1 but were not affected in Patient 2. In Patient 1, meningoradiculitis developed after the infusion; Patient 2 was pretreated with immunosuppressive drugs and did not have this complication. Patient 1 had transient improvement in the strength of his right leg, a measure that had been relatively stable throughout his disease course, but there was no change in his vital capacity. Patient 2 had stable scores on a composite measure of ALS function and a stable vital capacity during a 12-month period. This study showed that intrathecal microRNA can be used as a potential treatment for SOD1-mediated ALS. Two patients with amyotrophic lateral sclerosis caused by SOD1 mutations received an intrathecal infusion of adeno-associated virus containing microRNA targeting SOD1. SOD1 protein levels did not change in the patients' cerebrospinal fluid, but one patient had reduced spinal cord SOD1 expression.	[Mueller, Christian; Gernoux, Gwladys; Blackwood, Meghan; Flotte, Terrence R.] Univ Massachusetts Med Sch UMMS, Horae Gene Therapy Ctr, Dept Pediat, Worcester, MA USA; [McKenna-Yasek, Diane M.; Owegi, Margaret A.; Douthwright, Catherine L.; Wightman, Nicholas S.; Brown, Robert H., Jr.] UMMS, Dept Neurol, Worcester, MA USA; [McKenna-Yasek, Diane M.; Owegi, Margaret A.; Douthwright, Catherine L.; Wightman, Nicholas S.; Brown, Robert H., Jr.] UMass Mem Med Ctr, Worcester, MA USA; [Berry, James D.; Pothier, Lindsay M.; Gelevski, Dario; Luppino, Sarah D.; Frosch, Matthew P.; Cudkowicz, Merit E.] Massachusetts Gen Hosp, Dept Neurol, Healey Ctr ALS, Boston, MA 02114 USA; [Oakley, Derek H.; Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Brown, RH (corresponding author), Univ Massachusetts, Dept Neurol, Sch Med, S5-753,55 Lake Ave N, Worcester, MA 01655 USA.	robert.brown@umassmed.edu	Frosch, Matthew P/ABD-7456-2021; GERNOUX, Gwladys/D-3267-2019; Oakley, Derek/ABA-4689-2020; CUDKOWICZ, MERIT/GWM-6585-2022	Frosch, Matthew P/0000-0002-3940-9861; GERNOUX, Gwladys/0000-0002-1268-7001; Oakley, Derek/0000-0002-6998-9510; CUDKOWICZ, MERIT/0000-0002-7075-1681; Mueller, Christian/0000-0003-3589-8749; Blackwood, Meghan/0000-0002-3051-6548	Alzheimer's Association [2018-AASCF-592307]; Jack Satter Foundation Award; ALS Association; Angel Fund for ALS Research; ALS Finding a Cure; ALS-One; Project ALS; Massachusetts General Hospital SOD1 Fund; Max Rosenfeld and Cellucci Funds for ALS Research; National Institute on Aging [1P30AG062421]; National Institute of Neurological Disorders and Stroke [R01-NS088698, RO1-NS111990]	Alzheimer's Association(Alzheimer's Association); Jack Satter Foundation Award; ALS Association; Angel Fund for ALS Research; ALS Finding a Cure; ALS-One; Project ALS; Massachusetts General Hospital SOD1 Fund; Max Rosenfeld and Cellucci Funds for ALS Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a fellowship grant (2018-AASCF-592307, to Dr. Oakley) from the Alzheimer's Association and a Jack Satter Foundation Award; by the ALS Association, the Angel Fund for ALS Research, ALS Finding a Cure, ALS-One, Project ALS, the Massachusetts General Hospital SOD1 Fund, the Max Rosenfeld and Cellucci Funds for ALS Research, and several senior members of Bain Capital. The Massachusetts Alzheimer's Disease Research Center is supported by a grant (1P30AG062421, to Drs. Oakley and Frosch) from the National Institute on Aging. Drs. Mueller and Brown receive support from grants (R01-NS088698 and RO1-NS111990) from the National Institute of Neurological Disorders and Stroke.	ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; Andres PL, 2017, MUSCLE NERVE, V56, P710, DOI 10.1002/mus.25586; Andres PL, 2013, MUSCLE NERVE, V47, P177, DOI 10.1002/mus.23516; Andres PL, 2012, MUSCLE NERVE, V45, P81, DOI 10.1002/mus.22253; Borel F, 2016, HUM GENE THER, V27, P19, DOI 10.1089/hum.2015.122; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1016/S0140-6736(10)61156-7, 10.1056/NEJMc1710379, 10.1038/nrdp.2017.85, 10.1016/S0140-6736(17)31287-4]; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Corti M, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.33; Foust KD, 2013, MOL THER, V21, P2148, DOI 10.1038/mt.2013.211; Hinderer C, 2018, HUM GENE THER, V29, P285, DOI 10.1089/hum.2018.015; Keeler AM, 2020, MOL THER-METH CLIN D, V17, P246, DOI 10.1016/j.omtm.2019.12.007; McCampbell A, 2018, J CLIN INVEST, V128, P3558, DOI 10.1172/JCI99081; Miller T, 2020, NEW ENGL J MED, V383, P109, DOI 10.1056/NEJMoa2003715; Stoica L, 2016, ANN NEUROL, V79, P687, DOI 10.1002/ana.24618; White MA, 2018, NAT NEUROSCI, V21, P552, DOI 10.1038/s41593-018-0113-5; 2018, CURR OPIN TOXICOL, V10, pEAAU6	17	79	81	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2020	383	2					151	158		10.1056/NEJMoa2005056	http://dx.doi.org/10.1056/NEJMoa2005056			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9PO	32640133	Bronze			2022-12-28	WOS:000571894800014
J	Torjesen, I				Torjesen, Ingrid			Covid-19: One in 10 cases in England occurred in frontline health and social care staff	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal Society DELVE Initiative, 2020, SCOP REP HOSP HLTH C	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2717	10.1136/bmj.m2717	http://dx.doi.org/10.1136/bmj.m2717			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636187	Bronze			2022-12-28	WOS:000548155700006
J	Ginsburg, O; Horton, R				Ginsburg, Ophira; Horton, Richard			A Lancet Commission on women and cancer	LANCET			English	Editorial Material									[Ginsburg, Ophira] NYU, Grossman Sch Med, Dept Populat Hlth, Sect Global Hlth, New York, NY 10016 USA; [Ginsburg, Ophira] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY 10016 USA; [Horton, Richard] The Lancet, London, England	New York University; NYU Langone Medical Center	Ginsburg, O (corresponding author), NYU, Grossman Sch Med, Dept Populat Hlth, Sect Global Hlth, New York, NY 10016 USA.; Ginsburg, O (corresponding author), NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY 10016 USA.	ophira.ginsburg@nyulangone.org		Ginsburg, Ophira/0000-0002-1384-2675				Arnold M, 2015, CANC OBESITY GLOBAL; Azenha GS, 2013, B WORLD HEALTH ORGAN, V91, P704, DOI 10.2471/BLT.13.117622; Bachelet M, 2017, LANCET, V389, P773, DOI [10.1016/S0140-6736(16)31800-1, 10.1016/S0140-6736(17)30071-5]; Bhadelia A, 2012, CLOSING CANC DIVIDE; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Ferlay J, 2018, CANC INCIDENCE FIVE; Ginsburg O, 2017, LANCET, V389, P847, DOI [10.1016/S0140-6736(16)31392-7, 10.1]; International Agency for Research on Cancer, 2019, WHO CLASSIFICATION T; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; Starrs AM, 2018, LANCET, V391, P2642, DOI 10.1016/S0140-6736(18)30293-9; Vega RBM, 2019, CANCER-AM CANCER SOC, V125, P109, DOI 10.1002/cncr.31780; WHO, 2018, WHO DIR GEN CALLS AL; World Health Organization, 2018, INT CLASS FUNCT DIS; World Health Organization (WHO), 2017, TACKL NCDS BEST BUYS	14	1	1	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					11	13						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32622382				2022-12-28	WOS:000561626100022
J	Kapp, C; Feller-Kopman, D				Kapp, Christopher; Feller-Kopman, David			Ambulatory management of primary spontaneous pneumothorax: when less is more	LANCET			English	Editorial Material									[Kapp, Christopher; Feller-Kopman, David] Johns Hopkins Univ Hosp, Div Pulm & Crit Care Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Feller-Kopman, D (corresponding author), Johns Hopkins Univ Hosp, Div Pulm & Crit Care Med, Baltimore, MD 21287 USA.	dfk@jhmi.edu	Kapp, Chris/AAC-2615-2022	Feller-Kopman, David/0000-0002-9008-3617				Baumann MH, 2001, CHEST, V119, P590, DOI 10.1378/chest.119.2.590; Bintcliffe OJ, 2015, LANCET RESP MED, V3, P578, DOI 10.1016/S2213-2600(15)00220-9; Brown SGA, 2020, NEW ENGL J MED, V382, P405, DOI 10.1056/NEJMoa1910775; Feller-Kopman D, 2018, NEW ENGL J MED, V378, P740, DOI 10.1056/NEJMra1403503; Gupta D, 2000, THORAX, V55, P666, DOI 10.1136/thorax.55.8.666; Hallifax RJ, 2020, LANCET, V396, P39, DOI 10.1016/S0140-6736(20)31043-6; Hallifax RJ, 2018, JAMA-J AM MED ASSOC, V320, P1471, DOI 10.1001/jama.2018.14299; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; SCHOENENBERGER RA, 1991, ARCH SURG-CHICAGO, V126, P764; STRADLING P, 1966, THORAX, V21, P145, DOI 10.1136/thx.21.2.145; Thelle A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01296-2016	11	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2020	396	10243					4	5						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ND0VO	32622395	hybrid			2022-12-28	WOS:000561626100004
J	Barrangou, R; Sontheimer, EJ				Barrangou, Rodolphe; Sontheimer, Erik J.			Shutting down RNA-targeting CRISPR	SCIENCE			English	Editorial Material									[Barrangou, Rodolphe] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA; [Sontheimer, Erik J.] Univ Massachusetts, Med Sch, RNA Therapeut Inst, Worcester, MA 01605 USA	University of North Carolina; North Carolina State University; University of Massachusetts System; University of Massachusetts Worcester	Barrangou, R (corresponding author), North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	rbarran@ncsu.edu; erik.sontheimer@umassmed.edu	Barrangou, Rodolphe/I-2878-2014	Barrangou, Rodolphe/0000-0002-0648-3504	NIGMS NIH HHS [R01 GM125797] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Ackerman CM, 2020, NATURE, V582, P277, DOI 10.1038/s41586-020-2279-8; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Borges AL, 2018, CELL, V174, P917, DOI 10.1016/j.cell.2018.06.013; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Davidson AR, 2020, ANNU REV BIOCHEM, V89, P309, DOI 10.1146/annurev-biochem-011420-111224; Landsberger M, 2018, CELL, V174, P908, DOI 10.1016/j.cell.2018.05.058; Lin P, 2020, MOL CELL, V78, P850, DOI 10.1016/j.molcel.2020.03.033; Makarova KS, 2020, NAT REV MICROBIOL, V18, P67, DOI 10.1038/s41579-019-0299-x; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meeske AJ, 2020, SCIENCE, V369, P54, DOI 10.1126/science.abb6151; Meeske AJ, 2019, NATURE, V570, P241, DOI 10.1038/s41586-019-1257-5	14	1	1	4	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					31	32		10.1126/science.abc8243	http://dx.doi.org/10.1126/science.abc8243			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MK4IZ	32631881				2022-12-28	WOS:000548751700033
J	Barran, P				Barran, Perdita			Action spectra of chiral secondary structure	SCIENCE			English	Editorial Material									[Barran, Perdita] Univ Manchester, Dept Chem, Manchester, Lancs, England; [Barran, Perdita] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Manchester; University of Manchester	Barran, P (corresponding author), Univ Manchester, Dept Chem, Manchester, Lancs, England.; Barran, P (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	perdita.barran@manchester.ac.uk	Barran, Perdita/AAY-6303-2021					Biot J.-B., 1836, MEMOIRES ACAD, V15, P93; Daly S, 2020, SCIENCE, V368, P1465, DOI 10.1126/science.abb1822; Pasteur L, 1848, CR HEBD ACAD SCI, V26, P535; Porrini M, 2017, ACS CENTRAL SCI, V3, P454, DOI 10.1021/acscentsci.7b00084	4	0	0	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1426	1427		10.1126/science.abc1294	http://dx.doi.org/10.1126/science.abc1294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587006				2022-12-28	WOS:000545264600021
J	Hong, S; Lee, CS; Lee, MH; Lee, Y; Ma, KY; Kim, G; Yoon, SI; Ihm, K; Kim, KJ; Shin, TJ; Kim, SW; Jeon, EC; Jeon, H; Kim, JY; Lee, HI; Lee, Z; Antidormi, A; Roche, S; Chhowalla, M; Shin, HJ; Shin, HS				Hong, Seokmo; Lee, Chang-Seok; Lee, Min-Hyun; Lee, Yeongdong; Ma, Kyung Yeol; Kim, Gwangwoo; Yoon, Seong In; Ihm, Kyuwook; Kim, Ki-Jeong; Shin, Tae Joo; Kim, Sang Won; Jeon, Eun-chae; Jeon, Hansol; Kim, Ju-Young; Lee, Hyung-Ik; Lee, Zonghoon; Antidormi, Aleandro; Roche, Stephan; Chhowalla, Manish; Shin, Hyeon-Jin; Shin, Hyeon Suk			Ultralow-dielectric-constant amorphous boron nitride	NATURE			English	Article								Decrease in processing speed due to increased resistance and capacitance delay is a major obstacle for the down-scaling of electronics(1-3). Minimizing the dimensions of interconnects (metal wires that connect different electronic components on a chip) is crucial for the miniaturization of devices. Interconnects are isolated from each other by non-conducting (dielectric) layers. So far, research has mostly focused on decreasing the resistance of scaled interconnects because integration of dielectrics using low-temperature deposition processes compatible with complementary metal-oxide-semiconductors is technically challenging. Interconnect isolation materials must have low relative dielectric constants (kappa values), serve as diffusion barriers against the migration of metal into semiconductors, and be thermally, chemically and mechanically stable. Specifically, the International Roadmap for Devices and Systems recommends(4) the development of dielectrics with kappa values of less than 2 by 2028. Existing low-kappa materials (such as silicon oxide derivatives, organic compounds and aerogels) have kappa values greater than 2 and poor thermo-mechanical properties(5). Here we report three-nanometre-thick amorphous boron nitride films with ultralow kappa values of 1.78 and 1.16 (close to that of air, kappa = 1) at operation frequencies of 100 kilohertz and 1 megahertz, respectively. The films are mechanically and electrically robust, with a breakdown strength of 7.3 megavolts per centimetre, which exceeds requirements. Cross-sectional imaging reveals that amorphous boron nitride prevents the diffusion of cobalt atoms into silicon under very harsh conditions, in contrast to reference barriers. Our results demonstrate that amorphous boron nitride has excellent low-kappa dielectric characteristics for high-performance electronics.	[Hong, Seokmo; Kim, Gwangwoo; Shin, Tae Joo; Shin, Hyeon Suk] Ulsan Natl Inst Sci & Technol UNIST, Dept Chem, Ulsan, South Korea; [Lee, Chang-Seok; Lee, Min-Hyun; Kim, Sang Won; Shin, Hyeon-Jin] Samsung Adv Inst Technol SAIT, Inorgan Mat Lab, Suwon, South Korea; [Lee, Yeongdong; Jeon, Hansol; Kim, Ju-Young; Lee, Zonghoon] Ulsan Natl Inst Sci & Technol UNIST, Sch Mat Sci & Engn, Ulsan, South Korea; [Lee, Yeongdong; Ma, Kyung Yeol; Yoon, Seong In; Lee, Zonghoon; Shin, Hyeon Suk] Inst Basic Sci IBS, Ctr Multidimens Carbon Mat, Ulsan, South Korea; [Ma, Kyung Yeol; Yoon, Seong In; Shin, Hyeon Suk] Ulsan Natl Inst Sci & Technol UNIST, Dept Energy Engn, Ulsan, South Korea; [Ihm, Kyuwook; Kim, Ki-Jeong] Pohang Accelerator Lab, Gyeongbuk, South Korea; [Shin, Tae Joo] UNIST Cent Res Facil, Ulsan, South Korea; [Jeon, Eun-chae] Univ Ulsan, Sch Mat Sci & Engn, Ulsan, South Korea; [Lee, Hyung-Ik] Samsung Adv Inst Technol SAIT, Analyt Engn Grp, Suwon, South Korea; [Antidormi, Aleandro; Roche, Stephan] CSIC, Catalan Inst Nanosci & Nanotechnol ICN2, Barcelona, Spain; [Antidormi, Aleandro; Roche, Stephan] BIST, Barcelona, Spain; [Roche, Stephan] Inst Catalana Recerca Estudis Avancats ICREA, Barcelona, Spain; [Chhowalla, Manish] Univ Cambridge, Dept Mat Sci Met, Cambridge, England; [Shin, Hyeon Suk] Ulsan Natl Inst Sci & Technol UNIST, Low Dimens Carbon Mat Ctr, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Samsung; Ulsan National Institute of Science & Technology (UNIST); Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST); Pohang University of Science & Technology (POSTECH); Ulsan National Institute of Science & Technology (UNIST); University of Ulsan; Samsung; Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Consejo Superior de Investigaciones Cientificas (CSIC); Barcelona Institute of Science & Technology; ICREA; University of Cambridge; Ulsan National Institute of Science & Technology (UNIST)	Shin, HS (corresponding author), Ulsan Natl Inst Sci & Technol UNIST, Dept Chem, Ulsan, South Korea.; Shin, HJ (corresponding author), Samsung Adv Inst Technol SAIT, Inorgan Mat Lab, Suwon, South Korea.; Shin, HS (corresponding author), Inst Basic Sci IBS, Ctr Multidimens Carbon Mat, Ulsan, South Korea.; Chhowalla, M (corresponding author), Univ Cambridge, Dept Mat Sci Met, Cambridge, England.; Shin, HS (corresponding author), Ulsan Natl Inst Sci & Technol UNIST, Low Dimens Carbon Mat Ctr, Ulsan, South Korea.	mc209@cam.ac.uk; hyeonjin.shin@samsung.com; shin@unist.ac.kr	Kim, Gwangwoo/GRF-2194-2022; Shin, Hyeon Suk/E-5901-2010; Antidormi, Aleandro/AAB-5617-2021; Lee, Zonghoon/G-1474-2011; Roche, Stephan/B-1116-2012; Shin, Hyeon-Jin/AAK-2278-2021	Kim, Gwangwoo/0000-0001-8519-4411; Antidormi, Aleandro/0000-0002-5266-8147; Lee, Zonghoon/0000-0003-3246-4072; Roche, Stephan/0000-0003-0323-4665; Shin, Hyeon-Jin/0000-0002-6992-6341; Lee, Yeongdong/0000-0001-9749-5270	Samsung Electronics (Samsung-SKKU Graphene/2D Center); IBS [IBS-R-019-D1]; Centre for Advanced Soft Electronics under the Global Frontier Research Program via the National Research Foundation of the Ministry of Science and ICT, South Korea [CASE-2013M3A6A5073173]; Ministry of Science and ICT; POSTECH; UNIST; European Union Horizon 2020 research and innovation programme [785219, 881603]; Project MECHANIC - Ministerio de Ciencia, Innovacion y Universidades [PCI2018-093120]; CERCA Programme/Generalitat de Catalunya; Severo Ochoa Centres of Excellence programme - Spanish Research Agency [SEV-20170706]; Leverhulme Trust Research Grant [RPG-2019-227];  [NRF-2017R1E1A1A01074493];  [NRF-2019R1A4A1027934]	Samsung Electronics (Samsung-SKKU Graphene/2D Center)(Samsung); IBS; Centre for Advanced Soft Electronics under the Global Frontier Research Program via the National Research Foundation of the Ministry of Science and ICT, South Korea; Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); POSTECH; UNIST; European Union Horizon 2020 research and innovation programme; Project MECHANIC - Ministerio de Ciencia, Innovacion y Universidades; CERCA Programme/Generalitat de Catalunya; Severo Ochoa Centres of Excellence programme - Spanish Research Agency; Leverhulme Trust Research Grant(Leverhulme Trust); ; 	We thank UNIST Central Research Facilities (UCRF) and Y. K. Kim for the cross-sectional high-resolution TEM images. This work was supported by Samsung Electronics (Samsung-SKKU Graphene/2D Center), the research fund (NRF-2017R1E1A1A01074493 and NRF-2019R1A4A1027934), the IBS (IBS-R-019-D1) and a grant (CASE-2013M3A6A5073173) from the Centre for Advanced Soft Electronics under the Global Frontier Research Program via the National Research Foundation of the Ministry of Science and ICT, South Korea. The NEXAFS experiments performed at the 4D, 6D and 10A2 beamlines of the Pohang Accelerator Laboratory (PAL) were supported in part by the Ministry of Science and ICT, POSTECH and UNIST. M.C. acknowledges support from Leverhulme Trust Research Grant RPG-2019-227. S.R., A.A. and M.C. acknowledge the European Union Horizon 2020 research and innovation programme for grant number 785219 and 881603 (Graphene Flagship). A.A. is supported by Project MECHANIC (PCI2018-093120) funded by Ministerio de Ciencia, Innovacion y Universidades. The Catalan Institute of Nanoscience and Nanotechnology is funded by the CERCA Programme/Generalitat de Catalunya and supported by the Severo Ochoa Centres of Excellence programme, funded by the Spanish Research Agency (grant number SEV-20170706).	Akinwande D, 2019, NATURE, V573, P507, DOI 10.1038/s41586-019-1573-9; Al-Ghalith J, 2016, J PHYS CHEM C, V120, P24346, DOI 10.1021/acs.jpcc.6b07507; [Anonymous], 2017, NAT NANOTECHNOL, V12, P1105, DOI 10.1038/nnano.2017.237; Brandrup J., 2004, POLYM HDB; Chang SY, 2004, THIN SOLID FILMS, V460, P167, DOI 10.1016/j.tsf.2004.01.074; Cheng Y.-L, 2018, NANOPOROUS MAT POROU; Das A, 2002, MICROELECTRON ENG, V64, P25, DOI 10.1016/S0167-9317(02)00768-2; del Alamo JA, 2011, NATURE, V479, P317, DOI 10.1038/nature10677; DHARMAWARDANA MWC, 1976, J PHYS A-MATH GEN, V9, pL93, DOI 10.1088/0305-4470/9/8/003; Franklin AD, 2015, SCIENCE, V349, DOI 10.1126/science.aab2750; Glavin NR, 2016, ADV FUNCT MATER, V26, P2640, DOI 10.1002/adfm.201505455; Grill A, 2003, J APPL PHYS, V93, P1785, DOI 10.1063/1.1534628; Grill A, 2016, J VAC SCI TECHNOL B, V34, DOI 10.1116/1.4943049; Hatton BD, 2006, MATER TODAY, V9, P22, DOI 10.1016/S1369-7021(06)71387-6; Im J., 2002, METALLIZATION POLYM, V2, P53; IRDS, 2017, INT ROADM DEV SYST 2; IRTS, 2015, INT TECHN ROADM SEM; IRTS, 2015, INT TECHN ROADM SEM, P15; Jang AR, 2016, NANO LETT, V16, P3360, DOI 10.1021/acs.nanolett.6b01051; Jimenez I, 1997, PHYS REV B, V55, P12025, DOI 10.1103/PhysRevB.55.12025; Kim DY, 2017, AIP ADV, V7, DOI 10.1063/1.4982029; Kim G, 2013, NANO LETT, V13, P1834, DOI 10.1021/nl400559s; Kimura K, 2004, NUCL INSTRUM METH B, V219, P351, DOI 10.1016/j.nimb.2004.01.081; King SW, 2015, ECS J SOLID STATE SC, V4, pN3029, DOI 10.1149/2.0051501jss; Kitahara A., 2009, T MAT RES SOC JPN, V34, P613; Koenderink AF, 2015, SCIENCE, V348, P516, DOI 10.1126/science.1261243; Laturia A, 2018, NPJ 2D MATER APPL, V2, DOI 10.1038/s41699-018-0050-x; Lee HJ, 2004, J APPL PHYS, V95, P2355, DOI 10.1063/1.1641955; Li HY, 2005, MICROELECTRON RELIAB, V45, P1134, DOI 10.1016/j.microrel.2004.11.057; Ling X, 2011, J PHYS CHEM C, V115, P2835, DOI 10.1021/jp111502n; Liu CS, 2019, NAT NANOTECHNOL, V14, P662, DOI 10.1038/s41565-019-0462-6; Liu J, 2004, J APPL PHYS, V96, P6679, DOI 10.1063/1.1808909; Los JH, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.184108; Matsunaga K, 2001, J AM CERAM SOC, V84, P2213, DOI 10.1111/j.1151-2916.2001.tb00990.x; Pang B, 1999, NEW CVD PROCESS DAMA, P285; Plass MF, 1996, APPL PHYS LETT, V69, P46, DOI 10.1063/1.118113; Plimpton S., 2007, LAMMPS LARGE SCALE A; Sekhar N. V, 2012, NANOINDENTATION MAT; Shamiryan D, 2004, MATER TODAY, V7, P34, DOI 10.1016/S1369-7021(03)00052-X; TERSOFF J, 1988, PHYS REV B, V38, P9902, DOI 10.1103/PhysRevB.38.9902; Tyberg C, 2004, ACS SYM SER, V874, P161; Venema L, 2011, NATURE, V479, P309, DOI 10.1038/479309a; Volinsky A. A, 2002, MRS P, V750, P567; Xiang D, 2019, NAT NANOTECHNOL, V14, P642, DOI 10.1038/s41565-019-0476-0; Zhao L, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3664405	45	97	97	44	228	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					S11	+		10.1038/s41586-020-2375-9	http://dx.doi.org/10.1038/s41586-020-2375-9			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP4OT	32581381				2022-12-28	WOS:000623816400004
J	Ingelfinger, JR				Ingelfinger, Julie R.			Kinder, Gentler Dementia-Friendly Alzheimer's Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Alzheimer's Association, 2019, ALZH DIS FACTS FIG; Fazio S, 2018, GERONTOLOGIST, V58, pS1, DOI 10.1093/geront/gnx182; Jennings LA, 2019, JAMA INTERN MED, V179, P161, DOI 10.1001/jamainternmed.2018.5579; Powell T., 2019, DEMENTIA REIMAGINED; Zukerman E., 2019, FALLING CLOUD LYRICA	5	0	0	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2487	2489		10.1056/NEJMp2002140	http://dx.doi.org/10.1056/NEJMp2002140			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MF9CW	32579808				2022-12-28	WOS:000545636400018
J	Plavchan, P; Barclay, T; Gagne, J; Gao, P; Cale, B; Matzko, W; Dragomir, D; Quinn, S; Feliz, D; Stassun, K; Crossfield, IJM; Berardo, DA; Latham, DW; Tieu, B; Anglada-Escude, G; Ricker, G; Vanderspek, R; Seager, S; Winn, JN; Jenkins, JM; Rinehart, S; Krishnamurthy, A; Dynes, S; Doty, J; Adams, F; Afanasev, DA; Beichman, C; Bottom, M; Bowler, BP; Brinkworth, C; Brown, CJ; Cancino, A; Ciardi, DR; Clampin, M; Clark, JT; Collins, K; Davison, C; Foreman-Mackey, D; Furlan, E; Gaidos, EJ; Geneser, C; Giddens, F; Gilbert, E; Hall, R; Hellier, C; Henry, T; Horner, J; Howard, AW; Huang, C; Huber, J; Kane, SR; Kenworthy, M; Kielkopf, J; Kipping, D; Klenke, C; Kruse, E; Latouf, N; Lowrance, P; Mennesson, B; Mengel, M; Mills, SM; Morton, T; Narita, N; Newton, E; Nishimoto, A; Okumura, J; Palle, E; Pepper, J; Quintana, EV; Roberge, A; Roccatagliata, V; Schlieder, JE; Tanner, A; Teske, J; Tinney, CG; Vanderburg, A; von Braun, K; Walp, B; Wang, J; Wang, SX; Weigand, D; White, R; Wittenmyer, RA; Wright, DJ; Youngblood, A; Zhang, H; Zilberman, P				Plavchan, Peter; Barclay, Thomas; Gagne, Jonathan; Gao, Peter; Cale, Bryson; Matzko, William; Dragomir, Diana; Quinn, Sam; Feliz, Dax; Stassun, Keivan; Crossfield, Ian J. M.; Berardo, David A.; Latham, David W.; Tieu, Ben; Anglada-Escude, Guillem; Ricker, George; Vanderspek, Roland; Seager, Sara; Winn, Joshua N.; Jenkins, Jon M.; Rinehart, Stephen; Krishnamurthy, Akshata; Dynes, Scott; Doty, John; Adams, Fred; Afanasev, Dennis A.; Beichman, Chas; Bottom, Mike; Bowler, Brendan P.; Brinkworth, Carolyn; Brown, Carolyn J.; Cancino, Andrew; Ciardi, David R.; Clampin, Mark; Clark, Jake T.; Collins, Karen; Davison, Cassy; Foreman-Mackey, Daniel; Furlan, Elise; Gaidos, Eric J.; Geneser, Claire; Giddens, Frank; Gilbert, Emily; Hall, Ryan; Hellier, Coel; Henry, Todd; Horner, Jonathan; Howard, Andrew W.; Huang, Chelsea; Huber, Joseph; Kane, Stephen R.; Kenworthy, Matthew; Kielkopf, John; Kipping, David; Klenke, Chris; Kruse, Ethan; Latouf, Natasha; Lowrance, Patrick; Mennesson, Bertrand; Mengel, Matthew; Mills, Sean M.; Morton, Tim; Narita, Norio; Newton, Elisabeth; Nishimoto, America; Okumura, Jack; Palle, Enric; Pepper, Joshua; Quintana, Elisa V.; Roberge, Aki; Roccatagliata, Veronica; Schlieder, Joshua E.; Tanner, Angelle; Teske, Johanna; Tinney, C. G.; Vanderburg, Andrew; von Braun, Kaspar; Walp, Bernie; Wang, Jason; Wang, Sharon Xuesong; Weigand, Denise; White, Russel; Wittenmyer, Robert A.; Wright, Duncan J.; Youngblood, Allison; Zhang, Hui; Zilberman, Perri			A planet within the debris disk around the pre-main-sequence star AU Microscopii	NATURE			English	Article							LOW-MASS STARS; YOUNG; HOST	AU Microscopii (AU Mic) is the second closest pre-main-sequence star, at a distance of 9.79 parsecs and with an age of 22 million years(1). AU Mic possesses a relatively rare(2) and spatially resolved(3) edge-on debris disk extending from about 35 to 210 astronomical units from the star(4), and with clumps exhibiting non-Keplerian motion(5-7). Detection of newly formed planets around such a star is challenged by the presence of spots, plage, flares and other manifestations of magnetic 'activity' on the star(8,9). Here we report observations of a planet transiting AU Mic. The transiting planet, AU Mic b, has an orbital period of 8.46 days, an orbital distance of 0.07 astronomical units, a radius of 0.4 Jupiter radii, and a mass of less than 0.18 Jupiter masses at 3 sigma confidence. Our observations of a planet co-existing with a debris disk offer the opportunity to test the predictions of current models of planet formation and evolution.	[Plavchan, Peter; Cale, Bryson; Matzko, William; Tieu, Ben; Latouf, Natasha] George Mason Univ, Dept Phys & Astron, Fairfax, VA 22030 USA; [Barclay, Thomas] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21228 USA; [Gagne, Jonathan] Univ Montreal, Dept Phys, Inst Res Exoplanets, Montreal, PQ, Canada; [Gao, Peter; Wang, Jason] Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA; [Dragomir, Diana; Crossfield, Ian J. M.; Berardo, David A.; Ricker, George; Vanderspek, Roland; Seager, Sara; Krishnamurthy, Akshata; Dynes, Scott; Huang, Chelsea] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dragomir, Diana] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Quinn, Sam; Latham, David W.; Collins, Karen] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Feliz, Dax; Stassun, Keivan] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Crossfield, Ian J. M.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Anglada-Escude, Guillem] Queen Mary Univ London, Sch Phys & Astron, London, England; [Winn, Joshua N.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Jenkins, Jon M.] SETI Inst, Mountain View, CA USA; [Barclay, Thomas; Rinehart, Stephen; Doty, John; Afanasev, Dennis A.; Clampin, Mark; Kruse, Ethan; Quintana, Elisa V.; Roberge, Aki; Schlieder, Joshua E.; Walp, Bernie; Youngblood, Allison] NASA, Exoplanets & Stellar Astrophys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Adams, Fred] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Beichman, Chas; Furlan, Elise; Mennesson, Bertrand] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Beichman, Chas; Ciardi, David R.] CALTECH, NASA, Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Bottom, Mike] Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; [Bowler, Brendan P.; Vanderburg, Andrew] Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA; [Brinkworth, Carolyn] Univ Corp Atmospher Res, Boulder, CO USA; [Brown, Carolyn J.; Clark, Jake T.; Horner, Jonathan; Mengel, Matthew; Okumura, Jack; Wittenmyer, Robert A.; Wright, Duncan J.] Univ Southern Queensland, Ctr Astrophys, Toowoomba, Qld, Australia; [Cancino, Andrew; Giddens, Frank; Huber, Joseph; Klenke, Chris; Nishimoto, America; Weigand, Denise] Missouri State Univ, Dept Phys Astron & Mat Sci, Springfield, MO USA; [Davison, Cassy; Hall, Ryan; White, Russel] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA; [Foreman-Mackey, Daniel] Flatiron Inst, Ctr Computat Astrophys, New York, NY USA; [Gaidos, Eric J.] Univ Hawaii Manoa, Dept Earth Sci, Honolulu, HI 96822 USA; [Geneser, Claire; Tanner, Angelle] Mississippi State Univ, Dept Phys & Astron, Starkville, MS USA; [Gilbert, Emily] Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Hellier, Coel] Keele Univ, Keele, Staffs, England; [Henry, Todd] RECONS Inst, Chambersburg, PA USA; [Howard, Andrew W.; Mills, Sean M.; Wang, Jason] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Kane, Stephen R.] Univ Calif Riverside, Dept Earth & Planetary Sci, Riverside, CA 92521 USA; [Kenworthy, Matthew] Leiden Univ, Leiden Observ, Leiden, Netherlands; [Kielkopf, John] Univ Louisville, Dept Phys & Astron, Louisville, KY 40292 USA; [Kipping, David] Columbia Univ, Dept Astron, New York, NY 10027 USA; [Lowrance, Patrick] CALTECH, IPAC, Pasadena, CA 91125 USA; [Morton, Tim] Univ Florida, Dept Astron, Gainesville, FL 32611 USA; [Narita, Norio] Univ Tokyo, Dept Astron, 7-3-1 Hongo, Tokyo 113, Japan; [Narita, Norio] JST, PRESTO, Tokyo, Japan; [Narita, Norio] NINS, Astrobiol Ctr, Tokyo, Japan; [Narita, Norio] NINS, Natl Astron Observ Japan, Tokyo, Japan; [Narita, Norio; Palle, Enric] Inst Astrofis Canarias, Tenerife, Spain; [Newton, Elisabeth] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Pepper, Joshua] Lehigh Univ, Dept Phys, Bldg 16, Bethlehem, PA 18015 USA; [Roccatagliata, Veronica] Univ Pisa, Dipartimento Fis Enrico Fermi, Pisa, Italy; [Roccatagliata, Veronica] INAF Osservatorio Astrofis Arcetri, Florence, Italy; [Roccatagliata, Veronica] Ist Nazl Fis Nucl, Sez Pisa, Pisa, Italy; [Teske, Johanna; Wang, Sharon Xuesong] Observ Carnegie Inst Sci, Pasadena, CA USA; [Tinney, C. G.] UNSW Sydney, Sch Phys, UNSW, Exoplanetary Sci, Sydney, NSW, Australia; [von Braun, Kaspar] Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA; NASA, Infrared Telescope Facil, Hilo, HI USA; [Zhang, Hui] Nanjing Univ, Minist Educ, Sch Astron & Space Sci, Key Lab, Nanjing, Peoples R China; [Zilberman, Perri] SUNY Stony Brook, Stony Brook, NY 11794 USA	George Mason University; University System of Maryland; University of Maryland Baltimore County; Universite de Montreal; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); University of New Mexico; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Vanderbilt University; University of Kansas; University of London; Queen Mary University London; University College London; Princeton University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; National Aeronautics & Space Administration (NASA); University of Hawaii System; University of Hawaii Manoa; University of Texas System; University of Texas Austin; National Center Atmospheric Research (NCAR) - USA; University of Southern Queensland; Missouri State University; University System of Georgia; Georgia State University; University of Hawaii System; University of Hawaii Manoa; Mississippi State University; University of Chicago; Keele University; California Institute of Technology; University of California System; University of California Riverside; Leiden University; Leiden University - Excl LUMC; University of Louisville; Columbia University; California Institute of Technology; State University System of Florida; University of Florida; University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; Astrobiology Center (ABC); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Instituto de Astrofisica de Canarias; Dartmouth College; Lehigh University; University of Pisa; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); Carnegie Institution for Science; University of New South Wales Sydney; National Aeronautics & Space Administration (NASA); Nanjing University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Plavchan, P (corresponding author), George Mason Univ, Dept Phys & Astron, Fairfax, VA 22030 USA.	pplavcha@gmu.edu	Vanderburg, Andrew/AAF-6208-2021; Anglada-Escude, Guillem/Y-3162-2018; Gagne, Jonathan/X-2006-2018; Gao, Peter/N-1187-2017	Vanderburg, Andrew/0000-0001-7246-5438; Roccatagliata, Veronica/0000-0002-4650-594X; Bottom, Michael/0000-0003-1341-5531; Kruse, Ethan/0000-0002-0493-1342; Latouf, Natasha/0000-0001-8079-1882; Wright, Duncan/0000-0001-7294-5386; Tinney, C.G./0000-0002-7595-0970; Gilbert, Emily/0000-0002-0388-8004; Kielkopf, John/0000-0003-0497-2651; Plavchan, Peter/0000-0002-8864-1667; Anglada-Escude, Guillem/0000-0002-3645-5977; Zilberman, Perri/0000-0003-4714-0679; Latham, David/0000-0001-9911-7388; Lowrance, Patrick/0000-0001-8014-0270; Huang, Xu/0000-0003-0918-7484; Wang, Jason/0000-0003-0774-6502; Furlan, Elise/0000-0001-9800-6248; Clark, Jake/0000-0003-3964-4658; Gagne, Jonathan/0000-0002-2592-9612; Wang, Xuesong/0000-0002-6937-9034; Mengel, Matthew/0000-0002-7830-6822; Stassun, Keivan/0000-0002-3481-9052; Gao, Peter/0000-0002-8518-9601; Ciardi, David/0000-0002-5741-3047	NASA [16-APROBES16-0020, NNH14CK55B, NAS5-26555]; NASA (Exoplanet Exploration Program); National Science Foundation (Astronomy and Astrophysics grant) [1716202]; Mount Cuba Astronomical Foundation; George Mason University; NASA's Science Mission directorate; W. M. Keck Foundation; Australian Research Council [LE160100001, DP180100972]; University of Southern Queensland; MIT; Nanjing University; University of Louisville; University of California Riverside; University of Florida; University of Texas at Austin; JSPS KAKENHI [JP18H01265, 18H05439]; JST PRESTO grant [JPMJPR1775]; NSFC [11673011]; MINECO [ESP2016-80435-C2-2-R]; NASA through Hubble Fellowship - Space Telescope Science Institute [HST-HF2-51372.001-A]; National Science Foundation [AST-1909209]; Heising-Simons Foundation 51 Pegasi b fellowship	NASA(National Aeronautics & Space Administration (NASA)); NASA (Exoplanet Exploration Program); National Science Foundation (Astronomy and Astrophysics grant); Mount Cuba Astronomical Foundation; George Mason University; NASA's Science Mission directorate; W. M. Keck Foundation(W.M. Keck Foundation); Australian Research Council(Australian Research Council); University of Southern Queensland; MIT; Nanjing University(Nanjing University); University of Louisville; University of California Riverside(University of California System); University of Florida(University of Florida); University of Texas at Austin; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO grant; NSFC(National Natural Science Foundation of China (NSFC)); MINECO(Spanish Government); NASA through Hubble Fellowship - Space Telescope Science Institute; National Science Foundation(National Science Foundation (NSF)); Heising-Simons Foundation 51 Pegasi b fellowship	This work was supported by grants to P.P. from NASA (award 16-APROBES16-0020 and support from the Exoplanet Exploration Program) and the National Science Foundation (Astronomy and Astrophysics grant 1716202), the Mount Cuba Astronomical Foundation and George Mason University start-up funds.The NASA Infrared Telescope Facility is operated by the University of Hawaii under contract NNH14CK55B with NASA. Funding for the TESS mission is provided by NASA's Science Mission directorate. Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA. The Observatory was made possible by the generous financial support of the W. M. Keck Foundation. The authors wish to recognize and acknowledge the very significant cultural role and reverence that the summit of Maunakea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. This research has made use of the NASA Exoplanet Archive, which is operated by the California Institute of Technology, under contract with NASA under the Exoplanet Exploration Program. Some of the data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). The Space Telescope Science Institute is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. This research has made use of the services of the ESO Science Archive Facility, based on observations collected at the European Organisation for Astronomical Research in the Southern Hemisphere with the HARPS spectrometer. This work has made use of data from the European Space Agency (ESA) mission Gaia, processed by the Gaia Data Processing and Analysis Consortium (DPAC). Funding for the DPAC has been provided by national institutions, in particular the institutions participating in the Gaia Multilateral Agreement. MINERVA-Australis is supported by Australian Research Council LIEF Grant LE160100001, Discovery Grant DP180100972, Mount Cuba Astronomical Foundation, and institutional partners University of Southern Queensland, MIT, Nanjing University, George Mason University, University of Louisville, University of California Riverside, University of Florida and University of Texas at Austin. This work was partly supported by JSPS KAKENHI grant numbers JP18H01265 and 18H05439, JST PRESTO grant number JPMJPR1775, NSFC grant number 11673011 and MINECO grant ESP2016-80435-C2-2-R. D.D. acknowledges support for this work provided by NASA through Hubble Fellowship grant HST-HF2-51372.001-A awarded by the Space Telescope Science Institute. B.P.B. acknowledges support from National Science Foundation grant AST-1909209. J.W. and P.G. acknowledge support from the Heising-Simons Foundation 51 Pegasi b fellowship.	Anglada-Escude G, 2012, ASTROPHYS J SUPPL S, V200, DOI 10.1088/0067-0049/200/2/15; Baraffe I, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425481; Barnes JR, 2017, MON NOT R ASTRON SOC, V466, P1733, DOI 10.1093/mnras/stw3170; Boccaletti A, 2015, NATURE, V526, P230, DOI 10.1038/nature15705; Cale B, 2019, ASTRON J, V158, DOI 10.3847/1538-3881/ab3b0f; Chiang E, 2017, ASTROPHYS J, V848, DOI 10.3847/1538-4357/aa89e6; Cody AM, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/4/82; Deming D, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/2/132; Eastman J., 2017, ASCL1710003; EGGEN OJ, 1968, ASTROPHYS J SUPPL S, V16, P49, DOI 10.1086/190170; Fulton BJ, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aaaaa8; Haywood R. D., 2015, THESIS; Hebb L, 2007, MON NOT R ASTRON SOC, V379, P63, DOI 10.1111/j.1365-2966.2007.11904.x; Howard AW, 2010, ASTROPHYS J, V721, P1467, DOI 10.1088/0004-637X/721/2/1467; Jenkins JM, 2016, PROC SPIE, V9913, DOI 10.1117/12.2233418; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Kalas P, 2004, SCIENCE, V303, P1990, DOI 10.1126/science.1093420; Kipping DM, 2014, MON NOT R ASTRON SOC, V440, P2164, DOI 10.1093/mnras/stu318; Lannier J, 2017, ASTRON ASTROPHYS, V603, DOI 10.1051/0004-6361/201628677; Linder Esther F., 2019, Astronomy & Astrophysics, V623, DOI 10.1051/0004-6361/201833873; MacGregor MA, 2013, ASTROPHYS J LETT, V762, DOI 10.1088/2041-8205/762/2/L21; Mamajek EE, 2014, MON NOT R ASTRON SOC, V445, P2169, DOI 10.1093/mnras/stu1894; Marchwinski RC, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/63; Mayor M., 2003, MESSENGER, V114, P20; Nava C, 2020, ASTRON J, V159, DOI 10.3847/1538-3881/ab53ec; Nettelmann N, 2016, ICARUS, V275, P107, DOI 10.1016/j.icarus.2016.04.008; Nortmann L, 2018, SCIENCE, V362, P1388, DOI 10.1126/science.aat5348; Parks JR, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/3; Plavchan P, 2005, ASTROPHYS J, V631, P1161, DOI 10.1086/432568; Plavchan P, 2009, ASTROPHYS J, V698, P1068, DOI 10.1088/0004-637X/698/2/1068; Pollacco DL, 2006, PUBL ASTRON SOC PAC, V118, P1407, DOI 10.1086/508556; Rasca AP, 2016, ASTROPHYS J, V832, DOI 10.3847/0004-637X/832/1/53; Rayner J, 2016, PROC SPIE, V9908, DOI 10.1117/12.2232064; Reiners A, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220437; Reiners A, 2010, ASTROPHYS J, V710, P432, DOI 10.1088/0004-637X/710/1/432; Ricker GR, 2015, J ASTRON TELESC INST, V1, DOI 10.1117/1.JATIS.1.1.014003; Roccatagliata V, 2009, ASTRON ASTROPHYS, V497, P409, DOI 10.1051/0004-6361/200811018; Sezestre E, 2017, ASTRON ASTROPHYS, V607, DOI 10.1051/0004-6361/201731061; Smith JC, 2012, PUBL ASTRON SOC PAC, V124, P1000, DOI 10.1086/667697; Strubbe LE, 2006, ASTROPHYS J, V648, P652, DOI 10.1086/505736; Stumpe MC, 2014, PUBL ASTRON SOC PAC, V126, P100, DOI 10.1086/674989; Tal-Or L, 2018, ASTRON ASTROPHYS, V614, DOI 10.1051/0004-6361/201732362; Torres C. A. O., 1972, ASTROPHYS J, V11, pL13; van Eyken JC, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/42; Vanderburg A, 2016, MON NOT R ASTRON SOC, V459, P3565, DOI 10.1093/mnras/stw863; Wang JJ, 2015, ASTROPHYS J LETT, V811, DOI 10.1088/2041-8205/811/2/L19; White R., 2015, P AAS MEET, V233; Wilson PA, 2019, ASTRON ASTROPHYS, V621, DOI 10.1051/0004-6361/201834346	53	88	88	2	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					497	+		10.1038/s41586-020-2400-z	http://dx.doi.org/10.1038/s41586-020-2400-z			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OL0CX	32581383	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000585012000003
J	Shepherd, A				Shepherd, Alison			Covid-19: Footballers mark silent respect for victims	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2020	369								m2504	10.1136/bmj.m2504	http://dx.doi.org/10.1136/bmj.m2504			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK1US	32580931	Bronze			2022-12-28	WOS:000548572500002
J	Terao, C; Suzuki, A; Momozawa, Y; Akiyama, M; Ishigaki, K; Yamamoto, K; Matsuda, K; Murakami, Y; McCarroll, SA; Kubo, M; Loh, PR; Kamatani, Y				Terao, Chikashi; Suzuki, Akari; Momozawa, Yukihide; Akiyama, Masato; Ishigaki, Kazuyoshi; Yamamoto, Kazuhiko; Matsuda, Koichi; Murakami, Yoshinori; McCarroll, Steven A.; Kubo, Michiaki; Loh, Po-Ru; Kamatani, Yoichiro			Chromosomal alterations among age-related haematopoietic clones in Japan	NATURE			English	Article							JAK2 HAPLOTYPE; MOSAICISM; MUTATIONS; CANCER; COMMON; RISK; ASSOCIATION; LEUKEMIA; GENE; CLL	The extent to which the biology of oncogenesis and ageing are shaped by factors that distinguish human populations is unknown. Haematopoietic clones with acquired mutations become common with advancing age and can lead to blood cancers(1-10). Here we describe shared and population-specific patterns of genomic mutations and clonal selection in haematopoietic cells on the basis of 33,250 autosomal mosaic chromosomal alterations that we detected in 179,417 Japanese participants in the BioBank Japan cohort and compared with analogous data from the UK Biobank. In this long-lived Japanese population, mosaic chromosomal alterations were detected in more than 35.0% (s.e.m., 1.4%) of individuals older than 90 years, which suggests that such clones trend towards inevitability with advancing age. Japanese and European individuals exhibited key differences in the genomic locations of mutations in their respective haematopoietic clones; these differences predicted the relative rates of chronic lymphocytic leukaemia (which is more common among European individuals) and T cell leukaemia (which is more common among Japanese individuals) in these populations. Three different mutational precursors of chronic lymphocytic leukaemia (including trisomy 12, loss of chromosomes 13q and 13q, and copy-neutral loss of heterozygosity) were between two and six times less common among Japanese individuals, which suggests that the Japanese and European populations differ in selective pressures on clones long before the development of clinically apparent chronic lymphocytic leukaemia. Japanese and British populations also exhibited very different rates of clones that arose from B and T cell lineages, which predicted the relative rates of B and T cell cancers in these populations. We identified six previously undescribed loci at which inherited variants predispose to mosaic chromosomal alterations that duplicate or remove the inherited risk alleles, including large-effect rare variants at NBN, MRE11 and CTU2 (odds ratio, 28-91). We suggest that selective pressures on clones are modulated by factors that are specific to human populations. Further genomic characterization of clonal selection and cancer in populations from around the world is therefore warranted. Population-specific patterns of genomic mutations and selection of haematopoietic clones in Japanese and European participants predict the divergent rates of chronic lymphocytic leukaemia and T cell leukaemia in these populations.	[Terao, Chikashi; Akiyama, Masato; Ishigaki, Kazuyoshi; Kamatani, Yoichiro] RIKEN, Ctr Integrat Med Sci, Lab Stat & Translat Genet, Yokohama, Kanagawa, Japan; [Terao, Chikashi] Shizuoka Prefectural Gen Hosp, Clin Res Ctr, Shizuoka, Japan; [Terao, Chikashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Appl Genet, Shizuoka, Japan; [Suzuki, Akari; Yamamoto, Kazuhiko] RIKEN, Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan; [Momozawa, Yukihide; Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Akiyama, Masato] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan; [Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Lab Genome Technol, Tokyo, Japan; [Matsuda, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Clin Genome Sequencing, Tokyo, Japan; [Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Tokyo, Japan; [McCarroll, Steven A.; Loh, Po-Ru] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [McCarroll, Steven A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Loh, Po-Ru] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Loh, Po-Ru] Harvard Med Sch, Boston, MA 02115 USA; [Kamatani, Yoichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Complex Trait Genom, Tokyo, Japan	RIKEN; Shizuoka General Hospital; University of Shizuoka; RIKEN; RIKEN; Kyushu University; University of Tokyo; University of Tokyo; University of Tokyo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Tokyo	Terao, C; Kamatani, Y (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Stat & Translat Genet, Yokohama, Kanagawa, Japan.; Terao, C (corresponding author), Shizuoka Prefectural Gen Hosp, Clin Res Ctr, Shizuoka, Japan.; Terao, C (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Appl Genet, Shizuoka, Japan.; Kamatani, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Complex Trait Genom, Tokyo, Japan.	chikashi.terao@riken.jp; yoichiro.kamatani@riken.jp	Terao, Chikashi/AAY-1207-2021; Akiyama, Masato/AHC-2589-2022; Suzuki, Akari/N-5389-2015; Ishigaki, Kazuyoshi/ABF-6926-2021; Matsuda, Koichi/D-4597-2011	Terao, Chikashi/0000-0002-6452-4095; Matsuda, Koichi/0000-0001-7292-2686	BioBank Japan project - Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese Government; AMED [17km0305002, 18km0605001]; NIH [DP2 ES030554]; Burroughs Wellcome Fund Career Award at the Scientific Interfaces; Next Generation Fund at the Broad Institute of MIT and Harvard; Glenn Foundation for Medical Research; AFAR Grants for Junior Faculty award; Sloan Research Fellowship	BioBank Japan project - Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award at the Scientific Interfaces; Next Generation Fund at the Broad Institute of MIT and Harvard; Glenn Foundation for Medical Research; AFAR Grants for Junior Faculty award; Sloan Research Fellowship(Alfred P. Sloan Foundation)	We thank the staff of the BBJ for collecting and managing samples and clinical information. This study was funded by the BioBank Japan project, which was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese Government and AMED under grant numbers 17km0305002 and 18km0605001. This research was conducted using the UK Biobank Resource under application no. 19808. P.-R.L. was supported by NIH grant DP2 ES030554, a Burroughs Wellcome Fund Career Award at the Scientific Interfaces, the Next Generation Fund at the Broad Institute of MIT and Harvard, a Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty award, and a Sloan Research Fellowship.	Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; DeAntoni A, 2005, PHILOS T R SOC B, V360, P637, DOI 10.1098/rstb.2004.1618; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Forsberg LA, 2017, NAT REV GENET, V18, P128, DOI 10.1038/nrg.2016.145; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Hinds DA, 2016, BLOOD, V128, P1121, DOI 10.1182/blood-2015-06-652941; Hirata M, 2017, J EPIDEMIOL, V27, pS22, DOI 10.1016/j.je.2016.12.006; Iwai M, 2005, LEUKEMIA, V19, P1367, DOI 10.1038/sj.leu.2403805; Iwanaga M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00322; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li Y, 2015, CANCER EPIDEMIOL, V39, P8, DOI 10.1016/j.canep.2014.12.001; Liu Y, 2017, NAT GENET, V49, P1211, DOI 10.1038/ng.3909; Loh PR, 2018, NATURE, V559, P350, DOI 10.1038/s41586-018-0321-x; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Machiela MJ, 2015, AM J HUM GENET, V96, P487, DOI 10.1016/j.ajhg.2015.01.011; Nagai A, 2017, J EPIDEMIOL, V27, pS2, DOI 10.1016/j.je.2016.12.005; Okada Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03274-0; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tamura K, 2001, EUR J HAEMATOL, V67, P152, DOI 10.1034/j.1600-0609.2001.5790514.x; Vattathil S, 2016, AM J HUM GENET, V98, P571, DOI 10.1016/j.ajhg.2016.02.003; Wright DJ, 2017, NAT GENET, V49, P674, DOI 10.1038/ng.3821; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484; Zhou WY, 2016, NAT GENET, V48, P563, DOI 10.1038/ng.3545; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869	48	48	48	3	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2020	584	7819					130	+		10.1038/s41586-020-2426-2	http://dx.doi.org/10.1038/s41586-020-2426-2		JUN 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB1QU	32581364	Green Accepted			2022-12-28	WOS:000556398300001
J	Makkar, RR; Cheng, W; Waksman, R; Satler, LF; Chakravarty, T; Groh, M; Abernethy, W; Russo, MJ; Heimansohn, D; Hermiller, J; Worthley, S; Chehab, B; Cunningham, M; Matthews, R; Ramana, RK; Yong, G; Ruiz, CE; Chen, CG; Asch, FM; Nakamura, M; Jilaihawi, H; Sharma, R; Yoon, SH; Pichard, AD; Kapadia, S; Reardon, MJ; Bhatt, DL; Fontana, GP				Makkar, Raj R.; Cheng, Wen; Waksman, Ron; Satler, Lowell F.; Chakravarty, Tarun; Groh, Mark; Abernethy, William; Russo, Mark J.; Heimansohn, David; Hermiller, James; Worthley, Stephen; Chehab, Bassem; Cunningham, Mark; Matthews, Ray; Ramana, Ravi K.; Yong, Gerald; Ruiz, Carlos E.; Chen, Chunguang; Asch, Federico M.; Nakamura, Mamoo; Jilaihawi, Hasan; Sharma, Rahul; Yoon, Sung-Han; Pichard, Augusto D.; Kapadia, Samir; Reardon, Michael J.; Bhatt, Deepak L.; Fontana, Gregory P.			Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial	LANCET			English	Article							REPLACEMENT; OUTCOMES; IMPLANTATION; VOLUME; TAVR	Background Randomised trial data assessing the safety and efficacy of the self-expanding intra-annular Portico transcatheter aortic valve system (Abbott Structural Heart, St Paul, MN, USA) compared with any commercially available valves are needed to compare performance among designs. Methods In this prospective, multicentre, non-inferiority, randomised controlled trial (the Portico Re-sheathable Transcatheter Aortic Valve System US Investigational Device Exemption trial [PORTICO IDE]), high and extreme risk patients with severe symptomatic aortic stenosis were recruited from 52 medical centres experienced in performing transcatheter aortic valve replacement in the USA and Australia. Patients were eligible if they were aged 21 years or older, in New York Heart Association functional class II or higher, and had severe native aortic stenosis. Eligible patients were randomly assigned (1:1) using permuted block randomisation (block sizes of 2 and 4) and stratified by clinical investigational site, surgical risk cohort, and vascular access method, to transcatheter aortic valve replacement with the first generation Portico valve and delivery system or a commercially available valve (either an intra-annular balloon-expandable Edwards-SAPIEN, SAPIEN XT, or SAPIEN 3 valve [Edwards LifeSciences, Irvine, CA, USA]; or a supra-annular self-expanding CoreValve, Evolut-R, or Evolut-PRO valve [Medtronic, Minneapolis, MN, USA]). Investigational site staff, implanting physician, and study participant were unmasked to treatment assignment. Core laboratories and clinical event assessors were masked to treatment allocation. The primary safety endpoint was a composite of all-cause mortality, disabling stroke, life-threatening bleeding requiring transfusion, acute kidney injury requiring dialysis, or major vascular complication at 30 days. The primary efficacy endpoint was all-cause mortality or disabling stroke at 1 year. Clinical outcomes and valve performance were assessed up to 2 years after the procedure. Primary analyses were by intention to treat and the Kaplan-Meier method to estimate event rates. The non-inferiority margin was 8.5% for primary safety and 8.0% for primary efficacy endpoints. This study is registered with ClinicalTrials.gov, NCT02000115, and is ongoing. Findings Between May 30 and Sept 12, 2014, and between Aug 21, 2015, and Oct 10, 2017, with recruitment paused for 11 months by the funder, we recruited 1034 patients, of whom 750 were eligible and randomly assigned to the Portico valve group (n=381) or commercially available valve group (n=369). Mean age was 83 years (SD 7) and 395 (52.7%) patients were female. For the primary safety endpoint at 30 days, the event rate was higher in the Portico valve group than in the commercial valve group (52 [13.8%] vs 35 [9.6%]; absolute difference 4.2, 95% CI -0.4 to 8.8 [upper confidence bound {UCB} 8.1%]; p(non-inferiority)=0.034, p(superiority)=0.071). At 1 year, the rates of the primary efficacy endpoint were similar between the groups (55 [14.8%] in the Portico group vs 48 [13.4%] in the commercial valve group; difference 1.5%, 95% CI -3.6 to 6.5 [UCB 5.7%]; p(non-inferiority)=0.0058, p(superiority)=0.50). At 2 years, rates of death (80 [22.3%] vs 70 [20.2%]; p=0.40) or disabling stroke (10 [3.1%] vs 16 [5.0%]; p=0.23) were similar between groups. Interpretation The Portico valve was associated with similar rates of death or disabling stroke at 2 years compared with commercial valves, but was associated with higher rates of the primary composite safety endpoint including death at 30 days. The first-generation Portico valve and delivery system did not offer advantages over other commercially available valves. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Makkar, Raj R.; Cheng, Wen; Chakravarty, Tarun; Nakamura, Mamoo; Yoon, Sung-Han] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Waksman, Ron; Satler, Lowell F.] Washington Hosp Ctr, Washington, DC 20010 USA; [Groh, Mark; Abernethy, William] Mission Hlth & Hosp, Asheville, NC USA; [Russo, Mark J.] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Russo, Mark J.; Chen, Chunguang] Newark Beth Israel Med Ctr, Newark, NY USA; [Heimansohn, David; Hermiller, James] St Vincent Heart Ctr, Indianapolis, IN USA; [Worthley, Stephen] Royal Adelaide Hosp, Adelaide, SA, Australia; [Worthley, Stephen] Genesis Care, Sydney, NSW, Australia; [Chehab, Bassem] Ascens Via Christi Hosp, Cardiovasc Res Inst Kansas, Wichita, KS USA; [Cunningham, Mark; Matthews, Ray] Univ Southern Calif, Los Angeles, CA 90007 USA; [Ramana, Ravi K.] Advocate Christ Med Ctr, Oak Lawn, IL USA; [Ramana, Ravi K.] Heart Care Ctr Illinois, Palos Pk, IL USA; [Yong, Gerald] Fiona Stanley Hosp, Murdoch, WA, Australia; [Ruiz, Carlos E.] Hackensack Univ Med Ctr, Hackensack, NJ USA; [Asch, Federico M.] MedStar Hlth Res Inst, Washington, DC USA; [Jilaihawi, Hasan] NYU Langone Hlth, New York, NY USA; [Sharma, Rahul] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Pichard, Augusto D.] Abbott, Abbott Pk, IL USA; [Kapadia, Samir] Cleveland Clin, Cleveland, OH 44106 USA; [Reardon, Michael J.] Houston Methodist Hosp, Houston, TX 77030 USA; [Bhatt, Deepak L.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Fontana, Gregory P.] Los Robles Reg Med Ctr, Cardiovasc Inst, Thousand Oaks, CA USA	Cedars Sinai Medical Center; MedStar Washington Hospital Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Royal Adelaide Hospital; University of Southern California; Hackensack University Medical Center; MedStar Health Research Institute; NYU Langone Medical Center; Stanford University; Abbott Laboratories; Abbott Vascular; Cleveland Clinic Foundation; The Methodist Hospital System; The Methodist Hospital - Houston; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Makkar, RR (corresponding author), Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA.	raj.makkar@cshs.org	Reardon, Michael/ABF-8880-2021; Asch, Federico/AAS-7653-2021	Asch, Federico/0000-0002-1744-5271	Abbott	Abbott(Abbott Laboratories)	Abbott.	Abdel-Wahab M, 2014, JAMA-J AM MED ASSOC, V311, P1503, DOI 10.1001/jama.2014.3316; Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Carroll JD, 2017, J AM COLL CARDIOL, V70, P29, DOI 10.1016/j.jacc.2017.04.056; Fontana GP, 2020, JACC-CARDIOVASC INTE, V13, P2467, DOI 10.1016/j.jcin.2020.06.041; Forrest JK, 2018, JACC-CARDIOVASC INTE, V11, P160, DOI 10.1016/j.jcin.2017.10.014; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1093/ejcts/ezs533, 10.1016/j.jacc.2012.09.001]; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kodali S, 2016, EUR HEART J, V37, P2252, DOI 10.1093/eurheartj/ehw112; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2019, NEW ENGL J MED, V380, P1695, DOI 10.1056/NEJMoa1814052; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Makkar RR, 2015, NEW ENGL J MED, V373, P2015, DOI 10.1056/NEJMoa1509233; Makkar RR, 2020, NEW ENGL J MED, V382, P799, DOI 10.1056/NEJMoa1910555; Modolo R, 2020, JACC-CARDIOVASC INTE, V13, P1303, DOI 10.1016/j.jcin.2020.03.002; Mollmann H, 2017, JACC-CARDIOVASC INTE, V10, P1538, DOI 10.1016/j.jcin.2017.05.021; Popma JJ, 2019, NEW ENGL J MED, V380, P1706, DOI 10.1056/NEJMoa1816885; Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456; Russo MJ, 2019, J AM COLL CARDIOL, V73, P427, DOI 10.1016/j.jacc.2018.11.031; Salemi A, 2019, JACC-CARDIOVASC INTE, V12, P90, DOI 10.1016/j.jcin.2018.10.030; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Sondergaard L, 2018, J AM COLL CARDIOL, V72, P2859, DOI 10.1016/j.jacc.2018.09.014; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Wassef AWA, 2018, JACC-CARDIOVASC INTE, V11, P1669, DOI 10.1016/j.jcin.2018.06.044; Willson AB, 2012, J AM COLL CARDIOL, V60, P581, DOI 10.1016/j.jacc.2012.02.045	26	42	42	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2020	396	10252					669	683		10.1016/S0140-6736(20)31358-1	http://dx.doi.org/10.1016/S0140-6736(20)31358-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OC4OX	32593323				2022-12-28	WOS:000579138700027
J	Barnes, M; Sax, PE				Barnes, Mark; Sax, Paul E.			Challenges of "Return to Work" in an Ongoing Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Barnes, Mark] Ropes & Gray, Prudential Tower,800 Boylston St, Boston, MA 02199 USA; [Barnes, Mark] Brigham & Womens Hosp, Multireg Clin Trials Ctr, 75 Francis St, Boston, MA 02115 USA; [Barnes, Mark] Harvard Univ, Boston, MA 02115 USA; [Sax, Paul E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Sax, Paul E.] Harvard Med Sch, Boston, MA 02115 USA; [Barnes, Mark] Yale Law Sch, Solomon Ctr Hlth Law & Policy, New Haven, CT USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University	Barnes, M (corresponding author), Ropes & Gray, Prudential Tower,800 Boylston St, Boston, MA 02199 USA.	mark.barnes@ropesgray.com						American Society of Heating Refrigerating and Air-Conditioning Engineers Air Conditioning Contractors of America American National Standards Institute, 2018, STAND PRACT INSP MAI; [Anonymous], 2020, TRANSCR MARCH 27 202; [Anonymous], 2020, TRAV FAQS; [Anonymous], 2020, END HOM IS; [Anonymous], 2020, RISK SEV ILLN; [Anonymous], 2020, WAR COVID 19 REC RET; [Anonymous], 2020, COVID 19 ESS SERV; Armour S., 2020, WALL STREET J; Carpenter SA, 2020, NATL LAW REV    0429; Castle S., 2020, NEW YORK TIMES; CDC, 2020, CDC ACT IN SUPP COVI; Centers for Disease Control and Prevention, 2020, INT GUID IMPL SAF PR; Centers for Disease Control and Prevention, 2020, PROT YOURS; Centers for Disease Control and Prevention, 2020, CDC ACT IN SUPP COVI; Centers for Disease Control and Prevention, 2020, EMPL INF OFF BUILD; Centers for Disease Control and Prevention, 2020, THE WELL; Centre for the Mathematical Modeling of Infectious Diseases COVID-19 Working Group, 2020, EST OV COVID 19 TRAN; Collins T., 2020, FORTUNE; Collins T., 2020, THESE ARE WORKERS US; Cybersecurity and Infrastructure Security Agency, 2020, ADV MEM ID ESS CRIT; Flannery D, 2020, JD SUPRA        0512; Food and Drug Administration (US), 2020, FDA CLEARANCE K19200; Furukawa Nathan W, 2020, Emerg Infect Dis, V26, DOI 10.3201/eid2607.201595; Halbfinger D. M., 2020, NYTIMES, V16; Hanage W, 2020, WASHINGTON POST; Huang Y., 2020, HARVARD BUS REV; Hunt Jerome, 2012, STATE BY STATE EXAMI; Leswing K, 2020, CNBC; Lewsing K, 2020, CNBC; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Luo L, 2020, MEDRXIV, V26, DOI [10.1101/2020.03.24.20042606, DOI 10.1101/2020.03.24.20042606]; Means SP, 2020, SALT LAKE TRIBUNE; OSHA, 2020, GUID PREP WORKPL COV; SaifAddin BK, 2020, ACS PHOTONICS, V7, P554, DOI 10.1021/acsphotonics.9b00600; Sneppen K., 2020, MEDRXIV, DOI [10.1101/2020.05.17.20104745, DOI 10.1101/2020.05.17.20104745]; University of Cambridge, 2015, SCIENCEDAILY; Villaneuve M, 2020, ASS PRESS; Waldstein David, 2020, NEW YORK TIMES; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x	40	40	42	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2020	383	8					779	786		10.1056/NEJMsr2019953	http://dx.doi.org/10.1056/NEJMsr2019953			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NG2MJ	32558484	Green Published, Bronze			2022-12-28	WOS:000563818700020
J	Yokota, T; McCourt, J; Ma, FY; Ren, SX; Li, S; Kim, TH; Kurmangaliyev, YZ; Nasiri, R; Ahadian, S; Nguyen, T; Tan, XHM; Zhou, YG; Wu, RM; Rodriguez, A; Cohn, W; Wang, YB; Whitelegge, J; Ryazantsev, S; Khademhosseini, A; Teitell, MA; Chiou, PY; Birk, DE; Rowat, AC; Crosbie, RH; Pellegrini, M; Seldin, M; Lusis, AJ; Deb, A				Yokota, Tomohiro; McCourt, Jackie; Ma, Feiyang; Ren, Shuxun; Li, Shen; Kim, Tae-Hyung; Kurmangaliyev, Yerbol Z.; Nasiri, Rohollah; Ahadian, Samad; Thang Nguyen; Tan, Xing Haw Marvin; Zhou, Yonggang; Wu, Rimao; Rodriguez, Abraham; Cohn, Whitaker; Wang, Yibin; Whitelegge, Julian; Ryazantsev, Sergey; Khademhosseini, Ali; Teitell, Michael A.; Chiou, Pei-Yu; Birk, David E.; Rowat, Amy C.; Crosbie, Rachelle H.; Pellegrini, Matteo; Seldin, Marcus; Lusis, Aldons J.; Deb, Arjun			Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury	CELL			English	Article							EXTRACELLULAR-MATRIX; CARDIAC FIBROBLASTS; INTEGRINS; EXPRESSION; ALPHA-V-BETA-3; RECOMBINATION; VISUALIZATION; CONTRIBUTES; MICROSCOPY; PEPTIDES	Scar tissue size following myocardial infarction is an independent predictor of cardiovascular outcomes, yet little is known about factors regulating scar size. We demonstrate that collagen V, aminor constituent of heart scars, regulates the size of heart scars after ischemic injury. Depletion of collagen V led to a paradoxical increase in post-infarction scar size with worsening of heart function. A systems genetics approach across 100 in-bred strains of mice demonstrated that collagen V is a critical driver of postinjury heart function. We show that collagen V deficiency alters the mechanical properties of scar tissue, and altered reciprocal feedback between matrix and cells induces expression of mechanosensitive integrins that drive fibroblast activation and increase scar size. Cilengitide, an inhibitor of specific integrins, rescues the phenotype of increased post-injury scarring in collagen-V-deficient mice. These observations demonstrate that collagen V regulates scar size in an integrin-dependent manner.	[Yokota, Tomohiro; Li, Shen; Zhou, Yonggang; Wu, Rimao; Rodriguez, Abraham; Lusis, Aldons J.; Deb, Arjun] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Yokota, Tomohiro; Li, Shen; Zhou, Yonggang; Wu, Rimao; Rodriguez, Abraham; Deb, Arjun] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Cardiovasc Theme, Los Angeles, CA 90095 USA; [Yokota, Tomohiro; Ma, Feiyang; Li, Shen; Zhou, Yonggang; Wu, Rimao; Rodriguez, Abraham; Pellegrini, Matteo; Deb, Arjun] Univ Calif Los Angeles, Coll Letters & Sci, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Yokota, Tomohiro; Ma, Feiyang; Li, Shen; Zhou, Yonggang; Wu, Rimao; Rodriguez, Abraham; Crosbie, Rachelle H.; Pellegrini, Matteo; Deb, Arjun] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Yokota, Tomohiro; Ma, Feiyang; Ren, Shuxun; Li, Shen; Zhou, Yonggang; Wu, Rimao; Rodriguez, Abraham; Wang, Yibin; Crosbie, Rachelle H.; Pellegrini, Matteo; Deb, Arjun] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Yokota, Tomohiro; Li, Shen; Nasiri, Rohollah; Ahadian, Samad; Tan, Xing Haw Marvin; Zhou, Yonggang; Wu, Rimao; Rodriguez, Abraham; Ryazantsev, Sergey; Khademhosseini, Ali; Chiou, Pei-Yu; Deb, Arjun] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [McCourt, Jackie; Kim, Tae-Hyung; Rowat, Amy C.; Crosbie, Rachelle H.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Kurmangaliyev, Yerbol Z.] David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Nasiri, Rohollah; Ahadian, Samad; Thang Nguyen; Tan, Xing Haw Marvin; Khademhosseini, Ali; Teitell, Michael A.; Chiou, Pei-Yu; Rowat, Amy C.] Univ Calif Los Angeles, Sch Engn, Dept Bioengn, Los Angeles, CA 90095 USA; [Nasiri, Rohollah] Sharif Univ Technol, Dept Mech Engn, Tehran 1136511155, Iran; [Ahadian, Samad; Khademhosseini, Ali] Terasaki Inst Biomed Innovat TIBI, Los Angeles, CA 90024 USA; [Khademhosseini, Ali] Univ Calif Los Angeles, Sch Engn, Dept Chem Engn, Los Angeles, CA 90095 USA; [Khademhosseini, Ali] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA; [Tan, Xing Haw Marvin; Chiou, Pei-Yu] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA; [Cohn, Whitaker; Whitelegge, Julian] David Geffen Sch Med, Semel Inst Neurosci & Behav, Passarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Seldin, Marcus] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Seldin, Marcus] Univ Calif Irvine, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Birk, David E.] Univ S Florida, Coll Med, Tampa, FL 33612 USA; [Lusis, Aldons J.] David Geffen Sch Med, Dept Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Sharif University of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Los Angeles; State University System of Florida; University of South Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Deb, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA.; Deb, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Cardiovasc Theme, Los Angeles, CA 90095 USA.; Deb, A (corresponding author), Univ Calif Los Angeles, Coll Letters & Sci, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.; Deb, A (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.; Deb, A (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.; Deb, A (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA.	adeb@mednet.ucla.edu	Ma, Feiyang/GLN-6180-2022; Tan, Xing Haw Marvin/GVS-0204-2022; Kim, Tae-Hyung/B-1523-2009; Nasiri, Rohollah/AAB-4257-2022	Nasiri, Rohollah/0000-0002-8245-692X; Khademhosseini, Ali/0000-0002-2692-1524; Cohn, Whitaker/0000-0001-9198-8904; Tan, Xing Haw Marvin/0000-0002-5674-2906; McCourt, Jackie/0000-0001-8490-5269; Nguyen, Thang/0000-0002-9809-3836; Yokota, Tomohiro/0000-0003-2540-3810; Kurmangaliyev, Yerbol/0000-0003-4829-2025; Rodriguez, Abraham/0000-0002-6625-2409	National Institutes of Health, U.S.A. [HL129178, HL137241, AR075867, HL126204, HL147883]; Department of Defense, U.S.A. [W81XWH-17-1-0464, W81XWH-20-1-0238]; National Science Foundation, U.S.A. [BMMB-1906165]; Eli and Edythe Broad Stem Cell Center at UCLA; California Nanosystems Institute (BSCRC/CNSI innovation award); James Eason Cardiovascular Discovery funds; NIH National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute (CTSI), U.S.A. [UL1TR001881]; UPLIFT: UCLA Postdocs' Longitudinal Investment in Faculty [NIH K12 GM106996]	National Institutes of Health, U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense, U.S.A.(United States Department of Defense); National Science Foundation, U.S.A.(National Science Foundation (NSF)); Eli and Edythe Broad Stem Cell Center at UCLA; California Nanosystems Institute (BSCRC/CNSI innovation award); James Eason Cardiovascular Discovery funds; NIH National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute (CTSI), U.S.A.; UPLIFT: UCLA Postdocs' Longitudinal Investment in Faculty	We thank Dr. Eric Olson, University of Texas Southwestern Medical Center and Dr. Andrew Leask, University of Western Ontario, Canada for providing us the TCF21MerCreMer and Col1a2CreERT mice, respectively. We thank Dr. Siobhan Braybrook (UCLA) and Dr. Dan Cohn (UCLA) for AFM and ECM expertise. This work was funded by grants from the National Institutes of Health, U.S.A. (HL129178, HL137241, AR075867, HL126204, and HL147883), Department of Defense, U.S.A. (W81XWH-17-1-0464 and W81XWH-20-1-0238), National Science Foundation, U.S.A. (BMMB-1906165), grants from the Eli and Edythe Broad Stem Cell Center at UCLA and California Nanosystems Institute (BSCRC/CNSI innovation award), and James Eason Cardiovascular Discovery funds. This research was also partly supported by NIH National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute (CTSI), U.S.A. (grant number UL1TR001881). J.L.M. was supported by UPLIFT: UCLA Postdocs' Longitudinal Investment in Faculty (NIH K12 GM106996).	Acharya A, 2011, GENESIS, V49, P870, DOI 10.1002/dvg.20750; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Bagnato GL, 2018, CLIN SCI, V132, P231, DOI 10.1042/CS20171426; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; BASHEY RI, 1992, CIRC RES, V70, P1006, DOI 10.1161/01.RES.70.5.1006; Belvisi L, 2005, MOL CANCER THER, V4, P1670, DOI 10.1158/1535-7163.MCT-05-0120; Bendat J.S, 2013, RANDOM DATA ANAL MEA; Beussman KM, 2016, METHODS, V94, P43, DOI 10.1016/j.ymeth.2015.09.005; Bon P, 2009, OPT EXPRESS, V17, P13080, DOI 10.1364/OE.17.013080; Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; DAVIES HG, 1952, NATURE, V169, P541, DOI 10.1038/169541a0; Deb A, 2004, CIRCULATION, V110, P2673, DOI 10.1161/01.CIR.0000139842.15651.B2; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frangogiannis NG, 2019, CIRC RES, V125, P117, DOI 10.1161/CIRCRESAHA.119.311148; Frangogiannis NG, 2017, J CLIN INVEST, V127, P1600, DOI 10.1172/JCI87491; Ghali N, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4966; Ghazalpour A, 2012, MAMM GENOME, V23, P680, DOI 10.1007/s00335-012-9411-5; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Heras-Bautista CO, 2019, ACTA BIOMATER, V89, P180, DOI 10.1016/j.actbio.2019.03.017; Hinkel R, 2015, J MOL CELL CARDIOL, V87, P113, DOI 10.1016/j.yjmcc.2015.07.004; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kim TH, 2019, FASEB J, V33, P3997, DOI 10.1096/fj.201801429RR; Kim TH, 2016, J CELL SCI, V129, P4563, DOI 10.1242/jcs.194803; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lincoln J, 2006, DEV DYNAM, V235, P3295, DOI 10.1002/dvdy.20980; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Lusis AJ, 2016, J LIPID RES, V57, P925, DOI 10.1194/jlr.R066944; Lygoe KA, 2004, WOUND REPAIR REGEN, V12, P461, DOI 10.1111/j.1067-1927.2004.12402.x; Ma XY, 2019, ACTA BIOMATER, V95, P319, DOI 10.1016/j.actbio.2018.12.026; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Oyunbaatar NE, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081258; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005; Qi DP, 2015, SCI REP-UK, V5, DOI 10.1038/srep17595; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rau CD, 2017, CELL SYST, V4, P121, DOI 10.1016/j.cels.2016.10.016; Rau CD, 2015, CIRC-CARDIOVASC GENE, V8, P40, DOI 10.1161/CIRCGENETICS.113.000732; Ren J, 2005, J MOL CELL CARDIOL, V38, P617, DOI 10.1016/j.yjmcc.2005.01.012; Ribeiro AJS, 2016, METHODS, V94, P51, DOI 10.1016/j.ymeth.2015.08.005; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rog-Zielinska EA, 2016, TRENDS MOL MED, V22, P99, DOI 10.1016/j.molmed.2015.12.006; Sarrazy V, 2014, CARDIOVASC RES, V102, P407, DOI 10.1093/cvr/cvu053; Scaringi C, 2012, ANTICANCER RES, V32, P4213; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Sun M, 2011, J CELL SCI, V124, P4096, DOI 10.1242/jcs.091363; Truitt JM, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0256-16.2016; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Wang JJC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006038; Wang ZX, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41050; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Xiao F, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5005525; Zangle TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115726; Zangle TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068916; Zangle TA, 2013, BIOPHYS J, V105, P593, DOI 10.1016/j.bpj.2013.06.041; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X; Zoppi N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040982	66	58	59	7	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					545	+		10.1016/j.cell.2020.06.030	http://dx.doi.org/10.1016/j.cell.2020.06.030			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32621799	Bronze, Green Accepted			2022-12-28	WOS:000558649000005
J	Naidoo, R; Fisher, B				Naidoo, Robin; Fisher, Brendan			Sustainable Development Goals: pandemic reset	NATURE			English	Editorial Material						Sustainability; Policy; Climate change; Economics		COVID-19 is exposing the fragility of the goals adopted by the United Nations - two-thirds are now unlikely to be met. COVID-19 is exposing the fragility of the goals adopted by the United Nations - two-thirds are now unlikely to be met.	[Naidoo, Robin] WWF US, Washington, DC 20037 USA; [Naidoo, Robin] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada; [Fisher, Brendan] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Environm Program, Burlington, VT USA; [Fisher, Brendan] Univ Vermont, Gund Inst Environm, Burlington, VT USA	World Wildlife Fund; University of British Columbia; University of Vermont; University of Vermont	Naidoo, R (corresponding author), WWF US, Washington, DC 20037 USA.; Naidoo, R (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada.	robin.naidoo@WWFUS.ORG; brendan.fisher@uvm.edu						Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Crist E, 2017, SCIENCE, V356, P260, DOI 10.1126/science.aal2011; Daly HE, 2005, SCI AM, V293, P100, DOI 10.1038/scientificamerican0905-100; Field C. B., 2014, CLIMATE CHANGE 201 A, P195; Fisher B, 2019, LANCET PLANET HEALTH, V3, pE112, DOI 10.1016/S2542-5196(18)30281-X; Hopcraft JGC, 2015, CONSERV BIOL, V29, P932, DOI 10.1111/cobi.12470; Johnson CK, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2736; Laurance WF, 2017, SCIENCE, V358, P442, DOI 10.1126/science.aao0312; Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a; Shepherd K, 2015, NATURE, V523, P152, DOI 10.1038/523152a; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Stiglitz J., 2010, MIS MEASURING OUR LI	12	139	144	15	79	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					198	201		10.1038/d41586-020-01999-x	http://dx.doi.org/10.1038/d41586-020-01999-x			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MH5KF	32632244	Bronze			2022-12-28	WOS:000546767100009
J	Dyer, C				Dyer, Clare			Ophthalmologists are fined for illegal price fixing for self paying patients	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2718	10.1136/bmj.m2718	http://dx.doi.org/10.1136/bmj.m2718			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636192				2022-12-28	WOS:000548155700011
J	Dyer, C				Dyer, Clare			Surgeon who said covid-19 was a hoax has been suspended pending GMC investigation	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2020	370								m2714	10.1136/bmj.m2714	http://dx.doi.org/10.1136/bmj.m2714			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5XW	32631817	Bronze			2022-12-28	WOS:000548163900009
J	Novitzky, P; Bernstein, MJ; Blok, V; Braun, R; Chan, TT; Lamers, W; Loeber, A; Meijer, I; Lindner, R; Griessler, E				Novitzky, Peter; Bernstein, Michael J.; Blok, Vincent; Braun, Robert; Chan, Tung Tung; Lamers, Wout; Loeber, Anne; Meijer, Ingeborg; Lindner, Ralf; Griessler, Erich			Improve alignment of research policy and societal values	SCIENCE			English	Editorial Material							SCIENCE		[Novitzky, Peter; Blok, Vincent] Wageningen Univ & Res, Wageningen, Netherlands; [Bernstein, Michael J.] Arizona State Univ, Tempe, AZ USA; [Braun, Robert; Griessler, Erich] Inst Adv Studies, Vienna, Austria; [Chan, Tung Tung; Lamers, Wout; Meijer, Ingeborg] Leiden Univ, Ctr Sci & Technol Studies, Leiden, Netherlands; [Loeber, Anne] Univ Amsterdam, Amsterdam, Netherlands; [Lindner, Ralf] Fraunhofer Insitute Syst & Innovat Res, Karlsruhe, Germany	Wageningen University & Research; Arizona State University; Arizona State University-Tempe; Leiden University; Leiden University - Excl LUMC; University of Amsterdam	Novitzky, P (corresponding author), Wageningen Univ & Res, Wageningen, Netherlands.	pnovitzky@gmail.com; vincent.blok@wur.nl	Novitzky, Peter/ABA-8765-2020; Lindner, Ralf/AAL-8018-2021	Novitzky, Peter/0000-0002-3838-1668; Lindner, Ralf/0000-0002-6927-8866; Bernstein, Michael/0000-0001-7980-0489; Chan, Tung Tung/0000-0003-0732-3315; Griessler, Erich/0000-0003-4129-8168; Meijer, Ingeborg/0000-0003-1481-1739; Loeber, Anne/0000-0002-7944-0580; Lamers, Wout/0000-0001-7176-9579	EU's Horizon 2020 research and innovation programme [741402]	EU's Horizon 2020 research and innovation programme	This project received funding from the EU's Horizon 2020 research and innovation programme under grant agreement no.741402.We acknowledge all the consortium members who contributed to the data collection and writing of the reports (SM S11),which this study is based on. We express our gratitude to H. Tobi and N. Mejlgaard,as well as to the reviewers, for their helpful and constructive comments.	Buhrer S., 2018, KI118886ENN EUR COMM; Colebatch HK, 2018, PUBLIC POLICY ADMIN, V33, P365, DOI 10.1177/0952076717709525; DGRI, 2016, OPEN INNOVATION OPEN; DGRI, 2015, IND PROM MON RESP RE; Howlett M, 2017, POLITICS GOV, V5, P69, DOI 10.17645/pag.v5i2.928; Mejlgaard N, 2018, SCIENCE, V361, P761, DOI 10.1126/science.aav0400; Owen R., 2019, HDB SCI PUBLIC POLIC, DOI 10.4337/9781784715946.00010; Owen R, 2012, SCI PUBL POLICY, V39, P751, DOI 10.1093/scipol/scs093; OwenForsberg R., 2019, SHELLEY EGAN RRI PRA; Peters B.G., 2018, DESIGNING POLICY EFF; Polanyi M, 2000, MINERVA, V38, P1, DOI 10.1023/A:1026591624255; Rip A, 2016, J RESPONSIBLE INNOV, V3, P290, DOI 10.1080/23299460.2016.1255701; Rodriguez H, 2013, RES POLICY, V42, P1126, DOI 10.1016/j.respol.2013.02.006; Rommetveit K., 2013, JRC84065 EUR COMM; Von Schomberg Rene, 2019, INT HDB RESPONSIBLE	15	26	26	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					39	+		10.1126/science.abb3415	http://dx.doi.org/10.1126/science.abb3415			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MK4IZ	32631886	Green Submitted, Green Accepted			2022-12-28	WOS:000548751700038
J	Villabona-Arenas, CJ; Hall, M; Lythgoe, KA; Gaffney, SG; Regoes, RR; Hue, S; Atkins, KE				Villabona-Arenas, Ch Julian; Hall, Matthew; Lythgoe, Katrina A.; Gaffney, Stephen G.; Regoes, Roland R.; Hue, Stephane; Atkins, Katherine E.			Number of HIV-1 founder variants is determined by the recency of the source partner infection	SCIENCE			English	Article							MAXIMUM-LIKELIHOOD; COITAL-ACT; TRANSMISSION; METAANALYSIS; EVOLUTION; INFERENCE; MRBAYES; HOST; RISK	During sexual transmission, the high genetic diversity of HIV-1 within an individual is frequently reduced to one founder variant that initiates infection. Understanding the drivers of this bottleneck is crucial to developing effective infection control strategies. Little is known about the importance of the source partner during this bottleneck. To test the hypothesis that the source partner affects the number of HIV founder variants, we developed a phylodynamic model calibrated using genetic and epidemiological data on all existing transmission pairs for whom the direction of transmission and the infection stage of the source partner are known. Our results suggest that acquiring infection from someone in the acute (early) stage of infection increases the risk of multiple-founder variant transmission compared with acquiring infection from someone in the chronic (later) stage of infection. This study provides the first direct test of source partner characteristics to explain the low frequency of multiple-founder strain infections.	[Villabona-Arenas, Ch Julian; Hue, Stephane; Atkins, Katherine E.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England; [Villabona-Arenas, Ch Julian; Hue, Stephane; Atkins, Katherine E.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Hall, Matthew; Lythgoe, Katrina A.] Univ Oxford, Big Data Inst, Nuffield Dept Med, Oxford, England; [Gaffney, Stephen G.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Regoes, Roland R.] Swiss Fed Inst Technol, Inst Integrat Biol, Dept Environm Syst Sci, Zurich, Switzerland; [Atkins, Katherine E.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth, Edinburgh, Midlothian, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Yale University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Edinburgh	Atkins, KE (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England.; Atkins, KE (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.; Atkins, KE (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth, Edinburgh, Midlothian, Scotland.	katherine.atkins@ed.ac.uk		Hue, Stephane/0000-0002-8580-6905; Hall, Matthew/0000-0002-2671-3864; Villabona Arenas, Christian Julian/0000-0001-9928-3968; Gaffney, Stephen/0000-0002-5490-2945; Atkins, Katherine/0000-0001-5250-0558	ERC Starting Grant [757688]; Wellcome Trust; Royal Society [107652/Z/15/Z]; HIV Prevention Trials Network [H5R00701.CR00.01]; Bill and Melinda Gates Foundation [OPP1175094]	ERC Starting Grant(European Research Council (ERC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); HIV Prevention Trials Network; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	C.J.V.-A. and K.E.A. were funded by an ERC Starting Grant (award number 757688) awarded to K.E.A. K.A.L. was supported by The Wellcome Trust and The Royal Society grant no. 107652/Z/15/Z. M.H. was funded by The HIV Prevention Trials Network (grant number H5R00701.CR00.01) and The Bill and Melinda Gates Foundation (grant number OPP1175094).	Abecasis AB, 2018, AIDS, V32, P543, DOI 10.1097/QAD.0000000000001728; Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bellan SE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001801; Beretta M, 2018, AIDS, V32, P1917, DOI [10.1097/qad.0000000000001906, 10.1097/QAD.0000000000001906]; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Cole SR, 2014, AM J EPIDEMIOL, V179, P252, DOI 10.1093/aje/kwt245; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Geoghegan JL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0727; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hollingsworth TD, 2015, J INFECT DIS, V211, P1757, DOI 10.1093/infdis/jiu831; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Iyer SS, 2017, P NATL ACAD SCI USA, V114, pE590, DOI 10.1073/pnas.1620144114; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Kariuki SM, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0343-8; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leitner T, 2018, NAT MICROBIOL, V3, P983, DOI 10.1038/s41564-018-0204-9; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Lythgoe KA, 2017, TRENDS MICROBIOL, V25, P336, DOI 10.1016/j.tim.2017.03.003; Lythgoe KA, 2012, P ROY SOC B-BIOL SCI, V279, P3367, DOI 10.1098/rspb.2012.0595; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Ojwach DBA, 2018, J VIROL, V92, DOI 10.1128/JVI.00811-18; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Ratmann O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09139-4; Ratmann O, 2017, MOL BIOL EVOL, V34, P185, DOI 10.1093/molbev/msw217; Romero-Severson EO, 2016, P NATL ACAD SCI USA, V113, P2690, DOI 10.1073/pnas.1522930113; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rose R, 2019, J INFECT DIS, V220, P1406, DOI 10.1093/infdis/jiy734; Sagar M, 2014, J INFECT DIS, V210, pS667, DOI 10.1093/infdis/jiu369; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Shafer RW, 2008, AIDS REV, V10, P67; Talbert-Slagle K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004092; Thompson RN, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vey038; Tully DC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005619; Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568; Wymant C, 2018, MOL BIOL EVOL, V35, P719, DOI 10.1093/molbev/msx304	46	3	3	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2020	369	6499					103	+		10.1126/science.aba5443	http://dx.doi.org/10.1126/science.aba5443			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4IZ	32631894	Green Accepted, Green Submitted			2022-12-28	WOS:000548751700054
J	Rabe, KF; Martinez, FJ; Ferguson, GT; Wang, C; Singh, D; Wedzicha, JA; Trivedi, R; St Rose, E; Ballal, S; McLaren, J; Darken, P; Aurivillius, M; Reisner, C; Dorinsky, P				Rabe, Klaus F.; Martinez, Fernando J.; Ferguson, Gary T.; Wang, Chen; Singh, Dave; Wedzicha, Jadwiga A.; Trivedi, Roopa; St Rose, Earl; Ballal, Shaila; McLaren, Julie; Darken, Patrick; Aurivillius, Magnus; Reisner, Colin; Dorinsky, Paul		ETHOS Investigators	Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DOUBLE-BLIND; FLUTICASONE FUROATE; PARALLEL-GROUP; RISK; CORTICOSTEROIDS; VILANTEROL; SURVIVAL	BACKGROUND Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting beta(2)-agonist (LABA) for chronic obstructive pulmonary disease (COPD) have been studied at single dose levels of inhaled glucocorticoid, but studies at two dose levels are lacking. METHODS In a 52-week, phase 3, randomized trial to evaluate the efficacy and safety of triple therapy at two dose levels of inhaled glucocorticoid in patients with moderate-to-very-severe COPD and at least one exacerbation in the past year, we assigned patients in a 1:1:1:1 ratio to receive twice-daily inhaled doses of triple therapy (inhaled glucocorticoid [320 mu g or 160 mu g of budesonide], a LAMA [18 mu g of glycopyrrolate], and a LABA [9.6 mu g of formoterol]) or one of two dual therapies (18 mu g of glycopyrrolate plus 9.6 mu g of formoterol or 320 mu g of budesonide plus 9.6 mu g of formoterol). The primary end point was the annual rate (the estimated mean number per patient per year) of moderate or severe COPD exacerbations, as analyzed in the modified intention-to-treat population with the use of on-treatment data only. RESULTS The modified intention-to-treat population comprised 8509 patients. The annual rates of moderate or severe exacerbations were 1.08 in the 320-mu g-budesonide triple-therapy group (2137 patients), 1.07 in the 160-mu g-budesonide triple-therapy group (2121 patients), 1.42 in the glycopyrrolate-formoterol group (2120 patients), and 1.24 in the budesonide-formoterol group (2131 patients). The rate was significantly lower with 320-mu g-budesonide triple therapy than with glycopyrrolate-formoterol (24% lower: rate ratio, 0.76; 95% confidence interval [CI], 0.69 to 0.83; P<0.001) or budesonide-formoterol (13% lower: rate ratio, 0.87; 95% CI, 0.79 to 0.95; P=0.003). Similarly, the rate was significantly lower with 160-mu g-budesonide triple therapy than with glycopyrrolate-formoterol (25% lower: rate ratio, 0.75; 95% CI, 0.69 to 0.83; P<0.001) or budesonide-formoterol (14% lower: rate ratio, 0.86; 95% CI, 0.79 to 0.95; P=0.002). The incidence of any adverse event was similar across the treatment groups (range, 61.7 to 64.5%); the incidence of confirmed pneumonia ranged from 3.5 to 4.5% in the groups that included inhaled glucocorticoid use and was 2.3% in the glycopyrrolate-formoterol group. CONCLUSIONS Triple therapy with twice-daily budesonide (at either the 160-mu g or 320-mu g dose), glycopyrrolate, and formoterol resulted in a lower rate of moderate or severe COPD exacerbations than glycopyrrolate-formoterol or budesonide-formoterol.	[Rabe, Klaus F.] LungenClin Grosshansdorf, Wohrendamm 80, D-22927 Grosshansdorf, Germany; [Rabe, Klaus F.] Christian Albrechts Univ Kiel, Airway Res Ctr North, German Ctr Lung Res DZL, Grosshansdorf, Germany; [Martinez, Fernando J.] Weill Cornell Med, Joan & Sanford I Weill Dept Med, New York, NY USA; [Ferguson, Gary T.] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA; [Wang, Chen] China Japan Friendship Hosp, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [Singh, Dave] Univ Manchester, Manchester Univ NHS Fdn Hosp Trust, Med Evaluat Unit, Manchester, Lancs, England; [Wedzicha, Jadwiga A.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Trivedi, Roopa; Dorinsky, Paul] AstraZeneca, Durham, NC USA; [St Rose, Earl; Ballal, Shaila; Darken, Patrick; Reisner, Colin] AstraZeneca, Morristown, NJ USA; [McLaren, Julie] AstraZeneca, Gaithersburg, MD USA; [Aurivillius, Magnus] AstraZeneca, Gothenburg, Sweden	Grosshansdorf Hospital; University of Kiel; Cornell University; China-Japan Friendship Hospital; University of Manchester; Imperial College London; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Rabe, KF (corresponding author), LungenClin Grosshansdorf, Wohrendamm 80, D-22927 Grosshansdorf, Germany.	k.f.rabe@lungenclinic.de	Rabe, Klaus F./AAW-6296-2021; RAMOS-BARBON, DAVID/C-6624-2009; Knorst, Marli M/P-4959-2015; Sanmartin Berglund, Johan/HGB-0471-2022; Fang, Wen-Feng/AAT-6296-2021; Cho, Jae Hwa/Y-8474-2019	Rabe, Klaus F./0000-0002-7020-1401; RAMOS-BARBON, DAVID/0000-0002-9615-6557; Knorst, Marli M/0000-0001-8191-7926; Fang, Wen-Feng/0000-0003-0350-9059; Cho, Jae Hwa/0000-0002-3432-3997; Krull, Matthias/0000-0001-7034-2119; GARCIA RIVERO, JUAN LUIS/0000-0002-6407-5832; van den Berg, Jan/0000-0002-5259-0482; Kopitovic, Ivan/0000-0003-4733-0093; Puente-Maestu, Luis/0000-0001-8501-0117	AstraZeneca; National Institute for Health Research, Manchester Biomedical Research Centre	AstraZeneca(AstraZeneca); National Institute for Health Research, Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	Supported by AstraZeneca. Dr. Singh is supported by the National Institute for Health Research, Manchester Biomedical Research Centre.	Bafadhel M, 2018, LANCET RESP MED, V6, P117, DOI 10.1016/S2213-2600(18)30006-7; Battisti WP, 2015, ANN INTERN MED, V163, P461, DOI 10.7326/M15-0288; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2010, THORAX, V65, P719, DOI 10.1136/thx.2010.136077; Chapman KR, 2018, AM J RESP CRIT CARE, V198, P329, DOI 10.1164/rccm.201803-0405OC; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; Darken P, 2020, PHARM STAT, V19, P626, DOI 10.1002/pst.2019; Ferguson GT, 2018, LANCET RESP MED, V6, P747, DOI 10.1016/S2213-2600(18)30327-8; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2019, GUID STAT PRINC CLIN; Kew KM, 2014, COCHRANE DB SYST REV, pCD010115; Lipson DA, 2018, NEW ENGL J MED, V378, P1671, DOI 10.1056/NEJMoa1713901; Lipson DA, 2017, AM J RESP CRIT CARE, V196, P438, DOI 10.1164/rccm.201703-0449OC; Loke YK, 2011, THORAX, V66, P699, DOI 10.1136/thx.2011.160028; Papi A, 2018, LANCET, V391, P783, DOI 10.1016/S0140-6736(17)33311-1; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Rabe KF, 2019, RESP MED, V158, P59, DOI 10.1016/j.rmed.2019.08.010; Singh D, 2016, LANCET, V388, P963, DOI 10.1016/S0140-6736(16)31354-X; Suissa S, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01848-2018; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Vestbo J, 2016, LANCET, V387, P1817, DOI 10.1016/S0140-6736(16)30069-1; Williams NP, 2017, INT J CHRONIC OBSTR, V12, P313, DOI 10.2147/COPD.S121389	21	169	179	7	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2020	383	1					35	48		10.1056/NEJMoa1916046	http://dx.doi.org/10.1056/NEJMoa1916046			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ2UD	32579807	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000552751800009
J	Iacobucci, G				Iacobucci, Gareth			Government's "new deal" does not erase years of underinvestment in NHS buildings, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2020	370								m2646	10.1136/bmj.m2646	http://dx.doi.org/10.1136/bmj.m2646			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK0PJ	32611586	Bronze			2022-12-28	WOS:000548489100008
J	Dyer, C				Dyer, Clare			Judge approves 2m pound award for girl brain damaged at birth after both sides halt court case	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		PQ. (a child proceeding by her father and litigation friend RS) v Royal Free London NHS Foundation Trust, 2020, EWHC, V1676	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2619	10.1136/bmj.m2619	http://dx.doi.org/10.1136/bmj.m2619			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601064				2022-12-28	WOS:000548112700015
J	Dyer, O				Dyer, Owen			US hospitals must publish price lists after losing court challenge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4374; Hsia RY, 2012, ARCH INTERN MED, V172, P818, DOI 10.1001/archinternmed.2012.1173	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2020	369								m2621	10.1136/bmj.m2621	http://dx.doi.org/10.1136/bmj.m2621			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5EF	32601050				2022-12-28	WOS:000548112700001
J	Roberts-Galbraith, R				Roberts-Galbraith, Rachel			Guide cells help navigate axon regeneration	SCIENCE			English	Editorial Material									[Roberts-Galbraith, Rachel] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Roberts-Galbraith, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	robertsgalbraith@uga.edu			McKnight Foundation; Alfred P. Sloan Foundation	McKnight Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	R.R.-G. is supported by funding from the Alfred P. Sloan and McKnight Foundations.	BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; Chao DL, 2009, NAT REV NEUROSCI, V10, P262, DOI 10.1038/nrn2594; Currie KW, 2016, ELIFE, V5, DOI 10.7554/eLife.19735; Hill EM, 2015, DEVELOPMENT, V142, P4217, DOI 10.1242/dev.123612; Hilton BJ, 2017, DEVELOPMENT, V144, P3417, DOI 10.1242/dev.148312; Ivankovic M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.167684; Okamoto K, 2005, ZOOL SCI, V22, P535, DOI 10.2108/zsj.22.535; Palka John, 1992, Current Opinion in Neurobiology, V2, P48, DOI 10.1016/0959-4388(92)90161-D; Roberts-Galbraith RH, 2016, ELIFE, V5, DOI 10.7554/eLife.17002; Ross KG, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.266; Scimone M. L., 2020, SCIENCE, V368; Witchley JN, 2013, CELL REP, V4, P633, DOI 10.1016/j.celrep.2013.07.022	12	1	1	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1428	1429		10.1126/science.abc8066	http://dx.doi.org/10.1126/science.abc8066			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587008				2022-12-28	WOS:000545264600023
J	Kloosterman, DJ; Akkari, L				Kloosterman, Daan Juri; Akkari, Leila			Mapping the Uncharted Territories of Human Brain Malignancies	CELL			English	Editorial Material							EVOLUTION	Despite its success in multiple tumor types, immunotherapy remains poorly efficacious in brain malignancies. In this issue of Cell, Friebel et al. and Klemm et al. provide in-depth insights into the versatile nuances of immune cells in primary and metastatic brain tumors, granting the field with a rich framework to explore novel therapeutic avenues.	[Kloosterman, Daan Juri; Akkari, Leila] Netherlands Canc Inst, Div Tumor Biol & Immunol, Oncode Inst, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Akkari, L (corresponding author), Netherlands Canc Inst, Div Tumor Biol & Immunol, Oncode Inst, NL-1066 CX Amsterdam, Netherlands.	l.akkari@nki.nl						Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cloughesy TF, 2019, NAT MED, V25, P477, DOI 10.1038/s41591-018-0337-7; Kielbassa K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02215; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Rothschilds AM, 2019, TRENDS IMMUNOL, V40, P12, DOI 10.1016/j.it.2018.11.003; Rudie JD, 2019, RADIOLOGY, V290, P607, DOI 10.1148/radiol.2018181928; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Waldman AD, 2020, NAT REV IMMUNOL, V20, P651, DOI 10.1038/s41577-020-0306-5; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003	10	1	1	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1454	1457		10.1016/j.cell.2020.06.003	http://dx.doi.org/10.1016/j.cell.2020.06.003			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32589956	Bronze			2022-12-28	WOS:000543822100005
J	Fessell, D				Fessell, David			Laughter Leaves Me Lighter: Coping With COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fessell, David] Univ Michigan, Dept Radiol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fessell, D (corresponding author), Univ Michigan, Dept Radiol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	fessell@umich.edu						Fessell D, 2020, MED SCI EDUC, V30, P87, DOI 10.1007/s40670-019-00885-0; Gander F, 2013, J HAPPINESS STUD, V14, P1241, DOI 10.1007/s10902-012-9380-0; Gunderman RB, 2016, ACAD RADIOL, V23, P655, DOI 10.1016/j.acra.2015.12.022; Martin RA, 2018, PSYCHOL HUMOR INTEGR, V2nd; Miller G, 2011, SCIENCE, V331, P138, DOI 10.1126/science.331.6014.138; Ruch W, 2014, WILEY BLACKWELL HANDBOOK OF POSITIVE PSYCHOLOGICAL INTERVENTIONS, P179; Wellenzohn S, 2016, J POSIT PSYCHOL, V11, P584, DOI 10.1080/17439760.2015.1137624	7	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2476	2477		10.1001/jama.2020.9283	http://dx.doi.org/10.1001/jama.2020.9283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32573673	Bronze			2022-12-28	WOS:000590149400016
J	Kuehn, BM				Kuehn, Bridget M.			Postpartum Depression Screening Needs More Consistency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2454	2454		10.1001/jama.2020.9737	http://dx.doi.org/10.1001/jama.2020.9737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32573676				2022-12-28	WOS:000590149400005
J	Rubin, R				Rubin, Rita			Pandemic Highlights Behavioral Health Disparities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2452	2452		10.1001/jama.2020.10318	http://dx.doi.org/10.1001/jama.2020.10318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2EU	32573656	Bronze			2022-12-28	WOS:000595447000001
J	Allen, S; Cortina, CS				Allen, Sara; Cortina, Chandler S.			An unusual cause of breast hypertrophy: pseudoangiomatous stromal hyperplasia secondary to contraceptive implant	LANCET			English	Editorial Material									[Allen, Sara; Cortina, Chandler S.] Med Coll Wisconsin, Dept Surg, Div Surg Oncol, Sect Breast Surg, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Cortina, CS (corresponding author), Med Coll Wisconsin, Dept Surg, Div Surg Oncol, Sect Breast Surg, Milwaukee, WI 53226 USA.	ccortina@mcw.edu	Cortina, Chandler/AAI-3609-2021	Cortina, Chandler/0000-0002-4750-5028					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2020	395	10241					1937	1937						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ2MV	32563379				2022-12-28	WOS:000552732200034
J	Maziarz, M; Park, JC; Leyme, A; Marivin, A; Garcia-Lopez, A; Patel, PP; Garcia-Marcos, M				Maziarz, Marcin; Park, Jong-Chan; Leyme, Anthony; Marivin, Arthur; Garcia-Lopez, Alberto; Patel, Prachi P.; Garcia-Marcos, Mikel			Revealing the Activity of Trimeric G-proteins in Live Cells with a Versatile Biosensor Design	CELL			English	Article							HETEROTRIMERIC G-PROTEINS; GTPASE-ACTIVATING PROTEINS; G-ALPHA; COUPLED RECEPTORS; ADENYLYL-CYCLASE; MOLECULAR-BASIS; RGRGS DOMAIN; GOLOCO MOTIF; INTACT-CELLS; SUBUNIT	Heterotrimeric G-proteins (G alpha beta gamma) are the main transducers of signals from GPCRs, mediating the action of countless natural stimuli and therapeutic agents. However, there are currently no robust approaches to directly measure the activity of endogenous G-proteins in cells. Here, we describe a suite of optical biosensors that detect endogenous active G-proteins with sub-second resolution in live cells. Using a modular design principle, we developed genetically encoded, unimolecular biosensors for endogenous G alpha-GTP and free G beta gamma: the two active species of heterotrimeric G-proteins. This design was leveraged to generate biosensors with specificity for different heterotrimeric G-proteins or for other G-proteins, such as Rho GTPases. Versatility was further validated by implementing the biosensors in multiple contexts, from characterizing cancer-associated G-protein mutants to neurotransmitter signaling in primary neurons. Overall, the versatile biosensor design introduced here enables studying the activity of endogenous G-proteins in live cells with high fidelity, temporal resolution, and convenience.	[Maziarz, Marcin; Park, Jong-Chan; Leyme, Anthony; Marivin, Arthur; Garcia-Lopez, Alberto; Patel, Prachi P.; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	mgm1@bu.edu	patel, prachi/GRY-0386-2022		NIH [R21MH118745, R01GM136132, R01GM130120]; American Cancer Society Funding Hope postdoctoral fellowship [PF-19-084-01-CDD]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Funding Hope postdoctoral fellowship(American Cancer Society)	This work was supported by NIH grants R21MH118745, R01GM136132, and R01GM130120 (to M.G.-M.). M.M. was supported by American Cancer Society Funding Hope postdoctoral fellowship PF-19-084-01-CDD. We thank K. Martemyanov (Scripps Research Institute), N. Lambert (Augusta University), P. Wedegaertner (Thomas Jefferson University), J. Blumer and S. Lanier (Medical University of South Carolina), Mathew Layne (Boston University), and Richard Neubig (Michigan State University) for providing plasmids. We thank Vincent DiGiacomo for cloning the plasmid encoding Ga13-YFP and Lance Encell (Promega) for kindly providing the nanoluciferase antibody. We thank A. Amelio and K. Parag-Sharma (University of North Carolina, Chapel Hill) for providing the Lenti-X 293T cell line and related protocols of lentivirus production.	Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Z, 2003, J BIOL CHEM, V278, P9912, DOI 10.1074/jbc.M212695200; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chua V, 2017, MOL CANCER RES, V15, P501, DOI 10.1158/1541-7786.MCR-17-0007; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; DiGiacomo V, 2018, BIOCHEMISTRY-US, V57, P255, DOI 10.1021/acs.biochem.7b00845; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Garcia-Marcos M, 2011, ONCOGENE, V30, P2691, DOI 10.1038/onc.2010.645; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; ISHII K, 1993, J BIOL CHEM, V268, P9780; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Johnston CA, 2008, COMB CHEM HIGH T SCR, V11, P370, DOI 10.2174/138620708784534798; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Levitt ES, 2011, MOL PHARMACOL, V79, P461, DOI 10.1124/mol.110.064816; Leyme A, 2017, P NATL ACAD SCI USA, V114, pE10319, DOI 10.1073/pnas.1707992114; Leyme A, 2015, J CELL BIOL, V210, P1165, DOI 10.1083/jcb.201506041; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Marivin A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad2429; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Maziarz M, 2018, J BIOL CHEM, V293, P19586, DOI 10.1074/jbc.RA118.005291; Maziarz M, 2018, J BIOL CHEM, V293, P16964, DOI 10.1074/jbc.RA118.003580; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; O'Hayre M, 2016, ONCOGENE, V35, P3771, DOI 10.1038/onc.2015.442; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; Parag-Sharma K, 2016, J BIOL CHEM, V291, P27098, DOI 10.1074/jbc.M116.764431; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Ritt M, 2013, J BIOL CHEM, V288, P8875, DOI 10.1074/jbc.M112.421164; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sakurai K, 2016, NEURON, V92, P739, DOI 10.1016/j.neuron.2016.10.015; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2013, J RECEPT SIG TRANSD, V33, P139, DOI 10.3109/10799893.2013.763828; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Weis WI, 2018, ANNU REV BIOCHEM, V87, P897, DOI 10.1146/annurev-biochem-060614-033910; Wells C, 2002, METHOD ENZYMOL, V345, P371; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wisler JW, 2018, CIRCULATION, V137, P2315, DOI 10.1161/CIRCULATIONAHA.117.028194; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Yost EA, 2007, MOL PHARMACOL, V72, P812, DOI 10.1124/mol.107.038075	83	24	24	6	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2020	182	3					770	+		10.1016/j.cell.2020.06.020	http://dx.doi.org/10.1016/j.cell.2020.06.020			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MY8EK	32634377	Green Accepted, Bronze			2022-12-28	WOS:000558649000020
J	White, DB; Angus, DC				White, Douglas B.; Angus, Derek C.			A Proposed Lottery System to Allocate Scarce COVID-19 Medications Promoting Fairness and Generating Knowledge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[White, Douglas B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Program Eth & Decis Making Crit Illness, 3550 Terrace St,Scaife Hall,Room 608,HPU010604, Pittsburgh, PA 15261 USA; [Angus, Derek C.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	White, DB (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Program Eth & Decis Making Crit Illness, 3550 Terrace St,Scaife Hall,Room 608,HPU010604, Pittsburgh, PA 15261 USA.	douglas.white@pitt.edu			National Institutes of Health [K24 HL148314]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr White received funding for this work from National Institutes of Health grant K24 HL148314.	ANGRIST JD, 1990, AM ECON REV, V80, P313; [Anonymous], 1948, Br Med J, V2, P769; Dunning T, 2012, NATURAL EXPT SOCIAL, DOI 10.1017/CBO9781139084444; Evans M., 2020, WALL STREET J; Ison MG, 2020, JAMA-J AM MED ASSOC, V323, P2365, DOI 10.1001/jama.2020.8863; Li L, 2020, JAMA; National Institute of Allergy and Infectious Diseases, 2020, NIH CLIN TRIAL SHOWS; White DB, 2020, MODEL HOSP POLICY FA; Yoshioka A, 1998, BRIT MED J, V317, P1220, DOI 10.1136/bmj.317.7167.1220	9	29	29	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2020	324	4					329	330		10.1001/jama.2020.11464	http://dx.doi.org/10.1001/jama.2020.11464			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE8JP	32579158	Bronze			2022-12-28	WOS:000562851000014
J	Lonhienne, T; Low, YS; Garcia, MD; Croll, T; Gao, Y; Wang, Q; Brillault, L; Williams, CM; Fraser, JA; McGeary, RP; West, NP; Landsberg, MJ; Rao, ZH; Schenk, G; Guddat, LW				Lonhienne, Thierry; Low, Yu Shang; Garcia, Mario D.; Croll, Tristan; Gao, Yan; Wang, Quan; Brillault, Lou; Williams, Craig M.; Fraser, James A.; McGeary, Ross P.; West, Nicholas P.; Landsberg, Michael J.; Rao, Zihe; Schenk, Gerhard; Guddat, Luke W.			Structures of fungal and plant acetohydroxyacid synthases	NATURE			English	Article							REGULATORY SUBUNIT; CRYSTAL-STRUCTURES; ISOZYME-III; AHAS; INHIBITION; INSIGHTS; ENZYMES	Acetohydroxyacid synthase (AHAS), also known as acetolactate synthase, is a flavin adenine dinucleotide-, thiamine diphosphate- and magnesium-dependent enzyme that catalyses the first step in the biosynthesis of branched-chain amino acids(1). It is the target for more than 50 commercial herbicides(2). AHAS requires both catalytic and regulatory subunits for maximal activity and functionality. Here we describe structures of the hexadecameric AHAS complexes ofSaccharomyces cerevisiaeand dodecameric AHAS complexes ofArabidopsis thaliana. We found that the regulatory subunits of these AHAS complexes form a core to which the catalytic subunit dimers are attached, adopting the shape of a Maltese cross. The structures show how the catalytic and regulatory subunits communicate with each other to provide a pathway for activation and for feedback inhibition by branched-chain amino acids. We also show that the AHAS complex ofMycobacterium tuberculosisadopts a similar structure, thus demonstrating that the overall AHAS architecture is conserved across kingdoms. Structures of the acetohydroxyacid synthase complexes ofSaccharomyces cerevisiaeandArabidopsis thalianaprovide insights into the biosynthesis of and feedback inhibition by branched-chain amino acids.	[Lonhienne, Thierry; Low, Yu Shang; Garcia, Mario D.; Williams, Craig M.; Fraser, James A.; McGeary, Ross P.; West, Nicholas P.; Landsberg, Michael J.; Schenk, Gerhard; Guddat, Luke W.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Croll, Tristan] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Gao, Yan; Wang, Quan; Rao, Zihe] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China; [Brillault, Lou] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Rao, Zihe] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Rao, Zihe] Tsinghua Univ, Lab Struct Biol, Beijing, Peoples R China	University of Queensland; University of Cambridge; ShanghaiTech University; University of Queensland; Nankai University; Tsinghua University	Lonhienne, T; Guddat, LW (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	t.lonhienne@uq.edu.au; luke.guddat@uq.edu.au	West, Nicholas P/C-3119-2008; Guddat, Luke/AAI-2930-2021; Rao, Zihe/HCH-6944-2022; Schenk, Gerhard/AFJ-8595-2022; Schenk, Gerhard/AAG-5101-2022; Landsberg, Michael/A-3363-2011	West, Nicholas P/0000-0003-0955-9890; Schenk, Gerhard/0000-0001-8619-0631; Schenk, Gerhard/0000-0001-8619-0631; Landsberg, Michael/0000-0002-2464-990X; Garcia, Mario/0000-0001-8378-7475; Croll, Tristan/0000-0002-3514-8377; Wang, Quan/0000-0001-5148-5210	National Health and Medical Research Council [1087713, 1147297]; Australian Government Department of Agriculture and Water Resources [CT-06]; Bio-Electron Microscopy facility (iHuman Institute) at ShanghaiTech University; Cryo-EM Facility Center of Southern University of Science and Technology (Shenzhen); Wellcome Trust [209407/Z/17/Z]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Agriculture and Water Resources(Australian Government); Bio-Electron Microscopy facility (iHuman Institute) at ShanghaiTech University; Cryo-EM Facility Center of Southern University of Science and Technology (Shenzhen); Wellcome Trust(Wellcome TrustEuropean Commission)	Crystallization was performed at the University of Queensland Remote-Operation Crystallization and X-ray diffraction facility (UQROCX). Data collection was carried out at the Australian Synchrotron, part of ANSTO and made use of the Australian Cancer Research Foundation (ACRF) detector. This work was supported by funds from the National Health and Medical Research Council (grant numbers 1087713 and 1147297), and the Australian Government Department of Agriculture and Water Resources (CT-06). We thank the Bio-Electron Microscopy facility (iHuman Institute) at ShanghaiTech University and the Cryo-EM Facility Center of Southern University of Science and Technology (Shenzhen) for providing support and acknowledge the facilities and scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy and Microanalysis, The University of Queensland. T.C. is supported by a Wellcome Trust grant (209407/Z/17/Z), awarded to R. Read. We thank R. Duggleby for initiating the early functional and structural studies on AHASs.	Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bansal A, 2019, BIOCHEMISTRY-US, V58, P1992, DOI 10.1021/acs.biochem.9b00050; Barak Z, 2012, ARCH BIOCHEM BIOPHYS, V519, P167, DOI 10.1016/j.abb.2011.11.025; Belenky I, 2012, FEBS J, V279, P1967, DOI 10.1111/j.1742-4658.2012.08577.x; Dai S, 2019, NATURE, V573, P609, DOI 10.1038/s41586-019-1581-9; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Garcia MD, 2018, P NATL ACAD SCI USA, V115, pE9649, DOI 10.1073/pnas.1809422115; Garcia MD, 2017, P NATL ACAD SCI USA, V114, pE1091, DOI 10.1073/pnas.1616142114; Kaplun A, 2006, J MOL BIOL, V357, P951, DOI 10.1016/j.jmb.2005.12.077; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Lee YT, 2001, BIOCHEMISTRY-US, V40, P6836, DOI 10.1021/bi002775q; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Lonhienne T, 2018, P NATL ACAD SCI USA, V115, pE1945, DOI 10.1073/pnas.1714392115; Lonhienne T, 2017, CHEMISTRYSELECT, V2, P11981, DOI 10.1002/slct.201702128; Lonhienne T, 2017, J BIOL CHEM, V292, P5101, DOI 10.1074/jbc.M116.773242; Lonhienne T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171443; Lonhienne T, 2016, ANGEW CHEM INT EDIT, V55, P4247, DOI 10.1002/anie.201511985; McCourt JA, 2006, AMINO ACIDS, V31, P173, DOI 10.1007/s00726-005-0297-3; Nandula VK, 2019, WEED SCI, V67, P149, DOI 10.1017/wsc.2018.88; Pang SS, 2002, J MOL BIOL, V317, P249, DOI 10.1006/jmbi.2001.5419; Pang SS, 2001, BIOCHEM J, V357, P749, DOI 10.1042/0264-6021:3570749; Petkowski JJ, 2007, PROTEIN SCI, V16, P1360, DOI 10.1110/ps.072793807; SCHLOSS JV, 1988, NATURE, V331, P360, DOI 10.1038/331360a0; Xie YH, 2018, CHEMBIOCHEM, V19, P2387, DOI 10.1002/cbic.201800367	24	19	19	2	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2020	586	7828					317	+		10.1038/s41586-020-2514-3	http://dx.doi.org/10.1038/s41586-020-2514-3		JUL 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX9PR	32640464	Green Submitted			2022-12-28	WOS:000567779800001
J	Shepherd, A				Shepherd, Alison			The faces of NHS resilience and courage	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2020	370								m2711	10.1136/bmj.m2711	http://dx.doi.org/10.1136/bmj.m2711			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5US	32636190	Bronze			2022-12-28	WOS:000548155700010
J	O'Dowd, A				O'Dowd, Adrian			Psychiatrists urge royal college to tackle racism	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		James Adrian, 2020, COMMUNICATION   0701	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2020	370								m2657	10.1136/bmj.m2657	http://dx.doi.org/10.1136/bmj.m2657			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MJ5ZW	32620545				2022-12-28	WOS:000548169100008
J	Burns, VF				Burns, Victoria F.			WHAT YOUR PATIENT IS THINKING I live with "the world's most dangerous" eating disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Victoriafrances49@gmail.com						Torjesen I, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l982	1	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2020	370								m1886	10.1136/bmj.m1886	http://dx.doi.org/10.1136/bmj.m1886			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MM0GY	32616474	Bronze			2022-12-28	WOS:000549840000010
J	Ceccherini, G; Duveiller, G; Grassi, G; Lemoine, G; Avitabile, V; Pilli, R; Cescatti, A				Ceccherini, Guido; Duveiller, Gregory; Grassi, Giacomo; Lemoine, Guido; Avitabile, Valerio; Pilli, Roberto; Cescatti, Alessandro			Abrupt increase in harvested forest area over Europe after 2015	NATURE			English	Article							CLIMATE; IMPACTS	Fine-scale satellite data are used to quantify forest harvest rates in 26 European countries, finding an increase in harvested forest area of 49% and an increase in biomass loss of 69% between 2011-2015 and 2016-2018. Forests provide a series of ecosystem services that are crucial to our society. In the European Union (EU), forests account for approximately 38% of the total land surface(1). These forests are important carbon sinks, and their conservation efforts are vital for the EU's vision of achieving climate neutrality by 2050(2). However, the increasing demand for forest services and products, driven by the bioeconomy, poses challenges for sustainable forest management. Here we use fine-scale satellite data to observe an increase in the harvested forest area (49 per cent) and an increase in biomass loss (69 per cent) over Europe for the period of 2016-2018 relative to 2011-2015, with large losses occurring on the Iberian Peninsula and in the Nordic and Baltic countries. Satellite imagery further reveals that the average patch size of harvested area increased by 34 per cent across Europe, with potential effects on biodiversity, soil erosion and water regulation. The increase in the rate of forest harvest is the result of the recent expansion of wood markets, as suggested by econometric indicators on forestry, wood-based bioenergy and international trade. If such a high rate of forest harvest continues, the post-2020 EU vision of forest-based climate mitigation may be hampered, and the additional carbon losses from forests would require extra emission reductions in other sectors in order to reach climate neutrality by 2050(3).	[Ceccherini, Guido; Duveiller, Gregory; Grassi, Giacomo; Avitabile, Valerio; Pilli, Roberto; Cescatti, Alessandro] European Commiss, Bioecon Unit, Joint Res Ctr, Ispra, Italy; [Lemoine, Guido] European Commiss, Food Secur Unit, Joint Res Ctr, Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC ISPRA Site	Ceccherini, G (corresponding author), European Commiss, Bioecon Unit, Joint Res Ctr, Ispra, Italy.	guido.ceccherini@ec.europa.eu	ceccherini, guido/G-9406-2018; 郭, 青霞/GZH-2618-2022; Olabarria, Jose Ramon Gonzalez/D-2575-2009; Cescatti, Alessandro/ABE-6319-2020; Duveiller, Gregory/A-4932-2016	ceccherini, guido/0000-0003-1772-9554; Olabarria, Jose Ramon Gonzalez/0000-0002-5040-712X; Duveiller, Gregory/0000-0002-6471-8404; Lemoine, Guido/0000-0002-2734-4538				Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Alkama R, 2016, SCIENCE, V351, P600, DOI 10.1126/science.aac8083; [Anonymous], 2018, NAT FOR ACC PLAN REP; [Anonymous], 2018, NATL FORESTRY ACCOUN; [Anonymous], 2015, MIN C PROT FOR EUR; Baccini A, 2019, SCIENCE, V363, DOI 10.1126/science.aat1205; Ballin M., 2018, REDESIGN SAMPLE LAND; Barka I., 2018, NATL FORESTRY ACCOUN; Bastrup-Birk A, 2016, 52016 EAA EUR ENV AG; Bontemps S., 2013, P ESA LIV PLAN S ED, V2013, P9; Buongiorno J, 2018, FORESTRY, V91, P541, DOI 10.1093/forestry/cpy025; Cienciala E, 2017, EUR J FOREST RES, V136, P307, DOI 10.1007/s10342-017-1032-9; Duncker PS, 2012, ECOL SOC, V17, DOI 10.5751/ES-05262-170451; Duveiller G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02810-8; EFFIS, 2019, STAT PORT; Ericsson K, 2016, BIOMASS BIOENERG, V94, P57, DOI 10.1016/j.biombioe.2016.08.011; European Commission, 2019, 52019DC0640 EUR COMM; European Commission, 2013, 52013DC0659 EUR COMM; European Space Agency, COP OP ACC HUB; Eurostat, 2019, EC AGGR FOR; FAO, 2015, GLOBAL FOREST RESOUR; FAOSTAT, FOR PROD TRAD; FAOSTAT, 2019, FOR LAND; Foglar-Deinhardstein A., 2008, SUSTAINABLE FOREST M; Forestry and Timber-UNECE, 2018, FOR ROD ANN MARK REV; Gasparini P, 2013, ENVIRON MONIT ASSESS, V185, P6155, DOI 10.1007/s10661-012-3014-1; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Grassi G, 2018, FOREST POLICY ECON, V95, P10, DOI 10.1016/j.forpol.2018.07.002; Grassi G, 2018, CARBON BAL MANAGE, V13, DOI 10.1186/s13021-018-0096-2; Grassi G, 2017, NAT CLIM CHANGE, V7, P220, DOI [10.1038/NCLIMATE3227, 10.1038/nclimate3227]; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hengeveld GM, 2012, ECOL SOC, V17, DOI 10.5751/ES-05149-170453; Hoepffner N, 2018, BIOMASS PRODUCTION S; Johannsen V. K., 2019, DANISH NATL FOREST A; Joint Research Centre, 2019, BRIEF BIOM EN EUR UN; Kallio AMI, 2018, FORESTS, V9, DOI 10.3390/f9070407; Kallio AMI, 2018, FOREST POLICY ECON, V92, P193, DOI 10.1016/j.forpol.2018.04.010; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Levers C, 2014, FOREST ECOL MANAG, V315, P160, DOI 10.1016/j.foreco.2013.12.030; Linder R, 2018, THEMARKER 0324; Luyssaert S, 2018, NATURE, V562, P259, DOI 10.1038/s41586-018-0577-1; Mandl N., 2018, 52018 EAA EUR ENV AG; Masson-Delmotte V., 2018, GLOB WARM 1 5 C IPCC; McNicol IM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05386-z; Ministry of Agriculture & Ministry of the Environment Czech Republic, 2018, NAT FOR ACC PLAN CZE; Ministry of the Environment, 2018, POL NAT FOR ACC PLAN; Nabuurs GJ, 2019, NAT SUSTAIN, V2, P815, DOI 10.1038/s41893-019-0374-3; Nabuurs GJ, 2018, CARBON BAL MANAGE, V13, DOI 10.1186/s13021-018-0107-3; Nabuurs GJ, 2013, NAT CLIM CHANGE, V3, P792, DOI [10.1038/NCLIMATE1853, 10.1038/nclimate1853]; National Forestry Accounting Plan for Austria, 2018, NAT FOR ACC PLAN AUS; Noss RF, 1999, FOREST ECOL MANAG, V115, P135, DOI 10.1016/S0378-1127(98)00394-6; Orazio C., 2010, DESTRUCTIVE STORMS E, DOI DOI 10.13140/RG.2.1.1420.4006; Pilli R, 2016, CARBON BAL MANAGE, V11, DOI 10.1186/s13021-016-0047-8; Potapov PV, 2015, REMOTE SENS ENVIRON, V159, P28, DOI 10.1016/j.rse.2014.11.027; Reid W.V., 2005, ECOSYSTEMS HUMAN WEL; Santoro M, 2018, GLOBBIOMASS GLOBAL D; Schelhaas MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207151; Searchinger TD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06175-4; Shukla P.R., 2019, IPCC 2019 CLIMATE CH; Slovenian National Forestry Accounting Plan, 2018, SLOVENIAN NATL FORES; Somogyi Z, 2018, NATL FOREST ACCOUNTI; State Forest Service Environment Protection and Forest Department & Aleksandras Stulginskis University, 2018, NAT FOR ACC PLAN LIT; Stoeva L., 2018, NATL FORESTRY ACCOUN; Tyukavina A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601047; UNFCCC, 2001, C PART 7 SESS; United Nations, 2015, AD PAR AGR; United Nations Climate Change, 2019, NAT INV SUBM 2019; Vaahtera E., 2018, FINNISH FOREST STAT; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Wolf-Crowther M, 2011, FORESTRY EU WORLD ST; Zhu Z, 2019, REMOTE SENS ENVIRON, V224, P382, DOI 10.1016/j.rse.2019.02.016	73	110	114	32	178	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					72	+		10.1038/s41586-020-2438-y	http://dx.doi.org/10.1038/s41586-020-2438-y			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME6OV	32612223				2022-12-28	WOS:000544773600012
J	Fleming, N				Fleming, Nic			FIGHTING CORONAVIRUS MISINFORMATION	NATURE			English	Editorial Material								Bogus remedies, myths and fake news about COVID-19 can cost lives. Here's how some scientists are fighting back.											0	48	48	5	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2020	583	7814					155	156		10.1038/d41586-020-01834-3	http://dx.doi.org/10.1038/d41586-020-01834-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MD5NW	32601491				2022-12-28	WOS:000544019300007
J	Adams, J; Hofman, K; Moubarac, JC; Thow, AM				Adams, Jean; Hofman, Karen; Moubarac, Jean-Claude; Thow, Anne Marie			Public health response to ultra-processed food and drinks	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; PRODUCTS; COOKING; IMPACT		[Adams, Jean] Univ Cambridge, MRC Epidemiol Unit, Ctr Diet & Act Res, Cambridge, England; [Hofman, Karen] Univ Witwatersrand, South Africa MRC Wits Ctr Hlth Econ & Decis Sci, Johannesburg, South Africa; [Moubarac, Jean-Claude] Univ Montreal, Dept Nutr, Fac Med, Montreal, PQ, Canada; [Thow, Anne Marie] Univ Sydney, Sch Publ Hlth, Menzies Ctr Hlth Policy, Sydney, NSW, Australia	University of Cambridge; University of Witwatersrand; Universite de Montreal; University of Sydney	Adams, J (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Ctr Diet & Act Res, Cambridge, England.	Jma79@medschl.cam.ac.uk	Moubarac, Jean-Claude/J-8235-2014; Moubarac, Jean-Claude/ABE-6439-2020		Medical Research Council [MR/K023187/1, MC_UU_00006/7] Funding Source: Medline; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_00006/7, MR/K023187/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2015, ULTRAPROCESSED FOOD; Baker P, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0223-3; Battersby J., 2014, URBAN FORUM, V25, P153, DOI DOI 10.1007/S12132-014-9217-5; Bowen Sarah, 2019, PRESSURE COOKER WHY; Cairns G, 2013, APPETITE, V62, P209, DOI 10.1016/j.appet.2012.04.017; Carpentier FRD, 2020, PUBLIC HEALTH NUTR, V23, P747, DOI 10.1017/S1368980019003355; Djupegot IL, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4408-3; FIOLET T, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.K32210.1136/BMJ.K322; Gamboa-Gamboa T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112738; Gibney MJ, 2017, AM J CLIN NUTR, V106, P717, DOI 10.3945/ajcn.117.160440; Gibson AA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112679; Government of Canada, 2020, CAN FOOD GUID 2020; Hall KD, 2019, CELL METAB, V30, P67, DOI 10.1016/j.cmet.2019.05.008; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; Hill J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223535; Hunter-Adams J, 2019, APPETITE, V137, P244, DOI 10.1016/j.appet.2019.03.012; Jones NRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109343; Laudan R., 2001, GASTRONOMICA, V1, P36, DOI [10.1525/gfc.2001.1.1.36, DOI 10.1525/GFC.2001.1.1.36]; Luiten CM, 2016, PUBLIC HEALTH NUTR, V19, P530, DOI 10.1017/S1368980015002177; Mills S, 2017, APPETITE, V111, P116, DOI 10.1016/j.appet.2016.12.022; Mills SDH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010198; Monteiro C. A., 2019, ULTRA PROCESSED FOOD; Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P497, DOI 10.1017/S1368980017003287; Monteiro CA, 2015, PUBLIC HEALTH NUTR, V18, P2311, DOI 10.1017/S1368980015002165; Moubarac JC, 2014, CURR OBES REP, V3, P256, DOI 10.1007/s13679-014-0092-0; Moubarac JC, 2014, CAN J DIET PRACT RES, V75, P15, DOI 10.3148/75.1.2014.15; Moubarac JC, 2013, PUBLIC HEALTH NUTR, V16, P2240, DOI 10.1017/S1368980012005009; Moubarac JC, 2013, GLOB PUBLIC HEALTH, V8, P845, DOI 10.1080/17441692.2013.796401; Nestle M, 2013, FOOD POLITICS FOOD I, DOI DOI 10.1525/9780520955066/HTML; Nguyen PK, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2015.43; Penney TL., 2017, THEORISING UK SOFT D; Poti J, 2015, FASEB J, V29; Pulker CE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040853; Pulker CE, 2018, PUBLIC HEALTH NUTR, V21, P38, DOI 10.1017/S1368980017001148; Reicks M, 2018, J NUTR EDUC BEHAV, V50, P148, DOI 10.1016/j.jneb.2017.08.004; Schnabel L, 2019, JAMA INTERN MED, V179, P490, DOI 10.1001/jamainternmed.2018.7289; Scrinis G, 2018, PUBLIC HEALTH NUTR, V21, P247, DOI 10.1017/S1368980017001392; Simoes BD, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00019717, 10.1590/0102-311x00019717]; Srour B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1451; Stacey N, 2019, SOC SCI MED, V238, DOI 10.1016/j.socscimed.2019.112465; Stafford L, 2012, ATLANTA J; Taillie LS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003015; Teng AM, 2019, OBES REV, V20, P1187, DOI 10.1111/obr.12868; Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860; Vidler AC, 2018, AUST NZ J PUBL HEAL, V42, P519, DOI 10.1111/1753-6405.12828; Zlatevska N, 2018, J RETAILING, V94, P89, DOI 10.1016/j.jretai.2017.09.007	47	33	33	3	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2020	369								m2391	10.1136/bmj.m2391	http://dx.doi.org/10.1136/bmj.m2391			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MJ7IA	32591348	hybrid, Green Published			2022-12-28	WOS:000548259500012
J	Ehrenreich, IM				Ehrenreich, Ian M.			Evolution after genome duplication Genetic interactions in yeast reveal factors governing duplicate gene retention and divergence	SCIENCE			English	Editorial Material							ROBUSTNESS		[Ehrenreich, Ian M.] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	University of Southern California	Ehrenreich, IM (corresponding author), Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.				NIH [R35GM130381]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Thanks to the Ehrenreich lab members for feedback.The author is supported by NIH grant R35GM130381.	Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Diss G, 2017, SCIENCE, V355, P630, DOI 10.1126/science.aai7685; Force A, 1999, GENETICS, V151, P1531; Gu X, 2005, P NATL ACAD SCI USA, V102, P707, DOI 10.1073/pnas.0409186102; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Kuzmin E., 2020, SCIENCE, V368; Kuzmin E, 2018, SCIENCE, V360, DOI 10.1126/science.aao1729; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marchant A, 2019, ELIFE, V8, DOI 10.7554/eLife.46754; Ohno S., 1970, EVOLUTION GENE DUPLI; Taylor MB, 2015, TRENDS GENET, V31, P34, DOI 10.1016/j.tig.2014.09.001; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	15	3	3	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2020	368	6498					1424	1425		10.1126/science.abc1796	http://dx.doi.org/10.1126/science.abc1796			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF3SA	32587005				2022-12-28	WOS:000545264600020
J	Landrigan, CP; Rahman, SA; Sullivan, JP; Vittinghoff, E; Barger, LK; Sanderson, AL; Wright, KP; O'Brien, CS; Qadri, S; St Hilaire, MA; Halbower, AC; Segar, JL; McGuire, JK; Vitiello, MV; de la Iglesia, HO; Poynter, SE; Yu, PL; Zee, PC; Lockley, SW; Stone, KL; Czeisler, CA				Landrigan, C. P.; Rahman, S. A.; Sullivan, J. P.; Vittinghoff, E.; Barger, L. K.; Sanderson, A. L.; Wright, K. P., Jr.; O'Brien, C. S.; Qadri, S.; St Hilaire, M. A.; Halbower, A. C.; Segar, J. L.; McGuire, J. K.; Vitiello, M. V.; de la Iglesia, H. O.; Poynter, S. E.; Yu, P. L.; Zee, P. C.; Lockley, S. W.; Stone, K. L.; Czeisler, C. A.		ROSTERS Study Grp	Effect on Patient Safety of a Resident Physician Schedule without 24-Hour Shifts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SERIOUS MEDICAL ERRORS; SLEEP-DEPRIVATION; WORK HOURS; ADVERSE EVENTS; PERFORMANCE; FATIGUE; NIGHT; RISK	BACKGROUND The effects on patient safety of eliminating extended-duration work shifts for resident physicians remain controversial. METHODS We conducted a multicenter, cluster-randomized, crossover trial comparing two schedules for pediatric resident physicians during their intensive care unit (ICU) rotations: extended-duration work schedules that included shifts of 24 hours or more (control schedules) and schedules that eliminated extended shifts and cycled resident physicians through day and night shifts of 16 hours or less (intervention schedules). The primary outcome was serious medical errors made by resident physicians, assessed by intensive surveillance, including direct observation and chart review. RESULTS The characteristics of ICU patients during the two work schedules were similar, but resident physician workload, described as the mean (+/- SD) number of ICU patients per resident physician, was higher during the intervention schedules than during the control schedules (8.8 +/- 2.8 vs. 6.7 +/- 2.2). Resident physicians made more serious errors during the intervention schedules than during the control schedules (97.1 vs. 79.0 per 1000 patient-days; relative risk, 1.53; 95% confidence interval [CI], 1.37 to 1.72; P<0.001). The number of serious errors unitwide were likewise higher during the intervention schedules (181.3 vs. 131.5 per 1000 patient-days; relative risk, 1.56; 95% CI, 1.43 to 1.71). There was wide variability among sites, however; errors were lower during intervention schedules than during control schedules at one site, rates were similar during the two schedules at two sites, and rates were higher during intervention schedules than during control schedules at three sites. In a secondary analysis that was adjusted for the number of patients per resident physician as a potential confounder, intervention schedules were no longer associated with an increase in errors. CONCLUSIONS Contrary to our hypothesis, resident physicians who were randomly assigned to schedules that eliminated extended shifts made more serious errors than resident physicians assigned to schedules with extended shifts, although the effect varied by site. The number of ICU patients cared for by each resident physician was higher during schedules that eliminated extended shifts.	[Landrigan, C. P.; Rahman, S. A.; Sullivan, J. P.; Barger, L. K.; O'Brien, C. S.; Qadri, S.; St Hilaire, M. A.; Lockley, S. W.; Czeisler, C. A.] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Landrigan, C. P.; Rahman, S. A.; Sullivan, J. P.; Barger, L. K.; O'Brien, C. S.; Qadri, S.; St Hilaire, M. A.; Lockley, S. W.; Czeisler, C. A.] Brigham & Womens Hosp, Dept Neurol, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Landrigan, C. P.; Rahman, S. A.; Barger, L. K.; St Hilaire, M. A.; Lockley, S. W.; Czeisler, C. A.] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA; [Landrigan, C. P.] Boston Childrens Hosp, Div Gen Pediat, Dept Pediat, 300 Longwood Ave, Boston, MA 02115 USA; [Sanderson, A. L.] Boston Childrens Hosp, Div Crit Care Med, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Vittinghoff, E.; Stone, K. L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Stone, K. L.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Wright, K. P., Jr.] Univ Colorado, Sleep & Chronobiol Lab, Dept Integrat Physiol, Boulder, CO 80309 USA; [Halbower, A. C.] Univ Colorado, Childrens Hosp Colorado, Sch Med, Aurora, CO USA; [Segar, J. L.] Univ Iowa, Stead Family Childrens Hosp, Iowa City, IA USA; [McGuire, J. K.] Seattle Childrens Hosp, Seattle, WA USA; [Vitiello, M. V.; de la Iglesia, H. O.] Univ Washington, Seattle, WA 98195 USA; [Poynter, S. E.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Yu, P. L.] Univ Virginia, Childrens Hosp, Charlottesville, VA USA; [Zee, P. C.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zee, P. C.] Northwestern Univ, Ctr Circadian & Sleep Med, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Colorado System; University of Colorado Boulder; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Iowa; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Virginia; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Landrigan, CP (corresponding author), Boston Childrens Hosp, Div Gen Pediat, Dept Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	christopher.landrigan@childrens.harvard.edu	Sanderson, Amy/AAP-3603-2021; Zee, Phyllis C/GPF-3704-2022; Vitiello, Michael V/AAA-5298-2022	Lockley, Steven/0000-0001-5209-2881; Czeisler, Charles Andrew/0000-0002-7408-1849; Landrigan, Christopher/0000-0001-8386-4100	National Heart, Lung, and Blood Institute [U01-HL-111478, U01-HL-111691]; National Institute of Occupational Safety and Health [R01-OH-010300]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	Supported by grants (U01-HL-111478 and U01-HL-111691) from the National Heart, Lung, and Blood Institute. Drs. Barger, Lockley, and Czeisler were supported in part by a grant (R01-OH-010300) from the National Institute of Occupational Safety and Health.	Accreditation Council for Graduate Medical Education, 2017, COMM PROGR REQ EFF; Accreditation Council for Graduate Medical Education, 2011, COMM PROGR REQ EFF; Aiken LH, 2010, HEALTH SERV RES, V45, P904, DOI 10.1111/j.1475-6773.2010.01114.x; Barger LK, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz110; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; Berry Jay G, 2017, Hosp Pediatr, V7, P365, DOI 10.1542/hpeds.2016-0179; Bilimoria KY, 2016, NEW ENGL J MED, V374, P713, DOI 10.1056/NEJMoa1515724; Blackwell T, 2019, CONTEMP CLIN TRIALS, V80, P22, DOI 10.1016/j.cct.2019.03.005; Buysse Daniel J, 2003, Sleep, V26, P218; Chua KP, 2011, PEDIATRICS, V128, P1142, DOI 10.1542/peds.2011-1049; COOPER JB, 1982, ANESTHESIOLOGY, V56, P456, DOI 10.1097/00000542-198206000-00010; Eastridge BJ, 2003, AM J SURG, V186, P169, DOI 10.1016/S0002-9610(03)00183-1; Folkard S, 2006, AM J IND MED, V49, P953, DOI 10.1002/ajim.20307; FRIEDMAN RC, 1971, NEW ENGL J MED, V285, P201, DOI 10.1056/NEJM197107222850405; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Gershengorn HB, 2017, JAMA INTERN MED, V177, P388, DOI 10.1001/jamainternmed.2016.8457; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; Institute of Medicine, 2009, RESIDENT DUTY HOURS; Kaushal R, 2007, CRIT CARE MED, V35, P2479, DOI 10.1097/01.CCM.0000284510.04248.66; Khan A, 2017, JAMA PEDIATR, V171, P372, DOI 10.1001/jamapediatrics.2016.4812; Landrigan CP, 2019, NEW ENGL J MED, V380, P2379, DOI 10.1056/NEJMc1905064; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Levine AC, 2010, SLEEP, V33, P1043, DOI 10.1093/sleep/33.8.1043; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Rahman SA, 2019, SLEEP 2019 JUN 8 12; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; SAMKOFF JS, 1991, ACAD MED, V66, P687, DOI 10.1097/00001888-199111000-00013; Silber JH, 2019, NEW ENGL J MED, V380, P905, DOI 10.1056/NEJMoa1810642; Starmer AJ, 2014, NEW ENGL J MED, V371, P1803, DOI 10.1056/NEJMsa1405556; Veasey S, 2002, JAMA-J AM MED ASSOC, V288, P1116, DOI 10.1001/jama.288.9.1116; Weinger MB, 2002, JAMA-J AM MED ASSOC, V287, P955, DOI 10.1001/jama.287.8.955	38	38	39	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2020	382	26					2514	2523		10.1056/NEJMoa1900669	http://dx.doi.org/10.1056/NEJMoa1900669			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF9CW	32579812	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000545636400022
J	Qian, H; Kang, XJ; Hu, J; Zhang, DY; Liang, ZY; Meng, F; Zhang, X; Xue, YC; Maimon, R; Dowdy, SF; Devaraj, NK; Zhou, Z; Mobley, WC; Cleveland, DW; Fu, XD				Qian, Hao; Kang, Xinjiang; Hu, Jing; Zhang, Dongyang; Liang, Zhengyu; Meng, Fan; Zhang, Xuan; Xue, Yuanchao; Maimon, Roy; Dowdy, Steven F.; Devaraj, Neal K.; Zhou, Zhuan; Mobley, William C.; Cleveland, Don W.; Fu, Xiang-Dong			Reversing a model of Parkinson's disease with in situ converted nigral neurons	NATURE			English	Article							MOUSE MODEL; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; RAT MODEL; CELL; CONVERSION; ASTROCYTES; LESIONS; MICE; KEY	Parkinson's disease is characterized by loss of dopamine neurons in the substantia nigra(1). Similar to other major neurodegenerative disorders, there are no disease-modifying treatments for Parkinson's disease. While most treatment strategies aim to prevent neuronal loss or protect vulnerable neuronal circuits, a potential alternative is to replace lost neurons to reconstruct disrupted circuits(2). Here we report an efficient one-step conversion of isolated mouse and human astrocytes to functional neurons by depleting the RNA-binding protein PTB (also known as PTBP1). Applying this approach to the mouse brain, we demonstrate progressive conversion of astrocytes to new neurons that innervate into and repopulate endogenous neural circuits. Astrocytes from different brain regions are converted to different neuronal subtypes. Using a chemically induced model of Parkinson's disease in mouse, we show conversion of midbrain astrocytes to dopaminergic neurons, which provide axons to reconstruct the nigrostriatal circuit. Notably, re-innervation of striatum is accompanied by restoration of dopamine levels and rescue of motor deficits. A similar reversal of disease phenotype is also accomplished by converting astrocytes to neurons using antisense oligonucleotides to transiently suppress PTB. These findings identify a potentially powerful and clinically feasible approach to treating neurodegeneration by replacing lost neurons.	[Qian, Hao; Hu, Jing; Liang, Zhengyu; Meng, Fan; Zhang, Xuan; Xue, Yuanchao; Maimon, Roy; Dowdy, Steven F.; Cleveland, Don W.; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kang, Xinjiang; Zhou, Zhuan] Peking Univ, State Key Lab Membrane Biol, Beijing, Peoples R China; [Kang, Xinjiang; Zhou, Zhuan] Peking Univ, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Kang, Xinjiang] Southwest Med Univ, MOE Key Lab Med Electrophysiol, ICR, Luzhou, Peoples R China; [Zhang, Dongyang; Devaraj, Neal K.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Maimon, Roy; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Mobley, William C.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Mobley, William C.] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Fu, Xiang-Dong] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Hu, Jing] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Xue, Yuanchao] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing, Peoples R China	University of California System; University of California San Diego; Peking University; Peking University; Southwest Medical University; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Institute of Biophysics, CAS	Fu, XD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	xdfu@ucsd.edu	Cleveland, Don/AAN-9783-2021	QIAN, HAO/0000-0001-5771-5865; XUE, YUANCHAO/0000-0002-8113-2333	NSFC [31930061, 31761133016, 21790394, 81974203]; Larry Hillblom Foundation [2019-A-006-NET]; NIH [GM049369, GM052872]	NSFC(National Natural Science Foundation of China (NSFC)); Larry Hillblom Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Fu laboratory for cooperation, reagent sharing and insightful discussion during the course of this investigation and A. Muotri for the gift of the human embryonic stem cell-derived neural progenitors. D.W.C. received a salary from the Ludwig Institute for Cancer Research and is a Nomis Foundation Distinguished Scientist. Z.Z. and X.K. were supported by NSFC grants (31930061, 31761133016, 21790394 and 81974203). W.C.M. and X.-D.F. were supported by a grant from the Larry Hillblom Foundation (2019-A-006-NET). This work was supported by NIH grants (GM049369 and GM052872) to X.-D.F.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bahat-Stroomza M, 2009, J MOL NEUROSCI, V39, P199, DOI 10.1007/s12031-008-9166-3; BAKER H, 1980, P NATL ACAD SCI-BIOL, V77, P4369, DOI 10.1073/pnas.77.7.4369; Barkers RA, 2018, NATURE, V557, P329, DOI 10.1038/s41586-018-0087-1; Beal MF, 2010, NATURE, V466, pS8, DOI 10.1038/466S8a; Bennett CF, 2019, ANNU REV NEUROSCI, V42, P385, DOI 10.1146/annurev-neuro-070918-050501; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Boix J, 2015, BEHAV BRAIN RES, V284, P196, DOI 10.1016/j.bbr.2015.01.053; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Cervo PRD, 2017, NAT BIOTECHNOL, V35, P444, DOI 10.1038/nbt.3835; Chen YJ, 2016, CELL STEM CELL, V18, P817, DOI 10.1016/j.stem.2016.03.014; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; De Benedetto GE, 2014, J PHARMACEUT BIOMED, V98, P266, DOI 10.1016/j.jpba.2014.05.039; DUNNETT SB, 1981, BRAIN RES, V215, P147, DOI 10.1016/0006-8993(81)90498-4; Falk T, 2011, NEUROSCI LETT, V496, P43, DOI 10.1016/j.neulet.2011.03.088; Gascon S, 2017, CELL STEM CELL, V21, P18, DOI 10.1016/j.stem.2017.06.011; Grealish S, 2014, CELL STEM CELL, V15, P653, DOI 10.1016/j.stem.2014.09.017; Grealish S, 2010, EUR J NEUROSCI, V31, P2266, DOI 10.1111/j.1460-9568.2010.07265.x; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Hu Jing, 2018, Biophys Rep, V4, P204, DOI 10.1007/s41048-018-0066-y; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Kimm T, 2015, J NEUROSCI, V35, P16404, DOI 10.1523/JNEUROSCI.5291-14.2015; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Li Q, 2014, ELIFE, V3, DOI 10.7554/eLife.01201; Liu GS, 2004, J CHROMATOGR B, V805, P281, DOI 10.1016/j.jchromb.2004.03.011; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Nott A, 2019, SCIENCE, V366, P1134, DOI 10.1126/science.aay0793; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Piallat B, 1996, EUR J NEUROSCI, V8, P1408, DOI 10.1111/j.1460-9568.1996.tb01603.x; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1111/ene.14108, 10.1038/nrdp.2017.13]; Sofroniew MV, 2012, METHODS MOL BIOL, V814, P531, DOI 10.1007/978-1-61779-452-0_35; Sonntag KC, 2018, PROG NEUROBIOL, V168, P1, DOI 10.1016/j.pneurobio.2018.04.005; Srivastava A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1670-y; Stott SRW, 2014, EUR J NEUROSCI, V39, P1042, DOI 10.1111/ejn.12459; Tareke E, 2007, RAPID COMMUN MASS SP, V21, P3898, DOI 10.1002/rcm.3295; Tateno T, 2011, J NEUROPHYSIOL, V106, P1901, DOI 10.1152/jn.00162.2011; Thiele SL, 2012, JOVE-J VIS EXP, DOI 10.3791/3234; Wang CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02593-y; Wang L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4925; Wang SR, 2011, J NEUROCHEM, V119, P342, DOI 10.1111/j.1471-4159.2011.07440.x; Wu Z, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14855-3; Xu HD, 2015, ANALYST, V140, P3840, DOI 10.1039/c4an02074j; Xue YC, 2016, NAT NEUROSCI, V19, P807, DOI 10.1038/nn.4297; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yu XZ, 2020, NAT REV NEUROSCI, V21, P121, DOI 10.1038/s41583-020-0264-8; Zhou HB, 2020, CELL, V181, P590, DOI 10.1016/j.cell.2020.03.024; Zhu H, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu007	53	181	190	19	216	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2020	582	7813					550	+		10.1038/s41586-020-2388-4	http://dx.doi.org/10.1038/s41586-020-2388-4			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OL0DJ	32581380	Green Accepted, Green Submitted			2022-12-28	WOS:000585013200008
J	Theriot, CM; Petri, WA				Theriot, Casey M.; Petri, William A., Jr.			Role of Microbiota-Derived Bile Acids in Enteric Infections	CELL			English	Editorial Material								In this issue of Cell, Alavi et al. report that infection by Vibrio cholerae is blocked by gut microbiome-mediated hydrolysis of bile acids. Cholera therefore joins amebic dysentery and Clostridioides difficile colitis as enteric infections profoundly influenced by the microbiome's impact on bile acid metabolism.	[Theriot, Casey M.] North Carolina State Univ, Raleigh, NC USA; [Petri, William A., Jr.] Univ Virginia, Dept Med, POB 801340, Charlottesville, VA 22908 USA	University of North Carolina; North Carolina State University; University of Virginia	Petri, WA (corresponding author), Univ Virginia, Dept Med, POB 801340, Charlottesville, VA 22908 USA.	wap3g@virginia.edu			National Institutes of Health [R35 GM119438, 2R37 AI026649-31, R01 AI043596-22]; Henske family; McGrath family	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henske family; McGrath family	Work from the authors' labs is supported by National Institutes of Health grants R35 GM119438 (to C.M.T.), 2R37 AI026649-31, and R01 AI043596-22 (to W.A.P.) and the Henske and McGrath families.	Biagioli M, 2017, J IMMUNOL, V199, P718, DOI 10.4049/jimmunol.1700183; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Burgess SL, 2020, J CLIN INVEST, V130, P4019, DOI 10.1172/JCI133605; Foley MH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007581; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Reed AD, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00039-20; Seekatz AM, 2018, ANAEROBE, V53, P64, DOI 10.1016/j.anaerobe.2018.04.001; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0	8	8	8	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2020	181	7					1452	1454		10.1016/j.cell.2020.05.033	http://dx.doi.org/10.1016/j.cell.2020.05.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MD2SA	32589955	Green Accepted, Bronze			2022-12-28	WOS:000543822100004
J	Rimmer, A				Rimmer, Abi			Covid-19: BMA demands full death in service benefits for UK doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2020, DEATH SERV YOUR PENS; BMA Scotland, 2020, DEATH SERV UPD	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2020	369								m1634	10.1136/bmj.m1634	http://dx.doi.org/10.1136/bmj.m1634			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK9NU	32605971	Bronze			2022-12-28	WOS:000531187100006
J	Lurie, N; Sharfstein, JM; Goodman, JL				Lurie, Nicole; Sharfstein, Joshua M.; Goodman, Jesse L.			The Development of COVID-19 Vaccines Safeguards Needed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint lists 4 safeguards policy makers should consider before release of a COVID-19 vaccine, including ensuring effectiveness through clinical trials, providing evidence of safety, requiring informed consent before vaccination, and establishing comprehensive adverse effects monitoring systems.	[Lurie, Nicole] Harvard Med Sch, Coalit Epidem Preparedness Innovat CEPI, Boston, MA 02115 USA; [Sharfstein, Joshua M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Goodman, Jesse L.] Georgetown Univ, Sch Med, Washington, DC USA	Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Lurie, N (corresponding author), Coalit Epidem Preparedness Innovat CEPI, 1900 Penn Ave NW, Washington, DC 20006 USA.	nicole.lurie@cepi.net						[Anonymous], 2020, ASS PRESS; Emanuel EJ, 2020, NY TIMES; Goodman JL, 2020, JAMA-J AM MED ASSOC, V323, P1899, DOI 10.1001/jama.2020.6434; Ison MG, 2020, JAMA-J AM MED ASSOC, V323, P2365, DOI 10.1001/jama.2020.8863; Lambert PH, 2020, VACCINE, V38, P4783, DOI 10.1016/j.vaccine.2020.05.064; Neustadt RE, 1978, SWINE FLU AFFAIR DEC, DOI [10.17226/12660, DOI 10.17226/12660]; Salmon DA, 2011, PEDIATRICS, V127, pS78, DOI 10.1542/peds.2010-1722L; Weiland Noah, 2020, NEW YORK TIMES; Zhang S, 2020, ATLANTIC	9	37	38	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					439	440		10.1001/jama.2020.12461	http://dx.doi.org/10.1001/jama.2020.12461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32628262	Bronze			2022-12-28	WOS:000561261900007
J	Bindman, A				Bindman, Andrew			Avoiding a Health Care Financial Meltdown	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Bindman, Andrew] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, 3333 Calif St, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Bindman, A (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, 3333 Calif St, San Francisco, CA 94118 USA.	andrew.bindman@ucsf.edu							0	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					17	18		10.1001/jama.2020.10415	http://dx.doi.org/10.1001/jama.2020.10415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM5FX	32633793	Bronze			2022-12-28	WOS:000568123600004
J	Yancy, CW				Yancy, Clyde W.			Academic Medicine and Black Lives Matter Time for Deep Listening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In the context of the Black Lives Matter movement, this Viewpoint considers the demand that academic medicine address its own structural racism, and concludes on the basis of its history, culture, role, and influence that the institution can, should, and must make racial justice a part of its work and mission.	[Yancy, Clyde W.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, 676 N St Clair,Ste 600, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Yancy, CW (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, 676 N St Clair,Ste 600, Chicago, IL 60611 USA.	cyancy@nm.org						Carnethon MR, 2020, JAMA-J AM MED ASSOC, V323, P211, DOI 10.1001/jama.2019.19329; Cooper LA, 2019, JAMA INTERN MED, V179, P1686, DOI 10.1001/jamainternmed.2019.4100; Polite BN, 2019, JAMA-J AM MED ASSOC, V321, P1663, DOI 10.1001/jama.2019.4266; Thorp HH, 2020, SCIENCE, V368, P1161, DOI 10.1126/science.abd1896; Williams D. R., 2020, JAMA-J AM MED ASSOC, V323, P2478; Williams DR, 2019, ANNU REV PUBL HEALTH, V40, P105, DOI 10.1146/annurev-publhealth-040218-043750	6	33	33	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2020	324	5					435	436		10.1001/jama.2020.12532	http://dx.doi.org/10.1001/jama.2020.12532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NC5NN	32749497				2022-12-28	WOS:000561261900005
J	Butler, SM				Butler, Stuart M.			After COVID-19: Thinking Differently About Running the Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Butler, Stuart M.] Brookings Inst, 1775 Massachusetts Ave NW, Washington, DC 20036 USA	Brookings Institution	Butler, SM (corresponding author), Brookings Inst, 1775 Massachusetts Ave NW, Washington, DC 20036 USA.	smbutler@brookings.edu							0	28	29	3	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2020	323	24					2450	2451		10.1001/jama.2020.8484	http://dx.doi.org/10.1001/jama.2020.8484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OS4QL	32573658	Bronze			2022-12-28	WOS:000590149400002
J	Rimmer, A				Rimmer, Abi			Nearly half of physicians expect to be working under capacity for at least a RCP finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2020	369								m2634	10.1136/bmj.m2634	http://dx.doi.org/10.1136/bmj.m2634			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ5FQ	32605971	Bronze			2022-12-28	WOS:000548116400011
J	Huang, LW; Kebschull, JM; Furth, D; Musall, S; Kaufman, MT; Churchland, AK; Zador, AM				Huang, Longwen; Kebschull, Justus M.; Furth, Daniel; Musall, Simon; Kaufman, Matthew T.; Churchland, Anne K.; Zador, Anthony M.			BRICseq Bridges Brain-wide Interregional Connectivity to Neural Activity and Gene Expression in Single Animals	CELL			English	Article							NEURONAL-ACTIVITY; MOUSE-BRAIN; REVEALS; CONNECTOME; NETWORK; PROJECTIONS; MODULES; ANATOMY; VIRUS	Comprehensive analysis of neuronal networks requires brain-wide measurement of connectivity, activity, and gene expression. Although high-throughput methods are available for mapping brain-wide activity and transcriptomes, comparable methods for mapping region-to-region connectivity remain slow and expensive because they require averaging across hundreds of brains. Here we describe BRICseq (brain-wide individual animal connectome sequencing), which leverages DNA barcoding and sequencing to map connectivity from single individuals in a few weeks and at low cost. Applying BRICseq to the mouse neocortex, we find that region-to-region connectivity provides a simple bridge relating transcriptome to activity: the spatial expression patterns of a few genes predict region-to-region connectivity, and connectivity predicts activity correlations. We also exploited BRICseq to map the mutant BTBR mouse brain, which lacks a corpus callosum, and recapitulated its known connectopathies. BRICseq allows individual laboratories to compare how age, sex, environment, genetics, and species affect neuronal wiring and to integrate these with functional activity and gene expression.	[Huang, Longwen; Kebschull, Justus M.; Furth, Daniel; Musall, Simon; Kaufman, Matthew T.; Churchland, Anne K.; Zador, Anthony M.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Kebschull, Justus M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kaufman, Matthew T.] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA; [Kaufman, Matthew T.] Univ Chicago, Grossman Inst Neurosci Quantitat Biol & Human Beh, Chicago, IL 60637 USA	Cold Spring Harbor Laboratory; Stanford University; University of Chicago; University of Chicago	Zador, AM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu	Musall, Simon/AAE-5335-2019; Kaufman, Matthew/B-6273-2014	Musall, Simon/0000-0002-9461-1042; Kaufman, Matthew/0000-0002-8072-023X	National Institutes of Health [5RO1NS073129, 5RO1DA036913, RF1MH114132, U19MH114821, U01MH109113, EY R01EY022979]; Brain Research Foundation [BRF-SIA-2014-03]; IARPA (MICrONS) [D16PC0008]; Simons Foundation [382793/SIMONS]; Paul Allen Distinguished Investigator Award; Boehringer Ingelheim Fonds; Genentech Foundation; Army Research Office [W911NF-16-1-0368]; Simons Collaboration on the Global Brain	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation; IARPA (MICrONS); Simons Foundation; Paul Allen Distinguished Investigator Award; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Genentech Foundation(Roche HoldingGenentech); Army Research Office; Simons Collaboration on the Global Brain	We would like to thank Pavel Osten, Hongwei Dong, and Liqun Luo for comments on the manuscript. This work was supported by the National Institutes of Health (5RO1NS073129, 5RO1DA036913, RF1MH114132, U19MH114821, and U01MH109113 to A.M.Z. and EY R01EY022979 to A.K.C.); the Brain Research Foundation (BRF-SIA-2014-03 to A.M.Z.); IARPA (MICrONS D16PC0008 to A.M.Z.); the Simons Foundation (382793/SIMONS to A.M.Z.); a Paul Allen Distinguished Investigator Award (to A.M.Z.); Robert Lourie (to A.M.Z.); a PhD fellowship from the Boehringer Ingelheim Fonds (to J.M.K.); a PhD fellowship from the Genentech Foundation (to J.M.K.); the Simons Collaboration on the Global Brain (to A.K.C.); and the Army Research Office under contract W911NF-16-1-0368 (to A.K.C.).	Abdeladim L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09552-9; Banerjee A, 2019, CURR BIOL, V29, pR190, DOI 10.1016/j.cub.2018.11.048; Bedford NL, 2015, ELIFE, V4, DOI 10.7554/eLife.06813; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bota M, 2015, P NATL ACAD SCI USA, V112, pE2093, DOI 10.1073/pnas.1504394112; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calabrese E, 2015, CEREB CORTEX, V25, P4628, DOI 10.1093/cercor/bhv121; Chambers J.M., 2017, STAT MODELS S, P1; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Chen XY, 2019, CELL, V179, P772, DOI 10.1016/j.cell.2019.09.023; Fakhry A, 2015, METHODS, V73, P71, DOI 10.1016/j.ymeth.2014.07.011; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fenlon LR, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0033-y; Fornito A, 2019, TRENDS COGN SCI, V23, P34, DOI 10.1016/j.tics.2018.10.005; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Furth D, 2018, NAT NEUROSCI, V21, P139, DOI 10.1038/s41593-017-0027-7; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Han YY, 2018, NATURE, V556, P51, DOI 10.1038/nature26159; Harris JA, 2019, NATURE, V575, P195, DOI 10.1038/s41586-019-1716-z; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Kebschull JM, 2016, NEURON, V91, P975, DOI 10.1016/j.neuron.2016.07.036; Kebschull JM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00056; Kebschull JM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv717; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.191; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mace E, 2018, NEURON, V100, P1241, DOI 10.1016/j.neuron.2018.11.031; Mace E, 2011, NAT METHODS, V8, P662, DOI [10.1038/nmeth.1641, 10.1038/NMETH.1641]; Makino H, 2017, NEURON, V94, P880, DOI 10.1016/j.neuron.2017.04.015; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Metz HC, 2017, CURR BIOL, V27, P3837, DOI 10.1016/j.cub.2017.10.061; Morris J, 2011, JOVE-J VIS EXP, DOI 10.3791/2634; Musall S, 2019, NAT NEUROSCI, V22, P1677, DOI 10.1038/s41593-019-0502-4; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Okobi DE, 2019, SCIENCE, V363, P983, DOI 10.1126/science.aau9480; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Seung HS, 2014, NEURON, V83, P1262, DOI 10.1016/j.neuron.2014.08.054; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stirman JN, 2016, NAT BIOTECHNOL, V34, P857, DOI 10.1038/nbt.3594; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Sur I., 2016, NAT REV CANC SSC, V4, P100; Swanson LW, 2017, P NATL ACAD SCI USA, V114, pE9692, DOI 10.1073/pnas.1712928114; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Vanni MP, 2017, J NEUROSCI, V37, P7513, DOI 10.1523/JNEUROSCI.3560-16.2017; Vanni MP, 2014, J NEUROSCI, V34, P15931, DOI 10.1523/JNEUROSCI.1818-14.2014; Vickovic S, 2019, NAT METHODS, V16, P987, DOI 10.1038/s41592-019-0548-y; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Yan G, 2017, NATURE, V550, P519, DOI 10.1038/nature24056; Yartsev MM, 2017, SCIENCE, V358, P466, DOI 10.1126/science.aan8865; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023	68	31	31	5	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2020	182	1					177	+		10.1016/j.cell.2020.05.029	http://dx.doi.org/10.1016/j.cell.2020.05.029			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ML0RP	32619423	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000549184500016
